,trial_id,trial_status,pcd,scd,reg_results_status,other_results_1,other_results_2,last_updated,web_address,relevant_comp_date,tabular_results,potential_other_results
0,NCT04246242,,,,,,,,https://clinicaltrials.gov/show/NCT04246242,,0,0
1,NCT04252885,Completed,2020-04-30,2020-05-31,No Results Posted,"['Li Y, Xie Z, Lin W, Cai W, Wen C, Guan Y, Mo X, Wang J, Wang Y, Peng P, Chen X, Hong W, Xiao G, Liu J, Zhang L, Hu F, Li F, Zhang F, Deng X, Li L. Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med (N Y). 2020 Dec 18;1(1):105-113.e4. doi: 10.1016/j.medj.2020.04.001. Epub 2020 May 19.']",,2020-07-01,https://clinicaltrials.gov/show/NCT04252885,2020-04-30,0,1
2,NCT04255940,Unknown,2020-04-30,2020-04-30,No Results Posted,,,2020-02-05,https://clinicaltrials.gov/show/NCT04255940,2020-04-30,0,0
3,NCT04260308,Unknown,2020-04-15,2020-04-20,No Results Posted,,,2020-02-07,https://clinicaltrials.gov/show/NCT04260308,2020-04-15,0,0
4,NCT04260594,Completed,2020-03-12,2020-12-30,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04260594,2020-03-12,0,0
5,NCT04261426,Unknown,2020-04-30,2020-06-30,No Results Posted,,,2020-02-07,https://clinicaltrials.gov/show/NCT04261426,2020-04-30,0,0
6,NCT04261907,Unknown,2020-05-31,2020-06-30,No Results Posted,,,2020-02-10,https://clinicaltrials.gov/show/NCT04261907,2020-05-31,0,0
7,NCT04268537,Unknown,2020-04-30,2020-10-31,No Results Posted,,,2020-02-13,https://clinicaltrials.gov/show/NCT04268537,2020-04-30,0,0
8,NCT04283825,Withdrawn,2020-04-30,2020-05-15,No Results Posted,,,2020-03-17,,2020-04-30,0,0
9,NCT04270383,Unknown,2020-12-31,2020-12-31,No Results Posted,,,2020-02-17,https://clinicaltrials.gov/show/NCT04270383,2020-12-31,0,0
10,NCT04273529,Unknown,2020-05-30,2020-06-30,No Results Posted,,"['Bartlett JB, Dredge K, Dalgleish AG. The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer. 2004 Apr;4(4):314-22. doi: 10.1038/nrc1323. Review.']",2020-02-21,https://clinicaltrials.gov/show/NCT04273529,2020-05-30,0,1
11,NCT04273581,Unknown,2020-04-30,2020-05-30,No Results Posted,,,2020-02-21,https://clinicaltrials.gov/show/NCT04273581,2020-04-30,0,0
12,NCT04275245,Completed,2020-03-09,2020-03-09,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-04-09,https://clinicaltrials.gov/show/NCT04275245,2020-03-09,0,1
13,NCT04275947,Unknown,2020-04-30,2020-05-31,No Results Posted,,,2020-02-19,https://clinicaltrials.gov/show/NCT04275947,2020-04-30,0,0
14,NCT04279197,Completed,2021-03-24,2021-03-24,No Results Posted,,,2022-01-03,https://clinicaltrials.gov/show/NCT04279197,2021-03-24,0,0
15,NCT04279782,Unknown,2021-01-31,2021-02-28,No Results Posted,"['Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. 2020 Sep;92(9):1676-1680. doi: 10.1002/jmv.25936. Epub 2020 Apr 30.']",,2020-02-24,https://clinicaltrials.gov/show/NCT04279782,2021-01-31,0,1
16,NCT04279795,Unknown,2021-01-31,2021-02-28,No Results Posted,,,2020-02-21,https://clinicaltrials.gov/show/NCT04279795,2021-01-31,0,0
17,NCT04279899,Recruiting,2023-11-30,2023-12-31,No Results Posted,"['Xiao T, Xia S, Zeng L, Lin G, Wei Q, Zhou W, Zhuang D, Chen X, Yi B, Li L, Mi H, Yin Z, Cheng X, Wang L, Hu X, Zhou W. A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol. BMJ Open. 2020 Jul 22;10(7):e038004. doi: 10.1136/bmjopen-2020-038004.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04279899,2023-11-30,0,1
18,NCT04280588,Withdrawn,2020-07-01,2020-07-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04280588,2020-07-01,0,0
19,NCT04276987,Completed,2020-05-31,2020-07-31,Results Submitted,,,2020-09-07,https://clinicaltrials.gov/show/NCT04276987,2020-05-31,0,0
20,NCT04281693,Unknown,2020-03-01,2020-03-01,No Results Posted,,,2020-02-24,https://clinicaltrials.gov/show/NCT04281693,2020-03-01,0,0
21,NCT04282902,Unknown,2020-04-30,2020-06-01,No Results Posted,,"['Dewage SNV, Organ L, Koumoundouros E, Derseh HB, Perera KUE, Samuel CS, Stent AW, Snibson KJ. The efficacy of pirfenidone in a sheep model of pulmonary fibrosis. Exp Lung Res. 2019 Nov - Dec;45(9-10):310-322. doi: 10.1080/01902148.2019.1695019. Epub 2019 Nov 25.', 'Lehmann M, Buhl L, Alsafadi HN, Klee S, Hermann S, Mutze K, Ota C, Lindner M, Behr J, Hilgendorff A, Wagner DE, K√∂nigshoff M. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir Res. 2018 Sep 15;19(1):175. doi: 10.1186/s12931-018-0876-y.', 'Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, Ogura T. Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2019 Apr 11;19(1):78. doi: 10.1186/s12890-019-0841-7.', 'Epstein Shochet G, Wollin L, Shitrit D. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Respirology. 2018 Aug;23(8):756-763. doi: 10.1111/resp.13287. Epub 2018 Mar 12.']",2020-02-25,https://clinicaltrials.gov/show/NCT04282902,2020-04-30,0,1
22,NCT04284046,Completed,2020-02-18,2020-02-18,No Results Posted,,,2020-02-25,https://clinicaltrials.gov/show/NCT04284046,2020-02-18,0,0
23,NCT04286503,Unknown,2021-02-28,2021-02-28,No Results Posted,,,2020-02-27,https://clinicaltrials.gov/show/NCT04286503,2021-02-28,0,0
24,NCT04293887,Unknown,2020-05-30,2020-06-30,No Results Posted,,"['Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. Treatment with interferon-Œ±2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct;19(10):1313-7. doi: 10.1038/nm.3362. Epub 2013 Sep 8.', 'Kim UJ, Won EJ, Kee SJ, Jung SI, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-Œ± for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455-9. doi: 10.3851/IMP3002. Epub 2015 Oct 22.', 'Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, Mushtaq A. IFN-Œ±2a or IFN-Œ≤1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015 Jul;70(7):2129-32. doi: 10.1093/jac/dkv085. Epub 2015 Apr 21.', 'Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi JY, Inn KS, Kim JH, Moon JY, Choi MS, Cho NH, Kim YS. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016 May 5;6:25359. doi: 10.1038/srep25359.']",2020-03-03,https://clinicaltrials.gov/show/NCT04293887,2020-05-30,0,1
25,NCT04292327,Unknown,2020-04-30,2020-07-31,No Results Posted,,,2020-03-03,https://clinicaltrials.gov/show/NCT04292327,2020-04-30,0,0
26,NCT04292340,Unknown,2020-07-31,2020-12-31,No Results Posted,,,2020-03-03,https://clinicaltrials.gov/show/NCT04292340,2020-07-31,0,0
27,NCT04293887,Unknown,2020-05-30,2020-06-30,No Results Posted,,"['Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. Treatment with interferon-Œ±2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct;19(10):1313-7. doi: 10.1038/nm.3362. Epub 2013 Sep 8.', 'Kim UJ, Won EJ, Kee SJ, Jung SI, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-Œ± for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455-9. doi: 10.3851/IMP3002. Epub 2015 Oct 22.', 'Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, Mushtaq A. IFN-Œ±2a or IFN-Œ≤1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015 Jul;70(7):2129-32. doi: 10.1093/jac/dkv085. Epub 2015 Apr 21.', 'Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi JY, Inn KS, Kim JH, Moon JY, Choi MS, Cho NH, Kim YS. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016 May 5;6:25359. doi: 10.1038/srep25359.']",2020-03-03,https://clinicaltrials.gov/show/NCT04293887,2020-05-30,0,1
28,NCT04295551,Unknown,2020-07-14,2021-04-14,No Results Posted,,,2020-03-04,https://clinicaltrials.gov/show/NCT04295551,2020-07-14,0,0
29,NCT04296643,Unknown,2021-02-01,2021-04-01,No Results Posted,"['Sch√ºnemann HJ, Akl EA, Chou R, Chu DK, Loeb M, Lotfi T, Mustafa RA, Neumann I, Saxinger L, Sultan S, Mertz D. Use of facemasks during the COVID-19 pandemic. Lancet Respir Med. 2020 Oct;8(10):954-955. doi: 10.1016/S2213-2600(20)30352-0. Epub 2020 Aug 3.']",,2021-02-12,https://clinicaltrials.gov/show/NCT04296643,2021-02-01,0,1
30,NCT04298814,Withdrawn,2020-12-30,2020-12-30,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04298814,2020-12-30,0,0
31,NCT04299711,Unknown,2020-11-15,2022-03-15,No Results Posted,,,2020-03-09,https://clinicaltrials.gov/show/NCT04299711,2020-11-15,0,0
32,NCT04264533,Terminated,2020-03-02,2020-03-29,No Results Posted,"['Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020 Jul 8;10(7):e039519. doi: 10.1136/bmjopen-2020-039519.']",,2020-10-12,https://clinicaltrials.gov/show/NCT04264533,2020-03-02,0,1
33,NCT04285801,Completed,2020-02-25,2020-02-25,No Results Posted,,,2020-03-10,https://clinicaltrials.gov/show/NCT04285801,2020-02-25,0,0
34,NCT04299724,Recruiting,2023-07-31,2024-12-31,No Results Posted,,,2020-03-09,https://clinicaltrials.gov/show/NCT04299724,2023-07-31,0,0
35,NCT04302519,Unknown,2021-06-30,2021-07-30,No Results Posted,,,2020-03-10,https://clinicaltrials.gov/show/NCT04302519,2021-06-30,0,0
36,NCT04302688,Completed,2020-02-10,2020-03-04,No Results Posted,,,2020-03-10,https://clinicaltrials.gov/show/NCT04302688,2020-02-10,0,0
37,NCT04308187,Unknown,2022-03-01,2022-03-01,No Results Posted,,,2020-03-13,https://clinicaltrials.gov/show/NCT04308187,2022-03-01,0,0
38,NCT04313127,Completed,2021-01-20,2021-02-20,No Results Posted,"['Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.']",,2021-08-04,https://clinicaltrials.gov/show/NCT04313127,2021-01-20,0,1
39,NCT04251767,Withdrawn,2020-04-30,2020-04-30,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04251767,2020-04-30,0,0
40,NCT04254874,Unknown,2020-06-01,2020-07-01,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04254874,2020-06-01,0,0
41,NCT04255017,Unknown,2020-06-01,2020-07-01,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04255017,2020-06-01,0,0
42,NCT04261270,Unknown,2020-05-01,2020-07-01,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04261270,2020-05-01,0,0
43,NCT04263402,Unknown,2020-06-01,2020-07-01,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04263402,2020-06-01,0,0
44,NCT04264858,Unknown,2020-04-30,2020-05-31,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04264858,2020-04-30,0,0
45,NCT04272710,Withdrawn,2020-03-31,2020-04-30,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04272710,2020-03-31,0,0
46,NCT04276896,Recruiting,2023-07-31,2024-12-31,No Results Posted,,,2020-03-19,https://clinicaltrials.gov/show/NCT04276896,2023-07-31,0,0
47,NCT04283396,Unknown,2020-05-30,2020-07-30,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04283396,2020-05-30,0,0
48,NCT04287686,Withdrawn,2020-04-01,2020-04-01,No Results Posted,"['Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020 Jul;96(1137):403-407. doi: 10.1136/postgradmedj-2020-137935. Epub 2020 Jun 10. Review.']",,2020-03-17,https://clinicaltrials.gov/show/NCT04287686,2020-04-01,0,1
49,NCT04291053,Unknown,2020-08-01,2020-09-01,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04291053,2020-08-01,0,0
50,NCT04292964,Completed,2020-03-13,2020-03-13,No Results Posted,"['Wen XS, Jiang D, Gao L, Zhou JZ, Xiao J, Cheng XC, He B, Chen Y, Lei P, Tan XW, Qin S, Zhang DY. Clinical characteristics and predictive value of lower CD4(+)T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study. BMC Infect Dis. 2021 Jan 12;21(1):57. doi: 10.1186/s12879-020-05741-w.', 'Gao L, Jiang D, Wen XS, Cheng XC, Sun M, He B, You LN, Lei P, Tan XW, Qin S, Cai GQ, Zhang DY. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020 Apr 15;21(1):83. doi: 10.1186/s12931-020-01352-w.']",,2020-03-17,https://clinicaltrials.gov/show/NCT04292964,2020-03-13,0,1
51,NCT04293692,Withdrawn,2020-02-25,2020-02-25,No Results Posted,,,2020-03-18,https://clinicaltrials.gov/show/NCT04293692,2020-02-25,0,0
52,NCT04304313,Unknown,2020-03-01,2020-11-09,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,2020-03-17,https://clinicaltrials.gov/show/NCT04304313,2020-03-01,0,1
53,NCT04305574,Completed,2020-04-21,2020-04-21,No Results Posted,"['Liu JCJ, Tong EMW. The Relation Between Official WhatsApp-Distributed COVID-19 News Exposure and Psychological Symptoms: Cross-Sectional Survey Study. J Med Internet Res. 2020 Sep 25;22(9):e22142. doi: 10.2196/22142.']",,2020-07-07,https://clinicaltrials.gov/show/NCT04305574,2020-04-21,0,1
54,NCT04306705,Unknown,2020-05-30,2020-06-20,No Results Posted,,,2020-03-17,https://clinicaltrials.gov/show/NCT04306705,2020-05-30,0,0
55,NCT04308317,Unknown,2021-03-01,2021-05-01,No Results Posted,,,2020-03-16,https://clinicaltrials.gov/show/NCT04308317,2021-03-01,0,0
56,NCT04312100,Unknown,2020-10-01,2021-02-01,No Results Posted,,,2020-03-18,https://clinicaltrials.gov/show/NCT04312100,2020-10-01,0,0
57,NCT04312464,Unknown,2020-03-15,2020-03-18,No Results Posted,,,2020-03-18,https://clinicaltrials.gov/show/NCT04312464,2020-03-15,0,0
58,NCT04313322,Unknown,2020-06-30,2020-09-30,No Results Posted,,,2020-03-18,https://clinicaltrials.gov/show/NCT04313322,2020-06-30,0,0
59,NCT04314271,Unknown,2020-05-01,2020-05-31,No Results Posted,,,2020-03-19,https://clinicaltrials.gov/show/NCT04314271,2020-05-01,0,0
60,NCT04314817,Recruiting,2023-01-01,2023-01-01,No Results Posted,"['Jung SY, Kim MS, Li H, Lee KH, Koyanagi A, Solmi M, Kronbichler A, Dragioti E, Tizaoui K, Cargnin S, Terrazzino S, Hong SH, Abou Ghayda R, Kim NK, Chung SK, Jacob L, Salem JE, Yon DK, Lee SW, Kostev K, Kim AY, Jung JW, Choi JY, Shin JS, Park SJ, Choi SW, Ban K, Moon SH, Go YY, Shin JI, Smith L. Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database. Clin Transl Sci. 2022 Feb;15(2):501-513. doi: 10.1111/cts.13168. Epub 2021 Oct 31.']",,2021-04-14,https://clinicaltrials.gov/show/NCT04314817,2023-01-01,0,1
61,NCT04315870,Unknown,2020-04-20,2020-04-30,No Results Posted,,,2020-03-20,https://clinicaltrials.gov/show/NCT04315870,2020-04-20,0,0
62,NCT04316728,Unknown,2020-09-01,2020-11-01,No Results Posted,,,2020-03-20,https://clinicaltrials.gov/show/NCT04316728,2020-09-01,0,0
63,NCT04316884,Recruiting,2021-12-31,2021-12-31,No Results Posted,,"['Hultstr√∂m M, von Seth M, Frithiof R. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care. J Hypertens. 2020 Aug;38(8):1613-1614. doi: 10.1097/HJH.0000000000002531.', 'Hultstr√∂m M, Persson B, Eriksson O, Lipcsey M, Frithiof R, Nilsson B. Blood type A associates with critical COVID-19 and death in a Swedish cohort. Crit Care. 2020 Aug 12;24(1):496. doi: 10.1186/s13054-020-03223-8.', 'Eriksson O, Hultstr√∂m M, Persson B, Lipcsey M, Ekdahl KN, Nilsson B, Frithiof R. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients. Thromb Haemost. 2020 Dec;120(12):1720-1724. doi: 10.1055/s-0040-1715835. Epub 2020 Sep 1.', 'Stattin K, Lipcsey M, Andersson H, Pont√©n E, B√ºlow Anderberg S, Gradin A, Larsson A, Lubenow N, von Seth M, Rubertsson S, Hultstr√∂m M, Frithiof R. Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients. J Crit Care. 2020 Dec;60:249-252. doi: 10.1016/j.jcrc.2020.08.026. Epub 2020 Sep 3.', 'Frithiof R, Bergqvist A, J√§rhult JD, Lipcsey M, Hultstr√∂m M. Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients. Crit Care. 2020 Sep 29;24(1):587. doi: 10.1186/s13054-020-03302-w.', 'Asif S, Frithiof R, Lipcsey M, Kristensen B, Alving K, Hultstr√∂m M. Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care. Crit Care. 2020 Nov 6;24(1):639. doi: 10.1186/s13054-020-03362-y.', 'Luther T, B√ºlow-Anderberg S, Larsson A, Rubertsson S, Lipcsey M, Frithiof R, Hultstr√∂m M. COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury. Acta Anaesthesiol Scand. 2021 Mar;65(3):364-372. doi: 10.1111/aas.13746. Epub 2020 Nov 28.', 'B√ºlow Anderberg S, Luther T, Berglund M, Larsson R, Rubertsson S, Lipcsey M, Larsson A, Frithiof R, Hultstr√∂m M. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients. Cytokine. 2021 Feb;138:155389. doi: 10.1016/j.cyto.2020.155389. Epub 2020 Dec 14.', 'Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, Laurent L, Pietzner M, Kerrison N, Zhao K, Brunet-Ratnasingham E, Henry D, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Chen Y, Chass√© M, Durand M, Paterson C, Normark J, Frithiof R, Lipcsey M, Hultstr√∂m M, Greenwood CMT, Zeberg H, Langenberg C, Thysell E, Pollak M, Mooser V, Forgetta V, Kaufmann DE, Richards JB. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021 Apr;27(4):659-667. doi: 10.1038/s41591-021-01281-1. Epub 2021 Feb 25.', 'Lipcsey M, Persson B, Eriksson O, Blom AM, Fromell K, Hultstr√∂m M, Huber-Lang M, Ekdahl KN, Frithiof R, Nilsson B. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Front Immunol. 2021 Feb 22;12:627579. doi: 10.3389/fimmu.2021.627579. eCollection 2021.', 'J√§rhult JD, Hultstr√∂m M, Bergqvist A, Frithiof R, Lipcsey M. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients. Sci Rep. 2021 Mar 30;11(1):7163. doi: 10.1038/s41598-021-86500-y.', 'Frithiof R, Rostami E, Kumlien E, Virhammar J, F√§llmar D, Hultstr√∂m M, Lipcsey M, Ashton N, Blennow K, Zetterberg H, Punga AR. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin Neurophysiol. 2021 Jul;132(7):1733-1740. doi: 10.1016/j.clinph.2021.03.016. Epub 2021 Apr 1.', 'Galien S, Hultstr√∂m M, Lipcsey M, Stattin K, Frithiof R, Ros√©n J; Uppsala Intensive Care COVID-19 Research Group. Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study. Thromb J. 2021 Jun 2;19(1):38. doi: 10.1186/s12959-021-00272-z.', 'Gradin A, Andersson H, Luther T, Anderberg SB, Rubertsson S, Lipcsey M, √Öberg M, Larsson A, Frithiof R, Hultstr√∂m M. Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. Cytokine. 2021 Oct;146:155589. doi: 10.1016/j.cyto.2021.155589. Epub 2021 May 24.', 'Huckriede J, Anderberg SB, Morales A, de Vries F, Hultstr√∂m M, Bergqvist A, Ortiz-P√©rez JT, Sels JW, Wichapong K, Lipcsey M, van de Poll M, Larsson A, Luther T, Reutelingsperger C, de Frutos PG, Frithiof R, Nicolaes GAF. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Sci Rep. 2021 Aug 3;11(1):15701. doi: 10.1038/s41598-021-95209-x.', 'Pellegrini M, Larina A, Mourtos E, Frithiof R, Lipcsey M, Hultstr√∂m M, Segelsj√∂ M, Hansen T, Perchiazzi G. A quantitative analysis of extension and distribution of lung injury in COVID-19: a prospective study based on chest computed tomography. Crit Care. 2021 Aug 4;25(1):276. doi: 10.1186/s13054-021-03685-4.', 'Karawajczyk M, Douhan H√•kansson L, Lipcsey M, Hultstr√∂m M, Pauksens K, Frithiof R, Larsson A. High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19. Ther Adv Infect Dis. 2021 Jul 31;8:20499361211034065. doi: 10.1177/20499361211034065. eCollection 2021 Jan-Dec.', 'Huckriede J, de Vries F, Hultstr√∂m M, Wichapong K, Reutelingsperger C, Lipcsey M, Garcia de Frutos P, Frithiof R, Nicolaes GAF. Histone H3 Cleavage in Severe COVID-19 ICU Patients. Front Cell Infect Microbiol. 2021 Sep 10;11:694186. doi: 10.3389/fcimb.2021.694186. eCollection 2021.', 'B√ºlow Anderberg S, Lipcsey M, Hultstr√∂m M, Eriksson AK, Venge P, Frithiof R, On Behalf Of The Uppsala Intensive Care Covid-Research Group. Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia. J Clin Med. 2021 Sep 14;10(18). pii: 4144. doi: 10.3390/jcm10184144.', 'Sancho Ferrando E, Hanslin K, Hultstr√∂m M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine. 2022 Jan;149:155727. doi: 10.1016/j.cyto.2021.155727. Epub 2021 Oct 5.', 'Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, Bujanda L, Bouysran Y, Niemi ME, Palom A, Ellinghaus D, Khan A, Mart√≠nez-Bueno M, Rolker S, Amitrano S, Roade Tato L, Fava F; FinnGen; COVID-19 Host Genetics Initiative (HGI), Spinner CD, Prati D, Bernardo D, Garcia F, Darcis G, Fern√°ndez-Cadenas I, Holter JC, Banales JM, Frithiof R, Kiryluk K, Duga S, Asselta R, Pereira AC, Romero-G√≥mez M, Nafr√≠a-Jim√©nez B, Hov JR, Migeotte I, Renieri A, Planas AM, Ludwig KU, Buti M, Rahmouni S, Alarc√≥n-Riquelme ME, Schulte EC, Franke A, Karlsen TH, Valenti L, Zeberg H, Richards JB, Ganna A. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021 Dec 1;131(23). pii: e152386. doi: 10.1172/JCI152386.', 'COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021 Dec;600(7889):472-477. doi: 10.1038/s41586-021-03767-x. Epub 2021 Jul 8.']",2021-10-25,https://clinicaltrials.gov/show/NCT04316884,2021-12-31,0,1
64,NCT04318418,Completed,2020-05-10,2020-06-30,No Results Posted,['COVID-19 RISk and Treatments (CORIST) Collaboration. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020 Dec;135:106805. doi: 10.1016/j.vph.2020.106805. Epub 2020 Sep 28.'],,2020-09-16,https://clinicaltrials.gov/show/NCT04318418,2020-05-10,0,1
65,NCT04336254,Recruiting,2021-11-30,2021-12-31,No Results Posted,"['Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.']",,2021-03-10,https://clinicaltrials.gov/show/NCT04336254,2021-11-30,0,1
66,NCT04288713,,,,,,,2020-03-30,https://clinicaltrials.gov/show/NCT04288713,,0,0
67,NCT04290871,Withdrawn,2021-03-01,2022-03-01,No Results Posted,,,2020-03-24,https://clinicaltrials.gov/show/NCT04290871,2021-03-01,0,0
68,NCT04305106,Unknown,2020-06-30,2020-07-31,No Results Posted,,,2020-03-26,https://clinicaltrials.gov/show/NCT04305106,2020-06-30,0,0
69,NCT04316299,Completed,2020-02-28,2020-03-08,No Results Posted,,,2020-03-30,https://clinicaltrials.gov/show/NCT04316299,2020-02-28,0,0
70,NCT04319211,Unknown,2020-05-15,2020-07-20,No Results Posted,,,2020-03-24,https://clinicaltrials.gov/show/NCT04319211,2020-05-15,0,0
71,NCT04319900,Unknown,2020-04-30,2020-06-25,No Results Posted,,,2020-03-24,https://clinicaltrials.gov/show/NCT04319900,2020-04-30,0,0
72,NCT04322344,Recruiting,2020-06-30,2020-12-30,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04322344,2020-06-30,0,0
73,NCT04322786,Unknown,2016-05-31,2021-03-31,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04322786,2016-05-31,0,0
74,NCT04323332,Unknown,2020-03-01,2020-04-01,No Results Posted,,,2020-03-26,https://clinicaltrials.gov/show/NCT04323332,2020-03-01,0,0
75,NCT04323514,Unknown,2021-03-13,2021-03-13,No Results Posted,,,2020-03-26,https://clinicaltrials.gov/show/NCT04323514,2021-03-13,0,0
76,NCT04323631,Withdrawn,2020-04-30,2020-04-30,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04323631,2020-04-30,0,0
77,NCT04324866,Unknown,2020-11-01,2020-12-01,No Results Posted,,,2020-03-27,https://clinicaltrials.gov/show/NCT04324866,2020-11-01,0,0
78,NCT04324996,Recruiting,2022-02-20,2022-08-31,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04324996,2022-02-20,0,0
79,NCT04325412,Recruiting,2021-03-23,2021-06-23,No Results Posted,"['Henkens MTHM, Raafs AG, Verdonschot JAJ, Linschoten M, van Smeden M, Wang P, van der Hooft BHM, Tieleman R, Janssen MLF, Ter Bekke RMA, Hazebroek MR, van der Horst ICC, Asselbergs FW, Magdelijns FJH, Heymans SRB; CAPACITY-COVID collaborative consortium. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022 Mar 5;22(1):184. doi: 10.1186/s12877-021-02673-1.']",,2020-11-10,https://clinicaltrials.gov/show/NCT04325412,2021-03-23,0,1
80,NCT04325919,Recruiting,2023-02-28,2023-06-17,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04325919,2023-02-28,0,0
81,NCT04326309,"Active, not recruiting",2022-09-25,2022-09-25,No Results Posted,,,2021-08-25,https://clinicaltrials.gov/show/NCT04326309,2022-09-25,0,0
82,NCT04331860,,,,,,,,https://clinicaltrials.gov/show/NCT04331860,,0,0
83,NCT04316377,"Active, not recruiting",2020-05-25,2025-03-03,No Results Posted,"['Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics. Nat Commun. 2020 Oct 20;11(1):5284. doi: 10.1038/s41467-020-19056-6.', 'Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.']",,2020-06-05,https://clinicaltrials.gov/show/NCT04316377,2020-05-25,0,1
84,NCT03331445,Terminated,2021-06-30,2021-06-30,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT03331445,2021-06-30,0,0
85,NCT04275414,Completed,2020-04-05,2020-05-02,No Results Posted,"['Pang J, Xu F, Aondio G, Li Y, Fumagalli A, Lu M, Valmadre G, Wei J, Bian Y, Canesi M, Damiani G, Zhang Y, Yu D, Chen J, Ji X, Sui W, Wang B, Wu S, Kovacs A, Revera M, Wang H, Jing X, Zhang Y, Chen Y, Cao Y. Efficacy and tolerability of bevacizumab in patients with severe Covid-19. Nat Commun. 2021 Feb 5;12(1):814. doi: 10.1038/s41467-021-21085-8.']",,2020-09-14,https://clinicaltrials.gov/show/NCT04275414,2020-04-05,0,1
86,NCT04298060,Not yet recruiting,2021-03-01,2022-09-01,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04298060,2021-03-01,0,0
87,NCT04320238,Unknown,2020-05-01,2020-06-01,No Results Posted,,,2020-03-31,https://clinicaltrials.gov/show/NCT04320238,2020-05-01,0,0
88,NCT04321811,"Active, not recruiting",2021-02-09,2022-03-20,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04321811,2021-02-09,0,0
89,NCT04323878,"Active, not recruiting",2021-05-31,2022-01-01,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04323878,2021-05-31,0,0
90,NCT04324047,Unknown,2021-03-27,2021-12-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2020-04-01,https://clinicaltrials.gov/show/NCT04324047,2021-03-27,0,1
91,NCT04324528,Completed,2021-01-27,2021-01-27,No Results Posted,"['Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, M√ºller S, Kuhl M, Benk C, Maier S, Trummer G, Fl√ºgler A, Kr√ºger K, Sekandarzad A, Stachon P, Zotzmann V, Bode C, Biever PM, Staudacher D, Wengenmayer T, Graf E, Duerschmied D. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021 Jul;9(7):755-762. doi: 10.1016/S2213-2600(21)00177-6. Epub 2021 May 14. Erratum in: Lancet Respir Med. 2021 Jun 4;:.']",,2021-03-15,https://clinicaltrials.gov/show/NCT04324528,2021-01-27,0,1
92,NCT04325867,Unknown,2020-10-01,2020-10-01,No Results Posted,,,2020-04-01,https://clinicaltrials.gov/show/NCT04325867,2020-10-01,0,0
93,NCT04326036,Enrolling by invitation,2023-01-01,2023-01-31,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04326036,2023-01-01,0,0
94,NCT04326075,Recruiting,2021-06-30,2022-01-31,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04326075,2021-06-30,0,0
95,NCT04326452,Unknown,2021-03-27,2021-03-27,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04326452,2021-03-27,0,0
96,NCT04327180,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2020-04-06,https://clinicaltrials.gov/show/NCT04327180,2021-09-01,0,0
97,NCT04327349,Unknown,2020-05-20,2020-09-30,No Results Posted,,,2020-03-31,https://clinicaltrials.gov/show/NCT04327349,2020-05-20,0,0
98,NCT04327674,Unknown,2020-05-15,2020-05-15,Results Submitted,,,2020-03-31,https://clinicaltrials.gov/show/NCT04327674,2020-05-15,0,0
99,NCT04328272,Unknown,2020-05-28,2020-06-28,No Results Posted,,,2020-04-02,https://clinicaltrials.gov/show/NCT04328272,2020-05-28,0,0
100,NCT04328454,Unknown,2020-04-02,2020-04-15,No Results Posted,,,2020-03-31,https://clinicaltrials.gov/show/NCT04328454,2020-04-02,0,0
101,NCT04329507,Completed,2021-01-31,2021-05-30,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04329507,2021-01-31,0,0
102,NCT04329559,Completed,2021-02-10,2021-02-10,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04329559,2021-02-10,0,0
103,NCT04330144,Withdrawn,2020-06-29,2020-06-29,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04330144,2020-06-29,0,0
104,NCT04330261,"Active, not recruiting",2021-06-15,2021-10-01,No Results Posted,"['Funk AL, Florin TA, Dalziel SR, Mintegi S, Salvadori MI, Tancredi DJ, Neuman MI, Payne DC, Plint AC, Klassen TP, Malley R, Ambroggio L, Kim K, Kuppermann N, Freedman SB. Prospective cohort study of children with suspected SARS-CoV-2 infection presenting to paediatric emergency departments: a Paediatric Emergency Research Networks (PERN) Study Protocol. BMJ Open. 2021 Jan 15;11(1):e042121. doi: 10.1136/bmjopen-2020-042121.']",,2021-09-30,https://clinicaltrials.gov/show/NCT04330261,2021-06-15,0,1
105,NCT04330521,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04330521,2022-05-01,0,0
106,NCT04330586,Completed,2021-03-31,2021-03-31,No Results Posted,"['Song JY, Yoon JG, Seo YB, Lee J, Eom JS, Lee JS, Choi WS, Lee EY, Choi YA, Hyun HJ, Seong H, Noh JY, Cheong HJ, Kim WJ. Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial. J Clin Med. 2021 Aug 12;10(16). pii: 3545. doi: 10.3390/jcm10163545.', 'Farne H, Singanayagam A. Reply. J Allergy Clin Immunol. 2021 Mar;147(3):1117-1118. doi: 10.1016/j.jaci.2020.11.019. Epub 2020 Dec 30.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2021-06-24,https://clinicaltrials.gov/show/NCT04330586,2021-03-31,0,1
107,NCT04331574,Recruiting,2020-04-10,2020-04-30,No Results Posted,"['Iaccarino G, Grassi G, Borghi C, Grassi D, Mancusi C, Muiesan ML, Salvetti M, Volpe M, Ferri C. Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients. Front Cardiovasc Med. 2021 May 13;8:633878. doi: 10.3389/fcvm.2021.633878. eCollection 2021.', 'Iaccarino G, Grassi G, Borghi C, Carugo S, Fallo F, Ferri C, Giannattasio C, Grassi D, Letizia C, Mancusi C, Minuz P, Perlini S, Pucci G, Rizzoni D, Salvetti M, Sarzani R, Sechi L, Veglio F, Volpe M, Muiesan ML; SARS-RAS Investigators. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2020 Oct 6;15(10):e0237297. doi: 10.1371/journal.pone.0237297. eCollection 2020. Erratum in: PLoS One. 2021 Sep 2;16(9):e0257181.', 'Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M; SARS-RAS Investigators. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.']",,2020-04-02,https://clinicaltrials.gov/show/NCT04331574,2020-04-10,0,1
108,NCT04331613,Unknown,2020-12-01,2020-12-01,No Results Posted,,,2020-04-02,https://clinicaltrials.gov/show/NCT04331613,2020-12-01,0,0
109,NCT04332016,Recruiting,2023-03-01,2023-03-01,No Results Posted,,,2020-04-03,https://clinicaltrials.gov/show/NCT04332016,2023-03-01,0,0
110,NCT04332666,Not yet recruiting,2022-12-30,2023-06-15,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04332666,2022-12-30,0,0
111,NCT04333251,Not yet recruiting,2022-12-31,2022-12-31,No Results Posted,,,2020-04-06,https://clinicaltrials.gov/show/NCT04333251,2022-12-31,0,0
112,NCT04333472,"Active, not recruiting",2022-03-06,2022-07-06,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04333472,2022-03-06,0,0
113,NCT04333693,Unknown,2020-10-01,2020-11-01,No Results Posted,"['San Norberto EM, De Haro J, Pe√±a R, Riera L, Fern√°ndez-Caballero D, Sesma A, Rodr√≠guez-Cabeza P, Ballesteros M, G√≥mez-Jabalera E, Taneva GT, Aparicio C, Moradillo N, Soguero I, Badrenas AM, Lara R, Torres A, Sala VA, Vaquero C; COVID-VAS Investigators from the Vascular Investigation Network (RIV) of the Spanish Society of Angiology and Vascular Surgery (SEACV). Outcomes After Vascular Surgery Procedures in Patients with COVID-19 Infection: A National Multicenter Cohort Study (COVID-VAS). Ann Vasc Surg. 2021 May;73:86-96. doi: 10.1016/j.avsg.2021.01.054. Epub 2021 Jan 22.']",,2020-04-03,https://clinicaltrials.gov/show/NCT04333693,2020-10-01,0,1
114,NCT04333862,"Active, not recruiting",2022-01-31,2022-01-31,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04333862,2022-01-31,0,0
115,NCT04335019,Completed,2020-05-26,2020-05-26,No Results Posted,,,2021-12-01,https://clinicaltrials.gov/show/NCT04335019,2020-05-26,0,0
116,NCT04335201,"Active, not recruiting",2021-04-07,2022-03-01,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04335201,2021-04-07,0,0
117,NCT04341389,"Active, not recruiting",2021-01-31,2021-01-31,No Results Posted,"['Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04341389,2021-01-31,0,1
118,NCT03680274,"Active, not recruiting",2022-06-30,2022-12-31,No Results Posted,"['Lachance O, Goyer F, Adhikari NKJ, Masse MH, Bilodeau JF, Lamontagne F, Leclair MA. High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report. J Med Case Rep. 2021 May 21;15(1):297. doi: 10.1186/s13256-021-02869-4.', ""Masse MH, M√©nard J, Sprague S, Battista MC, Cook DJ, Guyatt GH, Heyland DK, Kanji S, Pinto R, Day AG, Cohen D, Annane D, McGuinness S, Parke R, Carr A, Arabi Y, Vijayaraghavan BKT, D'Aragon F, Carbonneau √â, Maslove D, Hunt M, Rochwerg B, Millen T, Chass√© M, Lebrasseur M, Archambault P, Deblois E, Drouin C, Lellouche F, Lizotte P, Watpool I, Porteous R, Clarke F, Marinoff N, Belley-C√¥t√© √â, Bolduc B, Walker S, Iazzetta J, Adhikari NKJ, Lamontagne F; Canadian Critical Care Trials Group. Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial. Trials. 2020 Jan 8;21(1):42. doi: 10.1186/s13063-019-3834-1.""]",,2022-02-04,https://clinicaltrials.gov/show/NCT03680274,2022-06-30,0,1
119,NCT04245631,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-04-10,https://clinicaltrials.gov/show/NCT04245631,2020-12-31,0,0
120,NCT04252274,Recruiting,2020-08-31,2020-12-31,No Results Posted,"['Chen J, Xia L, Liu L, Xu Q, Ling Y, Huang D, Huang W, Song S, Xu S, Shen Y, Lu H. Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19. Open Forum Infect Dis. 2020 Jun 21;7(7):ofaa241. doi: 10.1093/ofid/ofaa241. eCollection 2020 Jul.']",,2020-04-13,https://clinicaltrials.gov/show/NCT04252274,2020-08-31,0,1
121,NCT04261517,Completed,2020-02-25,2020-02-25,No Results Posted,"['Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03. Chinese.']",,2020-04-13,https://clinicaltrials.gov/show/NCT04261517,2020-02-25,0,1
122,NCT04274322,"Active, not recruiting",2020-04-04,2020-07-01,No Results Posted,,,2020-04-08,https://clinicaltrials.gov/show/NCT04274322,2020-04-04,0,0
123,NCT04290780,Completed,2020-06-30,2020-06-30,No Results Posted,"['Vanhems P. A breath of humanity in the era of Covid-19 vaccine. Vaccine. 2021 Jun 23;39(28):3649. doi: 10.1016/j.vaccine.2021.05.052. Epub 2021 May 24.', 'Saadatian-Elahi M, Picot V, H√©naff L, Pradel FK, Escuret V, Dananch√© C, Elias C, Endtz HP, Vanhems P. Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project. BMJ Open. 2020 Oct 22;10(10):e039088. doi: 10.1136/bmjopen-2020-039088.']",,2022-02-18,https://clinicaltrials.gov/show/NCT04290780,2020-06-30,0,1
124,NCT04291729,Completed,2020-03-19,2020-03-19,No Results Posted,,,2020-04-13,https://clinicaltrials.gov/show/NCT04291729,2020-03-19,0,0
125,NCT04302766,,,,,,,2022-02-17,https://clinicaltrials.gov/show/NCT04302766,,0,0
126,NCT04306055,Completed,2020-03-13,2020-04-03,No Results Posted,,,2020-04-13,https://clinicaltrials.gov/show/NCT04306055,2020-03-13,0,0
127,NCT04310228,Recruiting,2020-05-01,2020-05-01,No Results Posted,,,2020-04-10,https://clinicaltrials.gov/show/NCT04310228,2020-05-01,0,0
128,NCT04315480,"Active, not recruiting",2020-04-09,2020-05-01,No Results Posted,"['Sabbatinelli J, Giuliani A, Matacchione G, Latini S, Laprovitera N, Pomponio G, Ferrarini A, Svegliati Baroni S, Pavani M, Moretti M, Gabrielli A, Procopio AD, Ferracin M, Bonaf√® M, Olivieri F. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech Ageing Dev. 2021 Jan;193:111413. doi: 10.1016/j.mad.2020.111413. Epub 2020 Dec 8.']",,2020-04-13,https://clinicaltrials.gov/show/NCT04315480,2020-04-09,0,1
129,NCT04317092,"Active, not recruiting",2021-12-19,2022-12-19,No Results Posted,"['Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. Erratum in: J Transl Med. 2021 Oct 21;19(1):442.', 'Chiodini P, Arenare L, Piccirillo MC, Perrone F, Gallo C. A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan. Contemp Clin Trials Commun. 2020 Dec;20:100665. doi: 10.1016/j.conctc.2020.100665. Epub 2020 Oct 7.', 'Piccirillo MC, Ascierto P, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo N, Fraganza F, Marata A, Massari M, Montesarchio V, Mussini C, Negri EA, Parrella R, Popoli P, Botti G, Arenare L, Chiodini P, Gallo C, Salvarani C, Perrone F. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 Nov;98:106165. doi: 10.1016/j.cct.2020.106165. Epub 2020 Oct 6.']",,2021-03-03,https://clinicaltrials.gov/show/NCT04317092,2021-12-19,0,1
130,NCT04319315,Recruiting,2020-04-01,2020-04-16,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04319315,2020-04-01,0,0
131,NCT04321265,Completed,2021-06-15,2021-09-15,No Results Posted,"['Bruno RR, Wernly B, Flaatten H, Fj√∏lner J, Artigas A, Baldia PH, Binneboessel S, Bollen Pinto B, Schefold JC, Wolff G, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Elhadi M, Joannidis M, Oeyen S, Kondili E, Marsh B, Wollborn J, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Jung C; COVIP study group. The association of the Activities of Daily Living and the outcome of old intensive care patients suffering from COVID-19. Ann Intensive Care. 2022 Mar 18;12(1):26. doi: 10.1186/s13613-022-00996-9.', 'Bruno RR, Wernly B, Wolff G, Fj√∏lner J, Artigas A, Bollen Pinto B, Schefold JC, Kindgen-Milles D, Baldia PH, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Topeli A, Elhadi M, Joannidis M, Oeyen S, Kondili E, Marsh B, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Flaatten H, Jung C; COVIP study group. Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19. ESC Heart Fail. 2022 Mar 10. doi: 10.1002/ehf2.13854. [Epub ahead of print]', 'Guidet B, Jung C, Flaatten H, Fj√∏lner J, Artigas A, Pinto BB, Schefold JC, Beil M, Sigal S, van Heerden PV, Szczeklik W, Joannidis M, Oeyen S, Kondili E, Marsh B, Andersen FH, Moreno R, Cecconi M, Leaver S, De Lange DW, Boumendil A; VIP2 and COVIP study groups. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med. 2022 Apr;48(4):435-447. doi: 10.1007/s00134-022-06642-z. Epub 2022 Feb 26.', 'Polok K, Fronczek J, van Heerden PV, Flaatten H, Guidet B, De Lange DW, Fj√∏lner J, Leaver S, Beil M, Sviri S, Bruno RR, Wernly B, Artigas A, Pinto BB, Schefold JC, Studzi≈Ñska D, Joannidis M, Oeyen S, Marsh B, Andersen FH, Moreno R, Cecconi M, Jung C, Szczeklik W; COVIP study group. Association between tracheostomy timing and outcomes for older critically ill COVID-19 patients: prospective observational study in European intensive care units. Br J Anaesth. 2022 Mar;128(3):482-490. doi: 10.1016/j.bja.2021.11.027. Epub 2021 Nov 29.', 'Jung C, Flaatten H, de Lange D, Beil M, Guidet B. The relationship between treatment limitations and pressure on intensive care units in elderly patients. Intensive Care Med. 2022 Jan;48(1):124-125. doi: 10.1007/s00134-021-06553-5. Epub 2021 Nov 5.', 'Jung C, Fj√∏lner J, Bruno RR, Wernly B, Artigas A, Bollen Pinto B, Schefold JC, Wolff G, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Czuczwar M, Joannidis M, Oeyen S, Zafeiridis T, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Flaatten H; , COVIP Study Group. Differences in mortality in critically ill elderly patients during the second COVID-19 surge in Europe. Crit Care. 2021 Sep 23;25(1):344. doi: 10.1186/s13054-021-03739-7.', 'Bruno RR, Wernly B, Flaatten H, Fj√∏lner J, Artigas A, Bollen Pinto B, Schefold JC, Binneb√∂ssel S, Baldia PH, Kelm M, Beil M, Sigal S, van Heerden PV, Szczeklik W, Elhadi M, Joannidis M, Oeyen S, Zafeiridis T, Wollborn J, Arche Banzo MJ, Fuest K, Marsh B, Andersen FH, Moreno R, Leaver S, Boumendil A, De Lange DW, Guidet B, Jung C; COVIP Study Group. Lactate is associated with mortality in very old intensive care patients suffering from COVID-19: results from an international observational study of 2860 patients. Ann Intensive Care. 2021 Aug 21;11(1):128. doi: 10.1186/s13613-021-00911-8.', 'Jung C, Flaatten H, Fj√∏lner J, Bruno RR, Wernly B, Artigas A, Bollen Pinto B, Schefold JC, Wolff G, Kelm M, Beil M, Sviri S, van Heerden PV, Szczeklik W, Czuczwar M, Elhadi M, Joannidis M, Oeyen S, Zafeiridis T, Marsh B, Andersen FH, Moreno R, Cecconi M, Leaver S, Boumendil A, De Lange DW, Guidet B; COVIP study group. The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study. Crit Care. 2021 Apr 19;25(1):149. doi: 10.1186/s13054-021-03551-3.', 'Jung C, Bruno RR, Wernly B, Joannidis M, Oeyen S, Zafeiridis T, Marsh B, Andersen FH, Moreno R, Fernandes AM, Artigas A, Pinto BB, Schefold J, Wolff G, Kelm M, De Lange DW, Guidet B, Flaatten H, Fj√∏lner J; COVIP study group. Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients. Eur Heart J Cardiovasc Pharmacother. 2021 Jan 16;7(1):76-77. doi: 10.1093/ehjcvp/pvaa083.']",,2021-09-27,https://clinicaltrials.gov/show/NCT04321265,2021-06-15,0,1
132,NCT04321369,Completed,2020-03-23,2020-03-23,Results Submitted,,"['Coronavirus Disease 2019 (COVID-19) in the US. Centers for Disease Control and Prevention, accessed March 13, 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html', 'Personal communication per Dr. Scott Lindquist, MD State of Washington Epidemiologist (March 2020', 'Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020 Mar 21;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9.', 'Frazee BW, Rodr√≠guez-Hoces de la Guardia A, Alter H, Chen CG, Fuentes EL, Holzer AK, Lolas M, Mitra D, Vohra J, Dekker CL. Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients. Ann Emerg Med. 2018 Apr;71(4):509-517.e1. doi: 10.1016/j.annemergmed.2017.09.010. Epub 2017 Nov 24.']",2020-04-13,https://clinicaltrials.gov/show/NCT04321369,2020-03-23,0,1
133,NCT04322773,Terminated,2020-10-08,2020-10-08,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04322773,2020-10-08,0,0
134,NCT04324021,Terminated,2020-11-13,2020-11-13,Study Results,"['Brands X, de Vries FMC, Uhel F, Haak BW, Peters-Sengers H, Schuurman AR, van Engelen TSR, Lutter R, Cremer OL, Bonten MJ, Schultz MJ, Scicluna BP, van der Poll T; MARS Consortium. Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired Pneumonia. Crit Care Med. 2021 Nov 1;49(11):1901-1911. doi: 10.1097/CCM.0000000000005072.']",,2022-03-10,https://clinicaltrials.gov/show/NCT04324021,2020-11-13,1,1
135,NCT04325672,Withdrawn,2022-12-31,2022-12-31,No Results Posted,,,2020-04-08,https://clinicaltrials.gov/show/NCT04325672,2022-12-31,0,0
136,NCT04326725,"Active, not recruiting",2020-07-01,2020-09-01,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04326725,2020-07-01,0,0
137,NCT04328012,Terminated,2021-07-01,2021-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-24,https://clinicaltrials.gov/show/NCT04328012,2021-07-01,0,1
138,NCT04329546,"Active, not recruiting",2022-01-31,2022-03-31,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04329546,2022-01-31,0,0
139,NCT04330300,Suspended,2021-07-31,2021-12-01,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04330300,2021-07-31,0,0
140,NCT04330495,Withdrawn,2020-11-06,2021-08-27,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04330495,2020-11-06,0,0
141,NCT04331106,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Olsson A, Olsson M, Fedorowski A, Hagell P, Wictorin K. The Orthostatic Hypotension Questionnaire in Swedish tested in patients with parkinsonism. Brain Behav. 2020 Sep;10(9):e01746. doi: 10.1002/brb3.1746. Epub 2020 Jul 7.']",,2021-01-27,https://clinicaltrials.gov/show/NCT04331106,2022-04-01,0,1
142,NCT04331470,Recruiting,2020-04-20,2020-05-20,No Results Posted,"['Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2020-04-13,https://clinicaltrials.gov/show/NCT04331470,2020-04-20,0,1
143,NCT04331509,Recruiting,2023-03-23,2023-03-23,No Results Posted,"['Lo CH, Nguyen LH, Drew DA, Warner ET, Joshi AD, Graham MS, Anyane-Yeboa A, Shebl FM, Astley CM, Figueiredo JC, Guo CG, Ma W, Mehta RS, Kwon S, Song M, Davies R, Capdevila J, Sudre CH, Wolf J, Cozier YC, Rosenberg L, Wilkens LR, Haiman CA, Marchand LL, Palmer JR, Spector TD, Ourselin S, Steves CJ, Chan AT; COPE Consortium. Race, ethnicity, community-level socioeconomic factors, and risk of COVID-19 in the United States and the United Kingdom. EClinicalMedicine. 2021 Aug;38:101029. doi: 10.1016/j.eclinm.2021.101029. Epub 2021 Jul 17.', 'Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W, Mehta RS, Warner ET, Sikavi DR, Lo CH, Kwon S, Song M, Mucci LA, Stampfer MJ, Willett WC, Eliassen AH, Hart JE, Chavarro JE, Rich-Edwards JW, Davies R, Capdevila J, Lee KA, Lochlainn MN, Varsavsky T, Sudre CH, Cardoso MJ, Wolf J, Spector TD, Ourselin S, Steves CJ, Chan AT; COronavirus Pandemic Epidemiology Consortium. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020 Sep;5(9):e475-e483. doi: 10.1016/S2468-2667(20)30164-X. Epub 2020 Jul 31.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04331509,2023-03-23,0,1
144,NCT04331665,Terminated,2021-01-05,2021-03-24,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04331665,2021-01-05,0,0
145,NCT04331834,Completed,2020-06-25,2020-12-31,No Results Posted,"['Grau-Pujol B, Camprub√≠-Ferrer D, Marti-Soler H, Fern√°ndez-Pardos M, Carreras-Abad C, Andr√©s MV, Ferrer E, Muelas-Fernandez M, Jullien S, Barilaro G, Ajanovic S, Vera I, Moreno L, Gonzalez-Redondo E, Cortes-Serra N, Rold√°n M, Arcos AA, Mur I, Domingo P, Garcia F, Guinovart C, Mu√±oz J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021 Nov 15;22(1):808. doi: 10.1186/s13063-021-05758-9.', 'Grau-Pujol B, Camprub√≠ D, Marti-Soler H, Fern√°ndez-Pardos M, Guinovart C, Mu√±oz J. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. Trials. 2020 Jul 29;21(1):688. doi: 10.1186/s13063-020-04621-7.']",,2021-02-16,https://clinicaltrials.gov/show/NCT04331834,2020-06-25,0,1
146,NCT04332094,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04332094,2021-06-01,0,0
147,NCT04332913,Recruiting,2020-12-31,2021-03-31,No Results Posted,,"['Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses - a statement of the Coronavirus Study Group. BioRxivchinaXiv:202003.00026v172020:2020.02.07.937862.']",2020-04-13,https://clinicaltrials.gov/show/NCT04332913,2020-12-31,0,1
148,NCT04333407,Recruiting,2021-03-30,2021-03-30,No Results Posted,,,2020-04-09,https://clinicaltrials.gov/show/NCT04333407,2021-03-30,0,0
149,NCT04333849,Completed,2020-05-11,2020-05-11,No Results Posted,"['Sacco G, Ll√©onart S, Simon R, Noublanche F, Annweiler C; TOVID Study Group. Communication Technology Preferences of Hospitalized and Institutionalized Frail Older Adults During COVID-19 Confinement: Cross-Sectional Survey Study. JMIR Mhealth Uhealth. 2020 Sep 18;8(9):e21845. doi: 10.2196/21845.']",,2020-07-20,https://clinicaltrials.gov/show/NCT04333849,2020-05-11,0,1
150,NCT04333953,Recruiting,2020-07-01,2022-04-01,No Results Posted,"['Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, Llibre JM, Camazine M, D√≠az-De Santiago A, Carlucci PM, Zacharioudakis IM, Rahimian J, Wanjalla CN, Slim J, Arinze F, Kratz AMP, Jones JL, Patel SM, Kitchell E, Francis A, Ray M, Koren DE, Baddley JW, Hill B, Sax PE, Chow J. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019. Clin Infect Dis. 2021 Oct 5;73(7):e1964-e1972. doi: 10.1093/cid/ciaa1339.']",,2021-04-21,https://clinicaltrials.gov/show/NCT04333953,2020-07-01,0,1
151,NCT04334005,Not yet recruiting,2020-06-30,2020-06-30,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04334005,2020-06-30,0,0
152,NCT04334382,Recruiting,2020-12-31,2021-12-31,No Results Posted,,,2020-04-09,https://clinicaltrials.gov/show/NCT04334382,2020-12-31,0,0
153,NCT04335188,Recruiting,2021-07-31,2021-09-30,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04335188,2021-07-31,0,0
154,NCT04335630,Recruiting,2021-03-01,2022-03-01,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04335630,2021-03-01,0,0
155,NCT04336254,Recruiting,2021-11-30,2021-12-31,No Results Posted,"['Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.']",,2021-03-10,https://clinicaltrials.gov/show/NCT04336254,2021-11-30,0,1
156,NCT04336462,Recruiting,2020-02-21,2020-08-01,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04336462,2020-02-21,0,0
157,NCT04336657,Recruiting,2020-05-01,2020-05-01,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04336657,2020-05-01,0,0
158,NCT04336787,Completed,2020-05-10,2020-06-10,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04336787,2020-05-10,0,0
159,NCT04336904,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,,,2020-04-08,https://clinicaltrials.gov/show/NCT04336904,2020-07-01,0,0
160,NCT04337151,Recruiting,2021-01-01,2021-03-01,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04337151,2021-01-01,0,0
161,NCT04337190,Recruiting,2020-10-06,2020-12-06,No Results Posted,,,2020-04-10,https://clinicaltrials.gov/show/NCT04337190,2020-10-06,0,0
162,NCT04337216,,,,,,,,https://clinicaltrials.gov/show/NCT04337216,,0,0
163,NCT04337489,Completed,2021-03-26,2021-03-26,No Results Posted,"['Iqbal FM, Joshi M, Davies G, Khan S, Ashrafian H, Darzi A. The pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV 2). BMC Public Health. 2021 Apr 1;21(1):638. doi: 10.1186/s12889-021-10660-9.', 'Iqbal FM, Joshi M, Davies G, Khan S, Ashrafian H, Darzi A. Design of the pilot, proof of concept REMOTE-COVID trial: remote monitoring use in suspected cases of COVID-19 (SARS-CoV-2). Pilot Feasibility Stud. 2021 Mar 5;7(1):62. doi: 10.1186/s40814-021-00804-4.']",,2022-02-24,https://clinicaltrials.gov/show/NCT04337489,2021-03-26,0,1
164,NCT04337502,Completed,2020-01-20,2020-03-03,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04337502,2020-01-20,0,0
165,NCT04337541,Completed,2020-06-02,2020-06-02,No Results Posted,"['Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, Todsen T, Norsk JB, Pries-Heje MM, Vissing CR, Nielsen PB, Winsl√∏w UC, Fogh K, Hasselbalch R, Kristensen JH, Ringgaard A, Porsborg Andersen M, Goecke NB, Trebbien R, Skovgaard K, Benfield T, Ullum H, Torp-Pedersen C, Iversen K. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial. Ann Intern Med. 2021 Mar;174(3):335-343. doi: 10.7326/M20-6817. Epub 2020 Nov 18.', 'Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, Mariager AF, Schytte N, von Buchwald C, Todsen T, Skovgaard K, Trebbien R, Andersen MP, Benfield T, Ullum H, Torp-Pedersen C, Iversen K. Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19. Dan Med J. 2020 Aug 18;67(9). pii: A05200363.']",,2020-08-03,https://clinicaltrials.gov/show/NCT04337541,2020-06-02,0,1
166,NCT04337762,Recruiting,2020-12-01,2021-07-01,No Results Posted,,,2020-04-09,https://clinicaltrials.gov/show/NCT04337762,2020-12-01,0,0
167,NCT04337983,Completed,2020-10-30,2020-11-30,No Results Posted,"['Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X. COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study. Crit Care. 2021 Jun 1;25(1):186. doi: 10.1186/s13054-021-03594-6.']",,2021-09-14,https://clinicaltrials.gov/show/NCT04337983,2020-10-30,0,1
168,NCT04338100,Completed,2020-06-05,2020-06-23,No Results Posted,"['Morin F, Douillet D, Hamel JF, Rakotonjanahary J, Dupriez F, Savary D, Aub√© C, Riou J, Dub√©e V, Roy PM. Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission (POCUSCO): a study protocol of an international study. BMJ Open. 2021 Feb 10;11(2):e041118. doi: 10.1136/bmjopen-2020-041118.']","['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Rodriguez-Morales AJ, Cardona-Ospina JA, Guti√©rrez-Ocampo E, Villamizar-Pe√±a R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ram√≠rez-Vallejo E, Su√°rez JA, Zambrano LI, Villamil-G√≥mez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.', 'Lichtenstein DA, Mezi√®re GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008 Jul;134(1):117-25. doi: 10.1378/chest.07-2800. Epub 2008 Apr 10. Erratum in: Chest. 2013 Aug;144(2):721.', 'Zhao Z, Jiang L, Xi X, Jiang Q, Zhu B, Wang M, Xing J, Zhang D. Prognostic value of extravascular lung water assessed with lung ultrasound score by chest sonography in patients with acute respiratory distress syndrome. BMC Pulm Med. 2015 Aug 23;15:98. doi: 10.1186/s12890-015-0091-2.']",2022-03-22,https://clinicaltrials.gov/show/NCT04338100,2020-06-05,0,1
169,NCT04338360,,,,,"['Senefeld JW, Johnson PW, Kunze KL, Bloch EM, van Helmond N, Golafshar MA, Klassen SA, Klompas AM, Sexton MA, Diaz Soto JC, Grossman BJ, Tobian AAR, Goel R, Wiggins CC, Bruno KA, van Buskirk CM, Stubbs JR, Winters JL, Casadevall A, Paneth NS, Shaz BH, Petersen MM, Sachais BS, Buras MR, Wieczorek MA, Russoniello B, Dumont LJ, Baker SE, Vassallo RR, Shepherd JRA, Young PP, Verdun NC, Marks P, Haley NR, Rea RF, Katz L, Herasevich V, Waxman DA, Whelan ER, Bergman A, Clayburn AJ, Grabowski MK, Larson KF, Ripoll JG, Andersen KJ, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Buchholtz ZA, Pletsch MC, Wright K, Greenshields JT, Joyner MJ, Wright RS, Carter RE, Fairweather D. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study. PLoS Med. 2021 Dec 20;18(12):e1003872. doi: 10.1371/journal.pmed.1003872. eCollection 2021 Dec.', 'Kunze KL, Johnson PW, van Helmond N, Senefeld JW, Petersen MM, Klassen SA, Wiggins CC, Klompas AM, Bruno KA, Mills JR, Theel ES, Buras MR, Golafshar MA, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, Verdun NC, Marks P, Paneth NS, Fairweather D, Wright RS, van Buskirk CM, Winters JL, Stubbs JR, Senese KA, Pletsch MC, Buchholtz ZA, Rea RF, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Lesser ER, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Casadevall A, Carter RE, Joyner MJ. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 Aug 11;12(1):4864. doi: 10.1038/s41467-021-25113-5.', 'Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, van Helmond N, Verdun NC, Marks P, van Buskirk CM, Winters JL, Stubbs JR, Rea RF, Hodge DO, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Paneth NS, Fairweather D, Wright RS, Casadevall A. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 Mar 18;384(11):1015-1027. doi: 10.1056/NEJMoa2031893. Epub 2021 Jan 13.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Joyner MJ, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, van Helmond N, van Buskirk CM, Winters JL, Stubbs JR, Rea RF, Hodge DO, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Paneth NS, Fairweather D, Wright RS, Carter RE, Casadevall A. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. medRxiv. 2020 Aug 12. pii: 2020.08.12.20169359. doi: 10.1101/2020.08.12.20169359.', 'Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. Update in: Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600.', 'Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JR, Rea RF, Whelan ER, Clayburn AJ, Spiegel MR, Johnson PW, Lesser ER, Baker SE, Larson KF, Ripoll JG, Andersen KJ, Hodge DO, Kunze KL, Buras MR, Vogt MN, Herasevich V, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Van Buskirk CM, Winters JL, Stubbs JR, Paneth NS, Verdun NC, Marks P, Casadevall A. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 Sep 1;130(9):4791-4797. doi: 10.1172/JCI140200.']",,2020-09-02,https://clinicaltrials.gov/show/NCT04338360,,0,1
170,NCT04338698,Completed,2020-11-15,2020-11-22,No Results Posted,"['Akram J, Azhar S, Shahzad M, Latif W, Khan KS. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Aug 8;21(1):702. doi: 10.1186/s13063-020-04616-4. Erratum in: Trials. 2020 Aug 22;21(1):733. Trials. 2022 Feb 15;23(1):150.']",,2022-02-10,https://clinicaltrials.gov/show/NCT04338698,2020-11-15,0,1
171,NCT04338802,Not yet recruiting,2020-05-04,2020-08-01,No Results Posted,,,2020-04-08,https://clinicaltrials.gov/show/NCT04338802,2020-05-04,0,0
172,NCT04338906,Withdrawn,2021-12-01,2021-12-01,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04338906,2021-12-01,0,0
173,NCT04339322,Not yet recruiting,2020-07-30,2020-07-30,No Results Posted,,,2020-04-09,https://clinicaltrials.gov/show/NCT04339322,2020-07-30,0,0
174,NCT04339387,Completed,2020-04-26,2020-04-26,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04339387,2020-04-26,0,0
175,NCT04339608,Recruiting,2020-05-30,2020-06-30,No Results Posted,"['Jha S, Soni A, Siddiqui S, Batra N, Goel N, Dey S, Budhiraja S, Naithani R. Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India. J Assoc Physicians India. 2020 Jul;68(7):27-29.']",,2020-04-09,https://clinicaltrials.gov/show/NCT04339608,2020-05-30,0,1
176,NCT04339660,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,2020-04-09,https://clinicaltrials.gov/show/NCT04339660,2020-06-30,0,0
177,NCT04341012,Completed,2021-09-03,2021-09-03,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04341012,2021-09-03,0,0
178,NCT04341038,Recruiting,2020-06-01,2020-07-01,No Results Posted,"['Solanich X, Antol√≠ A, Rocamora-Blanch G, Padull√©s N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Riera-Mestre A, Bas J, Vicens-Zygmunt V, Niub√≥ J, Calvo N, Bolivar S, Rigo-Bonnin R, Mensa-Vilar√≥ A, Arregui L, Tebe C, Videla S, Hereu P, Corbella X. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Front Med (Lausanne). 2021 Jun 14;8:691712. doi: 10.3389/fmed.2021.691712. eCollection 2021.', 'Solanich X, Antol√≠ A, Padull√©s N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilar√≥ A, Niub√≥ J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Teb√© C, Hereu P, Videla S, Corbella X. Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol. Contemp Clin Trials Commun. 2021 Mar;21:100716. doi: 10.1016/j.conctc.2021.100716. Epub 2021 Jan 19. Review.']",,2020-04-10,https://clinicaltrials.gov/show/NCT04341038,2020-06-01,0,1
179,NCT04341103,Not yet recruiting,2020-12-01,2021-03-01,No Results Posted,,,2020-04-10,https://clinicaltrials.gov/show/NCT04341103,2020-12-01,0,0
180,NCT04341207,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2020-04-10,https://clinicaltrials.gov/show/NCT04341207,2022-04-01,0,0
181,NCT04341480,"Active, not recruiting",2022-12-10,2023-01-10,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04341480,2022-12-10,0,0
182,NCT04341506,Recruiting,2021-07-15,2021-12-15,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04341506,2021-07-15,0,0
183,NCT04341519,Recruiting,2020-11-30,2021-12-31,No Results Posted,"['Azoulay E, Resche-Rigon M, Megarbane B, Reuter D, Labb√© V, Cariou A, G√©ri G, Van der Meersch G, Kouatchet A, Guisset O, Bruneel F, Reignier J, Souppart V, Barbier F, Argaud L, Quenot JP, Papazian L, Guidet B, Thi√©ry G, Klouche K, Lesieur O, Demoule A, Guitton C, Capellier G, Mourvillier B, Biard L, Pochard F, Kentish-Barnes N. Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge. JAMA. 2022 Mar 15;327(11):1042-1050. doi: 10.1001/jama.2022.2017.']",,2020-10-06,https://clinicaltrials.gov/show/NCT04341519,2020-11-30,0,1
184,NCT04341792,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04341792,2021-04-01,0,0
185,NCT04342104,Recruiting,2020-11-30,2021-11-15,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04342104,2020-11-30,0,0
186,NCT04342208,Completed,2020-07-01,2020-08-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04342208,2020-07-01,0,0
187,NCT04342221,Terminated,2021-02-26,2021-02-26,No Results Posted,,,2021-05-03,,2021-02-26,0,0
188,NCT04343404,Completed,2020-04-15,2020-04-15,No Results Posted,,,2020-06-29,https://clinicaltrials.gov/show/NCT04343404,2020-04-15,0,0
189,NCT04343677,,,,,,,,https://clinicaltrials.gov/show/NCT04343677,,0,0
190,NCT04344080,Completed,2021-04-10,2021-04-28,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04344080,2021-04-10,0,0
191,NCT04344197,Completed,2020-04-08,2020-04-15,No Results Posted,"['Bellato V, Konishi T, Pellino G, An Y, Piciocchi A, Sensi B, Siragusa L, Khanna K, Pirozzi BM, Franceschilli M, Campanelli M, Efetov S, Sica GS; S-COVID Collaborative Group. Screening policies, preventive measures and in-hospital infection of COVID-19 in global surgical practices. J Glob Health. 2020 Dec;10(2):020507. doi: 10.7189/jogh.10.020507.']",,2020-12-29,https://clinicaltrials.gov/show/NCT04344197,2020-04-08,0,1
192,NCT04392531,Completed,2021-03-31,2021-03-31,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04392531,2021-03-31,0,0
193,NCT03042143,"Active, not recruiting",2022-07-01,2024-03-01,No Results Posted,"[""Gorman E, Shankar-Hari M, Hopkins P, Tunnicliffe WS, Perkins GD, Silversides J, McGuigan P, Krasnodembskaya A, Jackson C, Boyle R, McFerran J, McDowell C, Campbell C, McFarland M, Smythe J, Thompson J, Williams B, Curley G, Laffey JG, Clarke M, McAuley DF, O'Kane CM. Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial. EClinicalMedicine. 2021 Oct 24;41:101167. doi: 10.1016/j.eclinm.2021.101167. eCollection 2021 Nov."", ""Gorman E, Shankar-Hari M, Hopkins P, Tunnicliffe WS, Perkins GD, Silversides J, McGuigan P, Jackson C, Boyle R, McFerran J, McDowell C, Campbell C, McFarland M, Smythe J, Thompson J, Williams B, Curley G, Laffey JG, Clarke M, O'Kane C, McAuley DF. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Trials. 2020 Jun 3;21(1):462. doi: 10.1186/s13063-020-04416-w.""]",,2021-08-20,https://clinicaltrials.gov/show/NCT03042143,2022-07-01,0,1
194,NCT03891420,Terminated,2021-01-31,2021-04-30,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT03891420,2021-01-31,0,0
195,NCT04092478,Completed,2020-01-08,2020-01-31,No Results Posted,,,2020-09-16,,2020-01-08,0,0
196,NCT04252118,Recruiting,2020-12-01,2021-12-01,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04252118,2020-12-01,0,0
197,NCT04252664,Suspended,2020-04-10,2020-04-27,No Results Posted,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04252664,2020-04-10,0,1
198,NCT04257656,Terminated,2020-03-30,2020-04-10,No Results Posted,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.', 'Wang Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.', 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04257656,2020-03-30,0,1
199,NCT04273646,Not yet recruiting,2020-06-30,2022-02-15,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04273646,2020-06-30,0,0
200,NCT04276688,Completed,2020-03-30,2020-03-31,No Results Posted,"['Moschen AR. IBD in the time of corona - vigilance for immune-mediated diseases. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):529-530. doi: 10.1038/s41575-020-0333-5. Review.', 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04276688,2020-03-30,0,1
201,NCT04280224,Recruiting,2022-12-31,2023-12-31,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04280224,2022-12-31,0,0
202,NCT04299152,Not yet recruiting,2022-04-09,2022-06-10,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04299152,2022-04-09,0,0
203,NCT04304690,"Active, not recruiting",2021-05-16,2021-10-16,No Results Posted,,,2020-12-01,https://clinicaltrials.gov/show/NCT04304690,2021-05-16,0,0
204,NCT04315896,Completed,2020-07-01,2020-08-15,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04315896,2020-07-01,0,0
205,NCT04318015,Completed,2020-12-31,2021-03-31,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04318015,2020-12-31,0,0
206,NCT04320277,Not yet recruiting,2020-06-30,2020-07-30,No Results Posted,"['Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.']",,2020-04-22,https://clinicaltrials.gov/show/NCT04320277,2020-06-30,0,1
207,NCT04320953,Completed,2020-03-26,2020-04-09,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04320953,2020-03-26,0,0
208,NCT04321174,"Active, not recruiting",2021-08-27,2022-03-31,No Results Posted,"['Tan DHS, Chan AK, J√ºni P, Tomlinson G, Daneman N, Walmsley S, Muller M, Fowler R, Murthy S, Press N, Cooper C, Lee T, Mazzulli T, McGeer A. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial. Trials. 2021 Mar 22;22(1):224. doi: 10.1186/s13063-021-05134-7.', 'Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,2021-12-14,https://clinicaltrials.gov/show/NCT04321174,2021-08-27,0,1
209,NCT04322487,Completed,2021-12-31,2021-12-31,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04322487,2021-12-31,0,0
210,NCT04323345,Recruiting,2020-12-15,2021-01-15,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04323345,2020-12-15,0,0
211,NCT04323787,Recruiting,2022-04-30,2022-12-31,No Results Posted,"['Turek JR, Bansal V, Tekin A, Singh S, Deo N, Sharma M, Bogojevic M, Qamar S, Singh R, Kumar V, Kashyap R. Lessons From a Rapid Project Management Exercise in the Time of Pandemic: Methodology for a Global COVID-19 VIRUS Registry Database. JMIR Res Protoc. 2022 Mar 15;11(3):e27921. doi: 10.2196/27921.', ""Kirkup C, Pawlowski C, Puranik A, Conrad I, O'Horo JC, Gomaa D, Banner-Goodspeed VM, Mosier JM, Zabolotskikh IB, Daugherty SK, Bernstein MA, Zaren HA, Bansal V, Pickering B, Badley AD, Kashyap R, Venkatakrishnan AJ, Soundararajan V. Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry. J Med Virol. 2021 Jul;93(7):4303-4318. doi: 10.1002/jmv.26918. Epub 2021 Mar 30."", 'Domecq JP, Lal A, Sheldrick CR, Kumar VK, Boman K, Bolesta S, Bansal V, Harhay MO, Garcia MA, Kaufman M, Danesh V, Cheruku S, Banner-Goodspeed VM, Anderson HL 3rd, Milligan PS, Denson JL, St Hill CA, Dodd KW, Martin GS, Gajic O, Walkey AJ, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry. Crit Care Med. 2021 Mar 1;49(3):437-448. doi: 10.1097/CCM.0000000000004879. Erratum in: Crit Care Med. 2021 May 1;49(5):e562.']",,2021-07-23,https://clinicaltrials.gov/show/NCT04323787,2022-04-30,0,1
212,NCT04324073,Unknown,2021-03-27,2021-12-31,No Results Posted,"['Hermine O, Mariette X, Porcher R, Resche-Rigon M, Tharaux PL, Ravaud P; on the behalf of the CORIMUNO-19 collaborative group. Effect of Interleukin-6 Receptor Antagonists in Critically Ill Adult Patients with COVID-19 Pneumonia: two Randomised Controlled Trials of the CORIMUNO-19 Collaborative Group. Eur Respir J. 2022 Feb 3. pii: 2102523. doi: 10.1183/13993003.02523-2021. [Epub ahead of print]', 'CORIMUNO-19 Collaborative group. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. Lancet Rheumatol. 2022 Jan;4(1):e24-e32. doi: 10.1016/S2665-9913(21)00315-5. Epub 2021 Nov 17.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04324073,2021-03-27,0,1
213,NCT04324190,Recruiting,2020-06-01,2021-12-01,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04324190,2020-06-01,0,0
214,NCT04324736,Completed,2020-04-10,2020-12-31,No Results Posted,"['Tramunt B, Smati S, Coudol S, Wargny M, Pichelin M, Guyomarch B, Al-Salameh A, Amadou C, Barraud S, Bigot E, Bordier L, Borot S, Bourgeon M, Bourron O, Charri√®re S, Chevalier N, Cosson E, F√®ve B, Flaus-Furmaniuk A, Fontaine P, Galioot A, Gonfroy-Leymarie C, Guerci B, Lablanche S, Lalau JD, Larger E, Lasbleiz A, Laviolle B, Marre M, Munch M, Potier L, Prevost G, Renard E, Reznik Y, Seret-B√©gu√© D, Sibilia P, Thuillier P, Verg√®s B, Gautier JF, Hadjadj S, Cariou B, Mauvais-Jarvis F, Gourdy P. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study. Eur J Endocrinol. 2021 Jul 5;185(2):299-311. doi: 10.1530/EJE-21-0068.', 'Wargny M, Potier L, Gourdy P, Pichelin M, Amadou C, Benhamou PY, Bonnet JB, Bordier L, Bourron O, Chaumeil C, Chevalier N, Darmon P, Delenne B, Demarsy D, Dumas M, Dupuy O, Flaus-Furmaniuk A, Gautier JF, Guedj AM, Jeandidier N, Larger E, Le Berre JP, Lungo M, Montanier N, Moulin P, Plat F, Rigalleau V, Robert R, Seret-B√©gu√© D, S√©rusclat P, Smati S, Th√©baut JF, Tramunt B, Vatier C, Velayoudom FL, Verg√®s B, Winiszewski P, Zabulon A, Gourraud PA, Roussel R, Cariou B, Hadjadj S; CORONADO investigators. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021 Apr;64(4):778-794. doi: 10.1007/s00125-020-05351-w. Epub 2021 Feb 17.', 'Wargny M, Gourdy P, Ludwig L, Seret-B√©gu√© D, Bourron O, Darmon P, Amadou C, Pichelin M, Potier L, Thivolet C, Gautier JF, Hadjadj S, Cariou B; CORONADO investigators. Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study. Diabetes Care. 2020 Nov;43(11):e174-e177. doi: 10.2337/dc20-1217. Epub 2020 Aug 26.', 'Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Th√©baut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29. Erratum in: Diabetologia. 2020 Jul 2;:.']",,2021-02-23,https://clinicaltrials.gov/show/NCT04324736,2020-04-10,0,1
215,NCT04325048,Unknown,2021-06-01,2021-09-01,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04325048,2021-06-01,0,0
216,NCT04325061,Terminated,2020-06-19,2020-06-19,No Results Posted,"['Villar J, A√±√≥n JM, Ferrando C, Aguilar G, Mu√±oz T, Ferreres J, Ambr√≥s A, Aldecoa C, Su√°rez-Sipmann F, Thorpe KE, J√ºni P, Slutsky AS; DEXA-COVID19 Network. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial. Trials. 2020 Aug 16;21(1):717. doi: 10.1186/s13063-020-04643-1.']","['Villar J, Belda J, A√±√≥n JM, Blanco J, P√©rez-M√©ndez L, Ferrando C, Mart√≠nez D, Soler JA, Ambr√≥s A, Mu√±oz T, Rivas R, Corpas R, D√≠az-Dominguez FJ, Soro M, Garc√≠a-Bello MA, Fern√°ndez RL, Kacmarek RM; DEXA-ARDS Network. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4.', 'Villar J, Ferrando C, Mart√≠nez D, Ambr√≥s A, Mu√±oz T, Soler JA, Aguilar G, Alba F, Gonz√°lez-Higueras E, Conesa LA, Mart√≠n-Rodr√≠guez C, D√≠az-Dom√≠nguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, A√±√≥n JM, Fern√°ndez RL, Gonz√°lez-Mart√≠n JM; dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.']",2021-02-03,https://clinicaltrials.gov/show/NCT04325061,2020-06-19,0,1
217,NCT04325633,Terminated,2020-12-15,2020-12-15,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04325633,2020-12-15,0,0
218,NCT04326426,Enrolling by invitation,2020-08-01,2020-08-31,No Results Posted,"[""Smieszek SP, Przychodzen BP, Polymeropoulos VM, Polymeropoulos CM, Polymeropoulos MH. Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'. Cytokine. 2021 Dec;148:155662. doi: 10.1016/j.cyto.2021.155662. Epub 2021 Jul 29. Erratum in: Cytokine. 2022 Jan;149:155752.""]",,2020-04-20,https://clinicaltrials.gov/show/NCT04326426,2020-08-01,0,1
219,NCT04327804,Completed,2020-08-18,2020-10-10,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04327804,2020-08-18,0,0
220,NCT04329650,Recruiting,2020-05-20,2020-05-20,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04329650,2020-05-20,0,0
221,NCT04331054,Terminated,2021-05-28,2021-05-28,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04331054,2021-05-28,0,0
222,NCT04331171,Completed,2020-11-15,2020-11-15,No Results Posted,"['Denis F, Fontanet A, Le Douarin YM, Le Goff F, Jeanneau S, Lescure FX. A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study. J Med Internet Res. 2021 Mar 12;23(3):e26182. doi: 10.2196/26182.', 'Galmiche S, Rahbe E, Fontanet A, Dinh A, B√©n√©zit F, Lescure FX, Denis F. Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study. J Med Internet Res. 2020 Nov 23;22(11):e22924. doi: 10.2196/22924.', 'Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX. Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application. J Med Internet Res. 2020 Jun 11;22(6):e19855. doi: 10.2196/19855.']",,2021-04-08,https://clinicaltrials.gov/show/NCT04331171,2020-11-15,0,1
223,NCT04333420,Completed,2021-10-31,2021-12-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Vlaar APJ, de Bruin S, Busch M, Timmermans SAMEG, van Zeggeren IE, Koning R, Ter Horst L, Bulle EB, van Baarle FEHP, van de Poll MCG, Kemper EM, van der Horst ICC, Schultz MJ, Horn J, Paulus F, Bos LD, Wiersinga WJ, Witzenrath M, Rueckinger S, Pilz K, Brouwer MC, Guo RF, Heunks L, van Paassen P, Riedemann NC, van de Beek D. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec;2(12):e764-e773. doi: 10.1016/S2665-9913(20)30341-6. Epub 2020 Sep 28.']",,2022-02-08,,2021-10-31,0,1
224,NCT04333628,Terminated,2020-09-01,2020-09-01,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04333628,2020-09-01,0,0
225,NCT04334044,Completed,2021-04-12,2021-04-30,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04334044,2021-04-12,0,0
226,NCT04334434,Completed,2020-09-15,2020-12-15,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04334434,2020-09-15,0,0
227,NCT04335773,Recruiting,2030-12-31,2030-12-31,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04335773,2030-12-31,0,0
228,NCT04336215,"Active, not recruiting",2022-08-31,2024-08-31,No Results Posted,"['Horton DB, Barrett ES, Roy J, Gennaro ML, Andrews T, Greenberg P, Bruiners N, Datta P, Ukey R, Velusamy SK, Fine D, Honnen WJ, Yin YS, Pinter A, Brooks A, Tischfield J, Hussain S, Jagpal S, Swaminathan S, Parmar V, Reilly N, Gaur S, Panettieri RA, Carson JL, Blaser MJ. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study. J Infect Dis. 2021 Oct 28;224(8):1345-1356. doi: 10.1093/infdis/jiab411.']",,2021-11-03,https://clinicaltrials.gov/show/NCT04336215,2022-08-31,0,1
229,NCT04336384,Completed,2020-12-01,2020-12-30,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04336384,2020-12-01,0,0
230,NCT04338568,Recruiting,2020-11-30,2020-12-30,No Results Posted,,"['Pisani L, Vercesi V, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MAM, Henwood PC, Walden A, Smit MR, Riviello ED, Pelosi P, Dondorp AM, Schultz MJ; Lung Ultrasound Consortium. The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):44. doi: 10.1186/s40635-019-0241-6.', 'Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020 Aug;30(8):4407-4416. doi: 10.1007/s00330-020-06817-6. Epub 2020 Mar 25.']",2020-08-17,https://clinicaltrials.gov/show/NCT04338568,2020-11-30,0,1
231,NCT04338672,Recruiting,2021-04-01,2022-04-01,No Results Posted,"['Anteby R, Zager Y, Barash Y, Nadler R, Cordoba M, Klang E, Klein Y, Ram E, Gutman M, Horesh N. The Impact of the Coronavirus Disease 2019 Outbreak on the Attendance of Patients with Surgical Complaints at a Tertiary Hospital Emergency Department. J Laparoendosc Adv Surg Tech A. 2020 Sep;30(9):1001-1007. doi: 10.1089/lap.2020.0465. Epub 2020 Jun 23.']",,2020-04-21,https://clinicaltrials.gov/show/NCT04338672,2021-04-01,0,1
232,NCT04339634,Enrolling by invitation,2023-04-01,2023-10-01,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04339634,2023-04-01,0,0
233,NCT04340466,Completed,2020-07-03,2020-07-03,No Results Posted,,,2020-12-19,https://clinicaltrials.gov/show/NCT04340466,2020-07-03,0,0
234,NCT04341168,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04341168,2020-10-01,0,0
235,NCT04341584,Completed,2020-05-10,2020-07-25,No Results Posted,['CORIMUNO-19 Collaborative group. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Lancet Respir Med. 2021 Mar;9(3):295-304. doi: 10.1016/S2213-2600(20)30556-7. Epub 2021 Jan 22.'],,2021-02-01,https://clinicaltrials.gov/show/NCT04341584,2020-05-10,0,1
236,NCT04342156,Withdrawn,2020-08-01,2020-10-01,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04342156,2020-08-01,0,0
237,NCT04342169,"Active, not recruiting",2021-06-01,2021-10-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04342169,2021-06-01,0,0
238,NCT04342195,Completed,2021-03-12,2021-03-12,No Results Posted,,,2021-07-06,https://clinicaltrials.gov/show/NCT04342195,2021-03-12,0,0
239,NCT04342650,Completed,2020-05-14,2020-06-08,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04342650,2020-05-14,0,0
240,NCT04343001,Withdrawn,2021-04-01,2021-08-01,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04343001,2021-04-01,0,0
241,NCT04343144,Not yet recruiting,2020-07-31,2020-09-30,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04343144,2020-07-31,0,0
242,NCT04343183,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,2020-04-13,https://clinicaltrials.gov/show/NCT04343183,2020-06-01,0,0
243,NCT04343339,Completed,2020-07-30,2020-09-30,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04343339,2020-07-30,0,0
244,NCT04343664,Not yet recruiting,2021-11-01,2021-12-31,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04343664,2021-11-01,0,0
245,NCT04343690,Withdrawn,2020-05-01,2020-05-01,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04343690,2020-05-01,0,0
246,NCT04343755,"Active, not recruiting",2022-04-01,2022-04-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04343755,2022-04-01,0,0
247,NCT04343794,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04343794,2021-12-31,0,0
248,NCT04343963,Recruiting,2020-09-30,2021-04-30,Results Submitted,"['Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, Garc√≠a-Gonz√°lez HB, Nu√±ez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Mart√≠nez S, Caro-Vega Y, Calva JJ, Luque√±o-Mart√≠nez V, Gonz√°lez-Duarte A, Crabtree-Ram√≠rez B, Crisp√≠n JC, Sierra-Madero J, Belaunzar√°n-Zamudio PF, Vald√©s-Ferrer SI. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol. BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7.']",,2020-07-07,https://clinicaltrials.gov/show/NCT04343963,2020-09-30,0,1
249,NCT04344106,Recruiting,2020-04-15,2020-05-01,Results Submitted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04344106,2020-04-15,0,0
250,NCT04344171,Recruiting,2022-12-31,2023-06-30,No Results Posted,"[""Budweiser S, Ba≈ü ≈û, J√∂rres RA, Engelhardt S, von Delius S, Lenherr K, Deerberg-Wittram J, Bauer A. Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections. Respir Res. 2021 Jun 4;22(1):168. doi: 10.1186/s12931-021-01756-2.""]",,2020-04-21,https://clinicaltrials.gov/show/NCT04344171,2022-12-31,0,1
251,NCT04344210,Completed,2020-09-20,2020-09-20,No Results Posted,"['Alessi J, Becker AS, Amaral B, de Oliveira GB, Franco DW, Knijnik CP, Kobe GL, de Brito A, de Carvalho TR, Telo GH, Schaan BD, Telo GH. Type 1 diabetes and the challenges of emotional support in crisis situations: results from a randomized clinical trial of a multidisciplinary teleintervention. Sci Rep. 2022 Feb 23;12(1):3086. doi: 10.1038/s41598-022-07005-w. Retraction in: Sci Rep. 2022 Mar 11;12(1):4265.\n\nRetraction in:\nSci Rep. 2022 Mar 11;12(1):4265', 'Retraction in:\nSci Rep. 2022 Mar 11;12(1):4265']",,2020-10-14,https://clinicaltrials.gov/show/NCT04344210,2020-09-20,0,1
252,NCT04344236,Withdrawn,2020-05-01,2020-05-09,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04344236,2020-05-01,0,0
253,NCT04344444,Terminated,2021-04-10,2022-01-05,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04344444,2021-04-10,0,0
254,NCT04344535,Terminated,2021-01-01,2021-02-01,Study Results,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, Hearing JC, Salman H, Holiprosad DD, Freedenberg AT, Carter JA, Browne NJ, Cosgrove ME, Shevik ME, Generale LM, Andrew MA, Nachman S, Fries BC; Stony Brook Medicine COVID Plasma Trial Group. Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Crit Care Med. 2021 Jul 1;49(7):1015-1025. doi: 10.1097/CCM.0000000000005066.']",,2021-12-06,https://clinicaltrials.gov/show/NCT04344535,2021-01-01,1,1
255,NCT04344548,Withdrawn,2020-06-30,2020-10-30,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04344548,2020-06-30,0,0
256,NCT04344730,"Active, not recruiting",2021-12-31,2021-12-31,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04344730,2021-12-31,0,0
257,NCT04344756,Not yet recruiting,2020-07-31,2020-09-30,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04344756,2020-07-31,0,1
258,NCT04344782,Not yet recruiting,2020-09-30,2020-11-30,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04344782,2020-09-30,0,0
259,NCT04344834,Recruiting,2021-03-30,2021-06-30,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04344834,2021-03-30,0,0
260,NCT04344938,Not yet recruiting,2020-06-01,2020-07-01,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04344938,2020-06-01,0,0
261,NCT04344964,Completed,2020-05-29,2020-07-03,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04344964,2020-05-29,0,0
262,NCT04345315,Recruiting,2021-03-01,2022-03-01,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04345315,2021-03-01,0,0
263,NCT04345406,Not yet recruiting,2029-12-01,2029-12-01,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04345406,2029-12-01,0,0
264,NCT04345445,Not yet recruiting,2020-10-31,2020-10-31,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04345445,2020-10-31,0,0
265,NCT04345510,Completed,2021-09-30,2021-09-30,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04345510,2021-09-30,0,0
266,NCT04345523,Completed,2021-02-05,2021-04-05,No Results Posted,"['Avenda√±o-Sol√° C, Ramos-Mart√≠nez A, Mu√±ez-Rubio E, Ruiz-Antor√°n B, Malo de Molina R, Torres F, Fern√°ndez-Cruz A, Calder√≥n-Parra J, Payares-Herrera C, D√≠az de Santiago A, Romera-Mart√≠nez I, Pintos I, Lora-Tamayo J, Manche√±o-Losa M, Paciello ML, Mart√≠nez-Gonz√°lez AL, Vid√°n-Est√©vez J, Nu√±ez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fern√°ndez MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-S√°nchez ME, Rubio-Batll√©s M, Velasco-Iglesias A, Pa√±o-Pardo JR, Moreno-Chulilla JA, Mu√±iz-D√≠az E, Casas-Flecha I, P√©rez-Olmeda M, Garc√≠a-P√©rez J, Alcam√≠ J, Bueno JL, Duarte RF; ConPlas-19 Study Group. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. J Clin Invest. 2021 Oct 15;131(20). pii: e152740. doi: 10.1172/JCI152740.', 'Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Diago-Sempere E, Bueno JL, Sancho-L√≥pez A, Rubio EM, Torres F, de Molina RM, Fern√°ndez-Cruz A, de Diego IS, Velasco-Iglesias A, Payares-Herrera C, Flecha IC, Avenda√±o-Sol√† C, Palomino RD, Ramos-Mart√≠nez A, Ruiz-Antor√°n B. Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial. Trials. 2021 Jan 20;22(1):70. doi: 10.1186/s13063-020-05011-9.']",,2021-05-13,https://clinicaltrials.gov/show/NCT04345523,2021-02-05,0,1
267,NCT04345536,Recruiting,2022-01-01,2022-05-01,No Results Posted,"['Holten AR, Nore KG, Tveiten CEVWK, Olasveengen TM, Tonby K. Predicting severe COVID-19 in the Emergency Department. Resusc Plus. 2020 Dec;4:100042. doi: 10.1016/j.resplu.2020.100042. Epub 2020 Oct 21.']",,2021-09-10,https://clinicaltrials.gov/show/NCT04345536,2022-01-01,0,1
268,NCT04345549,Completed,2020-03-30,2020-03-30,No Results Posted,,,2020-04-14,https://clinicaltrials.gov/show/NCT04345549,2020-03-30,0,0
269,NCT04345640,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04345640,2020-12-31,0,0
270,NCT04345887,Completed,2020-06-15,2020-07-05,No Results Posted,,,2021-10-28,https://clinicaltrials.gov/show/NCT04345887,2020-06-15,0,0
271,NCT04346017,Completed,2020-11-23,2020-11-23,No Results Posted,"['Ponthieux F, Dauby N, Maillart E, Fils JF, Smet J, Claus M, Besse-Hammer T, Bels D, Corazza F, Nagant C. Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6. Viral Immunol. 2022 Jan-Feb;35(1):60-70. doi: 10.1089/vim.2021.0111. Epub 2022 Jan 27.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04346017,2020-11-23,0,1
272,NCT04346043,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04346043,2020-10-01,0,0
273,NCT04346056,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04346056,2020-10-01,0,0
274,NCT04346160,Not yet recruiting,2020-04-30,2020-04-30,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04346160,2020-04-30,0,0
275,NCT04346186,Enrolling by invitation,2020-10-01,2021-08-01,No Results Posted,"['Iversen K, Kristensen JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Juul Jensen CA, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, M√∏gelvang R, Gybel-Brask M, Dessau RB, S√∏rensen E, Harritsh√∏j L, Folke F, Sten C, Engel M√∏ller ME, Benfield T, Ullum H, J√∏rgensen CS, Erikstrup C, Ostrowski SR, Nielsen SD, Bundgaard H. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers. Clin Microbiol Infect. 2021 Sep 17. pii: S1198-743X(21)00495-X. doi: 10.1016/j.cmi.2021.09.005. [Epub ahead of print]', 'Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, Knudsen AD, Christensen CE, Fogh K, Norsk JB, Andersen O, Fischer TK, Jensen CAJ, Larsen M, Torp-Pedersen C, Rungby J, Ditlev SB, Hageman I, M√∏gelvang R, Hother CE, Gybel-Brask M, S√∏rensen E, Harritsh√∏j L, Folke F, Sten C, Benfield T, Nielsen SD, Ullum H. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020 Dec;20(12):1401-1408. doi: 10.1016/S1473-3099(20)30589-2. Epub 2020 Aug 3. Erratum in: Lancet Infect Dis. 2020 Oct;20(10):e250.']",,2020-09-25,https://clinicaltrials.gov/show/NCT04346186,2020-10-01,0,1
276,NCT04346264,Enrolling by invitation,2020-06-01,2020-09-30,No Results Posted,,"['Breyer-Kohansal R, Faner R, Breyer MK, Ofenheimer A, Schrott A, Studnicka M, Wouters EFM, Burghuber OC, Hartl S, Agusti A. Factors Associated with Low Lung Function in Different Age Bins in the General Population. Am J Respir Crit Care Med. 2020 Jul 15;202(2):292-296. doi: 10.1164/rccm.202001-0172LE.']",2020-04-16,https://clinicaltrials.gov/show/NCT04346264,2020-06-01,0,1
277,NCT04346329,Withdrawn,2020-06-30,2020-10-30,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04346329,2020-06-30,0,0
278,NCT04346342,Completed,2020-09-01,2020-09-01,No Results Posted,"['Schuijt MTU, van Meenen DMP, Martin-Loeches I, Mazzinari G, Schultz MJ, Paulus F, Serpa Neto A. Association of Time-Varying Intensity of Ventilation With Mortality in Patients With COVID-19 ARDS: Secondary Analysis of the PRoVENT-COVID Study. Front Med (Lausanne). 2021 Nov 18;8:725265. doi: 10.3389/fmed.2021.725265. eCollection 2021.', 'Bos LDJ, Sjoding M, Sinha P, Bhavani SV, Lyons PG, Bewley AF, Botta M, Tsonas AM, Serpa Neto A, Schultz MJ, Dickson RP, Paulus F; PRoVENT-COVID collaborative group. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med. 2021 Dec;9(12):1377-1386. doi: 10.1016/S2213-2600(21)00365-9. Epub 2021 Oct 13. Erratum in: Lancet Respir Med. 2021 Dec;9(12):e114.', 'Schuijt MTU, Schultz MJ, Paulus F, Serpa Neto A; PRoVENT-COVID Collaborative Group. Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study. Crit Care. 2021 Aug 6;25(1):283. doi: 10.1186/s13054-021-03710-6.', 'Valk CMA, Tsonas AM, Botta M, Bos LDJ, Pillay J, Serpa Neto A, Schultz MJ, Paulus F; Writing Committee for the PRoVENT-COVID‚àó Collaborative Group. Association of early positive end-expiratory pressure settings with ventilator-free days in patients with coronavirus disease 2019 acute respiratory distress syndrome: A secondary analysis of the Practice of VENTilation in COVID-19 study. Eur J Anaesthesiol. 2021 Dec 1;38(12):1274-1283. doi: 10.1097/EJA.0000000000001565.', 'Boers NS, Botta M, Tsonas AM, Algera AG, Pillay J, Dongelmans DA, Horn J, Vlaar APJ, Hollmann MW, Bos LDJ, Paulus F, Neto AS, Schultz MJ; PRoVENT-COVID investigators‚Ä†. PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands. Ann Transl Med. 2020 Oct;8(19):1251. doi: 10.21037/atm-20-5107.', 'Botta M, Tsonas AM, Pillay J, Boers LS, Algera AG, Bos LDJ, Dongelmans DA, Hollmann MW, Horn J, Vlaar APJ, Schultz MJ, Neto AS, Paulus F; PRoVENT-COVID Collaborative Group. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2021 Feb;9(2):139-148. doi: 10.1016/S2213-2600(20)30459-8. Epub 2020 Oct 23.']",,2021-07-06,https://clinicaltrials.gov/show/NCT04346342,2020-09-01,0,1
279,NCT04346368,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04346368,2020-12-01,0,0
280,NCT04346810,Not yet recruiting,2020-08-15,2020-09-01,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04346810,2020-08-15,0,0
281,NCT04346927,Completed,2020-10-10,2020-11-30,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04346927,2020-10-10,0,0
282,NCT04346953,Completed,2020-10-01,2020-11-30,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04346953,2020-10-01,0,0
283,NCT04347070,"Active, not recruiting",2020-09-01,2022-12-01,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04347070,2020-09-01,0,0
284,NCT04347369,Recruiting,2020-08-30,2020-12-31,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04347369,2020-08-30,0,0
285,NCT04347460,Recruiting,2020-07-01,2020-08-31,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04347460,2020-07-01,0,0
286,NCT04347850,Recruiting,2022-12-01,2022-12-30,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04347850,2022-12-01,0,0
287,NCT04347876,Recruiting,2020-06-16,2020-06-30,No Results Posted,,,2020-04-15,https://clinicaltrials.gov/show/NCT04347876,2020-06-16,0,0
288,NCT04347889,Withdrawn,2020-12-30,2020-12-30,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04347889,2020-12-30,0,0
289,NCT04347941,Terminated,2021-01-26,2021-01-26,Study Results,,"['Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",2021-12-02,https://clinicaltrials.gov/show/NCT04347941,2021-01-26,1,1
290,NCT04347980,Terminated,2020-08-07,2020-08-07,No Results Posted,,,2021-08-12,https://clinicaltrials.gov/show/NCT04347980,2020-08-07,0,0
291,NCT04348227,"Active, not recruiting",2020-01-01,2021-02-04,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04348227,2020-01-01,0,0
292,NCT04348383,Recruiting,2021-04-15,2021-05-15,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04348383,2021-04-15,0,0
293,NCT04348396,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04348396,2020-12-01,0,0
294,NCT04348422,Recruiting,2021-12-01,2021-12-31,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04348422,2021-12-01,0,0
295,NCT04348448,Not yet recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-04-16,https://clinicaltrials.gov/show/NCT04348448,2020-07-01,0,0
296,NCT04348461,Suspended,2020-09-15,2021-09-30,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04348461,2020-09-15,0,0
297,NCT04348695,Recruiting,2020-05-13,2020-05-13,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,2020-04-17,https://clinicaltrials.gov/show/NCT04348695,2020-05-13,0,1
298,NCT04348864,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04348864,2022-04-01,0,0
299,NCT04348877,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04348877,2020-10-01,0,0
300,NCT04349371,Terminated,2021-02-10,2021-02-10,Results Submitted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04349371,2021-02-10,0,0
301,NCT04349410,Completed,2020-09-14,2020-09-14,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04349410,2020-09-14,0,0
302,NCT04349618,Recruiting,2023-04-15,2023-04-15,No Results Posted,"['Richard JC, Yonis H, Bitker L, Roche S, Wallet F, Dupuis C, Serrier H, Argaud L, Thiery G, Delannoy B, Pommier C, Abraham P, Muller M, Aubrun F, Sigaud F, Rigault G, Joffredo E, Mezidi M, Terzi N, Rabilloud M. Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial. Trials. 2021 Oct 11;22(1):692. doi: 10.1186/s13063-021-05665-z.']",,2021-02-15,https://clinicaltrials.gov/show/NCT04349618,2023-04-15,0,1
303,NCT04349982,Recruiting,2022-06-30,2022-07-31,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04349982,2022-06-30,0,0
304,NCT04350086,Withdrawn,2020-11-20,2020-11-20,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04350086,2020-11-20,0,0
305,NCT04350099,Recruiting,2021-02-15,2021-06-15,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04350099,2021-02-15,0,0
306,NCT04350281,Completed,2020-07-01,2020-07-07,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04350281,2020-07-01,0,0
307,NCT04350671,Enrolling by invitation,2020-04-20,2020-04-24,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04350671,2020-04-20,0,0
308,NCT04350684,Enrolling by invitation,2020-04-22,2020-04-24,No Results Posted,"['Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi MA, Rabiei MM, Hatami F, Shabani M, Moradi O, Gharehbagh FJ, Irvani SSN, Amirdosara M, Hajiesmaeili M, Rezaei O, Khoshkar A, Lotfollahi L, Gachkar L, Dehbsneh HS, Khalili N, Soleymaninia A, Kusha AH, Shoushtari MT, Torabinavid P. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10. Review.']",,2020-04-20,https://clinicaltrials.gov/show/NCT04350684,2020-04-22,0,1
309,NCT04350931,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04350931,2020-10-01,0,0
310,NCT04351295,Completed,2020-09-28,2020-09-28,No Results Posted,"['Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA. Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar;166(3):949-954. doi: 10.1007/s00705-021-04956-9. Epub 2021 Jan 25. Retraction in: Arch Virol. 2022 Jan;167(1):277.\n\nRetraction in:\nArch Virol. 2022 Jan;167(1):277', 'Retraction in:\nArch Virol. 2022 Jan;167(1):277']",,2021-11-01,https://clinicaltrials.gov/show/NCT04351295,2020-09-28,0,1
311,NCT04351490,Withdrawn,2020-07-01,2020-07-01,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.']",,2021-03-11,https://clinicaltrials.gov/show/NCT04351490,2020-07-01,0,1
312,NCT04351529,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04351529,2021-12-01,0,0
313,NCT04351542,Completed,2020-04-06,2020-04-12,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04351542,2020-04-06,0,0
314,NCT04351620,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04351620,2020-06-01,0,0
315,NCT04351646,Not yet recruiting,2022-04-15,2022-04-15,No Results Posted,"['Staines HM, Kirwan DE, Clark DJ, Adams ER, Augustin Y, Byrne RL, Cocozza M, Cubas-Atienzar AI, Cuevas LE, Cusinato M, Davies BMO, Davis M, Davis P, Duvoix A, Eckersley NM, Forton D, Fraser AJ, Garrod G, Hadcocks L, Hu Q, Johnson M, Kay GA, Klekotko K, Lewis Z, Macallan DC, Mensah-Kane J, Menzies S, Monahan I, Moore CM, Nebe-von-Caron G, Owen SI, Sainter C, Sall AA, Schouten J, Williams CT, Wilkins J, Woolston K, Fitchett JRA, Krishna S, Planche T. IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Emerg Infect Dis. 2021 Jan;27(1). doi: 10.3201/eid2701.203074. Epub 2020 Nov 30.']",,2020-04-17,https://clinicaltrials.gov/show/NCT04351646,2022-04-15,0,1
316,NCT04351659,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04351659,2022-09-01,0,0
317,NCT04351711,Recruiting,2024-04-01,2024-04-01,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04351711,2024-04-01,0,0
318,NCT04351763,Completed,2021-05-25,2021-06-05,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04351763,2021-05-25,0,0
319,NCT04351789,Recruiting,2023-04-01,2023-04-01,No Results Posted,,,2020-08-24,https://clinicaltrials.gov/show/NCT04351789,2023-04-01,0,0
320,NCT04351802,Completed,2021-02-15,2021-02-15,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04351802,2021-02-15,0,0
321,NCT04352400,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']","['Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Minakata D, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. Int J Hematol. 2019 Feb;109(2):141-146. doi: 10.1007/s12185-018-02567-w. Epub 2018 Dec 8.', 'Yu G, Li S, Wan R, Wang X, Hu G. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials. Pancreas. 2015 May;44(4):561-9. doi: 10.1097/MPA.0000000000000310.', 'Ferreira FL, Bota DP, Bross A, M√©lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8.']",2021-06-09,https://clinicaltrials.gov/show/NCT04352400,2021-12-01,0,1
322,NCT04352517,Completed,2020-08-31,2020-09-30,No Results Posted,"['Camacho-Cardenosa A, Camacho-Cardenosa M, Merellano-Navarro E, Trap√© √ÅA, Brazo-Sayavera J. [Influence of physical activity during outbreak on psychological states in adults in the Covid-19 pandemic: a study protocol.]. Rev Esp Salud Publica. 2020 Jun 12;94. pii: e202006063. Spanish.']",,2021-02-21,https://clinicaltrials.gov/show/NCT04352517,2020-08-31,0,1
323,NCT04352582,Completed,2020-04-30,2020-04-30,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04352582,2020-04-30,0,0
324,NCT04352803,Not yet recruiting,2024-04-01,2026-04-01,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04352803,2024-04-01,0,0
325,NCT04352959,Completed,2020-12-11,2020-12-11,No Results Posted,"['Carrouel F, Viennot S, Valette M, Cohen JM, Dussart C, Bourgeois D. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 2;21(1):906. doi: 10.1186/s13063-020-04846-6.', 'Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013627. doi: 10.1002/14651858.CD013627.pub2.']",,2021-02-11,https://clinicaltrials.gov/show/NCT04352959,2020-12-11,0,1
326,NCT04353154,"Active, not recruiting",2021-01-31,2022-02-28,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04353154,2021-01-31,0,0
327,NCT04354155,Completed,2021-06-04,2021-06-04,Study Results,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04354155,2021-06-04,1,1
328,NCT04354272,Completed,2020-05-10,2020-05-18,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04354272,2020-05-10,0,0
329,NCT04354558,Recruiting,2021-07-01,2021-08-01,No Results Posted,"['Beyls C, Hermida A, Bohbot Y, Martin N, Viart C, Boisgard S, Daumin C, Huette P, Dupont H, Abou-Arab O, Mahjoub Y. Automated left atrial strain analysis for predicting atrial fibrillation in severe COVID-19 pneumonia: a prospective study. Ann Intensive Care. 2021 Dec 7;11(1):168. doi: 10.1186/s13613-021-00955-w.']",,2020-09-11,https://clinicaltrials.gov/show/NCT04354558,2021-07-01,0,1
330,NCT04354584,Completed,2022-01-10,2022-01-10,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04354584,2022-01-10,0,0
331,NCT04354753,Completed,2020-04-14,2020-04-17,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04354753,2020-04-14,0,0
332,NCT04354857,Completed,2020-07-31,2020-11-30,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04354857,2020-07-31,0,0
333,NCT04355026,Recruiting,2020-06-30,2020-07-31,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04355026,2020-06-30,0,0
334,NCT04355247,Recruiting,2020-07-31,2021-04-30,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04355247,2020-07-31,0,0
335,NCT04355494,,,,,,,2021-03-09,https://clinicaltrials.gov/show/NCT04355494,,0,0
336,NCT04355676,Withdrawn,2020-08-30,2020-08-30,No Results Posted,,,2020-12-07,https://clinicaltrials.gov/show/NCT04355676,2020-08-30,0,0
337,NCT04355741,Completed,2020-07-01,2020-07-16,No Results Posted,,,2020-08-25,https://clinicaltrials.gov/show/NCT04355741,2020-07-01,0,0
338,NCT04356417,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04356417,2020-06-01,0,0
339,NCT04356443,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04356443,2020-12-31,0,0
340,NCT04356508,Not yet recruiting,2020-06-30,2021-08-31,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04356508,2020-06-30,0,0
341,NCT04357275,Recruiting,2021-03-01,2022-03-01,No Results Posted,"['Hilty MP, Moser A, David S, Wendel Garcia PD, Capaldo G, Keiser S, Fumeaux T, Guerci P, Montomoli J, Van Boeckel TP, Jeitziner MM, Que YA, Jakob S, Sch√ºpbach RA, Risc-Icu Investigators For Switzerland. Near real-time observation reveals increased prevalence of young patients in the ICU during the emerging third SARS-CoV-2 wave in Switzerland. Swiss Med Wkly. 2021 Jul 21;151:w20553. doi: 10.4414/smw.2021.20553. eCollection 2021 Jul 19.']",,2020-04-22,https://clinicaltrials.gov/show/NCT04357275,2021-03-01,0,1
342,NCT04357769,Completed,2020-04-20,2020-04-25,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04357769,2020-04-20,0,0
343,NCT04357847,Recruiting,2021-07-31,2021-08-31,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04357847,2021-07-31,0,0
344,NCT04256395,Completed,2020-07-01,2020-07-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04256395,2020-07-01,0,0
345,NCT04313946,Recruiting,2020-08-16,2020-08-18,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04313946,2020-08-16,0,0
346,NCT04318444,Recruiting,2021-03-01,2022-03-01,Results Submitted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,2020-04-27,https://clinicaltrials.gov/show/NCT04318444,2021-03-01,0,1
347,NCT04319016,Recruiting,2020-04-30,2020-05-01,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04319016,2020-04-30,0,0
348,NCT04319445,Completed,2020-07-28,2020-07-28,Study Results,,,2022-03-02,https://clinicaltrials.gov/show/NCT04319445,2020-07-28,1,0
349,NCT04320017,Recruiting,2020-05-20,2020-05-20,No Results Posted,"['Fenioux C, Allenbach Y, Vozy A, Salem J√â, Maalouf G, Vieira M, Le Joncour A, Benveniste O, Saadoun D, Fr√®re C, Campedel L, Salem P, Gligorov J, Funck-Brentano C, Cacoub P, Gougis P. [Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection]. Bull Cancer. 2021 Jun;108(6):581-588. doi: 10.1016/j.bulcan.2021.03.004. Epub 2021 Mar 20. French.']",,2020-04-22,https://clinicaltrials.gov/show/NCT04320017,2020-05-20,0,1
350,NCT04320056,Recruiting,2021-04-30,2021-10-31,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04320056,2021-04-30,0,0
351,NCT04320862,Completed,2021-04-30,2021-04-30,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04320862,2021-04-30,0,0
352,NCT04323839,"Active, not recruiting",2024-03-31,2024-03-31,No Results Posted,"['Afshar Y, Gaw SL, Flaherman VJ, Chambers BD, Krakow D, Berghella V, Shamshirsaz AA, Boatin AA, Aldrovandi G, Greiner A, Riley L, Boscardin WJ, Jamieson DJ, Jacoby VL; Pregnancy CoRonavIrus Outcomes RegIsTrY (PRIORITY) Study. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. Obstet Gynecol. 2020 Dec;136(6):1117-1125. doi: 10.1097/AOG.0000000000004178.']",,2021-11-11,https://clinicaltrials.gov/show/NCT04323839,2024-03-31,0,1
353,NCT04326920,Completed,2020-09-28,2021-02-26,No Results Posted,"['Mehta P, Porter JC, Manson JJ, Isaacs JD, Openshaw PJM, McInnes IB, Summers C, Chambers RC. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respir Med. 2020 Aug;8(8):822-830. doi: 10.1016/S2213-2600(20)30267-8. Epub 2020 Jun 16. Review.', 'Bosteels C, Maes B, Van Damme K, De Leeuw E, Declercq J, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):491. doi: 10.1186/s13063-020-04451-7. Erratum in: Trials. 2020 Jun 22;21(1):554.']",,2021-03-02,https://clinicaltrials.gov/show/NCT04326920,2020-09-28,0,1
354,NCT04327479,"Active, not recruiting",2026-03-25,2026-03-25,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04327479,2026-03-25,0,0
355,NCT04329572,Suspended,2020-05-31,2020-06-30,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04329572,2020-05-31,0,0
356,NCT04330599,"Active, not recruiting",2025-04-01,2025-04-01,No Results Posted,"['Holt H, Talaei M, Greenig M, Zenner D, Symons J, Relton C, Young KS, Davies MR, Thompson KN, Ashman J, Rajpoot SS, Kayyale AA, El Rifai S, Lloyd PJ, Jolliffe D, Timmis O, Finer S, Iliodromiti S, Miners A, Hopkinson NS, Alam B, Lloyd-Jones G, Dietrich T, Chapple I, Pfeffer PE, McCoy D, Davies G, Lyons RA, Griffiths C, Kee F, Sheikh A, Breen G, Shaheen SO, Martineau AR. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 2021 Nov 30. pii: thoraxjnl-2021-217487. doi: 10.1136/thoraxjnl-2021-217487. [Epub ahead of print]']",,2022-01-31,https://clinicaltrials.gov/show/NCT04330599,2025-04-01,0,1
357,NCT04330638,Completed,2020-12-18,2021-04-12,No Results Posted,"['Davidson M, Menon S, Chaimani A, Evrenoglou T, Ghosn L, Gra√±a C, Henschke N, Cogo E, Villanueva G, Ferrand G, Riveros C, Bonnet H, Kapp P, Moran C, Devane D, Meerpohl JJ, Rada G, Hr√≥bjartsson A, Grasselli G, Tovey D, Ravaud P, Boutron I. Interleukin-1 blocking agents for treating COVID-19. Cochrane Database Syst Rev. 2022 Jan 26;1:CD015308. doi: 10.1002/14651858.CD015308. Review.', 'Declercq J, Van Damme KFA, De Leeuw E, Maes B, Bosteels C, Tavernier SJ, De Buyser S, Colman R, Hites M, Verschelden G, Fivez T, Moerman F, Demedts IK, Dauby N, De Schryver N, Govaerts E, Vandecasteele SJ, Van Laethem J, Anguille S, van der Hilst J, Misset B, Slabbynck H, Wittebole X, Li√©nart F, Legrand C, Buyse M, Stevens D, Bauters F, Seys LJM, Aegerter H, Smole U, Bosteels V, Hoste L, Naesens L, Haerynck F, Vandekerckhove L, Depuydt P, van Braeckel E, Rottey S, Peene I, Van Der Straeten C, Hulstaert F, Lambrecht BN. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. Lancet Respir Med. 2021 Dec;9(12):1427-1438. doi: 10.1016/S2213-2600(21)00377-5. Epub 2021 Oct 29.', 'Brands X, de Vries FMC, Uhel F, Haak BW, Peters-Sengers H, Schuurman AR, van Engelen TSR, Lutter R, Cremer OL, Bonten MJ, Schultz MJ, Scicluna BP, van der Poll T; MARS Consortium. Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired Pneumonia. Crit Care Med. 2021 Nov 1;49(11):1901-1911. doi: 10.1097/CCM.0000000000005072.', 'Maes B, Bosteels C, De Leeuw E, Declercq J, Van Damme K, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5. Erratum in: Trials. 2020 Jun 22;21(1):556.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04330638,2020-12-18,0,1
358,NCT04331808,Unknown,2021-03-31,2021-12-31,No Results Posted,"['Hermine O, Mariette X, Porcher R, Resche-Rigon M, Tharaux PL, Ravaud P; on the behalf of the CORIMUNO-19 collaborative group. Effect of Interleukin-6 Receptor Antagonists in Critically Ill Adult Patients with COVID-19 Pneumonia: two Randomised Controlled Trials of the CORIMUNO-19 Collaborative Group. Eur Respir J. 2022 Feb 3. pii: 2102523. doi: 10.1183/13993003.02523-2021. [Epub ahead of print]', 'Tleyjeh IM. The Misleading ""Pooled Effect Estimate"" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 Jun 15;72(12):e1154-e1155. doi: 10.1093/cid/ciaa1735.', 'Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P; CORIMUNO-19 Collaborative Group. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820. Erratum in: JAMA Intern Med. 2021 Jan 1;181(1):144. Erratum in: JAMA Intern Med. 2021 Jul 1;181(7):1021.']",,2020-04-28,https://clinicaltrials.gov/show/NCT04331808,2021-03-31,0,1
359,NCT04332380,Completed,2020-07-28,2020-07-28,No Results Posted,,,2020-08-17,https://clinicaltrials.gov/show/NCT04332380,2020-07-28,0,0
360,NCT04332835,Completed,2020-10-31,2020-11-15,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04332835,2020-10-31,0,0
361,NCT04333589,Recruiting,2020-06-01,2020-09-15,No Results Posted,"['Li J, Zhang C, Wu Z, Wang G, Zhao H. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):488. doi: 10.1186/s13063-020-04430-y.']",,2020-04-24,https://clinicaltrials.gov/show/NCT04333589,2020-06-01,0,1
362,NCT04334265,Recruiting,2020-06-01,2020-12-01,No Results Posted,"['Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):495. doi: 10.1186/s13063-020-04399-8.']",,2020-04-24,https://clinicaltrials.gov/show/NCT04334265,2020-06-01,0,1
363,NCT04334291,Completed,2020-05-01,2020-05-31,No Results Posted,"['Biol√® C, Bianco M, N√∫√±ez-Gil IJ, Cerrato E, Spirito A, Roubin SR, Viana-Llamas MC, Gonzalez A, Castro-Mej√≠a AF, Eid CM, Fern√°ndez-P√©rez C, Uribarri A, Alfonso-Rodriguez E, Ugo F, Guerra F, Feltes G, Akin I, Fern√°ndez-Rozas I, Blasco-Angulo N, Huang J, Aguado MG, Pepe M, Romero R, Becerra-Mu√±oz VM, Estrada V, Macaya C. Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19. J Hosp Med. 2021 Jun;16(6):349-352. doi: 10.12788/jhm.3594.']","['Rivera-Caravaca JM, N√∫√±ez-Gil IJ, Vivas D, Viana-Llamas MC, Uribarri A, Becerra-Mu√±oz VM, Trabattoni D, Fern√°ndez Rozas I, Feltes G, L√≥pez-Pais J, El-Battrawy I, Macaya C, Fernandez-Ortiz A, Estrada V, Mar√≠n F; HOPE COVID-19 Investigators. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19. Eur J Clin Invest. 2021 Jan;51(1):e13436. doi: 10.1111/eci.13436. Epub 2020 Nov 7.', ""N√∫√±ez-Gil IJ, Fern√°ndez-P√©rez C, Estrada V, Becerra-Mu√±oz VM, El-Battrawy I, Uribarri A, Fern√°ndez-Rozas I, Feltes G, Viana-Llamas MC, Trabattoni D, L√≥pez-Pa√≠s J, Pepe M, Romero R, Castro-Mej√≠a AF, Cerrato E, Astrua TC, D'Ascenzo F, Fabregat-Andres O, Moreu J, Guerra F, Signes-Costa J, Mar√≠n F, Buosenso D, Bardaj√≠ A, Raposeiras-Roub√≠n S, Elola J, Molino √Å, G√≥mez-Doblas JJ, Abumayyaleh M, Aparisi √Å, Molina M, Guerri A, Arroyo-Espliguero R, Assanelli E, Mapelli M, Garc√≠a-Acu√±a JM, Brindicci G, Manzone E, Ortega-Armas ME, Bianco M, Trung CP, N√∫√±ez MJ, Castellanos-Lluch C, Garc√≠a-V√°zquez E, Cabello-Clotet N, Jamhour-Chelh K, Tellez MJ, Fern√°ndez-Ortiz A, Macaya C; HOPE COVID-19 Investigators. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2021 Jun;16(4):957-966. doi: 10.1007/s11739-020-02543-5. Epub 2020 Nov 9."", 'N√∫√±ez-Gil IJ, Estrada V, Fern√°ndez-P√©rez C, Fern√°ndez-Rozas I, Mart√≠n-S√°nchez FJ, Macaya C. The COVID-19 curve, health system overload, and mortality. Emergencias. 2020 Ago;32(4):293-295. English, Spanish.', ""Uribarri A, N√∫√±ez-Gil IJ, Aparisi A, Becerra-Mu√±oz VM, Feltes G, Trabattoni D, Fern√°ndez-Rozas I, Viana-Llamas MC, Pepe M, Cerrato E, Capel-Astrua T, Romero R, Castro-Mej√≠a AF, El-Battrawy I, L√≥pez-Pa√≠s J, D'Ascenzo F, Fabregat-Andres O, Bardaj√≠ A, Raposeiras-Roubin S, Mar√≠n F, Fern√°ndez-Ortiz A, Macaya C, Estrada V; HOPE COVID-19 Investigators. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry. J Nephrol. 2020 Aug;33(4):737-745. doi: 10.1007/s40620-020-00790-5. Epub 2020 Jun 29."", ""N√∫√±ez-Gil IJ, Fern√°ndez-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Mu√±oz VM, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas MC, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mej√≠a AF, Raposeiras-Roubin S, D'Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-P√©rez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Underlying heart diseases and acute COVID-19 outcomes. Cardiol J. 2021;28(2):202-214. doi: 10.5603/CJ.a2020.0183. Epub 2020 Dec 21."", 'Becerra-Mu√±oz VM, N√∫√±ez-Gil IJ, Eid CM, Garc√≠a Aguado M, Romero R, Huang J, Mulet A, Ugo F, Rametta F, Liebetrau C, Aparisi A, Fern√°ndez-Rozas I, Viana-Llamas MC, Feltes G, Pepe M, Moreno-Rond√≥n LA, Cerrato E, Raposeiras-Roub√≠n S, Alfonso E, Carrero-Fern√°ndez A, Buz√≥n-Mart√≠n L, Abumayyaleh M, Gonzalez A, Fern√°ndez Ortiz A, Macaya C, Estrada V, Fern√°ndez-P√©rez C, G√≥mez-Doblas JJ. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258.', ""Ruiz-S√°nchez JG, N√∫√±ez-Gil IJ, Cuesta M, Rubio MA, Maroun-Eid C, Arroyo-Espliguero R, Romero R, Becerra-Mu√±oz VM, Uribarri A, Feltes G, Trabattoni D, Molina M, Garc√≠a Aguado M, Pepe M, Cerrato E, Alfonso E, Castro Mej√≠a AF, Roubin SR, Buz√≥n L, Bondia E, Marin F, L√≥pez Pais J, Abumayyaleh M, D'Ascenzo F, Rondano E, Huang J, Fernandez-Perez C, Macaya C, de Miguel Novoa P, Calle-Pascual AL, Estrada Perez V, Runkle I; HOPE COVID-19 investigators. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Front Endocrinol (Lausanne). 2020 Nov 30;11:599255. doi: 10.3389/fendo.2020.599255. eCollection 2020."", ""El-Battrawy I, Nu√±ez-Gil IJ, Abumayyaleh M, Estrada V, Manuel Becerra-Mu√±oz V, Uribarri A, Fern√°ndez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, L√≥pez-Pa√≠s J, Pepe M, Romero R, Castro-Mej√≠a AF, Cerrato E, Capel Astrua T, D'Ascenzo F, Fabregat-Andres O, Signes-Costa J, Mar√≠n F, Buonsenso D, Bardaj√≠ A, Jes√∫s Tellez M, Fern√°ndez-Ortiz A, Macaya C, Akin I. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). Eur J Clin Invest. 2021 Nov;51(11):e13582. doi: 10.1111/eci.13582. Epub 2021 Aug 19."", 'Signes-Costa J, N√∫√±ez-Gil IJ, Soriano JB, Arroyo-Espliguero R, Eid CM, Romero R, Uribarri A, Fern√°ndez-Rozas I, Aguado MG, Becerra-Mu√±oz VM, Huang J, Pepe M, Cerrato E, Raposeiras S, Gonzalez A, Franco-Leon F, Wang L, Alfonso E, Ugo F, Garc√≠a-Prieto JF, Feltes G, Abumayyaleh M, Espejo-Paeres C, Jativa J, Masjuan AL, Macaya C, Carbonell As√≠ns JA, Estrada V; HOPE COVID-19 investigators. Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases. Arch Bronconeumol. 2021 Apr;57:13-20. doi: 10.1016/j.arbres.2020.11.012. Epub 2020 Dec 16.', 'Santoro F, Nu√±ez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, Feltez Guzman G, Fernandez Rozas I, Uribarri A, Becerra-Mu√±oz VM, Alfonso-Rodriguez E, Garcia-Aguado M, Huang J, Ortega-Armas ME, Garcia Prieto JF, Corral Rubio EM, Ugo F, Bianco M, Mulet A, Raposeiras-Roubin S, Jativa Mendez JL, Espejo Paeres C, Albarr√°n AR, Mar√≠n F, Guerra F, Akin I, Cortese B, Ramakrishna H, Macaya C, Fernandez-Ortiz A, Brunetti ND. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry. Heart. 2022 Jan;108(2):130-136. doi: 10.1136/heartjnl-2021-319552. Epub 2021 Oct 5.', 'N√∫√±ez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fern√°ndez-Rozas I, Uribarri A, Becerra-Mu√±oz VM, Alfonso-Rodriguez E, Garc√≠a-Aguado M, Elola J, Castro-Mej√≠a A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras-Roubin S, Mendez JLJ, Espejo C, L√≥pez-Masjuan √Å, Marin F, L√≥pez-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrishna H, Estrada V, Macaya C, Fernandez-Ortiz A; HOPE COVID-19 Investigators (Cols Appendix). Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Am Heart J. 2021 Jul;237:104-115. doi: 10.1016/j.ahj.2021.04.001. Epub 2021 Apr 15.', 'Porta-Etessam J, N√∫√±ez-Gil IJ, Gonz√°lez Garc√≠a N, Fernandez-Perez C, Viana-Llamas MC, Eid CM, Romero R, Molina M, Uribarri A, Becerra-Mu√±oz VM, Aguado MG, Huang J, Rondano E, Cerrato E, Alfonso E, Mej√≠a AFC, Marin F, Roubin SR, Pepe M, Feltes G, Mat√© P, Cortese B, Buz√≥n L, Mendez JJ, Estrada V. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection. 2021 Aug;49(4):677-684. doi: 10.1007/s15010-021-01587-9. Epub 2021 Mar 1.', 'Espejo-Paeres C, N√∫√±ez-Gil IJ, Estrada V, Fern√°ndez-P√©rez C, Uribe-Heredia G, Cabr√©-Verdiell C, Uribarri A, Romero R, Garc√≠a-Aguado M, Fern√°ndez-Rozas I, Becerra-Mu√±oz V, Pepe M, Cerrato E, Raposeiras-Roub√≠n S, Barrionuevo-Ramos M, Aveiga-Ligua F, Aguilar-Andrea C, Alfonso-Rodr√≠guez E, Ugo F, Garc√≠a-Prieto JF, Feltes G, Akin I, Huang J, Jativa J, Fern√°ndez-Ortiz A, Macaya C, Carrero-Fern√°ndez A, Signes-Costa J. Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis. BMJ Nutr Prev Health. 2021 Jun 17;4(1):285-292. doi: 10.1136/bmjnph-2021-000269. eCollection 2021.', 'Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obreg√≥n JA, Uribe-Heredia G, N√∫√±ez-Gil I, Garc√≠a-Magall√≥n B, Tor√°n-Mart√≠nez CG, Castillo-Sandoval A, D√≠az-Caraballo E, Rodr√≠guez-Guinea I, Dom√≠nguez-L√≥pez J. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc). 2021 May 7;156(9):428-436. doi: 10.1016/j.medcli.2020.12.018. Epub 2021 Jan 28. English, Spanish.', 'Abumayyaleh M, N√∫√±ez Gil IJ, El-Battrawy I, Estrada V, Becerra-Mu√±oz VM, Aparisi A, Fern√°ndez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, L√≥pez-Pa√≠s J, Pepe M, Romero R, Garc√≠a DRV, Biole C, Astrua TC, Eid CM, Alfonso E, Fernandez-Presa L, Espejo C, Buonsenso D, Raposeiras S, Fern√°ndez C, Macaya C, Akin I; HOPE COVID-19 investigators. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry. Obes Res Clin Pract. 2021 May-Jun;15(3):275-280. doi: 10.1016/j.orcp.2021.02.008. Epub 2021 Mar 3.', ""Abumayyaleh M, Nu√±ez-Gil IJ, El-Battrawy I, Estrada V, Becerra-Mu√±oz VM, Uribarri A, Fern√°ndez-Rozas I, Feltes G, Arroyo-Espliguero R, Trabattoni D, L√≥pez Pais J, Pepe M, Romero R, Ortega-Armas ME, Bianco M, Astrua TC, D'Ascenzo F, Fabregat-Andres O, Ballester A, Mar√≠n F, Buonsenso D, Sanchez-Gimenez R, Wei√ü C, Fernandez Perez C, Fern√°ndez-Ortiz A, Macaya C, Akin I. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score. Front Med (Lausanne). 2021 Oct 14;8:728102. doi: 10.3389/fmed.2021.728102. eCollection 2021."", 'P√©rez-Segura P, Paz-Cabezas M, N√∫√±ez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fern√°ndez Rozas I, Uribarri A, Becerra-Mu√±oz VM, Garc√≠a Aguado M, Huang J, Rondano E, Cerrato E, Rodr√≠guez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buz√≥n L, El-Battrawy I, Estrada V. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. Med Clin (Barc). 2021 Oct 8;157(7):318-324. doi: 10.1016/j.medcli.2021.02.021. Epub 2021 May 6. English, Spanish.', 'Salgado-Aranda R, P√©rez-Castellano N, N√∫√±ez-Gil I, Orozco AJ, Torres-Esquivel N, Flores-Soler J, Chamaisse-Akari A, Mclnerney A, Vergara-Uzcategui C, Wang L, Gonz√°lez-Ferrer JJ, Filgueiras-Rama D, Ca√±adas-Godoy V, Macaya-Miguel C, P√©rez-Villacast√≠n J. Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study. Infect Dis Ther. 2021 Jun;10(2):801-814. doi: 10.1007/s40121-021-00418-6. Epub 2021 Mar 14.', 'Bertaina M, Nu√±ez-Gil IJ, Franchin L, Fern√°ndez Rozas I, Arroyo-Espliguero R, Viana-Llamas MC, Romero R, Maroun Eid C, Uribarri A, Becerra-Mu√±oz VM, Huang J, Alfonso E, Marmol-Mosquera F, Ugo F, Cerrato E, Fernandez-Presa L, Raposeiras Roubin S, Feltes Guzman G, Gonzalez A, Abumayyaleh M, Fernandez-Ortiz A, Macaya C, Estrada V; HOPE COVID-19 investigators. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry. Emerg Med J. 2021 May;38(5):359-365. doi: 10.1136/emermed-2020-210411. Epub 2021 Mar 16.']",2022-01-25,https://clinicaltrials.gov/show/NCT04334291,2020-05-01,0,1
364,NCT04334980,"Active, not recruiting",2022-02-08,2022-02-28,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04334980,2022-02-08,0,0
365,NCT04335032,Recruiting,2021-11-30,2021-12-01,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04335032,2021-11-30,0,0
366,NCT04335123,Completed,2020-06-21,2020-08-17,Results Submitted,"['Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']",,2021-05-10,https://clinicaltrials.gov/show/NCT04335123,2020-06-21,0,1
367,NCT04337008,Recruiting,2020-06-03,2020-07-31,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04337008,2020-06-03,0,0
368,NCT04338009,Completed,2020-08-20,2020-08-20,Study Results,"['Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C, Rodriguez-Mori JE, Renna N, Chang TI, Corrales-Medina V, Andrade-Villanueva JF, Barbagelata A, Cristodulo-Cortez R, D√≠az-Cucho OA, Spaak J, Alfonso CE, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-Garc√≠a RJ, Castro-Callirgos CA, Gonz√°lez-Hern√°ndez LA, Bernales-Salas EF, Coacalla-Guerra JC, Salinas-Herrera CD, Nicolosi L, Basconcel M, Byrd JB, Sharkoski T, Bendez√∫-Huasasquiche LE, Chittams J, Edmonston DL, Vasquez CR, Chirinos JA. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021 Mar;9(3):275-284. doi: 10.1016/S2213-2600(20)30558-0. Epub 2021 Jan 7.']",,2021-04-09,https://clinicaltrials.gov/show/NCT04338009,2020-08-20,1,1
369,NCT04339712,Completed,2020-12-01,2021-01-08,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04339712,2020-12-01,0,0
370,NCT04341493,Terminated,2020-08-30,2020-12-30,No Results Posted,"['Calder√≥n JM, Zer√≥n HM, Padmanabhan S. Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):504. doi: 10.1186/s13063-020-04448-2.']",,2021-04-01,https://clinicaltrials.gov/show/NCT04341493,2020-08-30,0,1
371,NCT04344184,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04344184,2022-06-01,0,0
372,NCT04344327,Completed,2020-04-21,2020-04-21,No Results Posted,"['Sutter W, Duceau B, Vignac M, Bonnet G, Carlier A, Roussel R, Trimaille A, Pommier T, Guilleminot P, Sagnard A, Pastier J, Weizman O, Giordano G, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Karsenty C, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Gautier A, Fauvel C, Chaumont C, Mika D, Pezel T, Cohen A, Potier L; Critical COVID-19 France Investigators. Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort. Diabetes Metab. 2021 Jul;47(4):101222. doi: 10.1016/j.diabet.2020.101222. Epub 2020 Dec 31.']",,2020-04-28,https://clinicaltrials.gov/show/NCT04344327,2020-04-21,0,1
373,NCT04344431,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04344431,2022-04-01,0,0
374,NCT04345601,Recruiting,2022-10-01,2022-10-01,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04345601,2022-10-01,0,0
375,NCT04345679,Recruiting,2021-06-01,2021-09-01,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04345679,2021-06-01,0,0
376,NCT04346212,Recruiting,2020-12-01,2021-01-01,No Results Posted,"['Martin-Martinez A, Ortega O, Vi√±as P, Arreola V, Nascimento W, Costa A, Riera SA, Alarc√≥n C, Clav√© P. COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients during the spring 2020 wave of the pandemic. Clin Nutr. 2021 Jun 15. pii: S0261-5614(21)00297-1. doi: 10.1016/j.clnu.2021.06.010. [Epub ahead of print]']",,2020-09-23,https://clinicaltrials.gov/show/NCT04346212,2020-12-01,0,1
377,NCT04346797,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04346797,2020-09-30,0,0
378,NCT04347694,Recruiting,2021-04-11,2021-04-11,No Results Posted,"['Reiter T, Pajenda S, Wagner L, Gaggl M, Atamaniuk J, Holzer B, Zimpernik I, Gerges D, Mayer K, Aigner C, Stra√ül R, Jansen-Skoupy S, F√∂dinger M, Sunder-Plassmann G, Schmidt A. COVID-19 serology in nephrology healthcare workers. Wien Klin Wochenschr. 2021 Sep;133(17-18):923-930. doi: 10.1007/s00508-021-01848-5. Epub 2021 Apr 9.']",,2020-09-02,https://clinicaltrials.gov/show/NCT04347694,2021-04-11,0,1
379,NCT04347993,Recruiting,2022-03-01,2022-03-01,No Results Posted,"['Berry DA, Ip A, Lewis BE, Berry SM, Berry NS, MrKulic M, Gadalla V, Sat B, Wright K, Serna M, Unawane R, Trpeski K, Koropsak M, Kaur P, Sica Z, McConnell A, Bednarz U, Marafelias M, Goy AH, Pecora AL, Sawczuk IS, Goldberg SL. Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19. PLoS One. 2021 Jul 30;16(7):e0255228. doi: 10.1371/journal.pone.0255228. eCollection 2021.', 'Biran N, Ip A, Ahn J, Go RC, Wang S, Mathura S, Sinclaire BA, Bednarz U, Marafelias M, Hansen E, Siegel DS, Goy AH, Pecora AL, Sawczuk IS, Koniaris LS, Simwenyi M, Varga DW, Tank LK, Stein AA, Allusson V, Lin GS, Oser WF, Tuma RA, Reichman J, Brusco L Jr, Carpenter KL, Costanzo EJ, Vivona V, Goldberg SL. Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020 Oct;2(10):e603-e612. doi: 10.1016/S2665-9913(20)30277-0. Epub 2020 Aug 14.', 'Ip A, Berry DA, Hansen E, Goy AH, Pecora AL, Sinclaire BA, Bednarz U, Marafelias M, Berry SM, Berry NS, Mathura S, Sawczuk IS, Biran N, Go RC, Sperber S, Piwoz JA, Balani B, Cicogna C, Sebti R, Zuckerman J, Rose KM, Tank L, Jacobs LG, Korcak J, Timmapuri SL, Underwood JP, Sugalski G, Barsky C, Varga DW, Asif A, Landolfi JC, Goldberg SL. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study. PLoS One. 2020 Aug 13;15(8):e0237693. doi: 10.1371/journal.pone.0237693. eCollection 2020.']",,2021-05-04,https://clinicaltrials.gov/show/NCT04347993,2022-03-01,0,1
380,NCT04348474,Suspended,2020-06-30,2020-07-31,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04348474,2020-06-30,0,0
381,NCT04348929,Recruiting,2023-08-16,2023-10-01,No Results Posted,"['Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04348929,2023-08-16,0,1
382,NCT04349202,Completed,2021-01-19,2021-01-19,No Results Posted,"['Sims MD, Maine GN, Childers KL, Podolsky RH, Voss DR, Berkiw-Scenna N, Oh J, Heinrich KE, Keil H, Kennedy RH, Homayouni R. Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking. Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S154-S162. doi: 10.1093/cid/ciaa1684.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04349202,2021-01-19,0,1
383,NCT04350580,Completed,2020-11-20,2021-02-20,No Results Posted,"['Mazeraud A, Jamme M, Mancusi RL, Latroche C, Megarbane B, Siami S, Zarka J, Moneger G, Santoli F, Argaud L, Chillet P, Muller G, Bruel C, Asfar P, Beloncle F, Reignier J, Vinsonneau C, Schimpf C, Amour J, Goulenok C, Lemaitre C, Rohaut B, Mateu P, De Rudnicki S, Mourvillier B, Declercq PL, Schwebel C, Stoclin A, Garnier M, Madeux B, Gaudry S, Bailly K, Lamer C, Aegerter P, Rieu C, Sylla K, Lucas B, Sharshar T. Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022 Feb;10(2):158-166. doi: 10.1016/S2213-2600(21)00440-9. Epub 2021 Nov 11.', 'Mazeraud A, Gon√ßalves B, Aegerter P, Mancusi L, Rieu C, Bozza F, Sylla K, Siami S, Sharshar T. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial. Trials. 2021 Feb 28;22(1):170. doi: 10.1186/s13063-021-05118-7.']",,2021-08-19,https://clinicaltrials.gov/show/NCT04350580,2020-11-20,0,1
384,NCT04351724,Recruiting,2021-12-01,2022-03-31,No Results Posted,"['Heber S, Pereyra D, Schrottmaier WC, Kammerer K, Santol J, Rumpf B, Pawelka E, Hanna M, Scholz A, Liu M, Hell A, Heiplik K, Lickefett B, Havervall S, Traugott MT, Neub√∂ck MJ, Sch√∂rgenhofer C, Seitz T, Firbas C, Karolyi M, Weiss G, Jilma B, Th√•lin C, Bellmann-Weiler R, Salzer HJF, Szepannek G, Fischer MJM, Zoufaly A, Gleiss A, Assinger A. A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation. Front Cell Infect Microbiol. 2022 Jan 24;11:795026. doi: 10.3389/fcimb.2021.795026. eCollection 2021.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-03-02,https://clinicaltrials.gov/show/NCT04351724,2021-12-01,0,1
385,NCT04351854,Recruiting,2025-12-31,2026-08-31,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04351854,2025-12-31,0,0
386,NCT04352608,Completed,2020-07-10,2021-07-24,No Results Posted,"['Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, Wu Z, Jiang D, Deng X, Chu K, Zheng W, Wang L, Lu W, Han B, Zhao Y, Zhu F, Yu H, Yin W. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect Dis. 2021 Dec 7. pii: S1473-3099(21)00681-2. doi: 10.1016/S1473-3099(21)00681-2. [Epub ahead of print]', 'Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.']",,2022-02-24,https://clinicaltrials.gov/show/NCT04352608,2020-07-10,0,1
387,NCT04352764,Recruiting,2020-12-31,2021-01-31,No Results Posted,"['Mohanty S, Lakkireddy D, Trivedi C, MacDonald B, Quintero Mayedo A, Della Rocca DG, Atkins D, Park P, Shah A, Gopinathannair R, Al-Ahmad A, Burkhardt JD, Gallinghouse GJ, Bassiouny M, Di Biase L, Kessler D, Tschopp D, Coffeen P, Horton R, Canby R, Natale A. Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience. J Interv Card Electrophysiol. 2021 Oct;62(1):171-176. doi: 10.1007/s10840-020-00886-9. Epub 2020 Oct 1.']",,2020-04-27,https://clinicaltrials.gov/show/NCT04352764,2020-12-31,0,1
388,NCT04352946,Not yet recruiting,2020-06-24,2020-08-24,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04352946,2020-06-24,0,0
389,NCT04353037,Terminated,2020-07-11,2020-07-11,Study Results,,,2021-10-19,https://clinicaltrials.gov/show/NCT04353037,2020-07-11,1,0
390,NCT04353518,Recruiting,2021-03-30,2021-05-30,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04353518,2021-03-30,0,0
391,NCT04353609,Recruiting,2020-12-01,2020-12-01,No Results Posted,"['Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors; FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25.', 'FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients. Ann Rheum Dis. 2020 Dec 2. pii: annrheumdis-2020-218310. doi: 10.1136/annrheumdis-2020-218310. [Epub ahead of print]']",,2020-04-22,https://clinicaltrials.gov/show/NCT04353609,2020-12-01,0,1
392,NCT04354870,Completed,2020-09-15,2020-10-01,Study Results,,,2021-10-06,https://clinicaltrials.gov/show/NCT04354870,2020-09-15,1,0
393,NCT04355052,Recruiting,2020-10-11,2020-12-11,No Results Posted,,,2020-04-21,https://clinicaltrials.gov/show/NCT04355052,2020-10-11,0,0
394,NCT04355234,"Active, not recruiting",2021-08-31,2021-08-31,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04355234,2021-08-31,0,0
395,NCT04355338,Recruiting,2021-05-30,2022-05-30,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04355338,2021-05-30,0,0
396,NCT04355429,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005 Sep 16;309(5742):1864-8.', 'Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005 Jul 7;436(7047):112-6.', 'Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.']",2020-04-28,https://clinicaltrials.gov/show/NCT04355429,2020-07-01,0,1
397,NCT04355481,Recruiting,2020-10-17,2020-12-17,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04355481,2020-10-17,0,0
398,NCT04355507,Completed,2020-10-16,2020-10-16,No Results Posted,"['Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, Chassagnon G, Milon A, Lederlin M, Bennani S, Moli√®re S, Debray MP, Bompard F, Dangeard S, Hani C, Ohana M, Bommart S, Jalaber C, El Hajjam M, Petit I, Fournier L, Khalil A, Brillet PY, Bellin MF, Redheuil A, Rocher L, Bousson V, Rousset P, Gr√©gory J, Deux JF, Dion E, Valeyre D, Porcher R, Jilet L, Abdoul H. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021 Oct;301(1):E361-E370. doi: 10.1148/radiol.2021210384. Epub 2021 Jun 29.']",,2020-12-21,https://clinicaltrials.gov/show/NCT04355507,2020-10-16,0,1
399,NCT04355715,Completed,2020-10-01,2020-10-20,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04355715,2020-10-01,0,0
400,NCT04355754,Recruiting,2020-05-01,2020-12-31,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04355754,2020-05-01,0,0
401,NCT04355793,,,,,,,2021-12-15,https://clinicaltrials.gov/show/NCT04355793,,0,0
402,NCT04355884,Not yet recruiting,2020-05-01,2020-05-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04355884,2020-05-01,0,0
403,NCT04355962,Completed,2021-06-25,2021-07-16,No Results Posted,,,2021-07-19,https://clinicaltrials.gov/show/NCT04355962,2021-06-25,0,0
404,NCT04356365,Completed,2020-04-07,2020-04-07,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04356365,2020-04-07,0,0
405,NCT04356560,Enrolling by invitation,2020-09-30,2020-12-31,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04356560,2020-09-30,0,0
406,NCT04356586,Completed,2020-08-21,2020-08-21,No Results Posted,,,2020-09-07,https://clinicaltrials.gov/show/NCT04356586,2020-08-21,0,0
407,NCT04356677,Withdrawn,2021-08-01,2021-08-01,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04356677,2021-08-01,0,0
408,NCT04357106,Recruiting,2020-07-01,2020-08-01,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,2020-04-22,https://clinicaltrials.gov/show/NCT04357106,2020-07-01,0,1
409,NCT04357327,Completed,2020-05-31,2020-07-31,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04357327,2020-05-31,0,0
410,NCT04357366,Recruiting,2022-04-15,2022-04-15,No Results Posted,"['Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N, Karakike E, Saridaki M, Loli G, Stefos A, Prasianaki D, Georgiadou S, Tsachouridou O, Petrakis V, Tsiakos K, Kosmidou M, Lygoura V, Dareioti M, Milionis H, Papanikolaou IC, Akinosoglou K, Myrodia DM, Gravvani A, Stamou A, Gkavogianni T, Katrini K, Marantos T, Trontzas IP, Syrigos K, Chatzis L, Chatzis S, Vechlidis N, Avgoustou C, Chalvatzis S, Kyprianou M, van der Meer JW, Eugen-Olsen J, Netea MG, Giamarellos-Bourboulis EJ. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 Mar 8;10. pii: e66125. doi: 10.7554/eLife.66125.']",,2021-02-15,https://clinicaltrials.gov/show/NCT04357366,2022-04-15,0,1
411,NCT04357418,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-08-03,https://clinicaltrials.gov/show/NCT04357418,2020-06-30,0,0
412,NCT04357496,Withdrawn,2021-05-01,2021-05-01,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04357496,2021-05-01,0,0
413,NCT04357574,Enrolling by invitation,2022-04-01,2022-04-01,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04357574,2022-04-01,0,0
414,NCT04357613,Not yet recruiting,2020-12-01,2021-12-01,No Results Posted,"['Zhao H, Mendenhall M, Deininger MW. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia. 2020 Nov;34(11):3085-3087. doi: 10.1038/s41375-020-01045-9. Epub 2020 Sep 30.']",,2020-08-07,https://clinicaltrials.gov/show/NCT04357613,2020-12-01,0,1
415,NCT04357782,Completed,2020-10-13,2020-10-13,Study Results,,,2022-02-25,https://clinicaltrials.gov/show/NCT04357782,2020-10-13,1,0
416,NCT04357808,Completed,2020-11-30,2020-12-04,No Results Posted,"['Garc√≠a-Vicu√±a R, Rodriguez-Garc√≠a SC, Abad-Santos F, Bautista Hern√°ndez A, Garc√≠a-Fraile L, Barrios Blandino A, Guti√©rrez Liarte A, Alonso-P√©rez T, Carde√±oso L, Alfranca A, Mej√≠a-Abril G, Sanz Sanz J, Gonz√°lez-Alvaro I. Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial. Front Med (Lausanne). 2022 Feb 23;9:819621. doi: 10.3389/fmed.2022.819621. eCollection 2022.', 'Garcia-Vicu√±a R, Abad-Santos F, Gonz√°lez-Alvaro I, Ramos-Lima F, Sanz JS. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 9;21(1):772. doi: 10.1186/s13063-020-04588-5.']",,2021-02-11,https://clinicaltrials.gov/show/NCT04357808,2020-11-30,0,1
417,NCT04357834,Completed,2021-06-30,2021-06-30,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04357834,2021-06-30,0,0
418,NCT04357860,Completed,2021-03-09,2021-04-06,No Results Posted,"['Merchante N, C√°rcel S, Garrido-Gracia JC, Trigo-Rodr√≠guez M, Moreno M√ÅE, Le√≥n-L√≥pez R, Esp√≠ndola-G√≥mez R, Alonso EA, Garc√≠a DV, Romero-Palacios A, P√©rez-Camacho I, Guti√©rrez-Guti√©rrez B, Mart√≠nez-Marcos FJ, Fern√°ndez-Rold√°n C, P√©rez-Crespo PMM, Ca√±o AA, Le√≥n E, Corzo JE, de la Fuente C, Torre-Cisneros J. Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0210721. doi: 10.1128/AAC.02107-21. Epub 2021 Dec 13.', 'Le√≥n L√≥pez R, Fern√°ndez SC, Limia P√©rez L, Romero Palacios A, Fern√°ndez-Rold√°n MC, Aguilar Alonso E, P√©rez Camacho I, Rodriguez-Ba√±o J, Merchante N, Olalla J, Esteban-Moreno M√Å, Santos M, Luque-Pineda A, Torre-Cisneros J. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial. BMJ Open. 2020 Nov 14;10(11):e039951. doi: 10.1136/bmjopen-2020-039951.']",,2021-07-07,https://clinicaltrials.gov/show/NCT04357860,2021-03-09,0,1
419,NCT04357886,Completed,2020-06-01,2020-06-01,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04357886,2020-06-01,0,0
420,NCT04358042,Terminated,2020-07-02,2020-07-02,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04358042,2020-07-02,0,0
421,NCT04358211,,,,,"['Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE, Bilton SJ, Linhuber JP, Norton EB, Dietrich ML, Yee J, Lai W, Scott JW, Yin XM, Rappaport J, Robinson JE, Saba NS, Roy CJ, Zwezdaryk KJ, Zhao Z, Hu TY. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest. 2021 Apr 1;131(7). pii: 146031. doi: 10.1172/JCI146031.']","['van Erp EA, Luytjes W, Ferwerda G, van Kasteren PB. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. Front Immunol. 2019 Mar 22;10:548. doi: 10.3389/fimmu.2019.00548. eCollection 2019. Review.', 'Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, He L, Chen Y, Wu J, Shi Z, Zhou Y, Du L, Li F. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J Virol. 2020 Feb 14;94(5). pii: e02015-19. doi: 10.1128/JVI.02015-19. Print 2020 Feb 14.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.']",2021-03-08,https://clinicaltrials.gov/show/NCT04358211,,0,1
422,NCT04358406,"Active, not recruiting",2021-05-01,2021-06-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04358406,2021-05-01,0,0
423,NCT04358510,Completed,2020-04-17,2020-04-17,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04358510,2020-04-17,0,0
424,NCT04358536,Completed,2020-04-17,2020-04-17,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04358536,2020-04-17,0,0
425,NCT04358614,Completed,2020-04-05,2020-04-07,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04358614,2020-04-05,0,0
426,NCT04358627,Not yet recruiting,2020-05-30,2020-06-30,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04358627,2020-05-30,0,0
427,NCT04358640,Completed,2020-04-27,2020-04-27,No Results Posted,,,2020-12-19,https://clinicaltrials.gov/show/NCT04358640,2020-04-27,0,0
428,NCT04358809,Recruiting,2021-02-28,2021-04-30,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04358809,2021-02-28,0,0
429,NCT04359095,Completed,2021-03-20,2021-06-30,No Results Posted,"['Gait√°n-Duarte HG, √Ålvarez-Moreno C, Rinc√≥n-Rodr√≠guez CJ, Yomayusa-Gonz√°lez N, Cort√©s JA, Villar JC, Bravo-Ojeda JS, Garc√≠a-Pe√±a A, Adarme-Jaimes W, Rodr√≠guez-Romero VA, Villate-Soto SL, Buitrago G, Chac√≥n-Sarmiento J, Macias-Quintero M, Vaca CP, G√≥mez-Restrepo C, Rodr√≠guez-Malag√≥n N. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial. EClinicalMedicine. 2022 Jan;43:101242. doi: 10.1016/j.eclinm.2021.101242. Epub 2021 Dec 20.']","['Hatem A, Mohamed S, Abu Elhassan UE, Ismael EAM, Rizk MS, El-Kholy A, El-Harras M. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014. Multidiscip Respir Med. 2019 Apr 1;14:11. doi: 10.1186/s40248-019-0174-7. eCollection 2019.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.', 'Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21. Review.', 'Asociaci√≥n Colombiana de Infectolog√≠a. Consenso Colombiano de atenci√≥n, diagn√≥stico y manejo de la Infecci√≥n por SARS COV-2 / COVID 19 en establecimientos de atenci√≥n de la salud. 2020.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Mo Y, Fisher D. A review of treatment modalities for Middle East Respiratory Syndrome. J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. Epub 2016 Sep 1. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Romanelli F, Smith KM, Hoven AD. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. Curr Pharm Des. 2004;10(21):2643-8. Review.', 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.', 'Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol. 2010 May;82(5):817-24. doi: 10.1002/jmv.21663.', 'Farias KJ, Machado PR, de Almeida Junior RF, de Aquino AA, da Fonseca BA. Chloroquine interferes with dengue-2 virus replication in U937 cells. Microbiol Immunol. 2014 Jun;58(6):318-26. doi: 10.1111/1348-0421.12154.', 'Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.', 'Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Review.', 'Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol. 2018 Oct 8;8:343. doi: 10.3389/fcimb.2018.00343. eCollection 2018. Review.', 'Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG. Influenza: emergence and control. J Virol. 2004 Sep;78(17):8951-9. Review.', 'Remolina YA, Ulloa MM, Vargas H, D√≠az L, G√≥mez SL, Saavedra A, S√°nchez E, Cort√©s JA. Viral Infection in Adults with Severe Acute Respiratory Infection in Colombia. PLoS One. 2015 Nov 17;10(11):e0143152. doi: 10.1371/journal.pone.0143152. eCollection 2015.', 'Lachin JM. A review of methods for futility stopping based on conditional power. Stat Med. 2005 Sep 30;24(18):2747-64. Review.']",2021-08-12,https://clinicaltrials.gov/show/NCT04359095,2021-03-20,0,1
430,NCT04359251,Completed,2020-03-25,2020-03-25,No Results Posted,"['Pan C, Lu C, She X, Ren H, Wei H, Xu L, Huang Y, Xia J, Yu Y, Chen L, Du B, Qiu H. Evaluation of Positive End-Expiratory Pressure Strategies in Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021 Jul 20;8:637747. doi: 10.3389/fmed.2021.637747. eCollection 2021.']",,2020-04-24,https://clinicaltrials.gov/show/NCT04359251,2020-03-25,0,1
431,NCT04359290,Completed,2020-12-31,2021-07-30,No Results Posted,"['Neubauer A, Johow J, Mack E, Burchert A, Meyn D, Kadlubiec A, Torje I, Wulf H, Vogelmeier CF, Hoyer J, Skevaki C, Muellenbach RM, Keller C, Schade-Brittinger C, Rolfes C, Wiesmann T. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia. 2021 Oct;35(10):2917-2923. doi: 10.1038/s41375-021-01374-3. Epub 2021 Aug 12. Erratum in: Leukemia. 2021 Sep 13;:.']",,2021-08-24,https://clinicaltrials.gov/show/NCT04359290,2020-12-31,0,1
432,NCT04359316,Not yet recruiting,2020-05-03,2020-05-05,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04359316,2020-05-03,0,0
433,NCT04359329,Terminated,2020-07-30,2020-07-30,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,2021-11-26,https://clinicaltrials.gov/show/NCT04359329,2020-07-30,0,1
434,NCT04359459,Not yet recruiting,2022-06-01,2022-06-01,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04359459,2022-06-01,0,0
435,NCT04359615,Not yet recruiting,2020-05-03,2020-05-05,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04359615,2020-05-03,0,0
436,NCT04359836,Recruiting,2024-04-30,2025-07-31,No Results Posted,"['Papoutsis A, Borody T, Dolai S, Daniels J, Steinberg S, Barrows B, Hazan S. Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing. Gut Pathog. 2021 Jan 30;13(1):7. doi: 10.1186/s13099-021-00398-5.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04359836,2024-04-30,0,1
437,NCT04359849,Recruiting,2022-05-01,2022-09-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04359849,2022-05-01,0,0
438,NCT04359875,Completed,2020-06-30,2020-12-31,No Results Posted,,,2021-04-12,https://clinicaltrials.gov/show/NCT04359875,2020-06-30,0,0
439,NCT04359914,Recruiting,2021-10-31,2022-03-31,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04359914,2021-10-31,0,0
440,NCT04359953,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04359953,2022-04-01,0,0
441,NCT04359992,Not yet recruiting,2021-04-17,2021-05-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04359992,2021-04-17,0,0
442,NCT04360096,Recruiting,2021-12-15,2021-12-31,No Results Posted,,,2021-12-01,https://clinicaltrials.gov/show/NCT04360096,2021-12-15,0,0
443,NCT04360356,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04360356,2020-10-01,0,0
444,NCT04360486,,,,,,,2022-03-04,https://clinicaltrials.gov/show/NCT04360486,,0,0
445,NCT04360538,Recruiting,2022-07-01,2022-12-30,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04360538,2022-07-01,0,0
446,NCT04360551,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-08-03,https://clinicaltrials.gov/show/NCT04360551,2021-06-30,0,0
447,NCT04360733,Recruiting,2022-04-01,2022-09-01,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04360733,2022-04-01,0,0
448,NCT04360759,Withdrawn,2021-05-30,2021-06-30,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04360759,2021-05-30,0,0
449,NCT04360811,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04360811,2022-04-01,0,0
450,NCT04360850,Completed,2020-06-03,2020-06-03,No Results Posted,,"['Sampaio M, Navarro Haro MV, Wilks C, De Sousa B, Garcia-Palacios A, Hoffman HG. Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next. Telemed J E Health. 2021 Aug;27(8):919-928. doi: 10.1089/tmj.2021.0124. Epub 2021 Jun 28.', 'Sampaio M, Haro MVN, De Sousa B, Melo WV, Hoffman HG. Therapists Make the Switch to Telepsychology to Safely Continue Treating Their Patients During the COVID-19 Pandemic. Virtual Reality Telepsychology May Be Next. Front Virtual Real. 2021 Jan;1. pii: 576421. doi: 10.3389/frvir.2020.576421. Epub 2021 Jan 15.']",2021-10-29,https://clinicaltrials.gov/show/NCT04360850,2020-06-03,0,1
451,NCT04360863,Recruiting,2021-12-30,2021-12-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04360863,2021-12-30,0,0
452,NCT04360876,Withdrawn,2020-12-31,2021-01-30,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04360876,2020-12-31,0,0
453,NCT04360954,Completed,2020-07-08,2020-07-08,No Results Posted,,,2020-12-31,https://clinicaltrials.gov/show/NCT04360954,2020-07-08,0,0
454,NCT04360980,Completed,2021-01-01,2021-01-30,No Results Posted,"['Dalili N, Kashefizadeh A, Nafar M, Poorrezagholi F, Firouzan A, Samadian F, Samavat S, Ziaie S, Fatemizadeh S. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Trials. 2020 Jun 5;21(1):489. doi: 10.1186/s13063-020-04455-3.']",,2022-01-28,https://clinicaltrials.gov/show/NCT04360980,2021-01-01,0,1
455,NCT04361019,Completed,2020-05-20,2021-05-20,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04361019,2020-05-20,0,0
456,NCT04361318,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04361318,2020-10-01,0,0
457,NCT04361422,Not yet recruiting,2021-08-01,2021-12-01,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04361422,2021-08-01,0,0
458,NCT04361435,Not yet recruiting,2020-07-31,2020-12-31,No Results Posted,"['Kawaguchi A, Bernier G, Lacroix J, El Salti S, Cheng MP, Lee TC, Khwaja K, Jouvet P. Comparison of two methods to clear the airways of critically ill children and adults with COVID-19 infection: a structured summary of a study protocol for a pilot randomized controlled trial. Trials. 2020 Jul 3;21(1):610. doi: 10.1186/s13063-020-04533-6.']","['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology. 2020 Aug;296(2):E113-E114. doi: 10.1148/radiol.2020200527. Epub 2020 Feb 27.', 'Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, Zheng C. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.', 'Roqu√© i Figuls M, Gin√©-Garriga M, Granados Rugeles C, Perrotta C, Vilar√≥ J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;2:CD004873. doi: 10.1002/14651858.CD004873.pub5. Review.', 'Chaves GS, Freitas DA, Santino TA, Nogueira PAM, Fregonezi GA, Mendon√ßa KM. Chest physiotherapy for pneumonia in children. Cochrane Database Syst Rev. 2019 Jan 2;1:CD010277. doi: 10.1002/14651858.CD010277.pub3.', 'Hough JL, Flenady V, Johnston L, Woodgate PG. Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006445. doi: 10.1002/14651858.CD006445.pub2. Review.', 'Lauwers E, Ides K, Van Hoorenbeeck K, Verhulst S. The effect of intrapulmonary percussive ventilation in pediatric patients: A systematic review. Pediatr Pulmonol. 2018 Nov;53(11):1463-1474. doi: 10.1002/ppul.24135. Epub 2018 Jul 18.', 'Ferreira LL, Valenti VE, Vanderlei LC. Chest physiotherapy on intracranial pressure of critically ill patients admitted to the intensive care unit: a systematic review. Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):327-33. doi: 10.5935/0103-507X.20130055. Review. English, Portuguese.', 'Schieppati D, Germon R, Galli F, Rigamonti MG, Stucchi M, Boffito DC. Influence of frequency and amplitude on the mucus viscoelasticity of the novel mechano-acoustic Frequencer‚Ñ¢. Respir Med. 2019 Jul;153:52-59. doi: 10.1016/j.rmed.2019.04.011. Epub 2019 May 27.', 'Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Clin Invest Med. 2006 Jun;29(3):159-65.', 'Adams JY, Rogers AJ, Schuler A, Marelich GP, Fresco JM, Taylor SL, Riedl AW, Baker JM, Escobar GJ, Liu VX. Association Between Peripheral Blood Oxygen Saturation (SpO(2))/Fraction of Inspired Oxygen (FiO(2)) Ratio Time at Risk and Hospital Mortality in Mechanically Ventilated Patients. Perm J. 2020;24. doi: 10.7812/TPP/19.113. Epub 2020 Jan 31.', 'Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res. 2015;7(1):28-31. doi: 10.15171/jcvtr.2014.06. Epub 2015 Mar 29.', 'Ghazal S, Sauthier M, Brossier D, Bouachir W, Jouvet PA, Noumeir R. Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: A single center pilot study. PLoS One. 2019 Feb 20;14(2):e0198921. doi: 10.1371/journal.pone.0198921. eCollection 2019.', 'Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327.', 'Kwack WG, Lee DS, Min H, Choi YY, Yun M, Kim Y, Lee SH, Song I, Park JS, Cho YJ, Jo YH, Yoon HI, Lee JH, Lee CT, Lee YJ. Evaluation of the SpO2/FiO2 ratio as a predictor of intensive care unit transfers in respiratory ward patients for whom the rapid response system has been activated. PLoS One. 2018 Jul 31;13(7):e0201632. doi: 10.1371/journal.pone.0201632. eCollection 2018.', 'Wiedermann FJ, Stichlberger M, Glodny B. ARDS diagnosed by SpO(2)/FiO(2) ratio compared with PaO(2)/FiO(2) ratio: the role as a diagnostic tool for early enrolment into clinical trials. Open Med (Wars). 2016 Aug 2;11(1):297. doi: 10.1515/med-2016-0056. eCollection 2016.']",2020-04-28,https://clinicaltrials.gov/show/NCT04361435,2020-07-31,0,1
459,NCT04361448,Terminated,2020-06-30,2020-06-30,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04361448,2020-06-30,0,0
460,NCT04361461,Withdrawn,2020-11-04,2020-11-04,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04361461,2020-11-04,0,0
461,NCT04361500,Recruiting,2020-10-01,2021-10-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04361500,2020-10-01,0,0
462,NCT04361526,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04361526,2020-07-01,0,0
463,NCT04361591,Unknown,2021-03-01,2021-03-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04361591,2021-03-01,0,0
464,NCT04361604,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-04-24,https://clinicaltrials.gov/show/NCT04361604,2020-10-01,0,0
465,NCT04361786,Completed,2020-06-30,2020-10-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04361786,2020-06-30,0,0
466,NCT04361903,Not yet recruiting,2020-05-24,2020-05-31,No Results Posted,"['Capochiani E, Frediani B, Iervasi G, Paolicchi A, Sani S, Roncucci P, Cuccaro A, Franchi F, Simonetti F, Carrara D, Bertaggia I, Nasso D, Riccioni R, Scolletta S, Valente S, Conticini E, Gozzetti A, Bocchia M. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol. Front Med (Lausanne). 2020 Aug 4;7:466. doi: 10.3389/fmed.2020.00466. eCollection 2020.']",,2020-04-24,https://clinicaltrials.gov/show/NCT04361903,2020-05-24,0,1
467,NCT04361916,Terminated,2020-06-30,2020-06-30,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04361916,2020-06-30,0,0
468,NCT04361981,Not yet recruiting,2020-08-31,2020-12-31,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04361981,2020-08-31,0,0
469,NCT04362111,"Active, not recruiting",2022-01-01,2022-03-01,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04362111,2022-01-01,0,0
470,NCT04362124,Withdrawn,2021-06-01,2021-11-01,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04362124,2021-06-01,0,0
471,NCT04362358,Completed,2021-09-01,2021-09-01,No Results Posted,"['Weiner L, Berna F, Nourry N, Severac F, Vidailhet P, Mengin AC. Efficacy of an online cognitive behavioral therapy program developed for healthcare workers during the COVID-19 pandemic: the REduction of STress (REST) study protocol for a randomized controlled trial. Trials. 2020 Oct 21;21(1):870. doi: 10.1186/s13063-020-04772-7.']",,2021-09-27,https://clinicaltrials.gov/show/NCT04362358,2021-09-01,0,1
472,NCT04362943,Completed,2021-04-15,2021-04-15,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04362943,2021-04-15,0,0
473,NCT04362956,Completed,2020-10-01,2020-10-01,No Results Posted,"['Larcade R, DeShea L, Lang GA, Caballero MT, Ferretti A, Beasley WH, Tipple TE, Vain N, Prudent L, Lang ML, Polack FP, Ofman G. Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort. J Infect Dis. 2022 Mar 2;225(5):800-809. doi: 10.1093/infdis/jiab591.']",,2021-02-09,https://clinicaltrials.gov/show/NCT04362956,2020-10-01,0,1
474,NCT04363099,Recruiting,2020-06-30,2020-12-31,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04363099,2020-06-30,0,0
475,NCT04363268,Recruiting,2030-04-20,2031-10-01,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04363268,2030-04-20,0,0
476,NCT04363372,Withdrawn,2020-12-01,2021-01-01,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04363372,2020-12-01,0,0
477,NCT04363489,Recruiting,2021-05-30,2021-06-30,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04363489,2021-05-30,0,0
478,NCT04363528,"Active, not recruiting",2020-12-30,2021-12-30,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04363528,2020-12-30,0,0
479,NCT04363541,Recruiting,2022-04-01,2022-06-01,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04363541,2022-04-01,0,0
480,NCT04363671,Not yet recruiting,2020-06-01,2020-12-01,No Results Posted,,,2020-04-27,https://clinicaltrials.gov/show/NCT04363671,2020-06-01,0,0
481,NCT04363749,Completed,2021-01-11,2021-01-11,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04363749,2021-01-11,0,0
482,NCT04363788,Completed,2020-04-24,2020-04-24,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04363788,2020-04-24,0,0
483,NCT04363840,Withdrawn,2020-12-01,2020-12-01,No Results Posted,,,2021-12-27,https://clinicaltrials.gov/show/NCT04363840,2020-12-01,0,0
484,NCT04363866,Withdrawn,2021-03-01,2021-09-01,No Results Posted,,,2020-10-29,https://clinicaltrials.gov/show/NCT04363866,2021-03-01,0,0
485,NCT04364022,Completed,2021-03-24,2021-03-24,No Results Posted,"['Labhardt ND, Smit M, Petignat I, Perneger T, Marinosci A, Ustero P, Diniz Ribeiro MP, Ragozzino S, Nicoletti GJ, Far√© PB, Andrey DO, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Guessous I, Chappuis F, Kaiser L, Decosterd LA, Grinsztejn B, Bernasconi E, Cardoso SW, Calmy A, Team FTCS. Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial. EClinicalMedicine. 2021 Dec;42:101188. doi: 10.1016/j.eclinm.2021.101188. Epub 2021 Nov 6.', 'Smit M, Marinosci A, Nicoletti GJ, Perneger T, Ragozzino S, Andrey DO, Stoeckle M, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Back M, Schaubhut C, Fuchs S, Decosterd L, Battegay M, Guessous I, Chappuis F, Kaiser L, Labhardt ND, Calmy A. Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial. BMJ Open. 2020 Nov 12;10(11):e040110. doi: 10.1136/bmjopen-2020-040110.']",,2021-04-12,https://clinicaltrials.gov/show/NCT04364022,2021-03-24,0,1
486,NCT04364711,Not yet recruiting,2022-04-30,2022-04-30,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04364711,2022-04-30,0,0
487,NCT04364984,Completed,2021-07-24,2021-08-01,Study Results,,,2022-02-18,https://clinicaltrials.gov/show/NCT04364984,2021-07-24,1,0
488,NCT04365127,Completed,2020-08-20,2020-08-20,No Results Posted,"['Ghandehari S, Matusov Y, Pepkowitz S, Stein D, Kaderi T, Narayanan D, Hwang J, Chang S, Goodman R, Ghandehari H, Mirocha J, Bresee C, Tapson V, Lewis M. Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19: A Randomized, Controlled Pilot Trial. Chest. 2021 Jul;160(1):74-84. doi: 10.1016/j.chest.2021.02.024. Epub 2021 Feb 20.']",,2021-01-27,https://clinicaltrials.gov/show/NCT04365127,2020-08-20,0,1
489,NCT04365439,"Active, not recruiting",2020-12-20,2021-06-30,No Results Posted,,,2021-03-29,https://clinicaltrials.gov/show/NCT04365439,2020-12-20,0,0
490,NCT04365634,Completed,2020-03-15,2020-04-01,No Results Posted,"['Han M, Ma K, Wang X, Yan W, Wang H, You J, Wang Q, Chen H, Guo W, Chen T, Ning Q, Luo X. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients. Front Endocrinol (Lausanne). 2021 Mar 11;12:596518. doi: 10.3389/fendo.2021.596518. eCollection 2021.']",,2020-04-28,https://clinicaltrials.gov/show/NCT04365634,2020-03-15,0,1
491,NCT04365699,Completed,2021-01-31,2021-01-31,Study Results,,,2021-09-16,https://clinicaltrials.gov/show/NCT04365699,2021-01-31,1,0
492,NCT04365738,Completed,2020-04-10,2020-04-26,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04365738,2020-04-10,0,0
493,NCT04365881,Completed,2020-04-07,2020-04-07,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04365881,2020-04-07,0,0
494,NCT04365959,"Active, not recruiting",2020-04-09,2021-06-30,No Results Posted,"['Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, Cairo M, Mori S, Messinesi G, Contro E, Bonfanti P, Benini A, Valsecchi MG, Antolini L, Foti G. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020 Aug;8(8):765-774. doi: 10.1016/S2213-2600(20)30268-X. Epub 2020 Jun 19.']",,2021-04-21,https://clinicaltrials.gov/show/NCT04365959,2020-04-09,0,1
495,NCT04366050,Recruiting,2021-05-01,2021-05-01,No Results Posted,"['Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021 Apr;103:106330. doi: 10.1016/j.cct.2021.106330. Epub 2021 Feb 22.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04366050,2021-05-01,0,1
496,NCT04366830,,,,,,,2021-02-18,https://clinicaltrials.gov/show/NCT04366830,,0,0
497,NCT04372069,,,,,,,,https://clinicaltrials.gov/show/NCT04372069,,0,0
498,NCT04330690,Recruiting,2022-03-18,2022-05-18,No Results Posted,"[""Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, Costiniuk C, Daley P, Daneman N, Douglas J, Downey C, Duan E, Duceppe E, Durand M, English S, Farjou G, Fera E, Fontela P, Fowler R, Fralick M, Geagea A, Grant J, Harrison LB, Havey T, Hoang H, Kelly LE, Keynan Y, Khwaja K, Klein G, Klein M, Kolan C, Kronfli N, Lamontagne F, Lau R, Fralick M, Lee TC, Lee N, Lim R, Longo S, Lostun A, MacIntyre E, Malham√© I, Mangof K, McGuinty M, Mergler S, Munan MP, Murthy S, O'Neil C, Ovakim D, Papenburg J, Parhar K, Parvathy SN, Patel C, Perez-Patrigeon S, Pinto R, Rajakumaran S, Rishu A, Roba-Oshin M, Rushton M, Saleem M, Salvadori M, Scherr K, Schwartz K, Semret M, Silverman M, Singh A, Sligl W, Smith S, Somayaji R, Tan DHS, Tobin S, Todd M, Tran TV, Tremblay A, Tsang J, Turgeon A, Vakil E, Weatherald J, Yansouni C, Zarychanski R; Canadian Treatments for COVID-19 (CATCO); Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care Trials Group. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ. 2022 Feb 22;194(7):E242-E251. doi: 10.1503/cmaj.211698. Epub 2022 Jan 19."", 'Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.']",,2021-05-21,https://clinicaltrials.gov/show/NCT04330690,2022-03-18,0,1
499,NCT04321616,Recruiting,2020-08-01,2020-11-01,No Results Posted,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.', 'Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, K√•sine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg √Ö, Johannessen A, Heggelund L, Dahl TB, Sk√•ra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB, Tholin B, Ystr√∏m CM, Skei NV, Tran T, Dudman S, Andersen JT, Hannula R, Dalgard O, Finbr√•ten AK, Tonby K, Blomberg B, Aballi S, Fladeby C, Steffensen A, M√ºller F, Dyrhol-Riise AM, Tr√∏seid M, Aukrust P; NOR-Solidarity trial. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial. Ann Intern Med. 2021 Sep;174(9):1261-1269. doi: 10.7326/M21-0653. Epub 2021 Jul 13.']",,2020-04-14,https://clinicaltrials.gov/show/NCT04321616,2020-08-01,0,1
500,NCT04575064,"Active, not recruiting",2022-03-01,2022-11-01,No Results Posted,,,2020-10-05,,2022-03-01,0,0
501,NCT04647669,Not yet recruiting,2021-11-30,2021-12-31,No Results Posted,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.']",,2021-05-13,https://clinicaltrials.gov/show/NCT04647669,2021-11-30,0,1
502,NCT04322396,Terminated,2021-02-02,2021-02-02,Study Results,"['Sivapalan P, Ulrik CS, Lappere TS, Ekl√∂f JV, Shaker SB, B√∏dtger UCS, Browatzki A, Meyer CN, Weinreich UM, Laursen CB, Biering-S√∏rensen T, Knop FK, Lundgren JD, Jensen JS. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.', 'Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Ekl√∂f JV, H√•kansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-S√∏rensen T, Ghanizada M, Sonne TP, B√∏dtger UCS, Jensen SG, Rasmussen DB, Br√∏ndum E, Tupper OD, S√∏rensen SW, Alstrup G, Laursen CB, M√∏ller UW, Sverrild A, Jensen JS. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.']",,2021-06-29,https://clinicaltrials.gov/show/NCT04322396,2021-02-02,1,1
503,NCT04273763,"Active, not recruiting",2020-05-10,2020-06-01,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04273763,2020-05-10,0,0
504,NCT04318301,Completed,2020-03-28,2020-03-30,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04318301,2020-03-28,0,0
505,NCT04321096,Recruiting,2022-01-31,2022-05-01,No Results Posted,"['Gunst JD, Staerke NB, Pahus MH, Kristensen LH, Bodilsen J, Lohse N, Dalgaard LS, Br√∏nnum D, Fr√∂bert O, H√∏nge B, Johansen IS, Monrad I, Erikstrup C, Rosendal R, Vilstrup E, Mariager T, Bove DG, Offersen R, Shakar S, Cajander S, J√∏rgensen NP, Sritharan SS, Breining P, Jespersen S, Mortensen KL, Jensen ML, Kolte L, Frattari GS, Larsen CS, Storgaard M, Nielsen LP, Tolstrup M, S√¶dder EA, √òstergaard LJ, Ngo HTT, Jensen MH, H√∏jen JF, Kjolby M, S√∏gaard OS. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May;35:100849. doi: 10.1016/j.eclinm.2021.100849. Epub 2021 Apr 22.']",,2021-04-30,https://clinicaltrials.gov/show/NCT04321096,2022-01-31,0,1
506,NCT04328441,"Active, not recruiting",2021-03-31,2021-05-30,No Results Posted,"['Ten Doesschate T, Moorlag SJCFM, van der Vaart TW, Taks E, Debisarun P, Ten Oever J, Bleeker-Rovers CP, Verhagen PB, Lalmohamed A, Ter Heine R, van Crevel R, van de Wijgert J, Janssen AB, Bonten MJ, van Werkhoven CH, Netea MG; BCG-CORONA study team#. Two Randomized Controlled Trials of Bacillus Calmette-Gu√©rin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Trials. 2020 Jun 5;21(1):481. doi: 10.1186/s13063-020-04389-w. Erratum in: Trials. 2020 Jun 22;21(1):555.']",,2021-05-11,https://clinicaltrials.gov/show/NCT04328441,2021-03-31,0,1
507,NCT04328480,Completed,2021-04-25,2021-04-26,No Results Posted,"['Diaz R, Orlandini A, Castellana N, Caccavo A, Corral P, Corral G, Chac√≥n C, Lamelas P, Botto F, D√≠az ML, Dom√≠nguez JM, Pascual A, Rovito C, Galatte A, Scarafia F, Sued O, Gutierrez O, Jolly SS, Mir√≥ JM, Eikelboom J, Loeb M, Maggioni AP, Bhatt DL, Yusuf S; ECLA PHRI COLCOVID Trial Investigators. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. JAMA Netw Open. 2021 Dec 1;4(12):e2141328. doi: 10.1001/jamanetworkopen.2021.41328. Erratum in: JAMA Netw Open. 2022 Feb 1;5(2):e223150.']","['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.']",2021-04-27,https://clinicaltrials.gov/show/NCT04328480,2021-04-25,0,1
508,NCT04329923,Terminated,2020-11-11,2020-11-13,Study Results,,"['Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, Hensley SE, Gill S, Vogl DT, Maillard I, Babushok DV, Huang AC, Nasta SD, Walsh JC, Wiletyo EP, Gimotty PA, Milone MC, Amaravadi RK; Prevention and Treatment of COVID-19 With Hydroxychloroquine (PATCH) Investigators. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med. 2021 Feb 1;181(2):195-202. doi: 10.1001/jamainternmed.2020.6319.']",2020-12-10,https://clinicaltrials.gov/show/NCT04329923,2020-11-11,1,1
509,NCT04334928,Completed,2021-02-25,2021-07-11,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04334928,2021-02-25,0,0
510,NCT04335071,Terminated,2020-09-27,2020-09-27,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04335071,2020-09-27,0,0
511,NCT04338958,Completed,2021-07-15,2021-07-15,No Results Posted,"['La Ros√©e F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Ros√©e P. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia. 2020 Jul;34(7):1805-1815. doi: 10.1038/s41375-020-0891-0. Epub 2020 Jun 9.']",,2021-08-13,https://clinicaltrials.gov/show/NCT04338958,2021-07-15,0,1
512,NCT04344249,Recruiting,2021-09-30,2021-09-30,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04344249,2021-09-30,0,0
513,NCT04344457,Recruiting,2020-06-20,2020-09-30,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04344457,2020-06-20,0,0
514,NCT04345848,Terminated,2021-06-02,2021-06-02,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,2021-09-14,https://clinicaltrials.gov/show/NCT04345848,2021-06-02,0,1
515,NCT04347226,Terminated,2021-03-01,2021-03-01,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04347226,2021-03-01,0,0
516,NCT04348435,Completed,2021-07-09,2021-07-30,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04348435,2021-07-09,0,0
517,NCT04349631,Completed,2020-11-24,2021-05-01,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04349631,2020-11-24,0,0
518,NCT04351191,Terminated,2020-08-23,2020-08-30,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04351191,2020-08-23,0,0
519,NCT04352465,Not yet recruiting,2020-06-30,2020-11-30,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04352465,2020-06-30,0,0
520,NCT04353271,Terminated,2020-07-08,2020-07-08,Study Results,,,2022-01-03,https://clinicaltrials.gov/show/NCT04353271,2020-07-08,1,0
521,NCT04355611,Recruiting,2022-04-20,2022-04-20,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04355611,2022-04-20,0,0
522,NCT04356833,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04356833,2021-04-30,0,0
523,NCT04356950,"Active, not recruiting",2022-02-14,2022-07-01,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04356950,2022-02-14,0,0
524,NCT04358939,Completed,2021-02-21,2021-02-21,No Results Posted,"['Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.', 'Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,2021-04-19,https://clinicaltrials.gov/show/NCT04358939,2021-02-21,0,1
525,NCT04359225,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04359225,2021-12-31,0,0
526,NCT04359654,Completed,2021-08-12,2021-11-05,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04359654,2021-08-12,0,0
527,NCT04359706,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04359706,2020-09-01,0,0
528,NCT04359797,Completed,2020-12-17,2021-01-17,Study Results,,,2021-12-27,https://clinicaltrials.gov/show/NCT04359797,2020-12-17,1,0
529,NCT04359810,Completed,2020-12-30,2020-12-30,Results Submitted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', ""O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, Jo√£o E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 Jul 1;131(13). pii: 150646. doi: 10.1172/JCI150646."", ""Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y. Erratum in: Trials. 2020 Jun 16;21(1):536. Trials. 2020 Nov 17;21(1):927.""]",,2021-05-18,https://clinicaltrials.gov/show/NCT04359810,2020-12-30,0,1
530,NCT04361123,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Peacock JE Jr, Herrington DM, Edelstein SL, Seals AL, Plumb ID, Saydah S, Lagarde WH, Runyon MS, Maguire PD, Correa A, Weintraub WS, Wierzba TF, Sanders JW; COVID-19 Community Research Partnership Study Group. Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research Partnership. J Community Health. 2022 Feb;47(1):71-78. doi: 10.1007/s10900-021-01021-z. Epub 2021 Aug 12.']",,2021-12-21,https://clinicaltrials.gov/show/NCT04361123,2022-04-01,0,1
531,NCT04361643,Not yet recruiting,2021-08-31,2021-12-31,No Results Posted,,,2020-07-31,https://clinicaltrials.gov/show/NCT04361643,2021-08-31,0,0
532,NCT04361877,Completed,2020-04-20,2020-04-20,No Results Posted,"['Steffen J, Schlichtiger J, Huber BC, Brunner S. Altered alcohol consumption during COVID-19 pandemic lockdown. Nutr J. 2021 May 11;20(1):44. doi: 10.1186/s12937-021-00699-0.', 'Huber BC, Steffen J, Schlichtiger J, Brunner S. Altered nutrition behavior during COVID-19 pandemic lockdown in young adults. Eur J Nutr. 2021 Aug;60(5):2593-2602. doi: 10.1007/s00394-020-02435-6. Epub 2020 Dec 1.']",,2021-05-05,https://clinicaltrials.gov/show/NCT04361877,2020-04-20,0,1
533,NCT04361942,Recruiting,2021-11-30,2021-12-31,No Results Posted,,"['Vega A, Mart√≠n-Ferrero MA, Del Canto F, Alberca M, Garc√≠a V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, S√°nchez A, Garc√≠a-Sancho J. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015 Aug;99(8):1681-90. doi: 10.1097/TP.0000000000000678.', 'Noriega DC, Ardura F, Hern√°ndez-Ramajo R, Mart√≠n-Ferrero M√Å, S√°nchez-Lite I, Toribio B, Alberca M, Garc√≠a V, Moraleda JM, S√°nchez A, Garc√≠a-Sancho J. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial. Transplantation. 2017 Aug;101(8):1945-1951. doi: 10.1097/TP.0000000000001484.', 'Barbado J, Tabera S, S√°nchez A, Garc√≠a-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018 Nov;27(13):2161-2165. doi: 10.1177/0961203318804922. Epub 2018 Oct 5.', 'Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.']",2021-03-10,https://clinicaltrials.gov/show/NCT04361942,2021-11-30,0,1
534,NCT04362176,Completed,2021-07-06,2021-08-06,No Results Posted,"[""Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR Jr, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW; Passive Immunity Trial for Our Nation (PassITON) Investigators. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Trials. 2021 Mar 20;22(1):221. doi: 10.1186/s13063-021-05171-2."", ""Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Res Sq. 2021 Mar 2. pii: rs.3.rs-227796. doi: 10.21203/rs.3.rs-227796/v1. Update in: Trials. 2021 Mar 20;22(1):221.""]",,2021-11-04,https://clinicaltrials.gov/show/NCT04362176,2021-07-06,0,1
535,NCT04362267,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04362267,2020-09-01,0,0
536,NCT04362345,Recruiting,2021-01-09,2021-01-09,No Results Posted,,,2020-12-28,https://clinicaltrials.gov/show/NCT04362345,2021-01-09,0,0
537,NCT04363034,,,,,,,2022-03-29,https://clinicaltrials.gov/show/NCT04363034,,0,0
538,NCT04363047,Enrolling by invitation,2021-05-01,2021-05-01,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04363047,2021-05-01,0,0
539,NCT04363060,Not yet recruiting,2020-07-30,2020-07-30,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04363060,2020-07-30,0,0
540,NCT04363450,Recruiting,2021-03-31,2021-06-01,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04363450,2021-03-31,0,0
541,NCT04364828,Recruiting,2022-04-01,2022-08-01,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04364828,2022-04-01,0,0
542,NCT04365231,Withdrawn,2020-06-01,2021-04-01,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04365231,2020-06-01,0,0
543,NCT04365309,Unknown,2020-04-01,2020-06-01,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04365309,2020-04-01,0,0
544,NCT04365530,Recruiting,2022-04-01,2022-12-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04365530,2022-04-01,0,0
545,NCT04365608,Completed,2020-11-30,2020-12-10,No Results Posted,"['Szarpak L, Peacock FW, Rafique Z, Ladny JR, Nadolny K, Malysz M, Dabrowski M, Chirico F, Smereka J. Comparison of Vie Scope¬Æ and Macintosh laryngoscopes for intubation during resuscitation by paramedics wearing personal protective equipment. Am J Emerg Med. 2022 Mar;53:122-126. doi: 10.1016/j.ajem.2021.12.069. Epub 2022 Jan 4.']",,2020-12-19,https://clinicaltrials.gov/show/NCT04365608,2020-11-30,0,1
546,NCT04365816,Completed,2020-07-10,2020-07-10,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04365816,2020-07-10,0,0
547,NCT04366024,Recruiting,2020-08-30,2021-12-31,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04366024,2020-08-30,0,0
548,NCT04366063,Recruiting,2020-06-06,2020-12-10,No Results Posted,,,2020-04-30,https://clinicaltrials.gov/show/NCT04366063,2020-06-06,0,0
549,NCT04366089,Recruiting,2020-10-30,2020-12-31,No Results Posted,,"['Hern√°ndez A, Papadakos PJ, Torres A, Gonz√°lez DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim (Engl Ed). 2020 May;67(5):245-252. doi: 10.1016/j.redar.2020.03.004. Epub 2020 Apr 14. English, Spanish.', 'Conti P, Gallenga CE, Tet√® G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 March-April,;34(2):333-338. doi: 10.23812/Editorial-Conti-2.', 'Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2022 Feb 5. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02. Chinese.']",2020-04-28,https://clinicaltrials.gov/show/NCT04366089,2020-10-30,0,1
550,NCT04366154,"Active, not recruiting",2020-07-15,2021-05-01,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04366154,2020-07-15,0,0
551,NCT04366167,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04366167,2022-12-31,0,0
552,NCT04366180,Recruiting,2020-06-01,2020-10-01,No Results Posted,,,2020-04-30,https://clinicaltrials.gov/show/NCT04366180,2020-06-01,0,0
553,NCT04366206,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04366206,2020-07-31,0,0
554,NCT04366297,Completed,2020-02-25,2020-02-25,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04366297,2020-02-25,0,0
555,NCT04366739,Not yet recruiting,2020-08-30,2020-09-30,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04366739,2020-08-30,0,0
556,NCT04366752,Recruiting,2020-08-22,2020-09-22,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04366752,2020-08-22,0,0
557,NCT04366817,"Active, not recruiting",2021-08-01,2021-08-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04366817,2021-08-01,0,0
558,NCT04366856,Completed,2021-09-23,2021-09-23,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04366856,2021-09-23,0,0
559,NCT04366882,Recruiting,2020-12-01,2020-12-01,No Results Posted,"[""Van Cleemput J, van Snippenberg W, Lambrechts L, Dendooven A, D'Onofrio V, Couck L, Trypsteen W, Vanrusselt J, Theuns S, Vereecke N, van den Bosch TPP, Lammens M, Driessen A, Achten R, Bracke KR, Van den Broeck W, Von der Th√ºsen J, Nauwynck H, Van Dorpe J, Gerlo S, Maes P, Cox J, Vandekerckhove L. Organ-specific genome diversity of replication-competent SARS-CoV-2. Nat Commun. 2021 Nov 16;12(1):6612. doi: 10.1038/s41467-021-26884-7."", ""D'Onofrio V, Donders E, Vanden Abeele ME, Dubois J, Cartuyvels R, Achten R, Lammens M, Dendooven A, Driessen A, Augsburg L, Vanrusselt J, Cox J. The clinical value of minimal invasive autopsy in COVID-19 patients. PLoS One. 2020 Nov 11;15(11):e0242300. doi: 10.1371/journal.pone.0242300. eCollection 2020.""]",,2020-04-29,https://clinicaltrials.gov/show/NCT04366882,2020-12-01,0,1
560,NCT04366908,Recruiting,2021-12-30,2021-12-30,No Results Posted,"['Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04366908,2021-12-30,0,1
561,NCT04366921,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04366921,2022-04-01,0,0
562,NCT04366947,Completed,2020-09-20,2020-10-30,No Results Posted,,,2020-12-19,https://clinicaltrials.gov/show/NCT04366947,2020-09-20,0,0
563,NCT04367064,Recruiting,2020-11-25,2020-12-25,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04367064,2020-11-25,0,0
564,NCT04367129,Recruiting,2021-04-01,2021-04-01,No Results Posted,"[""Bertini M, Ferrari R, Guardigli G, Malag√π M, Vitali F, Zucchetti O, D'Aniello E, Volta CA, Cimaglia P, Piovaccari G, Corzani A, Galvani M, Ortolani P, Rubboli A, Tortorici G, Casella G, Sassone B, Navazio A, Rossi L, Aschieri D, Rapezzi C. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace. 2020 Dec 23;22(12):1848-1854. doi: 10.1093/europace/euaa258.""]",,2021-02-09,https://clinicaltrials.gov/show/NCT04367129,2021-04-01,0,1
565,NCT04367142,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04367142,2022-06-01,0,0
566,NCT04367350,Recruiting,2021-03-31,2022-03-31,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04367350,2021-03-31,0,0
567,NCT04367363,Completed,2020-05-07,2020-05-31,No Results Posted,"['Tan EY, Wee RR, Saw YE, Heng KJ, Chin JW, Tong EM, Liu JC. Tracking Private WhatsApp Discourse About COVID-19 in Singapore: Longitudinal Infodemiology Study. J Med Internet Res. 2021 Dec 23;23(12):e34218. doi: 10.2196/34218.']",,2020-12-29,https://clinicaltrials.gov/show/NCT04367363,2020-05-07,0,1
568,NCT04367402,Recruiting,2020-04-24,2020-09-01,No Results Posted,,,2020-04-30,https://clinicaltrials.gov/show/NCT04367402,2020-04-24,0,0
569,NCT04367636,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04367636,2021-09-01,0,0
570,NCT04367714,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-12-30,https://clinicaltrials.gov/show/NCT04367714,2021-12-01,0,0
571,NCT04367792,"Active, not recruiting",2020-10-01,2021-03-01,No Results Posted,,,2020-08-10,https://clinicaltrials.gov/show/NCT04367792,2020-10-01,0,0
572,NCT04367805,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04367805,2020-10-01,0,0
573,NCT04367857,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-12-29,https://clinicaltrials.gov/show/NCT04367857,2022-01-01,0,0
574,NCT04367896,Completed,2020-04-17,2020-04-17,No Results Posted,,"['Ritschl PV, Nevermann N, Wiering L, Wu HH, Moroder P, Brandl A, Hillebrandt K, Tacke F, Friedersdorff F, Schlomm T, Sch√∂ning W, √ñllinger R, Schmelzle M, Pratschke J. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach. Am J Transplant. 2020 Jul;20(7):1826-1836. doi: 10.1111/ajt.15933. Epub 2020 May 10.', 'The Lancet. India under COVID-19 lockdown. Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.', 'Redelmeier DA, Shafir E. Pitfalls of judgment during the COVID-19 pandemic. Lancet Public Health. 2020 Jun;5(6):e306-e308. doi: 10.1016/S2468-2667(20)30096-7. Epub 2020 Apr 23. Review.', 'Leon DA, Shkolnikov VM, Smeeth L, Magnus P, Pechholdov√° M, Jarvis CI. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet. 2020 May 2;395(10234):e81. doi: 10.1016/S0140-6736(20)30933-8. Epub 2020 Apr 22.']",2020-04-29,https://clinicaltrials.gov/show/NCT04367896,2020-04-17,0,1
575,NCT04368013,Not yet recruiting,2026-04-14,2026-04-14,No Results Posted,,,2020-04-29,https://clinicaltrials.gov/show/NCT04368013,2026-04-14,0,0
576,NCT04368065,Recruiting,2022-12-31,2023-06-01,No Results Posted,"['Dreyer N, Reynolds MW, Albert L, Brinkley E, Kwon T, Mack C, Toovey S. How frequent are acute reactions to COVID-19 vaccination and who is at risk? Vaccine. 2022 Mar 15;40(12):1904-1912. doi: 10.1016/j.vaccine.2021.12.072. Epub 2022 Feb 9.']",,2021-07-12,https://clinicaltrials.gov/show/NCT04368065,2022-12-31,0,1
577,NCT04368143,Recruiting,2021-12-30,2021-12-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04368143,2021-12-30,0,0
578,NCT04368156,Completed,2021-02-17,2021-02-17,No Results Posted,"['Tornero C, Vallejo R, Cede√±o D, Ordu√±a J, Pastor E, Belaouchi M, Escamilla B, Laredo M, Del Mar Garzando M. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore¬Æ-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial"". Trials. 2020 Jun 26;21(1):576. doi: 10.1186/s13063-020-04486-w.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04368156,2021-02-17,0,1
579,NCT04368208,Completed,2020-10-21,2020-11-27,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04368208,2020-10-21,0,0
580,NCT04368234,Recruiting,2025-04-30,2025-04-30,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04368234,2025-04-30,0,0
581,NCT04368260,Completed,2020-08-01,2020-08-01,Study Results,,,2022-02-17,https://clinicaltrials.gov/show/NCT04368260,2020-08-01,1,0
582,NCT04368299,Completed,2022-01-17,2022-01-31,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04368299,2022-01-17,0,0
583,NCT04368312,Completed,2020-09-30,2020-12-30,No Results Posted,"['Wesemann U, Hadjamu N, Wakili R, Willmund G, Vogel J, Rassaf T, Siebermair J. Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19. Health Equity. 2021 Apr 19;5(1):181-184. doi: 10.1089/heq.2020.0119. eCollection 2021.']",,2021-05-06,https://clinicaltrials.gov/show/NCT04368312,2020-09-30,0,1
584,NCT04368338,Completed,2021-01-28,2021-07-20,No Results Posted,"['Bar S, Lecourtois A, Diouf M, Goldberg E, Bourbon C, Arnaud E, Domisse L, Dupont H, Gosset P. The association of lung ultrasound images with COVID-19 infection in an emergency room cohort. Anaesthesia. 2020 Dec;75(12):1620-1625. doi: 10.1111/anae.15175. Epub 2020 Jul 1.']",,2021-07-21,https://clinicaltrials.gov/show/NCT04368338,2021-01-28,0,1
585,NCT04368351,"Active, not recruiting",2020-06-30,2020-07-31,No Results Posted,,"['Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02. Chinese.', 'Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015 May 15;60 Suppl 2:S108-21. doi: 10.1093/cid/civ177. Review.', 'Jiang X, Hou X, Tang L, Jiang Y, Ma G, Li Y. A phase trial of the oral Lactobacillus casei vaccine polarizes Th2 cell immunity against transmissible gastroenteritis coronavirus infection. Appl Microbiol Biotechnol. 2016 Sep;100(17):7457-69. doi: 10.1007/s00253-016-7424-9. Epub 2016 Mar 28.', 'Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr. 2020 Jul - Aug;14(4):367-382. doi: 10.1016/j.dsx.2020.04.015. Epub 2020 Apr 16.']",2020-05-04,https://clinicaltrials.gov/show/NCT04368351,2020-06-30,0,1
586,NCT04368377,Completed,2020-04-23,2020-04-23,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2020-04-29,https://clinicaltrials.gov/show/NCT04368377,2020-04-23,0,1
587,NCT04368390,Recruiting,2021-04-01,2021-04-01,No Results Posted,"['Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterl√© H, Bolognini F, Messie J, Khalil A, Gaudemer A, Carr√© S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Jager L, Nesser P, Mba YT, Hmeydia G, Benzakoun J, Oppenheim C, Ferr√© JC, Maamar A, Carsin-Nicol B, Comby PO, Ricolfi F, Thouant P, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Desal H, Boulouis G, Berge J, Kaz√©mi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Constans JM, Zorn PE, Mathieu M, Baloglu S, Ardellier FD, Willaume T, Brisset JC, Caillard S, Collange O, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, Meyer N, Helms J, Cotton F. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study. Neurology. 2020 Sep 29;95(13):e1868-e1882. doi: 10.1212/WNL.0000000000010112. Epub 2020 Jul 17.']",,2020-12-24,https://clinicaltrials.gov/show/NCT04368390,2021-04-01,0,1
588,NCT04368676,"Active, not recruiting",2022-06-30,2022-06-30,No Results Posted,"['Lai KSP, Watt C, Ionson E, Baruss I, Forchuk C, Sukhera J, Burhan AM, Vasudev A. Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial. Trials. 2020 Jul 14;21(1):648. doi: 10.1186/s13063-020-04583-w.', 'Kunzler AM, Helmreich I, Chmitorz A, K√∂nig J, Binder H, Wessa M, Lieb K. Psychological interventions to foster resilience in healthcare professionals. Cochrane Database Syst Rev. 2020 Jul 5;7:CD012527. doi: 10.1002/14651858.CD012527.pub2.']",,2021-04-01,https://clinicaltrials.gov/show/NCT04368676,2022-06-30,0,1
589,NCT04368884,Recruiting,2021-06-30,2021-07-30,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04368884,2021-06-30,0,0
590,NCT04368975,Recruiting,2020-04-21,2020-12-31,No Results Posted,"['Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hern√°ndez M, Gea A, Arruti E, Aldecoa C, Mart√≠nez-Pall√≠ G, Mart√≠nez-Gonz√°lez MA, Slutsky AS, Villar J; COVID-19 Spanish ICU Network. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020 Dec;46(12):2200-2211. doi: 10.1007/s00134-020-06192-2. Epub 2020 Jul 29. Erratum in: Intensive Care Med. 2020 Dec 2;:.']",,2020-04-30,https://clinicaltrials.gov/show/NCT04368975,2020-04-21,0,1
591,NCT04369274,Not yet recruiting,2021-11-01,2021-11-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04369274,2021-11-01,0,0
592,NCT04369300,Recruiting,2020-11-24,2021-02-24,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04369300,2020-11-24,0,0
593,NCT04369365,Recruiting,2020-08-27,2020-12-27,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04369365,2020-08-27,0,0
594,NCT04369378,Completed,2021-04-28,2021-08-26,No Results Posted,"[""O'Donnell KT, Dunbar M, Speelman DL. Effectiveness of using a meditation app in reducing anxiety and improving well-being during the COVID-19 pandemic: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Dec 9;21(1):1006. doi: 10.1186/s13063-020-04935-6.""]",,2021-08-30,https://clinicaltrials.gov/show/NCT04369378,2021-04-28,0,1
595,NCT04369469,Terminated,2021-02-08,2021-04-08,Results Submitted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'McEneny-King AC, Monteleone JPR, Kazani SD, Ortiz SR. Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019. Infect Dis Ther. 2021 Jun;10(2):1045-1054. doi: 10.1007/s40121-021-00425-7. Epub 2021 Apr 7.', 'Smith K, Pace A, Ortiz S, Kazani S, Rottinghaus S. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 13;21(1):639. doi: 10.1186/s13063-020-04548-z.', 'Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe? JCI Insight. 2020 Aug 6;5(15). pii: 140711. doi: 10.1172/jci.insight.140711. Review.']",,2021-09-22,,2021-02-08,0,1
596,NCT04369690,Recruiting,2021-04-03,2021-04-03,No Results Posted,"['Robillard R, Saad M, Edwards J, Solomonova E, Pennestri MH, Daros A, Veissi√®re SPL, Quilty L, Dion K, Nixon A, Phillips J, Bhatla R, Spilg E, Godbout R, Yazji B, Rushton C, Gifford WA, Gautam M, Boafo A, Swartz R, Kendzerska T. Social, financial and psychological stress during an emerging pandemic: observations from a population survey in the acute phase of COVID-19. BMJ Open. 2020 Dec 12;10(12):e043805. doi: 10.1136/bmjopen-2020-043805.']",,2020-04-30,https://clinicaltrials.gov/show/NCT04369690,2021-04-03,0,1
597,NCT04369794,Recruiting,2021-06-01,2023-08-01,No Results Posted,,,2020-08-07,https://clinicaltrials.gov/show/NCT04369794,2021-06-01,0,0
598,NCT04369807,"Active, not recruiting",2023-05-31,2023-05-31,No Results Posted,"['Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.']","['Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ, Gyngell ML, Groves KE, McKay A, Herlihy AH, Fernandes CC, Halberstadt M, Maguire M, Jayaratne N, Linden S, Neubauer S, Banerjee R. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS One. 2019 Apr 10;14(4):e0214921. doi: 10.1371/journal.pone.0214921. eCollection 2019.', 'Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014 Jan;60(1):69-77. doi: 10.1016/j.jhep.2013.09.002. Epub 2013 Sep 12.', ""Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O'Connell J, Cortes A, Welsh S, Young A, Effingham M, McVean G, Leslie S, Allen N, Donnelly P, Marchini J. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018 Oct;562(7726):203-209. doi: 10.1038/s41586-018-0579-z. Epub 2018 Oct 10."", 'Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091. Erratum in: BMJ. 2020 Mar 31;368:m1295.', 'Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.', 'Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Kang W, Weng D, Liang P, Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004 Jun;203(2):622-30.', 'Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19. Review.', 'Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.', 'Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, Taub R, Moussa SE. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2019 Nov 30;394(10213):2012-2024. doi: 10.1016/S0140-6736(19)32517-6. Epub 2019 Nov 11.', 'Harrison SA, Rossi SJ, Paredes AH, Trotter JF, Bashir MR, Guy CD, Banerjee R, Jaros MJ, Owers S, Baxter BA, Ling L, DePaoli AM. NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis. Hepatology. 2020 Apr;71(4):1198-1212. doi: 10.1002/hep.30590. Epub 2019 Apr 10.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Pavlides M, Banerjee R, Sellwood J, Kelly CJ, Robson MD, Booth JC, Collier J, Neubauer S, Barnes E. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 2016 Feb;64(2):308-315. doi: 10.1016/j.jhep.2015.10.009. Epub 2015 Nov 10.', 'Pavlides M, Banerjee R, Tunnicliffe EM, Kelly C, Collier J, Wang LM, Fleming KA, Cobbold JF, Robson MD, Neubauer S, Barnes E. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int. 2017 Jul;37(7):1065-1073. doi: 10.1111/liv.13284. Epub 2017 May 30.', 'Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunub√° Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30. Erratum in: Lancet Infect Dis. 2020 Apr 15;:. Lancet Infect Dis. 2020 May 4;:.', 'Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.', 'Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30. Review.', 'Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.']",2022-01-14,https://clinicaltrials.gov/show/NCT04369807,2023-05-31,0,1
599,NCT04369989,Enrolling by invitation,2021-04-14,2021-04-14,No Results Posted,,,2020-04-30,https://clinicaltrials.gov/show/NCT04369989,2021-04-14,0,0
600,NCT04370197,Recruiting,2020-04-30,2020-04-30,No Results Posted,,,2020-04-30,https://clinicaltrials.gov/show/NCT04370197,2020-04-30,0,0
601,NCT04370249,Completed,2020-08-31,2020-08-31,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04370249,2020-08-31,0,0
602,NCT04370275,Recruiting,2020-05-23,2020-05-31,No Results Posted,"['Di Gioia CC, Artusi N, Xotta G, Bonsano M, Sisto UG, Tecchiolli M, Orso D, Cominotto F, Amore G, Meduri S, Copetti R. Lung ultrasound in ruling out COVID-19 pneumonia in the ED: a multicentre prospective sensitivity study. Emerg Med J. 2022 Mar;39(3):199-205. doi: 10.1136/emermed-2020-210973. Epub 2021 Dec 22.']",,2020-04-30,https://clinicaltrials.gov/show/NCT04370275,2020-05-23,0,1
603,NCT04370938,Withdrawn,2020-10-29,2020-10-29,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04370938,2020-10-29,0,0
604,NCT04371289,"Active, not recruiting",2020-07-10,2021-09-10,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04371289,2020-07-10,0,0
605,NCT04371315,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-07-06,https://clinicaltrials.gov/show/NCT04371315,2022-06-30,0,0
606,NCT04371523,Withdrawn,2020-07-31,2020-08-30,No Results Posted,,,2021-09-27,https://clinicaltrials.gov/show/NCT04371523,2020-07-31,0,0
607,NCT04371692,Completed,2020-07-09,2020-07-09,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04371692,2020-07-09,0,0
608,NCT04372043,Not yet recruiting,2020-09-30,2020-09-30,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04372043,2020-09-30,0,0
609,NCT04372199,Recruiting,2020-05-27,2020-05-27,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04372199,2020-05-27,0,0
610,NCT04372368,,,,,,,2020-08-28,https://clinicaltrials.gov/show/NCT04372368,,0,0
611,NCT04324489,Completed,2020-04-16,2020-04-30,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04324489,2020-04-16,0,0
612,NCT04333550,Recruiting,2020-09-01,2021-03-01,No Results Posted,,"['Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol. 2008 Jul;6(7):541-52. doi: 10.1038/nrmicro1930. Review.', 'Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol. 2014 Jul 16;5:152. doi: 10.3389/fphar.2014.00152. eCollection 2014. Review.', 'Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000 Feb;181(2):484-90.', 'Vlahakos D, Arkadopoulos N, Kostopanagiotou G, Siasiakou S, Kaklamanis L, Degiannis D, Demonakou M, Smyrniotis V. Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs. Artif Organs. 2012 Apr;36(4):400-8. doi: 10.1111/j.1525-1594.2011.01385.x. Epub 2011 Dec 21.', 'Wang H, Li Z, Niu J, Xu Y, Ma L, Lu A, Wang X, Qian Z, Huang Z, Jin X, Leng Q, Wang J, Zhong J, Sun B, Meng G. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018 Mar 27;4:14. doi: 10.1038/s41421-018-0013-6. eCollection 2018.', 'Cinatl J Jr, Cinatl J, Rabenau H, G√ºmbel HO, Kornhuber B, Doerr HW. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res. 1994 Sep;25(1):73-7.', 'Visseren F, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest. 2002 Mar;32 Suppl 1:84-90.', 'Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1049-61.', 'Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H. Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retroviruses. 2015 Mar;31(3):305-12. doi: 10.1089/aid.2014.0169. Epub 2014 Oct 7.', 'Meyer D. Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload. Curr Pharm Des. 2006;12(16):1943-7. Review.', 'Cinatl J, Scholz M, Weber B, Cinatl J, Rabenau H, Markus BH, Encke A, Doerr HW. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transpl Immunol. 1995 Dec;3(4):313-20.', 'Mabeza GF, Loyevsky M, Gordeuk VR, Weiss G. Iron chelation therapy for malaria: a review. Pharmacol Ther. 1999 Jan;81(1):53-75. Review.', 'Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother. 1994 May;38(5):997-1003.', 'Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008 Aug 1;112(3):866-74. doi: 10.1182/blood-2007-12-126854. Epub 2008 Mar 27.', 'Giannakopoulou E, Pardali V, Zoidis G. Metal-chelating agents against viruses and parasites. Future Med Chem. 2018 Jun 1;10(11):1283-1285. doi: 10.4155/fmc-2018-0100. Epub 2018 May 3. Review.', 'Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med. 1992 Nov 19;327(21):1473-7.', 'Duchemin JB, Paradkar PN. Iron availability affects West Nile virus infection in its mosquito vector. Virol J. 2017 Jun 5;14(1):103. doi: 10.1186/s12985-017-0770-0.']",2020-05-04,https://clinicaltrials.gov/show/NCT04333550,2020-09-01,0,1
613,NCT04337047,Completed,2020-04-30,2020-05-03,No Results Posted,"['Chaix B, Delamon G, Guillemass√© A, Brouard B, Bibault JE. Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations. Gen Psychiatr. 2020 Nov 26;33(6):e100349. doi: 10.1136/gpsych-2020-100349. eCollection 2020.']",,2020-05-05,https://clinicaltrials.gov/show/NCT04337047,2020-04-30,0,1
614,NCT04337359,,,,,"['Stanevich OV, Fomina DS, Bakulin IG, Galeev SI, Bakin EA, Belash VA, Kulikov AN, Lebedeva AA, Lioznov DA, Polushin YS, Shlyk IV, Vorobyev EA, Vorobyeva SV, Surovceva TV, Bakulina NV, Lysenko MA, Moiseev IS. Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study. BMC Infect Dis. 2021 Dec 22;21(1):1277. doi: 10.1186/s12879-021-06982-z.', ""D'Alessio A, Del Poggio P, Bracchi F, Cesana G, Sertori N, Di Mauro D, Fargnoli A, Motta M, Giussani C, Moro P, Vitale G, Giacomini M, Borra G. Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia. Leukemia. 2021 Feb;35(2):635-638. doi: 10.1038/s41375-020-01087-z. Epub 2020 Nov 10.""]",,2021-01-26,https://clinicaltrials.gov/show/NCT04337359,,0,1
615,NCT04342702,"Active, not recruiting",2021-03-01,2021-03-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04342702,2021-03-01,0,0
616,NCT04343768,Completed,2020-04-27,2020-04-27,No Results Posted,"['Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M, Amirdosara M, Torabinavid P, Golmohammadi M, Hashemi S, Azimi A, Jafarazadeh Maivan MH, Rezaei O, Zali A, Hajiesmaeili M, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, Khoshkar A. Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. Sci Rep. 2021 Apr 13;11(1):8059. doi: 10.1038/s41598-021-86859-y.', 'Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.']",,2020-05-05,https://clinicaltrials.gov/show/NCT04343768,2020-04-27,0,1
617,NCT04345614,Completed,2021-06-28,2021-07-30,No Results Posted,"['Miller J, Bruen C, Schnaus M, Zhang J, Ali S, Lind A, Stoecker Z, Stauderman K, Hebbar S. Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial. Crit Care. 2020 Aug 14;24(1):502. doi: 10.1186/s13054-020-03220-x.']",,2021-08-03,https://clinicaltrials.gov/show/NCT04345614,2021-06-28,0,1
618,NCT04346667,Terminated,2020-08-23,2020-08-30,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04346667,2020-08-23,0,0
619,NCT04350320,Completed,2020-10-20,2020-12-30,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.', 'Pascual-Figal DA, Roura-Piloto AE, Moral-Escudero E, Bernal E, Albend√≠n-Iglesias H, P√©rez-Mart√≠nez MT, Noguera-Velasco JA, Cebreiros-L√≥pez I, Hern√°ndez-Vicente √Å, V√°zquez-Andr√©s D, S√°nchez-P√©rez C, Khan A, S√°nchez-Cabo F, Garc√≠a-V√°zquez E; COL-COVID Investigators. Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID). Int J Gen Med. 2021 Sep 11;14:5517-5526. doi: 10.2147/IJGM.S329810. eCollection 2021.']",,2021-01-12,https://clinicaltrials.gov/show/NCT04350320,2020-10-20,0,1
620,NCT04354597,Withdrawn,2020-08-15,2020-10-15,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04354597,2020-08-15,0,0
621,NCT04354701,Recruiting,2023-12-01,2025-12-01,No Results Posted,"['Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol. 2021 Jun;32(6):787-800. doi: 10.1016/j.annonc.2021.02.024. Epub 2021 Mar 19.', 'Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL; COVID-19 and Cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28. Erratum in: Lancet. 2020 Sep 12;396(10253):758.']",,2022-01-27,https://clinicaltrials.gov/show/NCT04354701,2023-12-01,0,1
622,NCT04354766,Completed,2020-05-18,2020-05-18,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04354766,2020-05-18,0,0
623,NCT04358926,Completed,2020-10-15,2020-11-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04358926,2020-10-15,0,0
624,NCT04359212,Completed,2020-06-30,2020-07-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2020-09-17,https://clinicaltrials.gov/show/NCT04359212,2020-06-30,0,1
625,NCT04359602,"Active, not recruiting",2021-09-29,2042-04-20,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04359602,2021-09-29,0,0
626,NCT04360122,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04360122,2020-11-01,0,0
627,NCT04361032,Not yet recruiting,2020-09-04,2020-10-04,No Results Posted,,,2020-08-27,https://clinicaltrials.gov/show/NCT04361032,2020-09-04,0,0
628,NCT04364815,Withdrawn,2021-05-01,2021-05-01,No Results Posted,,,2020-11-06,https://clinicaltrials.gov/show/NCT04364815,2021-05-01,0,0
629,NCT04366765,Completed,2021-01-05,2021-06-30,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04366765,2021-01-05,0,0
630,NCT04369456,Recruiting,2020-10-22,2020-10-22,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04369456,2020-10-22,0,0
631,NCT04369820,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-05-04,https://clinicaltrials.gov/show/NCT04369820,2020-09-01,0,0
632,NCT04369859,Completed,2022-01-15,2022-01-15,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04369859,2022-01-15,0,0
633,NCT04370171,Completed,2020-05-29,2020-05-29,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04370171,2020-05-29,0,0
634,NCT04370288,Recruiting,2020-09-20,2020-09-21,No Results Posted,"['Hamidi-Alamdari D, Hafizi-Lotfabadi S, Bagheri-Moghaddam A, Safari H, Mozdourian M, Javidarabshahi Z, Peivandi-Yazdi A, Ali-Zeraati A, Sedaghat A, Poursadegh F, Barazandeh-Ahmadabadi F, Agheli-Rad M, Tavousi SM, Vojouhi S, Amini S, Amini M, Majid-Hosseini S, Tavanaee-Sani A, Ghiabi A, Nabavi-Mahalli S, Morovatdar N, Rajabi O, Koliakos G. METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2. Rev Invest Clin. 2021;73(3):190-198. doi: 10.24875/RIC.21000028.', 'Alamdari DH, Moghaddam AB, Amini S, Keramati MR, Zarmehri AM, Alamdari AH, Damsaz M, Banpour H, Yarahmadi A, Koliakos G. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur J Pharmacol. 2020 Oct 15;885:173494. doi: 10.1016/j.ejphar.2020.173494. Epub 2020 Aug 20.']",,2020-05-04,https://clinicaltrials.gov/show/NCT04370288,2020-09-20,0,1
635,NCT04371302,Terminated,2020-06-30,2020-06-30,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04371302,2020-06-30,0,0
636,NCT04371367,Completed,2021-03-30,2021-03-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-05-27,https://clinicaltrials.gov/show/NCT04371367,2021-03-30,0,1
637,NCT04371406,Withdrawn,2020-08-01,2020-09-01,No Results Posted,,,2020-10-27,https://clinicaltrials.gov/show/NCT04371406,2020-08-01,0,0
638,NCT04371510,Recruiting,2020-10-22,2021-02-22,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04371510,2020-10-22,0,0
639,NCT04371562,Completed,2020-03-31,2020-04-15,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04371562,2020-03-31,0,0
640,NCT04371601,"Active, not recruiting",2021-12-31,2022-12-31,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04371601,2021-12-31,0,0
641,NCT04371679,Recruiting,2022-10-01,2022-12-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04371679,2022-10-01,0,0
642,NCT04371835,Completed,2021-12-31,2021-12-31,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04371835,2021-12-31,0,0
643,NCT04371848,Completed,2020-05-07,2020-05-07,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04371848,2020-05-07,0,0
644,NCT04371965,Completed,2020-10-23,2020-10-23,No Results Posted,"['Guenezan J, Garcia M, Strasters D, Jousselin C, L√©v√™que N, Frasca D, Mimoz O. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):400-401. doi: 10.1001/jamaoto.2020.5490.']",,2020-10-26,https://clinicaltrials.gov/show/NCT04371965,2020-10-23,0,1
645,NCT04371978,Terminated,2021-04-04,2021-05-04,No Results Posted,"['Abuhasira R, Ayalon-Dangur I, Zaslavsky N, Koren R, Keller M, Dicker D, Grossman A. A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19. Front Endocrinol (Lausanne). 2021 Dec 22;12:794382. doi: 10.3389/fendo.2021.794382. eCollection 2021.']",,2021-06-02,https://clinicaltrials.gov/show/NCT04371978,2021-04-04,0,1
646,NCT04372030,Not yet recruiting,2020-06-30,2021-10-31,No Results Posted,,,2020-05-01,https://clinicaltrials.gov/show/NCT04372030,2020-06-30,0,0
647,NCT04372082,Withdrawn,2023-05-01,2023-05-01,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04372082,2023-05-01,0,0
648,NCT04372472,"Active, not recruiting",2020-08-14,2022-04-30,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04372472,2020-08-14,0,0
649,NCT04372576,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,2020-05-04,https://clinicaltrials.gov/show/NCT04372576,2020-08-01,0,0
650,NCT04372602,"Active, not recruiting",2022-02-05,2023-07-19,No Results Posted,,,2022-02-22,https://clinicaltrials.gov/show/NCT04372602,2022-02-05,0,0
651,NCT04372680,Recruiting,2021-10-22,2021-10-22,No Results Posted,,,2021-03-04,https://clinicaltrials.gov/show/NCT04372680,2021-10-22,0,0
652,NCT04372693,Enrolling by invitation,2021-07-30,2021-07-31,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04372693,2021-07-30,0,0
653,NCT04373005,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04373005,2021-06-30,0,0
654,NCT04373109,Completed,2020-10-12,2020-10-12,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04373109,2020-10-12,0,0
655,NCT04373148,Completed,2021-12-07,2021-12-07,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04373148,2021-12-07,0,0
656,NCT04373213,Not yet recruiting,2020-06-05,2020-06-15,No Results Posted,,"['de Oliveira OH, Freitas FG, Ladeira RT, Fischer CH, Bafi AT, Azevedo LC, Machado FR. Comparison between respiratory changes in the inferior vena cava diameter and pulse pressure variation to predict fluid responsiveness in postoperative patients. J Crit Care. 2016 Aug;34:46-9. doi: 10.1016/j.jcrc.2016.03.017. Epub 2016 Mar 30.', 'Pi≈ükin √ñ, √ñz ƒ∞ƒ∞. Accuracy of pleth variability index compared with inferior vena cava diameter to predict fluid responsiveness in mechanically ventilated patients. Medicine (Baltimore). 2017 Nov;96(47):e8889. doi: 10.1097/MD.0000000000008889.', 'Liu T, Xu C, Wang M, Niu Z, Qi D. Reliability of pleth variability index in predicting preload responsiveness of mechanically ventilated patients under various conditions: a systematic review and meta-analysis. BMC Anesthesiol. 2019 May 8;19(1):67. doi: 10.1186/s12871-019-0744-4.']",2020-05-04,https://clinicaltrials.gov/show/NCT04373213,2020-06-05,0,1
657,NCT04373291,Completed,2021-07-31,2021-10-01,No Results Posted,"['Madsen AMR, Schaltz-Buchholzer F, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, Dam C, Ditlev SB, Faizi G, Johansen IS, Kofoed PE, Kristensen GS, Loekkegaard ECL, Mogensen CB, Mohamed L, Ostenfeld A, Oedegaard ES, Soerensen MK, Wejse C, Jensen AKG, Nielsen S, Krause TG, Netea MG, Aaby P, Benn CS. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3.']",,2021-10-08,https://clinicaltrials.gov/show/NCT04373291,2021-07-31,0,1
658,NCT04373382,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04373382,2022-02-01,0,0
659,NCT04373486,Completed,2020-04-30,2020-05-01,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04373486,2020-04-30,0,0
660,NCT04373824,Recruiting,2020-07-25,2020-07-25,No Results Posted,,,2020-05-04,https://clinicaltrials.gov/show/NCT04373824,2020-07-25,0,0
661,NCT04374058,"Active, not recruiting",2021-03-01,2021-03-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04374058,2021-03-01,0,0
662,NCT04374071,Completed,2020-03-27,2020-04-30,No Results Posted,"['Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.']",,2020-05-05,https://clinicaltrials.gov/show/NCT04374071,2020-03-27,0,1
663,NCT04374123,Completed,2020-05-20,2020-06-15,No Results Posted,,"['Han J, Wang Y, Zhu L, Cui Y, Li L, Zeng Z, Zhang S. Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures. Gastrointest Endosc. 2020 Aug;92(2):445-447. doi: 10.1016/j.gie.2020.03.3855. Epub 2020 Apr 5.', 'Repici A, Pace F, Gabbiadini R, Colombo M, Hassan C, Dinelli M; ITALIAN GI-COVID19 Working Group. Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy. Gastroenterology. 2020 Jul;159(1):363-366.e3. doi: 10.1053/j.gastro.2020.04.003. Epub 2020 Apr 10.', 'Thompson CC, Shen L, Lee LS. COVID-19 in endoscopy: Time to do more? Gastrointest Endosc. 2020 Aug;92(2):435-439. doi: 10.1016/j.gie.2020.03.3848. Epub 2020 Mar 29.']",2020-07-28,https://clinicaltrials.gov/show/NCT04374123,2020-05-20,0,1
664,NCT04374149,Completed,2020-09-30,2020-12-01,Study Results,"['Gluck WL, Callahan SP, Brevetta RA, Stenbit AE, Smith WM, Martin JC, Blenda AV, Arce S, Edenfield WJ. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19. Respir Med. 2020 Dec;175:106188. doi: 10.1016/j.rmed.2020.106188. Epub 2020 Nov 7.']",,2021-12-02,https://clinicaltrials.gov/show/NCT04374149,2020-09-30,1,1
665,NCT04374422,Completed,2020-04-12,2020-04-12,No Results Posted,,"['Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. 2020 Feb;46(2):357-360. doi: 10.1007/s00134-020-05954-2. Epub 2020 Feb 5.', 'Liu S, Han J, Xiao D, Ma C, Chen B. A report on the reproductive health of women after the massive 2008 Wenchuan earthquake. Int J Gynaecol Obstet. 2010 Feb;108(2):161-4. doi: 10.1016/j.ijgo.2009.08.030. Epub 2009 Nov 4.']",2020-05-05,https://clinicaltrials.gov/show/NCT04374422,2020-04-12,0,1
666,NCT04374474,Withdrawn,2021-12-10,2022-03-10,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04374474,2021-12-10,0,0
667,NCT04374487,"Active, not recruiting",2021-08-09,2021-08-09,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04374487,2021-08-09,0,0
668,NCT04374539,Recruiting,2021-05-05,2021-08-29,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04374539,2021-05-05,0,0
669,NCT04374552,Withdrawn,2020-11-01,2021-04-01,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04374552,2020-11-01,0,0
670,NCT04374695,Not yet recruiting,2020-06-01,2020-07-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04374695,2020-06-01,0,0
671,NCT04374903,Not yet recruiting,2022-08-01,2022-09-01,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04374903,2022-08-01,0,0
672,NCT04375176,Recruiting,2020-06-30,2020-10-31,No Results Posted,"['Ietto G, Mortara L, Dalla Gasperina D, Iovino D, Azzi L, Baj A, Ageno W, Genoni AP, Acquati F, Gallazzi M, Spina G, Coco G, Pierin F, Noonan D, Vigezzi A, Monti E, Iori V, Masci F, Franchi C, Di Saverio S, Carcano G. Immune-Mediated Mechanisms in Patients Testing Positive for SARS-CoV-2: Protocol for a Multianalysis Study. JMIR Res Protoc. 2022 Jan 25;11(1):e29892. doi: 10.2196/29892.']",,2020-05-05,https://clinicaltrials.gov/show/NCT04375176,2020-06-30,0,1
673,NCT04375202,Recruiting,2022-10-31,2022-10-31,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2021-09-28,https://clinicaltrials.gov/show/NCT04375202,2022-10-31,0,1
674,NCT04251871,Recruiting,2021-01-22,2021-01-22,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Wang JB, Wang ZX, Jing J, Zhao P, Dong JH, Zhou YF, Yang G, Niu M, Zhao X, Jiang TJ, Bi JF, Xu Z, Zhang P, Wu D, Bai ZF, Guo YM, Yu SM, Sun YQ, Zhang ZT, Zhan XY, Li PY, Ding JB, Zhao PF, Song XA, Tang JY, He DC, Chen Z, Qin EQ, Wang RL, Xiao XH. Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial. Chin J Integr Med. 2020 Sep;26(9):648-655. doi: 10.1007/s11655-020-3426-7. Epub 2020 Jul 16.']",,2020-05-05,https://clinicaltrials.gov/show/NCT04251871,2021-01-22,0,1
675,NCT04280705,Completed,2020-05-21,2020-05-21,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.', 'Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.', 'Maleszewski JJ, Young PM, Ackerman MJ, Halushka MK. Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System. Circulation. 2021 Mar 30;143(13):1271-1273. doi: 10.1161/CIRCULATIONAHA.120.051362. Epub 2020 Sep 24.', 'Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.']",,2022-03-14,https://clinicaltrials.gov/show/NCT04280705,2020-05-21,1,1
676,NCT04322513,Recruiting,2021-06-30,2022-12-30,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04322513,2021-06-30,0,0
677,NCT04326790,Terminated,2020-04-27,2020-04-27,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.', 'Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martin√®z-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136.', 'Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, Gargalianos P, Giamarellou H, Gogos C, Daikos G, Lazanas M, Lagiou P, Saroglou G, Sipsas N, Tsiodras S, Chatzigeorgiou D, Moussas N, Kotanidou A, Koulouris N, Oikonomou E, Kaoukis A, Kossyvakis C, Raisakis K, Fountoulaki K, Comis M, Tsiachris D, Sarri E, Theodorakis A, Martinez-Dolz L, Sanz-S√°nchez J, Reimers B, Stefanini GG, Cleman M, Filippou D, Olympios CD, Pyrgakis VN, Goudevenos J, Hahalis G, Kolettis TM, Iliodromitis E, Tousoulis D, Stefanadis C. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design. Hellenic J Cardiol. 2020 Jan - Feb;61(1):42-45. doi: 10.1016/j.hjc.2020.03.002. Epub 2020 Apr 3.']",,2021-04-06,https://clinicaltrials.gov/show/NCT04326790,2020-04-27,0,1
678,NCT04333225,Completed,2020-06-30,2020-06-30,Study Results,,,2021-08-20,https://clinicaltrials.gov/show/NCT04333225,2020-06-30,1,0
679,NCT04333355,Terminated,2020-08-20,2020-08-20,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04333355,2020-08-20,0,0
680,NCT04333732,Completed,2021-08-10,2021-12-03,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-27,https://clinicaltrials.gov/show/NCT04333732,2021-08-10,0,1
681,NCT04336332,"Active, not recruiting",2022-06-30,2022-06-30,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04336332,2022-06-30,0,0
682,NCT04336774,Withdrawn,2020-11-01,2020-11-09,No Results Posted,,,2020-08-10,https://clinicaltrials.gov/show/NCT04336774,2020-11-01,0,0
683,NCT04340232,Withdrawn,2021-08-01,2021-10-01,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04340232,2021-08-01,0,0
684,NCT04341441,Terminated,2020-12-15,2020-12-15,Results Submitted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04341441,2020-12-15,0,0
685,NCT04341870,Suspended,2020-05-08,2020-08-01,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04341870,2020-05-08,0,0
686,NCT04342806,Recruiting,2099-12-31,2099-12-31,No Results Posted,"[""Forrest CB, Xu H, Thomas LE, Webb LE, Cohen LW, Carey TS, Chuang CH, Daraiseh NM, Kaushal R, McClay JC, Modave F, Nauman E, Todd JV, Wallia A, Bruno C, Hernandez AF, O'Brien EC; HERO Registry Research Group. Impact of the Early Phase of the COVID-19 Pandemic on US Healthcare Workers: Results from the HERO Registry. J Gen Intern Med. 2021 May;36(5):1319-1326. doi: 10.1007/s11606-020-06529-z. Epub 2021 Mar 10.""]",,2021-10-22,https://clinicaltrials.gov/show/NCT04342806,2099-12-31,0,1
687,NCT04343898,"Active, not recruiting",2020-08-01,2022-08-01,No Results Posted,,"['Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Sutherland A, Green A, Shehata AM, Goyal N, Vijayan A, Velez JCQ, Shaefi S, Parikh CR, Arunthamakun J, Athavale AM, Friedman AN, Short SAP, Kibbelaar ZA, Abu Omar S, Admon AJ, Donnelly JP, Gershengorn HB, Hern√°n MA, Semler MW, Leaf DE; STOP-COVID Investigators. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. doi: 10.1001/jamainternmed.2020.3596. Erratum in: JAMA Intern Med. 2020 Nov 1;180(11):1555. JAMA Intern Med. 2021 Aug 1;181(8):1144.', 'Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hern√°n MA, Leaf DE; STOP-COVID Investigators. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 Jan 1;181(1):41-51. doi: 10.1001/jamainternmed.2020.6252. Erratum in: JAMA Intern Med. 2021 Apr 1;181(4):570.', ""Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, Pan M, Meloche C, Feroz R, O'Hayer P, Kaakati R, Bitar A, Padalia K, Perry D, Blakely P, Gupta S, Shaefi S, Srivastava A, Charytan DM, Bansal A, Mallappallil M, Melamed ML, Shehata AM, Sunderram J, Mathews KS, Sutherland AK, Nallamothu BK, Leaf DE; STOP-COVID Investigators. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ. 2020 Sep 30;371:m3513. doi: 10.1136/bmj.m3513."", 'Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; STOP-COVID Investigators. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol. 2021 Jan;32(1):161-176. doi: 10.1681/ASN.2020060897. Epub 2020 Oct 16.', 'Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE, Kovesdy CP; STOP-COVID Investigators. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant. 2020 Nov;20(11):3061-3071. doi: 10.1111/ajt.16280. Epub 2020 Sep 15.', 'Leaf RK, Al-Samkari H, Brenner SK, Gupta S, Leaf DE. ABO phenotype and death in critically ill patients with COVID-19. Br J Haematol. 2020 Aug;190(4):e204-e208. doi: 10.1111/bjh.16984. Epub 2020 Jul 30.', 'Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, Sosa MA, Renaghan AD, Melamed ML, Wilson FP, Neyra JA, Rashidi A, Boyle SM, Anand S, Christov M, Thomas LF, Edmonston D, Leaf DE; STOP-COVID Investigators. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021 Feb;77(2):190-203.e1. doi: 10.1053/j.ajkd.2020.09.003. Epub 2020 Sep 19.', 'Easter SR, Gupta S, Brenner SK, Leaf DE. Outcomes of Critically Ill Pregnant Women with COVID-19 in the United States. Am J Respir Crit Care Med. 2021 Jan 1;203(1):122-125. doi: 10.1164/rccm.202006-2182LE.', 'Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, Hayek SS, Berlin H, Kapoor R, Shaefi S, Melamed ML, Sutherland A, Radbel J, Green A, Garibaldi BT, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Goyal N, Chan L, Mathews KS, Hedayati SS, Dy R, Toth-Manikowski SM, Zhang J, Mallappallil M, Redfern RE, Bansal AD, Short SAP, Vangel MG, Admon AJ, Semler MW, Bauer KA, Hern√°n MA, Leaf DE; STOP-COVID Investigators. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 May;174(5):622-632. doi: 10.7326/M20-6739. Epub 2021 Jan 26. Erratum in: Ann Intern Med. 2021 Jun;174(6):888.', ""Shaefi S, Brenner SK, Gupta S, O'Gara BP, Krajewski ML, Charytan DM, Chaudhry S, Mirza SH, Peev V, Anderson M, Bansal A, Hayek SS, Srivastava A, Mathews KS, Johns TS, Leonberg-Yoo A, Green A, Arunthamakun J, Wille KM, Shaukat T, Singh H, Admon AJ, Semler MW, Hern√°n MA, Mueller AL, Wang W, Leaf DE; STOP-COVID Investigators. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med. 2021 Feb;47(2):208-221. doi: 10.1007/s00134-020-06331-9. Epub 2021 Feb 2."", 'Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, Singh H, Wu B, Bagchi A, Al-Samkari H, Dy R, Wilkinson K, Zakai NA, Leaf DE; STOP-COVID Investigators. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 May 1;49(5):e500-e511. doi: 10.1097/CCM.0000000000004917.', 'Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, Radbel J, Green A, Sutherland A, Leonberg-Yoo A, Shehata A, Schenck EJ, Short SAP, Hern√°n MA, Chan L, Leaf DE; STOP-COVID Investigators. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med. 2021 Jul 1;49(7):1026-1037. doi: 10.1097/CCM.0000000000004938.', 'Douin DJ, Shaefi S, Brenner SK, Gupta S, Park I, Wright FL, Mathews KS, Chan L, Al-Samkari H, Orfanos S, Radbel J, Leaf DE. Tissue Plasminogen Activator in Critically Ill Adults with COVID-19. Ann Am Thorac Soc. 2021 Nov;18(11):1917-1921. doi: 10.1513/AnnalsATS.202102-127RL.', 'Churpek MM, Gupta S, Spicer AB, Parker WF, Fahrenbach J, Brenner SK, Leaf DE; STOP-COVID Investigators. Hospital-Level Variation in Death for Critically Ill Patients with COVID-19. Am J Respir Crit Care Med. 2021 Aug 15;204(403-411). doi: 10.1164/rccm.202012-4547OC.', 'Vasquez CR, Gupta S, Miano TA, Roche M, Hsu J, Yang W, Holena DN, Reilly JP, Schrauben SJ, Leaf DE, Shashaty MGS; STOP-COVID Investigators. Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19. Chest. 2021 Sep;160(3):929-943. doi: 10.1016/j.chest.2021.04.062. Epub 2021 May 6.', 'Friedman AN, Guirguis J, Kapoor R, Gupta S, Leaf DE, Timsina LR; STOP-COVID Investigators. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021 Oct;29(10):1719-1730. doi: 10.1002/oby.23245. Epub 2021 Aug 6.', 'Jezmir JL, Bharadwaj M, Chaitoff A, Diephuis B, Crowley CP, Kishore SP, Goralnick E, Merriam LT, Milliken A, Rhee C, Sadovnikoff N, Shah SB, Gupta S, Leaf DE, Feldman WB, Kim EY; STOP-COVID Investigators. Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States. Cell Rep Med. 2021 Sep 21;2(9):100376. doi: 10.1016/j.xcrm.2021.100376. Epub 2021 Jul 28.', 'Churpek MM, Gupta S, Spicer AB, Hayek SS, Srivastava A, Chan L, Melamed ML, Brenner SK, Radbel J, Madhani-Lovely F, Bhatraju PK, Bansal A, Green A, Goyal N, Shaefi S, Parikh CR, Semler MW, Leaf DE; STOP-COVID Investigators. Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2021 Aug 19;3(8):e0515. doi: 10.1097/CCE.0000000000000515. eCollection 2021 Aug.', 'Merriam LT, Bharadwaj M, Jezmir JL, Leaf DE, Kim EY. Protocol to assess performance of crisis standards of care guidelines for clinical triage. STAR Protoc. 2021 Dec 17;2(4):100943. doi: 10.1016/j.xpro.2021.100943. Epub 2021 Nov 10.', 'Hsu CM, Gupta S, Tighiouart H, Goyal N, Faugno AJ, Tariq A, Raichoudhury R, Sharma JH, Meyer L, Kshirsagar RK, Jose A, Leaf DE, Weiner DE; STOP-COVID Investigators. Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study. Am J Kidney Dis. 2022 Mar;79(3):404-416.e1. doi: 10.1053/j.ajkd.2021.11.004. Epub 2021 Dec 4.', 'Toth-Manikowski SM, Caldwell J, Joo M, Chen J, Meza N, Bruinius J, Gupta S, Hannan M, Kagalwalla M, Madrid S, Melamed ML, Pacheco E, Srivastava A, Viamontes C, Lash JP, Leaf DE, Ricardo AC; STOP-COVID Investigators. Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19. Medicine (Baltimore). 2021 Dec 17;100(50):e28302. doi: 10.1097/MD.0000000000028302.']",2022-01-12,https://clinicaltrials.gov/show/NCT04343898,2020-08-01,0,1
688,NCT04343989,Completed,2021-02-03,2021-03-12,Study Results,,,2022-02-15,https://clinicaltrials.gov/show/NCT04343989,2021-02-03,1,0
689,NCT04344041,Completed,2021-01-14,2021-01-14,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.', 'Annweiler C, Beaudenon M, Gautier J, Simon R, Dub√©e V, Gonsard J, Parot-Schinkel E; COVIT-TRIAL study group. COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial. Trials. 2020 Dec 28;21(1):1031. doi: 10.1186/s13063-020-04928-5.']",,2021-04-30,https://clinicaltrials.gov/show/NCT04344041,2021-01-14,0,1
690,NCT04346082,Withdrawn,2021-07-30,2021-07-30,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04346082,2021-07-30,0,0
691,NCT04348071,Withdrawn,2021-08-01,2021-10-01,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04348071,2021-08-01,0,0
692,NCT04349098,Completed,2020-10-05,2020-10-05,Study Results,,,2021-11-01,https://clinicaltrials.gov/show/NCT04349098,2020-10-05,1,0
693,NCT04351906,Recruiting,2022-05-31,2022-06-30,No Results Posted,"['Husain-Syed F, Birk HW, Wilhelm J, Ronco C, Ranieri VM, Karle B, Kuhnert S, Tello K, Hecker M, Morty RE, Herold S, Kehl O, Walmrath HD, Seeger W, Vad√°sz I. Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2020 Nov 12;7:598379. doi: 10.3389/fmed.2020.598379. eCollection 2020.']","['Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A. Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care. 2018 May 10;22(1):122. doi: 10.1186/s13054-018-2038-5.']",2021-09-14,https://clinicaltrials.gov/show/NCT04351906,2022-05-31,0,1
694,NCT04353141,Recruiting,2020-05-31,2020-12-31,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04353141,2020-05-31,0,0
695,NCT04353583,Recruiting,2021-12-31,2022-06-30,No Results Posted,,"['Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7.']",2021-09-05,https://clinicaltrials.gov/show/NCT04353583,2021-12-31,0,1
696,NCT04354610,Completed,2020-12-19,2021-03-26,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04354610,2020-12-19,0,0
697,NCT04355637,Completed,2021-06-30,2021-06-30,No Results Posted,"['Agust√≠ A, De Stefano G, Levi A, Mu√±oz X, Romero-Mesones C, Sibila O, Lopez-Giraldo A, Plaza Moral V, Curto E, Echazarreta AL, M√°rquez SE, Pascual-Gu√†rdia S, Santos S, Marin A, Vald√©s L, Saldarini F, Salgado C, Casanovas G, Varea S, R√≠os J, Faner R. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. Eur Respir J. 2022 Mar 10;59(3). pii: 2103036. doi: 10.1183/13993003.03036-2021. Print 2022 Mar.', 'Agusti A, Torres F, Faner R. Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19. Lancet Respir Med. 2021 Jul;9(7):682-683. doi: 10.1016/S2213-2600(21)00171-5. Epub 2021 Apr 9. Erratum in: Lancet Respir Med. 2021 Jun;9(6):e55.', 'Farne H, Singanayagam A. Reply. J Allergy Clin Immunol. 2021 Mar;147(3):1117-1118. doi: 10.1016/j.jaci.2020.11.019. Epub 2020 Dec 30.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2021-09-22,https://clinicaltrials.gov/show/NCT04355637,2021-06-30,0,1
698,NCT04356885,Completed,2020-07-30,2020-08-01,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04356885,2020-07-30,0,0
699,NCT04357314,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04357314,2020-05-31,0,0
700,NCT04357990,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2020-09-17,https://clinicaltrials.gov/show/NCT04357990,2021-03-01,0,0
701,NCT04359121,Recruiting,2023-11-15,2023-11-15,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04359121,2023-11-15,0,0
702,NCT04359927,Recruiting,2021-08-31,2025-08-31,No Results Posted,"['Ar√©valos V, Ortega-Paz L, Fernandez-Rodr√≠guez D, Alfonso Jim√©nez-D√≠az V, Rius JB, Campo G, Rodr√≠guez-Santamarta M, de Prado AP, G√≥mez-Menchero A, D√≠az Fern√°ndez JF, Scardino C, Gonzalo N, Pernigotti A, Alfonso F, Jes√∫s Amat-Santos I, Silvestro A, Ielasi A, Mar√≠a de la Torre J, Bastidas G, G√≥mez-Lara J, Sabat√© M, Brugaletta S; CV COVID-19 Registry Investigators. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS One. 2021 Jul 29;16(7):e0255263. doi: 10.1371/journal.pone.0255263. eCollection 2021.']",,2020-05-07,https://clinicaltrials.gov/show/NCT04359927,2021-08-31,0,1
703,NCT04362969,Not yet recruiting,2020-05-01,2020-05-01,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04362969,2020-05-01,0,0
704,NCT04363008,Recruiting,2020-04-30,2021-09-30,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04363008,2020-04-30,0,0
705,NCT04363216,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04363216,2021-05-01,0,0
706,NCT04363437,Terminated,2020-07-31,2020-07-31,Study Results,,,2022-02-18,https://clinicaltrials.gov/show/NCT04363437,2020-07-31,1,0
707,NCT04363593,Completed,2020-11-16,2020-11-16,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04363593,2020-11-16,0,0
708,NCT04365972,Completed,2020-04-30,2020-04-30,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04365972,2020-04-30,0,0
709,NCT04366934,Completed,2020-10-29,2020-10-29,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04366934,2020-10-29,0,0
710,NCT04367207,Recruiting,2020-12-01,2020-12-31,No Results Posted,"['African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. Lancet. 2021 May 22;397(10288):1885-1894. doi: 10.1016/S0140-6736(21)00441-4. Erratum in: Lancet. 2021 Jun 26;397(10293):2466.']",,2020-09-10,https://clinicaltrials.gov/show/NCT04367207,2020-12-01,0,1
711,NCT04368637,Recruiting,2020-07-30,2020-08-30,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04368637,2020-07-30,0,0
712,NCT04370015,Not yet recruiting,2020-06-30,2020-10-15,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04370015,2020-06-30,0,0
713,NCT04370678,Completed,2020-04-24,2020-04-24,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04370678,2020-04-24,0,0
714,NCT04371250,Completed,2020-05-31,2020-12-30,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04371250,2020-05-31,0,0
715,NCT04371640,Withdrawn,2021-07-30,2021-07-30,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04371640,2021-07-30,0,0
716,NCT04372004,Recruiting,2021-05-01,2021-06-01,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04372004,2021-05-01,0,0
717,NCT04373161,Completed,2020-04-22,2020-04-22,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04373161,2020-04-22,0,0
718,NCT04373889,Completed,2021-04-30,2021-04-30,No Results Posted,"['Mortgat L, Verdonck K, Hutse V, Thomas I, Barbezange C, Heyndrickx L, Fischer N, Vuylsteke B, Kabouche I, Ari√´n KK, Desombere I, Duysburgh E. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study. BMJ Open. 2021 Jun 29;11(6):e050824. doi: 10.1136/bmjopen-2021-050824.']",,2021-10-04,https://clinicaltrials.gov/show/NCT04373889,2021-04-30,0,1
719,NCT04374019,Terminated,2020-12-21,2022-01-12,Study Results,,,2022-01-20,https://clinicaltrials.gov/show/NCT04374019,2020-12-21,1,0
720,NCT04374032,Completed,2020-10-07,2020-11-03,No Results Posted,,,2020-12-24,https://clinicaltrials.gov/show/NCT04374032,2020-10-07,0,0
721,NCT04374045,Completed,2020-06-17,2020-06-18,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04374045,2020-06-17,0,0
722,NCT04374097,Completed,2020-04-07,2020-04-07,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04374097,2020-04-07,0,0
723,NCT04374110,Recruiting,2020-06-24,2021-08-24,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04374110,2020-06-24,0,0
724,NCT04374279,Withdrawn,2022-01-01,2022-01-01,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04374279,2022-01-01,0,0
725,NCT04374370,,,,,,,2021-05-06,https://clinicaltrials.gov/show/NCT04374370,,0,0
726,NCT04374617,Completed,2020-04-25,2020-05-01,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04374617,2020-04-25,0,0
727,NCT04374838,Recruiting,2020-08-01,2021-09-01,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04374838,2020-08-01,0,0
728,NCT04374942,Terminated,2021-03-31,2021-03-31,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04374942,2021-03-31,0,0
729,NCT04375137,Recruiting,2022-04-01,2022-05-30,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04375137,2022-04-01,0,0
730,NCT04375644,Completed,2020-07-15,2020-07-15,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04375644,2020-07-15,0,0
731,NCT04375748,Recruiting,2021-10-15,2021-10-15,No Results Posted,,,2020-11-23,https://clinicaltrials.gov/show/NCT04375748,2021-10-15,0,0
732,NCT04375774,Recruiting,2020-05-01,2020-05-01,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04375774,2020-05-01,0,0
733,NCT04376398,Completed,2020-06-30,2020-08-30,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04376398,2020-06-30,0,0
734,NCT04376515,Not yet recruiting,2021-11-01,2021-12-01,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04376515,2021-11-01,0,0
735,NCT04376593,Enrolling by invitation,2022-06-01,2022-12-01,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04376593,2022-06-01,0,0
736,NCT04376710,Completed,2020-10-01,2020-10-01,No Results Posted,"['Diaz-Miron J, Ogle S, Kaizer A, Acker SN, Rove KO, Inge TH. Surgeon, patient, and caregiver perspective of pediatric surgical telemedicine in the COVID-19 pandemic era. Pediatr Surg Int. 2022 Feb;38(2):241-248. doi: 10.1007/s00383-021-05016-8. Epub 2021 Sep 22.']",,2020-10-28,https://clinicaltrials.gov/show/NCT04376710,2020-10-01,0,1
737,NCT04376788,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04376788,2020-07-01,0,0
738,NCT04376853,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04376853,2020-06-01,0,0
739,NCT04376905,Completed,2020-09-01,2020-09-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04376905,2020-09-01,0,0
740,NCT04376944,Recruiting,2020-12-01,2020-12-30,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04376944,2020-12-01,0,0
741,NCT04376996,Completed,2020-11-15,2020-12-15,No Results Posted,,"['Maver Vodiƒçar P, O≈°trbenk Valenƒçak A, Zupan B, Av≈°iƒç ≈Ωupanc T, Kurdija S, Korva M, Petrovec M, Dem≈°ar J, Knap N, ≈†trumbelj E, Vehovar V, Poljak M. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample. Clin Microbiol Infect. 2020 Nov;26(11):1514-1519. doi: 10.1016/j.cmi.2020.07.013. Epub 2020 Jul 18.', 'Poljak M, O≈°trbenk Valenƒçak A, ≈†trumbelj E, Maver Vodiƒçar P, Vehovar V, Resman Rus K, Korva M, Knap N, Seme K, Petrovec M, Zupan B, Dem≈°ar J, Kurdija S, Av≈°iƒç ≈Ωupanc T. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned. Clin Microbiol Infect. 2021 Jul;27(7):1039.e1-1039.e7. doi: 10.1016/j.cmi.2021.03.009. Epub 2021 Apr 7.']",2021-10-06,https://clinicaltrials.gov/show/NCT04376996,2020-11-15,0,1
742,NCT04377035,Recruiting,2021-03-01,2021-03-01,No Results Posted,"['Espersen C, Platz E, Skaarup KG, Lassen MCH, Lind JN, Johansen ND, Sengel√∏v M, Alhakak AS, Nielsen AB, Bundgaard H, Hassager C, Jabbari R, Carlsen J, Kirk O, Lindholm MG, Kristiansen OP, Nielsen OW, Jeschke KN, Ulrik CS, Sivapalan P, Gislason G, Iversen K, Jensen JUS, Schou M, Skaarup SH, Biering-S√∏rensen T. Lung Ultrasound Findings Associated With COVID-19 ARDS, ICU Admission, and All-Cause Mortality. Respir Care. 2021 Nov 23. pii: respcare.09108. doi: 10.4187/respcare.09108. [Epub ahead of print]', 'Skaarup KG, Lassen MCH, Espersen C, Lind JN, Johansen ND, Sengel√∏v M, Alhakak AS, Nielsen AB, Ravnkilde K, Hauser R, Sch√∂ps LB, Holt E, Bundgaard H, Hassager C, Jabbari R, Carlsen J, Kirk O, Bodtger U, Lindholm MG, Wiese L, Kristiansen OP, Walsted ES, Nielsen OW, Lindegaard B, T√∏nder N, Jeschke KN, Ulrik CS, Lamberts M, Sivapalan P, Pallisgaard J, Gislason G, Iversen K, Jensen JUS, Schou M, Skaarup SH, Platz E, Biering-S√∏rensen T. Lung ultrasound findings in hospitalized COVID-19 patients in relation to venous thromboembolic events: the ECHOVID-19 study. J Ultrasound. 2021 Jul 2. doi: 10.1007/s40477-021-00605-8. [Epub ahead of print]']",,2020-11-16,https://clinicaltrials.gov/show/NCT04377035,2021-03-01,0,1
743,NCT04377074,Completed,2020-04-07,2020-04-07,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377074,2020-04-07,0,0
744,NCT04377308,Recruiting,2021-04-20,2021-10-20,Results Submitted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377308,2021-04-20,0,0
745,NCT04377412,Recruiting,2020-08-31,2020-10-31,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377412,2020-08-31,0,0
746,NCT04377425,Withdrawn,2020-11-29,2022-06-30,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04377425,2020-11-29,0,0
747,NCT04377464,Not yet recruiting,2021-04-30,2022-04-30,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377464,2021-04-30,0,0
748,NCT04377477,Recruiting,2021-08-10,2022-08-30,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04377477,2021-08-10,0,0
749,NCT04377503,Terminated,2020-08-31,2020-11-30,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04377503,2020-08-31,0,0
750,NCT04377581,Completed,2020-07-10,2020-07-10,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04377581,2020-07-10,0,0
751,NCT04377646,Not yet recruiting,2020-05-24,2020-07-31,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377646,2020-05-24,0,0
752,NCT04377750,Recruiting,2020-04-29,2021-05-08,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377750,2020-04-29,0,0
753,NCT04377763,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04377763,2021-03-01,0,0
754,NCT04377802,Not yet recruiting,2020-11-16,2020-12-30,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04377802,2020-11-16,0,0
755,NCT04377815,Completed,2020-05-14,2020-06-24,No Results Posted,"['Makaronidis J, Firman C, Magee CG, Mok J, Balogun N, Lechner M, Carnemolla A, Batterham RL. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK. BMC Infect Dis. 2021 Feb 25;21(1):221. doi: 10.1186/s12879-021-05927-w.', 'Makaronidis J, Mok J, Balogun N, Magee CG, Omar RZ, Carnemolla A, Batterham RL. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study. PLoS Med. 2020 Oct 1;17(10):e1003358. doi: 10.1371/journal.pmed.1003358. eCollection 2020 Oct.']",,2021-01-19,https://clinicaltrials.gov/show/NCT04377815,2020-05-14,0,1
756,NCT04377997,Recruiting,2022-06-01,2022-06-01,No Results Posted,,"['Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Frencken JF, Donker DW, Spitoni C, Koster-Brouwer ME, Soliman IW, Ong DSY, Horn J, van der Poll T, van Klei WA, Bonten MJM, Cremer OL. Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome. Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004040. doi: 10.1161/CIRCOUTCOMES.117.004040.', 'Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.', 'C. P. COVID-19: Abnormal Clotting Common in More Severe Disease. 2020.', 'Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008 Nov 25;118(22):2286-97. doi: 10.1161/CIRCULATIONAHA.108.778837. Review.', 'Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med. 2008 Nov;36(11):2973-9. doi: 10.1097/CCM.0b013e31818b8c6b.', 'Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Mu√±oz A. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med. 2009 Apr;37(4):1185-96. doi: 10.1097/CCM.0b013e31819c06bc.', 'Safety of Heparin in Patients with Septic Shock.', 'Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.', 'Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13. Review.', 'Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, H√©bert P, Cook DJ, Fergusson DA; Canadian Critical Care Trials Group. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763. Review.', 'Zidane M, Schram MT, Planken EW, Molendijk WH, Rosendaal FR, van der Meer FJ, Huisman MV. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice. Arch Intern Med. 2000 Aug 14-28;160(15):2369-73.', 'Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005 Apr;3(4):692-4.', 'Morris TA, Castrejon S, Devendra G, Gamst AC. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Chest. 2007 Oct;132(4):1131-9. Epub 2007 Jul 23.', 'Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med. 2009 Oct;122(10):919-30. doi: 10.1016/j.amjmed.2009.03.026. Epub 2009 Aug 13. Review.']",2022-02-22,https://clinicaltrials.gov/show/NCT04377997,2022-06-01,0,1
757,NCT04378244,Not yet recruiting,2022-01-12,2022-03-12,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04378244,2022-01-12,0,0
758,NCT04378257,Not yet recruiting,2020-09-30,2020-10-20,No Results Posted,"['Al-Alawi M, McCall RK, Sultan A, Al Balushi N, Al-Mahrouqi T, Al Ghailani A, Al Sabti H, Al-Maniri A, Panchatcharam SM, Al Sinawi H. Efficacy of a Six-Week-Long Therapist-Guided Online Therapy Versus Self-help Internet-Based Therapy for COVID-19-Induced Anxiety and Depression: Open-label, Pragmatic, Randomized Controlled Trial. JMIR Ment Health. 2021 Feb 12;8(2):e26683. doi: 10.2196/26683.']",,2020-05-08,https://clinicaltrials.gov/show/NCT04378257,2020-09-30,0,1
759,NCT04378452,Completed,2021-03-22,2021-04-07,No Results Posted,"['Farr√©s J, Ruiz JL, Mas JM, Arias L, Sarrias MR, Armengol C, Cardona PJ, Munoz-Moreno JA, Vilaplana M, Arranz B, Usall J, Serrano-Blanco A, Vilaplana C. Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic. BMJ Open. 2021 Nov 26;11(11):e052140. doi: 10.1136/bmjopen-2021-052140.']",,2021-04-08,https://clinicaltrials.gov/show/NCT04378452,2021-03-22,0,1
760,NCT04378595,Recruiting,2020-12-30,2021-07-30,No Results Posted,"['Abrams SA, Avalos A, Gray M, Hawthorne KM. High Level of Food Insecurity among Families with Children Seeking Routine Care at Federally Qualified Health Centers during the Coronavirus Disease 2019 Pandemic. J Pediatr X. 2020 Fall;4:100044. doi: 10.1016/j.ympdx.2020.100044. Epub 2020 Jun 22.']",,2020-05-08,https://clinicaltrials.gov/show/NCT04378595,2020-12-30,0,1
761,NCT04378829,Completed,2020-10-11,2020-10-21,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04378829,2020-10-11,0,0
762,NCT04378881,Enrolling by invitation,2023-06-11,2023-11-11,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04378881,2023-06-11,0,0
763,NCT04379037,Completed,2020-09-01,2020-11-01,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04379037,2020-09-01,0,0
764,NCT04379089,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04379089,2022-12-31,0,0
765,NCT04379154,Completed,2021-06-01,2021-06-01,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04379154,2021-06-01,0,0
766,NCT04379232,Completed,2020-04-20,2020-04-25,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04379232,2020-04-20,0,0
767,NCT04379245,Completed,2020-04-30,2020-05-04,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04379245,2020-04-30,0,0
768,NCT04379297,"Active, not recruiting",2021-06-11,2022-09-30,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04379297,2021-06-11,0,0
769,NCT04379336,Completed,2022-01-02,2022-01-02,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04379336,2022-01-02,0,0
770,NCT04379440,Recruiting,2020-09-30,2020-11-30,No Results Posted,"['Okoye C, Finamore P, Bellelli G, Coin A, Del Signore S, Fumagalli S, Gareri P, Malara A, Mossello E, Trevisan C, Volpato S, Zia G, Monzani F, Incalzi RA. Computed tomography findings and prognosis in older COVID-19 patients. BMC Geriatr. 2022 Mar 1;22(1):166. doi: 10.1186/s12877-022-02837-7.', 'Fumagalli S, Trevisan C, Del Signore S, Pelagalli G, Fumagalli C, Herbst A, Volpato S, Gareri P, Mossello E, Malara A, Monzani F, Okoye C, Coin A, Bellelli G, Zia G, Ungar A, Ranhoff AH, Antonelli Incalzi R; GeroCovid Working Group. Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry. Aging Clin Exp Res. 2022 Jan;34(1):249-256. doi: 10.1007/s40520-021-02008-5. Epub 2021 Oct 30.', 'Trevisan C, Del Signore S, Fumagalli S, Gareri P, Malara A, Mossello E, Volpato S, Monzani F, Coin A, Bellelli G, Zia G, Ranhoff AH, Antonelli Incalzi R; GeroCovid Working Group. Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study. Eur J Intern Med. 2021 May;87:29-35. doi: 10.1016/j.ejim.2021.01.017. Epub 2021 Jan 31.']",,2020-05-07,https://clinicaltrials.gov/show/NCT04379440,2020-09-30,0,1
771,NCT04379466,"Active, not recruiting",2022-01-01,2022-01-01,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04379466,2022-01-01,0,0
772,NCT04379479,Not yet recruiting,2020-08-01,2020-12-01,No Results Posted,,,2020-05-07,https://clinicaltrials.gov/show/NCT04379479,2020-08-01,0,0
773,NCT04379518,Recruiting,2023-11-17,2023-11-17,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04379518,2023-11-17,0,0
774,NCT04379661,Completed,2020-07-07,2020-08-31,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04379661,2020-07-07,0,0
775,NCT04380519,Completed,2020-07-10,2020-07-24,Study Results,,,2022-01-24,https://clinicaltrials.gov/show/NCT04380519,2020-07-10,1,0
776,NCT04380870,Recruiting,2021-12-11,2025-05-11,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04380870,2021-12-11,0,0
777,NCT04380948,,,,,,,,https://clinicaltrials.gov/show/NCT04380948,,0,0
778,NCT04475588,Completed,2020-07-07,2020-07-07,Study Results,,,2021-06-14,https://clinicaltrials.gov/show/NCT04475588,2020-07-07,1,0
779,NCT04273321,Completed,2020-04-15,2020-04-15,No Results Posted,"['Tang X, Feng YM, Ni JX, Zhang JY, Liu LM, Hu K, Wu XZ, Zhang JX, Chen JW, Zhang JC, Su J, Li YL, Zhao Y, Xie J, Ding Z, He XL, Wang W, Jin RH, Shi HZ, Sun B. Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial. Respiration. 2021;100(2):116-126. doi: 10.1159/000512063. Epub 2021 Jan 22.']",,2020-05-11,https://clinicaltrials.gov/show/NCT04273321,2020-04-15,0,1
780,NCT04278963,Suspended,2022-12-01,2023-05-01,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04278963,2022-12-01,0,0
781,NCT04310865,Suspended,2022-12-01,2023-04-01,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04310865,2022-12-01,0,0
782,NCT04322396,Terminated,2021-02-02,2021-02-02,Study Results,"['Sivapalan P, Ulrik CS, Lappere TS, Ekl√∂f JV, Shaker SB, B√∏dtger UCS, Browatzki A, Meyer CN, Weinreich UM, Laursen CB, Biering-S√∏rensen T, Knop FK, Lundgren JD, Jensen JS. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan. Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.', 'Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Ekl√∂f JV, H√•kansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-S√∏rensen T, Ghanizada M, Sonne TP, B√∏dtger UCS, Jensen SG, Rasmussen DB, Br√∏ndum E, Tupper OD, S√∏rensen SW, Alstrup G, Laursen CB, M√∏ller UW, Sverrild A, Jensen JS. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.']",,2021-06-29,https://clinicaltrials.gov/show/NCT04322396,2021-02-02,1,1
783,NCT04334512,Recruiting,2023-06-01,2024-09-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04334512,2023-06-01,0,0
784,NCT04335084,Recruiting,2024-12-01,2025-07-01,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04335084,2024-12-01,0,0
785,NCT04340219,Completed,2020-04-10,2020-09-18,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04340219,2020-04-10,0,0
786,NCT04340544,Terminated,2020-10-12,2020-10-12,No Results Posted,,,2020-11-02,,2020-10-12,0,0
787,NCT04344015,Completed,2020-06-02,2020-06-02,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04344015,2020-06-02,0,0
788,NCT04346147,"Active, not recruiting",2021-06-02,2021-09-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04346147,2021-06-02,0,0
789,NCT04346199,Completed,2020-11-17,2020-11-17,Study Results,,,2021-09-17,https://clinicaltrials.gov/show/NCT04346199,2020-11-17,1,0
790,NCT04347915,Recruiting,2021-01-30,2021-03-31,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04347915,2021-01-30,0,0
791,NCT04353323,Not yet recruiting,2020-06-25,2020-12-25,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04353323,2020-06-25,0,0
792,NCT04354389,Withdrawn,2020-09-30,2020-11-30,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04354389,2020-09-30,0,0
793,NCT04355871,Completed,2020-04-15,2020-04-17,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04355871,2020-04-15,0,0
794,NCT04356690,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04356690,2022-06-01,0,0
795,NCT04365985,Terminated,2021-04-01,2021-04-01,Study Results,,,2022-01-26,https://clinicaltrials.gov/show/NCT04365985,2021-04-01,1,0
796,NCT04366271,Withdrawn,2020-07-31,2021-05-31,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04366271,2020-07-31,0,0
797,NCT04370821,"Active, not recruiting",2024-06-05,2024-06-05,No Results Posted,"[""Kaufmann PG, Havens DS, Mensinger JL, Bradley PK, Brom HM, Copel LC, Costello A, D'Annunzio C, Dean Durning J, Maldonado L, Barrow McKenzie A, Smeltzer SC, Yost J; CHAMPS Study Investigators. The COVID-19 Study of Healthcare and Support Personnel (CHAMPS): Protocol for a Longitudinal Observational Study. JMIR Res Protoc. 2021 Oct 7;10(10):e30757. doi: 10.2196/30757.""]",,2021-08-24,https://clinicaltrials.gov/show/NCT04370821,2024-06-05,0,1
798,NCT04372056,Completed,2021-06-04,2021-06-04,No Results Posted,"['Lie I, Stafseth S, Skogstad L, Hovland IS, Hovde H, Ekeberg √ò, R√¶der J. Healthcare professionals in COVID-19-intensive care units in Norway: preparedness and working conditions: a cohort study. BMJ Open. 2021 Oct 11;11(10):e049135. doi: 10.1136/bmjopen-2021-049135.']",,2021-11-23,https://clinicaltrials.gov/show/NCT04372056,2021-06-04,0,1
799,NCT04373135,"Active, not recruiting",2021-02-01,2021-03-01,No Results Posted,"['Wisk LE, Buhr RG. Rapid deployment of a community engagement study and educational trial via social media: implementation of the UC-COVID study. Trials. 2021 Aug 2;22(1):513. doi: 10.1186/s13063-021-05467-3.', 'Wisk LE, Buhr RG. Rapid Deployment of A Community Engagement Study And Educational Trial Via Social Media: Implementation of The UC-COVID Study. Res Sq. 2021 May 7. pii: rs.3.rs-359099. doi: 10.21203/rs.3.rs-359099/v1. Update in: Trials. 2021 Aug 2;22(1):513.']",,2020-10-14,https://clinicaltrials.gov/show/NCT04373135,2021-02-01,0,1
800,NCT04375046,Not yet recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04375046,2021-08-01,0,0
801,NCT04375709,Recruiting,2021-06-30,2021-08-31,Results Submitted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04375709,2021-06-30,0,0
802,NCT04376476,Recruiting,2021-06-05,2021-06-05,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04376476,2021-06-05,0,0
803,NCT04377490,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04377490,2020-10-01,0,0
804,NCT04377607,Recruiting,2020-11-20,2020-12-30,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04377607,2020-11-20,0,0
805,NCT04378686,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04378686,2021-05-01,0,0
806,NCT04379271,Completed,2021-01-12,2021-02-23,Results Submitted,,,2021-04-26,,2021-01-12,0,0
807,NCT04379453,Recruiting,2020-04-27,2020-04-27,No Results Posted,"['Lemos PA, Franken M, Mariani J Jr, Pitta FG, Oliveira FA, Cunha-Lima G, Caixeta AM, Almeida BO, Garcia RG. Use of robotic assistance to reduce proximity and air-sharing during percutaneous cardiovascular intervention. Future Cardiol. 2021 Aug;17(5):865-873. doi: 10.2217/fca-2021-0024. Epub 2021 Apr 9.']",,2020-05-08,https://clinicaltrials.gov/show/NCT04379453,2020-04-27,0,1
808,NCT04379492,Withdrawn,2020-09-25,2020-09-25,No Results Posted,,,2020-10-30,https://clinicaltrials.gov/show/NCT04379492,2020-09-25,0,0
809,NCT04379544,"Active, not recruiting",2020-09-01,2021-12-01,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04379544,2020-09-01,0,0
810,NCT04380376,Recruiting,2020-10-30,2020-10-30,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04380376,2020-10-30,0,0
811,NCT04380688,Completed,2020-11-16,2020-11-16,Study Results,,,2021-09-13,https://clinicaltrials.gov/show/NCT04380688,2020-11-16,1,0
812,NCT04380714,Completed,2020-05-30,2020-08-01,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04380714,2020-05-30,0,0
813,NCT04380727,Completed,2020-04-14,2020-04-25,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04380727,2020-04-14,0,0
814,NCT04380766,Completed,2020-07-31,2020-07-31,Results Submitted,"['Quero G, Pecorelli N, Paiella S, Fiorillo C, Petrone MC, Rosa F, Capretti G, Laterza V, Kauffmann E, Nobile S, Butturini G, Ferrari G, Coratti A, Casadei R, Mazzaferro V, Boggi U, Zerbi A, Salvia R, Falconi M, Alfieri S. Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers. Updates Surg. 2022 Feb;74(1):255-266. doi: 10.1007/s13304-021-01171-8. Epub 2021 Nov 24.']",,2020-08-03,https://clinicaltrials.gov/show/NCT04380766,2020-07-31,0,1
815,NCT04380779,Completed,2020-10-13,2020-10-13,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04380779,2020-10-13,0,0
816,NCT04380792,Completed,2020-10-13,2020-10-13,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04380792,2020-10-13,0,0
817,NCT04380909,Completed,2021-07-29,2021-07-29,No Results Posted,"['Brog NA, Hegy JK, Berger T, Znoj H. An internet-based self-help intervention for people with psychological distress due to COVID-19: study protocol for a randomized controlled trial. Trials. 2021 Mar 1;22(1):171. doi: 10.1186/s13063-021-05089-9.']",,2021-08-24,https://clinicaltrials.gov/show/NCT04380909,2021-07-29,0,1
818,NCT04380935,Recruiting,2020-10-31,2020-10-31,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04380935,2020-10-31,0,0
819,NCT04380987,Recruiting,2022-03-31,2022-12-31,No Results Posted,"['Fagherazzi G, Fischer A, Betsou F, Vaillant M, Ernens I, Masi S, Mossong J, Staub T, Brault D, Bahlawane C, Rashid MA, Ollert M, Gantenbein M, Huiart L. Protocol for a prospective, longitudinal cohort of people with COVID-19 and their household members to study factors associated with disease severity: the Predi-COVID study. BMJ Open. 2020 Nov 23;10(11):e041834. doi: 10.1136/bmjopen-2020-041834.']",,2022-02-24,https://clinicaltrials.gov/show/NCT04380987,2022-03-31,0,1
820,NCT04381000,Completed,2020-05-29,2020-06-10,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04381000,2020-05-29,0,0
821,NCT04381052,Completed,2021-02-03,2021-03-12,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04381052,2021-02-03,0,0
822,NCT04381273,Completed,2020-08-08,2020-08-08,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04381273,2020-08-08,0,0
823,NCT04381286,Recruiting,2021-04-01,2021-12-31,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04381286,2021-04-01,0,0
824,NCT04381312,Recruiting,2021-07-09,2021-10-09,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04381312,2021-07-09,0,0
825,NCT04381338,Not yet recruiting,2020-09-30,2020-09-30,No Results Posted,,,2020-05-08,https://clinicaltrials.gov/show/NCT04381338,2020-09-30,0,0
826,NCT04381364,"Active, not recruiting",2021-08-01,2022-01-31,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04381364,2021-08-01,0,0
827,NCT04381377,"Active, not recruiting",2021-04-01,2021-04-01,No Results Posted,,,2021-02-16,https://clinicaltrials.gov/show/NCT04381377,2021-04-01,0,0
828,NCT04381819,Recruiting,2022-02-28,2023-12-31,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04381819,2022-02-28,0,0
829,NCT04381858,Completed,2020-11-26,2020-11-26,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,2020-11-30,https://clinicaltrials.gov/show/NCT04381858,2020-11-26,0,1
830,NCT04381871,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,"['Kaddam L, Babiker R, Ali S, Satti S, Ali N, Elamin M, Mukhtar M, Elnimeiri M, Saeed A. Potential Role of Acacia Senegal (Gum Arabic) as Immunomodulatory Agent among newly diagnosed COVID 19 Patients: A structured summary of a protocol for a randomised, controlled, clinical trial. Trials. 2020 Sep 5;21(1):766. doi: 10.1186/s13063-020-04707-2.']",,2020-05-12,https://clinicaltrials.gov/show/NCT04381871,2020-08-01,0,1
831,NCT04382092,Completed,2020-04-24,2020-04-24,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04382092,2020-04-24,0,0
832,NCT04382131,Recruiting,2020-10-31,2020-10-31,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04382131,2020-10-31,0,0
833,NCT04382196,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04382196,2022-12-31,0,0
834,NCT04382235,"Active, not recruiting",2021-04-30,2021-06-30,No Results Posted,"['Bellani G, Grasselli G, Cecconi M, Antolini L, Borelli M, De Giacomi F, Bosio G, Latronico N, Filippini M, Gemma M, Giannotti C, Antonini B, Petrucci N, Zerbi SM, Maniglia P, Castelli GP, Marino G, Subert M, Citerio G, Radrizzani D, Mediani TS, Lorini FL, Russo FM, Faletti A, Beindorf A, Covello RD, Greco S, Bizzarri MM, Ristagno G, Mojoli F, Pradella A, Severgnini P, Da Macall√® M, Albertin A, Ranieri VM, Rezoagli E, Vitale G, Magliocca A, Cappelleri G, Docci M, Aliberti S, Serra F, Rossi E, Valsecchi MG, Pesenti A, Foti G. Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units (WARd-COVID). Ann Am Thorac Soc. 2021 Jun;18(6):1020-1026. doi: 10.1513/AnnalsATS.202008-1080OC.']",,2021-04-21,https://clinicaltrials.gov/show/NCT04382235,2021-04-30,0,1
835,NCT04382469,Completed,2020-04-30,2020-05-01,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04382469,2020-04-30,0,0
836,NCT04382534,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04382534,2020-09-30,0,0
837,NCT04382560,Completed,2020-05-31,2020-05-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04382560,2020-05-31,0,0
838,NCT04382625,Withdrawn,2022-01-01,2022-06-01,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04382625,2022-01-01,0,0
839,NCT04382729,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,2020-05-11,https://clinicaltrials.gov/show/NCT04382729,2020-07-01,0,0
840,NCT04382755,Completed,2020-12-29,2021-04-09,No Results Posted,"['Declercq J, Bosteels C, Van Damme K, De Leeuw E, Maes B, Vandecauter A, Vermeersch S, Delporte A, Demeyere B, Vuylsteke M, Lalla M, Smart T, Detalle L, Bouw R, Streffer J, Degeeter T, Vergotte M, Guisez T, Van Braeckel E, Van Der Straeten C, Lambrecht BN. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 19;21(1):934. doi: 10.1186/s13063-020-04884-0.']",,2022-01-27,https://clinicaltrials.gov/show/NCT04382755,2020-12-29,0,1
841,NCT04382781,Recruiting,2020-05-01,2020-05-01,Results Submitted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04382781,2020-05-01,0,0
842,NCT04382846,Recruiting,2030-12-01,2030-12-01,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04382846,2030-12-01,0,0
843,NCT04382924,Completed,2020-12-24,2021-01-26,Study Results,,,2021-12-03,https://clinicaltrials.gov/show/NCT04382924,2020-12-24,1,0
844,NCT04383002,"Active, not recruiting",2021-05-11,2021-06-11,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04383002,2021-05-11,0,0
845,NCT04383574,"Active, not recruiting",2021-12-28,2022-07-30,No Results Posted,"['Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, Wu Z, Jiang D, Deng X, Chu K, Zheng W, Wang L, Lu W, Han B, Zhao Y, Zhu F, Yu H, Yin W. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect Dis. 2021 Dec 7. pii: S1473-3099(21)00681-2. doi: 10.1016/S1473-3099(21)00681-2. [Epub ahead of print]', 'Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Jun;21(6):803-812. doi: 10.1016/S1473-3099(20)30987-7. Epub 2021 Feb 3.']",,2021-08-18,https://clinicaltrials.gov/show/NCT04383574,2021-12-28,0,1
846,NCT04383587,Completed,2020-07-01,2020-07-31,Results Submitted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04383587,2020-07-01,0,0
847,NCT04383626,Completed,2020-04-05,2020-05-05,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04383626,2020-04-05,0,0
848,NCT04383652,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04383652,2022-06-30,0,0
849,NCT04383886,Recruiting,2020-08-18,2020-08-18,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04383886,2020-08-18,0,0
850,NCT04384029,Completed,2021-06-30,2021-07-31,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04384029,2021-06-30,0,0
851,NCT04384250,Recruiting,2020-08-31,2021-05-01,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04384250,2020-08-31,0,0
852,NCT04384380,Completed,2020-05-31,2020-05-31,No Results Posted,,"['Cheng SC, Chang YC, Fan Chiang YL, Chien YC, Cheng M, Yang CH, Huang CH, Hsu YN. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc. 2020 Mar;119(3):747-751. doi: 10.1016/j.jfma.2020.02.007. Epub 2020 Feb 26.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.', 'Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.']",2020-08-04,https://clinicaltrials.gov/show/NCT04384380,2020-05-31,0,1
853,NCT04384419,Completed,2021-05-30,2021-06-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04384419,2021-05-30,0,0
854,NCT04384471,Completed,2020-07-01,2020-07-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04384471,2020-07-01,0,0
855,NCT04384549,Recruiting,2021-02-20,2021-02-20,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04384549,2021-02-20,0,0
856,NCT04384588,Recruiting,2021-04-06,2021-04-06,Results Submitted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04384588,2021-04-06,0,0
857,NCT04385212,Completed,2020-04-14,2020-04-14,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04385212,2020-04-14,0,0
858,NCT04385576,Recruiting,2020-09-15,2020-12-30,No Results Posted,,"['Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020 May 14;382(20):1957-1958. doi: 10.1056/NEJMc2007589. Epub 2020 Apr 3.']",2020-05-13,https://clinicaltrials.gov/show/NCT04385576,2020-09-15,0,1
859,NCT04278404,Recruiting,2024-04-24,2024-04-24,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04278404,2024-04-24,0,0
860,NCT04307459,Recruiting,2020-09-01,2020-12-31,No Results Posted,"['Santus P, Radovanovic D, Saderi L, Marino P, Cogliati C, De Filippis G, Rizzi M, Franceschi E, Pini S, Giuliani F, Del Medico M, Nucera G, Valenti V, Tursi F, Sotgiu G. Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study. BMJ Open. 2020 Oct 10;10(10):e043651. doi: 10.1136/bmjopen-2020-043651.']",,2020-05-13,https://clinicaltrials.gov/show/NCT04307459,2020-09-01,0,1
861,NCT04311398,Not yet recruiting,2020-06-01,2020-12-01,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04311398,2020-06-01,0,0
862,NCT04323644,Recruiting,2020-09-30,2020-09-30,No Results Posted,"['COVIDSurg Collaborative. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study. BMJ Open. 2021 Nov 30;11(11):e050830. doi: 10.1136/bmjopen-2021-050830.', 'Seeliger B, Philouze G, Cherkaoui Z, Felli E, Mutter D, Pessaux P. Acute abdomen in patients with SARS-CoV-2 infection or co-infection. Langenbecks Arch Surg. 2020 Sep;405(6):861-866. doi: 10.1007/s00423-020-01948-2. Epub 2020 Jul 27.']",,2020-05-12,https://clinicaltrials.gov/show/NCT04323644,2020-09-30,0,1
863,NCT04324684,Completed,2020-05-07,2020-05-07,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04324684,2020-05-07,0,0
864,NCT04328961,Completed,2020-09-24,2020-10-08,Study Results,"['Barnabas RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, Johnston C, Thorpe LE, Kottkamp A, Neuzil KM, Laufer MK, Deming M, Paasche-Orlow MK, Kissinger PJ, Luk A, Paolino K, Landovitz RJ, Hoffman R, Schaafsma TT, Krows ML, Thomas KK, Morrison S, Haugen HS, Kidoguchi L, Wener M, Greninger AL, Huang ML, Jerome KR, Wald A, Celum C, Chu HY, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 Mar;174(3):344-352. doi: 10.7326/M20-6519. Epub 2020 Dec 8. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.']",,2021-12-16,https://clinicaltrials.gov/show/NCT04328961,2020-09-24,1,1
865,NCT04331886,Recruiting,2024-03-01,2024-03-01,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04331886,2024-03-01,0,0
866,NCT04334148,Completed,2020-12-10,2021-01-09,Study Results,,,2021-10-12,https://clinicaltrials.gov/show/NCT04334148,2020-12-10,1,0
867,NCT04335097,Recruiting,2022-04-08,2025-12-20,No Results Posted,,"['Samsudin MI, Liu N, Prabhakar SM, Chong SL, Kit Lye W, Koh ZX, Guo D, Rajesh R, Ho AFW, Ong MEH. A novel heart rate variability based risk prediction model for septic patients presenting to the emergency department. Medicine (Baltimore). 2018 Jun;97(23):e10866. doi: 10.1097/MD.0000000000010866.', 'Melillo P, Izzo R, Orrico A, Scala P, Attanasio M, Mirra M, De Luca N, Pecchia L. Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis. PLoS One. 2015 Mar 20;10(3):e0118504. doi: 10.1371/journal.pone.0118504. eCollection 2015.']",2021-05-17,https://clinicaltrials.gov/show/NCT04335097,2022-04-08,0,1
868,NCT04335162,Recruiting,2021-08-31,2021-08-31,No Results Posted,"['Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F, Levraut J, Doyen D, Dellamonica J, Mondain V, Chirio D, Risso K, Cua E, Orban JC, Ichai C, Labbaoui M, Mossaz B, Moceri P, Appert-Flory A, Fischer F, Toulon P. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. J Am Heart Assoc. 2020 Nov 3;9(21):e017773. doi: 10.1161/JAHA.120.017773. Epub 2020 Sep 25.']",,2020-11-24,https://clinicaltrials.gov/show/NCT04335162,2021-08-31,0,1
869,NCT04339998,"Active, not recruiting",2020-10-01,2022-10-01,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04339998,2020-10-01,0,0
870,NCT04340050,Completed,2020-12-23,2020-12-23,Results Submitted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,2020-12-28,https://clinicaltrials.gov/show/NCT04340050,2020-12-23,0,1
871,NCT04340349,Enrolling by invitation,2021-05-30,2021-06-30,No Results Posted,"['Granados-Montiel J, Hazan-Lasri E, Franco-Cendejas R, Ch√°vez-Heres T, Silva-Bermudez P, Aguilar-Gayt√°n R, Manzano-Le√≥n N, M√©ndez-Maldonado K, Alvarez-Arce A, Mart√≠nez-Portilla RJ. New prophylaxis regimen for SARS-CoV-2 infection in health professionals with low doses of hydroxychloroquine and bromhexine: a randomised, double-blind placebo clinical trial (ELEVATE Trial). BMJ Open. 2021 Aug 3;11(8):e045190. doi: 10.1136/bmjopen-2020-045190.']","['Lai C, Yu R, Wang M, Xian W, Zhao X, Tang Q, Chen R, Zhou X, Li X, Li Z, Li Z, Deng G, Wang F. Shorter incubation period is associated with severe disease progression in patients with COVID-19. Virulence. 2020 Dec;11(1):1443-1452. doi: 10.1080/21505594.2020.1836894.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li C, Ji F, Wang L, Wang L, Hao J, Dai M, Liu Y, Pan X, Fu J, Li L, Yang G, Yang J, Yan X, Gu B. Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China. Emerg Infect Dis. 2020 Jul;26(7):1626-1628. doi: 10.3201/eid2607.200718. Epub 2020 Jun 21.', 'Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020 Feb 24;12(1):8. doi: 10.1038/s41368-020-0074-x.', 'Levy A, Yagil Y, Bursztyn M, Barkalifa R, Scharf S, Yagil C. ACE2 expression and activity are enhanced during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1953-61. doi: 10.1152/ajpregu.90592.2008. Epub 2008 Oct 22.', 'Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.', 'Zhan M, Qin Y, Xue X, Zhu S. Death from Covid-19 of 23 Health Care Workers in China. N Engl J Med. 2020 Jun 4;382(23):2267-2268. doi: 10.1056/NEJMc2005696. Epub 2020 Apr 15.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Liu Q, Bi G, Chen G, Guo X, Tu S, Tong X, Xu M, Liu M, Wang B, Jiang H, Wang J, Li H, Wang K, Liu D, Song C. Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method. Front Pharmacol. 2021 Jan 14;11:602880. doi: 10.3389/fphar.2020.602880. eCollection 2020.', 'Wang LF, Lin YS, Huang NC, Yu CY, Tsai WL, Chen JJ, Kubota T, Matsuoka M, Chen SR, Yang CS, Lu RW, Lin YL, Chang TH. Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res. 2015 Mar;35(3):143-56. doi: 10.1089/jir.2014.0038. Epub 2014 Oct 16.', 'Helal GK, Gad MA, Abd-Ellah MF, Eid MS. Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients. J Med Virol. 2016 Dec;88(12):2170-2178. doi: 10.1002/jmv.24575. Epub 2016 May 25.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. doi: 10.1080/22221751.2020.1770129.', 'Chude CI, Amaravadi RK. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. Int J Mol Sci. 2017 Jun 16;18(6). pii: E1279. doi: 10.3390/ijms18061279. Review.', 'Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson DK, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.', 'Zahr N, Urien S, Llopis B, Pourcher V, Paccoud O, Bleibtreu A, Mayaux J, Gandjbakhch E, Hekimian G, Combes A, Benveniste O, Saadoun D, Allenbach Y, Pinna B, Cacoub P, Funck-Brentano C, Salem JE. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Therapie. 2021 Jul-Aug;76(4):285-295. doi: 10.1016/j.therap.2021.01.056. Epub 2021 Jan 28.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Mareev VY, Orlova YA, Pavlikova EP, Matskeplishvili ST, Akopyan ZA, Plisyk AG, Seredenina EM, Asratyan DA, Potapenko AV, Malakhov PS, Samokhodskaya LM, Mershina EA, Sinitsyn VE, Bulanova MM, Fuks AA, Mareev YV, Begrambekova YL, Kamalov AA. [Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial ""BromhexIne and Spironolactone for Coron–∞virUs Infection requiring hospiTalization (BISCUIT)""]. Kardiologiia. 2020 Sep 7;60(8):4-15. doi: 10.18087/cardio.2020.8.n1307. Russian.']",2021-06-29,https://clinicaltrials.gov/show/NCT04340349,2021-05-30,0,1
872,NCT04341415,Terminated,2020-11-20,2021-01-15,No Results Posted,"['Rangon CM, Barruet R, Mazouni A, Le Cossec C, Thevenin S, Guillaume J, L√©guillier T, Huysman F, Luis D. Auricular Neuromodulation for Mass Vagus Nerve Stimulation: Insights From SOS COVID-19 a Multicentric, Randomized, Controlled, Double-Blind French Pilot Study. Front Physiol. 2021 Aug 2;12:704599. doi: 10.3389/fphys.2021.704599. eCollection 2021.']",,2021-04-13,https://clinicaltrials.gov/show/NCT04341415,2020-11-20,0,1
873,NCT04342728,Completed,2020-12-30,2021-02-11,No Results Posted,"[""O'Byrne L, Webster KE, MacKeith S, Philpott C, Hopkins C, Burton MJ. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2021 Jul 22;7:CD013876. doi: 10.1002/14651858.CD013876.pub2."", ""Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, Il'Giovine ZJ, Mehra R, McWilliams C, Nissen SE, Desai MY. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw Open. 2021 Feb 1;4(2):e210369. doi: 10.1001/jamanetworkopen.2021.0369.""]",,2021-02-16,https://clinicaltrials.gov/show/NCT04342728,2020-12-30,0,1
874,NCT04344002,Recruiting,2022-03-30,2022-10-30,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04344002,2022-03-30,0,0
875,NCT04344119,Recruiting,2021-04-30,2021-04-30,No Results Posted,"['Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, Giordanengo V, Gonfrier G, Raimondi V, Bausset O, Adjtoutah Z, Garnier M, Burel-Vandenbos F, Dadone-Montaudi√© B, Fassbender V, Palladini A, Courjon J, Mondain V, Contenti J, Dellamonica J, Leftheriotis G, Passeron T. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic. JAMA Dermatol. 2021 Feb 1;157(2):202-206. doi: 10.1001/jamadermatol.2020.4324.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04344119,2021-04-30,0,1
876,NCT04345159,Completed,2020-11-30,2020-11-30,No Results Posted,"['Guillaume D, Magalie B, Sina E, Im√®ne SM, Fr√©d√©ric V, Mathieu D, Aurore M, Yoni G, Emma E, Charlotte B, Laura F, Alain S, Steven N, Pierre Z, Jean-Luc F, Romain C, Alice GD, Adrien M, Wassim G, Pierre-Emmanuel R, Christophe P, Catherine C, Kevin B, Thomas S, Damien G. Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study. Rheumatol Ther. 2021 Dec;8(4):1887-1895. doi: 10.1007/s40744-021-00373-1. Epub 2021 Sep 16.']",,2021-01-07,https://clinicaltrials.gov/show/NCT04345159,2020-11-30,0,1
877,NCT04347538,"Active, not recruiting",2022-03-01,2022-06-01,No Results Posted,,,2021-10-28,https://clinicaltrials.gov/show/NCT04347538,2022-03-01,0,0
878,NCT04350476,Withdrawn,2020-05-01,2020-05-01,No Results Posted,,,2020-08-20,https://clinicaltrials.gov/show/NCT04350476,2020-05-01,0,0
879,NCT04352348,"Active, not recruiting",2022-05-31,2022-05-31,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04352348,2022-05-31,0,0
880,NCT04352751,Recruiting,2021-04-01,2021-04-01,No Results Posted,"['Khan TNS, Mukry SN, Masood S, Meraj L, Devrajani BR, Akram J, Fatima N, Maqsood S, Mahesar A, Siddiqui R, Ishaque S, Afzal MB, Mukhtar S, Ahmed S, Naz A, Shamsi TS. Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan. BMC Infect Dis. 2021 Sep 27;21(1):1014. doi: 10.1186/s12879-021-06451-7.']",,2020-09-29,https://clinicaltrials.gov/show/NCT04352751,2021-04-01,0,1
881,NCT04352933,Recruiting,2020-10-31,2021-04-01,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04352933,2020-10-31,0,0
882,NCT04353206,Terminated,2020-11-01,2020-11-01,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04353206,2020-11-01,0,0
883,NCT04354259,Recruiting,2022-12-15,2023-01-15,No Results Posted,"[""Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C, Borgia SM, Boggild AK, Powis J, McCready J, Tan DHS, Chan T, Coburn B, Kumar D, Humar A, Chan A, O'Neil B, Noureldin S, Booth J, Hong R, Smookler D, Aleyadeh W, Patel A, Barber B, Casey J, Hiebert R, Mistry H, Choong I, Hislop C, Santer DM, Lorne Tyrrell D, Glenn JS, Gehring AJ, Janssen HLA, Hansen BE. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir Med. 2021 May;9(5):498-510. doi: 10.1016/S2213-2600(20)30566-X. Epub 2021 Feb 5."", 'Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.', 'Moschen AR. IBD in the time of corona - vigilance for immune-mediated diseases. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):529-530. doi: 10.1038/s41575-020-0333-5. Review.']",,2022-01-19,https://clinicaltrials.gov/show/NCT04354259,2022-12-15,0,1
884,NCT04354831,"Active, not recruiting",2022-05-01,2023-05-01,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04354831,2022-05-01,0,0
885,NCT04355624,Recruiting,2020-04-30,2020-07-30,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04355624,2020-04-30,0,0
886,NCT04357431,Completed,2020-05-26,2020-05-30,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04357431,2020-05-26,0,0
887,NCT04357457,"Active, not recruiting",2021-10-01,2021-10-01,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04357457,2021-10-01,0,0
888,NCT04358029,Recruiting,2022-05-01,2022-05-01,No Results Posted,"['Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Bier BA, Malick W, Hashemi H, Miller MA, Choudry S, Pumill C, Ruiz-Maya T, Hadley M, Giustino G, Koruth JS, Langan N, Sofi A, Dukkipati SR, Halperin JL, Fuster V, Kohli-Seth R, Reddy VY. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008920. doi: 10.1161/CIRCEP.120.008920. Epub 2020 Oct 7.']",,2021-04-13,https://clinicaltrials.gov/show/NCT04358029,2022-05-01,0,1
889,NCT04361565,Enrolling by invitation,2020-04-10,2020-05-31,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04361565,2020-04-10,0,0
890,NCT04362085,Completed,2021-05-10,2021-10-14,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, √Åinle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, J√ºni P; RAPID trial investigators. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.', 'Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, N√≠ √Åinle F, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci L, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, J√ºni P; RAPID Trial investigators. Heparin for Moderately Ill Patients with Covid-19. medRxiv. 2021 Jul 12. pii: 2021.07.08.21259351. doi: 10.1101/2021.07.08.21259351. Update in: BMJ. 2021 Oct 14;375:n2400.', 'Sholzberg M, Tang GH, Negri E, Rahhal H, Kreuziger LB, Pompilio CE, James P, Fralick M, AlHamzah M, Alomran F, Tseng E, Lim G, Lillicrap D, Carrier M, √Åinle FN, Beckett A, da Costa BR, Thorpe K, Middeldorp S, Lee A, Cushman M, J√ºni P. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04362085,2021-05-10,0,1
891,NCT04362930,Recruiting,2022-04-24,2022-04-24,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04362930,2022-04-24,0,0
892,NCT04363333,"Active, not recruiting",2021-05-31,2021-07-31,No Results Posted,"['Peker Y, Celik Y, Arbatli S, Isik SR, Balcan B, Karata≈ü F, Uzel FI, Tabak L, √áetin B, Bayg√ºl A, √ñzt√ºrk AB, Altuƒü E, ƒ∞liaz S, Atasoy C, Kapmaz M, Yazici D, Bayram H, √áetin BD, √áaƒülayan B; OSACOVID-19 Study Collaborators. Effect of High-Risk Obstructive Sleep Apnea on Clinical Outcomes in Adults with Coronavirus Disease 2019: A Multicenter, Prospective, Observational Clinical Trial. Ann Am Thorac Soc. 2021 Sep;18(9):1548-1559. doi: 10.1513/AnnalsATS.202011-1409OC.']",,2021-02-17,https://clinicaltrials.gov/show/NCT04363333,2021-05-31,0,1
893,NCT04364009,Terminated,2020-10-20,2020-11-03,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04364009,2020-10-20,0,0
894,NCT04364698,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04364698,2020-06-01,0,0
895,NCT04364802,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013626. doi: 10.1002/14651858.CD013626.pub2.']",,2021-06-07,https://clinicaltrials.gov/show/NCT04364802,2022-04-01,0,1
896,NCT04365166,Recruiting,2022-04-21,2022-04-21,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04365166,2022-04-21,0,0
897,NCT04365257,Recruiting,2022-03-30,2022-03-30,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04365257,2022-03-30,0,0
898,NCT04365335,Completed,2020-06-12,2020-06-12,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04365335,2020-06-12,0,0
899,NCT04365517,Not yet recruiting,2022-03-30,2022-12-30,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04365517,2022-03-30,0,0
900,NCT04365725,Completed,2020-06-12,2020-06-12,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04365725,2020-06-12,0,0
901,NCT04367077,Recruiting,2023-01-01,2023-12-01,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04367077,2023-01-01,0,0
902,NCT04368221,Completed,2021-02-23,2021-02-23,No Results Posted,"['Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N, Tadi√© JM, Reizine F, Houz√© S, Timsit JF, Iriart X, Riu-Poulenc B, Sendid B, Nseir S, Persat F, Wallet F, Le Pape P, Canet E, Novara A, Manai M, Cateau E, Thille AW, Brun S, Cohen Y, Alanio A, M√©garbane B, Cornet M, Terzi N, Lamhaut L, Sabourin E, Desoubeaux G, Ehrmann S, Hennequin C, Voiriot G, Nevez G, Aubron C, Letscher-Bru V, Meziani F, Blaize M, Mayaux J, Monsel A, Boquel F, Robert-Gangneux F, Le Tulzo Y, Seguin P, Guegan H, Autier B, Lesouhaitier M, Pelletier R, Belaz S, Bonnal C, Berry A, Leroy J, Fran√ßois N, Richard JC, Paulus S, Argaud L, Dupont D, Menotti J, Morio F, Souli√© M, Schwebel C, Garnaud C, Guitard J, Le Gal S, Quinio D, Morcet J, Laviolle B, Zahar JR, Bougnoux ME. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2022 Feb;10(2):180-190. doi: 10.1016/S2213-2600(21)00442-2. Epub 2021 Nov 26.']",,2021-03-30,https://clinicaltrials.gov/show/NCT04368221,2021-02-23,0,1
903,NCT04378712,Completed,2020-03-23,2020-03-23,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04378712,2020-03-23,0,0
904,NCT04378777,"Active, not recruiting",2021-03-19,2022-03-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04378777,2021-03-19,0,0
905,NCT04378920,Completed,2021-08-24,2021-08-24,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04378920,2021-08-24,0,0
906,NCT04379076,Recruiting,2021-10-30,2021-12-30,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04379076,2021-10-30,0,0
907,NCT04379258,Completed,2021-02-08,2021-02-08,No Results Posted,"['Pe√±uelas O, Del Campo-Albendea L, de Aledo ALG, A√±√≥n JM, Rodr√≠guez-Sol√≠s C, Mancebo J, Vera P, Ballesteros D, Jim√©nez J, Maseda E, Figueira JC, Franco N, Algaba √Å, Avil√©s JP, D√≠az R, Abad B, Canabal A, Abella A, Gordo F, Garc√≠a J, Suarez JG, Cede√±o J, Mart√≠nez-Palacios B, Manteiga E, Mart√≠nez √ì, Blancas R, Bardi T, Pesta√±a D, Lorente J√Å, Muriel A, Esteban A, Frutos-Vivar F. Long-term survival of mechanically ventilated patients with severe COVID-19: an observational cohort study. Ann Intensive Care. 2021 Oct 2;11(1):143. doi: 10.1186/s13613-021-00929-y.']","['Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.']",2021-09-28,https://clinicaltrials.gov/show/NCT04379258,2021-02-08,0,1
908,NCT04380896,Recruiting,2026-07-27,2026-07-27,No Results Posted,"['Ortiz AT, Torrente FF, Twigg A, Hatcher J, Saso A, Lam T, Johnson M, Wagstaffe H, Dhillon R, Mai AL, Goldblatt D, Still R, Buckland M, Gilmour K, Grandjean L. The Influence of Time on the Sensitivity of SARS-CoV-2 Serological Testing. Res Sq. 2022 Feb 17. pii: rs.3.rs-1286644. doi: 10.21203/rs.3.rs-1286644/v1.']",,2021-06-25,https://clinicaltrials.gov/show/NCT04380896,2026-07-27,0,1
909,NCT04381988,Terminated,2021-04-21,2021-04-21,Study Results,,,2021-10-27,https://clinicaltrials.gov/show/NCT04381988,2021-04-21,1,0
910,NCT04382391,"Active, not recruiting",2021-07-21,2022-12-01,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04382391,2021-07-21,0,0
911,NCT04383470,Recruiting,2021-12-01,2022-06-01,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04383470,2021-12-01,0,0
912,NCT04384042,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04384042,2021-03-31,0,0
913,NCT04384614,Withdrawn,2020-07-15,2020-07-15,No Results Posted,,,2020-08-27,https://clinicaltrials.gov/show/NCT04384614,2020-07-15,0,0
914,NCT04384731,Recruiting,2021-05-29,2021-07-31,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04384731,2021-05-29,0,0
915,NCT04384887,Completed,2020-08-25,2020-08-26,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04384887,2020-08-25,0,0
916,NCT04384900,Withdrawn,2021-05-25,2021-05-25,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04384900,2021-05-25,0,0
917,NCT04384926,Recruiting,2020-12-31,2020-12-31,No Results Posted,"['COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5.', 'Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-M√©ndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6.']",,2020-05-12,https://clinicaltrials.gov/show/NCT04384926,2020-12-31,0,1
918,NCT04385017,Recruiting,2022-06-30,2022-06-30,No Results Posted,"['Courjon J, Dufies O, Robert A, Bailly L, Torre C, Chirio D, Contenti J, Vitale S, Loubatier C, Doye A, Pomares-Estran C, Gonfrier G, Lotte R, Munro P, Visvikis O, Dellamonica J, Giordanengo V, Carles M, Yvan-Charvet L, Ivanov S, Auberger P, Jacquel A, Boyer L. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity. Blood Adv. 2021 Mar 9;5(5):1523-1534. doi: 10.1182/bloodadvances.2020003918.']",,2021-09-14,https://clinicaltrials.gov/show/NCT04385017,2022-06-30,0,1
919,NCT04385043,Recruiting,2020-10-15,2021-05-15,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Linee Guida Cinesi sulla Gestione di COVID-19 Versione 7¬∞ Pubblicate in data 3/3/2020 dalla Commissione della Salute Nazionale della R.P.C..', 'Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015 Nov 19;4:709. doi: 10.1186/s40064-015-1490-9. eCollection 2015.', 'Dean CL, Hooper JW, Dye JM, Zak SE, Koepsell SA, Corash L, Benjamin RJ, Kwilas S, Bonds S, Winkler AM, Kraft CS. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States. Transfusion. 2020 May;60(5):1024-1031. doi: 10.1111/trf.15739. Epub 2020 Mar 4.']",2020-05-12,https://clinicaltrials.gov/show/NCT04385043,2020-10-15,0,1
920,NCT04385069,Recruiting,2020-07-05,2020-07-05,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04385069,2020-07-05,0,0
921,NCT04385095,"Active, not recruiting",2021-02-17,2021-05-31,No Results Posted,"['Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, Gabbay FJ, Davies DE, Holgate ST, Ho LP, Clark T, Djukanovic R, Wilkinson TMA; Inhaled Interferon Beta COVID-19 Study Group. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021 Feb;9(2):196-206. doi: 10.1016/S2213-2600(20)30511-7. Epub 2020 Nov 12.', 'Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,2021-03-23,https://clinicaltrials.gov/show/NCT04385095,2021-02-17,0,1
922,NCT04385108,Recruiting,2021-12-31,2021-12-31,No Results Posted,"['Kreutmair S, Unger S, N√∫√±ez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, H√§berle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021 Jul 13;54(7):1578-1593.e5. doi: 10.1016/j.immuni.2021.05.002. Epub 2021 May 9. Erratum in: Immunity. 2022 Feb 8;55(2):366-375.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04385108,2021-12-31,0,1
923,NCT04385121,Recruiting,2020-04-16,2021-03-01,No Results Posted,"['Cattelan J, Castellano S, Merdji H, Audusseau J, Claude B, Feuillassier L, Cunat S, Astri√© M, Aquin C, Buis G, Gehant E, Granier A, Kercha H, Le Guillou C, Martin G, Roulot K, Meziani F, Putois O, Helms J. Psychological effects of remote-only communication among reference persons of ICU patients during COVID-19 pandemic. J Intensive Care. 2021 Jan 9;9(1):5. doi: 10.1186/s40560-020-00520-w.']",,2020-07-21,https://clinicaltrials.gov/show/NCT04385121,2020-04-16,0,1
924,NCT04385199,Completed,2020-08-01,2020-08-01,Results Submitted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04385199,2020-08-01,0,0
925,NCT04385264,Suspended,2022-08-01,2022-12-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04385264,2022-08-01,0,0
926,NCT04385771,Suspended,2021-05-31,2021-10-31,No Results Posted,"['Shekar K, McAuley DF, Brodie D. Cytokine adsorption during ECMO for COVID-19-related ARDS. Lancet Respir Med. 2021 Jul;9(7):680-682. doi: 10.1016/S2213-2600(21)00207-1. Epub 2021 May 14.', 'Rieder M, Duerschmied D, Zahn T, Lang C, Benk C, Lother A, Biever P, Bode C, Wengenmayer T, Staudacher D, Supady A. Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation. ASAIO J. 2021 Mar 1;67(3):332-338. doi: 10.1097/MAT.0000000000001302.', 'Rieder M, Schubach F, Schmoor C, von Spee-Mayer C, Wengenmayer T, Rilinger J, Staudacher D, Bode C, Duerschmied D, Supady A. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial. BMJ Open. 2021 Jan 17;11(1):e043345. doi: 10.1136/bmjopen-2020-043345.']",,2021-03-15,https://clinicaltrials.gov/show/NCT04385771,2021-05-31,0,1
927,NCT04385797,"Active, not recruiting",2020-12-31,2020-12-31,No Results Posted,"['Dura-Perez E, Goodman-Casanova JM, Vega-Nu√±ez A, Guerrero-Perti√±ez G, Varela-Moreno E, Garolera M, Quintana M, Cuesta-Vargas AI, Barnestein-Fonseca P, G√≥mez S√°nchez-Lafuente C, Mayoral-Cleries F, Guzman-Parra J. The Impact of COVID-19 Confinement on Cognition and Mental Health and Technology Use Among Socially Vulnerable Older People: Retrospective Cohort Study. J Med Internet Res. 2022 Feb 22;24(2):e30598. doi: 10.2196/30598.', 'Goodman-Casanova JM, Dura-Perez E, Guerrero-Perti√±ez G, Barnestein-Fonseca P, Guzman-Parra J, Vega-Nu√±ez A, Varela-Moreno E, Cuesta-Vargas A, Mayoral-Cleries F. Cognitive Outcomes During COVID-19 Confinement Among Older People and Their Caregivers Using Technologies for Dementia: Protocol for an Observational Cohort Study. JMIR Res Protoc. 2021 May 18;10(5):e26431. doi: 10.2196/26431.']",,2020-12-04,https://clinicaltrials.gov/show/NCT04385797,2020-12-31,0,1
928,NCT04385823,Completed,2020-05-04,2020-05-04,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04385823,2020-05-04,0,0
929,NCT04385914,Not yet recruiting,2020-09-01,2020-12-01,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04385914,2020-09-01,0,0
930,NCT04386044,Completed,2020-08-08,2020-09-08,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04386044,2020-08-08,0,0
931,NCT04386070,Not yet recruiting,2022-05-30,2026-05-14,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-31,https://clinicaltrials.gov/show/NCT04386070,2022-05-30,0,1
932,NCT04386083,Recruiting,2020-12-01,2021-03-01,No Results Posted,"['Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG; Philippine CORONA Study Group Investigators. COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study). J Neural Transm (Vienna). 2021 Nov;128(11):1687-1703. doi: 10.1007/s00702-021-02400-5. Epub 2021 Aug 27.', 'Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. The Philippine COVID-19 Outcomes: a Retrospective study Of Neurological manifestations and Associated symptoms (The Philippine CORONA study): a protocol study. BMJ Open. 2020 Nov 30;10(11):e040944. doi: 10.1136/bmjopen-2020-040944.']",,2020-07-28,https://clinicaltrials.gov/show/NCT04386083,2020-12-01,0,1
933,NCT04386109,Recruiting,2021-03-31,2021-09-30,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04386109,2021-03-31,0,0
934,NCT04386239,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04386239,2021-12-01,0,0
935,NCT04386395,Completed,2020-05-30,2021-06-30,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04386395,2020-05-30,0,0
936,NCT04386460,Recruiting,2020-06-05,2021-05-11,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04386460,2020-06-05,0,0
937,NCT04386512,Completed,2020-06-01,2020-07-15,No Results Posted,,,2020-08-07,https://clinicaltrials.gov/show/NCT04386512,2020-06-01,0,0
938,NCT04386551,Completed,2020-08-05,2020-08-05,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04386551,2020-08-05,0,0
939,NCT04386564,Completed,2020-08-01,2020-09-01,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04386564,2020-08-01,0,0
940,NCT04386759,Completed,2021-07-26,2021-07-26,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04386759,2021-07-26,0,0
941,NCT04387279,Recruiting,2021-03-30,2021-03-30,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04387279,2021-03-30,0,0
942,NCT04387292,Completed,2021-01-21,2021-05-15,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04387292,2021-01-21,0,0
943,NCT04387643,Completed,2020-04-02,2020-04-02,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04387643,2020-04-02,0,0
944,NCT04387786,Completed,2020-04-24,2020-09-04,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04387786,2020-04-24,0,0
945,NCT04387929,Recruiting,2021-05-30,2021-05-30,No Results Posted,"['Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, Rescigno M. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19. J Clin Invest. 2021 Jun 15;131(12). pii: 149154. doi: 10.1172/JCI149154.']",,2020-05-15,https://clinicaltrials.gov/show/NCT04387929,2021-05-30,0,1
946,NCT04387955,Completed,2021-07-30,2021-07-30,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04387955,2021-07-30,0,0
947,NCT04387968,Completed,2021-07-13,2021-10-04,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04387968,2021-07-13,0,0
948,NCT04388410,Recruiting,2020-11-30,2020-12-31,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04388410,2020-11-30,0,0
949,NCT04388579,Completed,2020-03-27,2020-03-27,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04388579,2020-03-27,0,0
950,NCT04388605,Recruiting,2023-06-01,2023-12-01,No Results Posted,"['Huddleston HG, Jaswa EG, Lindquist KJ, Kaing A, Morris JR, Hariton E, Corley J, Hoskin E, Gaw SL, Cedars MI. COVID-19 vaccination patterns and attitudes among American pregnant individuals. Am J Obstet Gynecol MFM. 2022 Jan;4(1):100507. doi: 10.1016/j.ajogmf.2021.100507. Epub 2021 Oct 11.']",,2021-11-10,https://clinicaltrials.gov/show/NCT04388605,2023-06-01,0,1
951,NCT04388644,Unknown,2020-05-20,2020-05-30,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04388644,2020-05-20,0,0
952,NCT04388657,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-05-14,https://clinicaltrials.gov/show/NCT04388657,2020-09-01,0,0
953,NCT04388670,Recruiting,2020-08-22,2020-08-31,No Results Posted,"['Zanella A, Florio G, Antonelli M, Bellani G, Berselli A, Bove T, Cabrini L, Carlesso E, Castelli GP, Cecconi M, Citerio G, Coloretti I, Corti D, Dalla Corte F, De Robertis E, Foti G, Fumagalli R, Girardis M, Giudici R, Guiotto L, Langer T, Mirabella L, Pasero D, Protti A, Ranieri MV, Rona R, Scudeller L, Severgnini P, Spadaro S, Stocchetti N, Vigan√≤ M, Pesenti A, Grasselli G; COVID-19 Italian ICU Network. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med. 2021 Sep;47(9):995-1008. doi: 10.1007/s00134-021-06495-y. Epub 2021 Aug 9.', 'Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, Bellani G, Biagioni E, Bonfanti P, Bottino N, Coloretti I, Cutuli SL, De Pascale G, Ferlicca D, Fior G, Forastieri A, Franzetti M, Greco M, Guzzardella A, Linguadoca S, Meschiari M, Messina A, Monti G, Morelli P, Muscatello A, Redaelli S, Stefanini F, Tonetti T, Antonelli M, Cecconi M, Foti G, Fumagalli R, Girardis M, Ranieri M, Viale P, Raviglione M, Pesenti A, Gori A, Bandera A. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021 Aug;160(2):454-465. doi: 10.1016/j.chest.2021.04.002. Epub 2021 Apr 20.', 'Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, Dalla Corte F, De Robertis E, Favarato M, Forastieri A, Forlini C, Girardis M, Grieco DL, Mirabella L, Noseda V, Previtali P, Protti A, Rona R, Tardini F, Tonetti T, Zannoni F, Antonelli M, Foti G, Ranieri M, Pesenti A, Fumagalli R, Grasselli G; PRONA-COVID Group. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021 Apr 6;25(1):128. doi: 10.1186/s13054-021-03552-2.']",,2020-05-14,https://clinicaltrials.gov/show/NCT04388670,2020-08-22,0,1
954,NCT04389294,Completed,2020-06-16,2020-09-04,Results Submitted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04389294,2020-06-16,0,0
955,NCT04389320,Completed,2020-05-01,2020-05-01,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04389320,2020-05-01,0,0
956,NCT04389359,Withdrawn,2021-08-01,2025-08-01,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04389359,2021-08-01,0,0
957,NCT04389671,Recruiting,2021-12-31,2022-01-30,No Results Posted,"['Cohen CL, Walker KH, Hsiang M, Sonenthal PD, Riviello ED, Rouhani SA, Lipnick MS, Merriam LT, Kim EY. Combating information chaos: a case for collaborative clinical guidelines in a pandemic. Cell Rep Med. 2021 Aug 17;2(8):100375. doi: 10.1016/j.xcrm.2021.100375. Epub 2021 Jul 27.']",,2021-11-09,https://clinicaltrials.gov/show/NCT04389671,2021-12-31,0,1
958,NCT04390139,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04390139,2021-10-01,0,0
959,NCT04390165,Completed,2020-11-30,2020-11-30,No Results Posted,"['Lee SH, Yeoh ZX, Sachlin IS, Gazali N, Soelar SA, Foo CY, Low LL, Syed Alwi SB, Tengku Kamalden TMI, Shanmuganathan J, Zaid M, Wong CY, Chua HH, Yusuf S, Muhamad D, Devesahayam PR, Ker HB, Salahuddin Z, Mustafa M, Sawali H, Lee HG, Din S, Misnan NA, Mohamad A, Ismail MN, Periasamy C, Chow TS, Krishnan EK, Leong CL, Lim LPF, Zaidan NZ, Ibrahim MZ, Abd Wahab S, Mohd Hashim SS; Malaysian COVID-19 Anosmia Research Group. Self-reported symptom study of COVID-19 chemosensory dysfunction in Malaysia. Sci Rep. 2022 Feb 8;12(1):2111. doi: 10.1038/s41598-022-06029-6.']",,2021-02-25,https://clinicaltrials.gov/show/NCT04390165,2020-11-30,0,1
960,NCT04390178,Completed,2020-06-30,2020-12-31,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04390178,2020-06-30,0,0
961,NCT04390191,Terminated,2021-02-18,2021-07-07,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04390191,2021-02-18,0,0
962,NCT04394039,Completed,2020-08-01,2020-12-31,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04394039,2020-08-01,0,0
963,NCT04275388,Not yet recruiting,2020-07-14,2021-12-14,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04275388,2020-07-14,0,0
964,NCT04313127,Completed,2021-01-20,2021-02-20,No Results Posted,"['Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.']",,2021-08-04,https://clinicaltrials.gov/show/NCT04313127,2021-01-20,0,1
965,NCT04321993,Recruiting,2023-02-01,2023-03-01,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04321993,2023-02-01,0,0
966,NCT04322565,Recruiting,2020-12-20,2020-12-21,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2020-07-10,https://clinicaltrials.gov/show/NCT04322565,2020-12-20,0,1
967,NCT04325893,Terminated,2020-06-18,2020-06-18,No Results Posted,"[""Dub√©e V, Roy PM, Vielle B, Parot-Schinkel E, Blanchet O, Darsonval A, Lefeuvre C, Abbara C, Boucher S, Devaud E, Robineau O, Rispal P, Guimard T, d'Anglejean E, Diamantis S, Custaud MA, Pellier I, Mercat A; HYCOVID study group; HYCOVID investigators; Angers University Hospital; Cholet Hospital; Laval Hospital; Le Mans Hospital; Tours University Hospital; Quimper Hospital; La Roche sur Yon Hospital; Tourcoing Hospital; Orl√©ans Hospital; Nantes University Hospital; Niort Hospital; Lorient Hospital; Brest University Hospital; Cherbourg Hospital; Saint-Brieuc Hospital; Cr√©teil - APHP University Hospital; Saint-Antoine - APHP University Hospital; Saint-Etienne University Hospital; Toulouse University Hospital; Melun Hospital; Dijon University Hospital; Princesse Grace - Monaco Hospital; Versailles Hospital; Colmar Hospital; Agen-Nerac Hospital; Caen University Hospital; Saint-Nazaire Hospital; Nantes - Confluent Hospital; Limoges University Hospital; Poitiers University Hospital; Amiens University Hospital; Bobigny - APHP University Hospital; Cergy-Pontoise Hospital; Valencienne Hospital; Valencienne - Clinique Tessier Hospital; Henri-Mondor - APHP University Hospital; Chalon-sur-Sa√¥ne Hospital; Marseille European Hospital; Auxerre Hospital; Diaconnesses Croix-Saint-Simon Hospital; Marseille - Saint Joseph Hospital; HYCOVID management team: Steering committee (authors); HYCOVID management team: Independant data safety and monitoring board; HYCOVID management team: Independent adjudication of clinical events committee; Study management: Coordination; Study management: Data management. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial. Clin Microbiol Infect. 2021 Aug;27(8):1124-1130. doi: 10.1016/j.cmi.2021.03.005. Epub 2021 Apr 1.""]",,2020-10-06,https://clinicaltrials.gov/show/NCT04325893,2020-06-18,0,1
968,NCT04326387,Recruiting,2021-04-07,2021-10-07,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04326387,2021-04-07,0,0
969,NCT04328129,Completed,2021-09-30,2021-09-30,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04328129,2021-09-30,0,0
970,NCT04334252,Completed,2020-12-20,2020-12-20,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04334252,2020-12-20,0,0
971,NCT04338932,Completed,2020-05-15,2020-05-15,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04338932,2020-05-15,0,0
972,NCT04340921,Recruiting,2021-11-10,2021-11-10,No Results Posted,"['Bajaj R, Sinclair HC, Patel K, Low B, Pericao A, Manisty C, Guttmann O, Zemrak F, Miller O, Longhi P, Proudfoot A, Lams B, Agarwal S, Marelli-Berg FM, Tiberi S, Cutino-Moguel T, Carr-White G, Mohiddin SA. Delayed-onset myocarditis following COVID-19. Lancet Respir Med. 2021 Apr;9(4):e32-e34. doi: 10.1016/S2213-2600(21)00085-0. Epub 2021 Feb 19.']","['Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Komarowska I, Coe D, Wang G, Haas R, Mauro C, Kishore M, Cooper D, Nadkarni S, Fu H, Steinbruchel DA, Pitzalis C, Anderson G, Bucy P, Lombardi G, Breckenridge R, Marelli-Berg FM. Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release. Immunity. 2015 Jun 16;42(6):1087-99. doi: 10.1016/j.immuni.2015.05.014. Epub 2015 Jun 9.']",2020-05-18,https://clinicaltrials.gov/show/NCT04340921,2021-11-10,0,1
973,NCT04341389,"Active, not recruiting",2021-01-31,2021-01-31,No Results Posted,"['Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 Aug 15;396(10249):479-488. doi: 10.1016/S0140-6736(20)31605-6. Epub 2020 Jul 20.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04341389,2021-01-31,0,1
974,NCT04341935,Withdrawn,2021-12-30,2021-12-30,No Results Posted,,"['Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020 Mar 17;9(1):601-604. doi: 10.1080/22221751.2020.1739565. eCollection 2020.', 'Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.']",2021-06-10,https://clinicaltrials.gov/show/NCT04341935,2021-12-30,0,1
975,NCT04342182,Terminated,2020-07-01,2020-09-30,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04342182,2020-07-01,0,1
976,NCT04352699,Completed,2020-04-17,2020-05-01,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04352699,2020-04-17,0,0
977,NCT04352842,Completed,2020-04-08,2020-04-08,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04352842,2020-04-08,0,0
978,NCT04358783,Completed,2021-05-01,2021-05-01,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04358783,2021-05-01,0,0
979,NCT04359537,Recruiting,2020-08-25,2020-09-25,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04359537,2020-08-25,0,0
980,NCT04361253,Terminated,2021-04-01,2021-06-30,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04361253,2021-04-01,0,0
981,NCT04363346,"Active, not recruiting",2022-01-01,2022-01-01,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04363346,2022-01-01,0,0
982,NCT04363502,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04363502,2022-05-01,0,0
983,NCT04366960,Completed,2021-05-25,2021-05-25,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,2021-06-08,https://clinicaltrials.gov/show/NCT04366960,2021-05-25,0,1
984,NCT04367831,Completed,2021-05-12,2021-05-12,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04367831,2021-05-12,0,1
985,NCT04370782,Completed,2020-09-30,2020-09-30,No Results Posted,,,2020-12-09,https://clinicaltrials.gov/show/NCT04370782,2020-09-30,0,0
986,NCT04370808,Completed,2021-01-01,2021-01-31,No Results Posted,"['Freitas AT, Calhau C, Antunes G, Ara√∫jo B, Bandeira M, Barreira S, Bazenga F, Braz S, Caldeira D, Santos SCR, Faria A, Faria D, Fraga M, Nogueira-Garcia B, Gon√ßalves L, Kovalchuk P, Lacerda L, Lopes H, Lu√≠s D, Medeiros F, Melo AMP, Melo-Cristino J, Miranda A, Pereira C, Pinto AT, Pinto J, Proen√ßa H, Ramos A, Rato JPR, Rocha F, Rocha JC, Moreira-Ros√°rio A, Vaz√£o H, Volovetska Y, Guimar√£es JT, Pinto FJ. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity. Sci Rep. 2021 Oct 21;11(1):20837. doi: 10.1038/s41598-021-99952-z.']",,2021-04-28,https://clinicaltrials.gov/show/NCT04370808,2021-01-01,0,1
987,NCT04371952,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04371952,2020-12-01,0,0
988,NCT04372979,Recruiting,2021-05-01,2021-06-01,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04372979,2021-05-01,0,0
989,NCT04374513,Completed,2020-06-01,2020-07-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04374513,2020-06-01,0,0
990,NCT04375124,Completed,2020-08-31,2020-09-30,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04375124,2020-08-31,0,0
991,NCT04377685,Completed,2020-11-28,2020-12-26,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04377685,2020-11-28,0,0
992,NCT04377724,"Active, not recruiting",2022-02-28,2022-02-28,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04377724,2022-02-28,0,0
993,NCT04377789,Completed,2020-07-31,2020-08-31,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04377789,2020-07-31,0,0
994,NCT04388436,"Active, not recruiting",2021-07-10,2021-10-10,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04388436,2021-07-10,0,0
995,NCT04388631,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04388631,2021-05-01,0,0
996,NCT04388683,Terminated,2020-11-23,2020-11-23,Results Submitted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04388683,2020-11-23,0,0
997,NCT04389333,Completed,2020-04-26,2020-05-20,Study Results,,,2022-01-05,https://clinicaltrials.gov/show/NCT04389333,2020-04-26,1,0
998,NCT04389372,Recruiting,2021-03-01,2021-12-01,No Results Posted,"['Rizzoli PB, Grazzi L. Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID-19 pandemic: Lessons from a tertiary headache center in Milan-6-month results. Headache. 2021 Jun;61(6):961-962. doi: 10.1111/head.14140. Epub 2021 Jun 21.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04389372,2021-03-01,0,1
999,NCT04389385,"Active, not recruiting",2020-09-30,2021-05-31,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04389385,2020-09-30,0,0
1000,NCT04389463,Recruiting,2022-05-11,2022-06-30,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04389463,2022-05-11,0,0
1001,NCT04389645,Completed,2020-05-12,2020-05-12,No Results Posted,"[""Lev S, Gottesman T, Sahaf Levin G, Lederfein D, Berkov E, Diker D, Zaidman A, Nutman A, Ilan Ber T, Angel A, Kellerman L, Barash E, Navon R, Boico O, Israeli Y, Rosenberg M, Gelman A, Kalfon R, Simon E, Avni N, Hainrichson M, Zarchin O, Gottlieb TM, Oved K, Eden E, Tadmor B. Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19. PLoS One. 2021 Jan 12;16(1):e0245296. doi: 10.1371/journal.pone.0245296. eCollection 2021.""]",,2020-05-15,https://clinicaltrials.gov/show/NCT04389645,2020-05-12,0,1
1002,NCT04389658,Completed,2020-06-10,2020-08-25,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04389658,2020-06-10,0,0
1003,NCT04389684,Completed,2020-11-20,2020-11-20,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04389684,2020-11-20,0,0
1004,NCT04389801,Not yet recruiting,2020-09-30,2020-12-31,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04389801,2020-09-30,0,0
1005,NCT04389944,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04389944,2020-06-30,0,0
1006,NCT04390061,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04390061,2020-09-01,0,0
1007,NCT04390152,Recruiting,2021-12-01,2022-04-01,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04390152,2021-12-01,0,0
1008,NCT04390217,Not yet recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04390217,2021-12-31,0,0
1009,NCT04390269,Recruiting,2021-10-10,2022-05-09,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04390269,2021-10-10,0,0
1010,NCT04390412,"Active, not recruiting",2020-08-30,2020-12-01,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04390412,2020-08-30,0,0
1011,NCT04390464,Recruiting,2021-05-07,2022-05-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB. Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 8;21(1):626. doi: 10.1186/s13063-020-04535-4.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04390464,2021-05-07,0,1
1012,NCT04390477,Completed,2021-03-21,2021-04-30,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04390477,2021-03-21,0,0
1013,NCT04390503,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04390503,2022-04-01,0,0
1014,NCT04390555,Recruiting,2020-12-01,2021-07-01,No Results Posted,,,2020-05-15,https://clinicaltrials.gov/show/NCT04390555,2020-12-01,0,0
1015,NCT04391400,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04391400,2021-06-30,0,0
1016,NCT04391686,Completed,2021-11-04,2021-11-04,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04391686,2021-11-04,0,0
1017,NCT04391712,Completed,2020-05-15,2020-07-16,No Results Posted,,,2020-08-05,https://clinicaltrials.gov/show/NCT04391712,2020-05-15,0,0
1018,NCT04391829,Recruiting,2021-08-31,2021-08-31,No Results Posted,,"['Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020 May 1;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292. Erratum in: JAMA Netw Open. 2020 Jun 1;3(6):e2010845.']",2020-10-28,https://clinicaltrials.gov/show/NCT04391829,2021-08-31,0,1
1019,NCT04391881,Recruiting,2020-08-30,2020-08-30,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04391881,2020-08-30,0,0
1020,NCT04391920,Completed,2022-01-20,2022-01-20,No Results Posted,"['Song T, Hayanga J, Durham L, Garrison L, McCarthy P, Barksdale A, Smith D, Bartlett R, Jaros M, Nelson P, Molnar Z, Deliargyris E, Moazami N. CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry. Front Med (Lausanne). 2021 Dec 20;8:773461. doi: 10.3389/fmed.2021.773461. eCollection 2021.']",,2022-01-21,https://clinicaltrials.gov/show/NCT04391920,2022-01-20,0,1
1021,NCT04391946,Recruiting,2022-05-01,2022-12-31,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04391946,2022-05-01,0,0
1022,NCT04392089,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04392089,2021-05-01,0,0
1023,NCT04392141,Completed,2020-11-01,2020-11-01,Study Results,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2021-04-20,https://clinicaltrials.gov/show/NCT04392141,2020-11-01,1,1
1024,NCT04392245,Completed,2020-04-26,2020-04-26,No Results Posted,"['Gallo G, Sturiale A, De Simone V, Mancini S, Di Tanna GL, Milito G, Bianco F, Perinotti R, Giani I, Grossi U; ProctoLock2020 Working Group, Aiello D, Bianco F, Bondurri A, Gallo G, La Torre M, Milito G, Perinotti R, Pietroletti R, Serventi A, Fiorino M, De Simone V, Grossi U, Manigrasso M, Sturiale A, Zaffaroni G, Boffi F, Bellato V, Cantarella F, Deidda S, Marino F, Martellucci J, Milone M, Picciariello A, Bravo AM, Vigorita V, Cunha MF, Leventoglu S, Garmanova T, Tsarkov P, El-Hussuna A, Frontali A, Ioannidis A, Bislenghi G, Shalaby M, Porzio FC, Wu J, Zimmerman D, Elbetti C, Mayol J, Naldini G, Trompetto M, Sammarco G, Santoro GA. Deadlock of proctologic practice in Italy during COVID-19 pandemic: a national report from ProctoLock2020. Updates Surg. 2020 Dec;72(4):1255-1261. doi: 10.1007/s13304-020-00860-0. Epub 2020 Aug 8.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04392245,2020-04-26,0,1
1025,NCT04392323,Completed,2020-10-01,2020-10-04,No Results Posted,"['Nizam A, Nimaroff ML, Menzin AW, Goldberg GL, Miyara SJ, Molmenti E. Nosocomial COVID-19 infection in women undergoing elective cesarean delivery: a prospective cohort study. Am J Obstet Gynecol MFM. 2022 Jan;4(1):100490. doi: 10.1016/j.ajogmf.2021.100490. Epub 2021 Sep 17.']","['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Erratum in: Lancet. 2020 Feb 4;:.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.', 'Brindle ME, Gawande A. Managing COVID-19 in Surgical Systems. Ann Surg. 2020 Jul;272(1):e1-e2. doi: 10.1097/SLA.0000000000003923.', 'Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan LY, Jia Y, Zhang L, Liu D, Xia ZY, Xia Z. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020 Apr 5;21:100331. doi: 10.1016/j.eclinm.2020.100331. eCollection 2020 Apr.', 'Aminian A, Kermansaravi M, Azizi S, Alibeigi P, Safamanesh S, Mousavimaleki A, Rezaei MT, Faridi M, Mokhber S, Pazouki A, Safari S. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. Obes Surg. 2020 Sep;30(9):3624-3627. doi: 10.1007/s11695-020-04617-x.', 'Luong-Nguyen M, Hermand H, Abdalla S, Cabrit N, Hobeika C, Brouquet A, Go√©r√© D, Sauvanet A. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. J Visc Surg. 2020 Jun;157(3S1):S13-S18. doi: 10.1016/j.jviscsurg.2020.04.016. Epub 2020 Apr 27.', 'Yang S, Zhang Y, Cai J, Wang Z. Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records. Oncologist. 2020 Jun;25(6):e982-e985. doi: 10.1634/theoncologist.2020-0157. Epub 2020 Apr 7.', 'Wong SCY, Kwong RT, Wu TC, Chan JWM, Chu MY, Lee SY, Wong HY, Lung DC. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020 Jun;105(2):119-127. doi: 10.1016/j.jhin.2020.03.036. Epub 2020 Apr 4.', 'Zhong Q, Liu YY, Luo Q, Zou YF, Jiang HX, Li H, Zhang JJ, Li Z, Yang X, Ma M, Tang LJ, Chen YY, Zheng F, Ke JJ, Zhang ZZ. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study. Br J Anaesth. 2020 Jun;124(6):670-675. doi: 10.1016/j.bja.2020.03.007. Epub 2020 Mar 28. Erratum in: Br J Anaesth. 2020 Sep;125(3):408.']",2021-11-08,https://clinicaltrials.gov/show/NCT04392323,2020-10-01,0,1
1026,NCT04392388,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-08-05,https://clinicaltrials.gov/show/NCT04392388,2020-12-31,0,0
1027,NCT04392401,Recruiting,2021-02-01,2021-02-01,No Results Posted,"['Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis MA, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F, Rimmel√© T, Lukaszewicz AC, Argaud L, Cour M, Monneret G, Venet F; RICO Study Group. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients. Ann Intensive Care. 2022 Mar 5;12(1):21. doi: 10.1186/s13613-022-00982-1.']",,2020-05-18,https://clinicaltrials.gov/show/NCT04392401,2021-02-01,0,1
1028,NCT04392427,Not yet recruiting,2022-05-01,2022-05-01,No Results Posted,,"['Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019 Mar;17(3):181-192. doi: 10.1038/s41579-018-0118-9. Review.', 'Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res. 2014 Oct;110:94-103. doi: 10.1016/j.antiviral.2014.07.014. Epub 2014 Aug 7. Review.', 'Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006 Jan-Feb;16(1):37-48. Review.', 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",2020-09-03,https://clinicaltrials.gov/show/NCT04392427,2022-05-01,0,1
1029,NCT04392453,Completed,2021-05-18,2021-05-18,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04392453,2021-05-18,0,0
1030,NCT04392713,Recruiting,2020-07-01,2020-07-01,No Results Posted,,"['≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Review.']",2020-05-19,https://clinicaltrials.gov/show/NCT04392713,2020-07-01,0,1
1031,NCT04392778,Completed,2020-11-01,2020-11-30,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04392778,2020-11-01,0,0
1032,NCT04393961,Recruiting,2020-07-29,2020-08-29,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04393961,2020-07-29,0,0
1033,NCT04394000,Completed,2020-05-15,2020-05-15,No Results Posted,"['Stessel B, Vanvuchelen C, Bruckers L, Geebelen L, Callebaut I, Vandenbrande J, Pellens B, Van Tornout M, Ory JP, van Halem K, Messiaen P, Herbots L, Ramaekers D, Dubois J. Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study. Thromb Res. 2020 Oct;194:209-215. doi: 10.1016/j.thromres.2020.07.038. Epub 2020 Jul 22.']",,2020-05-19,https://clinicaltrials.gov/show/NCT04394000,2020-05-15,0,1
1034,NCT04394026,Recruiting,2021-06-30,2021-07-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04394026,2021-06-30,0,0
1035,NCT04394169,Completed,2021-10-15,2021-10-22,No Results Posted,"['Ojeda A, Calvo A, Cu√±at T, Mellado-Artigas R, Comino-Trinidad O, Aliaga J, Arias M, Ferrando C, Martinez-Pall√≠ G, D√ºrsteler C. Characteristics and influence on quality of life of new-onset pain in critical COVID-19 survivors. Eur J Pain. 2022 Mar;26(3):680-694. doi: 10.1002/ejp.1897. Epub 2021 Dec 15.', 'Ojeda A, Calvo A, Cu√±at T, Artigas RM, Comino-Trinidad O, Aliaga J, Arias M, Ahuir M, Ferrando C, D√ºrsteler C. Rationale and study design of an early care, therapeutic education, and psychological intervention program for the management of post-intensive care syndrome and chronic pain after COVID-19 infection (PAIN-COVID): study protocol for a randomized controlled trial. Trials. 2021 Jul 24;22(1):486. doi: 10.1186/s13063-021-05463-7.']",,2021-12-14,https://clinicaltrials.gov/show/NCT04394169,2021-10-15,0,1
1036,NCT04394182,Suspended,2020-12-31,2022-03-21,No Results Posted,"['Moreno-Olmedo E, Su√°rez-Gironzini V, P√©rez M, Filigheddu T, M√≠nguez C, Sanjuan-Sanjuan A, Gonz√°lez JA, Rivas D, Gorospe L, Larrea L, L√≥pez E. COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases. Strahlenther Onkol. 2021 May;197(5):429-437. doi: 10.1007/s00066-020-01743-4. Epub 2021 Jan 27.']","['Kirkby C, Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 2020 Jun;147:221. doi: 10.1016/j.radonc.2020.04.004. Epub 2020 Apr 6.', 'Berk LB, Hodes PJ. Roentgen therapy for infections: an historical review. Yale J Biol Med. 1991 Mar-Apr;64(2):155-65.', 'Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013 Dec 13;86(4):555-70.', 'Cuttler JM. Application of Low Doses of Ionizing Radiation in Medical Therapies. Dose Response. 2020 Jan 6;18(1):1559325819895739. doi: 10.1177/1559325819895739. eCollection 2020 Jan-Mar.', 'Arenas M, Sabater S, Hern√°ndez V, Rovirosa A, Lara PC, Biete A, Pan√©s J. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 2012 Nov;188(11):975-81. doi: 10.1007/s00066-012-0170-8. Epub 2012 Aug 22. Review.', 'Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose. Hum Exp Toxicol. 2019 Aug;38(8):888-898. doi: 10.1177/0960327119846925. Epub 2019 May 6. Review.', 'R√∂del F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007 Jun;83(6):357-66. Review.', 'Schaue D, Jahns J, Hildebrandt G, Trott KR. Radiation treatment of acute inflammation in mice. Int J Radiat Biol. 2005 Sep;81(9):657-67.', 'Torres Royo L, Antelo Redondo G, √Årquez Pianetta M, Arenas Prat M. Low-Dose radiation therapy for benign pathologies. Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):250-254. doi: 10.1016/j.rpor.2020.02.004. Epub 2020 Feb 22. Review.', 'Lara PC, Burgos J, Macias D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29. doi: 10.1016/j.ctro.2020.04.006. eCollection 2020 Jul.']",2022-03-29,https://clinicaltrials.gov/show/NCT04394182,2020-12-31,0,1
1037,NCT04394195,Completed,2020-05-01,2020-09-01,No Results Posted,"['Dupont V, Kanagaratnam L, Goury A, Poitevin G, Bard M, Julien G, Bonnivard M, Champenois V, Noel V, Mourvillier B, Nguyen P. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients. Clin Infect Dis. 2021 May 18;72(10):1834-1837. doi: 10.1093/cid/ciaa1007.']",,2021-04-01,https://clinicaltrials.gov/show/NCT04394195,2020-05-01,0,1
1038,NCT04394208,Recruiting,2021-01-30,2021-02-28,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04394208,2021-01-30,0,0
1039,NCT04395833,Completed,2020-05-11,2020-05-11,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04395833,2020-05-11,0,0
1040,NCT04259892,Unknown,2020-10-04,2021-02-04,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04259892,2020-10-04,0,0
1041,NCT04306393,"Active, not recruiting",2021-12-21,2022-12-21,No Results Posted,"['Gibson LE, Fenza RD, Lang M, Capriles MI, Li MD, Kalpathy-Cramer J, Little BP, Arora P, Mueller AL, Ichinose F, Bittner EA, Berra L, G Chang M. Right Ventricular Strain Is Common in Intubated COVID-19 Patients and Does Not Reflect Severity of Respiratory Illness. J Intensive Care Med. 2021 Aug;36(8):900-909. doi: 10.1177/08850666211006335. Epub 2021 Mar 30.', 'Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Safaee Fakhr B, Gianni S, Grassi LG, Kacmarek R, Araujo Morais CC, Pinciroli R, Vassena E, Berra L. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv. 2020 Mar 13. pii: 2020.03.09.20033530. doi: 10.1101/2020.03.09.20033530.']",,2021-05-25,https://clinicaltrials.gov/show/NCT04306393,2021-12-21,0,1
1042,NCT04318314,Recruiting,2021-04-30,2022-04-30,No Results Posted,"['Astbury S, Reynolds CJ, Butler DK, Mu√±oz-Sandoval DC, Lin KM, Pieper FP, Otter A, Kouraki A, Cusin L, Nightingale J, Vijay A, Craxford S, Aithal GP, Tighe PJ, Gibbons JM, Pade C, Joy G, Maini M, Chain B, Semper A, Brooks T, Ollivere BJ, McKnight √Å, Noursadeghi M, Treibel TA, Manisty C, Moon JC; COVIDsortium Investigators*, Valdes AM, Boyton RJ, Altmann DM. HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. Immunology. 2022 Feb 14. doi: 10.1111/imm.13450. [Epub ahead of print]', 'Valdes AM, Moon JC, Vijay A, Chaturvedi N, Norrish A, Ikram A, Craxford S, Cusin LML, Nightingale J, Semper A, Brooks T, McKnight A, Kurdi H, Menni C, Tighe P, Noursadeghi M, Aithal G, Treibel TA, Ollivere BJ, Manisty C. Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. EClinicalMedicine. 2021 Apr;34:100835. doi: 10.1016/j.eclinm.2021.100835. Epub 2021 Apr 15.']",,2022-02-22,https://clinicaltrials.gov/show/NCT04318314,2021-04-30,0,1
1043,NCT04336761,Completed,2021-01-01,2021-01-01,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04336761,2021-01-01,0,0
1044,NCT04337346,Completed,2020-04-20,2020-04-25,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04337346,2020-04-20,0,0
1045,NCT04338828,Terminated,2021-01-14,2021-03-01,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04338828,2021-01-14,0,0
1046,NCT04338945,Completed,2020-04-15,2020-05-01,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04338945,2020-04-15,0,0
1047,NCT04341675,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04341675,2020-07-01,0,0
1048,NCT04342637,Completed,2020-04-25,2020-05-01,No Results Posted,,"['Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.', 'Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13. Review.', 'Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB; AGA Institute. Electronic address: ewilson@gastro.org. AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology. 2020 Aug;159(2):739-758.e4. doi: 10.1053/j.gastro.2020.03.072. Epub 2020 Apr 1. Review.', 'Chiu PWY, Ng SC, Inoue H, Reddy DN, Ling Hu E, Cho JY, Ho LK, Hewett DG, Chiu HM, Rerknimitr R, Wang HP, Ho SH, Seo DW, Goh KL, Tajiri H, Kitano S, Chan FKL. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020 Jun;69(6):991-996. doi: 10.1136/gutjnl-2020-321185. Epub 2020 Apr 2.']",2020-05-20,https://clinicaltrials.gov/show/NCT04342637,2020-04-25,0,1
1049,NCT04342663,Completed,2020-08-20,2020-12-12,Study Results,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.', 'Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, Miller JP, Yang L, Yingling M, Avidan MS, Reiersen AM. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.']",,2021-07-09,https://clinicaltrials.gov/show/NCT04342663,2020-08-20,1,1
1050,NCT04347681,Completed,2020-11-01,2020-11-16,No Results Posted,"['AlShehry N, Zaidi SZA, AlAskar A, Al Odayani A, Alotaibi JM, AlSagheir A, Al-Eyadhy A, Balelah S, Salam A, Zaidi ARZ, Alawami D, Alshahrani MS, AlMozain N, Abulhamayel YM, Al Qunfoidi R, Alfaraj M, Qushmaq N, Alansari R, Dayel A, Elgohary G, Al Bahrani A, Nabhan Abdelhameed AA, AlZahrani HA, Alturkistani H, AlShehry N, Albalawi MA, Elalfy I, Alhumaidan H, Al-Hashmi H; KSA COVID-19 Convalescent Plasma Study Group. Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia. Saudi J Med Med Sci. 2021 Jan-Apr;9(1):16-23. doi: 10.4103/sjmms.sjmms_731_20. Epub 2020 Dec 26. Erratum in: Saudi J Med Med Sci. 2021 May-Aug;9(2):199.', 'Albalawi M, Zaidi SZA, AlShehry N, AlAskar A, Zaidi ARZ, Abdallah RNM, Salam A, AlSagheir A, AlMozain N, Elgohary G, Batarfi K, Alfaraedi A, Khojah O, Al-Ansari R, Alfaraj M, Dayel A, Al Bahrani A, Abdelhameed AN, Alhumaidan H, Al-Otaibi JM, Radwi G, Raizah A, Shatry H, Alsaleh S, AlZahrani H, Al-Hashmi H. Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study. JMIR Res Protoc. 2020 Oct 2;9(10):e23543. doi: 10.2196/23543.']",,2021-11-16,https://clinicaltrials.gov/show/NCT04347681,2020-11-01,0,1
1051,NCT04347928,Completed,2020-11-06,2020-11-06,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04347928,2020-11-06,0,0
1052,NCT04348240,Completed,2021-12-15,2022-01-27,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04348240,2021-12-15,0,0
1053,NCT04350736,Completed,2020-06-24,2020-07-01,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04350736,2020-06-24,0,0
1054,NCT04351399,Completed,2020-05-04,2020-05-04,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04351399,2020-05-04,0,0
1055,NCT04351633,Completed,2020-04-30,2020-04-30,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04351633,2020-04-30,0,0
1056,NCT04353011,Completed,2020-04-27,2020-04-27,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04353011,2020-04-27,0,0
1057,NCT04354714,Withdrawn,2021-07-31,2021-12-31,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04354714,2021-07-31,0,0
1058,NCT04355143,Completed,2021-07-21,2021-07-21,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-16,https://clinicaltrials.gov/show/NCT04355143,2021-07-21,0,1
1059,NCT04355533,Recruiting,2022-07-01,2022-12-01,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04355533,2022-07-01,0,0
1060,NCT04355897,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04355897,2020-07-01,0,0
1061,NCT04358081,Completed,2020-07-27,2020-07-27,Study Results,,,2021-10-11,https://clinicaltrials.gov/show/NCT04358081,2020-07-27,1,0
1062,NCT04360837,Completed,2020-07-01,2020-07-01,No Results Posted,,"['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.']",2022-02-15,https://clinicaltrials.gov/show/NCT04360837,2020-07-01,0,1
1063,NCT04361214,Recruiting,2021-02-01,2021-02-01,No Results Posted,,,2020-10-29,https://clinicaltrials.gov/show/NCT04361214,2021-02-01,0,0
1064,NCT04361344,Terminated,2020-10-25,2020-10-25,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04361344,2020-10-25,0,0
1065,NCT04362189,Terminated,2021-09-30,2021-09-30,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04362189,2021-09-30,0,0
1066,NCT04365153,Completed,2021-02-02,2021-04-01,Study Results,,,2021-04-15,https://clinicaltrials.gov/show/NCT04365153,2021-02-02,1,0
1067,NCT04365348,Recruiting,2023-05-31,2023-06-30,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04365348,2023-05-31,0,0
1068,NCT04365361,Recruiting,2022-12-31,2023-12-31,No Results Posted,"['Lai AY, Sit SM, Lam SK, Choi AC, Yiu DY, Lai TT, Ip MS, Lam TH. A Phenomenological Study on the Positive and Negative Experiences of Chinese International University Students From Hong Kong Studying in the U.K. and U.S. in the Early Stage of the COVID-19 Pandemic. Front Psychiatry. 2021 Dec 13;12:738474. doi: 10.3389/fpsyt.2021.738474. eCollection 2021.']",,2021-12-10,https://clinicaltrials.gov/show/NCT04365361,2022-12-31,0,1
1069,NCT04365764,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04365764,2022-12-31,0,0
1070,NCT04368000,Terminated,2020-08-06,2020-08-06,No Results Posted,,,2020-12-03,https://clinicaltrials.gov/show/NCT04368000,2020-08-06,0,0
1071,NCT04368845,Completed,2020-06-30,2021-07-31,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04368845,2020-06-30,0,0
1072,NCT04372628,"Active, not recruiting",2022-04-01,2022-06-01,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04372628,2022-04-01,0,0
1073,NCT04373096,Recruiting,2021-08-31,2021-10-31,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04373096,2021-08-31,0,0
1074,NCT04374656,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04374656,2022-05-01,0,0
1075,NCT04375501,Completed,2020-04-15,2020-04-15,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04375501,2020-04-15,0,0
1076,NCT04376580,Enrolling by invitation,2020-10-31,2020-11-30,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04376580,2020-10-31,0,0
1077,NCT04380402,Recruiting,2021-12-31,2022-05-08,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04380402,2021-12-31,0,0
1078,NCT04383678,Completed,2021-04-01,2021-04-01,No Results Posted,"['Biancari F, Mariscalco G, Dal√©n M, Settembre N, Welp H, Perrotti A, Wiebe K, Leo E, Loforte A, Chocron S, Pacini D, Juvonen T, Broman LM, Perna DD, Yusuff H, Harvey C, Mongardon N, Maureira JP, Levy B, Falk L, Ruggieri VG, Zipfel S, Folliguet T, Fiore A. Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19. J Cardiothorac Vasc Anesth. 2021 Jul;35(7):1999-2006. doi: 10.1053/j.jvca.2021.01.027. Epub 2021 Jan 19.']",,2021-04-20,https://clinicaltrials.gov/show/NCT04383678,2021-04-01,0,1
1079,NCT04384406,Completed,2020-05-01,2020-05-09,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04384406,2020-05-01,0,0
1080,NCT04384445,"Active, not recruiting",2022-05-31,2022-06-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04384445,2022-05-31,0,0
1081,NCT04385147,Completed,2020-07-01,2020-07-05,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04385147,2020-07-01,0,0
1082,NCT04386265,Enrolling by invitation,2022-05-11,2022-05-11,No Results Posted,,,2020-10-23,https://clinicaltrials.gov/show/NCT04386265,2022-05-11,0,0
1083,NCT04386447,Withdrawn,2020-10-31,2020-12-31,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04386447,2020-10-31,0,0
1084,NCT04387240,Not yet recruiting,2022-09-01,2022-12-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04387240,2022-09-01,0,0
1085,NCT04388618,Recruiting,2021-08-31,2021-11-30,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04388618,2021-08-31,0,0
1086,NCT04390022,Completed,2020-09-17,2020-10-09,Study Results,"['Chaccour C, Casellas A, Blanco-Di Matteo A, Pineda I, Fernandez-Montero A, Ruiz-Castillo P, Richardson MA, Rodr√≠guez-Mateos M, Jord√°n-Iborra C, Brew J, Carmona-Torre F, Gir√°ldez M, Laso E, Gabald√≥n-Figueira JC, Doba√±o C, Moncunill G, Yuste JR, Del Pozo JL, Rabinovich NR, Sch√∂ning V, Hammann F, Reina G, Sadaba B, Fern√°ndez-Alonso M. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine. 2021 Feb;32:100720. doi: 10.1016/j.eclinm.2020.100720. Epub 2021 Jan 19.']",,2020-12-17,https://clinicaltrials.gov/show/NCT04390022,2020-09-17,1,1
1087,NCT04390074,Completed,2020-06-04,2020-06-04,No Results Posted,,,2020-08-25,https://clinicaltrials.gov/show/NCT04390074,2020-06-04,0,0
1088,NCT04391101,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04391101,2021-06-01,0,0
1089,NCT04391738,Completed,2020-05-15,2020-09-01,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04391738,2020-05-15,0,0
1090,NCT04392128,Withdrawn,2020-09-02,2020-09-02,No Results Posted,,,2020-09-04,https://clinicaltrials.gov/show/NCT04392128,2020-09-02,0,0
1091,NCT04392232,Completed,2021-09-21,2021-09-21,No Results Posted,,,2021-12-07,https://clinicaltrials.gov/show/NCT04392232,2021-09-21,0,0
1092,NCT04393038,Terminated,2021-03-05,2021-04-16,Results Submitted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04393038,2021-03-05,0,0
1093,NCT04393051,Not yet recruiting,2020-06-30,2020-07-30,No Results Posted,,"['Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Erratum in: Lancet. 2020 Jun 20;395(10241):1906.', 'Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.']",2020-05-20,https://clinicaltrials.gov/show/NCT04393051,2020-06-30,0,1
1094,NCT04393155,Terminated,2021-01-20,2021-01-25,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04393155,2021-01-20,0,0
1095,NCT04393402,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04393402,2020-12-31,0,0
1096,NCT04393428,Completed,2020-06-01,2020-06-30,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04393428,2020-06-01,0,0
1097,NCT04393558,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04393558,2022-12-31,0,0
1098,NCT04393727,Terminated,2020-09-30,2020-09-30,No Results Posted,,"['Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.']",2020-11-12,https://clinicaltrials.gov/show/NCT04393727,2020-09-30,0,1
1099,NCT04393792,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04393792,2022-03-01,0,0
1100,NCT04393805,Completed,2021-02-26,2021-02-26,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-03-18,https://clinicaltrials.gov/show/NCT04393805,2021-02-26,0,1
1101,NCT04393818,Completed,2020-08-24,2020-08-24,Results Submitted,"['Fiol-DeRoque MA, Serrano-Ripoll MJ, Jim√©nez R, Zamanillo-Campos R, Y√°√±ez-Juan AM, Bennasar-Veny M, Leiva A, Gervilla E, Garc√≠a-Buades ME, Garc√≠a-Toro M, Alonso-Coello P, Pastor-Moreno G, Ruiz-P√©rez I, Sitges C, Garc√≠a-Campayo J, Llobera-C√°naves J, Ricci-Cabello I. A Mobile Phone-Based Intervention to Reduce Mental Health Problems in Health Care Workers During the COVID-19 Pandemic (PsyCovidApp): Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 May 18;9(5):e27039. doi: 10.2196/27039.', 'Serrano-Ripoll MJ, Ricci-Cabello I, Jim√©nez R, Zamanillo-Campos R, Ya√±ez-Juan AM, Bennasar-Veny M, Sitges C, Gervilla E, Leiva A, Garc√≠a-Campayo J, Garc√≠a-Buades ME, Garc√≠a-Toro M, Pastor-Moreno G, Ruiz-Perez I, Alonso-Coello P, Llobera J, Fiol-deRoque MA. Effect of a mobile-based intervention on mental health in frontline healthcare workers against COVID-19: Protocol for a randomized controlled trial. J Adv Nurs. 2021 Jun;77(6):2898-2907. doi: 10.1111/jan.14813. Epub 2021 Mar 6.']",,2020-09-10,https://clinicaltrials.gov/show/NCT04393818,2020-08-24,0,1
1102,NCT04393974,Recruiting,2022-03-24,2024-03-24,No Results Posted,"['Pinato DJ, Tabernero J, Bower M, Scotti L, Patel M, Colomba E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Dalla Pria A, Aguilar-Company J, Ottaviani D, Chowdhury A, Merry E, Salazar R, Bertuzzi A, Brunet J, Lambertini M, Tagliamento M, Pous A, Sita-Lumsden A, Srikandarajah K, Colomba J, Pommeret F, Segu√≠ E, Generali D, Grisanti S, Pedrazzoli P, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Harbeck N, Vincenzi B, Biello F, Bertulli R, Li√±an R, Rossi S, Carmona-Garc√≠a MC, Tondini C, Fox L, Baggi A, Fotia V, Parisi A, Porzio G, Saponara M, Cruz CA, Garc√≠a-Illescas D, Felip E, Roqu√© Lloveras A, Sharkey R, Rold√°n E, Reyes R, Earnshaw I, Ferrante D, Marco-Hern√°ndez J, Ruiz-Camps I, Gaidano G, Patriarca A, Bruna R, Sureda A, Martinez-Vila C, Sanchez de Torre A, Cantini L, Filetti M, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Van Hemelrijck M, Diamantis N, Newsom-Davis T, Gennari A, Cortellini A; OnCovid study group. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021 Dec;22(12):1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04393974,2022-03-24,0,1
1103,NCT04394013,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04394013,2020-12-31,0,0
1104,NCT04394390,Enrolling by invitation,2020-06-15,2020-06-30,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04394390,2020-06-15,0,0
1105,NCT04394403,Recruiting,2021-12-31,2022-06-30,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04394403,2021-12-31,0,0
1106,NCT04394429,Recruiting,2021-06-24,2021-06-24,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04394429,2021-06-24,0,0
1107,NCT04394442,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,2020-05-19,https://clinicaltrials.gov/show/NCT04394442,2020-08-01,0,0
1108,NCT04395144,Completed,2021-03-15,2021-03-15,No Results Posted,"['Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.', 'Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,2021-03-23,https://clinicaltrials.gov/show/NCT04395144,2021-03-15,0,1
1109,NCT04395456,Not yet recruiting,2022-09-01,2022-12-01,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04395456,2022-09-01,0,0
1110,NCT04395664,Completed,2020-09-01,2020-09-01,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04395664,2020-09-01,0,0
1111,NCT04395742,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,"['Belaroussi Y, Roblot P, Peiffer-Smadja N, Delaye T, Mathoulin-Pelissier S, Lemeux J, Le Moal G, Caumes E, Roblot F, Bleibtreu A. Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19? J Clin Med. 2020 Nov 17;9(11). pii: E3691. doi: 10.3390/jcm9113691.']",,2020-05-20,https://clinicaltrials.gov/show/NCT04395742,2020-12-01,0,1
1112,NCT04395755,Completed,2020-05-15,2020-05-15,No Results Posted,,,2022-02-22,https://clinicaltrials.gov/show/NCT04395755,2020-05-15,0,0
1113,NCT04395768,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2020-09-11,https://clinicaltrials.gov/show/NCT04395768,2021-09-30,0,0
1114,NCT04395794,Recruiting,2020-08-31,2020-11-30,No Results Posted,,,2020-05-20,https://clinicaltrials.gov/show/NCT04395794,2020-08-31,0,0
1115,NCT04395885,Completed,2020-08-31,2020-09-15,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04395885,2020-08-31,0,0
1116,NCT04395911,Completed,2021-07-05,2021-07-21,Results Submitted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04395911,2021-07-05,0,0
1117,NCT04395976,Withdrawn,2020-06-10,2020-09-01,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04395976,2020-06-10,0,0
1118,NCT04396106,Recruiting,2022-06-01,2022-08-01,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04396106,2022-06-01,0,0
1119,NCT04396197,Completed,2020-05-08,2020-05-08,No Results Posted,"['McWilliams D, Weblin J, Hodson J, Veenith T, Whitehouse T, Snelson C. Rehabilitation Levels in Patients with COVID-19 Admitted to Intensive Care Requiring Invasive Ventilation. An Observational Study. Ann Am Thorac Soc. 2021 Jan;18(1):122-129. doi: 10.1513/AnnalsATS.202005-560OC.']",,2020-05-20,https://clinicaltrials.gov/show/NCT04396197,2020-05-08,0,1
1120,NCT04396210,Completed,2020-06-18,2020-06-18,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04396210,2020-06-18,0,0
1121,NCT04396314,Not yet recruiting,2021-12-30,2022-04-30,No Results Posted,,"['Bravo C, Skjaerven LH, Espart A, Guitard Sein-Echaluce L, Catalan-Matamoros D. Basic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial. Physiother Theory Pract. 2019 Oct;35(10):919-929. doi: 10.1080/09593985.2018.1467520. Epub 2018 May 3.', 'Madsen TS, Carlsson J, Nordbrandt M, Jensen JA. Refugee experiences of individual basic body awareness therapy and the level of transference into daily life. An interview study. J Bodyw Mov Ther. 2016 Apr;20(2):243-51. doi: 10.1016/j.jbmt.2015.10.007. Epub 2015 Oct 26.']",2021-03-19,https://clinicaltrials.gov/show/NCT04396314,2021-12-30,0,1
1122,NCT04396600,Enrolling by invitation,2022-05-25,2022-05-25,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04396600,2022-05-25,0,0
1123,NCT04397172,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2021-07-09,https://clinicaltrials.gov/show/NCT04397172,2022-06-01,0,0
1124,NCT04397237,"Active, not recruiting",2020-12-08,2021-01-01,No Results Posted,"['Saadoun D, Vieira M, Vautier M, Baraliakos X, Andreica I, da Silva JAP, Sousa M, Luis M, Khmelinskii N, Grac√≠a JMA, Castrejon I, Gonzalez JCN, Scir√® CA, Silvagni E, Bortoluzzi A, Penn H, Hamdulay S, Machado PM, Fautrel B, Cacoub P, Resche-Rigon M, Gossec L. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study. Lancet Rheumatol. 2021 Jul;3(7):e481-e488. doi: 10.1016/S2665-9913(21)00112-0. Epub 2021 Apr 28.']",,2020-12-21,https://clinicaltrials.gov/show/NCT04397237,2020-12-08,0,1
1125,NCT04397328,Not yet recruiting,2021-04-30,2021-04-30,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04397328,2021-04-30,0,0
1126,NCT04397380,Not yet recruiting,2020-06-03,2020-07-01,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04397380,2020-06-03,0,0
1127,NCT04397523,Completed,2021-05-10,2021-05-10,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04397523,2021-05-10,0,0
1128,NCT04397588,Recruiting,2020-10-21,2020-10-21,No Results Posted,,,2020-08-31,https://clinicaltrials.gov/show/NCT04397588,2020-10-21,0,0
1129,NCT04397614,Completed,2021-11-12,2021-11-12,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04397614,2021-11-12,0,0
1130,NCT04397666,"Active, not recruiting",2020-12-15,2021-12-15,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04397666,2020-12-15,0,0
1131,NCT04397705,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04397705,2021-04-01,0,0
1132,NCT04397822,Recruiting,2021-10-01,2022-04-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04397822,2021-10-01,0,0
1133,NCT04397835,Recruiting,2021-04-20,2021-04-20,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04397835,2021-04-20,0,0
1134,NCT04397848,Completed,2020-07-03,2020-07-03,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04397848,2020-07-03,0,0
1135,NCT04398264,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04398264,2021-03-31,0,0
1136,NCT04398277,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04398277,2021-04-01,0,0
1137,NCT04398290,Withdrawn,2021-06-01,2021-07-15,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04398290,2021-06-01,0,0
1138,NCT04398303,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04398303,2020-10-01,0,0
1139,NCT04399746,Completed,2020-05-20,2020-06-10,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04399746,2020-05-20,0,0
1140,NCT04400032,Completed,2021-04-22,2021-04-22,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04400032,2021-04-22,0,0
1141,NCT04404634,,,,,,,,https://clinicaltrials.gov/show/NCT04404634,,0,0
1142,NCT04594668,Recruiting,2021-04-24,2021-12-31,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04594668,2021-04-24,0,0
1143,NCT03648372,Recruiting,2022-12-01,2023-10-01,No Results Posted,,,2022-03-31,,2022-12-01,0,0
1144,NCT04061382,"Active, not recruiting",2021-06-30,2022-06-30,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04061382,2021-06-30,0,0
1145,NCT04305457,"Active, not recruiting",2021-04-01,2022-04-01,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04305457,2021-04-01,0,0
1146,NCT04320511,Terminated,2021-05-14,2021-05-14,No Results Posted,,,2022-01-05,https://clinicaltrials.gov/show/NCT04320511,2021-05-14,0,0
1147,NCT04321278,Completed,2020-06-14,2020-06-14,No Results Posted,"['Furtado RHM, Berwanger O, Fonseca HA, Corr√™a TD, Ferraz LR, Lapa MG, Zampieri FG, Veiga VC, Azevedo LCP, Rosa RG, Lopes RD, Avezum A, Manoel ALO, Piza FMT, Martins PA, Lisboa TC, Pereira AJ, Olivato GB, Dantas VCS, Milan EP, Gebara OCE, Amazonas RB, Oliveira MB, Soares RVP, Moia DDF, Piano LPA, Castilho K, Momesso RGRAP, Schettino GPP, Rizzo LV, Neto AS, Machado FR, Cavalcanti AB; COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020 Oct 3;396(10256):959-967. doi: 10.1016/S0140-6736(20)31862-6. Epub 2020 Sep 5.', 'Lasheras I, Santab√°rbara J. Use of antimalarial drugs in the treatment of COVID-19: A window of opportunity? Med Clin (Barc). 2020 Jul 10;155(1):23-25. doi: 10.1016/j.medcli.2020.04.004. Epub 2020 Apr 22. English, Spanish.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04321278,2020-06-14,0,1
1148,NCT04331600,Completed,2020-12-17,2020-12-17,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04331600,2020-12-17,0,0
1149,NCT04332107,Terminated,2021-03-16,2021-03-30,Study Results,"['Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, Nyatigo F, Cook CA, Hinterwirth A, Lebas E, Redd T, Porco TC, Lietman TM, Arnold BF, Doan T. Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. 2021 Aug 10;326(6):490-498. doi: 10.1001/jama.2021.11517.']",,2021-10-07,https://clinicaltrials.gov/show/NCT04332107,2021-03-16,1,1
1150,NCT04336956,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-07-17,https://clinicaltrials.gov/show/NCT04336956,2021-06-30,0,0
1151,NCT04338347,,,,,,,2020-12-01,https://clinicaltrials.gov/show/NCT04338347,,0,0
1152,NCT04341766,Completed,2020-05-27,2020-06-30,No Results Posted,,,2020-07-17,https://clinicaltrials.gov/show/NCT04341766,2020-05-27,0,0
1153,NCT04343742,Recruiting,2020-04-07,2020-06-01,No Results Posted,,"['Zhu Z, Guo Y, Yu P, Wang X, Zhang X, Dong W, Liu X, Guo C. Chlorine dioxide inhibits the replication of porcine reproductive and respiratory syndrome virus by blocking viral attachment. Infect Genet Evol. 2019 Jan;67:78-87. doi: 10.1016/j.meegid.2018.11.002. Epub 2018 Nov 3.']",2020-05-27,https://clinicaltrials.gov/show/NCT04343742,2020-04-07,0,1
1154,NCT04346693,Completed,2020-11-01,2020-11-20,No Results Posted,,,2021-10-13,https://clinicaltrials.gov/show/NCT04346693,2020-11-01,0,0
1155,NCT04348370,"Active, not recruiting",2022-05-01,2022-05-01,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04348370,2022-05-01,0,0
1156,NCT04350450,Withdrawn,2020-08-01,2020-08-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04350450,2020-08-01,0,0
1157,NCT04352634,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04352634,2021-12-31,0,0
1158,NCT04362995,Recruiting,2022-09-01,2025-03-01,No Results Posted,"['Schultz-Cherry S, McGargill MA, Thomas PG, Estepp JH, Gaur AH, Allen EK, Allison KJ, Tang L, Webby RJ, Cherry SD, Lin CY, Fabrizio T, Tuomanen EI, Wolf J; SJTRC Investigative Team . Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy. Open Forum Infect Dis. 2021 Aug 10;8(9):ofab420. doi: 10.1093/ofid/ofab420. eCollection 2021 Sep.']",,2021-07-01,https://clinicaltrials.gov/show/NCT04362995,2022-09-01,0,1
1159,NCT04363814,"Active, not recruiting",2022-01-01,2022-01-31,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04363814,2022-01-01,0,0
1160,NCT04373811,"Active, not recruiting",2021-07-13,2022-12-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04373811,2021-07-13,0,0
1161,NCT04374591,"Active, not recruiting",2020-11-01,2020-11-01,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04374591,2020-11-01,0,0
1162,NCT04376658,Recruiting,2022-04-15,2022-07-15,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04376658,2022-04-15,0,0
1163,NCT04377737,Withdrawn,2020-08-01,2020-09-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04377737,2020-08-01,0,0
1164,NCT04379375,Terminated,2020-09-30,2020-09-30,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04379375,2020-09-30,0,0
1165,NCT04380532,"Active, not recruiting",2021-05-15,2021-06-15,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04380532,2021-05-15,0,0
1166,NCT04381351,Recruiting,2021-03-01,2021-07-31,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04381351,2021-03-01,0,0
1167,NCT04381884,Completed,2020-09-29,2020-09-29,No Results Posted,"['Krolewiecki A, Lifschitz A, Moragas M, Travacio M, Valentini R, Alonso DF, Solari R, Tinelli MA, Cimino RO, √Ålvarez L, Fleitas PE, Ceballos L, Golemba M, Fern√°ndez F, Fern√°ndez de Oliveira D, Astudillo G, Baeck I, Farina J, Cardama GA, Mangano A, Spitzer E, Gold S, Lanusse C. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. EClinicalMedicine. 2021 Jun 18;37:100959. doi: 10.1016/j.eclinm.2021.100959. eCollection 2021 Jul. Erratum in: EClinicalMedicine. 2021 Sep;39:101119.']",,2020-10-05,https://clinicaltrials.gov/show/NCT04381884,2020-09-29,0,1
1168,NCT04389996,Completed,2020-07-21,2021-07-21,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04389996,2020-07-21,0,0
1169,NCT04390594,Recruiting,2021-02-12,2021-08-12,No Results Posted,,,2020-09-07,https://clinicaltrials.gov/show/NCT04390594,2021-02-12,0,0
1170,NCT04392869,Completed,2020-07-31,2020-10-31,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04392869,2020-07-31,0,0
1171,NCT04393415,Recruiting,2020-08-25,2020-09-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04393415,2020-08-25,0,0
1172,NCT04395105,Terminated,2021-04-05,2021-05-21,No Results Posted,"['Maskin LP, Olarte GL, Palizas F Jr, Velo AE, Lurbet MF, Bonelli I, Baredes ND, Rodr√≠guez PO. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Aug 26;21(1):743. doi: 10.1186/s13063-020-04646-y.']",,2021-06-02,https://clinicaltrials.gov/show/NCT04395105,2021-04-05,0,1
1173,NCT04395482,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04395482,2021-06-15,0,0
1174,NCT04395781,Recruiting,2022-12-31,2023-12-31,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04395781,2022-12-31,0,0
1175,NCT04395872,Not yet recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04395872,2020-12-31,0,0
1176,NCT04397497,Not yet recruiting,2020-09-22,2020-11-22,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04397497,2020-09-22,0,0
1177,NCT04397575,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04397575,2021-12-01,0,0
1178,NCT04398004,Completed,2020-11-30,2020-11-30,No Results Posted,"['Tsiakos K, Tsakiris A, Tsibris G, Voutsinas PM, Panagopoulos P, Kosmidou M, Petrakis V, Gravvani A, Gkavogianni T, Klouras E, Katrini K, Koufargyris P, Rapti I, Karageorgos A, Vrentzos E, Damoulari C, Zarkada V, Sidiropoulou C, Artemi S, Ioannidis A, Papapostolou A, Michelakis E, Georgiopoulou M, Myrodia DM, Tsiamalos P, Syrigos K, Chrysos G, Nitsotolis T, Milionis H, Poulakou G, Giamarellos-Bourboulis EJ. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infect Dis Ther. 2021 Dec;10(4):2333-2351. doi: 10.1007/s40121-021-00505-8. Epub 2021 Aug 6.']",,2021-01-11,https://clinicaltrials.gov/show/NCT04398004,2020-11-30,0,1
1179,NCT04398147,Not yet recruiting,2021-12-20,2021-12-30,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04398147,2021-12-20,0,0
1180,NCT04399109,Recruiting,2021-05-19,2021-05-19,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04399109,2021-05-19,0,0
1181,NCT04399252,Completed,2021-07-08,2021-07-08,No Results Posted,"['Tang H, Bohannon L, Lew M, Jensen D, Jung SH, Zhao A, Sung AD, Wischmeyer PE. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open. 2021 May 5;11(5):e047069. doi: 10.1136/bmjopen-2020-047069.']",,2022-03-15,https://clinicaltrials.gov/show/NCT04399252,2021-07-08,0,1
1182,NCT04399356,Completed,2021-04-20,2021-08-19,No Results Posted,,"['Cairns DM, Dulko D, Griffiths JK, Golan Y, Cohen T, Trinquart L, Price LL, Beaulac KR, Selker HP. Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e2144942. doi: 10.1001/jamanetworkopen.2021.44942.']",2022-03-10,https://clinicaltrials.gov/show/NCT04399356,2021-04-20,0,1
1183,NCT04399603,Recruiting,2021-11-17,2021-11-17,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04399603,2021-11-17,0,0
1184,NCT04399681,Recruiting,2020-08-10,2020-09-10,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04399681,2020-08-10,0,0
1185,NCT04399798,Not yet recruiting,2020-09-15,2020-11-15,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04399798,2020-09-15,0,0
1186,NCT04400006,Completed,2020-05-16,2020-05-17,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04400006,2020-05-16,0,0
1187,NCT04400058,Completed,2022-02-01,2022-02-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04400058,2022-02-01,0,0
1188,NCT04400305,Completed,2021-08-30,2021-08-30,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04400305,2021-08-30,0,0
1189,NCT04400461,Completed,2021-02-25,2021-03-01,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04400461,2021-02-25,0,0
1190,NCT04400799,Recruiting,2022-03-14,2022-04-14,No Results Posted,"['Barco S, Bingisser R, Colucci G, Frenk A, Gerber B, Held U, Mach F, Mazzolai L, Righini M, Rosemann T, Sebastian T, Spescha R, Stortecky S, Windecker S, Kucher N. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Sep 9;21(1):770. doi: 10.1186/s13063-020-04678-4.']",,2022-01-26,https://clinicaltrials.gov/show/NCT04400799,2022-03-14,0,1
1191,NCT04400812,Enrolling by invitation,2020-09-01,2020-10-01,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04400812,2020-09-01,0,0
1192,NCT04400838,"Active, not recruiting",2023-03-31,2023-03-31,No Results Posted,"['Flaxman A, Marchevsky NG, Jenkin D, Aboagye J, Aley PK, Angus B, Belij-Rammerstorfer S, Bibi S, Bittaye M, Cappuccini F, Cicconi P, Clutterbuck EA, Davies S, Dejnirattisai W, Dold C, Ewer KJ, Folegatti PM, Fowler J, Hill AVS, Kerridge S, Minassian AM, Mongkolsapaya J, Mujadidi YF, Plested E, Ramasamy MN, Robinson H, Sanders H, Sheehan E, Smith H, Snape MD, Song R, Woods D, Screaton G, Gilbert SC, Voysey M, Pollard AJ, Lambe T; Oxford COVID Vaccine Trial group. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet. 2021 Sep 11;398(10304):981-990. doi: 10.1016/S0140-6736(21)01699-8. Epub 2021 Sep 1.', 'Frater J, Ewer KJ, Ogbe A, Pace M, Adele S, Adland E, Alagaratnam J, Aley PK, Ali M, Ansari MA, Bara A, Bittaye M, Broadhead S, Brown A, Brown H, Cappuccini F, Cooney E, Dejnirattisai W, Dold C, Fairhead C, Fok H, Folegatti PM, Fowler J, Gibbs C, Goodman AL, Jenkin D, Jones M, Makinson R, Marchevsky NG, Mujadidi YF, Nguyen H, Parolini L, Petersen C, Plested E, Pollock KM, Ramasamy MN, Rhead S, Robinson H, Robinson N, Rongkard P, Ryan F, Serrano S, Tipoe T, Voysey M, Waters A, Zacharopoulou P, Barnes E, Dunachie S, Goulder P, Klenerman P, Screaton GR, Winston A, Hill AVS, Gilbert SC, Pollard AJ, Fidler S, Fox J, Lambe T; Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021 Aug;8(8):e474-e485. doi: 10.1016/S2352-3018(21)00103-X. Epub 2021 Jun 18.', 'Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, Clutterbuck EA, Collins AM, Cox T, Darton TC, Dold C, Douglas AD, Duncan CJA, Ewer KJ, Flaxman AL, Faust SN, Ferreira DM, Feng S, Finn A, Folegatti PM, Fuskova M, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hallis B, Heath PT, Hay J, Hill HC, Jenkin D, Kerridge S, Lazarus R, Libri V, Lillie PJ, Ludden C, Marchevsky NG, Minassian AM, McGregor AC, Mujadidi YF, Phillips DJ, Plested E, Pollock KM, Robinson H, Smith A, Song R, Snape MD, Sutherland RK, Thomson EC, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Williams CJ, Hill AVS, Lambe T, Gilbert SC, Voysey M, Ramasamy MN, Pollard AJ; COVID-19 Genomics UK consortium; AMPHEUS Project; Oxford COVID-19 Vaccine Trial Group. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 Apr 10;397(10282):1351-1362. doi: 10.1016/S0140-6736(21)00628-0. Epub 2021 Mar 30.', 'Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet. 2021 Mar 6;397(10277):880.', 'Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M, Dold C, Provine NM, Aboagye J, Fowler J, Silk SE, Alderson J, Aley PK, Angus B, Berrie E, Bibi S, Cicconi P, Clutterbuck EA, Chelysheva I, Folegatti PM, Fuskova M, Green CM, Jenkin D, Kerridge S, Lawrie A, Minassian AM, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Song R, Snape MD, Tarrant R, Voysey M, Watson MEE, Douglas AD, Hill AVS, Gilbert SC, Pollard AJ, Lambe T; Oxford COVID Vaccine Trial Group. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021 Feb;27(2):270-278. doi: 10.1038/s41591-020-01194-5. Epub 2020 Dec 17. Erratum in: Nat Med. 2021 Jun;27(6):1116.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98."", 'Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, Voysey M, Aley PK, Angus B, Babbage G, Belij-Rammerstorfer S, Berry L, Bibi S, Bittaye M, Cathie K, Chappell H, Charlton S, Cicconi P, Clutterbuck EA, Colin-Jones R, Dold C, Emary KRW, Fedosyuk S, Fuskova M, Gbesemete D, Green C, Hallis B, Hou MM, Jenkin D, Joe CCD, Kelly EJ, Kerridge S, Lawrie AM, Lelliott A, Lwin MN, Makinson R, Marchevsky NG, Mujadidi Y, Munro APS, Pacurar M, Plested E, Rand J, Rawlinson T, Rhead S, Robinson H, Ritchie AJ, Ross-Russell AL, Saich S, Singh N, Smith CC, Snape MD, Song R, Tarrant R, Themistocleous Y, Thomas KM, Villafana TL, Warren SC, Watson MEE, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Faust SN, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19. Erratum in: Lancet. 2021 Dec 19;396(10267):1978. Lancet. 2021 Apr 10;397(10282):1350.']",,2022-01-21,,2023-03-31,0,1
1193,NCT04400890,Terminated,2021-03-01,2021-03-01,No Results Posted,"['McCreary MR, Schnell PM, Rhoda DA. Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19). Res Sq. 2021 Sep 13. pii: rs.3.rs-861831. doi: 10.21203/rs.3.rs-861831/v1.']",,2021-08-26,https://clinicaltrials.gov/show/NCT04400890,2021-03-01,0,1
1194,NCT04400929,Recruiting,2021-06-01,2022-06-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04400929,2021-06-01,0,0
1195,NCT04401072,Recruiting,2020-05-22,2020-10-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401072,2020-05-22,0,0
1196,NCT04401098,Recruiting,2020-10-01,2021-04-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401098,2020-10-01,0,0
1197,NCT04401111,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04401111,2021-06-15,0,0
1198,NCT04401124,Not yet recruiting,2020-05-31,2020-06-07,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04401124,2020-05-31,0,0
1199,NCT04401150,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-01-24,https://clinicaltrials.gov/show/NCT04401150,2022-12-01,0,0
1200,NCT04401202,Completed,2020-12-31,2020-12-31,Study Results,"['Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement Ther Med. 2021 Sep;61:102769. doi: 10.1016/j.ctim.2021.102769. Epub 2021 Aug 15.', 'Koshak AE, Koshak EA, Mobeireek AF, Badawi MA, Wali SO, Malibary HM, Atwah AF, Alhamdan MM, Almalki RA, Madani TA. Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial. Trials. 2020 Aug 8;21(1):703. doi: 10.1186/s13063-020-04647-x.']",,2021-05-26,https://clinicaltrials.gov/show/NCT04401202,2020-12-31,1,1
1201,NCT04401228,"Active, not recruiting",2020-05-01,2021-01-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401228,2020-05-01,0,0
1202,NCT04401241,Completed,2020-05-01,2020-05-15,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401241,2020-05-01,0,0
1203,NCT04401254,Recruiting,2022-07-30,2022-07-30,No Results Posted,"['Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, Bissett B, Boden IJ, Bradley S, Burrell A, Cooper DJ, Fulcher BJ, Haines KJ, Hopkins J, Jones AYM, Lane S, Lawrence D, van der Lee L, Liacos J, Linke NJ, Gomes LM, Nickels M, Ntoumenopoulos G, Myles PS, Patman S, Paton M, Pound G, Rai S, Rix A, Rollinson TC, Sivasuthan J, Tipping CJ, Thomas P, Trapani T, Udy AA, Whitehead C, Hodgson IT, Anderson S, Neto AS; COVID-Recovery Study Investigators and the ANZICS Clinical Trials Group. The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study. Crit Care. 2021 Nov 8;25(1):382. doi: 10.1186/s13054-021-03794-0.']",,2022-03-22,https://clinicaltrials.gov/show/NCT04401254,2022-07-30,0,1
1204,NCT04401371,Completed,2021-05-10,2021-07-10,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04401371,2021-05-10,0,0
1205,NCT04401410,Terminated,2021-10-12,2021-10-12,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04401410,2021-10-12,0,0
1206,NCT04401423,Completed,2021-06-10,2021-06-10,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04401423,2021-06-10,0,0
1207,NCT04401527,Withdrawn,2020-08-15,2020-08-15,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04401527,2020-08-15,0,0
1208,NCT04401540,Recruiting,2020-10-30,2020-12-30,No Results Posted,"['Akin IM, Kanburoglu MK, Tayman C, Oncel MY, Imdadoglu T, Dilek M, Yaman A, Narter F, Er I, Kahveci H, Erdeve O, Koc E; Neo-Covid Study Group. Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society. Eur J Pediatr. 2022 Jan 21. doi: 10.1007/s00431-021-04358-8. [Epub ahead of print]', 'Oncel MY, Akƒ±n IM, Kanburoglu MK, Tayman C, Coskun S, Narter F, Er I, Oncan TG, Memisoglu A, Cetinkaya M, Oguz D, Erdeve O, Koc E; Neo-Covid Study Group. A multicenter study on epidemiological and clinical characteristics of 125 newborns born to women infected with COVID-19 by Turkish Neonatal Society. Eur J Pediatr. 2021 Mar;180(3):733-742. doi: 10.1007/s00431-020-03767-5. Epub 2020 Aug 10. Erratum in: Eur J Pediatr. 2020 Aug 22;:.']","['Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H, Mirjalili SR, Behforouz A, Ferdosian F, Bahrami R. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review. Fetal Pediatr Pathol. 2020 Jun;39(3):246-250. doi: 10.1080/15513815.2020.1747120. Epub 2020 Apr 2. Review.', 'Mimouni F, Lakshminrusimha S, Pearlman SA, Raju T, Gallagher PG, Mendlovic J. Perinatal aspects on the covid-19 pandemic: a practical resource for perinatal-neonatal specialists. J Perinatol. 2020 May;40(5):820-826. doi: 10.1038/s41372-020-0665-6. Epub 2020 Apr 10. Review.', 'Liu W, Wang J, Li W, Zhou Z, Liu S, Rong Z. Clinical characteristics of 19 neonates born to mothers with COVID-19. Front Med. 2020 Apr;14(2):193-198. doi: 10.1007/s11684-020-0772-y. Epub 2020 Apr 13.']",2020-07-14,https://clinicaltrials.gov/show/NCT04401540,2020-10-30,0,1
1209,NCT04401644,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401644,2021-12-01,0,0
1210,NCT04402203,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04402203,2020-07-01,0,0
1211,NCT04402229,Completed,2020-07-31,2020-07-31,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04402229,2020-07-31,0,0
1212,NCT04402814,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04402814,2020-10-01,0,0
1213,NCT04402840,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04402840,2021-12-01,0,0
1214,NCT04402983,Completed,2020-12-01,2020-12-01,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04402983,2020-12-01,0,0
1215,NCT04403009,Recruiting,2020-06-06,2020-06-20,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04403009,2020-06-06,0,0
1216,NCT04403035,Withdrawn,2020-07-01,2021-05-09,No Results Posted,,"['Accula SARS-CoV-2 Test IFU (EUA). Mesa Biotech, 2020.', 'ID NOW COVID-19 Assay IFU (EUA). Abbott, 2020.', 'Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance. World Health Organization. 19 March 2020.']",2021-07-23,https://clinicaltrials.gov/show/NCT04403035,2020-07-01,0,1
1217,NCT04403269,Recruiting,2021-05-05,2021-05-05,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04403269,2021-05-05,0,0
1218,NCT04403438,Enrolling by invitation,2020-05-01,2020-06-15,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04403438,2020-05-01,0,0
1219,NCT04403477,Recruiting,2020-07-20,2020-10-30,No Results Posted,"['Chowdhury FR, Hoque A, Chowdhury FUH, Amin MR, Rahim A, Rahman MM, Yasmin R, Amin MR, Miah MT, Kalam MA, Rahman MS. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial. Trials. 2020 Oct 26;21(1):883. doi: 10.1186/s13063-020-04734-z.']",,2020-05-27,https://clinicaltrials.gov/show/NCT04403477,2020-07-20,0,1
1220,NCT04403555,Completed,2020-10-31,2020-12-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04403555,2020-10-31,0,0
1221,NCT04403581,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04403581,2020-06-01,0,0
1222,NCT04403906,Not yet recruiting,2021-06-01,2021-08-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04403906,2021-06-01,0,0
1223,NCT04404192,Recruiting,2022-08-01,2022-11-01,No Results Posted,,,2021-10-20,,2022-08-01,0,0
1224,NCT04404218,Recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04404218,2021-12-01,0,0
1225,NCT04307693,Terminated,2020-04-30,2020-04-30,No Results Posted,"['Lipsitch M, Perlman S, Waldor MK. Testing COVID-19 therapies to prevent progression of mild disease. Lancet Infect Dis. 2020 Dec;20(12):1367. doi: 10.1016/S1473-3099(20)30372-8. Epub 2020 May 6.']",,2020-05-27,https://clinicaltrials.gov/show/NCT04307693,2020-04-30,0,1
1226,NCT04317040,Completed,2020-10-20,2020-10-20,Study Results,"['Welker J, Pulido JD, Catanzaro AT, Malvestutto CD, Li Z, Cohen JB, Whitman ED, Byrne D, Giddings OK, Lake JE, Chua JV, Li E, Chen J, Zhou X, He K, Gates D, Kaur A, Chen J, Chou HY, Devenport M, Touomou R, Kottilil S, Liu Y, Zheng P; SAC-COVID Study Team. Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Infect Dis. 2022 Mar 11. pii: S1473-3099(22)00058-5. doi: 10.1016/S1473-3099(22)00058-5. [Epub ahead of print]', 'Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. J Hematol Oncol. 2022 Jan 10;15(1):5. doi: 10.1186/s13045-021-01222-y.']",,2021-10-15,https://clinicaltrials.gov/show/NCT04317040,2020-10-20,1,1
1227,NCT04321421,Completed,2020-04-28,2020-05-07,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Piechotta V, Chai KL, Valk SJ, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. Update in: Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600.', 'Perotti C, Del Fante C, Baldanti F, Franchini M, Percivalle E, Vecchio Nepita E, Seminari E, De Silvestri A, Bruno R, Klersy C. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Intern Emerg Med. 2020 Aug;15(5):819-824. doi: 10.1007/s11739-020-02384-2. Epub 2020 May 28.']",,2020-05-28,https://clinicaltrials.gov/show/NCT04321421,2020-04-28,0,1
1228,NCT04327206,"Active, not recruiting",2021-11-10,2022-03-30,No Results Posted,"['Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, Bonten M, Campbell JL, Croda J, Dalcolmo M, Elia S, Germano S, Goodall C, Gwee A, Jamieson T, Jardim B, Kollmann TR, Guimar√£es Lacerda MV, Lee KJ, Legge D, Lucas M, Lynn DJ, McDonald E, Manning L, Munns CF, Perrett KP, Prat Aymerich C, Richmond P, Shann F, Sudbury E, Villanueva P, Wood NJ, Lieschke K, Subbarao K, Davidson A, Curtis N; BRACE trial Consortium Group. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial). BMJ Open. 2021 Oct 28;11(10):e052101. doi: 10.1136/bmjopen-2021-052101.', 'Crisan-Dabija R, Grigorescu C, Pavel CA, Artene B, Popa IV, Cernomaz A, Burlacu A. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes. Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020. Review.']",,2022-01-26,https://clinicaltrials.gov/show/NCT04327206,2021-11-10,0,1
1229,NCT04327570,Recruiting,2023-03-30,2023-03-30,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04327570,2023-03-30,0,0
1230,NCT04328467,Completed,2020-07-13,2020-07-13,Study Results,"['Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov.']","['Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, Pullen MF, Nascene AA, Williams DA, Engen NW, Okafor EC, Rini BI, Mayer IA, McDonald EG, Lee TC, Li P, MacKenzie LJ, Balko JM, Dunlop SJ, Hullsiek KH, Boulware DR, Lofgren SM; COVID PREP team. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 Jun 1;72(11):e835-e843. doi: 10.1093/cid/ciaa1571.']",2021-07-02,https://clinicaltrials.gov/show/NCT04328467,2020-07-13,1,1
1231,NCT04328493,Completed,2020-09-10,2020-09-10,No Results Posted,"['Kestelyn E, Dung NTP, Lam Minh Y, Hung LM, Quan NM, Dung NT, Minh NNQ, Xuan TC, Phong NT, Ninh Thi Thanh V, Donovan J, Tu TNH, Nhat LTH, Truong NT, Man DNH, Thao HP, Ngoc NM, Lam VT, Phat HH, Phuong PM, Geskus RB, Ha VTN, Quang NN, Tran Tinh H, Tan LV, Thwaites GE, Day JN, Chau NVV; OUCRU COVID-19 Research Group. A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam. Wellcome Open Res. 2020 Jun 12;5:141. doi: 10.12688/wellcomeopenres.15936.1. eCollection 2020.']",,2021-05-24,https://clinicaltrials.gov/show/NCT04328493,2020-09-10,0,1
1232,NCT04334629,Recruiting,2021-05-25,2021-09-25,No Results Posted,,,2020-10-23,https://clinicaltrials.gov/show/NCT04334629,2021-05-25,0,0
1233,NCT04334850,Completed,2020-12-20,2021-06-23,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04334850,2020-12-20,0,0
1234,NCT04341610,Withdrawn,2021-01-30,2021-04-30,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04341610,2021-01-30,0,0
1235,NCT04341714,Completed,2020-05-30,2020-06-15,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04341714,2020-05-30,0,0
1236,NCT04345289,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,2020-07-31,https://clinicaltrials.gov/show/NCT04345289,2021-06-15,0,0
1237,NCT04351516,Withdrawn,2020-12-31,2021-05-01,No Results Posted,"['G√∂pel S, Bethge W, Martus P, Kreth F, Iftner T, Joos S, D√∂bele S, Mordm√ºller B, Kremsner P, Ettrich T, Seufferlein T, Bitzer M, Malek N. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 10;21(1):635. doi: 10.1186/s13063-020-04556-z.']",,2021-01-15,https://clinicaltrials.gov/show/NCT04351516,2020-12-31,0,1
1238,NCT04354428,"Active, not recruiting",2020-12-01,2021-01-01,Results Submitted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Johnston C, Brown ER, Stewart J, Karita HCS, Kissinger PJ, Dwyer J, Hosek S, Oyedele T, Paasche-Orlow MK, Paolino K, Heller KB, Leingang H, Haugen HS, Dong TQ, Bershteyn A, Sridhar AR, Poole J, Noseworthy PA, Ackerman MJ, Morrison S, Greninger AL, Huang ML, Jerome KR, Wener MH, Wald A, Schiffer JT, Celum C, Chu HY, Barnabas RV, Baeten JM; COVID-19 Early Treatment Study Team. Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine. 2021 Mar;33:100773. doi: 10.1016/j.eclinm.2021.100773. Epub 2021 Feb 27.']",,2020-11-12,https://clinicaltrials.gov/show/NCT04354428,2020-12-01,0,1
1239,NCT04359264,"Active, not recruiting",2020-05-29,2020-12-30,No Results Posted,"['Persaud N, Thorpe KE, Bedard M, Hwang SW, Pinto A, J√ºni P, da Costa BR; DISTANSE COVID-19 (Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a randomized controlled trial) study team. Cash transfer during the COVID-19 pandemic: a multicentre, randomised controlled trial. Fam Med Community Health. 2021 Dec;9(4). pii: e001452. doi: 10.1136/fmch-2021-001452.']",,2020-07-07,https://clinicaltrials.gov/show/NCT04359264,2020-05-29,0,1
1240,NCT04359693,Completed,2020-07-01,2020-07-01,No Results Posted,"['Rouz√© A, Lemaitre E, Martin-Loeches I, Povoa P, Diaz E, Nyga R, Torres A, Metzelard M, Du Cheyron D, Lambiotte F, Tamion F, Labruyere M, Boulle Geronimi C, Luyt CE, Nyunga M, Pouly O, Thille AW, Megarbane B, Saade A, Magira E, Llitjos JF, Ioannidou I, Pierre A, Reignier J, Garot D, Kreitmann L, Baudel JL, Voiriot G, Plantefeve G, Morawiec E, Asfar P, Boyer A, Mekontso-Dessap A, Makris D, Vinsonneau C, Floch PE, Marois C, Ceccato A, Artigas A, Gaudet A, Nora D, Cornu M, Duhamel A, Labreuche J, Nseir S; coVAPid study group. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study. Crit Care. 2022 Jan 4;26(1):11. doi: 10.1186/s13054-021-03874-1.', 'Nseir S, Martin-Loeches I, Povoa P, Metzelard M, Du Cheyron D, Lambiotte F, Tamion F, Labruyere M, Makris D, Boulle Geronimi C, Pinetonde Chambrun M, Nyunga M, Pouly O, M√©garbane B, Saade A, Gom√† G, Magira E, Llitjos JF, Torres A, Ioannidou I, Pierre A, Coelho L, Reignier J, Garot D, Kreitmann L, Baudel JL, Voiriot G, Contou D, Beurton A, Asfar P, Boyer A, Thille AW, Mekontso-Dessap A, Tsolaki V, Vinsonneau C, Floch PE, Le Guennec L, Ceccato A, Artigas A, Bouchereau M, Labreuche J, Duhamel A, Rouz√© A; coVAPid study group. Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort. Crit Care. 2021 May 25;25(1):177. doi: 10.1186/s13054-021-03588-4. Erratum in: Crit Care. 2021 Aug 9;25(1):284.']",,2020-07-22,https://clinicaltrials.gov/show/NCT04359693,2020-07-01,0,1
1241,NCT04362059,Recruiting,2021-07-27,2021-11-16,No Results Posted,"['Dushianthan A, Clark H, Madsen J, Mogg R, Matthews L, Berry L, de la Serna JB, Batchelor J, Brealey D, Hussell T, Porter J, Djukanovic R, Feelisch M, Postle A, Grocott MPW. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Dec 10;21(1):1014. doi: 10.1186/s13063-020-04944-5.']","['Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Ravent√≥s AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30;334(22):1417-21.', 'Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics. 1988 Nov;82(5):683-91.', 'Dushianthan A, Goss V, Cusack R, Grocott MP, Postle AD. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Respir Res. 2014 Nov 7;15:128. doi: 10.1186/s12931-014-0128-8.', 'Goss V, Hunt AN, Postle AD. Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim Biophys Acta. 2013 Feb;1831(2):448-58. doi: 10.1016/j.bbalip.2012.11.009. Epub 2012 Nov 27. Review.', 'G√ºnther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, Grimminger F, Seeger W. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J. 2002 May;19(5):797-804.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'M√∂ller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L, Reiss I, Kohl M, Demirakca S, Hentschel R, Paul T, Vierzig A, Groneck P, von Seefeld H, Schumacher H, Gortner L; Surfactant ARDS Study Group. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003 Mar;29(3):437-46. Epub 2003 Feb 15.', 'Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol. 1999 Jan;20(1):90-8.', 'Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. doi: 10.1016/j.bbrc.2020.03.044. Epub 2020 Mar 19.', 'Rebello CM, Jobe AH, Eisele JW, Ikegami M. Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):625-8.', 'Rodr√≠guez-Capote K, Manzanares D, Haines T, Possmayer F. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J. 2006 Apr 15;90(8):2808-21. Epub 2006 Jan 27.', 'Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res. 2007 Jul 27;8:55.', 'Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641-9. Review.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.']",2020-09-09,https://clinicaltrials.gov/show/NCT04362059,2021-07-27,0,1
1242,NCT04362150,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04362150,2022-12-31,0,0
1243,NCT04364594,Completed,2020-04-24,2020-05-30,No Results Posted,,,2020-07-23,https://clinicaltrials.gov/show/NCT04364594,2020-04-24,0,0
1244,NCT04366115,Not yet recruiting,2024-12-01,2025-03-01,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04366115,2024-12-01,0,0
1245,NCT04366141,Completed,2021-02-01,2021-02-01,Results Submitted,"['Jen TTH, Gusti V, Badh C, Mehta S, Denomme J, Lockhart S, Shams B, Klaibert B, Chau A. The impact of a barrier enclosure on time to tracheal intubation: a randomized controlled trial. Can J Anaesth. 2021 Sep;68(9):1358-1367. doi: 10.1007/s12630-021-02024-z. Epub 2021 May 10.']",,2021-02-24,https://clinicaltrials.gov/show/NCT04366141,2021-02-01,0,1
1246,NCT04367337,Completed,2020-09-24,2020-09-24,No Results Posted,"['Szczuka Z, Abraham C, Baban A, Brooks S, Cipolletta S, Danso E, Dombrowski SU, Gan Y, Gaspar T, de Matos MG, Griva K, Jongenelis M, Keller J, Knoll N, Ma J, Miah MAA, Morgan K, Peraud W, Quintard B, Shah V, Schenkel K, Scholz U, Schwarzer R, Siwa M, Szymanski K, Taut D, Tomaino SCM, Vilchinsky N, Wolf H, Luszczynska A. The trajectory of COVID-19 pandemic and handwashing adherence: findings from 14 countries. BMC Public Health. 2021 Oct 5;21(1):1791. doi: 10.1186/s12889-021-11822-5.']",,2021-08-10,https://clinicaltrials.gov/show/NCT04367337,2020-09-24,0,1
1247,NCT04368988,"Active, not recruiting",2022-05-21,2022-05-21,No Results Posted,"['Formica N, Mallory R, Albert G, Robinson M, Plested JS, Cho I, Robertson A, Dubovsky F, Glenn GM; 2019nCoV-101 Study Group. Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Med. 2021 Oct 1;18(10):e1003769. doi: 10.1371/journal.pmed.1003769. eCollection 2021 Oct.', 'Tian JH, Patel N, Haupt R, Zhou H, Weston S, Hammond H, Logue J, Portnoff AD, Norton J, Guebre-Xabier M, Zhou B, Jacobson K, Maciejewski S, Khatoon R, Wisniewska M, Moffitt W, Kluepfel-Stahl S, Ekechukwu B, Papin J, Boddapati S, Jason Wong C, Piedra PA, Frieman MB, Massare MJ, Fries L, Bengtsson KL, Stertman L, Ellingsworth L, Glenn G, Smith G. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun. 2021 Jan 14;12(1):372. doi: 10.1038/s41467-020-20653-8.', 'Guebre-Xabier M, Patel N, Tian JH, Zhou B, Maciejewski S, Lam K, Portnoff AD, Massare MJ, Frieman MB, Piedra PA, Ellingsworth L, Glenn G, Smith G. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine. 2020 Nov 25;38(50):7892-7896. doi: 10.1016/j.vaccine.2020.10.064. Epub 2020 Oct 23.', 'Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, Plested JS, Zhu M, Cloney-Clark S, Zhou H, Smith G, Patel N, Frieman MB, Haupt RE, Logue J, McGrath M, Weston S, Piedra PA, Desai C, Callahan K, Lewis M, Price-Abbott P, Formica N, Shinde V, Fries L, Lickliter JD, Griffin P, Wilkinson B, Glenn GM. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med. 2020 Dec 10;383(24):2320-2332. doi: 10.1056/NEJMoa2026920. Epub 2020 Sep 2.']",,2021-12-06,https://clinicaltrials.gov/show/NCT04368988,2022-05-21,0,1
1248,NCT04373200,Recruiting,2022-09-25,2022-09-25,No Results Posted,"['Hamzeh-Cognasse H, Mansour A, Reizine F, Mismetti P, Gouin-Thibault I, Cognasse F. Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection. Virol J. 2021 Oct 29;18(1):211. doi: 10.1186/s12985-021-01680-3.']",,2021-06-29,https://clinicaltrials.gov/show/NCT04373200,2022-09-25,0,1
1249,NCT04374526,Completed,2021-05-26,2021-05-26,No Results Posted,"['Teofili L, Landolfi R, Cingolani A, Antinori A, Vecchiet J, Sanguinetti M, Gasbarrini A, Pasciuto T, Orlando N, Lamonica S. ""Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial"". Trials. 2020 Oct 22;21(1):875. doi: 10.1186/s13063-020-04821-1.']",,2021-05-28,https://clinicaltrials.gov/show/NCT04374526,2021-05-26,0,1
1250,NCT04376879,Completed,2021-05-31,2021-05-31,No Results Posted,,,2021-09-10,https://clinicaltrials.gov/show/NCT04376879,2021-05-31,0,0
1251,NCT04377659,"Active, not recruiting",2023-05-01,2023-05-01,No Results Posted,,,2022-01-24,https://clinicaltrials.gov/show/NCT04377659,2023-05-01,0,0
1252,NCT04378582,Completed,2020-07-28,2020-08-05,No Results Posted,"['Ferreira JC, Ho YL, Besen BAMP, Malbuisson LMS, Taniguchi LU, Mendes PV, Costa ELV, Park M, Daltro-Oliveira R, Roepke RML, Silva JM Jr, Carmona MJC, Carvalho CRR; EPICCoV Study Group, Hirota A, Kanasiro AK, Crescenzi A, Fernandes AC, Miethke-Morais A, Bellintani AP, Canasiro AR, Carneiro BV, Zanbon BK, Batista BPSN, Nicolao BR, Besen BAMP, Biselli B, Macedo BR, Toledo CMG, Pompilio CE, Carvalho CRR, Mol CG, Stipanich C, Bueno CG, Garzillo C, Tanaka C, Forte DN, Joelsons D, Robira D, Costa ELV, Silva EM J√∫nior, Regalio FA, Segura GC, Marcelino GB, Louro GS, Ho YL, Ferreira IA, Gois JO, Silva JM Junior, Reusing JO Junior, Ribeiro JF, Ferreira JC, Galleti KV, Silva KR, Isensee LP, Oliveira LS, Taniguchi LU, Letaif LS, Lima LT, Park LY, Chaves L Netto, Nobrega LC, Haddad L, Hajjar L, Malbouisson LM, Pandolfi MCA, Park M, Carmona MJC, Andrade MCPH, Santos MM, Bateloche MP, Suiama MA, Oliveira MF, Sousa ML, Louvaes M, Huemer N, Mendes P, Lins PRG, Santos PG, Moreira PFP, Guazzelli RM, Reis RB, Oliveira RD, Roepke RML, Pedro RAM, Kondo R, Rached SZ, Fonseca SRS, Borges TS, Ferreira T, Cobello V Junior, Sales VVT, Ferreira WSC. Characteristics and outcomes of patients with COVID-19 admitted to the ICU in a university hospital in S√£o Paulo, Brazil - study protocol. Clinics (Sao Paulo). 2020;75:e2294. doi: 10.6061/clinics/2020/e2294. Epub 2020 Aug 26.']",,2020-08-26,https://clinicaltrials.gov/show/NCT04378582,2020-07-28,0,1
1253,NCT04378803,Completed,2020-08-04,2020-08-04,No Results Posted,,,2020-08-17,https://clinicaltrials.gov/show/NCT04378803,2020-08-04,0,0
1254,NCT04378842,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04378842,2021-05-01,0,0
1255,NCT04379063,"Active, not recruiting",2020-09-28,2022-09-28,No Results Posted,"['Bailey JG, Wong M, Bailey K, Banfield JC, Barry G, Munro A, Kirkland S, Leiter M. Pandemic-related factors predicting physician burnout beyond established organizational factors: cross-sectional results from the COPING survey. Psychol Health Med. 2021 Oct 14:1-15. doi: 10.1080/13548506.2021.1990366. [Epub ahead of print]']",,2022-01-06,https://clinicaltrials.gov/show/NCT04379063,2020-09-28,0,1
1256,NCT04382417,Completed,2020-11-12,2020-11-12,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04382417,2020-11-12,0,0
1257,NCT04382547,Completed,2021-06-30,2021-06-30,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04382547,2021-06-30,0,0
1258,NCT04384497,Completed,2020-06-01,2020-12-01,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04384497,2020-06-01,0,0
1259,NCT04385004,Recruiting,2020-07-01,2020-07-01,No Results Posted,"['Beloncle F, Studer A, Seegers V, Richard JC, Desprez C, Fage N, Merdji H, Pavlovsky B, Helms J, Cunat S, Mortaza S, Demiselle J, Brochard L, Mercat A, Meziani F. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome. Crit Care. 2021 Jul 15;25(1):248. doi: 10.1186/s13054-021-03665-8.']",,2020-05-28,https://clinicaltrials.gov/show/NCT04385004,2020-07-01,0,1
1260,NCT04386291,"Active, not recruiting",2021-04-19,2022-01-30,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04386291,2021-04-19,0,0
1261,NCT04386720,Recruiting,2022-05-25,2022-05-25,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04386720,2022-05-25,0,0
1262,NCT04387890,Not yet recruiting,2020-08-31,2020-08-31,No Results Posted,,"['The Lancet. COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9.', 'Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13. Review.', 'Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Chisty Z, Bell JM, Methner M, Harney J, Jacobs JR, Carlson CM, McLaughlin HP, Stone N, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Russell D, Hiatt B, Gant J, Duchin JS, Clark TA, Honein MA, Reddy SC, Jernigan JA; Public Health - Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):377-381. doi: 10.15585/mmwr.mm6913e1.', 'Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020 Apr 1;66(4):549-555. doi: 10.1093/clinchem/hvaa029.', 'Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, Gao G, Wang S, Ma C, Xie R, Wang F, Tan C, Zhu L, Guo Y, Zhang F. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients. Clin Infect Dis. 2020 Jul 28;71(15):793-798. doi: 10.1093/cid/ciaa345.', 'Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. Polymerase Chain Reaction Assays Reverted to Positive in 25 Discharged Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2230-2232. doi: 10.1093/cid/ciaa398.', 'Li Y, Yao L, Li J, Chen L, Song Y, Cai Z, Yang C. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020 Jul;92(7):903-908. doi: 10.1002/jmv.25786. Epub 2020 Apr 5.', 'Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180. Erratum in: Euro Surveill. 2020 Jun;25(22):.', 'Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.', ""Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall. 2017 Jan 10;1(1):33-46. doi: 10.1002/gch2.1018. eCollection 2017 Jan."", 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y, Wang J, Hu Z, Yi Y, Shen H. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020 May;63(5):706-711. doi: 10.1007/s11427-020-1661-4. Epub 2020 Mar 4.', 'Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.', 'Guo L, Ren L, Yang S, Xiao M, Chang, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang QW, Xu SY, Zhu HD, Xu YC, Jin Q, Sharma L, Wang L, Wang J. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.']",2020-05-28,https://clinicaltrials.gov/show/NCT04387890,2020-08-31,0,1
1263,NCT04388527,Completed,2021-01-25,2021-01-30,Results Submitted,,,2021-06-10,https://clinicaltrials.gov/show/NCT04388527,2021-01-25,0,0
1264,NCT04393324,Recruiting,2020-05-31,2020-06-30,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04393324,2020-05-31,0,0
1265,NCT04394104,Terminated,2020-05-31,2020-05-31,No Results Posted,,,2020-12-07,https://clinicaltrials.gov/show/NCT04394104,2020-05-31,0,0
1266,NCT04395391,Completed,2020-05-21,2020-06-16,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04395391,2020-05-21,0,0
1267,NCT04397692,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04397692,2020-09-30,0,0
1268,NCT04400448,Not yet recruiting,2020-08-31,2020-10-31,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04400448,2020-08-31,0,0
1269,NCT04401046,Completed,2020-11-26,2021-02-02,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04401046,2020-11-26,0,0
1270,NCT04402892,Not yet recruiting,2021-03-01,2021-03-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04402892,2021-03-01,0,0
1271,NCT04402905,Completed,2020-07-15,2020-08-15,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04402905,2020-07-15,0,0
1272,NCT04402918,Completed,2020-05-19,2021-08-02,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04402918,2020-05-19,0,0
1273,NCT04403061,Completed,2020-12-22,2021-01-10,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04403061,2020-12-22,0,0
1274,NCT04403243,Recruiting,2020-07-22,2020-08-23,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2020-05-27,https://clinicaltrials.gov/show/NCT04403243,2020-07-22,0,1
1275,NCT04403646,Terminated,2020-10-20,2020-11-01,No Results Posted,"['Molino S, Pisarevsky A, Mingorance FL, Vega P, Stefanolo JP, Repetti J, Ludue√±a G, Pepa P, Olmos JI, Fermepin MR, Uehara T, Villapol S, Savidge T, Treangen T, Viciani E, Castagnetti A, Piskorz MM. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Apr 28;22(1):310. doi: 10.1186/s13063-021-05281-x.']",,2020-12-22,https://clinicaltrials.gov/show/NCT04403646,2020-10-20,0,1
1276,NCT04403672,Recruiting,2020-07-24,2020-07-24,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04403672,2020-07-24,0,0
1277,NCT04403685,Terminated,2020-07-08,2020-07-21,No Results Posted,"['Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, Machado FR, Lopes RD, Berwanger O, Azevedo LCP, Avezum √Å, Lisboa TC, Rojas SSO, Coelho JC, Leite RT, Carvalho JC, Andrade LEC, Sandes AF, Pint√£o MCT, Castro CG Jr, Santos SV, de Almeida TML, Costa AN, Gebara OCE, de Freitas FGR, Pacheco ES, Machado DJB, Martin J, Concei√ß√£o FG, Siqueira SRR, Damiani LP, Ishihara LM, Schneider D, de Souza D, Cavalcanti AB, Scheinberg P; Coalition covid-19 Brazil VI Investigators. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 Jan 20;372:n84. doi: 10.1136/bmj.n84.']",,2020-08-26,https://clinicaltrials.gov/show/NCT04403685,2020-07-08,0,1
1278,NCT04404062,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04404062,2021-12-01,0,0
1279,NCT04404179,Completed,2020-05-02,2020-05-02,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04404179,2020-05-02,0,0
1280,NCT04404244,Recruiting,2022-01-01,2022-06-01,No Results Posted,,"['Ebeid FSE, Ragab IA, Elsherif NHK, Makkeyah S, Mostafa S, Eltonbary K, Matbouly S, Mostafa A, Goma H, Agwa SH, Hafez HM, Girgis S, El Gendy YG, El-Sayed MH. COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience. J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1077-e1081. doi: 10.1097/MPH.0000000000002025.']",2021-04-20,https://clinicaltrials.gov/show/NCT04404244,2022-01-01,0,1
1281,NCT04404426,Completed,2021-03-25,2021-05-28,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04404426,2021-03-25,0,0
1282,NCT04405102,Recruiting,2023-01-01,2024-01-01,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04405102,2023-01-01,0,0
1283,NCT04405271,Not yet recruiting,2020-11-15,2020-11-15,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04405271,2020-11-15,0,0
1284,NCT04405310,Completed,2020-11-20,2020-12-10,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04405310,2020-11-20,0,0
1285,NCT04405362,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04405362,2021-05-01,0,0
1286,NCT04405492,Not yet recruiting,2021-03-25,2021-03-25,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04405492,2021-03-25,0,0
1287,NCT04405843,Completed,2020-12-21,2020-12-21,No Results Posted,"['L√≥pez-Medina E, L√≥pez P, Hurtado IC, D√°valos DM, Ramirez O, Mart√≠nez E, D√≠azgranados JA, O√±ate JM, Chavarriaga H, Herrera S, Parra B, Libreros G, Jaramillo R, Avenda√±o AC, Toro DF, Torres M, Lesmes MC, Rios CA, Caicedo I. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.']",,2020-12-28,https://clinicaltrials.gov/show/NCT04405843,2020-12-21,0,1
1288,NCT04405869,Recruiting,2021-04-01,2021-04-01,No Results Posted,"['Tacquard C, Mansour A, Godon A, Godet J, Poissy J, Garrigue D, Kipnis E, Rym Hamada S, Mertes PM, Steib A, Ulliel-Roche M, Bouhemad B, Nguyen M, Reizine F, Gouin-Thibault I, Besse MC, Collercandy N, Mankikian S, Levy JH, Gruel Y, Albaladejo P, Susen S, Godier A; French Working Group on Perioperative Hemostasis. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia. Chest. 2021 Jun;159(6):2417-2427. doi: 10.1016/j.chest.2021.01.017. Epub 2021 Jan 16.']",,2020-05-29,https://clinicaltrials.gov/show/NCT04405869,2021-04-01,0,1
1289,NCT04405999,Completed,2020-08-09,2020-08-31,Results Submitted,"['Mikhaylov EN, Lyubimtseva TA, Vakhrushev AD, Stepanov D, Lebedev DS, Vasilieva EY, Konradi AO, Shlyakhto EV. Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study. Interdiscip Perspect Infect Dis. 2022 Jan 29;2022:4693121. doi: 10.1155/2022/4693121. eCollection 2022.']",,2020-09-03,https://clinicaltrials.gov/show/NCT04405999,2020-08-09,0,1
1290,NCT04406038,"Active, not recruiting",2021-10-28,2021-10-28,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04406038,2021-10-28,0,0
1291,NCT04406064,Withdrawn,2024-06-01,2025-06-01,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04406064,2024-06-01,0,0
1292,NCT04406090,Completed,2020-06-30,2020-06-30,No Results Posted,"['Cagnazzo F, Piotin M, Escalard S, Maier B, Ribo M, Requena M, Pop R, Hasiu A, Gasparotti R, Mardighian D, Piano M, Cervo A, Eker OF, Durous V, Sourour NA, Elhorany M, Zini A, Simonetti L, Marcheselli S, Paolo NN, Houdart E, Gu√©don A, Ligot N, Mine B, Consoli A, Lapergue B, Cordona Portela P, Urra X, Rodriguez A, Bolognini F, Lebedinsky PA, Pasco-Papon A, Godard S, Marnat G, Sibon I, Limbucci N, Nencini P, Nappini S, Saia V, Caldiera V, Romano D, Frauenfelder G, Gallesio I, Gola G, Menozzi R, Genovese A, Terrana A, Giorgianni A, Cappellari M, Augelli R, Invernizzi P, Pavia M, Lafe E, Cavallini A, Giossi A, Besana M, Valvassori L, Macera A, Castellan L, Salsano G, Di Caterino F, Biondi A, Arquizan C, Lebreuche J, Galvano G, Cannella A, Cosottini M, Lazzarotti G, Guizzardi G, Stecco A, Tassi R, Bracco S, Bianchini E, Micieli C, Pascarella R, Napoli M, Causin F, Desal H, Cotton F, Costalat V; ET-COVID-19 Study Group*. European Multicenter Study of ET-COVID-19. Stroke. 2021 Jan;52(1):31-39. doi: 10.1161/STROKEAHA.120.031514. Epub 2020 Nov 23.']",,2020-07-29,https://clinicaltrials.gov/show/NCT04406090,2020-06-30,0,1
1293,NCT04406233,Recruiting,2022-05-23,2022-05-23,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04406233,2022-05-23,0,0
1294,NCT04406246,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04406246,2020-12-31,0,0
1295,NCT04406324,Recruiting,2021-03-05,2026-03-05,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04406324,2021-03-05,0,0
1296,NCT04406389,Recruiting,2022-06-01,2022-12-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-08-02,https://clinicaltrials.gov/show/NCT04406389,2022-06-01,0,1
1297,NCT04406493,Recruiting,2021-04-28,2021-04-28,No Results Posted,,,2020-05-28,https://clinicaltrials.gov/show/NCT04406493,2021-04-28,0,0
1298,NCT04406532,Withdrawn,2022-01-01,2022-03-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04406532,2022-01-01,0,0
1299,NCT04406571,Recruiting,2021-11-01,2022-04-01,No Results Posted,"[""Brugel M, Letrillart L, Evrard C, Thierry A, Tougeron D, El Amrani M, Piessen G, Truant S, Turpin A, d'Engremont C, Roth G, Hautefeuille V, Regimbeau JM, Williet N, Schwarz L, Di Fiore F, Borg C, Doussot A, Lambert A, Moulin V, Trelohan H, Bolliet M, Topolscki A, Ayav A, Lopez A, Botsen D, Piardi T, Carlier C, Bouch√© O. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID). Eur J Cancer. 2022 Feb 10;166:8-20. doi: 10.1016/j.ejca.2022.01.040. [Epub ahead of print]""]",,2020-05-28,https://clinicaltrials.gov/show/NCT04406571,2021-11-01,0,1
1300,NCT04406688,Recruiting,2021-02-01,2021-03-01,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04406688,2021-02-01,0,0
1301,NCT04406844,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04406844,2021-06-30,0,0
1302,NCT04407221,Enrolling by invitation,2024-05-01,2024-05-01,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04407221,2024-05-01,0,0
1303,NCT04407273,Completed,2020-08-20,2020-12-30,No Results Posted,,"['Masana L, Correig E, Rodr√≠guez-Borjabad C, Anoro E, Arroyo JA, Jeric√≥ C, Pedragosa A, Miret M, N√§f S, Pardo A, Perea V, P√©rez-Bernalte R, Plana N, Ram√≠rez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):157-164. doi: 10.1093/ehjcvp/pvaa128.']",2021-03-11,https://clinicaltrials.gov/show/NCT04407273,2020-08-20,0,1
1304,NCT04407286,Completed,2020-08-30,2020-11-30,No Results Posted,,,2021-12-30,https://clinicaltrials.gov/show/NCT04407286,2020-08-30,0,0
1305,NCT04407299,Completed,2020-05-10,2020-05-20,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04407299,2020-05-10,0,0
1306,NCT04407429,Recruiting,2021-06-27,2021-06-27,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04407429,2021-06-27,0,0
1307,NCT04407468,Completed,2020-07-13,2020-07-13,No Results Posted,"['Perez-Nieto OR, Escarraman-Martinez D, Guerrero-Gutierrez MA, Zamarron-Lopez EI, Mancilla-Galindo J, Kammar-Garc√≠a A, Martinez-Camacho MA, Deloya-Tom√°s E, Sanchez-D√≠az JS, Mac√≠as-Garc√≠a LA, Soriano-Orozco R, Cruz-S√°nchez G, Salmeron-Gonzalez JD, Toledo-Rivera MA, Mata-Maqueda I, Morgado-Villase√±or LA, Martinez-Mazariegos JJ, Flores Ramirez R, Medina-Estrada JL, √ëamendys-Silva SA; APRONOX Group. Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study. Eur Respir J. 2022 Feb 24;59(2). pii: 2100265. doi: 10.1183/13993003.00265-2021. Print 2022 Feb.']","['Valter C, Christensen AM, Tollund C, Sch√∏nemann NK. Response to the prone position in spontaneously breathing patients with hypoxemic respiratory failure. Acta Anaesthesiol Scand. 2003 Apr;47(4):416-8.', 'Scaravilli V, Grasselli G, Castagna L, Zanella A, Isgr√≤ S, Lucchini A, Patroniti N, Bellani G, Pesenti A. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study. J Crit Care. 2015 Dec;30(6):1390-4. doi: 10.1016/j.jcrc.2015.07.008. Epub 2015 Jul 16.', 'Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. 2020 Jan 30;24(1):28. doi: 10.1186/s13054-020-2738-5.', 'P√©rez-Nieto OR, Guerrero-Guti√©rrez MA, Deloya-Tomas E, √ëamendys-Silva SA. Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit Care. 2020 Mar 23;24(1):114. doi: 10.1186/s13054-020-2821-y.', 'Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020 Mar 18;10(1):33. doi: 10.1186/s13613-020-00650-2.', ""Caputo ND, Strayer RJ, Levitan R. Early Self-Proning in Awake, Non-intubated Patients in the Emergency Department: A Single ED's Experience During the COVID-19 Pandemic. Acad Emerg Med. 2020 May;27(5):375-378. doi: 10.1111/acem.13994."", 'Slessarev M, Cheng J, Ondrejicka M, Arntfield R; Critical Care Western Research Group. Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia. Can J Anaesth. 2020 Sep;67(9):1288-1290. doi: 10.1007/s12630-020-01661-0. Epub 2020 Apr 21.', 'Lomoro P, Verde F, Zerboni F, Simonetti I, Borghi C, Fachinetti C, Natalizi A, Martegani A. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review. Eur J Radiol Open. 2020;7:100231. doi: 10.1016/j.ejro.2020.100231. Epub 2020 Apr 4.', 'Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.']",2020-07-15,https://clinicaltrials.gov/show/NCT04407468,2020-07-13,0,1
1308,NCT04407507,Completed,2021-01-29,2021-01-29,Study Results,,"['Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.', 'Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J. 2013 May 7;12:153. doi: 10.1186/1475-2875-12-153.', ""Smit MR, Ochomo E, Aljayyoussi G, Kwambai T, Abong'o B, Bayoh N, Gimnig J, Samuels A, Desai M, Phillips-Howard PA, Kariuki S, Wang D, Ward S, Ter Kuile FO. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya. JMIR Res Protoc. 2016 Nov 17;5(4):e213."", 'Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020 May;94:119-124. doi: 10.1016/j.ijid.2020.03.071. Epub 2020 Apr 1. Review.', 'Yang SNY, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, Borg NA, Jans DA. The broad spectrum antiviral ivermectin targets the host nuclear transport importin Œ±/Œ≤1 heterodimer. Antiviral Res. 2020 May;177:104760. doi: 10.1016/j.antiviral.2020.104760. Epub 2020 Mar 3.']",2021-05-21,https://clinicaltrials.gov/show/NCT04407507,2021-01-29,1,1
1309,NCT04407533,"Active, not recruiting",2022-08-31,2022-08-31,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04407533,2022-08-31,0,0
1310,NCT04407598,"Active, not recruiting",2020-06-08,2021-06-01,Results Submitted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04407598,2020-06-08,0,0
1311,NCT04408014,Not yet recruiting,2020-07-15,2020-07-30,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04408014,2020-07-15,0,0
1312,NCT04408027,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04408027,2022-06-01,0,0
1313,NCT04408040,Terminated,2021-09-14,2021-09-14,Results Submitted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04408040,2021-09-14,0,0
1314,NCT04408222,Completed,2021-04-16,2022-03-06,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04408222,2021-04-16,0,0
1315,NCT04408235,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2020-05-29,https://clinicaltrials.gov/show/NCT04408235,2021-06-01,0,1
1316,NCT04408365,Recruiting,2022-07-31,2022-12-31,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04408365,2022-07-31,0,0
1317,NCT04408391,Withdrawn,2020-07-06,2020-07-06,No Results Posted,,,2020-08-05,https://clinicaltrials.gov/show/NCT04408391,2020-07-06,0,0
1318,NCT04283461,"Active, not recruiting",2022-11-22,2022-11-22,No Results Posted,"['Jochum S, Kirste I, Hortsch S, Grunert VP, Legault H, Eichenlaub U, Kashlan B, Pajon R. Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial. Front Immunol. 2022 Jan 19;12:798117. doi: 10.3389/fimmu.2021.798117. eCollection 2021.', 'Garrett ME, Galloway JG, Wolf C, Logue JK, Franko N, Chu HY, Matsen FA 4th, Overbaugh JM. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Elife. 2022 Jan 24;11. pii: e73490. doi: 10.7554/eLife.73490.', 'Jochum S, Kirste I, Hortsch S, Grunert VP, Legault H, Eichenlaub U, Kashlan B, Pajon R. Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial. medRxiv. 2021 Oct 19. pii: 2021.10.04.21264521. doi: 10.1101/2021.10.04.21264521. Update in: Front Immunol. 2022 Jan 19;12:798117.', 'Mendes BB, Sousa DP, Conniot J, Conde J. Nanomedicine-based strategies to target and modulate the tumor microenvironment. Trends Cancer. 2021 Sep;7(9):847-862. doi: 10.1016/j.trecan.2021.05.001. Epub 2021 Jun 3. Review.', ""Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott AB, Flach B, Lin BC, Doria-Rose NA, O'Dell S, Schmidt SD, Corbett KS, Swanson PA 2nd, Padilla M, Neuzil KM, Bennett H, Leav B, Makowski M, Albert J, Cross K, Edara VV, Floyd K, Suthar MS, Martinez DR, Baric R, Buchanan W, Luke CJ, Phadke VK, Rostad CA, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020 Dec 17;383(25):2427-2438. doi: 10.1056/NEJMoa2028436. Epub 2020 Sep 29."", ""Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.""]",,2022-02-11,https://clinicaltrials.gov/show/NCT04283461,2022-11-22,0,1
1319,NCT04292730,Completed,2020-04-29,2020-06-26,Study Results,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.']","['Spinner CD, Gottlieb RL, Criner GJ, Arribas L√≥pez JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.']",2021-01-26,https://clinicaltrials.gov/show/NCT04292730,2020-04-29,1,1
1320,NCT04292899,Completed,2020-04-09,2020-06-30,Study Results,"['Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, Singh U, Jagannathan P, Grant P. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021 Aug 2;73(3):e826-e829. doi: 10.1093/cid/ciab103.', 'Olender SA, Perez KK, Go AS, Balani B, Price-Haywood EG, Shah NS, Wang S, Walunas TL, Swaminathan S, Slim J, Chin B, De Wit S, Ali SM, Soriano Viladomiu A, Robinson P, Gottlieb RL, Tsang TYO, Lee IH, Hu H, Haubrich RH, Chokkalingam AP, Lin L, Zhong L, Bekele BN, Mera-Giler R, Phulpin C, Edgar H, Gallant J, Diaz-Cuervo H, Smith LE, Osinusi AO, Brainard DM, Bernardino JI; GS-US-540-5773 and GS-US-540-5807 Investigators. Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care. Clin Infect Dis. 2021 Dec 6;73(11):e4166-e4174. doi: 10.1093/cid/ciaa1041.']",,2020-12-31,https://clinicaltrials.gov/show/NCT04292899,2020-04-09,1,1
1321,NCT04320615,Completed,2020-06-24,2020-07-28,Study Results,"['Tom J, Bao M, Tsai L, Qamra A, Summers D, Carrasco-Triguero M, McBride J, Rosenberger CM, Lin CJF, Stubbings W, Blyth KG, Carratal√† J, Fran√ßois B, Benfield T, Haslem D, Bonfanti P, van der Leest CH, Rohatgi N, Wiese L, Luyt CE, Kheradmand F, Rosas IO, Cai F. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial. Crit Care Med. 2022 Mar 1;50(3):398-409. doi: 10.1097/CCM.0000000000005229.', 'Rosas IO, Br√§u N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.']",,2021-06-30,https://clinicaltrials.gov/show/NCT04320615,2020-06-24,1,1
1322,NCT04322123,"Active, not recruiting",2020-08-30,2021-08-30,No Results Posted,"['Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, Damiani LP, Marcadenti A, Kawano-Dourado L, Lisboa T, Junqueira DLM, de Barros E Silva PGM, Tramujas L, Abreu-Silva EO, Laranjeira LN, Soares AT, Echenique LS, Pereira AJ, Freitas FGR, Gebara OCE, Dantas VCS, Furtado RHM, Milan EP, Golin NA, Cardoso FF, Maia IS, Hoffmann Filho CR, Kormann APM, Amazonas RB, Bocchi de Oliveira MF, Serpa-Neto A, Falavigna M, Lopes RD, Machado FR, Berwanger O; Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23. Erratum in: N Engl J Med. 2020 Nov 19;383(21):e119.']",,2021-04-19,https://clinicaltrials.gov/show/NCT04322123,2020-08-30,0,1
1323,NCT04322188,Completed,2020-05-08,2020-05-08,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04322188,2020-05-08,0,0
1324,NCT04323228,Recruiting,2020-12-01,2020-12-30,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04323228,2020-12-01,0,0
1325,NCT04329832,"Active, not recruiting",2020-12-18,2021-12-31,Results Submitted,"['Brown SM, Peltan I, Kumar N, Leither L, Webb BJ, Starr N, Grissom CK, Buckel WR, Srivastava R, Butler AM, Groat D, Haaland B, Ying J, Harris E, Johnson S, Paine R 3rd, Greene T. Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with COVID-19 (HAHPS): Results of a Randomized, Active Comparator Trial. Ann Am Thorac Soc. 2020 Nov 9. doi: 10.1513/AnnalsATS.202008-940OC. [Epub ahead of print]', 'Brown SM, Peltan ID, Webb B, Kumar N, Starr N, Grissom C, Buckel WR, Srivastava R, Harris ES, Leither LM, Johnson SA, Paine R 3rd, Greene T. Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial. Ann Am Thorac Soc. 2020 Aug;17(8):1008-1015. doi: 10.1513/AnnalsATS.202004-309SD.']",,2020-09-02,https://clinicaltrials.gov/show/NCT04329832,2020-12-18,0,1
1326,NCT04334967,Suspended,2021-05-27,2022-05-27,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04334967,2021-05-27,0,0
1327,NCT04335747,Terminated,2021-07-01,2021-07-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04335747,2021-07-01,0,0
1328,NCT04336345,Completed,2020-04-30,2020-06-04,No Results Posted,"['√ëamendys-Silva SA, Alvarado-√Åvila PE, Dom√≠nguez-Cherit G, Rivero-Sigarroa E, S√°nchez-Hurtado LA, Guti√©rrez-Villase√±or A, Romero-Gonz√°lez JP, Rodr√≠guez-Bautista H, Garc√≠a-Briones A, Garnica-Camacho CE, Cruz-Ruiz NG, Gonz√°lez-Herrera MO, Garc√≠a-Guill√©n FJ, Guerrero-Guti√©rrez MA, Salmer√≥n-Gonz√°lez JD, Romero-Guti√©rrez L, Canto-Castro JL, Cervantes VH; Mexico COVID-19 Critical Care Collaborative Group. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study. Heart Lung. 2021 Jan - Feb;50(1):28-32. doi: 10.1016/j.hrtlng.2020.10.013. Epub 2020 Oct 21.']","['√ëamendys-Silva SA, Alvarado-√Åvila PE, Dom√≠nguez-Cherit G, et al. Outcomes of patients with COVID-19 in the intensive care unit in Mexico: A multicenter observational study [published online ahead of print, 2020 Oct 21]. Heart Lung. 2020;S0147-9563(20)30412-X. doi:10.1016/j.hrtlng.2020.10.013']",2020-11-10,https://clinicaltrials.gov/show/NCT04336345,2020-04-30,0,1
1329,NCT04337788,Not yet recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04337788,2020-07-01,0,0
1330,NCT04344509,Not yet recruiting,2020-09-01,2020-12-01,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04344509,2020-09-01,0,0
1331,NCT04344600,Terminated,2021-09-24,2021-09-24,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,2021-09-30,https://clinicaltrials.gov/show/NCT04344600,2021-09-24,0,1
1332,NCT04344951,Terminated,2020-11-30,2020-11-30,No Results Posted,,"['Arabi YM, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Mar 18;:.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.']",2021-09-23,https://clinicaltrials.gov/show/NCT04344951,2020-11-30,0,1
1333,NCT04347278,Recruiting,2021-10-15,2022-01-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04347278,2021-10-15,0,0
1334,NCT04348214,Completed,2020-10-01,2020-12-01,No Results Posted,,"['Mostafa A, Kandil S, El-Sayed MH, Girgis S, Hafez H, Yosef M, Saber S, Ezzelarab H, Ramadan M, Algohary E, Fahmy G, Afifi I, Hassan F, Elsayed S, Reda A, Fattuh D, Mahmoud A, Mansour A, Sabry M, Habeb P, Ebeid FS, Elanwar A, Saleh A, Mansour O, Omar A, El-Meteini M. SARS-CoV-2 seroconversion among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective cohort study. Int J Infect Dis. 2021 Mar;104:534-542. doi: 10.1016/j.ijid.2021.01.037. Epub 2021 Jan 20.', 'Mostafa A, Kandil S, El-Sayed MH, Girgis S, Hafez H, Yosef M, Saber S, Ezzelarab H, Ramadan M, Afifi I, Hassan F, Elsayed S, Reda A, Fattuh D, Mahmoud A, Mansour A, Sabry M, Habeb P, Ebeid FS, Saleh A, Mansour O, Omar A, El-Meteini M. Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers. Int J Epidemiol. 2021 Mar 3;50(1):50-61. doi: 10.1093/ije/dyaa173.']",2021-04-20,https://clinicaltrials.gov/show/NCT04348214,2020-10-01,0,1
1335,NCT04348513,Terminated,2021-04-19,2021-04-19,No Results Posted,"['Pantos C, Apostolaki V, Kokkinos L, Trikas A, Mourouzis I. Acute triiodothyronine treatment and red blood cell sedimentation rate (ESR) in critically ill COVID-19 patients: A novel association? Clin Hemorheol Microcirc. 2021;79(3):485-488. doi: 10.3233/CH-211215.', 'Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 26;21(1):573. doi: 10.1186/s13063-020-04474-0.']",,2021-09-23,https://clinicaltrials.gov/show/NCT04348513,2021-04-19,0,1
1336,NCT04351243,Completed,2020-12-01,2021-04-01,Study Results,"['Criner GJ, Lang FM, Gottlieb RL, Mathews KS, Wang TS, Rice TW, Madduri D, Bellam S, Jeanfreau R, Case AH, Glassberg MK, Lyon GM, Ahmad K, Mendelson R, DiMaio JM, Tran MP, Spak CW, Abbasi JA, Davis SG, Ghamande S, Shen S, Sherman L, Lowry S. Anti-GM-CSF Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Trial. Am J Respir Crit Care Med. 2022 Mar 15. doi: 10.1164/rccm.202108-1859OC. [Epub ahead of print]']",,2021-12-14,https://clinicaltrials.gov/show/NCT04351243,2020-12-01,1,1
1337,NCT04355364,Terminated,2021-12-20,2021-12-20,No Results Posted,"['Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, Lambiotte F, Le Tacon S, Cantier M, Engrand N, Trouiller P, Pottecher J. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 19;21(1):548. doi: 10.1186/s13063-020-04488-8.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04355364,2021-12-20,0,1
1338,NCT04355442,Completed,2020-05-01,2020-05-30,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04355442,2020-05-01,0,0
1339,NCT04357340,Completed,2020-04-30,2020-05-30,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04357340,2020-04-30,0,0
1340,NCT04359407,Completed,2021-05-10,2021-05-10,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04359407,2021-05-10,0,0
1341,NCT04363736,Completed,2020-08-12,2020-08-12,Study Results,"['Kumar PN, Hern√°ndez-S√°nchez J, Nagel S, Feng Y, Cai F, Rabin J, Morse CG, Nadig NR, Ashraf O, Gotur DB, McComsey GA, Gafoor K, Perin P, Thornton SC, Stubbings W, Lin CJF, Tsai L. Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial. Open Forum Infect Dis. 2021 Dec 4;9(1):ofab608. doi: 10.1093/ofid/ofab608. eCollection 2022 Jan.', 'Tom J, Bao M, Tsai L, Qamra A, Summers D, Carrasco-Triguero M, McBride J, Rosenberger CM, Lin CJF, Stubbings W, Blyth KG, Carratal√† J, Fran√ßois B, Benfield T, Haslem D, Bonfanti P, van der Leest CH, Rohatgi N, Wiese L, Luyt CE, Kheradmand F, Rosas IO, Cai F. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial. Crit Care Med. 2022 Mar 1;50(3):398-409. doi: 10.1097/CCM.0000000000005229.']",,2021-08-30,https://clinicaltrials.gov/show/NCT04363736,2020-08-12,1,1
1342,NCT04363827,"Active, not recruiting",2021-06-01,2021-09-01,No Results Posted,"['Nanni O, Viale P, Vertogen B, Lilli C, Zingaretti C, Donati C, Masini C, Monti M, Serra P, Vespignani R, Grossi V, Biggeri A, Scarpi E, Galardi F, Bertoni L, Colamartini A, Falcini F, Altini M, Massa I, Gaggeri R, Martinelli G. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4.']",,2021-02-12,https://clinicaltrials.gov/show/NCT04363827,2021-06-01,0,1
1343,NCT04365322,Recruiting,2020-09-01,2025-04-20,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04365322,2020-09-01,0,0
1344,NCT04370210,Completed,2020-06-04,2020-06-04,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04370210,2020-06-04,0,0
1345,NCT04370236,Terminated,2021-10-13,2021-11-18,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04370236,2021-10-13,0,0
1346,NCT04370886,Completed,2020-04-30,2020-05-10,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04370886,2020-04-30,0,0
1347,NCT04373044,Terminated,2021-05-12,2021-05-12,Results Submitted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04373044,2021-05-12,0,0
1348,NCT04374461,"Active, not recruiting",2023-05-01,2023-05-01,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04374461,2023-05-01,0,0
1349,NCT04377672,Completed,2021-09-01,2021-12-13,No Results Posted,"['Gordon O, Brosnan MK, Yoon S, Jung D, Littlefield K, Ganesan A, Caputo CA, Li M, Morgenlander WR, Henson SN, Ordonez AA, De Jesus P, Tucker EW, Peart Akindele N, Ma Z, Wilson J, Ruiz-Bedoya CA, Younger MEM, Bloch EM, Shoham S, Sullivan D, Tobian AA, Cooke KR, Larman B, Gobburu JV, Casadevall A, Pekosz A, Lederman HM, Klein SL, Jain SK. Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children. JCI Insight. 2022 Jan 25;7(2). pii: e151518. doi: 10.1172/jci.insight.151518.']",,2021-12-15,https://clinicaltrials.gov/show/NCT04377672,2021-09-01,0,1
1350,NCT04384965,"Active, not recruiting",2022-05-01,2022-11-01,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04384965,2022-05-01,0,0
1351,NCT04385186,Not yet recruiting,2020-11-30,2020-12-30,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04385186,2020-11-30,0,0
1352,NCT04385849,"Active, not recruiting",2022-07-11,2022-07-11,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04385849,2022-07-11,0,0
1353,NCT04389554,Completed,2020-05-28,2020-05-29,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04389554,2020-05-28,0,0
1354,NCT04391179,Completed,2021-02-22,2021-02-22,Study Results,,,2022-03-24,https://clinicaltrials.gov/show/NCT04391179,2021-02-22,1,0
1355,NCT04393233,Recruiting,2020-05-23,2020-05-23,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04393233,2020-05-23,0,0
1356,NCT04396067,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-10-27,https://clinicaltrials.gov/show/NCT04396067,2020-10-01,0,0
1357,NCT04397757,Completed,2021-02-06,2021-03-08,Results Submitted,"['Bar KJ, Shaw PA, Choi GH, Aqui N, Fesnak A, Yang JB, Soto-Calderon H, Grajales L, Starr J, Andronov M, Mastellone M, Amonu C, Feret G, DeMarshall M, Buchanan M, Caturla M, Gordon J, Wanicur A, Monroy MA, Mampe F, Lindemuth E, Gouma S, Mullin AM, Barilla H, Pronina A, Irwin L, Thomas R, Eichinger RA, Demuth F, Luning Prak ET, Pascual JL, Short WR, Elovitz MA, Baron J, Meyer NJ, Degnan KO, Frank I, Hensley SE, Siegel DL, Tebas P. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. J Clin Invest. 2021 Dec 15;131(24). pii: e155114. doi: 10.1172/JCI155114.']",,2021-06-10,https://clinicaltrials.gov/show/NCT04397757,2021-02-06,0,1
1358,NCT04397796,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04397796,2022-06-01,0,0
1359,NCT04401085,Completed,2020-05-01,2020-05-01,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04401085,2020-05-01,0,0
1360,NCT04401475,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04401475,2021-04-01,0,0
1361,NCT04402827,Completed,2021-08-30,2021-09-30,No Results Posted,"['Vizcarra P, Haemmerle J, Velasco H, Velasco T, Fern√°ndez-Escribano M, Vallejo A, Casado JL. BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity. Vaccine. 2021 Dec 17;39(51):7367-7374. doi: 10.1016/j.vaccine.2021.10.074. Epub 2021 Nov 11.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04402827,2021-08-30,0,1
1362,NCT04402879,Recruiting,2021-12-01,2022-06-01,No Results Posted,"['Weatherald J, Norrie J, Parhar KKS. Awake prone positioning in COVID-19: is tummy time ready for prime time? Lancet Respir Med. 2021 Dec;9(12):1347-1349. doi: 10.1016/S2213-2600(21)00368-4. Epub 2021 Aug 20.']",,2020-12-17,https://clinicaltrials.gov/show/NCT04402879,2021-12-01,0,1
1363,NCT04403932,Completed,2020-06-01,2020-08-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04403932,2020-06-01,0,0
1364,NCT04405544,Completed,2020-07-22,2020-10-29,No Results Posted,"['Vinogradov OI, Ogarkova TK, Shamtieva KV, Alexandrov PV, Mushba AV, Kanshina DS, Yakovleva DV, Surma MA, Nikolaev IS, Gorst NK. Predictors of Acute Encephalopathy in Patients with COVID-19. J Clin Med. 2021 Oct 20;10(21). pii: 4821. doi: 10.3390/jcm10214821.']",,2020-10-30,https://clinicaltrials.gov/show/NCT04405544,2020-07-22,0,1
1365,NCT04405973,Completed,2020-09-30,2020-09-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04405973,2020-09-30,0,0
1366,NCT04405986,Completed,2021-03-10,2021-03-10,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04405986,2021-03-10,0,0
1367,NCT04406181,Recruiting,2020-12-31,2021-01-01,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04406181,2020-12-31,0,0
1368,NCT04406545,Completed,2022-01-10,2022-01-10,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04406545,2022-01-10,0,0
1369,NCT04407143,"Active, not recruiting",2021-09-30,2022-03-30,No Results Posted,"['Provencio M, Rodr√≠guez-Abreu D, Ortega AL, Serrano G, Aguado C, Franco F, Gutierrez V, L√≥pez Vivanco G, Guirado M, Ben√≠tez G, Estival A, Calvo V, Jim√©nez B, Arasanz H, Coves J, Majem M, Massut√≠ B, V√°zquez S, Juan-Vidal O, Collazo-Lorduy A, Goz√°lvez CL, Del Barco E, Rosero A, Bosch-Barrerra J, Moreno MA, Mielgo-Rubio X, Villa JC, L√≥pez-Martin A, C√≥rdoba JF, de As√≠s Aparisi F, Zafra M, Mosquera J, P√©rez Altozano J, Nadal E, Catot S, Balsalobre J, de Portugal T, Mart√≠n P, Cuesta de Juan S, Cobo M. Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study. Transl Lung Cancer Res. 2022 Jan;11(1):53-63. doi: 10.21037/tlcr-21-504.']",,2021-11-11,https://clinicaltrials.gov/show/NCT04407143,2021-09-30,0,1
1370,NCT04407169,Completed,2020-11-17,2020-11-17,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, Cong S, Juan J, Fan J, Lu K, Wang N, Hu Y, Wang L. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018 Jun;6(6):421-430. doi: 10.1016/S2213-2600(18)30103-6. Epub 2018 Apr 9.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.']",2020-11-20,https://clinicaltrials.gov/show/NCT04407169,2020-11-17,0,1
1371,NCT04407182,Completed,2020-08-01,2020-10-01,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04407182,2020-08-01,0,0
1372,NCT04407195,Completed,2021-06-01,2021-06-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04407195,2021-06-01,0,0
1373,NCT04407208,Completed,2020-06-22,2020-06-22,No Results Posted,"['Rejeki MS, Sarnadi N, Wihastuti R, Fazharyasti V, Samin WY, Yudhaputri FA, Johar E, Nurainy N, Bachtiar NS, Muljono DH. Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine. 2021 Jun;36:100931. doi: 10.1016/j.eclinm.2021.100931. Epub 2021 Jun 4.']",,2020-06-30,https://clinicaltrials.gov/show/NCT04407208,2020-06-22,0,1
1374,NCT04407260,Completed,2020-05-01,2020-05-01,No Results Posted,"[""Dayya D, O'Neill OJ, Feiertag TD, Tuazon-Boer R, Sullivan J, Perez L, Gurash S, Eaton M, Bodley T, Marker J, Smykowski E, Hall T. The use of oxygen hoods in patients failing on conventional high-flow oxygen delivery systems, the effects on oxygenation, mechanical ventilation and mortality rates in hypoxic patients with COVID-19. A Prospective Controlled Cohort Study. Respir Med. 2021 Apr;179:106312. doi: 10.1016/j.rmed.2021.106312. Epub 2021 Feb 12.""]",,2021-02-16,https://clinicaltrials.gov/show/NCT04407260,2020-05-01,0,1
1375,NCT04407390,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04407390,2021-05-01,0,0
1376,NCT04407494,Completed,2020-04-01,2020-04-30,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04407494,2020-04-01,0,0
1377,NCT04407559,Completed,2020-09-01,2020-09-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04407559,2020-09-01,0,0
1378,NCT04407663,Completed,2020-05-04,2020-05-04,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04407663,2020-05-04,0,0
1379,NCT04407923,Recruiting,2020-11-25,2020-11-25,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04407923,2020-11-25,0,0
1380,NCT04408131,Recruiting,2021-01-27,2021-01-27,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04408131,2021-01-27,0,0
1381,NCT04408157,"Active, not recruiting",2021-10-01,2021-12-22,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04408157,2021-10-01,0,0
1382,NCT04408170,Recruiting,2022-03-30,2022-03-30,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04408170,2022-03-30,0,0
1383,NCT04408196,Completed,2021-02-15,2021-02-22,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04408196,2021-02-15,0,0
1384,NCT04408209,Recruiting,2021-08-30,2021-09-15,No Results Posted,"['Pappa V, Bouchla A, Terpos E, Thomopoulos TP, Rosati M, Stellas D, Antoniadou A, Mentis A, Papageorgiou SG, Politou M, Kotanidou A, Kalomenidis I, Poulakou G, Jahaj E, Korompoki E, Grigoropoulou S, Hu X, Bear J, Karaliota S, Burns R, Pagoni M, Trontzas I, Grouzi E, Labropoulou S, Stamoulis K, Bamias A, Tsiodras S, Felber BK, Pavlakis GN, Dimopoulos MA. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021 Apr 11;9(4). pii: 806. doi: 10.3390/microorganisms9040806.']",,2020-11-04,https://clinicaltrials.gov/show/NCT04408209,2021-08-30,0,1
1385,NCT04408287,Recruiting,2021-12-28,2021-12-31,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04408287,2021-12-28,0,0
1386,NCT04408378,Recruiting,2020-07-20,2020-08-20,No Results Posted,,,2020-05-29,https://clinicaltrials.gov/show/NCT04408378,2020-07-20,0,0
1387,NCT04408456,Completed,2020-07-31,2020-07-31,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04408456,2020-07-31,0,0
1388,NCT04409184,Withdrawn,2020-08-14,2020-08-14,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04409184,2020-08-14,0,0
1389,NCT04409197,Completed,2020-06-08,2020-07-11,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04409197,2020-06-08,0,0
1390,NCT04409327,Terminated,2020-12-27,2021-01-24,Results Submitted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04409327,2020-12-27,0,0
1391,NCT04409483,Withdrawn,2020-12-31,2020-12-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04409483,2020-12-31,0,0
1392,NCT04409509,Completed,2021-01-12,2021-01-12,Study Results,,,2022-01-24,https://clinicaltrials.gov/show/NCT04409509,2021-01-12,1,0
1393,NCT04409522,Recruiting,2020-06-05,2020-09-25,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04409522,2020-06-05,0,0
1394,NCT04409535,"Active, not recruiting",2021-02-25,2021-03-31,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04409535,2021-02-25,0,0
1395,NCT04409743,"Active, not recruiting",2021-10-14,2022-04-01,No Results Posted,"[""O'Hora KP, Osorno RA, Sadeghi-Bahmani D, Lopez M, Morehouse A, Kim JP, Manber R, Goldstein-Piekarski AN. Viability of an Early Sleep Intervention to Mitigate Poor Sleep and Improve Well-being in the COVID-19 Pandemic: Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2022 Mar 14;11(3):e34409. doi: 10.2196/34409.""]",,2021-11-08,https://clinicaltrials.gov/show/NCT04409743,2021-10-14,0,1
1396,NCT04409821,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04409821,2022-02-01,0,0
1397,NCT04409847,Recruiting,2021-04-30,2021-05-31,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04409847,2021-04-30,0,0
1398,NCT04409873,Recruiting,2022-02-28,2022-02-28,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04409873,2022-02-28,0,0
1399,NCT04409899,"Active, not recruiting",2020-06-30,2020-12-31,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04409899,2020-06-30,0,0
1400,NCT04409951,Not yet recruiting,2021-03-01,2021-09-01,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04409951,2021-03-01,0,0
1401,NCT04410107,Recruiting,2021-12-31,2022-08-02,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04410107,2021-12-31,0,0
1402,NCT04410263,Recruiting,2023-12-30,2023-12-31,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04410263,2023-12-30,0,0
1403,NCT04410328,Completed,2021-10-15,2021-10-15,No Results Posted,,"['Macatangay BJC, Jackson EK, Abebe KZ, Comer D, Cyktor J, Klamar-Blain C, Borowski L, Gillespie DG, Mellors JW, Rinaldo CR, Riddler SA. A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation. J Infect Dis. 2020 Apr 27;221(10):1598-1606. doi: 10.1093/infdis/jiz344.', 'Li Z LX, Huang Yi-Y et al. FEP-based screening prompts drug repositioning against COVID-19. 2020.', 'Liu X LZ, Liu S et al. . Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction. 2020.', 'K√∂hler D, Streienberger A, Morote-Garc√≠a JC, Granja TF, Schneider M, Straub A, Boison D, Rosenberger P. Inhibition of Adenosine Kinase Attenuates Acute Lung Injury. Crit Care Med. 2016 Apr;44(4):e181-9. doi: 10.1097/CCM.0000000000001370.', 'Fata-Hartley CL, Palmenberg AC. Dipyridamole reversibly inhibits mengovirus RNA replication. J Virol. 2005 Sep;79(17):11062-70.', 'Weyrich AS, Skalabrin EJ, Kraiss LW. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther. 2009 Mar-Apr;16(2):164-70. doi: 10.1097/MJT.0b013e31814b17bf. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.']",2022-02-16,https://clinicaltrials.gov/show/NCT04410328,2021-10-15,0,1
1404,NCT04410458,Enrolling by invitation,2020-05-31,2020-06-12,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04410458,2020-05-31,0,0
1405,NCT04410471,Recruiting,2020-05-29,2021-06-30,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04410471,2020-05-29,0,0
1406,NCT04410510,Recruiting,2021-06-30,2021-11-30,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04410510,2021-06-30,0,0
1407,NCT04410536,Recruiting,2021-12-01,2022-07-01,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04410536,2021-12-01,0,0
1408,NCT04410549,Completed,2021-09-30,2021-09-30,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04410549,2021-09-30,0,0
1409,NCT04410562,Completed,2021-06-30,2021-10-31,No Results Posted,"['Gonz√°lez R, Garc√≠a-Otero L, Pons-Duran C, Marb√°n-Castro E, Gonc√© A, Llurba E, Gil MDM, Rodr√≠guez-Zambrano M√Å, Chen H, Ram√≠rez M, Bardaj√≠ A, Menendez C. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial. Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.']",,2022-01-12,https://clinicaltrials.gov/show/NCT04410562,2021-06-30,0,1
1410,NCT04410692,Completed,2020-05-16,2020-05-17,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04410692,2020-05-16,0,0
1411,NCT04410718,Recruiting,2021-12-30,2022-04-30,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04410718,2021-12-30,0,0
1412,NCT04410939,Completed,2020-05-20,2020-05-21,No Results Posted,,,2020-06-01,https://clinicaltrials.gov/show/NCT04410939,2020-05-20,0,0
1413,NCT04411433,"Active, not recruiting",2020-12-31,2021-06-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04411433,2020-12-31,0,0
1414,NCT04411511,Recruiting,2022-11-12,2022-12-12,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04411511,2022-11-12,0,0
1415,NCT04411563,Recruiting,2020-09-01,2020-12-01,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04411563,2020-09-01,0,0
1416,NCT04411602,Withdrawn,2021-04-07,2021-04-07,No Results Posted,,,2021-07-09,https://clinicaltrials.gov/show/NCT04411602,2021-04-07,0,0
1417,NCT04411680,Completed,2021-03-02,2021-05-19,Study Results,,,2022-02-18,https://clinicaltrials.gov/show/NCT04411680,2021-03-02,1,0
1418,NCT04412226,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04412226,2020-06-30,0,0
1419,NCT04412239,Recruiting,2020-12-20,2020-12-20,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04412239,2020-12-20,0,0
1420,NCT04412343,Completed,2020-10-05,2020-10-05,No Results Posted,"[""Beauchamp MR, Hulteen RM, Ruissen GR, Liu Y, Rhodes RE, Wierts CM, Waldhauser KJ, Harden SH, Puterman E. Online-Delivered Group and Personal Exercise Programs to Support Low Active Older Adults' Mental Health During the COVID-19 Pandemic: Randomized Controlled Trial. J Med Internet Res. 2021 Jul 30;23(7):e30709. doi: 10.2196/30709.""]",,2020-11-03,https://clinicaltrials.gov/show/NCT04412343,2020-10-05,0,1
1421,NCT04412369,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04412369,2022-06-01,0,0
1422,NCT04412382,Recruiting,2020-12-31,2021-12-31,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04412382,2020-12-31,0,0
1423,NCT04412395,Not yet recruiting,2022-08-01,2022-12-30,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04412395,2022-08-01,0,0
1424,NCT04412460,Withdrawn,2021-12-31,2021-12-31,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04412460,2021-12-31,0,0
1425,NCT04412473,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04412473,2021-06-01,0,0
1426,NCT04412486,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,2021-12-01,https://clinicaltrials.gov/show/NCT04412486,2022-05-31,0,0
1427,NCT04413058,Completed,2020-09-10,2020-09-10,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04413058,2020-09-10,0,0
1428,NCT04413877,Not yet recruiting,2023-09-01,2023-11-01,No Results Posted,,"['Sanchez-Rodriguez D, Annweiler C, Gillain S, Vellas B. Implementation of the Integrated Care of Older People (ICOPE) App in Primary Care: New Technologies in Geriatric Care during Quarantine of COVID-19 and Beyond. J Frailty Aging. 2021;10(2):139-140. doi: 10.14283/jfa.2020.24.', 'de Kerimel J, Tavassoli N, Lafont C, Soto M, Pedra M, Nourhashemi F, Lagourdette C, Bouchon L, Chal√©on A, Sourdet S, Rolland Y, Cesari M, Vellas B. How to Manage Frail Older Adults in the Community? Proposal of a Health Promotion Program Experienced in a City of 16,638 Inhabitants in France. J Frailty Aging. 2018;7(2):120-126. doi: 10.14283/jfa.2017.47.', 'Takeda C, Guyonnet S, Sumi Y, Vellas B, Araujo de Carvalho I. Integrated Care for Older People and the Implementation in the INSPIRE Care Cohort. J Prev Alzheimers Dis. 2020;7(2):70-74. doi: 10.14283/jpad.2020.8. Review.', 'Cesari M, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Cooper C, Martin FC, Reginster JY, Vellas B, Beard JR. Evidence for the Domains Supporting the Construct of Intrinsic Capacity. J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1653-1660. doi: 10.1093/gerona/gly011. Review.', 'Belloni G, Cesari M. Frailty and Intrinsic Capacity: Two Distinct but Related Constructs. Front Med (Lausanne). 2019 Jun 18;6:133. doi: 10.3389/fmed.2019.00133. eCollection 2019.']",2021-07-28,https://clinicaltrials.gov/show/NCT04413877,2023-09-01,0,1
1429,NCT04306497,Completed,2020-04-30,2020-05-30,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04306497,2020-04-30,0,0
1430,NCT04311697,Completed,2021-02-22,2021-02-22,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04311697,2021-02-22,0,0
1431,NCT04315948,Recruiting,2023-03-01,2023-03-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.', 'Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15.']","['WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hern√°ndez Garc√≠a C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garc√≠a PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portol√©s A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, R√∏ttingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.', 'Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabi√© A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, L√™ MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentr√© F; DisCoVeRy study group. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-Œ≤-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26.', 'Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, L√™ MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentr√© F; DisCoVeRy Study Group. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14.', 'Lingas G, N√©ant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentr√© F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M; DisCoVeRy study group . Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. J Antimicrob Chemother. 2022 Mar 2. pii: dkac048. doi: 10.1093/jac/dkac048. [Epub ahead of print]']",2022-03-21,https://clinicaltrials.gov/show/NCT04315948,2023-03-01,0,1
1432,NCT04326114,Not yet recruiting,2020-12-15,2020-12-20,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04326114,2020-12-15,0,0
1433,NCT04327401,Terminated,2020-07-22,2020-07-22,No Results Posted,"['Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP; COALITION COVID-19 Brazil III Investigators. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.']",,2020-08-07,https://clinicaltrials.gov/show/NCT04327401,2020-07-22,0,1
1434,NCT04327505,Recruiting,2022-04-30,2022-12-31,No Results Posted,"['Kjellberg A, Douglas J, Pawlik MT, Kraus M, Oscarsson N, Zheng X, Bergman P, Fr√•nberg O, Kowalski JH, Nyren SP, Silvanius M, Skold M, Catrina SB, Rodriguez-Wallberg KA, Lindholm P. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19. BMJ Open. 2021 Jul 5;11(7):e046738. doi: 10.1136/bmjopen-2020-046738.']",,2021-11-08,https://clinicaltrials.gov/show/NCT04327505,2022-04-30,0,1
1435,NCT04327531,Completed,2020-05-22,2020-05-28,No Results Posted,"['Yal√ßƒ±n Bahat P, Aldƒ±ka√ßtƒ±oƒülu Talma√ß M, Bestel A, Topbas Selcuki NF, Karadeniz O, Polat I. Evaluating the effects of the COVID-19 pandemic on the physical and mental well-being of obstetricians and gynecologists in Turkey. Int J Gynaecol Obstet. 2020 Oct;151(1):67-73. doi: 10.1002/ijgo.13287. Epub 2020 Aug 11.']",,2020-06-05,https://clinicaltrials.gov/show/NCT04327531,2020-05-22,0,1
1436,NCT04332081,Terminated,2020-05-29,2020-05-29,Study Results,,,2021-06-22,https://clinicaltrials.gov/show/NCT04332081,2020-05-29,1,0
1437,NCT04333654,Terminated,2020-05-26,2020-05-26,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04333654,2020-05-26,0,0
1438,NCT04336410,Completed,2022-02-10,2022-02-10,No Results Posted,"['Tebas P, Yang S, Boyer JD, Reuschel EL, Patel A, Christensen-Quick A, Andrade VM, Morrow MP, Kraynyak K, Agnes J, Purwar M, Sylvester A, Pawlicki J, Gillespie E, Maricic I, Zaidi FI, Kim KY, Dia Y, Frase D, Pezzoli P, Schultheis K, Smith TRF, Ramos SJ, McMullan T, Buttigieg K, Carroll MW, Ervin J, Diehl MC, Blackwood E, Mammen MP, Lee J, Dallas MJ, Brown AS, Shea JE, Kim JJ, Weiner DB, Broderick KE, Humeau LM. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine. 2021 Jan;31:100689. doi: 10.1016/j.eclinm.2020.100689. Epub 2020 Dec 24.']",,2022-03-08,https://clinicaltrials.gov/show/NCT04336410,2022-02-10,0,1
1439,NCT04339816,Terminated,2020-11-04,2020-11-04,No Results Posted,"['Du≈°ka F, Waldauf P, Halaƒçov√° M, Zvon√≠ƒçek V, Bala J, Bal√≠k M, Bene≈° J, Klementov√° O, Koz√°kov√° I, Kubricht V, Le Roy A, Vymazal T, ≈òeho≈ôov√° V, ƒåern√Ω V; Czech Anaesthesia Clinical Trials and Audit Network. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU. Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.']",,2020-11-06,https://clinicaltrials.gov/show/NCT04339816,2020-11-04,0,1
1440,NCT04340479,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04340479,2021-09-01,0,0
1441,NCT04341142,Recruiting,2023-04-09,2024-04-09,No Results Posted,"['Trouillet-Assant S, Albert Vega C, Bal A, Nazare JA, Fascia P, Paul A, Massardier-Pilonchery A, D Aubarede C, Guibert N, Pitiot V, Lahousse M, Boibieux A, Makhloufi D, Simon C, Rabilloud M, Trabaud MA, Gueyffier F, Fassier JB; COVID-SER study group. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study. BMJ Open. 2020 Nov 24;10(11):e041268. doi: 10.1136/bmjopen-2020-041268.']",,2020-07-31,https://clinicaltrials.gov/show/NCT04341142,2023-04-09,0,1
1442,NCT04343092,Completed,2020-05-31,2020-06-01,Study Results,,,2020-11-04,https://clinicaltrials.gov/show/NCT04343092,2020-05-31,1,0
1443,NCT04343248,"Active, not recruiting",2021-06-30,2021-06-30,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04343248,2021-06-30,0,0
1444,NCT04345276,Completed,2020-04-15,2020-04-15,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04345276,2020-04-15,0,0
1445,NCT04345692,Terminated,2020-08-31,2020-08-31,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04345692,2020-08-31,0,0
1446,NCT04347512,Withdrawn,2020-06-02,2020-06-02,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04347512,2020-06-02,0,0
1447,NCT04347798,Enrolling by invitation,2021-04-01,2021-04-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04347798,2021-04-01,0,0
1448,NCT04347824,Completed,2020-12-31,2021-03-31,No Results Posted,"['Gross O, Moerer O, Rauen T, B√∂ckhaus J, Hoxha E, J√∂rres A, Kamm M, Elfanish A, Windisch W, Dreher M, Floege J, Kluge S, Schmidt-Lauber C, Turner JE, Huber S, Addo MM, Scheithauer S, Friede T, Braun GS, Huber TB, Blaschke S. Validation of a Prospective Urinalysis-Based Prediction Model for ICU Resources and Outcome of COVID-19 Disease: A Multicenter Cohort Study. J Clin Med. 2021 Jul 9;10(14). pii: 3049. doi: 10.3390/jcm10143049.']",,2021-04-28,https://clinicaltrials.gov/show/NCT04347824,2020-12-31,0,1
1449,NCT04348500,Completed,2020-09-30,2020-09-30,Study Results,,,2021-12-02,https://clinicaltrials.gov/show/NCT04348500,2020-09-30,1,0
1450,NCT04352985,,,,,,,2021-09-20,https://clinicaltrials.gov/show/NCT04352985,,0,0
1451,NCT04355936,Completed,2020-11-02,2020-11-30,No Results Posted,"['Duarte M, Pelorosso F, Nicolosi LN, Salgado MV, Vetulli H, Aquieri A, Azzato F, Castro M, Coyle J, Davolos I, Criado IF, Gregori R, Mastrodonato P, Rubio MC, Sarquis S, Wahlmann F, Rothlin RP. Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine. 2021 Jun 18;37:100962. doi: 10.1016/j.eclinm.2021.100962. eCollection 2021 Jul.', 'Rothlin RP, Vetulli HM, Duarte M, Pelorosso FG. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19. Drug Dev Res. 2020 Nov;81(7):768-770. doi: 10.1002/ddr.21679. Epub 2020 May 1.']",,2020-12-24,https://clinicaltrials.gov/show/NCT04355936,2020-11-02,0,1
1452,NCT04356482,Recruiting,2020-11-01,2020-12-01,No Results Posted,,"['Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Rajam G, Sampson J, Carlone GM, Ades EW. An augmented passive immune therapy to treat fulminant bacterial infections. Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.', 'Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000 Oct;13(4):602-14. Review.', 'Burnouf T, Seghatchian J. Ebola virus convalescent blood products: where we are now and where we may need to go. Transfus Apher Sci. 2014 Oct;51(2):120-5. Review.', 'Jahrling PB, Frame JD, Rhoderick JB, Monson MH. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg. 1985;79(3):380-4.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.']",2020-06-05,https://clinicaltrials.gov/show/NCT04356482,2020-11-01,0,1
1453,NCT04358003,Recruiting,2021-12-31,2022-03-01,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04358003,2021-12-31,0,0
1454,NCT04359511,Withdrawn,2020-07-03,2020-07-03,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04359511,2020-07-03,0,0
1455,NCT04359680,"Active, not recruiting",2021-03-29,2021-03-29,No Results Posted,,,2021-02-08,https://clinicaltrials.gov/show/NCT04359680,2021-03-29,0,0
1456,NCT04359901,"Active, not recruiting",2022-04-01,2023-04-01,No Results Posted,"['Branch-Elliman W, Ferguson R, Doros G, Woods P, Leatherman S, Strymish J, Datta R, Goswami R, Jankowich MD, Shah NR, Taylor TH, Page ST, Schiller SJ, Shannon C, Hau C, Flynn M, Holmberg E, Visnaw K, Dhond R, Brophy M, Monach PA. Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022 Feb 25;17(2):e0263591. doi: 10.1371/journal.pone.0263591. eCollection 2022.']",,2021-03-08,https://clinicaltrials.gov/show/NCT04359901,2022-04-01,0,1
1457,NCT04361838,Terminated,2021-04-30,2021-04-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04361838,2021-04-30,0,0
1458,NCT04367870,"Active, not recruiting",2021-05-31,2022-04-30,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04367870,2021-05-31,0,0
1459,NCT04371926,Withdrawn,2021-06-01,2021-07-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04371926,2021-06-01,0,0
1460,NCT04372589,Completed,2021-05-17,2021-05-17,No Results Posted,"['REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators, Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, D≈æav√≠k V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Gallego Lima F, Linstrum K, Litton E, Lopez-Sendon J, Lother SA, Marten N, Saud Marinez A, Martinez M, Mateos Garcia E, Mavromichalis S, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nicolau JC, Nunez-Garcia B, Park JJ, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pompilio M, Quigley JG, Rosenson RS, Rost NS, Rowan K, Santos FO, Santos M, Santos MO, Satterwhite L, Saunders CT, Schreiber J, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Singhal AB, Slutsky AS, Solvason D, Stanworth SJ, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Widmer RJ, Wilson JG, Yuriditsky E, Zhong Y, Berry SM, McArthur CJ, Neal MD, Hochman JS, Webb SA, Zarychanski R. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.', 'ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, D≈æav√≠k V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, Garc√≠a-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, Knudson MM, Kornblith AE, Krishnan V, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Lima FG, Linstrum K, Litton E, Lopez-Sendon J, Lopez-Sendon Moreno JL, Lother SA, Malhotra S, Marcos M, Saud Marinez A, Marshall JC, Marten N, Matthay MA, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Moore SC, Morillo Guerrero R, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nunez-Garcia B, Pandey A, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, P√©rez Gonz√°lez YS, Pompilio M, Prekker ME, Quigley JG, Rost NS, Rowan K, Santos FO, Santos M, Olombrada Santos M, Satterwhite L, Saunders CT, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Shankar-Hari M, Sheehan JP, Singhal AB, Solvason D, Stanworth SJ, Tritschler T, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Wells BJ, Widmer RJ, Wilson JG, Yuriditsky E, Zampieri FG, Angus DC, McArthur CJ, Webb SA, Farkouh ME, Hochman JS, Zarychanski R. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.', 'Houston BL, Lawler PR, Goligher EC, Farkouh ME, Bradbury C, Carrier M, Dzavik V, Fergusson DA, Fowler RA, Galanaud JP, Gross PL, McDonald EG, Husain M, Kahn SR, Kumar A, Marshall J, Murthy S, Slutsky AS, Turgeon AF, Berry SM, Rosenson RS, Escobedo J, Nicolau JC, Bond L, Kirwan BA, de Brouwer S, Zarychanski R. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20.', 'Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,2021-07-27,https://clinicaltrials.gov/show/NCT04372589,2021-05-17,0,1
1461,NCT04374084,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04374084,2021-12-01,0,0
1462,NCT04374786,Enrolling by invitation,2020-09-01,2020-10-01,No Results Posted,,"['Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the Mindfulness Meditation Mobile App ""Calm"" to Reduce Stress Among College Students: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Jun 25;7(6):e14273. doi: 10.2196/14273.', 'Huberty J, Vranceanu AM, Carney C, Breus M, Gordon M, Puzia ME. Characteristics and Usage Patterns Among 12,151 Paid Subscribers of the Calm Meditation App: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2019 Nov 3;7(11):e15648. doi: 10.2196/15648.', ""Huberty J, Puzia M, Eckert R, Larkey L. Cancer Patients' and Survivors' Perceptions of the Calm App: Cross-Sectional Descriptive Study. JMIR Cancer. 2020 Jan 25;6(1):e16926. doi: 10.2196/16926."", 'Wen L, Sweeney TE, Welton L, Trockel M, Katznelson L. Encouraging Mindfulness in Medical House Staff via Smartphone App: A Pilot Study. Acad Psychiatry. 2017 Oct;41(5):646-650. doi: 10.1007/s40596-017-0768-3. Epub 2017 Aug 9.']",2020-06-04,https://clinicaltrials.gov/show/NCT04374786,2020-09-01,0,1
1463,NCT04382040,Completed,2020-11-05,2020-12-21,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04382040,2020-11-05,0,0
1464,NCT04382066,Completed,2020-11-26,2020-11-26,Study Results,"['Varona JF, Landete P, Lopez-Martin JA, Estrada V, Paredes R, Guisado-Vasco P, Fernandez de Orueta L, Torralba M, Fortun J, Vates R, Barberan J, Clotet B, Ancochea J, Carnevali D, Cabello N, Porras L, Gijon P, Monereo A, Abad D, Zu√±iga S, Sola I, Rodon J, Vergara-Alert J, Izquierdo-Useros N, Fudio S, Pontes MJ, de Rivas B, Giron de Velasco P, Nieto A, Gomez J, Aviles P, Lubomirov R, Belgrano A, Sopesen B, White KM, Rosales R, Yildiz S, Reuschl AK, Thorne LG, Jolly C, Towers GJ, Zuliani-Alvarez L, Bouhaddou M, Obernier K, McGovern BL, Rodriguez ML, Enjuanes L, Fernandez-Sousa JM, Krogan NJ, Jimeno JM, Garcia-Sastre A. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. Life Sci Alliance. 2022 Jan 10;5(4). pii: e202101200. doi: 10.26508/lsa.202101200. Print 2022 Apr.']",,2021-09-24,https://clinicaltrials.gov/show/NCT04382066,2020-11-26,1,1
1465,NCT04382950,Not yet recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04382950,2021-08-01,0,0
1466,NCT04384458,Recruiting,2020-09-10,2021-04-01,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04384458,2020-09-10,0,0
1467,NCT04385251,"Active, not recruiting",2022-05-31,2022-05-31,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04385251,2022-05-31,0,0
1468,NCT04385901,Completed,2020-09-19,2020-09-19,No Results Posted,,"['Holland AE, Hill CJ, Rochford P, Fiore J, Berlowitz DJ, McDonald CF. Telerehabilitation for people with chronic obstructive pulmonary disease: feasibility of a simple, real time model of supervised exercise training. J Telemed Telecare. 2013 Jun;19(4):222-6. doi: 10.1177/1357633X13487100. Epub 2013 May 23.', 'Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2022 Feb 5. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S383-412. doi: 10.1002/acr.20541. Review.']",2021-02-08,https://clinicaltrials.gov/show/NCT04385901,2020-09-19,0,1
1469,NCT04385940,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04385940,2023-01-01,0,0
1470,NCT04389567,Completed,2020-05-25,2020-05-25,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04389567,2020-05-25,0,0
1471,NCT04389580,Not yet recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04389580,2021-10-01,0,0
1472,NCT04392414,Completed,2020-07-10,2020-09-23,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,2020-09-25,https://clinicaltrials.gov/show/NCT04392414,2020-07-10,0,1
1473,NCT04393246,Recruiting,2022-02-15,2022-06-15,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Lu IN, Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Kadyan S, Bond S, Norton S, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB, Cheriyan J. muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jul 31;21(1):690. doi: 10.1186/s13063-020-04618-2.']",,2021-06-10,https://clinicaltrials.gov/show/NCT04393246,2022-02-15,0,1
1474,NCT04394416,Recruiting,2022-06-01,2023-06-01,No Results Posted,"['Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.', 'Zhao H, Mendenhall M, Deininger MW. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia. 2020 Nov;34(11):3085-3087. doi: 10.1038/s41375-020-01045-9. Epub 2020 Sep 30.']",,2021-08-12,https://clinicaltrials.gov/show/NCT04394416,2022-06-01,0,1
1475,NCT04395508,,,,,,,2022-03-10,https://clinicaltrials.gov/show/NCT04395508,,0,0
1476,NCT04395924,Completed,2021-05-04,2021-05-04,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04395924,2021-05-04,0,0
1477,NCT04400279,Completed,2020-11-28,2020-11-28,No Results Posted,"['Puterman E, Hives B, Mazara N, Grishin N, Webster J, Hutton S, Koehle MS, Liu Y, Beauchamp MR. COVID-19 Pandemic and Exercise (COPE) trial: a multigroup pragmatic randomised controlled trial examining effects of app-based at-home exercise programs on depressive symptoms. Br J Sports Med. 2021 Sep 27. pii: bjsports-2021-104379. doi: 10.1136/bjsports-2021-104379. [Epub ahead of print]']",,2021-01-11,https://clinicaltrials.gov/show/NCT04400279,2020-11-28,0,1
1478,NCT04403607,Enrolling by invitation,2021-03-18,2023-05-01,No Results Posted,"['Mangion K, Morrow A, Bagot C, Bayes H, Blyth KG, Church C, Corcoran D, Delles C, Gillespie L, Grieve D, Ho A, Kean S, Lang NN, Lennie V, Lowe DJ, Kellman P, Macfarlane PW, McConnachie A, Roditi G, Sykes R, Touyz RM, Sattar N, Wereski R, Wright S, Berry C. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovasc Res. 2020 Dec 1;116(14):2185-2196. doi: 10.1093/cvr/cvaa209.']",,2022-03-03,https://clinicaltrials.gov/show/NCT04403607,2021-03-18,0,1
1479,NCT04408066,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-07-23,https://clinicaltrials.gov/show/NCT04408066,2022-04-30,0,0
1480,NCT04408183,Recruiting,2022-04-01,2022-12-01,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04408183,2022-04-01,0,0
1481,NCT04408326,Recruiting,2022-07-31,2022-12-31,No Results Posted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04408326,2022-07-31,0,0
1482,NCT04409496,Completed,2021-01-22,2021-01-22,No Results Posted,"['Luk TT, Cheung DY, Chan HC, Wai-Yin Fok P, Ho KS, Sze CD, Lam TH, Wang MP. Mobile chat messaging for preventing smoking relapse amid the COVID-19 pandemic: a pilot randomized controlled trial. Nicotine Tob Res. 2022 Feb 15. pii: ntac045. doi: 10.1093/ntr/ntac045. [Epub ahead of print]']",,2021-03-04,https://clinicaltrials.gov/show/NCT04409496,2021-01-22,0,1
1483,NCT04409574,Not yet recruiting,2021-03-01,2021-06-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04409574,2021-03-01,0,0
1484,NCT04409834,Recruiting,2022-03-01,2022-03-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-11-30,https://clinicaltrials.gov/show/NCT04409834,2022-03-01,0,1
1485,NCT04410484,"Active, not recruiting",2022-08-31,2022-08-31,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04410484,2022-08-31,0,0
1486,NCT04411446,Completed,2021-07-28,2021-07-28,No Results Posted,"['Mariani J, Tajer C, Antonietti L, Inserra F, Ferder L, Manucha W. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials. 2021 Feb 1;22(1):111. doi: 10.1186/s13063-021-05073-3.']","['Mart√≠n Gim√©nez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, Manucha W. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020 Aug 1;254:117808. doi: 10.1016/j.lfs.2020.117808. Epub 2020 May 15. Review.']",2021-07-30,https://clinicaltrials.gov/show/NCT04411446,2021-07-28,0,1
1487,NCT04411459,Completed,2020-06-30,2020-10-16,No Results Posted,"['Dalpiaz G, Gamberini L, Carnevale A, Spadaro S, Mazzoli CA, Piciucchi S, Allegri D, Capozzi C, Neziri E, Bartolucci M, Muratore F, Coppola F, Poerio A, Giampalma E, Baldini L, Tonetti T, Cappellini I, Colombo D, Zani G, Mellini L, Agnoletti V, Damiani F, Gordini G, Laici C, Gola G, Potalivo A, Montomoli J, Ranieri VM, Russo E, Taddei S, Volta CA, Scaramuzzo G. Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation. Radiol Med. 2022 Feb;127(2):162-173. doi: 10.1007/s11547-021-01444-7. Epub 2022 Jan 16.', 'Gamberini L, Mazzoli CA, Prediletto I, Sintonen H, Scaramuzzo G, Allegri D, Colombo D, Tonetti T, Zani G, Capozzi C, Dalpiaz G, Agnoletti V, Cappellini I, Melegari G, Damiani F, Fusari M, Gordini G, Laici C, Lanza MC, Leo M, Marudi A, Papa R, Potalivo A, Montomoli J, Taddei S, Mazzolini M, Ferravante AF, Nicali R, Ranieri VM, Russo E, Volta CA, Spadaro S; ICU-RER COVID-19 Collaboration; Radiology Collaborators (to be indexed and searchable into PubMed); Pneumology Collaborators (to be indexed and searchable into PubMed). Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respir Med. 2021 Nov-Dec;189:106665. doi: 10.1016/j.rmed.2021.106665. Epub 2021 Oct 22.', 'Gamberini L, Mazzoli CA, Sintonen H, Colombo D, Scaramuzzo G, Allegri D, Tonetti T, Zani G, Capozzi C, Giampalma E, Agnoletti V, Becherucci F, Bertellini E, Castelli A, Cappellini I, Cavalli I, Crimaldi F, Damiani F, Fusari M, Gordini G, Laici C, Lanza MC, Leo M, Marudi A, Nardi G, Ottaviani I, Papa R, Potalivo A, Ranieri VM, Russo E, Taddei S, Volta CA, Spadaro S; ICU-RER COVID-19 Collaboration. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up. Qual Life Res. 2021 Oct;30(10):2805-2817. doi: 10.1007/s11136-021-02865-7. Epub 2021 May 12.', 'Gamberini L, Tonetti T, Spadaro S, Zani G, Mazzoli CA, Capozzi C, Giampalma E, Bacchi Reggiani ML, Bertellini E, Castelli A, Cavalli I, Colombo D, Crimaldi F, Damiani F, Fogagnolo A, Fusari M, Gamberini E, Gordini G, Laici C, Lanza MC, Leo M, Marudi A, Nardi G, Ottaviani I, Papa R, Potalivo A, Russo E, Taddei S, Volta CA, Ranieri VM; ICU-RER COVID-19 Collaboration. Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs. J Intensive Care. 2020 Oct 15;8:80. doi: 10.1186/s40560-020-00499-4. eCollection 2020. Erratum in: J Intensive Care. 2020 Dec 17;8(1):96.']","['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.', ""Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O'Mahony S, Mikacenic C. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30."", 'Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum in: JAMA. 2020 May 26;323(20):2098.']",2021-08-30,https://clinicaltrials.gov/show/NCT04411459,2020-06-30,0,1
1488,NCT04411576,Completed,2020-07-01,2020-12-31,No Results Posted,"['Dillner J, Elfstr√∂m KM, Blomqvist J, Eklund C, Lagheden C, Nordqvist-Kleppe S, Hellstr√∂m C, Olofsson J, Andersson E, Jernbom Falk A, Bergstr√∂m S, Hultin E, Pin E, M√•nberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, M√ºhr LSA, Conneryd Lundgren K. Antibodies to SARS-CoV-2 and risk of past or future sick leave. Sci Rep. 2021 Mar 4;11(1):5160. doi: 10.1038/s41598-021-84356-w.', 'Dillner J, Elfstr√∂m KM, Blomqvist J, Engstrand L, Uhl√©n M, Eklund C, Boulund F, Lagheden C, Hamsten M, Nordqvist-Kleppe S, Seifert M, Hellstr√∂m C, Olofsson J, Andersson E, Falk AJ, Bergstr√∂m S, Hultin E, Pin E, Pimenoff VN, Hassan S, M√•nberg A, Nilsson P, Hedhammar M, Hober S, Mattsson J, Arroyo M√ºhr LS, Lundgren KC. High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers. J Infect Dis. 2021 Jul 2;224(1):14-20. doi: 10.1093/infdis/jiab099.']",,2021-12-03,https://clinicaltrials.gov/show/NCT04411576,2020-07-01,0,1
1489,NCT04411667,Completed,2020-06-23,2020-06-23,Study Results,,,2021-06-25,https://clinicaltrials.gov/show/NCT04411667,2020-06-23,1,0
1490,NCT04411784,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,"['Sebastian S, Patel KV, Segal JP, Subramanian S, Conley TE, Gonzalez HA, Kent AJ, Saifuddin A, Hicks L, Mehta S, Bhala N, Brookes MJ, Lamb CA, Kennedy NA; PROTECT ASUC collaborators, Walker GJ. Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study. BMJ Open Gastroenterol. 2022 Jan;9(1). pii: e000763. doi: 10.1136/bmjgast-2021-000763.', 'Sebastian S, Walker GJ, Kennedy NA, Conley TE, Patel KV, Subramanian S, Kent AJ, Segal JP, Brookes MJ, Bhala N, Gonzalez HA, Hicks LC, Mehta SJ, Lamb CA; PROTECT-ASUC Study Group. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-281. doi: 10.1016/S2468-1253(21)00016-9. Epub 2021 Feb 2. Erratum in: Lancet Gastroenterol Hepatol. 2021 Apr;6(4):e3.']",,2020-06-02,https://clinicaltrials.gov/show/NCT04411784,2020-07-01,0,1
1491,NCT04412018,Completed,2020-11-06,2020-12-12,Results Submitted,"['Kosmopoulos A, Bhatt DL, Meglis G, Verma R, Pan Y, Quan A, Teoh H, Verma M, Jiao L, Wang R, Juliano RA, Kajil M, Kosiborod MN, Bari B, Berih AA, Aguilar M, Escano A, Leung A, Coelho I, Hibino M, D√≠az R, Mason RP, Steg PG, Simon T, Go AS, Ambrosy AP, Choi R, Kushner AM, Leiter LA, Al-Omran M, Verma S, Mazer CD. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19. iScience. 2021 Sep 24;24(9):103040. doi: 10.1016/j.isci.2021.103040. Epub 2021 Aug 26.']",,2021-12-22,https://clinicaltrials.gov/show/NCT04412018,2020-11-06,0,1
1492,NCT04412031,Completed,2020-05-14,2020-05-15,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04412031,2020-05-14,0,0
1493,NCT04412538,Recruiting,2020-09-01,2021-09-01,No Results Posted,"['Pu J, Yu Q, Yin Z, Zhang Y, Li X, Yin Q, Chen H, Long R, Zhao Z, Mou T, Zhao H, Feng S, Xie Z, Wang L, He Z, Liao Y, Fan S, Jiang R, Wang J, Zhang L, Li J, Zheng H, Cui P, Jiang G, Guo L, Xu M, Yang H, Lu S, Wang X, Gao Y, Xu X, Cai L, Zhou J, Yu L, Chen Z, Hong C, Du D, Zhao H, Li Y, Ma K, Ma Y, Liu D, Yao S, Li C, Che Y, Liu L, Li Q. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 May 12;39(20):2746-2754. doi: 10.1016/j.vaccine.2021.04.006. Epub 2021 Apr 9.', 'Che Y, Liu X, Pu Y, Zhou M, Zhao Z, Jiang R, Yin Z, Xu M, Yin Q, Wang J, Pu J, Zhao H, Zhang Y, Wang L, Jiang Y, Lei J, Zheng Y, Liao Y, Long R, Yu L, Cui P, Yang H, Zhang Y, Li J, Chen W, He Z, Ma K, Hong C, Li D, Jiang G, Liu D, Xu X, Fan S, Cheng C, Zhao H, Yang J, Li Y, Zou Y, Zhu Y, Zhou Y, Guo Y, Yang T, Chen H, Xie Z, Li C, Li Q. Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults. Clin Infect Dis. 2021 Dec 6;73(11):e3949-e3955. doi: 10.1093/cid/ciaa1703.']",,2020-06-04,https://clinicaltrials.gov/show/NCT04412538,2020-09-01,0,1
1494,NCT04412551,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04412551,2020-12-31,0,0
1495,NCT04412746,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04412746,2020-06-30,0,0
1496,NCT04412772,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04412772,2021-12-31,0,0
1497,NCT04412785,Completed,2021-10-25,2021-10-25,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04412785,2021-10-25,0,0
1498,NCT04413006,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04413006,2020-12-31,0,0
1499,NCT04413045,Completed,2020-07-28,2020-07-28,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04413045,2020-07-28,0,0
1500,NCT04413838,Not yet recruiting,2021-06-15,2021-09-15,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04413838,2021-06-15,0,0
1501,NCT04413864,Recruiting,2022-10-24,2022-10-24,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04413864,2022-10-24,0,0
1502,NCT04413955,Enrolling by invitation,2022-12-31,2022-12-31,No Results Posted,"['Sun X, Yang S, Al-Dossary AA, Broitman S, Ni Y, Guan M, Yang M, Li J. Nanobody-Functionalized Cellulose for Capturing SARS-CoV-2. Appl Environ Microbiol. 2022 Mar 8;88(5):e0230321. doi: 10.1128/aem.02303-21. Epub 2022 Jan 5.']",,2021-09-16,https://clinicaltrials.gov/show/NCT04413955,2022-12-31,0,1
1503,NCT04413968,Completed,2020-07-02,2020-10-02,No Results Posted,"['Lachassinne E, de Pontual L, Caseris M, Lorrot M, Guilluy C, Naud A, Dommergues MA, Pinquier D, Wannepain E, Hausherr E, Jung C, Gajdos V, Cohen R, Zahar JR, Brichler S, Basmaci R, Boelle PY, Bloch-Queyrat C, Aupiais C; COVIDOCRECHE collaborators. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study. Lancet Child Adolesc Health. 2021 Apr;5(4):256-264. doi: 10.1016/S2352-4642(21)00024-9. Epub 2021 Feb 8.']",,2020-10-26,https://clinicaltrials.gov/show/NCT04413968,2020-07-02,0,1
1504,NCT04414059,Recruiting,2022-03-10,2022-03-10,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04414059,2022-03-10,0,0
1505,NCT04414098,Not yet recruiting,2020-08-15,2020-09-15,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04414098,2020-08-15,0,0
1506,NCT04414124,Completed,2021-02-02,2021-02-02,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04414124,2021-02-02,0,0
1507,NCT04414371,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04414371,2020-12-31,0,0
1508,NCT04414410,Enrolling by invitation,2021-09-30,2021-09-30,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04414410,2021-09-30,0,0
1509,NCT04414631,Terminated,2021-09-15,2021-09-15,No Results Posted,"['Urwyler P, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, St√ºssi-Helbling M, Albrich WC, Sendi P, Osthoff M. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Trials. 2021 Jan 4;22(1):1. doi: 10.1186/s13063-020-04976-x.']",,2021-11-09,https://clinicaltrials.gov/show/NCT04414631,2021-09-15,0,1
1510,NCT04414904,Withdrawn,2020-06-10,2020-06-10,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04414904,2020-06-10,0,0
1511,NCT04415073,Suspended,2020-11-15,2020-11-15,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2020-08-11,https://clinicaltrials.gov/show/NCT04415073,2020-11-15,0,1
1512,NCT04415151,Terminated,2021-02-28,2021-02-28,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04415151,2021-02-28,0,0
1513,NCT04416009,Recruiting,2020-12-20,2021-02-20,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04416009,2020-12-20,0,0
1514,NCT04416048,Terminated,2021-07-20,2021-07-20,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2022-01-12,https://clinicaltrials.gov/show/NCT04416048,2021-07-20,0,1
1515,NCT04416061,"Active, not recruiting",2020-07-31,2020-08-31,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04416061,2020-07-31,0,0
1516,NCT04416100,Recruiting,2022-04-28,2022-04-28,No Results Posted,"['Luger AK, Sonnweber T, Gruber L, Schwabl C, Cima K, Tymoszuk P, Gerstner AK, Pizzini A, Sahanic S, Boehm A, Coen M, Strolz CJ, W√∂ll E, Weiss G, Kirchmair R, Feuchtner GM, Prosch H, Tancevski I, L√∂ffler-Ragg J, Widmann G. Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study. Radiology. 2022 Mar 29:211670. doi: 10.1148/radiol.211670. [Epub ahead of print]', 'Sonnweber T, Tymoszuk P, Sahanic S, Boehm A, Pizzini A, Luger A, Schwabl C, Nairz M, Grubwieser P, Kurz K, Koppelst√§tter S, Aichner M, Puchner B, Egger A, Hoermann G, W√∂ll E, Weiss G, Widmann G, Tancevski I, L√∂ffler-Ragg J. Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial. Elife. 2022 Feb 8;11. pii: e72500. doi: 10.7554/eLife.72500.', 'Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, Kurz K, Koppelst√§tter S, Haschka D, Petzer V, Boehm A, Aichner M, Tymoszuk P, Lener D, Theurl M, Lorsbach-K√∂hler A, Tancevski A, Schapfl A, Schaber M, Hilbe R, Nairz M, Puchner B, H√ºttenberger D, Tschurtschenthaler C, A√ühoff M, Peer A, Hartig F, Bellmann R, Joannidis M, Gollmann-Tepek√∂yl√º C, Holfeld J, Feuchtner G, Egger A, Hoermann G, Schroll A, Fritsche G, Wildner S, Bellmann-Weiler R, Kirchmair R, Helbok R, Prosch H, Rieder D, Trajanoski Z, Kronenberg F, W√∂ll E, Weiss G, Widmann G, L√∂ffler-Ragg J, Tancevski I. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021 Apr 29;57(4). pii: 2003481. doi: 10.1183/13993003.03481-2020. Print 2021 Apr.', ""Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, Kurz K, Koppelst√§tter S, Haschka D, Petzer V, Hilbe R, Theurl M, Lehner D, Nairz M, Puchner B, Luger A, Schwabl C, Bellmann-Weiler R, W√∂ll E, Widmann G, Tancevski I, Judith-L√∂ffler-Ragg, Weiss G. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study. Respir Res. 2020 Oct 21;21(1):276. doi: 10.1186/s12931-020-01546-2.""]",,2020-12-02,https://clinicaltrials.gov/show/NCT04416100,2022-04-28,0,1
1517,NCT04416113,"Active, not recruiting",2021-12-01,2022-02-01,No Results Posted,,,2021-08-06,https://clinicaltrials.gov/show/NCT04416113,2021-12-01,0,0
1518,NCT04416139,Recruiting,2021-04-30,2021-05-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04416139,2021-04-30,0,0
1519,NCT04416256,Recruiting,2022-02-01,2022-02-01,No Results Posted,"['Aubert O, Yoo D, Zielinski D, Cozzi E, Cardillo M, D√ºrr M, Dom√≠nguez-Gil B, Coll E, Da Silva MI, Sallinen V, Lemstr√∂m K, Midtvedt K, Ulloa C, Immer F, Weissenbacher A, Vallant N, Basic-Jukic N, Tanabe K, Papatheodoridis G, Menoudakou G, Torres M, Soratti C, Hansen Krogh D, Lefaucheur C, Ferreira G, Silva HT Jr, Hartell D, Forsythe J, Mumford L, Reese PP, Kerbaul F, Jacquelinet C, Vogelaar S, Papalois V, Loupy A. COVID-19 pandemic and worldwide organ transplantation: a population-based study. Lancet Public Health. 2021 Oct;6(10):e709-e719. doi: 10.1016/S2468-2667(21)00200-0. Epub 2021 Aug 30.']","['Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M, Kasiske B, K√∂ttgen A, Kretzler M, Levey AS, Luyckx VA, Mehta R, Moe O, Obrador G, Pannu N, Parikh CR, Perkovic V, Pollock C, Stenvinkel P, Tuttle KR, Wheeler DC, Eckardt KU; ISN Global Kidney Health Summit participants. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20. Review.']",2020-06-04,https://clinicaltrials.gov/show/NCT04416256,2022-02-01,0,1
1520,NCT04416308,Completed,2020-07-10,2020-10-12,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04416308,2020-07-10,0,0
1521,NCT04416360,Recruiting,2020-07-01,2021-01-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04416360,2020-07-01,0,0
1522,NCT04416373,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04416373,2023-12-01,0,0
1523,NCT04416438,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04416438,2021-12-31,0,0
1524,NCT04416919,"Active, not recruiting",2020-06-01,2021-07-01,No Results Posted,,"['van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998 Feb;59(2):128-32.']",2021-03-05,https://clinicaltrials.gov/show/NCT04416919,2020-06-01,0,1
1525,NCT04417270,Completed,2020-11-30,2020-11-30,Results Submitted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04417270,2020-11-30,0,0
1526,NCT04417335,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04417335,2021-05-01,0,0
1527,NCT04418544,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-10-30,https://clinicaltrials.gov/show/NCT04418544,2020-12-01,0,0
1528,NCT04418947,Completed,2020-07-17,2020-07-17,Study Results,"['Cappola AR, Schriver ER, Mowery DL, Wollack C, Ives CT, Gonzales R, Cappella JN. Effect of Targeted Messaging on Return to In-Person Visits During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jun 1;4(6):e2115211. doi: 10.1001/jamanetworkopen.2021.15211.']",,2021-10-28,https://clinicaltrials.gov/show/NCT04418947,2020-07-17,1,1
1529,NCT04419025,Completed,2021-05-14,2021-05-14,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04419025,2021-05-14,0,0
1530,NCT04387409,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04387409,2021-05-01,0,0
1531,NCT04315298,Completed,2020-07-24,2020-09-02,Study Results,"[""Sivapalasingam S, Lederer DJ, Bhore R, Hajizadeh N, Criner G, Hosain R, Mahmood A, Giannelou A, Somersan-Karakaya S, O'Brien MP, Boyapati A, Parrino J, Musser BJ, Labriola-Tompkins E, Ramesh D, Purcell LA, Gulabani D, Kampman W, Waldron A, Gong MN, Saggar S, Sperber SJ, Menon V, Stein DK, Sobieszczyk ME, Park W, Aberg JA, Brown SM, Kosmicki JA, Horowitz JE, Ferreira MA, Baras A, Kowal B, DiCioccio AT, Akinlade B, Nivens MC, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; Sarilumab-COVID-19 Study Team. Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. Clin Infect Dis. 2022 Feb 26. pii: ciac153. doi: 10.1093/cid/ciac153. [Epub ahead of print]"", 'Boyapati A, Wipperman MF, Ehmann PJ, Hamon S, Lederer DJ, Waldron A, Flanagan JJ, Karayusuf E, Bhore R, Nivens MC, Hamilton JD, Sumner G, Sivapalasingam S. Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial. J Infect Dis. 2021 Dec 1;224(11):1830-1838. doi: 10.1093/infdis/jiab445.']",,2021-09-23,https://clinicaltrials.gov/show/NCT04315298,2020-07-24,1,1
1532,NCT04316377,"Active, not recruiting",2020-05-25,2025-03-03,No Results Posted,"['Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rueegg CS, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics. Nat Commun. 2020 Oct 20;11(1):5284. doi: 10.1038/s41467-020-19056-6.', 'Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.']",,2020-06-05,https://clinicaltrials.gov/show/NCT04316377,2020-05-25,0,1
1533,NCT04321928,Terminated,2021-08-31,2021-09-30,No Results Posted,"['Er≈ëss B, Moln√°r Z, Szak√°cs Z, Z√°dori N, Szak√≥ L, V√°ncsa S, Juh√°sz MF, Ocskay K, V√∂rhendi N, M√°rta K, Szentesi A, P√°rniczky A, Hegyi PJ, Kiss S, F√∂ldi M, Dembrovszky F, Kanjo A, P√°zm√°ny P, Varr√≥ A, Csath√≥ √Å, Helyes Z, P√©terfi Z, Czopf L, Kiss I, Zempl√©nyi A, Czap√°ri D, Hegyi E, Dobszai D, Mikl√≥s E, M√°rta A, T√≥th D, Farkas R, Farkas N, Birk√°s B, Pint√©r E, Peth≈ë G, Zsigmond B, S√°rk√∂zi A, Nagy A, Hegyi P. Personalised health education against health damage of COVID-19 epidemic in the elderly Hungarian population (PROACTIVE-19): protocol of an adaptive randomised controlled clinical trial. Trials. 2020 Sep 29;21(1):809. doi: 10.1186/s13063-020-04733-0.']",,2022-02-15,https://clinicaltrials.gov/show/NCT04321928,2021-08-31,0,1
1534,NCT04335279,Completed,2020-06-03,2020-07-24,No Results Posted,"['Thombs BD, Kwakkenbos L, Levis B, Bourgeault A, Henry RS, Levis AW, Harb S, Tao L, Carrier ME, Bustamante L, Duchek D, Dyas L, El-Baalbaki G, Ellis K, Rice DB, Wurz A, Nordlund J, Gagarine M, Turner KA, √òstb√∏ N, Culos-Reed N, Hebblethwaite S, Patten S, Bartlett SJ, Varga J, Mouthon L, Markham S, Martin MS, Benedetti A; SPIN-CHAT Patient Advisory Team and Program Facilitators; Scleroderma Patient-centered Intervention Network Investigators. Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e427-e437. doi: 10.1016/S2665-9913(21)00060-6. Epub 2021 Apr 16.']",,2020-11-30,https://clinicaltrials.gov/show/NCT04335279,2020-06-03,0,1
1535,NCT04335305,Recruiting,2020-12-31,2021-06-30,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04335305,2020-12-31,0,0
1536,NCT04335851,Completed,2020-05-15,2020-06-03,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04335851,2020-05-15,0,0
1537,NCT04339426,Terminated,2022-02-11,2022-02-11,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04339426,2022-02-11,0,0
1538,NCT04345653,Completed,2020-06-05,2021-05-10,Study Results,,,2021-05-12,https://clinicaltrials.gov/show/NCT04345653,2020-06-05,1,0
1539,NCT04346420,Completed,2020-05-01,2020-05-01,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04346420,2020-05-01,0,0
1540,NCT04346589,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04346589,2020-08-01,0,0
1541,NCT04347382,Completed,2020-08-30,2020-08-30,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04347382,2020-08-30,0,0
1542,NCT04348656,Terminated,2021-03-05,2021-06-16,Study Results,"['B√©gin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussi√®res G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chass√© M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A; CONCOR-1 Study Group, Arnold DM. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. 2021 Nov;27(11):2012-2024. doi: 10.1038/s41591-021-01488-2. Epub 2021 Sep 9. Erratum in: Nat Med. 2022 Jan;28(1):212.', 'B√©gin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chass√© M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair MC, Cerro S, Avram M, Arnold DM. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 2021 May 4;22(1):323. doi: 10.1186/s13063-021-05235-3.']",,2022-03-03,https://clinicaltrials.gov/show/NCT04348656,2021-03-05,1,1
1543,NCT04348942,Completed,2021-03-21,2021-03-21,No Results Posted,"['Shah P, Magee K, Buccellato KH, Ismond M, Watson J. Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study. Cardiovasc Diabetol. 2022 Feb 14;21(1):24. doi: 10.1186/s12933-022-01462-3.']",,2022-03-04,https://clinicaltrials.gov/show/NCT04348942,2021-03-21,0,1
1544,NCT04350073,Recruiting,2022-10-01,2022-12-01,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04350073,2022-10-01,0,0
1545,NCT04351139,Completed,2020-11-30,2020-11-30,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04351139,2020-11-30,0,0
1546,NCT04351581,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04351581,2022-06-01,0,0
1547,NCT04355702,Completed,2020-12-01,2020-12-30,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04355702,2020-12-01,0,0
1548,NCT04357041,"Active, not recruiting",2021-06-01,2021-12-01,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04357041,2021-06-01,0,0
1549,NCT04357444,Completed,2020-11-02,2021-04-05,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04357444,2020-11-02,0,0
1550,NCT04359667,Recruiting,2021-04-16,2021-05-15,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04359667,2021-04-16,0,0
1551,NCT04366323,"Active, not recruiting",2021-10-01,2021-10-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04366323,2021-10-01,0,0
1552,NCT04367545,Completed,2020-05-17,2020-05-17,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04367545,2020-05-17,0,0
1553,NCT04367662,Completed,2020-05-14,2020-05-14,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04367662,2020-05-14,0,0
1554,NCT04368728,Recruiting,2024-02-08,2024-02-08,No Results Posted,"['Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, T√ºreci √ñ, ≈ûahin U, Xu X, Koury K, Dychter SS, Lu C, Gentile TC, Gruber WC. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine. 2022 Mar 1;40(10):1483-1492. doi: 10.1016/j.vaccine.2021.12.046. Epub 2021 Dec 24.', 'Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Polack FP, Zerbini C, Bailey R, Swanson KA, Xu X, Roychoudhury S, Koury K, Bouguermouh S, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Yang Q, Liberator P, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Gruber WC, Jansen KU; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.', 'Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, Cooper D, Jennings T, Brandon DM, Thomas SJ, T√ºreci √ñ, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.', 'Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, G√ºler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, S√§nger B, Wallisch AK, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Schille S, Kr√∂ner C, de la Caridad G√ºimil Garcia R, Hiller T, Fischer L, Sellers RS, Choudhary S, Gonzalez O, Vascotto F, Gutman MR, Fontenot JA, Hall-Ursone S, Brasky K, Griffor MC, Han S, Su AAH, Lees JA, Nedoma NL, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi PY, Klamp T, Rosenbaum C, Kuhn AN, T√ºreci √ñ, Dormitzer PR, Jansen KU, Sahin U. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. doi: 10.1038/s41586-021-03275-y. Epub 2021 Feb 1.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, ≈ûahin U, Gruber WC. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.', 'Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, ≈ûahin U, Jansen KU. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12. Erratum in: Nature. 2021 Feb;590(7844):E26.']",,2022-03-28,https://clinicaltrials.gov/show/NCT04368728,2024-02-08,0,1
1555,NCT04370223,Not yet recruiting,2020-10-25,2020-12-25,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04370223,2020-10-25,0,0
1556,NCT04371328,Completed,2020-06-05,2020-06-30,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04371328,2020-06-05,0,0
1557,NCT04371744,Completed,2020-06-04,2020-06-05,No Results Posted,"['Maille B, Wilkin M, Million M, Ress√©guier N, Franceschi F, Koutbi-Franceschi L, Hourdain J, Martinez E, Zabern M, Gardella C, Tissot-Dupont H, Singh JP, Deharo JC, Fiorina L. Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. Int J Cardiol. 2021 May 15;331:333-339. doi: 10.1016/j.ijcard.2021.01.002. Epub 2021 Jan 29.']",,2020-06-09,https://clinicaltrials.gov/show/NCT04371744,2020-06-04,0,1
1558,NCT04372017,Terminated,2021-06-04,2021-06-04,Study Results,,,2021-12-10,https://clinicaltrials.gov/show/NCT04372017,2021-06-04,1,0
1559,NCT04374565,Completed,2021-03-05,2021-03-05,Study Results,,,2022-04-01,https://clinicaltrials.gov/show/NCT04374565,2021-03-05,1,0
1560,NCT04379310,Completed,2020-05-05,2020-05-08,No Results Posted,,,2020-06-05,https://clinicaltrials.gov/show/NCT04379310,2020-05-05,0,0
1561,NCT04381923,Not yet recruiting,2022-11-15,2022-12-15,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04381923,2022-11-15,0,0
1562,NCT04381962,Completed,2021-01-29,2021-04-20,Results Submitted,"['Hinks TSC, Cureton L, Knight R, Wang A, Cane JL, Barber VS, Black J, Dutton SJ, Melhorn J, Jabeen M, Moss P, Garlapati R, Baron T, Johnson G, Cantle F, Clarke D, Elkhodair S, Underwood J, Lasserson D, Pavord ID, Morgan S, Richards D. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir Med. 2021 Oct;9(10):1130-1140. doi: 10.1016/S2213-2600(21)00263-0. Epub 2021 Jul 9. Erratum in: Lancet Respir Med. 2021 Sep 2;:.']",,2021-05-06,https://clinicaltrials.gov/show/NCT04381962,2021-01-29,0,1
1563,NCT04382495,Completed,2021-12-01,2022-01-30,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04382495,2021-12-01,0,0
1564,NCT04387838,Completed,2020-08-15,2020-08-15,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04387838,2020-08-15,0,0
1565,NCT04393636,Recruiting,2022-12-31,2022-12-31,No Results Posted,,"['Plomp J, Redekop WK, Dekker FW, van Geldorp TR, Haalebos MM, Jambroes G, Kingma JH, Zijlstra F, Tijssen JG. Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart. 1999 Jun;81(6):593-7.', 'Morgan CD, Sykora K, Naylor CD. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. The Steering Committee of the Cardiac Care Network of Ontario. Heart. 1998 Apr;79(4):345-9.', 'Malaisrie SC, McDonald E, Kruse J, Li Z, McGee EC Jr, Abicht TO, Russell H, McCarthy PM, Andrei AC. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014 Nov;98(5):1564-70; discussion 1570-1. doi: 10.1016/j.athoracsur.2014.06.040. Epub 2014 Sep 18.', 'da Fonseca VBP, De Lorenzo A, Tura BR, Pittella FJM, da Rocha ASC. Mortality and morbidity of patients on the waiting list for coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2018 Jan 1;26(1):34-40. doi: 10.1093/icvts/ivx276.', 'Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004 Jun;25(6):291-4. Review.', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Al-Sarraf N, Thalib L, Hughes A, Tolan M, Young V, McGovern E. Effect of smoking on short-term outcome of patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2008 Aug;86(2):517-23. doi: 10.1016/j.athoracsur.2008.03.070.', 'Grabas MP, Hansen SM, Torp-Pedersen C, B√∏ggild H, Ullits LR, Deding U, Nielsen BJ, Jensen PF, Overgaard C. Alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study. BMC Cardiovasc Disord. 2016 Nov 11;16(1):219.', 'Guo P. Preoperative education interventions to reduce anxiety and improve recovery among cardiac surgery patients: a review of randomised controlled trials. J Clin Nurs. 2015 Jan;24(1-2):34-46. doi: 10.1111/jocn.12618. Epub 2014 Jun 3. Review.', 'Hulzebos EH, Helders PJ, Favi√© NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006 Oct 18;296(15):1851-7.', 'Mariscalco G, Wozniak MJ, Dawson AG, Serraino GF, Porter R, Nath M, Klersy C, Kumar T, Murphy GJ. Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis. Circulation. 2017 Feb 28;135(9):850-863. doi: 10.1161/CIRCULATIONAHA.116.022840. Epub 2016 Dec 28. Review.', 'Navaratnarajah M, Rea R, Evans R, Gibson F, Antoniades C, Keiralla A, Demosthenous M, Kassimis G, Krasopoulos G. Effect of glycaemic control on complications following cardiac surgery: literature review. J Cardiothorac Surg. 2018 Jan 17;13(1):10. doi: 10.1186/s13019-018-0700-2. Review.', 'Marmelo F, Rocha V, Moreira-Gon√ßalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018 Mar;25(4):404-417. doi: 10.1177/2047487317752373. Epub 2018 Jan 17. Erratum in: Eur J Prev Cardiol. 2018 Jun;25(9):NP2.']",2020-06-09,https://clinicaltrials.gov/show/NCT04393636,2022-12-31,0,1
1566,NCT04395807,Terminated,2021-04-12,2021-04-12,No Results Posted,"['Tverring J, √Ökesson A, Nielsen N. Helmet continuous positive airway pressure versus high-flow nasal cannula in COVID-19: a pragmatic randomised clinical trial (COVID HELMET). Trials. 2020 Dec 3;21(1):994. doi: 10.1186/s13063-020-04863-5.']",,2021-04-15,https://clinicaltrials.gov/show/NCT04395807,2021-04-12,0,1
1567,NCT04397510,Enrolling by invitation,2021-12-31,2021-12-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-02-23,https://clinicaltrials.gov/show/NCT04397510,2021-12-31,0,1
1568,NCT04401293,Completed,2021-05-14,2021-05-14,Study Results,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI; HEP-COVID Investigators. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203. Erratum in: JAMA Intern Med. 2022 Feb 1;182(2):239.', 'Short SAP, Gupta S, Brenner SK, Hayek SS, Srivastava A, Shaefi S, Singh H, Wu B, Bagchi A, Al-Samkari H, Dy R, Wilkinson K, Zakai NA, Leaf DE; STOP-COVID Investigators. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 May 1;49(5):e500-e511. doi: 10.1097/CCM.0000000000004917.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-11-22,https://clinicaltrials.gov/show/NCT04401293,2021-05-14,1,1
1569,NCT04401436,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04401436,2023-12-31,0,0
1570,NCT04402060,Completed,2021-02-13,2021-02-13,Study Results,,,2022-03-23,https://clinicaltrials.gov/show/NCT04402060,2021-02-13,1,0
1571,NCT04403100,Recruiting,2021-02-01,2021-02-01,Results Submitted,"['Reis G, Moreira Silva EADS, Medeiros Silva DC, Thabane L, Singh G, Park JJH, Forrest JI, Harari O, Quirino Dos Santos CV, Guimar√£es de Almeida APF, Figueiredo Neto AD, Savassi LCM, Milagres AC, Teixeira MM, Simplicio MIC, Ribeiro LB, Oliveira R, Mills EJ; TOGETHER Investigators. Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial. JAMA Netw Open. 2021 Apr 1;4(4):e216468. doi: 10.1001/jamanetworkopen.2021.6468. Erratum in: JAMA Netw Open. 2021 Sep 1;4(9):e2130442.']",,2021-01-26,https://clinicaltrials.gov/show/NCT04403100,2021-02-01,0,1
1572,NCT04403828,Completed,2020-06-01,2020-07-15,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04403828,2020-06-01,0,0
1573,NCT04404270,Completed,2021-03-13,2021-03-13,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04404270,2021-03-13,0,0
1574,NCT04408001,"Active, not recruiting",2021-09-30,2021-09-30,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04408001,2021-09-30,0,0
1575,NCT04412265,Recruiting,2021-06-30,2021-12-31,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04412265,2021-06-30,0,0
1576,NCT04412356,Completed,2021-06-01,2021-09-20,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04412356,2021-06-01,0,0
1577,NCT04413747,Not yet recruiting,2021-06-01,2021-09-30,No Results Posted,,,2020-08-07,https://clinicaltrials.gov/show/NCT04413747,2021-06-01,0,0
1578,NCT04415086,"Active, not recruiting",2022-04-20,2022-05-22,No Results Posted,"['Song ATW, Rocha V, Mendrone-J√∫nior A, Calado RT, De Santis GC, Benites BD, Costa-Lima C, Vargas T, Marques LS, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Avelino-Silva VI, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Reg Health Am. 2022 Jun;10:100216. doi: 10.1016/j.lana.2022.100216. Epub 2022 Mar 15.']",,2021-10-27,https://clinicaltrials.gov/show/NCT04415086,2022-04-20,0,1
1579,NCT04415879,Completed,2020-08-01,2020-08-01,No Results Posted,,,2020-08-13,https://clinicaltrials.gov/show/NCT04415879,2020-08-01,0,0
1580,NCT04416399,Terminated,2021-01-12,2021-01-12,No Results Posted,"['Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9. Erratum in: Lancet Respir Med. 2021 Jun;9(6):e55.', 'Farne H, Singanayagam A. Reply. J Allergy Clin Immunol. 2021 Mar;147(3):1117-1118. doi: 10.1016/j.jaci.2020.11.019. Epub 2020 Dec 30.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2021-02-08,https://clinicaltrials.gov/show/NCT04416399,2021-01-12,0,1
1581,NCT04417374,Completed,2020-05-30,2020-06-30,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04417374,2020-05-30,0,0
1582,NCT04418128,Not yet recruiting,2021-03-30,2021-04-30,No Results Posted,"['Moon K, Hong KW, Bae IG. Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial. Trials. 2021 Nov 23;22(1):832. doi: 10.1186/s13063-021-05760-1.']","['Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Hoffmann M, Schroeder S, Kleine-Weber H, M√ºller MA, Drosten C, P√∂hlmann S. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 May 21;64(6). pii: e00754-20. doi: 10.1128/AAC.00754-20. Print 2020 May 21.']",2020-06-09,https://clinicaltrials.gov/show/NCT04418128,2021-03-30,0,1
1583,NCT04418193,Withdrawn,2021-02-04,2021-02-04,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04418193,2021-02-04,0,0
1584,NCT04418206,Recruiting,2022-12-01,2023-06-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04418206,2022-12-01,0,0
1585,NCT04418245,"Active, not recruiting",2021-09-01,2021-09-01,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04418245,2021-09-01,0,0
1586,NCT04418375,"Active, not recruiting",2022-08-01,2022-08-01,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04418375,2022-08-01,0,0
1587,NCT04418505,"Active, not recruiting",2021-07-30,2021-09-30,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04418505,2021-07-30,0,0
1588,NCT04418518,Terminated,2021-03-05,2021-06-16,Study Results,"['B√©gin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussi√®res G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chass√© M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A; CONCOR-1 Study Group, Arnold DM. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. 2021 Nov;27(11):2012-2024. doi: 10.1038/s41591-021-01488-2. Epub 2021 Sep 9. Erratum in: Nat Med. 2022 Jan;28(1):212.', 'B√©gin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chass√© M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair MC, Cerro S, Avram M, Arnold DM. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 2021 May 4;22(1):323. doi: 10.1186/s13063-021-05235-3.']",,2022-03-03,https://clinicaltrials.gov/show/NCT04418518,2021-03-05,1,1
1589,NCT04348656,Terminated,2021-03-05,2021-06-16,Study Results,"['B√©gin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussi√®res G, Amorim L, Bazin R, Loftsgard KC, Carl R, Chass√© M, Cushing MM, Daneman N, Devine DV, Dumaresq J, Fergusson DA, Gabe C, Glesby MJ, Li N, Liu Y, McGeer A, Robitaille N, Sachais BS, Scales DC, Schwartz L, Shehata N, Turgeon AF, Wood H, Zarychanski R, Finzi A; CONCOR-1 Study Group, Arnold DM. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. 2021 Nov;27(11):2012-2024. doi: 10.1038/s41591-021-01488-2. Epub 2021 Sep 9. Erratum in: Nat Med. 2022 Jan;28(1):212.', 'B√©gin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chass√© M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair MC, Cerro S, Avram M, Arnold DM. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 2021 May 4;22(1):323. doi: 10.1186/s13063-021-05235-3.']",,2022-03-03,https://clinicaltrials.gov/show/NCT04348656,2021-03-05,1,1
1590,NCT04418531,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-06-05,https://clinicaltrials.gov/show/NCT04418531,2020-09-01,0,0
1591,NCT04418557,Recruiting,2021-07-31,2021-07-31,No Results Posted,,"['Dong L, Tian J, He S, Zhu C, Wang J, Liu C, Yang J. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020 May 12;323(18):1846-1848. doi: 10.1001/jama.2020.4621.', 'Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.']",2021-04-01,https://clinicaltrials.gov/show/NCT04418557,2021-07-31,0,1
1592,NCT04418609,Recruiting,2022-04-30,2022-05-30,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04418609,2022-04-30,0,0
1593,NCT04419571,Completed,2020-06-16,2020-06-16,No Results Posted,,,2020-07-23,https://clinicaltrials.gov/show/NCT04419571,2020-06-16,0,0
1594,NCT04419623,Completed,2020-09-22,2020-12-15,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04419623,2020-09-22,0,0
1595,NCT04420182,Recruiting,2022-02-11,2023-01-01,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04420182,2022-02-11,0,0
1596,NCT04420260,Completed,2021-06-23,2021-07-05,No Results Posted,,"['Schindewolf C, Menachery VD. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses. 2019 Jan 17;11(1). pii: E74. doi: 10.3390/v11010074. Review.']",2021-07-15,https://clinicaltrials.gov/show/NCT04420260,2021-06-23,0,1
1597,NCT04420273,Completed,2021-03-01,2021-03-01,Study Results,,,2021-11-23,https://clinicaltrials.gov/show/NCT04420273,2021-03-01,1,0
1598,NCT04420286,Completed,2020-06-12,2020-06-12,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04420286,2020-06-12,0,0
1599,NCT04420364,Withdrawn,2021-05-04,2021-05-04,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04420364,2021-05-04,0,0
1600,NCT04420390,Recruiting,2020-07-31,2020-09-08,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04420390,2020-07-31,0,0
1601,NCT04420416,Recruiting,2020-07-30,2020-07-30,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04420416,2020-07-30,0,0
1602,NCT04420468,Recruiting,2021-08-01,2021-08-01,No Results Posted,"['Borgel D, Chocron R, Grimaud M, Philippe A, Chareyre J, Brakta C, Lasne D, Bonnet D, Toubiana J, Angoulvant F, Desvages M, Renolleau S, Smadja DM, Oualha M. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock. Crit Care Med. 2021 Nov 1;49(11):e1151-e1156. doi: 10.1097/CCM.0000000000005093.']",,2021-05-24,https://clinicaltrials.gov/show/NCT04420468,2021-08-01,0,1
1603,NCT04420637,Enrolling by invitation,2022-09-01,2022-12-01,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04420637,2022-09-01,0,0
1604,NCT04420676,"Active, not recruiting",2022-12-01,2023-12-01,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04420676,2022-12-01,0,0
1605,NCT04420806,Completed,2020-07-30,2020-10-30,No Results Posted,"['Kemmler W, Hettchen M, Kohl M, Murphy M, Bragonzoni L, Julin M, Risto T, von Stengel S. Detraining Effects on Musculoskeletal Parameters in Early Postmenopausal Osteopenic Women: 3-Month Follow-Up of the Randomized Controlled ACTLIFE Study. Calcif Tissue Int. 2021 Jul;109(1):1-11. doi: 10.1007/s00223-021-00829-0. Epub 2021 Mar 12.']",,2020-11-13,https://clinicaltrials.gov/show/NCT04420806,2020-07-30,0,1
1606,NCT04420988,,,,,"['Klapholz M, Pentakota SR, Zertuche JP, McKenna M, Roque W, Forsberg M, Packer J, Lal DS, Dever L. Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients. Open Forum Infect Dis. 2021 Jan 4;8(2):ofab001. doi: 10.1093/ofid/ofab001. eCollection 2021 Feb.']",,2021-08-02,https://clinicaltrials.gov/show/NCT04420988,,0,1
1607,NCT04421391,Recruiting,2020-11-01,2020-11-08,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04421391,2020-11-01,0,0
1608,NCT04421534,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04421534,2020-09-01,0,0
1609,NCT04421625,Recruiting,2022-06-15,2022-06-15,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04421625,2022-06-15,0,0
1610,NCT04421664,Terminated,2020-08-17,2020-08-17,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04421664,2020-08-17,0,0
1611,NCT04422379,Not yet recruiting,2020-07-30,2020-08-30,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04422379,2020-07-30,0,0
1612,NCT04422418,Recruiting,2020-12-14,2020-12-31,No Results Posted,"['Al Tunaiji H, Al Qubaisi M, Dalkilinc M, Campos LA, Ugwuoke NV, Alefishat E, Aloum L, Ross R, Almahmeed W, Baltatu OC. Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol: A Multicenter Exploratory Longitudinal Study. Front Med (Lausanne). 2020 Dec 22;7:571057. doi: 10.3389/fmed.2020.571057. eCollection 2020.']",,2020-11-03,https://clinicaltrials.gov/show/NCT04422418,2020-12-14,0,1
1613,NCT04422535,Recruiting,2020-09-01,2020-12-01,No Results Posted,,"['Fernandes FM, Silva EP, Martins RR, Oliveira AG. QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications. PLoS One. 2018 Jun 13;13(6):e0199028. doi: 10.1371/journal.pone.0199028. eCollection 2018.', 'Pickham D, Helfenbein E, Shinn JA, Chan G, Funk M, Drew BJ. How many patients need QT interval monitoring in critical care units? Preliminary report of the QT in Practice study. J Electrocardiol. 2010 Nov-Dec;43(6):572-6. doi: 10.1016/j.jelectrocard.2010.05.016.', 'Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ. Torsade de pointes: the clinical considerations. Int J Cardiol. 2004 Jul;96(1):1-6. Review.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.']",2020-06-09,https://clinicaltrials.gov/show/NCT04422535,2020-09-01,0,1
1614,NCT04422691,Terminated,2021-06-15,2021-06-15,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04422691,2021-06-15,0,0
1615,NCT04422769,Completed,2021-04-15,2021-04-15,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04422769,2021-04-15,0,0
1616,NCT04423042,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04423042,2021-06-01,0,0
1617,NCT04423315,Completed,2020-07-15,2020-07-20,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04423315,2020-07-15,0,0
1618,NCT04423692,Recruiting,2020-08-15,2020-08-20,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04423692,2020-08-15,0,0
1619,NCT04424134,Recruiting,2020-07-18,2020-08-23,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04424134,2020-07-18,0,0
1620,NCT04425616,Recruiting,2021-11-30,2022-11-30,No Results Posted,"['Grimmett C, Bates A, West M, Leggett S, Varkonyi-Sepp J, Campbell A, Davis J, Wootton S, Shaw C, Barlow R, Ashcroft J, Scott A, Moyes H, Hawkins L, Levett DZH, Williams F, Grocott MPW, Jack S. SafeFit Trial: virtual clinics to deliver a multimodal intervention to improve psychological and physical well-being in people with cancer. Protocol of a COVID-19 targeted non-randomised phase III trial. BMJ Open. 2021 Aug 26;11(8):e048175. doi: 10.1136/bmjopen-2020-048175.']",,2021-01-25,https://clinicaltrials.gov/show/NCT04425616,2021-11-30,0,1
1621,NCT03376854,Withdrawn,2021-04-27,2021-04-27,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT03376854,2021-04-27,0,0
1622,NCT04193878,Enrolling by invitation,2024-04-01,2024-06-01,No Results Posted,"['Levitt JE, Festic E, Desai M, Hedlin H, Mahaffey KW, Rogers AJ, Gajic O, Matthay MA; ARREST Pneumonia Clinical Trial Investigators. The ARREST Pneumonia Clinical Trial. Rationale and Design. Ann Am Thorac Soc. 2021 Apr;18(4):698-708. doi: 10.1513/AnnalsATS.202009-1115SD.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2021-03-19,,2024-04-01,0,1
1623,NCT04303507,"Active, not recruiting",2022-03-21,2022-03-21,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,2022-02-04,https://clinicaltrials.gov/show/NCT04303507,2022-03-21,0,1
1624,NCT04315987,Unknown,2020-08-01,2020-08-01,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04315987,2020-08-01,0,0
1625,NCT04322682,Terminated,2021-01-21,2021-01-21,Study Results,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.', ""Tardif JC, Bouabdallaoui N, L'Allier PL, Gaudet D, Shah B, Pillinger MH, Lopez-Sendon J, da Luz P, Verret L, Audet S, Dupuis J, Denault A, Pelletier M, Tessier PA, Samson S, Fortin D, Tardif JD, Busseuil D, Goulet E, Lacoste C, Dubois A, Joshi AY, Waters DD, Hsue P, Lepor NE, Lesage F, Sainturet N, Roy-Clavel E, Bassevitch Z, Orfanos A, Stamatescu G, Gr√©goire JC, Busque L, Lavall√©e C, H√©tu PO, Paquette JS, Deftereos SG, Levesque S, Cossette M, Nozza A, Chabot-Blanchet M, Dub√© MP, Guertin MC, Boivin G; COLCORONA Investigators. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. Lancet Respir Med. 2021 Aug;9(8):924-932. doi: 10.1016/S2213-2600(21)00222-8. Epub 2021 May 27.""]",,2021-09-08,https://clinicaltrials.gov/show/NCT04322682,2021-01-21,1,1
1626,NCT04325906,Completed,2021-01-26,2021-02-21,Study Results,,"['Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.', 'Kaur R, Vines DL, Mirza S, Elshafei A, Jackson JA, Harnois LJ, Weiss T, Scott JB, Trump MW, Mogri I, Cerda F, Alolaiwat AA, Miller AR, Klein AM, Oetting TW, Morris L, Heckart S, Capouch L, He H, Li J. Early versus late awake prone positioning in non-intubated patients with COVID-19. Crit Care. 2021 Sep 17;25(1):340. doi: 10.1186/s13054-021-03761-9.']",2022-03-02,https://clinicaltrials.gov/show/NCT04325906,2021-01-26,1,1
1627,NCT04331795,Completed,2020-06-05,2020-06-05,Results Submitted,,"['Strohbehn GW, Heiss BL, Rouhani SJ, Trujillo JA, Yu J, Kacew AJ, Higgs EF, Bloodworth JC, Cabanov A, Wright RC, Koziol AK, Weiss A, Danahey K, Karrison TG, Edens CC, Bauer Ventura I, Pettit NN, Patel BK, Pisano J, Strek ME, Gajewski TF, Ratain MJ, Reid PD. COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 Mar;109(3):688-696. doi: 10.1002/cpt.2117. Epub 2020 Dec 10.']",2021-03-09,https://clinicaltrials.gov/show/NCT04331795,2020-06-05,0,1
1628,NCT04334460,"Active, not recruiting",2020-11-11,2021-11-01,Results Submitted,,,2021-02-23,https://clinicaltrials.gov/show/NCT04334460,2020-11-11,0,0
1629,NCT04335786,Terminated,2021-05-25,2021-05-25,No Results Posted,"['Gommans DHF, Nas J, Pinto-Sietsma SJ, Koop Y, Konst RE, Mensink F, Aarts GWA, Konijnenberg LSF, Cortenbach K, Verhaert DVM, Thannhauser J, Mol JQ, Rooijakkers MJP, Vos JL, van Rumund A, Vart P, Hassing RJ, Cornel JH, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Royen N, van Kimmenade RRJ; Event committee, de Leeuw PW, van Agtmael MA, Bresser P; Data Safety Monitoring Board, van Gilst WH, Vonk-Noordergraaf A, Tijssen JGP; Steering committee, van Royen N, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Kimmenade RRJ. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease. Am Heart J. 2020 Aug;226:60-68. doi: 10.1016/j.ahj.2020.05.010. Epub 2020 May 21.']",,2021-09-24,https://clinicaltrials.gov/show/NCT04335786,2021-05-25,0,1
1630,NCT04337320,Completed,2020-05-25,2020-05-30,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04337320,2020-05-25,0,0
1631,NCT04337996,Completed,2021-01-13,2021-01-13,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04337996,2021-01-13,0,0
1632,NCT04338074,Terminated,2021-04-21,2021-04-21,Study Results,,,2021-05-13,https://clinicaltrials.gov/show/NCT04338074,2021-04-21,1,0
1633,NCT04341116,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-02,https://clinicaltrials.gov/show/NCT04341116,2021-12-01,0,1
1634,NCT04341922,"Active, not recruiting",2020-08-20,2021-09-10,No Results Posted,"['Wahlund T, Mataix-Cols D, Olofsdotter Lauri K, de Schipper E, Lj√≥tsson B, Aspvall K, Andersson E. Brief Online Cognitive Behavioural Intervention for Dysfunctional Worry Related to the COVID-19 Pandemic: A Randomised Controlled Trial. Psychother Psychosom. 2021;90(3):191-199. doi: 10.1159/000512843. Epub 2020 Nov 19.']",,2020-10-19,https://clinicaltrials.gov/show/NCT04341922,2020-08-20,0,1
1635,NCT04342884,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Peacock JE Jr, Herrington DM, Edelstein SL, Seals AL, Plumb ID, Saydah S, Lagarde WH, Runyon MS, Maguire PD, Correa A, Weintraub WS, Wierzba TF, Sanders JW; COVID-19 Community Research Partnership Study Group. Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research Partnership. J Community Health. 2022 Feb;47(1):71-78. doi: 10.1007/s10900-021-01021-z. Epub 2021 Aug 12.']",,2021-12-21,https://clinicaltrials.gov/show/NCT04342884,2022-04-01,0,1
1636,NCT04343651,Completed,2020-07-21,2021-09-20,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04343651,2020-07-21,0,0
1637,NCT04344145,Completed,2020-05-25,2020-05-29,No Results Posted,"['Tiete J, Guatteri M, Lachaux A, Matossian A, Hougardy JM, Loas G, Rotsaert M. Mental Health Outcomes in Healthcare Workers in COVID-19 and Non-COVID-19 Care Units: A Cross-Sectional Survey in Belgium. Front Psychol. 2021 Jan 5;11:612241. doi: 10.3389/fpsyg.2020.612241. eCollection 2020.']","['Vandenbroeck S, Van Gerven E, De Witte H, Vanhaecht K, Godderis L. Burnout in Belgian physicians and nurses. Occup Med (Lond). 2017 Oct 1;67(7):546-554. doi: 10.1093/occmed/kqx126.', 'Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, West CP, Sloan J, Oreskovich MR. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012 Oct 8;172(18):1377-85.', 'Wurm W, Vogel K, Holl A, Ebner C, Bayer D, M√∂rkl S, Szilagyi IS, Hotter E, Kapfhammer HP, Hofmann P. Depression-Burnout Overlap in Physicians. PLoS One. 2016 Mar 1;11(3):e0149913. doi: 10.1371/journal.pone.0149913. eCollection 2016.', 'Aiken LH, Clarke SP, Sloane DM, Sochalski J, Silber JH. Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA. 2002 Oct 23-30;288(16):1987-93.', 'Shanafelt TD, Hasan O, Dyrbye LN, Sinsky C, Satele D, Sloan J, West CP. Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014. Mayo Clin Proc. 2015 Dec;90(12):1600-13. doi: 10.1016/j.mayocp.2015.08.023. Erratum in: Mayo Clin Proc. 2016 Feb;91(2):276.', 'van der Heijden F, Dillingh G, Bakker A, Prins J. Suicidal thoughts among medical residents with burnout. Arch Suicide Res. 2008;12(4):344-6. doi: 10.1080/13811110802325349.', 'Shanafelt TD, Mungo M, Schmitgen J, Storz KA, Reeves D, Hayes SN, Sloan JA, Swensen SJ, Buskirk SJ. Longitudinal Study Evaluating the Association Between Physician Burnout and Changes in Professional Work Effort. Mayo Clin Proc. 2016 Apr;91(4):422-31. doi: 10.1016/j.mayocp.2016.02.001.', 'West CP, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA. 2006 Sep 6;296(9):1071-8.', 'West CP, Tan AD, Habermann TM, Sloan JA, Shanafelt TD. Association of resident fatigue and distress with perceived medical errors. JAMA. 2009 Sep 23;302(12):1294-300. doi: 10.1001/jama.2009.1389.', 'Fahrenkopf AM, Sectish TC, Barger LK, Sharek PJ, Lewin D, Chiang VW, Edwards S, Wiedermann BL, Landrigan CP. Rates of medication errors among depressed and burnt out residents: prospective cohort study. BMJ. 2008 Mar 1;336(7642):488-91. doi: 10.1136/bmj.39469.763218.BE. Epub 2008 Feb 7.', 'Linzer M, Visser MR, Oort FJ, Smets EM, McMurray JE, de Haes HC; Society of General Internal Medicine (SGIM) Career Satisfaction Study Group (CSSG). Predicting and preventing physician burnout: results from the United States and the Netherlands. Am J Med. 2001 Aug;111(2):170-5.', 'Meo SA, Alhowikan AM, Al-Khlaiwi T, Meo IM, Halepoto DM, Iqbal M, Usmani AM, Hajjar W, Ahmed N. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.', 'Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists. Anaesthesia. 2020 Jun;75(6):785-799. doi: 10.1111/anae.15054. Epub 2020 Apr 1.', 'Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020 Mar;83(3):217-220. doi: 10.1097/JCMA.0000000000000270.', 'Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R, Tan H, Kang L, Yao L, Huang M, Wang H, Wang G, Liu Z, Hu S. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw Open. 2020 Mar 2;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976.', 'Trockel M, Bohman B, Lesure E, Hamidi MS, Welle D, Roberts L, Shanafelt T. A Brief Instrument to Assess Both Burnout and Professional Fulfillment in Physicians: Reliability and Validity, Including Correlation with Self-Reported Medical Errors, in a Sample of Resident and Practicing Physicians. Acad Psychiatry. 2018 Feb;42(1):11-24. doi: 10.1007/s40596-017-0849-3. Epub 2017 Dec 1.', 'Antony, MM, Bieling, PJ, Cox, BJ, Enns, MW, Swinson, RP. (1998). Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychological Assessment 10, 176-81.', 'Lovibond, SH, Lovibond, PF. (1995). Manual for the Depression Anxiety & Stress Scales (2nd Ed.) Sydney: Psychology Foundation.', 'Morin, CM. (1993). Insomnia: Psychological assessment and management. New York: Guilford Press']",2020-09-09,https://clinicaltrials.gov/show/NCT04344145,2020-05-25,0,1
1638,NCT04344288,Terminated,2020-08-18,2020-08-18,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04344288,2020-08-18,0,0
1639,NCT04344925,Terminated,2020-11-27,2020-11-27,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04344925,2020-11-27,0,0
1640,NCT04344977,Completed,2020-11-20,2021-03-03,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04344977,2020-11-20,0,0
1641,NCT04345861,Terminated,2021-02-09,2021-04-09,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04345861,2021-02-09,0,0
1642,NCT04346121,Completed,2020-06-29,2020-06-29,No Results Posted,"['Fournier JP, Am√©lineau JB, Hild S, Nguyen-Soenen J, Daviot A, Simonneau B, Bowie P, Donaldson L, Carson-Stevens A. Patient-safety incidents during COVID-19 health crisis in France: An exploratory sequential multi-method study in primary care. Eur J Gen Pract. 2021 Dec;27(1):142-151. doi: 10.1080/13814788.2021.1945029.']",,2020-10-19,https://clinicaltrials.gov/show/NCT04346121,2020-06-29,0,1
1643,NCT04346628,Completed,2021-04-16,2021-04-16,No Results Posted,"['Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, Singh U, Jagannathan P, Grant P. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021 Aug 2;73(3):e826-e829. doi: 10.1093/cid/ciab103.']",,2021-04-20,https://clinicaltrials.gov/show/NCT04346628,2021-04-16,0,1
1644,NCT04347174,Completed,2020-08-10,2020-08-21,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04347174,2020-08-10,0,0
1645,NCT04347239,"Active, not recruiting",2021-10-24,2022-06-15,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04347239,2021-10-24,0,0
1646,NCT04348409,Recruiting,2020-07-31,2020-07-31,No Results Posted,"['Blum VF, Cimerman S, Hunter JR, Tierno P, Lacerda A, Soeiro A, Cardoso F, Bellei NC, Maricato J, Mantovani N, Vassao M, Dias D, Galinskas J, Janini LMR, Santos-Oliveira JR, Da-Cruz AM, Diaz RS. Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial. EClinicalMedicine. 2021 Jul;37:100981. doi: 10.1016/j.eclinm.2021.100981. Epub 2021 Jun 27. Erratum in: EClinicalMedicine. 2021 Nov;41:101203.']",,2020-06-09,https://clinicaltrials.gov/show/NCT04348409,2020-07-31,0,1
1647,NCT04348552,Recruiting,2020-06-28,2020-06-28,No Results Posted,,,2020-06-29,https://clinicaltrials.gov/show/NCT04348552,2020-06-28,0,0
1648,NCT04351152,"Active, not recruiting",2021-03-01,2021-03-01,No Results Posted,"['Temesgen Z, Burger CD, Baker J, Polk C, Libertin CR, Kelley CF, Marconi VC, Orenstein R, Catterson VM, Aronstein WS, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD; LIVE-AIR Study Group. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022 Mar;10(3):237-246. doi: 10.1016/S2213-2600(21)00494-X. Epub 2021 Dec 1.', 'Temesgen Z, Burger CD, Baker J, Polk C, Libertin C, Kelley C, Marconi VC, Orenstein R, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD. LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL. medRxiv. 2021 May 5. pii: 2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470.', 'Aroldi A, Chiarle R, Gambacorti-Passerini C. Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019. Mayo Clin Proc. 2021 Mar;96(3):817. doi: 10.1016/j.mayocp.2020.12.030. Epub 2021 Jan 11.', 'Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov;95(11):2382-2394. doi: 10.1016/j.mayocp.2020.08.038. Epub 2020 Sep 3.']",,2021-03-03,https://clinicaltrials.gov/show/NCT04351152,2021-03-01,0,1
1649,NCT04351503,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Stange M, Mari A, Roloff T, Seth-Smith HM, Schweitzer M, Brunner M, Leuzinger K, S√∏gaard KK, Gensch A, Tschudin-Sutter S, Fuchs S, Bielicki J, Pargger H, Siegemund M, Nickel CH, Bingisser R, Osthoff M, Bassetti S, Schneider-Sliwa R, Battegay M, Hirsch HH, Egli A. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021 Mar 19;17(3):e1009374. doi: 10.1371/journal.ppat.1009374. eCollection 2021 Mar.']","['Sava M, Sommer G, Daikeler T, Woischnig AK, Martinez AE, Leuzinger K, Hirsch HH, Erlanger T, Wiencierz A, Bassetti S, Tamm M, Tschudin-Sutter S, Stoeckle M, Pargger H, Siegemund M, Boss R, Zimmer G, Vu DL, Kaiser L, Dell-Kuster S, Weisser M, Battegay M, Hostettler K, Khanna N. Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. Swiss Med Wkly. 2021 Aug 10;151:w20550. doi: 10.4414/smw.2021.20550. eCollection 2021 Aug 2.']",2021-08-27,https://clinicaltrials.gov/show/NCT04351503,2022-04-01,0,1
1650,NCT04353596,Completed,2021-02-16,2021-02-24,No Results Posted,"['Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, G√§nzer H, von Bary C, May AE, W√∂ll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, K√§√§b S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von St√ºlpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021 Aug;9(8):863-872. doi: 10.1016/S2213-2600(21)00214-9. Epub 2021 Jun 11. Erratum in: Lancet Respir Med. 2021 Aug 6;:.']",,2021-03-02,https://clinicaltrials.gov/show/NCT04353596,2021-02-16,0,1
1651,NCT04355351,Recruiting,2021-10-22,2021-10-22,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04355351,2021-10-22,0,0
1652,NCT04356495,Completed,2021-10-08,2021-10-22,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Cr√©mer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lef√®vre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thi√©baut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D; COVERAGE study group. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1.']",,2022-02-04,,2021-10-08,0,1
1653,NCT04358588,,,,,,,2020-06-12,https://clinicaltrials.gov/show/NCT04358588,,0,0
1654,NCT04360278,Recruiting,2030-04-14,2030-04-14,No Results Posted,"['De Giorgi V, West KA, Henning AN, Chen LN, Holbrook MR, Gross R, Liang J, Postnikova E, Trenbeath J, Pogue S, Scinto T, Alter HJ, Cantilena CC. Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection. J Infect Dis. 2021 Oct 28;224(8):1294-1304. doi: 10.1093/infdis/jiab295.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04360278,2030-04-14,0,1
1655,NCT04361474,Completed,2020-11-24,2021-06-25,No Results Posted,"['Daval M, Corr√© A, Palpacuer C, Housset J, Poillon G, Eliezer M, Verillaud B, Slama D, Ayache D, Herman P, Jourdaine C, Herv√© C, El Bakkouri W, Salmon D, Hautefort C. Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jul 20;21(1):666. doi: 10.1186/s13063-020-04585-8.']",,2021-08-03,https://clinicaltrials.gov/show/NCT04361474,2020-11-24,0,1
1656,NCT04362813,Completed,2020-09-16,2020-12-22,Study Results,"['Sedhai YR, Sears M, Vecchi√® A, Bonaventura A, Greer J, Spence K, Tackett H, Turner J, Pak M, Patel N, Black M, Wohlford G, Clary RE, Duke C, Hardin M, Kemp H, Priday A, Sims EK Jr, Mihalick V, Ho AC, Ibe I, Harmon M, Markley R, Van Tassell B, Abbate A. Clinical trial enrollment at a rural satellite hospital during COVID-19 pandemic. J Clin Transl Sci. 2021 Apr 8;5(1):e136. doi: 10.1017/cts.2021.777. eCollection 2021.', 'Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, G√≥nzalez-Garc√≠a A, Chen Y, Li Y, Whelan S, Noviello S; CAN-COVID Investigators. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jul 20;326(3):230-239. doi: 10.1001/jama.2021.9508.']",,2022-01-24,https://clinicaltrials.gov/show/NCT04362813,2020-09-16,1,1
1657,NCT04363606,Recruiting,2022-04-01,2022-12-01,No Results Posted,,,2021-04-20,https://clinicaltrials.gov/show/NCT04363606,2022-04-01,0,0
1658,NCT04365595,Completed,2021-02-17,2021-02-17,No Results Posted,,,2021-02-23,https://clinicaltrials.gov/show/NCT04365595,2021-02-17,0,0
1659,NCT04366232,Terminated,2020-10-02,2020-10-02,No Results Posted,,"['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zalinger ZB, Elliott R, Weiss SR. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus. J Neurovirol. 2017 Dec;23(6):845-854. doi: 10.1007/s13365-017-0574-4. Epub 2017 Sep 11.']",2020-12-16,https://clinicaltrials.gov/show/NCT04366232,2020-10-02,0,1
1660,NCT04366245,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04366245,2021-12-01,0,0
1661,NCT04368871,Recruiting,2020-06-30,2021-05-30,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04368871,2020-06-30,0,0
1662,NCT04369599,Enrolling by invitation,2022-12-01,2022-12-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04369599,2022-12-01,0,0
1663,NCT04373798,Completed,2020-08-30,2021-03-30,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04373798,2020-08-30,0,0
1664,NCT04375098,Completed,2020-08-17,2020-08-17,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Balcells ME, Rojas L, Le Corre N, Mart√≠nez-Valdebenito C, Ceballos ME, Ferr√©s M, Chang M, Vizcaya C, Mondaca S, Huete √Å, Castro R, Sarmiento M, Villarroel L, Pizarro A, Ross P, Santander J, Lara B, Ferrada M, Vargas-Salas S, Beltr√°n-Pavez C, Soto-Rifo R, Valiente-Echeverr√≠a F, Caglevic C, Mahave M, Selman C, Gazit√∫a R, Briones JL, Villarroel-Espindola F, Balmaceda C, Espinoza MA, Pereira J, Nervi B. Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial. PLoS Med. 2021 Mar 3;18(3):e1003415. doi: 10.1371/journal.pmed.1003415. eCollection 2021 Mar.']",,2020-09-16,https://clinicaltrials.gov/show/NCT04375098,2020-08-17,0,1
1665,NCT04375735,Completed,2021-09-01,2021-10-06,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04375735,2021-09-01,0,0
1666,NCT04377711,Completed,2021-01-05,2021-01-05,Study Results,"['Clemency BM, Varughese R, Gonzalez-Rojas Y, Morse CG, Phipatanakul W, Koster DJ, Blaiss MS. Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA Intern Med. 2022 Jan 1;182(1):42-49. doi: 10.1001/jamainternmed.2021.6759.', 'Farne H, Singanayagam A. Reply. J Allergy Clin Immunol. 2021 Mar;147(3):1117-1118. doi: 10.1016/j.jaci.2020.11.019. Epub 2020 Dec 30.', 'Nicolau DV, Bafadhel M. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04377711,2021-01-05,1,1
1667,NCT04379531,Completed,2020-05-22,2020-05-22,No Results Posted,,,2020-06-12,https://clinicaltrials.gov/show/NCT04379531,2020-05-22,0,0
1668,NCT04380961,Completed,2021-04-09,2021-06-24,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04380961,2021-04-09,0,0
1669,NCT04381013,Withdrawn,2021-07-01,2021-07-01,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04381013,2021-07-01,0,0
1670,NCT04382768,Recruiting,2021-01-01,2021-01-01,No Results Posted,"['Salva O, Doreski PA, Giler CS, Quinodoz DC, Guzm√°n LG, Mu√±oz SE, Carrillo MN, Porta DJ, Ambasch G, Coscia E, Diaz JLT, Bueno GD, Fandi JO, Maldonado MA, Pe√±a Chiappero LE, Fournier F, P√©rez HA, Quiroga MA, Sala Mercado JA, Mart√≠nez Picco C, Beltr√°n MA, Arga√±ar√°s LA, R√≠os NM, Kalayan GI, Beltramo DM, Garc√≠a NH. Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program. Infect Dis Ther. 2021 Dec;10(4):2511-2524. doi: 10.1007/s40121-021-00527-2. Epub 2021 Aug 30.']","['Mu√±oz AJ, Alasino RV, Garro AG, Heredia V, Garc√≠a NH, Cremonezzi DC, Beltramo DM. High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens. Pharmaceuticals (Basel). 2018 May 17;11(2). pii: E47. doi: 10.3390/ph11020047.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Veljkovic V, Vergara-Alert J, Segal√©s J, Paessler S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target. Version 4. F1000Res. 2020 Jan 27 [revised 2021 Jan 1];9:52. doi: 10.12688/f1000research.22149.4. eCollection 2020.']",2020-06-11,https://clinicaltrials.gov/show/NCT04382768,2021-01-01,0,1
1671,NCT04383899,Withdrawn,2020-10-31,2020-11-30,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04383899,2020-10-31,0,0
1672,NCT04385160,Recruiting,2022-02-15,2022-08-31,No Results Posted,,,2021-11-12,https://clinicaltrials.gov/show/NCT04385160,2022-02-15,0,0
1673,NCT04386694,Completed,2020-09-17,2020-09-17,No Results Posted,"['De Marchi T, Fr√¢ncio F, Ferlito JV, Weigert R, de Oliveira C, Merlo AP, Pandini DL, Pasqual-J√∫nior BA, Giovanella D, Tomazoni SS, Leal-Junior EC. Effects of Photobiomodulation Therapy Combined with Static Magnetic Field in Severe COVID-19 Patients Requiring Intubation: A Pragmatic Randomized Placebo-Controlled Trial. J Inflamm Res. 2021 Jul 24;14:3569-3585. doi: 10.2147/JIR.S318758. eCollection 2021.']",,2020-10-29,https://clinicaltrials.gov/show/NCT04386694,2020-09-17,0,1
1674,NCT04386850,Recruiting,2020-11-15,2021-03-15,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.']",,2020-06-12,https://clinicaltrials.gov/show/NCT04386850,2020-11-15,0,1
1675,NCT04388813,"Active, not recruiting",2021-10-01,2021-10-01,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04388813,2021-10-01,0,0
1676,NCT04389450,"Active, not recruiting",2021-05-17,2022-06-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04389450,2021-05-17,0,0
1677,NCT04389489,Recruiting,2020-09-25,2020-09-30,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04389489,2020-09-25,0,0
1678,NCT04389515,Recruiting,2020-09-25,2020-09-30,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04389515,2020-09-25,0,0
1679,NCT04390516,Completed,2020-05-04,2020-05-30,No Results Posted,,,2020-06-12,https://clinicaltrials.gov/show/NCT04390516,2020-05-04,0,0
1680,NCT04391127,Completed,2020-11-06,2020-11-06,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04391127,2020-11-06,0,0
1681,NCT04391166,Completed,2020-07-10,2020-12-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04391166,2020-07-10,0,0
1682,NCT04393142,Completed,2021-02-16,2021-02-16,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04393142,2021-02-16,0,0
1683,NCT04394078,Completed,2020-05-18,2020-05-18,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04394078,2020-05-18,0,0
1684,NCT04395170,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, Ng MH, Chan P, Cheng G, Sung JJ. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004 Jul;10(7):676-8.', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Francis F, Hall M, Surg, Gaines A. Early use of convalescent serum in influenza. Mil Surg. 1920;47:177-9.', 'rice H, Genereux M, Sinclair C. Hyperimmune Immunoglobulin G. In: Production of Plasma Proteins for Therapeutic Use [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2012.', 'Vargas M, Segura √Å, Wu YW, Herrera M, Chou ML, Villalta M, Le√≥n G, Burnouf T. Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity. Vox Sang. 2015 Feb;108(2):169-77. doi: 10.1111/vox.12209. Epub 2014 Dec 3.', 'Redden WR. Treatment of Influenza-Pneumonia by Use of Convalescent Human Serum. Bost Med Surg J. 1919 Dec 11;181(24):688-91.', 'Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Jun;9(3):199-201.', 'van Griensven J, Edwards T, Baize S; Ebola-Tx Consortium. Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies. N Engl J Med. 2016 Dec 8;375(23):2307-2309. doi: 10.1056/NEJMc1609116. Epub 2016 Nov 14.', 'Zingher A, Mortimer P. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187. Rev Med Virol. 2005 Nov-Dec;15(6):407-18; discussion 418-21.', 'Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks Interim Guidance for National Health Authorities and Blood Transfusion Services Use of Convale. 2014.', 'FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency | FDA [Internet]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency']",2020-07-10,https://clinicaltrials.gov/show/NCT04395170,2020-12-01,0,1
1685,NCT04463004,Completed,2020-11-30,2020-11-30,Study Results,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,2021-08-11,https://clinicaltrials.gov/show/NCT04463004,2020-11-30,1,1
1686,NCT04492514,Recruiting,2021-05-31,2021-05-31,No Results Posted,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,2020-07-30,https://clinicaltrials.gov/show/NCT04492514,2021-05-31,0,1
1687,NCT04399980,Completed,2021-04-23,2021-04-23,Study Results,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,2021-05-13,https://clinicaltrials.gov/show/NCT04399980,2021-04-23,1,1
1688,NCT04400877,Completed,2020-07-30,2020-09-30,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04400877,2020-07-30,0,0
1689,NCT04403880,"Active, not recruiting",2022-03-31,2022-03-31,No Results Posted,"['Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D; HVTN 405/HPTN 1901 Study Team. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Med. 2021 Dec 6;18(12):e1003868. doi: 10.1371/journal.pmed.1003868. eCollection 2021 Dec.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04403880,2022-03-31,0,1
1690,NCT04405466,Recruiting,2020-08-28,2021-01-31,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04405466,2020-08-28,0,0
1691,NCT04407546,Recruiting,2022-05-28,2023-05-28,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04407546,2022-05-28,0,0
1692,NCT04409249,Completed,2020-05-25,2020-05-28,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04409249,2020-05-25,0,0
1693,NCT04409886,Terminated,2021-01-31,2021-01-31,Study Results,,,2021-06-29,https://clinicaltrials.gov/show/NCT04409886,2021-01-31,1,0
1694,NCT04410016,Completed,2020-07-31,2020-10-30,No Results Posted,,"['Blake H, Gupta A, Javed M, Wood B, Knowles S, Coyne E, Cooper J. COVID-Well Study: Qualitative Evaluation of Supported Wellbeing Centres and Psychological First Aid for Healthcare Workers during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021 Mar 31;18(7). pii: 3626. doi: 10.3390/ijerph18073626.', 'Blake H, Yildirim M, Wood B, Knowles S, Mancini H, Coyne E, Cooper J. COVID-Well: Evaluation of the Implementation of Supported Wellbeing Centres for Hospital Employees during the COVID-19 Pandemic. Int J Environ Res Public Health. 2020 Dec 15;17(24). pii: E9401. doi: 10.3390/ijerph17249401.']",2021-08-30,https://clinicaltrials.gov/show/NCT04410016,2020-07-31,0,1
1695,NCT04410835,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04410835,2022-04-30,0,0
1696,NCT04412252,Withdrawn,2020-09-16,2020-10-18,No Results Posted,,,2020-07-31,https://clinicaltrials.gov/show/NCT04412252,2020-09-16,0,0
1697,NCT04412278,Completed,2020-06-08,2020-06-08,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04412278,2020-06-08,0,0
1698,NCT04412655,"Active, not recruiting",2020-05-30,2020-06-02,No Results Posted,"['De Luca G, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, Zimbakov Z, Cercek M, Jensen LO, Loh PH, Calmac L, Roura-Ferrer G, Quadros A, Milewski M, Scotto di Uccio F, von Birgelen C, Versaci F, Ten Berg J, Casella G, Wong ASL, Kala P, Diez Gil JL, Carrillo X, Dirksen MT, Becerra-Mu√±oz VM, Kang-Yin Lee M, Juzar DA, de Moura Joaquim R, Paladino R, Milicic D, Davlouros P, Bakraceski N, Zilio F, Donazzan L, Kraaijeveld AO, Galasso G, Lux A, Marinucci L, Guiducci V, Menichelli M, Scoccia A, Yamac A, Ugur Mert K, Flores Rios X, Kovarnik T, Kidawa M, Moreu J, Flavien V, Fabris E, Lozano Mart√¨nez-Luengas I, Boccalatte M, Bosa Ojeda F, Arellano-Serrano C, Caiazzo G, Cirrincione G, Kao HL, Sanchis Fores J, Vignali L, Pereira H, Manzo-Silberman S, Ordonez S, √ñzkan AA, Scheller B, Lehtola H, Teles R, Mantis C, Ylitalo A, Brum Silveira JA, Zoni R, Bessonov I, Savonitto S, Kochiadakis G, Alexopoulos D, Uribe C, Kanakakis J, Faurie B, Gabrielli G, Guti√©rrez A, Bachini JP, Rocha A, Tam FC, Rodriguez A, Lukito A, Saint-Joy V, Pessah G, Tuccillo B, Cortese G, Parodi G, Bouraghda MA, Kedhi E, Lamelas P, Suryapranata H, Nardin M, Verdoia M; ISACS-STEMI COVID-19; Collaborators. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction. Heart. 2022 Mar;108(6):458-466. doi: 10.1136/heartjnl-2021-319750. Epub 2021 Oct 28.', ""De Luca G, Debel N, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Ferrer GR, Ganyukov V, Wojakowski W, Kinnaird T, von Birgelen C, Cottin Y, IJsselmuiden A, Tuccillo B, Versaci F, Royaards KJ, Berg JT, Laine M, Dirksen M, Siviglia M, Casella G, Kala P, D√≠ez Gil JL, Banning A, Becerra V, De Simone C, Santucci A, Carrillo X, Scoccia A, Amoroso G, Van't Hof AW, Kovarnik T, Tsigkas G, Mehilli J, Gabrielli G, Rios XF, Bakraceski N, Levesque S, Cirrincione G, Guiducci V, Kidawa M, Spedicato L, Marinucci L, Ludman P, Zilio F, Galasso G, Fabris E, Menichelli M, Garcia-Touchard A, Manzo S, Caiazzo G, Moreu J, For√©s JS, Donazzan L, Vignali L, Teles R, Benit E, Agostoni P, Ojeda FB, Lehtola H, Camacho-Freiere S, Kraaijeveld A, Antti Y, Boccalatte M, Deharo P, Mart√≠nez-Luengas IL, Scheller B, Varytimiadi E, Moreno R, Uccello G, Faurie B, Gutierrez Barrios A, Milewski M, Bruwiere E, Smits P, Wilbert B, Di Uccio FS, Parodi G, Kedhi E, Verdoia M. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry. Atherosclerosis. 2021 Sep;332:48-54. doi: 10.1016/j.atherosclerosis.2021.06.926. Epub 2021 Jul 21."", 'De Luca G, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Roura I Ferrer G, Ganyukov V, Wojakowski W, von Birgelen C, Versaci F, Ten Berg J, Laine M, Dirksen M, Casella G, Kala P, D√≠ez Gil JL, Becerra V, De Simone C, Carrill X, Scoccia A, Lux A, Kovarnik T, Davlouros P, Gabrielli G, Flores Rios X, Bakraceski N, Levesque S, Guiducci V, Kidawa M, Marinucci L, Zilio F, Galasso G, Fabris E, Menichelli M, Manzo S, Caiazzo G, Moreu J, Sanchis For√©s J, Donazzan L, Vignali L, Teles R, Bosa Ojeda F, Lehtola H, Camacho-Freiere S, Kraaijeveld A, Antti Y, Boccalatte M, Mart√≠nez-Luengas IL, Scheller B, Alexopoulos D, Uccello G, Faurie B, Gutierrez Barrios A, Wilbert B, Cortese G, Moreno R, Parodi G, Kedhi E, Verdoia M. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry. Cardiovasc Diabetol. 2020 Dec 18;19(1):215. doi: 10.1186/s12933-020-01196-0.', 'De Luca G, Verdoia M, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Ferrer GR, Ganyukov V, Wojakowski W, Kinnaird T, van Birgelen C, Cottin Y, IJsselmuiden A, Tuccillo B, Versaci F, Royaards KJ, Berg JT, Laine M, Dirksen M, Siviglia M, Casella G, Kala P, D√≠ez Gil JL, Banning A, Becerra V, De Simone C, Santucci A, Carrillo X, Scoccia A, Amoroso G, Lux A, Kovarnik T, Davlouros P, Mehilli J, Gabrielli G, Rios XF, Bakraceski N, Levesque S, Cirrincione G, Guiducci V, Kidawa M, Spedicato L, Marinucci L, Ludman P, Zilio F, Galasso G, Fabris E, Menichelli M, Garcia-Touchard A, Manzo S, Caiazzo G, Moreu J, For√©s JS, Donazzan L, Vignali L, Teles R, Benit E, Agostoni P, Bosa Ojeda F, Lehtola H, Camacho-Freiere S, Kraaijeveld A, Antti Y, Boccalatte M, Deharo P, Mart√≠nez-Luengas IL, Scheller B, Alexopoulos D, Moreno R, Kedhi E, Uccello G, Faurie B, Gutierrez Barrios A, Di Uccio FS, Wilbert B, Smits P, Cortese G, Parodi G, Dudek D. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI. J Am Coll Cardiol. 2020 Nov 17;76(20):2321-2330. doi: 10.1016/j.jacc.2020.09.546.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04412655,2020-05-30,0,1
1699,NCT04414293,Recruiting,2021-07-31,2021-12-31,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04414293,2021-07-31,0,0
1700,NCT04414618,Completed,2020-11-26,2020-12-23,Study Results,,,2022-03-21,https://clinicaltrials.gov/show/NCT04414618,2020-11-26,1,0
1701,NCT04415359,Completed,2020-10-31,2020-12-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04415359,2020-10-31,0,0
1702,NCT04416334,Recruiting,2021-12-25,2021-12-31,No Results Posted,"['Estebanez EB, Alconero LL, Fern√°ndez BJ, Marguello MG, Caro JCL, Vallejo JD, Sampedro MF, Cacho PM, Espiga CR, Saiz MMG. The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care-COLCHICOVID study. Trials. 2021 Sep 6;22(1):590. doi: 10.1186/s13063-021-05544-7.']",,2021-09-09,https://clinicaltrials.gov/show/NCT04416334,2021-12-25,0,1
1703,NCT04420299,Recruiting,2021-03-31,2021-03-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04420299,2021-03-31,0,1
1704,NCT04422353,Recruiting,2021-06-30,2024-12-30,No Results Posted,,"[""Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, Pantoja PD, Schuch FB, Rieder CR, Martinez FG, Peyr√©-Tartaruga LA. Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial. Scand J Med Sci Sports. 2017 Mar;27(3):351-358. doi: 10.1111/sms.12652. Epub 2016 Feb 2.""]",2021-05-14,https://clinicaltrials.gov/show/NCT04422353,2021-06-30,0,1
1705,NCT04422509,Completed,2021-02-25,2021-04-30,No Results Posted,,,2021-07-13,https://clinicaltrials.gov/show/NCT04422509,2021-02-25,0,0
1706,NCT04422522,"Active, not recruiting",2020-05-15,2020-06-30,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04422522,2020-05-15,0,0
1707,NCT04422574,Completed,2020-05-01,2020-05-30,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04422574,2020-05-01,0,0
1708,NCT04422587,Completed,2020-06-05,2020-06-07,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04422587,2020-06-05,0,0
1709,NCT04422613,Completed,2021-07-01,2021-10-29,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04422613,2021-07-01,0,0
1710,NCT04422626,Not yet recruiting,2022-07-01,2022-12-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04422626,2022-07-01,0,0
1711,NCT04422678,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04422678,2020-09-01,0,0
1712,NCT04422873,Completed,2020-07-15,2021-03-15,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04422873,2020-07-15,0,0
1713,NCT04423003,Completed,2020-05-15,2020-05-15,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04423003,2020-05-15,0,0
1714,NCT04423289,Completed,2020-05-04,2020-05-18,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04423289,2020-05-04,0,0
1715,NCT04423640,Recruiting,2020-06-15,2020-08-15,No Results Posted,,,2020-08-13,https://clinicaltrials.gov/show/NCT04423640,2020-06-15,0,0
1716,NCT04423770,Completed,2021-06-08,2021-06-08,No Results Posted,"['Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.']",,2021-07-22,https://clinicaltrials.gov/show/NCT04423770,2021-06-08,0,1
1717,NCT04423861,Not yet recruiting,2021-04-01,2021-05-01,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04423861,2021-04-01,0,0
1718,NCT04423991,Completed,2020-06-04,2020-06-04,No Results Posted,,,2020-06-09,https://clinicaltrials.gov/show/NCT04423991,2020-06-04,0,0
1719,NCT04424004,Completed,2021-12-02,2021-12-02,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04424004,2021-12-02,0,0
1720,NCT04424017,Completed,2020-10-30,2020-10-30,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04424017,2020-10-30,0,0
1721,NCT04424082,Completed,2020-06-25,2021-05-27,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04424082,2020-06-25,0,0
1722,NCT04424771,Completed,2020-06-30,2020-07-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04424771,2020-06-30,0,0
1723,NCT04424797,Recruiting,2022-07-31,2022-07-31,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04424797,2022-07-31,0,0
1724,NCT04424849,Recruiting,2020-06-15,2020-07-15,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04424849,2020-06-15,0,0
1725,NCT04424901,Recruiting,2022-05-01,2022-05-30,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04424901,2022-05-01,0,0
1726,NCT04424992,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Coppadoro A, Benini A, Fruscio R, Verga L, Mazzola P, Bellelli G, Carbone M, Mulinacci G, Soria A, No√® B, Beck E, Di Sciacca R, Ippolito D, Citerio G, Valsecchi MG, Biondi A, Pesci A, Bonfanti P, Gaudesi D, Bellani G, Foti G. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care. 2021 Feb 24;25(1):80. doi: 10.1186/s13054-021-03502-y.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04424992,2021-12-01,0,1
1727,NCT04425005,Completed,2020-12-07,2020-12-07,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04425005,2020-12-07,0,0
1728,NCT04425044,Completed,2020-05-18,2020-05-28,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425044,2020-05-18,0,0
1729,NCT04425317,Completed,2021-06-01,2022-01-01,No Results Posted,"['Boudry L, Essahib W, Mateizel I, Van de Velde H, De Geyter D, Pi√©rard D, Waelput W, Uvin V, Tournaye H, De Vos M, De Brucker M. Undetectable viral RNA in follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2-positive women. Fertil Steril. 2022 Jan 1. pii: S0015-0282(21)02325-6. doi: 10.1016/j.fertnstert.2021.12.032. [Epub ahead of print]']",,2022-02-17,https://clinicaltrials.gov/show/NCT04425317,2021-06-01,0,1
1730,NCT04425382,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425382,2020-07-01,0,0
1731,NCT04425460,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425460,2020-08-01,0,0
1732,NCT04425499,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,"['Gu√©rard-Poirier N, Beniey M, Meloche-Dumas L, Lebel-Guay F, Misheva B, Abbas M, Dhane M, Elraheb M, Dubrowski A, Patocskai E. An Educational Network for Surgical Education Supported by Gamification Elements: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Dec 14;9(12):e21273. doi: 10.2196/21273.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04425499,2020-06-01,0,1
1733,NCT04425538,Completed,2021-01-22,2021-01-22,Study Results,,"['Hachem H, Godara A, Schroeder C, Fein D, Mann H, Lawlor C, Marshall J, Klein A, Poutsiaka D, Breeze JL, Joshi R, Mathew P. Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNF-Œ± antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure. medRxiv. 2021 Jun 2. pii: 2021.05.29.21258010. doi: 10.1101/2021.05.29.21258010. Update in: J Clin Transl Sci. 2021 Jun 25;5(1):e146.', 'Hachem H, Godara A, Schroeder C, Fein D, Mann H, Lawlor C, Marshall J, Klein A, Poutsiaka D, Breeze JL, Joshi R, Mathew P. Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFŒ±-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure. J Clin Transl Sci. 2021 Jun 25;5(1):e146. doi: 10.1017/cts.2021.805. eCollection 2021.']",2022-02-24,https://clinicaltrials.gov/show/NCT04425538,2021-01-22,1,1
1734,NCT04425707,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425707,2020-07-01,0,0
1735,NCT04425733,Withdrawn,2020-11-10,2020-11-10,No Results Posted,,,2020-08-14,https://clinicaltrials.gov/show/NCT04425733,2020-11-10,0,0
1736,NCT04425772,Not yet recruiting,2020-08-12,2020-08-12,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425772,2020-08-12,0,0
1737,NCT04425837,Not yet recruiting,2021-02-01,2021-02-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04425837,2021-02-01,0,0
1738,NCT04425889,Completed,2020-05-30,2020-06-01,No Results Posted,,,2020-06-12,https://clinicaltrials.gov/show/NCT04425889,2020-05-30,0,0
1739,NCT04425915,Completed,2020-12-15,2020-12-15,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04425915,2020-12-15,0,0
1740,NCT04426006,"Active, not recruiting",2022-01-01,2023-01-01,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04426006,2022-01-01,0,0
1741,NCT04426071,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04426071,2021-12-01,0,0
1742,NCT04426084,"Active, not recruiting",2020-05-11,2022-12-31,No Results Posted,"['Svensson P, Hofmann R, H√§bel H, Jernberg T, Nordberg P. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021 Feb 17;11(2):e044486. doi: 10.1136/bmjopen-2020-044486.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04426084,2020-05-11,0,1
1743,NCT04426201,Recruiting,2021-12-30,2021-12-31,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",2021-06-03,https://clinicaltrials.gov/show/NCT04426201,2021-12-30,0,1
1744,NCT04426253,"Active, not recruiting",2020-12-31,2021-07-31,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04426253,2020-12-31,0,0
1745,NCT04426279,Terminated,2021-03-01,2021-08-30,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04426279,2021-03-01,0,0
1746,NCT04426292,Recruiting,2021-12-23,2021-12-25,No Results Posted,,,2021-11-04,https://clinicaltrials.gov/show/NCT04426292,2021-12-23,0,0
1747,NCT04426305,Completed,2020-06-20,2020-10-30,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04426305,2020-06-20,0,0
1748,NCT04426318,Completed,2021-01-12,2021-01-12,Study Results,,"['Goldberg SB, Baldwin SA, Riordan KM, Torous J, Dahl CJ, Davidson RJ, Hirshberg MJ. Alliance With an Unguided Smartphone App: Validation of the Digital Working Alliance Inventory. Assessment. 2021 May 18:10731911211015310. doi: 10.1177/10731911211015310. [Epub ahead of print]']",2022-02-10,https://clinicaltrials.gov/show/NCT04426318,2021-01-12,1,1
1749,NCT04426344,Withdrawn,2020-12-01,2020-12-01,No Results Posted,"['Bonfanti N, Gundert E, Drewry AM, Goff K, Bedimo R, Kulstad E. Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study. PLoS One. 2020 Dec 1;15(12):e0243190. doi: 10.1371/journal.pone.0243190. eCollection 2020.']",,2020-10-19,https://clinicaltrials.gov/show/NCT04426344,2020-12-01,0,1
1750,NCT04427176,Completed,2020-05-28,2020-05-28,No Results Posted,,,2020-06-29,https://clinicaltrials.gov/show/NCT04427176,2020-05-28,0,0
1751,NCT04427280,Completed,2021-06-29,2021-06-29,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04427280,2021-06-29,0,0
1752,NCT04427332,Completed,2020-10-16,2020-10-16,No Results Posted,"['Galluzzi F, Rossi V, Bosetti C, Garavello W. Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection. Neuroepidemiology. 2021;55(2):154-161. doi: 10.1159/000514888. Epub 2021 Apr 1.']",,2021-01-27,https://clinicaltrials.gov/show/NCT04427332,2020-10-16,0,1
1753,NCT04427345,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04427345,2021-04-30,0,0
1754,NCT04427358,Completed,2020-08-07,2020-09-07,No Results Posted,,,2020-11-25,https://clinicaltrials.gov/show/NCT04427358,2020-08-07,0,0
1755,NCT04427631,Not yet recruiting,2021-01-01,2021-06-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04427631,2021-01-01,0,0
1756,NCT04427735,Recruiting,2021-07-24,2021-07-24,No Results Posted,"['Gong X, Zhou L, Dong T, Ding X, Zhao H, Chen H, Li H. Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China. Am J Emerg Med. 2022 Mar;53:68-72. doi: 10.1016/j.ajem.2021.11.034. Epub 2021 Nov 24.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04427735,2021-07-24,0,1
1757,NCT04428021,Completed,2021-03-31,2021-10-31,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04428021,2021-03-31,0,0
1758,NCT04428073,Not yet recruiting,2021-07-01,2021-12-01,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04428073,2021-07-01,0,0
1759,NCT04428099,Recruiting,2022-01-12,2022-07-12,No Results Posted,"['Navarro C, Y√°√±ez AM, Garcia A, Segu√≠ A, Gazquez F, Marino JA, Ibarra O, Serrano-Ripoll MJ, Gomez-Juanes R, Bennasar-Veny M, Salva J, Oliv√°n B, Roca M, Gili M, Garcia-Toro M. Effectiveness of a healthy lifestyle promotion program as adjunctive teletherapy for treatment-resistant major depression during COVID 19 pandemic: A randomized clinical trial protocol. Medicine (Baltimore). 2020 Nov 6;99(45):e22958. doi: 10.1097/MD.0000000000022958.']",,2020-06-11,https://clinicaltrials.gov/show/NCT04428099,2022-01-12,0,1
1760,NCT04428801,Not yet recruiting,2022-09-01,2024-09-01,No Results Posted,,,2021-07-23,https://clinicaltrials.gov/show/NCT04428801,2022-09-01,0,0
1761,NCT04429477,Completed,2020-07-15,2020-07-31,Results Submitted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04429477,2020-07-15,0,0
1762,NCT04429529,Completed,2020-11-19,2021-01-20,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-04-08,https://clinicaltrials.gov/show/NCT04429529,2020-11-19,0,1
1763,NCT04429763,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-06-12,https://clinicaltrials.gov/show/NCT04429763,2020-09-01,0,0
1764,NCT04429854,Completed,2021-04-30,2021-04-30,No Results Posted,"['Devos T, Geukens T, Schauwvlieghe A, Ari√´n KK, Barbezange C, Cleeren M, Compernolle V, Dauby N, Desmecht D, Grimaldi D, Lambrecht BN, Luyten A, Maes P, Moutschen M, Romano M, Seyler L, Nevessignsky MT, Vandenberghe K, van Griensven J, Verbeke G, Vlieghe E, Yombi JC, Liesenborghs L, Verhamme P, Meyfroidt G. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials. 2020 Nov 27;21(1):981. doi: 10.1186/s13063-020-04876-0. Erratum in: Trials. 2020 Dec 14;21(1):1024.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04429854,2021-04-30,0,1
1765,NCT04536051,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04536051,2021-09-01,0,0
1766,NCT04244591,Completed,2020-04-13,2020-04-13,No Results Posted,"['Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifir√≤ G. Challenges for Drug Repurposing in the COVID-19 Pandemic Era. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Review.']",,2020-06-16,https://clinicaltrials.gov/show/NCT04244591,2020-04-13,0,1
1767,NCT04285190,Withdrawn,2020-04-15,2020-04-20,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04285190,2020-04-15,0,0
1768,NCT04303299,Completed,2021-08-28,2021-08-28,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04303299,2021-08-28,0,0
1769,NCT04311177,Completed,2021-02-01,2021-02-01,Results Submitted,"['Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']","['Puskarich MA, Cummins NW, Ingraham NE, Wacker DA, Reilkoff RA, Driver BE, Biros MH, Bellolio F, Chipman JG, Nelson AC, Beckman K, Langlois R, Bold T, Aliota MT, Schacker TW, Voelker HT, Murray TA, Koopmeiners JS, Tignanelli CJ. A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19. EClinicalMedicine. 2021 Jun 17;37:100957. doi: 10.1016/j.eclinm.2021.100957. eCollection 2021 Jul.']",2021-09-24,https://clinicaltrials.gov/show/NCT04311177,2021-02-01,0,1
1770,NCT04312009,Completed,2021-02-01,2021-02-01,Results Submitted,"['Puskarich MA, Ingraham NE, Merck LH, Driver BE, Wacker DA, Black LP, Jones AE, Fletcher CV, South AM, Murray TA, Lewandowski C, Farhat J, Benoit JL, Biros MH, Cherabuddi K, Chipman JG, Schacker TW, Guirgis FW, Voelker HT, Koopmeiners JS, Tignanelli CJ; Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators. Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 1;5(3):e222735. doi: 10.1001/jamanetworkopen.2022.2735.', 'Smolander J, Bruchfeld A. [COVID-19 and kidney disease]. Lakartidningen. 2020 Jul 13;117. pii: 20110. Swedish.']",,2021-08-18,https://clinicaltrials.gov/show/NCT04312009,2021-02-01,0,1
1771,NCT04312243,"Active, not recruiting",2021-04-07,2022-04-07,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']",,2021-03-10,https://clinicaltrials.gov/show/NCT04312243,2021-04-07,0,1
1772,NCT04333914,"Active, not recruiting",2021-07-06,2021-12-01,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04333914,2021-07-06,0,0
1773,NCT04340414,Recruiting,2020-08-15,2020-10-15,No Results Posted,"['Ding X, Chen H, Zhao H, Zhang H, He H, Cheng W, Wang C, Jiang W, Ma J, Qin Y, Liu Z, Wang J, Yan X, Li T, Zhou X, Long Y, Zhang S. ECCO(2)R in 12 COVID-19 ARDS Patients With Extremely Low Compliance and Refractory Hypercapnia. Front Med (Lausanne). 2021 Jul 8;8:654658. doi: 10.3389/fmed.2021.654658. eCollection 2021.']",,2020-06-16,https://clinicaltrials.gov/show/NCT04340414,2020-08-15,0,1
1774,NCT04343781,Completed,2020-04-05,2020-04-05,No Results Posted,"['Annweiler C, Sacco G, Salles N, Aquino JP, Gautier J, Berrut G, Gu√©rin O, Gavazzi G. National French Survey of Coronavirus Disease (COVID-19) Symptoms in People Aged 70 and Over. Clin Infect Dis. 2021 Feb 1;72(3):490-494. doi: 10.1093/cid/ciaa792.']",,2020-06-16,https://clinicaltrials.gov/show/NCT04343781,2020-04-05,0,1
1775,NCT04346446,Completed,2020-05-30,2020-05-30,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,2020-06-12,https://clinicaltrials.gov/show/NCT04346446,2020-05-30,0,1
1776,NCT04347408,Recruiting,2021-12-01,2024-12-01,Study Results,"['Waterfield T, Watson C, Moore R, Ferris K, Tonry C, Watt A, McGinn C, Foster S, Evans J, Lyttle MD, Ahmad S, Ladhani S, Corr M, McFetridge L, Mitchell H, Brown K, Amirthalingam G, Maney JA, Christie S. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study. Arch Dis Child. 2021 Jul;106(7):680-686. doi: 10.1136/archdischild-2020-320558. Epub 2020 Nov 10.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04347408,2021-12-01,1,1
1777,NCT04353128,Completed,2020-10-01,2020-12-01,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04353128,2020-10-01,0,0
1778,NCT04354818,"Active, not recruiting",2022-04-27,2022-04-27,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04354818,2022-04-27,0,0
1779,NCT04362319,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04362319,2020-05-31,0,0
1780,NCT04369066,"Active, not recruiting",2022-01-06,2022-03-01,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04369066,2022-01-06,0,0
1781,NCT04370262,Completed,2020-09-07,2020-09-07,Results Submitted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2020-12-11,https://clinicaltrials.gov/show/NCT04370262,2020-09-07,0,1
1782,NCT04371029,Completed,2020-09-09,2020-12-09,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04371029,2020-09-09,0,0
1783,NCT04374643,Recruiting,2021-12-01,2021-12-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04374643,2021-12-01,0,0
1784,NCT04376814,Completed,2020-04-05,2020-05-25,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04376814,2020-04-05,0,0
1785,NCT04382053,Completed,2020-12-10,2020-12-24,Study Results,,,2021-11-30,,2020-12-10,1,0
1786,NCT04383535,Completed,2020-09-27,2020-09-27,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Simonovich VA, Burgos Pratx LD, Scibona P, Beruto MV, Vallone MG, V√°zquez C, Savoy N, Giunta DH, P√©rez LG, S√°nchez MDL, Gamarnik AV, Ojeda DS, Santoro DM, Camino PJ, Antelo S, Rainero K, Vidiella GP, Miyazaki EA, Cornistein W, Trabadelo OA, Ross FM, Spotti M, Funtowicz G, Scordo WE, Losso MH, Ferniot I, Pardo PE, Rodriguez E, Rucci P, Pasquali J, Fuentes NA, Esperatti M, Speroni GA, Nannini EC, Matteaccio A, Michelangelo HG, Follmann D, Lane HC, Belloso WH; PlasmAr Study Group. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.']","['Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006 Oct 17;145(8):599-609. Epub 2006 Aug 29.']",2020-09-30,https://clinicaltrials.gov/show/NCT04383535,2020-09-27,0,1
1787,NCT04383730,Completed,2021-04-30,2021-04-30,No Results Posted,"['Blondonnet R, Quinson A, Lambert C, Audard J, Godet T, Zhai R, Pereira B, Futier E, Bazin JE, Constantin JM, Jabaudon M. Use of volatile agents for sedation in the intensive care unit: A national survey in France. PLoS One. 2021 Apr 15;16(4):e0249889. doi: 10.1371/journal.pone.0249889. eCollection 2021.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04383730,2021-04-30,0,1
1788,NCT04386369,Completed,2020-06-01,2020-06-01,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04386369,2020-06-01,0,0
1789,NCT04387214,Completed,2020-08-10,2020-08-10,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04387214,2020-08-10,0,0
1790,NCT04387409,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04387409,2021-05-01,0,0
1791,NCT04388709,Withdrawn,2021-02-05,2021-02-05,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,2021-02-26,https://clinicaltrials.gov/show/NCT04388709,2021-02-05,0,1
1792,NCT04389476,Not yet recruiting,2023-07-31,2023-07-31,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04389476,2023-07-31,0,0
1793,NCT04391140,Recruiting,2020-12-01,2021-06-01,No Results Posted,"['Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.', 'Tavernier E, McNicholas B, Pavlov I, Roca O, Perez Y, Laffey J, Mirza S, Cosgrave D, Vines D, Frat JP, Ehrmann S, Li J. Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 Nov 11;10(11):e041520. doi: 10.1136/bmjopen-2020-041520.']",,2020-08-18,https://clinicaltrials.gov/show/NCT04391140,2020-12-01,0,1
1794,NCT04394455,Enrolling by invitation,2020-11-30,2020-12-30,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04394455,2020-11-30,0,0
1795,NCT04395716,Withdrawn,2021-06-01,2021-11-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04395716,2021-06-01,0,0
1796,NCT04397562,Completed,2020-07-03,2020-08-03,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04397562,2020-07-03,0,0
1797,NCT04397900,Completed,2021-04-12,2021-04-12,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04397900,2021-04-12,0,0
1798,NCT04397939,Recruiting,2022-03-01,2023-03-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04397939,2022-03-01,0,0
1799,NCT04399733,Withdrawn,2023-02-01,2024-02-01,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04399733,2023-02-01,0,0
1800,NCT04402944,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04402944,2021-12-31,0,0
1801,NCT04402957,"Active, not recruiting",2021-05-31,2021-06-30,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04402957,2021-05-31,0,0
1802,NCT04408339,Recruiting,2021-04-14,2022-04-14,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04408339,2021-04-14,0,0
1803,NCT04412057,Completed,2020-12-14,2021-01-19,Study Results,"['Perlin DS, Zafir-Lavie I, Roadcap L, Raines S, Ware CF, Neil GA. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS. mSphere. 2020 Aug 12;5(4). pii: e00699-20. doi: 10.1128/mSphere.00699-20.']","['Perlin DS, Neil GA, Anderson C, Zafir-Lavie I, Raines S, Ware CF, Wilkins HJ. Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome. J Clin Invest. 2022 Feb 1;132(3). pii: e153173. doi: 10.1172/JCI153173.']",2022-03-24,https://clinicaltrials.gov/show/NCT04412057,2020-12-14,1,1
1804,NCT04412317,Recruiting,2021-05-30,2021-05-31,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04412317,2021-05-30,0,0
1805,NCT04413071,Completed,2020-06-12,2020-06-12,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04413071,2020-06-12,0,0
1806,NCT04413435,Completed,2020-12-15,2020-12-25,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04413435,2020-12-15,0,0
1807,NCT04418284,Completed,2020-11-05,2020-11-05,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04418284,2020-11-05,0,0
1808,NCT04421404,Completed,2021-04-30,2021-04-30,Study Results,,,2021-08-25,https://clinicaltrials.gov/show/NCT04421404,2021-04-30,1,0
1809,NCT04422340,Recruiting,2020-08-15,2020-08-15,No Results Posted,"['Falandry C, Malapert A, Roche M, Subtil F, Berthiller J, Boin C, Dubreuil J, Ravot C, Bitker L, Abraham P, Collange V, Balan√ßa B, Goutte S, Guichon C, Gadea E, Argaud L, Dayde D, Jallades L, Lepape A, Pialat JB, Friggeri A, Thiolli√®re F; Senior-COVID-Rea study Group. Risk factors associated with day-30 mortality in patients over 60 years old admitted in ICU for severe COVID-19: the Senior-COVID-Rea Multicentre Survey protocol. BMJ Open. 2021 Jul 6;11(7):e044449. doi: 10.1136/bmjopen-2020-044449.']",,2020-07-30,https://clinicaltrials.gov/show/NCT04422340,2020-08-15,0,1
1810,NCT04424355,Recruiting,2021-07-19,2021-12-20,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04424355,2021-07-19,0,0
1811,NCT04424836,Completed,2020-06-04,2020-06-05,No Results Posted,,"['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.', 'Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014 Mar 18;160(6):389-97. doi: 10.7326/M13-2486.', 'Akerstr√∂m S, Gunalan V, Keng CT, Tan YJ, Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology. 2009 Dec 5;395(1):1-9. doi: 10.1016/j.virol.2009.09.007. Epub 2009 Oct 1.']",2020-07-16,https://clinicaltrials.gov/show/NCT04424836,2020-06-04,0,1
1812,NCT04424940,Not yet recruiting,2021-06-01,2021-09-01,No Results Posted,,"['Now is the time to give extra attention to a balanced diet and assure an optimum dietary micronutrient and vitamin intake! Particularly the micronutrient selenium plays an essential role in antioxidant functioning and helps to alleviate negative health impacts of viral infections, including inflammation of the lungs', 'Particularly elderly people are often selenium-deficient, which was proven to be the case in e.g. Italy', 'However, when taking micronutrient and vitamin supplements, also follow the instructions to avoid over-supplementation! A healthy and balanced diet is the safest way towards an appropriate dietary micronutrient and vitamin intake.', 'Vitamin D is a prohormone synthesized in the dermis under the effect of ultraviolet rays, that is to say of the rays of the sun, then transported in the liver and the kidney where it is transformed into an active hormone. It is responsible for the intestinal absorption of calcium and bone health, but vitamin D also has unconventional effects. In particular, it modulates the functioning of the immune system by stimulating macrophages and dendritic cells.', 'It plays a role in regulating and suppressing the cytokine inflammatory response which causes acute respiratory distress syndrome which characterizes the severe and often lethal forms of Covid-19. A significant correlation between low serum vitamin D levels and mortality by Covid-19 has been shown.']",2020-06-16,https://clinicaltrials.gov/show/NCT04424940,2021-06-01,0,1
1813,NCT04425213,Completed,2020-05-25,2020-05-26,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04425213,2020-05-25,0,0
1814,NCT04425252,Completed,2020-12-29,2021-01-12,Study Results,,,2022-02-17,https://clinicaltrials.gov/show/NCT04425252,2020-12-29,1,0
1815,NCT04425759,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04425759,2021-06-30,0,0
1816,NCT04427267,Completed,2020-06-27,2020-06-27,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04427267,2020-06-27,0,0
1817,NCT04427865,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04427865,2020-09-01,0,0
1818,NCT04427878,Not yet recruiting,2020-07-09,2021-07-09,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04427878,2020-07-09,0,0
1819,NCT04428268,Withdrawn,2020-06-10,2021-02-16,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04428268,2020-06-10,0,0
1820,NCT04429334,Recruiting,2023-06-01,2023-06-01,No Results Posted,,,2021-07-09,https://clinicaltrials.gov/show/NCT04429334,2023-06-01,0,0
1821,NCT04429555,Recruiting,2022-06-30,2022-12-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04429555,2022-06-30,0,0
1822,NCT04429711,Recruiting,2020-09-30,2020-10-31,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04429711,2020-09-30,0,0
1823,NCT04429724,"Active, not recruiting",2021-03-16,2021-12-01,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04429724,2021-03-16,0,0
1824,NCT04429815,Completed,2021-05-26,2021-05-26,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04429815,2021-05-26,0,0
1825,NCT04429828,Completed,2020-09-30,2020-12-30,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04429828,2020-09-30,0,0
1826,NCT04429867,"Active, not recruiting",2020-12-07,2020-12-07,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04429867,2020-12-07,0,0
1827,NCT04430062,Completed,2020-05-20,2020-05-30,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04430062,2020-05-20,0,0
1828,NCT04430608,Recruiting,2021-04-25,2021-05-25,No Results Posted,"['Klarskov CK, Windum NA, Olsen MT, Dungu AM, Jensen AK, Lindegaard B, Pedersen-Bjergaard U, Kristensen PL. Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial. Diabetes Technol Ther. 2022 Feb;24(2):102-112. doi: 10.1089/dia.2021.0291. Epub 2022 Jan 4.', 'Klarskov CK, Lindegaard B, Pedersen-Bjergaard U, Kristensen PL. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 25;21(1):968. doi: 10.1186/s13063-020-04872-4.']",,2020-06-12,https://clinicaltrials.gov/show/NCT04430608,2021-04-25,0,1
1829,NCT04431180,Enrolling by invitation,2020-06-13,2020-06-30,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04431180,2020-06-13,0,0
1830,NCT04431284,Completed,2020-12-16,2020-12-16,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04431284,2020-12-16,0,0
1831,NCT04431297,Completed,2021-05-14,2021-05-14,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04431297,2021-05-14,0,0
1832,NCT04431310,Recruiting,2025-08-01,2025-08-01,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04431310,2025-08-01,0,0
1833,NCT04431453,Recruiting,2023-02-01,2023-02-01,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04431453,2023-02-01,0,0
1834,NCT04431466,Terminated,2020-12-01,2020-12-01,No Results Posted,"['Pott-Junior H, Paoliello MMB, Miguel AQC, da Cunha AF, de Melo Freire CC, Neves FF, da Silva de Av√≥ LR, Roscani MG, Dos Santos SS, Chach√° SGF. Use of ivermectin in the treatment of Covid-19: A pilot trial. Toxicol Rep. 2021;8:505-510. doi: 10.1016/j.toxrep.2021.03.003. Epub 2021 Mar 9.']",,2021-10-12,https://clinicaltrials.gov/show/NCT04431466,2020-12-01,0,1
1835,NCT04431856,Completed,2020-11-17,2020-11-17,No Results Posted,,,2020-12-01,https://clinicaltrials.gov/show/NCT04431856,2020-11-17,0,0
1836,NCT04431908,Completed,2020-10-15,2020-11-18,Study Results,"['Patel RA, Torabi SJ, Kasle DA, Manes RP. Five-item odorant test as an indicator of COVID-19 infection in a general population. Am J Otolaryngol. 2022 Jan 29;43(2):103376. doi: 10.1016/j.amjoto.2022.103376. [Epub ahead of print]']",,2021-06-02,https://clinicaltrials.gov/show/NCT04431908,2020-10-15,1,1
1837,NCT04432272,Terminated,2020-11-13,2020-11-28,Study Results,,,2022-03-09,https://clinicaltrials.gov/show/NCT04432272,2020-11-13,1,0
1838,NCT04432324,Completed,2021-03-03,2021-03-03,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04432324,2021-03-03,0,0
1839,NCT04432948,Recruiting,2020-08-01,2020-12-01,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04432948,2020-08-01,0,0
1840,NCT04433000,Recruiting,2020-06-10,2020-06-10,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433000,2020-06-10,0,0
1841,NCT04433039,Completed,2020-06-12,2020-06-14,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433039,2020-06-12,0,0
1842,NCT04433286,Not yet recruiting,2020-07-31,2020-08-31,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433286,2020-07-31,0,0
1843,NCT04434131,Recruiting,2021-04-28,2025-04-28,Results Submitted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.', 'Bradfute SB, Hurwitz I, Yingling AV, Ye C, Cheng Q, Noonan TP, Raval JS, Sosa NR, Mertz GJ, Perkins DJ, Harkins MS. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019. J Infect Dis. 2020 Oct 13;222(10):1620-1628. doi: 10.1093/infdis/jiaa505.']",,2020-06-16,https://clinicaltrials.gov/show/NCT04434131,2021-04-28,0,1
1844,NCT04434157,Completed,2020-05-05,2020-05-05,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04434157,2020-05-05,0,0
1845,NCT02765191,Completed,2021-05-10,2021-08-10,No Results Posted,,,2021-12-06,https://clinicaltrials.gov/show/NCT02765191,2021-05-10,0,0
1846,NCT03963622,Recruiting,2022-05-01,2022-11-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT03963622,2022-05-01,0,0
1847,NCT04269525,Recruiting,2020-12-01,2020-12-30,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04269525,2020-12-01,0,0
1848,NCT04288102,Completed,2020-05-12,2020-07-09,No Results Posted,"['Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, Li Y, Xu R, Li TT, Dong J, Cai J, Li G, Xie Y, Shi M, Li Y, Zhang Y, Xie WF, Wang FS. Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2022 Jan;75:103789. doi: 10.1016/j.ebiom.2021.103789. Epub 2021 Dec 25.', 'Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, Wang S, Zhang C, Yuan X, Xu Z, Huang L, Fu JL, Li Y, Zhang Y, Yao WQ, Liu T, Song J, Sun L, Yang F, Zhang X, Zhang B, Shi M, Meng F, Song Y, Yu Y, Wen J, Li Q, Mao Q, Maeurer M, Zumla A, Yao C, Xie WF, Wang FS. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 Feb 10;6(1):58. doi: 10.1038/s41392-021-00488-5.']",,2020-08-19,https://clinicaltrials.gov/show/NCT04288102,2020-05-12,0,1
1849,NCT04304053,Completed,2020-06-15,2020-06-15,No Results Posted,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.', 'Mitj√† O, Corbacho-Monn√© M, Ubals M, Alemany A, Su√±er C, Teb√© C, Tobias A, Pe√±afiel J, Ballana E, P√©rez CA, Admella P, Riera-Mart√≠ N, Laporte P, Mitj√† J, Clua M, Bertran L, Sarquella M, Gavil√°n S, Ara J, Argimon JM, Cuatrecasas G, Ca√±adas P, Elizalde-Torrent A, Fabregat R, Farr√© M, Forcada A, Flores-Mateo G, L√≥pez C, Muntada E, Nadal N, Narejos S, Nieto A, Prat N, Puig J, Qui√±ones C, Ram√≠rez-Viaplana F, Reyes-Urue√±a J, Riveira-Mu√±oz E, Ruiz L, Sanz S, Sent√≠s A, Sierra A, Velasco C, Vivanco-Hidalgo RM, Zamora J, Casabona J, Vall-Mayans M, Gonz√°lez-Beiras C, Clotet B; BCN-PEP-CoV2 Research Group. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19. N Engl J Med. 2021 Feb 4;384(5):417-427. doi: 10.1056/NEJMoa2021801. Epub 2020 Nov 24.']",,2020-06-30,https://clinicaltrials.gov/show/NCT04304053,2020-06-15,0,1
1850,NCT04308668,Completed,2020-05-20,2020-05-20,Study Results,"['Akhtar S, Das JK, Ismail T, Wahid M, Saeed W, Bhutta ZA. Nutritional perspectives for the prevention and mitigation of COVID-19. Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.']","['Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.', 'Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov.', 'Skipper CP, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med. 2021 Mar;174(3):434-435. doi: 10.7326/L20-1426.', 'Nicol MR, Boulware DR, Rajasingham R. Reply to Neves. Clin Infect Dis. 2021 Oct 5;73(7):e1772-e1774. doi: 10.1093/cid/ciaa1809.']",2021-05-13,https://clinicaltrials.gov/show/NCT04308668,2020-05-20,1,1
1851,NCT04312997,Completed,2021-07-02,2021-07-02,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04312997,2021-07-02,0,0
1852,NCT04313023,Completed,2021-07-31,2021-07-31,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04313023,2021-07-31,0,0
1853,NCT04314232,Recruiting,2021-12-31,2021-12-31,No Results Posted,"['Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL. Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19. Open Heart. 2021 Dec;8(2). pii: e001884. doi: 10.1136/openhrt-2021-001884.', 'Myhre PL, Heck SL, Skranes JB, Prebensen C, Jonassen CM, Berge T, Mecinaj A, Melles W, Einvik G, Ingul CB, Tveit A, Berdal JE, R√∏sj√∏ H, Lyngbakken MN, Omland T. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. Am Heart J. 2021 Dec;242:61-70. doi: 10.1016/j.ahj.2021.08.001. Epub 2021 Aug 13.', 'Myhre PL, Prebensen C, Jonassen CM, Berdal JE, Omland T. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 May 4;10(9):e019756. doi: 10.1161/JAHA.120.019756. Epub 2021 Feb 18.', 'Myhre PL, Prebensen C, Strand H, R√∏ysland R, Jonassen CM, Rangberg A, S√∏rensen V, S√∏vik S, R√∏sj√∏ H, Svensson M, Berdal JE, Omland T. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19. Circulation. 2020 Dec;142(22):2128-2137. doi: 10.1161/CIRCULATIONAHA.120.050360. Epub 2020 Oct 15.']",,2020-06-26,https://clinicaltrials.gov/show/NCT04314232,2021-12-31,0,1
1854,NCT04318366,Recruiting,2023-03-19,2023-03-19,No Results Posted,"['Conte C, Esposito A, De Lorenzo R, Di Filippo L, Palmisano A, Vignale D, Leone R, Nicoletti V, Ruggeri A, Gallone G, Secchi A, Bosi E, Tresoldi M, Castagna A, Landoni G, Zangrillo A, De Cobelli F, Ciceri F, Camici P, Rovere-Querini P. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2156-2164. doi: 10.1016/j.numecd.2021.04.020. Epub 2021 May 3.', 'Di Filippo L, De Lorenzo R, Cinel E, Falbo E, Ferrante M, Cilla M, Martinenghi S, Vitali G, Bosi E, Giustina A, Rovere-Querini P, Conte C. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity. Int J Obes (Lond). 2021 Sep;45(9):1986-1994. doi: 10.1038/s41366-021-00861-y. Epub 2021 May 17.', 'Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A, Boskoski I, Bronswijk M, Tyberg A, Krishna Kumar Nair G, Angeletti S, Mauro A, Zingone F, Oppong KW, de la Iglesia-Garcia D, Pouillon L, Papanikolaou IS, Fracasso P, Ciceri F, Rovere-Querini P, Tomba C, Viale E, Eusebi LH, Riccioni ME, van der Merwe S, Shahid H, Sarkar A, Yoo JWG, Dilaghi E, Speight RA, Azzolini F, Buttitta F, Porcari S, Petrone MC, Iglesias-Garcia J, Savarino EV, Di Sabatino A, Di Giulio E, Farrell JJ, Kahaleh M, Roelandt P, Costamagna G, Artifon ELA, Bazzoli F, Testoni PA, Greco S, Arcidiacono PG. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol. 2021 Feb;8(1). pii: e000578. doi: 10.1136/bmjgast-2020-000578.', ""Di Filippo L, De Lorenzo R, D'Amico M, Sofia V, Roveri L, Mele R, Saibene A, Rovere-Querini P, Conte C. COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study. Clin Nutr. 2021 Apr;40(4):2420-2426. doi: 10.1016/j.clnu.2020.10.043. Epub 2020 Oct 29."", 'Secchi M, Bazzigaluppi E, Brigatti C, Marzinotto I, Tresoldi C, Rovere-Querini P, Poli A, Castagna A, Scarlatti G, Zangrillo A, Ciceri F, Piemonti L, Lampasona V. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 Dec 1;130(12):6366-6378. doi: 10.1172/JCI142804.', 'Mushtaq J, Pennella R, Lavalle S, Colarieti A, Steidler S, Martinenghi CMA, Palumbo D, Esposito A, Rovere-Querini P, Tresoldi M, Landoni G, Ciceri F, Zangrillo A, De Cobelli F. Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients. Eur Radiol. 2021 Mar;31(3):1770-1779. doi: 10.1007/s00330-020-07269-8. Epub 2020 Sep 18.', 'Zangrillo A, Beretta L, Scandroglio AM, Monti G, Fominskiy E, Colombo S, Morselli F, Belletti A, Silvani P, Crivellari M, Monaco F, Azzolini ML, Reineke R, Nardelli P, Sartorelli M, Votta CD, Ruggeri A, Ciceri F, De Cobelli F, Tresoldi M, Dagna L, Rovere-Querini P, Serpa Neto A, Bellomo R, Landoni G; COVID-BioB Study Group . Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep;22(3):200-211.', 'Pagnesi M, Baldetti L, Beneduce A, Calvo F, Gramegna M, Pazzanese V, Ingallina G, Napolano A, Finazzi R, Ruggeri A, Ajello S, Melisurgo G, Camici PG, Scarpellini P, Tresoldi M, Landoni G, Ciceri F, Scandroglio AM, Agricola E, Cappelletti AM. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020 Sep;106(17):1324-1331. doi: 10.1136/heartjnl-2020-317355. Epub 2020 Jul 16.', 'Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.', 'Zangrillo A, Beretta L, Scandroglio AM, Monti G, Fominskiy E, Colombo S, Morselli F, Belletti A, Silvani P, Crivellari M, Monaco F, Azzolini ML, Reineke R, Nardelli P, Sartorelli M, Votta CD, Ruggeri A, Ciceri F, De Cobelli F, Tresoldi M, Dagna L, Rovere-Querini P, Serpa Neto A, Bellomo R, Landoni G; COVID-BioB Study Group. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23. [Epub ahead of print]']",,2021-12-22,https://clinicaltrials.gov/show/NCT04318366,2023-03-19,0,1
1855,NCT04320472,,,,,,,,https://clinicaltrials.gov/show/NCT04320472,,0,0
1856,NCT04320732,Recruiting,2025-03-27,2030-03-20,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04320732,2025-03-27,0,0
1857,NCT04323592,Completed,2020-05-10,2020-05-10,Study Results,"[""Salton F, Confalonieri P, Meduri GU, Santus P, Harari S, Scala R, Lanini S, Vertui V, Oggionni T, Caminati A, Patruno V, Tamburrini M, Scartabellati A, Parati M, Villani M, Radovanovic D, Tomassetti S, Ravaglia C, Poletti V, Vianello A, Gaccione AT, Guidelli L, Raccanelli R, Lucernoni P, Lacedonia D, Foschino Barbaro MP, Centanni S, Mondoni M, Dav√¨ M, Fantin A, Cao X, Torelli L, Zucchetto A, Montico M, Casarin A, Romagnoli M, Gasparini S, Bonifazi M, D'Agaro P, Marcello A, Licastro D, Ruaro B, Volpe MC, Umberger R, Confalonieri M. Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia. Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa421. doi: 10.1093/ofid/ofaa421. eCollection 2020 Oct.""]",,2020-06-24,https://clinicaltrials.gov/show/NCT04323592,2020-05-10,1,1
1858,NCT04323761,,,,,,,2020-11-13,https://clinicaltrials.gov/show/NCT04323761,,0,0
1859,NCT04323800,Completed,2021-04-22,2021-06-22,No Results Posted,"['Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D. Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection. medRxiv. 2021 Dec 14. pii: 2021.12.13.21267611. doi: 10.1101/2021.12.13.21267611.']",,2022-03-10,https://clinicaltrials.gov/show/NCT04323800,2021-04-22,0,1
1860,NCT04324463,"Active, not recruiting",2022-05-15,2022-10-01,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2022-03-15,https://clinicaltrials.gov/show/NCT04324463,2022-05-15,0,1
1861,NCT04325646,Recruiting,2022-12-31,2023-02-28,No Results Posted,"['Benetos A, Lai TP, Toupance S, Labat C, Verhulst S, Gautier S, Ungeheuer MN, Perret-Guillaume C, Levy D, Susser E, Aviv A. The Nexus Between Telomere Length and Lymphocyte Count in Seniors Hospitalized With COVID-19. J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):e97-e101. doi: 10.1093/gerona/glab026.']",,2022-03-23,https://clinicaltrials.gov/show/NCT04325646,2022-12-31,0,1
1862,NCT04328285,"Active, not recruiting",2022-03-30,2022-03-30,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04328285,2022-03-30,0,0
1863,NCT04329533,Completed,2020-11-01,2020-11-01,No Results Posted,"['Smith RB, Mahnert ND, Foote J, Saunders KT, Mourad J, Huberty J. Mindfulness Effects in Obstetric and Gynecology Patients During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Randomized Controlled Trial. Obstet Gynecol. 2021 Jun 1;137(6):1032-1040. doi: 10.1097/AOG.0000000000004316.']",,2020-11-13,https://clinicaltrials.gov/show/NCT04329533,2020-11-01,0,1
1864,NCT04329611,Terminated,2020-07-20,2020-07-20,No Results Posted,"['Schwartz I, Boesen ME, Cerchiaro G, Doram C, Edwards BD, Ganesh A, Greenfield J, Jamieson S, Karnik V, Kenney C, Lim R, Menon BK, Mponponsuo K, Rathwell S, Ryckborst KJ, Stewart B, Yaskina M, Metz L, Richer L, Hill MD; ALBERTA HOPE COVID-19 Collaborators. Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial. CMAJ Open. 2021 Jun 18;9(2):E693-E702. doi: 10.9778/cmajo.20210069. Print 2021 Apr-Jun.']",,2020-07-31,https://clinicaltrials.gov/show/NCT04329611,2020-07-20,0,1
1865,NCT04331366,Completed,2020-08-31,2020-08-31,Study Results,,,2021-02-18,https://clinicaltrials.gov/show/NCT04331366,2020-08-31,1,0
1866,NCT04331899,Completed,2020-08-14,2021-05-06,Study Results,"['Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, Singh U, Jagannathan P, Grant P. Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic. Clin Infect Dis. 2021 Aug 2;73(3):e826-e829. doi: 10.1093/cid/ciab103.']","['Jagannathan P, Andrews JR, Bonilla H, Hedlin H, Jacobson KB, Balasubramanian V, Purington N, Kamble S, de Vries CR, Quintero O, Feng K, Ley C, Winslow D, Newberry J, Edwards K, Hislop C, Choong I, Maldonado Y, Glenn J, Bhatt A, Blish C, Wang T, Khosla C, Pinsky BA, Desai M, Parsonnet J, Singh U. Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial. Nat Commun. 2021 Mar 30;12(1):1967. doi: 10.1038/s41467-021-22177-1.']",2021-11-30,https://clinicaltrials.gov/show/NCT04331899,2020-08-14,1,1
1867,NCT04332991,Completed,2020-06-19,2020-07-23,Study Results,"[""Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR, Files DC, Gibbs KW, Ginde AA, Gong MN, Harrell FE Jr, Hayden DL, Hough CL, Johnson NJ, Khan A, Lindsell CJ, Matthay MA, Moss M, Park PK, Rice TW, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Ulysse CA, Weissman A, Yealy DM, Thompson BT, Brown SM; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Steingrub J, Smithline H, Tiru B, Tidswell M, Kozikowski L, Thornton-Thompson S, De Souza L, Hou P, Baron R, Massaro A, Aisiku I, Fredenburgh L, Seethala R, Johnsky L, Riker R, Seder D, May T, Baumann M, Eldridge A, Lord C, Shapiro N, Talmor D, O'Mara T, Kirk C, Harrison K, Kurt L, Schermerhorn M, Banner-Goodspeed V, Boyle K, Dubosh N, Filbin M, Hibbert K, Parry B, Lavin-Parsons K, Pulido N, Lilley B, Lodenstein C, Margolin J, Brait K, Jones A, Galbraith J, Peacock R, Nandi U, Wachs T, Matthay M, Liu K, Kangelaris K, Wang R, Calfee C, Yee K, Hendey G, Chang S, Lim G, Qadir N, Tam A, Beutler R, Levitt J, Wilson J, Rogers A, Vojnik R, Roque J, Albertson T, Chenoweth J, Adams J, Pearson S, Juarez M, Almasri E, Fayed M, Hughes A, Hillard S, Huebinger R, Wang H, Vidales E, Patel B, Ginde A, Moss M, Baduashvili A, McKeehan J, Finck L, Higgins C, Howell M, Douglas I, Haukoos J, Hiller T, Lyle C, Cupelo A, Caruso E, Camacho C, Gravitz S, Finigan J, Griesmer C, Park P, Hyzy R, Nelson K, McDonough K, Olbrich N, Williams M, Kapoor R, Nash J, Willig M, Ford H, Gardner-Gray J, Ramesh M, Moses M, Ng Gong M, Aboodi M, Asghar A, Amosu O, Torres M, Kaur S, Chen JT, Hope A, Lopez B, Rosales K, Young You J, Mosier J, Hypes C, Natt B, Borg B, Salvagio Campbell E, Hite RD, Hudock K, Cresie A, Alhasan F, Gomez-Arroyo J, Duggal A, Mehkri O, Hastings A, Sahoo D, Abi Fadel F, Gole S, Shaner V, Wimer A, Meli Y, King A, Terndrup T, Exline M, Pannu S, Robart E, Karow S, Hough C, Robinson B, Johnson N, Henning D, Campo M, Gundel S, Seghal S, Katsandres S, Dean S, Khan A, Krol O, Jouzestani M, Huynh P, Weissman A, Yealy D, Scholl D, Adams P, McVerry B, Huang D, Angus D, Schooler J, Moore S, Files C, Miller C, Gibbs K, LaRose M, Flores L, Koehler L, Morse C, Sanders J, Langford C, Nanney K, MdalaGausi M, Yeboah P, Morris P, Sturgill J, Seif S, Cassity E, Dhar S, de Wit M, Mason J, Goodwin A, Hall G, Grady A, Chamberlain A, Brown S, Bledsoe J, Leither L, Peltan I, Starr N, Fergus M, Aston V, Montgomery Q, Smith R, Merrill M, Brown K, Armbruster B, Harris E, Middleton E, Paine R, Johnson S, Barrios M, Eppensteiner J, Limkakeng A, McGowan L, Porter T, Bouffler A, Leahy JC, deBoisblanc B, Lammi M, Happel K, Lauto P, Self W, Casey J, Semler M, Collins S, Harrell F, Lindsell C, Rice T, Stubblefield W, Gray C, Johnson J, Roth M, Hays M, Torr D, Zakaria A, Schoenfeld D, Thompson T, Hayden D, Ringwood N, Oldmixon C, Ulysse C, Morse R, Muzikansky A, Fitzgerald L, Whitaker S, Lagakos A, Brower R, Reineck L, Aggarwal N, Bienstock K, Freemer M, Maclawiw M, Weinmann G, Morrison L, Gillespie M, Kryscio R, Brodie D, Zareba W, Rompalo A, Boeckh M, Parsons P, Christie J, Hall J, Horton N, Zoloth L, Dickert N, Diercks D. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240."", 'Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Ann Am Thorac Soc. 2020 Sep;17(9):1144-1153. doi: 10.1513/AnnalsATS.202005-478SD.']",,2021-03-17,https://clinicaltrials.gov/show/NCT04332991,2020-06-19,1,1
1868,NCT04335136,Completed,2020-12-26,2020-12-26,Study Results,,,2021-08-02,https://clinicaltrials.gov/show/NCT04335136,2020-12-26,1,0
1869,NCT04337918,Completed,2021-01-31,2021-02-02,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04337918,2021-01-31,0,0
1870,NCT04339790,Completed,2021-05-17,2021-06-02,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04339790,2021-05-17,0,0
1871,NCT04341285,Withdrawn,2022-04-01,2022-05-01,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04341285,2022-04-01,0,0
1872,NCT04341688,Not yet recruiting,2022-06-30,2022-07-31,No Results Posted,"['Burton MJ, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AG, Webster KE, Worthington HV. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. Cochrane Database Syst Rev. 2020 Sep 16;9:CD013627. doi: 10.1002/14651858.CD013627.pub2.', 'Khan FR, Kazmi SMR, Iqbal NT, Iqbal J, Ali ST, Abbas SA. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 14;21(1):785. doi: 10.1186/s13063-020-04634-2.']",,2021-07-20,https://clinicaltrials.gov/show/NCT04341688,2022-06-30,0,1
1873,NCT04342689,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04342689,2022-03-01,0,0
1874,NCT04342897,Terminated,2020-10-12,2020-10-12,Study Results,,,2021-08-12,https://clinicaltrials.gov/show/NCT04342897,2020-10-12,1,0
1875,NCT04343261,Completed,2020-07-23,2020-08-13,Study Results,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']","['Dulipsingh L, Ibrahim D, Schaefer EJ, Crowell R, Diffenderfer MR, Williams K, Lima C, McKenzie J, Cook L, Puff J, Onoroski M, Wakefield DB, Eadie RJ, Kleiboeker SB, Nabors P, Hussain SA. SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma. Transfus Apher Sci. 2020 Dec;59(6):102922. doi: 10.1016/j.transci.2020.102922. Epub 2020 Aug 25.', 'Ibrahim D, Dulipsingh L, Zapatka L, Eadie R, Crowell R, Williams K, Wakefield DB, Cook L, Puff J, Hussain SA. Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial. Infect Dis Ther. 2020 Dec;9(4):913-926. doi: 10.1007/s40121-020-00341-2. Epub 2020 Sep 20.']",2020-09-24,https://clinicaltrials.gov/show/NCT04343261,2020-07-23,1,1
1876,NCT04343729,Completed,2020-06-16,2020-10-20,No Results Posted,"['Barros CMSS, Freire RS, Frota E, Rezende Santos AG, Farias MEL, Rodrigues MGA, Silva BM, Prado Jeronimo CM, Netto RLA, Silva Borba MG, Ba√≠a-da-Silva D, Brito-Sousa JD, Xavier MS, Ara√∫jo-Alexandre MA, Sampaio VS, Melo GC, Ar√™as GT, Hajjar LA, Monteiro WM, Gomes Naveca F, Costa FTM, Val FFA, Lacerda MVG; Metcovid team. Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial. Front Med (Lausanne). 2021 Nov 30;8:758405. doi: 10.3389/fmed.2021.758405. eCollection 2021.', 'Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Netto RLA, Maciel ABS, Neto JRS, Oliveira LB, Figueiredo EFG, Oliveira Dinelly KM, de Almeida Rodrigues MG, Brito M, Mour√£o MPG, Pivoto Jo√£o GA, Hajjar LA, Bassat Q, Romero GAS, Naveca FG, Vasconcelos HL, de Ara√∫jo Tavares M, Brito-Sousa JD, Costa FTM, Nogueira ML, Ba√≠a-da-Silva DC, Xavier MS, Monteiro WM, Lacerda MVG; Metcovid Team. Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clin Infect Dis. 2021 May 4;72(9):e373-e381. doi: 10.1093/cid/ciaa1177.']",,2021-07-28,https://clinicaltrials.gov/show/NCT04343729,2020-06-16,0,1
1877,NCT04343976,Terminated,2021-07-30,2021-07-30,No Results Posted,"['Lee JS, Shin EC. The type I interferon response in COVID-19: implications for treatment. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3.']",,2021-10-11,https://clinicaltrials.gov/show/NCT04343976,2021-07-30,0,1
1878,NCT04344561,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04344561,2022-05-01,0,0
1879,NCT04344587,Completed,2021-05-07,2021-05-07,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04344587,2021-05-07,0,0
1880,NCT04345419,Completed,2020-12-01,2020-12-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04345419,2020-12-01,0,0
1881,NCT04346277,,,,,,,2021-06-21,https://clinicaltrials.gov/show/NCT04346277,,0,0
1882,NCT04346355,Terminated,2020-06-06,2020-06-06,No Results Posted,"['Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turr√† C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04346355,2020-06-06,0,1
1883,NCT04346615,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04346615,2022-04-30,0,0
1884,NCT04347954,Completed,2020-12-13,2020-12-13,Study Results,,,2021-10-21,https://clinicaltrials.gov/show/NCT04347954,2020-12-13,1,0
1885,NCT04349241,Completed,2020-06-01,2020-06-20,No Results Posted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04349241,2020-06-01,0,0
1886,NCT04350593,Completed,2021-03-31,2021-06-11,Results Submitted,"['Kosiborod MN, Esterline R, Furtado RHM, Oscarsson J, Gasparyan SB, Koch GG, Martinez F, Mukhtar O, Verma S, Chopra V, Buenconsejo J, Langkilde AM, Ambery P, Tang F, Gosch K, Windsor SL, Akin EE, Soares RVP, Moia DDF, Aboudara M, Hoffmann Filho CR, Feitosa ADM, Fonseca A, Garla V, Gordon RA, Javaheri A, Jaeger CP, Leaes PE, Nassif M, Pursley M, Silveira FS, Barroso WKS, Lazcano Soto JR, Nigro Maia L, Berwanger O. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594. doi: 10.1016/S2213-8587(21)00180-7. Epub 2021 Jul 21.']",,2021-09-14,https://clinicaltrials.gov/show/NCT04350593,2021-03-31,0,1
1887,NCT04351347,Recruiting,2030-12-01,2030-12-01,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04351347,2030-12-01,0,0
1888,NCT04352491,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04352491,2020-05-31,0,0
1889,NCT04353180,Not yet recruiting,2021-10-01,2021-11-01,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04353180,2021-10-01,0,0
1890,NCT04353284,Completed,2021-03-03,2021-04-22,Study Results,"['Chupp G, Spichler-Moffarah A, S√∏gaard OS, Esserman D, Dziura J, Danzig L, Chaurasia R, Patra KP, Salovey A, Nunez A, May J, Astorino L, Patel A, Halene S, Wang J, Hui P, Patel P, Lu J, Li F, Gan G, Parziale S, Katsovich L, Desir GV, Vinetz JM. A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste. medRxiv. 2022 Jan 31. pii: 2022.01.28.22270035. doi: 10.1101/2022.01.28.22270035.']",,2022-03-24,https://clinicaltrials.gov/show/NCT04353284,2021-03-03,1,1
1891,NCT04353336,Completed,2020-06-01,2020-07-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04353336,2020-06-01,0,0
1892,NCT04353674,Recruiting,2021-12-01,2021-12-01,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Liu HG. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', ""Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18."", 'Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol. 2005 Dec;5(12):917-27. Review.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009 Jun;7(6):439-50. doi: 10.1038/nrmicro2147. Review.', 'Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7. Epub 2005 Jan 18.', 'Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005 Jun;79(12):7819-26.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003 May 24;361(9371):1773-8.', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020 Jun;48(6):e440-e469. doi: 10.1097/CCM.0000000000004363.', 'Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One. 2011 Apr 14;6(4):e18584. doi: 10.1371/journal.pone.0018584.', 'Ding F, Yevzlin AS, Xu ZY, Zhou Y, Xie QH, Liu JF, Zheng Y, DaSilva JR, Humes HD. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J. 2011 Sep-Oct;57(5):426-32. doi: 10.1097/MAT.0b013e31820a1494.', 'Humes HD, Sobota JT, Ding F, Song JH; RAD Investigator Group. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif. 2010;29(2):183-90. doi: 10.1159/000245645. Epub 2010 Jan 8.', 'Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group. A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.']",2021-04-01,https://clinicaltrials.gov/show/NCT04353674,2021-12-01,0,1
1893,NCT04354441,Withdrawn,2020-05-01,2020-05-01,No Results Posted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04354441,2020-05-01,0,0
1894,NCT04354519,Recruiting,2022-07-14,2022-07-14,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04354519,2022-07-14,0,0
1895,NCT04354792,Completed,2020-06-10,2020-06-10,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04354792,2020-06-10,0,0
1896,NCT04354805,Not yet recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04354805,2020-10-01,0,0
1897,NCT04355728,Completed,2020-10-31,2020-10-31,Study Results,,,2021-12-06,https://clinicaltrials.gov/show/NCT04355728,2020-10-31,1,0
1898,NCT04355767,Completed,2021-03-29,2021-03-29,Study Results,,"['Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, Van Huysen C, Stevenson VLW, Yadav K, Jones CW, Kea B, Burnett A, Reynolds JC, Greineder CF, Haas NL, Beiser DG, Silbergleit R, Barsan W, Callaway CW; SIREN-C3PO Investigators. Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 Nov 18;385(21):1951-1960. doi: 10.1056/NEJMoa2103784. Epub 2021 Aug 18.']",2021-10-19,https://clinicaltrials.gov/show/NCT04355767,2021-03-29,1,1
1899,NCT04356534,Completed,2020-06-15,2020-07-09,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'AlQahtani M, Abdulrahman A, Almadani A, Alali SY, Al Zamrooni AM, Hejab AH, Conroy RM, Wasif P, Otoom S, Atkin SL, Abduljalil M. Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep. 2021 May 11;11(1):9927. doi: 10.1038/s41598-021-89444-5.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04356534,2020-06-15,0,1
1900,NCT04356937,Completed,2020-07-13,2020-08-27,Study Results,"[""Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK; BACC Bay Tocilizumab Trial Investigators. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.""]",,2021-07-27,https://clinicaltrials.gov/show/NCT04356937,2020-07-13,1,1
1901,NCT04357028,Suspended,2020-12-31,2021-01-01,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04357028,2020-12-31,0,0
1902,NCT04357535,Completed,2020-07-01,2020-08-01,No Results Posted,"['Hakeam HA, Alsemari M, Duhailib ZA, Ghonem L, Alharbi SA, Almutairy E, Sheraim NMB, Alsalhi M, Alhijji A, AlQahtani S, Khalid M, Barry M. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study. J Cardiovasc Pharmacol Ther. 2021 May;26(3):244-252. doi: 10.1177/1074248420976279. Epub 2020 Nov 24.']",,2020-08-04,https://clinicaltrials.gov/show/NCT04357535,2020-07-01,0,1
1903,NCT04357639,Completed,2021-01-31,2021-07-31,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04357639,2021-01-31,0,0
1904,NCT04357730,Completed,2021-03-21,2021-09-30,Study Results,"['Barrett CD, Moore HB, Moore EE, Wang J, Hajizadeh N, Biffl WL, Lottenberg L, Patel PR, Truitt MS, McIntyre RC Jr, Bull TM, Ammons LA, Ghasabyan A, Chandler J, Douglas IS, Schmidt EP, Moore PK, Wright FL, Ramdeo R, Borrego R, Rueda M, Dhupa A, McCaul DS, Dandan T, Sarkar PK, Khan B, Sreevidya C, McDaniel C, Grossman Verner HM, Pearcy C, Anez-Bustillos L, Baedorf-Kassis EN, Jhunjhunwala R, Shaefi S, Capers K, Banner-Goodspeed V, Talmor DS, Sauaia A, Yaffe MB. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial. Chest. 2022 Mar;161(3):710-727. doi: 10.1016/j.chest.2021.09.024. Epub 2021 Sep 27.', 'Moore HB, Barrett CD, Moore EE, Jhunjhnuwala R, McIntyre RC, Moore PK, Wang J, Hajizadeh N, Talmor DS, Sauaia A, Yaffe MB. STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial. Res Pract Thromb Haemost. 2020 May 21. doi: 10.1002/rth2.12395. [Epub ahead of print]']",,2022-01-20,https://clinicaltrials.gov/show/NCT04357730,2021-03-21,1,1
1905,NCT04358068,Terminated,2020-07-08,2020-07-08,Study Results,,,2021-11-16,https://clinicaltrials.gov/show/NCT04358068,2020-07-08,1,0
1906,NCT04358380,Enrolling by invitation,2020-12-31,2020-12-31,No Results Posted,"['Mendizabal M, Ridruejo E, Pi√±ero F, Anders M, Padilla M, Toro LG, Torre A, Montes P, Urz√∫a A, Gonzalez Ballerga E, Silveyra MD, Michelato D, D√≠az J, Peralta M, Pages J, Garc√≠a SR, Gutierrez Lozano I, Macias Y, Cocozzella D, Chavez-Tapia N, Tagle M, Dominguez A, Var√≥n A, Vera Pozo E, Higuera-de la Tijera F, Bustios C, Conte D, Escajadillo N, G√≥mez AJ, Tenorio L, Castillo Barradas M, Schinoni MI, Bessone F, Contreras F, Nazal L, Sanchez A, Garc√≠a M, Brutti J, Cabrera MC, Miranda-Zazueta G, Rojas G, Cattaneo M, Castro-Narro G, Rubinstein F, Silva MO. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. Ann Hepatol. 2021 Nov-Dec;25:100350. doi: 10.1016/j.aohep.2021.100350. Epub 2021 Apr 14.', 'Mendizabal M, Pi√±ero F, Ridruejo E, Anders M, Silveyra MD, Torre A, Montes P, Urz√∫a A, Pages J, Toro LG, D√≠az J, Gonzalez Ballerga E, Miranda-Zazueta G, Peralta M, Guti√©rrez I, Michelato D, Venturelli MG, Var√≥n A, Vera-Pozo E, Tagle M, Garc√≠a M, Tassara A, Brutti J, Ruiz Garc√≠a S, Bustios C, Escajadillo N, Macias Y, Higuera-de la Tijera F, G√≥mez AJ, Dominguez A, Castillo-Barradas M, Contreras F, Scarpin A, Schinoni MI, Toledo C, Girala M, Mainardi V, Sanchez A, Bessone F, Rubinstein F, Silva MO. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission. Ann Hepatol. 2021 Mar-Apr;21:100298. doi: 10.1016/j.aohep.2020.100298. Epub 2021 Jan 7.']",,2020-07-21,https://clinicaltrials.gov/show/NCT04358380,2020-12-31,0,1
1907,NCT04358549,Completed,2020-09-30,2020-10-30,Study Results,"['Finberg RW, Ashraf M, Julg B, Ayoade F, Marathe JG, Issa NC, Wang JP, Jaijakul S, Baden LR, Epstein C. US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19. Open Forum Infect Dis. 2021 Dec 7;8(12):ofab563. doi: 10.1093/ofid/ofab563. eCollection 2021 Dec.']",,2022-03-29,https://clinicaltrials.gov/show/NCT04358549,2020-09-30,1,1
1908,NCT04358835,Withdrawn,2021-09-01,2021-12-31,No Results Posted,,,2020-08-25,https://clinicaltrials.gov/show/NCT04358835,2021-09-01,0,0
1909,NCT04359277,Recruiting,2022-09-01,2022-12-01,No Results Posted,"['Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD; ACTIV-4a Investigators. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Jan 18;327(3):227-236. doi: 10.1001/jama.2021.23605.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04359277,2022-09-01,0,1
1910,NCT04360824,Recruiting,2021-04-16,2021-04-16,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2020-06-19,https://clinicaltrials.gov/show/NCT04360824,2021-04-16,0,1
1911,NCT04361396,Completed,2021-12-16,2021-12-16,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04361396,2021-12-16,0,0
1912,NCT04361552,Withdrawn,2020-06-02,2020-06-02,No Results Posted,,,2020-06-18,https://clinicaltrials.gov/show/NCT04361552,2020-06-02,0,0
1913,NCT04362137,Completed,2020-10-17,2020-10-17,Study Results,,,2021-10-11,https://clinicaltrials.gov/show/NCT04362137,2020-10-17,1,0
1914,NCT04362332,Terminated,2020-06-08,2020-06-08,No Results Posted,,,2020-06-19,https://clinicaltrials.gov/show/NCT04362332,2020-06-08,0,0
1915,NCT04362865,Recruiting,2023-12-01,2024-12-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04362865,2023-12-01,0,0
1916,NCT04363203,Suspended,2021-03-01,2021-08-01,No Results Posted,"['Keyhani S, Kelly JD, Bent S, Boscardin WJ, Shlipak MG, Leonard S, Abraham A, Lum E, Lau N, Austin C, Oldenburg CE, Zillich A, Lopez L, Zhang Y, Lietman T, Bravata DM. A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic. Clin Trials. 2021 Aug;18(4):514-517. doi: 10.1177/17407745211011577. Epub 2021 May 20.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04363203,2021-03-01,0,1
1917,NCT04363385,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04363385,2022-05-31,0,0
1918,NCT04363463,Recruiting,2022-08-28,2022-08-28,No Results Posted,,,2021-12-02,https://clinicaltrials.gov/show/NCT04363463,2022-08-28,0,0
1919,NCT04363853,"Active, not recruiting",2021-06-01,2021-08-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04363853,2021-06-01,0,0
1920,NCT04364737,"Active, not recruiting",2021-03-29,2022-12-31,Study Results,"[""Ortigoza MB, Yoon H, Goldfeld KS, Troxel AB, Daily JP, Wu Y, Li Y, Wu D, Cobb GF, Baptiste G, O'Keeffe M, Corpuz MO, Ostrosky-Zeichner L, Amin A, Zacharioudakis IM, Jayaweera DT, Wu Y, Philley JV, Devine MS, Desruisseaux MS, Santin AD, Anjan S, Mathew R, Patel B, Nigo M, Upadhyay R, Kupferman T, Dentino AN, Nanchal R, Merlo CA, Hager DN, Chandran K, Lai JR, Rivera J, Bikash CR, Lasso G, Hilbert TP, Paroder M, Asencio AA, Liu M, Petkova E, Bragat A, Shaker R, McPherson DD, Sacco RL, Keller MJ, Grudzen CR, Hochman JS, Pirofski LA; CONTAIN COVID-19 Consortium for the CONTAIN COVID-19 Study Group, Parameswaran L, Corcoran AT, Rohatgi A, Wronska MW, Wu X, Srinivasan R, Deng FM, Filardo TD, Pendse J, Blaser SB, Whyte O, Gallagher JM, Thomas OE, Ramos D, Sturm-Reganato CL, Fong CC, Daus IM, Payoen AG, Chiofolo JT, Friedman MT, Wu DW, Jacobson JL, Schneider JG, Sarwar UN, Wang HE, Huebinger RM, Dronavalli G, Bai Y, Grimes CZ, Eldin KW, Umana VE, Martin JG, Heath TR, Bello FO, Ransford DL, Laurent-Rolle M, Shenoi SV, Akide-Ndunge OB, Thapa B, Peterson JL, Knauf K, Patel SU, Cheney LL, Tormey CA, Hendrickson JE. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial. JAMA Intern Med. 2022 Feb 1;182(2):115-126. doi: 10.1001/jamainternmed.2021.6850.""]",,2022-04-01,https://clinicaltrials.gov/show/NCT04364737,2021-03-29,1,1
1921,NCT04364763,Terminated,2021-09-02,2021-09-30,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04364763,2021-09-02,0,0
1922,NCT04364893,Recruiting,2020-10-01,2020-12-01,No Results Posted,"[""Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, Feldman A, D'Andr√©a Saba Arruda G, de Albuquerque DC, Camiletti AS, de Sousa AS, de Paula TC, Giusti KGD, Domiciano RAM, Noya-Rabelo MM, Hamilton AM, Loures VA, Dion√≠sio RM, Furquim TAB, De Luca FA, Dos Santos Sousa √çB, Bandeira BS, Zukowski CN, de Oliveira RGG, Ribeiro NB, de Moraes JL, Petriz JLF, Pimentel AM, Miranda JS, de Jesus Abufaiad BE, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA Investigators. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan 19;325(3):254-264. doi: 10.1001/jama.2020.25864.""]",,2020-07-02,https://clinicaltrials.gov/show/NCT04364893,2020-10-01,0,1
1923,NCT04365101,"Active, not recruiting",2021-12-30,2022-06-30,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04365101,2021-12-30,0,0
1924,NCT04365582,Withdrawn,2020-12-31,2021-04-19,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04365582,2020-12-31,0,0
1925,NCT04366778,Completed,2021-01-01,2021-01-01,No Results Posted,,,2021-01-25,https://clinicaltrials.gov/show/NCT04366778,2021-01-01,0,0
1926,NCT04366791,Terminated,2022-03-11,2022-03-11,No Results Posted,"['Hess CB, Eng TY, Nasti TH, Dhere VR, Kleber TJ, Switchenko JM, Weinberg BD, Rouphael N, Tian S, Rudra S, Taverna LS, Daisson AP, Ahmed R, Khan MK. Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir. Radiother Oncol. 2021 Dec;165:20-31. doi: 10.1016/j.radonc.2021.10.003. Epub 2021 Oct 13.']",,2022-03-29,https://clinicaltrials.gov/show/NCT04366791,2022-03-11,0,1
1927,NCT04366986,Completed,2021-08-31,2021-08-31,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04366986,2021-08-31,0,0
1928,NCT04367740,Enrolling by invitation,2022-12-01,2022-12-01,No Results Posted,,,2022-01-05,https://clinicaltrials.gov/show/NCT04367740,2022-12-01,0,0
1929,NCT04368897,Recruiting,2022-12-01,2022-12-01,No Results Posted,,"['Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020 Jul;33(4):e13365. doi: 10.1111/dth.13365. Epub 2020 Apr 8.', 'Wambier CG, Goren A. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated. J Am Acad Dermatol. 2020 Jul;83(1):308-309. doi: 10.1016/j.jaad.2020.04.032. Epub 2020 Apr 10.', 'Goren A, Va√±o-Galv√°n S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washenik K. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020 Jul;19(7):1545-1547. doi: 10.1111/jocd.13443. Epub 2020 Apr 23.', 'McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Ramos PM, Washenik K, Andrade M, Herrera S, Goren A. Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? J Cosmet Dermatol. 2020 Jul;19(7):1542-1543. doi: 10.1111/jocd.13455. Epub 2020 Jun 14.']",2022-02-18,https://clinicaltrials.gov/show/NCT04368897,2022-12-01,0,1
1930,NCT04368923,"Active, not recruiting",2020-06-21,2020-06-23,No Results Posted,"['Adly AS, Adly MS, Adly AS. Telemanagement of Home-Isolated COVID-19 Patients Using Oxygen Therapy With Noninvasive Positive Pressure Ventilation and Physical Therapy Techniques: Randomized Clinical Trial. J Med Internet Res. 2021 Apr 28;23(4):e23446. doi: 10.2196/23446.']",,2020-06-23,https://clinicaltrials.gov/show/NCT04368923,2020-06-21,0,1
1931,NCT04369742,Terminated,2021-04-01,2021-04-01,Results Submitted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04369742,2021-04-01,0,0
1932,NCT04370834,Terminated,2021-01-14,2021-01-14,Study Results,,,2021-07-20,https://clinicaltrials.gov/show/NCT04370834,2021-01-14,1,0
1933,NCT04371354,"Active, not recruiting",2021-06-14,2021-12-27,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04371354,2021-06-14,0,0
1934,NCT04371393,"Active, not recruiting",2021-01-14,2022-02-01,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04371393,2021-01-14,0,0
1935,NCT04371419,Completed,2020-05-24,2020-05-26,Study Results,"['Alsan M, Stanford FC, Banerjee A, Breza E, Chandrasekhar AG, Eichmeyer S, Goldsmith-Pinkham P, Ogbu-Nwobodo L, Olken BA, Torres C, Sankar A, Vautrey PL, Duflo E. Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities : A Randomized Controlled Trial. Ann Intern Med. 2021 Apr;174(4):484-492. doi: 10.7326/M20-6141. Epub 2020 Dec 21.']",,2021-07-27,https://clinicaltrials.gov/show/NCT04371419,2020-05-24,1,1
1936,NCT04371432,Suspended,2025-06-01,2025-06-01,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04371432,2025-06-01,0,0
1937,NCT04371471,Completed,2020-04-30,2020-04-30,Results Submitted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04371471,2020-04-30,0,0
1938,NCT04371822,Not yet recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04371822,2020-10-01,0,0
1939,NCT04372186,"Active, not recruiting",2020-08-18,2021-12-01,Study Results,"['Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, Criner GJ, Kaplan-Lewis E, Baden R, Pandit L, Cameron ML, Garcia-Diaz J, Ch√°vez V, Mekebeb-Reuter M, Lima de Menezes F, Shah R, Gonz√°lez-Lara MF, Assman B, Freedman J, Mohan SV. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.', 'Tleyjeh IM. The Misleading ""Pooled Effect Estimate"" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 Jun 15;72(12):e1154-e1155. doi: 10.1093/cid/ciaa1735.']",,2021-09-27,https://clinicaltrials.gov/show/NCT04372186,2020-08-18,1,1
1940,NCT04373460,"Active, not recruiting",2022-12-21,2023-01-31,No Results Posted,"['Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2119657. [Epub ahead of print]', 'Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21. pii: 2021.12.10.21267485. doi: 10.1101/2021.12.10.21267485.']",,2021-11-22,https://clinicaltrials.gov/show/NCT04373460,2022-12-21,0,1
1941,NCT04373707,Completed,2021-04-29,2021-09-14,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-12-20,https://clinicaltrials.gov/show/NCT04373707,2021-04-29,0,1
1942,NCT04373733,Completed,2021-06-25,2021-06-25,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04373733,2021-06-25,0,0
1943,NCT04373759,Completed,2020-09-30,2020-09-30,No Results Posted,,"['Chelly J, Plantef√®ve G, Kamel T, Bruel C, Nseir S, Lai C, Cirillo G, Skripkina E, Ehrminger S, Berdaguer-Ferrari FD, Le Marec J, Paul M, Autret A, Deye N; ACICOVID-19 study group. Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry. Ann Intensive Care. 2021 Nov 13;11(1):155. doi: 10.1186/s13613-021-00945-y.']",2022-02-15,https://clinicaltrials.gov/show/NCT04373759,2020-09-30,0,1
1944,NCT04375397,Completed,2021-05-10,2021-06-08,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04375397,2021-05-10,0,0
1945,NCT04375761,Completed,2021-01-24,2021-01-24,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04375761,2021-01-24,0,0
1946,NCT04376684,Completed,2021-07-15,2021-08-16,Study Results,,,2022-03-23,,2021-07-15,1,0
1947,NCT04376775,Completed,2020-05-11,2020-05-11,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04376775,2020-05-11,0,0
1948,NCT04377100,Completed,2021-04-09,2021-11-19,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04377100,2021-04-09,0,0
1949,NCT04377334,Not yet recruiting,2022-11-01,2023-02-01,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04377334,2022-11-01,0,0
1950,NCT04377568,Withdrawn,2021-12-01,2022-05-01,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04377568,2021-12-01,0,0
1951,NCT04377620,Terminated,2021-02-26,2021-02-26,Study Results,,,2022-01-19,https://clinicaltrials.gov/show/NCT04377620,2021-02-26,1,0
1952,NCT04377776,Completed,2020-05-18,2020-05-18,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04377776,2020-05-18,0,0
1953,NCT04380818,Recruiting,2021-09-04,2021-11-01,No Results Posted,"['Algara M, Arenas M, Marin J, Vallverdu I, Fernandez-Let√≥n P, Villar J, Fabrer G, Rubio C, Montero A. Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial. Clin Transl Radiat Oncol. 2020 Jun 15;24:29-33. doi: 10.1016/j.ctro.2020.06.005. eCollection 2020 Sep.']",,2021-07-30,https://clinicaltrials.gov/show/NCT04380818,2021-09-04,0,1
1954,NCT04382586,Completed,2021-02-01,2021-02-01,Study Results,,,2022-03-02,https://clinicaltrials.gov/show/NCT04382586,2021-02-01,1,0
1955,NCT04382651,Completed,2021-01-06,2021-04-21,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-07-08,https://clinicaltrials.gov/show/NCT04382651,2021-01-06,0,1
1956,NCT04382794,Completed,2020-06-15,2020-06-15,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04382794,2020-06-15,0,0
1957,NCT04383444,Completed,2021-03-01,2022-02-10,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04383444,2021-03-01,0,0
1958,NCT04383457,Completed,2020-10-08,2020-10-08,No Results Posted,,,2020-12-01,https://clinicaltrials.gov/show/NCT04383457,2020-10-08,0,0
1959,NCT04383613,"Active, not recruiting",2021-06-01,2021-06-01,No Results Posted,"['Fralick M, Colacci M, Munshi L, Venus K, Fidler L, Hussein H, Britto K, Fowler R, da Costa BR, Dhalla I, Dunbar-Yaffe R, Branfield Day L, MacMillan TE, Zipursky J, Carpenter T, Tang T, Cooke A, Hensel R, Bregger M, Gordon A, Worndl E, Go S, Mandelzweig K, Castellucci LA, Tamming D, Razak F, Verma AA; COVID Prone Study Investigators. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE). BMJ. 2022 Mar 23;376:e068585. doi: 10.1136/bmj-2021-068585.']",,2021-05-13,https://clinicaltrials.gov/show/NCT04383613,2021-06-01,0,1
1960,NCT04384055,Completed,2021-11-15,2021-11-15,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04384055,2021-11-15,0,0
1961,NCT04385238,Completed,2020-06-20,2020-06-20,Study Results,,,2021-01-07,https://clinicaltrials.gov/show/NCT04385238,2020-06-20,1,0
1962,NCT04386252,Not yet recruiting,2023-06-01,2024-01-01,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04386252,2023-06-01,0,0
1963,NCT04386616,Completed,2021-01-08,2021-02-12,Study Results,,,2022-01-10,https://clinicaltrials.gov/show/NCT04386616,2021-01-08,1,0
1964,NCT04387656,"Active, not recruiting",2023-05-31,2023-05-31,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04387656,2023-05-31,0,0
1965,NCT04387760,Completed,2021-03-06,2021-04-07,No Results Posted,"['AlQahtani M, Kumar N, Aljawder D, Abdulrahman A, Alnashaba F, Fayyad MA, Alshaikh F, Alsahaf F, Saeed S, Almahroos A, Abdulrahim Z, Otoom S, Atkin SL. Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease. Sci Rep. 2022 Mar 23;12(1):4925. doi: 10.1038/s41598-022-08794-w.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04387760,2021-03-06,0,1
1966,NCT04387799,Completed,2020-06-12,2020-06-17,No Results Posted,,,2020-06-19,https://clinicaltrials.gov/show/NCT04387799,2020-06-12,0,0
1967,NCT04388826,Completed,2020-12-18,2021-08-13,Study Results,,,2021-11-24,https://clinicaltrials.gov/show/NCT04388826,2020-12-18,1,0
1968,NCT04389411,Not yet recruiting,2021-09-01,2021-12-01,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04389411,2021-09-01,0,0
1969,NCT04389710,Completed,2020-11-03,2020-12-07,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04389710,2020-11-03,0,0
1970,NCT04389840,Terminated,2021-05-20,2021-05-20,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Lasky JA, Fuloria J, Morrison ME, Lanier R, Naderer O, Brundage T, Melemed A. Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19. Adv Ther. 2021 Jan;38(1):782-791. doi: 10.1007/s12325-020-01539-z. Epub 2020 Oct 27.']",,2021-05-26,https://clinicaltrials.gov/show/NCT04389840,2021-05-20,0,1
1971,NCT04390126,"Active, not recruiting",2021-05-07,2021-11-07,No Results Posted,"['Volot F, Soudry-Faure A, Callegarin A, Ksiazek E, Delienne S, Cottin Y, Maynadi√© M, Boulin M. Impact of first COVID-19 lockdown on paediatric and adult haemophilia patients treated in a French Haemophilia Comprehensive Care Centre. Haemophilia. 2022 Mar 3. doi: 10.1111/hae.14526. [Epub ahead of print]']",,2021-01-20,https://clinicaltrials.gov/show/NCT04390126,2021-05-07,0,1
1972,NCT04391309,Terminated,2022-02-04,2022-02-04,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04391309,2022-02-04,0,0
1973,NCT04391816,Recruiting,2022-12-31,2024-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04391816,2022-12-31,0,0
1974,NCT04392219,Completed,2020-08-11,2020-08-11,Study Results,,,2021-07-19,https://clinicaltrials.gov/show/NCT04392219,2020-08-11,1,0
1975,NCT04392973,Completed,2021-01-26,2021-04-26,No Results Posted,"['Bosaeed M, Mahmoud E, Alharbi A, Altayib H, Albayat H, Alharbi F, Ghalilah K, Al Arfaj A, AlJishi J, Alarfaj A, Alqahtani H, Almutairi BM, Almaghaslah M, Alyahya NM, Bawazir A, AlEisa S, Alsaedy A, Bouchama A, Alharbi M, AlShamrani M, Al Johani S, Aljeraisy M, Alzahrani M, Althaqafi AO, Almarhabi H, Alotaibi A, Alqahtani N, Arabi YM, Aldibasi OS, Alaskar A. Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial. Infect Dis Ther. 2021 Dec;10(4):2291-2307. doi: 10.1007/s40121-021-00496-6. Epub 2021 Jul 28.', 'Bosaeed M, Mahmoud E, Hussein M, Alharbi A, Alsaedy A, Alothman A, Aljeraisy M, Alqahtani H, Nashabat M, Almutairi B, Almaghaslah M, Aldibasi O, AlJohani S, Bouchama A, Arabi Y, Alaskar A. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.']",,2021-08-20,https://clinicaltrials.gov/show/NCT04392973,2021-01-26,0,1
1976,NCT04393311,Withdrawn,2022-08-01,2022-08-01,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04393311,2022-08-01,0,0
1977,NCT04393948,Withdrawn,2021-06-01,2021-09-01,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04393948,2021-06-01,0,0
1978,NCT04394117,Completed,2021-11-14,2022-01-17,No Results Posted,"['Hockham C, Kotwal S, Wilcox A, Bassi A, McGree J, Pollock C, Burrell LM, Bathla N, Kunigari M, Rathore V, John M, Lin E, Jenkins C, Ritchie A, McLachlan A, Snelling T, Jones M, Jha V, Jardine M; CLARITY Investigators. Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial. Trials. 2021 Aug 28;22(1):573. doi: 10.1186/s13063-021-05521-0.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04394117,2021-11-14,0,1
1979,NCT04394377,Completed,2021-03-26,2021-05-30,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Bronhara B, Damiani LP, Barbosa LM, de Aveiro Morata J, Ramacciotti E, de Aquino Martins P, de Oliveira AL, Nunes VS, Ritt LEF, Rocha AT, Tramujas L, Santos SV, Diaz DRA, Viana LS, Melro LMG, de Alc√¢ntara Chaud MS, Figueiredo EL, Neuenschwander FC, Dracoulakis MDA, Lima RGSD, de Souza Dantas VC, Fernandes ACS, Gebara OCE, Hernandes ME, Queiroz DAR, Veiga VC, Canesin MF, de Faria LM, Feitosa-Filho GS, Gazzana MB, Liporace IL, de Oliveira Twardowsky A, Maia LN, Machado FR, de Matos Soeiro A, Concei√ß√£o-Souza GE, Armaganijan L, Guimar√£es PO, Rosa RG, Azevedo LCP, Alexander JH, Avezum A, Cavalcanti AB, Berwanger O; ACTION Coalition COVID-19 Brazil IV Investigators. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021 Jun 12;397(10291):2253-2263. doi: 10.1016/S0140-6736(21)01203-4. Epub 2021 Jun 4.', 'Lopes RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, Ramacciotti E, Damini LP, Bronhara B, Cavalcanti AB, Rosa RG, Azevedo LCP, Veiga VC, Machado FR, Ritt LE, Martins PA, Alexander JH, Avezum A, Berwanger O; Coalition COVID-19 Brazil IV Investigators. Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial. Am Heart J. 2021 Aug;238:1-11. doi: 10.1016/j.ahj.2021.04.005. Epub 2021 Apr 20.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-06-10,https://clinicaltrials.gov/show/NCT04394377,2021-03-26,0,1
1980,NCT04394793,"Active, not recruiting",2020-08-27,2020-09-01,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04394793,2020-08-27,0,0
1981,NCT04394884,Withdrawn,2022-02-17,2022-02-17,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04394884,2022-02-17,0,0
1982,NCT04395300,Completed,2020-04-30,2020-05-16,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04395300,2020-04-30,0,0
1983,NCT04395859,Completed,2021-12-15,2022-02-15,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04395859,2021-12-15,0,0
1984,NCT04396353,Completed,2020-10-01,2020-10-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04396353,2020-10-01,0,0
1985,NCT04397718,Completed,2021-06-08,2021-06-08,No Results Posted,"['Nickols NG, Goetz MB, Graber CJ, Bhattacharya D, Soo Hoo G, Might M, Goldstein DB, Wang X, Ramoni R, Myrie K, Tran S, Ghayouri L, Tsai S, Geelhoed M, Makarov D, Becker DJ, Tsay JC, Diamond M, George A, Al-Ajam M, Belligund P, Montgomery RB, Mostaghel EA, Sulpizio C, Mi Z, Dematt E, Tadalan J, Norman LE, Briones D, Clise CE, Taylor ZW, Huminik JR, Biswas K, Rettig MB. Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial. Trials. 2021 Jul 5;22(1):431. doi: 10.1186/s13063-021-05389-0.']",,2021-07-02,https://clinicaltrials.gov/show/NCT04397718,2021-06-08,0,1
1986,NCT04399005,Completed,2020-06-05,2020-06-10,No Results Posted,"['Jin B, Hu Y, Huang L, Cheng X, Zhao J, Yang X, Sun X, Gan T, Lu B. Effectiveness Between Daily and After-Each-Case Room Disinfection of the Endoscopy Unit. Front Public Health. 2021 Oct 5;9:700041. doi: 10.3389/fpubh.2021.700041. eCollection 2021.']",,2020-06-25,https://clinicaltrials.gov/show/NCT04399005,2020-06-05,0,1
1987,NCT04399317,Recruiting,2020-07-01,2020-08-01,No Results Posted,"['Roehrig S, Ait Hssain A, Shallik NAH, Elsaid IMA, Mustafa SF, Smain OAM, Molokhia AA, Lance MD. Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 11;21(1):781. doi: 10.1186/s13063-020-04708-1.']",,2020-06-25,https://clinicaltrials.gov/show/NCT04399317,2020-07-01,0,1
1988,NCT04399889,Terminated,2022-02-16,2022-02-16,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04399889,2022-02-16,0,0
1989,NCT04399967,"Active, not recruiting",2021-06-30,2022-06-30,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04399967,2021-06-30,0,0
1990,NCT04401449,Recruiting,2024-05-01,2024-05-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04401449,2024-05-01,0,0
1991,NCT04401579,Completed,2020-07-31,2020-07-31,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N, Ahuja N, Frank M, Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M, Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH; ACTT-2 Study Group Members. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.', 'Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation. 2021 Jan 1;105(1):37-55. doi: 10.1097/TP.0000000000003523. Review.']",,2022-03-14,,2020-07-31,1,1
1992,NCT04402866,Completed,2021-04-21,2021-04-21,Study Results,,,2022-03-17,,2021-04-21,1,0
1993,NCT04403386,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04403386,2022-05-31,0,0
1994,NCT04404361,Terminated,2021-09-21,2021-09-21,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04404361,2021-09-21,0,0
1995,NCT04405076,Completed,2021-10-26,2021-10-26,No Results Posted,"['Choi A, Koch M, Wu K, Chu L, Ma L, Hill A, Nunna N, Huang W, Oestreicher J, Colpitts T, Bennett H, Legault H, Paila Y, Nestorova B, Ding B, Montefiori D, Pajon R, Miller JM, Leav B, Carfi A, McPhee R, Edwards DK. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis. Nat Med. 2021 Nov;27(11):2025-2031. doi: 10.1038/s41591-021-01527-y. Epub 2021 Sep 15.', 'Chu L, McPhee R, Huang W, Bennett H, Pajon R, Nestorova B, Leav B; mRNA-1273 Study Group. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine. 2021 May 12;39(20):2791-2799. doi: 10.1016/j.vaccine.2021.02.007. Epub 2021 Feb 9.']",,2021-11-30,https://clinicaltrials.gov/show/NCT04405076,2021-10-26,0,1
1996,NCT04405570,Completed,2021-02-21,2021-02-21,Study Results,"['Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL, Loftis AJ, Degli-Angeli EJ, Brown AJ, Dragavon JA, Won JJ, Keys J, Hudgens MG, Fang L, Wohl DA, Cohen MS, Baric RS, Coombs RW, Sheahan TP, Fischer WA. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates. Clin Infect Dis. 2021 Nov 23. pii: ciab968. doi: 10.1093/cid/ciab968. [Epub ahead of print]', 'Fischer W, Eron JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, Sheahan TP, Baric R, Mollan KR, Wolfe CR, Duke ER, Azizad MM, Borroto-Esoda K, Wohl DA, Loftis AJ, Alabanza P, Lipansky F, Painter WP. Molnupiravir, an Oral Antiviral Treatment for COVID-19. medRxiv. 2021 Jun 17. pii: 2021.06.17.21258639. doi: 10.1101/2021.06.17.21258639. Update in: Sci Transl Med. 2022 Jan 19;14(628):eabl7430.', 'Mollan KR, Eron JJ, Krajewski TJ, Painter W, Duke ER, Morse CG, Goecker EA, Premkumar L, Wolfe CR, Szewczyk LJ, Alabanza PL, Loftis AJ, Degli-Angeli EJ, Brown AJ, Dragavon JA, Won JJ, Keys J, Hudgens MG, Fang L, Wohl DA, Cohen MS, Baric RS, Coombs RW, Sheahan TP, Fischer WA 2nd. Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates. medRxiv. 2021 Jun 25. pii: 2021.05.28.21258011. doi: 10.1101/2021.05.28.21258011. Update in: Clin Infect Dis. 2021 Nov 23;:.', 'Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2. Epub 2020 Dec 3.']",,2022-02-16,https://clinicaltrials.gov/show/NCT04405570,2021-02-21,1,1
1997,NCT04405739,Completed,2022-02-21,2022-02-21,No Results Posted,"['Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2. Epub 2020 Dec 3.']",,2022-03-21,https://clinicaltrials.gov/show/NCT04405739,2022-02-21,0,1
1998,NCT04405908,Completed,2021-10-20,2021-12-08,No Results Posted,"['Richmond P, Hatchuel L, Dong M, Ma B, Hu B, Smolenov I, Li P, Liang P, Han HH, Liang J, Clemens R. Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial. Lancet. 2021 Feb 20;397(10275):682-694. doi: 10.1016/S0140-6736(21)00241-5. Epub 2021 Jan 29.']",,2022-02-18,https://clinicaltrials.gov/show/NCT04405908,2021-10-20,0,1
1999,NCT04405921,Not yet recruiting,2020-12-01,2021-03-01,No Results Posted,,,2020-06-19,https://clinicaltrials.gov/show/NCT04405921,2020-12-01,0,0
2000,NCT04405934,Completed,2021-04-26,2021-10-08,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04405934,2021-04-26,0,0
2001,NCT04407117,Completed,2020-04-19,2020-04-19,No Results Posted,,,2020-06-19,https://clinicaltrials.gov/show/NCT04407117,2020-04-19,0,0
2002,NCT04407130,Completed,2020-10-30,2020-11-20,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04407130,2020-10-30,0,0
2003,NCT04407572,Completed,2020-06-01,2020-06-14,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04407572,2020-06-01,0,0
2004,NCT04407585,Recruiting,2023-05-10,2023-05-10,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04407585,2023-05-10,0,0
2005,NCT04407689,Recruiting,2021-07-30,2021-12-30,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.']",2021-01-15,https://clinicaltrials.gov/show/NCT04407689,2021-07-30,0,1
2006,NCT04408248,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04408248,2022-12-31,0,0
2007,NCT04409262,Completed,2021-02-01,2021-03-08,Study Results,,,2022-02-14,https://clinicaltrials.gov/show/NCT04409262,2021-02-01,1,0
2008,NCT04409925,Recruiting,2021-04-01,2021-08-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04409925,2021-04-01,0,0
2009,NCT04410159,Completed,2020-06-29,2020-07-06,Study Results,,,2020-07-21,https://clinicaltrials.gov/show/NCT04410159,2020-06-29,1,0
2010,NCT04410354,Terminated,2020-12-01,2020-12-01,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04410354,2020-12-01,0,0
2011,NCT04411147,Recruiting,2027-12-31,2027-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04411147,2027-12-31,0,0
2012,NCT04411628,Completed,2020-08-26,2020-08-26,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Nathan R, Shawa I, De La Torre I, Pustizzi JM, Haustrup N, Patel DR, Huhn G. A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. Infect Dis Ther. 2021 Dec;10(4):1933-1947. doi: 10.1007/s40121-021-00515-6. Epub 2021 Aug 10. Review.']",,2021-11-12,https://clinicaltrials.gov/show/NCT04411628,2020-08-26,1,1
2013,NCT04412291,Recruiting,2021-03-01,2021-06-01,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04412291,2021-03-01,0,0
2014,NCT04412304,Completed,2020-04-30,2020-05-28,No Results Posted,"['Jonmarker S, Hollenberg J, Dahlberg M, Stackelberg O, Litorell J, Everhov √ÖH, J√§rnbert-Pettersson H, S√∂derberg M, Grip J, Schandl A, G√ºnther M, Cronhjort M. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients. Crit Care. 2020 Nov 23;24(1):653. doi: 10.1186/s13054-020-03375-7.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04412304,2020-04-30,0,1
2015,NCT04412330,Completed,2021-05-05,2021-05-05,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04412330,2021-05-05,0,0
2016,NCT04412668,Completed,2020-12-21,2020-12-21,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04412668,2020-12-21,0,0
2017,NCT04414267,Completed,2021-04-28,2021-05-07,No Results Posted,,,2021-05-11,,2021-04-28,0,0
2018,NCT04415060,Recruiting,2023-06-15,2023-06-15,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04415060,2023-06-15,0,0
2019,NCT04416347,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04416347,2022-04-30,0,0
2020,NCT04416464,"Active, not recruiting",2021-07-31,2022-10-01,No Results Posted,,,2021-09-10,https://clinicaltrials.gov/show/NCT04416464,2021-07-31,0,0
2021,NCT04417257,Recruiting,2022-10-15,2022-10-15,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04417257,2022-10-15,0,0
2022,NCT04417673,Recruiting,2024-12-31,2024-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04417673,2024-12-31,0,0
2023,NCT04419610,Completed,2021-05-12,2021-05-12,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04419610,2021-05-12,0,0
2024,NCT04420247,Completed,2020-08-20,2020-09-03,No Results Posted,"['R√©a-Neto √Å, Bernardelli RS, C√¢mara BMD, Reese FB, Queiroga MVO, Oliveira MC. An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients. Sci Rep. 2021 Apr 27;11(1):9023. doi: 10.1038/s41598-021-88509-9.']",,2021-05-12,https://clinicaltrials.gov/show/NCT04420247,2020-08-20,0,1
2025,NCT04420312,Completed,2020-04-20,2020-04-20,No Results Posted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04420312,2020-04-20,0,0
2026,NCT04420338,Recruiting,2020-12-15,2020-12-15,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04420338,2020-12-15,0,0
2027,NCT04420741,Completed,2021-02-23,2021-04-23,No Results Posted,,"['Johansson PI, Bestle M, S√∏e-Jensen P, Kristiansen KT, Stensballe J, Clausen NE, Perner A. The effect of prostacyclin (Iloprost) infusion at a dose of 1 ng/kg/min for 72 hours compared to placebo in mechanically ventilated patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Aug 26;21(1):746. doi: 10.1186/s13063-020-04696-2.']",2021-12-29,https://clinicaltrials.gov/show/NCT04420741,2021-02-23,0,1
2028,NCT04421027,Completed,2021-02-12,2021-06-10,Study Results,"['Ely EW, Ramanan AV, Kartman CE, de Bono S, Liao R, Piruzeli MLB, Goldman JD, Saraiva JFK, Chakladar S, Marconi VC; COV-BARRIER Study Group. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med. 2022 Feb 3. pii: S2213-2600(22)00006-6. doi: 10.1016/S2213-2600(22)00006-6. [Epub ahead of print] Erratum in: Lancet Respir Med. 2022 Feb 11;:.', 'Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021 Dec;9(12):1407-1418. doi: 10.1016/S2213-2600(21)00331-3. Epub 2021 Sep 1. Erratum in: Lancet Respir Med. 2021 Oct;9(10):e102.']",,2022-03-24,https://clinicaltrials.gov/show/NCT04421027,2021-02-12,1,1
2029,NCT04421508,Terminated,2020-12-28,2021-01-22,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04421508,2020-12-28,0,0
2030,NCT04422470,"Active, not recruiting",2021-08-22,2022-01-18,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04422470,2021-08-22,0,0
2031,NCT04422561,Completed,2020-07-14,2020-07-27,Study Results,,,2020-08-27,https://clinicaltrials.gov/show/NCT04422561,2020-07-14,1,0
2032,NCT04423978,Completed,2020-06-15,2020-06-15,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04423978,2020-06-15,0,0
2033,NCT04424446,Completed,2020-09-04,2020-09-04,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04424446,2020-09-04,0,0
2034,NCT04425031,Recruiting,2022-12-01,2024-03-01,No Results Posted,,,2021-11-01,,2022-12-01,0,0
2035,NCT04425629,"Active, not recruiting",2022-01-21,2022-06-09,No Results Posted,"['Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Sim√≥n-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Musser BJ, Soo Y, Rofail D, Im J, Perry C, Pan C, Hosain R, Mahmood A, Davis JD, Turner KC, Hooper AT, Hamilton JD, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Kohli A, Sachdeva Y, Graber X, Kowal B, DiCioccio T, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):238-251. doi: 10.1056/NEJMoa2035002. Epub 2020 Dec 17.']",,2022-02-11,https://clinicaltrials.gov/show/NCT04425629,2022-01-21,0,1
2036,NCT04425720,Completed,2021-02-10,2021-12-10,Study Results,,,2022-01-24,https://clinicaltrials.gov/show/NCT04425720,2021-02-10,1,0
2037,NCT04425850,Completed,2020-08-10,2020-08-10,Study Results,,,2020-10-19,https://clinicaltrials.gov/show/NCT04425850,2020-08-10,1,0
2038,NCT04425863,Completed,2020-08-30,2020-08-30,Study Results,,,2020-10-19,https://clinicaltrials.gov/show/NCT04425863,2020-08-30,1,0
2039,NCT04426266,Completed,2020-09-28,2020-09-28,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04426266,2020-09-28,0,0
2040,NCT04426695,Completed,2021-05-07,2021-10-22,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-01,https://clinicaltrials.gov/show/NCT04426695,2021-05-07,0,1
2041,NCT04427098,Recruiting,2020-10-30,2020-10-30,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04427098,2020-10-30,0,0
2042,NCT04427137,"Active, not recruiting",2022-06-09,2022-11-09,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04427137,2022-06-09,0,0
2043,NCT04427501,Completed,2021-02-16,2021-12-14,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Nathan R, Shawa I, De La Torre I, Pustizzi JM, Haustrup N, Patel DR, Huhn G. A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. Infect Dis Ther. 2021 Dec;10(4):1933-1947. doi: 10.1007/s40121-021-00515-6. Epub 2021 Aug 10. Review.', 'Meng X, Wang P, Xiong Y, Wu Y, Lin X, Lu S, Li R, Zhao B, Liu J, Zeng S, Zeng L, Wu Y, Lu Y, Zhang J, Liu D, Wang S, Lu H. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Emerg Microbes Infect. 2021 Dec;10(1):1638-1648. doi: 10.1080/22221751.2021.1960900.', 'Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Dabora MC, Klekotka P, Shen L, Skovronsky DM; BLAZE-1 Investigators. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. N Engl J Med. 2021 Oct 7;385(15):1382-1392. doi: 10.1056/NEJMoa2102685. Epub 2021 Jul 14.', 'Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, Durante M, Oakley G, Schade AE, Holzer TR, Ebert PJ, Higgs RE, Kallewaard NL, Sabo J, Patel DR, Klekotka P, Shen L, Skovronsky DM. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2021 Feb 16;325(7):632-644. doi: 10.1001/jama.2021.0202.', 'Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, Oakley G, Schade AE, Sabo J, Patel DR, Klekotka P, Skovronsky DM; BLAZE-1 Investigators. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med. 2021 Jan 21;384(3):229-237. doi: 10.1056/NEJMoa2029849. Epub 2020 Oct 28.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04427501,2021-02-16,1,1
2044,NCT04427566,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04427566,2021-12-31,0,0
2045,NCT04428008,Recruiting,2022-07-01,2023-01-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04428008,2022-07-01,0,0
2046,NCT04429620,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04429620,2020-12-31,0,0
2047,NCT04430049,Recruiting,2021-10-22,2023-01-22,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04430049,2021-10-22,0,0
2048,NCT04430322,Recruiting,2021-06-30,2022-06-30,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04430322,2021-06-30,0,0
2049,NCT04430374,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-06-26,https://clinicaltrials.gov/show/NCT04430374,2020-12-31,0,0
2050,NCT04431414,"Active, not recruiting",2022-10-06,2022-11-05,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04431414,2022-10-06,0,0
2051,NCT04431869,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04431869,2021-09-01,0,0
2052,NCT04432051,,,,,,,,https://clinicaltrials.gov/show/NCT04432051,,0,0
2053,NCT04432103,Terminated,2021-01-29,2021-01-29,No Results Posted,,"['Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3. Erratum in: Nature. 2020 Apr;580(7803):E7.', 'van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.', 'Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M, Ghinai I, Jarashow MC, Lo J, McPherson TD, Rudman S, Scott S, Hall AJ, Fry AM, Rolfes MA. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 6;69(9):245-246. doi: 10.15585/mmwr.mm6909e1.', 'Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.', 'Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, W√∂lfel R, Hoelscher M. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):173.', 'Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16;14(1):69-71. doi: 10.5582/bst.2020.01020. Epub 2020 Jan 28.', 'Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Str√∂her U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.', 'van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N; Ebola-Tx Consortium. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med. 2016 Jan 7;374(1):33-42. doi: 10.1056/NEJMoa1511812.', 'Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U, Uyeki TM, Smith PW. Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease. Clin Infect Dis. 2015 Sep 15;61(6):969-73. doi: 10.1093/cid/civ395. Epub 2015 May 19.', 'Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.', 'Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.', 'Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Aug;9(4):309; author reply 310.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.', 'Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S. Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. Review.', ""O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004 Jul;126(1):11-28.""]",2021-08-02,https://clinicaltrials.gov/show/NCT04432103,2021-01-29,0,1
2054,NCT04432298,Terminated,2021-03-22,2021-03-22,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04432298,2021-03-22,0,0
2055,NCT04432766,Withdrawn,2021-01-20,2021-08-18,No Results Posted,,,2021-08-12,https://clinicaltrials.gov/show/NCT04432766,2021-01-20,0,0
2056,NCT04432779,"Active, not recruiting",2024-06-01,2024-06-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04432779,2024-06-01,0,0
2057,NCT04432805,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04432805,2021-06-15,0,0
2058,NCT04432870,Completed,2021-05-30,2021-06-30,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04432870,2021-05-30,0,0
2059,NCT04432922,Completed,2020-11-15,2020-11-15,No Results Posted,,,2021-02-23,https://clinicaltrials.gov/show/NCT04432922,2020-11-15,0,0
2060,NCT04432961,Completed,2021-07-01,2021-07-01,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04432961,2021-07-01,0,0
2061,NCT04432987,Recruiting,2020-08-25,2020-09-25,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04432987,2020-08-25,0,0
2062,NCT04433013,Withdrawn,2020-12-01,2021-02-01,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04433013,2020-12-01,0,0
2063,NCT04433026,Not yet recruiting,2021-07-01,2021-09-01,No Results Posted,,,2020-08-21,https://clinicaltrials.gov/show/NCT04433026,2021-07-01,0,0
2064,NCT04433078,Withdrawn,2021-04-13,2021-04-13,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04433078,2021-04-13,0,0
2065,NCT04433260,Completed,2021-03-31,2021-03-31,No Results Posted,"['Khanji MY, Maniero C, Ng S, Siddiqui I, Gupta J, Crosby L, Antoniou S, Khan R, Kapil V, Gupta A. Early and Mid-Term Implications of the COVID-19 Pandemic on the Physical, Behavioral and Mental Health of Healthcare Professionals: The CoPE-HCP Study Protocol. Front Psychol. 2021 Feb 2;12:616280. doi: 10.3389/fpsyg.2021.616280. eCollection 2021.']",,2022-02-08,https://clinicaltrials.gov/show/NCT04433260,2021-03-31,0,1
2066,NCT04433312,Not yet recruiting,2020-10-30,2020-12-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04433312,2020-10-30,0,0
2067,NCT04433325,Not yet recruiting,2020-07-01,2020-09-01,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433325,2020-07-01,0,0
2068,NCT04433364,Recruiting,2021-06-02,2041-06-02,No Results Posted,"['Carlsson Y, Bergman L, Zaigham M, Linden K, Andersson O, Veje M, Sandstr√∂m A, Wikstr√∂m AK, √ñstling H, Fadl H, Domell√∂f M, Blomberg M, Brismar Wendel S, √Öden U, Sengpiel V; COPE study group. COVID-19 in Pregnancy and Early Childhood (COPE): study protocol for a prospective, multicentre biobank, survey and database cohort study. BMJ Open. 2021 Sep 14;11(9):e049376. doi: 10.1136/bmjopen-2021-049376.']",,2021-06-08,https://clinicaltrials.gov/show/NCT04433364,2021-06-02,0,1
2069,NCT04433546,Terminated,2020-12-02,2020-12-02,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04433546,2020-12-02,0,0
2070,NCT04433754,Completed,2020-06-11,2020-06-12,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433754,2020-06-11,0,0
2071,NCT04433871,Recruiting,2022-04-27,2023-04-27,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04433871,2022-04-27,0,0
2072,NCT04433910,Completed,2021-01-21,2021-02-22,No Results Posted,"['K√∂rper S, Weiss M, Zickler D, Wiesmann T, Zacharowski K, Corman VM, Gr√ºner B, Ernst L, Spieth P, Lepper PM, Bentz M, Zinn S, Paul G, Kalbhenn J, Dollinger MM, Rosenberger P, Kirschning T, Thiele T, Appl T, Mayer B, Schmidt M, Drosten C, Wulf H, Kruse JM, Jungwirth B, Seifried E, Schrezenmeier H; CAPSID Clinical Trial Group. Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19. J Clin Invest. 2021 Oct 15;131(20). pii: e152264. doi: 10.1172/JCI152264.', 'Conzelmann C, Gilg A, Gro√ü R, Sch√ºtz D, Preising N, St√§ndker L, Jahrsd√∂rfer B, Schrezenmeier H, Sparrer KMJ, Stamminger T, Stenger S, M√ºnch J, M√ºller JA. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection. Antiviral Res. 2020 Sep;181:104882. doi: 10.1016/j.antiviral.2020.104882. Epub 2020 Jul 29.']",,2021-03-17,https://clinicaltrials.gov/show/NCT04433910,2021-01-21,0,1
2073,NCT04433949,Recruiting,2022-05-30,2022-05-30,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04433949,2022-05-30,0,0
2074,NCT04434118,Enrolling by invitation,2021-12-30,2021-12-30,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04434118,2021-12-30,0,0
2075,NCT04434248,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,"['Ivashchenko AA, Dmitriev KA, Vostokova NV, Azarova VN, Blinow AA, Egorova AN, Gordeev IG, Ilin AP, Karapetian RN, Kravchenko DV, Lomakin NV, Merkulova EA, Papazova NA, Pavlikova EP, Savchuk NP, Simakina EN, Sitdekov TA, Smolyarchuk EA, Tikhomolova EG, Yakubova EV, Ivachtchenko AV. AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial. Clin Infect Dis. 2021 Aug 2;73(3):531-534. doi: 10.1093/cid/ciaa1176.']",,2020-06-16,https://clinicaltrials.gov/show/NCT04434248,2020-07-01,0,1
2076,NCT04434261,Recruiting,2020-12-31,2021-09-30,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04434261,2020-12-31,0,0
2077,NCT04434417,Recruiting,2021-07-31,2021-12-31,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04434417,2021-07-31,0,0
2078,NCT04435015,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04435015,2021-12-31,0,0
2079,NCT04435028,Completed,2019-08-13,2019-08-13,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04435028,2019-08-13,0,0
2080,NCT04435041,"Active, not recruiting",2021-05-31,2021-11-30,No Results Posted,"['Fiorentino F, Prociuk D, Espinosa Gonzalez AB, Neves AL, Husain L, Ramtale SC, Mi E, Mi E, Macartney J, Anand SN, Sherlock J, Saravanakumar K, Mayer E, de Lusignan S, Greenhalgh T, Delaney BC. An Early Warning Risk Prediction Tool (RECAP-V1) for Patients Diagnosed With COVID-19: Protocol for a Statistical Analysis Plan. JMIR Res Protoc. 2021 Oct 5;10(10):e30083. doi: 10.2196/30083.', 'Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 ""long Covid"" patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec 20;20(1):1144. doi: 10.1186/s12913-020-06001-y.', 'Greenhalgh T, Thompson P, Weiringa S, Neves AL, Husain L, Dunlop M, Rushforth A, Nunan D, de Lusignan S, Delaney B. What items should be included in an early warning score for remote assessment of suspected COVID-19? qualitative and Delphi study. BMJ Open. 2020 Nov 12;10(11):e042626. doi: 10.1136/bmjopen-2020-042626.']",,2020-06-17,https://clinicaltrials.gov/show/NCT04435041,2021-05-31,0,1
2081,NCT04435080,Completed,2020-06-11,2020-06-11,No Results Posted,,"['Reid CL, Campbell IT, Little RA. Muscle wasting and energy balance in critical illness. Clin Nutr. 2004 Apr;23(2):273-80.', 'Clavet H, H√©bert PC, Fergusson D, Doucette S, Trudel G. Joint contracture following prolonged stay in the intensive care unit. CMAJ. 2008 Mar 11;178(6):691-7. doi: 10.1503/cmaj.071056.', 'Sosnowski K, Lin F, Mitchell ML, White H. Early rehabilitation in the intensive care unit: an integrative literature review. Aust Crit Care. 2015 Nov;28(4):216-25. doi: 10.1016/j.aucc.2015.05.002. Epub 2015 Jul 2. Review.', ""Connolly B, O'Neill B, Salisbury L, Blackwood B; Enhanced Recovery After Critical Illness Programme Group. Physical rehabilitation interventions for adult patients during critical illness: an overview of systematic reviews. Thorax. 2016 Oct;71(10):881-90. doi: 10.1136/thoraxjnl-2015-208273. Epub 2016 May 24. Review."", 'Walsh CJ, Batt J, Herridge MS, Dos Santos CC. Muscle wasting and early mobilization in acute respiratory distress syndrome. Clin Chest Med. 2014 Dec;35(4):811-26. doi: 10.1016/j.ccm.2014.08.016. Epub 2014 Sep 30. Review.', 'Akar O, G√ºnay E, Sarinc Ulasli S, Ulasli AM, Kacar E, Sariaydin M, Solak √ñ, Celik S, √únl√º M. Efficacy of neuromuscular electrical stimulation in patients with COPD followed in intensive care unit. Clin Respir J. 2017 Nov;11(6):743-750. doi: 10.1111/crj.12411. Epub 2015 Dec 16.', 'Kleyweg RP, van der Mech√© FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr√© syndrome. Muscle Nerve. 1991 Nov;14(11):1103-9.', 'Turan Z, √ñzyemi≈ü√ßi Ta≈ükƒ±ran √ñ, Erden Z, K√∂kt√ºrk N, Kaymak Karata≈ü G. Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study. Turk J Med Sci. 2019 Jun 18;49(3):802-808. doi: 10.3906/sag-1811-22.', 'Yoo JI, Choi H, Ha YC. Mean Hand Grip Strength and Cut-off Value for Sarcopenia in Korean Adults Using KNHANES VI. J Korean Med Sci. 2017 May;32(5):868-872. doi: 10.3346/jkms.2017.32.5.868.', 'Dodoo-Schittko F, Brandstetter S, Blecha S, Thomann-Hackner K, Brandl M, Kn√ºttel H, Bein T, Apfelbacher C. Determinants of Quality of Life and Return to Work Following Acute Respiratory Distress Syndrome. Dtsch Arztebl Int. 2017 Feb 17;114(7):103-109. doi: 10.3238/arztebl.2017.0103. Review.']",2020-06-17,https://clinicaltrials.gov/show/NCT04435080,2020-06-11,0,1
2082,NCT04435106,Completed,2020-05-01,2020-05-15,Results Submitted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04435106,2020-05-01,0,0
2083,NCT04435119,Completed,2020-05-15,2020-05-15,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04435119,2020-05-15,0,0
2084,NCT04435184,Completed,2020-11-28,2021-01-04,Study Results,"['Leucker TM, Osburn WO, Reventun P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial. JACC Basic Transl Sci. 2021 Dec;6(12):935-945. doi: 10.1016/j.jacbts.2021.09.013. Epub 2021 Dec 8.', 'Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021 Feb 9;143(6):553-565. doi: 10.1161/CIRCULATIONAHA.120.050543. Epub 2020 Nov 13.']",,2021-11-09,https://clinicaltrials.gov/show/NCT04435184,2020-11-28,1,1
2085,NCT04435223,Completed,2020-05-07,2020-05-07,No Results Posted,"['Nguyen M, Bourredjem A, Piroth L, Bouhemad B, Jalil A, Pallot G, Le Guern N, Thomas C, Pilot T, Bergas V, Choubley H, Quenot JP, Charles PE, Lagrost L, Deckert V, de Barros JP, Guinot PG, Masson D, Binquet C, Gautier T, Blot M; Lymphonie study group. High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia. Sci Rep. 2021 May 24;11(1):10824. doi: 10.1038/s41598-021-90362-9.']",,2020-06-23,https://clinicaltrials.gov/show/NCT04435223,2020-05-07,0,1
2086,NCT04435275,Recruiting,2021-03-31,2021-05-01,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04435275,2021-03-31,0,0
2087,NCT04435314,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04435314,2020-08-01,0,0
2088,NCT04435327,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04435327,2021-04-01,0,0
2089,NCT04435353,Recruiting,2020-12-31,2021-02-01,No Results Posted,,,2020-06-17,https://clinicaltrials.gov/show/NCT04435353,2020-12-31,0,0
2090,NCT04435379,Completed,2021-10-12,2021-10-12,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04435379,2021-10-12,0,0
2091,NCT04435457,"Active, not recruiting",2022-04-30,2022-04-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04435457,2022-04-30,0,0
2092,NCT04435587,Recruiting,2021-06-01,2021-11-01,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04435587,2021-06-01,0,0
2093,NCT04435717,Terminated,2020-11-04,2021-02-10,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04435717,2020-11-04,0,0
2094,NCT04435795,Terminated,2021-06-08,2021-07-08,No Results Posted,"['Ezer N, Belga S, Daneman N, Chan A, Smith BM, Daniels SA, Moran K, Besson C, Smyth LY, Bartlett SJ, Benedetti A, Martin JG, Lee TC, McDonald EG. Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial. BMJ. 2021 Nov 2;375:e068060. doi: 10.1136/bmj-2021-068060.']",,2021-07-30,https://clinicaltrials.gov/show/NCT04435795,2021-06-08,0,1
2095,NCT04435808,Terminated,2020-07-15,2020-07-15,Study Results,,,2022-02-14,https://clinicaltrials.gov/show/NCT04435808,2020-07-15,1,0
2096,NCT04436276,"Active, not recruiting",2024-02-02,2024-04-01,No Results Posted,"['Stephenson KE, Le Gars M, Sadoff J, de Groot AM, Heerwegh D, Truyers C, Atyeo C, Loos C, Chandrashekar A, McMahan K, Tostanoski LH, Yu J, Gebre MS, Jacob-Dolan C, Li Z, Patel S, Peter L, Liu J, Borducchi EN, Nkolola JP, Souza M, Tan CS, Zash R, Julg B, Nathavitharana RR, Shapiro RL, Azim AA, Alonso CD, Jaegle K, Ansel JL, Kanjilal DG, Guiney CJ, Bradshaw C, Tyler A, Makoni T, Yanosick KE, Seaman MS, Lauffenburger DA, Alter G, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H, Barouch DH. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 Apr 20;325(15):1535-1544. doi: 10.1001/jama.2021.3645.', 'Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.', 'Bos R, Rutten L, van der Lubbe JEM, Bakkers MJG, Hardenberg G, Wegmann F, Zuijdgeest D, de Wilde AH, Koornneef A, Verwilligen A, van Manen D, Kwaks T, Vogels R, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Li Z, Barouch DH, Vellinga J, Langedijk JPM, Zahn RC, Custers J, Schuitemaker H. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines. 2020 Sep 28;5:91. doi: 10.1038/s41541-020-00243-x. eCollection 2020.']",,2022-03-16,https://clinicaltrials.gov/show/NCT04436276,2024-02-02,0,1
2097,NCT04436458,Withdrawn,2022-01-20,2022-01-20,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04436458,2022-01-20,0,0
2098,NCT04436471,Completed,2020-08-03,2020-08-10,No Results Posted,"['Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4. Erratum in: Lancet. 2021 Jan 9;397(10269):98.']",,2020-08-12,https://clinicaltrials.gov/show/NCT04436471,2020-08-03,0,1
2099,NCT04436484,Completed,2021-06-14,2021-06-14,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04436484,2021-06-14,0,0
2100,NCT04437121,Completed,2020-05-24,2020-05-24,No Results Posted,,,2020-06-18,https://clinicaltrials.gov/show/NCT04437121,2020-05-24,0,0
2101,NCT04437342,Completed,2020-08-30,2020-10-27,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04437342,2020-08-30,0,0
2102,NCT04437693,Not yet recruiting,2021-08-30,2021-12-31,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04437693,2021-08-30,0,0
2103,NCT04437706,Enrolling by invitation,2022-06-30,2022-06-30,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04437706,2022-06-30,0,0
2104,NCT04437719,"Active, not recruiting",2021-06-28,2022-03-31,No Results Posted,,"['Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', ""Gliklich RE, Dreyer NA, Leavy MB, Christian JB, editors. 21st Century Patient Registries: Registries for Evaluating Patient Outcomes: A User's Guide: 3rd Edition, Addendum [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. Available from http://www.ncbi.nlm.nih.gov/books/NBK493818/""]",2022-01-31,https://clinicaltrials.gov/show/NCT04437719,2021-06-28,0,1
2105,NCT04437823,Recruiting,2021-05-31,2021-06-30,No Results Posted,,,2020-06-18,https://clinicaltrials.gov/show/NCT04437823,2021-05-31,0,0
2106,NCT04437875,Completed,2020-08-03,2020-08-10,No Results Posted,"['Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4. Erratum in: Lancet. 2021 Jan 9;397(10269):98.']",,2020-08-12,https://clinicaltrials.gov/show/NCT04437875,2020-08-03,0,1
2107,NCT04437901,Not yet recruiting,2020-12-01,2021-12-01,No Results Posted,,,2020-06-18,https://clinicaltrials.gov/show/NCT04437901,2020-12-01,0,0
2108,NCT04437940,Completed,2020-07-10,2020-11-30,No Results Posted,,"['Qiu L, Liu X, Xiao M, Xie J, Cao W, Liu Z, Morse A, Xie Y, Li T, Zhu L. SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection. Clin Infect Dis. 2020 Jul 28;71(15):813-817. doi: 10.1093/cid/ciaa375.']",2021-01-12,https://clinicaltrials.gov/show/NCT04437940,2020-07-10,0,1
2109,NCT04438057,Recruiting,2020-08-12,2021-08-12,No Results Posted,,,2020-08-21,https://clinicaltrials.gov/show/NCT04438057,2020-08-12,0,0
2110,NCT04438070,Recruiting,2020-06-01,2020-06-01,No Results Posted,"[""O'Shea T, Mbuagbaw L, Mokashi V, Bulir D, Gilchrist J, Smieja N, Chong S, Marttala S, Vera V, Cvetkovic A, Smieja M. Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 23;21(1):941. doi: 10.1186/s13063-020-04890-2.""]",,2020-06-18,https://clinicaltrials.gov/show/NCT04438070,2020-06-01,0,1
2111,NCT04438239,Completed,2020-12-31,2020-12-31,No Results Posted,"['Schiavi M, Fugazzaro S, Bertolini A, Denti M, Mainini C, Accogli MA, Bedogni G, Ghizzoni D, Esseroukh O, Gualdi C, Costi S. ""Like before, but not exactly"": the Qualy-REACT qualitative inquiry into the lived experience of long COVID. BMC Public Health. 2022 Mar 28;22(1):599. doi: 10.1186/s12889-022-13035-w.']",,2021-01-26,https://clinicaltrials.gov/show/NCT04438239,2020-12-31,0,1
2112,NCT04438629,Unknown,2020-06-10,2020-11-26,No Results Posted,"['Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Can√® S, Batani V, Trovato R, Fiore A, Petrova V, Hofer F, Barouni RM, Musiu C, Caligola S, Pinton L, Torroni L, Polati E, Donadello K, Friso S, Pizzolo F, Iezzi M, Facciotti F, Pelicci PG, Righetti D, Bazzoni P, Rampudda M, Comel A, Mosaner W, Lunardi C, Olivieri O. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest. 2020 Dec 1;130(12):6409-6416. doi: 10.1172/JCI141772.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04438629,2020-06-10,0,1
2113,NCT04438694,Recruiting,2021-05-31,2021-12-31,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04438694,2021-05-31,0,0
2114,NCT04438837,Not yet recruiting,2022-06-01,2022-06-01,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Chang, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020 Mar;8(3):e13. doi: 10.1016/S2213-2600(20)30066-7. Epub 2020 Feb 13.', 'Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, Huang CT, Strongin AY, Muotri AR, Terskikh AV. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017 Nov 17;7(1):15771. doi: 10.1038/s41598-017-15467-6.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.']",2020-07-23,https://clinicaltrials.gov/show/NCT04438837,2022-06-01,0,1
2115,NCT04438850,Terminated,2021-06-08,2021-06-08,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04438850,2021-06-08,0,0
2116,NCT04438863,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04438863,2022-01-01,0,0
2117,NCT04438941,Recruiting,2020-06-20,2020-06-20,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04438941,2020-06-20,0,0
2118,NCT04438954,Completed,2020-06-05,2020-06-18,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04438954,2020-06-05,0,0
2119,NCT04438967,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04438967,2021-12-31,0,0
2120,NCT04438980,Completed,2021-03-12,2021-04-09,No Results Posted,"['Les Bujanda I, Loureiro-Amigo J, Bastons FC, Guerra IE, S√°nchez JA, Murgadella-Sancho A, Rey RG, L√≥pez JL, √Ålvarez JS. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.']",,2021-05-17,https://clinicaltrials.gov/show/NCT04438980,2021-03-12,0,1
2121,NCT04438993,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-06-19,https://clinicaltrials.gov/show/NCT04438993,2020-10-01,0,0
2122,NCT04439006,"Active, not recruiting",2022-12-31,2023-12-31,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04439006,2022-12-31,0,0
2123,NCT04439045,"Active, not recruiting",2021-09-02,2021-12-01,No Results Posted,,,2021-03-22,https://clinicaltrials.gov/show/NCT04439045,2021-09-02,0,0
2124,NCT04439071,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04439071,2022-03-31,0,0
2125,NCT04439084,Completed,2021-07-31,2021-07-31,No Results Posted,,"['Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch AD, Viveiros K, Chan W, Chascsa DM, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul;19(7):1469-1479.e19. doi: 10.1016/j.cgh.2020.09.027. Epub 2020 Sep 17.', 'Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R; COLD Consortium. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology. 2020 Dec;72(6):1900-1911. doi: 10.1002/hep.31574. Epub 2020 Dec 9.', 'Adeniji N, Carr RM, Aby ES, Catana AM, Wegermann K, Dhanasekaran R. Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases. Gastroenterology. 2021 Mar;160(4):1406-1409.e3. doi: 10.1053/j.gastro.2020.11.035. Epub 2020 Nov 20.', 'Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rƒ±za Calƒ±≈ükan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batƒ±bay E, Urzua √Å, Snijders R, Kƒ±yƒ±cƒ± M, Akyƒ±ldƒ±z M, Ekin N, Carr RM, Harputluoƒülu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Bj√∂rnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology. 2021 Jun;73(6):2099-2109. doi: 10.1002/hep.31797. Erratum in: Hepatology. 2022 Mar;75(3):774.']",2021-08-09,https://clinicaltrials.gov/show/NCT04439084,2021-07-31,0,1
2126,NCT04440007,Completed,2021-07-01,2021-08-23,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04440007,2021-07-01,0,0
2127,NCT04440098,Completed,2020-05-11,2020-05-11,No Results Posted,"['Horigian VE, Schmidt RD, Feaster DJ. Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19. J Psychoactive Drugs. 2021 Jan-Mar;53(1):1-9. doi: 10.1080/02791072.2020.1836435. Epub 2020 Oct 28.']",,2020-06-19,https://clinicaltrials.gov/show/NCT04440098,2020-05-11,0,1
2128,NCT04441372,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04441372,2021-12-01,0,0
2129,NCT04441385,Terminated,2021-02-08,2021-02-08,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04441385,2021-02-08,0,0
2130,NCT04441398,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04441398,2020-09-01,0,0
2131,NCT04441424,Completed,2020-06-01,2020-06-01,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Chai KL, Valk SJ, Piechotta V, Kimber C, Monsef I, Doree C, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. Update in: Cochrane Database Syst Rev. 2021 May 20;5:CD013600.']",,2020-06-23,https://clinicaltrials.gov/show/NCT04441424,2020-06-01,0,1
2132,NCT04441489,Completed,2020-05-03,2020-05-27,No Results Posted,"['Dietz M, Chironi G, Claessens YE, Farhad RL, Rouquette I, Serrano B, Nataf V, Hugonnet F, Paulmier B, Berthier F, Keita-Perse O, Giammarile F, Perrin C, Faraggi M; MONACOVID Group. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268. doi: 10.1007/s00259-020-04968-8. Epub 2020 Jul 25.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04441489,2020-05-03,0,1
2133,NCT04441502,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04441502,2021-09-30,0,0
2134,NCT04441632,Completed,2020-07-26,2020-07-30,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04441632,2020-07-26,0,0
2135,NCT04441684,Completed,2020-05-07,2021-07-16,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04441684,2020-05-07,0,0
2136,NCT04441814,Enrolling by invitation,2021-07-01,2021-07-01,No Results Posted,,"['Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, Zheng C. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', ""Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, Zhang HY, Sun W, Wang Y. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23. Review."", 'Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020 Apr 2;12(4). pii: E988. doi: 10.3390/nu12040988. Review.', 'Gallivanone F, Cava C, Corsi F, Bertoli G, Castiglioni I. In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis. Int J Mol Sci. 2019 Nov 20;20(23). pii: E5825. doi: 10.3390/ijms20235825.', 'Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchian√≤ A. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019 Oct 1;30(10):1672. doi: 10.1093/annonc/mdz169.', 'Silva M, Schaefer-Prokop CM, Jacobs C, Capretti G, Ciompi F, van Ginneken B, Pastorino U, Sverzellati N. Detection of Subsolid Nodules in Lung Cancer Screening: Complementary Sensitivity of Visual Reading and Computer-Aided Diagnosis. Invest Radiol. 2018 Aug;53(8):441-449. doi: 10.1097/RLI.0000000000000464.', 'Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.']",2020-06-23,https://clinicaltrials.gov/show/NCT04441814,2021-07-01,0,1
2137,NCT04441918,Recruiting,2020-12-11,2020-12-11,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Wu X, Li N, Wang G, Liu W, Yu J, Cao G, Wang J, Chen Y, Ma J, Wu J, Yang H, Mao X, He J, Yu Y, Qiu C, Li N, Yao S, Feng H, Yan J, Zhang W, Zhang J. Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0035021. doi: 10.1128/AAC.00350-21. Epub 2021 Jul 16.']",,2020-06-22,https://clinicaltrials.gov/show/NCT04441918,2020-12-11,0,1
2138,NCT04441996,Completed,2021-03-18,2021-03-18,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04441996,2021-03-18,0,0
2139,NCT04442048,"Active, not recruiting",2021-12-31,2022-03-31,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04442048,2021-12-31,0,0
2140,NCT04442152,Completed,2020-09-04,2020-09-04,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04442152,2020-09-04,0,0
2141,NCT04442165,"Active, not recruiting",2022-04-30,2022-04-30,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04442165,2022-04-30,0,0
2142,NCT04442178,Recruiting,2021-10-30,2021-12-31,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",2021-02-16,https://clinicaltrials.gov/show/NCT04442178,2021-10-30,0,1
2143,NCT04442191,Recruiting,2021-05-05,2021-05-05,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04442191,2021-05-05,0,0
2144,NCT04442204,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04442204,2020-07-13,0,0
2145,NCT04442217,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04442217,2020-07-13,0,0
2146,NCT04442230,Terminated,2021-02-15,2021-02-15,Results Submitted,,,2021-07-19,https://clinicaltrials.gov/show/NCT04442230,2021-02-15,0,0
2147,NCT04442243,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04442243,2020-07-13,0,0
2148,NCT04442282,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04442282,2020-07-13,0,0
2149,NCT04442308,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04442308,2020-07-13,0,0
2150,NCT04442360,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,"['Amundsen OM, Hoffart A, Johnson SU, Ebrahimi OV. Pandemic Information Dissemination and Its Associations With the Symptoms of Mental Distress During the COVID-19 Pandemic: Cross-sectional Study. JMIR Form Res. 2021 Dec 3;5(12):e28239. doi: 10.2196/28239.']",,2020-06-23,https://clinicaltrials.gov/show/NCT04442360,2020-07-13,0,1
2151,NCT04442386,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04442386,2020-07-13,0,0
2152,NCT04442958,Completed,2020-06-15,2020-06-17,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04442958,2020-06-15,0,0
2153,NCT04443075,Completed,2020-12-04,2020-12-24,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04443075,2020-12-04,0,0
2154,NCT04443140,Completed,2020-07-01,2020-07-10,No Results Posted,,"['Mendoza M, Garcia-Ruiz I, Maiz N, Rodo C, Garcia-Manau P, Serrano B, Lopez-Martinez RM, Balcells J, Fernandez-Hidalgo N, Carreras E, Suy A. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG. 2020 Oct;127(11):1374-1380. doi: 10.1111/1471-0528.16339. Epub 2020 Jun 21.']",2020-07-28,https://clinicaltrials.gov/show/NCT04443140,2020-07-01,0,1
2155,NCT04443179,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04443179,2023-12-01,0,0
2156,NCT04443270,Not yet recruiting,2020-10-31,2021-01-31,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04443270,2020-10-31,0,0
2157,NCT04443361,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04443361,2020-07-13,0,0
2158,NCT04443673,Recruiting,2021-02-28,2021-06-30,No Results Posted,,,2020-08-24,https://clinicaltrials.gov/show/NCT04443673,2021-02-28,0,0
2159,NCT04443699,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04443699,2020-07-13,0,0
2160,NCT04443725,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-06-25,https://clinicaltrials.gov/show/NCT04443725,2020-10-01,0,0
2161,NCT04443764,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04443764,2020-07-13,0,0
2162,NCT04443803,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-07-12,https://clinicaltrials.gov/show/NCT04443803,2020-12-31,0,0
2163,NCT04443868,Withdrawn,2021-04-01,2021-07-01,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04443868,2021-04-01,0,0
2164,NCT04443881,Completed,2021-03-31,2021-03-31,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04443881,2021-03-31,0,0
2165,NCT04444115,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,"['Hoffart A, Johnson SU, Ebrahimi OV. Loneliness during the COVID-19 pandemic: change and predictors of change from strict to discontinued social distancing protocols. Anxiety Stress Coping. 2022 Jan;35(1):44-57. doi: 10.1080/10615806.2021.1958790. Epub 2021 Jul 27.']",,2020-06-23,https://clinicaltrials.gov/show/NCT04444115,2020-07-13,0,1
2166,NCT04444271,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04444271,2020-08-30,0,0
2167,NCT04444310,"Active, not recruiting",2020-06-18,2020-09-30,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04444310,2020-06-18,0,0
2168,NCT04444336,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04444336,2020-07-13,0,0
2169,NCT04444401,Recruiting,2021-12-15,2021-12-15,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04444401,2021-12-15,0,0
2170,NCT04444531,Completed,2020-05-19,2020-05-26,No Results Posted,"['Hern√°ndez A, Vi√±als M, Pablos A, Vil√°s F, Papadakos PJ, Wijeysundera DN, Bergese SD, Vives M. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol. 2021 Jan;90:107261. doi: 10.1016/j.intimp.2020.107261. Epub 2020 Dec 5.']",,2020-11-25,https://clinicaltrials.gov/show/NCT04444531,2020-05-19,0,1
2171,NCT04444557,Completed,2020-05-01,2020-05-01,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04444557,2020-05-01,0,0
2172,NCT04444596,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04444596,2021-03-31,0,0
2173,NCT04444609,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04444609,2022-06-01,0,0
2174,NCT04444661,Completed,2020-11-11,2020-12-31,No Results Posted,"['Kemmler W, Kohl M, Fr√∂hlich M, Schoene D, von Stengel S. Detraining effects after 18 months of high intensity resistance training on osteosarcopenia in older men-Six-month follow-up of the randomized controlled Franconian Osteopenia and Sarcopenia Trial (FrOST). Bone. 2021 Jan;142:115772. doi: 10.1016/j.bone.2020.115772. Epub 2020 Nov 26.']",,2021-04-28,https://clinicaltrials.gov/show/NCT04444661,2020-11-11,0,1
2175,NCT04444674,"Active, not recruiting",2020-12-01,2021-12-01,No Results Posted,"['Madhi SA, Koen AL, Izu A, Fairlie L, Cutland CL, Baillie V, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Aley PK, Bhikha S, Hermanus T, Horne E, Jose A, Kgagudi P, Lambe T, Masenya M, Masilela M, Mkhize N, Moultrie A, Mukendi CK, Moyo-Gwete T, Nana AJ, Nzimande A, Patel F, Rhead S, Taoushanis C, Thombrayil A, van Eck S, Voysey M, Villafana TL, Vekemans J, Gilbert SC, Pollard AJ, Moore PL, Kwatra G; Wits VIDA COVID team. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 Sep;8(9):e568-e580. doi: 10.1016/S2352-3018(21)00157-0. Epub 2021 Aug 17.', 'Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A; NGS-SA Group; Wits-VIDA COVID Group. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.', 'Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet. 2021 Mar 6;397(10277):880.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98.""]",,2020-11-27,https://clinicaltrials.gov/show/NCT04444674,2020-12-01,0,1
2176,NCT04444687,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04444687,2020-12-01,0,0
2177,NCT04444700,Completed,2021-05-10,2021-10-14,No Results Posted,"['Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, N√≠ √Åinle F, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci L, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, J√ºni P; RAPID Trial investigators. Heparin for Moderately Ill Patients with Covid-19. medRxiv. 2021 Jul 12. pii: 2021.07.08.21259351. doi: 10.1101/2021.07.08.21259351. Update in: BMJ. 2021 Oct 14;375:n2400.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04444700,2021-05-10,0,1
2178,NCT04362085,Completed,2021-05-10,2021-10-14,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, √Åinle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, J√ºni P; RAPID trial investigators. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.', 'Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, N√≠ √Åinle F, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci L, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, J√ºni P; RAPID Trial investigators. Heparin for Moderately Ill Patients with Covid-19. medRxiv. 2021 Jul 12. pii: 2021.07.08.21259351. doi: 10.1101/2021.07.08.21259351. Update in: BMJ. 2021 Oct 14;375:n2400.', 'Sholzberg M, Tang GH, Negri E, Rahhal H, Kreuziger LB, Pompilio CE, James P, Fralick M, AlHamzah M, Alomran F, Tseng E, Lim G, Lillicrap D, Carrier M, √Åinle FN, Beckett A, da Costa BR, Thorpe K, Middeldorp S, Lee A, Cushman M, J√ºni P. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04362085,2021-05-10,0,1
2179,NCT04444713,Not yet recruiting,2020-07-13,2020-07-13,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04444713,2020-07-13,0,0
2180,NCT04445194,"Active, not recruiting",2020-10-22,2021-09-20,No Results Posted,"['Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24.']",,2020-12-03,https://clinicaltrials.gov/show/NCT04445194,2020-10-22,0,1
2181,NCT04445207,,,,,,,2022-03-08,https://clinicaltrials.gov/show/NCT04445207,,0,0
2182,NCT04445220,"Active, not recruiting",2022-03-01,2022-09-01,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04445220,2022-03-01,0,0
2183,NCT04445233,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04445233,2021-12-01,0,0
2184,NCT04445246,Completed,2021-05-31,2021-05-31,No Results Posted,"['Mulia EPB, Luke K. Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale. Egypt Heart J. 2021 Sep 16;73(1):82. doi: 10.1186/s43044-021-00208-y.']",,2022-03-29,https://clinicaltrials.gov/show/NCT04445246,2021-05-31,0,1
2185,NCT04445259,Recruiting,2022-07-31,2022-12-31,No Results Posted,"['Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, Lane K, Leach R, Ostermann M. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021 Aug 6;11(1):123. doi: 10.1186/s13613-021-00914-5.']",,2021-08-04,https://clinicaltrials.gov/show/NCT04445259,2022-07-31,0,1
2186,NCT04445272,Completed,2020-12-23,2020-12-23,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04445272,2020-12-23,0,0
2187,NCT04445285,Recruiting,2021-11-30,2022-02-28,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04445285,2021-11-30,0,0
2188,NCT04445311,Recruiting,2020-07-30,2020-08-15,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04445311,2020-07-30,0,0
2189,NCT04445324,"Active, not recruiting",2020-08-25,2020-12-01,No Results Posted,"['Pelletier JF, Houle J, Goulet MH, Juster RP, Gigu√®re C√â, Bordet J, H√©nault I, Lesage A, De Benedictis L, Denis F, Ng R. Online and Recovery-Oriented Support Groups Facilitated by Peer Support Workers in Times of COVID-19: Protocol for a Feasibility Pre-Post Study. JMIR Res Protoc. 2020 Dec 18;9(12):e22500. doi: 10.2196/22500.']",,2020-11-23,https://clinicaltrials.gov/show/NCT04445324,2020-08-25,0,1
2190,NCT04445337,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04445337,2021-07-01,0,0
2191,NCT04445376,Completed,2020-09-10,2020-10-03,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04445376,2020-09-10,0,0
2192,NCT04445389,"Active, not recruiting",2021-12-30,2022-03-30,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04445389,2021-12-30,0,0
2193,NCT04445402,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04445402,2021-05-01,0,0
2194,NCT04445415,Not yet recruiting,2021-06-01,2021-09-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04445415,2021-06-01,0,0
2195,NCT04445428,"Active, not recruiting",2022-01-31,2022-05-01,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04445428,2022-01-31,0,0
2196,NCT04445441,Completed,2020-09-03,2020-11-30,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04445441,2020-09-03,0,0
2197,NCT04445454,Recruiting,2022-09-30,2022-09-30,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04445454,2022-09-30,0,0
2198,NCT04445467,"Active, not recruiting",2021-11-01,2021-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'McMahon JH, Lau JSY, Roney J, Rogers BA, Trubiano J, Sasadeusz J, Molton JS, Gardiner B, Lee SJ, Hoy JF, Cheng A, Peleg AY. An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 13;21(1):847. doi: 10.1186/s13063-020-04766-5.']",,2021-10-07,https://clinicaltrials.gov/show/NCT04445467,2021-11-01,0,1
2199,NCT04445493,Recruiting,2022-06-01,2022-12-01,No Results Posted,,"['Smith WS, Keenan KJ, Lovoi PA. A Unique Signature of Cardiac-Induced Cranial Forces During Acute Large Vessel Stroke and Development of a Predictive Model. Neurocrit Care. 2020 Aug;33(1):58-63. doi: 10.1007/s12028-019-00845-x.']",2022-01-20,https://clinicaltrials.gov/show/NCT04445493,2022-06-01,0,1
2200,NCT04445506,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04445506,2020-05-31,0,0
2201,NCT04445597,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2020-12-01,https://clinicaltrials.gov/show/NCT04445597,2022-12-31,0,0
2202,NCT04445610,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-06-26,https://clinicaltrials.gov/show/NCT04445610,2020-09-01,0,0
2203,NCT04445623,Not yet recruiting,2020-10-01,2021-01-01,No Results Posted,,,2020-06-26,https://clinicaltrials.gov/show/NCT04445623,2020-10-01,0,0
2204,NCT04445870,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04445870,2021-12-01,0,0
2205,NCT04445935,Recruiting,2020-09-28,2021-03-28,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Kharma N, Roehrig S, Shible AA, Elshafei MS, Osman D, Elsaid IM, Mustafa SF, Aldabi A, Smain OAM, Lance MD. Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 7;21(1):769. doi: 10.1186/s13063-020-04689-1.']",,2020-06-24,https://clinicaltrials.gov/show/NCT04445935,2020-09-28,0,1
2206,NCT04445961,Completed,2020-08-14,2020-08-14,No Results Posted,"['Yaroshetskiy AI, Avdeev SN, Politov ME, Nogtev PV, Beresneva VG, Sorokin YD, Konanykhin VD, Krasnoshchekova AP, Merzhoeva ZM, Tsareva NA, Trushenko NV, Mandel IA, Yavorovskiy AG. Potential for the lung recruitment and the risk of lung overdistension during 21 days of mechanical ventilation in patients with COVID-19 after noninvasive ventilation failure: the COVID-VENT observational trial. BMC Anesthesiol. 2022 Mar 4;22(1):59. doi: 10.1186/s12871-022-01600-0.']","['Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Toufen Junior C, De Santis Santiago RR, Hirota AS, Carvalho ARS, Gomes S, Amato MBP, Carvalho CRR. Driving pressure and long-term outcomes in moderate/severe acute respiratory distress syndrome. Ann Intensive Care. 2018 Dec 7;8(1):119. doi: 10.1186/s13613-018-0469-4.']",2020-08-27,https://clinicaltrials.gov/show/NCT04445961,2020-08-14,0,1
2207,NCT04446065,Not yet recruiting,2021-09-30,2021-10-30,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04446065,2021-09-30,0,0
2208,NCT04446104,Completed,2020-08-31,2020-08-31,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04446104,2020-08-31,0,0
2209,NCT04446169,Completed,2020-09-01,2021-09-02,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04446169,2020-09-01,0,0
2210,NCT04446286,Completed,2020-08-18,2020-08-18,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04446286,2020-08-18,0,0
2211,NCT04446338,Recruiting,2020-06-30,2020-08-01,No Results Posted,,,2020-06-24,https://clinicaltrials.gov/show/NCT04446338,2020-06-30,0,0
2212,NCT04446377,Recruiting,2021-03-31,2021-04-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04446377,2021-03-31,0,0
2213,NCT04446429,Completed,2020-12-24,2021-01-21,Study Results,"['McCoy J, Goren A, Cadegiani FA, Va√±o-Galv√°n S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA, Wambier CG. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Front Med (Lausanne). 2021 Jul 19;8:668698. doi: 10.3389/fmed.2021.668698. eCollection 2021.']",,2021-12-10,https://clinicaltrials.gov/show/NCT04446429,2020-12-24,1,1
2214,NCT04447131,Recruiting,2020-06-30,2022-03-30,No Results Posted,"['Bertolin AJ, Dal√ß√≥quio TF, Salsoso R, de M Furtado RH, Kalil-Filho R, Hajjar LA, Siciliano RF, Kall√°s EG, Baracioli LM, Lima FG, Giraldez RR, Cavalheiro-Filho C, Vieira A, Strunz CMC, Giugliano RP, Tantry US, Gurbel PA, Nicolau JC. Platelet Reactivity and Coagulation Markers in Patients with COVID-19. Adv Ther. 2021 Jul;38(7):3911-3923. doi: 10.1007/s12325-021-01803-w. Epub 2021 Jun 4.']",,2022-02-25,https://clinicaltrials.gov/show/NCT04447131,2020-06-30,0,1
2215,NCT04447144,Recruiting,2020-08-01,2020-09-01,Results Submitted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04447144,2020-08-01,0,0
2216,NCT04447209,"Active, not recruiting",2021-12-31,2022-03-31,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04447209,2021-12-31,0,0
2217,NCT04447222,Recruiting,2023-07-30,2024-07-30,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04447222,2023-07-30,0,0
2218,NCT04447235,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04447235,2020-12-01,0,0
2219,NCT04447469,Completed,2021-11-12,2022-01-14,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04447469,2021-11-12,0,0
2220,NCT04447495,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04447495,2020-12-31,0,0
2221,NCT04447534,Completed,2020-07-15,2020-08-15,No Results Posted,"['Abd-Elsalam S, Soliman S, Esmail ES, Khalaf M, Mostafa EF, Medhat MA, Ahmed OA, El Ghafar MSA, Alboraie M, Hassany SM. Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial. Biol Trace Elem Res. 2021 Oct;199(10):3642-3646. doi: 10.1007/s12011-020-02512-1. Epub 2020 Nov 27.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04447534,2020-07-15,0,1
2222,NCT04447638,Completed,2020-06-01,2020-06-01,No Results Posted,,,2020-09-24,https://clinicaltrials.gov/show/NCT04447638,2020-06-01,0,0
2223,NCT04448054,Recruiting,2022-02-20,2022-02-20,No Results Posted,,,2022-02-02,,2022-02-20,0,0
2224,NCT04448119,"Active, not recruiting",2021-11-01,2021-11-01,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04448119,2021-11-01,0,0
2225,NCT04448145,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04448145,2022-05-01,0,0
2226,NCT04448405,Completed,2020-10-01,2020-10-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04448405,2020-10-01,0,0
2227,NCT04448418,Completed,2020-06-20,2020-06-20,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04448418,2020-06-20,0,0
2228,NCT04448704,Completed,2020-10-11,2020-10-11,No Results Posted,,,2021-02-23,https://clinicaltrials.gov/show/NCT04448704,2020-10-11,0,0
2229,NCT04448717,Recruiting,2023-12-01,2023-12-01,No Results Posted,"['Blankenberger J, Haile SR, Puhan MA, Berger C, Radtke T, Kriemler S, Ulyte A. Prediction of Past SARS-CoV-2 Infections: A Prospective Cohort Study Among Swiss Schoolchildren. Front Pediatr. 2021 Aug 16;9:710785. doi: 10.3389/fped.2021.710785. eCollection 2021.', 'Ulyte A, Radtke T, Abela IA, Haile SR, Blankenberger J, Jung R, Capelli C, Berger C, Frei A, Huber M, Schanz M, Schwarzmueller M, Trkola A, Fehr J, Puhan MA, Kriemler S. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland. BMJ Open. 2021 Jul 26;11(7):e047483. doi: 10.1136/bmjopen-2020-047483.', 'Kriemler S, Ulyte A, Ammann P, Peralta GP, Berger C, Puhan MA, Radtke T. Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland. Front Pediatr. 2021 Mar 16;9:645577. doi: 10.3389/fped.2021.645577. eCollection 2021.', 'Ulyte A, Radtke T, Abela IA, Haile SR, Berger C, Huber M, Schanz M, Schwarzmueller M, Trkola A, Fehr J, Puhan MA, Kriemler S. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools. BMJ. 2021 Mar 17;372:n616. doi: 10.1136/bmj.n616.', 'Ulyte A, Radtke T, Abela IA, Haile SR, Braun J, Jung R, Berger C, Trkola A, Fehr J, Puhan MA, Kriemler S. Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study. Int J Public Health. 2020 Dec;65(9):1549-1557. doi: 10.1007/s00038-020-01495-z. Epub 2020 Oct 15.']",,2021-12-30,https://clinicaltrials.gov/show/NCT04448717,2023-12-01,0,1
2230,NCT04448743,Not yet recruiting,2021-11-01,2021-11-01,No Results Posted,,,2020-06-26,https://clinicaltrials.gov/show/NCT04448743,2021-11-01,0,0
2231,NCT04448756,Completed,2021-08-16,2021-08-16,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04448756,2021-08-16,0,0
2232,NCT04448769,Completed,2020-07-24,2020-07-24,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04448769,2020-07-24,0,0
2233,NCT04448782,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04448782,2020-06-30,0,0
2234,NCT04449042,Completed,2020-10-31,2020-10-31,No Results Posted,,,2021-10-22,https://clinicaltrials.gov/show/NCT04449042,2020-10-31,0,0
2235,NCT04449081,Completed,2020-06-10,2020-06-20,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04449081,2020-06-10,0,0
2236,NCT04449094,Completed,2020-03-30,2020-04-04,No Results Posted,,,2020-06-26,https://clinicaltrials.gov/show/NCT04449094,2020-03-30,0,0
2237,NCT04449276,Completed,2021-12-21,2021-12-21,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04449276,2021-12-21,0,0
2238,NCT04449380,Terminated,2021-03-30,2021-03-30,No Results Posted,"['Bosi E, Bosi C, Rovere Querini P, Mancini N, Calori G, Ruggeri A, Canzonieri C, Callegaro L, Clementi M, De Cobelli F, Filippi M, Bregni M. Interferon Œ≤-1a (IFNŒ≤-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial. Trials. 2020 Nov 23;21(1):939. doi: 10.1186/s13063-020-04864-4.']",,2021-05-03,https://clinicaltrials.gov/show/NCT04449380,2021-03-30,0,1
2239,NCT04324606,"Active, not recruiting",2023-03-31,2023-03-31,No Results Posted,"['Flaxman A, Marchevsky NG, Jenkin D, Aboagye J, Aley PK, Angus B, Belij-Rammerstorfer S, Bibi S, Bittaye M, Cappuccini F, Cicconi P, Clutterbuck EA, Davies S, Dejnirattisai W, Dold C, Ewer KJ, Folegatti PM, Fowler J, Hill AVS, Kerridge S, Minassian AM, Mongkolsapaya J, Mujadidi YF, Plested E, Ramasamy MN, Robinson H, Sanders H, Sheehan E, Smith H, Snape MD, Song R, Woods D, Screaton G, Gilbert SC, Voysey M, Pollard AJ, Lambe T; Oxford COVID Vaccine Trial group. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet. 2021 Sep 11;398(10304):981-990. doi: 10.1016/S0140-6736(21)01699-8. Epub 2021 Sep 1.', 'Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet. 2021 Mar 6;397(10277):880.', 'Barrett JR, Belij-Rammerstorfer S, Dold C, Ewer KJ, Folegatti PM, Gilbride C, Halkerston R, Hill J, Jenkin D, Stockdale L, Verheul MK, Aley PK, Angus B, Bellamy D, Berrie E, Bibi S, Bittaye M, Carroll MW, Cavell B, Clutterbuck EA, Edwards N, Flaxman A, Fuskova M, Gorringe A, Hallis B, Kerridge S, Lawrie AM, Linder A, Liu X, Madhavan M, Makinson R, Mellors J, Minassian A, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Rollier CS, Song R, Snape MD, Tarrant R, Taylor S, Thomas KM, Voysey M, Watson MEE, Wright D, Douglas AD, Green CM, Hill AVS, Lambe T, Gilbert S, Pollard AJ; Oxford COVID Vaccine Trial Group. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021 Feb;27(2):279-288. doi: 10.1038/s41591-020-01179-4. Epub 2020 Dec 17. Erratum in: Nat Med. 2021 Jun;27(6):1113.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98."", 'Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, Bellamy D, Bibi S, Bittaye M, Clutterbuck EA, Dold C, Faust SN, Finn A, Flaxman AL, Hallis B, Heath P, Jenkin D, Lazarus R, Makinson R, Minassian AM, Pollock KM, Ramasamy M, Robinson H, Snape M, Tarrant R, Voysey M, Green C, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20. Erratum in: Lancet. 2020 Aug 15;396(10249):466. Erratum in: Lancet. 2020 Dec 12;396(10266):1884.']",,2022-01-21,https://clinicaltrials.gov/show/NCT04324606,2023-03-31,0,1
2240,NCT04381936,Recruiting,2022-11-01,2032-11-01,No Results Posted,"['RECOVERY Collaborative Group. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022 Feb 12;399(10325):665-676. doi: 10.1016/S0140-6736(22)00163-5.', 'Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', ""Tume LN, Menzies JC, Ray S, Scholefield BR; UK Paediatric Intensive Care Society Study Group. Research Priorities for U.K. Pediatric Critical Care in 2019: Healthcare Professionals' and Parents' Perspectives. Pediatr Crit Care Med. 2021 May 1;22(5):e294-e301. doi: 10.1097/PCC.0000000000002647.""]","['RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.', 'RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020 Oct 24;396(10259):1345-1352. doi: 10.1016/S0140-6736(20)32013-4. Epub 2020 Oct 5.', 'RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.', 'RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2.', 'RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.', 'RECOVERY Collaborative Group. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet. 2021 May 29;397(10289):2049-2059. doi: 10.1016/S0140-6736(21)00897-7. Epub 2021 May 14.', 'RECOVERY Collaborative Group, Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Pre-print medRxiv, 2021.06.21; doi: https://doi.org/10.1101/2021.06.15.21258542', 'RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med. 2021 Dec;9(12):1419-1426. doi: 10.1016/S2213-2600(21)00435-5. Epub 2021 Oct 18.', 'RECOVERY Collaborative Group. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17.']",2022-01-20,,2022-11-01,0,1
2241,NCT04348305,Completed,2020-09-10,2021-09-08,No Results Posted,"['Munch MW, Granholm A, Kjaer MN, Aksnes TS, S√∏lling CG, Christensen S, Perner A. Long-term mortality and health-related quality of life in the COVID STEROID trial. Acta Anaesthesiol Scand. 2022 Apr;66(4):543-545. doi: 10.1111/aas.14029. Epub 2022 Feb 3.', 'Munch MW, Meyhoff TS, Helleberg M, Kjaer MN, Granholm A, Hjorts√∏ CJS, Jensen TS, M√∏ller MH, Hjortrup PB, Wetterslev M, Vesterlund GK, Russell L, J√∏rgensen VL, Kristiansen KT, Benfield T, Ulrik CS, Andreasen AS, Bestle MH, Poulsen LM, Hildebrandt T, Knudsen LS, M√∏ller A, S√∏lling CG, Br√∏chner AC, Rasmussen BS, Nielsen H, Christensen S, Str√∏m T, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Venkatesh B, Hammond N, Jha V, Myatra SN, Jensen MQ, Leistner JW, Mikkelsen VS, Svenningsen JS, Laursen SB, Hatley EV, Kristensen CM, Al-Alak A, Clapp E, Jonassen TB, Bjerregaard CL, √òsterby NCH, Jespersen MM, Abou-Kassem D, Lassen ML, Zaabalawi R, Daoud MM, Abdi S, Meier N, la Cour K, Derby CB, Damlund BR, Laigaard J, Andersen LL, Mikkelsen J, Jensen JLS, Rasmussen AH, Arnerl√∂v E, Lykke M, Holst-Hansen MZB, T√∏stesen BW, Schwab J, Madsen EK, Gluud C, Lange T, Perner A. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial. Acta Anaesthesiol Scand. 2021 Nov;65(10):1421-1430. doi: 10.1111/aas.13941. Epub 2021 Sep 20.']",,2021-09-21,https://clinicaltrials.gov/show/NCT04348305,2020-09-10,0,1
2242,NCT04327388,Completed,2020-07-31,2020-09-02,Study Results,"['Lescure FX, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, Patel N, Hagino O; Sarilumab COVID-19 Global Study Group. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 May;9(5):522-532. doi: 10.1016/S2213-2600(21)00099-0. Epub 2021 Mar 4.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04327388,2020-07-31,1,1
2243,NCT04451083,Completed,2020-08-17,2020-08-17,No Results Posted,,,2021-06-16,,2020-08-17,0,0
2244,NCT00223119,Terminated,2005-11-01,2005-11-01,No Results Posted,,,2012-10-25,,2005-11-01,0,0
2245,NCT00223132,Completed,2007-04-01,2007-04-01,No Results Posted,,,2012-10-25,,2007-04-01,0,0
2246,NCT00289523,Completed,2007-07-01,2007-07-01,No Results Posted,"['Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry. 2013 Jan;74(1):51-6. doi: 10.4088/JCP.10m06813.']","['Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 Sep 30;169(2):124-31. doi: 10.1016/j.psychres.2009.06.004. Epub 2009 Aug 27.', 'Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26.']",2012-03-07,,2007-07-01,0,1
2247,NCT00308984,Completed,2007-12-01,2008-05-01,No Results Posted,,"['Malviya S, Galinkin JL, Bannister CF, Burke C, Zuk J, Popenhagen M, Brown S, Voepel-Lewis T. The incidence of intraoperative awareness in children: childhood awareness and recall evaluation. Anesth Analg. 2009 Nov;109(5):1421-7. doi: 10.1213/ANE.0b013e3181b620b0. Epub 2009 Aug 27.']",2012-03-07,,2007-12-01,0,1
2248,NCT00450710,Completed,2008-09-01,2009-09-01,No Results Posted,,,2014-08-22,,2008-09-01,0,0
2249,NCT00456352,Completed,2009-04-01,2010-10-01,No Results Posted,,,2014-08-22,,2009-04-01,0,0
2250,NCT00596973,Withdrawn,2009-01-01,2009-03-01,No Results Posted,,,2014-11-17,,2009-01-01,0,0
2251,NCT00689130,Completed,2008-10-01,2008-10-01,No Results Posted,,,2012-03-07,,2008-10-01,0,0
2252,NCT00832767,Completed,2011-09-01,2012-01-01,Study Results,"['Solomon D, Shariff AH, Silasi DA, Duffy AJ, Bell RL, Roberts KE. Transvaginal cholecystectomy versus single-incision laparoscopic cholecystectomy versus four-port laparoscopic cholecystectomy: a prospective cohort study. Surg Endosc. 2012 Oct;26(10):2823-7. Epub 2012 May 2.']",,2017-12-18,,2011-09-01,1,1
2253,NCT01026025,Withdrawn,2011-05-01,2011-06-01,No Results Posted,,,2013-08-07,,2011-05-01,0,0
2254,NCT01110109,Completed,2010-09-01,2010-10-01,No Results Posted,,,2010-10-26,,2010-09-01,0,0
2255,NCT01241617,Terminated,2012-01-01,2012-01-01,No Results Posted,,,2012-01-24,,2012-01-01,0,0
2256,NCT01483547,Completed,2012-12-01,2012-12-01,No Results Posted,,,2013-02-18,,2012-12-01,0,0
2257,NCT01531426,Completed,2013-01-01,2013-01-01,No Results Posted,,,2013-02-25,,2013-01-01,0,0
2258,NCT01720355,Completed,2012-11-01,2012-11-01,No Results Posted,,,2013-02-13,,2012-11-01,0,0
2259,NCT01747460,Completed,2012-12-01,2012-12-01,No Results Posted,,,2013-12-06,,2012-12-01,0,0
2260,NCT01747473,Completed,2012-11-01,2012-11-01,No Results Posted,,,2013-12-06,,2012-11-01,0,0
2261,NCT01791569,Completed,2012-09-01,2012-09-01,No Results Posted,,,2013-12-06,,2012-09-01,0,0
2262,NCT01791582,Completed,2012-10-01,2012-10-01,No Results Posted,,,2013-12-06,,2012-10-01,0,0
2263,NCT01797250,Completed,2013-07-01,2013-07-01,No Results Posted,,,2013-12-06,,2013-07-01,0,0
2264,NCT01881269,Completed,2013-07-01,2013-09-01,No Results Posted,,,2013-11-06,,2013-07-01,0,0
2265,NCT02075346,Completed,2013-11-01,2013-11-01,No Results Posted,,,2014-03-03,,2013-11-01,0,0
2266,NCT02075398,Completed,2013-12-01,2013-12-01,No Results Posted,,,2014-03-03,,2013-12-01,0,0
2267,NCT02617355,Completed,2011-11-01,2011-11-01,No Results Posted,,,2015-11-30,,2011-11-01,0,0
2268,NCT02658903,Unknown,2017-01-01,2017-01-01,No Results Posted,,,2016-01-20,,2017-01-01,0,0
2269,NCT02308995,Unknown,2016-03-01,2016-03-01,No Results Posted,,,2016-01-29,,2016-03-01,0,0
2270,NCT02805322,Completed,2016-06-01,2016-06-01,No Results Posted,,,2016-06-20,,2016-06-01,0,0
2271,NCT02748629,Completed,2016-05-01,2016-10-01,No Results Posted,,"['Sanders DL, Nienhuijs S, Ziprin P, Miserez M, Gingell-Littlejohn M, Smeds S. Randomized clinical trial comparing self-gripping mesh with suture fixation of lightweight polypropylene mesh in open inguinal hernia repair. Br J Surg. 2014 Oct;101(11):1373-82; discussion 1382. doi: 10.1002/bjs.9598. Epub 2014 Aug 21.']",2016-10-06,,2016-05-01,0,1
2272,NCT02949856,Unknown,2017-04-01,2017-07-01,No Results Posted,,,2016-10-31,,2017-04-01,0,0
2273,NCT01169311,Completed,2011-03-01,2011-07-01,Study Results,,,2014-10-06,,2011-03-01,1,0
2274,NCT01306877,Completed,2012-08-01,2013-01-01,Study Results,,,2014-10-29,,2012-08-01,1,0
2275,NCT01664806,Completed,2011-08-01,2012-05-01,Study Results,"['Jones EL, Dunn CL, Townsend NT, Jones TS, Bruce Dunne J, Montero PN, Govekar HR, Stiegmann GV, Robinson TN. Blend mode reduces unintended thermal injury by laparoscopic monopolar instruments: a randomized controlled trial. Surg Endosc. 2013 Nov;27(11):4016-20. doi: 10.1007/s00464-013-3032-2. Epub 2013 Jun 6.']",,2013-03-25,,2011-08-01,1,1
2276,NCT01706822,Terminated,2013-11-01,2013-11-01,Study Results,,,2015-03-18,,2013-11-01,1,0
2277,NCT01717014,Terminated,2013-11-01,2013-11-01,Study Results,,,2015-03-02,,2013-11-01,1,0
2278,NCT00489268,Completed,2007-02-01,2009-10-01,Study Results,,"[""Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, Pleskow DK, Chuttani R, Reymunde A, Santiago N, Chang KJ, Kimmey MB, Fleischer DE. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007 Feb;65(2):185-95."", ""Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Lightdale CJ, Santiago N, Pleskow DK, Dean PJ, Wang KK. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008 Nov;68(5):867-76. doi: 10.1016/j.gie.2008.03.008. Epub 2008 Jun 17."", ""Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Muthasamy R, Lightdale CJ, Santiago N, Pleskow DK, Dean PJ, Wang KK. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010 Oct;42(10):781-9. doi: 10.1055/s-0030-1255779. Epub 2010 Sep 20.""]",2017-03-13,,2007-02-01,1,1
2279,NCT01455519,Completed,2014-12-01,2014-12-01,Study Results,,,2017-10-24,,2014-12-01,1,0
2280,NCT01765686,Completed,2016-06-01,2016-09-01,No Results Posted,"['Lee SH, Nguyen TK, Ong WS, Haaland B, Tay GC, Tan NC, Tan HK, Ng JCF, Iyer NG. Comparing the Utility and Surgical Outcomes of Harmonic Focus Ultrasonic Scalpel with Ligasure Small Jaw Bipolar Device in Thyroidectomies: A Prospective Randomized Controlled Trial. Ann Surg Oncol. 2019 Dec;26(13):4414-4422. doi: 10.1245/s10434-019-07806-w. Epub 2019 Sep 11.']",,2017-05-22,,2016-06-01,0,1
2281,NCT02065453,Completed,2014-01-01,2014-01-01,Study Results,,,2017-06-14,,2014-01-01,1,0
2282,NCT02822820,Completed,2017-03-01,2017-03-01,No Results Posted,"['Ta≈ükƒ±n S, ≈û√ºk√ºr YE, Altƒ±n D, Turgay B, Varlƒ± B, Bayta≈ü V, Orta√ß F. Bipolar Energy Instruments in Laparoscopic Uterine Cancer Surgery: A Randomized Study. J Laparoendosc Adv Surg Tech A. 2018 Jun;28(6):645-649. doi: 10.1089/lap.2017.0639. Epub 2018 Jan 11.']",,2017-04-25,,2017-03-01,0,1
2283,NCT02886806,Completed,2017-01-01,2017-01-01,No Results Posted,,,2017-01-04,,2017-01-01,0,0
2284,NCT02698982,Completed,2017-03-01,2017-03-01,No Results Posted,,,2017-12-26,,2017-03-01,0,0
2285,NCT04471662,,,,,,,,https://clinicaltrials.gov/show/NCT04471662,,0,0
2286,NCT04379076,Recruiting,2021-10-30,2021-12-30,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04379076,2021-10-30,0,0
2287,NCT04525118,,,,,,,,https://clinicaltrials.gov/show/NCT04525118,,0,0
2288,NCT02735707,Recruiting,2023-12-01,2025-12-01,No Results Posted,"['REMAP-CAP Writing Committee for the REMAP-CAP Investigators, Bradbury CA, Lawler PR, Stanworth SJ, McVerry BJ, McQuilten Z, Higgins AM, Mouncey PR, Al-Beidh F, Rowan KM, Berry LR, Lorenzi E, Zarychanski R, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Bhimani Z, Bihari S, Bonten MJM, Brunkhorst FM, Buzgau A, Buxton M, Carrier M, Cheng AC, Cove M, Detry MA, Estcourt LJ, Fitzgerald M, Girard TD, Goligher EC, Goossens H, Haniffa R, Hills T, Huang DT, Horvat CM, Hunt BJ, Ichihara N, Lamontagne F, Leavis HL, Linstrum KM, Litton E, Marshall JC, McAuley DF, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Morpeth SC, Murthy S, Neal MD, Nichol AD, Parke RL, Parker JC, Reyes L, Saito H, Santos MS, Saunders CT, Serpa-Neto A, Seymour CW, Shankar-Hari M, Singh V, Tolppa T, Turgeon AF, Turner AM, van de Veerdonk FL, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Derde LPG, Webb SA, Gordon AC. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Mar 22. doi: 10.1001/jama.2022.2910. [Epub ahead of print]', 'Writing Committee for the REMAP-CAP Investigators, Estcourt LJ, Turgeon AF, McQuilten ZK, McVerry BJ, Al-Beidh F, Annane D, Arabi YM, Arnold DM, Beane A, B√©gin P, van Bentum-Puijk W, Berry LR, Bhimani Z, Birchall JE, Bonten MJM, Bradbury CA, Brunkhorst FM, Buxton M, Callum JL, Chass√© M, Cheng AC, Cove ME, Daly J, Derde L, Detry MA, De Jong M, Evans A, Fergusson DA, Fish M, Fitzgerald M, Foley C, Goossens H, Gordon AC, Gosbell IB, Green C, Haniffa R, Harvala H, Higgins AM, Hills TE, Hoad VC, Horvat C, Huang DT, Hudson CL, Ichihara N, Laing E, Lamikanra AA, Lamontagne F, Lawler PR, Linstrum K, Litton E, Lorenzi E, MacLennan S, Marshall J, McAuley DF, McDyer JF, McGlothlin A, McGuinness S, Miflin G, Montgomery S, Mouncey PR, Murthy S, Nichol A, Parke R, Parker JC, Priddee N, Purcell DFJ, Reyes LF, Richardson P, Robitaille N, Rowan KM, Rynne J, Saito H, Santos M, Saunders CT, Serpa Neto A, Seymour CW, Silversides JA, Tinmouth AA, Triulzi DJ, Turner AM, van de Veerdonk F, Walsh TS, Wood EM, Berry S, Lewis RJ, Menon DK, McArthur C, Zarychanski R, Angus DC, Webb SA, Roberts DJ, Shankar-Hari M. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Nov 2;326(17):1690-1702. doi: 10.1001/jama.2021.18178.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'REMAP-CAP Investigators; ACTIV-4a Investigators; ATTACC Investigators, Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ, Kahn SR, Marshall JC, Kim KS, Houston BL, Derde LPG, Cushman M, Tritschler T, Angus DC, Godoy LC, McQuilten Z, Kirwan BA, Farkouh ME, Brooks MM, Lewis RJ, Berry LR, Lorenzi E, Gordon AC, Ahuja T, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Contreras A, Costantini TW, de Brouwer S, Detry MA, Duggal A, D≈æav√≠k V, Effron MB, Eng HF, Escobedo J, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Froess JD, Fu Z, Galanaud JP, Galen BT, Gandotra S, Girard TD, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Haniffa R, Hegde SM, Hendrickson CM, Higgins AM, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Huang DT, Hudock K, Hunt BJ, Husain M, Hyzy RC, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski A, King AJ, Knudson MM, Kornblith AE, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Gallego Lima F, Linstrum K, Litton E, Lopez-Sendon J, Lother SA, Marten N, Saud Marinez A, Martinez M, Mateos Garcia E, Mavromichalis S, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nicolau JC, Nunez-Garcia B, Park JJ, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, Pompilio M, Quigley JG, Rosenson RS, Rost NS, Rowan K, Santos FO, Santos M, Santos MO, Satterwhite L, Saunders CT, Schreiber J, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Singhal AB, Slutsky AS, Solvason D, Stanworth SJ, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Widmer RJ, Wilson JG, Yuriditsky E, Zhong Y, Berry SM, McArthur CJ, Neal MD, Hochman JS, Webb SA, Zarychanski R. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.', 'ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR, Turgeon AF, Escobedo J, Huang DT, Bradbury CA, Houston BL, Kornblith LZ, Kumar A, Kahn SR, Cushman M, McQuilten Z, Slutsky AS, Kim KS, Gordon AC, Kirwan BA, Brooks MM, Higgins AM, Lewis RJ, Lorenzi E, Berry SM, Berry LR, Aday AW, Al-Beidh F, Annane D, Arabi YM, Aryal D, Baumann Kreuziger L, Beane A, Bhimani Z, Bihari S, Billett HH, Bond L, Bonten M, Brunkhorst F, Buxton M, Buzgau A, Castellucci LA, Chekuri S, Chen JT, Cheng AC, Chkhikvadze T, Coiffard B, Costantini TW, de Brouwer S, Derde LPG, Detry MA, Duggal A, D≈æav√≠k V, Effron MB, Estcourt LJ, Everett BM, Fergusson DA, Fitzgerald M, Fowler RA, Galanaud JP, Galen BT, Gandotra S, Garc√≠a-Madrona S, Girard TD, Godoy LC, Goodman AL, Goossens H, Green C, Greenstein YY, Gross PL, Hamburg NM, Haniffa R, Hanna G, Hanna N, Hegde SM, Hendrickson CM, Hite RD, Hindenburg AA, Hope AA, Horowitz JM, Horvat CM, Hudock K, Hunt BJ, Husain M, Hyzy RC, Iyer VN, Jacobson JR, Jayakumar D, Keller NM, Khan A, Kim Y, Kindzelski AL, King AJ, Knudson MM, Kornblith AE, Krishnan V, Kutcher ME, Laffan MA, Lamontagne F, Le Gal G, Leeper CM, Leifer ES, Lim G, Lima FG, Linstrum K, Litton E, Lopez-Sendon J, Lopez-Sendon Moreno JL, Lother SA, Malhotra S, Marcos M, Saud Marinez A, Marshall JC, Marten N, Matthay MA, McAuley DF, McDonald EG, McGlothlin A, McGuinness SP, Middeldorp S, Montgomery SK, Moore SC, Morillo Guerrero R, Mouncey PR, Murthy S, Nair GB, Nair R, Nichol AD, Nunez-Garcia B, Pandey A, Park PK, Parke RL, Parker JC, Parnia S, Paul JD, P√©rez Gonz√°lez YS, Pompilio M, Prekker ME, Quigley JG, Rost NS, Rowan K, Santos FO, Santos M, Olombrada Santos M, Satterwhite L, Saunders CT, Schutgens REG, Seymour CW, Siegal DM, Silva DG Jr, Shankar-Hari M, Sheehan JP, Singhal AB, Solvason D, Stanworth SJ, Tritschler T, Turner AM, van Bentum-Puijk W, van de Veerdonk FL, van Diepen S, Vazquez-Grande G, Wahid L, Wareham V, Wells BJ, Widmer RJ, Wilson JG, Yuriditsky E, Zampieri FG, Angus DC, McArthur CJ, Webb SA, Farkouh ME, Hochman JS, Zarychanski R. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.', 'Arabi YM, Gordon AC, Derde LPG, Nichol AD, Murthy S, Beidh FA, Annane D, Swaidan LA, Beane A, Beasley R, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buxton M, Buzgau A, Cheng A, De Jong M, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Fowler R, Girard TD, Goligher EC, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Huang DT, King AJ, Lamontagne F, Lawler PR, Lewis R, Linstrum K, Litton E, Lorenzi E, Malakouti S, McAuley DF, McGlothlin A, Mcguinness S, McVerry BJ, Montgomery SK, Morpeth SC, Mouncey PR, Orr K, Parke R, Parker JC, Patanwala AE, Rowan KM, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Tong SYC, Turgeon AF, Turner AM, Van de Veerdonk FL, Zarychanski R, Green C, Berry S, Marshall JC, McArthur C, Angus DC, Webb SA; REMAP-CAP Investigators. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug;47(8):867-886. doi: 10.1007/s00134-021-06448-5. Epub 2021 Jul 12.', 'REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Buzgau A, Cheng AC, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Lamontagne F, Lawler PR, Leavis HL, Linstrum KM, Litton E, Lorenzi E, Marshall JC, Mayr FB, McAuley DF, McGlothlin A, McGuinness SP, McVerry BJ, Montgomery SK, Morpeth SC, Murthy S, Orr K, Parke RL, Parker JC, Patanwala AE, Pettil√§ V, Rademaker E, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Sligl WI, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Webb SA, Derde LPG. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.', 'UPMC REMAP-COVID Group, on behalf of the REMAP-CAP Investigators. Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system-lessons learned and recommendations. Trials. 2021 Jan 28;22(1):100. doi: 10.1186/s13063-020-04997-6. Erratum in: Trials. 2021 Feb 16;22(1):145.', ""Tume LN, Menzies JC, Ray S, Scholefield BR; UK Paediatric Intensive Care Society Study Group. Research Priorities for U.K. Pediatric Critical Care in 2019: Healthcare Professionals' and Parents' Perspectives. Pediatr Crit Care Med. 2021 May 1;22(5):e294-e301. doi: 10.1097/PCC.0000000000002647."", ""Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, van Bentum-Puijk W, Berry L, Bhimani Z, Bonten M, Bradbury C, Brunkhorst F, Buxton M, Buzgau A, Cheng AC, de Jong M, Detry M, Estcourt L, Fitzgerald M, Goossens H, Green C, Haniffa R, Higgins AM, Horvat C, Hullegie SJ, Kruger P, Lamontagne F, Lawler PR, Linstrum K, Litton E, Lorenzi E, Marshall J, McAuley D, McGlothin A, McGuinness S, McVerry B, Montgomery S, Mouncey P, Murthy S, Nichol A, Parke R, Parker J, Rowan K, Sanil A, Santos M, Saunders C, Seymour C, Turner A, van de Veerdonk F, Venkatesh B, Zarychanski R, Berry S, Lewis RJ, McArthur C, Webb SA, Gordon AC; Writing Committee for the REMAP-CAP Investigators, Al-Beidh F, Angus D, Annane D, Arabi Y, van Bentum-Puijk W, Berry S, Beane A, Bhimani Z, Bonten M, Bradbury C, Brunkhorst F, Buxton M, Cheng A, De Jong M, Derde L, Estcourt L, Goossens H, Gordon A, Green C, Haniffa R, Lamontagne F, Lawler P, Litton E, Marshall J, McArthur C, McAuley D, McGuinness S, McVerry B, Montgomery S, Mouncey P, Murthy S, Nichol A, Parke R, Rowan K, Seymour C, Turner A, van de Veerdonk F, Webb S, Zarychanski R, Campbell L, Forbes A, Gattas D, Heritier S, Higgins L, Kruger P, Peake S, Presneill J, Seppelt I, Trapani T, Young P, Bagshaw S, Daneman N, Ferguson N, Misak C, Santos M, Hullegie S, Pletz M, Rohde G, Rowan K, Alexander B, Basile K, Girard T, Horvat C, Huang D, Linstrum K, Vates J, Beasley R, Fowler R, McGloughlin S, Morpeth S, Paterson D, Venkatesh B, Uyeki T, Baillie K, Duffy E, Fowler R, Hills T, Orr K, Patanwala A, Tong S, Netea M, Bihari S, Carrier M, Fergusson D, Goligher E, Haidar G, Hunt B, Kumar A, Laffan M, Lawless P, Lother S, McCallum P, Middeldopr S, McQuilten Z, Neal M, Pasi J, Schutgens R, Stanworth S, Turgeon A, Weissman A, Adhikari N, Anstey M, Brant E, de Man A, Lamonagne F, Masse MH, Udy A, Arnold D, Begin P, Charlewood R, Chasse M, Coyne M, Cooper J, Daly J, Gosbell I, Harvala-Simmonds H, Hills T, MacLennan S, Menon D, McDyer J, Pridee N, Roberts D, Shankar-Hari M, Thomas H, Tinmouth A, Triulzi D, Walsh T, Wood E, Calfee C, O'Kane C, Shyamsundar M, Sinha P, Thompson T, Young I, Bihari S, Hodgson C, Laffey J, McAuley D, Orford N, Neto A, Detry M, Fitzgerald M, Lewis R, McGlothlin A, Sanil A, Saunders C, Berry L, Lorenzi E, Miller E, Singh V, Zammit C, van Bentum Puijk W, Bouwman W, Mangindaan Y, Parker L, Peters S, Rietveld I, Raymakers K, Ganpat R, Brillinger N, Markgraf R, Ainscough K, Brickell K, Anjum A, Lane JB, Richards-Belle A, Saull M, Wiley D, Bion J, Connor J, Gates S, Manax V, van der Poll T, Reynolds J, van Beurden M, Effelaar E, Schotsman J, Boyd C, Harland C, Shearer A, Wren J, Clermont G, Garrard W, Kalchthaler K, King A, Ricketts D, Malakoutis S, Marroquin O, Music E, Quinn K, Cate H, Pearson K, Collins J, Hanson J, Williams P, Jackson S, Asghar A, Dyas S, Sutu M, Murphy S, Williamson D, Mguni N, Potter A, Porter D, Goodwin J, Rook C, Harrison S, Williams H, Campbell H, Lomme K, Williamson J, Sheffield J, van't Hoff W, McCracken P, Young M, Board J, Mart E, Knott C, Smith J, Boschert C, Affleck J, Ramanan M, D'Souza R, Pateman K, Shakih A, Cheung W, Kol M, Wong H, Shah A, Wagh A, Simpson J, Duke G, Chan P, Cartner B, Hunter S, Laver R, Shrestha T, Regli A, Pellicano A, McCullough J, Tallott M, Kumar N, Panwar R, Brinkerhoff G, Koppen C, Cazzola F, Brain M, Mineall S, Fischer R, Biradar V, Soar N, White H, Estensen K, Morrison L, Smith J, Cooper M, Health M, Shehabi Y, Al-Bassam W, Hulley A, Whitehead C, Lowrey J, Gresha R, Walsham J, Meyer J, Harward M, Venz E, Williams P, Kurenda C, Smith K, Smith M, Garcia R, Barge D, Byrne D, Byrne K, Driscoll A, Fortune L, Janin P, Yarad E, Hammond N, Bass F, Ashelford A, Waterson S, Wedd S, McNamara R, Buhr H, Coles J, Schweikert S, Wibrow B, Rauniyar R, Myers E, Fysh E, Dawda A, Mevavala B, Litton E, Ferrier J, Nair P, Buscher H, Reynolds C, Santamaria J, Barbazza L, Homes J, Smith R, Murray L, Brailsford J, Forbes L, Maguire T, Mariappa V, Smith J, Simpson S, Maiden M, Bone A, Horton M, Salerno T, Sterba M, Geng W, Depuydt P, De Waele J, De Bus L, Fierens J, Bracke S, Reeve B, Dechert W, Chass√© M, Carrier FM, Boumahni D, Benettaib F, Ghamraoui A, Bellemare D, Cloutier √à, Francoeur C, Lamontagne F, D'Aragon F, Carbonneau E, Leblond J, Vazquez-Grande G, Marten N, Wilson M, Albert M, Serri K, Cavayas A, Duplaix M, Williams V, Rochwerg B, Karachi T, Oczkowski S, Centofanti J, Millen T, Duan E, Tsang J, Patterson L, English S, Watpool I, Porteous R, Miezitis S, McIntyre L, Brochard L, Burns K, Sandhu G, Khalid I, Binnie A, Powell E, McMillan A, Luk T, Aref N, Andric Z, Cviljevic S, ƒêimoti R, Zapalac M, Mirkoviƒá G, Bar≈°iƒá B, Kutle≈°a M, Kotarski V, Vujaklija Brajkoviƒá A, Babel J, Sever H, Dragija L, Ku≈°an I, Vaara S, Pettil√§ L, Heinonen J, Kuitunen A, Karlsson S, Vahtera A, Kiiski H, Ristim√§ki S, Azaiz A, Charron C, Godement M, Geri G, Vieillard-Baron A, Pourcine F, Monchi M, Luis D, Mercier R, Sagnier A, Verrier N, Caplin C, Siami S, Aparicio C, Vautier S, Jeblaoui A, Fartoukh M, Courtin L, Labbe V, Leparco C, Muller G, Nay MA, Kamel T, Benzekri D, Jacquier S, Mercier E, Chartier D, Salmon C, Dequin P, Schneider F, Morel G, L'Hotellier S, Badie J, Berdaguer FD, Malfroy S, Mezher C, Bourgoin C, Megarbane B, Voicu S, Deye N, Malissin I, Sutterlin L, Guitton C, Darreau C, Landais M, Chudeau N, Robert A, Moine P, Heming N, Maxime V, Bossard I, Nicholier TB, Colin G, Zinzoni V, Maquigneau N, Finn A, Kre√ü G, Hoff U, Friedrich Hinrichs C, Nee J, Pletz M, Hagel S, Ankert J, Kolanos S, Bloos F, Petros S, Pasieka B, Kunz K, Appelt P, Sch√ºtze B, Kluge S, Nierhaus A, Jarczak D, Roedl K, Weismann D, Frey A, Klinikum Neuk√∂lln V, Reill L, Distler M, Maselli A, B√©lteczki J, Magyar I, Fazekas √Å, Kov√°cs S, Sz≈ëke V, Szigligeti G, Leszkoven J, Collins D, Breen P, Frohlich S, Whelan R, McNicholas B, Scully M, Casey S, Kernan M, Doran P, O'Dywer M, Smyth M, Hayes L, Hoiting O, Peters M, Rengers E, Evers M, Prinssen A, Bosch Ziekenhuis J, Simons K, Rozendaal W, Polderman F, de Jager P, Moviat M, Paling A, Salet A, Rademaker E, Peters AL, de Jonge E, Wigbers J, Guilder E, Butler M, Cowdrey KA, Newby L, Chen Y, Simmonds C, McConnochie R, Ritzema Carter J, Henderson S, Van Der Heyden K, Mehrtens J, Williams T, Kazemi A, Song R, Lai V, Girijadevi D, Everitt R, Russell R, Hacking D, Buehner U, Williams E, Browne T, Grimwade K, Goodson J, Keet O, Callender O, Martynoga R, Trask K, Butler A, Schischka L, Young C, Lesona E, Olatunji S, Robertson Y, Jos√© N, Amaro dos Santos Catorze T, de Lima Pereira TNA, Neves Pessoa LM, Castro Ferreira RM, Pereira Sousa Bastos JM, Aysel Florescu S, Stanciu D, Zaharia MF, Kosa AG, Codreanu D, Marabi Y, Al Qasim E, Moneer Hagazy M, Al Swaidan L, Arishi H, Mu√±oz-Berm√∫dez R, Marin-Corral J, Salazar Degracia A, Parrilla G√≥mez F, Mateo L√≥pez MI, Rodriguez Fernandez J, C√°rcel Fern√°ndez S, Carmona Flores R, Le√≥n L√≥pez R, de la Fuente Martos C, Allan A, Polgarova P, Farahi N, McWilliam S, Hawcutt D, Rad L, O'Malley L, Whitbread J, Kelsall O, Wild L, Thrush J, Wood H, Austin K, Donnelly A, Kelly M, O'Kane S, McClintock D, Warnock M, Johnston P, Gallagher LJ, Mc Goldrick C, Mc Master M, Strzelecka A, Jha R, Kalogirou M, Ellis C, Krishnamurthy V, Deelchand V, Silversides J, McGuigan P, Ward K, O'Neill A, Finn S, Phillips B, Mullan D, Oritz-Ruiz de Gordoa L, Thomas M, Sweet K, Grimmer L, Johnson R, Pinnell J, Robinson M, Gledhill L, Wood T, Morgan M, Cole J, Hill H, Davies M, Antcliffe D, Templeton M, Rojo R, Coghlan P, Smee J, Mackay E, Cort J, Whileman A, Spencer T, Spittle N, Kasipandian V, Patel A, Allibone S, Genetu RM, Ramali M, Ghosh A, Bamford P, London E, Cawley K, Faulkner M, Jeffrey H, Smith T, Brewer C, Gregory J, Limb J, Cowton A, O'Brien J, Nikitas N, Wells C, Lankester L, Pulletz M, Williams P, Birch J, Wiseman S, Horton S, Alegria A, Turki S, Elsefi T, Crisp N, Allen L, McCullagh I, Robinson P, Hays C, Babio-Galan M, Stevenson H, Khare D, Pinder M, Selvamoni S, Gopinath A, Pugh R, Menzies D, Mackay C, Allan E, Davies G, Puxty K, McCue C, Cathcart S, Hickey N, Ireland J, Yusuff H, Isgro G, Brightling C, Bourne M, Craner M, Watters M, Prout R, Davies L, Pegler S, Kyeremeh L, Arbane G, Wilson K, Gomm L, Francia F, Brett S, Sousa Arias S, Elin Hall R, Budd J, Small C, Birch J, Collins E, Henning J, Bonner S, Hugill K, Cirstea E, Wilkinson D, Karlikowski M, Sutherland H, Wilhelmsen E, Woods J, North J, Sundaran D, Hollos L, Coburn S, Walsh J, Turns M, Hopkins P, Smith J, Noble H, Depante MT, Clarey E, Laha S, Verlander M, Williams A, Huckle A, Hall A, Cooke J, Gardiner-Hill C, Maloney C, Qureshi H, Flint N, Nicholson S, Southin S, Nicholson A, Borgatta B, Turner-Bone I, Reddy A, Wilding L, Chamara Warnapura L, Agno Sathianathan R, Golden D, Hart C, Jones J, Bannard-Smith J, Henry J, Birchall K, Pomeroy F, Quayle R, Makowski A, Misztal B, Ahmed I, KyereDiabour T, Naiker K, Stewart R, Mwaura E, Mew L, Wren L, Willams F, Innes R, Doble P, Hutter J, Shovelton C, Plumb B, Szakmany T, Hamlyn V, Hawkins N, Lewis S, Dell A, Gopal S, Ganguly S, Smallwood A, Harris N, Metherell S, Lazaro JM, Newman T, Fletcher S, Nortje J, Fottrell-Gould D, Randell G, Zaman M, Elmahi E, Jones A, Hall K, Mills G, Ryalls K, Bowler H, Sall J, Bourne R, Borrill Z, Duncan T, Lamb T, Shaw J, Fox C, Moreno Cuesta J, Xavier K, Purohit D, Elhassan M, Bakthavatsalam D, Rowland M, Hutton P, Bashyal A, Davidson N, Hird C, Chhablani M, Phalod G, Kirkby A, Archer S, Netherton K, Reschreiter H, Camsooksai J, Patch S, Jenkins S, Pogson D, Rose S, Daly Z, Brimfield L, Claridge H, Parekh D, Bergin C, Bates M, Dasgin J, McGhee C, Sim M, Hay SK, Henderson S, Phull MK, Zaidi A, Pogreban T, Rosaroso LP, Harvey D, Lowe B, Meredith M, Ryan L, Hormis A, Walker R, Collier D, Kimpton S, Oakley S, Rooney K, Rodden N, Hughes E, Thomson N, McGlynn D, Walden A, Jacques N, Coles H, Tilney E, Vowell E, Schuster-Bruce M, Pitts S, Miln R, Purandare L, Vamplew L, Spivey M, Bean S, Burt K, Moore L, Day C, Gibson C, Gordon E, Zitter L, Keenan S, Baker E, Cherian S, Cutler S, Roynon-Reed A, Harrington K, Raithatha A, Bauchmuller K, Ahmad N, Grecu I, Trodd D, Martin J, Wrey Brown C, Arias AM, Craven T, Hope D, Singleton J, Clark S, Rae N, Welters I, Hamilton DO, Williams K, Waugh V, Shaw D, Puthucheary Z, Martin T, Santos F, Uddin R, Somerville A, Tatham KC, Jhanji S, Black E, Dela Rosa A, Howle R, Tully R, Drummond A, Dearden J, Philbin J, Munt S, Vuylsteke A, Chan C, Victor S, Matsa R, Gellamucho M, Creagh-Brown B, Tooley J, Montague L, De Beaux F, Bullman L, Kersiake I, Demetriou C, Mitchard S, Ramos L, White K, Donnison P, Johns M, Casey R, Mattocks L, Salisbury S, Dark P, Claxton A, McLachlan D, Slevin K, Lee S, Hulme J, Joseph S, Kinney F, Senya HJ, Oborska A, Kayani A, Hadebe B, Orath Prabakaran R, Nichols L, Thomas M, Worner R, Faulkner B, Gendall E, Hayes K, Hamilton-Davies C, Chan C, Mfuko C, Abbass H, Mandadapu V, Leaver S, Forton D, Patel K, Paramasivam E, Powell M, Gould R, Wilby E, Howcroft C, Banach D, Fern√°ndez de Pinedo Artaraz Z, Cabreros L, White I, Croft M, Holland N, Pereira R, Zaki A, Johnson D, Jackson M, Garrard H, Juhaz V, Roy A, Rostron A, Woods L, Cornell S, Pillai S, Harford R, Rees T, Ivatt H, Sundara Raman A, Davey M, Lee K, Barber R, Chablani M, Brohi F, Jagannathan V, Clark M, Purvis S, Wetherill B, Dushianthan A, Cusack R, de Courcy-Golder K, Smith S, Jackson S, Attwood B, Parsons P, Page V, Zhao XB, Oza D, Rhodes J, Anderson T, Morris S, Xia Le Tai C, Thomas A, Keen A, Digby S, Cowley N, Wild L, Southern D, Reddy H, Campbell A, Watkins C, Smuts S, Touma O, Barnes N, Alexander P, Felton T, Ferguson S, Sellers K, Bradley-Potts J, Yates D, Birkinshaw I, Kell K, Marshall N, Carr-Knott L, Summers C. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 Oct 6;324(13):1317-1329. doi: 10.1001/jama.2020.17022."", ""Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K, Brunkhorst F, Cheng AC, Chiche JD, De Jong M, Detry M, Goossens H, Gordon A, Green C, Higgins AM, Hullegie SJ, Kruger P, Lamontagne F, Litton E, Marshall J, McGlothlin A, McGuinness S, Mouncey P, Murthy S, Nichol A, O'Neill GK, Parke R, Parker J, Rohde G, Rowan K, Turner A, Young P, Derde L, McArthur C, Webb SA. The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020 Jul;17(7):879-891. doi: 10.1513/AnnalsATS.202003-192SD.""]",,2021-12-21,,2023-12-01,0,1
2289,NCT04523571,Completed,2020-09-30,2021-08-10,No Results Posted,,,2021-11-11,,2020-09-30,0,0
2290,NCT04466241,Recruiting,2021-03-26,2021-03-26,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04466241,2021-03-26,0,0
2291,NCT04494204,Completed,2020-12-01,2020-12-20,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04494204,2020-12-01,0,0
2292,NCT00571389,Recruiting,2025-02-01,2025-02-01,No Results Posted,,,2020-09-10,https://clinicaltrials.gov/show/NCT00571389,2025-02-01,0,0
2293,NCT01306084,Recruiting,,,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT01306084,,0,0
2294,NCT01520506,Completed,2013-11-01,2014-06-01,Study Results,"['Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study. EuroIntervention. 2015 Feb;10(10):1221-9. doi: 10.4244/EIJY14M12_02.']",,2019-03-01,,2013-11-01,1,1
2295,NCT02047305,Completed,2016-08-01,2016-11-01,Study Results,"['Yu X, van Munster SN, Zhang Y, Xue L, Fleischer DE, Weusten BLAM, Lu N, Dawsey SSM, Bergman JJGHM, Wang G. Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China. Gastrointest Endosc. 2019 Apr;89(4):736-748.e2. doi: 10.1016/j.gie.2018.10.030. Epub 2018 Oct 26.']","['He S, Bergman J, Zhang Y, Weusten B, Xue L, Qin X, Dou L, Liu Y, Fleischer D, Lu N, Dawsey SM, Wang GQ. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy. 2015 May;47(5):398-408. doi: 10.1055/s-0034-1391285. Epub 2015 Feb 10.', 'Bergman JJ, Zhang YM, He S, Weusten B, Xue L, Fleischer DE, Lu N, Dawsey SM, Wang GQ. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc. 2011 Dec;74(6):1181-90. doi: 10.1016/j.gie.2011.05.024. Epub 2011 Aug 15.']",2020-05-21,,2016-08-01,1,1
2296,NCT02470416,"Active, not recruiting",2021-07-01,2021-07-01,No Results Posted,"['Awadie H, Klein A, Tate D, Jideh B, Bar-Yishai I, Goodrick K, Ahlenstiel G, Bourke MJ. The prevalence of small-bowel polyps on video capsule endoscopy in patients with sporadic duodenal or ampullary adenomas. Gastrointest Endosc. 2021 Mar;93(3):630-636. doi: 10.1016/j.gie.2020.07.029. Epub 2020 Jul 24.']",,2021-03-23,,2021-07-01,0,1
2297,NCT02586415,Terminated,2017-08-23,2017-08-23,Study Results,"['Tate WJ, Polding LC, Christensen S, Mlynash M, Kemp S, Heit JJ, Marks MP, Albers GW, Lansberg MG. Predictors of Early and Late Infarct Growth in DEFUSE 3. Front Neurol. 2021 Jul 1;12:699153. doi: 10.3389/fneur.2021.699153. eCollection 2021.', 'Polding LC, Tate WJ, Mlynash M, Marks MP, Heit JJ, Christensen S, Kemp S, Albers GW, Lansberg MG; DEFUSE 3 Investigators. Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial. Stroke. 2021 Apr;52(4):1185-1191. doi: 10.1161/STROKEAHA.120.031490. Epub 2021 Feb 18.', 'Sarraj A, Mlynash M, Heit J, Pujara D, Lansberg M, Marks M, Albers GW. Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3. Stroke. 2021 Mar;52(3):838-849. doi: 10.1161/STROKEAHA.120.031147. Epub 2021 Feb 10.', 'Cereda CW, Mlynash M, Cipp√† PE, Kemp S, Heit JJ, Marks MP, Lansberg MG, Albers GW. Renal Safety of Multimodal Brain Imaging Followed by Endovascular Therapy. Stroke. 2021 Jan;52(1):313-316. doi: 10.1161/STROKEAHA.120.030816. Epub 2020 Nov 30.', 'Heit JJ, Mlynash M, Christensen S, Kemp SM, Lansberg MG, Marks MP, Olivot JM, Gregory AW. What predicts poor outcome after successful thrombectomy in late time windows? J Neurointerv Surg. 2021 May;13(5):421-425. doi: 10.1136/neurintsurg-2020-016125. Epub 2020 Jun 17.', 'Kim-Tenser M, Mlynash M, Lansberg MG, Tenser M, Bulic S, Jagadeesan B, Christensen S, Simpkins A, Albers GW, Marks MP, Heit JJ. CT perfusion core and ASPECT score prediction of outcomes in DEFUSE 3. Int J Stroke. 2021 Apr;16(3):288-294. doi: 10.1177/1747493020915141. Epub 2020 Mar 31. Erratum in: Int J Stroke. 2020 Apr 29;:1747493020922800.', 'Dula AN, Mlynash M, Zuck ND, Albers GW, Warach SJ; DEFUSE 3 Investigators. Neuroimaging in Ischemic Stroke Is Different Between Men and Women in the DEFUSE 3 Cohort. Stroke. 2020 Feb;51(2):481-488. doi: 10.1161/STROKEAHA.119.028205. Epub 2019 Dec 12.', 'Amukotuwa SA, Fischbein NJ, Albers GW, Davis S, Donnan GA, Andre JB, Bammer R. Comparison of T2*GRE and DSC-PWI for hemorrhage detection in acute ischemic stroke patients: Pooled analysis of the EPITHET, DEFUSE 2, and SENSE 3 stroke studies. Int J Stroke. 2020 Feb;15(2):216-225. doi: 10.1177/1747493019858781. Epub 2019 Jul 10.', 'Tate WJ, Polding LC, Kemp S, Mlynash M, Heit JJ, Marks MP, Albers GW, Lansberg MG. Thrombectomy Results in Reduced Hospital Stay, More Home-Time, and More Favorable Living Situations in DEFUSE 3. Stroke. 2019 Sep;50(9):2578-2581. doi: 10.1161/STROKEAHA.119.025165. Epub 2019 Jul 10.', 'Heit JJ, Mlynash M, Kemp SM, Lansberg MG, Christensen S, Marks MP, Ortega-Gutierrez S, Albers GW. Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study. Stroke. 2019 May;50(5):1172-1177. doi: 10.1161/STROKEAHA.119.024928.', 'Christensen S, Mlynash M, Kemp S, Yennu A, Heit JJ, Marks MP, Lansberg MG, Albers GW. Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3. Stroke. 2019 Mar;50(3):754-757. doi: 10.1161/STROKEAHA.118.023392.', 'Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW. Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial. JAMA Neurol. 2019 Jun 1;76(6):682-689. doi: 10.1001/jamaneurol.2019.0118.', 'Rao V, Christensen S, Yennu A, Mlynash M, Zaharchuk G, Heit J, Marks MP, Lansberg MG, Albers GW. Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3. Stroke. 2019 Mar;50(3):626-631. doi: 10.1161/STROKEAHA.118.023177.', 'de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ; DEFUSE 3 Investigators. Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome. Stroke. 2019 Mar;50(3):632-638. doi: 10.1161/STROKEAHA.118.023407.', 'Lansberg MG, Mlynash M, Hamilton S, Yeatts SD, Christensen S, Kemp S, Lavori PW, Ortega-Gutierrez S, Broderick J, Heit J, Marks MP, Albers GW; DEFUSE 3 Investigators. Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial. JAMA Neurol. 2019 Apr 1;76(4):447-453. doi: 10.1001/jamaneurol.2018.4587.']","['Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.', 'Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW; DEFUSE 3 Investigators. Endovascular Treatment in the DEFUSE 3 Study. Stroke. 2018 Aug;49(8):2000-2003. doi: 10.1161/STROKEAHA.118.022147.']",2019-05-21,,2017-08-23,1,1
2298,NCT02731079,Unknown,2020-03-01,2021-03-01,No Results Posted,,,2018-11-06,,2020-03-01,0,0
2299,NCT02788903,Completed,2021-05-01,2021-05-01,Study Results,,,2021-10-01,https://clinicaltrials.gov/show/NCT02788903,2021-05-01,1,0
2300,NCT03024021,Completed,2018-09-01,2018-12-01,No Results Posted,,"['Genbrugge C, Eertmans W, Meex I, Van Kerrebroeck M, Daems N, Creemers A, Jans F, Boer W, Dens J, De Deyne C. What is the value of regional cerebral saturation in post-cardiac arrest patients? A prospective observational study. Crit Care. 2016 Oct 13;20(1):327.', 'Nishiyama K, Ito N, Orita T, Hayashida K, Arimoto H, Beppu S, Abe M, Unoki T, Endo T, Murai A, Hatada T, Yamada N, Mizobuchi M, Himeno H, Okuchi K, Yasuda H, Mochizuki T, Shiga K, Kikuchi M, Tsujimura Y, Hatanaka T, Nagao K; J-POP Registry Investigators. Regional cerebral oxygen saturation monitoring for predicting interventional outcomes in patients following out-of-hospital cardiac arrest of presumed cardiac cause: A prospective, observational, multicentre study. Resuscitation. 2015 Nov;96:135-41. doi: 10.1016/j.resuscitation.2015.07.049. Epub 2015 Aug 17.']",2020-03-10,,2018-09-01,0,1
2301,NCT03147534,Withdrawn,2018-05-08,2018-05-08,No Results Posted,,,2021-01-14,,2018-05-08,0,0
2302,NCT03183570,Recruiting,2022-04-14,2023-04-14,No Results Posted,,"['Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, Guo HH, Haywood T, Abou-Elkacem L, Baratto L, Habte F, Devulapally R, Witney TH, Cheng Y, Tikole S, Chakraborti S, Nix J, Bonagura CA, Hatami N, Mooney JJ, Desai T, Turner S, Gaster RS, Otte A, Visser BC, Poultsides GA, Norton J, Park W, Stolowitz M, Lau K, Yang E, Natarajan A, Ilovich O, Srinivas S, Srinivasan A, Paulmurugan R, Willmann J, Chin FT, Cheng Z, Iagaru A, Li F, Gambhir SS. Evaluation of integrin Œ±vŒ≤(6) cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nat Commun. 2019 Oct 14;10(1):4673. doi: 10.1038/s41467-019-11863-w.']",2021-03-16,https://clinicaltrials.gov/show/NCT03183570,2022-04-14,0,1
2303,NCT03226886,Recruiting,2023-09-01,2023-09-01,No Results Posted,"[""Fendler A, Shepherd STC, Au L, Wilkinson KA, Wu M, Byrne F, Cerrone M, Schmitt AM, Joharatnam-Hogan N, Shum B, Tippu Z, Rzeniewicz K, Boos LA, Harvey R, Carlyle E, Edmonds K, Del Rosario L, Sarker S, Lingard K, Mangwende M, Holt L, Ahmod H, Korteweg J, Foley T, Bazin J, Gordon W, Barber T, Emslie-Henry A, Xie W, Gerard CL, Deng D, Wall EC, Agua-Doce A, Namjou S, Caidan S, Gavrielides M, MacRae JI, Kelly G, Peat K, Kelly D, Murra A, Kelly K, O'Flaherty M, Dowdie L, Ash N, Gronthoud F, Shea RL, Gardner G, Murray D, Kinnaird F, Cui W, Pascual J, Rodney S, Mencel J, Curtis O, Stephenson C, Robinson A, Oza B, Farag S, Leslie I, Rogiers A, Iyengar S, Ethell M, Messiou C, Cunningham D, Chau I, Starling N, Turner N, Welsh L, van As N, Jones RL, Droney J, Banerjee S, Tatham KC, O'Brien M, Harrington K, Bhide S, Okines A, Reid A, Young K, Furness AJS, Pickering L, Swanton C; Crick COVID-19 Consortium, Gandhi S, Gamblin S, Bauer DLV, Kassiotis G, Kumar S, Yousaf N, Jhanji S, Nicholson E, Howell M, Walker S, Wilkinson RJ, Larkin J, Turajlic S; CAPTURE Consortium. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2021 Dec;2(12):1305-1320. doi: 10.1038/s43018-021-00274-w. Epub 2021 Oct 27."", ""Fendler A, Shepherd STC, Au L, Wilkinson KA, Wu M, Byrne F, Cerrone M, Schmitt AM, Joharatnam-Hogan N, Shum B, Tippu Z, Rzeniewicz K, Boos LA, Harvey R, Carlyle E, Edmonds K, Del Rosario L, Sarker S, Lingard K, Mangwende M, Holt L, Ahmod H, Korteweg J, Foley T, Bazin J, Gordon W, Barber T, Emslie-Henry A, Xie W, Gerard CL, Deng D, Wall EC, Agua-Doce A, Namjou S, Caidan S, Gavrielides M, MacRae JI, Kelly G, Peat K, Kelly D, Murra A, Kelly K, O'Flaherty M, Dowdie L, Ash N, Gronthoud F, Shea RL, Gardner G, Murray D, Kinnaird F, Cui W, Pascual J, Rodney S, Mencel J, Curtis O, Stephenson C, Robinson A, Oza B, Farag S, Leslie I, Rogiers A, Iyengar S, Ethell M, Messiou C, Cunningham D, Chau I, Starling N, Turner N, Welsh L, van As N, Jones RL, Droney J, Banerjee S, Tatham KC, O'Brien M, Harrington K, Bhide S, Okines A, Reid A, Young K, Furness AJS, Pickering L, Swanton C; Crick COVID19 consortium, Gandhi S, Gamblin S, Bauer DL, Kassiotis G, Kumar S, Yousaf N, Jhanji S, Nicholson E, Howell M, Walker S, Wilkinson RJ, Larkin J, Turajlic S. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study. Nat Cancer. 2021 Dec;2:1321-1337. doi: 10.1038/s43018-021-00274-w. Epub 2021 Oct 27."", ""Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O'Brien T, Larkin J, Horswell S, Stares M, Au L, Jamal-Hanjani M, Challacombe B, Chandra A, Hazell S, Eichler-Jonsson C, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Jabbar F, Spain L, Lall S, Guarch R, Falzon M, Proctor I, Pickering L, Gore M, Watkins TBK, Ward S, Stewart A, DiNatale R, Becerra MF, Reznik E, Hsieh JJ, Richmond TA, Mayhew GF, Hill SM, McNally CD, Jones C, Rosenbaum H, Stanislaw S, Burgess DL, Alexander NR, Swanton C; PEACE; TRACERx Renal Consortium. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12."", ""Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Gr√∂nroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12.""]",,2020-08-25,https://clinicaltrials.gov/show/NCT03226886,2023-09-01,0,1
2304,NCT03305341,"Active, not recruiting",2022-06-28,2022-07-28,No Results Posted,,,2021-12-06,https://clinicaltrials.gov/show/NCT03305341,2022-06-28,0,0
2305,NCT03348670,"Active, not recruiting",2022-03-28,2022-03-28,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT03348670,2022-03-28,0,0
2306,NCT03368911,Completed,2018-11-30,2018-11-30,No Results Posted,,,2019-02-28,,2018-11-30,0,0
2307,NCT03452774,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT03452774,2022-06-01,0,0
2308,NCT03527329,Completed,2018-05-01,2018-05-01,No Results Posted,,,2018-05-17,,2018-05-01,0,0
2309,NCT03630887,Completed,2018-10-31,2018-10-31,No Results Posted,"['Becerra √Å, Valencia L, Saavedra P, Rodr√≠guez-P√©rez A, Villar J. Effect of prewarming on body temperature in short-term bladder or prostatic transurethral resection under general anesthesia: A randomized, double-blind, controlled trial. Sci Rep. 2021 Oct 21;11(1):20762. doi: 10.1038/s41598-021-00350-2.']",,2020-06-11,,2018-10-31,0,1
2310,NCT03808922,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT03808922,2023-12-31,0,0
2311,NCT03907891,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT03907891,2023-05-01,0,0
2312,NCT04025580,Suspended,2025-12-31,2025-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04025580,2025-12-31,0,0
2313,NCT04107402,"Active, not recruiting",2021-03-15,2024-03-15,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04107402,2021-03-15,0,0
2314,NCT04148430,Recruiting,2023-10-01,2023-10-01,No Results Posted,"['Danish H, Santomasso BD. Neurotoxicity Biology and Management. Cancer J. 2021 Mar-Apr 01;27(2):126-133. doi: 10.1097/PPO.0000000000000507. Review.']",,2021-12-29,https://clinicaltrials.gov/show/NCT04148430,2023-10-01,0,1
2315,NCT04160975,Completed,2021-02-19,2021-02-19,Study Results,,,2021-06-29,https://clinicaltrials.gov/show/NCT04160975,2021-02-19,1,0
2316,NCT04177927,Completed,2020-07-01,2020-10-01,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04177927,2020-07-01,0,0
2317,NCT04233268,Recruiting,2023-02-28,2025-02-28,No Results Posted,"['Clark JA, Kean IRL, Curran MD, Khokhar F, White D, Daubney E, Conway Morris A, Navapurkar V, Bartholdson Scott J, Maes M, Bousfield R, Gouliouris T, Agrawal S, Inwald D, Zhang Z, T√∂r√∂k ME, Baker S, Pathan N. Rapid Assay for Sick Children with Acute Lung infection Study (RASCALS): diagnostic cohort study protocol. BMJ Open. 2021 Nov 29;11(11):e056197. doi: 10.1136/bmjopen-2021-056197.']",,2021-10-20,https://clinicaltrials.gov/show/NCT04233268,2023-02-28,0,1
2318,NCT04252820,Completed,2020-08-04,2020-08-04,No Results Posted,,,2020-08-06,,2020-08-04,0,0
2319,NCT04262921,Recruiting,2025-08-07,2025-08-07,No Results Posted,"['Gault N, Esposito-Far√®se M, Revest M, Inamo J, Cabi√© A, Polard √â, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lef√®vre B, Piroth L, De Montmollin E, Oziol E, Etienne M, Laou√©nan C, Rossignol P, Costagliola D, Vidal-Petiot E; French-Covid cohort investigators, study group. Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review. Fundam Clin Pharmacol. 2021 Dec;35(6):1141-1158. doi: 10.1111/fcp.12683. Epub 2021 May 16.', 'Buetti N, Wicky PH, Le Hingrat Q, Ruckly S, Mazzuchelli T, Loiodice A, Trimboli P, Forni Ogna V, de Montmollin E, Bernasconi E, Visseaux B, Timsit JF. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients. Crit Care. 2020 Oct 16;24(1):610. doi: 10.1186/s13054-020-03323-5.', 'Bouadma L, Wiedemann A, Patrier J, Sur√©naud M, Wicky PH, Foucat E, Diehl JL, Hejblum BP, Sinnah F, de Montmollin E, Lacabaratz C, Thi√©baut R, Timsit JF, L√©vy Y. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome. J Clin Immunol. 2020 Nov;40(8):1082-1092. doi: 10.1007/s10875-020-00839-x. Epub 2020 Aug 22.']",,2022-02-25,https://clinicaltrials.gov/show/NCT04262921,2025-08-07,0,1
2320,NCT04280913,Withdrawn,2020-03-31,2020-03-31,No Results Posted,,,2020-03-19,https://clinicaltrials.gov/show/NCT04280913,2020-03-31,0,0
2321,NCT04290858,Withdrawn,2021-03-01,2022-02-01,No Results Posted,,,2020-03-24,https://clinicaltrials.gov/show/NCT04290858,2021-03-01,0,0
2322,NCT04318431,Completed,2020-05-12,2020-06-01,No Results Posted,"['Cohen R, Jung C, Ouldali N, Sellam A, Batard C, Cahn-Sellem F, Elbez A, Wollner A, Romain O, Corrard F, Aberrane S, Soismier N, Creidy R, Smati-Lafarge M, Launay O, B√©chet S, Varon E, Levy C. Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: a cross-sectional study. BMJ Paediatr Open. 2020 Dec 29;4(1):e000887. doi: 10.1136/bmjpo-2020-000887. eCollection 2020.']",,2020-07-09,https://clinicaltrials.gov/show/NCT04318431,2020-05-12,0,1
2323,NCT04319172,Recruiting,2022-06-30,2022-12-31,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04319172,2022-06-30,0,0
2324,NCT04319731,Recruiting,2021-03-20,2021-03-20,No Results Posted,"['Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, Hatton ND, Phillips JD. A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes. 2021 Jan 22;14(1):32. doi: 10.1186/s13104-021-05443-9.']",,2020-04-17,https://clinicaltrials.gov/show/NCT04319731,2021-03-20,0,1
2325,NCT04322279,Unknown,2021-03-01,2021-06-01,No Results Posted,,,2020-05-22,https://clinicaltrials.gov/show/NCT04322279,2021-03-01,0,0
2326,NCT04334876,Completed,2020-11-01,2021-01-01,Study Results,,,2021-09-16,https://clinicaltrials.gov/show/NCT04334876,2020-11-01,1,0
2327,NCT04336748,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,,2020-04-07,https://clinicaltrials.gov/show/NCT04336748,2020-07-01,0,0
2328,NCT04338126,Withdrawn,2021-12-15,2021-12-31,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04338126,2021-12-15,0,0
2329,NCT04339686,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04339686,2020-09-01,0,0
2330,NCT04340557,Completed,2020-06-13,2020-06-13,Study Results,"['Geriak M, Haddad F, Kullar R, Greenwood KL, Habib M, Habib C, Willms D, Sakoulas G. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia. Infect Dis Ther. 2021 Sep;10(3):1323-1330. doi: 10.1007/s40121-021-00453-3. Epub 2021 May 11.']",,2021-05-26,https://clinicaltrials.gov/show/NCT04340557,2020-06-13,1,1
2331,NCT04344379,Completed,2020-06-18,2020-06-18,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04344379,2020-06-18,0,0
2332,NCT04344665,"Active, not recruiting",2020-10-28,2021-12-01,No Results Posted,"[""McGillion MH, Parlow J, Borges FK, Marcucci M, Jacka M, Adili A, Lalu MM, Ouellette C, Bird M, Ofori S, Roshanov PS, Patel A, Yang H, O'Leary S, Tandon V, Hamilton GM, Mrkobrada M, Conen D, Harvey V, Lounsbury J, Mian R, Bangdiwala SI, Arellano R, Scott T, Guyatt GH, Gao P, Graham M, Nenshi R, Forster AJ, Nagappa M, Levesque K, Marosi K, Chaudhry S, Haider S, Deuchar L, LeBlanc B, McCartney CJL, Schemitsch EH, Vincent J, Pettit SM, DuMerton D, Paulin AD, Simunovic M, Williams DC, Halman S, Harlock J, Meyer RM, Taylor DA, Shanthanna H, Schlachta CM, Parry N, Pichora DR, Yousuf H, Peter E, Lamy A, Petch J, Moloo H, Sehmbi H, Waggott M, Shelley J, Belley-Cote EP, Devereaux PJ; PVC-RAM-1 Investigators. Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomised controlled trial. BMJ. 2021 Sep 30;374:n2209. doi: 10.1136/bmj.n2209."", ""McGillion MH, Parlow J, Borges FK, Marcucci M, Jacka M, Adili A, Lalu MM, Yang H, Patel A, O'Leary S, Tandon V, Hamilton GM, Mrkobrada M, Ouellette C, Bird M, Ofori S, Conen D, Roshanov PS, Harvey V, Guyatt GH, Le Manach Y, Bangdiwala SI, Arellano R, Scott T, Lounsbury J, Taylor DA, Nenshi R, Forster AJ, Nagappa M, Lamy A, Peter E, Levesque K, Marosi K, Chaudhry S, Haider S, Deuchar L, LeBlanc B, McCartney CJL, Schemitsch EH, Vincent J, Pettit SM, Paul J, DuMerton D, Paulin AD, Simunovic M, Williams DC, Halman S, Schlachta CM, Shelley J, Harlock J, Meyer RM, Graham M, Shanthanna H, Parry N, Pichora DR, Yousef H, Moloo H, Sehmbi H, Waggott M, Belley-Cote EP, Whitlock R, Devereaux PJ; PVC-RAM Investigators. Post Discharge after Surgery Virtual Care with Remote Automated Monitoring Technology (PVC-RAM): protocol for a randomized controlled trial. CMAJ Open. 2021 Mar 2;9(1):E142-E148. doi: 10.9778/cmajo.20200176. Print 2021 Jan-Mar. Erratum in: CMAJ Open. 2021 Jun 18;9(2):E680.""]",,2021-07-23,https://clinicaltrials.gov/show/NCT04344665,2020-10-28,0,1
2333,NCT04344912,Recruiting,2020-06-01,2020-08-01,No Results Posted,,,2020-04-28,https://clinicaltrials.gov/show/NCT04344912,2020-06-01,0,0
2334,NCT04345991,Completed,2021-05-28,2021-05-28,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04345991,2021-05-28,0,0
2335,NCT04346602,Recruiting,2020-06-01,2020-12-01,No Results Posted,"['Yan B, Song L, Guo J, Wang Y, Peng L, Li D. Association Between Clinical Characteristics and Short-Term Outcomes in Adult Male COVID-19 Patients With Mild Clinical Symptoms: A Single-Center Observational Study. Front Med (Lausanne). 2021 Jan 5;7:571396. doi: 10.3389/fmed.2020.571396. eCollection 2020.']",,2020-04-15,https://clinicaltrials.gov/show/NCT04346602,2020-06-01,0,1
2336,NCT04347031,Completed,2020-11-01,2020-11-20,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04347031,2020-11-01,0,0
2337,NCT04349228,Withdrawn,2020-07-15,2020-07-15,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04349228,2020-07-15,0,0
2338,NCT04349540,"Active, not recruiting",2020-10-15,2021-01-15,No Results Posted,,,2020-04-16,https://clinicaltrials.gov/show/NCT04349540,2020-10-15,0,0
2339,NCT04349592,Completed,2020-08-14,2020-08-30,No Results Posted,"['Omrani AS, Pathan SA, Thomas SA, Harris TRE, Coyle PV, Thomas CE, Qureshi I, Bhutta ZA, Mawlawi NA, Kahlout RA, Elmalik A, Azad AM, Daghfal J, Mustafa M, Jeremijenko A, Soub HA, Khattab MA, Maslamani MA, Thomas SH. Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19. EClinicalMedicine. 2020 Dec;29:100645. doi: 10.1016/j.eclinm.2020.100645. Epub 2020 Nov 20.']",,2021-02-23,https://clinicaltrials.gov/show/NCT04349592,2020-08-14,0,1
2340,NCT04350710,Recruiting,2020-04-20,2020-12-31,No Results Posted,,,2020-04-17,https://clinicaltrials.gov/show/NCT04350710,2020-04-20,0,0
2341,NCT04350723,Completed,2021-07-17,2021-07-17,No Results Posted,"['Alhazzani W, Evans L, Alshamsi F, M√∏ller MH, Ostermann M, Prescott HC, Arabi YM, Loeb M, Ng Gong M, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Machado F, Wunsch H, Crowther M, Cecconi M, Koh Y, Burry L, Chertow DS, Szczeklik W, Belley-Cote E, Greco M, Bala M, Zarychanski R, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Nainan Myatra S, Arrington A, Kleinpell R, Citerio G, Lewis K, Bridges E, Memish ZA, Hammond N, Hayden FG, Alshahrani M, Al Duhailib Z, Martin GS, Kaplan LJ, Coopersmith CM, Antonelli M, Rhodes A. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med. 2021 Mar 1;49(3):e219-e234. doi: 10.1097/CCM.0000000000004899.']",,2021-10-15,https://clinicaltrials.gov/show/NCT04350723,2021-07-17,0,1
2342,NCT04351568,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,2020-06-02,https://clinicaltrials.gov/show/NCT04351568,2020-07-01,0,0
2343,NCT04351919,Withdrawn,2020-07-15,2020-07-15,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04351919,2020-07-15,0,0
2344,NCT04352556,Recruiting,2022-04-30,2022-04-30,No Results Posted,"['Visco C, Marcheselli L, Mina R, Sassone M, Guidetti A, Penna D, Cattaneo C, Bonuomo V, Busca A, Ferreri AJM, Bruna R, Petrucci L, Cairoli R, Salvini M, Bert√π L, Ladetto M, Pilerci S, Pinto A, Ramadan S, Marchesi F, Cavo M, Arcaini L, Coviello E, Romano A, Musto P, Massaia M, Fracchiolla N, Marchetti M, Scattolin A, Tisi MC, Cuneo A, Della Porta M, Trentin L, Turrini M, Gherlinzoni F, Tafuri A, Galimberti S, Bocchia M, Cardinali V, Cilloni D, Corso A, Armiento D, Rigacci L, La Barbera EO, Gambacorti-Passerini C, Visani G, Vallisa D, Venditti A, Selleri C, Conconi A, Tosi P, Lanza F, Candoni A, Krampera M, Corradini P, Passamonti F, Merli F; ITA-HEMA-COV investigators. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.', 'Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bert√π L, Corrao G, Pagano L, Corradini P; ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.']",,2021-05-18,https://clinicaltrials.gov/show/NCT04352556,2022-04-30,0,1
2345,NCT04353245,Not yet recruiting,2021-09-30,2021-09-30,No Results Posted,,,2020-04-20,https://clinicaltrials.gov/show/NCT04353245,2021-09-30,0,0
2346,NCT04353401,Enrolling by invitation,2022-04-01,2022-05-01,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04353401,2022-04-01,0,0
2347,NCT04353531,Completed,2020-08-30,2020-08-30,No Results Posted,"['Li J, Jing G, Fink JB, Porszasz J, Moran EM, Kiourkas RD, McLaughlin R, Vines DL, Dhand R. Airborne Particulate Concentrations During and After Pulmonary Function Testing. Chest. 2021 Apr;159(4):1570-1574. doi: 10.1016/j.chest.2020.10.064. Epub 2020 Nov 1.']",,2021-04-23,https://clinicaltrials.gov/show/NCT04353531,2020-08-30,0,1
2348,NCT04354779,Completed,2020-08-23,2020-09-28,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04354779,2020-08-23,0,0
2349,NCT04356144,Completed,2021-02-01,2021-02-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04356144,2021-02-01,0,0
2350,NCT04357977,Not yet recruiting,2020-08-01,2020-12-01,No Results Posted,,,2020-04-22,https://clinicaltrials.gov/show/NCT04357977,2020-08-01,0,0
2351,NCT04358952,Completed,2021-04-02,2021-04-02,No Results Posted,"['Lairez O, Blanchard V, Balardy L, Vardon-Bounes F, Cazalbou S, Ruiz S, Collot S, Houard V, Rolland Y, Conil JM, Minville V. COCARDE Study-Cardiac Imaging Phenotype in Patients With COVID-19: Protocol for a Prospective Observational Study. JMIR Res Protoc. 2022 Jan 6;11(1):e24931. doi: 10.2196/24931.']",,2021-06-01,https://clinicaltrials.gov/show/NCT04358952,2021-04-02,0,1
2352,NCT04359303,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04359303,2020-11-01,0,0
2353,NCT04359862,Terminated,2021-03-31,2021-03-31,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04359862,2021-03-31,0,0
2354,NCT04360707,Recruiting,2021-04-08,2021-04-08,No Results Posted,,,2020-05-05,https://clinicaltrials.gov/show/NCT04360707,2021-04-08,0,0
2355,NCT04363177,Not yet recruiting,2023-07-01,2024-12-01,No Results Posted,"['Schwank SE, Chung HF, Hsu M, Fu SC, Du L, Zhu L, Huang HY, Andersson E, Acharya G. Mental health of Urban Mothers (MUM) study: a multicentre randomised controlled trial, study protocol. BMJ Open. 2020 Nov 27;10(11):e041133. doi: 10.1136/bmjopen-2020-041133.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04363177,2023-07-01,0,1
2356,NCT04363229,Not yet recruiting,2021-05-01,2021-06-01,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04363229,2021-05-01,0,0
2357,NCT04366219,Recruiting,2022-06-01,2022-08-28,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04366219,2022-06-01,0,0
2358,NCT04367168,Recruiting,2021-04-27,2021-04-27,No Results Posted,"['Absal√≥n-Aguilar A, Rull-Gabayet M, P√©rez-Fragoso A, Mej√≠a-Dom√≠nguez NR, N√∫√±ez-√Ålvarez C, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J, Ponce-de-Le√≥n A, Gonz√°lez-Lara F, Mart√≠n-Nares E, Montesinos-Ram√≠rez S, Ram√≠rez-Alem√≥n M, Ram√≠rez-Rangel P, M√°rquez MF, Plata-Corona JC, Ju√°rez-Vega G, G√≥mez-Mart√≠n D, Torres-Ruiz J. Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID). J Gen Intern Med. 2022 Jan;37(1):4-14. doi: 10.1007/s11606-021-07203-8. Epub 2021 Nov 9.']",,2020-05-28,https://clinicaltrials.gov/show/NCT04367168,2021-04-27,0,1
2359,NCT04367883,Recruiting,2022-09-30,2023-08-31,No Results Posted,,"['Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.']",2022-03-10,https://clinicaltrials.gov/show/NCT04367883,2022-09-30,0,1
2360,NCT04368026,Completed,2020-12-01,2020-12-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04368026,2020-12-01,0,0
2361,NCT04368793,Recruiting,2020-12-31,2021-12-31,No Results Posted,"['Lei J, Yang L, Wen G, Qumu S, Ren X, Yang T. Pulmonary telerehabilitation and efficacy among discharged COVID-19 patients: Rational and design of a prospective real-world study. Clin Respir J. 2021 Nov;15(11):1158-1167. doi: 10.1111/crj.13422. Epub 2021 Aug 6.']",,2020-07-17,https://clinicaltrials.gov/show/NCT04368793,2020-12-31,0,1
2362,NCT04368832,Completed,2020-11-17,2020-11-17,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04368832,2020-11-17,0,0
2363,NCT04371107,Not yet recruiting,2020-06-01,2020-07-01,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04371107,2020-06-01,0,0
2364,NCT04375410,Completed,2020-04-30,2020-05-10,No Results Posted,"['Borch L, Thorsteinsson K, Warner TC, Mikkelsen CS, Bjerring P, Lundbye-Christensen S, Arvesen K, Hagstroem S. COVID-19 reopening causes high risk of irritant contact dermatitis in children. Dan Med J. 2020 Aug 6;67(9). pii: A05200357.']",,2021-04-01,https://clinicaltrials.gov/show/NCT04375410,2020-04-30,0,1
2365,NCT04375670,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04375670,2020-12-31,0,0
2366,NCT04376034,Recruiting,2021-03-30,2021-03-30,No Results Posted,,,2020-05-06,https://clinicaltrials.gov/show/NCT04376034,2021-03-30,0,0
2367,NCT04376840,Recruiting,2022-01-28,2022-10-28,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04376840,2022-01-28,0,0
2368,NCT04377165,Terminated,2020-08-26,2020-08-26,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04377165,2020-08-26,0,0
2369,NCT04378738,Enrolling by invitation,2020-05-07,2020-05-08,No Results Posted,,"['Khoong EC, Rivadeneira NA, Hiatt RA, Sarkar U. The Use of Technology for Communicating With Clinicians or Seeking Health Information in a Multilingual Urban Cohort: Cross-Sectional Survey. J Med Internet Res. 2020 Apr 6;22(4):e16951. doi: 10.2196/16951.']",2020-05-07,https://clinicaltrials.gov/show/NCT04378738,2020-05-07,0,1
2370,NCT04379284,Completed,2021-10-01,2021-10-01,No Results Posted,,,2021-10-22,https://clinicaltrials.gov/show/NCT04379284,2021-10-01,0,0
2371,NCT04380662,Not yet recruiting,2020-09-30,2020-12-30,No Results Posted,,,2020-06-22,https://clinicaltrials.gov/show/NCT04380662,2020-09-30,0,0
2372,NCT04368728,Recruiting,2024-02-08,2024-02-08,No Results Posted,"['Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, T√ºreci √ñ, ≈ûahin U, Xu X, Koury K, Dychter SS, Lu C, Gentile TC, Gruber WC. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine. 2022 Mar 1;40(10):1483-1492. doi: 10.1016/j.vaccine.2021.12.046. Epub 2021 Dec 24.', 'Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Polack FP, Zerbini C, Bailey R, Swanson KA, Xu X, Roychoudhury S, Koury K, Bouguermouh S, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Yang Q, Liberator P, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Gruber WC, Jansen KU; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.', 'Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, Cooper D, Jennings T, Brandon DM, Thomas SJ, T√ºreci √ñ, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.', 'Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, G√ºler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, S√§nger B, Wallisch AK, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Schille S, Kr√∂ner C, de la Caridad G√ºimil Garcia R, Hiller T, Fischer L, Sellers RS, Choudhary S, Gonzalez O, Vascotto F, Gutman MR, Fontenot JA, Hall-Ursone S, Brasky K, Griffor MC, Han S, Su AAH, Lees JA, Nedoma NL, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi PY, Klamp T, Rosenbaum C, Kuhn AN, T√ºreci √ñ, Dormitzer PR, Jansen KU, Sahin U. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. doi: 10.1038/s41586-021-03275-y. Epub 2021 Feb 1.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, ≈ûahin U, Gruber WC. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.', 'Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, T√ºreci √ñ, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, ≈ûahin U, Jansen KU. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020 Oct;586(7830):589-593. doi: 10.1038/s41586-020-2639-4. Epub 2020 Aug 12. Erratum in: Nature. 2021 Feb;590(7844):E26.']",,2022-03-28,https://clinicaltrials.gov/show/NCT04368728,2024-02-08,0,1
2373,NCT04380701,"Active, not recruiting",2023-04-01,2023-04-01,No Results Posted,"['Vogel AB, Kanevsky I, Che Y, Swanson KA, Muik A, Vormehr M, Kranz LM, Walzer KC, Hein S, G√ºler A, Loschko J, Maddur MS, Ota-Setlik A, Tompkins K, Cole J, Lui BG, Ziegenhals T, Plaschke A, Eisel D, Dany SC, Fesser S, Erbar S, Bates F, Schneider D, Jesionek B, S√§nger B, Wallisch AK, Feuchter Y, Junginger H, Krumm SA, Heinen AP, Adams-Quack P, Schlereth J, Schille S, Kr√∂ner C, de la Caridad G√ºimil Garcia R, Hiller T, Fischer L, Sellers RS, Choudhary S, Gonzalez O, Vascotto F, Gutman MR, Fontenot JA, Hall-Ursone S, Brasky K, Griffor MC, Han S, Su AAH, Lees JA, Nedoma NL, Mashalidis EH, Sahasrabudhe PV, Tan CY, Pavliakova D, Singh G, Fontes-Garfias C, Pride M, Scully IL, Ciolino T, Obregon J, Gazi M, Carrion R Jr, Alfson KJ, Kalina WV, Kaushal D, Shi PY, Klamp T, Rosenbaum C, Kuhn AN, T√ºreci √ñ, Dormitzer PR, Jansen KU, Sahin U. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 Apr;592(7853):283-289. doi: 10.1038/s41586-021-03275-y. Epub 2021 Feb 1.']",,2022-01-13,https://clinicaltrials.gov/show/NCT04380701,2023-04-01,0,1
2374,NCT04381845,Not yet recruiting,2021-03-10,2021-03-10,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04381845,2021-03-10,0,0
2375,NCT04382508,Unknown,2021-03-21,2021-03-21,No Results Posted,"['Shaunak M, Patel R, Driessens C, Mills L, Leahy A, Gbesemete D, Owens DR, Lucas JS, Faust SN, de Graaf H; ImmunoCOVID19 study group. COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open. 2021 Mar 17;11(3):e044899. doi: 10.1136/bmjopen-2020-044899.']",,2020-05-20,https://clinicaltrials.gov/show/NCT04382508,2021-03-21,0,1
2376,NCT04383548,Not yet recruiting,2020-12-01,2021-01-01,No Results Posted,,,2020-05-12,https://clinicaltrials.gov/show/NCT04383548,2020-12-01,0,0
2377,NCT04383717,Not yet recruiting,2020-08-30,2020-10-30,No Results Posted,,,2020-05-13,https://clinicaltrials.gov/show/NCT04383717,2020-08-30,0,0
2378,NCT04384705,"Active, not recruiting",2022-06-01,2022-07-01,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04384705,2022-06-01,0,0
2379,NCT04385810,Completed,2020-07-29,2020-07-29,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04385810,2020-07-29,0,0
2380,NCT04386668,Terminated,2020-07-12,2020-08-31,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04386668,2020-07-12,0,0
2381,NCT04387253,Recruiting,2022-07-25,2022-07-25,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04387253,2022-07-25,0,0
2382,NCT04392115,Not yet recruiting,2020-12-15,2021-09-15,No Results Posted,,,2020-05-18,https://clinicaltrials.gov/show/NCT04392115,2020-12-15,0,0
2383,NCT04393077,Completed,2020-05-15,2020-05-20,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04393077,2020-05-15,0,0
2384,NCT04393649,Recruiting,2022-04-19,2022-04-19,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04393649,2022-04-19,0,0
2385,NCT04395430,"Active, not recruiting",2022-04-01,2022-10-01,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04395430,2022-04-01,0,0
2386,NCT04395599,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04395599,2022-11-01,0,0
2387,NCT04397471,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04397471,2021-12-01,0,0
2388,NCT04398043,Not yet recruiting,2020-06-30,2020-07-30,No Results Posted,,,2020-05-21,https://clinicaltrials.gov/show/NCT04398043,2020-06-30,0,0
2389,NCT04400019,Not yet recruiting,2020-12-15,2021-04-01,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04400019,2020-12-15,0,0
2390,NCT04401033,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04401033,2020-06-30,0,0
2391,NCT04401163,Not yet recruiting,2021-12-01,2022-12-01,No Results Posted,,,2020-05-26,https://clinicaltrials.gov/show/NCT04401163,2021-12-01,0,0
2392,NCT04404608,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,2020-05-27,https://clinicaltrials.gov/show/NCT04404608,2021-06-01,0,0
2393,NCT04405232,Recruiting,2021-04-25,2021-06-25,No Results Posted,,,2020-07-31,https://clinicaltrials.gov/show/NCT04405232,2021-04-25,0,0
2394,NCT04405284,Completed,2020-06-30,2020-07-01,No Results Posted,,,2020-11-23,https://clinicaltrials.gov/show/NCT04405284,2020-06-30,0,0
2395,NCT04405726,Recruiting,2022-03-01,2022-03-01,No Results Posted,"['Gallais F, Velay A, Nazon C, Wendling MJ, Partisani M, Sibilia J, Candon S, Fafi-Kremer S. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. Emerg Infect Dis. 2021 Jan;27(1). doi: 10.3201/eid2701.203611. Epub 2020 Dec 1.']",,2020-06-25,https://clinicaltrials.gov/show/NCT04405726,2022-03-01,0,1
2396,NCT04406558,Recruiting,2021-03-01,2021-04-01,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04406558,2021-03-01,0,0
2397,NCT04407156,Completed,2020-06-07,2020-07-20,Results Submitted,"['Kolhe NV, Fluck RJ, Selby NM, Taal MW. Acute kidney injury associated with COVID-19: A retrospective cohort study. PLoS Med. 2020 Oct 30;17(10):e1003406. doi: 10.1371/journal.pmed.1003406. eCollection 2020 Oct.']",,2020-09-09,https://clinicaltrials.gov/show/NCT04407156,2020-06-07,0,1
2398,NCT04414657,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04414657,2022-04-30,0,0
2399,NCT04416893,Withdrawn,2021-01-01,2021-04-01,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04416893,2021-01-01,0,0
2400,NCT04419064,Completed,2020-05-20,2020-05-30,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04419064,2020-05-20,0,0
2401,NCT04419545,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,2020-06-05,https://clinicaltrials.gov/show/NCT04419545,2020-12-31,0,0
2402,NCT04421612,Completed,2021-01-01,2021-01-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04421612,2021-01-01,0,0
2403,NCT04422444,"Active, not recruiting",2021-06-30,2022-06-01,No Results Posted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04422444,2021-06-30,0,0
2404,NCT04422977,Not yet recruiting,2020-06-30,2020-06-30,No Results Posted,"['Vivier E, Pariset C, Rio S, Armand S, Doroszewski F, Richard D, Chardon M, Romero G, Metral P, Pecquet M, Didelot A. Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital. Ann Intensive Care. 2021 May 13;11(1):75. doi: 10.1186/s13613-021-00868-8.']",,2020-06-09,https://clinicaltrials.gov/show/NCT04422977,2020-06-30,0,1
2405,NCT04424056,Not yet recruiting,2022-09-30,2022-11-01,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04424056,2022-09-30,0,0
2406,NCT04427254,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04427254,2023-01-01,0,0
2407,NCT04427813,Not yet recruiting,2020-07-05,2020-07-12,No Results Posted,,,2020-06-11,https://clinicaltrials.gov/show/NCT04427813,2020-07-05,0,0
2408,NCT04429594,Recruiting,2025-07-15,2025-12-31,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04429594,2025-07-15,0,0
2409,NCT04432350,Enrolling by invitation,2023-06-11,2023-11-11,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04432350,2023-06-11,0,0
2410,NCT04433988,Not yet recruiting,2022-12-30,2022-12-30,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04433988,2022-12-30,0,0
2411,NCT04434014,Recruiting,2020-06-18,2020-06-28,No Results Posted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04434014,2020-06-18,0,0
2412,NCT04434144,Completed,2020-06-05,2020-06-05,Results Submitted,,,2020-06-16,https://clinicaltrials.gov/show/NCT04434144,2020-06-05,0,0
2413,NCT04435522,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04435522,2020-12-31,0,0
2414,NCT04439825,Completed,2020-09-03,2020-12-01,Results Submitted,,"['Dayan SH. Mind, Mood, and Aesthetics. Aesthet Surg J. 2015 Aug;35(6):759-61. doi: 10.1093/asj/sjv032. Epub 2015 Jun 4.']",2021-03-15,https://clinicaltrials.gov/show/NCT04439825,2020-09-03,0,1
2415,NCT04441476,Completed,2020-12-21,2020-12-21,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04441476,2020-12-21,0,0
2416,NCT04443712,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,2020-06-23,https://clinicaltrials.gov/show/NCT04443712,2021-06-01,0,0
2417,NCT04444297,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04444297,2021-12-31,0,0
2418,NCT04444323,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04444323,2022-03-31,0,0
2419,NCT04447781,Recruiting,2022-02-22,2022-02-22,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04447781,2022-02-22,0,0
2420,NCT04447833,"Active, not recruiting",2021-01-30,2025-06-30,No Results Posted,,,2021-03-04,https://clinicaltrials.gov/show/NCT04447833,2021-01-30,0,0
2421,NCT04449588,Recruiting,2022-01-01,2022-08-07,No Results Posted,,,2022-01-03,https://clinicaltrials.gov/show/NCT04449588,2022-01-01,0,0
2422,NCT04449627,Not yet recruiting,2020-10-31,2021-01-31,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04449627,2020-10-31,0,0
2423,NCT04449718,Completed,2020-10-07,2020-10-07,No Results Posted,"['Fernandes AL, Murai IH, Reis BZ, Sales LP, Santos MD, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, Baggio J, Balbi GGM, Antonangelo L, Caparbo VF, Gualano B, Pereira RMR. Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19. Am J Clin Nutr. 2022 Mar 4;115(3):790-798. doi: 10.1093/ajcn/nqab426.', 'Murai IH, Fernandes AL, Antonangelo L, Gualano B, Pereira RMR. Effect of a Single High-Dose Vitamin D3 on the Length of Hospital Stay of Severely 25-Hydroxyvitamin D-Deficient Patients with COVID-19. Clinics (Sao Paulo). 2021 Nov 26;76:e3549. doi: 10.6061/clinics/2021/e3549. eCollection 2021.', 'Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.', 'Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, Baggio J, Balbi GGM, Reis BZ, Antonangelo L, Caparbo VF, Gualano B, Pereira RMR. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.']",,2020-11-17,https://clinicaltrials.gov/show/NCT04449718,2020-10-07,0,1
2424,NCT04449731,Completed,2021-06-30,2021-06-30,No Results Posted,,"['Rodr√≠guez-P√©rez C, Molina-Montes E, Verardo V, Artacho R, Garc√≠a-Villanova B, Guerra-Hern√°ndez EJ, Ru√≠z-L√≥pez MD. Changes in Dietary Behaviours during the COVID-19 Outbreak Confinement in the Spanish COVIDiet Study. Nutrients. 2020 Jun 10;12(6). pii: E1730. doi: 10.3390/nu12061730.', 'Kriaucioniene V, Bagdonaviciene L, Rodr√≠guez-P√©rez C, Petkeviciene J. Associations between Changes in Health Behaviours and Body Weight during the COVID-19 Quarantine in Lithuania: The Lithuanian COVIDiet Study. Nutrients. 2020 Oct 13;12(10). pii: E3119. doi: 10.3390/nu12103119.', 'Giacalone D, Fr√∏st MB, Rodr√≠guez-P√©rez C. Reported Changes in Dietary Habits During the COVID-19 Lockdown in the Danish Population: The Danish COVIDiet Study. Front Nutr. 2020 Dec 8;7:592112. doi: 10.3389/fnut.2020.592112. eCollection 2020.']",2021-09-29,https://clinicaltrials.gov/show/NCT04449731,2021-06-30,0,1
2425,NCT04449783,Recruiting,2020-08-25,2020-09-25,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04449783,2020-08-25,0,0
2426,NCT04449965,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,2020-06-29,https://clinicaltrials.gov/show/NCT04449965,2020-11-01,0,0
2427,NCT04449978,Recruiting,2022-06-30,2022-12-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04449978,2022-06-30,0,0
2428,NCT04450004,"Active, not recruiting",2021-09-20,2021-12-31,No Results Posted,"[""Ward BJ, Gobeil P, S√©guin A, Atkins J, Boulay I, Charbonneau PY, Couture M, D'Aoust MA, Dhaliwall J, Finkle C, Hager K, Mahmood A, Makarkov A, Cheng MP, Pillet S, Schimke P, St-Martin S, Tr√©panier S, Landry N. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med. 2021 Jun;27(6):1071-1078. doi: 10.1038/s41591-021-01370-1. Epub 2021 May 18.""]",,2020-10-23,https://clinicaltrials.gov/show/NCT04450004,2021-09-20,0,1
2429,NCT04450017,Completed,2020-06-30,2020-06-30,No Results Posted,"['Bychinin MV, Klypa TV, Mandel IA, Andreichenko SA, Baklaushev VP, Yusubalieva GM, Kolyshkina NA, Troitsky AV. Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes. J Nutr. 2021 Aug 7;151(8):2199-2205. doi: 10.1093/jn/nxab107.']",,2021-05-20,https://clinicaltrials.gov/show/NCT04450017,2020-06-30,0,1
2430,NCT04450277,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04450277,2020-05-31,0,0
2431,NCT04451174,Terminated,2021-01-30,2021-01-30,No Results Posted,"['Salinas M, Andino P, Palma L, Valencia J, Figueroa E, Ortega J. Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 26;22(1):92. doi: 10.1186/s13063-021-05046-6.']",,2021-06-03,https://clinicaltrials.gov/show/NCT04451174,2021-01-30,0,1
2432,NCT04451239,Not yet recruiting,2020-07-01,2020-07-01,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04451239,2020-07-01,0,0
2433,NCT04451291,"Active, not recruiting",2021-09-25,2022-03-25,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04451291,2021-09-25,0,0
2434,NCT04451317,Completed,2020-12-31,2020-12-31,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04451317,2020-12-31,0,0
2435,NCT04451577,Recruiting,2021-06-01,2023-06-01,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04451577,2021-06-01,0,0
2436,NCT04451694,Recruiting,2020-07-30,2020-11-30,No Results Posted,"['Quilliot D, G√©rard M, Bonsack O, Malgras A, Vaillant MF, Di Patrizio P, Jaussaud R, Ziegler O, Nguyen-Thi PL. Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors. BMJ Open. 2021 Jul 14;11(7):e048948. doi: 10.1136/bmjopen-2021-048948.']",,2020-06-30,https://clinicaltrials.gov/show/NCT04451694,2020-07-30,0,1
2437,NCT04451889,Recruiting,2021-07-01,2021-09-01,No Results Posted,,,2020-07-24,https://clinicaltrials.gov/show/NCT04451889,2021-07-01,0,0
2438,NCT04451902,Recruiting,2022-04-30,2022-12-31,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04451902,2022-04-30,0,0
2439,NCT04451993,Completed,2020-09-01,2020-09-30,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04451993,2020-09-01,0,0
2440,NCT04452097,Not yet recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04452097,2022-03-31,0,0
2441,NCT04452422,Completed,2020-09-23,2020-09-23,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04452422,2020-09-23,0,0
2442,NCT04452435,Completed,2020-10-13,2020-10-13,Study Results,,,2021-06-23,https://clinicaltrials.gov/show/NCT04452435,2020-10-13,1,0
2443,NCT04452474,Withdrawn,2020-11-16,2021-01-29,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04452474,2020-11-16,0,0
2444,NCT04452487,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04452487,2021-06-01,0,0
2445,NCT04452565,Recruiting,2023-12-15,2023-12-15,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04452565,2023-12-15,0,0
2446,NCT04452604,Recruiting,2023-08-01,2023-12-01,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04452604,2023-08-01,0,0
2447,NCT04452617,Completed,2020-04-08,2020-07-01,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04452617,2020-04-08,0,0
2448,NCT04452630,Recruiting,2020-07-23,2021-11-30,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04452630,2020-07-23,0,0
2449,NCT04452643,Withdrawn,2021-12-01,2021-12-01,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04452643,2021-12-01,0,0
2450,NCT04452669,Completed,2021-06-29,2021-06-29,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04452669,2021-06-29,0,0
2451,NCT04452682,Completed,2020-06-21,2020-06-21,No Results Posted,,,2020-06-30,https://clinicaltrials.gov/show/NCT04452682,2020-06-21,0,0
2452,NCT04452695,Completed,2020-08-03,2020-08-10,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04452695,2020-08-03,0,0
2453,NCT04452708,Recruiting,2021-12-10,2021-12-10,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04452708,2021-12-10,0,0
2454,NCT04452773,Recruiting,2020-09-01,2021-12-01,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04452773,2020-09-01,0,0
2455,NCT04452799,Not yet recruiting,2020-10-01,2020-10-30,No Results Posted,,"['Haggag YA, El-Ashmawy NE, Okasha KM. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Med Hypotheses. 2020 Nov;144:109957. doi: 10.1016/j.mehy.2020.109957. Epub 2020 Jun 6.']",2020-06-30,https://clinicaltrials.gov/show/NCT04452799,2020-10-01,0,1
2456,NCT04452812,Not yet recruiting,2021-03-01,2021-04-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04452812,2021-03-01,0,0
2457,NCT04452942,Not yet recruiting,2020-09-01,2021-04-01,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04452942,2020-09-01,0,0
2458,NCT04453280,Completed,2020-06-03,2020-06-03,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04453280,2020-06-03,0,0
2459,NCT04453371,Withdrawn,2021-01-15,2021-02-15,No Results Posted,,,2021-03-12,https://clinicaltrials.gov/show/NCT04453371,2021-01-15,0,0
2460,NCT04453475,Recruiting,2022-12-31,2022-12-31,No Results Posted,,"['Keller FM, Dahmen A, Derksen C, K√∂tting L, Lippke S. Psychosomatic Rehabilitation Patients and the General Population During COVID-19: Online Cross-sectional and Longitudinal Study of Digital Trainings and Rehabilitation Effects. JMIR Ment Health. 2021 Aug 26;8(8):e30610. doi: 10.2196/30610.', 'Keller FM, Dahmen A, Derksen C, K√∂tting L, Lippke S. Implementing Digital Trainings within Medical Rehabilitations: Improvement of Mental Health and Synergetic Outcomes with Healthcare Service. Int J Environ Res Public Health. 2021 Aug 25;18(17). pii: 8936. doi: 10.3390/ijerph18178936.', 'Dahmen A, Keller F, K√∂tting L, Derksen C, Lippke S. [Fear of Coronavirus, Intention to Follow the AHA Rules and Risk Perception Regarding Visits to the Doctor: Cross-sectional Study with Patients suffering from Pre-existing Mental Illness]. Gesundheitswesen. 2021 Apr;83(4):274-281. doi: 10.1055/a-1397-7214. Epub 2021 Apr 8. German.', 'Dahmen A, Keller FM, Derksen C, K√∂tting L, Lippke S. [Which Digital Services do Psychosomatic Rehabilitation Patients Use During the Corona Pandemic and do Interrelations with Anxiety and Depressive Symptoms Exist?]. Psychother Psychosom Med Psychol. 2021 Dec;71(12):508-514. doi: 10.1055/a-1503-5548. Epub 2021 Sep 20. German.']",2022-03-31,https://clinicaltrials.gov/show/NCT04453475,2022-12-31,0,1
2461,NCT04453488,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04453488,2020-12-01,0,0
2462,NCT04453501,Completed,2020-04-25,2020-04-25,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04453501,2020-04-25,0,0
2463,NCT04453514,Completed,2021-06-19,2021-06-19,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04453514,2021-06-19,0,0
2464,NCT04453527,Recruiting,2021-05-01,2021-09-01,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04453527,2021-05-01,0,0
2465,NCT04453540,Not yet recruiting,2020-08-30,2020-08-30,No Results Posted,"['Novy E, Goury A, Thivilier C, Guillard T, Alauzet C. Algorithm for rational use of Film Array Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients. Diagn Microbiol Infect Dis. 2021 Nov;101(3):115507. doi: 10.1016/j.diagmicrobio.2021.115507. Epub 2021 Jul 23.']",,2020-07-01,https://clinicaltrials.gov/show/NCT04453540,2020-08-30,0,1
2466,NCT04453553,Not yet recruiting,2020-08-28,2020-09-28,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04453553,2020-08-28,0,0
2467,NCT04453566,Completed,2020-08-15,2020-08-24,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04453566,2020-08-15,0,0
2468,NCT04453579,Completed,2020-05-04,2020-05-30,No Results Posted,,"['Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.', 'Sockalingam S, Leung SE, Cassin SE. The Impact of Coronavirus Disease 2019 on Bariatric Surgery: Redefining Psychosocial Care. Obesity (Silver Spring). 2020 Jun;28(6):1010-1012. doi: 10.1002/oby.22836.']",2020-07-01,https://clinicaltrials.gov/show/NCT04453579,2020-05-04,0,1
2469,NCT04453657,Enrolling by invitation,2022-09-01,2022-09-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04453657,2022-09-01,0,0
2470,NCT04453670,Completed,2020-05-11,2020-05-15,No Results Posted,,,2020-07-01,https://clinicaltrials.gov/show/NCT04453670,2020-05-11,0,0
2471,NCT04453748,Enrolling by invitation,2021-10-31,2021-11-30,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04453748,2021-10-31,0,0
2472,NCT04453774,Recruiting,2022-02-01,2023-04-01,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04453774,2022-02-01,0,0
2473,NCT04453852,Completed,2021-02-01,2021-04-14,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04453852,2021-02-01,0,0
2474,NCT04453891,Not yet recruiting,2021-12-15,2021-12-15,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04453891,2021-12-15,0,0
2475,NCT04453969,Recruiting,2021-09-30,2022-03-30,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04453969,2021-09-30,0,0
2476,NCT04453982,Recruiting,2021-09-30,2022-03-30,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04453982,2021-09-30,0,0
2477,NCT04454307,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04454307,2020-08-01,0,0
2478,NCT04454333,Completed,2020-06-18,2020-06-20,No Results Posted,"['≈ûahin T, Ayyildiz A, Gencer-Atalay K, Akg√ºn C, √ñzdemir HM, Kuran B. Pain Symptoms in COVID-19. Am J Phys Med Rehabil. 2021 Apr 1;100(4):307-312. doi: 10.1097/PHM.0000000000001699.']",,2020-07-01,https://clinicaltrials.gov/show/NCT04454333,2020-06-18,0,1
2479,NCT04454372,Completed,2020-09-20,2020-11-30,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum in: JAMA. 2020 May 26;323(20):2098.', 'Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.']",2022-03-29,https://clinicaltrials.gov/show/NCT04454372,2020-09-20,0,1
2480,NCT04454398,Withdrawn,2021-01-01,2021-01-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-01-08,https://clinicaltrials.gov/show/NCT04454398,2021-01-01,0,1
2481,NCT04454606,Completed,2020-05-15,2020-05-31,No Results Posted,,"['Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, Yen HL, Li Y, Ip DKM, Peiris JSM, Seto WH, Leung GM, Milton DK, Cowling BJ. Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020 Jun;26(6):981. doi: 10.1038/s41591-020-0946-9.']",2020-07-01,https://clinicaltrials.gov/show/NCT04454606,2020-05-15,0,1
2482,NCT04455243,Not yet recruiting,2021-08-30,2021-08-30,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04455243,2021-08-30,0,0
2483,NCT04455308,Completed,2020-10-19,2020-10-19,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04455308,2020-10-19,0,0
2484,NCT04455347,Recruiting,2022-06-01,2022-06-01,No Results Posted,"['Aeschlimann FA, Misra N, Hussein T, Panaioli E, Soslow JH, Crum K, Steele JM, Huber S, Marcora S, Brambilla P, Jain S, Navallas M, Giuli V, R√ºcker B, Angst F, Patel MD, Azarine A, Caro-Dom√≠nguez P, Cavaliere A, Di Salvo G, Ferroni F, Agnoletti G, Bonnemains L, Martins D, Boddaert N, Wong J, Pushparajah K, Raimondi F. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson. 2021 Dec 30;23(1):140. doi: 10.1186/s12968-021-00841-1.']",,2021-09-16,https://clinicaltrials.gov/show/NCT04455347,2022-06-01,0,1
2485,NCT04455360,Completed,2021-09-20,2021-09-20,No Results Posted,"['Bates A, Rushbrook S, Shapiro E, Grocott M, Cusack R. CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 17;21(1):929. doi: 10.1186/s13063-020-04805-1.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04455360,2021-09-20,0,1
2486,NCT04455451,Completed,2021-08-15,2021-09-30,No Results Posted,"['Magunia H, Lederer S, Verbuecheln R, Gilot BJ, Koeppen M, Haeberle HA, Mirakaj V, Hofmann P, Marx G, Bickenbach J, Nohe B, Lay M, Spies C, Edel A, Schiefenh√∂vel F, Rahmel T, Putensen C, Sellmann T, Koch T, Brandenburger T, Kindgen-Milles D, Brenner T, Berger M, Zacharowski K, Adam E, Posch M, Moerer O, Scheer CS, Sedding D, Weigand MA, Fichtner F, Nau C, Pr√§tsch F, Wiesmann T, Koch C, Schneider G, Lahmer T, Straub A, Meiser A, Weiss M, Jungwirth B, Wappler F, Meybohm P, Herrmann J, Malek N, Kohlbacher O, Biergans S, Rosenberger P. Machine learning identifies ICU outcome predictors in a multicenter COVID-19 cohort. Crit Care. 2021 Aug 17;25(1):295. doi: 10.1186/s13054-021-03720-4.']",,2022-01-12,https://clinicaltrials.gov/show/NCT04455451,2021-08-15,0,1
2487,NCT04455958,Withdrawn,2021-11-01,2021-11-01,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04455958,2021-11-01,0,0
2488,NCT04456010,Completed,2020-07-30,2020-07-30,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04456010,2020-07-30,0,0
2489,NCT04456036,Recruiting,2020-12-31,2021-06-30,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04456036,2020-12-31,0,0
2490,NCT04456049,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04456049,2021-12-01,0,0
2491,NCT04456062,"Active, not recruiting",2021-07-20,2021-07-31,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04456062,2021-07-20,0,0
2492,NCT04456075,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2020-07-02,https://clinicaltrials.gov/show/NCT04456075,2022-04-01,0,0
2493,NCT04456088,Withdrawn,2020-11-15,2020-12-15,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04456088,2020-11-15,0,0
2494,NCT04456101,Recruiting,2020-12-01,2022-06-01,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04456101,2020-12-01,0,0
2495,NCT04456153,Completed,2021-01-31,2021-01-31,Study Results,,,2021-12-14,https://clinicaltrials.gov/show/NCT04456153,2021-01-31,1,0
2496,NCT04456361,"Active, not recruiting",2020-10-15,2020-12-15,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04456361,2020-10-15,0,0
2497,NCT04456413,Recruiting,2022-11-01,2023-11-01,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04456413,2022-11-01,0,0
2498,NCT04456426,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,"['Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001. Review.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', ""Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O'Mahony S, Mikacenic C. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30."", 'McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, Lewis J, Baer A, Kawakami V, Lukoff MD, Ferro J, Brostrom-Smith C, Rea TD, Sayre MR, Riedo FX, Russell D, Hiatt B, Montgomery P, Rao AK, Chow EJ, Tobolowsky F, Hughes MJ, Bardossy AC, Oakley LP, Jacobs JR, Stone ND, Reddy SC, Jernigan JA, Honein MA, Clark TA, Duchin JS; Public Health-Seattle and King County, EvergreenHealth, and CDC COVID-19 Investigation Team. Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington. N Engl J Med. 2020 May 21;382(21):2005-2011. doi: 10.1056/NEJMoa2005412. Epub 2020 Mar 27.', 'Page KR, Venkataramani M, Beyrer C, Polk S. Undocumented U.S. Immigrants and Covid-19. N Engl J Med. 2020 May 21;382(21):e62. doi: 10.1056/NEJMp2005953. Epub 2020 Mar 27.', ""Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18."", 'Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020 Feb 29;14(2):125-128. doi: 10.3855/jidc.12600.']",2020-07-02,https://clinicaltrials.gov/show/NCT04456426,2020-08-01,0,1
2499,NCT04456439,,,,,,,2021-02-18,https://clinicaltrials.gov/show/NCT04456439,,0,0
2500,NCT04456452,Completed,2020-09-08,2020-11-30,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04456452,2020-09-08,0,0
2501,NCT04456556,Completed,2020-06-20,2020-06-30,No Results Posted,"['Abdelkader MFSO, Elshafei AMK, Nassar MM, Abu Elela MA, Abdallah RMA. Combined endophthalmitis and orbital cellulitis in patients with corona virus disease (COVID-19). J Ophthalmic Inflamm Infect. 2021 Sep 15;11(1):27. doi: 10.1186/s12348-021-00258-y.']",,2020-07-02,https://clinicaltrials.gov/show/NCT04456556,2020-06-20,0,1
2502,NCT04456933,Recruiting,2021-12-31,2022-02-28,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04456933,2021-12-31,0,0
2503,NCT04457349,Recruiting,2020-12-29,2021-01-20,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04457349,2020-12-29,0,0
2504,NCT04457388,Completed,2020-06-15,2020-06-15,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04457388,2020-06-15,0,0
2505,NCT04457505,Recruiting,2021-09-30,2021-09-30,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04457505,2021-09-30,0,0
2506,NCT04457570,Recruiting,2020-12-15,2021-02-15,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04457570,2020-12-15,0,0
2507,NCT04457609,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04457609,2020-08-01,0,0
2508,NCT04457726,Recruiting,2021-03-01,2022-12-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04457726,2021-03-01,0,0
2509,NCT04457817,Terminated,2021-04-08,2021-04-08,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04457817,2021-04-08,0,0
2510,NCT04458246,Recruiting,2020-12-01,2021-06-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04458246,2020-12-01,0,0
2511,NCT04458298,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04458298,2022-08-01,0,0
2512,NCT04458337,Recruiting,2022-03-13,2022-04-13,No Results Posted,"[""Carrier FM, Amzallag √â, Lecluyse V, C√¥t√© G, Couture √âJ, D'Aragon F, Kandelman S, Turgeon AF, Deschamps A, Nitulescu R, Djade CD, Girard M, Beaulieu P, Richeb√© P. Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study. BMC Anesthesiol. 2021 Jan 12;21(1):15. doi: 10.1186/s12871-021-01233-9.""]",,2021-09-23,https://clinicaltrials.gov/show/NCT04458337,2022-03-13,0,1
2513,NCT04458363,Completed,2020-09-01,2020-09-01,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04458363,2020-09-01,0,0
2514,NCT04458519,Completed,2021-05-27,2021-05-27,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04458519,2021-05-27,0,0
2515,NCT04458948,"Active, not recruiting",2021-03-24,2025-03-24,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04458948,2021-03-24,0,0
2516,NCT04459247,Completed,2021-03-30,2021-04-10,No Results Posted,"['Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 24;5:CD015043. doi: 10.1002/14651858.CD015043.', 'Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, Puri GD, Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2022 Feb;98(1156):87-90. doi: 10.1136/postgradmedj-2020-139065. Epub 2020 Nov 12.']",,2021-11-02,https://clinicaltrials.gov/show/NCT04459247,2021-03-30,0,1
2517,NCT04459286,Terminated,2021-05-02,2021-05-02,No Results Posted,"['Olagunju A, Fowotade A, Olagunoye A, Ojo TO, Adefuye BO, Fagbamigbe AF, Adebiyi AO, Olagunju OI, Ladipo OT, Akinloye A, Adeagbo BA, Onayade A, Bolaji OO, Happi C, Rannard S, Owen A. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 4;22(1):3. doi: 10.1186/s13063-020-04987-8.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04459286,2021-05-02,0,1
2518,NCT04459312,Recruiting,2020-07-10,2020-09-30,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04459312,2020-07-10,0,0
2519,NCT04459325,Completed,2020-07-20,2020-07-20,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04459325,2020-07-20,0,0
2520,NCT04459351,Recruiting,2023-05-01,2023-06-01,No Results Posted,"['Vijayakumar B, Tonkin J, Devaraj A, Philip KEJ, Orton CM, Desai SR, Shah PL. CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology. 2021 Oct 5:211746. doi: 10.1148/radiol.2021211746. [Epub ahead of print]']",,2021-08-09,https://clinicaltrials.gov/show/NCT04459351,2023-05-01,0,1
2521,NCT04459364,Completed,2020-07-07,2020-07-15,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04459364,2020-07-07,0,0
2522,NCT04459390,Recruiting,2020-10-20,2020-11-20,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04459390,2020-10-20,0,0
2523,NCT04459403,Completed,2020-12-30,2020-12-30,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04459403,2020-12-30,0,0
2524,NCT04459455,Completed,2020-10-15,2020-10-15,No Results Posted,"['Mullarkey M, Dobias M, Sung J, Ahuvia I, Shumake J, Beevers C, Schleider J. Web-Based Single Session Intervention for Perceived Control Over Anxiety During COVID-19: Randomized Controlled Trial. JMIR Ment Health. 2022 Feb 22. doi: 10.2196/33473. [Epub ahead of print]']",,2020-10-20,https://clinicaltrials.gov/show/NCT04459455,2020-10-15,0,1
2525,NCT04459520,Completed,2020-07-28,2020-07-29,No Results Posted,"['Zhang JC, Christensen KL, Leuchter RK, Vangala S, Han M, Croymans DM. Examining the role of COVID-19 testing availability on intention to isolate: A Randomized hypothetical scenario. PLoS One. 2022 Feb 2;17(2):e0262659. doi: 10.1371/journal.pone.0262659. eCollection 2022.']",,2020-08-20,https://clinicaltrials.gov/show/NCT04459520,2020-07-28,0,1
2526,NCT04459533,Completed,2020-06-01,2020-06-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04459533,2020-06-01,0,0
2527,NCT04459637,Completed,2020-09-12,2021-04-15,No Results Posted,,,2022-03-28,https://clinicaltrials.gov/show/NCT04459637,2020-09-12,0,0
2528,NCT04459676,"Active, not recruiting",2021-04-30,2021-04-30,No Results Posted,,,2021-04-15,https://clinicaltrials.gov/show/NCT04459676,2021-04-30,0,0
2529,NCT04459689,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04459689,2022-03-31,0,0
2530,NCT04459702,Withdrawn,2021-07-01,2021-12-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04459702,2021-07-01,0,0
2531,NCT04459819,Completed,2020-09-30,2020-09-30,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.', 'Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009 May 30;373(9678):1874-82. doi: 10.1016/S0140-6736(09)60658-9. Epub 2009 May 14.', 'Kim RY, Murphy TE, Doyle M, Pulaski C, Singh M, Tsang S, Wicker D, Pisani MA, Connors GR, Ferrante LE. Factors Associated With Discharge Home Among Medical ICU Patients in an Early Mobilization Program. Crit Care Explor. 2019 Nov 11;1(11):e0060. doi: 10.1097/CCE.0000000000000060. eCollection 2019 Nov.', ""Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, D'Abrosca F, Del Monaco C, Gaudiello G, Paneroni M, Privitera E, Retucci M, Rossi V, Santambrogio M, Sommariva M, Frigerio P. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020 Mar 26;90(1). doi: 10.4081/monaldi.2020.1285.""]",2021-02-16,https://clinicaltrials.gov/show/NCT04459819,2020-09-30,0,1
2532,NCT04459962,Completed,2021-01-07,2021-01-07,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04459962,2021-01-07,0,0
2533,NCT04459975,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04459975,2020-10-01,0,0
2534,NCT04460014,Recruiting,2022-08-01,2022-12-01,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04460014,2022-08-01,0,0
2535,NCT04460027,Completed,2020-11-30,2020-11-30,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04460027,2020-11-30,0,0
2536,NCT04460105,Withdrawn,2021-01-27,2021-01-27,No Results Posted,,,2020-10-12,https://clinicaltrials.gov/show/NCT04460105,2021-01-27,0,0
2537,NCT04460170,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04460170,2022-02-01,0,0
2538,NCT04460183,Completed,2021-04-24,2021-05-21,No Results Posted,,,2022-01-12,https://clinicaltrials.gov/show/NCT04460183,2021-04-24,0,0
2539,NCT04460196,Completed,2020-09-18,2020-09-18,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04460196,2020-09-18,0,0
2540,NCT04460274,Completed,2020-06-15,2020-06-20,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04460274,2020-06-15,0,0
2541,NCT04460469,Completed,2020-09-01,2020-11-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04460469,2020-09-01,0,0
2542,NCT04460534,Completed,2021-05-12,2021-05-12,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04460534,2021-05-12,0,0
2543,NCT04460547,Not yet recruiting,2020-08-15,2020-09-20,No Results Posted,,,2020-07-07,https://clinicaltrials.gov/show/NCT04460547,2020-08-15,0,0
2544,NCT04460599,Recruiting,2020-07-30,2020-09-30,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04460599,2020-07-30,0,0
2545,NCT04460638,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04460638,2022-07-01,0,0
2546,NCT04460651,Completed,2021-08-30,2021-08-30,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04460651,2021-08-30,0,0
2547,NCT04460664,Enrolling by invitation,2021-01-31,2021-02-15,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04460664,2021-01-31,0,0
2548,NCT04460677,Enrolling by invitation,2022-05-31,2022-05-31,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04460677,2022-05-31,0,0
2549,NCT04460690,Completed,2021-03-31,2021-03-31,Study Results,,,2022-01-20,https://clinicaltrials.gov/show/NCT04460690,2021-03-31,1,0
2550,NCT04460703,Completed,2020-07-08,2020-07-08,No Results Posted,,"['James EK, Bokemper SE, Gerber AS, Omer SB, Huber GA. Persuasive messaging to increase COVID-19 vaccine uptake intentions. Vaccine. 2021 Dec 3;39(49):7158-7165. doi: 10.1016/j.vaccine.2021.10.039. Epub 2021 Oct 22.']",2021-11-05,https://clinicaltrials.gov/show/NCT04460703,2020-07-08,0,1
2551,NCT04461340,Recruiting,2020-10-30,2020-11-30,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04461340,2020-10-30,0,0
2552,NCT04461379,"Active, not recruiting",2021-01-01,2021-01-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04461379,2021-01-01,0,0
2553,NCT04461925,Recruiting,2021-05-02,2021-12-01,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04461925,2021-05-02,0,0
2554,NCT04462120,"Active, not recruiting",2020-06-18,2020-07-30,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04462120,2020-06-18,0,0
2555,NCT04462367,"Active, not recruiting",2022-06-30,2022-12-20,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04462367,2022-06-30,0,0
2556,NCT04462393,"Active, not recruiting",2020-05-06,2022-12-31,No Results Posted,"['Chew MS, Blixt PJ, √Öhman R, Engerstr√∂m L, Andersson H, Berggren RK, Tegnell A, McIntyre S. National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study. Eur J Anaesthesiol. 2021 Apr 1;38(4):335-343. doi: 10.1097/EJA.0000000000001459.']",,2022-03-14,https://clinicaltrials.gov/show/NCT04462393,2020-05-06,0,1
2557,NCT04462627,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04462627,2021-12-01,0,0
2558,NCT04462757,Terminated,2020-08-31,2020-12-23,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04462757,2020-08-31,0,0
2559,NCT04462783,Withdrawn,2021-11-01,2021-11-01,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04462783,2021-11-01,0,0
2560,NCT04462848,Not yet recruiting,2024-09-01,2024-12-01,No Results Posted,,,2020-07-08,https://clinicaltrials.gov/show/NCT04462848,2024-09-01,0,0
2561,NCT04463004,Completed,2020-11-30,2020-11-30,Study Results,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,2021-08-11,https://clinicaltrials.gov/show/NCT04463004,2020-11-30,1,1
2562,NCT04463264,Recruiting,2020-11-15,2020-12-26,Results Submitted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04463264,2020-11-15,0,0
2563,NCT04463420,Recruiting,2020-11-15,2020-12-15,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04463420,2020-11-15,0,0
2564,NCT04463433,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04463433,2021-12-31,0,0
2565,NCT04463472,Completed,2020-09-28,2021-08-12,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04463472,2020-09-28,0,0
2566,NCT04463628,"Active, not recruiting",2021-12-30,2022-03-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04463628,2021-12-30,0,0
2567,NCT04463706,Recruiting,2021-12-30,2021-12-31,No Results Posted,"['Portuondo-Jimenez J, Bilbao-Gonz√°lez A, T√≠scar-Gonz√°lez V, Garitano-Guti√©rrez I, Garc√≠a-Guti√©rrez S, Mart√≠nez-Mejuto A, Santiago-Garin J, Arribas-Garc√≠a S, Garc√≠a-Asensio J, Chart-Pascual J, Zorrilla-Mart√≠nez I, Quintana-Lopez JM; COVID-19-Osakidetza Working group. Modelling the risk of hospital admission of lab confirmed SARS-CoV-2-infected patients in primary care: a population-based study. Intern Emerg Med. 2022 Feb 10. doi: 10.1007/s11739-022-02931-z. [Epub ahead of print]', 'Espa√±a PP, Bilbao A, Garc√≠a-Guti√©rrez S, Lafuente I, Anton-Ladislao A, Villanueva A, Uranga A, Legarreta MJ, Aguirre U, Quintana JM; COVID-19-Osakidetza Working group. Predictors of mortality of COVID-19 in the general population and nursing homes. Intern Emerg Med. 2021 Sep;16(6):1487-1496. doi: 10.1007/s11739-020-02594-8. Epub 2021 Jan 5.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04463706,2021-12-30,0,1
2568,NCT04463758,Recruiting,2022-02-01,2022-10-01,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04463758,2022-02-01,0,0
2569,NCT04463823,Recruiting,2022-05-31,2025-05-31,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04463823,2022-05-31,0,0
2570,NCT04463849,Recruiting,2021-10-31,2021-12-31,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04463849,2021-10-31,0,0
2571,NCT04463862,Completed,2021-06-01,2021-06-01,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04463862,2021-06-01,0,0
2572,NCT04464395,Completed,2021-03-01,2021-07-09,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04464395,2021-03-01,0,0
2573,NCT04464408,Completed,2021-08-04,2021-08-04,No Results Posted,"['Bosaeed M, Alharbi A, Hussein M, Abalkhail M, Sultana K, Musattat A, Alqahtani H, Alshamrani M, Mahmoud E, Alothman A, Alsaedy A, Aldibasi O, Alhagan K, Asiri AM, AlJohani S, Al-Jeraisy M, Alaskar A. Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19. BMJ Open. 2021 Apr 14;11(4):e047495. doi: 10.1136/bmjopen-2020-047495.']",,2021-11-05,https://clinicaltrials.gov/show/NCT04464408,2021-08-04,0,1
2574,NCT04464460,Withdrawn,2020-10-30,2020-10-30,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04464460,2020-10-30,0,0
2575,NCT04464486,Enrolling by invitation,2021-07-30,2022-03-31,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04464486,2021-07-30,0,0
2576,NCT04465058,Recruiting,2020-08-08,2020-08-10,No Results Posted,,,2020-07-09,https://clinicaltrials.gov/show/NCT04465058,2020-08-08,0,0
2577,NCT04465474,Recruiting,2022-04-30,2022-12-31,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04465474,2022-04-30,0,0
2578,NCT04465513,Completed,2021-10-04,2021-10-04,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04465513,2021-10-04,0,0
2579,NCT04465552,Completed,2021-01-24,2021-01-24,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04465552,2021-01-24,0,0
2580,NCT04465604,Recruiting,2021-11-01,2022-05-01,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04465604,2021-11-01,0,0
2581,NCT04465656,Recruiting,2020-10-31,2021-04-30,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04465656,2020-10-31,0,0
2582,NCT04465695,Recruiting,2021-06-30,2021-09-30,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04465695,2021-06-30,0,0
2583,NCT04465981,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04465981,2022-06-01,0,0
2584,NCT04466098,"Active, not recruiting",2021-08-21,2022-12-01,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04466098,2021-08-21,0,0
2585,NCT04466280,Recruiting,2020-11-15,2020-12-15,No Results Posted,,,2020-07-10,https://clinicaltrials.gov/show/NCT04466280,2020-11-15,0,0
2586,NCT04466306,Completed,2021-07-01,2021-07-01,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04466306,2021-07-01,0,0
2587,NCT04466371,Recruiting,2022-11-01,2022-12-01,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04466371,2022-11-01,0,0
2588,NCT04466462,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-07-10,https://clinicaltrials.gov/show/NCT04466462,2020-06-30,0,0
2589,NCT04466540,Completed,2021-07-28,2021-09-28,No Results Posted,"['Oliveira Junior HA, Ferri CP, Boszczowski I, Oliveira GBF, Cavalcanti AB, Rosa RG, Lopes RD, Azevedo LCP, Veiga VC, Berwanger O, Avezum √Å. Rationale and Design of the COVID-19 Outpatient Prevention Evaluation (COPE - Coalition V) Randomized Clinical Trial: Hydroxychloroquine vs. Placebo in Non-Hospitalized Patients. Arq Bras Cardiol. 2022 Feb;118(2):378-387. doi: 10.36660/abc.20210832. Portuguese, English.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04466540,2021-07-28,0,1
2590,NCT04466605,Completed,2020-06-30,2020-07-06,No Results Posted,,,2020-07-10,https://clinicaltrials.gov/show/NCT04466605,2020-06-30,0,0
2591,NCT04466644,Completed,2020-08-24,2020-08-25,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04466644,2020-08-24,0,0
2592,NCT04466657,Withdrawn,2021-02-28,2021-04-30,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04466657,2021-02-28,0,0
2593,NCT04466670,Recruiting,2021-12-30,2022-05-30,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.', 'Arachchillage DRJ, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 May;18(5):1233-1234. doi: 10.1111/jth.14820.', 'Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.', 'Lippi G, Favaloro EJ. D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020 May;120(5):876-878. doi: 10.1055/s-0040-1709650. Epub 2020 Apr 3.', 'Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, Xiong W, Yang D, Chen R, Lu F, Lu Y, Liu X, Chen Y, Li X, Li Y, Summah HD, Lin H, Yan J, Zhou M, Lu H, Qu J. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.', 'Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.', 'Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.', 'Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl√©s-Cano E, Sattler L, Mertes PM, Meziani F; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.', 'Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.', 'Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M√ºller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, Smits LP, Bonta PI, van Es N. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.', 'Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.', 'Gralinski LE, Bankhead A 3rd, Jeng S, Menachery VD, Proll S, Belisle SE, Matzke M, Webb-Robertson BJ, Luna ML, Shukla AK, Ferris MT, Bolles M, Chang J, Aicher L, Waters KM, Smith RD, Metz TO, Law GL, Katze MG, McWeeney S, Baric RS. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio. 2013 Aug 6;4(4). pii: e00271-13. doi: 10.1128/mBio.00271-13.', 'Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9. Erratum in: Cell. 2020 Dec 10;183(6):1735.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7.', 'Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.', 'Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.', 'Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Saldiva PHN, Mauad T, Negri EM. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020 Jun;18(6):1517-1519. doi: 10.1111/jth.14844.', 'Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.', 'Escher R, Breakey N, L√§mmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020 Jun;190:62. doi: 10.1016/j.thromres.2020.04.014. Epub 2020 Apr 15.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020 Jul;18(7):1548-1555. doi: 10.1111/jth.14872. Epub 2020 Jun 3. Review.', 'White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D, Lavinio A, Varley J, Johnston A, Besser M, Thomas W. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0. Erratum in: J Thromb Thrombolysis. 2020 Jun 22;:.', 'Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e24S-e43S. doi: 10.1378/chest.11-2291. Review. Erratum in: Chest. 2012 May;141(5):1369. Dosage error in article text. Chest. 2013 Aug;144(2):721. Dosage error in article text.', 'Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment. J Thromb Haemost. 2020 Aug;18(8):2060-2063. doi: 10.1111/jth.14860. Epub 2020 Jun 14.', 'Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Qu√©r√© I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. Review.', 'Maatman TK, Jalali F, Feizpour C, Douglas A 2nd, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreutz RP, Kapoor R, Rahman O, Zyromski NJ, Meagher AD. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019. Crit Care Med. 2020 Sep;48(9):e783-e790. doi: 10.1097/CCM.0000000000004466.', 'Nahum J, Morichau-Beauchant T, Daviaud F, Echegut P, Fichet J, Maillet JM, Thierry S. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.', 'Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Blood. 2020 Jul 2;136(1):144-147. doi: 10.1182/blood.2020006941.', 'Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, Charney AW, Narula J, Fayad ZA, Bagiella E, Zhao S, Nadkarni GN. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.', 'Juschten J, Tuinman PR, Juffermans NP, Dixon B, Levi M, Schultz MJ. Nebulized anticoagulants in lung injury in critically ill patients-an updated systematic review of preclinical and clinical studies. Ann Transl Med. 2017 Nov;5(22):444. doi: 10.21037/atm.2017.08.23. Review.', 'Dixon B, Schultz MJ, Smith R, Fink JB, Santamaria JD, Campbell DJ. Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial. Crit Care. 2010;14(5):R180. doi: 10.1186/cc9286. Epub 2010 Oct 11.', 'Viecca M, Radovanovic D, Forleo GB, Santus P. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res. 2020 Aug;158:104950. doi: 10.1016/j.phrs.2020.104950. Epub 2020 May 23.', 'Connor JT, Elm JJ, Broglio KR; ESETT and ADAPT-IT Investigators. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol. 2013 Aug;66(8 Suppl):S130-7. doi: 10.1016/j.jclinepi.2013.02.015.', 'Gsponer T, Gerber F, Bornkamp B, Ohlssen D, Vandemeulebroecke M, Schmidli H. A practical guide to Bayesian group sequential designs. Pharm Stat. 2014 Jan-Feb;13(1):71-80. doi: 10.1002/pst.1593. Epub 2013 Aug 24.']",2021-06-09,https://clinicaltrials.gov/show/NCT04466670,2021-12-30,0,1
2594,NCT04466683,Recruiting,2021-12-31,2022-12-31,No Results Posted,"['McClelland S 3rd, Miller AC, Williams MD, Anthony BP, Chakravarti A, Anthony PA. Low-dose whole thorax radiation therapy for COVID-19 pneumonia: inpatient onboarding process for a randomized controlled trial. Rep Pract Oncol Radiother. 2021 Dec 30;26(6):1057-1059. doi: 10.5603/RPOR.a2021.0112. eCollection 2021.']",,2021-03-15,https://clinicaltrials.gov/show/NCT04466683,2021-12-31,0,1
2595,NCT04466800,Recruiting,2022-07-31,2023-06-30,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04466800,2022-07-31,0,0
2596,NCT04466839,Completed,2020-12-18,2020-12-18,No Results Posted,,"[""Fabbri M, Leung C, Baille G, B√©reau M, Brefel Courbon C, Castelnovo G, Carriere N, Damier P, Defebvre L, Doe de Maindreville A, Fluchere F, Fuzzatti M, Grabli D, Maltete D, Rousseau V, Sommet A A, Thalamas C, Thiriez C, Rascol O, Ory-Magne F. A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study. Parkinsonism Relat Disord. 2021 Aug;89:128-133. doi: 10.1016/j.parkreldis.2021.07.013. Epub 2021 Jul 13.""]",2021-09-14,https://clinicaltrials.gov/show/NCT04466839,2020-12-18,0,1
2597,NCT04467008,Completed,2020-08-15,2020-08-15,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04467008,2020-08-15,0,0
2598,NCT04467047,Not yet recruiting,2020-10-30,2020-12-30,No Results Posted,,,2020-07-10,https://clinicaltrials.gov/show/NCT04467047,2020-10-30,0,0
2599,NCT04467086,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04467086,2021-06-01,0,0
2600,NCT04467112,Completed,2020-12-19,2020-12-19,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04467112,2020-12-19,0,0
2601,NCT04467151,Withdrawn,2021-10-01,2021-12-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04467151,2021-10-01,0,0
2602,NCT04467840,Completed,2021-07-18,2021-07-18,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04467840,2021-07-18,0,0
2603,NCT04467918,"Active, not recruiting",2021-11-16,2021-11-16,No Results Posted,"['Crippa JAS, Pacheco JC, Zuardi AW, Guimar√£es FS, Campos AC, Os√≥rio FL, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Passos ADC, Dal Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Koenigkam-Santos M, Santos AC, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis Cannabinoid Res. 2021 Oct 7. doi: 10.1089/can.2021.0093. [Epub ahead of print]']",,2021-09-28,https://clinicaltrials.gov/show/NCT04467918,2021-11-16,0,1
2604,NCT04467931,Completed,2020-10-21,2020-12-31,No Results Posted,,"['Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One. 2021 Apr 23;16(4):e0248080. doi: 10.1371/journal.pone.0248080. eCollection 2021. Erratum in: PLoS One. 2021 May 13;16(5):e0251897.']",2021-04-28,https://clinicaltrials.gov/show/NCT04467931,2020-10-21,0,1
2605,NCT04468009,Completed,2021-01-19,2021-06-19,No Results Posted,,,2021-08-25,https://clinicaltrials.gov/show/NCT04468009,2021-01-19,0,0
2606,NCT04468035,"Active, not recruiting",2021-12-31,2022-12-31,No Results Posted,,"['Alkeridy WA, Almaghlouth I, Alrashed R, Alayed K, Binkhamis K, Alsharidi A, Liu-Ambrose T. A Unique Presentation of Delirium in a Patient with Otherwise Asymptomatic COVID-19. J Am Geriatr Soc. 2020 Jul;68(7):1382-1384. doi: 10.1111/jgs.16536. Epub 2020 May 16.', 'Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020 Jun 4;382(23):2268-2270. doi: 10.1056/NEJMc2008597. Epub 2020 Apr 15.', 'Bouattour N, Farhat N, Hadjkacem H, Hdiji O, Sakka S, Dammak M, Mhiri C. [Five-word test calibration in a Tunisian population of healthy subjects]. Pan Afr Med J. 2019 Sep 30;34:58. doi: 10.11604/pamj.2019.34.58.14472. eCollection 2019. French.', 'Maillet D, Matharan F, Le Cl√©siau H, Bailon O, P√©r√®s K, Amieva H, Belin C. TNI-93: A New Memory Test for Dementia Detection in Illiterate and Low-Educated Patients. Arch Clin Neuropsychol. 2016 Dec 1;31(8):896-903. doi: 10.1093/arclin/acw065.']",2022-03-31,https://clinicaltrials.gov/show/NCT04468035,2021-12-31,0,1
2607,NCT04468087,"Active, not recruiting",2021-08-04,2022-12-31,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04468087,2021-08-04,0,0
2608,NCT04468139,Recruiting,2020-07-20,2020-07-30,No Results Posted,,,2020-07-13,https://clinicaltrials.gov/show/NCT04468139,2020-07-20,0,0
2609,NCT04468217,Recruiting,2020-09-15,2020-09-25,No Results Posted,,,2020-07-13,https://clinicaltrials.gov/show/NCT04468217,2020-09-15,0,0
2610,NCT04468256,Recruiting,2022-07-01,2022-07-01,No Results Posted,"['Hammersley DJ, Buchan RJ, Lota AS, Mach L, Jones RE, Halliday BP, Tayal U, Meena D, Dehghan A, Tzoulaki I, Baksi AJ, Pantazis A, Roberts AM, Prasad SK, Ware JS. Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy. Open Heart. 2022 Jan;9(1). pii: e001918. doi: 10.1136/openhrt-2021-001918.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04468256,2022-07-01,0,1
2611,NCT04468308,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04468308,2021-03-01,0,0
2612,NCT04468386,Completed,2021-05-30,2021-05-30,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04468386,2021-05-30,0,0
2613,NCT04468412,"Active, not recruiting",2022-03-30,2022-03-30,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04468412,2022-03-30,0,0
2614,NCT04468646,Recruiting,2020-07-15,2020-08-30,No Results Posted,,,2020-07-13,https://clinicaltrials.gov/show/NCT04468646,2020-07-15,0,0
2615,NCT04468802,Completed,2020-06-30,2020-07-01,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04468802,2020-06-30,0,0
2616,NCT04468893,Completed,2021-07-31,2021-07-31,No Results Posted,"['Dominguez-Rodriguez A, De La Rosa-G√≥mez A, Hern√°ndez Jim√©nez MJ, Arenas-Landgrave P, Mart√≠nez-Luna SC, Alvarez Silva J, Garc√≠a Hern√°ndez JE, Arzola-S√°nchez C, Acosta Guzm√°n V. A Self-Administered Multicomponent Web-Based Mental Health Intervention for the Mexican Population During the COVID-19 Pandemic: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Nov 16;9(11):e23117. doi: 10.2196/23117.']","['Beck AT, Steer RA, Ranieri WF. Scale for Suicide Ideation: psychometric properties of a self-report version. J Clin Psychol. 1988 Jul;44(4):499-505.', 'Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Hishinuma ES, Miyamoto RH, Nishimura ST, Nahulu LB, Andrade NN, Makini GK Jr, Yuen NY, Johnson RC, Kim SP, Goebert DA, Guerrero AP. Psychometric properties of the state-trait anxiety inventory for Asian/Pacific-islander adolescents. Assessment. 2000 Mar;7(1):17-36.', 'Walsh S, Szymczynska P, Taylor SJC, Priebe S. The acceptability of an online intervention using positive psychology for depression: A qualitative study. Internet Interv. 2018 Jul 8;13:60-66. doi: 10.1016/j.invent.2018.07.003. eCollection 2018 Sep.', 'L√∂we B, Decker O, M√ºller S, Br√§hler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008 Mar;46(3):266-74. doi: 10.1097/MLR.0b013e318160d093.']",2021-10-13,https://clinicaltrials.gov/show/NCT04468893,2021-07-31,0,1
2617,NCT04468958,"Active, not recruiting",2021-02-23,2021-11-01,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04468958,2021-02-23,0,0
2618,NCT04468971,Completed,2021-10-22,2021-10-22,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04468971,2021-10-22,0,0
2619,NCT04469114,Completed,2021-01-09,2021-01-09,No Results Posted,"['Guimar√£es PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP, Veiga VC, Martins PA, Moia DDF, Sampaio BS, Assis SRL, Soares RVP, Piano LPA, Castilho K, Momesso RGRAP, Monfardini F, Guimar√£es HP, Ponce de Leon D, Dulcine M, Pinheiro MRT, Gunay LM, Deuring JJ, Rizzo LV, Koncz T, Berwanger O; STOP-COVID Trial Investigators. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 Jul 29;385(5):406-415. doi: 10.1056/NEJMoa2101643. Epub 2021 Jun 16.']",,2021-08-09,https://clinicaltrials.gov/show/NCT04469114,2021-01-09,0,1
2620,NCT04469153,Recruiting,2020-09-01,2020-12-31,No Results Posted,,,2020-07-13,https://clinicaltrials.gov/show/NCT04469153,2020-09-01,0,0
2621,NCT04469179,"Active, not recruiting",2021-02-25,2021-11-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04469179,2021-02-25,0,1
2622,NCT04469621,Completed,2020-10-23,2020-10-23,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04469621,2020-10-23,0,0
2623,NCT04469634,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04469634,2022-12-01,0,0
2624,NCT04469647,Enrolling by invitation,2021-01-15,2021-06-15,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04469647,2021-01-15,0,0
2625,NCT04469660,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04469660,2020-08-30,0,0
2626,NCT04470258,Completed,2020-08-30,2020-11-30,No Results Posted,"['Tomaz BS, Gomes GC, Lino JA, Menezes DGA, Soares JB, Furtado V, Soares J√∫nior L, Farias MDSQ, Lima DLN, Pereira EDB, Holanda MA. ELMO, a new helmet interface for CPAP to treat COVID-19-related acute hypoxemic respiratory failure outside the ICU: a feasibility study. J Bras Pneumol. 2022 Feb 2;48(1):e20210349. doi: 10.36416/1806-3756/e20210349. eCollection 2022. English, Portuguese.']",,2021-04-20,https://clinicaltrials.gov/show/NCT04470258,2020-08-30,0,1
2627,NCT04470297,Not yet recruiting,2020-11-01,2021-03-01,No Results Posted,,,2020-07-24,https://clinicaltrials.gov/show/NCT04470297,2020-11-01,0,0
2628,NCT04470323,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04470323,2020-10-01,0,0
2629,NCT04470414,Not yet recruiting,2021-07-01,2021-09-01,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04470414,2021-07-01,0,0
2630,NCT04470427,"Active, not recruiting",2022-10-27,2022-10-27,No Results Posted,"['El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Sch√∂del F, Tomassini JE, Zhou H, Miller J; COVE Study Group. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.', ""Gilbert PB, Montefiori DC, McDermott A, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi N, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Kutner M, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA. Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. medRxiv. 2021 Aug 15. pii: 2021.08.09.21261290. doi: 10.1101/2021.08.09.21261290. Update in: Science. 2021 Nov 23;:eab3435."", 'Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.']",,2021-12-21,https://clinicaltrials.gov/show/NCT04470427,2022-10-27,0,1
2631,NCT04470531,Recruiting,2020-10-12,2021-01-30,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04470531,2020-10-12,0,0
2632,NCT04470544,Recruiting,2022-09-15,2022-09-15,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04470544,2022-09-15,0,0
2633,NCT04470557,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,"['Alnor A, Sandberg MB, Gils C, Vinholt PJ. Laboratory Tests and Outcome for Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. J Appl Lab Med. 2020 Sep 1;5(5):1038-1049. doi: 10.1093/jalm/jfaa098.']",2020-07-14,https://clinicaltrials.gov/show/NCT04470557,2020-10-01,0,1
2634,NCT04470583,Recruiting,2021-11-01,2021-12-02,No Results Posted,,,2020-10-12,https://clinicaltrials.gov/show/NCT04470583,2021-11-01,0,0
2635,NCT04470609,Enrolling by invitation,2020-11-01,2021-11-01,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04470609,2020-11-01,0,0
2636,NCT04470622,Terminated,2021-04-09,2021-06-03,No Results Posted,,,2021-10-20,https://clinicaltrials.gov/show/NCT04470622,2021-04-09,0,0
2637,NCT04470648,Recruiting,2021-08-01,2021-08-01,No Results Posted,,"['Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Taba√Ø A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D; Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb;25(6). doi: 10.2807/1560-7917.ES.2020.25.6.2000094.', 'Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum in: Lancet Infect Dis. 2020 May 19;:. Erratum in: Lancet Infect Dis. 2020 Jun;20(6):e116.', 'Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, Brichler S, Cohen Y. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020 Jun;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006. Epub 2020 May 3.', 'Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.2000062.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. JAMA. 2020 Jun 2;323(21):2191-2192. doi: 10.1001/jama.2020.6887.']",2021-02-16,https://clinicaltrials.gov/show/NCT04470648,2021-08-01,0,1
2638,NCT04470739,Recruiting,2020-09-30,2020-10-30,No Results Posted,,,2020-07-14,https://clinicaltrials.gov/show/NCT04470739,2020-09-30,0,0
2639,NCT04470999,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04470999,2021-09-30,0,0
2640,NCT04471051,Completed,2020-08-20,2020-08-20,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04471051,2020-08-20,0,0
2641,NCT04471519,"Active, not recruiting",2020-07-31,2021-06-30,No Results Posted,"['Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 Jul;21(7):950-961. doi: 10.1016/S1473-3099(21)00070-0. Epub 2021 Mar 8.', 'Yadav PD, Ella R, Kumar S, Patil DR, Mohandas S, Shete AM, Vadrevu KM, Bhati G, Sapkal G, Kaushal H, Patil S, Jain R, Deshpande G, Gupta N, Agarwal K, Gokhale M, Mathapati B, Metkari S, Mote C, Nyayanit D, Patil DY, Sai Prasad BS, Suryawanshi A, Kadam M, Kumar A, Daigude S, Gopale S, Majumdar T, Mali D, Sarkale P, Baradkar S, Gawande P, Joshi Y, Fulari S, Dighe H, Sharma S, Gunjikar R, Kumar A, Kalele K, Srinivas VK, Gangakhedkar RR, Ella KM, Abraham P, Panda S, Bhargava B. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 2021 Mar 2;12(1):1386. doi: 10.1038/s41467-021-21639-w.', 'Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21. Erratum in: Lancet Infect Dis. 2021 Apr;21(4):e81.']",,2021-05-20,https://clinicaltrials.gov/show/NCT04471519,2020-07-31,0,1
2642,NCT04471636,Recruiting,2021-11-01,2021-12-01,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04471636,2021-11-01,0,0
2643,NCT04471649,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04471649,2020-10-01,0,0
2644,NCT04471701,Recruiting,2020-07-31,2020-08-31,No Results Posted,"['Prinelli F, Trevisan C, Noale M, Franchini M, Giacomelli A, Cori L, Jesuthasan N, Incalzi RA, Maggi S, Adorni F; EPICOVID19 Working Group. Sex- and gender-related differences linked to SARS-CoV-2 infection among the participants in the web-based EPICOVID19 survey: the hormonal hypothesis. Maturitas. 2022 Apr;158:61-69. doi: 10.1016/j.maturitas.2021.11.015. Epub 2021 Dec 4.', 'Prinelli F, Bianchi F, Drago G, Ruggieri S, Sojic A, Jesuthasan N, Molinaro S, Bastiani L, Maggi S, Noale M, Galli M, Giacomelli A, Antonelli Incalzi R, Adorni F, Cibella F; EPICOVID19 Working Group. Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey. JMIR Public Health Surveill. 2021 Apr 28;7(4):e27091. doi: 10.2196/27091.', 'Trevisan C, Noale M, Prinelli F, Maggi S, Sojic A, Di Bari M, Molinaro S, Bastiani L, Giacomelli A, Galli M, Adorni F, Antonelli Incalzi R, Pedone C; EPICOVID19 Working Group. Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey. Eur J Intern Med. 2021 Apr;86:41-47. doi: 10.1016/j.ejim.2021.01.028. Epub 2021 Jan 29.', 'Adorni F, Prinelli F, Bianchi F, Giacomelli A, Pagani G, Bernacchia D, Rusconi S, Maggi S, Trevisan C, Noale M, Molinaro S, Bastiani L, Fortunato L, Jesuthasan N, Sojic A, Pettenati C, Tavio M, Andreoni M, Mastroianni C, Antonelli Incalzi R, Galli M. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey. JMIR Public Health Surveill. 2020 Sep 18;6(3):e21866. doi: 10.2196/21866.']",,2020-07-16,https://clinicaltrials.gov/show/NCT04471701,2020-07-31,0,1
2645,NCT04471766,"Active, not recruiting",2021-10-01,2021-10-01,No Results Posted,,,2021-10-13,https://clinicaltrials.gov/show/NCT04471766,2021-10-01,0,0
2646,NCT04471831,Not yet recruiting,2021-06-21,2021-12-31,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04471831,2021-06-21,0,0
2647,NCT04472013,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2021-11-02,https://clinicaltrials.gov/show/NCT04472013,2022-12-01,0,0
2648,NCT04472052,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-07-15,https://clinicaltrials.gov/show/NCT04472052,2020-05-31,0,0
2649,NCT04472078,Completed,2020-06-26,2020-12-11,No Results Posted,,,2020-12-17,https://clinicaltrials.gov/show/NCT04472078,2020-06-26,0,0
2650,NCT04472494,Terminated,2021-09-12,2021-09-12,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04472494,2021-09-12,0,0
2651,NCT04472559,Recruiting,2021-10-01,2021-12-25,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04472559,2021-10-01,0,0
2652,NCT04472572,,,,,,,2021-10-05,https://clinicaltrials.gov/show/NCT04472572,,0,0
2653,NCT04472585,Recruiting,2021-08-15,2021-10-30,No Results Posted,"['Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium. Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Sep 6;22(1):591. doi: 10.1186/s13063-021-05487-z.']",,2021-02-17,https://clinicaltrials.gov/show/NCT04472585,2021-08-15,0,1
2654,NCT04472611,Recruiting,2021-10-30,2022-08-01,No Results Posted,"['Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz CS, Parise H, Lansky A. Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial. Contemp Clin Trials. 2021 Nov;110:106547. doi: 10.1016/j.cct.2021.106547. Epub 2021 Aug 28.']",,2021-03-02,https://clinicaltrials.gov/show/NCT04472611,2021-10-30,0,1
2655,NCT04472793,"Active, not recruiting",2022-12-01,2023-12-01,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04472793,2022-12-01,0,0
2656,NCT04473053,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,"['Gaughan E, Quinn T, Bruce A, Antonelli J, Young V, Mair J, Akram A, Hirani N, Koch O, Mackintosh C, Norrie J, Dear JW, Dhaliwal K. Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform. BMJ Open. 2021 Dec 15;11(12):e054442. doi: 10.1136/bmjopen-2021-054442.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-09-16,https://clinicaltrials.gov/show/NCT04473053,2022-12-31,0,1
2657,NCT04473105,Recruiting,2020-12-31,2021-01-31,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04473105,2020-12-31,0,0
2658,NCT04473118,Recruiting,2020-09-01,2021-06-01,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04473118,2020-09-01,0,0
2659,NCT04473131,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04473131,2022-06-01,0,0
2660,NCT04473157,Completed,2020-11-30,2020-12-30,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04473157,2020-11-30,0,0
2661,NCT04473170,Completed,2020-05-20,2020-07-14,No Results Posted,"['Castillo Aleman YM, Villegas Valverde CA, Ventura Carmenate Y, Abdel Hadi L, Rivero Jimenez RA, Rezgui R, Alagha SH, Shamat S, Bencomo Hernandez AA. Viability assessment of human peripheral blood-derived stem cells after three methods of nebulization. Am J Stem Cells. 2021 Oct 15;10(4):68-78. eCollection 2021.', 'Ventura-Carmenate Y, Alkaabi FM, Castillo-Aleman YM, Villegas-Valverde CA, Ahmed YM, Sanna P, Almarzooqi AA, Abdelrazik A, Torres-Zambrano GM, Wade-Mateo M, Quesada-Saliba D, Abdel Hadi L, Bencomo-Hernandez AA, Rivero-Jimenez RA. Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020. Transl Med Commun. 2021;6(1):25. doi: 10.1186/s41231-021-00101-5. Epub 2021 Nov 3.']",,2020-07-16,https://clinicaltrials.gov/show/NCT04473170,2020-05-20,0,1
2662,NCT04473183,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04473183,2022-01-01,0,0
2663,NCT04473248,Completed,2020-08-30,2020-08-30,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04473248,2020-08-30,0,0
2664,NCT04473261,Recruiting,2021-08-15,2021-10-15,No Results Posted,"['Ashraf S, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Siddiqui UN, Farooq I, Ghufran M, Khokhar RA, Akram MK, Shahid I, Sohaib Ur Rehman M, Akmal R, Tahir A, Zahid A, Ashraf S, Rafique S, Matti N, Nadeem MF, Humayun A, Malik A, Saboor QA, Ahmad A, Ashraf M, Izhar M. A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Feb 10;22(1):127. doi: 10.1186/s13063-021-05081-3.']",,2021-07-07,https://clinicaltrials.gov/show/NCT04473261,2021-08-15,0,1
2665,NCT04473352,Not yet recruiting,2021-09-01,2021-11-01,No Results Posted,,"['Castro R, Luz PM, Wakimoto MD, Veloso VG, Grinsztejn B, Perazzo H. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis. 2020 Mar - Apr;24(2):180-187. doi: 10.1016/j.bjid.2020.04.003. Epub 2020 Apr 18.', 'Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, Yang Y, Liu B, Wang W, Wei C, Yang J, Ye G, Cheng Z. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25.', 'Infantino M, Grossi V, Lari B, Bambi R, Perri A, Manneschi M, Terenzi G, Liotti I, Ciotta G, Taddei C, Benucci M, Casprini P, Veneziani F, Fabbri S, Pompetti A, Manfredi M. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience. J Med Virol. 2020 Sep;92(9):1671-1675. doi: 10.1002/jmv.25932. Epub 2020 May 10.']",2020-08-13,https://clinicaltrials.gov/show/NCT04473352,2021-09-01,0,1
2666,NCT04473365,Recruiting,2022-06-30,2022-06-30,No Results Posted,"['Wolday D, Gebrecherkos T, Arefaine ZG, Kiros YK, Gebreegzabher A, Tasew G, Abdulkader M, Abraha HE, Desta AA, Hailu A, Tollera G, Abdella S, Tesema M, Abate E, Endarge KL, Hundie TG, Miteku FK, Urban BC, Schallig HHDF, Harris VC, de Wit TFR. Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study. EClinicalMedicine. 2021 Sep;39:101054. doi: 10.1016/j.eclinm.2021.101054. Epub 2021 Jul 31.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04473365,2022-06-30,0,1
2667,NCT04473547,Completed,2020-08-20,2021-02-15,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04473547,2020-08-20,0,0
2668,NCT04473599,Recruiting,2022-04-17,2022-04-17,No Results Posted,"['Aguilera A, Hernandez-Ramos R, Haro-Ramos AY, Boone CE, Luo TC, Xu J, Chakraborty B, Karr C, Darrow S, Figueroa CA. A Text Messaging Intervention (StayWell at Home) to Counteract Depression and Anxiety During COVID-19 Social Distancing: Pre-Post Study. JMIR Ment Health. 2021 Nov 1;8(11):e25298. doi: 10.2196/25298.', 'Figueroa CA, Hernandez-Ramos R, Boone CE, G√≥mez-Pathak L, Yip V, Luo T, Sierra V, Xu J, Chakraborty B, Darrow S, Aguilera A. A Text Messaging Intervention for Coping With Social Distancing During COVID-19 (StayWell at Home): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Jan 14;10(1):e23592. doi: 10.2196/23592.']",,2021-11-11,https://clinicaltrials.gov/show/NCT04473599,2022-04-17,0,1
2669,NCT04473898,Completed,2020-10-19,2021-02-17,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04473898,2020-10-19,0,0
2670,NCT04474067,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04474067,2021-03-01,0,0
2671,NCT04474080,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04474080,2021-07-01,0,0
2672,NCT04474236,Completed,2021-03-07,2021-03-07,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04474236,2021-03-07,0,0
2673,NCT04474249,Recruiting,2022-12-01,2022-12-01,No Results Posted,,"['E E, R F, √ñi E, Im L, M L, S R, E W, C J, M H, A M. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021 Jun;182:106394. doi: 10.1016/j.rmed.2021.106394. Epub 2021 Apr 15. Review.', 'Hultstr√∂m M, Lipcsey M, Wallin E, Larsson IM, Larsson A, Frithiof R. Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19. Crit Care. 2021 Jan 25;25(1):37. doi: 10.1186/s13054-021-03461-4.']",2021-10-26,https://clinicaltrials.gov/show/NCT04474249,2022-12-01,0,1
2674,NCT04474288,Completed,2021-07-01,2022-02-28,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04474288,2021-07-01,0,0
2675,NCT04474301,Recruiting,2022-12-30,2023-12-30,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04474301,2022-12-30,0,0
2676,NCT04474340,Recruiting,2020-09-30,2020-12-30,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04474340,2020-09-30,0,0
2677,NCT04474444,Recruiting,2021-03-23,2021-03-23,No Results Posted,,,2020-07-16,https://clinicaltrials.gov/show/NCT04474444,2021-03-23,0,0
2678,NCT04474457,"Active, not recruiting",2020-12-31,2021-06-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04474457,2020-12-31,0,0
2679,NCT04474483,Recruiting,2022-09-30,2022-12-31,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04474483,2022-09-30,0,0
2680,NCT04474496,Completed,2020-11-30,2020-11-30,Study Results,,,2021-04-05,https://clinicaltrials.gov/show/NCT04474496,2020-11-30,1,0
2681,NCT04475068,Completed,2020-09-30,2020-10-31,No Results Posted,"['Rold√°n R, Rodriguez S, Barriga F, Tucci M, Victor M, Alcala G, Villamonte R, Su√°rez-Sipmann F, Amato M, Brochard L, Tusman G. Sequential lateral positioning as a new lung recruitment maneuver: an exploratory study in early mechanically ventilated Covid-19 ARDS patients. Ann Intensive Care. 2022 Feb 12;12(1):13. doi: 10.1186/s13613-022-00988-9.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04475068,2020-09-30,0,1
2682,NCT04475081,Not yet recruiting,2021-10-31,2021-12-01,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04475081,2021-10-31,0,0
2683,NCT04475107,Completed,2021-03-25,2021-04-15,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04475107,2021-03-25,0,0
2684,NCT04475120,Completed,2020-07-02,2020-07-02,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04475120,2020-07-02,0,0
2685,NCT04475185,Terminated,2020-12-19,2020-12-19,No Results Posted,,,2021-12-29,https://clinicaltrials.gov/show/NCT04475185,2020-12-19,0,0
2686,NCT04475211,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04475211,2022-08-01,0,0
2687,NCT04475302,"Active, not recruiting",2021-12-30,2021-12-30,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04475302,2021-12-30,0,0
2688,NCT04475471,Recruiting,2021-06-30,2021-12-30,No Results Posted,,"['Thienemann F, Pinto F, Grobbee DE, Boehm M, Bazargani N, Ge J, Sliwa K. World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries. Glob Heart. 2020 Apr 9;15(1):31. doi: 10.5334/gh.778.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 May;109(5):531-538. doi: 10.1007/s00392-020-01626-9. Epub 2020 Mar 11. Review.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11. Erratum in: Lancet Respir Med. 2020 Jun;8(6):e54.', 'Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004 Dec 16;351(25):2611-8.', 'Alsahafi AJ, Cheng AC. The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015. Int J Infect Dis. 2016 Apr;45:1-4. doi: 10.1016/j.ijid.2016.02.004. Epub 2016 Feb 10.', 'Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016 Jan-Feb;36(1):78-80. doi: 10.5144/0256-4947.2016.78.']",2020-09-07,https://clinicaltrials.gov/show/NCT04475471,2021-06-30,0,1
2689,NCT04475484,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-07-17,https://clinicaltrials.gov/show/NCT04475484,2020-12-31,0,0
2690,NCT04475562,Completed,2020-05-06,2020-07-01,No Results Posted,,,2020-07-17,https://clinicaltrials.gov/show/NCT04475562,2020-05-06,0,0
2691,NCT04475575,Completed,2020-06-30,2020-07-01,No Results Posted,,,2020-07-17,https://clinicaltrials.gov/show/NCT04475575,2020-06-30,0,0
2692,NCT04475588,Completed,2020-07-07,2020-07-07,Study Results,,,2021-06-14,https://clinicaltrials.gov/show/NCT04475588,2020-07-07,1,0
2693,NCT04475601,Terminated,2021-03-24,2021-05-29,No Results Posted,"['Wel√©n K, √ñverby AK, Ahlm C, Freyhult E, Robinsson D, Henningsson AJ, Stranne J, Bremell D, Angelin M, Lindquist E, Buckland R, Carlsson CT, Pauksens K, Bill-Axelsson A, Akre O, Ryden C, Wagenius M, Bjartell A, Nilsson AC, Styrke J, Repo J, Balkhed √Ö√ñ, Niward K, Gissl√©n M, Josefsson A. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 16;22(1):209. doi: 10.1186/s13063-021-05137-4.']",,2021-08-26,https://clinicaltrials.gov/show/NCT04475601,2021-03-24,0,1
2694,NCT04475913,Completed,2020-07-11,2020-08-20,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04475913,2020-07-11,0,0
2695,NCT04475991,Recruiting,2022-04-01,2022-08-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04475991,2022-04-01,0,0
2696,NCT04476589,Suspended,2022-06-30,2023-03-30,No Results Posted,"['Fischer D, Snider SB, Barra ME, Sanders WR, Rapalino O, Schaefer P, Foulkes AS, Bodien YG, Edlow BL. Disorders of Consciousness Associated With COVID-19: A Prospective Multimodal Study of Recovery and Brain Connectivity. Neurology. 2022 Jan 18;98(3):e315-e325. doi: 10.1212/WNL.0000000000013067. Epub 2021 Dec 3.']","['Fischer D, Threlkeld ZD, Bodien YG, Kirsch JE, Huang SY, Schaefer PW, Rapalino O, Hochberg LR, Rosen BR, Edlow BL. Intact Brain Network Function in an Unresponsive Patient with COVID-19. Ann Neurol. 2020 Oct;88(4):851-854. doi: 10.1002/ana.25838. Epub 2020 Aug 6.']",2021-09-21,https://clinicaltrials.gov/show/NCT04476589,2022-06-30,0,1
2697,NCT04476602,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04476602,2020-12-31,0,0
2698,NCT04476667,Completed,2021-05-01,2021-05-01,No Results Posted,"[""Alavi N, Yang M, Stephenson C, Nikjoo N, Malakouti N, Layzell G, Jagayat J, Shirazi A, Groll D, Omrani M, O'Riordan A, Khalid-Khan S, Freire R, Brietzke E, Gomes FA, Milev R, Soares CN. Using the Online Psychotherapy Tool to Address Mental Health Problems in the Context of the COVID-19 Pandemic: Protocol for an Electronically Delivered Cognitive Behavioral Therapy Program. JMIR Res Protoc. 2020 Dec 18;9(12):e24913. doi: 10.2196/24913.""]",,2021-09-09,https://clinicaltrials.gov/show/NCT04476667,2021-05-01,0,1
2699,NCT04476680,Recruiting,2021-04-28,2021-04-28,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04476680,2021-04-28,0,0
2700,NCT04476706,,,,,,,2021-02-03,https://clinicaltrials.gov/show/NCT04476706,,0,0
2701,NCT04476823,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04476823,2020-05-31,0,0
2702,NCT04476888,Completed,2020-09-15,2020-10-10,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04476888,2020-09-15,0,0
2703,NCT04476914,Completed,2021-06-15,2021-06-15,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04476914,2021-06-15,0,0
2704,NCT04476927,Not yet recruiting,2021-05-30,2021-06-30,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04476927,2021-05-30,0,0
2705,NCT04476940,Not yet recruiting,2021-10-01,2022-06-01,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04476940,2021-10-01,0,0
2706,NCT04476953,Enrolling by invitation,2022-09-01,2023-07-01,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04476953,2022-09-01,0,0
2707,NCT04476979,Recruiting,2021-06-30,2021-12-31,No Results Posted,"['Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, Ghosn J, Coupez E, Grapin K, Rapp C, Michel M, Lecapitaine AL, Michot JM, Costedoat-Chalumeau N, Nguyen LBL, Semerano L, Raffi F, Aguillar C, Rouzaud C, Gottenberg JE, Hansmann Y, Bienvenu B, London J, Fantchou FS, Ackermann F, Gros A, Morel A, Gambier N, S√®ne D, M√©garbane B, Azoulay E, Bureau S, Dougados M, Emmerich J, Fartoukh M, Guidet B, Humbert M, Mahevas M, P√®ne F, Schlemmer F, Pourcher-Martinez V, Tibi A, Baron G, Perrodeau E, Baron S, Steg G, Yazdapanah Y, Simon T, Resche-Rigon M, Tharaux PL, Ravaud P. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group. EClinicalMedicine. 2022 Mar 25;46:101362. doi: 10.1016/j.eclinm.2022.101362. eCollection 2022 Apr.']",,2021-04-19,https://clinicaltrials.gov/show/NCT04476979,2021-06-30,0,1
2708,NCT04476992,"Active, not recruiting",2021-07-17,2021-09-17,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04476992,2021-07-17,0,0
2709,NCT04477083,"Active, not recruiting",2020-08-15,2020-08-15,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04477083,2020-08-15,0,0
2710,NCT04477473,Completed,2020-08-30,2020-08-31,No Results Posted,,,2021-11-02,https://clinicaltrials.gov/show/NCT04477473,2020-08-30,0,0
2711,NCT04477642,Withdrawn,2020-10-01,2020-12-01,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04477642,2020-10-01,0,0
2712,NCT04477655,Completed,2021-01-26,2021-01-26,No Results Posted,"['Ibarra-Estrada M, Li J, Pavlov I, Perez Y, Roca O, Tavernier E, McNicholas B, Vines D, Mar√≠n-Rosales M, Vargas-Obieta A, Garc√≠a-Salcido R, Aguirre-D√≠az SA, L√≥pez-Pulgar√≠n JA, Ch√°vez-Pe√±a Q, Mijangos-M√©ndez JC, Aguirre-Avalos G, Ehrmann S, Laffey JG. Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial. Crit Care. 2022 Mar 28;26(1):84. doi: 10.1186/s13054-022-03950-0.', 'Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.', 'Ibarra-Estrada M√Å, Mar√≠n-Rosales M, Garc√≠a-Salcido R, Aguirre-D√≠az SA, Vargas-Obieta A, Ch√°vez-Pe√±a Q, L√≥pez-Pulgar√≠n JA, Mijangos-M√©ndez JC, Aguirre-Avalos G. Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 23;21(1):940. doi: 10.1186/s13063-020-04882-2.']",,2021-04-13,https://clinicaltrials.gov/show/NCT04477655,2021-01-26,0,1
2713,NCT04477668,Recruiting,2021-09-01,2022-02-01,No Results Posted,"['Arabi Y, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, Abdukahil SA, Jose J, Al Harbi MK, Al Haji H, Al Mutairi M, Al Zumai O, Al Qasim E, Al Wehaibi W, Alshahrani M, Albrahim T, Mady A, Al Bshabshe A, Al Aseri Z, Al Duhailib Z, Kharaba A, Alqahtani R, Algethamy H, Alfaris O, Alnafel O, Al-Fares AA, Tlayjeh H. Helmet noninvasive ventilation for COVID-19 patients (Helmet-COVID): statistical analysis plan for a randomized controlled trial. Trials. 2022 Feb 2;23(1):105. doi: 10.1186/s13063-021-05988-x.', 'Arabi YM, Tlayjeh H, Aldekhyl S, Al-Dorzi HM, Abdukahil SA, Al Harbi MK, Al Haji H, Al Mutairi M, Al Zumai O, Al Qasim E, Al Wehaibi W, Al Qahtani S, Al-Hameed F, Chalabi J, Alshahrani M, Albrahim T, Alharthy A, Mady A, Bin Eshaq A, Al Bshabshe AA, Al Aseri Z, Al Duhailib Z, Kharaba A, Alqahtani R, Al Ghamdi A, Altalag A, Alghamdi K, Almaani M, Algethamy H, Al Aqeily A, Al Baseet F, Al Samannoudi H, Al Obaidi M, Ismaiel YT, Al-Fares AA. Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial. BMJ Open. 2021 Aug 26;11(8):e052169. doi: 10.1136/bmjopen-2021-052169.']",,2021-09-13,https://clinicaltrials.gov/show/NCT04477668,2021-09-01,0,1
2714,NCT04477889,Recruiting,2025-12-01,2026-12-01,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04477889,2025-12-01,0,0
2715,NCT04477902,Completed,2021-06-22,2021-06-22,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04477902,2021-06-22,0,0
2716,NCT04477954,Terminated,2020-11-06,2020-12-30,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04477954,2020-11-06,0,0
2717,NCT04477993,Terminated,2021-03-29,2021-03-29,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04477993,2021-03-29,0,0
2718,NCT04478019,"Active, not recruiting",2022-04-30,2022-04-30,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04478019,2022-04-30,0,0
2719,NCT04478071,"Active, not recruiting",2022-02-16,2022-04-11,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04478071,2022-02-16,0,0
2720,NCT04478539,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2020-07-20,https://clinicaltrials.gov/show/NCT04478539,2021-06-01,0,0
2721,NCT04479124,Completed,2020-06-30,2020-07-14,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04479124,2020-06-30,0,0
2722,NCT04479137,Completed,2020-06-30,2020-07-14,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04479137,2020-06-30,0,0
2723,NCT04479150,Completed,2020-08-31,2020-08-31,No Results Posted,"['Osorio J, Madrazo Z, Videla S, Sainz B, Rodr√≠guez-Gonz√°lez A, Campos A, Santamar√≠a M, Pelegrina A, Gonz√°lez-Serrano C, Aldeano A, Sarriugarte A, G√≥mez-D√≠az CJ, Ruiz-Luna D, Garc√≠a-Ruiz-de-Gordejuela A, G√≥mez-Gavara C, Gil-Barrionuevo M, Vila M, Clavell A, Campillo B, Mill√°n L, Olona C, S√°nchez-Cordero S, Medrano R, L√≥pez-Ar√©valo CA, P√©rez-Romero N, Artigau E, Calle M, Echenagusia V, Otero A, Tebe C, Pallares N, Biondo S; COVID-CIR Collaborative Group Members of the COVID-CIR Collaborative Group. Analysis of outcomes of emergency general and gastrointestinal surgery during the COVID-19 pandemic. Br J Surg. 2021 Dec 1;108(12):1438-1447. doi: 10.1093/bjs/znab299.', 'Madrazo Z, Osorio J, Otero A, Biondo S, Videla S; COVID-CIR Collaborative Group. Postoperative complications and mortality following emergency digestive surgery during the COVID-19 pandemic: A multicenter collaborative retrospective cohort study protocol (COVID-CIR). Medicine (Baltimore). 2021 Feb 5;100(5):e24409. doi: 10.1097/MD.0000000000024409.']",,2021-02-23,https://clinicaltrials.gov/show/NCT04479150,2020-08-31,0,1
2724,NCT04479163,Completed,2020-10-25,2020-10-25,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Libster R, P√©rez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, Esteban I, Caballero MT, Wood C, Berrueta M, Rondan A, Lescano G, Cruz P, Ritou Y, Fern√°ndez Vi√±a V, √Ålvarez Paggi D, Esperante S, Ferreti A, Ofman G, Ciganda √Å, Rodriguez R, Lantos J, Valentini R, Itcovici N, Hintze A, Oyarvide ML, Etchegaray C, Neira A, Name I, Alfonso J, L√≥pez Castelo R, Caruso G, Rapelius S, Alvez F, Etchenique F, Dimase F, Alvarez D, Aranda SS, S√°nchez Yanotti C, De Luca J, Jares Baglivo S, Laudanno S, Nowogrodzki F, Larrea R, Silveyra M, Leberzstein G, Debonis A, Molinos J, Gonz√°lez M, Perez E, Kreplak N, Pastor Arg√ºello S, Gibbons L, Althabe F, Bergel E, Polack FP; Fundaci√≥n INFANT-COVID-19 Group. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.']",,2020-12-22,https://clinicaltrials.gov/show/NCT04479163,2020-10-25,0,1
2725,NCT04479202,Completed,2020-04-18,2020-04-23,No Results Posted,,"['Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, M√ºller T, Adolph TE, Tilg H. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020 Aug;69(8):1543-1544. doi: 10.1136/gutjnl-2020-321388. Epub 2020 Apr 20.', 'Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, Hao SR, Jia HY, Cai H, Zhang XL, Yu GD, Xu KJ, Wang XY, Gu JQ, Zhang SY, Ye CY, Jin CL, Lu YF, Yu X, Yu XP, Huang JR, Xu KL, Ni Q, Yu CB, Zhu B, Li YT, Liu J, Zhao H, Zhang X, Yu L, Guo YZ, Su JW, Tao JJ, Lang GJ, Wu XX, Wu WR, Qv TT, Xiang DR, Yi P, Shi D, Chen Y, Ren Y, Qiu YQ, Li LJ, Sheng J, Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.']",2020-07-21,https://clinicaltrials.gov/show/NCT04479202,2020-04-18,0,1
2726,NCT04479280,Completed,2020-08-16,2020-08-16,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04479280,2020-08-16,0,0
2727,NCT04479293,Recruiting,2020-10-30,2020-11-30,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04479293,2020-10-30,0,0
2728,NCT04479319,"Active, not recruiting",2021-11-01,2021-11-01,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04479319,2021-11-01,0,0
2729,NCT04479332,Completed,2021-02-23,2021-02-23,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04479332,2021-02-23,0,0
2730,NCT04479345,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04479345,2020-09-01,0,0
2731,NCT04479358,Recruiting,2022-03-01,2023-03-01,No Results Posted,,,2021-12-02,https://clinicaltrials.gov/show/NCT04479358,2022-03-01,0,0
2732,NCT04479488,"Active, not recruiting",2021-03-30,2022-05-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04479488,2021-03-30,0,0
2733,NCT04479540,Recruiting,2022-02-26,2022-03-05,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04479540,2022-02-26,0,0
2734,NCT04479982,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04479982,2020-12-31,0,0
2735,NCT04480034,Recruiting,2021-01-31,2021-05-30,No Results Posted,,"['Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.', 'Chen Q, Zheng Z, Zhang C, Zhang X, Wu H, Wang J, Wang S, Zheng C. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020 Aug;48(4):543-551. doi: 10.1007/s15010-020-01432-5. Epub 2020 Apr 28.', 'Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020 Jun;21(6):e13034. doi: 10.1111/obr.13034. Epub 2020 Apr 13.', 'Honce R, Schultz-Cherry S. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front Immunol. 2019 May 10;10:1071. doi: 10.3389/fimmu.2019.01071. eCollection 2019. Review.', 'Kornum JB, N√∏rgaard M, Dethlefsen C, Due KM, Thomsen RW, Tj√∏nneland A, S√∏rensen HT, Overvad K. Obesity and risk of subsequent hospitalisation with pneumonia. Eur Respir J. 2010 Dec;36(6):1330-6. doi: 10.1183/09031936.00184209. Epub 2010 Mar 29.', 'Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018 Sep;233(9):6425-6440. doi: 10.1002/jcp.26429. Epub 2018 Mar 1. Review.', 'Cheng CI, Chen PH, Lin YC, Kao YH. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway. Cell Signal. 2015 Feb;27(2):283-92. doi: 10.1016/j.cellsig.2014.11.012. Epub 2014 Nov 14.', 'Torres-Castro I, Arroyo-Camarena √öD, Mart√≠nez-Reyes CP, G√≥mez-Arauz AY, Due√±as-Andrade Y, Hern√°ndez-Ruiz J, B√©jar YL, Zaga-Clavellina V, Morales-Montor J, Terrazas LI, Kzhyshkowska J, Escobedo G. Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose. Immunol Lett. 2016 Aug;176:81-9. doi: 10.1016/j.imlet.2016.06.001. Epub 2016 Jun 4. Erratum in: Immunol Lett. 2017 Dec;192:106.', 'Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009 Jan 29;457(7229):557-61. doi: 10.1038/nature07665. Epub 2009 Jan 11. Erratum in: Nature. 2009 Feb 26;457(7233):1168.', 'van der Weerd K, Dik WA, Schrijver B, Schweitzer DH, Langerak AW, Drexhage HA, Kiewiet RM, van Aken MO, van Huisstede A, van Dongen JJ, van der Lelij AJ, Staal FJ, van Hagen PM. Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype. Diabetes. 2012 Feb;61(2):401-8. doi: 10.2337/db11-1065. Epub 2012 Jan 6.', 'Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr. 2007 May;137(5):1236-43.', 'Mauro C, Smith J, Cucchi D, Coe D, Fu H, Bonacina F, Baragetti A, Cermenati G, Caruso D, Mitro N, Catapano AL, Ammirati E, Longhi MP, Okkenhaug K, Norata GD, Marelli-Berg FM. Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4(+) T Cell Differentiation via PI3K p110Œ¥-Akt-Mediated Signals. Cell Metab. 2017 Mar 7;25(3):593-609. doi: 10.1016/j.cmet.2017.01.008. Epub 2017 Feb 9.', 'Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9. Erratum in: Cell. 2020 Dec 10;183(6):1735.', 'Schling P, Mallow H, Trindl A, L√∂ffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord. 1999 Apr;23(4):336-41.', 'Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000 Jun;35(6):1270-7. Review.', 'Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683. Erratum in: JAMA. 2020 Apr 28;323(16):1619.', 'Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020 Jun;16(6):297-298. doi: 10.1038/s41574-020-0353-9.', 'Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005 Apr 5;142(7):547-59.', 'Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015 Sep 5;386(9997):964-73. doi: 10.1016/S0140-6736(15)00075-6.', 'Capoccia D, Guida A, Coccia F, Guarisco G, Testa M, Leonetti F, Silecchia G. Weight Regain and Diabetes Evolution After Sleeve Gastrectomy: a Cohort Study with over 5 Years of Follow-Up. Obes Surg. 2020 Mar;30(3):1046-1051. doi: 10.1007/s11695-019-04350-0.', 'Sj√∂str√∂m L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8. Review.', 'Goto T, Hirayama A, Faridi MK, Camargo CA Jr, Hasegawa K. Association of Bariatric Surgery With Risk of Infectious Diseases: A Self-Controlled Case Series Analysis. Clin Infect Dis. 2017 Oct 15;65(8):1349-1355. doi: 10.1093/cid/cix541.', ""Sharma P, McCarty TR, Ngu JN, O'Donnell M, Njei B. Impact of bariatric surgery in patients with HIV infection: a nationwide inpatient sample analysis, 2004-2014. AIDS. 2018 Sep 10;32(14):1959-1965. doi: 10.1097/QAD.0000000000001915."", 'Yang W, Wang C, Shikora S, Kow L. Recommendations for Metabolic and Bariatric Surgery During the COVID-19 Pandemic from IFSO. Obes Surg. 2020 Jun;30(6):2071-2073. doi: 10.1007/s11695-020-04578-1.', 'Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, Carrano FM, Agresta F, Alar√ßon I, Azran C, Bouvy N, Balagu√® Ponz C, Buza M, Copaescu C, De Luca M, Dicker D, Di Vincenzo A, Felsenreich DM, Francis NK, Fried M, Gonzalo Prats B, Goitein D, Halford JCG, Herlesova J, Kalogridaki M, Ket H, Morales-Conde S, Piatto G, Prager G, Pruijssers S, Pucci A, Rayman S, Romano E, Sanchez-Cordero S, Vilallonga R, Silecchia G. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020 Jun;34(6):2332-2358. doi: 10.1007/s00464-020-07555-y. Epub 2020 Apr 23.']",2020-11-05,https://clinicaltrials.gov/show/NCT04480034,2021-01-31,0,1
2736,NCT04480060,Completed,2020-06-30,2020-07-14,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04480060,2020-06-30,0,0
2737,NCT04480112,Completed,2021-06-11,2021-06-11,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04480112,2021-06-11,0,0
2738,NCT04480138,"Active, not recruiting",2021-07-31,2021-08-31,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04480138,2021-07-31,0,0
2739,NCT04480333,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04480333,2020-12-31,0,0
2740,NCT04480398,Completed,2020-06-15,2020-07-03,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04480398,2020-06-15,0,0
2741,NCT04480411,Withdrawn,2022-12-01,2022-12-01,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04480411,2022-12-01,0,0
2742,NCT04480424,Completed,2021-08-19,2021-10-25,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04480424,2021-08-19,0,0
2743,NCT04480515,Completed,2020-06-15,2020-06-30,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04480515,2020-06-15,0,0
2744,NCT04480580,Completed,2020-04-30,2020-06-30,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04480580,2020-04-30,0,0
2745,NCT04480593,Completed,2020-08-30,2020-08-30,No Results Posted,,"['Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019. Review.', 'Maruta H, He H. PAK1-blockers: Potential Therapeutics against COVID-19. Med Drug Discov. 2020 Jun;6:100039. doi: 10.1016/j.medidd.2020.100039. Epub 2020 Apr 19. Review.', 'Serkedjieva J, Manolova N, Bankova V. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). J Nat Prod. 1992 Mar;55(3):294-302.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Machado JL, Assun√ß√£o AK, da Silva MC, Dos Reis AS, Costa GC, Arruda Dde S, Rocha BA, Vaz MM, Paes AM, Guerra RN, Berretta AA, do Nascimento FR. Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity. Evid Based Complement Alternat Med. 2012;2012:157652. doi: 10.1155/2012/157652. Epub 2012 Dec 19.', 'Mani JS, Johnson JB, Steel JC, Broszczak DA, Neilsen PM, Walsh KB, Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020 Jul 15;284:197989. doi: 10.1016/j.virusres.2020.197989. Epub 2020 Apr 30. Review.', 'Silveira MAD, Teles F, Berretta AA, Sanches TR, Rodrigues CE, Seguro AC, Andrade L. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. BMC Nephrol. 2019 Apr 25;20(1):140. doi: 10.1186/s12882-019-1337-7.', 'Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GCO, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF¬Æ) using an in vivo cocktail approach. J Ethnopharmacol. 2019 Dec 5;245:112174. doi: 10.1016/j.jep.2019.112174. Epub 2019 Aug 20.']",2020-09-30,https://clinicaltrials.gov/show/NCT04480593,2020-08-30,0,1
2746,NCT04480606,Not yet recruiting,2020-11-20,2020-11-20,No Results Posted,,,2020-07-21,https://clinicaltrials.gov/show/NCT04480606,2020-11-20,0,0
2747,NCT04480632,Not yet recruiting,2021-08-01,2022-08-01,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04480632,2021-08-01,0,0
2748,NCT04481360,Not yet recruiting,2021-08-01,2021-09-01,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04481360,2021-08-01,0,0
2749,NCT04481477,Recruiting,2021-04-15,2021-04-15,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04481477,2021-04-15,0,0
2750,NCT04481516,Recruiting,2021-12-31,2022-02-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04481516,2021-12-31,0,0
2751,NCT04481529,"Active, not recruiting",2020-12-15,2021-01-15,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04481529,2020-12-15,0,0
2752,NCT04481620,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04481620,2021-05-31,0,0
2753,NCT04481633,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04481633,2022-03-01,0,0
2754,NCT04481646,Recruiting,2022-06-01,2025-06-01,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04481646,2022-06-01,0,0
2755,NCT04481685,Completed,2021-02-25,2021-06-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04481685,2021-02-25,0,0
2756,NCT04482023,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04482023,2021-04-30,0,0
2757,NCT04482205,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-07-22,https://clinicaltrials.gov/show/NCT04482205,2020-05-31,0,0
2758,NCT04482361,Completed,2020-12-22,2020-12-22,No Results Posted,,,2021-01-25,https://clinicaltrials.gov/show/NCT04482361,2020-12-22,0,0
2759,NCT04482387,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04482387,2021-07-01,0,0
2760,NCT04482595,Recruiting,2023-02-28,2023-11-30,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04482595,2023-02-28,0,0
2761,NCT04482621,Recruiting,2022-05-01,2022-08-01,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04482621,2022-05-01,0,0
2762,NCT04482634,Recruiting,2022-08-01,2022-08-01,No Results Posted,,"['Held N, Moss M. Optimizing Post-Intensive Care Unit Rehabilitation. Turk Thorac J. 2019 Apr 1;20(2):147-152. doi: 10.5152/TurkThoracJ.2018.18172. Print 2019 Apr. Review.', 'Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van M√∂lken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.', 'Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005;51(4):213-9.', 'Bourne S, DeVos R, North M, Chauhan A, Green B, Brown T, Cornelius V, Wilkinson T. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open. 2017 Jul 17;7(7):e014580. doi: 10.1136/bmjopen-2016-014580.', 'Turan Z, √ñzyemi≈ü√ßi Ta≈ükƒ±ran √ñ, Erden Z, K√∂kt√ºrk N, Kaymak Karata≈ü G. Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study. Turk J Med Sci. 2019 Jun 18;49(3):802-808. doi: 10.3906/sag-1811-22.', 'Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6.', 'Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.', ""Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321-7."", 'Bergland A, J√∏rgensen L, Emaus N, Strand BH. Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Troms√∏ study. BMC Health Serv Res. 2017 Jan 10;17(1):22. doi: 10.1186/s12913-016-1950-0.', 'Beaudart C, McCloskey E, Bruy√®re O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Berti√®re MC, Brandi ML, Al-Daghri NM, Burlet N, Cavalier E, Cerreta F, Cherubini A, Fielding R, Gielen E, Landi F, Petermans J, Reginster JY, Visser M, Kanis J, Cooper C. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016 Oct 5;16(1):170. Review.']",2020-11-05,https://clinicaltrials.gov/show/NCT04482634,2022-08-01,0,1
2763,NCT04482647,"Active, not recruiting",2020-11-05,2024-11-01,Study Results,"['Narayanan S, Tennison J, Cohen L, Urso C, Subramaniam B, Bruera E. Yoga-Based Breathing Techniques for Health Care Workers During COVID-19 Pandemic: Interests, Feasibility, and Acceptance. J Altern Complement Med. 2021 Aug;27(8):706-709. doi: 10.1089/acm.2020.0536. Epub 2021 Apr 9.']",,2022-02-16,https://clinicaltrials.gov/show/NCT04482647,2020-11-05,1,1
2764,NCT04482673,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04482673,2022-12-31,0,0
2765,NCT04482699,Terminated,2021-09-13,2021-09-13,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04482699,2021-09-13,0,0
2766,NCT04482712,Withdrawn,2022-01-01,2023-01-01,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04482712,2022-01-01,0,0
2767,NCT04483375,Completed,2020-11-17,2020-11-17,No Results Posted,"['Li Y, Qi L, Bai H, Sun C, Xu S, Wang Y, Han C, Li Y, Liu L, Cheng X, Liu J, Lei C, Tong Y, Sun M, Yan L, Chen W, Liu X, Liu Q, Xie L, Wang X. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0106321. doi: 10.1128/AAC.01063-21. Epub 2021 Sep 7.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-03-23,https://clinicaltrials.gov/show/NCT04483375,2020-11-17,0,1
2768,NCT04483622,Recruiting,2021-01-13,2021-02-15,No Results Posted,,,2020-07-23,https://clinicaltrials.gov/show/NCT04483622,2021-01-13,0,0
2769,NCT04483635,Terminated,2021-05-04,2021-05-25,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04483635,2021-05-04,0,0
2770,NCT04483752,Recruiting,2021-12-24,2022-12-24,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04483752,2021-12-24,0,0
2771,NCT04483830,Completed,2020-08-06,2020-09-07,Results Submitted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2020-09-09,https://clinicaltrials.gov/show/NCT04483830,2020-08-06,0,1
2772,NCT04483908,Recruiting,2022-05-30,2022-05-30,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04483908,2022-05-30,0,0
2773,NCT04483960,Recruiting,2021-12-31,2022-12-31,No Results Posted,"['Bassi A, Arfin S, Joshi R, Bathla N, Hammond NE, Rajbhandari D, Tirupakuzhi Vijayaraghavan BK, Venkatesh B, Jha V. Challenges in operationalising clinical trials in India during the COVID-19 pandemic. Lancet Glob Health. 2022 Mar;10(3):e317-e319. doi: 10.1016/S2214-109X(21)00546-5. Epub 2021 Dec 22. Review.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04483960,2021-12-31,0,1
2774,NCT04483973,Enrolling by invitation,2022-08-01,2022-08-01,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04483973,2022-08-01,0,0
2775,NCT04484025,Enrolling by invitation,2022-08-01,2022-08-01,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04484025,2022-08-01,0,0
2776,NCT04484207,Completed,2020-10-20,2020-10-26,Study Results,"['Amsalem D, Lazarov A, Markowitz JC, Gorman D, Dixon LB, Neria Y. Increasing treatment-seeking intentions of US veterans in the Covid-19 era: A randomized controlled trial. Depress Anxiety. 2021 Jun;38(6):639-647. doi: 10.1002/da.23149. Epub 2021 Mar 18.']",,2021-10-28,https://clinicaltrials.gov/show/NCT04484207,2020-10-20,1,1
2777,NCT04484493,Completed,2020-10-25,2020-11-03,No Results Posted,"['Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial. Am J Otolaryngol. 2021 Mar-Apr;42(2):102884. doi: 10.1016/j.amjoto.2020.102884. Epub 2021 Jan 4.']",,2020-11-13,https://clinicaltrials.gov/show/NCT04484493,2020-10-25,0,1
2778,NCT04484545,"Active, not recruiting",2021-06-01,2021-06-01,Results Submitted,"['McGovern J, Al-Azzawi Y, Kemp O, Moffitt P, Richards C, Dolan RD, Laird BJ, McMillan DC, Maguire D. The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19. J Transl Med. 2022 Feb 21;20(1):98. doi: 10.1186/s12967-022-03300-2.', 'Maguire D, Richards C, Woods M, Dolan R, Wilson Veitch J, Sim WMJ, Kemmett OEH, Milton DC, Randall SLW, Bui LD, Goldmann N, Brown A, Gillen E, Cameron A, Laird B, Talwar D, Godber IM, Wadsworth J, Catchpole A, Davidson A, McMillan DC. The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts. PLoS One. 2021 May 27;16(5):e0251924. doi: 10.1371/journal.pone.0251924. eCollection 2021.']",,2020-07-23,https://clinicaltrials.gov/show/NCT04484545,2021-06-01,0,1
2779,NCT04484597,Recruiting,2020-08-15,2020-09-15,No Results Posted,,,2020-07-23,https://clinicaltrials.gov/show/NCT04484597,2020-08-15,0,0
2780,NCT04485130,Recruiting,2021-12-31,2022-04-30,No Results Posted,,"['Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2019 Mar;105(3):692-702. doi: 10.1002/cpt.1220. Epub 2018 Oct 9.', 'Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, Lewin SR. Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study. Lancet HIV. 2015 Dec;2(12):e520-9. doi: 10.1016/S2352-3018(15)00226-X. Epub 2015 Nov 17.', 'Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.', 'Lin MH, Moses DC, Hsieh CH, Cheng SC, Chen YH, Sun CY, Chou CY. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. Antiviral Res. 2018 Feb;150:155-163. doi: 10.1016/j.antiviral.2017.12.015. Epub 2017 Dec 28.', 'Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, Wang J, Hollingsworth LR, Magupalli VG, Zhao L, Luo HR, Kim J, Lieberman J, Wu H. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020 Jul;21(7):736-745. doi: 10.1038/s41590-020-0669-6. Epub 2020 May 4.', 'Lobo-Galo N, Terrazas-L√≥pez M, Mart√≠nez-Mart√≠nez A, D√≠az-S√°nchez √ÅG. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. J Biomol Struct Dyn. 2021 Jun;39(9):3419-3427. doi: 10.1080/07391102.2020.1764393. Epub 2020 May 14.']",2021-05-10,https://clinicaltrials.gov/show/NCT04485130,2021-12-31,0,1
2781,NCT04485169,Completed,2020-07-31,2020-07-31,No Results Posted,,"['Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9.']",2020-09-28,https://clinicaltrials.gov/show/NCT04485169,2020-07-31,0,1
2782,NCT04485338,Completed,2020-12-31,2021-09-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04485338,2020-12-31,0,0
2783,NCT04485351,Recruiting,2020-08-01,2020-09-01,No Results Posted,"['Ludwig L, Scheyer N, Remen T, Guerci B. The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study. Diabetes Ther. 2021 Aug;12(8):2207-2221. doi: 10.1007/s13300-021-01105-y. Epub 2021 Jul 9.']",,2020-07-24,https://clinicaltrials.gov/show/NCT04485351,2020-08-01,0,1
2784,NCT04485364,Recruiting,2022-12-31,2022-12-31,No Results Posted,,"['Bradley BT, Bryan A. Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella. Semin Diagn Pathol. 2019 May;36(3):152-159. doi: 10.1053/j.semdp.2019.04.006. Epub 2019 Apr 17. Review.', 'Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018 Feb;23(2):130-137. doi: 10.1111/resp.13196. Epub 2017 Oct 20. Review.', 'Vijayanand P, Wilkins E, Woodhead M. Severe acute respiratory syndrome (SARS): a review. Clin Med (Lond). 2004 Mar-Apr;4(2):152-60. Review.', 'Fehr AR, Channappanavar R, Perlman S. Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus. Annu Rev Med. 2017 Jan 14;68:387-399. doi: 10.1146/annurev-med-051215-031152. Epub 2016 Aug 26. Review.']",2022-01-31,https://clinicaltrials.gov/show/NCT04485364,2022-12-31,0,1
2785,NCT04485429,Withdrawn,2022-12-31,2022-12-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-08-11,https://clinicaltrials.gov/show/NCT04485429,2022-12-31,0,1
2786,NCT04486001,Completed,2021-06-09,2021-08-30,No Results Posted,,"['Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020 May 18;18(1):203. doi: 10.1186/s12967-020-02380-2. Review.']",2022-03-17,https://clinicaltrials.gov/show/NCT04486001,2021-06-09,0,1
2787,NCT04486144,Completed,2020-07-23,2020-07-23,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04486144,2020-07-23,0,0
2788,NCT04486313,Completed,2021-02-08,2021-02-08,No Results Posted,"['Rossignol JF, Bardin MC, Fulgencio J, Mogelnicki D, Br√©chot C. A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19. EClinicalMedicine. 2022 Feb 28;45:101310. doi: 10.1016/j.eclinm.2022.101310. eCollection 2022 Mar.']",,2022-02-11,https://clinicaltrials.gov/show/NCT04486313,2021-02-08,0,1
2789,NCT04486404,Enrolling by invitation,2020-06-30,2021-12-30,No Results Posted,"['Martin-Delgado J, Viteri E, Mula A, Serpa P, Pacheco G, Prada D, Campos de Andrade Louren√ß√£o D, Campos Pavan Baptista P, Ramirez G, Mira JJ. Availability of personal protective equipment and diagnostic and treatment facilities for healthcare workers involved in COVID-19 care: A cross-sectional study in Brazil, Colombia, and Ecuador. PLoS One. 2020 Nov 11;15(11):e0242185. doi: 10.1371/journal.pone.0242185. eCollection 2020.']",,2021-09-30,https://clinicaltrials.gov/show/NCT04486404,2020-06-30,0,1
2790,NCT04486417,Recruiting,2020-07-22,2020-07-31,No Results Posted,,,2020-07-24,https://clinicaltrials.gov/show/NCT04486417,2020-07-22,0,0
2791,NCT04486482,Completed,2021-03-30,2021-03-30,No Results Posted,"['Haran JP, Pinero JC, Zheng Y, Palma NA, Wingertzahn M. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.']",,2021-08-13,https://clinicaltrials.gov/show/NCT04486482,2021-03-30,0,1
2792,NCT04486508,Completed,2021-04-04,2021-07-05,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Erdem S, Ipek F, Bars A, Gen√ß V, Erpek E, Mohammadi S, Altƒ±nata A, Akar S. Investigating the effect of macro-scale estimators on worldwide COVID-19 occurrence and mortality through regression analysis using online country-based data sources. BMJ Open. 2022 Feb 14;12(2):e055562. doi: 10.1136/bmjopen-2021-055562.', 'INSPIRATION-S Investigators. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial. BMJ. 2022 Jan 7;376:e068407. doi: 10.1136/bmj-2021-068407.', 'INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.']","['Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 Dec;196:382-394. doi: 10.1016/j.thromres.2020.09.027. Epub 2020 Sep 24.']",2021-08-17,https://clinicaltrials.gov/show/NCT04486508,2021-04-04,0,1
2793,NCT04486729,Recruiting,2020-10-10,2020-10-20,No Results Posted,"['Dorado JH, P√©rez J, Navarro E, Gogniat E, Torres S, Cagide S, Accoce M. Impact of liberal versus conservative saturation targets on gas exchange indices in COVID-19 related acute respiratory distress syndrome: a physiological study. Rev Bras Ter Intensiva. 2022 Jan 24;33(4):537-543. doi: 10.5935/0103-507X.20210081. eCollection 2022. Portuguese, English.']",,2020-07-27,https://clinicaltrials.gov/show/NCT04486729,2020-10-10,0,1
2794,NCT04487119,Completed,2020-08-20,2020-08-23,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04487119,2020-08-20,0,0
2795,NCT04487171,Recruiting,2021-07-01,2021-08-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04487171,2021-07-01,0,0
2796,NCT04487197,Completed,2021-01-15,2021-01-15,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04487197,2021-01-15,0,0
2797,NCT04487210,Completed,2021-06-01,2021-12-06,No Results Posted,"['Hsieh SM, Liu WD, Huang YS, Lin YJ, Hsieh EF, Lian WC, Chen C, Janssen R, Shih SR, Huang CG, Tai IC, Chang SC. Safety and immunogenicity of a Recombinant Stabilized Prefusion SARS-CoV-2 Spike Protein Vaccine (MVC-COV1901) Adjuvanted with CpG 1018 and Aluminum Hydroxide in healthy adults: A Phase 1, dose-escalation study. EClinicalMedicine. 2021 Aug;38:100989. doi: 10.1016/j.eclinm.2021.100989. Epub 2021 Jun 26.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04487210,2021-06-01,0,1
2798,NCT04487444,Recruiting,2022-03-01,2022-06-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04487444,2022-03-01,0,0
2799,NCT04487574,Completed,2020-10-29,2020-10-29,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04487574,2020-10-29,0,0
2800,NCT04487639,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04487639,2021-07-01,0,0
2801,NCT04487665,Not yet recruiting,2020-11-15,2020-12-15,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04487665,2020-11-15,0,0
2802,NCT04487769,Recruiting,2021-08-01,2021-10-01,No Results Posted,"['Pierrakos C, Lieveld A, Pisani L, Smit MR, Heldeweg M, Hagens LA, Smit J, Haaksma M, Veldhuis L, Schmidt RW, Errico G, Marinelli V, Attou R, David CE, Zimatore C, Murgolo F, Grasso S, Mirabella L, Cinnella G, De Bels D, Schultz MJ, Tuinman PR, Bos LD. A Lower Global Lung Ultrasound Score Is Associated with Higher Likelihood of Successful Extubation in Invasively Ventilated COVID-19 Patients. Am J Trop Med Hyg. 2021 Oct 18;105(6):1490-1497. doi: 10.4269/ajtmh.21-0545.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04487769,2021-08-01,0,1
2803,NCT04487873,Completed,2020-12-18,2021-01-31,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04487873,2020-12-18,0,0
2804,NCT04487886,Completed,2021-06-10,2021-06-10,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04487886,2021-06-10,0,0
2805,NCT04487951,Recruiting,2020-11-01,2021-01-01,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04487951,2020-11-01,0,0
2806,NCT04487964,Completed,2021-11-01,2021-12-01,No Results Posted,"['Gomaa AA, Mohamed HS, Abd-Ellatief RB, Gomaa MA, Hammam DS. Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial. Inflammopharmacology. 2022 Apr;30(2):477-486. doi: 10.1007/s10787-022-00939-7. Epub 2022 Mar 1.', 'Armanini D, Fiore C, Bielenberg J, Sabbadin C, Bordin L. Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice). Front Pharmacol. 2020 Oct 22;11:558418. doi: 10.3389/fphar.2020.558418. eCollection 2020.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04487964,2021-11-01,0,1
2807,NCT04487977,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,2020-07-27,https://clinicaltrials.gov/show/NCT04487977,2020-09-30,0,0
2808,NCT04487990,"Active, not recruiting",2021-03-31,2021-08-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Lins PRG, de Albuquerque CCC, Assis CF, Rodrigues BCD, E Siqueira Campos BP, de Oliveira Valle E, Cabrera CPS, de Oliveira Gois J, Segura GC, Strufaldi FL, Mainardes LC, Ribeiro RG, Via Reque Cortes DDP, Lutf LG, de Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Rodrigues CE. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 11;21(1):920. doi: 10.1186/s13063-020-04814-0.']",,2021-05-17,https://clinicaltrials.gov/show/NCT04487990,2021-03-31,0,1
2809,NCT04488081,Recruiting,2022-07-24,2022-11-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-07-21,https://clinicaltrials.gov/show/NCT04488081,2022-07-24,0,1
2810,NCT04488471,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04488471,2022-06-30,0,0
2811,NCT04488484,"Active, not recruiting",2021-12-31,2022-12-31,No Results Posted,,"['Janice Oh HL, Ken-En Gan S, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect. 2012 Sep;1(9):e23. doi: 10.1038/emi.2012.26. Epub 2012 Sep 5. Review.', 'Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J. Coronavirus infections and immune responses. J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7. Review.', 'Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol. 2020 Sep;92(9):1475-1483. doi: 10.1002/jmv.25961. Epub 2020 May 12.', 'Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772. Review.', 'Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hoz√© N, Richet J, Dubost CL, Le Strat Y, Lessler J, Levy-Bruhl D, Fontanet A, Opatowski L, Boelle PY, Cauchemez S. Estimating the burden of SARS-CoV-2 in France. Science. 2020 Jul 10;369(6500):208-211. doi: 10.1126/science.abc3517. Epub 2020 May 13. Erratum in: Science. 2020 Jun 26;368(6498):.']",2022-03-31,https://clinicaltrials.gov/show/NCT04488484,2021-12-31,0,1
2812,NCT04488510,Recruiting,2022-09-10,2022-12-31,No Results Posted,,,2021-12-30,https://clinicaltrials.gov/show/NCT04488510,2022-09-10,0,0
2813,NCT04488549,Completed,2020-06-10,2020-06-10,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04488549,2020-06-10,0,0
2814,NCT04488562,"Active, not recruiting",2021-12-01,2021-12-31,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04488562,2021-12-01,0,0
2815,NCT04488575,Terminated,2021-05-16,2021-05-19,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04488575,2021-05-16,0,0
2816,NCT04488588,Completed,2020-05-01,2020-07-01,No Results Posted,,,2020-07-28,https://clinicaltrials.gov/show/NCT04488588,2020-05-01,0,0
2817,NCT04488796,Completed,2020-12-16,2020-12-16,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04488796,2020-12-16,0,0
2818,NCT04489446,Completed,2021-04-30,2021-06-30,No Results Posted,"['Santamarina MG, Beddings I, Lomakin FM, Boisier Riscal D, Guti√©rrez Claveria M, Vidal Marambio J, Retamal B√°ez N, Pavez Novoa C, Reyes Allende C, Ferreira Perey P, Guti√©rrez Torres M, Villalobos Mazza C, Vergara Sagredo C, Ahumada Bermejo S, Labarca Mellado E, Barthel Munchmeyer E, Marchant Ramos S, Volpacchio M, Vega J. Sildenafil for treating patients with COVID-19 and perfusion mismatch: a pilot randomized trial. Crit Care. 2022 Jan 3;26(1):1. doi: 10.1186/s13054-021-03885-y.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04489446,2021-04-30,0,1
2819,NCT04489628,Withdrawn,2021-06-01,2021-06-01,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04489628,2021-06-01,0,0
2820,NCT04490200,Recruiting,2021-12-30,2022-02-15,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04490200,2021-12-30,0,0
2821,NCT04490239,Completed,2020-11-18,2020-11-18,Study Results,,,2021-04-30,https://clinicaltrials.gov/show/NCT04490239,2020-11-18,1,0
2822,NCT04490278,Completed,2021-06-30,2021-06-30,Results Submitted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04490278,2021-06-30,0,0
2823,NCT04490486,Not yet recruiting,2024-06-01,2024-06-01,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04490486,2024-06-01,0,0
2824,NCT04490772,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04490772,2020-09-01,0,0
2825,NCT04490811,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04490811,2021-12-31,0,0
2826,NCT04490824,Recruiting,2021-03-30,2021-04-30,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04490824,2021-03-30,0,0
2827,NCT04490837,Completed,2020-07-31,2020-09-30,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04490837,2020-07-31,0,0
2828,NCT04490850,Completed,2021-09-24,2021-09-24,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04490850,2021-09-24,0,0
2829,NCT04491071,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04491071,2021-12-01,0,0
2830,NCT04491201,Recruiting,2020-09-27,2020-09-27,No Results Posted,"['Li L, Cao Y, Fan J, Li T, Lang J, Zhang H, Lv J, Zhu L; Chinese Medical Doctor Association. Impact of COVID-19 Pandemic on the Clinical Activities in Obstetrics and Gynecology: A National Survey in China. Front Med (Lausanne). 2021 Jul 30;8:633477. doi: 10.3389/fmed.2021.633477. eCollection 2021.']",,2020-07-29,https://clinicaltrials.gov/show/NCT04491201,2020-09-27,0,1
2831,NCT04491214,Completed,2021-01-21,2021-01-21,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04491214,2021-01-21,0,0
2832,NCT04491227,Enrolling by invitation,2022-04-30,2023-03-31,No Results Posted,,,2020-07-29,https://clinicaltrials.gov/show/NCT04491227,2022-04-30,0,0
2833,NCT04491240,Completed,2020-10-01,2020-10-20,Study Results,,,2020-11-04,https://clinicaltrials.gov/show/NCT04491240,2020-10-01,1,0
2834,NCT04491292,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04491292,2022-04-30,0,0
2835,NCT04491318,Completed,2020-07-25,2020-07-29,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04491318,2020-07-25,0,0
2836,NCT04491994,Completed,2020-05-31,2020-05-31,Study Results,,,2020-08-21,https://clinicaltrials.gov/show/NCT04491994,2020-05-31,1,0
2837,NCT04492189,Completed,2020-05-30,2020-06-30,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04492189,2020-05-30,0,0
2838,NCT04492202,Not yet recruiting,2020-11-20,2020-12-10,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04492202,2020-11-20,0,0
2839,NCT04492228,Recruiting,2020-12-31,2021-05-30,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04492228,2020-12-31,0,0
2840,NCT04492254,Recruiting,2021-07-01,2021-09-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04492254,2021-07-01,0,0
2841,NCT04492267,Recruiting,2021-01-07,2021-01-07,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04492267,2021-01-07,0,0
2842,NCT04492358,Recruiting,2021-10-01,2021-10-01,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04492358,2021-10-01,0,0
2843,NCT04492371,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04492371,2022-07-01,0,0
2844,NCT04492384,Completed,2021-01-14,2021-01-14,No Results Posted,"['Tarlovskaya EI, Arutyunov AG, Konradi AO, Lopatin YM, Rebrov AP, Tereshchenko SN, Chesnikova AI, Hayrapetyan HG, Babin AP, Bakulin IG, Bakulina NV, Balykova LA, Blagonravova AS, Boldina MV, Vaisberg AR, Galyavich AS, Gomonova VV, Grigorieva NY, Gubareva IV, Demko IV, Evzerikhina AV, Zharkov AV, Kamilova UK, Kim ZF, Kuznetsova TY, Lareva NV, Makarova EV, Malchikova SV, Nedogoda SV, Petrova MM, Pochinka IG, Protasov KV, Protsenko DN, Ruzanau DY, Sayganov SA, Sarybaev AS, Selezneva NM, Sugraliev AB, Fomin IV, Khlynova OV, Chizhova OY, Shaposhnik II, Sh—Åukarev DA, Abdrahmanova AK, Avetisian SA, Avoyan HG, Azarian KK, Aimakhanova GT, Ayipova DA, Akunov AC, Alieva MK, Aparkina AV, Aruslanova OR, Ashina EY, Badina OY, Barisheva OY, Batchayeva AS, Bitieva AM, Bikhteyev IU, Borodulina NA, Bragin MV, Budu AM, Burygina LA, Bykova GA, Vagapova KR, Varlamova DD, Vezikova NN, Verbitskaya EA, Vilkova OE, Vinnikova EA, Vustina VV, G–∞lova EA, Genkel VV, Gorshenina EI, Gostishev RV, Grigorieva EV, Gubareva EY, Dabylova GM, Demchenko AI, Dolgikh OY, Duyshobayev MY, Evdokimov DS, Egorova KE, Ermilova AN, Zheldybayeva AE, Zarechnova NV, Zimina YD, Ivanova SY, Ivanchenko EY, Ilina MV, Kazakovtseva MV, Kazymova EV, Kalinina YS, Kamardina NA, Karachenova AM, Karetnikov IA, Karoli NA, Karpov OV, Karsiev MK, –öaskaeva DS, Kasymova KF, Kerimbekova ZB, Kerimova AS, Kim ES, Kiseleva NV, Klimenko DA, Klimova AV, Kovalishena OV, Kolmakova EV, Kolchinskaya TP, Kolyadich MI, Kondriakova OV, Konoval MP, Konstantinov DY, Konstantinova EA, Kordukova VA, Koroleva EV, Kraposhina AY, Kriukova TV, Kuznetsova AS, Kuzmina TY, Kuzmichev KV, Kulchoroeva CK, Kuprina TV, Kouranova IM, Kurenkova LV, Kurchugina NY, Kushubakova NA, Levankova VI, Levin M–ï, Lyubavina NA, Magdeyeva NA, Mazalov KV, Majseenko VI, Makarova AS, Maripov AM, Marusina AA, Melnikov ES, Moiseenko NB, Muradova FN, Muradyan RG, Myshak AO, Nikitina NM, Ogurlieva BB, Odegova AA, Omarova YM, Omurzakova NA, Ospanova SO, Pahomova EV, Petrov LD, Plastinina SS, Pogrebetskaya VA, Polyakov DS, Ponomarenko EV, Popova LL, Prokofeva NA, Pudova IA, Rakov NA, Rakhimov AN, Rozanova NA, Serikbolkyzy S, Simonov AA, Skachkova VV, Soloveva DV, Soloveva IA, Sokhova FM, Subbotin AK, Sukhomlinova IM, Sushilova AG, Tagayeva DR, Titojkina YV, Tikhonova EP, Tokmin DS, Tolmacheva AA, Torgunakova MS, Trenogina KV, Trostianetckaia NA, Trofimov DA, Tulichev AA, Tursunova AT, Ulanova ND, Fatenkov OV, Fedorishina OV, Fil TS, Fomina IY, Fominova IS, Frolova IA, Tsvinger SM, Tsoma VV, Cholponbaeva MB, Chudinovskikh TI, Shevchenko OA, Sheshina TV, Shishkina EA, Shishkov KY, Sherbakov SY, Yausheva EA, Musaelian SN, Belenkov YN, Arutyunov GP. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry (""Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2""). Kardiologiia. 2021 Sep 30;61(9):20-32. doi: 10.18087/cardio.2021.9.n1680. Russian, English.']",,2022-02-17,https://clinicaltrials.gov/show/NCT04492384,2021-01-14,0,1
2845,NCT04492410,Completed,2021-05-12,2021-11-12,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04492410,2021-05-12,0,0
2846,NCT04492501,Completed,2020-07-20,2020-07-20,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04492501,2020-07-20,0,0
2847,NCT04492514,Recruiting,2021-05-31,2021-05-31,No Results Posted,"['Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchi√© A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group. Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun;3(6):e410-e418. doi: 10.1016/S2665-9913(21)00070-9. Epub 2021 Mar 17.']",,2020-07-30,https://clinicaltrials.gov/show/NCT04492514,2021-05-31,0,1
2848,NCT04492527,Completed,2021-04-30,2021-06-30,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04492527,2021-04-30,0,0
2849,NCT04492865,Not yet recruiting,2020-08-30,2020-10-30,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04492865,2020-08-30,0,0
2850,NCT04492891,Recruiting,2025-11-23,2025-11-23,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04492891,2025-11-23,0,0
2851,NCT04492904,Completed,2021-06-15,2021-06-15,No Results Posted,"['Sheen F, Tan V, Haldar S, Sengupta S, Allen D, Somani J, Chen HY, Tambyah P, Forde CG. Evaluating the Onset, Severity, and Recovery of Changes to Smell and Taste Associated With COVID-19 Infection in a Singaporean Population (the COVOSMIA-19 Trial): Protocol for a Prospective Case-Control Study. JMIR Res Protoc. 2020 Dec 31;9(12):e24797. doi: 10.2196/24797.']",,2021-12-14,https://clinicaltrials.gov/show/NCT04492904,2021-06-15,0,1
2852,NCT04492943,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04492943,2020-06-30,0,0
2853,NCT04493242,Completed,2021-05-01,2021-05-22,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04493242,2021-05-01,0,0
2854,NCT04493268,Completed,2020-07-20,2020-07-21,No Results Posted,"['Ayus JC, Negri AL, Moritz ML, Lee KM, Caputo D, Borda ME, Go AS, Eghi C. Hyponatremia, Inflammation at Admission, and Mortality in Hospitalized COVID-19 Patients: A Prospective Cohort Study. Front Med (Lausanne). 2021 Dec 2;8:748364. doi: 10.3389/fmed.2021.748364. eCollection 2021.']",,2020-07-30,https://clinicaltrials.gov/show/NCT04493268,2020-07-20,0,1
2855,NCT04493294,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-07-30,https://clinicaltrials.gov/show/NCT04493294,2021-12-01,0,0
2856,NCT04493307,Recruiting,2021-02-01,2021-06-01,No Results Posted,"['Gurbel PA, Bliden KP, Levy JH, Walia N, Rapista N, Cho A, Jerjian C, Tantry US. Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis. 2021 Dec 1;32(8):544-549. doi: 10.1097/MBC.0000000000001069.']",,2020-10-22,https://clinicaltrials.gov/show/NCT04493307,2021-02-01,0,1
2857,NCT04493359,Terminated,2021-09-28,2021-09-28,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04493359,2021-09-28,0,0
2858,NCT04494204,Completed,2020-12-01,2020-12-20,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04494204,2020-12-01,0,0
2859,NCT04494386,Recruiting,2021-10-30,2021-12-30,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04494386,2021-10-30,0,0
2860,NCT04494399,Recruiting,2022-07-01,2022-08-01,No Results Posted,,,2020-07-31,https://clinicaltrials.gov/show/NCT04494399,2022-07-01,0,0
2861,NCT04494646,Completed,2021-01-08,2021-01-08,Study Results,,,2022-01-13,https://clinicaltrials.gov/show/NCT04494646,2021-01-08,1,0
2862,NCT04494724,Recruiting,2020-12-31,2021-07-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']","['Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018 Dec;18(12):773-789. doi: 10.1038/s41577-018-0066-7. Review.', 'Tanaka T, Kishimoto T. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases. Int J Biol Sci. 2012;8(9):1227-36. doi: 10.7150/ijbs.4666. Epub 2012 Oct 24. Review.', 'Uciechowski P, Dempke WCM. Interleukin-6: A Masterplayer in the Cytokine Network. Oncology. 2020;98(3):131-137. doi: 10.1159/000505099. Epub 2020 Jan 20. Review.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Jun;46(6):1294-1297. doi: 10.1007/s00134-020-06028-z.', 'Gao Y, Li T, Han M, Li X, Wu D, Xu Y, Zhu Y, Liu Y, Wang X, Wang L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020 Jul;92(7):791-796. doi: 10.1002/jmv.25770. Epub 2020 Apr 10.', 'Le RQ, Li L, Yuan W, Shord SS, Nie L, Habtemariam BA, Przepiorka D, Farrell AT, Pazdur R. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome. Oncologist. 2018 Aug;23(8):943-947. doi: 10.1634/theoncologist.2018-0028. Epub 2018 Apr 5.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.']",2020-07-31,https://clinicaltrials.gov/show/NCT04494724,2020-12-31,0,1
2863,NCT04494776,Recruiting,2022-12-03,2023-04-02,No Results Posted,"['Modelli de Andrade LG, de Sandes-Freitas TV, Requi√£o-Moura LR, Viana LA, Cristelli MP, Garcia VD, Alc√¢ntara ALC, Esmeraldo RM, Abbud Filho M, Pacheco-Silva A, de Lima Carneiro ECR, Manfro RC, Costa KMAH, Sim√£o DR, de Sousa MV, Santana VBBM, Noronha IL, Rom√£o EA, Zanocco JA, Arimatea GGQ, De Boni Monteiro de Carvalho D, Tedesco-Silva H, Medina-Pestana J; COVID-19-KT Brazil. Development and validation of a simple web-based tool for early prediction of COVID-19-associated death in kidney transplant recipients. Am J Transplant. 2022 Feb;22(2):610-625. doi: 10.1111/ajt.16807. Epub 2021 Sep 2.']",,2022-03-18,https://clinicaltrials.gov/show/NCT04494776,2022-12-03,0,1
2864,NCT04494867,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2022-02-22,https://clinicaltrials.gov/show/NCT04494867,2022-07-01,0,0
2865,NCT04494893,Completed,2021-03-23,2021-04-23,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04494893,2021-03-23,0,0
2866,NCT04494984,Completed,2020-11-23,2020-12-30,Results Submitted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.', 'Lopardo G, Belloso WH, Nannini E, Colonna M, Sanguineti S, Zylberman V, Mu√±oz L, Dobarro M, Lebersztein G, Farina J, Vidiella G, Bertetti A, Crudo F, Alzogaray MF, Barcelona L, Teijeiro R, Lambert S, Scublinsky D, Iacono M, Stanek V, Solari R, Cruz P, Casas MM, Abusamra L, Luciardi HL, Cremona A, Caruso D, de Miguel B, Lloret SP, Mill√°n S, Kilstein Y, Pereiro A, Sued O, Cahn P, Spatz L, Goldbaum F; INM005 Study Group. RBD-specific polyclonal F(ab¬¥)(2) fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial. EClinicalMedicine. 2021 Apr;34:100843. doi: 10.1016/j.eclinm.2021.100843. Epub 2021 Apr 11.']",,2021-02-11,https://clinicaltrials.gov/show/NCT04494984,2020-11-23,0,1
2867,NCT04495101,Completed,2021-04-26,2021-06-10,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04495101,2021-04-26,0,0
2868,NCT04495543,Recruiting,2021-08-01,2021-08-01,No Results Posted,,,2020-12-24,https://clinicaltrials.gov/show/NCT04495543,2021-08-01,0,0
2869,NCT04495764,Completed,2021-02-12,2021-02-12,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04495764,2021-02-12,0,0
2870,NCT04495803,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04495803,2022-08-01,0,0
2871,NCT04495816,Completed,2021-12-31,2021-12-31,No Results Posted,"['Lerner D, Garvey K, Arrighi-Allisan A, Filimonov A, Filip P, Liu K, Ninan S, Schaberg M, Colley P, Del Signore A, Govindaraj S, Iloreta AM. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction. Trials. 2020 Nov 23;21(1):942. doi: 10.1186/s13063-020-04905-y.']",,2022-01-19,https://clinicaltrials.gov/show/NCT04495816,2021-12-31,0,1
2872,NCT04495842,Recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04495842,2021-12-31,0,0
2873,NCT04495907,Completed,2021-04-09,2021-08-31,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04495907,2021-04-09,0,0
2874,NCT04495933,"Active, not recruiting",2021-11-06,2022-02-02,No Results Posted,"['Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 Oct;21(10):1383-1394. doi: 10.1016/S1473-3099(21)00200-0. Epub 2021 Apr 19.']",,2021-08-27,https://clinicaltrials.gov/show/NCT04495933,2021-11-06,0,1
2875,NCT04496076,Completed,2021-03-31,2021-05-31,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04496076,2021-03-31,0,0
2876,NCT04496128,Completed,2021-03-31,2021-05-30,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04496128,2021-03-31,0,0
2877,NCT04496141,"Active, not recruiting",2020-11-30,2020-11-30,No Results Posted,,,2020-08-03,https://clinicaltrials.gov/show/NCT04496141,2020-11-30,0,0
2878,NCT04496245,Completed,2021-06-30,2021-09-30,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04496245,2021-06-30,0,0
2879,NCT04496869,Completed,2020-08-31,2020-08-31,No Results Posted,,,2021-07-13,https://clinicaltrials.gov/show/NCT04496869,2020-08-31,0,0
2880,NCT04497194,Completed,2020-08-30,2020-09-30,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04497194,2020-08-30,0,0
2881,NCT04497246,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04497246,2020-12-01,0,0
2882,NCT04497272,"Active, not recruiting",2021-03-01,2022-03-31,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04497272,2021-03-01,0,0
2883,NCT04497298,Completed,2021-05-12,2021-05-12,No Results Posted,,"['Launay O, Artaud C, Lach√¢tre M, Ait-Ahmed M, Klein J, Luong Nguyen LB, Durier C, Jansen B, Tomberger Y, Jolly N, Grossmann A, Tabbal H, Brunet J, Gransagne M, Choucha Z, Batalie D, Delgado A, M√ºllner M, Tschismarov R, Berghmans PJ, Martin A, Ramsauer K, Escriou N, Gerke C. Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study. EBioMedicine. 2022 Jan;75:103810. doi: 10.1016/j.ebiom.2021.103810. Epub 2022 Jan 16.']",2022-02-18,https://clinicaltrials.gov/show/NCT04497298,2021-05-12,0,1
2884,NCT04497311,Recruiting,2021-04-30,2022-04-30,No Results Posted,,"['Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med. 2018 Aug;66(6):957-965. doi: 10.1136/jim-2018-000712. Epub 2018 Apr 20. Review.', 'Fineberg HV. Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. N Engl J Med. 2014 Apr 3;370(14):1335-42. doi: 10.1056/NEJMra1208802. Review. Erratum in: N Engl J Med. 2015 Jan 8;372(2):197.', 'Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009 Nov 4;302(17):1896-902. doi: 10.1001/jama.2009.1583.', 'Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019 Mar 5;68(6):e1-e47. doi: 10.1093/cid/ciy866. Erratum in: Clin Infect Dis. 2019 May 2;68(10):1790.', 'Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT Features of Viral Pneumonia. Radiographics. 2018 May-Jun;38(3):719-739. doi: 10.1148/rg.2018170048. Review.', 'Shiley KT, Van Deerlin VM, Miller WT Jr. Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections. J Thorac Imaging. 2010 Feb;25(1):68-75. doi: 10.1097/RTI.0b013e3181b0ba8b.', 'Upchurch CP, Grijalva CG, Wunderink RG, Williams DJ, Waterer GW, Anderson EJ, Zhu Y, Hart EM, Carroll F, Bramley AM, Jain S, Edwards KM, Self WH. Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes. Chest. 2018 Mar;153(3):601-610. doi: 10.1016/j.chest.2017.07.035. Epub 2017 Aug 9.', 'Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21. Review.', 'Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, Pan I, Shi LB, Wang DC, Mei J, Jiang XL, Zeng QH, Egglin TK, Hu PF, Agarwal S, Xie FF, Li S, Healey T, Atalay MK, Liao WH. Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT. Radiology. 2020 Aug;296(2):E46-E54. doi: 10.1148/radiol.2020200823. Epub 2020 Mar 10.', 'Liu M, Zeng W, Wen Y, Zheng Y, Lv F, Xiao K. COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia. Eur Radiol. 2020 Oct;30(10):5463-5469. doi: 10.1007/s00330-020-06928-0. Epub 2020 May 12.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.']",2020-08-06,https://clinicaltrials.gov/show/NCT04497311,2021-04-30,0,1
2885,NCT04497324,Completed,2021-04-17,2021-04-17,No Results Posted,"['Soto A, Krapp F, Vargas A, Cabrejos L, Argumanis E, Garc√≠a PL, Altamirano K, Montes M, Chac√≥n-Uscamaita PR, Garc√≠a PJ. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.']",,2021-10-28,https://clinicaltrials.gov/show/NCT04497324,2021-04-17,0,1
2886,NCT04497389,Recruiting,2021-09-15,2021-09-15,No Results Posted,"['Tonna JE, Pierce J, Hatton N, Lewis G, Phillips JD, Messina A, Skidmore CR, Taylor K, Selzman CH. Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open. 2021 Feb 11;11(2):e045162. doi: 10.1136/bmjopen-2020-045162.']",,2020-11-06,https://clinicaltrials.gov/show/NCT04497389,2021-09-15,0,1
2887,NCT04497402,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04497402,2022-06-01,0,0
2888,NCT04497415,Completed,2020-11-30,2021-01-30,Study Results,,,2022-01-14,https://clinicaltrials.gov/show/NCT04497415,2020-11-30,1,0
2889,NCT04497441,Recruiting,2020-08-10,2020-08-15,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04497441,2020-08-10,0,0
2890,NCT04497454,Recruiting,2021-07-01,2021-12-01,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04497454,2021-07-01,0,0
2891,NCT04497467,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04497467,2021-12-31,0,0
2892,NCT04497519,Completed,2020-10-15,2020-11-01,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04497519,2020-10-15,0,0
2893,NCT04497610,Not yet recruiting,2020-08-15,2020-08-15,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04497610,2020-08-15,0,0
2894,NCT04497623,Completed,2020-08-13,2020-09-20,No Results Posted,,,2020-09-24,https://clinicaltrials.gov/show/NCT04497623,2020-08-13,0,0
2895,NCT04497636,Completed,2021-04-18,2021-04-18,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04497636,2021-04-18,0,0
2896,NCT04497779,Recruiting,2023-08-21,2023-08-21,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04497779,2023-08-21,0,0
2897,NCT04497818,Completed,2020-07-16,2020-07-25,Results Submitted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04497818,2020-07-16,0,0
2898,NCT04497922,Recruiting,2021-04-30,2021-05-15,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04497922,2021-04-30,0,0
2899,NCT04497987,Completed,2021-01-16,2021-05-20,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Nathan R, Shawa I, De La Torre I, Pustizzi JM, Haustrup N, Patel DR, Huhn G. A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. Infect Dis Ther. 2021 Dec;10(4):1933-1947. doi: 10.1007/s40121-021-00515-6. Epub 2021 Aug 10. Review.', 'Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM; BLAZE-2 Investigators. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 Jul 6;326(1):46-55. doi: 10.1001/jama.2021.8828.']",,2022-02-04,https://clinicaltrials.gov/show/NCT04497987,2021-01-16,1,1
2900,NCT04498065,"Active, not recruiting",2020-07-01,2021-07-01,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04498065,2020-07-01,0,0
2901,NCT04498091,"Active, not recruiting",2020-07-01,2021-07-01,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04498091,2020-07-01,0,0
2902,NCT04498273,Terminated,2021-08-05,2021-08-05,Study Results,"['Connors JM, Brooks MM, Sciurba FC, Krishnan JA, Bledsoe JR, Kindzelski A, Baucom AL, Kirwan BA, Eng H, Martin D, Zaharris E, Everett B, Castro L, Shapiro NL, Lin JY, Hou PC, Pepine CJ, Handberg E, Haight DO, Wilson JW, Majercik S, Fu Z, Zhong Y, Venugopal V, Beach S, Wisniewski S, Ridker PM; ACTIV-4B Investigators. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA. 2021 Nov 2;326(17):1703-1712. doi: 10.1001/jama.2021.17272.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-17,https://clinicaltrials.gov/show/NCT04498273,2021-08-05,1,1
2903,NCT04498286,"Active, not recruiting",2021-11-01,2021-12-01,No Results Posted,"['Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, van Dam KPJ, Stalman EW, Vogelzang EH, Cristianawati O, Keijzer S, Vidarsson G, Voskuyl AE, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G. Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6.']",,2021-04-30,https://clinicaltrials.gov/show/NCT04498286,2021-11-01,0,1
2904,NCT04498299,Recruiting,2020-10-01,2020-11-30,No Results Posted,,,2020-08-04,https://clinicaltrials.gov/show/NCT04498299,2020-10-01,0,0
2905,NCT04498325,Withdrawn,2022-04-30,2022-04-30,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04498325,2022-04-30,0,0
2906,NCT04498377,Terminated,2021-03-24,2021-03-24,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04498377,2021-03-24,0,0
2907,NCT04498416,Recruiting,2021-07-01,2021-07-01,No Results Posted,"['Gindt M, Fernandez A, Richez A, Nachon O, Battista M, Askenazy F. CoCo20 protocol: a pilot longitudinal follow-up study about the psychiatric outcomes in a paediatric population and their families during and after the stay-at-home related to coronavirus pandemic (COVID-19). BMJ Open. 2021 Apr 8;11(4):e044667. doi: 10.1136/bmjopen-2020-044667.']",,2021-02-03,https://clinicaltrials.gov/show/NCT04498416,2021-07-01,0,1
2908,NCT04498442,Completed,2020-10-22,2020-10-22,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04498442,2020-10-22,0,0
2909,NCT04498507,Completed,2020-10-30,2020-10-30,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04498507,2020-10-30,0,0
2910,NCT04498546,Recruiting,2021-03-30,2021-09-30,No Results Posted,"['Alkan B, Ozalevli S, Akkoyun Sert O. Maximal exercise outcomes with a face mask: the effects of gender and age differences on cardiorespiratory responses. Ir J Med Sci. 2021 Nov 26. doi: 10.1007/s11845-021-02861-3. [Epub ahead of print]']",,2021-02-18,https://clinicaltrials.gov/show/NCT04498546,2021-03-30,0,1
2911,NCT04498936,Completed,2020-10-30,2020-10-30,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04498936,2020-10-30,0,0
2912,NCT04499300,Completed,2020-11-23,2020-11-23,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04499300,2020-11-23,0,0
2913,NCT04499313,Recruiting,2020-11-15,2020-11-30,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04499313,2020-11-15,0,0
2914,NCT04499378,Recruiting,2021-04-30,2022-04-30,No Results Posted,,"['Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med. 2018 Aug;66(6):957-965. doi: 10.1136/jim-2018-000712. Epub 2018 Apr 20. Review.', 'Fineberg HV. Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. N Engl J Med. 2014 Apr 3;370(14):1335-42. doi: 10.1056/NEJMra1208802. Review. Erratum in: N Engl J Med. 2015 Jan 8;372(2):197.', 'Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009 Nov 4;302(17):1896-902. doi: 10.1001/jama.2009.1583.', 'Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis. 2019 Mar 5;68(6):e1-e47. doi: 10.1093/cid/ciy866. Erratum in: Clin Infect Dis. 2019 May 2;68(10):1790.', 'Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT Features of Viral Pneumonia. Radiographics. 2018 May-Jun;38(3):719-739. doi: 10.1148/rg.2018170048. Review.', 'Shiley KT, Van Deerlin VM, Miller WT Jr. Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections. J Thorac Imaging. 2010 Feb;25(1):68-75. doi: 10.1097/RTI.0b013e3181b0ba8b.', 'Upchurch CP, Grijalva CG, Wunderink RG, Williams DJ, Waterer GW, Anderson EJ, Zhu Y, Hart EM, Carroll F, Bramley AM, Jain S, Edwards KM, Self WH. Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes. Chest. 2018 Mar;153(3):601-610. doi: 10.1016/j.chest.2017.07.035. Epub 2017 Aug 9.', 'Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Aug;296(2):E15-E25. doi: 10.1148/radiol.2020200490. Epub 2020 Feb 21. Review.', 'Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, Pan I, Shi LB, Wang DC, Mei J, Jiang XL, Zeng QH, Egglin TK, Hu PF, Agarwal S, Xie FF, Li S, Healey T, Atalay MK, Liao WH. Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT. Radiology. 2020 Aug;296(2):E46-E54. doi: 10.1148/radiol.2020200823. Epub 2020 Mar 10.', 'Liu M, Zeng W, Wen Y, Zheng Y, Lv F, Xiao K. COVID-19 pneumonia: CT findings of 122 patients and differentiation from influenza pneumonia. Eur Radiol. 2020 Oct;30(10):5463-5469. doi: 10.1007/s00330-020-06928-0. Epub 2020 May 12.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.']",2021-05-03,https://clinicaltrials.gov/show/NCT04499378,2021-04-30,0,1
2915,NCT04499391,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04499391,2022-07-01,0,0
2916,NCT04499677,Completed,2021-12-01,2021-12-01,No Results Posted,"['Brown LK, Freemantle N, Breuer J, Dehbi HM, Chowdhury K, Jones G, Ikeji F, Ndoutoumou A, Santhirakumar K, Longley N, Checkley AM, Standing JF, Lowe DM. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 8;22(1):193. doi: 10.1186/s13063-021-05139-2.']",,2021-12-16,https://clinicaltrials.gov/show/NCT04499677,2021-12-01,0,1
2917,NCT04500067,Completed,2020-09-15,2020-09-15,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04500067,2020-09-15,0,0
2918,NCT04500132,Completed,2021-02-04,2021-02-15,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04500132,2021-02-04,0,0
2919,NCT04500366,Completed,2021-11-01,2021-11-01,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04500366,2021-11-01,0,0
2920,NCT04500418,Terminated,2021-07-27,2021-07-27,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04500418,2021-07-27,0,0
2921,NCT04500600,Recruiting,2022-12-30,2023-12-30,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04500600,2022-12-30,0,0
2922,NCT04500626,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04500626,2022-08-01,0,0
2923,NCT04500639,Recruiting,2021-12-31,2023-03-31,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04500639,2021-12-31,0,0
2924,NCT04500652,Recruiting,2020-08-30,2020-10-01,No Results Posted,,,2020-08-05,https://clinicaltrials.gov/show/NCT04500652,2020-08-30,0,0
2925,NCT04501172,Completed,2020-07-24,2020-08-14,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04501172,2020-07-24,0,0
2926,NCT04501445,Completed,2021-04-08,2021-07-31,Results Submitted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04501445,2021-04-08,0,0
2927,NCT04501458,"Active, not recruiting",2022-06-10,2022-06-10,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04501458,2022-06-10,0,0
2928,NCT04501783,"Active, not recruiting",2020-07-29,2020-08-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04501783,2020-07-29,0,0
2929,NCT04501796,Recruiting,2022-03-01,2022-06-01,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04501796,2022-03-01,0,0
2930,NCT04501822,"Active, not recruiting",2021-07-19,2021-12-31,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04501822,2021-07-19,0,0
2931,NCT04501965,Enrolling by invitation,2020-08-30,2020-09-30,No Results Posted,,"['Ayisi NK, Nyadedzor C. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections. Antiviral Res. 2003 Mar;58(1):25-33.', 'Bald√© AM, Traor√© MS, Bald√© MA, Barry MS, Diallo A, Camara M, Traor√© S, Kouyat√© M, Traor√© S, Ouo-Ouo S, Myanth√© AL, Keita N, Haba NL, Goumou K, Bah F, Camara A, Diallo MS, Sylla M, Bald√© ES, Dian√© S, Pieters L, Oular√© K. Ethnomedical and ethnobotanical investigations on the response capacities of Guinean traditional health practioners in the management of outbreaks of infectious diseases: The case of the Ebola virus epidemic. J Ethnopharmacol. 2016 Apr 22;182:137-49. doi: 10.1016/j.jep.2016.02.021. Epub 2016 Feb 18.', 'Bald√© ES, Megalizzi V, Traor√© MS, Cos P, Maes L, Decaestecker C, Pieters L, Bald√© AM. In vitro antiprotozoal, antimicrobial and antitumor activity of Pavetta crassipes K. Schum leaf extracts. J Ethnopharmacol. 2010 Aug 9;130(3):529-35. doi: 10.1016/j.jep.2010.05.042. Epub 2010 May 31.', 'Camara A, Haddad M, Reybier K, Traor√© MS, Bald√© MA, Royo J, Bald√© AO, Batigne P, Haidara M, Bald√© ES, Coste A, Bald√© AM, Aubouy A. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties. Malar J. 2019 Dec 18;18(1):431. doi: 10.1186/s12936-019-3071-9.', 'Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.', ""D'Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, Delbue S. The Use of Antimalarial Drugs against Viral Infection. Microorganisms. 2020 Jan 8;8(1). pii: E85. doi: 10.3390/microorganisms8010085. Review."", 'Ren JL, Zhang AH, Wang XJ. Corrigendum to ""Traditional Chinese medicine for COVID-19 treatment"" [Pharmacol. Res. 155 (2020) 104743]. Pharmacol Res. 2020 May;155:104768. doi: 10.1016/j.phrs.2020.104768. Epub 2020 Mar 25.', 'Langeder J, Grienke U, Chen Y, Kirchmair J, Schmidtke M, Rollinger JM. Natural products against acute respiratory infections: Strategies and lessons learned. J Ethnopharmacol. 2020 Feb 10;248:112298. doi: 10.1016/j.jep.2019.112298. Epub 2019 Oct 11. Review.', 'Ni L, Zhou L, Zhou M, Zhao J, Wang DW. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19. Front Med. 2020 Apr;14(2):210-214. doi: 10.1007/s11684-020-0757-x. Epub 2020 Mar 13.', 'Liu BY, He LY, Liang ZW, Tong XY, Hu JQ, Jiao Q, Ni Q, Liu XM, Xie YM, Li P, Gao FZ, Wen TC, Liu WM. [Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome (SARS)]. Zhongguo Zhong Yao Za Zhi. 2005 Dec;30(23):1874-7. Chinese.', 'Liu DH, Liang BZ, Huang LY. [Clinical observation on the preventive effect of kangdu bufei decoction on acute severe respiratory syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Aug;24(8):685-8. Chinese.', 'Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, Liu JP. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17. Review.', 'Magassouba FB, Diallo A, Kouyat√© M, Mara F, Mara O, Bangoura O, Camara A, Traor√© S, Diallo AK, Zaoro M, Lamah K, Diallo S, Camara G, Traor√© S, K√©ita A, Camara MK, Barry R, K√©ita S, Oular√© K, Barry MS, Donzo M, Camara K, Tot√© K, Berghe DV, Tott√© J, Pieters L, Vlietinck AJ, Bald√© AM. Ethnobotanical survey and antibacterial activity of some plants used in Guinean traditional medicine. J Ethnopharmacol. 2007 Oct 8;114(1):44-53. Epub 2007 Jul 14. Erratum in: J Ethnopharmacol. 2010 Apr 21;128(3):705-8.', 'Mahase E. Covid-19: WHO declares pandemic because of ""alarming levels"" of spread, severity, and inaction. BMJ. 2020 Mar 12;368:m1036. doi: 10.1136/bmj.m1036.', 'Schlagenhauf P, Grobusch MP, Maier JD, Gautret P. Repurposing antimalarials and other drugs for COVID-19. Travel Med Infect Dis. 2020 Mar - Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Tong X, Li A, Zhang Z, Duan J, Chen X, Hua C, Zhao D, Xu Y, Shi X, Li P, Tian X, Lin F, Cao Y, Jin L, Chang M, Wang Y. TCM treatment of infectious atypical pneumonia--a report of 16 cases. J Tradit Chin Med. 2004 Dec;24(4):266-9.', 'Traore MS, Bald√© MA, Diallo MS, Bald√© ES, Dian√© S, Camara A, Diallo A, Balde A, Ke√Øta A, Keita SM, Oular√© K, Magassouba FB, Diakit√© I, Diallo A, Pieters L, Bald√© AM. Ethnobotanical survey on medicinal plants used by Guinean traditional healers in the treatment of malaria. J Ethnopharmacol. 2013 Dec 12;150(3):1145-53. doi: 10.1016/j.jep.2013.10.048. Epub 2013 Oct 31.', '‚Ä¢ WHO, 2013. WHO Traditional medicine strategy 2014-2023. https://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/.', 'Li Y, Liu X, Guo L, Li J, Zhong D, Zhang Y, Clarke M, Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis. Syst Rev. 2020 Apr 8;9(1):75. doi: 10.1186/s13643-020-01343-4.']",2020-08-07,https://clinicaltrials.gov/show/NCT04501965,2020-08-30,0,1
2932,NCT04501978,"Active, not recruiting",2022-07-01,2022-07-01,No Results Posted,"['ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Lancet Infect Dis. 2021 Dec 23. pii: S1473-3099(21)00751-9. doi: 10.1016/S1473-3099(21)00751-9. [Epub ahead of print]', 'ACTIV-3/TICO Bamlanivimab Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, √òstergaard L, Chang CC, Goodman AL, Chang W, Dewar RL, Gerry NP, Higgs ES, Highbarger H, Murray DD, Murray TA, Natarajan V, Paredes R, Parmar MKB, Phillips AN, Reilly C, Rupert AW, Sharma S, Shaw-Saliba K, Sherman BT, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Davey VJ, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD. Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. Ann Intern Med. 2022 Feb;175(2):234-243. doi: 10.7326/M21-3507. Epub 2021 Dec 21.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, √òstergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. N Engl J Med. 2021 Mar 11;384(10):905-914. doi: 10.1056/NEJMoa2033130. Epub 2020 Dec 22.']",,2022-03-08,https://clinicaltrials.gov/show/NCT04501978,2022-07-01,0,1
2933,NCT04501991,Completed,2020-05-04,2020-06-30,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04501991,2020-05-04,0,0
2934,NCT04502056,Completed,2020-09-06,2020-09-06,Study Results,"[""Torres C, Ogbu-Nwobodo L, Alsan M, Stanford FC, Banerjee A, Breza E, Chandrasekhar AG, Eichmeyer S, Karnani M, Loisel T, Goldsmith-Pinkham P, Olken BA, Vautrey PL, Warner E, Duflo E; COVID-19 Working Group. Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults' Knowledge, Beliefs, and Practices Related to COVID-19: A Randomized Clinical Trial. JAMA Netw Open. 2021 Jul 1;4(7):e2117115. doi: 10.1001/jamanetworkopen.2021.17115.""]",,2021-07-27,https://clinicaltrials.gov/show/NCT04502056,2020-09-06,1,1
2935,NCT04502069,Withdrawn,2021-02-01,2021-06-01,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04502069,2021-02-01,0,0
2936,NCT04502108,Recruiting,2022-12-31,2022-12-31,No Results Posted,"['Taeymans J, Luijckx E, Rogan S, Haas K, Baur H. Physical Activity, Nutritional Habits, and Sleeping Behavior in Students and Employees of a Swiss University During the COVID-19 Lockdown Period: Questionnaire Survey Study. JMIR Public Health Surveill. 2021 Apr 13;7(4):e26330. doi: 10.2196/26330.', 'Rogan S, Luijckx E, Taeymans J, Haas K, Baur H. Physical Activity, Nutritional Habits, and Sleep Behavior Among Health Profession Students and Employees of a Swiss University During and After COVID-19 Confinement: Protocol for a Longitudinal Observational Study. JMIR Res Protoc. 2020 Dec 22;9(12):e25051. doi: 10.2196/25051.']",,2020-08-10,https://clinicaltrials.gov/show/NCT04502108,2022-12-31,0,1
2937,NCT04502342,Enrolling by invitation,2020-08-30,2020-09-30,No Results Posted,,"['Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008 Sep 15;47(6):804-11. doi: 10.1086/591195. Review.', '‚Ä¢ WHO | World Health Organization. Coronavirus (COVID-19) events as they happen [Internet]. 2020 [cited 2020 Mar 20]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen']",2020-08-07,https://clinicaltrials.gov/show/NCT04502342,2020-08-30,0,1
2938,NCT04502433,Recruiting,2022-04-15,2022-04-15,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04502433,2022-04-15,0,0
2939,NCT04502472,Terminated,2020-09-30,2020-09-30,Study Results,,,2022-01-10,https://clinicaltrials.gov/show/NCT04502472,2020-09-30,1,0
2940,NCT04502667,Recruiting,2021-02-01,2021-04-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04502667,2021-02-01,0,0
2941,NCT04503057,Recruiting,2023-05-01,2024-05-01,No Results Posted,,,2020-08-06,https://clinicaltrials.gov/show/NCT04503057,2023-05-01,0,0
2942,NCT04503434,Completed,2020-05-31,2020-06-06,No Results Posted,,"['Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Hern√°ndez C, Aibar J, Seijas N, Puig I, Alonso A, Garcia-Aymerich J, Roca J. Implementation of Home Hospitalization and Early Discharge as an Integrated Care Service: A Ten Years Pragmatic Assessment. Int J Integr Care. 2018 May 16;18(2):12. doi: 10.5334/ijic.3431.', 'Bertran MJ, Vi√±ar√°s M, Salamero M, Garcia F, Graham C, McCulloch A, Escarrabill J. Spanish and Catalan translation, cultural adaptation and validation of the Picker Patient Experience Questionnaire-15. J Healthc Qual Res. 2018 Jan - Feb;33(1):10-17. doi: 10.1016/j.cali.2017.12.004. Epub 2018 Feb 14.']",2020-08-07,https://clinicaltrials.gov/show/NCT04503434,2020-05-31,0,1
2943,NCT04503447,Completed,2020-09-09,2020-09-09,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04503447,2020-09-09,0,0
2944,NCT04503525,Completed,2021-05-25,2021-06-30,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04503525,2021-05-25,0,0
2945,NCT04504240,Completed,2021-04-15,2021-04-15,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04504240,2021-04-15,0,0
2946,NCT04504877,Completed,2020-11-16,2020-12-16,No Results Posted,"['Crippa JAS, Zuardi AW, Guimar√£es FS, Campos AC, de Lima Os√≥rio F, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Pacheco JC, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Pereira-Lima K, Sen S, Andraus MH, Hallak JEC; Burnout and Distress Prevention With Cannabidiol in Front-line Health Care Workers Dealing With COVID-19 (BONSAI) Trial Investigators. Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2120603. doi: 10.1001/jamanetworkopen.2021.20603.']",,2021-09-28,https://clinicaltrials.gov/show/NCT04504877,2020-11-16,0,1
2947,NCT04505098,"Active, not recruiting",2022-02-28,2023-02-28,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04505098,2022-02-28,0,0
2948,NCT04505592,Enrolling by invitation,2021-10-01,2021-10-01,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04505592,2021-10-01,0,0
2949,NCT04505605,Terminated,2021-10-18,2021-10-18,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04505605,2021-10-18,0,0
2950,NCT04505631,Completed,2021-01-15,2021-01-15,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04505631,2021-01-15,0,0
2951,NCT04505709,Enrolling by invitation,2021-08-01,2021-08-01,No Results Posted,,,2020-08-10,https://clinicaltrials.gov/show/NCT04505709,2021-08-01,0,0
2952,NCT04505761,Completed,2021-02-01,2021-03-31,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04505761,2021-02-01,0,0
2953,NCT04505774,Recruiting,2022-09-01,2022-12-01,No Results Posted,"['Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD; ACTIV-4a Investigators. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2022 Jan 18;327(3):227-236. doi: 10.1001/jama.2021.23605.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Flumignan RL, Tin√¥co JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04505774,2022-09-01,0,1
2954,NCT04506229,Recruiting,2021-08-01,2021-09-01,No Results Posted,,,2020-08-27,https://clinicaltrials.gov/show/NCT04506229,2021-08-01,0,0
2955,NCT04506515,Completed,2020-04-19,2020-04-30,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04506515,2020-04-19,0,0
2956,NCT04506528,Recruiting,2023-01-01,2023-12-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04506528,2023-01-01,0,0
2957,NCT04506632,Recruiting,2021-04-02,2022-04-26,No Results Posted,,,2020-08-10,https://clinicaltrials.gov/show/NCT04506632,2021-04-02,0,0
2958,NCT04507230,Completed,2020-10-31,2020-10-31,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04507230,2020-10-31,0,0
2959,NCT04507256,Completed,2021-10-19,2021-10-19,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-27,https://clinicaltrials.gov/show/NCT04507256,2021-10-19,0,1
2960,NCT04507282,Completed,2020-07-01,2020-07-15,No Results Posted,"['Ari S, Can V, Demir √ñF, Ari H, Aƒüca FV, Melek M, √áamci S, Diki≈ü √ñ≈û, Huysal K, T√ºrk T. Elevated eosinophil count is related with lower anti-factor Xa activity in COVID-19 patients. J Hematop. 2020 Oct 8;13(4):249-258. doi: 10.1007/s12308-020-00419-3. eCollection 2020 Dec.']",,2020-08-18,https://clinicaltrials.gov/show/NCT04507282,2020-07-01,0,1
2961,NCT04507867,Completed,2021-04-10,2021-04-10,Study Results,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.']","['Hummel T, Landis BN, H√ºttenbrink KB. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc04. doi: 10.3205/cto000077. Epub 2012 Apr 26.', 'Mortazavi H, Shafiei S, Sadr S, Safiaghdam H. Drug-related Dysgeusia: A Systematic Review. Oral Health Prev Dent. 2018;16(6):499-507. doi: 10.3290/j.ohpd.a41655.', 'Chumpitazi BP, Self MM, Czyzewski DI, Cejka S, Swank PR, Shulman RJ. Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations. Neurogastroenterol Motil. 2016 Mar;28(3):443-8. doi: 10.1111/nmo.12738. Epub 2015 Dec 21.', 'Seo AY, Kim N, Oh DH. Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil. 2013 Oct;19(4):433-53. doi: 10.5056/jnm.2013.19.4.433. Epub 2013 Oct 7. Review.', 'Silva DAS, de Lima TR, Tremblay MS. Association between Resting Heart Rate and Health-Related Physical Fitness in Brazilian Adolescents. Biomed Res Int. 2018 Jun 28;2018:3812197. doi: 10.1155/2018/3812197. eCollection 2018.', 'Moskowitz A, Patel PV, Grossestreuer AV, Chase M, Shapiro NI, Berg K, Cocchi MN, Holmberg MJ, Donnino MW; Center for Resuscitation Science. Quick Sequential Organ Failure Assessment and Systemic Inflammatory Response Syndrome Criteria as Predictors of Critical Care Intervention Among Patients With Suspected Infection. Crit Care Med. 2017 Nov;45(11):1813-1819. doi: 10.1097/CCM.0000000000002622.', 'Holvoet E, Vanden Wyngaert K, Van Craenenbroeck AH, Van Biesen W, Eloot S. The screening score of Mini Nutritional Assessment (MNA) is a useful routine screening tool for malnutrition risk in patients on maintenance dialysis. PLoS One. 2020 Mar 4;15(3):e0229722. doi: 10.1371/journal.pone.0229722. eCollection 2020.', 'Nuttall FQ. Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr Today. 2015 May;50(3):117-128. Epub 2015 Apr 7.', 'Babiker A, Al Dubayee M. Anti-diabetic medications: How to make a choice? Sudan J Paediatr. 2017;17(2):11-20. doi: 10.24911/SJP.2017.2.12. Review.', 'Pahan K. Lipid-lowering drugs. Cell Mol Life Sci. 2006 May;63(10):1165-78. Review.', 'Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. ScientificWorldJournal. 2014 Mar 3;2014:781857. doi: 10.1155/2014/781857. eCollection 2014.', 'Selders GS, Fetz AE, Radic MZ, Bowlin GL. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration. Regen Biomater. 2017 Feb;4(1):55-68. doi: 10.1093/rb/rbw041. Review.', 'Hayƒ±roƒülu Mƒ∞, √áƒ±nar T, Tekke≈üin Aƒ∞. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Med Bras (1992). 2020 Jun;66(6):842-848. doi: 10.1590/1806-9282.66.6.842. Epub 2020 Jul 20. Review.', 'Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009 May;23(3):95-104. doi: 10.1016/j.blre.2008.08.001. Epub 2008 Oct 2. Review.', 'Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun;127:104370. doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr 14.', 'Kashani K, Rosner MH, Ostermann M. Creatinine: From physiology to clinical application. Eur J Intern Med. 2020 Feb;72:9-14. doi: 10.1016/j.ejim.2019.10.025. Epub 2019 Nov 8. Review.', 'Wang H, Ran J, Jiang T. Urea. Subcell Biochem. 2014;73:7-29. doi: 10.1007/978-94-017-9343-8_2. Review.', 'Musso CG, √Ålvarez-Gregori J, Jauregui J, Mac√≠as-N√∫√±ez JF. Glomerular filtration rate equations: a comprehensive review. Int Urol Nephrol. 2016 Jul;48(7):1105-10. doi: 10.1007/s11255-016-1276-1. Epub 2016 Apr 6. Review.', 'Hamade B, Huang DT. Procalcitonin: Where Are We Now? Crit Care Clin. 2020 Jan;36(1):23-40. doi: 10.1016/j.ccc.2019.08.003. Epub 2019 Oct 21. Review.', 'Driscoll JJ, Rixe O. Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trials. Cancer J. 2009 Sep-Oct;15(5):401-5. doi: 10.1097/PPO.0b013e3181bdc2e0. Review.', 'Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.']",2021-10-15,https://clinicaltrials.gov/show/NCT04507867,2021-04-10,1,1
2962,NCT04507893,Recruiting,2020-09-30,2022-12-01,No Results Posted,"['Di Mitri C, Arcoleo G, Mazzuca E, Camarda G, Farinella EM, Soresi M, Carroccio A; IMUSG. COVID-19 and non-COVID-19 pneumonia: a comparison. Ann Med. 2021 Dec;53(1):2321-2331. doi: 10.1080/07853890.2021.2010797.']",,2021-02-23,https://clinicaltrials.gov/show/NCT04507893,2020-09-30,0,1
2963,NCT04508075,Completed,2021-01-09,2021-08-31,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04508075,2021-01-09,0,0
2964,NCT04508439,Recruiting,2020-08-30,2020-12-30,No Results Posted,,,2020-08-11,https://clinicaltrials.gov/show/NCT04508439,2020-08-30,0,0
2965,NCT04508556,Completed,2020-12-19,2020-12-19,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04508556,2020-12-19,0,0
2966,NCT04508712,Recruiting,2021-08-31,2021-08-31,No Results Posted,,,2020-10-23,https://clinicaltrials.gov/show/NCT04508712,2021-08-31,0,0
2967,NCT04508777,Completed,2020-12-08,2021-06-23,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04508777,2020-12-08,0,0
2968,NCT04508868,Terminated,2020-12-23,2020-12-23,No Results Posted,,,2020-12-31,https://clinicaltrials.gov/show/NCT04508868,2020-12-23,0,0
2969,NCT04508920,Recruiting,2021-06-15,2021-07-15,No Results Posted,,"['Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jun 3;63(21):2304-22. doi: 10.1016/j.jacc.2014.03.016. Epub 2014 Mar 27.']",2020-08-11,https://clinicaltrials.gov/show/NCT04508920,2021-06-15,0,1
2970,NCT04508933,Withdrawn,2020-09-30,2020-12-31,No Results Posted,,"['Monnet X, Teboul JL. Transpulmonary thermodilution: advantages and limits. Crit Care. 2017 Jun 19;21(1):147. doi: 10.1186/s13054-017-1739-5. Review.']",2021-10-26,https://clinicaltrials.gov/show/NCT04508933,2020-09-30,0,1
2971,NCT04508959,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04508959,2021-07-01,0,0
2972,NCT04508972,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,2020-09-28,https://clinicaltrials.gov/show/NCT04508972,2020-10-01,0,0
2973,NCT04508985,Not yet recruiting,2021-01-01,2021-09-01,No Results Posted,"['Aflaki M, Flannery A, Ferreira JP, Cheng MP, Kronfli N, Marelli A, Zannad F, Brophy J, Afillalo J, Huynh T, Giannetti N, Bessissow A, Ezekowitz JA, Lopes RD, Ambrosy AP, Craig M, Sharma A. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.']",,2020-08-19,https://clinicaltrials.gov/show/NCT04508985,2021-01-01,0,1
2974,NCT04509713,Recruiting,2020-09-30,2020-10-31,No Results Posted,"['Guest C, Dewhirst SY, Lindsay SW, Allen DJ, Aziz S, Baerenbold O, Bradley J, Chabildas U, Chen-Hussey V, Clifford S, Cottis L, Dennehy J, Foley E, Gezan SA, Gibson T, Greaves CK, Kleinschmidt I, Lambert S, Last A, Morant S, Parker JEA, Pickett J, Quilty BJ, Rooney A, Shah M, Somerville M, Squires C, Walker M, Logan JG. Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study. J Travel Med. 2022 Mar 24. pii: taac043. doi: 10.1093/jtm/taac043. [Epub ahead of print]']",,2020-08-12,https://clinicaltrials.gov/show/NCT04509713,2020-09-30,0,1
2975,NCT04509752,Recruiting,2021-02-15,2021-02-28,No Results Posted,,,2021-02-08,https://clinicaltrials.gov/show/NCT04509752,2021-02-15,0,0
2976,NCT04509947,Completed,2021-02-22,2021-11-16,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04509947,2021-02-22,0,0
2977,NCT04509986,Not yet recruiting,2020-10-31,2020-12-01,No Results Posted,"['Glasbey J; COVIDSurg and GlobalSurg Collaboratives. Peri-operative outcomes of surgery in children with SARS-CoV-2 infection. Anaesthesia. 2022 Jan;77(1):108-109. doi: 10.1111/anae.15614. Epub 2021 Nov 5.', 'Nepogodiev D; COVIDSurg and GlobalSurg Collaboratives. Timing of surgery following SARS-CoV-2 infection: country income analysis. Anaesthesia. 2022 Jan;77(1):111-112. doi: 10.1111/anae.15615. Epub 2021 Nov 5.', 'Lobo D, Devys JM. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2022 Jan;77(1):110. doi: 10.1111/anae.15540. Epub 2021 Jul 12.']",,2020-08-12,https://clinicaltrials.gov/show/NCT04509986,2020-10-31,0,1
2978,NCT04510012,Recruiting,2021-03-05,2021-03-05,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04510012,2021-03-05,0,0
2979,NCT04510025,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04510025,2023-05-01,0,0
2980,NCT04510038,Suspended,2021-03-12,2022-01-01,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04510038,2021-03-12,0,0
2981,NCT04510194,"Active, not recruiting",2023-02-01,2023-02-01,No Results Posted,"['Dodds MG, Doyle EB, Reiersen AM, Brown F, Rayner CR. Fluvoxamine for the treatment of COVID-19. Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04510194,2023-02-01,0,1
2982,NCT04510207,Recruiting,2021-06-16,2022-07-15,No Results Posted,"['Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, Hussein SE, Al Mazrouei SK, Al Karam M, Li X, Yang X, Wang W, Lai B, Chen W, Huang S, Wang Q, Yang T, Liu Y, Ma R, Hussain ZM, Khan T, Saifuddin Fasihuddin M, You W, Xie Z, Zhao Y, Jiang Z, Zhao G, Zhang Y, Mahmoud S, ElTantawy I, Xiao P, Koshy A, Zaher WA, Wang H, Duan K, Pan A, Yang X. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. 2021 Jul 6;326(1):35-45. doi: 10.1001/jama.2021.8565.']",,2022-02-04,https://clinicaltrials.gov/show/NCT04510207,2021-06-16,0,1
2983,NCT04510233,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04510233,2020-10-01,0,0
2984,NCT04510402,Not yet recruiting,2021-02-01,2021-04-01,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04510402,2021-02-01,0,0
2985,NCT04510441,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04510441,2022-05-01,0,0
2986,NCT04510454,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04510454,2021-12-01,0,0
2987,NCT04510467,Not yet recruiting,2021-08-01,2021-08-01,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04510467,2021-08-01,0,0
2988,NCT04510493,Completed,2021-08-17,2021-08-17,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04510493,2021-08-17,0,0
2989,NCT04510519,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-08-13,https://clinicaltrials.gov/show/NCT04510519,2021-06-30,0,0
2990,NCT04510623,Recruiting,2021-06-30,2022-06-30,No Results Posted,"['Russell JA, Marshall JC, Slutsky A, Murthy S, Sweet D, Lee T, Singer J, Patrick DM, Du B, Peng Z, Cheng M, Burns KD, Harhay MO. Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection. BMJ Open. 2020 Dec 7;10(12):e040768. doi: 10.1136/bmjopen-2020-040768.']",,2020-08-12,https://clinicaltrials.gov/show/NCT04510623,2021-06-30,0,1
2991,NCT04510662,Recruiting,2021-03-01,2021-04-01,No Results Posted,,,2020-08-12,https://clinicaltrials.gov/show/NCT04510662,2021-03-01,0,0
2992,NCT04511429,Recruiting,2020-10-01,2021-04-01,No Results Posted,,"['Danziger-Isakov L, Steinbach WJ, Paulsen G, Munoz FM, Sweet LR, Green M, Michaels MG, Englund JA, Murray A, Halasa N, Dulek DE, Madan RP, Herold BC, Fisher BT. A Multicenter Consortium to Define the Epidemiology and Outcomes of Pediatric Solid Organ Transplant Recipients With Inpatient Respiratory Virus Infection. J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):197-204. doi: 10.1093/jpids/piy024.', 'Lee KH, Yoo SG, Cho Y, Kwon DE, La Y, Han SH, Kim MS, Choi JS, Kim SI, Kim YS, Min YH, Cheong JW, Kim JS, Song YG. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect. 2021 Apr;54(2):253-260. doi: 10.1016/j.jmii.2019.05.007. Epub 2019 Jun 19.', ""D'Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24."", 'Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020 May;31(5):553-555. doi: 10.1016/j.annonc.2020.03.286. Epub 2020 Mar 19.', 'Ronco C, Reis T, De Rosa S. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. Blood Purif. 2020;49(3):255-258. doi: 10.1159/000507039. Epub 2020 Mar 13.', 'Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis. 2014 Jan;58(2):214-24. doi: 10.1093/cid/cit725. Epub 2013 Nov 1.', 'Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, Brown C, Clark S, Dueger E, Gross D, Hauge S, Hirve S, Jorgensen P, Katz MA, Mafi A, Malik M, McCarron M, Meerhoff T, Mori Y, Mott J, Olivera MTDC, Ortiz JR, Palekar R, Rebelo-de-Andrade H, Soetens L, Yahaya AA, Zhang W, Vandemaele K. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018 Feb 1;96(2):122-128. doi: 10.2471/BLT.17.194514. Epub 2017 Nov 27.', 'Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003 Aug;3(8):977-81.', 'Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.']",2020-08-13,https://clinicaltrials.gov/show/NCT04511429,2020-10-01,0,1
2993,NCT04511650,Terminated,2021-02-26,2021-02-26,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04511650,2021-02-26,0,0
2994,NCT04511780,Not yet recruiting,2022-09-01,2022-09-01,No Results Posted,,,2020-12-19,https://clinicaltrials.gov/show/NCT04511780,2022-09-01,0,0
2995,NCT04511819,Terminated,2021-03-31,2021-03-31,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04511819,2021-03-31,0,0
2996,NCT04511923,Recruiting,2021-12-01,2022-01-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04511923,2021-12-01,0,0
2997,NCT04511949,Completed,2020-09-30,2020-11-30,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04511949,2020-09-30,0,0
2998,NCT04511962,Recruiting,2021-11-25,2022-01-20,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04511962,2021-11-25,0,0
2999,NCT04512027,Completed,2020-09-19,2020-10-16,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04512027,2020-09-19,0,0
3000,NCT04512079,Recruiting,2022-07-01,2022-07-01,No Results Posted,"['Farkouh ME, Stone GW, Lala A, Bagiella E, Moreno PR, Nadkarni GN, Ben-Yehuda O, Granada JF, Dressler O, Tinuoye EO, Granada C, Bustamante J, Peyra C, Godoy LC, Palacios IF, Fuster V. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2022 Mar 8;79(9):917-928. doi: 10.1016/j.jacc.2021.12.023. Review.']",,2022-01-20,https://clinicaltrials.gov/show/NCT04512079,2022-07-01,0,1
3001,NCT04512118,Completed,2020-06-30,2020-07-30,No Results Posted,,,2020-08-13,https://clinicaltrials.gov/show/NCT04512118,2020-06-30,0,0
3002,NCT04512300,Completed,2020-06-25,2020-06-25,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04512300,2020-06-25,0,0
3003,NCT04513158,Recruiting,2021-08-01,2021-12-31,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04513158,2021-08-01,0,0
3004,NCT04513184,Recruiting,2021-03-30,2021-07-31,No Results Posted,"['C√°rdenas G, Ch√°vez-Canales M, Espinosa AM, Jord√°n-R√≠os A, Malagon DA, Murillo MFM, Araujo LVT, Campos RLB, Wong-Chew RM, Gonz√°lez LER, Cresencio KI, Vel√°zquez EG, de la Cerda MR, Leyva Y, Hern√°ndez-Ruiz J, Hern√°ndez-Medel ML, Le√≥n-Hern√°ndez M, Quero KM, Monciv√°is AS, D√≠az SH, Mart√≠nez IRZ, Mart√≠nez-Cuazitl A, Salazar INM, Sarmiento EB, Pe√±a AF, Hern√°ndez PS, Reynoso RIA, Reyes DM, Del R√≠o Ambriz LR, Bonilla RAA, Cruz J, Huerta L, Fierro NA, Hern√°ndez M, P√©rez-Tapia M, Meneses G, Esp√≠ndola-Arriaga E, Rosas G, Chinney A, Mendoza SR, Hern√°ndez-Aceves JA, Cervantes-Torres J, Rodr√≠guez AF, Alor RO, Francisco SO, Salazar EA, Besedovsky H, Romano MC, Bobes RJ, Jung H, Soldevila G, L√≥pez-Alvarenga J, Fragoso G, Laclette JP, Sciutto E. Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients. Trials. 2022 Feb 14;23(1):148. doi: 10.1186/s13063-022-06075-5.']",,2020-11-12,https://clinicaltrials.gov/show/NCT04513184,2021-03-30,0,1
3005,NCT04513210,"Active, not recruiting",2022-03-07,2022-08-28,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04513210,2022-03-07,0,0
3006,NCT04513314,Not yet recruiting,2023-11-01,2023-11-01,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04513314,2023-11-01,0,0
3007,NCT04513470,"Active, not recruiting",2021-01-01,2021-02-01,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04513470,2021-01-01,0,0
3008,NCT04513496,Not yet recruiting,2022-03-01,2022-07-01,No Results Posted,,,2020-08-14,https://clinicaltrials.gov/show/NCT04513496,2022-03-01,0,0
3009,NCT04513561,Completed,2020-08-27,2020-08-27,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04513561,2020-08-27,0,0
3010,NCT04513847,Completed,2020-09-13,2020-10-06,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04513847,2020-09-13,0,0
3011,NCT04513964,Recruiting,2021-12-31,2021-12-31,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091. Erratum in: BMJ. 2020 Mar 31;368:m1295.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 May 14;55(5). pii: 2000547. doi: 10.1183/13993003.00547-2020. Print 2020 May.', 'Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.', 'Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, Ng OT, Marimuthu K, Ang LW, Mak TM, Lau SK, Anderson DE, Chan KS, Tan TY, Ng TY, Cui L, Said Z, Kurupatham L, Chen MI, Chan M, Vasoo S, Wang LF, Tan BH, Lin RTP, Lee VJM, Leo YS, Lye DC; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204. Erratum in: JAMA. 2020 Apr 21;323(15):1510.', 'Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391. doi: 10.1016/j.pcad.2020.03.001. Epub 2020 Mar 10. Review.']",2021-04-27,https://clinicaltrials.gov/show/NCT04513964,2021-12-31,0,1
3012,NCT04513990,"Active, not recruiting",2023-04-30,2023-04-30,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04513990,2023-04-30,0,0
3013,NCT04514003,Recruiting,2023-12-31,2035-12-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04514003,2023-12-31,0,0
3014,NCT04514016,Completed,2021-03-17,2021-03-17,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04514016,2021-03-17,0,0
3015,NCT04514302,Recruiting,2022-02-20,2022-02-20,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04514302,2022-02-20,0,0
3016,NCT04514627,Recruiting,2021-07-31,2021-07-31,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04514627,2021-07-31,0,0
3017,NCT04514705,Recruiting,2021-12-31,2021-12-31,No Results Posted,,"['Kamalakannan S, Chakraborty S. Occupational therapy: The key to unlocking locked-up occupations during the COVID-19 pandemic. Wellcome Open Res. 2020 Jul 1;5:153. doi: 10.12688/wellcomeopenres.16089.1. eCollection 2020.', 'Torli≈Ñski T, Rakasz L, Wysota B, Czy≈º M, Snelson C. An interdisciplinary approach to the management of critically ill patients during covid-19 pandemic; an experience of a university hospital in England. Wiad Lek. 2020;73(7):1576-1579.', 'Rooney S, Webster A, Paul L. Systematic Review of Changes and Recovery in Physical Function and Fitness After Severe Acute Respiratory Syndrome-Related Coronavirus Infection: Implications for COVID-19 Rehabilitation. Phys Ther. 2020 Sep 28;100(10):1717-1729. doi: 10.1093/ptj/pzaa129.', 'Saeki T, Ogawa F, Chiba R, Nonogaki M, Uesugi J, Takeuchi I, Nakamura T. Rehabilitation Therapy for a COVID-19 Patient Who Received Mechanical Ventilation in Japan. Am J Phys Med Rehabil. 2020 Oct;99(10):873-875. doi: 10.1097/PHM.0000000000001545.', 'Grigoletto I, Cavalheri V, Lima FF, Ramos EMC. Recovery after COVID-19: The potential role of pulmonary rehabilitation. Braz J Phys Ther. 2020 Nov-Dec;24(6):463-464. doi: 10.1016/j.bjpt.2020.07.002. Epub 2020 Jul 19.', 'Abdullahi A, Bello B, Mukhtar NB, Kaka B, Abba MA, Usman JS, Shittu A, Mayana KI, Maiwada SA, Mohammed J. Physiotherapy management of COVID-19 in Africa: Ongoing efforts, challenges, and future directions. Physiother Theory Pract. 2020 Aug;36(8):871-872. doi: 10.1080/09593985.2020.1798163. Epub 2020 Jul 29.']",2020-08-17,https://clinicaltrials.gov/show/NCT04514705,2021-12-31,0,1
3018,NCT04514874,Completed,2020-10-05,2020-10-05,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04514874,2020-10-05,0,0
3019,NCT04514900,Completed,2021-03-08,2021-03-08,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04514900,2021-03-08,0,0
3020,NCT04515108,Completed,2020-08-05,2020-08-10,No Results Posted,,"['Cheng B, Jiang T, Zhang L, Hu R, Tian J, Jiang Y, Huang B, Li J, Wei M, Yang J, Ren S, Wang G. Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China. Open Forum Infect Dis. 2020 Jul 11;7(8):ofaa294. doi: 10.1093/ofid/ofaa294. eCollection 2020 Aug.', 'Peng J, Qi D, Yuan G, Deng X, Mei Y, Feng L, Wang D. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.', 'Sun S, Cai X, Wang H, He G, Lin Y, Lu B, Chen C, Pan Y, Hu X. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020 Aug;507:174-180. doi: 10.1016/j.cca.2020.04.024. Epub 2020 Apr 24.', 'Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, Choolani M, Mattar C, Su LL. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020 Jun;222(6):521-531. doi: 10.1016/j.ajog.2020.03.021. Epub 2020 Mar 23. Review.']",2020-08-17,https://clinicaltrials.gov/show/NCT04515108,2020-08-05,0,1
3021,NCT04515147,Completed,2022-02-21,2022-02-21,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04515147,2022-02-21,0,0
3022,NCT04515199,Recruiting,2021-01-01,2021-03-01,No Results Posted,,,2020-08-17,https://clinicaltrials.gov/show/NCT04515199,2021-01-01,0,0
3023,NCT04515225,"Active, not recruiting",2022-05-03,2022-05-03,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04515225,2022-05-03,0,0
3024,NCT04516486,"Active, not recruiting",2020-05-24,2020-12-31,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04516486,2020-05-24,0,0
3025,NCT04516512,Completed,2021-07-08,2021-07-08,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04516512,2021-07-08,0,0
3026,NCT04516564,Completed,2021-03-04,2021-06-18,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-18,https://clinicaltrials.gov/show/NCT04516564,2021-03-04,0,1
3027,NCT04516668,Not yet recruiting,2020-11-01,2020-11-01,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04516668,2020-11-01,0,0
3028,NCT04516759,Completed,2021-04-25,2021-05-12,No Results Posted,"['McCafferty K, Hollowood Z, Allen M, Lockhart D, Chorlton J, Martin J. ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19. BMJ Open. 2021 Dec 1;11(12):e049650. doi: 10.1136/bmjopen-2021-049650.']",,2021-09-16,https://clinicaltrials.gov/show/NCT04516759,2021-04-25,0,1
3029,NCT04516811,Recruiting,2021-12-30,2022-07-31,No Results Posted,,"['Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020 Mar 16;10:40. doi: 10.1186/s13578-020-00404-4. eCollection 2020.']",2020-09-25,https://clinicaltrials.gov/show/NCT04516811,2021-12-30,0,1
3030,NCT04516824,Completed,2020-07-13,2020-08-15,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04516824,2020-07-13,0,0
3031,NCT04516837,Recruiting,2021-08-01,2022-08-01,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04516837,2021-08-01,0,0
3032,NCT04516850,Not yet recruiting,2021-08-31,2021-08-31,No Results Posted,,,2020-08-18,https://clinicaltrials.gov/show/NCT04516850,2021-08-31,0,0
3033,NCT04516915,Recruiting,2021-05-01,2021-07-01,No Results Posted,,,2020-08-21,https://clinicaltrials.gov/show/NCT04516915,2021-05-01,0,0
3034,NCT04516928,Completed,2020-09-25,2020-09-25,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04516928,2020-09-25,0,0
3035,NCT04516941,Recruiting,2022-12-31,2023-06-30,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']","['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.', ""Zhou F, Fan G, Liu Z, Cao B. SARS-CoV-2 shedding and infectivity - Authors' reply. Lancet. 2020 Apr 25;395(10233):1340. doi: 10.1016/S0140-6736(20)30869-2. Epub 2020 Apr 15."", 'Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.', 'Ranucci M, Ballotta A, Di Dedda U, Baryshnikova E, Dei Poli M, Resta M, Falco M, Albano G, Menicanti L. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.', 'Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, Pesenti A, Peyvandi F, Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.', 'Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S; Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.']",2021-07-26,https://clinicaltrials.gov/show/NCT04516941,2022-12-31,0,1
3036,NCT04516954,Enrolling by invitation,2020-11-30,2020-12-30,No Results Posted,,,2020-08-20,https://clinicaltrials.gov/show/NCT04516954,2020-11-30,0,0
3037,NCT04517006,Completed,2021-04-04,2021-04-04,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04517006,2021-04-04,0,0
3038,NCT04517123,Completed,2021-12-31,2021-12-31,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04517123,2021-12-31,0,0
3039,NCT04517136,"Active, not recruiting",2022-03-01,2022-03-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04517136,2022-03-01,0,0
3040,NCT04517162,Recruiting,2021-02-19,2021-06-19,No Results Posted,,"['Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016 Feb 10;19(2):181-93. doi: 10.1016/j.chom.2016.01.007.', 'Elhai M, Avouac J, Allanore Y. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Semin Arthritis Rheum. 2020 Jun;50(3):480-491. doi: 10.1016/j.semarthrit.2020.01.006. Epub 2020 Jan 28.', 'Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9.', 'Furuzawa-Carballeda J, Lima G, Llorente L, Nu√±ez-√Ålvarez C, Ruiz-Ordaz BH, Echevarr√≠a-Zuno S, Hern√°ndez-Cuevas V. Polymerized-type I collagen downregulates inflammation and improves clinical outcomes in patients with symptomatic knee osteoarthritis following arthroscopic lavage: a randomized, double-blind, and placebo-controlled clinical trial. ScientificWorldJournal. 2012;2012:342854. doi: 10.1100/2012/342854. Epub 2012 Apr 1.', 'Furuzawa-Carballeda J, Mu√±oz-Chabl√© OA, Barrios-Pay√°n J, Hern√°ndez-Pando R. Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur J Clin Invest. 2009 Jul;39(7):591-7. doi: 10.1111/j.1365-2362.2009.02154.x.', 'Furuzawa-Carballeda J, Mu√±oz-Chabl√© OA, Mac√≠as-Hern√°ndez SI, Agualimpia-Janning A. Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study. Eur J Clin Invest. 2009 Jul;39(7):598-606. doi: 10.1111/j.1365-2362.2009.02144.x. Epub 2009 Apr 23.', 'Furuzawa-Carballeda J, Alcocer-Varela J, Diaz de Le√≥n L. Collagen-PVP decreases collagen turnover in synovial tissue cultures from rheumatoid arthritis patients. Ann N Y Acad Sci. 1999 Jun 30;878:598-602.', 'Furuzawa-Carballeda J, Cabral AR, Zapata-Zu√±iga M, Alcocer-Varela J. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial. J Rheumatol. 2003 Feb;30(2):256-9.', 'Furuzawa-Carballeda J, Fenutria-Ausmequet R, Gil-Espinosa V, Lozano-Soto F, Teliz-Meneses MA, Romero-Trejo C, Alcocer-Varela J. Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial. Clin Exp Rheumatol. 2006 Sep-Oct;24(5):514-20.', 'Furuzawa-Carballeda J, Kr√∂tzsch E, Barile-Fabris L, Alcal√° M, Espinosa-Morales R. Subcutaneous administration of collagen-polyvinylpyrrolidone down regulates IL-1beta, TNF-alpha, TGF-beta1, ELAM-1 and VCAM-1 expression in scleroderma skin lesions. Clin Exp Dermatol. 2005 Jan;30(1):83-6.', 'Furuzawa-Carballeda J, Macip-Rodr√≠guez P, Galindo-Feria AS, Cruz-Robles D, Soto-Abraham V, Escobar-Hern√°ndez S, Aguilar D, Alpizar-Rodr√≠guez D, F√©rez-Blando K, Llorente L. Polymerized-type I collagen induces upregulation of Foxp3-expressing CD4 regulatory T cells and downregulation of IL-17-producing CD4‚Å∫ T cells (Th17) cells in collagen-induced arthritis. Clin Dev Immunol. 2012;2012:618608. doi: 10.1155/2012/618608. Epub 2011 Oct 19.', 'Furuzawa-Carballeda J, Ort√≠z-√Åvalos M, Lima G, Jurado-Santa Cruz F, Llorente L. Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-Œ≤1 expression, and increases Foxp3-expressing cells in localized scleroderma. Clin Exp Dermatol. 2012 Aug;37(6):599-609. doi: 10.1111/j.1365-2230.2012.04385.x. Epub 2012 Jun 25.', 'Furuzawa-Carballeda J, Rojas E, Valverde M, Castillo I, Diaz de Le√≥n L, Kr√∂tzsch E. Cellular and humoral responses to collagen-polyvinylpyrrolidone administered during short and long periods in humans. Can J Physiol Pharmacol. 2003 Nov;81(11):1029-35.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Kr√∂tzsch-G√≥mez FE, Furuzawa-Carballeda J, Reyes-M√°rquez R, Quir√≥z-Hern√°ndez E, D√≠az de Le√≥n L. Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars. J Invest Dermatol. 1998 Nov;111(5):828-34.', 'Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.', 'Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J; China Medical Treatment Expert Group for COVID-19. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Moreno-Alvarez P, S√°nchez-Guerrero E, Mart√≠nez-Cordero E, Hern√°ndez-Pando R, Campos MG, Cetina L, Baz√°n-Perkins B. Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma. Lung. 2010 Apr;188(2):97-105. doi: 10.1007/s00408-009-9202-2. Epub 2009 Dec 9.', 'Olmos-Z√∫√±iga JR, Hern√°ndez-Jim√©nez C, D√≠az-Mart√≠nez E, Jasso-Victoria R, Sotres-Vega A, Gaxiola-Gaxiola MO, Villalba-Caloca J, Baltazares-Lipp M, Santill√°n-Doherty P, Santib√°√±ez-Salgado JA. Wound healing modulators in a tracheoplasty canine model. J Invest Surg. 2007 Nov-Dec;20(6):333-8.', 'Olmos-Zu√±iga JR, Silva-Mart√≠nez M, Jasso-Victoria R, Baltazares-Lipp M, Hern√°ndez-Jim√©nez C, Buend√≠a-Roldan I, Jasso-Arenas J, Mart√≠nez-Salas A, Calyeca-G√≥mez J, Guzm√°n-Cedillo AE, Gaxiola-Gaxiola M, Romero-Romero L. Effects of Pirfenidone and Collagen-Polyvinylpyrrolidone on Macroscopic and Microscopic Changes, TGF-Œ≤1 Expression, and Collagen Deposition in an Experimental Model of Tracheal Wound Healing. Biomed Res Int. 2017;2017:6471071. doi: 10.1155/2017/6471071. Epub 2017 May 11.', 'Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM. T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses. Front Immunol. 2018 Nov 9;9:2569. doi: 10.3389/fimmu.2018.02569. eCollection 2018. Review.', 'Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.', 'Sun L, Louie MC, Vannella KM, Wilke CA, LeVine AM, Moore BB, Shanley TP. New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. Am J Physiol Lung Cell Mol Physiol. 2011 Mar;300(3):L341-53. doi: 10.1152/ajplung.00122.2010. Epub 2010 Dec 3.', 'Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.', 'Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, Peng L, Yang M, Cao M, Zheng H, Wu W, Zou R, Li D, Xu Z, Wang H, Zhang M, Zhang Z, Gao GF, Jiang C, Liu L, Liu Y. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4. doi: 10.1016/j.jaci.2020.04.027. Epub 2020 Apr 29.', ""Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10. Review."", 'Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.', 'Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.', 'Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17.', 'Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.']",2021-02-17,https://clinicaltrials.gov/show/NCT04517162,2021-02-19,0,1
3041,NCT04517188,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04517188,2021-07-01,0,0
3042,NCT04517422,Completed,2021-02-02,2021-02-02,No Results Posted,,"['Bottari B, Castellone V, Neviani E. Probiotics and Covid-19. Int J Food Sci Nutr. 2021 May;72(3):293-299. doi: 10.1080/09637486.2020.1807475. Epub 2020 Aug 12. Review.', 'Klann E, Rich S, Mai V. Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target? Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191.', ""d'Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri F, Ruberto F, Rossi G, Celani L, Scagnolari C, Mastropietro C, Trinchieri V, Recchia GE, Mauro V, Antonelli G, Pugliese F, Mastroianni CM. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020 Jul 7;7:389. doi: 10.3389/fmed.2020.00389. eCollection 2020."", 'De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients. Biol Proced Online. 2020 Jul 25;22:18. doi: 10.1186/s12575-020-00131-7. eCollection 2020.', 'Villena J, Kitazawa H. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Front Physiol. 2020 Jun 16;11:699. doi: 10.3389/fphys.2020.00699. eCollection 2020. Review.', 'Marcialis MA, Bardanzellu F, Fanos V. Microbiota and Coronavirus Disease 2019. Which Came First, the Chicken or the Egg? Clin Infect Dis. 2021 Jun 15;72(12):2245-2246. doi: 10.1093/cid/ciaa965.', 'Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020 Jun 21;44(3):265-272. doi: 10.3906/biy-2005-102. eCollection 2020.']",2021-05-06,https://clinicaltrials.gov/show/NCT04517422,2021-02-02,0,1
3043,NCT04517630,Recruiting,2021-09-30,2022-09-30,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04517630,2021-09-30,0,0
3044,NCT04517682,Completed,2021-03-16,2021-08-05,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04517682,2021-03-16,0,0
3045,NCT04517695,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-08-25,https://clinicaltrials.gov/show/NCT04517695,2022-08-01,0,0
3046,NCT04518514,Recruiting,2020-10-31,2020-11-30,No Results Posted,"['Wienhold J, M√∂sch L, Rossaint R, Kemper I, Derwall M, Czaplik M, Follmann A. Teleconsultation for preoperative evaluation during the coronavirus disease 2019 pandemic: A technical and medical feasibility study. Eur J Anaesthesiol. 2021 Dec 1;38(12):1284-1292. doi: 10.1097/EJA.0000000000001616.']",,2020-08-19,https://clinicaltrials.gov/show/NCT04518514,2020-10-31,0,1
3047,NCT04518735,Completed,2020-06-30,2020-06-30,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04518735,2020-06-30,0,0
3048,NCT04518969,Completed,2021-09-16,2021-09-16,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04518969,2021-09-16,0,0
3049,NCT04519034,Completed,2021-01-30,2021-03-31,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04519034,2021-01-30,0,0
3050,NCT04519125,Not yet recruiting,2020-12-31,2021-04-01,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04519125,2020-12-31,0,0
3051,NCT04519216,Completed,2021-10-30,2021-12-10,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04519216,2021-10-30,0,0
3052,NCT04519255,"Active, not recruiting",2022-12-31,2023-07-31,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04519255,2022-12-31,0,0
3053,NCT04519307,"Active, not recruiting",2020-08-01,2020-08-31,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04519307,2020-08-01,0,0
3054,NCT04519320,"Active, not recruiting",2021-08-18,2025-08-18,No Results Posted,"['Eberst G, Claud√© F, Laurent L, Meurisse A, Roux-Claud√© P, Barnig C, Vernerey D, Paget-Bailly S, Bouiller K, Chirouze C, Behr J, Grillet F, Ritter O, Karaer S, Pili-Floury S, Winiszewski H, Samain E, Decavel P, Capellier G, Westeel V. Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia. Ann Intensive Care. 2022 Mar 9;12(1):23. doi: 10.1186/s13613-022-00997-8.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04519320,2021-08-18,0,1
3055,NCT04519372,Completed,2020-06-14,2021-03-31,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04519372,2020-06-14,0,0
3056,NCT04519385,Completed,2020-07-01,2020-08-05,No Results Posted,,,2020-08-25,https://clinicaltrials.gov/show/NCT04519385,2020-07-01,0,0
3057,NCT04519398,Recruiting,2021-02-17,2021-08-18,No Results Posted,,,2020-08-19,https://clinicaltrials.gov/show/NCT04519398,2021-02-17,0,0
3058,NCT04519411,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04519411,2022-12-31,0,0
3059,NCT04519424,Withdrawn,2021-04-01,2021-05-01,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04519424,2021-04-01,0,0
3060,NCT04519502,Completed,2021-08-31,2021-11-04,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04519502,2021-08-31,0,0
3061,NCT04520191,Recruiting,2021-12-01,2022-02-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04520191,2021-12-01,0,0
3062,NCT04520620,Withdrawn,2020-07-10,2020-07-10,No Results Posted,,,2020-08-20,https://clinicaltrials.gov/show/NCT04520620,2020-07-10,0,0
3063,NCT04520880,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,2020-08-20,https://clinicaltrials.gov/show/NCT04520880,2020-12-01,0,0
3064,NCT04521010,Completed,2020-04-30,2020-04-30,No Results Posted,,,2020-08-20,https://clinicaltrials.gov/show/NCT04521010,2020-04-30,0,0
3065,NCT04521036,Not yet recruiting,2021-06-30,2021-10-30,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04521036,2021-06-30,0,0
3066,NCT04521296,"Active, not recruiting",2020-12-17,2022-12-01,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04521296,2020-12-17,0,0
3067,NCT04521309,Completed,2021-01-26,2021-02-08,No Results Posted,"['Ali S, Uddin SM, Shalim E, Sayeed MA, Anjum F, Saleem F, Muhaymin SM, Ali A, Ali MR, Ahmed I, Mushtaq T, Khan S, Shahab F, Luxmi S, Kumar S, Arain H, Khan M, Khan AS, Mehmood H, Rasheed A, Jahangeer A, Baig S, Quraishy S. Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine. 2021 Jun;36:100926. doi: 10.1016/j.eclinm.2021.100926. Epub 2021 Jun 4.', 'Ali S, Uddin SM, Ali A, Anjum F, Ali R, Shalim E, Khan M, Ahmed I, M Muhaymin S, Bukhari U, Luxmi S, Khan AS, Quraishy S. Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma. Immunotherapy. 2021 Apr;13(5):397-407. doi: 10.2217/imt-2020-0263. Epub 2021 Feb 9.', 'Ali S, Luxmi S, Anjum F, Muhaymin SM, Uddin SM, Ali A, Ali MR, Tauheed S, Khan M, Bajwa M, Baig SU, Shalim E, Ahmed I, Khan AS, Quraishy S. Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 2;21(1):905. doi: 10.1186/s13063-020-04839-5.']",,2021-03-24,https://clinicaltrials.gov/show/NCT04521309,2021-01-26,0,1
3068,NCT04521322,Recruiting,2020-10-30,2020-11-30,No Results Posted,"['Figueroa JM, Lombardo ME, Dogliotti A, Flynn LP, Giugliano R, Simonelli G, Valentini R, Ramos A, Romano P, Marcote M, Michelini A, Salvado A, Sykora E, Kniz C, Kobelinsky M, Salzberg DM, Jerusalinsky D, Uchitel O. Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease. Int J Gen Med. 2021 Oct 1;14:6277-6286. doi: 10.2147/IJGM.S328486. eCollection 2021.']",,2020-08-21,https://clinicaltrials.gov/show/NCT04521322,2020-10-30,0,1
3069,NCT04521400,Not yet recruiting,2020-09-04,2020-09-11,No Results Posted,"['Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial. Int Immunopharmacol. 2021 Oct;99:107916. doi: 10.1016/j.intimp.2021.107916. Epub 2021 Jun 29.', 'Alavi Darazam I, Hatami F, Rabiei MM, Pourhoseingholi MA, Moradi O, Shokouhi S, Hajesmaeili MR, Shabani M, Irvani SSN. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial. Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.']",,2020-08-20,https://clinicaltrials.gov/show/NCT04521400,2020-09-04,0,1
3070,NCT04522037,Recruiting,2020-09-01,2021-02-01,No Results Posted,,,2020-08-21,https://clinicaltrials.gov/show/NCT04522037,2020-09-01,0,0
3071,NCT04522076,"Active, not recruiting",2022-09-01,2022-09-01,No Results Posted,,"['Drapkina O. M., Karpov O. E., Lukyanov M. M., Martsevich S. Yu., Pulin A. A., Kutishenko N. P., Akimkin V. G., Andreenko E. Yu., Voronina V. P., Dindikova V. A., Dmitrieva N. A., Zagrebelnyi A. V., Ler- man O. V., Makoveeva A. N., Okshina E. Yu., Kudryashov E. V., Klyashtorny V. G., Smirnov A. A., Fomina V. S. Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes. Cardiovascular Therapy and Prevention. 2020;19(6):2727. (In Russ.) doi:10.15829/1728-8800-2020-2727', 'Drapkina OM, Karpov OE, Loukyanov MM, Martsevich SYu, Pulin AA, Kutishenko NP, Akimkin VG, Andreenko EYu, Voronina VP, Dindikova VA, Dmitrieva NA, Zagrebelnyy AV, Lerman OV, Makoveeva AN, Okshina EYu, Kudryashov EV, Klyashtorniy VG, Smirnov AA, Fomina VS. Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavivirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP). The Russian Journal of Preventive Medicine. 2020;23(8):6- 13. (In Russ.). https://doi.org/10.17116/profmed2020230816', 'Lukyanov M.M., Martsevich S.Yu., Pulin A.A., Kutishenko N.P., Andreenko E.Yu., Voronina V.P., Dindikova V.A., Dmitrieva N.A., Zagrebelny A.V., Makoveeva A.N., Lerman O.V., Okshina E.Yu., Sgibneva A. S., Smirnov A. A., Belova E. N., Klyashtorny V. G., Kudryashov E.V., Karpov O.E., Drapkina O.M. Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-—Åardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry. Cardiovascular Therapy and Prevention. 2021;20(8):3106. (In Russ.) doi:10.15829/1728-8800-20213106', ': Martsevich S.Yu., Lukyanov M.M., Pulin A.A., Kutishenko N.P., Andreenko E.Yu., Voronina V.P., Dindikova V.A., Dmitrieva N.A., Zagrebelnyy A.V., Lerman O.V., Makoveeva A.N., Okshina E.Yu., Smirnov A.A., Kudryashov E.V., Budaeva I.V., Nikoshnova E.S., Karpov O.E., Drapkina O.M. Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data). Rational Pharmacotherapy in Cardiology 2021;17(6):873-879. DOI:10.20996/1819-6446-2021-12-13']",2022-02-10,https://clinicaltrials.gov/show/NCT04522076,2022-09-01,0,1
3072,NCT04522089,"Active, not recruiting",2020-11-20,2021-10-31,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04522089,2020-11-20,0,0
3073,NCT04522128,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04522128,2021-09-01,0,0
3074,NCT04522310,Completed,2021-02-28,2021-05-29,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04522310,2021-02-28,0,0
3075,NCT04522466,Terminated,2020-05-28,2020-05-28,No Results Posted,,,2020-09-07,https://clinicaltrials.gov/show/NCT04522466,2020-05-28,0,0
3076,NCT04522492,Completed,2021-03-01,2022-03-17,No Results Posted,,"['Xavier ACM, Souza CMB, Flores LHF, Prati C, Cassal C, Dreher CB. Improving skin picking diagnosis among Brazilians: validation of the Skin Picking Impact Scale and development of a photographic instrument. An Bras Dermatol. 2019 Sep - Oct;94(5):553-560. doi: 10.1016/j.abd.2018.10.001. Epub 2019 Sep 30.', 'Xavier ACM, de Souza CMB, Flores LHF, Bermudez MB, Silva RMF, de Oliveira AC, Dreher CB. Skin picking treatment with the Rothbaum cognitive behavioral therapy protocol: a randomized clinical trial. Braz J Psychiatry. 2020 Sep-Oct;42(5):510-518. doi: 10.1590/1516-4446-2019-0636.']",2022-03-31,https://clinicaltrials.gov/show/NCT04522492,2021-03-01,0,1
3077,NCT04522817,Withdrawn,2021-05-01,2021-05-01,No Results Posted,,,2020-12-17,https://clinicaltrials.gov/show/NCT04522817,2021-05-01,0,0
3078,NCT04522830,Completed,2021-02-28,2021-02-28,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04522830,2021-02-28,0,0
3079,NCT04522986,Completed,2021-02-02,2021-02-02,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04522986,2021-02-02,0,0
3080,NCT04523012,Recruiting,2021-06-30,2022-06-30,No Results Posted,,,2020-08-21,https://clinicaltrials.gov/show/NCT04523012,2021-06-30,0,0
3081,NCT04523051,Recruiting,2021-12-01,2022-05-01,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04523051,2021-12-01,0,0
3082,NCT04523090,Recruiting,2021-12-01,2022-02-01,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04523090,2021-12-01,0,0
3083,NCT04523246,"Active, not recruiting",2021-11-30,2022-09-30,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04523246,2021-11-30,0,0
3084,NCT04523831,Completed,2020-08-22,2020-09-10,Study Results,"['Mahmud R, Rahman MM, Alam I, Ahmed KGU, Kabir AKMH, Sayeed SKJB, Rassel MA, Monayem FB, Islam MS, Islam MM, Barshan AD, Hoque MM, Mallik MU, Yusuf MA, Hossain MZ. Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J Int Med Res. 2021 May;49(5):3000605211013550. doi: 10.1177/03000605211013550.']",,2020-10-09,https://clinicaltrials.gov/show/NCT04523831,2020-08-22,1,1
3085,NCT04524052,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-08-24,https://clinicaltrials.gov/show/NCT04524052,2020-12-01,0,0
3086,NCT04524156,Not yet recruiting,2021-09-04,2023-05-04,No Results Posted,,,2020-08-24,https://clinicaltrials.gov/show/NCT04524156,2021-09-04,0,0
3087,NCT04524234,Completed,2020-08-31,2020-09-30,No Results Posted,,,2020-12-24,https://clinicaltrials.gov/show/NCT04524234,2020-08-31,0,0
3088,NCT04524507,Completed,2021-01-04,2021-06-04,Study Results,,,2021-12-03,https://clinicaltrials.gov/show/NCT04524507,2021-01-04,1,0
3089,NCT04524520,Recruiting,2022-05-08,2023-05-08,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04524520,2022-05-08,0,0
3090,NCT04524598,"Active, not recruiting",2021-09-03,2022-01-16,Study Results,,,2021-12-13,https://clinicaltrials.gov/show/NCT04524598,2021-09-03,1,0
3091,NCT04524663,Completed,2021-05-15,2021-05-15,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04524663,2021-05-15,0,0
3092,NCT04524754,Recruiting,2020-09-11,2020-11-30,Results Submitted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04524754,2020-09-11,0,0
3093,NCT04524962,Recruiting,2022-09-25,2022-09-25,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04524962,2022-09-25,0,0
3094,NCT04525287,Completed,2020-08-20,2020-08-20,No Results Posted,,,2021-08-06,https://clinicaltrials.gov/show/NCT04525287,2020-08-20,0,0
3095,NCT04525378,Recruiting,2020-09-30,2020-10-31,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04525378,2020-09-30,0,0
3096,NCT04525404,"Active, not recruiting",2021-09-22,2022-09-30,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04525404,2021-09-22,0,0
3097,NCT04525417,Completed,2020-09-25,2020-10-25,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04525417,2020-09-25,0,0
3098,NCT04525443,Completed,2020-11-11,2021-02-11,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04525443,2020-11-11,0,0
3099,NCT04525716,Recruiting,2020-08-31,2020-12-31,No Results Posted,,,2020-08-25,https://clinicaltrials.gov/show/NCT04525716,2020-08-31,0,0
3100,NCT04525742,Completed,2020-08-30,2020-09-15,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04525742,2020-08-30,0,0
3101,NCT04525820,"Active, not recruiting",2021-08-30,2021-11-30,No Results Posted,"['Jaun F, Boesing M, L√ºthi-Corridori G, Abig K, Makhdoomi A, Bloch N, Lins C, Raess A, Grillmayr V, Haas P, Schuetz P, Gabutti L, Muser J, Leuppi-Taegtmeyer AB, Giezendanner S, Br√§ndle M, Leuppi JD. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial. Trials. 2022 Feb 4;23(1):114. doi: 10.1186/s13063-022-06016-2.']",,2021-09-21,https://clinicaltrials.gov/show/NCT04525820,2021-08-30,0,1
3102,NCT04525911,Recruiting,2022-08-01,2022-10-01,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04525911,2022-08-01,0,0
3103,NCT04526054,Recruiting,2021-09-03,2021-09-03,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04526054,2021-09-03,0,0
3104,NCT04526145,Recruiting,2022-12-01,2023-01-30,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04526145,2022-12-01,0,0
3105,NCT04526405,Completed,2020-11-03,2020-11-03,No Results Posted,,"['Hussain FA, Njoku FU, Saraf SL, Molokie RE, Gordeuk VR, Han J. COVID-19 infection in patients with sickle cell disease. Br J Haematol. 2020 Jun;189(5):851-852. doi: 10.1111/bjh.16734. Epub 2020 May 8.', 'Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, Gianesin B, Graziadei G, Cappellini MD, De Franceschi L, Piga A, Forni GL. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience. Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6.', 'Roy NBA, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F, Roberts D, Atoyebi W, Trompeter S, Layton DM, Lugthart S, Stuart-Smith S, Chakravorty S, Wright J, Porter J, Inusa B, Howard J; National Haemoglobinopathy Panel. Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. Br J Haematol. 2020 May;189(4):635-639. doi: 10.1111/bjh.16687. Epub 2020 May 10.', 'Taher AT, Bou-Fakhredin R, Kreidieh F, Motta I, De Franceschi L, Cappellini MD. Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations. Am J Hematol. 2020 Aug;95(8):E208-E210. doi: 10.1002/ajh.25857. Epub 2020 May 21.', 'Valenti L, Bergna A, Pelusi S, Facciotti F, Lai A, Tarkowski M, Berzuini A, Caprioli F, Santoro L, Baselli G, Della Ventura C, Erba E, Bosari S, Galli M, Zehender G, Prati D. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak. medRxiv doi.org/10.1101/2020.05.11.20098442.']",2020-11-09,https://clinicaltrials.gov/show/NCT04526405,2020-11-03,0,1
3106,NCT04526717,Withdrawn,2022-12-01,2022-12-01,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04526717,2022-12-01,0,0
3107,NCT04526769,Not yet recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04526769,2022-12-01,0,0
3108,NCT04526821,Terminated,2021-02-10,2021-02-10,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04526821,2021-02-10,0,0
3109,NCT04526912,Terminated,2021-04-08,2021-05-19,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04526912,2021-04-08,0,0
3110,NCT04526977,Recruiting,2021-12-30,2022-03-30,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04526977,2021-12-30,0,0
3111,NCT04527133,"Active, not recruiting",2020-08-11,2020-08-31,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04527133,2020-08-11,0,0
3112,NCT04527198,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04527198,2020-12-31,0,0
3113,NCT04527211,Not yet recruiting,2020-11-30,2020-12-16,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04527211,2020-11-30,0,0
3114,NCT04527224,Not yet recruiting,2022-10-01,2023-04-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04527224,2022-10-01,0,0
3115,NCT04527315,Recruiting,2023-08-01,2023-08-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04527315,2023-08-01,0,0
3116,NCT04527354,Completed,2021-02-10,2021-02-10,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04527354,2021-02-10,0,0
3117,NCT04527432,"Active, not recruiting",2022-03-31,2022-03-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04527432,2022-03-31,0,0
3118,NCT04527458,Completed,2020-08-02,2020-08-02,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04527458,2020-08-02,0,0
3119,NCT04527497,Recruiting,2021-05-30,2021-08-31,No Results Posted,,,2020-08-26,https://clinicaltrials.gov/show/NCT04527497,2021-05-30,0,0
3120,NCT04527562,Completed,2020-11-15,2020-12-10,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04527562,2020-11-15,0,0
3121,NCT04527575,Completed,2021-12-30,2021-12-30,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04527575,2021-12-30,0,0
3122,NCT04527601,Completed,2020-09-13,2020-09-13,No Results Posted,"['Rasmussen MI, Hansen ML, Pichler G, Dempsey E, Pellicer A, El-Khuffash A, A S, Piris-Borregas S, Alsina M, Cetinkaya M, Chalak L, √ñzkan H, Baserga M, Sirc J, Fuchs H, Ergenekon E, Arruza L, Mathur A, Stocker M, Otero Vaccarello O, Szczapa T, Sarafidis K, Kr√≥lak-Olejnik B, Memisoglu A, Reigstad H, Rafi≈Ñska-Wa≈ºny E, Hatzidaki E, Peng Z, Gkentzi D, Viellevoye R, De Buyst J, Mastretta E, Wang P, Hahn GH, Bender L, Cornette L, Tkaczyk J, Del Rio R, Fumagalli M, Papathoma E, Wilinska M, Naulaers G, Sadowska-Krawczenko I, Lecart C, Couce ML, Fredly S, Heuchan AM, Karen T, Greisen G. Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown. Front Pediatr. 2021 Jul 12;9:647880. doi: 10.3389/fped.2021.647880. eCollection 2021.']",,2020-10-08,https://clinicaltrials.gov/show/NCT04527601,2020-09-13,0,1
3123,NCT04527614,Enrolling by invitation,2022-05-30,2022-05-30,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04527614,2022-05-30,0,0
3124,NCT04528329,Recruiting,2022-04-01,2022-05-15,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04528329,2022-04-01,0,0
3125,NCT04528368,Recruiting,2021-12-30,2022-01-30,No Results Posted,,,2021-08-06,https://clinicaltrials.gov/show/NCT04528368,2021-12-30,0,0
3126,NCT04528641,Completed,2021-05-19,2021-05-19,Study Results,"['Capone S, Raggioli A, Gentile M, Battella S, Lahm A, Sommella A, Contino AM, Urbanowicz RA, Scala R, Barra F, Leuzzi A, Lilli E, Miselli G, Noto A, Ferraiuolo M, Talotta F, Tsoleridis T, Castilletti C, Matusali G, Colavita F, Lapa D, Meschi S, Capobianchi M, Soriani M, Folgori A, Ball JK, Colloca S, Vitelli A. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. Mol Ther. 2021 Aug 4;29(8):2412-2423. doi: 10.1016/j.ymthe.2021.04.022. Epub 2021 Apr 23.']",,2022-02-08,https://clinicaltrials.gov/show/NCT04528641,2021-05-19,1,1
3127,NCT04528667,Completed,2021-08-23,2021-10-07,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04528667,2021-08-23,0,0
3128,NCT04528771,"Active, not recruiting",2022-03-31,2022-04-30,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04528771,2022-03-31,0,0
3129,NCT04528888,Recruiting,2021-06-30,2021-07-30,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-05-06,https://clinicaltrials.gov/show/NCT04528888,2021-06-30,0,1
3130,NCT04528901,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04528901,2022-12-01,0,0
3131,NCT04528927,Withdrawn,2020-07-15,2020-07-15,No Results Posted,,,2020-08-27,https://clinicaltrials.gov/show/NCT04528927,2020-07-15,0,0
3132,NCT04529408,Recruiting,2022-08-10,2022-08-10,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04529408,2022-08-10,0,0
3133,NCT04529421,"Active, not recruiting",2020-12-31,2021-08-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04529421,2020-12-31,0,0
3134,NCT04529447,Completed,2020-08-10,2020-08-10,No Results Posted,,,2020-08-27,https://clinicaltrials.gov/show/NCT04529447,2020-08-10,0,0
3135,NCT04529460,Withdrawn,2021-01-29,2021-04-30,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04529460,2021-01-29,0,0
3136,NCT04529499,Terminated,2021-01-22,2021-01-27,Study Results,,,2022-03-21,https://clinicaltrials.gov/show/NCT04529499,2021-01-22,1,0
3137,NCT04529525,Completed,2021-02-22,2021-02-22,No Results Posted,"['Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A, Plano F, Campias C, Chaparro Campias E, Medina MF, Achinelli F, Guglielmone HA, Ojeda J, Farizano Salazar D, Andino G, Kawerin P, Dellamea S, Aquino AC, Flores V, Martemucci CN, Martinez SM, Segovia JE, Reynoso PI, Sosa NC, Robledo ME, Guarrochena JM, Vernengo MM, Ruiz Diaz N, Meza E, Aguirre MG. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis. 2021 Jul 2;21(1):635. doi: 10.1186/s12879-021-06348-5.', 'Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A, Plano F, Campias C, Chaparro Campias E, Achinelli F, Guglielmone HA, Ojeda J, Medina F, Farizano Salazar D, Andino G, Ruiz Diaz NE, Kawerin P, Meza E, Dellamea S, Aquino A, Flores V, Martemucci CN, Vernengo MM, Martinez SM, Segovia JE, Aguirre MG. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Nov 24;21(1):965. doi: 10.1186/s13063-020-04813-1.']","['≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Review.', 'Gonz√°lez Canga A, Sahag√∫n Prieto AM, Diez Li√©bana MJ, Fern√°ndez Mart√≠nez N, Sierra Vega M, Garc√≠a Vieitez JJ. The pharmacokinetics and interactions of ivermectin in humans--a mini-review. AAPS J. 2008;10(1):42-6. doi: 10.1208/s12248-007-9000-9. Epub 2008 Jan 25. Review.', 'G√∂tz V, Magar L, Dornfeld D, Giese S, Pohlmann A, H√∂per D, Kong BW, Jans DA, Beer M, Haller O, Schwemmle M. Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import. Sci Rep. 2016 Mar 18;6:23138. doi: 10.1038/srep23138. Erratum in: Sci Rep. 2016 May 09;6:25428.', 'Lundberg L, Pinkham C, Baer A, Amaya M, Narayanan A, Wagstaff KM, Jans DA, Kehn-Hall K. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication. Antiviral Res. 2013 Dec;100(3):662-72. doi: 10.1016/j.antiviral.2013.10.004. Epub 2013 Oct 22.', 'Tay MY, Fraser JE, Chan WK, Moreland NJ, Rathore AP, Wang C, Vasudevan SG, Jans DA. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antiviral Res. 2013 Sep;99(3):301-6. doi: 10.1016/j.antiviral.2013.06.002. Epub 2013 Jun 14.', 'Wagstaff KM, Sivakumaran H, Heaton SM, Harrich D, Jans DA. Ivermectin is a specific inhibitor of importin Œ±/Œ≤-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J. 2012 May 1;443(3):851-6. doi: 10.1042/BJ20120150.', 'Chi NC, Adam EJ, Adam SA. Sequence and characterization of cytoplasmic nuclear protein import factor p97. J Cell Biol. 1995 Jul;130(2):265-74.', 'G√∂rlich D, Mattaj IW. Nucleocytoplasmic transport. Science. 1996 Mar 15;271(5255):1513-8. Review.', 'Rowland RR, Chauhan V, Fang Y, Pekosz A, Kerrigan M, Burton MD. Intracellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein: absence of nucleolar accumulation during infection and after expression as a recombinant protein in vero cells. J Virol. 2005 Sep;79(17):11507-12.', 'Timani KA, Liao Q, Ye L, Zeng Y, Liu J, Zheng Y, Ye L, Yang X, Lingbao K, Gao J, Zhu Y. Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Res. 2005 Dec;114(1-2):23-34. Epub 2005 Jun 29.', 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",2021-07-07,https://clinicaltrials.gov/show/NCT04529525,2021-02-22,0,1
3138,NCT04530357,Completed,2020-11-25,2021-04-25,No Results Posted,"['Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, Sarsenbayeva G, Kulmagambetov I, Davlyatshin T, Sergeeva M, Stukova M, Khairullin B. Safety and immunogenicity of a QazCovid-in¬Æ inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan. EClinicalMedicine. 2021 Sep;39:101078. doi: 10.1016/j.eclinm.2021.101078. Epub 2021 Aug 14.']",,2021-05-04,https://clinicaltrials.gov/show/NCT04530357,2020-11-25,0,1
3139,NCT04530370,Recruiting,2020-09-01,2020-09-01,No Results Posted,"['Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021 May 20;5:CD013600. doi: 10.1002/14651858.CD013600.pub4.']",,2020-08-28,https://clinicaltrials.gov/show/NCT04530370,2020-09-01,0,1
3140,NCT04530396,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,"['Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04530396,2021-05-01,0,1
3141,NCT04530409,Completed,2021-11-01,2021-12-15,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04530409,2021-11-01,0,0
3142,NCT04530422,Completed,2020-07-08,2020-07-23,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04530422,2020-07-08,0,0
3143,NCT04530435,Completed,2021-03-29,2021-09-01,No Results Posted,"['Mollerup A, Henriksen M, Larsen SC, Bennetzen AS, Simonsen MK, Kofod LM, Knudsen JD, Nielsen XC, Weis N, Heitmann BL. Effect of PEP flute self-care versus usual care in early covid-19: non-drug, open label, randomised controlled trial in a Danish community setting. BMJ. 2021 Nov 24;375:e066952. doi: 10.1136/bmj-2021-066952.', 'Mollerup A, Larsen SC, Bennetzen AS, Henriksen M, Simonsen MK, Weis N, Kofod LM, Heitmann BL. PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19. BMJ Open. 2021 Jun 30;11(6):e050582. doi: 10.1136/bmjopen-2021-050582.']",,2022-03-22,https://clinicaltrials.gov/show/NCT04530435,2021-03-29,0,1
3144,NCT04530448,"Active, not recruiting",2021-07-15,2022-03-01,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04530448,2021-07-15,0,0
3145,NCT04530461,Recruiting,2020-11-30,2021-01-31,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04530461,2020-11-30,0,0
3146,NCT04530474,Withdrawn,2021-06-30,2021-06-30,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04530474,2021-06-30,0,0
3147,NCT04530539,"Active, not recruiting",2021-07-01,2022-06-30,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04530539,2021-07-01,0,0
3148,NCT04530578,Recruiting,2020-10-30,2021-06-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2020-08-31,https://clinicaltrials.gov/show/NCT04530578,2020-10-30,0,1
3149,NCT04530604,Completed,2021-03-26,2021-04-09,No Results Posted,,,2021-11-12,https://clinicaltrials.gov/show/NCT04530604,2021-03-26,0,0
3150,NCT04530617,Terminated,2021-06-10,2021-06-10,No Results Posted,,"['Del Rio C, Malani PN. COVID-19-New Insights on a Rapidly Changing Epidemic. JAMA. 2020 Apr 14;323(14):1339-1340. doi: 10.1001/jama.2020.3072.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606. Erratum in: BMJ. 2020 Feb 27;368:m792.', 'Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.', ""Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, Kawasaki B, Yousey-Hindes K, Niccolai L, Anderson EJ, Openo KP, Weigel A, Monroe ML, Ryan P, Henderson J, Kim S, Como-Sabetti K, Lynfield R, Sosin D, Torres S, Muse A, Bennett NM, Billing L, Sutton M, West N, Schaffner W, Talbot HK, Aquino C, George A, Budd A, Brammer L, Langley G, Hall AJ, Fry A. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3."", 'Ortiz-Brizuela E, Villanueva-Reza M, Gonz√°lez-Lara MF, Tamez-Torres KM, Rom√°n-Montes CM, D√≠az-Mej√≠a BA, P√©rez-Garc√≠a E, Olivas-Mart√≠nez A, Rajme-L√≥pez S, Martinez-Guerra BA, de-Le√≥n-Cividanes NA, Fern√°ndez-Garc√≠a OA, Guerrero-Torres L, Torres-Gonz√°lez L, Carrera-Pati√±o FA, Corral-Herrera EA, Hern√°ndez-Alem√≥n AN, Tovar-Vargas ML√Å, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz √ìA, C√°rdenas-Fragoso JL, Vidal-Mayo JJ, Hern√°ndez-Gilsoul T, Rivero-Sigarroa E, Dom√≠nguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-Gonz√°lez V, Calva-Mercado JJ, Sierra-Madero JG, L√≥pez-√ç√±iguez √Å, Ochoa-Hein E, Crabtree-Ram√≠rez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gul√≠as-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-Le√≥n A. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY. Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211. Erratum in: Rev Invest Clin. 2020;72(4):252-258.', ""Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27. pii: ciaa478. doi: 10.1093/cid/ciaa478. [Epub ahead of print]"", 'Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, Matsuo K, Kubo H, Nagatomi R, Hongo S, Homma M, Nishimura H. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol. 2012 Jun;86(12):6537-45. doi: 10.1128/JVI.00094-12. Epub 2012 Apr 11.', 'Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R Jr, Nunneley JW, Barnard D, P√∂hlmann S, McKerrow JH, Renslo AR, Simmons G. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015 Apr;116:76-84. doi: 10.1016/j.antiviral.2015.01.011. Epub 2015 Feb 7.', 'Coote K, Atherton-Watson HC, Sugar R, Young A, MacKenzie-Beevor A, Gosling M, Bhalay G, Bloomfield G, Dunstan A, Bridges RJ, Sabater JR, Abraham WM, Tully D, Pacoma R, Schumacher A, Harris J, Danahay H. Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease. J Pharmacol Exp Ther. 2009 May;329(2):764-74. doi: 10.1124/jpet.108.148155. Epub 2009 Feb 3.', 'Rowe SM, Reeves G, Hathorne H, Solomon GM, Abbi S, Renard D, Lock R, Zhou P, Danahay H, Clancy JP, Waltz DA. Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis. Chest. 2013 Jul;144(1):200-207. doi: 10.1378/chest.12-2431.', 'Krishna S, Bustamante L, Haynes RK, Staines HM. Artemisinins: their growing importance in medicine. Trends Pharmacol Sci. 2008 Oct;29(10):520-7. doi: 10.1016/j.tips.2008.07.004. Epub 2008 Aug 25. Review.', 'Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med. 2008 Apr 24;358(17):1829-36. doi: 10.1056/NEJMct0709050. Review.', 'Zhang X, Zhao Y, Guo L, Qiu Z, Huang L, Qu X. Differences in chemical constituents of Artemisia annua L from different geographical regions in China. PLoS One. 2017 Sep 7;12(9):e0183047. doi: 10.1371/journal.pone.0183047. eCollection 2017.', 'Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P. Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial. Phytomedicine. 2019 Apr;57:49-56. doi: 10.1016/j.phymed.2018.12.002. Epub 2018 Dec 5. Retraction in: Phytomedicine. 2020 Nov;78:153304.\n\nRetraction in:\nPhytomedicine. 2020 Nov;78:153304', 'Retraction in:\nPhytomedicine. 2020 Nov;78:153304', 'Naesens L, Bonnafous P, Agut H, De Clercq E. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J Clin Virol. 2006 Dec;37 Suppl 1:S69-75.', 'Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, Zhang X, Hua SN, Yu J, Xiao PG, Li RS, Tan X. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 2005 Jul;67(1):18-23.', 'Wang C, Xuan X, Yao W, Huang G, Jin J. Anti-profibrotic effects of artesunate on bleomycin-induced pulmonary fibrosis in Sprague Dawley rats. Mol Med Rep. 2015 Jul;12(1):1291-7. doi: 10.3892/mmr.2015.3500. Epub 2015 Mar 17.', 'Berry SM, Alarid ET, Beebe DJ. One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST). Lab Chip. 2011 May 21;11(10):1747-53. doi: 10.1039/c1lc00004g. Epub 2011 Mar 21.', 'Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, Lit LC, Hui DS, Chan MH, Chung SS, Sung JJ. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004 Apr;136(1):95-103.', 'Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018 Apr;104:8-13. doi: 10.1016/j.cyto.2018.01.025. Epub 2018 Feb 2.', 'Gee JR, Saltzstein DR, Kim K, Kolesar J, Huang W, Havighurst TC, Wollmer BW, Stublaski J, Downs T, Mukhtar H, House MG, Parnes HL, Bailey HH. A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers. Cancer Prev Res (Phila). 2017 May;10(5):298-307. doi: 10.1158/1940-6207.CAPR-16-0167. Epub 2017 Mar 21.']",2021-06-21,https://clinicaltrials.gov/show/NCT04530617,2021-06-10,0,1
3151,NCT04530656,Completed,2020-10-28,2021-11-23,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04530656,2020-10-28,0,0
3152,NCT04530682,"Active, not recruiting",2023-07-20,2024-07-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04530682,2023-07-20,0,0
3153,NCT04531111,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04531111,2020-08-01,0,0
3154,NCT04531202,Recruiting,2020-09-30,2021-09-30,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04531202,2020-09-30,0,0
3155,NCT04531254,Completed,2020-08-31,2020-08-31,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04531254,2020-08-31,0,0
3156,NCT04531319,Completed,2020-10-01,2020-10-01,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04531319,2020-10-01,0,0
3157,NCT04531345,Completed,2020-11-01,2020-11-15,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04531345,2020-11-01,0,0
3158,NCT04531501,Recruiting,2020-09-29,2020-09-29,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04531501,2020-09-29,0,0
3159,NCT04531618,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-08-31,https://clinicaltrials.gov/show/NCT04531618,2021-12-01,0,0
3160,NCT04531735,"Active, not recruiting",2020-08-01,2020-08-31,No Results Posted,,,2020-08-28,https://clinicaltrials.gov/show/NCT04531735,2020-08-01,0,0
3161,NCT04531748,Withdrawn,2022-09-01,2022-09-01,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04531748,2022-09-01,0,0
3162,NCT04531774,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04531774,2021-06-01,0,0
3163,NCT04532294,Completed,2021-02-13,2021-02-13,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-27,https://clinicaltrials.gov/show/NCT04532294,2021-02-13,1,1
3164,NCT04532372,Recruiting,2022-09-18,2022-09-18,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04532372,2022-09-18,0,0
3165,NCT04532411,Completed,2020-09-30,2020-09-30,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04532411,2020-09-30,0,0
3166,NCT04532554,Withdrawn,2020-12-10,2020-12-20,No Results Posted,,"['Meazza C, Pagani S, Travaglino P, Bozzola M. Effect of growth hormone (GH) on the immune system. Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:490-5. Review.']",2020-09-16,https://clinicaltrials.gov/show/NCT04532554,2020-12-10,0,1
3167,NCT04532632,Completed,2020-10-01,2020-10-09,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04532632,2020-10-01,0,0
3168,NCT04532931,Completed,2021-08-05,2021-08-23,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04532931,2021-08-05,0,0
3169,NCT04533048,Completed,2020-11-16,2020-12-02,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Meng X, Wang P, Xiong Y, Wu Y, Lin X, Lu S, Li R, Zhao B, Liu J, Zeng S, Zeng L, Wu Y, Lu Y, Zhang J, Liu D, Wang S, Lu H. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Emerg Microbes Infect. 2021 Dec;10(1):1638-1648. doi: 10.1080/22221751.2021.1960900.']",,2021-02-26,https://clinicaltrials.gov/show/NCT04533048,2020-11-16,0,1
3170,NCT04533347,"Active, not recruiting",2022-01-31,2022-02-28,No Results Posted,,"['Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.', 'Brueckner RP, Lasseter KC, Lin ET, Schuster BG. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg. 1998 May;58(5):645-9.', 'Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010 Jun 30;5(3):202-10. doi: 10.1186/2049-6958-5-3-202.', 'Dow GS, Luttick A, Fenner J, Wesche D, Yeo KR, Rayner C. Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro. bioRxiv. January 2020:2020.07.12.199059. doi:10.1101/2020.07.12.199059', 'Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005 Dec;79(23):14614-21.', 'Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA, Hullsiek KH, Cheng MP, Luke D, Lother SA, MacKenzie LJ, Drobot G, Kelly LE, Schwartz IS, Zarychanski R, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16. Erratum in: Ann Intern Med. 2021 Mar;174(3):435.', 'Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.', 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.', 'Worldometer. Coronavirus Update (Live). https://www.worldometers.info/coronavirus/. Accessed March 7, 2020.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.']",2021-10-07,https://clinicaltrials.gov/show/NCT04533347,2022-01-31,0,1
3171,NCT04533360,Completed,2020-10-09,2021-05-01,No Results Posted,"['Santarelli A, Lalitsasivimol D, Bartholomew N, Reid S, Reid J, Lyon C, Wells J, Ashurst J. The seroprevalence of SARS-CoV-2 in a rural southwest community. J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04533360,2020-10-09,0,1
3172,NCT04533399,Completed,2021-12-07,2022-01-19,No Results Posted,"['Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche L, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Kruger G, Carrim-Ganey N, Baillie V, de Oliveira T, Lombard Koen A, Lombaard JJ, Mngqibisa R, Bhorat AE, Benad√© G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen-Jose A, Foulkes S, Ahmed K, Thombrayil A, Fries L, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Robertson A, Neal S, Cho I, Glenn GM, Dubovsky F, Madhi SA; 2019nCoV-501 Study Group. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 May 20;384(20):1899-1909. doi: 10.1056/NEJMoa2103055. Epub 2021 May 5.']",,2022-02-17,https://clinicaltrials.gov/show/NCT04533399,2021-12-07,0,1
3173,NCT04534400,Recruiting,2024-03-01,2024-03-01,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04534400,2024-03-01,0,0
3174,NCT04534478,Not yet recruiting,2021-05-02,2021-12-15,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04534478,2021-05-02,0,0
3175,NCT04534569,Completed,2020-10-03,2020-10-06,No Results Posted,"['Nasa P, Azoulay E, Khanna AK, Jain R, Gupta S, Javeri Y, Juneja D, Rangappa P, Sundararajan K, Alhazzani W, Antonelli M, Arabi YM, Bakker J, Brochard LJ, Deane AM, Du B, Einav S, Esteban A, Gajic O, Galvagno SM Jr, Gu√©rin C, Jaber S, Khilnani GC, Koh Y, Lascarrou JB, Machado FR, Malbrain MLNG, Mancebo J, McCurdy MT, McGrath BA, Mehta S, Mekontso-Dessap A, Mer M, Nurok M, Park PK, Pelosi P, Peter JV, Phua J, Pilcher DV, Piquilloud L, Schellongowski P, Schultz MJ, Shankar-Hari M, Singh S, Sorbello M, Tiruvoipati R, Udy AA, Welte T, Myatra SN. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Crit Care. 2021 Mar 16;25(1):106. doi: 10.1186/s13054-021-03491-y.']",,2020-10-08,https://clinicaltrials.gov/show/NCT04534569,2020-10-03,0,1
3176,NCT04534595,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04534595,2022-03-01,0,0
3177,NCT04534608,"Active, not recruiting",2020-06-30,2021-03-31,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04534608,2020-06-30,0,0
3178,NCT04534621,Not yet recruiting,2020-09-06,2020-09-18,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04534621,2020-09-06,0,0
3179,NCT04534673,Recruiting,2023-12-31,2024-12-31,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04534673,2023-12-31,0,0
3180,NCT04534712,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04534712,2020-12-01,0,0
3181,NCT04534725,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-12,https://clinicaltrials.gov/show/NCT04534725,2021-12-01,0,1
3182,NCT04534790,Completed,2020-12-12,2021-01-08,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04534790,2020-12-12,0,0
3183,NCT04534803,Withdrawn,2022-05-01,2022-07-01,No Results Posted,,,2021-06-28,https://clinicaltrials.gov/show/NCT04534803,2022-05-01,0,0
3184,NCT04535063,Recruiting,2020-12-30,2021-02-25,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04535063,2020-12-30,0,0
3185,NCT04535128,Recruiting,2021-12-31,2022-03-30,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04535128,2021-12-31,0,0
3186,NCT04535154,"Active, not recruiting",2021-06-01,2022-06-01,No Results Posted,"['Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, Berger Nossen M, Andrup S, Grenne B, Dalen H, Einvik G, Stavem K, Follestad T, Josefsen T, Omland T, Jensen T. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J Am Heart Assoc. 2022 Feb;11(3):e023473. doi: 10.1161/JAHA.121.023473. Epub 2022 Jan 20.']",,2020-09-01,https://clinicaltrials.gov/show/NCT04535154,2021-06-01,0,1
3187,NCT04535167,Completed,2021-06-07,2021-06-07,No Results Posted,"['Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, Barcelo J, Sanz-Moreno V. Rho GTPase signaling in cancer progression and dissemination. Physiol Rev. 2022 Jan 1;102(1):455-510. doi: 10.1152/physrev.00045.2020. Epub 2021 Sep 20. Review.']",,2021-06-24,https://clinicaltrials.gov/show/NCT04535167,2021-06-07,0,1
3188,NCT04535297,Completed,2020-05-30,2020-06-30,No Results Posted,,,2020-09-01,https://clinicaltrials.gov/show/NCT04535297,2020-05-30,0,0
3189,NCT04535674,Completed,2021-10-29,2021-12-21,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04535674,2021-10-29,0,0
3190,NCT04535700,Recruiting,2021-03-10,2021-04-10,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04535700,2021-03-10,0,0
3191,NCT04535778,Completed,2021-07-01,2022-01-01,No Results Posted,"['Hulme K, Hudson JL, Picariello F, Seaton N, Norton S, Wroe A, Moss-Morris R. Clinical efficacy of COMPASS, a digital cognitive-behavioural therapy programme for treating anxiety and depression in patients with long-term physical health conditions: a protocol for randomised controlled trial. BMJ Open. 2021 Oct 25;11(10):e053971. doi: 10.1136/bmjopen-2021-053971.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04535778,2021-07-01,0,1
3192,NCT04535791,Completed,2020-12-30,2021-07-15,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04535791,2020-12-30,0,0
3193,NCT04535856,Completed,2021-01-14,2021-01-14,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04535856,2021-01-14,0,0
3194,NCT04535869,Recruiting,2021-04-01,2021-09-03,No Results Posted,,"['Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.']",2021-02-24,https://clinicaltrials.gov/show/NCT04535869,2021-04-01,0,1
3195,NCT04536051,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04536051,2021-09-01,0,0
3196,NCT04536090,Not yet recruiting,2022-12-01,2023-06-01,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04536090,2022-12-01,0,0
3197,NCT04536285,Completed,2020-08-31,2020-08-31,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04536285,2020-08-31,0,0
3198,NCT04536298,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04536298,2021-12-31,0,0
3199,NCT04536350,Recruiting,2022-03-01,2022-04-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04536350,2022-03-01,0,0
3200,NCT04536363,Not yet recruiting,2020-12-01,2021-03-01,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04536363,2020-12-01,0,0
3201,NCT04536441,Completed,2020-05-30,2020-06-30,No Results Posted,,,2020-09-02,https://clinicaltrials.gov/show/NCT04536441,2020-05-30,0,0
3202,NCT04536935,Completed,2021-06-20,2021-06-20,No Results Posted,,,2022-02-18,,2021-06-20,0,0
3203,NCT04537117,Completed,2020-05-05,2020-05-05,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04537117,2020-05-05,0,0
3204,NCT04537130,Not yet recruiting,2021-06-01,2022-06-01,No Results Posted,,,2020-09-24,https://clinicaltrials.gov/show/NCT04537130,2021-06-01,0,0
3205,NCT04537208,Completed,2021-11-19,2021-11-19,No Results Posted,"['De Rosa SC, Cohen KW, Bonaparte M, Fu B, Garg S, Gerard C, Goepfert PA, Huang Y, Larocque D, McElrath MJ, Morris D, Van der Most R, de Bruyn G, Pagnon A. Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate. Clin Transl Immunology. 2022 Jan 11;11(1):e1360. doi: 10.1002/cti2.1360. eCollection 2022.', 'Goepfert PA, Fu B, Chabanon AL, Bonaparte MI, Davis MG, Essink BJ, Frank I, Haney O, Janosczyk H, Keefer MC, Koutsoukos M, Kimmel MA, Masotti R, Savarino SJ, Schuerman L, Schwartz H, Sher LD, Smith J, Tavares-Da-Silva F, Gurunathan S, DiazGranados CA, de Bruyn G. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study. Lancet Infect Dis. 2021 Sep;21(9):1257-1270. doi: 10.1016/S1473-3099(21)00147-X. Epub 2021 Apr 19.']",,2021-12-27,https://clinicaltrials.gov/show/NCT04537208,2021-11-19,0,1
3206,NCT04537299,Enrolling by invitation,2023-12-01,2023-12-01,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04537299,2023-12-01,0,0
3207,NCT04537338,Not yet recruiting,2022-09-14,2022-09-14,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04537338,2022-09-14,0,0
3208,NCT04537351,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04537351,2021-12-31,0,0
3209,NCT04537559,Enrolling by invitation,2022-02-28,2023-02-28,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04537559,2022-02-28,0,0
3210,NCT04537572,Not yet recruiting,2022-09-01,2022-09-01,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04537572,2022-09-01,0,0
3211,NCT04537585,Not yet recruiting,2022-11-01,2022-12-01,No Results Posted,,,2020-09-03,https://clinicaltrials.gov/show/NCT04537585,2022-11-01,0,0
3212,NCT04537650,Enrolling by invitation,2021-09-30,2021-12-31,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04537650,2021-09-30,0,0
3213,NCT04537663,Recruiting,2021-06-25,2021-07-25,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04537663,2021-06-25,0,0
3214,NCT04537806,Terminated,2021-07-01,2021-07-01,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04537806,2021-07-01,0,0
3215,NCT04537858,"Active, not recruiting",2020-08-20,2020-12-01,No Results Posted,"['da Silva TD, de Oliveira PM, Dionizio JB, de Santana AP, Bahadori S, Dias ED, Ribeiro CM, Gomes RA, Ferreira M, Ferreira C, de Moraes √çAP, Silva DMM, Barnab√© V, de Ara√∫jo LV, Santana HBR, Monteiro CBM. Comparison Between Conventional Intervention and Non-immersive Virtual Reality in the Rehabilitation of Individuals in an Inpatient Unit for the Treatment of COVID-19: A Study Protocol for a Randomized Controlled Crossover Trial. Front Psychol. 2021 Feb 24;12:622618. doi: 10.3389/fpsyg.2021.622618. eCollection 2021.']",,2020-09-03,https://clinicaltrials.gov/show/NCT04537858,2020-08-20,0,1
3216,NCT04537949,Completed,2021-03-12,2022-02-07,Study Results,,,2022-03-24,https://clinicaltrials.gov/show/NCT04537949,2021-03-12,1,0
3217,NCT04537962,Completed,2020-12-30,2021-09-30,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04537962,2020-12-30,0,0
3218,NCT04538456,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04538456,2021-04-01,0,0
3219,NCT04538469,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-09-04,https://clinicaltrials.gov/show/NCT04538469,2021-12-01,0,0
3220,NCT04538586,Recruiting,2020-12-01,2025-12-01,No Results Posted,,,2020-09-04,https://clinicaltrials.gov/show/NCT04538586,2020-12-01,0,0
3221,NCT04539275,Terminated,2021-06-30,2021-09-30,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04539275,2021-06-30,0,0
3222,NCT04539626,Recruiting,2021-07-01,2022-12-01,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04539626,2021-07-01,0,0
3223,NCT04539795,Completed,2021-10-29,2021-10-29,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04539795,2021-10-29,0,0
3224,NCT04539821,Completed,2021-05-31,2021-08-12,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04539821,2021-05-31,0,0
3225,NCT04539834,Completed,2021-08-01,2021-10-30,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04539834,2021-08-01,0,0
3226,NCT04539873,Terminated,2021-10-30,2021-10-30,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006 Feb;6(2):67-9.', 'Tay MZ, Poh CM, R√©nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28. Review.']",2022-02-23,https://clinicaltrials.gov/show/NCT04539873,2021-10-30,0,1
3227,NCT04540029,Recruiting,2022-10-31,2023-05-31,No Results Posted,"['Provenzi L, Grumi S, Giorda R, Biasucci G, Bonini R, Cavallini A, Decembrino L, Drera B, Falcone R, Fazzi E, Gardella B, Giacchero R, Nacinovich R, Pisoni C, Prefumo F, Scelsa B, Spart√† MV, Veggiotti P, Orcesi S, Borgatti R; MOM-COPE Study Group. Measuring the Outcomes of Maternal COVID-19-related Prenatal Exposure (MOM-COPE): study protocol for a multicentric longitudinal project. BMJ Open. 2020 Dec 31;10(12):e044585. doi: 10.1136/bmjopen-2020-044585.']",,2020-09-07,https://clinicaltrials.gov/show/NCT04540029,2022-10-31,0,1
3228,NCT04540185,Enrolling by invitation,2022-11-01,2022-12-31,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04540185,2022-11-01,0,0
3229,NCT04540393,Withdrawn,2020-12-04,2022-05-11,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04540393,2020-12-04,0,0
3230,NCT04540406,Recruiting,2021-12-01,2022-01-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04540406,2021-12-01,0,0
3231,NCT04540419,"Active, not recruiting",2021-06-19,2021-07-31,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04540419,2021-06-19,0,0
3232,NCT04540484,Completed,2021-10-14,2021-12-14,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04540484,2021-10-14,0,0
3233,NCT04540926,Not yet recruiting,2020-09-01,2020-09-30,No Results Posted,,"['Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1. Review.', 'Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020 Mar;20(2):124-127. doi: 10.7861/clinmed.2019-coron. Epub 2020 Mar 5. Review.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, Fran√ßois B, S√®ve P. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020 Jul;19(7):102567. doi: 10.1016/j.autrev.2020.102567. Epub 2020 May 4. Review.', 'Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.', 'Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.', 'Villar J, Belda J, A√±√≥n JM, Blanco J, P√©rez-M√©ndez L, Ferrando C, Mart√≠nez D, Soler JA, Ambr√≥s A, Mu√±oz T, Rivas R, Corpas R, D√≠az-Dominguez FJ, Soro M, Garc√≠a-Bello MA, Fern√°ndez RL, Kacmarek RM; DEXA-ARDS Network. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4.', 'Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, M√∏ller MH, Annane D, Kho ME, Adhikari NKJ, Machado F, Vandvik PO, Dodek P, Leboeuf R, Briel M, Hashmi M, Camsooksai J, Shankar-Hari M, Baraki MK, Fugate K, Chua S, Marti C, Cohen D, Botton E, Agoritsas T, Siemieniuk RAC. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ. 2018 Aug 10;362:k3284. doi: 10.1136/bmj.k3284.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.', 'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.', 'Zeidler HK, Kvien TK, Hannonen P, Wollheim FA, F√∏rre O, Geidel H, Hafstr√∂m I, Kaltwasser JP, Leirisalo-Repo M, Manger B, Laasonen L, Markert ER, Prestele H, Kurki P. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Br J Rheumatol. 1998 Aug;37(8):874-82.', 'Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K, Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum. 1994 Apr;37(4):551-8.', 'Liddicoat AM, Lavelle EC. Modulation of innate immunity by cyclosporine A. Biochem Pharmacol. 2019 May;163:472-480. doi: 10.1016/j.bcp.2019.03.022. Epub 2019 Mar 15. Review.', 'Li HS, Kuok DIT, Cheung MC, Ng MMT, Ng KC, Hui KPY, Peiris JSM, Chan MCW, Nicholls JM. Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model. Antiviral Res. 2018 Jul;155:89-96. doi: 10.1016/j.antiviral.2018.05.007. Epub 2018 May 17.', 'Tanaka Y, Sato Y, Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 2013 May 22;5(5):1250-60. doi: 10.3390/v5051250. Review.', 'de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K, Makino S, Snijder EJ, van Hemert MJ. Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol. 2011 Nov;92(Pt 11):2542-2548. doi: 10.1099/vir.0.034983-0. Epub 2011 Jul 13.', 'Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, Shi H, Zhou M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020 Aug;296(2):E55-E64. doi: 10.1148/radiol.2020200843. Epub 2020 Mar 19.', 'Ji D, Zhang D, Xu J, Chen Z, Yang T, Zhao P, Chen G, Cheng G, Wang Y, Bi J, Tan L, Lau G, Qin E. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.', 'Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. Review.', 'Annane D, Renault A, Bellissant E. Glucocorticoids with or without Fludrocortisone in Septic Shock. N Engl J Med. 2018 Aug 30;379(9):895-6. doi: 10.1056/NEJMc1804993.', 'Venkatesh B, Finfer S, Myburgh J; ADRENAL investigators. Glucocorticoids with or without Fludrocortisone in Septic Shock. N Engl J Med. 2018 Aug 30;379(9):895. doi: 10.1056/NEJMc1804993.', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.', 'Wong SS, Yuen KY. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother. 2008 Sep;62(3):437-41. doi: 10.1093/jac/dkn243. Epub 2008 Jun 18. Review.', 'Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, Wong VW, Chan PK, Wong KT, Wong E, Cockram CS, Tam JS, Sung JJ, Lo YM. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. 2004 Dec;31(4):304-9.', 'Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Jose J, Pinto R, Al-Omari A, Kharaba A, Almotairi A, Al Khatib K, Alraddadi B, Shalhoub S, Abdulmomen A, Qushmaq I, Mady A, Solaiman O, Al-Aithan AM, Al-Raddadi R, Ragab A, Balkhy HH, Al Harthy A, Deeb AM, Al Mutairi H, Al-Dawood A, Merson L, Hayden FG, Fowler RA; Saudi Critical Care Trial Group. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767. doi: 10.1164/rccm.201706-1172OC.', 'Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. Ecancermedicalscience. 2020 Mar 27;14:1022. doi: 10.3332/ecancer.2020.1022. eCollection 2020. Review.', 'Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, Yin Z, Huang S, Deng Z, Wei M, Xiong J, Hawkey PM. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003 Aug;52(Pt 8):715-720. doi: 10.1099/jmm.0.05320-0.', 'Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.', 'Fern√°ndez-Cruz A, Ruiz-Antor√°n B, M√∫√±ez-Rubio E, Sancho-L√≥pez A, Callejas-D√≠az A, Avenda√±o-Sol√° C, Ramos-Mart√≠nez A. The Right Time for Steroids in COVID-19. Clin Infect Dis. 2021 Apr 26;72(8):1486-1487. doi: 10.1093/cid/ciaa865.', 'Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP. Short-Term Dexamethasone in Sars-CoV-2 Patients. R I Med J (2013). 2020 Jun 19;103(6):39-43.', 'Cour M, Ovize M, Argaud L. Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure? Crit Care. 2020 Jun 2;24(1):276. doi: 10.1186/s13054-020-03014-1.', 'Argaud L, Cour M, Dubien PY, Giraud F, Jossan C, Riche B, Hernu R, Darmon M, Poncelin Y, Tch√©nio X, Quenot JP, Freysz M, Kamga C, Beuret P, Usseglio P, Badet M, Anette B, Chaulier K, Alasan E, Sadoune S, Bobbia X, Z√©ni F, Gueugniaud PY, Robert D, Roy P, Ovize M; CYRUS Study Group. Effect of Cyclosporine in Nonshockable Out-of-Hospital Cardiac Arrest: The CYRUS Randomized Clinical Trial. JAMA Cardiol. 2016 Aug 1;1(5):557-65. doi: 10.1001/jamacardio.2016.1701.', 'Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Gu√©rin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Rand√© JL, Unterseeh T, Le Breton H, B√©ard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M. Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489. Epub 2015 Aug 30.', 'Kreitmann L, Argaud L, Ovize M, Cour M; CYRUS Study Group. Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trial. Intensive Care Med. 2020 Jun;46(6):1281-1283. doi: 10.1007/s00134-020-06043-0. Epub 2020 Apr 21.', 'Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908. Review.', ""Sanchez-Pernaute O, Romero-Bueno FI, Selva-O'Callaghan A. Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia. Reumatol Clin. 2021 Nov;17(9):555-557. doi: 10.1016/j.reuma.2020.03.001. Epub 2020 Apr 16."", 'Pino-Lagos K, Michea P, Sauma D, Alba A, Morales J, Bono MR, Fierro A, Rosemblatt M. Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation. Biol Res. 2010;43(3):333-7. doi: /S0716-97602010000300010. Epub 2010 Nov 30.', 'Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med. 2010 May 10;207(5):923-31. doi: 10.1084/jem.20092531. Epub 2010 Apr 26.', 'Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother. 1994 Dec;38(12):2883-8.', 'Gupta AK, Giaglis S, Hasler P, Hahn S. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS One. 2014 May 12;9(5):e97088. doi: 10.1371/journal.pone.0097088. eCollection 2014.', 'Edler C, Schr√∂der AS, Aepfelbacher M, Fitzek A, Heinemann A, Heinrich F, Klein A, Langenwalder F, L√ºtgehetmann M, Mei√üner K, P√ºschel K, Sch√§dler J, Steurer S, Mushumba H, Sperhake JP. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4. Erratum in: Int J Legal Med. 2020 Sep;134(5):1977.', 'Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Da√üler-Plenker J, Guerci P, Huynh C, Knight JS, Loda M, Looney MR, McAllister F, Rayes R, Renaud S, Rousseau S, Salvatore S, Schwartz RE, Spicer JD, Yost CC, Weber A, Zuo Y, Egeblad M. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020 Jun 1;217(6). pii: e20200652. doi: 10.1084/jem.20200652.', 'Narasaraju T, Tang BM, Herrmann M, Muller S, Chow VTK, Radic M. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Front Pharmacol. 2020 Jun 5;11:870. doi: 10.3389/fphar.2020.00870. eCollection 2020.', 'de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RWAL, Posthuma CC, van der Meer Y, B√°rcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-Œ± treatment. J Gen Virol. 2013 Aug;94(Pt 8):1749-1760. doi: 10.1099/vir.0.052910-0. Epub 2013 Apr 25.', 'Softic L, Brillet R, Berry F, Ahnou N, Nevers Q, Morin-Dewaele M, Hamadat S, Bruscella P, Fourati S, Pawlotsky JM, Ahmed-Belkacem A. Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025). Antimicrob Agents Chemother. 2020 Jun 23;64(7). pii: e00876-20. doi: 10.1128/AAC.00876-20. Print 2020 Jun 23.']",2020-09-07,https://clinicaltrials.gov/show/NCT04540926,2020-09-01,0,1
3234,NCT04540939,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04540939,2022-05-01,0,0
3235,NCT04541472,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04541472,2020-12-01,0,0
3236,NCT04541485,Terminated,2021-03-03,2021-03-23,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04541485,2021-03-03,0,0
3237,NCT04541979,Recruiting,2022-12-01,2022-12-31,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04541979,2022-12-01,0,0
3238,NCT04542031,Recruiting,2022-01-01,2022-10-01,No Results Posted,,,2022-01-05,https://clinicaltrials.gov/show/NCT04542031,2022-01-01,0,0
3239,NCT04542044,Completed,2020-05-05,2020-06-30,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04542044,2020-05-05,0,0
3240,NCT04542083,Recruiting,2022-01-01,2022-06-30,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04542083,2022-01-01,0,0
3241,NCT04542122,Not yet recruiting,2021-04-30,2021-08-02,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04542122,2021-04-30,0,0
3242,NCT04542200,Enrolling by invitation,2022-12-31,2022-12-31,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04542200,2022-12-31,0,0
3243,NCT04542213,Completed,2021-02-28,2021-02-28,No Results Posted,"['Guardado-Mendoza R, Garcia-Maga√±a MA, Mart√≠nez-Navarro LJ, Mac√≠as-Cervantes HE, Aguilar-Guerrero R, Su√°rez-P√©rez EL, Aguilar-Garc√≠a A. Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection. Sci Rep. 2022 Jan 11;12(1):536. doi: 10.1038/s41598-021-04511-1.']",,2021-03-23,https://clinicaltrials.gov/show/NCT04542213,2021-02-28,0,1
3244,NCT04542330,"Active, not recruiting",2022-12-31,2023-09-30,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04542330,2022-12-31,0,0
3245,NCT04542343,Recruiting,2022-10-30,2023-02-28,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04542343,2022-10-30,0,0
3246,NCT04542395,Recruiting,2022-11-30,2022-11-30,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04542395,2022-11-30,0,0
3247,NCT04542408,Recruiting,2022-03-01,2022-09-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04542408,2022-03-01,0,0
3248,NCT04542421,"Active, not recruiting",2021-07-01,2022-04-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04542421,2021-07-01,0,0
3249,NCT04542434,Withdrawn,2022-01-20,2022-01-20,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04542434,2022-01-20,0,0
3250,NCT04542447,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,2020-09-10,https://clinicaltrials.gov/show/NCT04542447,2020-09-30,0,0
3251,NCT04542512,Recruiting,2021-09-30,2021-12-01,No Results Posted,,"['Bourikian S, Anand RJ, Aboutanos M, Wolfe LG, Ferrada P. Risk factors for acute gangrenous cholecystitis in emergency general surgery patients. Am J Surg. 2015 Oct;210(4):730-3. doi: 10.1016/j.amjsurg.2015.05.003. Epub 2015 Jun 27.', '√ñnder A, Kapan M, √úlger BV, Oƒüuz A, T√ºrkoƒülu A, Uslukaya √ñ. Gangrenous cholecystitis: mortality and risk factors. Int Surg. 2015 Feb;100(2):254-60. doi: 10.9738/INTSURG-D-13-00222.1.', 'Gomes CA, Soares C, Di Saverio S, Sartelli M, de Souza Silva PG, Orlandi AS, Heringer TL, Gomes FC, Catena F. Gangrenous cholecystitis in male patients: A study of prevalence and predictive risk factors. Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):34-40. doi: 10.14701/ahbps.2019.23.1.34. Epub 2019 Feb 28.', 'Contini S, Corradi D, Busi N, Alessandri L, Pezzarossa A, Scarpignato C. Can gangrenous cholecystitis be prevented?: a plea against a ""wait and see"" attitude. J Clin Gastroenterol. 2004 Sep;38(8):710-6.', 'Pisano M, Ceresoli M, Cimbanassi S, Gurusamy K, Coccolini F, Borzellino G, Costa G, Allievi N, Amato B, Boerma D, Calcagno P, Campanati L, Campanile FC, Casati A, Chiara O, Crucitti A, di Saverio S, Filauro M, Gabrielli F, Guttadauro A, Kluger Y, Magnone S, Merli C, Poiasina E, Puzziello A, Sartelli M, Catena F, Ansaloni L. 2017 WSES and SICG guidelines on acute calcolous cholecystitis in elderly population. World J Emerg Surg. 2019 Mar 4;14:10. doi: 10.1186/s13017-019-0224-7. eCollection 2019. Review.', 'Hunt DR, Chu FC. Gangrenous cholecystitis in the laparoscopic era. Aust N Z J Surg. 2000 Jun;70(6):428-30.']",2021-03-26,https://clinicaltrials.gov/show/NCT04542512,2021-09-30,0,1
3252,NCT04542694,Completed,2020-08-10,2020-08-20,Study Results,,,2020-11-05,https://clinicaltrials.gov/show/NCT04542694,2020-08-10,1,0
3253,NCT04542850,Completed,2021-08-31,2021-10-28,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04542850,2021-08-31,0,0
3254,NCT04542876,Completed,2020-07-31,2020-08-18,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04542876,2020-07-31,0,0
3255,NCT04542915,Completed,2021-08-31,2021-08-31,No Results Posted,"['Estrich CG, Gurenlian JR, Battrell A, Bessner SK, Lynch A, Mikkelsen M, Morrissey R, Araujo MWB, Vujicic M. COVID-19 Prevalence and Related Practices among Dental Hygienists in the United States. J Dent Hyg. 2021 Feb;95(1):6-16.']",,2021-09-16,https://clinicaltrials.gov/show/NCT04542915,2021-08-31,0,1
3256,NCT04542941,Completed,2020-12-31,2020-12-31,No Results Posted,"['Kirenga B, Byakika-Kibwika P, Muttamba W, Kayongo A, Loryndah NO, Mugenyi L, Kiwanuka N, Lusiba J, Atukunda A, Mugume R, Ssali F, Ddungu H, Katagira W, Sekibira R, Kityo C, Kyeyune D, Acana S, Aanyu-Tukamuhebwa H, Kabweru W, Nakwagala F, Bagaya BS, Kimuli I, Nantanda R, Buregyeya E, Byarugaba B, Olaro C, Mwebesa H, Joloba ML, Siddharthan T, Bazeyo W. Efficacy of convalescent plasma for treatment of COVID-19 in Uganda. BMJ Open Respir Res. 2021 Aug;8(1). pii: e001017. doi: 10.1136/bmjresp-2021-001017.']",,2021-01-15,https://clinicaltrials.gov/show/NCT04542941,2020-12-31,0,1
3257,NCT04542954,Completed,2020-08-31,2020-08-31,No Results Posted,,,2020-09-09,https://clinicaltrials.gov/show/NCT04542954,2020-08-31,0,0
3258,NCT04542967,Completed,2020-09-02,2020-09-30,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04542967,2020-09-02,0,0
3259,NCT04542980,Completed,2020-12-31,2020-12-31,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04542980,2020-12-31,0,0
3260,NCT04542993,"Active, not recruiting",2021-02-05,2022-06-01,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04542993,2021-02-05,0,0
3261,NCT04543006,Not yet recruiting,2021-09-30,2021-12-31,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04543006,2021-09-30,0,0
3262,NCT04543760,Completed,2021-01-15,2021-03-14,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04543760,2021-01-15,0,0
3263,NCT04544033,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04544033,2021-04-01,0,0
3264,NCT04544072,Recruiting,2020-12-01,2021-03-01,No Results Posted,"['Van Laethem J, Wuyts S, Van Laere S, Dirkx S, Seyler L, Mertens R, Ilsen B, Lacor P, Pierard D, Allard SD. Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study. Infect Dis Ther. 2021 Dec;10(4):2575-2591. doi: 10.1007/s40121-021-00535-2. Epub 2021 Sep 16.']",,2020-09-10,https://clinicaltrials.gov/show/NCT04544072,2020-12-01,0,1
3265,NCT04544150,Completed,2020-09-01,2020-09-01,No Results Posted,,,2020-09-10,https://clinicaltrials.gov/show/NCT04544150,2020-09-01,0,0
3266,NCT04544176,Completed,2020-06-30,2021-01-01,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04544176,2020-06-30,0,0
3267,NCT04544605,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04544605,2021-09-30,0,0
3268,NCT04544878,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2020-09-10,https://clinicaltrials.gov/show/NCT04544878,2021-06-01,0,0
3269,NCT04544891,Completed,2022-03-01,2022-03-01,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04544891,2022-03-01,0,0
3270,NCT04545008,Terminated,2021-06-02,2021-06-02,Study Results,,,2022-02-18,https://clinicaltrials.gov/show/NCT04545008,2021-06-02,1,0
3271,NCT04545047,"Active, not recruiting",2021-12-31,2022-06-30,No Results Posted,,"['Cho K, Keithly SC, Kurgansky KE, Madenci AL, Gerlovin H, Marucci-Wellman H, Doubleday A, Thomas ER, Park Y, Ho YL, Sugimoto JD, Moore KP, Peterson AC, Hoag C, Gupta K, Jeans K, Klote M, Ramoni R, Huang GD, Casas JP, Gagnon DR, Hern√°n MA, Smith NL, Gaziano JM. Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial. J Infect Dis. 2021 Sep 17;224(6):967-975. doi: 10.1093/infdis/jiab330.']",2022-03-15,https://clinicaltrials.gov/show/NCT04545047,2021-12-31,0,1
3272,NCT04545242,Recruiting,2023-09-30,2023-12-30,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04545242,2023-09-30,0,0
3273,NCT04545541,Recruiting,2022-04-01,2022-06-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04545541,2022-04-01,0,0
3274,NCT04545749,Completed,2021-01-18,2021-05-24,No Results Posted,"['Wang CY, Hwang KP, Kuo HK, Peng WJ, Shen YH, Kuo BS, Huang JH, Liu H, Ho YH, Lin F, Ding S, Liu Z, Wu HT, Huang CT, Lee YJ, Liu MC, Yang YC, Lu PL, Tsai HC, Lee CH, Shi ZY, Liu CE, Liao CH, Chang FY, Cheng HC, Wang FD, Hou KL, Cheng J, Wang MS, Yang YT, Chiu HC, Jiang MH, Shih HY, Shen HY, Chang PY, Lan YR, Chen CT, Lin YL, Liang JJ, Liao CC, Chou YC, Morris MK, Hanson CV, Guirakhoo F, Hellerstein M, Yu HJ, King CC, Kemp T, Heppner DG, Monath TP. A multitope SARS-COV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest. 2022 Mar 22. pii: e157707. doi: 10.1172/JCI157707. [Epub ahead of print]']",,2022-02-21,https://clinicaltrials.gov/show/NCT04545749,2021-01-18,0,1
3275,NCT04546191,Completed,2020-09-01,2020-09-01,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04546191,2020-09-01,0,0
3276,NCT04546737,"Active, not recruiting",2021-07-01,2022-05-01,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04546737,2021-07-01,0,0
3277,NCT04546776,Enrolling by invitation,2022-06-01,2022-06-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04546776,2022-06-01,0,0
3278,NCT04546841,Completed,2021-09-30,2021-12-02,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04546841,2021-09-30,0,0
3279,NCT04547114,Recruiting,2020-12-31,2021-04-30,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04547114,2020-12-31,0,0
3280,NCT04547127,Completed,2021-02-04,2021-02-04,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04547127,2021-02-04,0,0
3281,NCT04547140,Recruiting,2021-11-01,2022-02-01,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04547140,2021-11-01,0,0
3282,NCT04547218,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04547218,2020-12-31,0,0
3283,NCT04547257,Recruiting,2022-07-31,2022-12-31,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04547257,2022-07-31,0,0
3284,NCT04547283,Completed,2020-09-20,2020-09-30,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04547283,2020-09-20,0,0
3285,NCT04547634,Enrolling by invitation,2020-11-01,2020-12-01,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04547634,2020-11-01,0,0
3286,NCT04547660,Completed,2021-01-07,2021-01-07,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04547660,2021-01-07,0,0
3287,NCT04548492,Not yet recruiting,2020-12-01,2021-01-01,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04548492,2020-12-01,0,0
3288,NCT04548505,Recruiting,2023-04-05,2023-04-05,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04548505,2023-04-05,0,0
3289,NCT04548531,Completed,2021-04-30,2021-04-30,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04548531,2021-04-30,0,0
3290,NCT04548544,Completed,2020-05-20,2020-05-20,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04548544,2020-05-20,0,0
3291,NCT04548557,Not yet recruiting,2020-10-15,2020-11-15,No Results Posted,,,2020-09-14,https://clinicaltrials.gov/show/NCT04548557,2020-10-15,0,0
3292,NCT04548895,Completed,2021-04-30,2021-06-09,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04548895,2021-04-30,0,0
3293,NCT04548908,Recruiting,2021-04-30,2021-06-30,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04548908,2021-04-30,0,0
3294,NCT04548934,Completed,2020-10-31,2021-01-31,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04548934,2020-10-31,0,0
3295,NCT04549337,Completed,2021-01-01,2021-05-01,No Results Posted,"['Rasmussen IE, Foged F, Bj√∏rn Budde J, Rasmussen RS, Rasmussen V, Lyngb√¶k M, J√∏nck S, Krogh-Madsen R, Lindegaard B, Ried-Larsen M, J√∏rgensen PG, Lund MAV, K√∏ber L, Vejlstrup N, Pedersen BK, Berg RMG, Christensen RH. Protective potential of high-intensity interval training on cardiac structure and function after COVID-19: protocol and statistical analysis plan for an investigator-blinded randomised controlled trial. BMJ Open. 2021 Nov 18;11(11):e048281. doi: 10.1136/bmjopen-2020-048281.']",,2022-02-02,https://clinicaltrials.gov/show/NCT04549337,2021-01-01,0,1
3296,NCT04549350,Completed,2020-08-18,2020-09-05,No Results Posted,,,2020-09-21,https://clinicaltrials.gov/show/NCT04549350,2020-08-18,0,0
3297,NCT04549376,Completed,2020-10-20,2020-10-30,No Results Posted,"['Hasan MJ, Rumi SKNF, Banu SS, Uddin AKMN, Islam MS, Arefin MK. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial. Trials. 2021 Jan 4;22(1):2. doi: 10.1186/s13063-020-04963-2.']",,2022-01-25,https://clinicaltrials.gov/show/NCT04549376,2020-10-20,0,1
3298,NCT04549636,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-09-10,https://clinicaltrials.gov/show/NCT04549636,2021-12-01,0,0
3299,NCT04549831,Recruiting,2021-04-08,2026-04-08,No Results Posted,"['Fallerini C, Daga S, Mantovani S, Benetti E, Picchiotti N, Francisci D, Paciosi F, Schiaroli E, Baldassarri M, Fava F, Palmieri M, Ludovisi S, Castelli F, Quiros-Roldan E, Vaghi M, Rusconi S, Siano M, Bandini M, Spiga O, Capitani K, Furini S, Mari F; GEN-COVID Multicenter Study, Renieri A, Mondelli MU, Frullanti E. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife. 2021 Mar 2;10. pii: e67569. doi: 10.7554/eLife.67569.']",,2020-09-17,https://clinicaltrials.gov/show/NCT04549831,2021-04-08,0,1
3300,NCT04550312,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04550312,2020-10-01,0,0
3301,NCT04550325,Completed,2020-11-26,2020-11-26,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04550325,2020-11-26,0,0
3302,NCT04550338,Withdrawn,2022-12-31,2023-03-31,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04550338,2022-12-31,0,0
3303,NCT04550390,Completed,2020-10-19,2020-10-19,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04550390,2020-10-19,0,0
3304,NCT04550403,Completed,2021-10-30,2021-12-31,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04550403,2021-10-30,0,0
3305,NCT04551274,Not yet recruiting,2020-11-30,2020-11-30,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04551274,2020-11-30,0,0
3306,NCT04551339,Completed,2021-05-28,2021-05-28,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04551339,2021-05-28,0,0
3307,NCT04551378,Recruiting,2024-12-31,2025-12-31,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04551378,2024-12-31,0,0
3308,NCT04551547,Enrolling by invitation,2021-04-30,2022-02-01,No Results Posted,"['Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q, Wu Z, Zhao Y, Li Q, Gao Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Dec;21(12):1645-1653. doi: 10.1016/S1473-3099(21)00319-4. Epub 2021 Jun 28.']",,2021-07-27,https://clinicaltrials.gov/show/NCT04551547,2021-04-30,0,1
3309,NCT04551690,Completed,2020-07-15,2020-07-15,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04551690,2020-07-15,0,0
3310,NCT04551755,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04551755,2020-11-01,0,0
3311,NCT04551768,Completed,2021-08-17,2021-08-17,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04551768,2021-08-17,0,0
3312,NCT04551781,Completed,2020-07-30,2020-07-30,No Results Posted,,,2020-09-16,https://clinicaltrials.gov/show/NCT04551781,2020-07-30,0,0
3313,NCT04551898,Completed,2021-05-25,2021-05-25,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04551898,2021-05-25,1,1
3314,NCT04551911,Completed,2021-10-08,2021-10-08,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04551911,2021-10-08,0,0
3315,NCT04552340,Recruiting,2023-03-01,2023-07-01,No Results Posted,,,2020-09-17,https://clinicaltrials.gov/show/NCT04552340,2023-03-01,0,0
3316,NCT04552392,Completed,2020-10-20,2020-10-20,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04552392,2020-10-20,0,0
3317,NCT04552483,Completed,2020-08-20,2020-09-05,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04552483,2020-08-20,0,0
3318,NCT04552951,Recruiting,2020-09-14,2020-12-30,No Results Posted,"['Cannata-And√≠a JB, D√≠az-Sottolano A, Fern√°ndez P, Palomo-Antequera C, Herrero-Puente P, Mouzo R, Carrillo-L√≥pez N, Panizo S, Iba√±ez GH, Cusumano CA, Ballarino C, S√°nchez-Polo V, Pefaur-Penna J, Maderuelo-Riesco I, Calvi√±o-Varela J, G√≥mez MD, G√≥mez-Alonso C, Cunningham J, Naves-D√≠az M, Douthat W, Fern√°ndez-Mart√≠n JL; COVID-VIT-D trial collaborators. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med. 2022 Feb 18;20(1):83. doi: 10.1186/s12916-022-02290-8.']",,2020-09-17,https://clinicaltrials.gov/show/NCT04552951,2020-09-14,0,1
3319,NCT04553575,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04553575,2022-09-01,0,0
3320,NCT04553705,Recruiting,2020-11-04,2020-12-04,No Results Posted,,,2020-09-18,https://clinicaltrials.gov/show/NCT04553705,2020-11-04,0,0
3321,NCT04554251,Enrolling by invitation,2020-12-01,2020-12-30,No Results Posted,,,2020-09-18,https://clinicaltrials.gov/show/NCT04554251,2020-12-01,0,0
3322,NCT04554264,Recruiting,2021-09-01,2022-09-01,No Results Posted,,,2020-09-18,https://clinicaltrials.gov/show/NCT04554264,2021-09-01,0,0
3323,NCT04554433,Not yet recruiting,2021-10-01,2022-06-01,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04554433,2021-10-01,0,0
3324,NCT04554979,Completed,2020-07-15,2020-07-15,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04554979,2020-07-15,0,0
3325,NCT04554992,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04554992,2022-06-01,0,0
3326,NCT04555005,Completed,2020-04-26,2020-04-26,No Results Posted,"['Rodriguez-Vega B, Palao √Å, Mu√±oz-Sanjose A, Torrijos M, Aguirre P, Fern√°ndez A, Amador B, Rocamora C, Blanco L, Marti-Esquitino J, Ortiz-Villalobos A, Alonso-Sa√±udo M, Cebolla S, Curto J, Villanueva R, de-la-Iglesia MJ, Carracedo D, Casado C, Vidal E, Trigo D, Iglesias N, Caba√±as D, Mellado L, Garc√≠a D, Fern√°ndez-Encinas C, Navarro R, Mediavilla R, Vidal-Villegas MP, Bravo-Ortiz MF, Bay√≥n C. Implementation of a Mindfulness-Based Crisis Intervention for Frontline Healthcare Workers During the COVID-19 Outbreak in a Public General Hospital in Madrid, Spain. Front Psychiatry. 2020 Oct 30;11:562578. doi: 10.3389/fpsyt.2020.562578. eCollection 2020.']",,2020-09-18,https://clinicaltrials.gov/show/NCT04555005,2020-04-26,0,1
3327,NCT04555109,"Active, not recruiting",2022-09-30,2022-10-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04555109,2022-09-30,0,0
3328,NCT04555122,Withdrawn,2022-05-28,2022-07-28,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04555122,2022-05-28,0,0
3329,NCT04555148,Completed,2021-01-22,2021-04-23,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04555148,2021-01-22,0,0
3330,NCT04555187,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04555187,2022-12-01,0,0
3331,NCT04555213,Completed,2021-08-10,2021-08-10,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04555213,2021-08-10,0,0
3332,NCT04555954,Completed,2020-07-31,2020-08-20,No Results Posted,,,2020-09-21,https://clinicaltrials.gov/show/NCT04555954,2020-07-31,0,0
3333,NCT04556318,Completed,2021-06-11,2021-06-11,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04556318,2021-06-11,0,0
3334,NCT04556513,Recruiting,2021-12-01,2022-11-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04556513,2021-12-01,0,0
3335,NCT04556565,"Active, not recruiting",2021-11-07,2022-11-01,No Results Posted,"['Mortier P, Vilagut G, Ferrer M, Alayo I, Bruffaerts R, Crist√≥bal-Narv√°ez P, Del Cura-Gonz√°lez I, Dom√®nech-Abella J, Felez-Nobrega M, Olaya B, Pijoan JI, Vieta E, P√©rez-Sol√† V, Kessler RC, Haro JM, Alonso J; MINDCOVID Working group ; MINDCOVID Working group. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic. Epidemiol Psychiatr Sci. 2021 Feb 17;30:e19. doi: 10.1017/S2045796021000093.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04556565,2021-11-07,0,1
3336,NCT04556604,Completed,2020-08-14,2020-08-14,No Results Posted,,,2020-09-21,https://clinicaltrials.gov/show/NCT04556604,2020-08-14,0,0
3337,NCT04556630,Completed,2021-06-22,2021-06-22,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04556630,2021-06-22,0,0
3338,NCT04556864,Not yet recruiting,2020-12-30,2021-04-01,No Results Posted,,,2020-09-21,https://clinicaltrials.gov/show/NCT04556864,2020-12-30,0,0
3339,NCT04557046,Recruiting,2021-11-30,2021-12-31,No Results Posted,"['Drain PK, Ampajwala M, Chappel C, Gvozden AB, Hoppers M, Wang M, Rosen R, Young S, Zissman E, Montano M. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study. Infect Dis Ther. 2021 Jun;10(2):753-761. doi: 10.1007/s40121-021-00413-x. Epub 2021 Feb 24.']",,2021-01-29,https://clinicaltrials.gov/show/NCT04557046,2021-11-30,0,1
3340,NCT04557241,Completed,2021-01-14,2021-01-31,No Results Posted,"['Agley J, Xiao Y, Thompson EE, Chen X, Golzarri-Arroyo L. Intervening on Trust in Science to Reduce Belief in COVID-19 Misinformation and Increase COVID-19 Preventive Behavioral Intentions: Randomized Controlled Trial. J Med Internet Res. 2021 Oct 14;23(10):e32425. doi: 10.2196/32425.', 'Agley J, Xiao Y, Thompson EE, Golzarri-Arroyo L. COVID-19 Misinformation Prophylaxis: Protocol for a Randomized Trial of a Brief Informational Intervention. JMIR Res Protoc. 2020 Dec 7;9(12):e24383. doi: 10.2196/24383.']",,2021-02-09,https://clinicaltrials.gov/show/NCT04557241,2021-01-14,0,1
3341,NCT04557358,Enrolling by invitation,2022-12-31,2022-12-31,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04557358,2022-12-31,0,0
3342,NCT04557605,Completed,2020-10-15,2020-10-15,No Results Posted,"['Shaw K, Butcher S, Ko J, Zello GA, Chilibeck PD. Wearing of Cloth or Disposable Surgical Face Masks has no Effect on Vigorous Exercise Performance in Healthy Individuals. Int J Environ Res Public Health. 2020 Nov 3;17(21). pii: E8110. doi: 10.3390/ijerph17218110.']",,2020-10-20,https://clinicaltrials.gov/show/NCT04557605,2020-10-15,0,1
3343,NCT04558021,Recruiting,2021-01-30,2021-02-14,No Results Posted,,,2020-10-12,https://clinicaltrials.gov/show/NCT04558021,2021-01-30,0,0
3344,NCT04558125,Terminated,2021-07-10,2021-08-08,Study Results,,,2021-10-26,https://clinicaltrials.gov/show/NCT04558125,2021-07-10,1,0
3345,NCT04558203,Recruiting,2022-03-10,2022-03-15,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04558203,2022-03-10,0,0
3346,NCT04558307,Completed,2021-06-01,2021-06-01,No Results Posted,,,2021-07-13,https://clinicaltrials.gov/show/NCT04558307,2021-06-01,0,0
3347,NCT04558320,Completed,2021-04-01,2021-09-01,No Results Posted,,,2021-11-04,https://clinicaltrials.gov/show/NCT04558320,2021-04-01,0,0
3348,NCT04558385,Completed,2021-03-31,2021-03-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04558385,2021-03-31,0,0
3349,NCT04558411,Completed,2020-12-15,2020-12-15,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04558411,2020-12-15,0,0
3350,NCT04558424,Not yet recruiting,2021-09-01,2021-09-01,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04558424,2021-09-01,0,0
3351,NCT04558437,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04558437,2020-12-31,0,0
3352,NCT04558450,Recruiting,2023-03-01,2033-03-01,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04558450,2023-03-01,0,0
3353,NCT04558463,Recruiting,2020-09-30,2020-10-30,No Results Posted,,,2020-09-22,https://clinicaltrials.gov/show/NCT04558463,2020-09-30,0,0
3354,NCT04558476,Recruiting,2022-09-01,2022-09-01,No Results Posted,"['Misset B, Hoste E, Donneau AF, Grimaldi D, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Garigliany M, Najdovski T, Laterre PF. A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol. BMC Pulm Med. 2020 Dec 7;20(1):317. doi: 10.1186/s12890-020-01361-x. Erratum in: BMC Pulm Med. 2021 Jul 26;21(1):248.']",,2021-05-28,https://clinicaltrials.gov/show/NCT04558476,2022-09-01,0,1
3355,NCT04558645,Completed,2020-12-18,2020-12-26,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04558645,2020-12-18,0,0
3356,NCT04558749,Recruiting,2022-10-01,2022-12-01,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04558749,2022-10-01,0,0
3357,NCT04558996,Recruiting,2020-12-31,2021-03-31,No Results Posted,"['Engels Calvo V, Cruz Melguizo S, Abascal-Saiz A, Forc√©n Acebal L, S√°nchez-Migall√≥n A, Pintado Recarte P, Cuenca Mar√≠n C, Marcos Puig B, Del Barrio Fern√°ndez PG, Nieto Velasco O, de la Cruz Conty ML, Mart√≠nez-Perez O; Spanish Obstetric Emergency Group. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study. Fertil Steril. 2021 Sep;116(3):731-740. doi: 10.1016/j.fertnstert.2021.04.005. Epub 2021 Apr 12.']","['Mart√≠nez-Perez O, Vouga M, Cruz Melguizo S, Forcen Acebal L, Panchaud A, Mu√±oz-Ch√°puli M, Baud D. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain. JAMA. 2020 Jul 21;324(3):296-299. doi: 10.1001/jama.2020.10125. Erratum in: JAMA. 2020 Jul 21;324(3):305.']",2020-09-22,https://clinicaltrials.gov/show/NCT04558996,2020-12-31,0,1
3358,NCT04559009,Recruiting,2023-12-31,2024-04-30,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04559009,2023-12-31,0,0
3359,NCT04559035,Completed,2021-01-18,2021-11-04,No Results Posted,,,2021-12-28,https://clinicaltrials.gov/show/NCT04559035,2021-01-18,0,0
3360,NCT04559074,Recruiting,2021-04-30,2021-07-31,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04559074,2021-04-30,0,0
3361,NCT04559100,Enrolling by invitation,2021-10-01,2021-10-01,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04559100,2021-10-01,0,0
3362,NCT04559542,Completed,2021-05-30,2021-05-30,No Results Posted,,,2021-07-12,https://clinicaltrials.gov/show/NCT04559542,2021-05-30,0,0
3363,NCT04560231,Recruiting,2020-11-30,2020-11-30,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04560231,2020-11-30,0,0
3364,NCT04560413,Completed,2020-07-25,2020-08-10,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04560413,2020-07-25,0,0
3365,NCT04560530,Completed,2020-07-30,2020-09-01,No Results Posted,,,2020-09-23,https://clinicaltrials.gov/show/NCT04560530,2020-07-30,0,0
3366,NCT04560855,Completed,2021-01-12,2021-05-12,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04560855,2021-01-12,0,0
3367,NCT04560881,Completed,2021-12-13,2021-12-13,No Results Posted,,,2022-01-12,https://clinicaltrials.gov/show/NCT04560881,2021-12-13,0,0
3368,NCT04561024,"Active, not recruiting",2020-10-30,2020-12-31,No Results Posted,,,2020-09-24,https://clinicaltrials.gov/show/NCT04561024,2020-10-30,0,0
3369,NCT04561063,Recruiting,2022-02-28,2022-02-28,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-06,https://clinicaltrials.gov/show/NCT04561063,2022-02-28,0,1
3370,NCT04561076,Withdrawn,2021-09-06,2021-09-18,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04561076,2021-09-06,0,1
3371,NCT04561089,Completed,2021-02-28,2021-02-28,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04561089,2021-02-28,0,0
3372,NCT04561102,Completed,2021-02-28,2021-02-28,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04561102,2021-02-28,0,0
3373,NCT04561141,Not yet recruiting,2021-12-01,2022-01-01,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04561141,2021-12-01,0,0
3374,NCT04561154,Recruiting,2021-06-11,2022-06-11,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04561154,2021-06-11,0,0
3375,NCT04561180,Not yet recruiting,2022-10-01,2022-12-01,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04561180,2022-10-01,0,0
3376,NCT04561193,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04561193,2022-05-01,0,0
3377,NCT04561219,Completed,2020-10-02,2020-10-02,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04561219,2020-10-02,0,0
3378,NCT04562246,"Active, not recruiting",2021-03-22,2022-04-01,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04562246,2021-03-22,0,0
3379,NCT04562285,Recruiting,2021-05-28,2022-06-01,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04562285,2021-05-28,0,0
3380,NCT04563065,Recruiting,2020-11-30,2023-12-31,No Results Posted,,,2021-07-13,https://clinicaltrials.gov/show/NCT04563065,2020-11-30,0,0
3381,NCT04563156,Enrolling by invitation,2021-06-30,2021-12-31,No Results Posted,,,2020-09-24,https://clinicaltrials.gov/show/NCT04563156,2021-06-30,0,0
3382,NCT04563208,Recruiting,2022-02-28,2022-02-28,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04563208,2022-02-28,0,0
3383,NCT04563247,Completed,2021-02-08,2021-02-08,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04563247,2021-02-08,0,0
3384,NCT04563442,Not yet recruiting,2022-10-15,2023-02-25,No Results Posted,,"['Layton DS, Choudhary A, Bean AGD. Breaking the chain of zoonoses through biosecurity in livestock. Vaccine. 2017 Oct 20;35(44):5967-5973. doi: 10.1016/j.vaccine.2017.07.110. Epub 2017 Aug 18. Review.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, Xi XM, Gu Q, Zhou XM, Qu HP, Yan Z, Li FM, Zhao W, Gao ZC, Wang GF, Ruan LX, Wang WH, Ye J, Cao HF, Li XW, Zhang WH, Fang XC, He J, Liang WF, Xie J, Zeng M, Wu XZ, Li J, Xia Q, Jin ZC, Chen Q, Tang C, Zhang ZY, Hou BM, Feng ZX, Sheng JF, Zhong NS, Li LJ. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013 Jun 13;368(24):2277-85. doi: 10.1056/NEJMoa1305584. Epub 2013 May 22. Erratum in: N Engl J Med. 2013 Nov 7;369(19):1869.', 'Placzek HE, Madoff LC. Association of age and comorbidity on 2009 influenza A pandemic H1N1-related intensive care unit stay in Massachusetts. Am J Public Health. 2014 Nov;104(11):e118-25. doi: 10.2105/AJPH.2014.302197. Epub 2014 Sep 11.', 'Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ. 2013;16(2):264-77. doi: 10.3111/13696998.2012.752376. Epub 2012 Dec 4. Review.', 'Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003 Jun 4;289(21):2801-9. Epub 2003 May 6. Erratum in: JAMA. 2003 Jul 16;290(3):334.', 'Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19. Review.']",2020-09-24,https://clinicaltrials.gov/show/NCT04563442,2022-10-15,0,1
3385,NCT04563650,Recruiting,2021-05-01,2021-11-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04563650,2021-05-01,0,0
3386,NCT04563676,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04563676,2021-12-01,0,0
3387,NCT04563689,Completed,2020-10-22,2020-10-23,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04563689,2020-10-22,0,0
3388,NCT04563702,"Active, not recruiting",2021-05-10,2021-10-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04563702,2021-05-10,0,0
3389,NCT04564040,Completed,2020-12-11,2020-12-11,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04564040,2020-12-11,0,0
3390,NCT04564287,Recruiting,2022-10-30,2022-10-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04564287,2022-10-30,0,0
3391,NCT04565106,Completed,2020-05-31,2020-05-31,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04565106,2020-05-31,0,0
3392,NCT04565249,Terminated,2021-06-01,2021-08-02,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04565249,2021-06-01,0,0
3393,NCT04565379,Completed,2021-04-13,2021-04-13,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04565379,2021-04-13,0,0
3394,NCT04565392,Withdrawn,2021-11-01,2022-01-31,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04565392,2021-11-01,0,0
3395,NCT04565509,Recruiting,2022-06-30,2023-03-31,No Results Posted,"['Sherby MR, Walsh TJ, Lai AM, Neidich JA, Balls-Berry JE, Morris SM, Head R, Prener CG, Newland JG, Gurnett CA; COMPASS-T Study Group. SARS-CoV-2 screening testing in schools for children with intellectual and developmental disabilities. J Neurodev Disord. 2021 Sep 1;13(1):31. doi: 10.1186/s11689-021-09376-z.', 'Sherby MR, Walsh T, Lai AM, Neidich JA, Balls-Berry JE, Morris SM, Head R, Prener C, Newland JG, Gurnett CA; COMPASS-T Study Group. SARS-CoV-2 Screening Testing in Schools for Children with Intellectual and Developmental Disabilities. Res Sq. 2021 Jul 20. pii: rs.3.rs-700296. doi: 10.21203/rs.3.rs-700296/v1. Update in: J Neurodev Disord. 2021 Sep 1;13(1):31.']",,2021-07-26,https://clinicaltrials.gov/show/NCT04565509,2022-06-30,0,1
3396,NCT04565522,Recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04565522,2021-12-31,0,0
3397,NCT04565665,Recruiting,2023-04-30,2023-04-30,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04565665,2023-04-30,0,0
3398,NCT04565782,Recruiting,2020-11-01,2020-12-31,No Results Posted,,,2020-09-25,https://clinicaltrials.gov/show/NCT04565782,2020-11-01,0,0
3399,NCT04566276,"Active, not recruiting",2022-09-01,2022-11-01,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04566276,2022-09-01,0,0
3400,NCT04566770,Recruiting,2021-08-21,2022-10-20,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04566770,2021-08-21,0,0
3401,NCT04566965,Terminated,2021-06-30,2021-06-30,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04566965,2021-06-30,0,0
3402,NCT04567173,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04567173,2021-06-30,0,0
3403,NCT04567576,Not yet recruiting,2021-05-01,2021-10-31,No Results Posted,,,2020-09-28,https://clinicaltrials.gov/show/NCT04567576,2021-05-01,0,0
3404,NCT04567810,Completed,2020-12-14,2020-12-14,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']","['Lyn R. Frumkin, Michaela Lucas, Curtis L. Scribner, Nastassja Ortega-Heinly, Jayden Rogers, Gang Yin, Trevor J Hallam, Alice Yam, Kristin Bedard, Rebecca Begley, Courtney A. Cohen, Catherine V. Badger, Shawn A. Abbasi, John M. Dye, Brian McMillan, Michael Wallach, Traci L. Bricker, Astha Joshi, Adrianus C.M. Boon, Suman Pokhrel, Benjamin R. Kraemer, Lucia Lee, Stephen Kargotich, Mahima Agogiya, Tom St. John, Daria Mochly-Rosen. Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19: preclinical studies and randomized controlled phase 1 clinical trial. medRxiv 2022.01.07.22268914; doi: https://doi.org/10.1101/2022.01.07.22268914']",2022-02-14,https://clinicaltrials.gov/show/NCT04567810,2020-12-14,0,1
3405,NCT04567836,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04567836,2021-06-01,0,0
3406,NCT04567927,Completed,2020-05-28,2020-05-28,No Results Posted,,"['Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. Erratum in: JAMA. 2021 May 25;325(20):2120.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Wang T, Chen R, Liu C, Liang W, Guan W, Tang R, Tang C, Zhang N, Zhong N, Li S. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.']",2020-09-29,https://clinicaltrials.gov/show/NCT04567927,2020-05-28,0,1
3407,NCT04567953,"Active, not recruiting",2021-01-30,2021-06-27,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04567953,2021-01-30,0,0
3408,NCT04567979,Completed,2020-09-30,2020-10-30,No Results Posted,,"['Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683. Erratum in: JAMA. 2020 Apr 28;323(16):1619.', 'Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, Peng P, Zhang P, Chu Q, Shen Q, Wang Y, Xu SY, Zhao JP, Zhou M. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.', 'Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.', 'Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.', 'Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Glob Oncol. 2020 Apr;6:557-559. doi: 10.1200/GO.20.00097.', 'You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R, Kaluzinski L, Krakowski I, Mayeur D, Grellety T, Lotz JP. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020 May;21(5):619-621. doi: 10.1016/S1470-2045(20)30204-7. Epub 2020 Mar 25.', 'Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020 Jun;17(6):336. doi: 10.1038/s41571-020-0366-2.', 'Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020 May;21(5):629-630. doi: 10.1016/S1470-2045(20)30217-5. Epub 2020 Apr 2.', 'Marijnen CAM, Peters FP, R√∂del C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother Oncol. 2020 Jul;148:213-215. doi: 10.1016/j.radonc.2020.03.039. Epub 2020 Apr 2.', 'Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunub√° Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30. Erratum in: Lancet Infect Dis. 2020 Apr 15;:. Lancet Infect Dis. 2020 May 4;:.', 'Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, Zhu Q, Liu L. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.', 'Guo L, Ren L, Yang S, Xiao M, Chang, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang QW, Xu SY, Zhu HD, Xu YC, Jin Q, Sharma L, Wang L, Wang J. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.']",2022-02-25,https://clinicaltrials.gov/show/NCT04567979,2020-09-30,0,1
3409,NCT04568005,Completed,2020-08-01,2020-08-01,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04568005,2020-08-01,0,0
3410,NCT04568018,"Active, not recruiting",2021-10-31,2021-12-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04568018,2021-10-31,0,0
3411,NCT04568044,Recruiting,2022-12-31,2023-07-03,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04568044,2022-12-31,0,0
3412,NCT04568096,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04568096,2020-12-01,0,0
3413,NCT04568135,Not yet recruiting,2021-12-31,2021-12-31,Results Submitted,"['Shah A, Darling M, Arstein-Kerslake O, Morgan T, Vance Tovrea A, Young J, Laines H. Measuring the Impact of COVID-19 on Siyan Mental Health Patients Using the Epidemic-Pandemic Impacts Inventory: Survey Study. JMIR Form Res. 2021 Jul 29;5(7):e29952. doi: 10.2196/29952.']",,2020-10-14,https://clinicaltrials.gov/show/NCT04568135,2021-12-31,0,1
3414,NCT04568148,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04568148,2021-12-31,0,0
3415,NCT04568356,Completed,2020-06-12,2020-09-24,No Results Posted,,"['Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MM, Spijker R, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705. doi: 10.1002/14651858.CD013705. Update in: Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705.', 'Kyosei Y, Namba M, Yamura S, Takeuchi R, Aoki N, Nakaishi K, Watabe S, Ito E. Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2. Diagnostics (Basel). 2020 Aug 14;10(8). pii: E594. doi: 10.3390/diagnostics10080594.', 'Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Yagi S, Kojima S, Omata M. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis. 2020 Oct;99:397-402. doi: 10.1016/j.ijid.2020.08.029. Epub 2020 Aug 12.', 'Nagura-Ikeda M, Imai K, Tabata S, Miyoshi K, Murahara N, Mizuno T, Horiuchi M, Kato K, Imoto Y, Iwata M, Mimura S, Ito T, Tamura K, Kato Y. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020 Aug 24;58(9). pii: e01438-20. doi: 10.1128/JCM.01438-20. Print 2020 Aug 24.', 'Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, Chan RC, Tsang DN. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020 Aug;129:104500. doi: 10.1016/j.jcv.2020.104500. Epub 2020 Jun 8.', 'Blairon L, Wilmet A, Beukinga I, Tr√©-Hardy M. Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital. J Clin Virol. 2020 Aug;129:104472. doi: 10.1016/j.jcv.2020.104472. Epub 2020 May 30.', 'Porte L, Legarraga P, Vollrath V, Aguilera X, Munita JM, Araos R, Pizarro G, Vial P, Iruretagoyena M, Dittrich S, Weitzel T. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020 Oct;99:328-333. doi: 10.1016/j.ijid.2020.05.098. Epub 2020 Jun 1.', 'Scohy A, Anantharajah A, Bod√©us M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020 Aug;129:104455. doi: 10.1016/j.jcv.2020.104455. Epub 2020 May 21.', 'Lambert-Niclot S, Cuffel A, Le Pape S, Vauloup-Fellous C, Morand-Joubert L, Roque-Afonso AM, Le Goff J, Delaugerre C. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs. J Clin Microbiol. 2020 Jul 23;58(8). pii: e00977-20. doi: 10.1128/JCM.00977-20. Print 2020 Jul 23.', 'Cui Z, Chang H, Wang H, Lim B, Hsu CC, Yu Y, Jia H, Wang Y, Zeng Y, Ji M, Liu W, Inverarity C, Huang WE. Development of a rapid test kit for SARS-CoV-2: an example of product design. Biodes Manuf. 2020 May 11:1-4. doi: 10.1007/s42242-020-00075-7. [Epub ahead of print]', ""Bosch I, de Puig H, Hiley M, Carr√©-Camps M, Perdomo-Celis F, Narv√°ez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, G√©lvez-Ram√≠rez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Mu√±√≥z-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, D√≠az FJ, Restrepo BN, Mar√≠n K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, G√≥mez-M√°rquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589."", 'Arnaout R, Lee RA, Lee GR, Callahan C, Yen CF, Smith KP, Arora R, Kirby JE. SARS-CoV2 Testing: The Limit of Detection Matters. bioRxiv. 2020 Jun 4. pii: 2020.06.02.131144. doi: 10.1101/2020.06.02.131144.', 'Carpenter CR, Mudd PA, West CP, Wilber E, Wilber ST. Diagnosing COVID-19 in the Emergency Department: A Scoping Review of Clinical Examinations, Laboratory Tests, Imaging Accuracy, and Biases. Acad Emerg Med. 2020 Aug;27(8):653-670. doi: 10.1111/acem.14048. Epub 2020 Jul 26. Review.', 'Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13. Review.', 'Wang X, Tan L, Wang X, Liu W, Lu Y, Cheng L, Sun Z. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020 May;94:107-109. doi: 10.1016/j.ijid.2020.04.023. Epub 2020 Apr 18.', 'Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.', 'Pondaven-Letourmy S, Alvin F, Boumghit Y, Simon F. How to perform a nasopharyngeal swab in adults and children in the COVID-19 era. Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):325-327. doi: 10.1016/j.anorl.2020.06.001. Epub 2020 Jun 5.']",2020-10-19,https://clinicaltrials.gov/show/NCT04568356,2020-06-12,0,1
3416,NCT04568421,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04568421,2021-12-31,0,0
3417,NCT04568499,Completed,2021-06-30,2021-09-30,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04568499,2021-06-30,0,0
3418,NCT04568525,Completed,2020-07-25,2020-08-01,No Results Posted,"['Osmonov B, Ovchinnikov L, Galazis C, Emilov B, Karaibragimov M, Seitov M, Vesnin S, Losev A, Levshinskii V, Popov I, Mustafin C, Kasymbekov T, Goryanin I. Passive Microwave Radiometry for the Diagnosis of Coronavirus Disease 2019 Lung Complications in Kyrgyzstan. Diagnostics (Basel). 2021 Feb 7;11(2). pii: 259. doi: 10.3390/diagnostics11020259.']",,2020-09-29,https://clinicaltrials.gov/show/NCT04568525,2020-07-25,0,1
3419,NCT04568551,Completed,2021-03-31,2021-07-31,No Results Posted,,,2021-12-28,https://clinicaltrials.gov/show/NCT04568551,2021-03-31,0,0
3420,NCT04568655,Completed,2020-07-01,2020-07-01,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04568655,2020-07-01,0,0
3421,NCT04568707,Recruiting,2022-10-15,2022-10-15,No Results Posted,"['Louapre C, Ibrahim M, Maillart E, Abdi B, Papeix C, Stankoff B, Dubessy AL, Bensa-Koscher C, Cr√©ange A, Chamekh Z, Lubetzki C, Marcelin AG, Corvol JC, Pourcher V; COVISEP and Bio-coco-neuroscience study group. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):24-31. doi: 10.1136/jnnp-2021-326904. Epub 2021 Aug 2.']",,2021-02-25,https://clinicaltrials.gov/show/NCT04568707,2022-10-15,0,1
3422,NCT04568811,Completed,2020-10-25,2021-09-11,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04568811,2020-10-25,0,0
3423,NCT04568850,Recruiting,2022-02-28,2022-02-28,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04568850,2022-02-28,0,0
3424,NCT04568863,Completed,2020-11-30,2020-11-30,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04568863,2020-11-30,0,0
3425,NCT04568876,Completed,2021-02-28,2021-02-28,No Results Posted,,,2021-08-25,https://clinicaltrials.gov/show/NCT04568876,2021-02-28,0,0
3426,NCT04568889,"Active, not recruiting",2022-08-31,2022-08-31,No Results Posted,,"['Meyer, Bruce D., Wallace KC Mok, and James X. Sullivan. Household surveys in crisis. Journal of Economic Perspectives. 2015; 29(4): 199-226.']",2021-08-13,https://clinicaltrials.gov/show/NCT04568889,2022-08-31,0,1
3427,NCT04569188,Completed,2020-08-15,2020-09-03,No Results Posted,"['Franchini M, Glingani C, Morandi M, Corghi G, Cerzosimo S, Beduzzi G, Storti A, Di Stasi V, Rastrelli G, Vignozzi L, Mengoli C, Garuti M, Beccaria M, Inglese F, Caruso B, Petilino RA, Amato M, Nicchio M, Pagani M, Bellani A, Castelli G, Casari S, De Donno G. Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):403-412. doi: 10.1016/j.mayocpiqo.2021.01.010. Epub 2021 Feb 8.']",,2020-10-05,https://clinicaltrials.gov/show/NCT04569188,2020-08-15,0,1
3428,NCT04569227,Recruiting,2021-09-01,2021-11-01,No Results Posted,,,2021-06-10,https://clinicaltrials.gov/show/NCT04569227,2021-09-01,0,0
3429,NCT04569266,Recruiting,2022-08-06,2022-12-31,No Results Posted,,,2021-12-30,https://clinicaltrials.gov/show/NCT04569266,2022-08-06,0,0
3430,NCT04569292,Recruiting,2021-04-01,2021-08-01,No Results Posted,,,2020-09-29,https://clinicaltrials.gov/show/NCT04569292,2021-04-01,0,0
3431,NCT04569344,"Active, not recruiting",2021-02-28,2022-06-21,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04569344,2021-02-28,0,0
3432,NCT04569383,Completed,2021-08-24,2021-08-24,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04569383,2021-08-24,0,0
3433,NCT04569825,Recruiting,2020-09-30,2020-10-15,No Results Posted,"['Rashid RA, Zgair A, Al-Ani RM. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study. Am J Otolaryngol. 2021 Sep-Oct;42(5):103033. doi: 10.1016/j.amjoto.2021.103033. Epub 2021 Apr 7.']",,2020-09-30,https://clinicaltrials.gov/show/NCT04569825,2020-09-30,0,1
3434,NCT04569851,Enrolling by invitation,2021-10-01,2021-10-30,No Results Posted,,,2020-09-30,https://clinicaltrials.gov/show/NCT04569851,2021-10-01,0,0
3435,NCT04569877,Recruiting,2022-12-25,2022-12-25,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04569877,2022-12-25,0,0
3436,NCT04570202,Recruiting,2022-08-19,2023-02-19,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04570202,2022-08-19,0,0
3437,NCT04570254,Completed,2020-12-01,2020-12-01,No Results Posted,,"['Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000 May 1;28(9):1405-20. Review.', 'Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003 Nov;31(11):2574-8.', 'Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, Hajibabayee M, Ghahremani MH. The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med. 2009 Mar;103(3):434-41. doi: 10.1016/j.rmed.2008.09.013. Epub 2008 Nov 7.', 'Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996 Aug;24(8):1302-10.', 'Escames G, Guerrero JM, Reiter RJ, Garcia JJ, Munoz-Hoyos A, Ortiz GG, Oh CS. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett. 1997 Jul 25;230(3):147-50.', 'Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011 Aug;51(1):1-16. doi: 10.1111/j.1600-079X.2011.00916.x. Review.', 'Hemil√§ H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999 Sep;3(9):756-61. Review.', 'Shabaan AE, Nasef N, Shouman B, Nour I, Mesbah A, Abdel-Hady H. Pentoxifylline therapy for late-onset sepsis in preterm infants: a randomized controlled trial. Pediatr Infect Dis J. 2015 Jun;34(6):e143-8. doi: 10.1097/INF.0000000000000698.', 'Akdag A, Dilmen U, Haque K, Dilli D, Erdeve O, Goekmen T. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis. Am J Perinatol. 2014 Nov;31(10):905-12. doi: 10.1055/s-0033-1363771. Epub 2014 Feb 10.', 'Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, Sculthorpe R, Nanchal R, Syed A, Sturgill J, Martin GS, Sevransky J, Kashiouris M, Hamman S, Egan KF, Hastings A, Spencer W, Tench S, Mehkri O, Bindas J, Duggal A, Graf J, Zellner S, Yanny L, McPolin C, Hollrith T, Kramer D, Ojielo C, Damm T, Cassity E, Wieliczko A, Halquist M. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019 Oct 1;322(13):1261-1270. doi: 10.1001/jama.2019.11825. Erratum in: JAMA. 2020 Jan 28;323(4):379.', 'Protti A, Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care. 2006;10(5):228. Review.', 'Vincent JL, Moreno R, Takala J, Willatts S, De Mendon√ßa A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10.']",2021-05-21,https://clinicaltrials.gov/show/NCT04570254,2020-12-01,0,1
3438,NCT04570384,Completed,2021-08-30,2021-09-30,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04570384,2021-08-30,0,0
3439,NCT04570397,Recruiting,2021-05-01,2021-11-01,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04570397,2021-05-01,0,0
3440,NCT04570449,Withdrawn,2021-11-01,2021-12-01,No Results Posted,,,2020-12-24,https://clinicaltrials.gov/show/NCT04570449,2021-11-01,0,0
3441,NCT04570462,Withdrawn,2020-12-31,2020-12-31,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04570462,2020-12-31,0,0
3442,NCT04570488,Completed,2021-12-07,2021-12-07,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04570488,2021-12-07,0,0
3443,NCT04570501,Withdrawn,2022-08-01,2022-08-01,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04570501,2022-08-01,0,0
3444,NCT04570982,Recruiting,2020-10-30,2020-12-30,No Results Posted,"['Koirala J, Gyanwali P, Gerzoff RB, Bhattarai S, Nepal B, Manandhar R, Jha R, Sharma S, Sharma YR, Bastola A, Murphy H, Acharya S, Adhikari P, Rajkarnikari M, Vaidya KM, Panthi CL, Bista B, Giri G, Aryal S, Pant S, Pokharel A, Karki S, Basnet S, Koirala B, Dhimal M; Nepal COVID-19 Clinical Study Collaborators . Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study. Open Forum Infect Dis. 2021 Aug 21;8(8):ofab391. doi: 10.1093/ofid/ofab391. eCollection 2021 Aug.']",,2020-09-30,https://clinicaltrials.gov/show/NCT04570982,2020-10-30,0,1
3445,NCT04572360,Recruiting,2022-12-31,2023-06-30,No Results Posted,"['Gao Y, Zhong LLD, Quach B, Davies B, Ash GI, Lin ZX, Feng Y, Lau BWM, Wagner PD, Yang X, Guo Y, Jia W, Bian Z, Baker JS. COVID-19 Rehabilitation With Herbal Medicine and Cardiorespiratory Exercise: Protocol for a Clinical Study. JMIR Res Protoc. 2021 May 26;10(5):e25556. doi: 10.2196/25556.']",,2021-06-24,https://clinicaltrials.gov/show/NCT04572360,2022-12-31,0,1
3446,NCT04572399,Completed,2020-12-28,2020-12-28,Study Results,,"['Rezaie A, Melmed GY, Leite G, Mathur R, Takakura W, Pedraza I, Lewis M, Murthy R, Chaux G, Pimentel M. Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study. Adv Ther. 2021 Aug;38(8):4556-4568. doi: 10.1007/s12325-021-01830-7. Epub 2021 Jun 26.']",2022-01-18,https://clinicaltrials.gov/show/NCT04572399,2020-12-28,1,1
3447,NCT04572412,"Active, not recruiting",2022-06-30,2022-06-30,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04572412,2022-06-30,0,0
3448,NCT04572438,Recruiting,2021-04-01,2021-08-01,No Results Posted,['COVIDTrach collaborative. COVIDTrach: a prospective cohort study of mechanically ventilated patients with COVID-19 undergoing tracheostomy in the UK. BMJ Surg Interv Health Technol. 2021 Jul;3(1):e000077. doi: 10.1136/bmjsit-2020-000077. Epub 2021 Jul 8.'],,2020-10-01,https://clinicaltrials.gov/show/NCT04572438,2021-04-01,0,1
3449,NCT04573153,Recruiting,2021-01-31,2021-03-31,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04573153,2021-01-31,0,0
3450,NCT04573270,Completed,2020-08-20,2020-09-01,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04573270,2020-08-20,0,0
3451,NCT04573322,Completed,2021-03-17,2021-04-29,Study Results,,,2022-04-01,https://clinicaltrials.gov/show/NCT04573322,2021-03-17,1,0
3452,NCT04573335,Completed,2020-07-15,2020-07-30,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04573335,2020-07-15,0,0
3453,NCT04573348,Recruiting,2021-05-10,2021-10-10,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04573348,2021-05-10,0,0
3454,NCT04573361,Completed,2020-05-27,2020-05-27,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04573361,2020-05-27,0,0
3455,NCT04573634,"Active, not recruiting",2023-12-31,2023-12-31,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04573634,2023-12-31,0,0
3456,NCT04573764,Recruiting,2021-10-01,2022-01-01,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04573764,2021-10-01,0,0
3457,NCT04573855,Not yet recruiting,2021-02-28,2021-03-31,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04573855,2021-02-28,0,0
3458,NCT04573868,Recruiting,2020-06-30,2020-09-30,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04573868,2020-06-30,0,0
3459,NCT04574050,Recruiting,2022-04-04,2022-06-30,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04574050,2022-04-04,0,0
3460,NCT04574219,Recruiting,2022-10-01,2022-12-01,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04574219,2022-10-01,0,0
3461,NCT04574765,Recruiting,2021-04-16,2021-04-16,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04574765,2021-04-16,0,0
3462,NCT04574869,Withdrawn,2022-09-01,2022-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-04,https://clinicaltrials.gov/show/NCT04574869,2022-09-01,0,1
3463,NCT04575168,Completed,2020-12-07,2020-12-07,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04575168,2020-12-07,0,0
3464,NCT04575532,Completed,2021-09-09,2021-09-09,No Results Posted,"['Larimer K, Wegerich S, Splan J, Chestek D, Prendergast H, Vanden Hoek T. Personalized Analytics and a Wearable Biosensor Platform for Early Detection of COVID-19 Decompensation (DeCODe): Protocol for the Development of the COVID-19 Decompensation Index. JMIR Res Protoc. 2021 May 26;10(5):e27271. doi: 10.2196/27271.']",,2021-09-13,https://clinicaltrials.gov/show/NCT04575532,2021-09-09,0,1
3465,NCT04575545,Not yet recruiting,2021-03-01,2022-04-01,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04575545,2021-03-01,0,0
3466,NCT04575558,Withdrawn,2020-09-01,2020-10-30,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04575558,2020-09-01,0,0
3467,NCT04575571,Recruiting,2025-04-29,2025-04-29,No Results Posted,,,2020-10-05,https://clinicaltrials.gov/show/NCT04575571,2025-04-29,0,0
3468,NCT04576299,"Active, not recruiting",2021-10-30,2021-12-15,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04576299,2021-10-30,0,0
3469,NCT04576312,Completed,2020-12-04,2020-12-04,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04576312,2020-12-04,0,0
3470,NCT04576351,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04576351,2023-12-31,0,0
3471,NCT04576728,"Active, not recruiting",2021-07-01,2021-07-01,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04576728,2021-07-01,0,0
3472,NCT04577105,Completed,2020-08-31,2020-10-01,No Results Posted,,"['Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, Cui J, Xu W, Yang Y, Fayad ZA, Jacobi A, Li K, Li S, Shan H. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020 Apr;295(1):202-207. doi: 10.1148/radiol.2020200230. Epub 2020 Feb 4.', 'Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur J Radiol. 2020 Jun;127:109009. doi: 10.1016/j.ejrad.2020.109009. Epub 2020 Apr 18.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.', 'Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020 Aug;30(8):4398-4406. doi: 10.1007/s00330-020-06816-7. Epub 2020 Mar 24.', 'Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, St√∂ger L, Beenen L, Geurts B, Gietema H, Krdzalic J, Schaefer-Prokop C, van Ginneken B, Brink M; COVID-19 Standardized Reporting Working Group of the Dutch Radiological Society. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020 Aug;296(2):E97-E104. doi: 10.1148/radiol.2020201473. Epub 2020 Apr 27.', 'Vincent JL, Moreno R, Takala J, Willatts S, De Mendon√ßa A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10.', 'Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hern√°ndez G, Garc√≠a-de-Acilu M, Frat JP, Masclans JR, Ricard JD. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC.', 'Santamar√Æa Herrero SA. [Alveolar-arterial gradient of oxygen in COPD patients]. An Med Interna. 2001 Mar;18(3):115-6. Spanish.', 'Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J; China Medical Treatment Expert Group for COVID-19. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.', 'Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14. English, Slovak.', 'Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017 Sep 27;7(9):e017046. doi: 10.1136/bmjopen-2017-017046.', 'Helmholz HF Jr. The abbreviated alveolar air equation. Chest. 1979 Jun;75(6):748.']",2020-10-08,https://clinicaltrials.gov/show/NCT04577105,2020-08-31,0,1
3473,NCT04577235,Completed,2020-08-05,2020-09-05,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04577235,2020-08-05,0,0
3474,NCT04577378,Not yet recruiting,2020-11-20,2020-11-20,No Results Posted,,,2020-10-06,https://clinicaltrials.gov/show/NCT04577378,2020-11-20,0,0
3475,NCT04577534,Completed,2021-06-16,2021-06-16,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04577534,2021-06-16,0,0
3476,NCT04578158,Completed,2021-03-28,2021-04-15,No Results Posted,,"['Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19). Front Immunol. 2020 Jun 19;11:1451. doi: 10.3389/fimmu.2020.01451. eCollection 2020. Review.', 'Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, Ceballos-Laita L, Vega S, Reyburn HT, Rizzuti B, Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020 Dec 1;164:1693-1703. doi: 10.1016/j.ijbiomac.2020.07.235. Epub 2020 Aug 1.', 'Liu X, Raghuvanshi R, Ceylan FD, Bolling BW. Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity. J Agric Food Chem. 2020 Nov 25;68(47):13982-13989. doi: 10.1021/acs.jafc.0c05064. Epub 2020 Nov 12.']",2021-04-22,https://clinicaltrials.gov/show/NCT04578158,2021-03-28,0,1
3477,NCT04578197,Recruiting,2022-06-01,2022-11-01,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04578197,2022-06-01,0,0
3478,NCT04578210,Recruiting,2021-01-01,2021-03-01,No Results Posted,"[""Herrera L, Martin-Inaraja M, Santos S, Ingl√©s-Ferr√°ndiz M, Azkarate A, Perez-Vaquero MA, Vesga MA, Vicario JL, Soria B, Solano C, De Paz R, Marcos A, Ferreras C, Perez-Martinez A, Eguizabal C. Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy. Immunology. 2022 Feb;165(2):234-249. doi: 10.1111/imm.13432. Epub 2021 Dec 2."", 'Garc√≠a-Garc√≠a I, Guerra-Garc√≠a P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, P√©rez-Mart√≠nez A. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials. 2021 Oct 2;22(1):674. doi: 10.1186/s13063-021-05625-7.', 'P√©rez-Mart√≠nez A, Mora-Rillo M, Ferreras C, Guerra-Garc√≠a P, Pascual-Miguel B, Mestre-Dur√°n C, Borobia AM, Carcas AJ, Queiruga-Parada J, Garc√≠a I, S√°nchez-Zapardiel E, Gasior M, De Paz R, Marcos A, Vicario JL, Balas A, Moreno MA, Eguizabal C, Solano C, Arribas JR, Buckley RM, Montejano R, Soria B. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE). EClinicalMedicine. 2021 Sep;39:101086. doi: 10.1016/j.eclinm.2021.101086. Epub 2021 Aug 13.', 'Del Pozo Mart√≠n Y. 47th Annual Meeting of the EBMT. Lancet Haematol. 2021 May;8(5):e317-e318. doi: 10.1016/S2352-3026(21)00104-6. Epub 2021 Mar 31.']",,2020-10-19,https://clinicaltrials.gov/show/NCT04578210,2021-01-01,0,1
3479,NCT04578236,Not yet recruiting,2020-12-01,2021-01-01,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04578236,2020-12-01,0,0
3480,NCT04578509,"Active, not recruiting",2021-06-09,2022-04-01,No Results Posted,"['LeGoff J, Kern√©is S, Elie C, Mercier-Delarue S, Gastli N, Choupeaux L, Fourgeaud J, Alby ML, Quentin P, Pavie J, Brazille P, N√©r√© ML, Minier M, Gabassi A, Leroy C, Parfait B, Tr√©luyer JM, Delaugerre C. Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Sci Rep. 2021 Oct 26;11(1):21126. doi: 10.1038/s41598-021-00560-8.', 'Kern√©is S, Elie C, Fourgeaud J, Choupeaux L, Delarue SM, Alby ML, Quentin P, Pavie J, Brazille P, N√©r√© ML, Minier M, Gabassi A, Gibaud A, Gauthier S, Leroy C, Voirin-Mathieu E, Poyart C, Vidaud M, Parfait B, Delaugerre C, Tr√©luyer JM, LeGoff J. Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study. Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2379-2388. doi: 10.1007/s10096-021-04327-x. Epub 2021 Aug 3.']",,2021-12-10,https://clinicaltrials.gov/show/NCT04578509,2021-06-09,0,1
3481,NCT04579289,Completed,2020-09-01,2020-09-01,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04579289,2020-09-01,0,0
3482,NCT04579458,Withdrawn,2021-01-22,2021-01-22,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04579458,2021-01-22,0,0
3483,NCT04579471,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04579471,2021-12-31,0,0
3484,NCT04579549,Completed,2021-03-31,2021-03-31,Study Results,,,2022-01-20,https://clinicaltrials.gov/show/NCT04579549,2021-03-31,1,0
3485,NCT04579562,Not yet recruiting,2021-03-31,2021-10-31,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04579562,2021-03-31,0,0
3486,NCT04579588,Completed,2021-03-15,2021-03-15,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04579588,2021-03-15,0,0
3487,NCT04579627,Completed,2020-06-08,2020-06-08,No Results Posted,,,2020-10-08,https://clinicaltrials.gov/show/NCT04579627,2020-06-08,0,0
3488,NCT04579640,"Active, not recruiting",2021-06-17,2022-02-28,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04579640,2021-06-17,0,0
3489,NCT04581018,Enrolling by invitation,2022-07-31,2023-07-31,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04581018,2022-07-31,0,0
3490,NCT04581031,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04581031,2021-12-01,0,0
3491,NCT04581044,Completed,2020-10-23,2020-10-23,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04581044,2020-10-23,0,0
3492,NCT04581070,Terminated,2020-10-09,2020-10-09,No Results Posted,,,2020-10-30,https://clinicaltrials.gov/show/NCT04581070,2020-10-09,0,0
3493,NCT04581083,Completed,2020-10-10,2020-10-30,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04581083,2020-10-10,0,0
3494,NCT04581096,Completed,2021-02-15,2021-06-15,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04581096,2021-02-15,0,0
3495,NCT04581135,Recruiting,2023-04-30,2023-06-01,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04581135,2023-04-30,0,0
3496,NCT04581148,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04581148,2022-06-30,0,0
3497,NCT04581161,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04581161,2020-10-01,0,0
3498,NCT04581187,Recruiting,2022-12-01,2024-12-01,No Results Posted,"['Efficace F, Breccia M, Fazi P, Cottone F, Holzner B, Vignetti M. The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study. JMIR Res Protoc. 2021 Jun 1;10(6):e25271. doi: 10.2196/25271.']",,2021-05-17,https://clinicaltrials.gov/show/NCT04581187,2022-12-01,0,1
3499,NCT04581200,"Active, not recruiting",2022-03-30,2022-06-30,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04581200,2022-03-30,0,0
3500,NCT04581291,Completed,2020-06-01,2020-10-01,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04581291,2020-06-01,0,0
3501,NCT04581577,Recruiting,2020-12-31,2021-04-30,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04581577,2020-12-31,0,0
3502,NCT04581746,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04581746,2021-12-01,0,0
3503,NCT04581811,Completed,2021-03-20,2021-03-20,Study Results,,,2022-03-31,https://clinicaltrials.gov/show/NCT04581811,2021-03-20,1,0
3504,NCT04581863,"Active, not recruiting",2021-02-05,2022-10-31,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04581863,2021-02-05,0,0
3505,NCT04581889,Recruiting,2021-07-01,2021-12-01,No Results Posted,"['Pinilla YT, Friessinger E, Griesbaum JM, Berner L, Heinzel C, Elsner K, Fendel R, Held J, Kreidenweiss A. Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy). JMIR Res Protoc. 2021 Oct 8;10(10):e27739. doi: 10.2196/27739.']",,2020-10-14,https://clinicaltrials.gov/show/NCT04581889,2021-07-01,0,1
3506,NCT04581915,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-12,https://clinicaltrials.gov/show/NCT04581915,2021-12-31,0,0
3507,NCT04581928,Recruiting,2022-03-10,2022-04-15,No Results Posted,,['Wiseman EJ. Denial in the medical interview. JAMA. 1995 Jun 14;273(22):1735; author reply 1735-6.'],2022-03-02,https://clinicaltrials.gov/show/NCT04581928,2022-03-10,0,1
3508,NCT04581954,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 12;22(1):270. doi: 10.1186/s13063-021-05190-z.']",,2021-09-02,https://clinicaltrials.gov/show/NCT04581954,2021-12-01,0,1
3509,NCT04582201,Recruiting,2022-10-01,2023-01-31,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04582201,2022-10-01,0,0
3510,NCT04582214,Recruiting,2021-01-01,2021-01-01,No Results Posted,,,2020-10-09,https://clinicaltrials.gov/show/NCT04582214,2021-01-01,0,0
3511,NCT04582266,"Active, not recruiting",2022-04-01,2022-04-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04582266,2022-04-01,0,0
3512,NCT04582318,Terminated,2021-02-18,2021-03-11,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04582318,2021-02-18,0,0
3513,NCT04582331,Completed,2021-05-12,2021-05-12,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04582331,2021-05-12,0,0
3514,NCT04582344,"Active, not recruiting",2022-04-15,2022-04-15,No Results Posted,"['Tanriover MD, Doƒüanay HL, Akova M, G√ºner HR, Azap A, Akhan S, K√∂se ≈û, Erdin√ß F≈û, Akalƒ±n EH, Tabak √ñF, Pulluk√ßu H, Batum √ñ, ≈ûim≈üek Yavuz S, Turhan √ñ, Yƒ±ldƒ±rmak MT, K√∂ksal ƒ∞, Ta≈üova Y, Korten V, Yƒ±lmaz G, √áelen MK, Altƒ±n S, √áelik ƒ∞, Bayƒ±ndƒ±r Y, Karaoƒülan ƒ∞, Yƒ±lmaz A, √ñzkul A, G√ºr H, Unal S; CoronaVac Study Group. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021 Jul 17;398(10296):213-222. doi: 10.1016/S0140-6736(21)01429-X. Epub 2021 Jul 8. Erratum in: Lancet. 2022 Jan 29;399(10323):436.', 'Akova M, Unal S. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04582344,2022-04-15,0,1
3515,NCT04583228,Completed,2021-07-15,2021-07-20,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04583228,2021-07-15,0,0
3516,NCT04583293,Recruiting,2022-10-01,2022-10-01,No Results Posted,,,2020-12-17,https://clinicaltrials.gov/show/NCT04583293,2022-10-01,0,0
3517,NCT04583306,Recruiting,2020-12-15,2021-06-01,No Results Posted,,,2020-10-12,https://clinicaltrials.gov/show/NCT04583306,2020-12-15,0,0
3518,NCT04583319,Recruiting,2021-12-30,2021-12-30,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04583319,2021-12-30,0,0
3519,NCT04583345,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04583345,2021-09-01,0,0
3520,NCT04583410,Recruiting,2021-12-01,2022-06-01,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04583410,2021-12-01,0,0
3521,NCT04583449,Recruiting,2020-12-01,2020-12-01,No Results Posted,['Conroy D. Mental imagery interventions to promote face covering use among UK university students and employees during the COVID-19 pandemic: study protocol for a randomized controlled trial. Trials. 2022 Jan 18;23(1):51. doi: 10.1186/s13063-021-05852-y.'],,2020-10-12,https://clinicaltrials.gov/show/NCT04583449,2020-12-01,0,1
3522,NCT04583566,Recruiting,2021-10-03,2022-10-03,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04583566,2021-10-03,0,0
3523,NCT04583761,Completed,2021-02-06,2021-02-06,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04583761,2021-02-06,0,0
3524,NCT04583865,"Active, not recruiting",2021-09-14,2022-03-14,No Results Posted,,,2020-10-12,https://clinicaltrials.gov/show/NCT04583865,2021-09-14,0,0
3525,NCT04584411,Not yet recruiting,2021-11-01,2024-01-01,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04584411,2021-11-01,0,0
3526,NCT04584424,Not yet recruiting,2021-09-14,2021-11-14,No Results Posted,"['Abdella S, Tessema M, Tasew G, Defar A, Deressa A, Regasa F, Teka F, Tigabu E, Nigussie D, Belachew T, Molla M, Deribew A, Abebe W, Yigzaw T, Nigatu T, Mitike G, Haile T, Taame H, Ahmed M, Nigatu F, Tolesa T, Wolka E, Amogne W, Laillou A, Amare M, Fufa Y, Argaw A, Waganew W, Azazh A, Worku A, Redae B, Sultan M, Walelegn M, Tefera M, Yifru S, Argaw R, Brehau N, Teklu S, Demoz G, Seman Y, Salasibew M, Ejeta E, Whiting SJ, Wolday D, Tollera G, Abate E, Duguma D. Prognostic factors and outcomes of COVID-19 cases in Ethiopia: multi-center cohort study protocol. BMC Infect Dis. 2021 Sep 16;21(1):956. doi: 10.1186/s12879-021-06652-0.']",,2020-10-14,https://clinicaltrials.gov/show/NCT04584424,2021-09-14,0,1
3527,NCT04584437,Withdrawn,2022-05-10,2022-07-10,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04584437,2022-05-10,0,0
3528,NCT04584450,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04584450,2020-12-31,0,0
3529,NCT04584541,Recruiting,2023-07-01,2023-12-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04584541,2023-07-01,0,0
3530,NCT04584580,Recruiting,2020-10-31,2020-12-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2020-10-14,https://clinicaltrials.gov/show/NCT04584580,2020-10-31,0,1
3531,NCT04584593,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04584593,2022-02-01,0,0
3532,NCT04584606,Recruiting,2020-10-31,2020-12-30,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04584606,2020-10-31,0,0
3533,NCT04584671,Not yet recruiting,2022-12-01,2024-12-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04584671,2022-12-01,0,0
3534,NCT04584684,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04584684,2022-06-01,0,0
3535,NCT04584697,Withdrawn,2021-04-01,2021-04-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-02-12,https://clinicaltrials.gov/show/NCT04584697,2021-04-01,0,1
3536,NCT04584710,"Active, not recruiting",2021-02-01,2021-02-01,Results Submitted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04584710,2021-02-01,0,0
3537,NCT04585945,"Active, not recruiting",2021-12-31,2021-12-31,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04585945,2021-12-31,0,0
3538,NCT04586114,"Active, not recruiting",2020-05-31,2020-12-31,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04586114,2020-05-31,0,0
3539,NCT04586140,"Active, not recruiting",2020-12-09,2022-04-30,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04586140,2020-12-09,0,0
3540,NCT04586153,Recruiting,2023-06-30,2023-09-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-21,https://clinicaltrials.gov/show/NCT04586153,2023-06-30,0,1
3541,NCT04586413,Recruiting,2022-10-01,2025-10-01,No Results Posted,"['Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021 Sep 28;19(1):229. doi: 10.1186/s12955-021-01862-1.']",,2021-11-08,https://clinicaltrials.gov/show/NCT04586413,2022-10-01,0,1
3542,NCT04587219,"Active, not recruiting",2021-03-30,2021-04-30,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04587219,2021-03-30,0,0
3543,NCT04587245,Recruiting,2022-10-15,2022-10-15,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04587245,2022-10-15,0,0
3544,NCT04587258,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04587258,2022-09-01,0,0
3545,NCT04587323,Recruiting,2023-03-20,2023-05-20,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04587323,2023-03-20,0,0
3546,NCT04587375,Completed,2020-05-01,2020-05-30,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04587375,2020-05-01,0,0
3547,NCT04587414,"Active, not recruiting",2020-10-31,2020-10-31,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04587414,2020-10-31,0,0
3548,NCT04587921,Recruiting,2021-01-22,2021-06-22,No Results Posted,,,2020-10-14,https://clinicaltrials.gov/show/NCT04587921,2021-01-22,0,0
3549,NCT04588415,Enrolling by invitation,2021-12-01,2022-01-01,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04588415,2021-12-01,0,0
3550,NCT04588441,Not yet recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04588441,2022-12-01,0,0
3551,NCT04588480,Completed,2021-11-25,2021-11-25,No Results Posted,"['Haranaka M, Baber J, Ogama Y, Yamaji M, Aizawa M, Kogawara O, Scully I, Lagkadinou E, T√ºreci ”¶, ≈ûahin U, Dormitzer PR, Gruber WC, Lockhart S. A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults. Nat Commun. 2021 Dec 14;12(1):7105. doi: 10.1038/s41467-021-27316-2.']",,2022-02-23,https://clinicaltrials.gov/show/NCT04588480,2021-11-25,0,1
3552,NCT04588909,"Active, not recruiting",2020-09-22,2020-10-22,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04588909,2020-09-22,0,0
3553,NCT04589104,Completed,2020-08-17,2020-08-17,No Results Posted,"['Bechard E, Evans J, Cho E, Lin Y, Kozhumam A, Jones J, Grob S, Glass O. Feasibility, acceptability, and potential effectiveness of an online expressive writing intervention for COVID-19 resilience. Complement Ther Clin Pract. 2021 Nov;45:101460. doi: 10.1016/j.ctcp.2021.101460. Epub 2021 Jul 27.']",,2020-10-19,https://clinicaltrials.gov/show/NCT04589104,2020-08-17,0,1
3554,NCT04589117,Completed,2020-08-02,2020-08-02,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04589117,2020-08-02,0,0
3555,NCT04589936,Recruiting,2021-06-30,2021-06-30,Results Submitted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04589936,2021-06-30,0,0
3556,NCT04589949,Terminated,2021-10-01,2022-03-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04589949,2021-10-01,0,0
3557,NCT04590053,Recruiting,2021-02-01,2021-03-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04590053,2021-02-01,0,0
3558,NCT04590170,Recruiting,2022-10-30,2023-04-30,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04590170,2022-10-30,0,0
3559,NCT04590209,Not yet recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04590209,2022-03-01,0,0
3560,NCT04590222,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04590222,2022-11-01,0,0
3561,NCT04590261,Not yet recruiting,2022-11-01,2023-11-01,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04590261,2022-11-01,0,0
3562,NCT04590274,Withdrawn,2021-12-01,2021-12-01,No Results Posted,,,2021-12-07,https://clinicaltrials.gov/show/NCT04590274,2021-12-01,0,0
3563,NCT04590352,Completed,2020-05-13,2020-05-13,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04590352,2020-05-13,0,0
3564,NCT04590365,Recruiting,2022-03-01,2022-12-01,No Results Posted,,,2021-12-02,https://clinicaltrials.gov/show/NCT04590365,2022-03-01,0,0
3565,NCT04590378,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04590378,2021-06-01,0,0
3566,NCT04590430,Completed,2021-07-26,2021-07-26,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-11,https://clinicaltrials.gov/show/NCT04590430,2021-07-26,0,1
3567,NCT04590469,Recruiting,2021-12-01,2022-01-01,No Results Posted,,"['Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program. Am J Psychiatry. 2016 Mar 1;173(3):252-62. doi: 10.1176/appi.ajp.2015.15010130. Epub 2015 Nov 20.']",2021-05-28,https://clinicaltrials.gov/show/NCT04590469,2021-12-01,0,1
3568,NCT04590586,Completed,2021-08-03,2021-08-03,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-23,https://clinicaltrials.gov/show/NCT04590586,2021-08-03,0,1
3569,NCT04591015,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT04591015,2022-06-01,0,0
3570,NCT04591158,Completed,2021-06-09,2021-06-09,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04591158,2021-06-09,0,0
3571,NCT04591184,"Active, not recruiting",2022-08-01,2022-08-01,No Results Posted,,,2021-09-14,https://clinicaltrials.gov/show/NCT04591184,2022-08-01,0,0
3572,NCT04591210,Recruiting,2022-08-01,2022-12-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04591210,2022-08-01,0,0
3573,NCT04591600,Completed,2020-09-30,2020-10-14,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04591600,2020-09-30,0,0
3574,NCT04591613,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04591613,2022-08-01,0,0
3575,NCT04591704,Recruiting,2020-10-15,2021-07-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04591704,2020-10-15,0,0
3576,NCT04591717,"Active, not recruiting",2022-11-19,2022-11-19,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04591717,2022-11-19,0,0
3577,NCT04591873,Not yet recruiting,2021-10-10,2021-10-30,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04591873,2021-10-10,0,0
3578,NCT04592055,Recruiting,2020-10-15,2021-07-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04592055,2020-10-15,0,0
3579,NCT04592354,Recruiting,2021-04-15,2021-06-15,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04592354,2021-04-15,0,0
3580,NCT04592510,Recruiting,2021-10-01,2022-01-01,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04592510,2021-10-01,0,0
3581,NCT04592705,Recruiting,2021-08-30,2021-08-30,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04592705,2021-08-30,0,0
3582,NCT04592835,Not yet recruiting,2020-12-13,2021-06-30,No Results Posted,,,2020-10-19,https://clinicaltrials.gov/show/NCT04592835,2020-12-13,0,0
3583,NCT04593069,Recruiting,2021-02-28,2021-02-28,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04593069,2021-02-28,0,0
3584,NCT04593433,Completed,2021-07-04,2021-07-04,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04593433,2021-07-04,0,0
3585,NCT04593641,"Active, not recruiting",2020-10-22,2020-12-23,Results Submitted,"['Kim JY, Jang YR, Hong JH, Jung JG, Park JH, Streinu-Cercel A, Streinu-Cercel A, SƒÉndulescu O, Lee SJ, Kim SH, Jung NH, Lee SG, Park JE, Kim MK, Jeon DB, Lee YJ, Kim BS, Lee YM, Kim YS. Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection. Clin Ther. 2021 Oct;43(10):1706-1727. doi: 10.1016/j.clinthera.2021.08.009. Epub 2021 Aug 23.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2020-10-20,https://clinicaltrials.gov/show/NCT04593641,2020-10-22,0,1
3586,NCT04593654,Completed,2020-08-15,2020-10-15,No Results Posted,"['Jonmarker S, Litorell J, Dahlberg M, Stackelberg O, Everhov √ÖH, S√∂derberg M, Rubenson-Wahlin R, G√ºnther M, M√•rtensson J, Hollenberg J, Joelsson-Alm E, Cronhjort M. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients. Acta Anaesthesiol Scand. 2022 Mar;66(3):365-374. doi: 10.1111/aas.14013. Epub 2021 Dec 16.']",,2020-10-20,https://clinicaltrials.gov/show/NCT04593654,2020-08-15,0,1
3587,NCT04593940,Completed,2022-01-30,2022-03-05,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04593940,2022-01-30,0,1
3588,NCT04594278,Not yet recruiting,2022-04-01,2022-07-01,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04594278,2022-04-01,0,0
3589,NCT04594291,Recruiting,2023-09-01,2023-09-01,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04594291,2023-09-01,0,0
3590,NCT04594330,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04594330,2020-12-31,0,0
3591,NCT04594343,Completed,2021-09-10,2021-09-25,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04594343,2021-09-10,0,0
3592,NCT04594356,"Active, not recruiting",2021-01-31,2022-12-30,No Results Posted,,"['Twaddell SH, Baines KJ, Grainge C, Gibson PG. The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease. Chest. 2019 Oct;156(4):774-782. doi: 10.1016/j.chest.2019.06.012. Epub 2019 Jun 29. Review.', 'Granger V, Peyneau M, Chollet-Martin S, de Chaisemartin L. Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work. Front Immunol. 2019 Dec 3;10:2824. doi: 10.3389/fimmu.2019.02824. eCollection 2019. Review.', 'Bendib I, de Chaisemartin L, Granger V, Schlemmer F, Maitre B, H√ºe S, Surenaud M, Beldi-Ferchiou A, Carteaux G, Razazi K, Chollet-Martin S, Mekontso Dessap A, de Prost N. Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome. Anesthesiology. 2019 Apr;130(4):581-591. doi: 10.1097/ALN.0000000000002619.', 'Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Jun;46(6):1294-1297. doi: 10.1007/s00134-020-06028-z.', 'Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. Epub 2020 Mar 22. Review.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Kupferschmidt K, Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020 Mar 27;367(6485):1412-1413. doi: 10.1126/science.367.6485.1412.', 'Mahase E. Covid-19: what treatments are being investigated? BMJ. 2020 Mar 26;368:m1252. doi: 10.1136/bmj.m1252.', 'Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.']",2022-03-31,https://clinicaltrials.gov/show/NCT04594356,2021-01-31,0,1
3593,NCT04594395,Withdrawn,2021-09-24,2021-09-30,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04594395,2021-09-24,0,0
3594,NCT04594460,Not yet recruiting,2021-10-31,2021-12-31,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04594460,2021-10-31,0,0
3595,NCT04594525,"Active, not recruiting",2021-10-27,2022-12-01,No Results Posted,"['Naja S, Elyamani R, Chehab M, Siddig M, Al Ibrahim A, Mohamad T, Singh R, Bougmiza I. Maternal low-intensity psychosocial telemental interventions in response to COVID-19 in Qatar: study protocol for a randomized controlled trial. Trials. 2021 Jun 7;22(1):382. doi: 10.1186/s13063-021-05339-w.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04594525,2021-10-27,0,1
3596,NCT04594668,Recruiting,2021-04-24,2021-12-31,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04594668,2021-04-24,0,0
3597,NCT04595084,Recruiting,2021-11-01,2022-11-01,No Results Posted,,,2021-08-06,https://clinicaltrials.gov/show/NCT04595084,2021-11-01,0,0
3598,NCT04595097,Recruiting,2022-04-30,2022-08-31,No Results Posted,"['Maldaner V, Coutinho J, Santana ANDC, Cipriano GFB, Oliveira MC, Carrijo MM, Lino MEM, Cahalin LP, Lima AG, Borges R, Santos DB, Silva IO, Oliveira LVF, Cipriano G Jr. Adjunctive inspiratory muscle training for patients with COVID-19 (COVIDIMT): protocol for randomised controlled double-blind trial. BMJ Open. 2021 Sep 22;11(9):e049545. doi: 10.1136/bmjopen-2021-049545.']",,2022-03-23,https://clinicaltrials.gov/show/NCT04595097,2022-04-30,0,1
3599,NCT04595110,Recruiting,2021-04-25,2021-05-10,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04595110,2021-04-25,0,0
3600,NCT04595123,Completed,2020-11-01,2021-02-28,No Results Posted,"['Motrico E, Bina R, Dom√≠nguez-Salas S, Mateus V, Contreras-Garc√≠a Y, Carrasco-Porti√±o M, Ajaz E, Apter G, Christoforou A, Dikmen-Yildiz P, Felice E, Hancheva C, Vousoura E, Wilson CA, Buhagiar R, Cadarso-Su√°rez C, Costa R, Devouche E, Ganho-√Åvila A, G√≥mez-Baya D, Gude F, Hadjigeorgiou E, Levy D, Osorio A, Rodriguez MF, Saldivia S, Gonz√°lez MF, Mattioli M, Mesquita A; Riseup-PPD-COVID-19 Group. Impact of the Covid-19 pandemic on perinatal mental health (Riseup-PPD-COVID-19): protocol for an international prospective cohort study. BMC Public Health. 2021 Feb 17;21(1):368. doi: 10.1186/s12889-021-10330-w.']",,2021-09-30,https://clinicaltrials.gov/show/NCT04595123,2020-11-01,0,1
3601,NCT04595136,Recruiting,2021-07-30,2021-08-30,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04595136,2021-07-30,0,0
3602,NCT04595175,Recruiting,2021-06-30,2021-12-30,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04595175,2021-06-30,0,0
3603,NCT04595240,Completed,2020-10-15,2020-10-15,No Results Posted,,,2020-10-20,https://clinicaltrials.gov/show/NCT04595240,2020-10-15,0,0
3604,NCT04595695,Completed,2020-11-12,2020-12-14,No Results Posted,"['Kratzke IM, Rosenbaum ME, Cox C, Ollila DW, Kapadia MR. Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters: A Randomized Clinical Trial. JAMA Surg. 2021 Apr 1;156(4):372-378. doi: 10.1001/jamasurg.2021.0836.']",,2021-01-14,https://clinicaltrials.gov/show/NCT04595695,2020-11-12,0,1
3605,NCT04595903,Not yet recruiting,2021-08-01,2021-08-01,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04595903,2021-08-01,0,0
3606,NCT04596085,Completed,2020-12-12,2020-12-12,Study Results,,,2021-08-12,https://clinicaltrials.gov/show/NCT04596085,2020-12-12,1,0
3607,NCT04596098,"Active, not recruiting",2023-12-15,2023-12-15,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04596098,2023-12-15,0,0
3608,NCT04596579,"Active, not recruiting",2021-10-16,2024-10-09,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04596579,2021-10-16,0,0
3609,NCT04596657,"Active, not recruiting",2021-11-30,2022-09-30,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04596657,2021-11-30,0,0
3610,NCT04596839,Completed,2021-04-30,2021-04-30,No Results Posted,"['Ansems K, Grundeis F, Dahms K, Mikolajewska A, Thieme V, Piechotta V, Metzendorf MI, Stegemann M, Benstoem C, Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Aug 5;8:CD014962. doi: 10.1002/14651858.CD014962.']",,2021-08-10,https://clinicaltrials.gov/show/NCT04596839,2021-04-30,0,1
3611,NCT04596943,Completed,2021-02-01,2021-03-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04596943,2021-02-01,0,0
3612,NCT04597034,Recruiting,2021-12-30,2022-03-30,No Results Posted,,"['Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020 Jun;16(6):308-310. doi: 10.1038/s41581-020-0284-7.', 'Ronco C, Reis T, De Rosa S. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. Blood Purif. 2020;49(3):255-258. doi: 10.1159/000507039. Epub 2020 Mar 13.', 'RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413.', 'Morgera S, Haase M, Kuss T, Vargas-Hein O, Zuckermann-Becker H, Melzer C, Krieg H, Wegner B, Bellomo R, Neumayer HH. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med. 2006 Aug;34(8):2099-104.']",2020-10-22,https://clinicaltrials.gov/show/NCT04597034,2021-12-30,0,1
3613,NCT04597047,Recruiting,2022-10-31,2022-12-31,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04597047,2022-10-31,0,0
3614,NCT04597216,Recruiting,2020-12-31,2021-12-31,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04597216,2020-12-31,0,0
3615,NCT04597242,,,,,,,2021-09-10,https://clinicaltrials.gov/show/NCT04597242,,0,0
3616,NCT04597736,Not yet recruiting,2021-11-01,2022-02-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04597736,2021-11-01,0,0
3617,NCT04597775,Not yet recruiting,2021-01-15,2021-01-31,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04597775,2021-01-15,0,0
3618,NCT04597853,Recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04597853,2021-12-31,0,0
3619,NCT04598256,Completed,2020-08-31,2020-08-31,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04598256,2020-08-31,0,0
3620,NCT04598334,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,"['Medicine JHU. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins 2020 [Available from: https://coronavirus.jhu.edu/map.html.', 'IEDCR. COVID-19: Institute of Epidemiology Disease Control and Research; 2020 [Available from: https://www.iedcr.gov.bd/website/index.php/component/content/article/73-ncov-2019.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.', ""National Guidelines on Clinical Management of Coronavirus Disease 2019 (COVID-19). version 7 ed. Government of the People's Republic of Bangladesh: Directorate General of Health Services; 2020."", 'Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.', 'library Phi. COVID-19: Centers for Didease Control and Prevention 2020 [Available from: https://phil.cdc.gov/Details.aspx?pid=23313.', ""Corona virus: Encyclop√¶dia Britannica, Inc./Patrick O'Neill Riley; 2020 [Available from: https://www.britannica.com/science/coronavirus-virus-group."", 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, Wang Y, Tang L, Deng J, Mei H, Hu Y. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.', 'de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009 Sep 28;10:52. doi: 10.1186/1471-2172-10-52.', 'Teijaro JR, Walsh KB, Rice S, Rosen H, Oldstone MB. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3799-804. doi: 10.1073/pnas.1400593111. Epub 2014 Feb 26.', 'Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014 Jul 10;124(2):188-95. doi: 10.1182/blood-2014-05-552729. Epub 2014 May 29. Erratum in: Blood. 2015 Aug 20;126(8):1048. Dosage error in article text. Blood. 2016 Sep 15;128(11):1533.', 'Soy M, Keser G, Atag√ºnd√ºz P, Tabak F, Atag√ºnd√ºz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020 Jul;39(7):2085-2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30. Review.', 'Monteagudo LA, Boothby A, Gertner E. Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome. ACR Open Rheumatol. 2020 May;2(5):276-282. doi: 10.1002/acr2.11135. Epub 2020 Apr 21.', 'Borthwick LA. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol. 2016 Jul;38(4):517-34. doi: 10.1007/s00281-016-0559-z. Epub 2016 Mar 21. Review.', 'Irving K. Acute phase reactants: UpToDate; 2020 [Available from: https://www.uptodate.com/contents/acute-phase-reactants?search=acute%20phase%20reactants&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.', 'Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, Zhi L, Wei H, Zhang Z, Qiu Y, Wang J, Wang A. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev. 2020 Jun;53:38-42. doi: 10.1016/j.cytogfr.2020.04.002. Epub 2020 Apr 25. Review.', 'Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020 Apr 14;18(1):164. doi: 10.1186/s12967-020-02339-3.', 'Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014 Sep 4;6(10):a016295. doi: 10.1101/cshperspect.a016295. Review.', 'Tobias Herold M, Arnreich C, Hellmuth JC, Matthias Klein M, Tobias Weinberger M. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients.', 'wikipedia. Tumor necrosis factor 2020 [Available from: https://en.wikipedia.org/wiki/Tumor_necrosis_factor.', 'Gong J, Dong H, Xia QS, Huang ZY, Wang DK, Zhao Y, Liu WH, Tu SH, Zhang MM, Wang Q, Lu FE. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 2020 Dec 21;20(1):963. doi: 10.1186/s12879-020-05681-5.', 'Wikipedia. Interleukin 1 beta 2020 [Available from: https://en.wikipedia.org/wiki/Interleukin_1_beta.', 'Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 March-April,;34(2):327-331. doi: 10.23812/CONTI-E.', 'Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2020 January-February,;34(1):9-14. doi: 10.23812/20-Editorial-Kritas.', ""Ye Q, Wang B, Mao J. The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19. J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10. Review."", 'NIH. COVID-19 treatment guideline, Pharmacologic Interventions [Available from: https://www.covid19treatmentguidelines.nih.gov/critical-care/pharmacologic-interventions/.', 'Tufan A, Avanoƒülu G√ºler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020 Apr 21;50(SI-1):620-632. doi: 10.3906/sag-2004-168. Review.', 'Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B, Camargo SM, Singer D, Richter A, Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P, Penninger JM. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012 Jul 25;487(7408):477-81. doi: 10.1038/nature11228.', 'Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007 Oct 18;449(7164):804-10.', 'Li√©vin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev. 2006 Apr;19(2):315-37. Review.', 'Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol. 2007 Apr;19(2):70-83. Epub 2007 May 7. Review.', 'Liang J, Sha SM, Wu KC. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases. J Dig Dis. 2014 Dec;15(12):641-6. doi: 10.1111/1751-2980.12211. Review.', 'Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR, Luth JE, Sjoding MW, Brown CA, Chanderraj R, Huffnagle GB, Bos LDJ; Biomarker Analysis in Septic ICU Patients (BASIC) Consortium. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients. Am J Respir Crit Care Med. 2020 Mar 1;201(5):555-563. doi: 10.1164/rccm.201907-1487OC.', 'Meyer NJ, Calfee CS. Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. Lancet Respir Med. 2017 Jun;5(6):512-523. doi: 10.1016/S2213-2600(17)30187-X. Epub 2017 May 26. Review.', 'Kyo M, Nishioka K, Nakaya T, Kida Y, Tanabe Y, Ohshimo S, Shime N. Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome. Respir Res. 2019 Nov 6;20(1):246. doi: 10.1186/s12931-019-1203-y.', 'Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR, Standiford TJ, Huffnagle GB. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016 Jul 18;1(10):16113. doi: 10.1038/nmicrobiol.2016.113.', 'He Y, Wang J, Li F, Shi Y. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections. Front Microbiol. 2020 Jun 5;11:1302. doi: 10.3389/fmicb.2020.01302. eCollection 2020. Review.', 'Medicine BSo. COVID-19 management guideline-Bangladesh Model. Dhaka, Bangladesh2020', 'Organization WH. Use of chest imaging in COVID-19 11 June 2020.']",2021-08-25,https://clinicaltrials.gov/show/NCT04598334,2021-12-01,0,1
3621,NCT04598347,Recruiting,2022-01-08,2022-01-23,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04598347,2022-01-08,0,0
3622,NCT04598581,Completed,2021-04-09,2021-04-09,No Results Posted,,"['Papachristofilou A, Finazzi T, Blum A, Zehnder T, Zellweger N, Lustenberger J, Bauer T, Dott C, Avcu Y, Kohler G, Zimmermann F, Pargger H, Siegemund M. Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1274-1282. doi: 10.1016/j.ijrobp.2021.02.054. Epub 2021 Mar 5.']",2021-04-19,https://clinicaltrials.gov/show/NCT04598581,2021-04-09,0,1
3623,NCT04598594,Completed,2021-04-29,2021-06-20,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04598594,2021-04-29,0,0
3624,NCT04598620,Completed,2021-10-01,2021-10-01,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04598620,2021-10-01,0,0
3625,NCT04598763,Recruiting,2020-07-01,2021-01-01,No Results Posted,,,2020-10-22,https://clinicaltrials.gov/show/NCT04598763,2020-07-01,0,0
3626,NCT04599959,Completed,2021-01-20,2021-01-20,Study Results,,,2021-07-26,https://clinicaltrials.gov/show/NCT04599959,2021-01-20,1,0
3627,NCT04599998,Enrolling by invitation,2021-02-15,2021-03-01,No Results Posted,,,2020-10-23,https://clinicaltrials.gov/show/NCT04599998,2021-02-15,0,0
3628,NCT04600141,Completed,2021-10-20,2021-12-31,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04600141,2021-10-20,0,0
3629,NCT04600440,Recruiting,2021-12-31,2022-02-28,No Results Posted,"['Holm K, Lundgren MN, Kjeldsen-Kragh J, Ljungquist O, B√∂ttiger B, Wik√©n C, √ñberg J, Fernstr√∂m N, Rosendal E, √ñverby AK, Wigren Bystr√∂m J, Forsell M, Landin-Olsson M, Rasmussen M. Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden. BMC Res Notes. 2021 Dec 4;14(1):440. doi: 10.1186/s13104-021-05847-7.']",,2020-10-23,https://clinicaltrials.gov/show/NCT04600440,2021-12-31,0,1
3630,NCT04600713,Not yet recruiting,2025-08-01,2025-10-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04600713,2025-08-01,0,0
3631,NCT04600895,Completed,2021-10-20,2021-10-20,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04600895,2021-10-20,0,0
3632,NCT04600999,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2020-10-23,https://clinicaltrials.gov/show/NCT04600999,2021-06-01,0,0
3633,NCT04601012,Completed,2020-10-20,2020-10-22,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04601012,2020-10-20,0,0
3634,NCT04601090,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04601090,2022-09-01,0,0
3635,NCT04601415,Recruiting,2022-10-01,2022-10-01,No Results Posted,"['Bachtiger P, Petri CF, Scott FE, Ri Park S, Kelshiker MA, Sahemey HK, Dumea B, Alquero R, Padam PS, Hatrick IR, Ali A, Ribeiro M, Cheung WS, Bual N, Rana B, Shun-Shin M, Kramer DB, Fragoyannis A, Keene D, Plymen CM, Peters NS. Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study. Lancet Digit Health. 2022 Feb;4(2):e117-e125. doi: 10.1016/S2589-7500(21)00256-9. Epub 2022 Jan 5.']",,2021-05-20,https://clinicaltrials.gov/show/NCT04601415,2022-10-01,0,1
3636,NCT04602000,Completed,2021-05-21,2021-10-20,No Results Posted,"['Streinu-Cercel A, SƒÉndulescu O, Preotescu LL, Kim JY, Kim YS, Cheon S, Jang YR, Lee SJ, Kim SH, Chang I, Suh JH, Lee SG, Kim MR, Chung DR, Kim HN, Streinu-Cercel A, Eom JS. Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019. Open Forum Infect Dis. 2022 Feb 2;9(4):ofac053. doi: 10.1093/ofid/ofac053. eCollection 2022 Apr.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-30,https://clinicaltrials.gov/show/NCT04602000,2021-05-21,0,1
3637,NCT04602260,Recruiting,2022-01-01,2022-01-01,No Results Posted,"['Reid JC, Costa AP, Duong M, Ho T, Kruisselbrink R, Raina P, Kirkwood R, Jones A, Corriveau S, Griffith LE, Haider S, Marcucci M, Markle-Reid M, Morrison H, Raghavan N, Schumacher C, Vrkljan B, Junek M, Martin L, Patel A, Girolametto C, Pitre T, Beauchamp MK; COREG Investigators. Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study. BMJ Open. 2021 Dec 13;11(12):e053021. doi: 10.1136/bmjopen-2021-053021.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-24,https://clinicaltrials.gov/show/NCT04602260,2022-01-01,0,1
3638,NCT04602286,Completed,2021-09-28,2021-09-28,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04602286,2021-09-28,0,0
3639,NCT04602312,Completed,2021-09-26,2021-09-26,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04602312,2021-09-26,0,0
3640,NCT04602442,Enrolling by invitation,2021-08-01,2021-12-30,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04602442,2021-08-01,0,0
3641,NCT04602481,Recruiting,2022-05-31,2025-05-31,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04602481,2022-05-31,0,0
3642,NCT04602637,"Active, not recruiting",2020-12-15,2021-01-15,No Results Posted,,,2020-10-26,https://clinicaltrials.gov/show/NCT04602637,2020-12-15,0,0
3643,NCT04602832,Enrolling by invitation,2020-12-01,2020-12-01,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04602832,2020-12-01,0,0
3644,NCT04602871,Completed,2021-01-30,2021-01-30,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04602871,2021-01-30,0,0
3645,NCT04602884,Completed,2021-12-30,2021-12-30,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04602884,2021-12-30,0,0
3646,NCT04602949,Recruiting,2023-07-28,2023-07-28,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04602949,2023-07-28,0,0
3647,NCT04603079,Not yet recruiting,2021-08-01,2021-09-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04603079,2021-08-01,0,0
3648,NCT04603105,Not yet recruiting,2021-10-31,2022-10-31,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04603105,2021-10-31,0,0
3649,NCT04603651,,,,,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04603651,,0,1
3650,NCT04603664,Completed,2021-06-30,2021-06-30,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04603664,2021-06-30,0,0
3651,NCT04603677,"Active, not recruiting",2022-11-30,2022-11-30,No Results Posted,"['LaVergne SM, Stromberg S, Baxter BA, Webb TL, Dutt TS, Berry K, Tipton M, Haberman J, Massey BR, McFann K, Alnachoukati O, Zier L, Heacock T, Ebel GD, Henao-Tamayo M, Dunn J, Ryan EP. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2.']",,2022-02-22,https://clinicaltrials.gov/show/NCT04603677,2022-11-30,0,1
3652,NCT04603729,Completed,2020-06-30,2020-07-01,No Results Posted,,,2020-10-27,https://clinicaltrials.gov/show/NCT04603729,2020-06-30,0,0
3653,NCT04603742,Withdrawn,2022-06-01,2022-09-01,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04603742,2022-06-01,0,0
3654,NCT04603755,Completed,2021-03-18,2021-03-18,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04603755,2021-03-18,0,0
3655,NCT04603794,Recruiting,2020-11-01,2020-11-01,No Results Posted,"['Chaudhary P, Melkonyan A, Meethil A, Saraswat S, Hall DL, Cottle J, Wenzel M, Ayouty N, Bense S, Casanova F, Chaney M, Chase H, Hermel R, McClement M, Sesson C, Woolsey B, Kumar P. Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial. J Am Dent Assoc. 2021 Nov;152(11):903-908. doi: 10.1016/j.adaj.2021.05.021. Epub 2021 Jun 11.']",,2020-10-27,https://clinicaltrials.gov/show/NCT04603794,2020-11-01,0,1
3656,NCT04603924,Recruiting,2021-12-01,2022-06-01,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04603924,2021-12-01,0,0
3657,NCT04603963,Terminated,2020-10-10,2020-10-23,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04603963,2020-10-10,0,0
3658,NCT04604080,Completed,2020-11-18,2020-11-18,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04604080,2020-11-18,0,0
3659,NCT04604119,Completed,2020-05-30,2020-06-01,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04604119,2020-05-30,0,0
3660,NCT04604223,Recruiting,2021-06-29,2021-06-29,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04604223,2021-06-29,0,0
3661,NCT04604249,"Active, not recruiting",2021-11-30,2021-12-31,No Results Posted,"['Champigneulle B, Hancco I, Renan R, Doutreleau S, Stauffer E, Pichon A, Brugniaux JV, P√©r√© H, Bouzat P, Veyer D, Verges S. High-Altitude Environment and COVID-19: SARS-CoV-2 Seropositivity in the Highest City in the World. High Alt Med Biol. 2021 Jul 1. doi: 10.1089/ham.2021.0020. [Epub ahead of print]']","['Castagnetto JM, Segovia-Juarez J, Gonzales GF. Letter to the Editor: COVID-19 Infections Do Not Change with Increasing Altitudes from 1,000 to 4,700 m. High Alt Med Biol. 2020 Dec;21(4):428-430. doi: 10.1089/ham.2020.0173. Epub 2020 Oct 13.', 'Secl√©n SN, Nunez-Robles E, Yovera-Aldana M, Arias-Chumpitaz A. Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population. Diabetes Res Clin Pract. 2020 Nov;169:108463. doi: 10.1016/j.diabres.2020.108463. Epub 2020 Sep 22.', 'Segovia-Juarez J, Castagnetto JM, Gonzales GF. High altitude reduces infection rate of COVID-19 but not case-fatality rate. Respir Physiol Neurobiol. 2020 Oct;281:103494. doi: 10.1016/j.resp.2020.103494. Epub 2020 Jul 15.', 'Woolcott OO, Bergman RN. Mortality Attributed to COVID-19 in High-Altitude Populations. High Alt Med Biol. 2020 Dec;21(4):409-416. doi: 10.1089/ham.2020.0098. Epub 2020 Aug 17.', 'Intimayta-Escalante C, Rojas-Bolivar D, Hancco I. Letter to the Editor: Influence of Altitude on the Prevalence and Case Fatality Rate of COVID-19 in Peru. High Alt Med Biol. 2020 Dec;21(4):426-427. doi: 10.1089/ham.2020.0133. Epub 2020 Aug 14.', 'Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, Aliaga-Raduan F, Carvajal-Rodriguez F, Dutschmann M, Schneider-Gasser EM, Zubieta-Calleja G, Soliz J. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respir Physiol Neurobiol. 2020 Jun;277:103443. doi: 10.1016/j.resp.2020.103443. Epub 2020 Apr 22.']",2021-02-04,https://clinicaltrials.gov/show/NCT04604249,2021-11-30,0,1
3662,NCT04604327,Recruiting,2021-05-31,2021-07-31,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.', 'Marcos-Jubilar M, Carmona-Torre F, Vidal R, Ruiz-Artacho P, Filella D, Carbonell C, Jim√©nez-Yuste V, Schwartz J, Llamas P, Alegre F, S√°daba B, N√∫√±ez-C√≥rdoba J, Yuste JR, Fern√°ndez-Garc√≠a J, Lecumberri R; BEMICOP Investigators. Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial. Thromb Haemost. 2022 Feb;122(2):295-299. doi: 10.1055/a-1667-7534. Epub 2021 Oct 12.']",,2020-10-27,https://clinicaltrials.gov/show/NCT04604327,2021-05-31,0,1
3663,NCT04604678,Not yet recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-01-07,https://clinicaltrials.gov/show/NCT04604678,2021-08-01,0,0
3664,NCT04604704,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04604704,2022-03-01,0,0
3665,NCT04604743,Recruiting,2023-06-30,2023-06-30,No Results Posted,"['Budhwani H, Sharma V, Long DM, Simpson T. Developing a clinic-based vaccine promoting intervention for African American adolescents in rural Alabama: protocol for a pilot cluster randomized controlled implementation science trial. JMIR Res Protoc. 2022 Feb 22. doi: 10.2196/33982. [Epub ahead of print]']",,2021-05-25,https://clinicaltrials.gov/show/NCT04604743,2023-06-30,0,1
3666,NCT04604769,Completed,2020-09-01,2020-09-01,No Results Posted,,,2020-10-27,https://clinicaltrials.gov/show/NCT04604769,2020-09-01,0,0
3667,NCT04604977,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2020-10-27,https://clinicaltrials.gov/show/NCT04604977,2021-10-01,0,0
3668,NCT04605692,Completed,2020-05-20,2020-05-20,No Results Posted,"['√ñzarslan M, Caliskan S. Attitudes and predictive factors of psychological distress and occupational burnout among dentists during COVID-19 pandemic in Turkey. Curr Psychol. 2021;40(7):3113-3124. doi: 10.1007/s12144-021-01764-x. Epub 2021 Apr 29.']",,2020-10-28,https://clinicaltrials.gov/show/NCT04605692,2020-05-20,0,1
3669,NCT04605757,Recruiting,2021-04-30,2021-07-30,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04605757,2021-04-30,0,0
3670,NCT04605887,Recruiting,2023-11-01,2024-04-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04605887,2023-11-01,0,0
3671,NCT04605926,Withdrawn,2021-04-01,2021-06-01,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04605926,2021-04-01,0,0
3672,NCT04605952,Completed,2020-08-30,2020-08-30,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04605952,2020-08-30,0,0
3673,NCT04606069,Recruiting,2023-01-30,2023-12-31,No Results Posted,,,2022-01-24,https://clinicaltrials.gov/show/NCT04606069,2023-01-30,0,0
3674,NCT04606498,"Active, not recruiting",2022-02-01,2022-03-01,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04606498,2022-02-01,0,0
3675,NCT04606563,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-10-28,https://clinicaltrials.gov/show/NCT04606563,2021-06-30,0,0
3676,NCT04606732,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04606732,2021-12-31,0,0
3677,NCT04607915,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04607915,2022-03-31,0,0
3678,NCT04607928,Recruiting,2022-01-30,2022-06-30,No Results Posted,,,2021-12-30,https://clinicaltrials.gov/show/NCT04607928,2022-01-30,0,0
3679,NCT04607941,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04607941,2022-05-31,0,0
3680,NCT04608214,Not yet recruiting,2021-05-06,2021-08-04,No Results Posted,,,2020-10-29,https://clinicaltrials.gov/show/NCT04608214,2021-05-06,0,0
3681,NCT04608305,Recruiting,2021-05-01,2022-06-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04608305,2021-05-01,0,0
3682,NCT04608383,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04608383,2022-01-01,0,0
3683,NCT04609332,Completed,2021-09-26,2021-11-30,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04609332,2021-09-26,0,0
3684,NCT04609371,Completed,2021-03-01,2021-05-01,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04609371,2021-03-01,0,0
3685,NCT04609423,Recruiting,2021-06-02,2023-05-01,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04609423,2021-06-02,0,0
3686,NCT04609462,Completed,2021-01-13,2021-02-10,No Results Posted,"['Ospina-Tasc√≥n GA, Calder√≥n-Tapia LE, Garc√≠a AF, Zarama V, G√≥mez-√Ålvarez F, √Ålvarez-Saa T, Pardo-Ot√°lvaro S, Bautista-Rinc√≥n DF, Vargas MP, Aldana-D√≠az JL, Marulanda √Å, Guti√©rrez A, Var√≥n J, G√≥mez M, Ochoa ME, Escobar E, Uma√±a M, D√≠ez J, Tob√≥n GJ, Albornoz LL, Celem√≠n Fl√≥rez CA, Ruiz GO, C√°ceres EL, Reyes LF, Damiani LP, Cavalcanti AB; HiFLo-Covid Investigators. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Dec 7;326(21):2161-2171. doi: 10.1001/jama.2021.20714. Erratum in: JAMA. 2022 Mar 15;327(11):1093.']",,2021-04-01,https://clinicaltrials.gov/show/NCT04609462,2021-01-13,0,1
3687,NCT04609488,Not yet recruiting,2022-09-30,2022-10-01,No Results Posted,,,2020-10-30,https://clinicaltrials.gov/show/NCT04609488,2022-09-30,0,0
3688,NCT04609501,"Active, not recruiting",2023-06-30,2024-06-30,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04609501,2023-06-30,0,0
3689,NCT04609722,Recruiting,2021-02-01,2021-02-15,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04609722,2021-02-01,0,0
3690,NCT04609774,Completed,2020-11-20,2020-12-01,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04609774,2020-11-20,0,0
3691,NCT04609839,Recruiting,2023-04-27,2023-04-27,No Results Posted,,,2020-10-30,https://clinicaltrials.gov/show/NCT04609839,2023-04-27,0,0
3692,NCT04609865,Recruiting,2021-12-31,2024-02-04,No Results Posted,"['Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Feb 11;22(1):131. doi: 10.1186/s13063-021-05095-x.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04609865,2021-12-31,0,1
3693,NCT04610138,"Active, not recruiting",2022-05-28,2022-05-28,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04610138,2022-05-28,0,0
3694,NCT04610489,Terminated,2021-03-10,2021-03-10,Study Results,,,2021-08-17,https://clinicaltrials.gov/show/NCT04610489,2021-03-10,1,0
3695,NCT04610502,Completed,2020-10-06,2020-12-06,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04610502,2020-10-06,0,0
3696,NCT04610515,Recruiting,2022-11-14,2022-11-14,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04610515,2022-11-14,0,0
3697,NCT04610541,"Active, not recruiting",2021-10-30,2021-11-30,No Results Posted,,"['Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.', 'Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK; Washington State 2019-nCoV Case Investigation Team. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.', 'Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, Enouf V, Houhou-Fidouh N, Valette M, Mailles A, Lucet JC, Mentre F, Duval X, Descamps D, Malvy D, Timsit JF, Lina B, van-der-Werf S, Yazdanpanah Y. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27. Erratum in: Lancet Infect Dis. 2020 May 19;:. Erratum in: Lancet Infect Dis. 2020 Jun;20(6):e116.', 'de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.', 'Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017 Jun 28;9(396). pii: eaal3653. doi: 10.1126/scitranslmed.aal3653.', 'Sheahan TP, Sims AC, Leist SR, Sch√§fer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 Jan 10;11(1):222. doi: 10.1038/s41467-019-13940-6.']",2020-11-27,https://clinicaltrials.gov/show/NCT04610541,2021-10-30,0,1
3698,NCT04610554,Completed,2020-10-12,2020-10-12,No Results Posted,"['Barisione G, Brusasco V. Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19. Physiol Rep. 2021 Feb;9(4):e14748. doi: 10.14814/phy2.14748.']","['Barisione G, Garlaschi A, Occhipinti M, Baroffio M, Pistolesi M, Brusasco V. Value of lung diffusing capacity for nitric oxide in systemic sclerosis. Physiol Rep. 2019 Aug;7(13):e14149. doi: 10.14814/phy2.14149.']",2020-10-30,https://clinicaltrials.gov/show/NCT04610554,2020-10-12,0,1
3699,NCT04610567,Recruiting,2021-03-15,2021-07-15,No Results Posted,,"[""Shah A, Kashyap R, Tosh P, Sampathkumar P, O'Horo JC. Guide to Understanding the 2019 Novel Coronavirus. Mayo Clin Proc. 2020 Apr;95(4):646-652. doi: 10.1016/j.mayocp.2020.02.003. Epub 2020 Feb 28."", 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Mitchell WB. Thromboinflammation in COVID-19 acute lung injury. Paediatr Respir Rev. 2020 Sep;35:20-24. doi: 10.1016/j.prrv.2020.06.004. Epub 2020 Jun 11. Review.', 'Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020 Aug;30(8):4398-4406. doi: 10.1007/s00330-020-06816-7. Epub 2020 Mar 24.', 'Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum. 1996 Dec;39(12):1951-60. Review.']",2021-01-14,https://clinicaltrials.gov/show/NCT04610567,2021-03-15,0,1
3700,NCT04610801,Not yet recruiting,2022-06-08,2022-08-08,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04610801,2022-06-08,0,0
3701,NCT04611243,Recruiting,2024-08-18,2025-02-17,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04611243,2024-08-18,0,0
3702,NCT04611256,Recruiting,2020-11-30,2020-12-30,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04611256,2020-11-30,0,0
3703,NCT04611269,Completed,2020-10-31,2020-10-31,No Results Posted,"['Estenssoro E, Loudet CI, R√≠os FG, Kanoore Edul VS, Plotnikow G, Andrian M, Romero I, Piezny D, Bezzi M, Mandich V, Groer C, Torres S, Orlandi C, Rubatto Birri PN, Valenti MF, Cunto E, S√°enz MG, Tiribelli N, Aphalo V, Reina R, Dubin A; SATI-COVID-19 Study Group. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.']","['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.', 'Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, Hern√°ndez M, Gea A, Arruti E, Aldecoa C, Mart√≠nez-Pall√≠ G, Mart√≠nez-Gonz√°lez MA, Slutsky AS, Villar J; COVID-19 Spanish ICU Network. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020 Dec;46(12):2200-2211. doi: 10.1007/s00134-020-06192-2. Epub 2020 Jul 29. Erratum in: Intensive Care Med. 2020 Dec 2;:.', 'Wunsch H. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology. Am J Respir Crit Care Med. 2020 Jul 1;202(1):1-4. doi: 10.1164/rccm.202004-1385ED.', 'Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020 Apr;46(4):579-582. doi: 10.1007/s00134-020-05967-x. Epub 2020 Feb 26.']",2020-11-13,https://clinicaltrials.gov/show/NCT04611269,2020-10-31,0,1
3704,NCT04611399,Recruiting,2022-03-05,2022-03-05,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04611399,2022-03-05,0,0
3705,NCT04611425,Completed,2020-12-02,2021-10-22,No Results Posted,,,2021-11-04,https://clinicaltrials.gov/show/NCT04611425,2020-12-02,0,0
3706,NCT04611802,"Active, not recruiting",2023-06-30,2023-06-30,No Results Posted,"['Dunkle LM, Kotloff KL, Gay CL, √Å√±ez G, Adelglass JM, Barrat Hern√°ndez AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ru√≠z-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04611802,2023-06-30,0,1
3707,NCT04611841,Enrolling by invitation,2022-12-01,2022-12-01,No Results Posted,,,2020-11-02,https://clinicaltrials.gov/show/NCT04611841,2022-12-01,0,0
3708,NCT04612972,"Active, not recruiting",2021-02-19,2021-12-19,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04612972,2021-02-19,0,0
3709,NCT04613050,Recruiting,2022-04-24,2022-04-30,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04613050,2022-04-24,0,0
3710,NCT04613271,Recruiting,2021-12-30,2021-12-30,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04613271,2021-12-30,0,0
3711,NCT04613297,"Active, not recruiting",2022-07-19,2022-07-19,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04613297,2022-07-19,0,0
3712,NCT04613310,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04613310,2020-12-31,0,0
3713,NCT04613739,Completed,2021-09-01,2021-09-01,Study Results,,,2022-03-09,https://clinicaltrials.gov/show/NCT04613739,2021-09-01,1,0
3714,NCT04613817,Recruiting,2021-12-30,2022-03-31,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04613817,2021-12-30,0,0
3715,NCT04613986,Not yet recruiting,2021-12-01,2022-07-01,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04613986,2021-12-01,0,0
3716,NCT04614012,Recruiting,2022-07-02,2022-07-02,No Results Posted,,,2020-11-03,https://clinicaltrials.gov/show/NCT04614012,2022-07-02,0,0
3717,NCT04614025,"Active, not recruiting",2021-08-04,2022-09-01,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04614025,2021-08-04,0,0
3718,NCT04614883,Completed,2021-02-26,2021-02-26,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04614883,2021-02-26,0,0
3719,NCT04615000,Recruiting,2021-11-01,2021-11-01,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04615000,2021-11-01,0,0
3720,NCT04615026,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04615026,2021-06-30,0,0
3721,NCT04615052,Recruiting,2021-10-31,2021-12-21,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04615052,2021-10-31,0,0
3722,NCT04615195,Completed,2020-07-02,2020-09-30,No Results Posted,,"['Claudet I, Marchand-Tonel C, Ricco L, Houz√©-Cerfon CH, Lang T, Br√©hin C. During the COVID-19 Quarantine, Home Has Been More Harmful Than the Virus for Children! Pediatr Emerg Care. 2020 Sep;36(9):e538-e540. doi: 10.1097/PEC.0000000000002205.']",2021-08-27,https://clinicaltrials.gov/show/NCT04615195,2020-07-02,0,1
3723,NCT04615208,Withdrawn,2021-10-30,2021-12-30,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04615208,2021-10-30,0,0
3724,NCT04615390,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04615390,2021-12-01,0,0
3725,NCT04615416,Recruiting,2022-03-01,2023-01-01,No Results Posted,,"[""Mennin DS, Fresco DM, O'Toole MS, Heimberg RG. A randomized controlled trial of emotion regulation therapy for generalized anxiety disorder with and without co-occurring depression. J Consult Clin Psychol. 2018 Mar;86(3):268-281. doi: 10.1037/ccp0000289."", 'Renna ME, Quintero JM, Soffer A, Pino M, Ader L, Fresco DM, Mennin DS. A Pilot Study of Emotion Regulation Therapy for Generalized Anxiety and Depression: Findings From a Diverse Sample of Young Adults. Behav Ther. 2018 May;49(3):403-418. doi: 10.1016/j.beth.2017.09.001. Epub 2017 Sep 8.']",2021-10-11,https://clinicaltrials.gov/show/NCT04615416,2022-03-01,0,1
3726,NCT04615429,Recruiting,2022-01-01,2022-02-01,No Results Posted,"['Payares-Herrera C, Mart√≠nez-Mu√±oz ME, Vallhonrat IL, de Molina RM, Torres MP, Trisan A, de Diego IS, Alonso R, Zafra R, Donaire T, S√°nchez R, Rubio JJ, Duarte Palomino RF, Sol√° CA. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.']",,2021-11-10,https://clinicaltrials.gov/show/NCT04615429,2022-01-01,0,1
3727,NCT04615676,Completed,2020-07-17,2020-07-17,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04615676,2020-07-17,0,0
3728,NCT04615728,Completed,2020-07-05,2020-10-06,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04615728,2020-07-05,0,0
3729,NCT04615741,Completed,2021-01-22,2021-04-20,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04615741,2021-01-22,0,0
3730,NCT04615871,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04615871,2022-03-31,0,0
3731,NCT04615936,Completed,2021-07-07,2021-10-19,No Results Posted,"['Lobo CS, Rodrigues-Santos P, Pereira D, N√∫√±ez J, Tr√™pa JCD, Sousa DL, Louren√ßo JV, Coelho MF, de Almeida LP, da Cunha JS, Arnaut LG. Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation. Photochem Photobiol Sci. 2022 Mar 19. doi: 10.1007/s43630-022-00202-6. [Epub ahead of print]']",,2021-11-08,https://clinicaltrials.gov/show/NCT04615936,2021-07-07,0,1
3732,NCT04615949,Recruiting,2022-03-01,2022-04-01,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04615949,2022-03-01,0,0
3733,NCT04615975,Recruiting,2021-07-30,2021-08-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04615975,2021-07-30,0,0
3734,NCT04616001,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,2020-11-04,https://clinicaltrials.gov/show/NCT04616001,2021-06-30,0,0
3735,NCT04616846,Completed,2022-01-25,2022-01-25,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04616846,2022-01-25,0,0
3736,NCT04616950,"Active, not recruiting",2021-06-30,2022-03-31,No Results Posted,,"[""Belle A, Barret M, Bernardini D, Tarrerias AL, Bories E, Costil V, Denis B, Gincul R, Karsenti D, Koch S, Laquiere A, Lecomte T, Quentin V, Rahmi G, Robaszkiewicz M, Vaillant E, Vanbiervliet G, Vienne A, Dumeiran F, Gronier O, Chaussade S; French Society of Digestive Endoscopy (Soci√©t√© Fran√ßaise d'Endoscopie Digestive). Impact of the COVID-19 pandemic on gastrointestinal endoscopy activity in France. Endoscopy. 2020 Dec;52(12):1111-1115. doi: 10.1055/a-1201-9618. Epub 2020 Jun 17."", 'S√∏reide K, Hallet J, Matthews JB, Schnitzbauer AA, Line PD, Lai PBS, Otero J, Callegaro D, Warner SG, Baxter NN, Teh CSC, Ng-Kamstra J, Meara JG, Hagander L, Lorenzon L. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020 Sep;107(10):1250-1261. doi: 10.1002/bjs.11670. Epub 2020 Apr 30. Review.', 'Grosclaude P, Azria D, Guimbaud R, Thibault S, Daubisse-Marliac L, Cartron G, Renaudie MJ, Dalbies PA, Delord JP, Bauvin E. [COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie]. Bull Cancer. 2020 Jul - Aug;107(7-8):730-737. doi: 10.1016/j.bulcan.2020.05.001. Epub 2020 May 18. French.', 'Sud A, Jones ME, Broggio J, Loveday C, Torr B, Garrett A, Nicol DL, Jhanji S, Boyce SA, Gronthoud F, Ward P, Handy JM, Yousaf N, Larkin J, Suh YE, Scott S, Pharoah PDP, Swanton C, Abbosh C, Williams M, Lyratzopoulos G, Houlston R, Turnbull C. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020 Aug;31(8):1065-1074. doi: 10.1016/j.annonc.2020.05.009. Epub 2020 May 19.', 'Gelman A, Rubin DB. Markov chain Monte Carlo methods in biostatistics. Stat Methods Med Res. 1996 Dec;5(4):339-55.']",2022-01-19,https://clinicaltrials.gov/show/NCT04616950,2021-06-30,0,1
3737,NCT04616976,Completed,2020-02-29,2020-11-01,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04616976,2020-02-29,0,0
3738,NCT04616989,Completed,2021-01-30,2021-01-30,No Results Posted,"['Akena D, Kiguba R, Muhwezi WW, Kwesiga B, Kigozi G, Nakasujja N, Lukwata H. The effectiveness of a psycho-education intervention on mental health literacy in communities affected by the COVID-19 pandemic-a cluster randomized trial of 24 villages in central Uganda-a research protocol. Trials. 2021 Jul 13;22(1):446. doi: 10.1186/s13063-021-05391-6.']",,2021-06-02,https://clinicaltrials.gov/show/NCT04616989,2021-01-30,0,1
3739,NCT04617119,Not yet recruiting,2021-02-06,2021-04-06,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04617119,2021-02-06,0,0
3740,NCT04617262,Recruiting,2021-09-01,2021-12-01,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04617262,2021-09-01,0,0
3741,NCT04617483,Completed,2020-11-28,2021-05-31,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04617483,2020-11-28,0,0
3742,NCT04617535,,,,,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-28,https://clinicaltrials.gov/show/NCT04617535,,0,1
3743,NCT04618042,Completed,2021-05-14,2021-06-13,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04618042,2021-05-14,0,0
3744,NCT04618341,Completed,2020-06-30,2020-07-28,No Results Posted,,,2020-11-05,https://clinicaltrials.gov/show/NCT04618341,2020-06-30,0,0
3745,NCT04618796,Not yet recruiting,2022-04-01,2022-05-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04618796,2022-04-01,0,0
3746,NCT04618835,Recruiting,2021-11-03,2021-11-03,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04618835,2021-11-03,0,0
3747,NCT04618861,Completed,2020-11-02,2020-11-02,No Results Posted,,,2020-11-06,https://clinicaltrials.gov/show/NCT04618861,2020-11-02,0,0
3748,NCT04619290,Recruiting,2020-11-30,2020-12-30,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04619290,2020-11-30,0,0
3749,NCT04619368,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2020-11-06,https://clinicaltrials.gov/show/NCT04619368,2022-07-01,0,0
3750,NCT04619407,Completed,2021-03-26,2021-03-26,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04619407,2021-03-26,0,0
3751,NCT04619576,Recruiting,2025-12-21,2025-12-21,No Results Posted,,,2020-11-06,https://clinicaltrials.gov/show/NCT04619576,2025-12-21,0,0
3752,NCT04619628,"Active, not recruiting",2021-06-26,2022-05-01,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04619628,2021-06-26,0,0
3753,NCT04619680,Recruiting,2024-04-01,2024-04-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04619680,2024-04-01,0,0
3754,NCT04619706,Recruiting,2021-08-14,2021-12-05,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04619706,2021-08-14,0,0
3755,NCT04619719,Recruiting,2022-12-15,2023-06-15,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04619719,2022-12-15,0,0
3756,NCT04620798,Completed,2020-11-11,2020-11-11,Study Results,"['Kianersi S, Luetke M, Ludema C, Valenzuela A, Rosenberg M. Use of research electronic data capture (REDCap) in a COVID-19 randomized controlled trial: a practical example. BMC Med Res Methodol. 2021 Aug 21;21(1):175. doi: 10.1186/s12874-021-01362-2.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04620798,2020-11-11,1,1
3757,NCT04621058,Recruiting,2021-11-30,2021-11-30,No Results Posted,,,2020-12-23,https://clinicaltrials.gov/show/NCT04621058,2021-11-30,0,0
3758,NCT04621071,Completed,2021-08-19,2021-10-12,No Results Posted,,,2021-10-29,https://clinicaltrials.gov/show/NCT04621071,2021-08-19,0,0
3759,NCT04621084,Recruiting,2025-12-31,2025-12-31,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04621084,2025-12-31,0,0
3760,NCT04621123,Completed,2021-05-31,2021-07-28,No Results Posted,"['Alemany A, Millat-Martinez P, Corbacho-Monn√© M, Malchair P, Ouchi D, Ruiz-Comellas A, Ram√≠rez-Morros A, Rodr√≠guez Codina J, Amado Simon R, Videla S, Costes G, Capdevila-J√°uregui M, Torrano-Soler P, San Jos√© A, Bonet Papell G, Puig J, Otero A, Ruibal Suarez JC, Zarauza Pellejero A, Llopis Roca F, Rodriguez Cortez O, Garcia Garcia V, Vidal-Alaball J, Millan A, Contreras E, Grifols JR, Ancochea √Ä, Galvan-Femenia I, Piccolo Ferreira F, Bonet M, Cantoni J, Prat N, Ara J, Forcada Arcarons A, Farr√© M, Pradenas E, Blanco J, √Ängel Rodriguez-Arias M, Fern√°ndez Rivas G, Marks M, Bassat Q, Blanco I, Baro B, Clotet B, Mitj√† O; CONV-ERT Group. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med. 2022 Mar;10(3):278-288. doi: 10.1016/S2213-2600(21)00545-2. Epub 2022 Feb 9.']",,2021-09-08,https://clinicaltrials.gov/show/NCT04621123,2021-05-31,0,1
3761,NCT04621149,Recruiting,2021-03-31,2021-03-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2020-12-29,https://clinicaltrials.gov/show/NCT04621149,2021-03-31,0,1
3762,NCT04621214,Completed,2020-04-28,2020-04-28,No Results Posted,,,2020-11-09,https://clinicaltrials.gov/show/NCT04621214,2020-04-28,0,0
3763,NCT04621461,Completed,2021-02-08,2021-02-08,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04621461,2021-02-08,0,0
3764,NCT04621903,Completed,2020-10-27,2020-11-03,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04621903,2020-10-27,0,0
3765,NCT04622332,Completed,2021-11-27,2021-11-27,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04622332,2021-11-27,0,0
3766,NCT04622748,Recruiting,2020-12-10,2020-12-10,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04622748,2020-12-10,0,0
3767,NCT04622826,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04622826,2020-12-31,0,0
3768,NCT04622865,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04622865,2022-06-01,0,0
3769,NCT04622891,Completed,2020-07-30,2020-07-30,No Results Posted,"['Rashad A, Nafady A, Hassan MH, Mansour H, Taya U, Bazeed SES, Aref ZF, Sayed MAA, Nafady-Hego H, Abdelmaksoud AA. Therapeutic efficacy of macrolides in management of patients with mild COVID-19. Sci Rep. 2021 Aug 11;11(1):16361. doi: 10.1038/s41598-021-95900-z.']",,2020-11-10,https://clinicaltrials.gov/show/NCT04622891,2020-07-30,0,1
3770,NCT04623021,Completed,2020-12-12,2020-12-12,No Results Posted,"['Zhuravel SV, Khmelnitskiy OK, Burlaka OO, Gritsan AI, Goloshchekin BM, Kim S, Hong KY. Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial. EClinicalMedicine. 2021 Nov;41:101169. doi: 10.1016/j.eclinm.2021.101169. Epub 2021 Oct 27.']",,2021-02-02,https://clinicaltrials.gov/show/NCT04623021,2020-12-12,0,1
3771,NCT04623047,Not yet recruiting,2023-12-31,2024-06-30,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04623047,2023-12-31,0,0
3772,NCT04623138,Completed,2021-06-01,2021-06-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04623138,2021-06-01,0,0
3773,NCT04623177,Completed,2020-09-30,2020-11-30,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04623177,2020-09-30,0,0
3774,NCT04623255,Recruiting,2021-10-15,2021-11-01,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04623255,2021-10-15,0,0
3775,NCT04623346,"Active, not recruiting",2020-11-01,2020-12-01,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04623346,2020-11-01,0,0
3776,NCT04623385,Not yet recruiting,2020-12-01,2021-12-01,No Results Posted,,,2020-11-10,https://clinicaltrials.gov/show/NCT04623385,2020-12-01,0,0
3777,NCT04623619,Not yet recruiting,2021-04-29,2021-07-31,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04623619,2021-04-29,0,0
3778,NCT04623671,Completed,2022-02-04,2022-02-04,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04623671,2022-02-04,0,0
3779,NCT04623697,Recruiting,2023-10-30,2023-11-30,No Results Posted,,"['Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 2008 Nov;57(11):2863-71. doi: 10.2337/db07-1023.', 'Coleman TJ, Gamble DR, Taylor KW. Diabetes in mice after Coxsackie B 4 virus infection. Br Med J. 1973 Jul 7;3(5870):25-7.', 'Christoffersson G, Flodstr√∂m-Tullberg M. Mouse Models of Virus-Induced Type 1 Diabetes. Methods Mol Biol. 2020;2128:93-105. doi: 10.1007/978-1-0716-0385-7_7.', 'Stone VM, Hankaniemi MM, Svedin E, Sioofy-Khojine A, Oikarinen S, Hy√∂ty H, Laitinen OH, Hyt√∂nen VP, Flodstr√∂m-Tullberg M. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia. 2018 Feb;61(2):476-481. doi: 10.1007/s00125-017-4492-z. Epub 2017 Nov 18.', 'Hy√∂ty H, Leon F, Knip M. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev Vaccines. 2018 Dec;17(12):1071-1083. doi: 10.1080/14760584.2018.1548281. Epub 2018 Nov 29. Review.', 'Moltchanova EV, Schreier N, Lammi N, Karvonen M. Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide. Diabet Med. 2009 Jul;26(7):673-8. doi: 10.1111/j.1464-5491.2009.02743.x.', 'Karaoglan M, Eksi F. The Coincidence of Newly Diagnosed Type 1 Diabetes Mellitus with IgM Antibody Positivity to Enteroviruses and Respiratory Tract Viruses. J Diabetes Res. 2018 Aug 16;2018:8475341. doi: 10.1155/2018/8475341. eCollection 2018.', 'Patterson CC, Gy√ºr√ºs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonait√© B, Rothe U, Kr≈æi≈°nik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M, de Beaufort CE, Green A, Solt√©sz G, Dahlquist GG. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature. Pediatr Diabetes. 2015 Dec;16(8):573-80. doi: 10.1111/pedi.12227. Epub 2014 Oct 15.', 'Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009 Apr 29;302(2):193-202. doi: 10.1016/j.mce.2008.09.020. Epub 2008 Oct 1. Review.', 'Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010 Sep;47(3):193-9. doi: 10.1007/s00592-009-0109-4. Epub 2009 Mar 31.']",2022-03-17,https://clinicaltrials.gov/show/NCT04623697,2023-10-30,0,1
3780,NCT04624048,Not yet recruiting,2021-01-04,2021-04-04,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04624048,2021-01-04,0,0
3781,NCT04624503,Recruiting,2021-06-01,2021-10-01,No Results Posted,,"['Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, De Marco A, Briani M, Bocciolone M, Bragato R, Corrada E, Gasparini GL, Marconi M, Monti L, Pagnotta PA, Panico C, Pini D, Regazzoli D, My I, Kallikourdis M, Ciccarelli M, Badalamenti S, Aghemo A, Reimers B, Condorelli G; Humanitas COVID-19 Task Force. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart. 2020 Oct;106(19):1512-1518. doi: 10.1136/heartjnl-2020-317322. Epub 2020 Aug 14.']",2020-11-10,https://clinicaltrials.gov/show/NCT04624503,2021-06-01,0,1
3782,NCT04624997,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04624997,2022-12-01,0,0
3783,NCT04625036,Completed,2021-04-30,2021-05-10,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04625036,2021-04-30,0,0
3784,NCT04625075,"Active, not recruiting",2021-06-10,2022-06-10,No Results Posted,"['Singh T, Kite TA, Joshi SS, Spath NB, Kershaw L, Baker A, Jordan H, Gulsin GS, Williams MC, van Beek EJR, Arnold JR, Semple SIK, Moss AJ, Newby DE, Dweck M, McCann GP. MRI and CT coronary angiography in survivors of COVID-19. Heart. 2022 Jan;108(1):46-53. doi: 10.1136/heartjnl-2021-319926. Epub 2021 Oct 6.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04625075,2021-06-10,0,1
3785,NCT04625114,Recruiting,2022-10-01,2023-01-01,No Results Posted,,,2021-08-25,https://clinicaltrials.gov/show/NCT04625114,2022-10-01,0,0
3786,NCT04625218,Suspended,2022-05-01,2022-05-01,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04625218,2022-05-01,0,0
3787,NCT04625257,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04625257,2021-12-01,0,0
3788,NCT04625296,Completed,2021-01-12,2021-01-12,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04625296,2021-01-12,0,0
3789,NCT04625738,Completed,2021-05-14,2021-09-01,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04625738,2021-05-14,0,0
3790,NCT04625985,Completed,2021-03-08,2021-03-18,No Results Posted,,"['Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002 Jul;51(7):2074-81.', 'Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005 Dec 9;310(5754):1642-6. Epub 2005 Nov 24.', 'Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol. 2002 Apr 1;63(7):1259-72.', 'Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes Metab. 2008 Sep;10(9):733-8. Epub 2007 Oct 15.', 'Standeven KF, Ari√´ns RA, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002 Jan;51(1):189-97.', 'Gonz√°lez-Ortiz M, Mart√≠nez-Abundis E, Robles-Cervantes JA, Ramos-Zavala MG, Barrera-Dur√°n C, Gonz√°lez-Canudas J. Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients (T2DM). Diabetes Technol Ther. 2012 Dec;14(12):1140-4. Diabetes Technol Ther. 2012 Dec;14(12):1140-4. doi: 10.1089/dia.2012.0097', 'Jorge Gonz√°lez Canudas, COMET GROUP Diabetes Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients. Diabetes 2019 Jun; 68(Supplement 1)', 'Garza-Oca√±as L, Tamez-de la O E, Iglesias-Chiesa J, Gonzalez Canudas J, Rivas-Ruiz R: Pharmacokinetics and gastrointestinal tolerability of DMMET 01 (glycinate of metformin): results of a prospective randomized trial in healthy volunteers [abstract]. Diabetes 2009;58(Suppl 1):A533']",2021-04-08,https://clinicaltrials.gov/show/NCT04625985,2021-03-08,0,1
3791,NCT04626050,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04626050,2022-07-01,0,0
3792,NCT04626076,Recruiting,2021-06-30,2021-10-31,No Results Posted,,,2020-11-12,https://clinicaltrials.gov/show/NCT04626076,2021-06-30,0,0
3793,NCT04626089,Withdrawn,2021-02-01,2021-02-01,No Results Posted,,"['Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem. 1988 Sep 15;263(26):13374-80.', ""Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003 Jun 19;348(25):2543-56. Review."", 'Quinones S, Bernal D, Garc√≠a-Sogo M, Elena SF, Saus J. Exon/intron structure of the human alpha 3(IV) gene encompassing the Goodpasture antigen (alpha 3(IV)NC1). Identification of a potentially antigenic region at the triple helix/NC1 domain junction. J Biol Chem. 1992 Oct 5;267(28):19780-4. Erratum in: J Biol Chem. 1994 Jun 24;269(25):17358.', 'Revert F, Penad√©s JR, Plana M, Bernal D, Johansson C, Itarte E, Cervera J, Wieslander J, Quinones S, Saus J. Phosphorylation of the Goodpasture antigen by type A protein kinases. J Biol Chem. 1995 Jun 2;270(22):13254-61.', 'Borza CM, Borza DB, Pedchenko V, Saleem MA, Mathieson PW, Sado Y, Hudson HM, Pozzi A, Saus J, Abrahamson DR, Zent R, Hudson BG. Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol. 2008 Apr;19(4):677-84. doi: 10.1681/ASN.2007070793. Epub 2008 Jan 30.', 'Raya A, Revert-Ros F, Martinez-Martinez P, Navarro S, Rosello E, Vieites B, Granero F, Forteza J, Saus J. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J Biol Chem. 2000 Dec 22;275(51):40392-9.', 'Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003 Dec 18;426(6968):803-9.', 'Revert F, Merino R, Monteagudo C, Macias J, Peydr√≥ A, Alc√°cer J, Muniesa P, Marquina R, Blanco M, Iglesias M, Revert-Ros F, Merino J, Saus J. Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane. Am J Pathol. 2007 Nov;171(5):1419-30. Epub 2007 Oct 4.', 'Revert-Ros F, L√≥pez-Pascual E, Granero-Molt√≥ F, Mac√≠as J, Breyer R, Zent R, Hudson BG, Saadeddin A, Revert F, Blasco R, Navarro C, Burks D, Saus J. Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130). J Biol Chem. 2011 Oct 7;286(40):35030-43. doi: 10.1074/jbc.M111.249458. Epub 2011 Aug 9.', 'Darris C, Revert F, Revert-Ros F, Gozalbo-Rovira R, Feigley A, Fidler A, Lopez-Pascual E, Saus J, Hudson BG. Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein. J Biol Chem. 2019 Jan 18;294(3):759-769. doi: 10.1074/jbc.RA118.006225. Epub 2018 Oct 30.', 'Revert F, Revert-Ros F, Blasco R, Artigot A, L√≥pez-Pascual E, Gozalbo-Rovira R, Ventura I, Guti√©rrez-Carbonell E, Roda N, Ru√≠z-Sanchis D, Forteza J, Alc√°cer J, P√©rez-Sastre A, D√≠az A, P√©rez-Pay√° E, Sanz-Cervera JF, Saus J. Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden. Oncotarget. 2018 Jan 19;9(13):11020-11045. doi: 10.18632/oncotarget.24280. eCollection 2018 Feb 16.', 'Swanton C, Marani M, Pardo O, Warne PH, Kelly G, Sahai E, Elustondo F, Chang J, Temple J, Ahmed AA, Brenton JD, Downward J, Nicke B. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell. 2007 Jun;11(6):498-512.', 'Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006 Sep;7(9):880-5. Review.', 'Fung TS, Liu DX. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol. 2019 Sep 8;73:529-557. doi: 10.1146/annurev-micro-020518-115759. Epub 2019 Jun 21. Review.', 'Catanzaro N, Meng XJ. Induction of the unfolded protein response (UPR) suppresses porcine reproductive and respiratory syndrome virus (PRRSV) replication. Virus Res. 2020 Jan 15;276:197820. doi: 10.1016/j.virusres.2019.197820. Epub 2019 Nov 16.', 'Schimmack G, Defronzo RA, Musi N. AMP-activated protein kinase: Role in metabolism and therapeutic implications. Diabetes Obes Metab. 2006 Nov;8(6):591-602. Review.', 'Sriwijitkamol A, Musi N. Advances in the development of AMPK-activating compounds. Expert Opin Drug Discov. 2008 Oct;3(10):1167-76. doi: 10.1517/17460441.3.10.1167.', 'Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002 Jul;51(7):2074-81.', 'Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005 Dec 9;310(5754):1642-6. Epub 2005 Nov 24.', 'Detaille D, Guigas B, Leverve X, Wiernsperger N, Devos P. Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function. Biochem Pharmacol. 2002 Apr 1;63(7):1259-72.', 'Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Aug 31;333(9):550-4.', 'Otto M, Breinholt J, Westergaard N. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94.', 'F√©ry F, Plat L, Balasse EO. Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients. Metabolism. 1997 Feb;46(2):227-33.', 'Hother-Nielsen O, Schmitz O, Andersen PH, Beck-Nielsen H, Pedersen O. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh). 1989 Mar;120(3):257-65.', 'Tamura Y, Watada H, Sato F, Kumashiro N, Sakurai Y, Hirose T, Tanaka Y, Kawamori R. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects. Diabetes Obes Metab. 2008 Sep;10(9):733-8. Epub 2007 Oct 15.', 'Fischer M, Timper K, Radimerski T, Dembinski K, Frey DM, Zulewski H, Keller U, M√ºller B, Christ-Crain M, Grisouard J. Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes Obes Metab. 2010 Apr;12(4):356-9. doi: 10.1111/j.1463-1326.2009.01169.x.', 'Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod. 2006 Jan;21(1):109-20. Epub 2005 Sep 9.', ""Cuthbertson J, Patterson S, O'Harte FP, Bell PM. Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes. Diabet Med. 2009 Jun;26(6):649-54. doi: 10.1111/j.1464-5491.2009.02748.x."", 'Standeven KF, Ari√´ns RA, Whitaker P, Ashcroft AE, Weisel JW, Grant PJ. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation. Diabetes. 2002 Jan;51(1):189-97.', 'Nichols GA, Gomez-Caminero A. Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes Metab. 2007 Jan;9(1):96-102.', 'Landman GW, Kleefstra N, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010 Feb;33(2):322-6. doi: 10.2337/dc09-1380. Epub 2009 Nov 16.', 'Gonz√°lez-Ortiz M, Mart√≠nez-Abundis E, Robles-Cervantes JA, Ramos-Zavala MG, Barrera-Dur√°n C, Gonz√°lez-Canudas J. Diabetes Technol Ther. 2012 Dec;14(12):1140-4. doi: 10.1089/dia.2012.0097. Epub 2012 Sep 13. Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients (T2DM)', 'JORGE GONZ√ÅLEZ-CANUDAS, COMET GROUP Diabetes Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients. Diabetes 2019 Jun; 68(Supplement 1):', 'Garza-Oca√±as L, Tamez-de la O E, Iglesias-Chiesa J, Gonzalez Canudas J, Rivas-Ruiz R: Pharmacokinetics and gastrointestinal tolerability of DMMET 01 (glycinate of metformin): results of a prospective randomized trial in healthy volunteers [abstract]. Diabetes 2009;58(Suppl 1):A533.', 'Granero F, Revert F, Revert-Ros F, Lainez S, Mart√≠nez-Mart√≠nez P, Saus J. A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein. FEBS J. 2005 Oct;272(20):5291-305.', 'Foretz M, H√©brard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, Sakamoto K, Andreelli F, Viollet B. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010 Jul;120(7):2355-69. doi: 10.1172/JCI40671. Epub 2010 Jun 23.', 'Rada P, Mosquera A, Muntan√© J, Ferrandiz F, Rodriguez-Ma√±as L, de Pablo F, Gonz√°lez-Canudas J, Valverde √ÅM. Differential effects of metformin glycinate and hydrochloride in glucose production, AMPK phosphorylation and insulin sensitivity in hepatocytes from non-diabetic and diabetic mice. Food Chem Toxicol. 2019 Jan;123:470-480. doi: 10.1016/j.fct.2018.11.019. Epub 2018 Nov 9.', 'Food Chem Toxicol. 2019 Jan;123:470-480. doi: 10.1016/j.fct.2018.11.019. Epub 2018 Nov 9.', 'Choi YH, Lee MG. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. Br J Pharmacol. 2006 Oct;149(4):424-30. Epub 2006 Aug 29.', 'Dianben¬Æ 1000 mg polvo para soluci√≥n oral. Ficha t√©cnica del producto. N¬∫ de autorizaci√≥n de comercializaci√≥n: 70545. Merck Sant√© S.A.S. 37 rue Saint Romain. 69008 Lyon. Francia. Fecha de revision 2010. Consultada en la web de la Agencia Espa√±ola del Medicamento y de Productos Sanitarios (www.aemps.gob.es) el 27 de Marzo del 2013', ""Giugliano D, De Rosa N, Di Maro G, Marfella R, Acampora R, Buoninconti R, D'Onofrio F. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 1993 Oct;16(10):1387-90."", 'Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 1991 Feb;229(2):181-7.', 'Quaile MP, Melich DH, Jordan HL, Nold JB, Chism JP, Polli JW, Smith GA, Rhodes MC. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7. doi: 10.1016/j.taap.2009.11.026. Epub 2010 Jan 13.', 'Santur√© M, Pitre M, Gaudreault N, Marette A, Nadeau A, Bachelard H. Effect of metformin on the vascular and glucose metabolic actions of insulin in hypertensive rats. Am J Physiol Gastrointest Liver Physiol. 2000 May;278(5):G682-92.', 'Verma S, Bhanot S, McNeill JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.']",2021-04-08,https://clinicaltrials.gov/show/NCT04626089,2021-02-01,0,1
3794,NCT04627194,"Active, not recruiting",2020-04-30,2020-12-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04627194,2020-04-30,0,0
3795,NCT04627233,Not yet recruiting,2021-03-01,2021-04-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04627233,2021-03-01,0,0
3796,NCT04627467,Completed,2020-07-09,2021-09-30,No Results Posted,,"['WHO. Coronavirus disease 2019 (COVID-19). Situation Report - 43 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus2019/technicalguidance/laboratoryguidance', 'Wang M, Su S, Lv J, Zhou G, Wang Q, Guo C. Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit. The Egyptian Rheumatologist. 2018;40(1):63-6.', 'Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.', 'Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670. doi: 10.1093/jac/dkaa114.', 'Rodriguez-Morales AJ, Cardona-Ospina JA, Guti√©rrez-Ocampo E, Villamizar-Pe√±a R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ram√≠rez-Vallejo E, Su√°rez JA, Zambrano LI, Villamil-G√≥mez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020 Mar - Apr;34:101623. doi: 10.1016/j.tmaid.2020.101623. Epub 2020 Mar 13.', 'Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, Chen B, Zhang Z, Guan W, Ling Z, Jiang R, Hu T, Ding Y, Lin L, Gan Q, Luo L, Tang X, Liu J. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Gostic K, Gomez AC, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife. 2020 Feb 24;9. pii: e55570. doi: 10.7554/eLife.55570.', 'Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015 Sep 3;13:210. doi: 10.1186/s12916-015-0450-0.', 'Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.', 'Su A. Doctors and nurses fighting coronavirus in China die of both infection and fatigue. Los Angeles Times. 2020.', 'Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, Lin J, Chen P, Liu JH, Li CH. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 17;43(0):E016. doi: 10.3760/cma.j.issn.1001-0939.2020.0016. [Epub ahead of print] Chinese.', 'Mitj√† O, Clotet B. Use of antiviral drugs to reduce COVID-19 transmission. Lancet Glob Health. 2020 May;8(5):e639-e640. doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.', 'Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, Jackson HC, Huson L, Ward P, Oxford JS; Oseltamivir Post Exposure Prophylaxis Investigator Group. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA. 2001 Feb 14;285(6):748-54.', 'Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) - Full Text View. ClinicalTrials.gov.', 'Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting - Full Text View. ClinicalTrials.gov', 'Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention - Full Text View. ClinicalTrials.gov', 'Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010 Jan;69(1):20-8. doi: 10.1136/ard.2008.101766. Review.', 'Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011 Apr 15;186(8):4794-804. doi: 10.4049/jimmunol.1000702. Epub 2011 Mar 11.', ""Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003 Nov;3(11):722-7. Review."", 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.', 'IDOATE A, IDOIPE √Å. 2.4. Investigaci√≥n y ensayos cl√≠nicos.', 'Schwartz E. Prophylaxis of malaria. Mediterr J Hematol Infect Dis. 2012;4(1):e2012045. doi: 10.4084/MJHID.2012.45. Epub 2012 Jun 29.', 'Gozal D, Hengy C, Fadat G. Prolonged malaria prophylaxis with chloroquine and proguanil (chloroguanide) in a nonimmune resident population of an endemic area with a high prevalence of chloroquine resistance. Antimicrob Agents Chemother. 1991 Feb;35(2):373-6.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.', 'Chen W, Huang Y. To Protect Health Care Workers Better, To Save More Lives With COVID-19. Anesth Analg. 2020 Jul;131(1):97-101. doi: 10.1213/ANE.0000000000004834. Review.']",2021-10-07,https://clinicaltrials.gov/show/NCT04627467,2020-07-09,0,1
3797,NCT04627519,"Active, not recruiting",2021-05-19,2021-09-01,No Results Posted,,"['Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020 Apr;20(4):400-402. doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.', 'Tay MZ, Poh CM, R√©nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28. Review.', 'Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review. Evid Based Complement Alternat Med. 2016;2016:3012462. doi: 10.1155/2016/3012462. Epub 2016 Dec 20. Review.', 'Yang L, Peng K, Zhao S, Zhao F, Chen L, Qiu F. 2-methyl-L-erythritol glycosides from Gardenia jasminoides. Fitoterapia. 2013 Sep;89:126-30. doi: 10.1016/j.fitote.2013.05.018. Epub 2013 May 31.', 'Zhang Y, Yao J, Qi X, Liu X, Lu X, Feng G. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo. Antivir Ther. 2017;22(7):599-611. doi: 10.3851/IMP3152. Epub 2017 Mar 8.', 'Wu S, Patel KB, Booth LJ, Metcalf JP, Lin HK, Wu W. Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells. BMC Complement Altern Med. 2010 Nov 15;10:69. doi: 10.1186/1472-6882-10-69.', 'Su S, Hua Y, Wang Y, Gu W, Zhou W, Duan JA, Jiang H, Chen T, Tang Y. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J Ethnopharmacol. 2012 Jan 31;139(2):649-56. doi: 10.1016/j.jep.2011.12.013. Epub 2011 Dec 13.', 'Tipton DA, Lyle B, Babich H, Dabbous MKh. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2003 Jun;17(3):301-10.', 'Nomicos EY. Myrrh: medical marvel or myth of the Magi? Holist Nurs Pract. 2007 Nov-Dec;21(6):308-23. Review.', 'Sharopov F, Valiev A, Satyal P, Gulmurodov I, Yusufi S, Setzer WN, Wink M. Cytotoxicity of the Essential Oil of Fennel (Foeniculum vulgare) from Tajikistan. Foods. 2017 Aug 28;6(9). pii: E73. doi: 10.3390/foods6090073.', 'Lee HS, Kang P, Kim KY, Seol GH. Foeniculum vulgare Mill. Protects against Lipopolysaccharide-induced Acute Lung Injury in Mice through ERK-dependent NF-Œ∫B Activation. Korean J Physiol Pharmacol. 2015 Mar;19(2):183-9. doi: 10.4196/kjpp.2015.19.2.183. Epub 2015 Feb 25.', 'Shalaby NM, Maghraby AS, el-Hagrassy AM. Effect of Daucus carota var. boissieri extracts on immune response of Schistosoma mansoni infected mice. Folia Microbiol (Praha). 1999;44(4):441-8. Erratum in: Folia Microbiol (Praha) 2000;45(2):191.', 'Alves-Silva JM, Zuzarte M, Gon√ßalves MJ, Cavaleiro C, Cruz MT, Cardoso SM, Salgueiro L. New Claims for Wild Carrot (Daucus carota subsp. carota) Essential Oil. Evid Based Complement Alternat Med. 2016;2016:9045196. doi: 10.1155/2016/9045196. Epub 2016 Feb 14.', 'Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, Piao G. How Can Synergism of Traditional Medicines Benefit from Network Pharmacology? Molecules. 2017 Jul 7;22(7). pii: E1135. doi: 10.3390/molecules22071135. Review.']",2021-06-10,https://clinicaltrials.gov/show/NCT04627519,2021-05-19,0,1
3798,NCT04627584,Recruiting,2021-05-01,2021-09-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Meng X, Wang P, Xiong Y, Wu Y, Lin X, Lu S, Li R, Zhao B, Liu J, Zeng S, Zeng L, Wu Y, Lu Y, Zhang J, Liu D, Wang S, Lu H. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody. Emerg Microbes Infect. 2021 Dec;10(1):1638-1648. doi: 10.1080/22221751.2021.1960900.']",,2021-02-26,https://clinicaltrials.gov/show/NCT04627584,2021-05-01,0,1
3799,NCT04627623,Recruiting,2021-03-22,2021-04-22,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04627623,2021-03-22,0,0
3800,NCT04627675,"Active, not recruiting",2022-07-01,2022-12-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04627675,2022-07-01,0,0
3801,NCT04628000,Recruiting,2021-10-14,2022-04-14,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04628000,2021-10-14,0,0
3802,NCT04628039,Recruiting,2023-12-31,2024-10-31,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04628039,2023-12-31,0,0
3803,NCT04628104,Not yet recruiting,2022-10-01,2023-10-01,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04628104,2022-10-01,0,0
3804,NCT04628143,Completed,2021-04-05,2021-04-05,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04628143,2021-04-05,0,0
3805,NCT04628195,Completed,2020-06-30,2020-08-01,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04628195,2020-06-30,0,0
3806,NCT04628637,Completed,2020-10-01,2020-10-10,No Results Posted,,,2020-11-13,https://clinicaltrials.gov/show/NCT04628637,2020-10-01,0,0
3807,NCT04629001,"Active, not recruiting",2021-09-01,2021-12-01,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04629001,2021-09-01,0,0
3808,NCT04629105,Recruiting,2023-08-01,2025-07-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04629105,2023-08-01,0,0
3809,NCT04629157,Completed,2021-02-01,2021-02-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04629157,2021-02-01,0,0
3810,NCT04629183,Completed,2021-01-11,2021-02-11,No Results Posted,,"['Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Gupta R, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Noursadeghi M, Olliaro PL, Pritchard MG, Russell CD, Shaw CA, Sheikh A, Solomon T, Sudlow C, Swann OV, Turtle LC, Openshaw PJ, Baillie JK, Semple MG, Docherty AB, Harrison EM; ISARIC4C investigators. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339. Erratum in: BMJ. 2020 Nov 13;371:m4334.', 'Liu RB, Tayal VS, Panebianco NL, Tung-Chen Y, Nagdev A, Shah S, Pivetta E, Henwood PC, Nelson MJ, Moore CL. Ultrasound on the Frontlines of COVID-19: Report From an International Webinar. Acad Emerg Med. 2020 Jun;27(6):523-526. doi: 10.1111/acem.14004. Epub 2020 Jun 9.']",2021-07-21,https://clinicaltrials.gov/show/NCT04629183,2021-01-11,0,1
3811,NCT04629222,Completed,2020-07-20,2020-07-23,No Results Posted,,,2020-11-16,https://clinicaltrials.gov/show/NCT04629222,2020-07-20,0,0
3812,NCT04629638,Completed,2020-11-15,2020-11-20,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04629638,2020-11-15,0,0
3813,NCT04629703,Recruiting,2022-04-01,2022-05-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-30,https://clinicaltrials.gov/show/NCT04629703,2022-04-01,0,1
3814,NCT04629755,Completed,2020-08-03,2020-08-03,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04629755,2020-08-03,0,0
3815,NCT04629989,Completed,2021-03-05,2021-03-05,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04629989,2021-03-05,0,0
3816,NCT04630015,Recruiting,2023-08-01,2023-12-31,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04630015,2023-08-01,0,0
3817,NCT04630054,Completed,2021-06-29,2021-06-29,No Results Posted,"['Abaluck J, Kwong LH, Styczynski A, Haque A, Kabir MA, Bates-Jefferys E, Crawford E, Benjamin-Chung J, Raihan S, Rahman S, Benhachmi S, Bintee NZ, Winch PJ, Hossain M, Reza HM, Jaber AA, Momen SG, Rahman A, Banti FL, Huq TS, Luby SP, Mobarak AM. Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh. Science. 2022 Jan 14;375(6577):eabi9069. doi: 10.1126/science.abi9069. Epub 2022 Jan 14.']",,2022-01-28,https://clinicaltrials.gov/show/NCT04630054,2021-06-29,0,1
3818,NCT04631172,Completed,2020-09-30,2020-10-15,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04631172,2020-09-30,0,0
3819,NCT04631367,Completed,2021-08-20,2021-10-31,No Results Posted,"['Logie CH, Okumu M, Berry I, Hakiza R, Kibuuka Musoke D, Kyambadde P, Mwima S, Lester RT, Perez-Brumer AG, Baral S, Mbuagbaw L. Kukaa Salama (Staying Safe): study protocol for a pre/post-trial of an interactive mHealth intervention for increasing COVID-19 prevention practices with urban refugee youth in Kampala, Uganda. BMJ Open. 2021 Nov 22;11(11):e055530. doi: 10.1136/bmjopen-2021-055530.']",,2021-12-28,https://clinicaltrials.gov/show/NCT04631367,2021-08-20,0,1
3820,NCT04631380,Completed,2021-06-01,2022-01-01,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04631380,2021-06-01,0,0
3821,NCT04631497,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04631497,2021-12-31,0,0
3822,NCT04631536,"Active, not recruiting",2022-03-29,2022-07-01,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04631536,2022-03-29,0,0
3823,NCT04631666,Completed,2021-08-11,2021-08-11,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-24,https://clinicaltrials.gov/show/NCT04631666,2021-08-11,0,1
3824,NCT04631705,Completed,2021-09-23,2021-09-23,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-26,https://clinicaltrials.gov/show/NCT04631705,2021-09-23,0,1
3825,NCT04631861,Completed,2020-07-31,2020-07-31,No Results Posted,,"['Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.', 'Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.', 'Kim DW, Byeon KH, Kim J, Cho KD, Lee N. The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data. J Korean Med Sci. 2020 Jul 6;35(26):e243. doi: 10.3346/jkms.2020.35.e243.', 'Hamer M, Kivim√§ki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020 Jul;87:184-187. doi: 10.1016/j.bbi.2020.05.059. Epub 2020 May 23.']",2020-11-17,https://clinicaltrials.gov/show/NCT04631861,2020-07-31,0,1
3826,NCT04632043,Recruiting,2021-05-01,2021-06-01,No Results Posted,,"['Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.', 'Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, Brodie D. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020 Aug;8(8):816-821. doi: 10.1016/S2213-2600(20)30304-0. Epub 2020 Jul 6. Review.', 'Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR Jr, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.', 'Bauer PR, Gajic O, Nanchal R, Kashyap R, Martin-Loeches I, Sakr Y, Jakob SM, Fran√ßois B, Wittebole X, Wunderink RG, Vincent JL; ICON Investigators (Supplemental Appendix 1). Association between timing of intubation and outcome in critically ill patients: A secondary analysis of the ICON audit. J Crit Care. 2017 Dec;42:1-5. doi: 10.1016/j.jcrc.2017.06.010. Epub 2017 Jun 16.', 'Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, Seo HS, Suh HJ, Seo GJ, Kim EY, Hong SB. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015 Apr;41(4):623-32. doi: 10.1007/s00134-015-3693-5. Epub 2015 Feb 18.']",2021-03-03,https://clinicaltrials.gov/show/NCT04632043,2021-05-01,0,1
3827,NCT04632082,Enrolling by invitation,2021-07-13,2021-07-20,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04632082,2021-07-13,0,0
3828,NCT04632173,Recruiting,2022-06-30,2022-12-30,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04632173,2022-06-30,0,0
3829,NCT04632355,Not yet recruiting,2021-07-31,2021-07-31,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04632355,2021-07-31,0,0
3830,NCT04632368,Completed,2021-08-10,2021-08-16,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04632368,2021-08-10,0,0
3831,NCT04632381,Recruiting,2021-12-29,2022-03-31,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04632381,2021-12-29,0,0
3832,NCT04632602,Completed,2020-11-29,2020-12-31,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04632602,2020-11-29,0,0
3833,NCT04632615,"Active, not recruiting",2021-03-31,2021-03-31,No Results Posted,,"['Vitale KC, Owens R, Hopkins SR, Malhotra A. Sleep Hygiene for Optimizing Recovery in Athletes: Review and Recommendations. Int J Sports Med. 2019 Aug;40(8):535-543. doi: 10.1055/a-0905-3103. Epub 2019 Jul 9. Review.', 'Vitale JA, Weydahl A. Chronotype, Physical Activity, and Sport Performance: A Systematic Review. Sports Med. 2017 Sep;47(9):1859-1868. doi: 10.1007/s40279-017-0741-z. Review.', 'Vitale JA, Roveda E, Montaruli A, Galasso L, Weydahl A, Caumo A, Carandente F. Chronotype influences activity circadian rhythm and sleep: differences in sleep quality between weekdays and weekend. Chronobiol Int. 2015 Apr;32(3):405-15. doi: 10.3109/07420528.2014.986273. Epub 2014 Dec 3.', 'Vitale JA, La Torre A, Banfi G, Bonato M. Acute sleep hygiene strategy improves objective sleep latency following a late-evening soccer-specific training session: A randomized controlled trial. J Sports Sci. 2019 Dec;37(23):2711-2719. doi: 10.1080/02640414.2019.1661938. Epub 2019 Sep 6.', ""Vitale JA, Banfi G, Sias M, La Torre A. Athletes' rest-activity circadian rhythm differs in accordance with the sport discipline. Chronobiol Int. 2019 Apr;36(4):578-586. doi: 10.1080/07420528.2019.1569673. Epub 2019 Feb 14."", 'Pillay L, Janse van Rensburg DCC, Jansen van Rensburg A, Ramagole DA, Holtzhausen L, Dijkstra HP, Cronje T. Nowhere to hide: The significant impact of coronavirus disease 2019 (COVID-19) measures on elite and semi-elite South African athletes. J Sci Med Sport. 2020 Jul;23(7):670-679. doi: 10.1016/j.jsams.2020.05.016. Epub 2020 May 19.', 'Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attin√† A, Cinelli G, Leggeri C, Caparello G, Barrea L, Scerbo F, Esposito E, De Lorenzo A. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med. 2020 Jun 8;18(1):229. doi: 10.1186/s12967-020-02399-5.', 'H√•kansson A, J√∂nsson C, Kentt√§ G. Psychological Distress and Problem Gambling in Elite Athletes during COVID-19 Restrictions-A Web Survey in Top Leagues of Three Sports during the Pandemic. Int J Environ Res Public Health. 2020 Sep 14;17(18). pii: E6693. doi: 10.3390/ijerph17186693.']",2021-03-05,https://clinicaltrials.gov/show/NCT04632615,2021-03-31,0,1
3834,NCT04632706,Completed,2021-03-09,2021-03-09,Study Results,,,2021-12-27,https://clinicaltrials.gov/show/NCT04632706,2021-03-09,1,0
3835,NCT04632719,Recruiting,2020-12-29,2023-12-29,No Results Posted,,,2020-11-17,https://clinicaltrials.gov/show/NCT04632719,2020-12-29,0,0
3836,NCT04632732,Completed,2021-10-01,2021-10-01,No Results Posted,,,2021-10-13,https://clinicaltrials.gov/show/NCT04632732,2021-10-01,0,0
3837,NCT04633772,Completed,2021-11-01,2021-11-01,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04633772,2021-11-01,0,0
3838,NCT04633915,Completed,2021-07-18,2021-07-18,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04633915,2021-07-18,0,0
3839,NCT04633941,Completed,2020-07-30,2020-07-30,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04633941,2020-07-30,0,0
3840,NCT04633980,Not yet recruiting,2021-08-30,2021-09-30,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04633980,2021-08-30,0,0
3841,NCT04634214,Not yet recruiting,2021-02-16,2021-05-16,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04634214,2021-02-16,0,0
3842,NCT04634370,Not yet recruiting,2021-03-30,2021-03-30,No Results Posted,,,2020-11-18,https://clinicaltrials.gov/show/NCT04634370,2021-03-30,0,0
3843,NCT04634422,Recruiting,2021-06-30,2022-06-30,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04634422,2021-06-30,0,0
3844,NCT04634799,Suspended,2023-04-23,2023-05-30,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04634799,2023-04-23,0,0
3845,NCT04635241,Recruiting,2022-11-01,2022-12-01,No Results Posted,"['van Haren FMP, Richardson A, Yoon HJ, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, van Loon LM, Camprubi-Rimblas M, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. Br J Clin Pharmacol. 2021 Aug;87(8):3075-3091. doi: 10.1111/bcp.14714. Epub 2021 Jan 19.']",,2022-02-16,https://clinicaltrials.gov/show/NCT04635241,2022-11-01,0,1
3846,NCT04635592,Not yet recruiting,2020-12-31,2021-01-31,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04635592,2020-12-31,0,0
3847,NCT04635605,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04635605,2021-12-31,0,0
3848,NCT04635618,Enrolling by invitation,2021-07-13,2021-07-20,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04635618,2021-07-13,0,0
3849,NCT04635787,"Active, not recruiting",2021-03-31,2022-10-30,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04635787,2021-03-31,0,0
3850,NCT04635813,Completed,2020-09-30,2020-11-12,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04635813,2020-09-30,0,0
3851,NCT04635943,Completed,2021-04-30,2021-04-30,No Results Posted,"['Garcia PJ, Mundaca H, Ugarte-Gil C, Leon P, Malaga G, Chaccour C, Carcamo CP. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial. Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.']",,2021-12-06,https://clinicaltrials.gov/show/NCT04635943,2021-04-30,0,1
3852,NCT04636021,Recruiting,2021-12-31,2022-06-30,No Results Posted,,,2020-11-19,https://clinicaltrials.gov/show/NCT04636021,2021-12-31,0,0
3853,NCT04636086,Recruiting,2023-02-01,2023-02-28,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.']",,2022-02-15,https://clinicaltrials.gov/show/NCT04636086,2023-02-01,0,1
3854,NCT04636203,Recruiting,2022-09-15,2022-12-31,No Results Posted,,,2022-01-12,https://clinicaltrials.gov/show/NCT04636203,2022-09-15,0,0
3855,NCT04636294,Completed,2021-02-15,2021-02-15,No Results Posted,"['Boeckmans J, Cartuyvels R, Hilkens P, Bruckers L, Magerman K, Waumans L, Raymaekers M. Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19. Diagn Microbiol Infect Dis. 2021 Jun;100(2):115350. doi: 10.1016/j.diagmicrobio.2021.115350. Epub 2021 Feb 18.']",,2021-02-16,https://clinicaltrials.gov/show/NCT04636294,2021-02-15,0,1
3856,NCT04636320,Recruiting,2022-04-13,2022-04-13,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04636320,2022-04-13,0,0
3857,NCT04636333,Recruiting,2021-12-07,2022-07-07,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04636333,2021-12-07,0,0
3858,NCT04636554,,,,,,,2021-12-21,https://clinicaltrials.gov/show/NCT04636554,,0,0
3859,NCT04636671,Recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04636671,2021-08-01,0,0
3860,NCT04636697,"Active, not recruiting",2021-12-31,2022-04-30,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04636697,2021-12-31,0,0
3861,NCT04637295,Completed,2021-06-17,2021-06-17,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04637295,2021-06-17,0,0
3862,NCT04637828,Recruiting,2021-07-30,2021-12-30,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04637828,2021-07-30,0,0
3863,NCT04637893,Not yet recruiting,2021-03-31,2021-03-31,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04637893,2021-03-31,0,0
3864,NCT04637906,Recruiting,2021-04-18,2021-09-18,Results Submitted,"['Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, Trimarco V, Santulli G, Trimarco B. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021 Oct;40:101125. doi: 10.1016/j.eclinm.2021.101125. Epub 2021 Sep 9.']",,2021-03-16,https://clinicaltrials.gov/show/NCT04637906,2021-04-18,0,1
3865,NCT04638634,Terminated,2021-06-09,2021-06-09,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04638634,2021-06-09,0,0
3866,NCT04638842,Completed,2021-06-01,2021-06-01,No Results Posted,,"['Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Carleton RN, Thibodeau MA, Teale MJ, Welch PG, Abrams MP, Robinson T, Asmundson GJ. The center for epidemiologic studies depression scale: a review with a theoretical and empirical examination of item content and factor structure. PLoS One. 2013;8(3):e58067. doi: 10.1371/journal.pone.0058067. Epub 2013 Mar 1. Review.', 'Norton PJ. Depression Anxiety and Stress Scales (DASS-21): psychometric analysis across four racial groups. Anxiety Stress Coping. 2007 Sep;20(3):253-65.', 'Koslowsky M, Bleich A, Greenspoon A, Wagner B, Apter A, Solomon Z. Assessing the validity of the Plutchik Suicide Risk Scale. J Psychiatr Res. 1991;25(4):155-8.', 'Spitzer RL, Kroenke K, Williams JB, L√∂we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.', 'Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974 Dec;42(6):861-5.', 'Novy DM, Stanley MA, Averill P, Daza P. Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Psychol Assess. 2001 Sep;13(3):347-55.']",2021-10-13,https://clinicaltrials.gov/show/NCT04638842,2021-06-01,0,1
3867,NCT04639349,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04639349,2021-03-01,0,0
3868,NCT04639375,"Active, not recruiting",2021-06-12,2022-06-12,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04639375,2021-06-12,0,0
3869,NCT04639427,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04639427,2021-07-01,0,0
3870,NCT04639440,Not yet recruiting,2021-11-22,2021-11-23,No Results Posted,,,2020-11-20,https://clinicaltrials.gov/show/NCT04639440,2021-11-22,0,0
3871,NCT04640181,Completed,2021-06-28,2021-06-28,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04640181,2021-06-28,0,0
3872,NCT04640233,"Active, not recruiting",2021-08-01,2021-09-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04640233,2021-08-01,0,0
3873,NCT04640402,Completed,2021-02-18,2021-11-23,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04640402,2021-02-18,0,0
3874,NCT04640428,Recruiting,2021-10-31,2021-10-31,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04640428,2021-10-31,0,0
3875,NCT04641182,Completed,2020-08-16,2020-09-16,No Results Posted,,,2020-11-23,https://clinicaltrials.gov/show/NCT04641182,2020-08-16,0,0
3876,NCT04641195,Recruiting,2022-07-29,2022-09-30,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04641195,2022-07-29,0,0
3877,NCT04641481,"Active, not recruiting",2021-01-08,2022-12-01,No Results Posted,"['Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Kanungo S, Rai S, Reddy P, Verma S, Singh C, Redkar S, Mohapatra S, Pandey A, Ranganadin P, Gumashta R, Multani M, Mohammad S, Bhatt P, Kumari L, Sapkal G, Gupta N, Abraham P, Panda S, Prasad S, Bhargava B, Ella K, Vadrevu KM; COVAXIN Study Group. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021 Dec 11;398(10317):2173-2184. doi: 10.1016/S0140-6736(21)02000-6. Epub 2021 Nov 11.']",,2021-03-19,https://clinicaltrials.gov/show/NCT04641481,2021-01-08,0,1
3878,NCT04641806,Withdrawn,2020-11-01,2020-11-01,No Results Posted,,"['Lamure S, Dul√©ry R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, No√´l N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thi√©blemont C, Cartron G, Lacombe K, Besson C. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine. 2020 Oct;27:100549. doi: 10.1016/j.eclinm.2020.100549. Epub 2020 Oct 13.']",2021-08-19,https://clinicaltrials.gov/show/NCT04641806,2020-11-01,0,1
3879,NCT04641988,Completed,2020-03-01,2020-06-30,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04641988,2020-03-01,0,0
3880,NCT04642014,Not yet recruiting,2022-02-21,2022-05-01,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04642014,2022-02-21,0,0
3881,NCT04642040,Recruiting,2021-01-01,2021-01-01,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04642040,2021-01-01,0,0
3882,NCT04642196,Completed,2020-10-10,2020-10-10,No Results Posted,"['Nilsson L, Andersson C, Sj√∂dahl R. COVID-19 as the sole cause of death is uncommon in frail home healthcare individuals: a population-based study. BMC Geriatr. 2021 Apr 20;21(1):262. doi: 10.1186/s12877-021-02176-z.']",,2020-11-24,https://clinicaltrials.gov/show/NCT04642196,2020-10-10,0,1
3883,NCT04642326,"Active, not recruiting",2020-07-01,2021-05-04,No Results Posted,,"['Yin R, Dai T, Avci P, Jorge AE, de Melo WC, Vecchio D, Huang YY, Gupta A, Hamblin MR. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol. 2013 Oct;13(5):731-62. doi: 10.1016/j.coph.2013.08.009. Epub 2013 Sep 20. Review.', 'Mohr H, Steil L, Gravemann U, Thiele T, Hammer E, Greinacher A, M√ºller TH, V√∂lker U. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion. 2009 Dec;49(12):2612-24. doi: 10.1111/j.1537-2995.2009.02334.x. Epub 2009 Aug 4.', 'Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M. Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion. Nat Commun. 2019 Jan 29;10(1):481. doi: 10.1038/s41467-018-08261-z.', 'Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, M√ºller TH, Seltsam A. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light. Vox Sang. 2020 Apr;115(3):146-151. doi: 10.1111/vox.12888. Epub 2020 Jan 12.', ""Dai T, Kharkwal GB, Zhao J, St Denis TG, Wu Q, Xia Y, Huang L, Sharma SK, d'Enfert C, Hamblin MR. Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochem Photobiol. 2011 Mar-Apr;87(2):342-9. doi: 10.1111/j.1751-1097.2011.00886.x. Epub 2011 Feb 10."", 'Cypel M, Feld JJ, Galasso M, Pinto Ribeiro RV, Marks N, Kuczynski M, Kumar D, Bahinskaya I, Bagnato VS, Kurachi C, Slutsky AS, Yeung JC, Donahoe L, de Perrot M, Yasufuku K, Pierre A, Binnie M, Chaparro C, Martinu T, Chen M, Tikkanen J, Chow CW, Sidhu A, Waddell TK, Keshavjee S, Singer LG, Humar A. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial. Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.', 'Bak J, J√∏rgensen TM, Helfmann J, Gravemann U, Vorontsova I. Potential in vivo UVC disinfection of catheter lumens: estimation of the doses received by the blood flow outside the catheter tip hole. Photochem Photobiol. 2011 Mar-Apr;87(2):350-6. doi: 10.1111/j.1751-1097.2011.00887.x. Epub 2011 Jan 31.', 'Ultroviolet,C lrrodiation for Prevention of Centrol Venous Cotheter-reloted ¬∑ lnfections: An in Vitro Study,Tianhong Dai 1,2, George P. Tegos 1,2¬ß, Tyler G. St. Denis l ,3, Don Anderson4,. Ed SinofskyS ond Michael R. Homblin* l ,2,6, Received 11 Moy 201 O, accepted 8 September 201 o; DOi: l 0.1111/ j.1751-1097.2010.00819 .x', 'Pathogen inactivation method using ultraviolet C light. Journal of Transfusion Medicine, 12(3), 83-87.']",2020-11-24,https://clinicaltrials.gov/show/NCT04642326,2020-07-01,0,1
3884,NCT04642339,Not yet recruiting,2021-10-01,2021-12-01,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04642339,2021-10-01,0,0
3885,NCT04642703,Recruiting,2020-11-30,2021-11-30,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04642703,2020-11-30,0,0
3886,NCT04642950,Completed,2021-10-25,2021-10-25,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04642950,2021-10-25,0,0
3887,NCT04643054,Not yet recruiting,2021-02-28,2021-03-30,No Results Posted,,,2020-11-24,https://clinicaltrials.gov/show/NCT04643054,2021-02-28,0,0
3888,NCT04643444,Enrolling by invitation,2022-01-01,2022-06-01,No Results Posted,"['Sendi P, Baldan R, Thierstein M, Widmer N, Gowland P, Gahl B, B√ºchi AE, G√ºntensperger D, Wider M, Blum MR, Tinguely C, Maillat C, Theel ES, Berbari E, Dijkman R, Niederhauser C. A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study. Open Forum Infect Dis. 2021 Oct 16;8(12):ofab524. doi: 10.1093/ofid/ofab524. eCollection 2021 Dec.']",,2021-02-16,https://clinicaltrials.gov/show/NCT04643444,2022-01-01,0,1
3889,NCT04643522,Completed,2020-10-05,2020-10-10,No Results Posted,,"['Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O, Kruessel JS, Bielfeld AP. Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020 Aug;114(2):233-238. doi: 10.1016/j.fertnstert.2020.05.028. Epub 2020 May 29.', 'Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, Xiong Y, Sun H, Zheng F, Chen Z, Qin J, Lyu J, Zhang Y, Zhang M. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol. 2021 Jan;93(1):456-462. doi: 10.1002/jmv.26259. Epub 2020 Jul 19.', 'Achua JK, Chu KY, Ibrahim E, Khodamoradi K, Delma KS, Iakymenko OA, Kryvenko ON, Arora H, Ramasamy R. Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis. World J Mens Health. 2021 Jan;39(1):65-74. doi: 10.5534/wjmh.200170. Epub 2020 Nov 3.', 'Yang M, Chen S, Huang B, Zhong JM, Su H, Chen YJ, Cao Q, Ma L, He J, Li XF, Li X, Zhou JJ, Fan J, Luo DJ, Chang XN, Arkun K, Zhou M, Nie X. Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications. Eur Urol Focus. 2020 Sep 15;6(5):1124-1129. doi: 10.1016/j.euf.2020.05.009. Epub 2020 May 31.']",2020-11-30,https://clinicaltrials.gov/show/NCT04643522,2020-10-05,0,1
3890,NCT04643548,Recruiting,2021-06-13,2021-08-13,No Results Posted,,,2020-12-01,https://clinicaltrials.gov/show/NCT04643548,2021-06-13,0,0
3891,NCT04643561,"Active, not recruiting",2020-12-31,2020-12-31,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04643561,2020-12-31,0,0
3892,NCT04643691,Recruiting,2022-09-30,2022-10-30,No Results Posted,,,2020-11-25,https://clinicaltrials.gov/show/NCT04643691,2022-09-30,0,0
3893,NCT04643860,Withdrawn,2021-08-01,2021-08-01,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04643860,2021-08-01,0,0
3894,NCT04643964,Completed,2021-06-05,2021-06-05,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04643964,2021-06-05,0,0
3895,NCT04644120,Completed,2021-08-24,2021-08-24,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-09-02,https://clinicaltrials.gov/show/NCT04644120,2021-08-24,0,1
3896,NCT04644146,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,2020-11-25,https://clinicaltrials.gov/show/NCT04644146,2021-06-01,0,0
3897,NCT04644159,Recruiting,2022-06-30,2023-11-01,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04644159,2022-06-30,0,0
3898,NCT04644172,Recruiting,2023-11-01,2024-11-01,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04644172,2023-11-01,0,0
3899,NCT04644185,Recruiting,2021-06-27,2021-12-27,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-04-12,https://clinicaltrials.gov/show/NCT04644185,2021-06-27,0,1
3900,NCT04644198,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04644198,2021-12-01,0,0
3901,NCT04644276,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04644276,2022-03-01,0,0
3902,NCT04644302,Completed,2021-07-01,2021-07-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04644302,2021-07-01,0,0
3903,NCT04644328,Completed,2021-02-11,2021-02-11,Study Results,,"['Breza E, Stanford FC, Alsan M, Alsan B, Banerjee A, Chandrasekhar AG, Eichmeyer S, Glushko T, Goldsmith-Pinkham P, Holland K, Hoppe E, Karnani M, Liegl S, Loisel T, Ogbu-Nwobodo L, Olken BA, Torres C, Vautrey PL, Warner ET, Wootton S, Duflo E. Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial. Nat Med. 2021 Sep;27(9):1622-1628. doi: 10.1038/s41591-021-01487-3. Epub 2021 Aug 19.']",2021-12-21,https://clinicaltrials.gov/show/NCT04644328,2021-02-11,1,1
3904,NCT04644341,Recruiting,2021-08-31,2021-11-01,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04644341,2021-08-31,0,0
3905,NCT04644705,Completed,2021-05-03,2021-05-03,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04644705,2021-05-03,0,0
3906,NCT04645368,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04645368,2021-07-01,0,0
3907,NCT04645407,Completed,2020-04-15,2020-04-15,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04645407,2020-04-15,0,0
3908,NCT04645433,Completed,2020-05-15,2020-05-15,No Results Posted,,,2020-11-27,https://clinicaltrials.gov/show/NCT04645433,2020-05-15,0,0
3909,NCT04645498,Recruiting,2023-02-01,2023-02-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04645498,2023-02-01,0,0
3910,NCT04645563,Completed,2020-05-30,2020-05-31,No Results Posted,"['Sabƒ±rlƒ± R, Karsli E, Canacik O, Ercin D, √áift√ßi H, Sahin L, Dolanbay T, Tutuncu EE. Use of WhatsApp for Polyclinic Consultation of Suspected Patients With COVID-19: Retrospective Case Control Study. JMIR Mhealth Uhealth. 2020 Dec 11;8(12):e22874. doi: 10.2196/22874.']",,2020-11-27,https://clinicaltrials.gov/show/NCT04645563,2020-05-30,0,1
3911,NCT04646031,,,,,,,2020-11-27,https://clinicaltrials.gov/show/NCT04646031,,0,0
3912,NCT04646044,Completed,2021-05-11,2021-05-18,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04646044,2021-05-11,0,0
3913,NCT04646109,Completed,2020-09-02,2020-09-02,Study Results,,,2021-01-27,https://clinicaltrials.gov/show/NCT04646109,2020-09-02,1,0
3914,NCT04646525,Recruiting,2021-02-01,2021-02-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04646525,2021-02-01,0,0
3915,NCT04646551,Not yet recruiting,2021-12-01,2022-01-01,No Results Posted,,,2020-11-30,https://clinicaltrials.gov/show/NCT04646551,2021-12-01,0,0
3916,NCT04646590,"Active, not recruiting",2021-11-28,2022-12-01,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04646590,2021-11-28,0,0
3917,NCT04646642,Completed,2021-02-01,2021-02-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04646642,2021-02-01,0,0
3918,NCT04646655,Recruiting,2022-12-31,2023-02-28,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04646655,2022-12-31,0,0
3919,NCT04647305,Completed,2021-03-04,2021-03-04,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04647305,2021-03-04,0,0
3920,NCT04647604,Completed,2021-01-05,2021-07-07,No Results Posted,"['Arnardottir H, Pawelzik SC, √ñhlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, B√§ck M. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial. Front Physiol. 2021 Jan 11;11:624657. doi: 10.3389/fphys.2020.624657. eCollection 2020. Review.']",,2022-01-05,https://clinicaltrials.gov/show/NCT04647604,2021-01-05,0,1
3921,NCT04647656,Completed,2021-12-27,2022-01-10,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04647656,2021-12-27,0,0
3922,NCT04647734,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,"['Rasmussen IE, Foged F, Bj√∏rn Budde J, Rasmussen RS, Rasmussen V, Lyngb√¶k M, J√∏nck S, Krogh-Madsen R, Lindegaard B, Ried-Larsen M, J√∏rgensen PG, Lund MAV, K√∏ber L, Vejlstrup N, Pedersen BK, Berg RMG, Christensen RH. Protective potential of high-intensity interval training on cardiac structure and function after COVID-19: protocol and statistical analysis plan for an investigator-blinded randomised controlled trial. BMJ Open. 2021 Nov 18;11(11):e048281. doi: 10.1136/bmjopen-2020-048281.']",,2020-12-01,https://clinicaltrials.gov/show/NCT04647734,2021-12-31,0,1
3923,NCT04648410,Recruiting,2021-07-30,2021-12-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04648410,2021-07-30,0,0
3924,NCT04648709,Recruiting,2022-12-01,2024-12-01,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04648709,2022-12-01,0,0
3925,NCT03944447,Recruiting,2025-12-31,2025-12-31,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT03944447,2025-12-31,0,0
3926,NCT04169542,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04169542,2022-03-31,0,0
3927,NCT04402853,Completed,2020-03-01,2020-05-20,No Results Posted,,"['Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020 Apr 26. doi: 10.1111/aos.14445. [Epub ahead of print]']",2020-12-03,https://clinicaltrials.gov/show/NCT04402853,2020-03-01,0,1
3928,NCT04419870,Recruiting,2025-05-01,2025-05-01,No Results Posted,"['Gordon-Lipkin EM, Marcum C, Kruk S, Thompson E, Kelly SEM, Kalish H, Sadtler K, McGuire PJ. Undiagnosed COVID-19 in households with a child with mitochondrial disease. medRxiv. 2022 Mar 23. pii: 2022.03.21.22272358. doi: 10.1101/2022.03.21.22272358.']",,2022-04-01,https://clinicaltrials.gov/show/NCT04419870,2025-05-01,0,1
3929,NCT04441710,Recruiting,2023-10-01,2023-10-01,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04441710,2023-10-01,0,0
3930,NCT04453384,Completed,2021-05-21,2021-08-19,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Gaborit B, Dailly E, Vanhove B, Josien R, Lacombe K, Dubee V, Ferre V, Brouard S, Ader F, Vibet MA, Le Thuaut A, Danger R, Flet L, Omnes A, Berly L, Chiffoleau A, Jobert A, Duvaux O, Raffi F; POLYCOR Trial Group. Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0123721. doi: 10.1128/AAC.01237-21. Epub 2021 Aug 17.', 'Gaborit B, Vanhove B, Vibet MA, Le Thuaut A, Lacombe K, Dubee V, Ader F, Ferre V, Vicaut E, Orain J, Le Bras M, Omnes A, Berly L, Jobert A, Morineau-Le Houssine P, Botturi K, Josien R, Flet L, Degauque N, Brouard S, Duvaux O, Poinas A, Raffi F; POLYCOR study group. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials. 2021 Mar 9;22(1):199. doi: 10.1186/s13063-021-05132-9.']",,2022-03-25,https://clinicaltrials.gov/show/NCT04453384,2021-05-21,0,1
3931,NCT04453839,,,,,,,2022-01-31,https://clinicaltrials.gov/show/NCT04453839,,0,0
3932,NCT04455815,"Active, not recruiting",2021-12-31,2021-12-31,No Results Posted,"['Halford S, Wan S, Dragoni I, Silvester J, Nazarov B, Anthony D, Anthony S, Ladds E, Norrie J, Dhaliwal K; CDD SPIKE-1 Project Team. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion. Trials. 2021 Aug 19;22(1):550. doi: 10.1186/s13063-021-05461-9.']",,2021-10-13,https://clinicaltrials.gov/show/NCT04455815,2021-12-31,0,1
3933,NCT04456595,"Active, not recruiting",2020-12-17,2022-02-01,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04456595,2020-12-17,0,0
3934,NCT04460443,Recruiting,2021-08-01,2021-08-31,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04460443,2021-08-01,0,0
3935,NCT04463602,Completed,2021-01-25,2021-03-31,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04463602,2021-01-25,0,0
3936,NCT04466085,"Active, not recruiting",2020-10-22,2021-12-15,No Results Posted,"['Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C, Zhong Z, Wang F, Duan X, Tian S, Wu L, Liu Y, Luo Y, Chen Z, Li F, Li J, Yu X, Ren H, Liu L, Meng S, Yan J, Hu Z, Gao L, Gao GF. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24.']",,2020-12-03,https://clinicaltrials.gov/show/NCT04466085,2020-10-22,0,1
3937,NCT04466241,Recruiting,2021-03-26,2021-03-26,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04466241,2021-03-26,0,0
3938,NCT04466982,Recruiting,2021-08-01,2022-01-01,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04466982,2021-08-01,0,0
3939,NCT04468789,Withdrawn,2022-10-01,2022-12-01,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04468789,2022-10-01,0,0
3940,NCT04469491,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04469491,2022-03-01,0,0
3941,NCT04472728,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Dioh W, Chabane M, Tourette C, Azbekyan A, Morelot-Panzini C, Hajjar LA, Lins M, Nair GB, Whitehouse T, Mariani J, Latil M, Camelo S, Lafont R, Dilda PJ, Veillet S, Agus S. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.']",,2021-11-12,https://clinicaltrials.gov/show/NCT04472728,2021-12-01,0,1
3942,NCT04473690,"Active, not recruiting",2022-05-31,2022-12-31,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04473690,2022-05-31,0,0
3943,NCT04476745,Completed,2021-03-22,2021-04-15,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04476745,2021-03-22,0,0
3944,NCT04477213,Completed,2021-09-30,2021-10-02,No Results Posted,,"['Nguyen LH, Drew DA, Joshi AD, Guo CG, Ma W, Mehta RS, Sikavi DR, Lo CH, Kwon S, Song M, Mucci LA, Stampfer MJ, Willett WC, Eliassen AH, Hart JE, Chavarro JE, Rich-Edwards JW, Davies R, Capdevila J, Lee KA, Lochlainn MN, Varsavsky T, Graham MS, Sudre CH, Cardoso MJ, Wolf J, Ourselin S, Steves CJ, Spector TD, Chan AT. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. medRxiv. 2020 May 25. pii: 2020.04.29.20084111. doi: 10.1101/2020.04.29.20084111. Update in: Lancet Public Health. 2020 Jul 30;:.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.']",2021-10-11,https://clinicaltrials.gov/show/NCT04477213,2021-09-30,0,1
3945,NCT04479631,Completed,2021-01-29,2021-01-29,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04479631,2021-01-29,0,1
3946,NCT04479644,Completed,2021-02-03,2021-02-03,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04479644,2021-02-03,0,1
3947,NCT04482686,"Active, not recruiting",2022-05-01,2022-07-01,No Results Posted,"['Hazan S, Dave S, Gunaratne AW, Dolai S, Clancy RL, McCullough PA, Borody TJ. Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients. Future Microbiol. 2022 Mar;17:339-350. doi: 10.2217/fmb-2022-0014. Epub 2022 Feb 9.']",,2021-11-02,https://clinicaltrials.gov/show/NCT04482686,2022-05-01,0,1
3948,NCT04483271,Completed,2020-12-15,2021-02-28,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04483271,2020-12-15,0,0
3949,NCT04487691,Terminated,2021-06-15,2021-06-15,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04487691,2021-06-15,0,0
3950,NCT04490174,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04490174,2023-12-31,0,0
3951,NCT04492449,Not yet recruiting,2021-04-01,2022-12-01,No Results Posted,,"['Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, Zheng C. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol. 2020 Jul;215(1):127-132. doi: 10.2214/AJR.20.23072. Epub 2020 Mar 18. Erratum in: AJR Am J Roentgenol. 2020 Jul;215(1):262.', 'Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol. 2016 Jan;47(1):6-7. doi: 10.1002/uog.15831.']",2020-12-11,https://clinicaltrials.gov/show/NCT04492449,2021-04-01,0,1
3952,NCT04492475,Completed,2020-12-21,2020-12-21,Study Results,"['Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D, Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA, Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH; ACTT-3 study group members. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 Dec;9(12):1365-1376. doi: 10.1016/S2213-2600(21)00384-2. Epub 2021 Oct 18.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and Solid Organ Transplantation: A Review Article. Transplantation. 2021 Jan 1;105(1):37-55. doi: 10.1097/TP.0000000000003523. Review.']",,2022-03-14,https://clinicaltrials.gov/show/NCT04492475,2020-12-21,1,1
3953,NCT04497649,Recruiting,2021-04-01,2021-04-10,No Results Posted,,,2020-12-03,https://clinicaltrials.gov/show/NCT04497649,2021-04-01,0,0
3954,NCT04497948,Terminated,2020-11-18,2020-11-18,Study Results,,,2021-11-17,https://clinicaltrials.gov/show/NCT04497948,2020-11-18,1,0
3955,NCT04498247,Terminated,2021-03-05,2021-03-05,Study Results,"['Vanhoutte F, Liu W, Wiedmann RT, Haspeslagh L, Cao X, Boundy K, Aliprantis A, Davila M, Hartzel J, Li J, McGuire M, Ramsauer K, Tomberger Y, Tschismarov R, Brown DD, Xu W, Sachs JR, Russell K, Stoch SA, Lai E. Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial. EBioMedicine. 2022 Jan;75:103811. doi: 10.1016/j.ebiom.2021.103811. Epub 2022 Jan 15.']",,2021-12-23,https://clinicaltrials.gov/show/NCT04498247,2021-03-05,1,1
3956,NCT04501432,Completed,2020-10-24,2020-10-24,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04501432,2020-10-24,0,0
3957,NCT04501952,Terminated,2021-05-06,2021-05-06,Study Results,"['Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, Hidalgo A, Sachdeva Y, Mittal S, Osiyemi O, Skarbinski J, Juneja K, Hyland RH, Osinusi A, Chen S, Camus G, Abdelghany M, Davies S, Behenna-Renton N, Duff F, Marty FM, Katz MJ, Ginde AA, Brown SM, Schiffer JT, Hill JA; GS-US-540-9012 (PINETREE) Investigators. Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. N Engl J Med. 2022 Jan 27;386(4):305-315. doi: 10.1056/NEJMoa2116846. Epub 2021 Dec 22.']",,2021-11-16,https://clinicaltrials.gov/show/NCT04501952,2021-05-06,1,1
3958,NCT04504032,Terminated,2021-03-10,2021-03-29,Study Results,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-10-22,https://clinicaltrials.gov/show/NCT04504032,2021-03-10,1,1
3959,NCT04504734,Enrolling by invitation,2022-03-31,2022-03-31,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04504734,2022-03-31,0,0
3960,NCT04505722,"Active, not recruiting",2021-01-22,2023-01-02,Results Submitted,"['Sadoff J, Gray G, Vandebosch A, C√°rdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Gui√±az√∫ J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. N Engl J Med. 2022 Mar 3;386(9):847-860. doi: 10.1056/NEJMoa2117608. Epub 2022 Feb 9.', 'Sadoff J, Struyf F, Douoguih M. A plain language summary of how well the single-dose Janssen vaccine works and how safe it is. Future Virol. 2021 Nov;16(11):725-739. doi: 10.2217/fvl-2021-0199. Epub 2021 Nov 1. Review.', 'Sadoff J, Gray G, Vandebosch A, C√°rdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K, Scheper G, Taylor KL, Robb ML, Treanor J, Barouch DH, Stoddard J, Ryser MF, Marovich MA, Neuzil KM, Corey L, Cauwenberghs N, Tanner T, Hardt K, Ruiz-Gui√±az√∫ J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.', 'Williams TC, Burgers WA. SARS-CoV-2 evolution and vaccines: cause for concern? Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.']",,2021-12-22,https://clinicaltrials.gov/show/NCT04505722,2021-01-22,0,1
3961,NCT04506268,Completed,2020-10-30,2020-10-30,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04506268,2020-10-30,0,0
3962,NCT04508023,Recruiting,2022-02-22,2022-05-19,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04508023,2022-02-22,0,0
3963,NCT04509999,Withdrawn,2021-06-30,2021-06-30,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04509999,2021-06-30,0,0
3964,NCT04516746,"Active, not recruiting",2021-03-05,2023-02-14,Study Results,"['Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A; AstraZeneca AZD1222 Clinical Study Group. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29.']",,2022-04-01,,2021-03-05,1,1
3965,NCT04517396,"Active, not recruiting",2022-04-30,2022-04-30,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04517396,2022-04-30,0,0
3966,NCT04518410,"Active, not recruiting",2022-03-01,2023-06-22,No Results Posted,"['Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs R, Ritz J, Giganti M, Javan AC, Li Y, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM. Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19. medRxiv. 2021 Dec 21. pii: 2021.12.17.21268009. doi: 10.1101/2021.12.17.21268009.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04518410,2022-03-01,0,1
3967,NCT04519437,Completed,2021-11-22,2021-11-22,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-26,https://clinicaltrials.gov/show/NCT04519437,2021-11-22,0,1
3968,NCT04521088,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04521088,2020-12-31,0,0
3969,NCT04523181,Completed,2021-12-23,2021-12-23,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04523181,2021-12-23,0,0
3970,NCT04524715,Not yet recruiting,2022-03-31,2022-03-31,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04524715,2022-03-31,0,0
3971,NCT04526990,Recruiting,2021-12-30,2022-01-30,No Results Posted,"['Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Mu√±oz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Erratum in: Lancet. 2022 Jan 15;399(10321):236.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04526990,2021-12-30,0,1
3972,NCT04527081,Completed,2020-11-09,2021-09-24,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04527081,2020-11-09,0,0
3973,NCT04527471,"Active, not recruiting",2021-02-15,2021-05-15,No Results Posted,,,2021-04-20,https://clinicaltrials.gov/show/NCT04527471,2021-02-15,0,0
3974,NCT04530136,Recruiting,2021-08-15,2021-11-30,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04530136,2021-08-15,0,0
3975,NCT04530500,Enrolling by invitation,2023-06-24,2023-06-24,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04530500,2023-06-24,0,0
3976,NCT04535453,"Active, not recruiting",2022-03-28,2022-03-28,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04535453,2022-03-28,0,0
3977,NCT04536376,"Active, not recruiting",2021-09-02,2022-12-31,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04536376,2021-09-02,0,0
3978,NCT04537975,Withdrawn,2020-11-15,2021-01-15,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04537975,2020-11-15,0,0
3979,NCT04539262,Completed,2021-02-26,2021-03-22,Study Results,,,2022-03-03,https://clinicaltrials.gov/show/NCT04539262,2021-02-26,1,0
3980,NCT04540120,Recruiting,2022-06-01,2022-07-01,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04540120,2022-06-01,0,0
3981,NCT04542226,Completed,2020-07-15,2020-10-30,Study Results,,,2020-12-09,https://clinicaltrials.gov/show/NCT04542226,2020-07-15,1,0
3982,NCT04545060,Completed,2021-04-08,2021-09-02,No Results Posted,"['Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Rodrigues Falci D, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Parra S, Sager JE, Austin D, Peppercorn A, Alexander E, Yeh WW, Brinson C, Aldinger M, Shapiro AE; COMET-ICE Investigators. Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2022 Mar 14. doi: 10.1001/jama.2022.2832. [Epub ahead of print]', 'Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Hebner CM, Sager J, Mogalian E, Tipple C, Peppercorn A, Alexander E, Pang PS, Free A, Brinson C, Aldinger M, Shapiro AE; COMET-ICE Investigators. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. N Engl J Med. 2021 Nov 18;385(21):1941-1950. doi: 10.1056/NEJMoa2107934. Epub 2021 Oct 27.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-09-27,https://clinicaltrials.gov/show/NCT04545060,2021-04-08,0,1
3983,NCT04546581,Completed,2021-05-21,2021-05-21,Results Submitted,"['ITAC (INSIGHT 013) Study Group. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Lancet. 2022 Feb 5;399(10324):530-540. doi: 10.1016/S0140-6736(22)00101-5. Epub 2022 Jan 28.', 'Vandeberg P, Cruz M, Diez JM, Merritt WK, Santos B, Trukawinski S, Wellhouse A, Jose M, Willis T. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma. Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.']",,2022-02-10,https://clinicaltrials.gov/show/NCT04546581,2021-05-21,0,1
3984,NCT04549922,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04549922,2022-02-01,0,0
3985,NCT04552366,"Active, not recruiting",2020-12-31,2021-06-30,No Results Posted,"['Wu S, Huang J, Zhang Z, Wu J, Zhang J, Hu H, Zhu T, Zhang J, Luo L, Fan P, Wang B, Chen C, Chen Y, Song X, Wang Y, Si W, Sun T, Wang X, Hou L, Chen W. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26.']",,2020-12-07,https://clinicaltrials.gov/show/NCT04552366,2020-12-31,0,1
3986,NCT04552379,Completed,2021-05-31,2021-06-30,No Results Posted,"['Iturriaga C, Eiffler N, Aniba R, Ben-Othman R, Perez-Mateluna G, Meyer JKV, Fish EN, Kollmann TR, Severino N, Stick S, Borzutzky A, Perret C, Castro-Rodriguez JA, Garcia-Huidobro D. A cluster randomized trial of interferon √ü-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19). BMC Infect Dis. 2021 Aug 13;21(1):814. doi: 10.1186/s12879-021-06519-4.']",,2021-09-10,https://clinicaltrials.gov/show/NCT04552379,2021-05-31,0,1
3987,NCT04553055,Completed,2020-09-15,2020-09-15,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04553055,2020-09-15,0,0
3988,NCT04555096,Terminated,2021-05-28,2021-05-28,Study Results,"['Karlsson JOG, Jynge P, Ignarro LJ. May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients? Antioxidants (Basel). 2020 Oct 10;9(10). pii: E971. doi: 10.3390/antiox9100971.']",,2022-03-18,https://clinicaltrials.gov/show/NCT04555096,2021-05-28,1,1
3989,NCT04556149,Completed,2020-12-02,2020-12-02,No Results Posted,,,2020-12-21,https://clinicaltrials.gov/show/NCT04556149,2020-12-02,0,0
3990,NCT04558372,Completed,2020-12-12,2020-12-12,No Results Posted,,,2020-12-29,https://clinicaltrials.gov/show/NCT04558372,2020-12-12,0,0
3991,NCT04559113,Recruiting,2020-12-30,2020-12-30,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04559113,2020-12-30,0,0
3992,NCT04560205,Recruiting,2020-12-30,2020-12-30,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04560205,2020-12-30,0,0
3993,NCT04560257,Recruiting,2020-12-30,2020-12-30,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04560257,2020-12-30,0,0
3994,NCT04560608,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04560608,2022-12-31,0,0
3995,NCT04564274,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04564274,2022-09-01,0,0
3996,NCT04564716,"Active, not recruiting",2021-03-28,2021-04-10,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04564716,2021-03-28,0,0
3997,NCT04565067,Recruiting,2022-09-20,2022-09-20,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04565067,2022-09-20,0,0
3998,NCT04565080,Completed,2021-03-04,2021-08-02,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04565080,2021-03-04,0,0
3999,NCT04565197,"Active, not recruiting",2020-12-30,2020-12-30,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04565197,2020-12-30,0,0
4000,NCT04568031,Completed,2021-11-22,2021-11-22,No Results Posted,"['Asano M, Okada H, Itoh Y, Hirata H, Ishikawa K, Yoshida E, Matsui A, Kelly EJ, Shoemaker K, Olsson U, Vekemans J. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial. Int J Infect Dis. 2022 Jan;114:165-174. doi: 10.1016/j.ijid.2021.10.030. Epub 2021 Oct 22.']",,2021-11-30,https://clinicaltrials.gov/show/NCT04568031,2021-11-22,0,1
4001,NCT04568122,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04568122,2022-11-01,0,0
4002,NCT04569786,Terminated,2021-02-18,2021-02-18,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-29,https://clinicaltrials.gov/show/NCT04569786,2021-02-18,1,1
4003,NCT04570189,Recruiting,2021-01-01,2021-01-01,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04570189,2021-01-01,0,0
4004,NCT04575038,Completed,2021-04-28,2021-04-28,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04575038,2021-04-28,0,0
4005,NCT04575584,Terminated,2021-08-11,2021-08-11,No Results Posted,,,2021-09-09,,2021-08-11,0,0
4006,NCT04575610,Terminated,2021-10-06,2021-10-06,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04575610,2021-10-06,0,0
4007,NCT04578132,"Active, not recruiting",2022-06-01,2022-10-01,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04578132,2022-06-01,0,0
4008,NCT04579393,Completed,2021-03-30,2021-04-30,Study Results,"['Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS. Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic. J Infect Dis. 2021 Mar 29;223(6):981-984. doi: 10.1093/infdis/jiaa789.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04579393,2021-03-30,1,1
4009,NCT04582903,Recruiting,2025-08-31,2025-08-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04582903,2025-08-31,0,0
4010,NCT04583189,Completed,2020-11-25,2020-11-25,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04583189,2020-11-25,0,0
4011,NCT04583592,Completed,2021-03-31,2021-03-31,Study Results,,,2022-01-18,https://clinicaltrials.gov/show/NCT04583592,2021-03-31,1,0
4012,NCT04583956,Completed,2021-09-13,2021-09-13,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-28,https://clinicaltrials.gov/show/NCT04583956,2021-09-13,0,1
4013,NCT04583969,"Active, not recruiting",2022-06-30,2022-10-29,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-28,https://clinicaltrials.gov/show/NCT04583969,2022-06-30,0,1
4014,NCT04583982,Completed,2020-12-04,2020-12-04,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04583982,2020-12-04,0,0
4015,NCT04584567,Completed,2021-02-01,2021-11-01,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04584567,2021-02-01,0,0
4016,NCT04584658,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04584658,2021-10-01,0,0
4017,NCT04588363,"Active, not recruiting",2022-08-01,2023-02-01,No Results Posted,,,2022-03-28,https://clinicaltrials.gov/show/NCT04588363,2022-08-01,0,0
4018,NCT04588792,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04588792,2022-01-01,0,0
4019,NCT04590794,Completed,2021-06-08,2021-06-08,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04590794,2021-06-08,0,0
4020,NCT04592549,Recruiting,2023-03-30,2023-03-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-09-24,https://clinicaltrials.gov/show/NCT04592549,2023-03-30,0,1
4021,NCT04595773,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04595773,2023-12-31,0,0
4022,NCT04601077,Recruiting,2021-11-01,2021-12-31,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04601077,2021-11-01,0,0
4023,NCT04602351,Completed,2021-04-07,2021-05-01,No Results Posted,,"['van Beusekom I, Bakhshi-Raiez F, de Keizer NF, Dongelmans DA, van der Schaaf M. Reported burden on informal caregivers of ICU survivors: a literature review. Crit Care. 2016 Jan 21;20:16. doi: 10.1186/s13054-016-1185-9. Review.', 'Cicekci F, Duran N, Ayhan B, Arican S, Ilban O, Kara I, Turkoglu M, Yildirim F, Hasirci I, Karaibrahimoglu A, Kara I. The communication between patient relatives and physicians in intensive care units. BMC Anesthesiol. 2017 Jul 17;17(1):97. doi: 10.1186/s12871-017-0388-1.']",2021-05-11,https://clinicaltrials.gov/show/NCT04602351,2021-04-07,0,1
4024,NCT04602507,Terminated,2021-12-09,2021-12-09,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04602507,2021-12-09,0,0
4025,NCT04603690,Completed,2022-01-31,2022-02-28,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04603690,2022-01-31,0,0
4026,NCT04603781,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04603781,2021-12-31,0,0
4027,NCT04604184,Terminated,2021-03-24,2021-05-31,Results Submitted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04604184,2021-03-24,0,0
4028,NCT04605588,Terminated,2021-01-17,2021-02-04,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04605588,2021-01-17,0,0
4029,NCT04605965,"Active, not recruiting",2023-11-01,2023-11-01,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04605965,2023-11-01,0,0
4030,NCT04606407,Recruiting,2022-09-07,2022-09-07,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04606407,2022-09-07,0,0
4031,NCT04606784,Completed,2021-06-15,2021-06-15,No Results Posted,"['Roshon M, Lemos-Filho L, Cherevka H, Goldberg L, Salottolo K, Bar-Or D. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection. Infect Dis Ther. 2022 Feb;11(1):595-605. doi: 10.1007/s40121-021-00562-z. Epub 2021 Nov 14.']",,2022-03-21,https://clinicaltrials.gov/show/NCT04606784,2021-06-15,0,1
4032,NCT04608097,Completed,2021-03-12,2021-03-12,No Results Posted,,"['James EL, Lau-Zhu A, Clark IA, Visser RM, Hagenaars MA, Holmes EA. The trauma film paradigm as an experimental psychopathology model of psychological trauma: intrusive memories and beyond. Clin Psychol Rev. 2016 Jul;47:106-42. doi: 10.1016/j.cpr.2016.04.010. Epub 2016 Apr 21. Review.']",2021-04-30,https://clinicaltrials.gov/show/NCT04608097,2021-03-12,0,1
4033,NCT04608201,Completed,2021-11-05,2021-11-05,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04608201,2021-11-05,0,0
4034,NCT04608266,Terminated,2021-09-27,2021-12-02,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04608266,2021-09-27,0,0
4035,NCT04609969,Completed,2020-10-17,2020-10-17,No Results Posted,,,2020-12-07,https://clinicaltrials.gov/show/NCT04609969,2020-10-17,0,0
4036,NCT04613245,Recruiting,2021-01-30,2021-03-01,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04613245,2021-01-30,0,0
4037,NCT04614844,Recruiting,2022-09-15,2022-11-15,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04614844,2022-09-15,0,0
4038,NCT04619693,Terminated,2021-10-06,2021-10-06,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04619693,2021-10-06,0,0
4039,NCT04625725,"Active, not recruiting",2021-05-05,2023-11-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04625725,2021-05-05,0,0
4040,NCT04625972,"Active, not recruiting",2021-04-07,2022-06-19,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04625972,2021-04-07,0,1
4041,NCT04628208,Completed,2020-12-07,2020-12-07,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04628208,2020-12-07,0,0
4042,NCT04632537,Withdrawn,2021-03-23,2021-03-23,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04632537,2021-03-23,0,0
4043,NCT04634318,Completed,2022-01-05,2022-01-05,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04634318,2022-01-05,0,0
4044,NCT04634409,Completed,2021-07-27,2021-10-20,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Nathan R, Shawa I, De La Torre I, Pustizzi JM, Haustrup N, Patel DR, Huhn G. A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. Infect Dis Ther. 2021 Dec;10(4):1933-1947. doi: 10.1007/s40121-021-00515-6. Epub 2021 Aug 10. Review.']",,2021-11-15,https://clinicaltrials.gov/show/NCT04634409,2021-07-27,0,1
4045,NCT04634903,Completed,2021-03-15,2021-03-15,Study Results,"['Schleider JL, Mullarkey MC, Fox KR, Dobias ML, Shroff A, Hart EA, Roulston CA. A randomized trial of online single-session interventions for adolescent depression during COVID-19. Nat Hum Behav. 2022 Feb;6(2):258-268. doi: 10.1038/s41562-021-01235-0. Epub 2021 Dec 9.']",,2021-05-25,https://clinicaltrials.gov/show/NCT04634903,2021-03-15,1,1
4046,NCT04636034,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04636034,2022-03-01,0,0
4047,NCT04637867,Completed,2021-05-12,2021-05-12,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04637867,2021-05-12,0,0
4048,NCT04638673,Completed,2021-06-30,2021-06-30,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04638673,2021-06-30,0,0
4049,NCT04639466,Recruiting,2023-07-31,2023-07-31,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04639466,2023-07-31,0,0
4050,NCT04640038,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04640038,2022-12-01,0,0
4051,NCT04640168,Completed,2021-05-18,2021-06-18,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04640168,2021-05-18,0,1
4052,NCT04640194,Recruiting,2022-12-13,2023-02-15,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04640194,2022-12-13,0,0
4053,NCT04641858,"Active, not recruiting",2022-06-01,2022-08-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04641858,2022-06-01,0,0
4054,NCT04642638,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-11-02,https://clinicaltrials.gov/show/NCT04642638,2023-01-01,0,0
4055,NCT04643678,Recruiting,2021-04-30,2021-10-30,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04643678,2021-04-30,0,0
4056,NCT04646239,Completed,2021-06-28,2021-06-28,No Results Posted,,,2021-11-26,https://clinicaltrials.gov/show/NCT04646239,2021-06-28,0,0
4057,NCT04646603,Recruiting,2022-03-31,2022-07-01,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04646603,2022-03-31,0,0
4058,NCT04646616,Recruiting,2021-10-31,2021-10-31,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04646616,2021-10-31,0,0
4059,NCT04647682,Completed,2022-01-17,2022-01-17,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04647682,2022-01-17,0,0
4060,NCT04647695,Recruiting,2021-07-31,2021-09-30,No Results Posted,,"['Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.', 'Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.']",2020-12-10,https://clinicaltrials.gov/show/NCT04647695,2021-07-31,0,1
4061,NCT04647747,Recruiting,2021-03-30,2021-12-31,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04647747,2021-03-30,0,0
4062,NCT04647994,Recruiting,2021-07-01,2022-06-13,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04647994,2021-07-01,0,0
4063,NCT04648800,Recruiting,2020-12-01,2021-04-01,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04648800,2020-12-01,0,0
4064,NCT04649086,Recruiting,2022-10-01,2022-10-01,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04649086,2022-10-01,0,0
4065,NCT04649151,"Active, not recruiting",2023-04-28,2023-04-28,No Results Posted,"['Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, Ding B, Dooley J, Girard B, Hillebrand W, Pajon R, Miller JM, Leav B, McPhee R. Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents. N Engl J Med. 2021 Dec 9;385(24):2241-2251. doi: 10.1056/NEJMoa2109522. Epub 2021 Aug 11.']",,2022-01-06,https://clinicaltrials.gov/show/NCT04649151,2023-04-28,0,1
4066,NCT04649320,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04649320,2020-12-31,0,0
4067,NCT04649333,Completed,2020-08-31,2020-08-31,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04649333,2020-08-31,0,0
4068,NCT04649424,Completed,2021-04-13,2021-04-13,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04649424,2021-04-13,0,0
4069,NCT04649515,Terminated,2022-03-04,2022-03-04,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-24,https://clinicaltrials.gov/show/NCT04649515,2022-03-04,0,1
4070,NCT04649658,Completed,2020-06-01,2020-11-30,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04649658,2020-06-01,0,0
4071,NCT04649736,Completed,2021-06-19,2021-06-19,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04649736,2021-06-19,0,0
4072,NCT04649775,Recruiting,2022-07-31,2022-07-31,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04649775,2022-07-31,0,0
4073,NCT04649827,Recruiting,2020-06-30,2021-12-30,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04649827,2020-06-30,0,0
4074,NCT04649840,Completed,2021-12-09,2021-12-09,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04649840,2021-12-09,0,0
4075,NCT04649879,Completed,2022-01-26,2022-01-26,No Results Posted,"['Dillner J, Ursing J. Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden. BMJ Open. 2021 Dec 8;11(12):e048337. doi: 10.1136/bmjopen-2020-048337.']",,2022-02-09,https://clinicaltrials.gov/show/NCT04649879,2022-01-26,0,1
4076,NCT04649918,Completed,2021-01-16,2021-01-16,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04649918,2021-01-16,0,0
4077,NCT04649931,Completed,2021-04-25,2021-04-25,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04649931,2021-04-25,0,0
4078,NCT04649944,Not yet recruiting,2021-11-01,2021-12-31,No Results Posted,,,2020-12-22,https://clinicaltrials.gov/show/NCT04649944,2021-11-01,0,0
4079,NCT04649957,Not yet recruiting,2021-12-17,2021-12-17,No Results Posted,,,2020-12-02,https://clinicaltrials.gov/show/NCT04649957,2021-12-17,0,0
4080,NCT04649996,Completed,2020-10-31,2020-11-30,No Results Posted,"['Ceresoli M, Coccolini F, Magnone S, Lucianetti A, Bisagni P, Armao T, Ansaloni L, Zago M, Chiarugi M, Catena F, Braga M; Appendicitis-COVID study group. The decrease of non-complicated acute appendicitis and the negative appendectomy rate during pandemic. Eur J Trauma Emerg Surg. 2021 Oct;47(5):1359-1365. doi: 10.1007/s00068-021-01663-7. Epub 2021 Apr 12. Erratum in: Eur J Trauma Emerg Surg. 2021 May 31;:.']",,2020-12-04,https://clinicaltrials.gov/show/NCT04649996,2020-10-31,0,1
4081,NCT04650035,Completed,2020-11-04,2020-11-10,No Results Posted,,,2020-12-03,https://clinicaltrials.gov/show/NCT04650035,2020-11-04,0,0
4082,NCT04650087,Recruiting,2022-05-01,2022-08-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04650087,2022-05-01,0,0
4083,NCT04650178,"Active, not recruiting",2023-07-01,2024-07-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04650178,2023-07-01,0,0
4084,NCT04650191,"Active, not recruiting",2021-06-30,2022-06-30,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04650191,2021-06-30,0,0
4085,NCT04651374,Not yet recruiting,2022-03-01,2022-04-01,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04651374,2022-03-01,0,0
4086,NCT04651387,Withdrawn,2021-12-01,2021-12-01,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04651387,2021-12-01,0,0
4087,NCT04651400,"Active, not recruiting",2022-04-01,2022-04-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04651400,2022-04-01,0,0
4088,NCT04651413,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04651413,2021-03-31,0,0
4089,NCT04651790,Recruiting,2022-01-01,2022-03-01,No Results Posted,"['Duarte LF, G√°lvez NMS, Iturriaga C, Melo-Gonz√°lez F, Soto JA, Schultz BM, Urz√∫a M, Gonz√°lez LA, V√°zquez Y, R√≠os M, Berr√≠os-Rojas RV, Rivera-P√©rez D, Moreno-Tapia D, Pacheco GA, Vallejos OP, Hoppe-Elsholz G, Navarrete MS, Rojas √Å, Fasce RA, Fern√°ndez J, Mora J, Ram√≠rez E, Zeng G, Meng W, Gonz√°lez-Aramundiz JV, Gonz√°lez PA, Abarca K, Bueno SM, Kalergis AM. Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine. Front Immunol. 2021 Sep 29;12:742914. doi: 10.3389/fimmu.2021.742914. eCollection 2021.']",,2021-03-02,https://clinicaltrials.gov/show/NCT04651790,2022-01-01,0,1
4090,NCT04652102,"Active, not recruiting",2022-06-04,2022-06-04,No Results Posted,"['Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados Gonz√°lez MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Res√©ndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, S√°ez-Llorens X, Sch√∂nborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L; HERALD Study Group. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial. Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23.']",,2022-03-07,https://clinicaltrials.gov/show/NCT04652102,2022-06-04,0,1
4091,NCT04652115,Recruiting,2022-11-01,2023-11-01,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04652115,2022-11-01,0,0
4092,NCT04652505,Completed,2022-01-12,2022-01-12,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04652505,2022-01-12,0,0
4093,NCT04652518,Recruiting,2021-12-01,2022-04-01,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04652518,2021-12-01,0,0
4094,NCT04652596,Enrolling by invitation,2022-06-01,2022-10-01,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04652596,2022-06-01,0,0
4095,NCT04652648,Completed,2020-10-31,2020-11-15,No Results Posted,"['Liu HH, Ezekowitz MD, Columbo M, Khan O, Martin J, Spahr J, Yaron D, Cushinotto L, Kapelusznik L. The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic. Trials. 2021 Sep 7;22(1):603. doi: 10.1186/s13063-021-05537-6.', 'Liu HH, Ezekowitz MD, Columbo M, Khan O, Martin J, Spahr J, Yaron D, Cushinotto L, Kapelusznik L. Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic. J Interv Card Electrophysiol. 2021 May 26. doi: 10.1007/s10840-021-00989-x. [Epub ahead of print]']",,2020-12-03,https://clinicaltrials.gov/show/NCT04652648,2020-10-31,0,1
4096,NCT04652674,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04652674,2021-06-30,0,0
4097,NCT04652765,Terminated,2021-09-15,2021-09-15,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04652765,2021-09-15,0,0
4098,NCT04653727,"Active, not recruiting",2021-03-06,2021-12-01,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04653727,2021-03-06,0,0
4099,NCT04653831,Recruiting,2021-11-01,2021-12-01,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04653831,2021-11-01,0,0
4100,NCT04653844,Recruiting,2022-12-31,2023-01-30,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04653844,2022-12-31,0,0
4101,NCT04653857,"Active, not recruiting",2020-04-30,2021-01-01,No Results Posted,,,2020-12-07,https://clinicaltrials.gov/show/NCT04653857,2020-04-30,0,0
4102,NCT04654325,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04654325,2021-12-01,0,0
4103,NCT04654416,Completed,2020-08-07,2020-08-20,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04654416,2020-08-07,0,0
4104,NCT04654442,Completed,2021-05-05,2021-05-05,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04654442,2021-05-05,0,0
4105,NCT04654481,Recruiting,2021-02-01,2021-11-01,No Results Posted,,,2020-12-04,https://clinicaltrials.gov/show/NCT04654481,2021-02-01,0,0
4106,NCT04655521,Completed,2021-06-30,2021-09-30,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04655521,2021-06-30,0,0
4107,NCT04655586,Completed,2021-12-06,2022-01-19,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04655586,2021-12-06,0,0
4108,NCT04655612,Completed,2021-07-01,2021-07-30,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04655612,2021-07-01,0,0
4109,NCT04655625,"Active, not recruiting",2021-04-02,2022-03-31,No Results Posted,,,2021-04-08,,2021-04-02,0,0
4110,NCT04655638,Completed,2021-09-22,2021-10-25,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04655638,2021-09-22,0,0
4111,NCT04655716,"Active, not recruiting",2022-06-30,2022-12-31,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04655716,2022-06-30,0,0
4112,NCT04656444,Withdrawn,2021-10-01,2021-10-01,No Results Posted,,,2021-07-19,https://clinicaltrials.gov/show/NCT04656444,2021-10-01,0,0
4113,NCT04656613,Not yet recruiting,2021-08-01,2021-12-01,No Results Posted,,,2020-12-07,https://clinicaltrials.gov/show/NCT04656613,2021-08-01,0,0
4114,NCT04656626,Completed,2020-07-21,2020-09-05,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04656626,2020-07-21,0,0
4115,NCT04656691,Terminated,2021-04-18,2021-04-18,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-18,https://clinicaltrials.gov/show/NCT04656691,2021-04-18,1,1
4116,NCT04657263,Completed,2021-05-01,2021-05-30,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04657263,2021-05-01,0,0
4117,NCT04657406,,,,,,,2022-02-03,https://clinicaltrials.gov/show/NCT04657406,,0,0
4118,NCT04657419,Completed,2021-06-13,2021-06-13,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04657419,2021-06-13,0,0
4119,NCT04657445,Completed,2021-05-31,2021-06-30,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04657445,2021-05-31,0,0
4120,NCT04657458,,,,,,,2022-02-09,https://clinicaltrials.gov/show/NCT04657458,,0,0
4121,NCT04657484,Recruiting,2021-12-07,2021-12-07,No Results Posted,"['Dhooria S, Chaudhary S, Sehgal IS, Agarwal R, Arora S, Garg M, Prabhakar N, Puri GD, Bhalla A, Suri V, Yaddanapudi LN, Muthu V, Prasad KT, Aggarwal AN. High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J. 2022 Feb 17;59(2). pii: 2102930. doi: 10.1183/13993003.02930-2021. Print 2022 Feb.']",,2021-06-25,https://clinicaltrials.gov/show/NCT04657484,2021-12-07,0,1
4122,NCT04657497,Completed,2021-03-26,2021-04-09,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04657497,2021-03-26,0,0
4123,NCT04657510,Recruiting,2020-12-01,2020-12-31,No Results Posted,,,2020-12-08,https://clinicaltrials.gov/show/NCT04657510,2020-12-01,0,0
4124,NCT04657809,Completed,2021-02-18,2021-03-20,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04657809,2021-02-18,0,0
4125,NCT04658121,Completed,2021-08-12,2021-08-12,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04658121,2021-08-12,0,0
4126,NCT04658433,Completed,2021-12-20,2022-02-10,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04658433,2021-12-20,0,0
4127,NCT04658979,Recruiting,2021-03-01,2022-01-01,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04658979,2021-03-01,0,0
4128,NCT04659109,Completed,2021-08-06,2021-08-06,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04659109,2021-08-06,0,0
4129,NCT04659122,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04659122,2022-01-01,0,0
4130,NCT04659135,Recruiting,2024-12-01,2025-12-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04659135,2024-12-01,0,0
4131,NCT04659187,Recruiting,2021-05-30,2021-07-01,No Results Posted,"['Gessler N, Gunawardene MA, Wohlmuth P, Arnold D, Behr J, Gloeckner C, Herrlinger K, Hoelting T, Pape UF, Schreiber R, Stang A, Wesseler C, Willems S, Arms C, Herborn CU. Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study. PLoS One. 2021 Jun 17;16(6):e0252867. doi: 10.1371/journal.pone.0252867. eCollection 2021.']",,2020-12-17,https://clinicaltrials.gov/show/NCT04659187,2021-05-30,0,1
4132,NCT04659200,Completed,2020-12-05,2020-12-07,No Results Posted,,"['van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, Sinclair CF, Genden E. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020 Aug 18;11:565. doi: 10.3389/fendo.2020.00565. eCollection 2020.']",2021-01-26,https://clinicaltrials.gov/show/NCT04659200,2020-12-05,0,1
4133,NCT04659239,Enrolling by invitation,2021-09-01,2022-07-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04659239,2021-09-01,0,0
4134,NCT04659252,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04659252,2021-12-01,0,0
4135,NCT04659304,Not yet recruiting,2022-09-01,2022-12-01,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04659304,2022-09-01,0,0
4136,NCT04659356,Recruiting,2021-07-01,2021-07-14,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04659356,2021-07-01,0,0
4137,NCT04659460,Not yet recruiting,2021-03-31,2021-09-01,No Results Posted,,,2020-12-09,https://clinicaltrials.gov/show/NCT04659460,2021-03-31,0,0
4138,NCT04659473,Not yet recruiting,2020-12-20,2020-12-20,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04659473,2020-12-20,0,0
4139,NCT04659486,Enrolling by invitation,2021-04-30,2021-04-30,No Results Posted,,,2020-12-09,https://clinicaltrials.gov/show/NCT04659486,2021-04-30,0,0
4140,NCT04659707,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04659707,2021-12-31,0,0
4141,NCT04659746,Completed,2021-02-28,2021-12-09,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04659746,2021-02-28,0,0
4142,NCT04659759,Recruiting,2021-12-31,2022-06-30,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04659759,2021-12-31,0,0
4143,NCT04659772,Completed,2021-02-03,2021-03-12,Study Results,,,2022-02-15,https://clinicaltrials.gov/show/NCT04659772,2021-02-03,1,0
4144,NCT04659876,Completed,2020-09-01,2020-12-08,No Results Posted,,,2020-12-09,https://clinicaltrials.gov/show/NCT04659876,2020-09-01,0,0
4145,NCT04659889,Completed,2021-06-01,2021-06-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04659889,2021-06-01,0,0
4146,NCT04659928,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04659928,2022-12-01,0,0
4147,NCT04659941,"Active, not recruiting",2021-10-01,2022-10-01,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04659941,2021-10-01,0,0
4148,NCT04660422,Completed,2021-12-31,2021-12-31,No Results Posted,"['Volandes AE, Zupanc SN, Paasche-Orlow MK, Lakin JR, Chang Y, Burns EA, LaVine NA, Carney MT, Martins-Welch D, Emmert K, Itty JE, Moseley ET, Davis AD, El-Jawahri A, Gundersen DA, Fix GM, Yacoub AM, Schwartz P, Gabry-Kalikow S, Garde C, Fischer J, Henault L, Burgess L, Goldman J, Kwok A, Singh N, Alvarez Suarez AL, Gromova V, Jacome S, Tulsky JA, Lindvall C. Association of an Advance Care Planning Video and Communication Intervention With Documentation of Advance Care Planning Among Older Adults: A Nonrandomized Controlled Trial. JAMA Netw Open. 2022 Feb 1;5(2):e220354. doi: 10.1001/jamanetworkopen.2022.0354.']",,2022-02-04,https://clinicaltrials.gov/show/NCT04660422,2021-12-31,0,1
4149,NCT04661410,Completed,2021-09-15,2021-09-15,No Results Posted,"['Juarascio AS, Michael ML, Srivastava P, Manasse SM, Drexler S, Felonis CR. The Reward Re-Training protocol: A novel intervention approach designed to alter the reward imbalance contributing to binge eating during COVID-19. Int J Eat Disord. 2021 Jul;54(7):1316-1322. doi: 10.1002/eat.23528. Epub 2021 Apr 28.']",,2022-03-24,https://clinicaltrials.gov/show/NCT04661410,2021-09-15,0,1
4150,NCT04661423,Recruiting,2023-03-01,2023-03-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04661423,2023-03-01,0,0
4151,NCT04661462,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2020-12-10,https://clinicaltrials.gov/show/NCT04661462,2021-09-30,0,0
4152,NCT04661527,Recruiting,2020-12-30,2020-12-30,No Results Posted,,,2020-12-16,https://clinicaltrials.gov/show/NCT04661527,2020-12-30,0,0
4153,NCT04661540,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04661540,2022-05-01,0,0
4154,NCT04661631,Recruiting,2021-07-31,2021-11-30,Results Submitted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020 Apr;93:201-204. doi: 10.1016/j.ijid.2020.02.033. Epub 2020 Feb 22.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29. Review.', 'Anelli F, Leoni G, Monaco R, Nume C, Rossi RC, Marinoni G, Spata G, De Giorgi D, Peccarisi L, Miani A, Burgio E, Gentile I, Colao A, Triassi M, Piscitelli P. Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak. BMJ. 2020 Mar 26;368:m1254. doi: 10.1136/bmj.m1254.', 'The Lancet. COVID-19: protecting health-care workers. Lancet. 2020 Mar 21;395(10228):922. doi: 10.1016/S0140-6736(20)30644-9.', 'Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Chisty Z, Bell JM, Methner M, Harney J, Jacobs JR, Carlson CM, McLaughlin HP, Stone N, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Russell D, Hiatt B, Gant J, Duchin JS, Clark TA, Honein MA, Reddy SC, Jernigan JA; Public Health - Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):377-381. doi: 10.15585/mmwr.mm6913e1.', 'Tong ZD, Tang A, Li KF, Li P, Wang HL, Yi JP, Zhang YL, Yan JB. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis. 2020 May;26(5):1052-1054. doi: 10.3201/eid2605.200198. Epub 2020 May 17.', 'Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, Shaman J. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020 May 1;368(6490):489-493. doi: 10.1126/science.abb3221. Epub 2020 Mar 16.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Li YK, Peng S, Li LQ, Wang Q, Ping W, Zhang N, Fu XN. Clinical and Transmission Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a Single Thoracic Surgery Department. Curr Med Sci. 2020 Apr;40(2):295-300. doi: 10.1007/s11596-020-2176-2. Epub 2020 Mar 30.', 'Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan LY, Jia Y, Zhang L, Liu D, Xia ZY, Xia Z. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020 Apr 5;21:100331. doi: 10.1016/j.eclinm.2020.100331. eCollection 2020 Apr.', 'Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.', 'Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis. J Med Virol. 2020 Sep;92(9):1449-1459. doi: 10.1002/jmv.25822. Epub 2020 Apr 10.', 'Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.', 'Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, Diao K, Lin B, Zhu X, Li K, Li S, Shan H, Jacobi A, Chung M. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology. 2020 Jun;295(3):200463. doi: 10.1148/radiol.2020200463. Epub 2020 Feb 20.', 'Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur J Radiol. 2020 Jun;127:109009. doi: 10.1016/j.ejrad.2020.109009. Epub 2020 Apr 18.', 'Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol. 2020 May;214(5):1072-1077. doi: 10.2214/AJR.20.22976. Epub 2020 Mar 3.', 'Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, Li X, Zeng W. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020 Aug;30(8):4398-4406. doi: 10.1007/s00330-020-06816-7. Epub 2020 Mar 24.', 'Huang Y, Cheng W, Zhao N, Qu H, Tian J. CT screening for early diagnosis of SARS-CoV-2 infection. Lancet Infect Dis. 2020 Sep;20(9):1010-1011. doi: 10.1016/S1473-3099(20)30241-3. Epub 2020 Mar 26. Erratum in: Lancet Infect Dis. 2020 Aug;20(8):e180.', 'Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, Lui MM, Lee JCY, Chiu KW, Chung TW, Lee EYP, Wan EYF, Hung IFN, Lam TPW, Kuo MD, Ng MY. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020 Aug;296(2):E72-E78. doi: 10.1148/radiol.2020201160. Epub 2020 Mar 27.', 'Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012 Apr;38(4):577-91. doi: 10.1007/s00134-012-2513-4. Epub 2012 Mar 6. Review.', 'Lichtenstein DA, Malbrain MLNG. Lung ultrasound in the critically ill (LUCI): A translational discipline. Anaesthesiol Intensive Ther. 2017;49(5):430-436. doi: 10.5603/AIT.a2017.0063. Epub 2017 Nov 18. Review.', 'Testa A, Soldati G, Copetti R, Giannuzzi R, Portale G, Gentiloni-Silveri N. Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound. Crit Care. 2012 Feb 17;16(1):R30. doi: 10.1186/cc11201.', 'Peng QY, Wang XT, Zhang LN; Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med. 2020 May;46(5):849-850. doi: 10.1007/s00134-020-05996-6. Epub 2020 Mar 12.', 'Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, Perlini S, Torri E, Mariani A, Mossolani EE, Tursi F, Mento F, Demi L. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method. J Ultrasound Med. 2020 Jul;39(7):1413-1419. doi: 10.1002/jum.15285. Epub 2020 Apr 13.', 'Vetrugno L, Bove T, Orso D, Barbariol F, Bassi F, Boero E, Ferrari G, Kong R. Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography. 2020 Apr;37(4):625-627. doi: 10.1111/echo.14664. Epub 2020 Apr 15. Review.', 'Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med. 1996 Sep;3(9):895-900. Review.']",2020-12-17,https://clinicaltrials.gov/show/NCT04661631,2021-07-31,0,1
4155,NCT04661657,Recruiting,2021-12-31,2022-09-30,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04661657,2021-12-31,0,0
4156,NCT04661813,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04661813,2022-12-31,0,0
4157,NCT04661839,Completed,2021-07-27,2021-07-27,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04661839,2021-07-27,0,0
4158,NCT04661930,Recruiting,2022-03-01,2022-06-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04661930,2022-03-01,0,0
4159,NCT04662021,Enrolling by invitation,2021-02-10,2021-02-25,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04662021,2021-02-10,0,0
4160,NCT04662060,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04662060,2022-08-01,0,0
4161,NCT04662073,"Active, not recruiting",2022-08-01,2022-08-01,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04662073,2022-08-01,0,0
4162,NCT04662086,Recruiting,2022-08-01,2022-08-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-20,https://clinicaltrials.gov/show/NCT04662086,2022-08-01,0,1
4163,NCT04662437,Completed,2020-12-01,2020-12-09,No Results Posted,,"['Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan XH, Dai L, Shi QK, Yuan ST, Yu WK, Xu HY, Gu W, Qi JW. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging (Albany NY). 2020 Jun 25;12(12):11287-11295. doi: 10.18632/aging.103526. Epub 2020 Jun 25.', 'di Filippo L, Formenti AM, Doga M, Frara S, Rovere-Querini P, Bosi E, Carlucci M, Giustina A. Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine. 2021 Jan;71(1):9-13. doi: 10.1007/s12020-020-02541-9. Epub 2020 Nov 9.', 'Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Katulanda P, Grossman AB. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. J Endocr Soc. 2020 Jul 2;4(8):bvaa082. doi: 10.1210/jendso/bvaa082. eCollection 2020 Aug 1. Review.']",2020-12-10,https://clinicaltrials.gov/show/NCT04662437,2020-12-01,0,1
4164,NCT04662671,Completed,2020-12-09,2021-01-30,Results Submitted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04662671,2020-12-09,0,0
4165,NCT04662684,"Active, not recruiting",2021-08-10,2021-08-30,No Results Posted,"['Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, Lins Dos Santos J, Volpiani GG, Sobreira ML, Joviliano EE, Bohatch J√∫nior MS, da Fonseca BAL, Ribeiro MS, Dusilek C, Itinose K, Sanches SMV, de Almeida Araujo Ramos K, de Moraes NF, Tierno PFGMM, de Oliveira ALML, Tachibana A, Chate RC, Santos MVB, de Menezes Cavalcante BB, Moreira RCR, Chang C, Tafur A, Fareed J, Lopes RD; MICHELLE investigators. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022 Jan 1;399(10319):50-59. doi: 10.1016/S0140-6736(21)02392-8. Epub 2021 Dec 15.']",,2021-08-03,https://clinicaltrials.gov/show/NCT04662684,2021-08-10,0,1
4166,NCT04662697,"Active, not recruiting",2021-12-31,2022-04-30,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04662697,2021-12-31,0,0
4167,NCT04663555,Recruiting,2022-04-30,2023-04-30,No Results Posted,"['Mal√°ska J, Sta≈°ek J, Du≈°ka F, Bal√≠k M, M√°ca J, Hruda J, Vymazal T, Klementov√° O, Zatloukal J, Gabrhel√≠k T, Novotn√Ω P, Demlov√° R, Kub√°tov√° J, Vinklerov√° J, Svobodn√≠k A, Kratochv√≠l M, Kluƒçka J, G√°l R, Singer M; REMED Study Group. Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial. Trials. 2022 Jan 15;23(1):35. doi: 10.1186/s13063-021-05963-6.', 'Mal√°ska J, Sta≈°ek J, Du≈°ka F, Bal√≠k M, M√°ca J, Hruda J, Vymazal T, Klementov√° O, Zatloukal J, Gabrhel√≠k T, Novotn√Ω P, Demlov√° R, Kub√°tov√° J, Vinklerov√° J, Svobodn√≠k A, Kratochv√≠l M, Kluƒçka J, G√°l R, Singer M; REMED Study Group. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.']",,2022-03-03,https://clinicaltrials.gov/show/NCT04663555,2022-04-30,0,1
4168,NCT04663594,Completed,2021-02-10,2021-02-10,No Results Posted,"['Syed Sheriff RJ, Vuorre M, Riga E, Przybylski AK, Adams H, Harmer CJ, Geddes JR. A cultural experience to support mental health in people aged 16-24 during the COVID-19 pandemic compared to a typical museum website: study protocol of an online randomised controlled trial. Trials. 2021 Jul 22;22(1):482. doi: 10.1186/s13063-021-05441-z.']",,2021-10-08,https://clinicaltrials.gov/show/NCT04663594,2021-02-10,0,1
4169,NCT04663659,Completed,2020-05-15,2020-05-15,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04663659,2020-05-15,0,0
4170,NCT04663737,"Active, not recruiting",2021-08-16,2021-09-30,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04663737,2021-08-16,0,0
4171,NCT04663776,Completed,2021-12-08,2021-12-08,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04663776,2021-12-08,0,0
4172,NCT04663906,Not yet recruiting,2021-05-31,2021-05-31,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04663906,2021-05-31,0,0
4173,NCT04663945,Completed,2021-08-12,2021-12-27,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04663945,2021-08-12,0,0
4174,NCT04664010,"Active, not recruiting",2021-01-14,2021-01-31,No Results Posted,,,2020-12-11,https://clinicaltrials.gov/show/NCT04664010,2021-01-14,0,0
4175,NCT04664023,Recruiting,2022-12-30,2022-12-30,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04664023,2022-12-30,0,0
4176,NCT04664049,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04664049,2022-12-31,0,0
4177,NCT04664075,Suspended,2022-04-30,2022-06-30,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04664075,2022-04-30,0,0
4178,NCT04664101,Recruiting,2024-01-01,2024-01-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04664101,2024-01-01,0,0
4179,NCT04664296,Completed,2021-03-23,2021-03-23,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04664296,2021-03-23,0,0
4180,NCT04664309,Completed,2022-01-06,2022-01-06,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04664309,2022-01-06,0,0
4181,NCT04665115,Withdrawn,2022-05-01,2025-05-01,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04665115,2022-05-01,0,0
4182,NCT04665193,Completed,2021-02-28,2021-04-28,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04665193,2021-02-28,0,0
4183,NCT04665245,Enrolling by invitation,2022-03-01,2022-03-01,No Results Posted,,,2021-11-04,https://clinicaltrials.gov/show/NCT04665245,2022-03-01,0,0
4184,NCT04665258,Recruiting,2022-06-14,2023-06-14,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04665258,2022-06-14,0,0
4185,NCT04665752,Completed,2022-01-28,2022-01-28,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04665752,2022-01-28,0,0
4186,NCT04665778,Completed,2021-03-01,2021-03-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04665778,2021-03-01,0,0
4187,NCT04665960,Completed,2021-04-25,2021-05-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04665960,2021-04-25,0,0
4188,NCT04666012,"Active, not recruiting",2021-07-09,2022-04-01,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04666012,2021-07-09,0,0
4189,NCT04666025,Recruiting,2022-09-23,2022-09-23,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04666025,2022-09-23,0,0
4190,NCT04666064,Completed,2021-04-28,2021-04-28,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04666064,2021-04-28,0,0
4191,NCT04666116,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,2020-12-16,https://clinicaltrials.gov/show/NCT04666116,2020-12-01,0,0
4192,NCT04666207,Completed,2020-12-10,2020-12-30,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04666207,2020-12-10,0,0
4193,NCT04666233,Completed,2021-03-23,2021-03-23,No Results Posted,"['Cavallin F, Lupi F, Bua B, Bellutti M, Staffler A, Trevisanuto D. Impact of personal protective equipment on neonatal resuscitation procedures: a randomised, cross-over, simulation study. Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107(2):211-215. doi: 10.1136/archdischild-2021-322216. Epub 2021 Sep 6.']","['Watson CM, Duval-Arnould JM, McCrory MC, Froz S, Connors C, Perl TM, Hunt EA. Simulated pediatric resuscitation use for personal protective equipment adherence measurement and training during the 2009 influenza (H1N1) pandemic. Jt Comm J Qual Patient Saf. 2011 Nov;37(11):515-23.', 'Trevisanuto D, Moschino L, Doglioni N, Roehr CC, Gervasi MT, Baraldi E. Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan. Neonatology. 2020;117(2):133-140. doi: 10.1159/000507935. Epub 2020 Apr 24. Review.', 'Aziz K, Lee HC, Escobedo MB, Hoover AV, Kamath-Rayne BD, Kapadia VS, Magid DJ, Niermeyer S, Schm√∂lzer GM, Szyld E, Weiner GM, Wyckoff MH, Yamada NK, Zaichkin J. Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020 Oct 20;142(16_suppl_2):S524-S550. doi: 10.1161/CIR.0000000000000902. Epub 2020 Oct 21.']",2021-04-01,,2021-03-23,0,1
4194,NCT04666246,Recruiting,2021-06-01,2023-02-01,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04666246,2021-06-01,0,0
4195,NCT04666285,Completed,2021-08-01,2021-08-01,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04666285,2021-08-01,0,0
4196,NCT04666311,Recruiting,2022-02-28,2022-05-31,No Results Posted,"['Gils T, Lynen L, Muhairwe J, Mashaete K, Lejone TI, Joseph P, Ngubane T, Keter AK, Reither K, van Heerden A. Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol. BMJ Open. 2022 Feb 7;12(2):e057291. doi: 10.1136/bmjopen-2021-057291.']",,2022-01-26,https://clinicaltrials.gov/show/NCT04666311,2022-02-28,0,1
4197,NCT04666441,Completed,2021-03-04,2021-09-21,Results Submitted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-10-08,https://clinicaltrials.gov/show/NCT04666441,2021-03-04,0,1
4198,NCT04666493,Recruiting,2021-11-30,2021-11-30,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04666493,2021-11-30,0,0
4199,NCT04666558,"Active, not recruiting",2021-12-17,2022-04-01,No Results Posted,"['Cruz C, Prado CM, Punja S, Tandon P. Use of digital technologies in the nutritional management of catabolism-prone chronic diseases: A rapid review. Clin Nutr ESPEN. 2021 Dec;46:152-166. doi: 10.1016/j.clnesp.2021.10.020. Epub 2021 Nov 1. Review.']",,2022-02-15,https://clinicaltrials.gov/show/NCT04666558,2021-12-17,0,1
4200,NCT04666753,Completed,2020-09-29,2020-09-29,No Results Posted,,,2020-12-14,https://clinicaltrials.gov/show/NCT04666753,2020-09-29,0,0
4201,NCT04666779,Completed,2021-02-21,2021-09-15,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04666779,2021-02-21,0,0
4202,NCT04667247,Recruiting,2022-06-30,2022-12-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04667247,2022-06-30,0,0
4203,NCT04667286,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04667286,2021-06-01,0,0
4204,NCT04667442,Completed,2021-12-14,2021-12-14,No Results Posted,,,2021-12-27,https://clinicaltrials.gov/show/NCT04667442,2021-12-14,0,0
4205,NCT04746183,Recruiting,2021-11-18,2022-04-30,No Results Posted,"['Walker LE, FitzGerald R, Saunders G, Lyon R, Fisher M, Martin K, Eberhart I, Woods C, Ewings S, Hale C, Rajoli RKR, Else L, Dilly-Penchala S, Amara A, Lalloo DG, Jacobs M, Pertinez H, Hatchard P, Waugh R, Lawrence M, Johnson L, Fines K, Reynolds H, Rowland T, Crook R, Okenyi E, Byrne K, Mozgunov P, Jaki T, Khoo S, Owen A, Griffiths G, Fletcher TE; AGILE platform. An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2. Clin Pharmacol Ther. 2022 Mar;111(3):585-594. doi: 10.1002/cpt.2463. Epub 2021 Nov 13.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Griffiths GO, FitzGerald R, Jaki T, Corkhill A, Reynolds H, Ewings S, Condie S, Tilt E, Johnson L, Radford M, Simpson C, Saunders G, Yeats S, Mozgunov P, Tansley-Hancock O, Martin K, Downs N, Eberhart I, Martin JWB, Goncalves C, Song A, Fletcher T, Byrne K, Lalloo DG, Owen A, Jacobs M, Walker L, Lyon R, Woods C, Gibney J, Chiong J, Chandiwana N, Jacob S, Lamorde M, Orrell C, Pirmohamed M, Khoo S; AGILE investigators. AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. Trials. 2021 Jul 26;22(1):487. doi: 10.1186/s13063-021-05458-4.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04746183,2021-11-18,0,1
4206,NCT04323527,Completed,2020-05-07,2020-06-07,No Results Posted,"['Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mour√£o MPG, Brito-Sousa JD, Ba√≠a-da-Silva D, Guerra MVF, Hajjar LA, Pinto RC, Balieiro AAS, Pacheco AGF, Santos JDO Jr, Naveca FG, Xavier MS, Siqueira AM, Schwarzbold A, Croda J, Nogueira ML, Romero GAS, Bassat Q, Fontes CJ, Albuquerque BC, Daniel-Ribeiro CT, Monteiro WM, Lacerda MVG; CloroCovid-19 Team. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Netw Open. 2020 Apr 24;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857.']",,2021-08-09,,2020-05-07,0,1
4207,NCT04335552,Terminated,2020-06-17,2020-06-26,Study Results,,,2021-05-17,,2020-06-17,1,0
4208,NCT04341727,Terminated,2021-04-01,2021-04-01,Results Submitted,,,2021-10-07,,2021-04-01,0,0
4209,NCT04337424,Completed,2020-10-07,2020-10-07,No Results Posted,,,2020-11-04,,2020-10-07,0,0
4210,NCT04370067,Recruiting,2021-05-01,2021-08-01,No Results Posted,"['Merkely B, Szab√≥ AJ, Kosztin A, Ber√©nyi E, Sebesty√©n A, Lengyel C, Merkely G, Kar√°dy J, V√°rkonyi I, Papp C, Miseta A, Betlehem J, Buri√°n K, Cs√≥ka I, V√°s√°rhelyi B, Ludwig E, Prinz G, Sink√≥ J, Hank√≥ B, Varga P, F√ºl√∂p G√Å, Mag K, Vok√≥ Z; HUNgarian COronaVirus-19 Epidemiological Research (H-UNCOVER) investigators. Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary. Geroscience. 2020 Aug;42(4):1063-1074. doi: 10.1007/s11357-020-00226-9. Epub 2020 Jul 17.']",,2020-06-16,,2021-05-01,0,1
4211,NCT04575597,"Active, not recruiting",2022-05-05,2022-05-05,No Results Posted,"['Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Mart√≠n-Quir√≥s A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.']",,2021-11-04,https://clinicaltrials.gov/show/NCT04575597,2022-05-05,0,1
4212,NCT04583995,"Active, not recruiting",2023-01-28,2023-01-28,No Results Posted,"['Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, Minassian AM, Cho I, Kumar L, Plested JS, Rivers EJ, Robertson A, Dubovsky F, Glenn G, Heath PT; 2019nCoV-302 Study Group. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022 Feb;10(2):167-179. doi: 10.1016/S2213-2600(21)00409-4. Epub 2021 Nov 17.']",,2022-03-10,,2023-01-28,0,1
4213,NCT04614948,"Active, not recruiting",2022-05-10,2023-05-31,No Results Posted,,,2022-03-16,,2022-05-10,0,0
4214,NCT04509973,Completed,2021-06-17,2022-02-01,No Results Posted,"['Durr KM, Hendin A, Perry JJ. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. CJEM. 2022 Mar 29. doi: 10.1007/s43678-022-00293-1. [Epub ahead of print]', 'Granholm A, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Kj√¶r MN, Vesterlund GK, Meyhoff TS, Helleberg M, M√∏ller MH, Benfield T, Venkatesh B, Hammond NE, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, J√∏rgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Br√∏chner AC, Str√∏m T, M√∏ller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Wamberg CA, Gluud C, Lange T, Perner A. Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med. 2022 Jan;48(1):45-55. doi: 10.1007/s00134-021-06573-1. Epub 2021 Nov 10.', 'COVID STEROID 2 Trial Group, Munch MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, Benfield T, Wahlin RR, Rasmussen BS, Andreasen AS, Poulsen LM, Cioccari L, Khan MS, Kapadia F, Divatia JV, Br√∏chner AC, Bestle MH, Helleberg M, Michelsen J, Padmanaban A, Bose N, M√∏ller A, Borawake K, Kristiansen KT, Shukla U, Chew MS, Dixit S, Ulrik CS, Amin PR, Chawla R, Wamberg CA, Shah MS, Darfelt IS, J√∏rgensen VL, Smitt M, Granholm A, Kj√¶r MN, M√∏ller MH, Meyhoff TS, Vesterlund GK, Hammond NE, Micallef S, Bassi A, John O, Jha A, Cronhjort M, Jakob SM, Gluud C, Lange T, Kadam V, Marcussen KV, Hollenberg J, Hedman A, Nielsen H, Schj√∏rring OL, Jensen MQ, Leistner JW, Jonassen TB, Kristensen CM, Clapp EC, Hjorts√∏ CJS, Jensen TS, Halstad LS, Bak ERB, Zaabalawi R, Metcalf-Clausen M, Abdi S, Hatley EV, Aksnes TS, Gleipner-Andersen E, Alarc√≥n AF, Yamin G, Heymowski A, Berggren A, La Cour K, Weihe S, Pind AH, Engstr√∏m J, Jha V, Venkatesh B, Perner A. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. JAMA. 2021 Nov 9;326(18):1807-1817. doi: 10.1001/jama.2021.18295. Erratum in: JAMA. 2021 Dec 14;326(22):2333. JAMA. 2022 Jan 18;327(3):286.', 'Granholm A, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Kjaer MN, Vesterlund GK, Meyhoff TS, Helleberg M, M√∏ller MH, Benfield T, Venkatesh B, Hammond N, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, J√∏rgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Br√∏chner AC, Str√∏m T, M√∏ller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Gluud C, Lange T, Perner A. Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis. Acta Anaesthesiol Scand. 2021 May;65(5):702-710. doi: 10.1111/aas.13793. Epub 2021 Feb 25.']",,2022-02-24,,2021-06-17,0,1
4215,NCT04452318,Completed,2021-10-04,2021-10-04,No Results Posted,"[""O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939."", 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', ""O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4."", ""O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM. Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention. medRxiv. 2021 Jun 17. pii: 2021.06.14.21258567. doi: 10.1101/2021.06.14.21258567. Update in: N Engl J Med. 2021 Aug 4;:."", ""O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial. medRxiv. 2021 Sep 18. pii: 2021.06.14.21258569. doi: 10.1101/2021.06.14.21258569. Update in: JAMA. 2022 Feb 1;327(5):432-441.""]",,2021-10-07,https://clinicaltrials.gov/show/NCT04452318,2021-10-04,0,1
4216,NCT04283825,Withdrawn,2020-04-30,2020-05-15,No Results Posted,,,2020-03-17,,2020-04-30,0,0
4217,NCT04417335,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,2020-06-04,https://clinicaltrials.gov/show/NCT04417335,2021-05-01,0,0
4218,NCT04555148,Completed,2021-01-22,2021-04-23,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04555148,2021-01-22,0,0
4219,NCT03188796,Recruiting,2022-12-01,2023-02-01,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.', 'Amrein K, Parekh D, Westphal S, Preiser JC, Berghold A, Riedl R, Eller P, Schellongowski P, Thickett D, Meybohm P; VITDALIZE Collaboration Group. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ Open. 2019 Nov 12;9(11):e031083. doi: 10.1136/bmjopen-2019-031083.']",,2021-12-16,https://clinicaltrials.gov/show/NCT03188796,2022-12-01,0,1
4220,NCT04672590,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04672590,2021-12-01,0,0
4221,NCT04676971,Completed,2021-08-29,2021-10-28,No Results Posted,,,2021-12-01,https://clinicaltrials.gov/show/NCT04676971,2021-08-29,0,0
4222,NCT04679415,Completed,2021-08-19,2021-08-19,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04679415,2021-08-19,0,0
4223,NCT04681001,Recruiting,2021-05-30,2021-06-30,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04681001,2021-05-30,0,0
4224,NCT04694482,Recruiting,2021-01-31,2021-01-31,Results Submitted,"['Caldiroli A, Capuzzi E, Tringali A, Tagliabue I, Turco M, Fortunato A, Sibilla M, Montana C, Maggioni L, Pellicioli C, Marcatili M, Nava R, Crespi G, Colmegna F, Buoli M, Clerici M. The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study. Psychiatry Res. 2022 Jan;307:114334. doi: 10.1016/j.psychres.2021.114334. Epub 2021 Dec 7.']",,2021-01-06,https://clinicaltrials.gov/show/NCT04694482,2021-01-31,0,1
4225,NCT04695457,Completed,2020-11-16,2020-11-16,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04695457,2020-11-16,0,0
4226,NCT04695678,"Active, not recruiting",2021-07-30,2021-12-30,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04695678,2021-07-30,0,0
4227,NCT04695743,Recruiting,2022-06-01,2022-09-01,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04695743,2022-06-01,0,0
4228,NCT04695756,Recruiting,2021-06-15,2021-07-15,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04695756,2021-06-15,0,0
4229,NCT04695821,Not yet recruiting,2021-02-01,2021-03-01,No Results Posted,,,2021-01-05,https://clinicaltrials.gov/show/NCT04695821,2021-02-01,0,0
4230,NCT04696562,Not yet recruiting,2021-03-31,2021-03-31,No Results Posted,"['√ñner Cengiz H, Ayhan M, G√ºner R. Effect of deep breathing exercise with Triflo on dyspnoea, anxiety and quality of life in patients receiving covid-19 treatment: A randomized controlled trial. J Clin Nurs. 2021 Dec 12. doi: 10.1111/jocn.16171. [Epub ahead of print]']",,2021-01-06,https://clinicaltrials.gov/show/NCT04696562,2021-03-31,0,1
4231,NCT04696601,Not yet recruiting,2021-02-10,2022-02-10,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04696601,2021-02-10,0,0
4232,NCT04696913,Not yet recruiting,2021-11-22,2021-11-22,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04696913,2021-11-22,0,0
4233,NCT04697030,Completed,2020-10-15,2020-12-22,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04697030,2020-10-15,0,0
4234,NCT04697927,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04697927,2022-12-01,0,0
4235,NCT04698044,Completed,2020-06-25,2020-06-25,No Results Posted,,,2021-01-07,https://clinicaltrials.gov/show/NCT04698044,2020-06-25,0,0
4236,NCT04698083,Completed,2020-10-15,2020-11-05,No Results Posted,,,2021-01-06,https://clinicaltrials.gov/show/NCT04698083,2020-10-15,0,0
4237,NCT04699097,Completed,2020-09-01,2020-11-01,No Results Posted,,,2021-01-07,https://clinicaltrials.gov/show/NCT04699097,2020-09-01,0,0
4238,NCT04699227,Recruiting,2023-04-30,2023-04-30,No Results Posted,"['Davidson SM, Lukhna K, Gorog DA, Salama AD, Castillo AR, Giesz S, Golforoush P, Kalkhoran SB, Lecour S, Imamdin A, do Carmo HRP, Bovi TG, Perroud MW Jr, Ntsekhe M, Sposito AC, Yellon DM. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovasc Drugs Ther. 2021 Jun 25. doi: 10.1007/s10557-021-07221-y. [Epub ahead of print] Erratum in: Cardiovasc Drugs Ther. 2021 Jul 7;:.']",,2021-09-29,https://clinicaltrials.gov/show/NCT04699227,2023-04-30,0,1
4239,NCT04699578,Recruiting,2021-12-31,2022-05-01,No Results Posted,,,2021-01-07,https://clinicaltrials.gov/show/NCT04699578,2021-12-31,0,0
4240,NCT04699851,Recruiting,2021-04-18,2021-05-18,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04699851,2021-04-18,0,0
4241,NCT04701515,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04701515,2022-12-31,0,0
4242,NCT04701528,Recruiting,2022-03-25,2022-10-25,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04701528,2022-03-25,0,0
4243,NCT04701905,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04701905,2021-04-30,0,0
4244,NCT04701944,Recruiting,2021-04-21,2021-04-21,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04701944,2021-04-21,0,0
4245,NCT04702295,Not yet recruiting,2023-02-01,2023-08-01,No Results Posted,,,2021-01-08,https://clinicaltrials.gov/show/NCT04702295,2023-02-01,0,0
4246,NCT04702945,Recruiting,2022-12-31,2023-12-31,No Results Posted,"[""Hohl CM, Rosychuk RJ, Archambault PM, O'Sullivan F, Leeies M, Mercier √â, Clark G, Innes GD, Brooks SC, Hayward J, Ho V, Jelic T, Welsford M, Sivilotti MLA, Morrison LJ, Perry JJ; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers and the Canadian Critical Care Trials Group. The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study. CMAJ Open. 2022 Feb 8;10(1):E90-E99. doi: 10.9778/cmajo.20210243. Print 2022 Jan-Mar."", 'McRae AD, Hohl CM, Rosychuk R, Vatanpour S, Ghaderi G, Archambault PM, Brooks SC, Cheng I, Davis P, Hayward J, Lang E, Ohle R, Rowe B, Welsford M, Yadav K, Morrison LJ, Perry J; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers and the Canadian Critical Care Trials Group. CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19. BMJ Open. 2021 Dec 2;11(12):e055832. doi: 10.1136/bmjopen-2021-055832.', 'Hohl CM, Rosychuk RJ, McRae AD, Brooks SC, Archambault P, Fok PT, Davis P, Jelic T, Turner JP, Rowe BH, Mercier √â, Cheng I, Taylor J, Daoust R, Ohle R, Andolfatto G, Atzema C, Hayward J, Khangura JK, Landes M, Lang E, Martin I, Mohindra R, Ting DK, Vaillancourt S, Welsford M, Brar B, Dahn T, Wiemer H, Yadav K, Yan JW, Stachura M, McGavin C, Perry JJ, Morrison LJ; Canadian COVID-19 Emergency Department Rapid Response Network investigators and for the Network of Canadian Emergency Researchers and the Canadian Critical Care Trials Group. Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology study. CMAJ Open. 2021 Mar 17;9(1):E261-E270. doi: 10.9778/cmajo.20200290. Print 2021 Jan-Mar.']",,2021-01-11,https://clinicaltrials.gov/show/NCT04702945,2022-12-31,0,1
4247,NCT04703270,Recruiting,2023-01-03,2023-01-03,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04703270,2023-01-03,0,0
4248,NCT04703478,Not yet recruiting,2021-04-20,2021-04-20,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04703478,2021-04-20,0,0
4249,NCT04703777,Completed,2021-04-04,2021-04-04,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04703777,2021-04-04,0,0
4250,NCT04703907,Recruiting,2021-08-01,2021-08-01,No Results Posted,,,2021-01-11,https://clinicaltrials.gov/show/NCT04703907,2021-08-01,0,0
4251,NCT04705831,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-01-12,https://clinicaltrials.gov/show/NCT04705831,2022-01-01,0,0
4252,NCT04706260,Completed,2021-04-14,2021-04-14,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04706260,2021-04-14,0,0
4253,NCT03963622,Recruiting,2022-05-01,2022-11-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT03963622,2022-05-01,0,0
4254,NCT04683328,Not yet recruiting,2021-05-25,2021-11-25,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-01-20,https://clinicaltrials.gov/show/NCT04683328,2021-05-25,0,1
4255,NCT04686773,"Active, not recruiting",2021-11-01,2022-03-07,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04686773,2021-11-01,0,0
4256,NCT04694573,Recruiting,2021-12-28,2022-12-28,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04694573,2021-12-28,0,0
4257,NCT04701996,Recruiting,2021-12-20,2022-02-28,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04701996,2021-12-20,0,0
4258,NCT04705753,Completed,2020-10-15,2020-10-15,No Results Posted,,"['Lionis C, Faresj√∂ A, Skoula M, Kapsokefalou M, Faresj√∂ T. Antioxidant effects of herbs in Crete. Lancet. 1998 Dec 19-26;352(9145):1987-8.', 'Duijker G, Bertsias A, Symvoulakis EK, Moschandreas J, Malliaraki N, Derdas SP, Tsikalas GK, Katerinopoulos HE, Pirintsos SA, Sourvinos G, Castanas E, Lionis C. Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: results from a double-blind randomized controlled trial. J Ethnopharmacol. 2015 Apr 2;163:157-66. doi: 10.1016/j.jep.2015.01.030. Epub 2015 Jan 30.', 'Tseliou, M., Pirintsos, S. A., Lionis, C., Castanas, E., and Sourvinos, G. (2019). Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract. J. Herb. Med. 17-18, 100288. doi:10.1016/j.hermed.2019.100288.', 'Pirintsos SA, Bariotakis M, Kampa M, Sourvinos G, Lionis C, Castanas E. The Therapeutic Potential of the Essential Oil of Thymbra capitata (L.) Cav., Origanum dictamnus L. and Salvia fruticosa Mill. And a Case of Plant-Based Pharmaceutical Development. Front Pharmacol. 2020 Nov 24;11:522213. doi: 10.3389/fphar.2020.522213. eCollection 2020. Review.', 'Anastasaki M, Bertsias A, Pirintsos SA, Castanas E, Lionis C. Post-market outcome of an extract of traditional Cretan herbs on upper respiratory tract infections: a pragmatic, prospective observational study. BMC Complement Altern Med. 2017 Sep 21;17(1):466. doi: 10.1186/s12906-017-1978-7.']",2021-01-12,https://clinicaltrials.gov/show/NCT04705753,2020-10-15,0,1
4259,NCT04706039,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04706039,2021-09-01,0,0
4260,NCT04706143,Not yet recruiting,2021-06-01,2021-08-01,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04706143,2021-06-01,0,0
4261,NCT04706325,Recruiting,2021-05-01,2021-05-15,No Results Posted,,"['Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.', 'Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour Sh, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9:e31. doi: 10.34172/jnp.2020.31', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.']",2021-01-12,https://clinicaltrials.gov/show/NCT04706325,2021-05-01,0,1
4262,NCT04706390,Recruiting,2022-01-12,2024-01-12,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04706390,2022-01-12,0,0
4263,NCT04706416,Completed,2021-01-15,2021-01-15,Study Results,['Hassan AE. An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting. Ann Med Surg (Lond). 2021 Aug;68:102574. doi: 10.1016/j.amsu.2021.102574. Epub 2021 Jul 16.'],,2021-11-04,https://clinicaltrials.gov/show/NCT04706416,2021-01-15,1,1
4264,NCT04707339,Recruiting,2020-10-31,2021-01-30,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04707339,2020-10-31,0,0
4265,NCT04707742,Completed,2021-09-18,2021-09-30,No Results Posted,"['Ferrer MD, Barrueco √ÅS, Martinez-Beneyto Y, Mateos-Moreno MV, Ausina-M√°rquez V, Garc√≠a-V√°zquez E, Puche-Torres M, Giner MJF, Gonz√°lez AC, Coello JMS, Rueda IA, Aub√° JMV, Espa√±ol CC, Velasco AL, Abad DS, Garc√≠a-Esteban S, Artacho A, L√≥pez-Labrador X, Mira A. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2. Sci Rep. 2021 Dec 22;11(1):24392. doi: 10.1038/s41598-021-03461-y.']",,2021-10-11,https://clinicaltrials.gov/show/NCT04707742,2021-09-18,0,1
4266,NCT04707820,Recruiting,2021-06-10,2021-06-10,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04707820,2021-06-10,0,0
4267,NCT04707833,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2021-01-13,https://clinicaltrials.gov/show/NCT04707833,2023-12-01,0,0
4268,NCT04708158,Recruiting,2023-04-30,2023-04-30,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04708158,2023-04-30,0,0
4269,NCT04708327,Recruiting,2022-06-30,2022-09-30,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04708327,2022-06-30,0,0
4270,NCT04708457,Not yet recruiting,2022-12-01,2023-01-31,No Results Posted,,,2021-08-06,https://clinicaltrials.gov/show/NCT04708457,2022-12-01,0,0
4271,NCT04709003,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04709003,2022-06-01,0,0
4272,NCT04709146,Not yet recruiting,2022-02-28,2022-06-30,No Results Posted,,,2021-01-14,https://clinicaltrials.gov/show/NCT04709146,2022-02-28,0,0
4273,NCT04709172,Completed,2021-08-15,2021-08-15,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04709172,2021-08-15,0,0
4274,NCT04709302,Recruiting,2022-06-01,2022-12-01,No Results Posted,"['Goswami N, Fredriksen PM, Lundin KEA, Agu C, Elias SO, Motaung KS, Brix B, Cvirn G, Sourij H, Stelzl E, Kessler HH, Salon A, Nkeh-Chungag B. COVID-19 and its effects on endothelium in HIV-positive patients in sub-Saharan Africa: Cardiometabolic risk, thrombosis and vascular function (ENDOCOVID STUDY). BMC Infect Dis. 2021 Jul 31;21(1):719. doi: 10.1186/s12879-021-06426-8.']",,2021-09-08,https://clinicaltrials.gov/show/NCT04709302,2022-06-01,0,1
4275,NCT04709744,Completed,2020-12-25,2020-12-30,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04709744,2020-12-25,0,0
4276,NCT04710316,Recruiting,2022-04-30,2022-09-30,No Results Posted,,,2021-09-27,https://clinicaltrials.gov/show/NCT04710316,2022-04-30,0,0
4277,NCT04711954,Recruiting,2021-11-01,2022-11-01,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04711954,2021-11-01,0,0
4278,NCT04712045,Completed,2020-12-12,2020-12-12,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04712045,2020-12-12,0,0
4279,NCT04712175,Recruiting,2021-08-05,2022-03-30,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04712175,2021-08-05,0,0
4280,NCT04712279,Not yet recruiting,2021-03-21,2021-04-20,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Li L, Liu J, Qin K. Comparison of double-dose vs standard-dose oseltamivir in the treatment of influenza: A systematic review and meta-analysis. J Clin Pharm Ther. 2020 Oct;45(5):918-926. doi: 10.1111/jcpt.13203. Epub 2020 Jun 4.', 'Varghese FS, Kaukinen P, Gl√§sker S, Bespalov M, Hanski L, Wennerberg K, K√ºmmerer BM, Ahola T. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Antiviral Res. 2016 Feb;126:117-24. doi: 10.1016/j.antiviral.2015.12.012. Epub 2016 Jan 2.', 'Padhy BM, Mohanty RR, Das S, Meher BR. Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis. J Pharm Pharm Sci. 2020;23:462-469. doi: 10.18433/jpps31457.', 'Rajter JC, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter JJ. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study. Chest. 2021 Jan;159(1):85-92. doi: 10.1016/j.chest.2020.10.009. Epub 2020 Oct 13.', 'Elgazzar, A et al. Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic. Research Square doi.org/10.21203, 2020', 'Chowdhury, ATMM et al. A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients. Research Square: https://doi.org/10.21203/rs.3.rs-38896/v1, 2020.', 'Niaee, MS et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial. Research Square: https://doi.org/10.21203/rs.3.rs-109670/v1, 2020.', 'Franc√©s-Monerris, A et al. Has Ivermectin Virus-Directed Effects against SARS-CoV-2? Rationalizing the Action of a Potential Multitarget Antiviral Agent. ChemRxiv, 2020.']",2021-01-15,https://clinicaltrials.gov/show/NCT04712279,2021-03-21,0,1
4281,NCT04712292,Recruiting,2022-02-15,2022-04-01,No Results Posted,,"['Greenwood E, Swanton C. Consequences of COVID-19 for cancer care - a CRUK perspective. Nat Rev Clin Oncol. 2021 Jan;18(1):3-4. doi: 10.1038/s41571-020-00446-0.', 'Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, Mula-Hussain L, Errihani H, Khattak A, De Guzman RB, Mathias C, Alkaiyat MOF, Jradi H, Rolfo C; International Research Network on COVID-19 Impact on Cancer Care. Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study. JCO Glob Oncol. 2020 Sep;6:1428-1438. doi: 10.1200/GO.20.00351.', 'Torzilli G, Vigan√≤ L, Galvanin J, Castoro C, Quagliuolo V, Spinelli A, Zerbi A, Donadon M, Montorsi M; COVID-SURGE-ITA group. A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives. Ann Surg. 2020 Aug;272(2):e112-e117. doi: 10.1097/SLA.0000000000004081.', 'Mitchell EP. Declines in Cancer Screening During COVID-19 Pandemic. J Natl Med Assoc. 2020 Dec;112(6):563-564. doi: 10.1016/j.jnma.2020.12.004.', 'Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683. Erratum in: JAMA. 2020 Apr 28;323(16):1619.']",2022-02-28,https://clinicaltrials.gov/show/NCT04712292,2022-02-15,0,1
4282,NCT04712357,Recruiting,2022-01-01,2023-01-01,No Results Posted,,,2021-01-15,https://clinicaltrials.gov/show/NCT04712357,2022-01-01,0,0
4283,NCT04713150,Recruiting,2022-09-01,2022-11-01,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04713150,2022-09-01,0,0
4284,NCT04713163,Not yet recruiting,2021-04-01,2021-12-01,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04713163,2021-04-01,0,0
4285,NCT04713852,Completed,2020-09-30,2020-12-31,No Results Posted,"['Vandenbrande J, Verbrugge L, Bruckers L, Geebelen L, Geerts E, Callebaut I, Gruyters I, Heremans L, Dubois J, Stessel B. Validation of the Acute Physiology and Chronic Health Evaluation (APACHE) II and IV Score in COVID-19 Patients. Crit Care Res Pract. 2021 Jun 19;2021:5443083. doi: 10.1155/2021/5443083. eCollection 2021.']",,2021-01-19,https://clinicaltrials.gov/show/NCT04713852,2020-09-30,0,1
4286,NCT04713878,Completed,2020-06-30,2020-07-15,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04713878,2020-06-30,0,0
4287,NCT04714008,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04714008,2022-12-31,0,0
4288,NCT04714125,Recruiting,2021-02-01,2022-06-01,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04714125,2021-02-01,0,0
4289,NCT04714515,Completed,2020-03-30,2020-04-20,No Results Posted,,,2021-01-19,https://clinicaltrials.gov/show/NCT04714515,2020-03-30,0,0
4290,NCT04715360,Recruiting,2021-11-29,2021-12-27,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04715360,2021-11-29,0,0
4291,NCT04715477,Recruiting,2021-04-01,2021-04-15,No Results Posted,"['Kupeli I, Kara MY, Yakƒ±n I, Caglayan AC. Anxiety and depression in the first 24 h in COVID-19 patients who underwent non-invasive mechanical ventilation in the intensive care unit. Ir J Med Sci. 2021 Oct 19. doi: 10.1007/s11845-021-02808-8. [Epub ahead of print]']","['Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021 Feb;1486(1):90-111. doi: 10.1111/nyas.14506. Epub 2020 Oct 2.', 'Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.', '3. Aydemir √ñ, G√ºvenir T, K√ºey L, K√ºlt√ºr S. Hastane Anksiyete ve Depresyon √ñl√ßeƒüi T√ºrk√ße Formunun Ge√ßerlik G√ºvenilirlik √áalƒ±≈ümasƒ±. T√ºrk Psikiyatri Dergisi 1997;8:280-287.']",2021-01-20,https://clinicaltrials.gov/show/NCT04715477,2021-04-01,0,1
4292,NCT04700254,Completed,2021-01-11,2021-01-11,No Results Posted,,"['Aragona M, Rodia C, Bertolotto A, Campi F, Coppelli A, Giannarelli R, Bianchi C, Dardano A, Del Prato S. Type 1 diabetes and COVID-19: The ""lockdown effect"". Diabetes Res Clin Pract. 2020 Dec;170:108468. doi: 10.1016/j.diabres.2020.108468. Epub 2020 Sep 25.', 'Sakelliadis EI, Katsos KD, Zouzia EI, Spiliopoulou CA, Tsiodras S. Impact of Covid-19 lockdown on characteristics of autopsy cases in Greece. Comparison between 2019 and 2020. Forensic Sci Int. 2020 Aug;313:110365. doi: 10.1016/j.forsciint.2020.110365. Epub 2020 Jun 12.', 'Sidor A, Rzymski P. Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients. 2020 Jun 3;12(6). pii: E1657. doi: 10.3390/nu12061657.', 'Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimart√≠n A, Sampedro-Nu√±ez MA, D√°valos A, Marazuela M. COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus. Nutrients. 2020 Aug 4;12(8). pii: E2327. doi: 10.3390/nu12082327.', 'Pellegrini M, Ponzo V, Rosato R, Scumaci E, Goitre I, Benso A, Belcastro S, Crespi C, De Michieli F, Ghigo E, Broglio F, Bo S. Changes in Weight and Nutritional Habits in Adults with Obesity during the ""Lockdown"" Period Caused by the COVID-19 Virus Emergency. Nutrients. 2020 Jul 7;12(7). pii: E2016. doi: 10.3390/nu12072016.']",2021-01-25,https://clinicaltrials.gov/show/NCT04700254,2021-01-11,0,1
4293,NCT04701892,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04701892,2023-01-01,0,0
4294,NCT04703452,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04703452,2022-01-01,0,0
4295,NCT04712344,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04712344,2021-09-01,0,0
4296,NCT04713540,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04713540,2021-04-01,0,0
4297,NCT04714138,Completed,2021-03-20,2021-06-15,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04714138,2021-03-20,0,0
4298,NCT04714333,Enrolling by invitation,2021-05-05,2021-05-05,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04714333,2021-05-05,0,0
4299,NCT04715295,Recruiting,2021-05-30,2021-09-05,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04715295,2021-05-30,0,0
4300,NCT04715919,Completed,2021-06-01,2021-06-01,No Results Posted,,,2021-09-14,https://clinicaltrials.gov/show/NCT04715919,2021-06-01,0,0
4301,NCT04715997,"Active, not recruiting",2021-07-30,2022-06-30,No Results Posted,"['Ahn JY, Lee J, Suh YS, Song YG, Choi YJ, Lee KH, Seo SH, Song M, Oh JW, Kim M, Seo HY, Kwak JE, Youn JW, Woo JW, Shin EC, Sung YC, Park SH, Choi JY. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults. Lancet Microbe. 2022 Mar;3(3):e173-e183. doi: 10.1016/S2666-5247(21)00358-X. Epub 2022 Feb 8.']",,2021-12-09,https://clinicaltrials.gov/show/NCT04715997,2021-07-30,0,1
4302,NCT04716023,Recruiting,2021-08-22,2022-02-02,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04716023,2021-08-22,0,0
4303,NCT04716088,Completed,2020-12-02,2020-12-22,No Results Posted,"['Jakobsen KK, Jensen JS, Todsen T, Tolsgaard MG, Kirkby N, Lippert F, Vangsted AM, Martel CJ, Klokker M, von Buchwald C. Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection. Dan Med J. 2021 Jun 14;68(7). pii: A03210217.', '≈†terbenc A, Tomiƒç V, Bidovec Stojkoviƒá U, Vrankar K, Rozman A, Zidarn M. Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study. Clin Exp Med. 2022 Feb;22(1):157-160. doi: 10.1007/s10238-021-00722-y. Epub 2021 May 22.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04716088,2020-12-02,0,1
4304,NCT04716179,Recruiting,2021-05-18,2021-08-31,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04716179,2021-05-18,0,0
4305,NCT04716465,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04716465,2023-01-01,0,0
4306,NCT04716543,Not yet recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04716543,2022-03-01,0,0
4307,NCT04716647,Completed,2020-12-12,2020-12-18,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04716647,2020-12-12,0,0
4308,NCT04716998,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04716998,2022-01-01,0,0
4309,NCT04717024,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-01-20,https://clinicaltrials.gov/show/NCT04717024,2021-12-31,0,0
4310,NCT04718285,Not yet recruiting,2021-04-30,2021-05-30,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04718285,2021-04-30,0,0
4311,NCT04718480,Recruiting,2022-08-01,2022-12-01,No Results Posted,,,2021-09-27,https://clinicaltrials.gov/show/NCT04718480,2022-08-01,0,0
4312,NCT04718506,Recruiting,2021-06-12,2021-12-12,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04718506,2021-06-12,0,0
4313,NCT04719182,"Active, not recruiting",2021-01-01,2021-07-01,No Results Posted,"['Valk CMA, Swart P, Boers LS, Botta M, Bos LDJ, de Abreu MG, Hol L, Hollmann MW, Horn J, Martin-Loeches I, Mazzinari G, Myatra SN, Nijbroek SG, Rosenberg NM, Stilma W, Tsonas AM, van der Ven WH, Neto AS, Schultz MJ, Paulus F. Practice of adjunctive treatments in critically ill COVID-19 patients-rational for the multicenter observational PRoAcT-COVID study in The Netherlands. Ann Transl Med. 2021 May;9(9):813. doi: 10.21037/atm-21-764.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04719182,2021-01-01,0,1
4314,NCT04719208,"Active, not recruiting",2023-07-01,2023-12-01,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04719208,2023-07-01,0,0
4315,NCT04719234,Completed,2020-12-01,2020-12-01,No Results Posted,"['√ñkmen K, Yƒ±ldƒ±z DK, Soyaslan E. Comparison of lung ultrasonography findings with chest computed tomography results in coronavirus (COVID-19) pneumonia. J Med Ultrason (2001). 2021 Apr;48(2):245-252. doi: 10.1007/s10396-021-01081-7. Epub 2021 Feb 26.']",,2021-01-22,https://clinicaltrials.gov/show/NCT04719234,2020-12-01,0,1
4316,NCT04720404,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2021-01-22,https://clinicaltrials.gov/show/NCT04720404,2022-02-01,0,0
4317,NCT04720612,Recruiting,2022-03-01,2022-07-01,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04720612,2022-03-01,0,0
4318,NCT04720794,Completed,2020-10-20,2020-10-20,Results Submitted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04720794,2020-10-20,0,0
4319,NCT04721236,"Active, not recruiting",2021-05-19,2022-05-19,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04721236,2021-05-19,0,0
4320,NCT04721457,Completed,2021-03-28,2021-12-10,No Results Posted,,"['To KK, Tsang OT, Yip CC, Chan KH, Wu TC, Chan JM, Leung WS, Chik TS, Choi CY, Kandamby DH, Lung DC, Tam AR, Poon RW, Fung AY, Hung IF, Cheng VC, Chan JF, Yuen KY. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis. 2020 Jul 28;71(15):841-843. doi: 10.1093/cid/ciaa149.', 'Ge ZY, Yang LM, Xia JJ, Fu XH, Zhang YZ. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ Sci B. 2020 May;21(5):361-368. doi: 10.1631/jzus.B2010010. Epub 2020 Mar 16. Review.', 'Vergara-Buenaventura A, Castro-Ruiz C. Use of mouthwashes against COVID-19 in dentistry. Br J Oral Maxillofac Surg. 2020 Oct;58(8):924-927. doi: 10.1016/j.bjoms.2020.08.016. Epub 2020 Aug 15. Review.', ""O'Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, Jones SA, Humphreys I, Wakelam MJO, Fegan C, Wise MP, Bosch A, Sattar SA. Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection. Function (Oxf). 2020;1(1):zqaa002. doi: 10.1093/function/zqaa002. Epub 2020 Jun 5."", 'Carrouel F, Conte MP, Fisher J, Gon√ßalves LS, Dussart C, Llodra JC, Bourgeois D. COVID-19: A Recommendation to Examine the Effect of Mouthrinses with Œ≤-Cyclodextrin Combined with Citrox in Preventing Infection and Progression. J Clin Med. 2020 Apr 15;9(4). pii: E1126. doi: 10.3390/jcm9041126.', 'Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.', 'Bruch MK. Toxicity and safety of topical sodium hypochlorite. Contrib Nephrol. 2007;154:24-38. doi: 10.1159/000096812. Review.', 'De Nardo R, Chiappe V, G√≥mez M, Romanelli H, Slots J. Effects of 0.05% sodium hypochlorite oral rinse on supragingival biofilm and gingival inflammation. Int Dent J. 2012 Aug;62(4):208-12. doi: 10.1111/j.1875-595X.2011.00111.x. Epub 2012 May 11.', 'Seo HW, Seo JP, Cho Y, Ko E, Kim YJ, Jung G. Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly. Virus Res. 2019 Apr 2;263:102-111. doi: 10.1016/j.virusres.2019.01.004. Epub 2019 Jan 9.', 'Feres M, Figueiredo LC, Faveri M, Stewart B, de Vizio W. The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office. J Am Dent Assoc. 2010 Apr;141(4):415-22.', 'Marui VC, Souto MLS, Rovai ES, Romito GA, Chambrone L, Pannuti CM. Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: A systematic review. J Am Dent Assoc. 2019 Dec;150(12):1015-1026.e1. doi: 10.1016/j.adaj.2019.06.024.', 'Pitten FA, Kramer A. Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic. Arzneimittelforschung. 2001;51(7):588-95.', 'Osso D, Kanani N. Antiseptic mouth rinses: an update on comparative effectiveness, risks and recommendations. J Dent Hyg. 2013 Feb;87(1):10-8. Epub 2013 Feb 5. Review.', 'Caruso AA, Del Prete A, Lazzarino AI. Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic. Med Hypotheses. 2020 Nov;144:109910. doi: 10.1016/j.mehy.2020.109910. Epub 2020 Jun 1. Review.', 'Walsh LJ. Safety issues relating to the use of hydrogen peroxide in dentistry. Aust Dent J. 2000 Dec;45(4):257-69; quiz 289. Review.', 'Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.', 'Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology. 2006;212 Suppl 1:119-23.']",2021-12-13,https://clinicaltrials.gov/show/NCT04721457,2021-03-28,0,1
4321,NCT04723407,Not yet recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04723407,2022-01-01,0,0
4322,NCT04723550,Recruiting,2021-11-05,2022-01-05,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04723550,2021-11-05,0,0
4323,NCT04723576,Recruiting,2022-02-01,2023-11-30,No Results Posted,,,2021-01-25,https://clinicaltrials.gov/show/NCT04723576,2022-02-01,0,0
4324,NCT04723589,Withdrawn,2021-04-30,2021-04-30,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04723589,2021-04-30,0,0
4325,NCT04724538,Completed,2021-02-10,2021-03-15,Study Results,,,2021-07-07,https://clinicaltrials.gov/show/NCT04724538,2021-02-10,1,0
4326,NCT04724616,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04724616,2021-06-01,0,0
4327,NCT04724629,Recruiting,2021-03-31,2021-07-30,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04724629,2021-03-31,0,0
4328,NCT04724681,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT04724681,2022-12-31,0,0
4329,NCT04728243,Recruiting,2021-12-01,2022-04-01,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04728243,2021-12-01,0,0
4330,NCT04674644,Completed,2020-10-23,2020-10-23,Study Results,,,2021-02-02,https://clinicaltrials.gov/show/NCT04674644,2020-10-23,1,0
4331,NCT04682041,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04682041,2021-06-30,0,0
4332,NCT04682912,Recruiting,2021-02-01,2021-02-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04682912,2021-02-01,0,0
4333,NCT04689542,Completed,2021-04-02,2021-04-02,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04689542,2021-04-02,0,0
4334,NCT04691180,Completed,2021-09-16,2021-09-16,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04691180,2021-09-16,0,1
4335,NCT04692129,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04692129,2021-12-31,0,0
4336,NCT04695301,Completed,2021-07-01,2021-10-01,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04695301,2021-07-01,0,0
4337,NCT04696679,Completed,2020-11-30,2020-12-31,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04696679,2020-11-30,0,0
4338,NCT04704466,Recruiting,2021-11-01,2021-11-01,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04704466,2021-11-01,0,0
4339,NCT04707534,Completed,2021-12-31,2022-03-04,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04707534,2021-12-31,0,0
4340,NCT04715763,Recruiting,2022-01-31,2022-12-31,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04715763,2022-01-31,0,0
4341,NCT04715815,Not yet recruiting,2021-12-01,2022-06-01,No Results Posted,,"[""Wolf MS, Serper M, Opsasnick L, O'Conor RM, Curtis L, Benavente JY, Wismer G, Batio S, Eifler M, Zheng P, Russell A, Arvanitis M, Ladner D, Kwasny M, Persell SD, Rowe T, Linder JA, Bailey SC. Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey. Ann Intern Med. 2020 Jul 21;173(2):100-109. doi: 10.7326/M20-1239. Epub 2020 Apr 9.""]",2021-01-29,https://clinicaltrials.gov/show/NCT04715815,2021-12-01,0,1
4342,NCT04721535,Not yet recruiting,2021-04-01,2021-07-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04721535,2021-04-01,0,0
4343,NCT04723524,Completed,2021-08-23,2021-08-23,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04723524,2021-08-23,0,0
4344,NCT04724434,"Active, not recruiting",2021-07-17,2026-07-01,No Results Posted,,,2021-07-23,https://clinicaltrials.gov/show/NCT04724434,2021-07-17,0,0
4345,NCT04724642,Recruiting,2021-05-28,2021-12-28,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04724642,2021-05-28,0,0
4346,NCT04724707,Recruiting,2021-12-01,2022-12-01,No Results Posted,,,2021-01-26,https://clinicaltrials.gov/show/NCT04724707,2021-12-01,0,0
4347,NCT04724850,Not yet recruiting,2022-07-01,2023-07-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04724850,2022-07-01,0,0
4348,NCT04725084,Completed,2020-12-15,2020-12-15,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04725084,2020-12-15,0,0
4349,NCT04725097,Terminated,2021-06-03,2021-06-03,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04725097,2021-06-03,0,0
4350,NCT04725110,Not yet recruiting,2023-03-01,2024-03-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04725110,2023-03-01,0,0
4351,NCT04726098,Completed,2021-08-31,2021-08-31,No Results Posted,,,2021-10-20,https://clinicaltrials.gov/show/NCT04726098,2021-08-31,0,0
4352,NCT04726111,Recruiting,2021-07-30,2021-08-30,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04726111,2021-07-30,0,0
4353,NCT04726137,Not yet recruiting,2021-07-31,2022-04-30,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04726137,2021-07-31,0,0
4354,NCT04726150,Not yet recruiting,2023-04-01,2026-04-01,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04726150,2023-04-01,0,0
4355,NCT04726163,Recruiting,2021-06-14,2021-06-14,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04726163,2021-06-14,0,0
4356,NCT04726371,Recruiting,2022-10-01,2022-10-01,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04726371,2022-10-01,0,0
4357,NCT04726865,Completed,2020-12-20,2020-12-31,No Results Posted,,,2021-01-27,https://clinicaltrials.gov/show/NCT04726865,2020-12-20,0,0
4358,NCT04727294,Recruiting,2021-09-01,2021-12-01,Results Submitted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04727294,2021-09-01,0,0
4359,NCT04728594,Completed,2021-01-17,2021-01-20,Study Results,"['Santos HC, Goren A, Chabris CF, Meyer MN. Effect of Targeted Behavioral Science Messages on COVID-19 Vaccination Registration Among Employees of a Large Health System: A Randomized Trial. JAMA Netw Open. 2021 Jul 1;4(7):e2118702. doi: 10.1001/jamanetworkopen.2021.18702.']",,2021-07-26,https://clinicaltrials.gov/show/NCT04728594,2021-01-17,1,1
4360,NCT04728698,Withdrawn,2021-09-01,2021-09-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04728698,2021-09-01,0,0
4361,NCT04728880,Recruiting,2021-03-31,2021-05-30,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04728880,2021-03-31,0,0
4362,NCT04728906,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04728906,2022-09-01,0,0
4363,NCT04728919,"Active, not recruiting",2023-01-15,2024-01-15,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04728919,2023-01-15,0,0
4364,NCT04728958,Not yet recruiting,2022-04-01,2022-09-01,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04728958,2022-04-01,0,0
4365,NCT04729075,Completed,2021-01-19,2021-01-19,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04729075,2021-01-19,0,0
4366,NCT04729153,Not yet recruiting,2022-02-01,2022-03-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04729153,2022-02-01,0,0
4367,NCT04729491,Completed,2020-09-15,2020-10-07,No Results Posted,,,2021-01-28,https://clinicaltrials.gov/show/NCT04729491,2020-09-15,0,0
4368,NCT04730284,Recruiting,2021-09-30,2022-03-31,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04730284,2021-09-30,0,0
4369,NCT04730323,Completed,2020-06-12,2020-06-12,No Results Posted,"['Chachar AZK, Khan KA, Iqbal J, Shahid AH, Asif M, Fatima SA, Khan AA, Younis BB. ""Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience"", a retrospective study-original article. Ann Med Surg (Lond). 2021 Mar;63:102165. doi: 10.1016/j.amsu.2021.02.011. Epub 2021 Feb 8.']",,2021-01-29,https://clinicaltrials.gov/show/NCT04730323,2020-06-12,0,1
4370,NCT04730427,"Active, not recruiting",2022-05-01,2022-05-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04730427,2022-05-01,0,0
4371,NCT04731051,Not yet recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04731051,2022-01-01,0,0
4372,NCT04731116,Recruiting,2021-12-31,2022-04-30,No Results Posted,,,2021-01-29,https://clinicaltrials.gov/show/NCT04731116,2021-12-31,0,0
4373,NCT04731870,Not yet recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-02-01,https://clinicaltrials.gov/show/NCT04731870,2023-01-01,0,0
4374,NCT04732767,Withdrawn,2021-06-30,2021-06-30,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04732767,2021-06-30,0,0
4375,NCT04733625,Completed,2020-12-17,2020-12-17,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04733625,2020-12-17,0,0
4376,NCT04733833,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04733833,2022-06-30,0,0
4377,NCT04734886,Completed,2021-09-13,2021-09-13,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04734886,2021-09-13,0,0
4378,NCT04734912,Recruiting,2021-06-15,2021-12-31,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04734912,2021-06-15,0,0
4379,NCT04668625,Completed,2020-12-20,2021-01-08,No Results Posted,"['Revollo B, Blanco I, Soler P, Toro J, Izquierdo-Useros N, Puig J, Puig X, Navarro-P√©rez V, Casa√± C, Ruiz L, Perez-Zsolt D, Videla S, Clotet B, Llibre JM. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial. Lancet Infect Dis. 2021 Oct;21(10):1365-1372. doi: 10.1016/S1473-3099(21)00268-1. Epub 2021 May 27.']",,2021-02-08,https://clinicaltrials.gov/show/NCT04668625,2020-12-20,0,1
4380,NCT04668911,Recruiting,2021-12-12,2021-12-12,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04668911,2021-12-12,0,0
4381,NCT04669912,Completed,2021-01-22,2021-01-22,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04669912,2021-01-22,0,0
4382,NCT04672395,Recruiting,2022-07-01,2022-07-01,No Results Posted,"['Bravo L, Smolenov I, Han HH, Li P, Hosain R, Rockhold F, Clemens SAC, Roa C Jr, Borja-Tabora C, Quinsaat A, Lopez P, L√≥pez-Medina E, Brochado L, Hern√°ndez EA, Reynales H, Medina T, Velasquez H, Toloza LB, Rodriguez EJ, de Salazar DIM, Rodr√≠guez CA, Sprinz E, Cerbino-Neto J, Luz KG, Schwarzbold AV, Paiva MS, Carlos J, Montellano MEB, de Los Reyes MRA, Yu CY, Alberto ER, Panaligan MM, Salvani-Bautista M, Buntinx E, Hites M, Martinot JB, Bhorat QE, Badat A, Baccarini C, Hu B, Jurgens J, Engelbrecht J, Ambrosino D, Richmond P, Siber G, Liang J, Clemens R. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2022 Jan 29;399(10323):461-472. doi: 10.1016/S0140-6736(22)00055-1. Epub 2022 Jan 20.']",,2022-02-24,https://clinicaltrials.gov/show/NCT04672395,2022-07-01,0,1
4383,NCT04678687,"Active, not recruiting",2021-06-01,2022-01-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04678687,2021-06-01,0,0
4384,NCT04678700,Recruiting,2021-06-01,2021-08-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04678700,2021-06-01,0,0
4385,NCT04685629,Recruiting,2022-05-22,2022-12-01,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04685629,2022-05-22,0,0
4386,NCT04686565,Recruiting,2021-02-28,2021-02-28,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04686565,2021-02-28,0,0
4387,NCT04686578,Recruiting,2021-02-15,2021-02-28,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04686578,2021-02-15,0,0
4388,NCT04703036,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04703036,2023-12-31,0,0
4389,NCT04713488,"Active, not recruiting",2021-07-20,2021-07-31,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04713488,2021-07-20,0,0
4390,NCT04716972,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04716972,2022-03-31,0,0
4391,NCT04726176,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04726176,2021-12-01,0,0
4392,NCT04729374,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04729374,2023-12-31,0,0
4393,NCT04730661,Recruiting,2021-12-21,2021-12-28,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04730661,2021-12-21,0,0
4394,NCT04732702,Recruiting,2021-01-31,2021-04-30,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04732702,2021-01-31,0,0
4395,NCT04732858,"Active, not recruiting",2020-08-31,2021-06-01,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04732858,2020-08-31,0,0
4396,NCT04733651,Not yet recruiting,2021-05-20,2021-08-15,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04733651,2021-05-20,0,0
4397,NCT04733729,Recruiting,2021-01-30,2021-12-31,No Results Posted,,"['Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bert√π L, Corrao G, Pagano L, Corradini P; ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.', 'Garc√≠a-Su√°rez J, de la Cruz J, Cedillo √Å, Llamas P, Duarte R, Jim√©nez-Yuste V, Hern√°ndez-Rivas J√Å, Gil-Manso R, Kwon M, S√°nchez-Godoy P, Mart√≠nez-Barranco P, Col√°s-Lahuerta B, Herrera P, Benito-Parra L, Alegre A, Velasco A, Matilla A, Al√°ez-Us√≥n MC, Martos-Mart√≠nez R, Mart√≠nez-Chamorro C, Susana-Quiroz K, Del Campo JF, de la Fuente A, Herr√°ez R, Pascual A, G√≥mez E, P√©rez-Oteyza J, Ruiz E, Alonso A, Gonz√°lez-Medina J, Mart√≠n-Buitrago LN, Canales M, Gonz√°lez-Gasc√≥n I, Vicente-Ayuso MC, Valenciano S, Roa MG, Monteliu PE, L√≥pez-Jim√©nez J, Escobar CE, Ortiz-Mart√≠n J, Diez-Martin JL, Martinez-Lopez J; Asociaci√≥n Madrile√±a de Hematolog√≠a y Hemoterapia (AMHH). Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020 Oct 8;13(1):133. doi: 10.1186/s13045-020-00970-7.', 'Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL; COVID-19 and Cancer Consortium. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28. Erratum in: Lancet. 2020 Sep 12;396(10253):758.']",2021-02-05,https://clinicaltrials.gov/show/NCT04733729,2021-01-30,0,1
4398,NCT04733846,Completed,2020-12-05,2021-12-05,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04733846,2020-12-05,0,0
4399,NCT04734171,Completed,2020-04-16,2020-04-16,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04734171,2020-04-16,0,0
4400,NCT04734223,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04734223,2020-12-31,0,0
4401,NCT04734678,Recruiting,2021-03-01,2021-06-01,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04734678,2021-03-01,0,0
4402,NCT04734717,Enrolling by invitation,2021-04-12,2021-04-12,No Results Posted,,,2021-02-02,https://clinicaltrials.gov/show/NCT04734717,2021-04-12,0,0
4403,NCT04735744,"Active, not recruiting",2022-07-17,2024-01-01,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04735744,2022-07-17,0,0
4404,NCT04736524,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-02-03,https://clinicaltrials.gov/show/NCT04736524,2022-03-01,0,0
4405,NCT04736680,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04736680,2021-09-01,0,0
4406,NCT04736732,Recruiting,2024-09-01,2025-03-01,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04736732,2024-09-01,0,0
4407,NCT04736901,Recruiting,2021-04-01,2021-06-01,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-02-04,https://clinicaltrials.gov/show/NCT04736901,2021-04-01,0,1
4408,NCT04738032,Completed,2021-01-07,2021-01-07,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04738032,2021-01-07,0,0
4409,NCT04738175,Withdrawn,2021-11-01,2021-11-01,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04738175,2021-11-01,0,0
4410,NCT04738435,Completed,2021-03-01,2021-03-01,No Results Posted,,"['Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Di Pasquale A, Bonanni P, Gar√ßon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Vaccine safety evaluation: Practical aspects in assessing benefits and risks. Vaccine. 2016 Dec 20;34(52):6672-6680. doi: 10.1016/j.vaccine.2016.10.039. Epub 2016 Nov 8. Review.', ""Herv√© C, Laup√®ze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how's and what's of vaccine reactogenicity. NPJ Vaccines. 2019 Sep 24;4:39. doi: 10.1038/s41541-019-0132-6. eCollection 2019. Review."", 'Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics. 2000 Nov;106(5):E62.', 'Mitchell TC, Casella CR. No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. Curr Opin Immunol. 2017 Aug;47:17-25. doi: 10.1016/j.coi.2017.06.009. Epub 2017 Jul 17. Review.', 'Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.', ""Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH; mRNA-1273 Study Group. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14."", ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98.""]",2021-08-25,https://clinicaltrials.gov/show/NCT04738435,2021-03-01,0,1
4411,NCT04738760,Recruiting,2021-04-01,2021-06-01,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04738760,2021-04-01,0,0
4412,NCT04739345,Recruiting,2021-04-01,2021-07-01,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04739345,2021-04-01,0,0
4413,NCT04739410,Completed,2020-06-30,2020-06-30,No Results Posted,,,2021-02-04,https://clinicaltrials.gov/show/NCT04739410,2020-06-30,0,0
4414,NCT04740125,Completed,2020-07-31,2020-11-30,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04740125,2020-07-31,0,0
4415,NCT04740372,Recruiting,2021-06-01,2021-11-01,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04740372,2021-06-01,0,0
4416,NCT04740489,Not yet recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04740489,2022-06-01,0,0
4417,NCT04741178,Recruiting,2021-01-02,2021-12-31,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04741178,2021-01-02,0,0
4418,NCT04742049,Recruiting,2021-03-01,2021-03-01,No Results Posted,,,2021-02-05,https://clinicaltrials.gov/show/NCT04742049,2021-03-01,0,0
4419,NCT04742569,Completed,2022-01-15,2022-01-15,No Results Posted,,"['Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, Salanti G, Low N. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.', 'Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020 Aug 18;173(4):262-267. doi: 10.7326/M20-1495. Epub 2020 May 13. Review.', 'Natarajan A, Su HW, Heneghan C. Assessment of physiological signs associated with COVID-19 measured using wearable devices. NPJ Digit Med. 2020 Nov 30;3(1):156. doi: 10.1038/s41746-020-00363-7.', 'Ra SH, Lim JS, Kim G, et al. Thorax Epub ahead of print: 2020 September 22; doi:10.1136/ thoraxjnl-2020-215042', 'Rudolph JL, Halladay CW, Barber M, McConeghy KW, Mor V, Nanda A, Gravenstein S. Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2. J Am Med Dir Assoc. 2020 Jul;21(7):895-899.e1. doi: 10.1016/j.jamda.2020.06.009. Epub 2020 Jun 9.']",2022-01-20,https://clinicaltrials.gov/show/NCT04742569,2022-01-15,0,1
4420,NCT04742595,Recruiting,2023-03-31,2024-03-31,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04742595,2023-03-31,0,0
4421,NCT04742712,Recruiting,2021-11-01,2021-12-01,No Results Posted,,,2021-02-08,https://clinicaltrials.gov/show/NCT04742712,2021-11-01,0,0
4422,NCT04742738,"Active, not recruiting",2021-07-30,2022-04-01,No Results Posted,"[""Arunachalam PS, Walls AC, Golden N, Atyeo C, Fischinger S, Li C, Aye P, Navarro MJ, Lai L, Edara VV, R√∂ltgen K, Rogers K, Shirreff L, Ferrell DE, Wrenn S, Pettie D, Kraft JC, Miranda MC, Kepl E, Sydeman C, Brunette N, Murphy M, Fiala B, Carter L, White AG, Trisal M, Hsieh CL, Russell-Lodrigue K, Monjure C, Dufour J, Spencer S, Doyle-Meyers L, Bohm RP, Maness NJ, Roy C, Plante JA, Plante KS, Zhu A, Gorman MJ, Shin S, Shen X, Fontenot J, Gupta S, O'Hagan DT, Van Der Most R, Rappuoli R, Coffman RL, Novack D, McLellan JS, Subramaniam S, Montefiori D, Boyd SD, Flynn JL, Alter G, Villinger F, Kleanthous H, Rappaport J, Suthar MS, King NP, Veesler D, Pulendran B. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.""]",,2021-10-15,https://clinicaltrials.gov/show/NCT04742738,2021-07-30,0,1
4423,NCT04742842,Recruiting,2022-02-28,2022-12-31,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04742842,2022-02-28,0,0
4424,NCT04742946,Not yet recruiting,2021-05-30,2021-09-30,No Results Posted,"['Pastora-Bernal JM, Estebanez-P√©rez MJ, Molina-Torres G, Garc√≠a-L√≥pez FJ, Sobrino-S√°nchez R, Mart√≠n-Valero R. Telerehabilitation Intervention in Patients with COVID-19 after Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial. Int J Environ Res Public Health. 2021 Mar 12;18(6). pii: 2924. doi: 10.3390/ijerph18062924.']","['Del Rio C, Malani PN. 2019 Novel Coronavirus-Important Information for Clinicians. JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490.', ""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.']",2021-02-10,https://clinicaltrials.gov/show/NCT04742946,2021-05-30,0,1
4425,NCT04743232,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04743232,2021-12-31,0,0
4426,NCT04743349,Recruiting,2021-10-31,2021-10-31,No Results Posted,,,2021-02-08,https://clinicaltrials.gov/show/NCT04743349,2021-10-31,0,0
4427,NCT04743908,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04743908,2023-12-01,0,0
4428,NCT04743947,Recruiting,2024-12-31,2025-12-31,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT04743947,2024-12-31,0,0
4429,NCT04744415,Completed,2021-02-09,2021-03-23,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04744415,2021-02-09,0,0
4430,NCT04745923,Recruiting,2021-02-28,2021-03-30,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04745923,2021-02-28,0,0
4431,NCT04747769,Recruiting,2021-10-01,2021-10-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04747769,2021-10-01,0,0
4432,NCT04748471,Not yet recruiting,2021-07-01,2023-01-25,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04748471,2021-07-01,0,0
4433,NCT04750018,Recruiting,2020-09-28,2021-06-01,No Results Posted,"['Chou CP, Lin HS. Delayed Breast Cancer Detection in an Asian Country (Taiwan) with Low COVID-19 Incidence. Cancer Manag Res. 2021 Jul 28;13:5899-5906. doi: 10.2147/CMAR.S314282. eCollection 2021.']","['Chou CP, Pan HB, Yang TL, Chiang CL, Huang JS, Tsai MY. Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan. Breast J. 2021 Jan;27(1):89-91. doi: 10.1111/tbj.14019. Epub 2020 Aug 20.']",2021-02-11,https://clinicaltrials.gov/show/NCT04750018,2020-09-28,0,1
4434,NCT04485741,Recruiting,2021-12-01,2021-12-31,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04485741,2021-12-01,0,0
4435,NCT04691921,Completed,2021-01-18,2021-01-31,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020 Dec 17;383(25):2451-2460. doi: 10.1056/NEJMcp2009575. Epub 2020 May 15. Review.']",2021-02-16,https://clinicaltrials.gov/show/NCT04691921,2021-01-18,0,1
4436,NCT04694703,Completed,2021-07-15,2021-08-29,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04694703,2021-07-15,0,0
4437,NCT04694716,Completed,2021-05-15,2021-08-15,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04694716,2021-05-15,0,0
4438,NCT04695158,Recruiting,2021-02-01,2021-03-01,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04695158,2021-02-01,0,0
4439,NCT04703140,Recruiting,2022-08-11,2022-09-11,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04703140,2022-08-11,0,0
4440,NCT04709068,Terminated,2021-05-03,2021-06-01,Study Results,,,2021-08-19,https://clinicaltrials.gov/show/NCT04709068,2021-05-03,1,0
4441,NCT04710329,Completed,2021-01-25,2021-02-10,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04710329,2021-01-25,0,0
4442,NCT04710771,Completed,2021-01-15,2021-01-29,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04710771,2021-01-15,0,0
4443,NCT04717011,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04717011,2021-07-01,0,0
4444,NCT04735588,Not yet recruiting,2022-01-01,2023-10-01,No Results Posted,,,2021-02-16,https://clinicaltrials.gov/show/NCT04735588,2022-01-01,0,0
4445,NCT04739020,Recruiting,2021-12-30,2021-12-31,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04739020,2021-12-30,0,0
4446,NCT04739462,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04739462,2022-02-01,0,0
4447,NCT04740320,Completed,2021-06-23,2021-07-09,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04740320,2021-06-23,0,0
4448,NCT04743388,Recruiting,2021-11-01,2022-04-01,No Results Posted,"['Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Trougakos IP, Dimopoulos MA. Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study. Blood Adv. 2021 Nov 9;5(21):4398-4405. doi: 10.1182/bloodadvances.2021005444.']",,2021-02-11,https://clinicaltrials.gov/show/NCT04743388,2021-11-01,0,1
4449,NCT04745377,Recruiting,2021-08-30,2022-01-31,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04745377,2021-08-30,0,0
4450,NCT04745416,Completed,2020-12-31,2021-01-25,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04745416,2020-12-31,0,0
4451,NCT04745442,Completed,2020-12-20,2021-01-15,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04745442,2020-12-20,0,0
4452,NCT04745533,Not yet recruiting,2021-04-30,2021-06-30,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04745533,2021-04-30,0,0
4453,NCT04745611,Recruiting,2021-09-01,2021-09-01,No Results Posted,"['Klinkhammer S, Horn J, Visser-Meilij JMA, Verwijk E, Duits A, Slooter AJC, van Heugten CM; NeNeSCo study group. Dutch multicentre, prospective follow-up, cohort study comparing the neurological and neuropsychological sequelae of hospitalised non-ICU- and ICU-treated COVID-19 survivors: a study protocol. BMJ Open. 2021 Oct 7;11(10):e054901. doi: 10.1136/bmjopen-2021-054901.']",,2021-02-09,https://clinicaltrials.gov/show/NCT04745611,2021-09-01,0,1
4454,NCT04746066,"Active, not recruiting",2030-12-01,2030-12-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04746066,2030-12-01,0,0
4455,NCT04746092,"Active, not recruiting",2022-05-24,2022-05-24,No Results Posted,"['Perry C, Luttwak E, Balaban R, Shefer G, Morales MM, Aharon A, Tabib Y, Cohen YC, Benyamini N, Beyar-Katz O, Neaman M, Vitkon R, Keren-Khadmy N, Levin M, Herishanu Y, Avivi I. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma. Blood Adv. 2021 Aug 24;5(16):3053-3061. doi: 10.1182/bloodadvances.2021005094.', 'Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, Morales M, Ziv T, Shorer Arbel Y, Scarf√≤ L, Joffe E, Perry C, Ghia P. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021 Jun 10;137(23):3165-3173. doi: 10.1182/blood.2021011568.']",,2021-08-16,https://clinicaltrials.gov/show/NCT04746092,2022-05-24,0,1
4456,NCT04746365,Completed,2021-01-31,2021-02-06,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04746365,2021-01-31,0,0
4457,NCT04746443,Recruiting,2021-03-08,2021-03-08,No Results Posted,,,2021-02-09,https://clinicaltrials.gov/show/NCT04746443,2021-03-08,0,0
4458,NCT04746521,Recruiting,2022-01-14,2022-12-14,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04746521,2022-01-14,0,0
4459,NCT04747132,Completed,2020-10-20,2020-11-16,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04747132,2020-10-20,0,0
4460,NCT04747249,Recruiting,2022-03-01,2022-09-01,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04747249,2022-03-01,0,0
4461,NCT04747366,Recruiting,2025-11-01,2025-11-30,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04747366,2025-11-01,0,0
4462,NCT04747405,Not yet recruiting,2022-06-22,2022-08-22,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04747405,2022-06-22,0,0
4463,NCT04747522,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04747522,2022-06-30,0,0
4464,NCT04747678,Enrolling by invitation,2021-02-28,2021-03-01,No Results Posted,,,2021-02-10,https://clinicaltrials.gov/show/NCT04747678,2021-02-28,0,0
4465,NCT04747756,Enrolling by invitation,2022-12-01,2022-12-01,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04747756,2022-12-01,0,0
4466,NCT04747782,Recruiting,2021-10-01,2021-12-31,No Results Posted,"['Trahtemberg U, Fritzler MJ; On behalf of the COVID-19 chapter of the ""Longitudinal Biomarkers in Lung Injury"" study group. COVID-19-associated autoimmunity as a feature of acute respiratory failure. Intensive Care Med. 2021 Jul;47(7):801-804. doi: 10.1007/s00134-021-06408-z. Epub 2021 Apr 30.', 'Trahtemberg U, Rottapel R, Dos Santos CC, Slutsky AS, Baker A, Fritzler MJ. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis. 2021 Sep;80(9):1236-1240. doi: 10.1136/annrheumdis-2021-220206. Epub 2021 Apr 26.']",,2021-02-10,https://clinicaltrials.gov/show/NCT04747782,2021-10-01,0,1
4467,NCT04748120,Terminated,2021-04-06,2021-04-06,Study Results,,,2022-03-14,https://clinicaltrials.gov/show/NCT04748120,2021-04-06,1,0
4468,NCT04748185,Recruiting,2023-01-30,2023-01-30,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04748185,2023-01-30,0,0
4469,NCT04748614,Not yet recruiting,2021-03-15,2021-03-30,No Results Posted,,"['Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah MH, Althunayyan SM, Alsofayan YM. Erratum: Khan, A.A., et al. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia). Int. J. Environ. Res. Public Health 2020, 17, 7458. Int J Environ Res Public Health. 2020 Dec 17;17(24). pii: E9458. doi: 10.3390/ijerph17249458.']",2021-02-10,https://clinicaltrials.gov/show/NCT04748614,2021-03-15,0,1
4470,NCT04749121,Completed,2021-02-05,2021-02-05,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04749121,2021-02-05,0,0
4471,NCT04750317,Completed,2020-08-01,2020-09-01,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04750317,2020-08-01,0,0
4472,NCT04750343,"Active, not recruiting",2021-07-28,2022-06-01,No Results Posted,"[""Arunachalam PS, Walls AC, Golden N, Atyeo C, Fischinger S, Li C, Aye P, Navarro MJ, Lai L, Edara VV, R√∂ltgen K, Rogers K, Shirreff L, Ferrell DE, Wrenn S, Pettie D, Kraft JC, Miranda MC, Kepl E, Sydeman C, Brunette N, Murphy M, Fiala B, Carter L, White AG, Trisal M, Hsieh CL, Russell-Lodrigue K, Monjure C, Dufour J, Spencer S, Doyle-Meyers L, Bohm RP, Maness NJ, Roy C, Plante JA, Plante KS, Zhu A, Gorman MJ, Shin S, Shen X, Fontenot J, Gupta S, O'Hagan DT, Van Der Most R, Rappuoli R, Coffman RL, Novack D, McLellan JS, Subramaniam S, Montefiori D, Boyd SD, Flynn JL, Alter G, Villinger F, Kleanthous H, Rappaport J, Suthar MS, King NP, Veesler D, Pulendran B. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.""]",,2021-10-15,https://clinicaltrials.gov/show/NCT04750343,2021-07-28,0,1
4473,NCT04750356,Recruiting,2024-12-31,2024-12-31,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04750356,2024-12-31,0,0
4474,NCT04750369,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,2021-02-11,https://clinicaltrials.gov/show/NCT04750369,2021-03-31,0,0
4475,NCT04751227,Completed,2021-01-30,2021-01-30,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04751227,2021-01-30,0,0
4476,NCT04751604,Recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-08-19,https://clinicaltrials.gov/show/NCT04751604,2021-12-01,0,0
4477,NCT04751617,Enrolling by invitation,2021-01-31,2021-03-31,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04751617,2021-01-31,0,0
4478,NCT04751630,Completed,2022-02-01,2022-03-01,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04751630,2022-02-01,0,0
4479,NCT04751695,Not yet recruiting,2021-03-01,2021-04-01,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04751695,2021-03-01,0,0
4480,NCT04751721,Not yet recruiting,2021-03-01,2021-04-01,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04751721,2021-03-01,0,0
4481,NCT04751734,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04751734,2022-12-01,0,0
4482,NCT04752839,Not yet recruiting,2021-03-01,2021-05-01,No Results Posted,,,2021-02-12,https://clinicaltrials.gov/show/NCT04752839,2021-03-01,0,0
4483,NCT04753346,Recruiting,2023-01-01,2023-01-01,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04753346,2023-01-01,0,0
4484,NCT04753762,Recruiting,2022-01-01,2022-11-01,No Results Posted,,"['Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis. 2020 Sep - Oct;63(5):682-689. doi: 10.1016/j.pcad.2020.05.013. Epub 2020 Jun 6. Review.', 'Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Der Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19. Review.', 'Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.', 'Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020 Jul 15;253:117723. doi: 10.1016/j.lfs.2020.117723. Epub 2020 Apr 28. Review.', 'Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;:.', 'Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020 May 5;153(6):725-733. doi: 10.1093/ajcp/aqaa062. Erratum in: Am J Clin Pathol. 2020 May 5;153(6):852.', 'Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149.', 'Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart. 2020 Aug;106(15):1127-1131. doi: 10.1136/heartjnl-2020-317186. Epub 2020 Jun 4. Review.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.']",2021-02-15,https://clinicaltrials.gov/show/NCT04753762,2022-01-01,0,1
4485,NCT04754113,Completed,2022-01-01,2022-01-15,No Results Posted,,,2022-01-25,https://clinicaltrials.gov/show/NCT04754113,2022-01-01,0,0
4486,NCT04754633,Completed,2020-07-20,2020-07-20,No Results Posted,,,2021-02-15,https://clinicaltrials.gov/show/NCT04754633,2020-07-20,0,0
4487,NCT04756193,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04756193,2022-12-31,0,0
4488,NCT04475107,Completed,2021-03-25,2021-04-15,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04475107,2021-03-25,0,0
4489,NCT04673292,Enrolling by invitation,2023-05-01,2024-05-01,No Results Posted,,,2021-12-27,https://clinicaltrials.gov/show/NCT04673292,2023-05-01,0,0
4490,NCT04692779,Recruiting,2022-01-31,2022-01-31,No Results Posted,,"['Arbelot C, Ferrari F, Bouhemad B, Rouby JJ. Lung ultrasound in acute respiratory distress syndrome and acute lung injury. Curr Opin Crit Care. 2008 Feb;14(1):70-4. doi: 10.1097/MCC.0b013e3282f43d05. Review.', 'Bouhemad B, Brisson H, Le-Guen M, Arbelot C, Lu Q, Rouby JJ. Bedside ultrasound assessment of positive end-expiratory pressure-induced lung recruitment. Am J Respir Crit Care Med. 2011 Feb 1;183(3):341-7. doi: 10.1164/rccm.201003-0369OC. Epub 2010 Sep 17.', 'Bouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: Bedside lung ultrasound in critical care practice. Crit Care. 2007;11(1):205. Review.', 'Doerschug KC, Schmidt GA. Intensive care ultrasound: III. Lung and pleural ultrasound for the intensivist. Ann Am Thorac Soc. 2013 Dec;10(6):708-12. doi: 10.1513/AnnalsATS.201308-288OT.', ""Haddam M, Zieleskiewicz L, Perbet S, Baldovini A, Guervilly C, Arbelot C, Noel A, Vigne C, Hammad E, Antonini F, Lehingue S, Peytel E, Lu Q, Bouhemad B, Golmard JL, Langeron O, Martin C, Muller L, Rouby JJ, Constantin JM, Papazian L, Leone M; CAR'Echo Collaborative Network; AzuRea Collaborative Network. Lung ultrasonography for assessment of oxygenation response to prone position ventilation in ARDS. Intensive Care Med. 2016 Oct;42(10):1546-1556. doi: 10.1007/s00134-016-4411-7. Epub 2016 Jun 20."", ""Prat G, Guinard S, Bizien N, Nowak E, Tonnelier JM, Alavi Z, Renault A, Boles JM, L'Her E. Can lung ultrasonography predict prone positioning response in acute respiratory distress syndrome patients? J Crit Care. 2016 Apr;32:36-41. doi: 10.1016/j.jcrc.2015.12.015. Epub 2015 Dec 30."", 'Wang XT, Ding X, Zhang HM, Chen H, Su LX, Liu DW; Chinese Critical Ultrasound Study Group (CCUSG). Lung ultrasound can be used to predict the potential of prone positioning and assess prognosis in patients with acute respiratory distress syndrome. Crit Care. 2016 Nov 30;20(1):385.', 'Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Gu√©rin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.', 'Munshi L, Del Sorbo L, Adhikari NKJ, Hodgson CL, Wunsch H, Meade MO, Uleryk E, Mancebo J, Pesenti A, Ranieri VM, Fan E. Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2017 Oct;14(Supplement_4):S280-S288. doi: 10.1513/AnnalsATS.201704-343OT. Review.', 'Marini JJ, Hurford WE. Should Early Prone Positioning Be a Standard of Care in ARDS With Refractory Hypoxemia? Wrong Question-Reply. Respir Care. 2016 Nov;61(11):1564-1565.', 'Scholten EL, Beitler JR, Prisk GK, Malhotra A. Treatment of ARDS With Prone Positioning. Chest. 2017 Jan;151(1):215-224. doi: 10.1016/j.chest.2016.06.032. Epub 2016 Jul 8. Review.', 'Kallet RH. A Comprehensive Review of Prone Position in ARDS. Respir Care. 2015 Nov;60(11):1660-87. doi: 10.4187/respcare.04271. Review.', 'Reilly JP, Calfee CS, Christie JD. Acute Respiratory Distress Syndrome Phenotypes. Semin Respir Crit Care Med. 2019 Feb;40(1):19-30. doi: 10.1055/s-0039-1684049. Epub 2019 May 6. Review.', 'Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.', 'Robba C, Battaglini D, Ball L, Patroniti N, Loconte M, Brunetti I, Vena A, Giacobbe DR, Bassetti M, Rocco PRM, Pelosi P. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020 Aug;279:103455. doi: 10.1016/j.resp.2020.103455. Epub 2020 May 11. Review.', 'Weiss TT, Cerda F, Scott JB, Kaur R, Sungurlu S, Mirza SH, Alolaiwat AA, Kaur R, Augustynovich AE, Li J. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study. Br J Anaesth. 2021 Jan;126(1):48-55. doi: 10.1016/j.bja.2020.09.042. Epub 2020 Oct 10.']",2021-11-01,https://clinicaltrials.gov/show/NCT04692779,2022-01-31,0,1
4491,NCT04704544,Recruiting,2022-11-30,2022-11-30,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04704544,2022-11-30,0,0
4492,NCT04710836,Recruiting,2032-08-31,2032-08-31,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04710836,2032-08-31,0,0
4493,NCT04715854,"Active, not recruiting",2021-04-01,2021-07-01,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04715854,2021-04-01,0,0
4494,NCT04741061,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04741061,2021-12-31,0,0
4495,NCT04749173,Completed,2021-06-18,2021-06-18,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04749173,2021-06-18,0,0
4496,NCT04750759,Terminated,2021-10-29,2021-10-29,No Results Posted,,,2021-12-09,https://clinicaltrials.gov/show/NCT04750759,2021-10-29,0,0
4497,NCT04756128,Enrolling by invitation,2021-12-31,2021-12-31,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04756128,2021-12-31,0,0
4498,NCT04756271,Completed,2021-12-20,2021-12-22,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04756271,2021-12-20,0,0
4499,NCT04756323,"Active, not recruiting",2021-06-30,2022-02-28,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04756323,2021-06-30,0,0
4500,NCT04756479,Completed,2020-06-30,2020-06-30,No Results Posted,,,2021-02-16,https://clinicaltrials.gov/show/NCT04756479,2020-06-30,0,0
4501,NCT04756518,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04756518,2022-03-31,0,0
4502,NCT04756609,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-02-16,https://clinicaltrials.gov/show/NCT04756609,2021-06-01,0,0
4503,NCT04756674,Recruiting,2022-10-01,2023-04-30,No Results Posted,,,2021-07-06,https://clinicaltrials.gov/show/NCT04756674,2022-10-01,0,0
4504,NCT04756817,Recruiting,2021-08-30,2021-09-30,No Results Posted,,,2021-02-16,https://clinicaltrials.gov/show/NCT04756817,2021-08-30,0,0
4505,NCT04756830,"Active, not recruiting",2021-09-01,2023-06-01,No Results Posted,,,2021-07-09,https://clinicaltrials.gov/show/NCT04756830,2021-09-01,0,0
4506,NCT04756869,Completed,2021-01-16,2021-01-16,No Results Posted,"['Clingan CA, Dittakavi M, Rozwadowski M, Gilley KN, Cislo CR, Barabas J, Sandford E, Olesnavich M, Flora C, Tyler J, Mayer C, Stoneman E, Braun T, Forger DB, Tewari M, Choi SW. Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology: Protocol for an Observational mHealth Study. JMIR Res Protoc. 2021 May 12;10(5):e29562. doi: 10.2196/29562.']",,2022-02-11,https://clinicaltrials.gov/show/NCT04756869,2021-01-16,0,1
4507,NCT04757285,Completed,2020-10-30,2020-10-30,No Results Posted,,"['McEwen BS. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci. 2006;8(4):367-81. Review.', 'Christ-Crain M, Fenske W. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis. Nat Rev Endocrinol. 2016 Mar;12(3):168-76. doi: 10.1038/nrendo.2015.224. Epub 2016 Jan 22. Review.']",2021-02-17,https://clinicaltrials.gov/show/NCT04757285,2020-10-30,0,1
4508,NCT04757298,Recruiting,2022-01-30,2022-12-31,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04757298,2022-01-30,0,0
4509,NCT04757792,Completed,2021-02-01,2021-02-11,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04757792,2021-02-01,0,0
4510,NCT04757818,Completed,2021-05-25,2021-06-03,No Results Posted,,,2021-07-19,https://clinicaltrials.gov/show/NCT04757818,2021-05-25,0,0
4511,NCT04757870,Not yet recruiting,2021-06-30,2021-12-31,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04757870,2021-06-30,0,0
4512,NCT04757883,Recruiting,2023-03-01,2023-03-01,No Results Posted,,,2021-09-14,https://clinicaltrials.gov/show/NCT04757883,2023-03-01,0,0
4513,NCT04758039,Completed,2020-07-10,2020-07-10,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04758039,2020-07-10,0,0
4514,NCT04758273,"Active, not recruiting",2021-06-30,2022-02-28,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04758273,2021-06-30,0,0
4515,NCT04758286,Completed,2021-02-01,2021-02-11,No Results Posted,,,2021-02-17,https://clinicaltrials.gov/show/NCT04758286,2021-02-01,0,0
4516,NCT04760418,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04760418,2022-08-01,0,0
4517,NCT04760561,Completed,2021-03-20,2021-04-20,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04760561,2021-03-20,0,0
4518,NCT04760639,"Active, not recruiting",2022-09-16,2022-10-16,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04760639,2022-09-16,0,0
4519,NCT04760730,Recruiting,2022-03-01,2022-06-30,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04760730,2022-03-01,0,0
4520,NCT04760743,"Active, not recruiting",2021-04-01,2022-04-01,No Results Posted,,,2021-02-18,https://clinicaltrials.gov/show/NCT04760743,2021-04-01,0,0
4521,NCT04760795,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04760795,2022-01-01,0,0
4522,NCT04760821,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04760821,2021-04-30,0,0
4523,NCT04761692,Not yet recruiting,2026-10-31,2026-12-31,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04761692,2026-10-31,0,0
4524,NCT04762186,Recruiting,2023-02-01,2023-02-01,No Results Posted,,,2021-12-20,https://clinicaltrials.gov/show/NCT04762186,2023-02-01,0,0
4525,NCT04762628,Completed,2021-07-05,2021-08-06,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04762628,2021-07-05,0,0
4526,NCT04763213,Completed,2019-12-31,2019-12-31,No Results Posted,,"[""Collet JP, Thiele H. The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020 Oct 1;41(37):3495-3497. doi: 10.1093/eurheartj/ehaa624."", 'Aktoz M, Altay H, Aslanger E, Atalar E, Aytekin V, Baykan AO, Bar√ßƒ±n C, Barƒ±≈ü N, Boyacƒ± AA, √áavu≈üoƒülu Y, √áelik A, √áinier G, Deƒüertekin M, Erg√∂n√ºl √ñ, Ert√ºrk M, Erol MK, G√∂renek B, G√ºrsoy MO, H√ºn√ºk B, Kahveci G, Karabay CY, Karaca I, Kayƒ±k√ßƒ±oƒülu M, Keskin M, Kƒ±lƒ±√ß T, Kƒ±rma C, Kocaba≈ü U, K√º√ß√ºkoƒülu S, Mutlu B, Nalbantgil S, Okuyan E, Okyay K, Kaptan √ñzen D, √ñzg√ºl S, √ñzpelit E, Pirat B, Sert S, Sinan √úY, ≈ûener YZ, Tatlƒ± E, Tekke≈üin Aƒ∞, Tutar E, Ural D, Yƒ±ldƒ±rƒ±mt√ºrk √ñ. [Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)]. Turk Kardiyol Dern Ars. 2020 Mar;48(Suppl 1):1-48. doi: 10.5543/tkda.2020.97198. Turkish.', 'Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Braunwald E, Gibson CM. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J Am Coll Cardiol. 2002 Nov 20;40(10):1761-8.', 'Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, Gobunsuy R, Jadonath S, Baldari D, McCord D, Lafferty J. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010 Aug 15;106(4):470-6. doi: 10.1016/j.amjcard.2010.03.062.', 'Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, Shevach A, Berliner S, Herz I, Keren G, Banai S. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012 Dec;225(2):456-60. doi: 10.1016/j.atherosclerosis.2012.09.009. Epub 2012 Sep 21.', 'Temiz A, Gazi E, G√ºng√∂r √ñ, Barut√ßu A, Altun B, Bekler A, Binnetoƒülu E, ≈ûen H, G√ºne≈ü F, Gazi S. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014 Apr 22;20:660-5. doi: 10.12659/MSM.890152.', 'Sansanayudh N, Anothaisintawee T, Muntham D, McEvoy M, Attia J, Thakkinstian A. Mean platelet volume and coronary artery disease: a systematic review and meta-analysis. Int J Cardiol. 2014 Aug 20;175(3):433-40. doi: 10.1016/j.ijcard.2014.06.028. Epub 2014 Jun 28. Review. Erratum in: Int J Cardiol. 2014 Dec 20;177(3):1145. AmmarinThakkinstian [corrected to Thakkinstian, Ammarin].', 'Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A, Ayhan E, Ergelen M, Bayram E, Gibson CM. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis. 2012 Jan;23(1):51-6. doi: 10.1097/MCA.0b013e32834e4f5c.', 'Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Leu HB. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020 May;50(5):e13230. doi: 10.1111/eci.13230. Epub 2020 May 11.']",2021-02-21,https://clinicaltrials.gov/show/NCT04763213,2019-12-31,0,1
4527,NCT04763395,Completed,2021-02-20,2021-03-01,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04763395,2021-02-20,0,0
4528,NCT04764032,Recruiting,2021-03-31,2021-04-30,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04764032,2021-03-31,0,0
4529,NCT04764721,Not yet recruiting,2022-07-12,2022-09-12,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04764721,2022-07-12,0,0
4530,NCT04764773,Completed,2021-02-28,2021-03-31,No Results Posted,"['Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol. 2021 Oct;93(10):5942-5946. doi: 10.1002/jmv.27156. Epub 2021 Jul 2.']",,2021-11-02,https://clinicaltrials.gov/show/NCT04764773,2021-02-28,0,1
4531,NCT04764981,Enrolling by invitation,2022-05-01,2024-05-01,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04764981,2022-05-01,0,0
4532,NCT04765254,Recruiting,2021-03-20,2021-04-10,No Results Posted,,,2021-02-21,https://clinicaltrials.gov/show/NCT04765254,2021-03-20,0,0
4533,NCT04765436,"Active, not recruiting",2022-02-12,2022-02-12,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04765436,2022-02-12,0,0
4534,NCT04766983,Recruiting,2022-07-31,2022-09-30,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04766983,2022-07-31,0,0
4535,NCT04767087,Recruiting,2022-02-15,2022-04-15,No Results Posted,"['Ashraf S, Ashraf S, Akmal R, Ashraf M, Kalsoom L, Maqsood A, Imran MA, Farooq I, Ashraf S, Siddiqui UN, Ghufran M, Akram MK, Majeed N, Rafique S, Habib Z, Shahab MS, Akmal A, Shaukat Z, Abdin ZU, Khaqan A, Arshad S, Rehman Virk MA, Gul M, Awais AB, Hassan M, Khalid N, Iqbal QUA, Ahmad T, Akram M, Muhammad A, Khalil M, Aslam A, Umer M, Sherazi SSH, Safdar Z, Ahmad S, Bilal M, Zahid MN, Koshak AE, Hilal A, Malik AA, Iqbal U, Baig AA, Alahmadi YM, Humayun A, Malik A, Ahmad A, Ashraf M, Saboor QA, Izhar M; DOCTORS LOUNGE consortium. Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Sep 15;22(1):618. doi: 10.1186/s13063-021-05510-3.']",,2021-07-02,https://clinicaltrials.gov/show/NCT04767087,2022-02-15,0,1
4536,NCT03256773,Recruiting,2022-12-31,2023-12-31,No Results Posted,,,2022-01-12,https://clinicaltrials.gov/show/NCT03256773,2022-12-31,0,0
4537,NCT04678843,"Active, not recruiting",2021-07-31,2022-01-01,No Results Posted,"['Couturier J, Pellegrini D, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Lock J. Adapting and adopting highly specialized pediatric eating disorder treatment to virtual care: a protocol for an implementation study in the COVID-19 context. Implement Sci Commun. 2021 Apr 8;2(1):38. doi: 10.1186/s43058-021-00143-8.']",,2021-12-02,https://clinicaltrials.gov/show/NCT04678843,2021-07-31,0,1
4538,NCT04679272,Completed,2021-01-30,2021-02-01,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04679272,2021-01-30,0,0
4539,NCT04679909,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04679909,2022-02-01,0,0
4540,NCT04681053,Recruiting,2021-04-30,2021-12-31,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04681053,2021-04-30,0,0
4541,NCT04695197,Recruiting,2022-11-01,2023-07-31,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04695197,2022-11-01,0,0
4542,NCT04700462,Completed,2021-10-30,2021-10-30,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04700462,2021-10-30,0,0
4543,NCT04701502,Completed,2021-02-15,2021-02-15,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04701502,2021-02-15,0,0
4544,NCT04701710,Completed,2020-12-18,2020-12-31,No Results Posted,,,2021-02-23,https://clinicaltrials.gov/show/NCT04701710,2020-12-18,0,0
4545,NCT04706156,Recruiting,2021-02-28,2021-03-31,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04706156,2021-02-28,0,0
4546,NCT04713176,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04713176,2021-06-30,0,0
4547,NCT04723563,Completed,2021-08-23,2021-08-23,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04723563,2021-08-23,0,0
4548,NCT04727372,Completed,2021-02-23,2021-02-23,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04727372,2021-02-23,0,0
4549,NCT04728828,Recruiting,2023-02-15,2023-08-15,No Results Posted,,"['Jager KJ, Kramer A, Chesnaye NC, Couchoud C, S√°nchez-√Ålvarez JE, Garneata L, Collart F, Hemmelder MH, Amb√ºhl P, Kerschbaum J, Legeai C, Del Pino Y Pino MD, Mircescu G, Mazzoleni L, Hoekstra T, Winzeler R, Mayer G, Stel VS, Wanner C, Zoccali C, Massy ZA. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020 Dec;98(6):1540-1548. doi: 10.1016/j.kint.2020.09.006. Epub 2020 Oct 15.', 'ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314.', 'Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007 Sep-Oct;20(5):440-51. Review.', 'Mahalingasivam V, Tomlinson L. The seroprevalence of SARS-CoV-2 in patients on haemodialysis. Nat Rev Nephrol. 2021 Apr;17(4):225-226. doi: 10.1038/s41581-020-00379-y.']",2021-02-26,https://clinicaltrials.gov/show/NCT04728828,2023-02-15,0,1
4550,NCT04729595,Recruiting,2022-06-30,2022-09-30,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04729595,2022-06-30,0,0
4551,NCT04730934,Completed,2021-02-25,2021-02-25,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04730934,2021-02-25,0,0
4552,NCT04733170,Not yet recruiting,2021-08-31,2021-08-31,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04733170,2021-08-31,0,0
4553,NCT04747158,Completed,2020-12-10,2021-01-10,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04747158,2020-12-10,0,0
4554,NCT04757857,Recruiting,2022-06-28,2022-10-30,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04757857,2022-06-28,0,0
4555,NCT04760132,Recruiting,2024-12-31,2024-12-31,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04760132,2024-12-31,0,0
4556,NCT04762693,"Active, not recruiting",2021-10-01,2021-11-01,No Results Posted,"['Gabaldon-Figueira JC, Brew J, Dor√© DH, Umashankar N, Chaccour J, Orrillo V, Tsang LY, Blavia I, Fern√°ndez-Montero A, Bartolom√© J, Grandjean Lapierre S, Chaccour C. Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study. BMJ Open. 2021 Jul 2;11(7):e051278. doi: 10.1136/bmjopen-2021-051278.']",,2021-09-09,https://clinicaltrials.gov/show/NCT04762693,2021-10-01,0,1
4557,NCT04766788,"Active, not recruiting",2022-07-01,2025-07-01,No Results Posted,"['Gilley KN, Baroudi L, Yu M, Gainsburg I, Reddy N, Bradley C, Cislo C, Rozwadowski ML, Clingan CA, DeMoss MS, Churay T, Birditt K, Colabianchi N, Chowdhury M, Forger D, Gagnier J, Zernicke RF, Cunningham JL, Cain SM, Tewari M, Choi SW. Risk Factors for COVID-19 in College Students Identified by Physical, Mental, and Social Health Reported During the Fall 2020 Semester: Observational Study Using the Roadmap App and Fitbit Wearable Sensors. JMIR Ment Health. 2022 Feb 10;9(2):e34645. doi: 10.2196/34645.', 'Cislo C, Clingan C, Gilley K, Rozwadowski M, Gainsburg I, Bradley C, Barabas J, Sandford E, Olesnavich M, Tyler J, Mayer C, DeMoss M, Flora C, Forger DB, Cunningham JL, Tewari M, Choi SW. Monitoring beliefs and physiological measures in students at risk for COVID-19 using wearable sensors and smartphone technology: Protocol for a mobile health study. JMIR Res Protoc. 2021 Jun 4. doi: 10.2196/29561. [Epub ahead of print]']",,2022-01-13,https://clinicaltrials.gov/show/NCT04766788,2022-07-01,0,1
4558,NCT04768153,"Active, not recruiting",2023-12-31,2024-12-31,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04768153,2023-12-31,0,0
4559,NCT04768179,Not yet recruiting,2021-06-30,2021-09-30,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04768179,2021-06-30,0,0
4560,NCT04768244,Recruiting,2022-12-01,2022-12-01,No Results Posted,"['B√§uerl C, Randazzo W, S√°nchez G, Selma-Royo M, Garc√≠a Verdevio E, Mart√≠nez L, Parra-Llorca A, Lerin C, Fumad√≥ V, Crovetto F, Crispi F, P√©rez-Cano FJ, Rodr√≠guez G, Ruiz-Redondo G, Campoy C, Mart√≠nez-Costa C, Collado MC; MilkCORONA study team. SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain. Arch Dis Child Fetal Neonatal Ed. 2022 Mar;107(2):216-221. doi: 10.1136/archdischild-2021-322463. Epub 2021 Aug 20.']",,2022-03-29,https://clinicaltrials.gov/show/NCT04768244,2022-12-01,0,1
4561,NCT04768257,Not yet recruiting,2022-07-01,2022-12-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04768257,2022-07-01,0,0
4562,NCT04768413,Recruiting,2021-04-30,2021-06-30,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04768413,2021-04-30,0,0
4563,NCT04769154,Recruiting,2023-02-01,2023-02-01,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04769154,2023-02-01,0,0
4564,NCT04769245,Recruiting,2021-04-01,2021-06-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04769245,2021-04-01,0,0
4565,NCT04769258,Not yet recruiting,2022-03-01,2022-06-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04769258,2022-03-01,0,0
4566,NCT04769284,Completed,2021-02-20,2021-02-21,No Results Posted,,"['Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020 Feb 22;395(10224):e37-e38. doi: 10.1016/S0140-6736(20)30309-3. Epub 2020 Feb 7.', 'Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 29;:.', 'Odriozola-Gonz√°lez P, Planchuelo-G√≥mez √Å, Irurtia MJ, de Luis-Garc√≠a R. Psychological symptoms of the outbreak of the COVID-19 confinement in Spain. J Health Psychol. 2022 Mar;27(4):825-835. doi: 10.1177/1359105320967086. Epub 2020 Oct 30.', 'Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26. Review.', 'Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, Sun C, Sylvia S, Rozelle S, Raat H, Zhou H. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x. Review.', 'Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb 26. Review.', 'Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020 Mar 6;17(5). pii: E1729. doi: 10.3390/ijerph17051729.']",2021-02-24,https://clinicaltrials.gov/show/NCT04769284,2021-02-20,0,1
4567,NCT04769297,"Active, not recruiting",2021-04-01,2021-04-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04769297,2021-04-01,0,0
4568,NCT04769349,Recruiting,2021-12-15,2022-12-15,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04769349,2021-12-15,0,0
4569,NCT04769700,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-02-24,https://clinicaltrials.gov/show/NCT04769700,2021-06-01,0,0
4570,NCT04769999,Completed,2020-10-16,2020-10-30,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04769999,2020-10-16,0,0
4571,NCT04770649,Recruiting,2022-12-01,2023-12-01,No Results Posted,,,2021-02-25,https://clinicaltrials.gov/show/NCT04770649,2022-12-01,0,0
4572,NCT04770740,Recruiting,2021-06-01,2021-10-01,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04770740,2021-06-01,0,0
4573,NCT04771052,Enrolling by invitation,2021-08-01,2021-08-01,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04771052,2021-08-01,0,0
4574,NCT04771117,Completed,2020-08-01,2020-12-01,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04771117,2020-08-01,0,0
4575,NCT04771585,Completed,2021-08-20,2021-08-20,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04771585,2021-08-20,0,0
4576,NCT04771598,Completed,2021-06-30,2021-07-30,No Results Posted,,,2022-02-22,https://clinicaltrials.gov/show/NCT04771598,2021-06-30,0,0
4577,NCT04771624,Completed,2021-04-30,2021-11-01,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04771624,2021-04-30,0,0
4578,NCT04772586,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04772586,2022-03-01,0,0
4579,NCT04772703,Recruiting,2021-02-28,2021-07-30,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04772703,2021-02-28,0,0
4580,NCT04772833,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04772833,2021-12-31,0,0
4581,NCT04773756,Completed,2020-11-30,2020-12-12,No Results Posted,,,2021-02-26,https://clinicaltrials.gov/show/NCT04773756,2020-11-30,0,0
4582,NCT04775017,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04775017,2021-12-01,0,0
4583,NCT04775056,Not yet recruiting,2023-12-01,2023-12-31,No Results Posted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04775056,2023-12-01,0,0
4584,NCT04775563,Recruiting,2021-08-30,2021-10-01,No Results Posted,,,2021-03-01,https://clinicaltrials.gov/show/NCT04775563,2021-08-30,0,0
4585,NCT04775784,Recruiting,2022-09-20,2022-12-20,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04775784,2022-09-20,0,0
4586,NCT04776941,Recruiting,2023-12-31,2023-12-31,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04776941,2023-12-31,0,0
4587,NCT04778033,Recruiting,2021-04-10,2021-05-01,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04778033,2021-04-10,0,0
4588,NCT04779138,Recruiting,2023-10-31,2023-11-30,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04779138,2023-10-31,0,0
4589,NCT04486521,Recruiting,2021-07-22,2021-07-22,No Results Posted,"['Amer M, Kamel AM, Bawazeer M, Maghrabi K, Butt A, Dahhan T, Kseibi E, Khurshid SM, Abujazar M, Alghunaim R, Rabee M, Abualkhair M, Al-Janoubi A, AlFirm AT, Gajic O, Walkey AJ, Mosier JM, Zabolotskikh IB, Gavidia OY, Teruel SY, Bernstein MA, Boman K, Kumar VK, Bansal V, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry. Eur J Med Res. 2021 Oct 2;26(1):117. doi: 10.1186/s40001-021-00591-x.']",,2021-03-08,https://clinicaltrials.gov/show/NCT04486521,2021-07-22,0,1
4590,NCT04690413,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04690413,2020-12-31,0,0
4591,NCT04695704,Not yet recruiting,2022-03-31,2022-12-31,No Results Posted,"['Mera-Cordero F, Bonet-Monne S, Almeda-Ortega J, Garc√≠a-Sangen√≠s A, Cunillera-Pu√®rtolas O, Contreras-Martos S, Alvarez-Mu√±oz G, Monf√† R, Balanzo-Jou√© M, Morros R, Salvador-Gonzalez B. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol. Trials. 2022 Jan 6;23(1):19. doi: 10.1186/s13063-021-05951-w. Erratum in: Trials. 2022 Feb 9;23(1):130.']",,2021-03-08,https://clinicaltrials.gov/show/NCT04695704,2022-03-31,0,1
4592,NCT04706403,Completed,2021-02-01,2021-02-01,Study Results,,,2022-01-05,https://clinicaltrials.gov/show/NCT04706403,2021-02-01,1,0
4593,NCT04716556,Completed,2021-01-14,2021-05-31,No Results Posted,"[""Menichetti F, Popoli P, Puopolo M, Spila Alegiani S, Tiseo G, Bartoloni A, De Socio GV, Luchi S, Blanc P, Puoti M, Toschi E, Massari M, Palmisano L, Marano G, Chiamenti M, Martinelli L, Franchi S, Pallotto C, Suardi LR, Luciani Pasqua B, Merli M, Fabiani P, Bertolucci L, Borchi B, Modica S, Moneta S, Marchetti G, d'Arminio Monforte A, Stoppini L, Ferracchiato N, Piconi S, Fabbri C, Beccastrini E, Saccardi R, Giacometti A, Esperti S, Pierotti P, Bernini L, Bianco C, Benedetti S, Lanzi A, Bonfanti P, Massari M, Sani S, Saracino A, Castagna A, Trabace L, Lanza M, Focosi D, Mazzoni A, Pistello M, Falcone M; TSUNAMI Study group. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Netw Open. 2021 Nov 1;4(11):e2136246. doi: 10.1001/jamanetworkopen.2021.36246. Erratum in: JAMA Netw Open. 2021 Dec 1;4(12):e2144236. JAMA Netw Open. 2022 Jan 4;5(1):e2146944.""]",,2021-08-26,https://clinicaltrials.gov/show/NCT04716556,2021-01-14,0,1
4594,NCT04717089,Completed,2021-02-28,2021-06-30,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04717089,2021-02-28,0,0
4595,NCT04730401,Recruiting,2021-08-31,2021-12-31,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04730401,2021-08-31,0,0
4596,NCT04747574,Recruiting,2021-02-25,2021-03-25,No Results Posted,,,2021-03-04,https://clinicaltrials.gov/show/NCT04747574,2021-02-25,0,0
4597,NCT04752085,"Active, not recruiting",2021-03-01,2023-06-30,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04752085,2021-03-01,0,0
4598,NCT04756466,"Active, not recruiting",2021-04-30,2021-12-31,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04756466,2021-04-30,0,0
4599,NCT04760990,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2021-03-02,https://clinicaltrials.gov/show/NCT04760990,2023-12-01,0,0
4600,NCT04761913,Completed,2021-12-31,2021-12-31,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04761913,2021-12-31,0,0
4601,NCT04771559,Completed,2021-06-01,2021-07-01,No Results Posted,"['Yasin AI, Aydin SG, S√ºmb√ºl B, Koral L, ≈ûim≈üek M, Geredeli √á, √ñzt√ºrk A, Perkin P, Demirta≈ü D, Erdemoglu E, Hacƒ±bekiroglu ƒ∞, √áakƒ±r E, Tanrƒ±kulu E, √áoban E, Ozcelik M, √áelik S, Teker F, Aksoy A, Fƒ±rat ST, Tekin √ñ, Kalkan Z, T√ºrken O, Oven BB, Dane F, Bilici A, Isƒ±kdogan A, Seker M, T√ºrk HM, G√ºm√º≈ü M. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study. Future Oncol. 2022 Mar;18(10):1235-1244. doi: 10.2217/fon-2021-1248. Epub 2022 Jan 27.']",,2021-08-03,https://clinicaltrials.gov/show/NCT04771559,2021-06-01,0,1
4602,NCT04775407,Recruiting,2022-03-01,2022-09-01,No Results Posted,"['Sass MR, Juul TS, Skov R, Iversen K, Harritsh√∏j LH, S√∏rensen E, Ostrowski SR, Andersen O, Ekstr√∏m CT, Ullum H, Nielsen J, Hageman I, Fink-Jensen A. SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study. PLoS One. 2022 Mar 1;17(3):e0264325. doi: 10.1371/journal.pone.0264325. eCollection 2022.']",,2021-03-03,https://clinicaltrials.gov/show/NCT04775407,2022-03-01,0,1
4603,NCT04775966,Completed,2021-02-15,2021-02-15,No Results Posted,,"['Bertelli F, Suehs CM, Mallet JP, Court-Fortune I, Gagnadoux F, Borel JC, Gaubert O, Molinari N, Bourdin A, Jaffuel D. Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea. Respir Res. 2022 Mar 4;23(1):46. doi: 10.1186/s12931-022-01969-z.']",2022-03-22,https://clinicaltrials.gov/show/NCT04775966,2021-02-15,0,1
4604,NCT04776005,Recruiting,2022-07-01,2023-01-01,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04776005,2022-07-01,0,0
4605,NCT04777981,Not yet recruiting,2022-12-05,2022-12-28,No Results Posted,,,2022-02-22,https://clinicaltrials.gov/show/NCT04777981,2022-12-05,0,0
4606,NCT04778020,Completed,2021-12-31,2022-01-10,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04778020,2021-12-31,0,0
4607,NCT04778059,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04778059,2022-03-01,0,0
4608,NCT04779021,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04779021,2021-12-31,0,0
4609,NCT04779359,Not yet recruiting,2021-08-01,2021-12-01,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04779359,2021-08-01,0,0
4610,NCT04779424,"Active, not recruiting",2021-12-31,2022-06-30,No Results Posted,"['Adriaenssens N, Scholtes B, Bruyndonckx R, Verbakel JY, De Sutter A, Heytens S, Van den Bruel A, Desombere I, Van Damme P, Goossens H, Buret L, Duysburgh E, Coenen S. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol. BMJ Open. 2022 Jan 31;12(1):e054688. doi: 10.1136/bmjopen-2021-054688.']",,2021-10-12,https://clinicaltrials.gov/show/NCT04779424,2021-12-31,0,1
4611,NCT04779749,Completed,2021-09-01,2021-09-01,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04779749,2021-09-01,0,0
4612,NCT04779879,"Active, not recruiting",2021-08-20,2022-06-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-08,https://clinicaltrials.gov/show/NCT04779879,2021-08-20,0,1
4613,NCT04779996,Recruiting,2021-08-31,2022-02-28,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04779996,2021-08-31,0,0
4614,NCT04780035,Completed,2021-08-31,2021-12-20,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04780035,2021-08-31,0,0
4615,NCT04780126,Recruiting,2021-04-30,2021-05-31,No Results Posted,,"['Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19-21, 1988. Am J Clin Nutr. 1989 Nov;50(5 Suppl):1121-235.', 'von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):129-133. Epub 2010 Dec 17.', 'Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkov√° E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.', 'Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011 May;12(4):249-56. doi: 10.1016/j.jamda.2011.01.003. Epub 2011 Mar 4.', 'Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010.', 'Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):702-712. doi: 10.1002/jcsm.12210. Epub 2017 Jul 12. Review.']",2021-03-03,https://clinicaltrials.gov/show/NCT04780126,2021-04-30,0,1
4616,NCT04780295,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-03-03,https://clinicaltrials.gov/show/NCT04780295,2021-12-01,0,0
4617,NCT04780334,Not yet recruiting,2023-04-01,2023-04-01,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04780334,2023-04-01,0,0
4618,NCT04780581,Recruiting,2021-12-01,2021-12-31,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04780581,2021-12-01,0,0
4619,NCT04780594,Completed,2020-05-15,2020-12-09,No Results Posted,"['Caballero-Mil√°n M, Colomina MJ, Marin-Carcey LA, Viguera-Fernandez L, Bayona-Domenge R, Garcia-Ballester S, L√≥pez-Farre A, Ruiz-Buera L, Sanz-Iturbe M, √Ålvarez-Villegas D, Jenssen-Paz EC, Puig-Sanz G, Arcos-Terrones A, Belmonte-Cuenca C, Perelada-Alonso E, Blasco-Blasco F, Sabat√© A. Impact of the SARS-CoV-2 (COVID19) pandemic on the morbidity and mortality of high risk patients undergoing surgery: a non-inferiority retrospective observational study. BMC Anesthesiol. 2021 Nov 26;21(1):295. doi: 10.1186/s12871-021-01495-3.']",,2021-03-03,https://clinicaltrials.gov/show/NCT04780594,2020-05-15,0,1
4620,NCT04780659,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,"['Cuapio A, Boulouis C, Filipovic I, Wullimann D, Kammann T, Parrot T, Chen P, Akber M, Gao Y, Hammer Q, Strunz B, P√©rez Potti A, Rivera Ballesteros O, Lange J, Muvva JR, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, S√∂derdahl G, √ñsterborg A, Smith CIE, Bogdanovic G, Muschiol S, Hellgren F, Lor√© K, Sobkowiak MJ, Gabarrini G, Healy K, S√§llberg Chen M, Alici E, Bj√∂rkstr√∂m NK, Buggert M, Ljungman P, Sandberg JK, Aleman S, Ljunggren HG. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals. Mol Med. 2022 Feb 8;28(1):20. doi: 10.1186/s10020-022-00443-2.']",,2021-09-09,https://clinicaltrials.gov/show/NCT04780659,2022-12-31,0,1
4621,NCT04780685,Recruiting,2022-09-30,2022-12-31,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04780685,2022-09-30,0,0
4622,NCT04781400,Recruiting,2022-02-08,2022-02-08,No Results Posted,,,2021-03-04,https://clinicaltrials.gov/show/NCT04781400,2022-02-08,0,0
4623,NCT04782336,Recruiting,2022-03-31,2022-05-31,No Results Posted,,,2021-03-04,https://clinicaltrials.gov/show/NCT04782336,2022-03-31,0,0
4624,NCT04782427,Completed,2021-04-13,2021-05-13,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04782427,2021-04-13,0,0
4625,NCT04784403,Completed,2021-02-24,2021-02-24,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04784403,2021-02-24,0,0
4626,NCT04784468,Recruiting,2021-03-31,2021-09-30,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04784468,2021-03-31,0,0
4627,NCT04784546,Completed,2021-09-06,2021-09-06,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04784546,2021-09-06,0,0
4628,NCT04784624,Not yet recruiting,2021-12-30,2022-03-31,No Results Posted,,,2021-03-05,https://clinicaltrials.gov/show/NCT04784624,2021-12-30,0,0
4629,NCT04785781,Completed,2021-04-14,2021-04-15,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04785781,2021-04-14,0,0
4630,NCT04785807,Recruiting,2022-07-30,2022-07-30,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04785807,2022-07-30,0,0
4631,NCT04785898,"Active, not recruiting",2020-12-22,2022-03-30,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04785898,2020-12-22,0,0
4632,NCT04786041,Completed,2020-05-30,2020-05-30,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04786041,2020-05-30,0,0
4633,NCT04786080,"Active, not recruiting",2021-10-30,2021-12-31,No Results Posted,"['Kostyrka-Allchorne K, Creswell C, Byford S, Day C, Goldsmith K, Koch M, Gutierrez WM, Palmer M, Raw J, Robertson O, Shearer J, Shum A, Slovak P, Waite P, Sonuga-Barke EJS. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 10;22(1):267. doi: 10.1186/s13063-021-05226-4.']",,2021-08-16,https://clinicaltrials.gov/show/NCT04786080,2021-10-30,0,1
4634,NCT04786353,Recruiting,2023-04-01,2023-04-01,No Results Posted,"['Kikkenborg Berg S, Dam Nielsen S, Nygaard U, Bundgaard H, Palm P, Rotvig C, Vinggaard Christensen A. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022 Feb 7. pii: S2352-4642(22)00004-9. doi: 10.1016/S2352-4642(22)00004-9. [Epub ahead of print]']",,2021-12-21,https://clinicaltrials.gov/show/NCT04786353,2023-04-01,0,1
4635,NCT04786483,"Active, not recruiting",2021-01-30,2021-05-10,No Results Posted,,['Sahu P. Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff. Cureus. 2020 Apr 4;12(4):e7541. doi: 10.7759/cureus.7541. Review.'],2021-03-08,https://clinicaltrials.gov/show/NCT04786483,2021-01-30,0,1
4636,NCT04786808,Terminated,2021-11-07,2021-11-07,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04786808,2021-11-07,0,0
4637,NCT04787510,Completed,2021-05-23,2021-06-23,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04787510,2021-05-23,0,0
4638,NCT04787536,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04787536,2022-12-31,0,0
4639,NCT04787588,Recruiting,2021-12-01,2022-02-01,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04787588,2021-12-01,0,0
4640,NCT04787614,Enrolling by invitation,2021-06-30,2021-06-30,No Results Posted,,,2021-03-08,https://clinicaltrials.gov/show/NCT04787614,2021-06-30,0,0
4641,NCT04788355,Completed,2020-11-15,2020-12-23,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04788355,2020-11-15,0,0
4642,NCT04788433,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04788433,2022-03-31,0,0
4643,NCT04382378,Recruiting,2021-09-30,2021-12-31,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04382378,2021-09-30,0,0
4644,NCT04667962,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04667962,2021-09-01,0,0
4645,NCT04671017,"Active, not recruiting",2021-02-26,2022-03-31,Study Results,,,2022-03-24,https://clinicaltrials.gov/show/NCT04671017,2021-02-26,1,0
4646,NCT04681040,Recruiting,2022-03-31,2023-08-31,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04681040,2022-03-31,0,0
4647,NCT04684446,Recruiting,2022-04-08,2022-04-08,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04684446,2022-04-08,0,0
4648,NCT04686721,Recruiting,2021-09-01,2021-10-01,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04686721,2021-09-01,0,0
4649,NCT04710303,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04710303,2022-04-01,0,0
4650,NCT04713111,Completed,2020-11-30,2020-11-30,No Results Posted,"['Goodday SM, Karlin E, Alfarano A, Brooks A, Chapman C, Desille R, Karlin DR, Emami H, Woods NF, Boch A, Foschini L, Wildman M, Cormack F, Taptiklis N, Pratap A, Ghassemi M, Goldenberg A, Nagaraj S, Walsh E; Stress And Recovery Participants, Friend S. An Alternative to the Light Touch Digital Health Remote Study: The Stress and Recovery in Frontline COVID-19 Health Care Workers Study. JMIR Form Res. 2021 Dec 10;5(12):e32165. doi: 10.2196/32165.']",,2021-03-12,https://clinicaltrials.gov/show/NCT04713111,2020-11-30,0,1
4651,NCT04715607,Completed,2021-05-30,2021-05-31,No Results Posted,"['Todsen T, Tolsgaard M, Folke F, Jakobsen KK, Ersb√∏ll AK, Benfield T, von Buchwald C, Kirkby N. SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens. Dan Med J. 2021 Apr 7;68(5). pii: A01210087.']",,2021-09-30,https://clinicaltrials.gov/show/NCT04715607,2021-05-30,0,1
4652,NCT04732663,Recruiting,2023-02-01,2023-12-01,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04732663,2023-02-01,0,0
4653,NCT04733105,Completed,2021-06-30,2021-10-30,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04733105,2021-06-30,0,0
4654,NCT04750720,Recruiting,2023-12-01,2023-12-01,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04750720,2023-12-01,0,0
4655,NCT04753463,Completed,2021-03-28,2021-04-15,No Results Posted,,"['Silva N, Laiginhas R, Meireles A, Barbosa Breda J. Impact of the COVID-19 Pandemic on Ophthalmology Residency Training in Portugal. Acta Med Port. 2020 Oct 1;33(10):640-648. doi: 10.20344/amp.14341. Epub 2020 Sep 10.', 'Mishra D, Nair AG, Gandhi RA, Gogate PJ, Mathur S, Bhushan P, Srivastav T, Singh H, Sinha BP, Singh MK. The impact of COVID-19 related lockdown on ophthalmology training programs in India - Outcomes of a survey. Indian J Ophthalmol. 2020 Jun;68(6):999-1004. doi: 10.4103/ijo.IJO_1067_20.', 'El-Saied HMA, Salah Eddin Abdelhakim MA. Impact of COVID-19 Pandemic on Young Ophthalmologists in Cairo University Hospitals. Semin Ophthalmol. 2020 Aug 17;35(5-6):296-306. doi: 10.1080/08820538.2020.1826046. Epub 2020 Oct 5.']",2021-09-28,https://clinicaltrials.gov/show/NCT04753463,2021-03-28,0,1
4656,NCT04757272,Completed,2021-04-30,2021-09-30,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04757272,2021-04-30,0,0
4657,NCT04775134,Recruiting,2022-01-31,2022-01-31,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04775134,2022-01-31,0,0
4658,NCT04776044,Recruiting,2022-04-01,2022-06-01,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04776044,2022-04-01,0,0
4659,NCT04780425,Completed,2021-06-09,2021-06-12,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04780425,2021-06-09,0,0
4660,NCT04780672,Recruiting,2022-05-31,2022-09-30,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04780672,2022-05-31,0,0
4661,NCT04786197,"Active, not recruiting",2021-09-10,2022-03-31,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04786197,2021-09-10,0,0
4662,NCT04786249,"Active, not recruiting",2021-02-26,2022-12-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04786249,2021-02-26,0,0
4663,NCT04786301,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-03-12,https://clinicaltrials.gov/show/NCT04786301,2022-01-01,0,0
4664,NCT04787211,Completed,2021-12-02,2021-12-02,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04787211,2021-12-02,0,1
4665,NCT04788394,Completed,2021-12-31,2021-12-31,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04788394,2021-12-31,0,0
4666,NCT04788407,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04788407,2022-04-30,0,0
4667,NCT04789226,Not yet recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04789226,2022-03-01,0,0
4668,NCT04789395,Recruiting,2021-09-20,2021-12-20,No Results Posted,,,2021-03-09,https://clinicaltrials.gov/show/NCT04789395,2021-09-20,0,0
4669,NCT04789525,Completed,2020-10-01,2020-12-25,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04789525,2020-10-01,0,0
4670,NCT04790994,"Active, not recruiting",2020-10-16,2021-04-16,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04790994,2020-10-16,0,0
4671,NCT04791072,Not yet recruiting,2021-03-01,2021-03-01,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04791072,2021-03-01,0,0
4672,NCT04791085,Recruiting,2021-05-08,2021-05-08,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04791085,2021-05-08,0,0
4673,NCT04791241,Recruiting,2022-01-03,2022-01-04,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04791241,2022-01-03,0,0
4674,NCT04791436,Recruiting,2021-12-30,2022-02-28,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04791436,2021-12-30,0,0
4675,NCT04791462,Recruiting,2021-12-30,2021-12-30,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04791462,2021-12-30,0,0
4676,NCT04792021,Recruiting,2021-06-01,2021-11-01,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04792021,2021-06-01,0,0
4677,NCT04792086,Recruiting,2023-11-01,2024-12-31,No Results Posted,,,2021-03-10,https://clinicaltrials.gov/show/NCT04792086,2023-11-01,0,0
4678,NCT04793243,Completed,2020-10-10,2020-10-24,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04793243,2020-10-10,0,0
4679,NCT04793269,Recruiting,2023-12-31,2024-04-30,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04793269,2023-12-31,0,0
4680,NCT04793984,Recruiting,2021-06-30,2021-10-30,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04793984,2021-06-30,0,0
4681,NCT04794062,Recruiting,2021-03-31,2021-12-31,No Results Posted,,,2021-03-11,https://clinicaltrials.gov/show/NCT04794062,2021-03-31,0,0
4682,NCT04794361,Completed,2020-05-05,2020-05-05,No Results Posted,,,2021-03-12,https://clinicaltrials.gov/show/NCT04794361,2020-05-05,0,0
4683,NCT04794374,Recruiting,2022-09-16,2022-09-16,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04794374,2022-09-16,0,0
4684,NCT04794803,Terminated,2020-11-27,2021-02-02,Study Results,,,2022-03-17,https://clinicaltrials.gov/show/NCT04794803,2020-11-27,1,0
4685,NCT04794920,"Active, not recruiting",2020-10-03,2022-12-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04794920,2020-10-03,0,0
4686,NCT04794998,Completed,2021-07-31,2021-07-31,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04794998,2021-07-31,0,0
4687,NCT04795557,Completed,2021-11-11,2021-12-26,No Results Posted,,,2021-12-28,https://clinicaltrials.gov/show/NCT04795557,2021-11-11,0,0
4688,NCT04796064,Completed,2020-11-05,2020-12-15,No Results Posted,,,2021-03-12,https://clinicaltrials.gov/show/NCT04796064,2020-11-05,0,0
4689,NCT04797624,Completed,2021-02-15,2021-02-15,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04797624,2021-02-15,0,0
4690,NCT04797871,Enrolling by invitation,2022-03-15,2022-03-15,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04797871,2022-03-15,0,0
4691,NCT04797936,Completed,2020-12-19,2021-01-08,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04797936,2020-12-19,0,0
4692,NCT04798599,Recruiting,2021-06-30,2022-06-30,No Results Posted,,,2021-03-15,https://clinicaltrials.gov/show/NCT04798599,2021-06-30,0,0
4693,NCT04798625,"Active, not recruiting",2026-02-15,2027-02-15,No Results Posted,"['Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, J√∏rgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Gr√∏deland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatol. 2022 Mar;4(3):e177-e187. doi: 10.1016/S2665-9913(21)00394-5. Epub 2021 Dec 23.']",,2021-10-25,https://clinicaltrials.gov/show/NCT04798625,2026-02-15,0,1
4694,NCT04799132,Completed,2021-03-01,2021-03-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04799132,2021-03-01,0,0
4695,NCT04799444,Recruiting,2022-06-30,2022-06-30,No Results Posted,,"['Lewek J, Jatczak-Pawlik I, Maciejewski M, Jankowski P, Banach M. COVID-19 and cardiovascular complications - preliminary results of the LATE-COVID study. Arch Med Sci. 2021 Mar 18;17(3):818-822. doi: 10.5114/aoms/134211. eCollection 2021.']",2021-03-16,https://clinicaltrials.gov/show/NCT04799444,2022-06-30,0,1
4696,NCT04799561,Recruiting,2022-09-15,2022-12-15,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04799561,2022-09-15,0,0
4697,NCT04799600,Completed,2021-06-15,2021-07-01,No Results Posted,,"['Kellum JA, Lameire N; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013 Feb 4;17(1):204. doi: 10.1186/cc11454. Review.', 'Wang L, Li X, Chen H, Yan S, Li D, Li Y, Gong Z. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020;51(5):343-348. doi: 10.1159/000507471. Epub 2020 Mar 31.', 'Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP, Chung CW, Friedman HJ, Hines DW. Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int J Infect Dis. 2021 Jan;102:571-576. doi: 10.1016/j.ijid.2020.11.003. Epub 2020 Nov 9.']",2021-07-27,https://clinicaltrials.gov/show/NCT04799600,2021-06-15,0,1
4698,NCT04799704,Completed,2020-12-13,2020-12-13,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04799704,2020-12-13,0,0
4699,NCT04800146,Recruiting,2022-06-30,2022-12-30,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04800146,2022-06-30,0,0
4700,NCT04802187,Recruiting,2022-08-31,2022-08-31,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04802187,2022-08-31,0,0
4701,NCT04684433,Completed,2021-03-15,2021-03-15,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04684433,2021-03-15,0,0
4702,NCT04705766,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04705766,2022-03-01,0,0
4703,NCT04705844,Withdrawn,2022-09-01,2022-09-01,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04705844,2022-09-01,0,0
4704,NCT04716569,Recruiting,2021-02-20,2021-03-20,Results Submitted,"['Aref ZF, Bazeed SEES, Hassan MH, Hassan AS, Rashad A, Hassan RG, Abdelmaksoud AA. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19. Int J Nanomedicine. 2021 Jun 15;16:4063-4072. doi: 10.2147/IJN.S313093. eCollection 2021.']",,2021-03-17,https://clinicaltrials.gov/show/NCT04716569,2021-02-20,0,1
4705,NCT04723459,Recruiting,2021-02-19,2021-03-28,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04723459,2021-02-19,0,0
4706,NCT04723706,Recruiting,2022-03-01,2022-04-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04723706,2022-03-01,0,0
4707,NCT04727424,Recruiting,2023-10-01,2023-11-01,No Results Posted,"['Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators. Effect of Early Treatment with Ivermectin among Patients with Covid-19. N Engl J Med. 2022 Mar 30. doi: 10.1056/NEJMoa2115869. [Epub ahead of print]']","['Reis G, Dos Santos Moreira-Silva EA, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, de Souza Campos VH, Nogueira AMR, de Almeida APFG, Callegari ED, de Figueiredo Neto AD, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Glushchenko AV, Rayner CR, Lenze EJ, Reiersen AM, Guyatt GH, Mills EJ; TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51. doi: 10.1016/S2214-109X(21)00448-4. Epub 2021 Oct 28. Erratum in: Lancet Glob Health. 2022 Feb 24;:.', 'Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, Cruz Milagres A, Ferreira TS, Quirino Dos Santos CV, de Figueiredo Neto AD, Diniz Callegari E, Monteiro Savassi LC, Campos Simplicio MI, Barra Ribeiro L, Oliveira R, Harari O, Bailey H, Forrest JI, Glushchenko A, Sprague S, McKay P, Rayner CR, Ruton H, Guyatt GH, Mills EJ. Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial. Lancet Reg Health Am. 2022 Feb;6:100142. doi: 10.1016/j.lana.2021.100142. Epub 2021 Dec 14.']",2022-02-01,https://clinicaltrials.gov/show/NCT04727424,2023-10-01,0,1
4708,NCT04735757,Recruiting,2023-01-19,2023-01-19,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04735757,2023-01-19,0,0
4709,NCT04738045,Recruiting,2021-03-28,2021-04-01,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04738045,2021-03-28,0,0
4710,NCT04738695,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04738695,2022-03-31,0,0
4711,NCT04741282,Not yet recruiting,2022-08-15,2022-08-15,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04741282,2022-08-15,0,0
4712,NCT04743609,Recruiting,2022-06-11,2023-01-11,No Results Posted,,"['Rybak A, Levy C, Jung C, B√©chet S, Batard C, Hassid F, Zouari M, Cahn-Sellem F, Bangert M, Cohen R. Delayed Bronchiolitis Epidemic in French Primary Care Setting Driven by Respiratory Syncytial Virus: Preliminary Data from the Oursyn Study, March 2021. Pediatr Infect Dis J. 2021 Dec 1;40(12):e511-e514. doi: 10.1097/INF.0000000000003270.']",2022-03-16,https://clinicaltrials.gov/show/NCT04743609,2022-06-11,0,1
4713,NCT04746339,Recruiting,2021-08-01,2021-12-01,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04746339,2021-08-01,0,0
4714,NCT04750265,"Active, not recruiting",2021-08-07,2022-02-03,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04750265,2021-08-07,0,0
4715,NCT04765384,Recruiting,2023-01-16,2024-09-18,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04765384,2023-01-16,0,0
4716,NCT04779047,Recruiting,2021-03-10,2021-04-05,No Results Posted,"['Sarhan RM, Harb HS, Abou Warda AE, Salem-Bekhit MM, Shakeel F, Alzahrani SA, Madney YM, Boshra MS. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients. J Infect Public Health. 2022 Jan;15(1):116-122. doi: 10.1016/j.jiph.2021.10.024. Epub 2021 Nov 2.']",,2021-03-17,https://clinicaltrials.gov/show/NCT04779047,2021-03-10,0,1
4717,NCT04779346,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-03-22,https://clinicaltrials.gov/show/NCT04779346,2021-12-31,0,0
4718,NCT04779541,Completed,2021-09-29,2021-09-29,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04779541,2021-09-29,0,0
4719,NCT04780061,Recruiting,2022-09-01,2022-12-01,No Results Posted,"['Legacy M, Seely D, Conte E, Psihogios A, Ramsay T, Fergusson DA, Kanji S, Simmons JG, Wilson K. Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protocol for a randomised, double-blind, placebo controlled clinical trial. BMJ Open. 2022 Mar 3;12(3):e057024. doi: 10.1136/bmjopen-2021-057024.']",,2022-02-28,https://clinicaltrials.gov/show/NCT04780061,2022-09-01,0,1
4720,NCT04788459,"Active, not recruiting",2021-12-01,2022-09-01,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04788459,2021-12-01,0,0
4721,NCT04789356,"Active, not recruiting",2021-07-05,2022-03-01,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04789356,2021-07-05,0,0
4722,NCT04790851,Completed,2021-09-05,2021-09-05,No Results Posted,,,2021-10-20,https://clinicaltrials.gov/show/NCT04790851,2021-09-05,0,0
4723,NCT04795414,Recruiting,2022-04-30,2023-01-31,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04795414,2022-04-30,0,0
4724,NCT04797091,Recruiting,2025-12-31,2026-08-31,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04797091,2025-12-31,0,0
4725,NCT04797208,Not yet recruiting,2022-10-01,2022-10-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04797208,2022-10-01,0,0
4726,NCT04797975,Withdrawn,2021-04-01,2021-04-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04797975,2021-04-01,0,0
4727,NCT04798716,Not yet recruiting,2024-09-01,2024-12-01,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04798716,2024-09-01,0,0
4728,NCT04799652,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04799652,2021-04-30,0,0
4729,NCT04799691,Completed,2022-01-15,2022-01-15,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04799691,2022-01-15,0,0
4730,NCT04799743,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04799743,2022-05-01,0,0
4731,NCT04799808,Recruiting,2022-07-15,2022-12-31,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04799808,2022-07-15,0,0
4732,NCT04799834,"Active, not recruiting",2022-06-01,2022-06-01,No Results Posted,,,2021-11-26,https://clinicaltrials.gov/show/NCT04799834,2022-06-01,0,0
4733,NCT04799873,Completed,2020-12-01,2020-12-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04799873,2020-12-01,0,0
4734,NCT04799977,Recruiting,2021-02-01,2022-12-31,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04799977,2021-02-01,0,0
4735,NCT04800120,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04800120,2021-12-01,0,0
4736,NCT04800770,Recruiting,2021-06-15,2021-07-31,No Results Posted,,"['Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch. 2004 Feb;447(5):763-7. Epub 2003 May 16. Review.', 'Pistolesi V, Zeppilli L, Polistena F, Sacco MI, Pierucci A, Tritapepe L, Regolisti G, Fiaccadori E, Morabito S. Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution in the Setting of Regional Citrate Anticoagulation. Blood Purif. 2017;44(1):8-15. doi: 10.1159/000453443. Epub 2017 Feb 21.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.']",2021-03-16,https://clinicaltrials.gov/show/NCT04800770,2021-06-15,0,1
4737,NCT04801017,Not yet recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-03-16,https://clinicaltrials.gov/show/NCT04801017,2021-08-01,0,0
4738,NCT04801030,Not yet recruiting,2023-05-30,2023-05-30,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04801030,2023-05-30,0,0
4739,NCT04801134,Not yet recruiting,2022-03-22,2022-05-30,No Results Posted,,"['Shi Q, Castillo F, Viswanathan K, Kupferman F, MacDermid JC. Facilitators and Barriers to Access to Pediatric Medical Services in a Community Hospital. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720904518. doi: 10.1177/2150132720904518.', 'Peltz A, Garg A. Food Insecurity and Health Care Use. Pediatrics. 2019 Oct;144(4). pii: e20190347. doi: 10.1542/peds.2019-0347. Epub 2019 Sep 9.', 'COUNCIL ON COMMUNITY PEDIATRICS; COMMITTEE ON NUTRITION. Promoting Food Security for All Children. Pediatrics. 2015 Nov;136(5):e1431-8. doi: 10.1542/peds.2015-3301.', 'Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020 Jun;78:185-193. doi: 10.1016/j.ijsu.2020.04.018. Epub 2020 Apr 17. Review.', 'Keenan DP, Olson C, Hersey JC, Parmer SM. Measures of food insecurity/security. J Nutr Educ. 2001;33 Suppl 1:S49-58. Review.', 'Kaiser LL, Melgar-Qui√±onez H, Townsend MS, Nicholson Y, Fujii ML, Martin AC, Lamp CL. Food insecurity and food supplies in Latino households with young children. J Nutr Educ Behav. 2003 May-Jun;35(3):148-53.', 'Matheson DM, Varady J, Varady A, Killen JD. Household food security and nutritional status of Hispanic children in the fifth grade. Am J Clin Nutr. 2002 Jul;76(1):210-7.']",2021-03-23,https://clinicaltrials.gov/show/NCT04801134,2022-03-22,0,1
4740,NCT04801888,Completed,2021-05-28,2021-05-28,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04801888,2021-05-28,0,0
4741,NCT04801940,Recruiting,2024-01-31,2024-01-31,No Results Posted,,,2021-07-23,https://clinicaltrials.gov/show/NCT04801940,2024-01-31,0,0
4742,NCT04802044,Recruiting,2022-02-28,2022-12-31,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04802044,2022-02-28,0,0
4743,NCT04802083,,,,,,,2021-10-04,https://clinicaltrials.gov/show/NCT04802083,,0,0
4744,NCT04802278,Recruiting,2021-06-01,2021-12-01,No Results Posted,"['Low JM, Lee LY, Ng YPM, Zhong Y, Amin Z. Breastfeeding Mother and Child Clinical Outcomes After COVID-19 Vaccination. J Hum Lact. 2022 Feb;38(1):37-42. doi: 10.1177/08903344211056522. Epub 2021 Oct 29.']",,2021-03-17,https://clinicaltrials.gov/show/NCT04802278,2021-06-01,0,1
4745,NCT04802382,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04802382,2021-12-01,0,0
4746,NCT04802408,Recruiting,2022-05-30,2022-05-30,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04802408,2022-05-30,0,0
4747,NCT04802642,Completed,2021-03-01,2021-03-01,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04802642,2021-03-01,0,0
4748,NCT04803227,Terminated,2021-05-28,2021-05-28,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04803227,2021-05-28,0,0
4749,NCT04803370,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-03-17,https://clinicaltrials.gov/show/NCT04803370,2021-09-01,0,0
4750,NCT04803812,Completed,2021-09-02,2021-09-02,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04803812,2021-09-02,0,0
4751,NCT04805086,Recruiting,2022-06-01,2023-03-05,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04805086,2022-06-01,0,0
4752,NCT04805203,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04805203,2022-12-01,0,0
4753,NCT04805645,Not yet recruiting,2021-04-01,2021-05-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04805645,2021-04-01,0,0
4754,NCT04805684,Completed,2021-03-05,2021-03-05,No Results Posted,,,2021-03-18,https://clinicaltrials.gov/show/NCT04805684,2021-03-05,0,0
4755,NCT04805840,Terminated,2021-06-02,2021-07-14,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04805840,2021-06-02,0,0
4756,NCT04806061,Not yet recruiting,2022-05-15,2022-12-31,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04806061,2022-05-15,0,0
4757,NCT04806074,Completed,2020-12-06,2021-09-06,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04806074,2020-12-06,0,0
4758,NCT04806529,Withdrawn,2020-12-15,2022-04-09,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04806529,2020-12-15,0,0
4759,NCT04806880,Completed,2021-08-01,2021-08-01,No Results Posted,,,2021-10-11,https://clinicaltrials.gov/show/NCT04806880,2021-08-01,0,0
4760,NCT04807075,Recruiting,2022-06-18,2022-09-30,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04807075,2022-06-18,0,0
4761,NCT04807699,Enrolling by invitation,2021-10-25,2022-03-25,No Results Posted,,,2021-03-19,https://clinicaltrials.gov/show/NCT04807699,2021-10-25,0,0
4762,NCT04808284,Completed,2021-10-11,2021-10-11,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04808284,2021-10-11,0,0
4763,NCT04808882,Recruiting,2021-12-01,2022-02-01,No Results Posted,,,2021-07-14,https://clinicaltrials.gov/show/NCT04808882,2021-12-01,0,0
4764,NCT04808895,Not yet recruiting,2021-07-01,2021-08-31,No Results Posted,,,2021-03-22,https://clinicaltrials.gov/show/NCT04808895,2021-07-01,0,0
4765,NCT04808986,Not yet recruiting,2021-08-31,2021-11-15,No Results Posted,,,2021-03-22,https://clinicaltrials.gov/show/NCT04808986,2021-08-31,0,0
4766,NCT04809272,Recruiting,2021-11-01,2021-12-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04809272,2021-11-01,0,0
4767,NCT04809480,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-03-22,https://clinicaltrials.gov/show/NCT04809480,2020-12-31,0,0
4768,NCT04809948,Not yet recruiting,2021-09-01,2021-12-30,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04809948,2021-09-01,0,0
4769,NCT04810689,Recruiting,2022-03-01,2022-09-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04810689,2022-03-01,0,0
4770,NCT04812327,Withdrawn,2021-09-01,2021-11-01,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04812327,2021-09-01,0,0
4771,NCT04819919,,,,,,,,https://clinicaltrials.gov/show/NCT04819919,,0,0
4772,NCT04320615,Completed,2020-06-24,2020-07-28,Study Results,"['Tom J, Bao M, Tsai L, Qamra A, Summers D, Carrasco-Triguero M, McBride J, Rosenberger CM, Lin CJF, Stubbings W, Blyth KG, Carratal√† J, Fran√ßois B, Benfield T, Haslem D, Bonfanti P, van der Leest CH, Rohatgi N, Wiese L, Luyt CE, Kheradmand F, Rosas IO, Cai F. Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial. Crit Care Med. 2022 Mar 1;50(3):398-409. doi: 10.1097/CCM.0000000000005229.', 'Rosas IO, Br√§u N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.']",,2021-06-30,https://clinicaltrials.gov/show/NCT04320615,2020-06-24,1,1
4773,NCT04357613,Not yet recruiting,2020-12-01,2021-12-01,No Results Posted,"['Zhao H, Mendenhall M, Deininger MW. Imatinib is not a potent anti-SARS-CoV-2 drug. Leukemia. 2020 Nov;34(11):3085-3087. doi: 10.1038/s41375-020-01045-9. Epub 2020 Sep 30.']",,2020-08-07,https://clinicaltrials.gov/show/NCT04357613,2020-12-01,0,1
4774,NCT04370119,"Active, not recruiting",2021-04-23,2025-05-01,No Results Posted,"['Handtke S, Wolff M, Zaninetti C, Wesche J, Sch√∂nborn L, Aurich K, Ulm L, H√ºbner NO, Becker K, Thiele T, Greinacher A. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination. Blood. 2021 Jul 1;137(26):3656-3659. doi: 10.1182/blood.2021012064.']",,2022-01-11,https://clinicaltrials.gov/show/NCT04370119,2021-04-23,0,1
4775,NCT04668209,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04668209,2022-03-31,0,0
4776,NCT04668339,"Active, not recruiting",2022-04-30,2022-04-30,No Results Posted,,,2021-03-29,https://clinicaltrials.gov/show/NCT04668339,2022-04-30,0,0
4777,NCT04678739,Completed,2021-01-30,2021-02-10,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04678739,2021-01-30,0,0
4778,NCT04679493,Completed,2021-04-09,2021-04-09,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04679493,2021-04-09,0,0
4779,NCT04680949,"Active, not recruiting",2021-03-31,2021-12-20,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04680949,2021-03-31,0,0
4780,NCT04689399,Completed,2021-03-25,2021-03-25,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04689399,2021-03-25,0,0
4781,NCT04690387,Completed,2021-01-13,2021-01-15,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04690387,2021-01-13,0,0
4782,NCT04695652,Completed,2021-05-15,2021-10-29,No Results Posted,"['Hsieh SM, Liu MC, Chen YH, Lee WS, Hwang SJ, Cheng SH, Ko WC, Hwang KP, Wang NC, Lee YL, Lin YL, Shih SR, Huang CG, Liao CC, Liang JJ, Chang CS, Chen C, Lien CE, Tai IC, Lin TY. Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. Lancet Respir Med. 2021 Dec;9(12):1396-1406. doi: 10.1016/S2213-2600(21)00402-1. Epub 2021 Oct 13.']",,2022-01-31,https://clinicaltrials.gov/show/NCT04695652,2021-05-15,0,1
4783,NCT04700163,"Active, not recruiting",2022-03-31,2022-06-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']","['Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S, H√§ggl√∂f T, Oliveira TY, Viant C, Hurley A, Hoffmann HH, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West AP Jr, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020 Aug;584(7821):437-442. doi: 10.1038/s41586-020-2456-9. Epub 2020 Jun 18.']",2021-07-08,https://clinicaltrials.gov/show/NCT04700163,2022-03-31,0,1
4784,NCT04701606,Recruiting,2022-04-15,2022-04-15,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04701606,2022-04-15,0,0
4785,NCT04704388,Completed,2020-10-01,2020-10-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04704388,2020-10-01,0,0
4786,NCT04706533,Recruiting,2022-07-01,2022-12-01,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04706533,2022-07-01,0,0
4787,NCT04708912,Recruiting,2021-03-30,2021-04-01,No Results Posted,,['Microbiota and viral infections'],2021-03-24,https://clinicaltrials.gov/show/NCT04708912,2021-03-30,0,1
4788,NCT04709328,Not yet recruiting,2022-01-01,2022-03-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-03-29,https://clinicaltrials.gov/show/NCT04709328,2022-01-01,0,1
4789,NCT04710394,"Active, not recruiting",2022-03-11,2022-03-11,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04710394,2022-03-11,0,0
4790,NCT04712110,"Active, not recruiting",2022-04-04,2022-04-04,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04712110,2022-04-04,0,0
4791,NCT04720118,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04720118,2021-04-01,0,0
4792,NCT04723290,Completed,2020-10-31,2020-12-31,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04723290,2020-10-31,0,0
4793,NCT04727762,Completed,2021-03-01,2021-03-30,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04727762,2021-03-01,0,0
4794,NCT04729140,Recruiting,2021-12-28,2022-03-28,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04729140,2021-12-28,0,0
4795,NCT04732637,Not yet recruiting,2021-05-31,2021-08-31,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04732637,2021-05-31,0,0
4796,NCT04733677,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04733677,2022-05-01,0,0
4797,NCT04737486,Completed,2021-03-10,2021-03-10,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04737486,2021-03-10,0,0
4798,NCT04741386,"Active, not recruiting",2022-04-05,2022-12-31,No Results Posted,"['Sanders JF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Fr√∂lke SC, Geers D, GeurtsvanKessel CH, den Hartog G, van der Heiden M, Imhof C, Kho MML, Koopmans MPG, Malahe SRK, Mattheussens WB, van der Molen R, van Mourik D, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Gansevoort RT, Hilbrands LB, Reinders MEJ; RECOVAC Collaborators. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant. Transplantation. 2022 Apr 1;106(4):821-834. doi: 10.1097/TP.0000000000003983.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04741386,2022-04-05,0,1
4799,NCT04748172,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,"['Mohr-Sasson A, Haas J, Abuhasira S, Sivan M, Doitch Amdurski H, Dadon T, Blumenfeld S, Derazne E, Hemi R, Orvieto R, Afek A, Rabinovici J. The effect of Covid-19 mRNA vaccine on serum anti-M√ºllerian hormone levels. Hum Reprod. 2022 Mar 1;37(3):534-541. doi: 10.1093/humrep/deab282.']","['Anifandis G, Messini CI, Daponte A, Messinis IE. COVID-19 and fertility: a virtual reality. Reprod Biomed Online. 2020 Aug;41(2):157-159. doi: 10.1016/j.rbmo.2020.05.001. Epub 2020 May 8.', 'Joguet G, Mansuy JM, Matusali G, Hamdi S, Walschaerts M, Pavili L, Guyomard S, Prisant N, Lamarre P, Dejucq-Rainsford N, Pasquier C, Bujan L. Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. Lancet Infect Dis. 2017 Nov;17(11):1200-1208. doi: 10.1016/S1473-3099(17)30444-9. Epub 2017 Aug 23.', 'Percivalle E, Zavattoni M, Fausto F, Rovida F. Zika virus isolation from semen. New Microbiol. 2017 Jul;40(3):197-198. Epub 2017 May 17.', 'Khomich OA, Kochetkov SN, Bartosch B, Ivanov AV. Redox Biology of Respiratory Viral Infections. Viruses. 2018 Jul 26;10(8). pii: E392. doi: 10.3390/v10080392. Review.', 'Liu M, Chen F, Liu T, Chen F, Liu S, Yang J. The role of oxidative stress in influenza virus infection. Microbes Infect. 2017 Dec;19(12):580-586. doi: 10.1016/j.micinf.2017.08.008. Epub 2017 Sep 14. Review.', 'Agarwal A, Rana M, Qiu E, AlBunni H, Bui AD, Henkel R. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018 Dec;50(11):e13126. doi: 10.1111/and.13126. Review.', 'Dutta S, Majzoub A, Agarwal A. Oxidative stress and sperm function: A systematic review on evaluation and management. Arab J Urol. 2019 Apr 24;17(2):87-97. doi: 10.1080/2090598X.2019.1599624. eCollection 2019. Review.', 'Homa ST, Vassiliou AM, Stone J, Killeen AP, Dawkins A, Xie J, Gould F, Ramsay JWA. A Comparison Between Two Assays for Measuring Seminal Oxidative Stress and their Relationship with Sperm DNA Fragmentation and Semen Parameters. Genes (Basel). 2019 Mar 19;10(3). pii: E236. doi: 10.3390/genes10030236.', 'Kuhn JH, Li W, Choe H, Farzan M. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci. 2004 Nov;61(21):2738-43. Review.', 'Reis FM, Bouissou DR, Pereira VM, Camargos AF, dos Reis AM, Santos RA. Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil Steril. 2011 Jan;95(1):176-81. doi: 10.1016/j.fertnstert.2010.06.060. Epub 2010 Aug 1.', 'Wang J, Peng Y, Xu H, Cui Z, Williams RO 3rd. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. 2020 Aug 5;21(6):225. doi: 10.1208/s12249-020-01744-7. Review.', 'Vartak A, Sucheck SJ. Recent Advances in Subunit Vaccine Carriers. Vaccines (Basel). 2016 Apr 19;4(2). pii: E12. doi: 10.3390/vaccines4020012. Review.']",2022-01-13,https://clinicaltrials.gov/show/NCT04748172,2022-02-01,0,1
4800,NCT04753632,Recruiting,2021-05-15,2021-06-15,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04753632,2021-05-15,0,0
4801,NCT04756141,Recruiting,2022-01-28,2022-01-28,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04756141,2022-01-28,0,0
4802,NCT04757831,Withdrawn,2026-02-15,2026-02-15,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04757831,2026-02-15,0,0
4803,NCT04760704,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04760704,2023-05-01,0,0
4804,NCT04764422,Recruiting,2022-05-01,2023-05-01,No Results Posted,"['Pitisuttithum P, Luvira V, Lawpoolsri S, Muangnoicharoen S, Kamolratanakul S, Sivakorn C, Narakorn P, Surichan S, Prangpratanporn S, Puksuriwong S, Lamola S, Mercer LD, Raghunandan R, Sun W, Liu Y, Carre√±o JM, Scharf R, Phumratanaprapin W, Amanat F, Gagnon L, Hsieh CL, Kaweepornpoj R, Khan S, Lal M, McCroskery S, McLellan J, Mena I, Meseck M, Phonrat B, Sabmee Y, Singchareon R, Slamanig S, Suthepakul N, Tcheou J, Thantamnu N, Theerasurakarn S, Tran S, Vilasmongkolchai T, White JA, Bhardwaj N, Garcia-Sastre A, Palese P, Krammer F, Poopipatpol K, Wirachwong P, Hjorth R, Innis BL. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. EClinicalMedicine. 2022 Mar 8;45:101323. doi: 10.1016/j.eclinm.2022.101323. eCollection 2022 Mar.', 'Pitisuttithum P, Luvira V, Lawpoolsri S, Muangnoicharoen S, Kamolratanakul S, Sivakorn C, Narakorn P, Surichan S, Prangpratanporn S, Puksuriwong S, Lamola S, Mercer LD, Raghunandan R, Sun W, Liu Y, Carre√±o JM, Scharf R, Phumratanaprapin W, Amanat F, Gagnon L, Hsieh CL, Kaweepornpoj R, Khan S, Lal M, McCroskery S, McLellan J, Mena I, Meseck M, Phonrat B, Sabmee Y, Singchareon R, Slamanig S, Suthepakul N, Tcheou J, Thantamnu N, Theerasurakarn S, Tran S, Vilasmongkolchai T, White JA, Garcia-Sastre A, Palese P, Krammer F, Poopipatpol K, Wirachwong P, Hjorth R, Innis BL. Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial. medRxiv. 2021 Sep 22. pii: 2021.09.17.21263758. doi: 10.1101/2021.09.17.21263758.']",,2022-03-29,https://clinicaltrials.gov/show/NCT04764422,2022-05-01,0,1
4805,NCT04765475,Recruiting,2022-02-01,2022-09-01,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04765475,2022-02-01,0,0
4806,NCT04766931,Recruiting,2022-02-01,2022-03-01,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04766931,2022-02-01,0,0
4807,NCT04767958,Recruiting,2022-02-28,2022-07-31,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04767958,2022-02-28,0,0
4808,NCT04772404,Recruiting,2021-05-15,2021-06-15,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04772404,2021-05-15,0,0
4809,NCT04784689,Recruiting,2023-02-01,2024-01-01,No Results Posted,,,2021-03-29,https://clinicaltrials.gov/show/NCT04784689,2023-02-01,0,0
4810,NCT04789512,Completed,2021-03-26,2021-03-29,No Results Posted,"['√áelik Z, G√ºzel NA, Kafa N, K√∂kt√ºrk N. Respiratory muscle strength in volleyball players suffered from COVID-19. Ir J Med Sci. 2021 Nov 8. doi: 10.1007/s11845-021-02849-z. [Epub ahead of print]']",,2021-04-01,https://clinicaltrials.gov/show/NCT04789512,2021-03-26,0,1
4811,NCT04793464,Recruiting,2022-08-31,2023-03-31,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04793464,2022-08-31,0,0
4812,NCT04794088,Recruiting,2021-12-01,2022-02-01,No Results Posted,"['Atmowihardjo L, Schippers JR, Bartelink IH, Bet PM, van Rein N, Purdy K, Cavalla D, Comberiati V, McElroy A, Snape SD, Bogaard HJ, Heunks L, Juffermans N, Schultz M, Tuinman PR, Bos LDJ, Aman J. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri¬Æ) in subjects with acute respiratory distress syndrome induced by COVID-19. Trials. 2022 Feb 16;23(1):158. doi: 10.1186/s13063-022-06055-9.']",,2021-03-24,https://clinicaltrials.gov/show/NCT04794088,2021-12-01,0,1
4813,NCT04798066,,,,,,,2021-12-30,https://clinicaltrials.gov/show/NCT04798066,,0,0
4814,NCT04798677,Recruiting,2021-07-01,2021-07-01,No Results Posted,,"['Salem ML, El-Hennawy D. The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses. 2020 Apr 22;140:109752. doi: 10.1016/j.mehy.2020.109752. [Epub ahead of print]', 'Arokiaraj MC. Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality-Perspectives. Front Public Health. 2020 Sep 22;8:444. doi: 10.3389/fpubh.2020.00444. eCollection 2020.', 'Menachery VD, Debbink K, Baric RS. Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments. Virus Res. 2014 Dec 19;194:191-9. doi: 10.1016/j.virusres.2014.09.009. Epub 2014 Sep 30. Review.', 'Zeng Q, Langereis MA, van Vliet AL, Huizinga EG, de Groot RJ. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9065-9. doi: 10.1073/pnas.0800502105. Epub 2008 Jun 11.', 'Wang J, Tang K, Feng K, Lin X, Lv W, Chen K, Wang F. Impact of temperature and relative humidity on the transmission of COVID-19: a modelling study in China and the United States. BMJ Open. 2021 Feb 17;11(2):e043863. doi: 10.1136/bmjopen-2020-043863.', 'Rayman MP. Selenium and human health. Lancet. 2012 Mar 31;379(9822):1256-68. doi: 10.1016/S0140-6736(11)61452-9. Epub 2012 Feb 29. Review.', 'Goldson AJ, Fairweather-Tait SJ, Armah CN, Bao Y, Broadley MR, Dainty JR, Furniss C, Hart DJ, Teucher B, Hurst R. Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial. PLoS One. 2011 Mar 21;6(3):e14771. doi: 10.1371/journal.pone.0014771.', 'Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007 Mar;85(3):837-44.', 'Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, Hamer DH. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007 Oct;86(4):1167-73. Erratum in: Am J Clin Nutr. 2008 Apr;87(4):1071.', 'Barnett JB, Dao MC, Hamer DH, Kandel R, Brandeis G, Wu D, Dallal GE, Jacques PF, Schreiber R, Kong E, Meydani SN. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2016 Mar;103(3):942-51. doi: 10.3945/ajcn.115.115188. Epub 2016 Jan 27.', 'Vetvicka V, Vannucci L, Sima P, Richter J. Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials. Molecules. 2019 Mar 30;24(7). pii: E1251. doi: 10.3390/molecules24071251. Review.', 'Engstad RE, Robertsen B. Recognition of yeast cell wall glucan by Atlantic salmon (Salmo salar L.) macrophages. Dev Comp Immunol. 1993 Jul-Aug;17(4):319-30.', 'Raa J. Immune modulation by non-digestible and non-absorbable beta-1,3/1,6-glucan. Microb Ecol Health Dis. 2015 May 29;26:27824. doi: 10.3402/mehd.v26.27824. eCollection 2015.', 'Vetvicka V, Vannucci L, Sima P. Œ≤-glucan as a new tool in vaccine development. Scand J Immunol. 2020 Feb;91(2):e12833. doi: 10.1111/sji.12833. Epub 2019 Nov 13. Review.', 'Novak M, Vetvicka V. Glucans as biological response modifiers. Endocr Metab Immune Disord Drug Targets. 2009 Mar;9(1):67-75. Review.', 'De Marco Castro E, Calder PC, Roche HM. Œ≤-1,3/1,6-Glucans and Immunity: State of the Art and Future Directions. Mol Nutr Food Res. 2021 Jan;65(1):e1901071. doi: 10.1002/mnfr.201901071. Epub 2020 Apr 27. Review.', 'F√ºl√∂p T, Dupuis G, Witkowski JM, Larbi A. The Role of Immunosenescence in the Development of Age-Related Diseases. Rev Invest Clin. 2016 Mar-Apr;68(2):84-91. Review.', 'Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006 Feb 20;24(8):1159-69. Epub 2005 Sep 19. Review.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.']",2021-07-21,https://clinicaltrials.gov/show/NCT04798677,2021-07-01,0,1
4815,NCT04800965,Enrolling by invitation,2021-12-31,2022-01-01,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04800965,2021-12-31,0,0
4816,NCT04801524,Enrolling by invitation,2021-12-31,2022-01-01,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04801524,2021-12-31,0,0
4817,NCT04802018,"Active, not recruiting",2022-03-01,2022-05-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04802018,2022-03-01,0,0
4818,NCT04805632,Completed,2022-01-30,2022-01-30,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04805632,2022-01-30,0,0
4819,NCT04806620,Recruiting,2025-05-01,2025-05-01,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04806620,2025-05-01,0,0
4820,NCT04806867,Completed,2020-07-01,2020-07-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04806867,2020-07-01,0,0
4821,NCT04810637,Recruiting,2021-06-01,2021-09-01,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04810637,2021-06-01,0,0
4822,NCT04810949,Terminated,2021-03-01,2021-03-01,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04810949,2021-03-01,0,0
4823,NCT04811339,Recruiting,2023-08-31,2023-08-31,Results Submitted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04811339,2023-08-31,0,0
4824,NCT04811352,Recruiting,2021-05-01,2021-06-01,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04811352,2021-05-01,0,0
4825,NCT04811391,Recruiting,2022-05-20,2022-05-20,No Results Posted,"['Sridhar S, Fico A, Preza I, Hatibi I, Sulo J, Kissling E, Daja R, Ibrahim R, Lemos D, Rubin-Smith J, Schmid A, Vasili A, Valenciano M, Jorgensen P, Pebody R, Lafond KE, Katz MA, Bino S. COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data. BMJ Open. 2022 Mar 23;12(3):e057741. doi: 10.1136/bmjopen-2021-057741.']",,2021-03-26,https://clinicaltrials.gov/show/NCT04811391,2022-05-20,0,1
4826,NCT04811456,Recruiting,2025-05-25,2025-08-25,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04811456,2025-05-25,0,0
4827,NCT04811859,Recruiting,2022-01-10,2022-03-10,No Results Posted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04811859,2022-01-10,0,0
4828,NCT04811885,"Active, not recruiting",2021-10-14,2021-10-14,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04811885,2021-10-14,0,0
4829,NCT04812041,Recruiting,2021-05-15,2021-05-25,No Results Posted,,"['Khan BA, Perkins AJ, Gao S, Hui SL, Campbell NL, Farber MO, Chlan LL, Boustani MA. The Confusion Assessment Method for the ICU-7 Delirium Severity Scale: A Novel Delirium Severity Instrument for Use in the ICU. Crit Care Med. 2017 May;45(5):851-857. doi: 10.1097/CCM.0000000000002368.', 'Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Gupta R, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Noursadeghi M, Olliaro PL, Pritchard MG, Russell CD, Shaw CA, Sheikh A, Solomon T, Sudlow C, Swann OV, Turtle LC, Openshaw PJ, Baillie JK, Semple MG, Docherty AB, Harrison EM; ISARIC4C investigators. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339. Erratum in: BMJ. 2020 Nov 13;371:m4334.']",2021-03-23,https://clinicaltrials.gov/show/NCT04812041,2021-05-15,0,1
4830,NCT04812184,Completed,2020-10-30,2020-10-30,Results Submitted,,,2021-03-23,https://clinicaltrials.gov/show/NCT04812184,2020-10-30,0,0
4831,NCT04812496,Completed,2020-05-30,2021-01-15,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04812496,2020-05-30,0,0
4832,NCT04813328,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-10-27,https://clinicaltrials.gov/show/NCT04813328,2022-04-01,0,0
4833,NCT04813471,Recruiting,2021-03-20,2021-04-30,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04813471,2021-03-20,0,0
4834,NCT04813497,Enrolling by invitation,2022-04-30,2022-04-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04813497,2022-04-30,0,0
4835,NCT04813575,Enrolling by invitation,2022-04-01,2022-06-01,No Results Posted,,"['Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD, Sverzellati N, Maher TM. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020 Aug;8(8):750-752. doi: 10.1016/S2213-2600(20)30222-8. Epub 2020 May 15.', 'Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Qu√©r√© I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. Review.', 'Claudia R, Sara T, GianLuca C etl. Complications and mortality of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases. Europpean Respiratory Journal. 2015 46: PA2031; DOI: 10.1183/13993003.congress-2015.PA2031.', 'WHO Statement: Knowing the risks for COVID 19. https://www.who.int/indonesia/news/detail/08-03-2020-knowing-the-risk-for-covid-19.', 'Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020 Jul;13(7):920-925. doi: 10.1016/j.jiph.2020.05.026. Epub 2020 Jun 8.']",2021-09-01,https://clinicaltrials.gov/show/NCT04813575,2022-04-01,0,1
4836,NCT04813692,Recruiting,2021-09-30,2021-10-31,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04813692,2021-09-30,0,0
4837,NCT04813731,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04813731,2022-06-30,0,0
4838,NCT04813939,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04813939,2021-12-31,0,0
4839,NCT04814914,Completed,2021-05-28,2021-05-28,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04814914,2021-05-28,0,0
4840,NCT04815018,Terminated,2021-05-30,2021-05-30,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04815018,2021-05-30,0,0
4841,NCT04815096,Recruiting,2023-03-01,2023-03-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04815096,2023-03-01,0,0
4842,NCT04815109,Recruiting,2022-02-28,2022-06-30,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04815109,2022-02-28,0,0
4843,NCT04815135,Completed,2020-05-31,2021-01-18,No Results Posted,,,2021-03-24,https://clinicaltrials.gov/show/NCT04815135,2020-05-31,0,0
4844,NCT04815304,Recruiting,2022-05-28,2022-06-13,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04815304,2022-05-28,0,0
4845,NCT04815759,Recruiting,2021-04-27,2021-04-30,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04815759,2021-04-27,0,0
4846,NCT04815850,Recruiting,2021-10-01,2021-12-31,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04815850,2021-10-01,0,0
4847,NCT04816084,Completed,2020-12-01,2021-03-15,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04816084,2020-12-01,0,0
4848,NCT04816630,Completed,2021-03-25,2021-09-22,No Results Posted,,,2021-12-07,https://clinicaltrials.gov/show/NCT04816630,2021-03-25,0,0
4849,NCT04816656,Completed,2021-02-01,2021-03-22,No Results Posted,,,2021-03-26,https://clinicaltrials.gov/show/NCT04816656,2021-02-01,0,0
4850,NCT04816682,Recruiting,2021-06-30,2021-12-30,No Results Posted,,"['Bosch-Barrera J, Martin-Castillo B, Bux√≥ M, Brunet J, Encinar JA, Menendez JA. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. J Clin Med. 2020 Jun 7;9(6). pii: E1770. doi: 10.3390/jcm9061770.']",2021-09-24,https://clinicaltrials.gov/show/NCT04816682,2021-06-30,0,1
4851,NCT04816760,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04816760,2021-06-01,0,0
4852,NCT04816786,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04816786,2021-06-01,0,0
4853,NCT04816942,Completed,2020-07-21,2020-10-12,No Results Posted,,,2021-03-25,https://clinicaltrials.gov/show/NCT04816942,2020-07-21,0,0
4854,NCT04817332,Completed,2021-02-28,2021-02-28,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04817332,2021-02-28,0,0
4855,NCT04817371,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04817371,2022-03-01,0,0
4856,NCT04817553,Recruiting,2022-06-30,2022-07-30,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04817553,2022-06-30,0,0
4857,NCT04817657,,,,,,,2021-03-26,https://clinicaltrials.gov/show/NCT04817657,,0,0
4858,NCT04818489,Completed,2021-08-25,2021-10-20,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2021-11-09,https://clinicaltrials.gov/show/NCT04818489,2021-08-25,0,1
4859,NCT04818697,Completed,2021-03-19,2021-03-19,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04818697,2021-03-19,0,0
4860,NCT04818801,"Active, not recruiting",2021-12-01,2022-07-01,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04818801,2021-12-01,0,0
4861,NCT04818866,"Active, not recruiting",2022-07-01,2022-12-30,No Results Posted,"[""Vasbinder A, Anderson E, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Michaud E, Catalan T, Feroze R, Blakely P, Launius C, Huang Y, Zhao L, Ang L, Mikhael M, Mizokami-Stout K, Pennathur S, Kretzler M, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Feldman EL, Pop-Busui R, Hayek SS; ISIC Study Group:, Hayek SS, Blakely P, Berlin H, Azam TU, Shadid H, Pan M, O'Hayer P, Meloche C, Feroze R, Padalia KJ, Anderson E, Perry D, Bitar A, Kaakati R, Huang Y, Zhao L, Reiser J, Samelko B, Hlepas A, Patel PP, Wang X, Eugen-Olsen J, Altintas I, Stauning M, Baltzer Houlind M, Lindstr√∏m MB, Gamst-Jensen H, Hartmann LJ, Nehlin JO, Kallemose T, Parvaiz I, Rasmussen C, Andersen O, Tingleff J, Giamarellos-Bourboulis EJ, Adami ME, Solomonidi N, Tsilika M, Saridaki M, Lekakis V, Loosen SH, Luedde T, Keitel V, Chalkias A, Arnaoutoglou E, Pantazopoulos I, Laou E, Kolonia K, Skoulakis A, Tacke F, Tober-Lau P, Mohr R, Kurth F, Sander LE, Jochum C. Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19. Diabetes Care. 2022 Mar 1;45(3):692-700. doi: 10.2337/dc21-2102."", ""Pan M, Vasbinder A, Anderson E, Catalan T, Shadid HR, Berlin H, Padalia K, O'Hayer P, Meloche C, Azam TU, Khaleel I, Michaud E, Blakely P, Bitar A, Huang Y, Zhao L, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Reiser J, Eugen-Olsen J, Hayek SS; ISIC Group. Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc. 2021 Dec 21;10(24):e023535. doi: 10.1161/JAHA.121.023535. Epub 2021 Dec 10.""]","[""Azam TU, Shadid HR, Blakely P, O'Hayer P, Berlin H, Pan M, Zhao P, Zhao L, Pennathur S, Pop-Busui R, Altintas I, Tingleff J, Stauning MA, Andersen O, Adami ME, Solomonidi N, Tsilika M, Tober-Lau P, Arnaoutoglou E, Keitel V, Tacke F, Chalkias A, Loosen SH, Giamarellos-Bourboulis EJ, Eugen-Olsen J, Reiser J, Hayek SS; International Study of Inflammation in COVID-19. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. J Am Soc Nephrol. 2020 Nov;31(11):2725-2735. doi: 10.1681/ASN.2020060829. Epub 2020 Sep 22.""]",2021-10-12,https://clinicaltrials.gov/show/NCT04818866,2022-07-01,0,1
4862,NCT04819165,Completed,2020-12-31,2021-01-31,No Results Posted,,"['Tufan A, Avanoƒülu G√ºler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 2020 Apr 21;50(SI-1):620-632. doi: 10.3906/sag-2004-168. Review.', 'Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C, Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F, Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A; COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi: 10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24.', 'Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.', 'Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014 Mar 18;18(2):208. doi: 10.1186/cc13775. Review. Erratum in: Crit Care. 2016;20:29. Zai, Wendy [corrected to Ziai, Wendy].', 'Rouz√© A, Nseir S. Continuous control of tracheal cuff pressure for the prevention of ventilator-associated pneumonia in critically ill patients: where is the evidence? Curr Opin Crit Care. 2013 Oct;19(5):440-7. doi: 10.1097/MCC.0b013e3283636b71. Review.', 'Duszy≈Ñska W, Rosenthal VD, Szczƒôsny A, Wo≈∫nica E, Ulfik K, Ostrowska E, Litwin A, K√ºbler A. Urinary tract infections in intensive care unit patients - a single-centre, 3-year observational study according to the INICC project. Anaesthesiol Intensive Ther. 2016;48(1):1-6. doi: 10.5603/AIT.2016.0001.', 'Rosenthal VD, Dwivedy A, Calder√≥n ME, Esen S, Hern√°ndez HT, Abouqal R, Medeiros EA, Espinoza TA, Kanj SS, Gikas A, Barnett AG, Graves N; International Nosocomial Infection Control Consortium (INICC) Members. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J Infect. 2011 Feb;62(2):136-41. doi: 10.1016/j.jinf.2010.12.004. Epub 2010 Dec 17.', 'Rouz√© A, Martin-Loeches I, Povoa P, Makris D, Artigas A, Bouchereau M, Lambiotte F, Metzelard M, Cuchet P, Boulle Geronimi C, Labruyere M, Tamion F, Nyunga M, Luyt CE, Labreuche J, Pouly O, Bardin J, Saade A, Asfar P, Baudel JL, Beurton A, Garot D, Ioannidou I, Kreitmann L, Llitjos JF, Magira E, M√©garbane B, Meguerditchian D, Moglia E, Mekontso-Dessap A, Reignier J, Turpin M, Pierre A, Plantefeve G, Vinsonneau C, Floch PE, Weiss N, Ceccato A, Torres A, Duhamel A, Nseir S; coVAPid study Group. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021 Feb;47(2):188-198. doi: 10.1007/s00134-020-06323-9. Epub 2021 Jan 3. Erratum in: Intensive Care Med. 2021 Nov 24;:.']",2021-03-26,https://clinicaltrials.gov/show/NCT04819165,2020-12-31,0,1
4863,NCT04819282,Completed,2020-12-30,2021-02-17,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04819282,2020-12-30,0,0
4864,NCT04819802,Recruiting,2022-04-01,2022-10-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04819802,2022-04-01,0,0
4865,NCT04820751,Not yet recruiting,2021-11-01,2022-01-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04820751,2021-11-01,0,0
4866,NCT04820803,Completed,2021-04-29,2021-06-30,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04820803,2021-04-29,0,0
4867,NCT04821570,Recruiting,2022-03-28,2023-03-28,No Results Posted,,,2021-03-29,https://clinicaltrials.gov/show/NCT04821570,2022-03-28,0,0
4868,NCT04821674,"Active, not recruiting",2021-08-13,2022-12-31,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04821674,2021-08-13,0,0
4869,NCT04821908,Recruiting,2025-07-01,2025-07-01,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04821908,2025-07-01,0,0
4870,NCT04821934,Completed,2021-12-20,2021-12-20,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04821934,2021-12-20,0,0
4871,NCT04821973,Recruiting,2021-05-15,2021-11-15,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04821973,2021-05-15,0,0
4872,NCT04822012,Recruiting,2021-04-30,2021-06-01,No Results Posted,"['Bentov Y, Beharier O, Moav-Zafrir A, Kabessa M, Godin M, Greenfield CS, Ketzinel-Gilad M, Ash Broder E, Holzer HEG, Wolf D, Oiknine-Djian E, Barghouti I, Goldman-Wohl D, Yagel S, Walfisch A, Hersko Klement A. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum Reprod. 2021 Aug 18;36(9):2506-2513. doi: 10.1093/humrep/deab182.']",,2021-03-30,https://clinicaltrials.gov/show/NCT04822012,2021-04-30,0,1
4873,NCT04822285,Completed,2020-04-22,2021-03-21,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04822285,2020-04-22,0,0
4874,NCT04822402,Not yet recruiting,2022-04-01,2022-06-01,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04822402,2022-04-01,0,0
4875,NCT04822818,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04822818,2022-06-01,0,0
4876,NCT04823182,"Active, not recruiting",2021-09-22,2022-09-22,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04823182,2021-09-22,0,0
4877,NCT04823234,Completed,2021-06-30,2021-09-15,No Results Posted,"['Vetrugno L, Sala A, Orso D, Meroi F, Fabbro S, Boero E, Valent F, Cammarota G, Restaino S, Vizzielli G, Girometti R, Merelli M, Tascini C, Bove T, Driul L; PINK-CO study investigators. Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The ""PINK-CO"" Observational Study. Front Med (Lausanne). 2022 Jan 21;8:768261. doi: 10.3389/fmed.2021.768261. eCollection 2021.']",,2021-09-28,https://clinicaltrials.gov/show/NCT04823234,2021-06-30,0,1
4878,NCT04823351,Not yet recruiting,2021-07-08,2021-11-01,No Results Posted,,,2021-03-30,https://clinicaltrials.gov/show/NCT04823351,2021-07-08,0,0
4879,NCT04824222,Not yet recruiting,2022-07-01,2022-12-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04824222,2022-07-01,0,0
4880,NCT04824313,"Active, not recruiting",2020-07-31,2021-03-31,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04824313,2020-07-31,0,0
4881,NCT04824391,Recruiting,2021-04-30,2022-04-30,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04824391,2021-04-30,0,0
4882,NCT04824495,Recruiting,2021-08-31,2021-12-31,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04824495,2021-08-31,0,0
4883,NCT04824638,"Active, not recruiting",2021-06-29,2023-10-30,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04824638,2021-06-29,0,0
4884,NCT04824651,"Active, not recruiting",2024-06-25,2024-06-25,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04824651,2024-06-25,0,0
4885,NCT04824664,Completed,2020-07-30,2020-12-30,No Results Posted,,"['Fransvea P, Sganga G, Cozza V, Di Grezia M, Fico V, Tirelli F, Pepe G, La Greca A. Set up of a dedicated COVID-19 surgical pathway and operating room for surgical emergencies. J Trauma Acute Care Surg. 2020 Oct;89(4):e97-e100. doi: 10.1097/TA.0000000000002852.']",2021-04-01,https://clinicaltrials.gov/show/NCT04824664,2020-07-30,0,1
4886,NCT04824677,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04824677,2021-12-01,0,0
4887,NCT04825093,Not yet recruiting,2022-10-30,2023-12-30,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04825093,2022-10-30,0,0
4888,NCT04826367,Recruiting,2022-06-01,2022-07-01,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04826367,2022-06-01,0,0
4889,NCT04826731,Completed,2021-06-01,2021-07-01,Study Results,,,2022-01-31,https://clinicaltrials.gov/show/NCT04826731,2021-06-01,1,0
4890,NCT04826770,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04826770,2021-12-31,0,0
4891,NCT04826822,Recruiting,2021-07-08,2021-09-02,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04826822,2021-07-08,0,0
4892,NCT04827160,Completed,2020-08-11,2020-08-11,No Results Posted,,,2021-04-01,https://clinicaltrials.gov/show/NCT04827160,2020-08-11,0,0
4893,NCT04828148,Recruiting,2021-05-30,2021-06-01,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04828148,2021-05-30,0,0
4894,NCT04828161,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04828161,2022-05-01,0,0
4895,NCT04828460,Recruiting,2021-12-01,2023-02-01,No Results Posted,,,2021-11-09,https://clinicaltrials.gov/show/NCT04828460,2021-12-01,0,0
4896,NCT04828538,"Active, not recruiting",2021-11-30,2021-11-30,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04828538,2021-11-30,0,0
4897,NCT04828564,Not yet recruiting,2021-09-30,2021-12-31,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04828564,2021-09-30,0,0
4898,NCT04828629,Recruiting,2021-12-01,2022-12-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04828629,2021-12-01,0,0
4899,NCT04828668,"Active, not recruiting",2021-12-30,2022-11-30,No Results Posted,,"['Lu D, Vemuri VK, Duclos RI Jr, Makriyannis A. The cannabinergic system as a target for anti-inflammatory therapies. Curr Top Med Chem. 2006;6(13):1401-26. Review.', 'Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol. 2008 Jun;13(2):196-212. doi: 10.1111/j.1369-1600.2008.00104.x. Epub 2008 Apr 16. Review.', 'Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009 Oct;1(7):1333-49. doi: 10.4155/fmc.09.93. Review.', 'Pini A, Mannaioni G, Pellegrini-Giampietro D, Passani MB, Mastroianni R, Bani D, Masini E. The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke. Curr Drug Targets. 2012 Jun;13(7):984-93. Review.', 'Russo EB. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis Cannabinoid Res. 2016 Jul 1;1(1):154-165. doi: 10.1089/can.2016.0009. eCollection 2016. Review.', 'Ruhaak LR, Felth J, Karlsson PC, Rafter JJ, Verpoorte R, Bohlin L. Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa. Biol Pharm Bull. 2011;34(5):774-8.', ""Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026.""]",2021-11-16,https://clinicaltrials.gov/show/NCT04828668,2021-12-30,0,1
4900,NCT04828772,"Active, not recruiting",2021-01-31,2021-06-30,No Results Posted,"['Flumignan RL, Civile VT, Tin√¥co JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah √ÅN, Nakano LC. Anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. doi: 10.1002/14651858.CD013739.pub2. Review.']",,2021-04-02,https://clinicaltrials.gov/show/NCT04828772,2021-01-31,0,1
4901,NCT04828915,Recruiting,2021-07-31,2021-12-31,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04828915,2021-07-31,0,0
4902,NCT04829188,Recruiting,2023-04-01,2023-07-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04829188,2023-04-01,0,0
4903,NCT04829552,Completed,2020-04-15,2020-04-15,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04829552,2020-04-15,0,0
4904,NCT04830020,Completed,2021-06-30,2021-09-30,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04830020,2021-06-30,0,0
4905,NCT04830046,Not yet recruiting,2021-11-01,2022-08-01,No Results Posted,,,2021-04-02,https://clinicaltrials.gov/show/NCT04830046,2021-11-01,0,0
4906,NCT04830800,Recruiting,2022-05-30,2022-09-30,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04830800,2022-05-30,0,0
4907,NCT04830943,Completed,2021-02-28,2021-03-30,No Results Posted,,"['Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.']",2021-04-05,https://clinicaltrials.gov/show/NCT04830943,2021-02-28,0,1
4908,NCT04831853,Not yet recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-04-05,https://clinicaltrials.gov/show/NCT04831853,2021-10-01,0,0
4909,NCT04832828,Completed,2020-11-28,2020-11-28,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04832828,2020-11-28,0,0
4910,NCT04832867,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04832867,2021-04-01,0,0
4911,NCT04832880,Not yet recruiting,2022-03-01,2022-12-01,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04832880,2022-03-01,0,0
4912,NCT04833010,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04833010,2022-12-01,0,0
4913,NCT04834102,Recruiting,2021-04-27,2021-04-27,Results Submitted,,"['Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320. Review.', 'Mieczkowska K, Deutsch A, Borok J, Guzman AK, Fruchter R, Patel P, Wind O, McLellan BN, Mann RE, Halverstam CP. Telogen effluvium: a sequela of COVID-19. Int J Dermatol. 2021 Jan;60(1):122-124. doi: 10.1111/ijd.15313. Epub 2020 Nov 23.', 'Rizzetto G, Diotallevi F, Campanati A, Radi G, Bianchelli T, Molinelli E, Mazzanti S, Offidani A. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.', 'Cline A, Kazemi A, Moy J, Safai B, Marmon S. A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19. J Am Acad Dermatol. 2021 Mar;84(3):773-775. doi: 10.1016/j.jaad.2020.11.032. Epub 2020 Dec 10.']",2021-04-06,https://clinicaltrials.gov/show/NCT04834102,2021-04-27,0,1
4914,NCT04834115,Recruiting,2021-04-30,2021-05-30,No Results Posted,,,2021-04-06,https://clinicaltrials.gov/show/NCT04834115,2021-04-30,0,0
4915,NCT04834375,Recruiting,2022-03-19,2022-04-19,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834375,2022-03-19,0,0
4916,NCT04834401,Recruiting,2023-02-15,2023-04-15,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834401,2023-02-15,0,0
4917,NCT04329195,Terminated,2020-12-09,2021-01-09,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04329195,2020-12-09,0,0
4918,NCT04667923,Completed,2021-06-30,2021-08-31,No Results Posted,,,2021-11-11,https://clinicaltrials.gov/show/NCT04667923,2021-06-30,0,0
4919,NCT04668196,Completed,2021-01-25,2021-01-25,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04668196,2021-01-25,0,0
4920,NCT04669925,"Active, not recruiting",2022-01-01,2022-01-01,No Results Posted,,,2021-12-13,https://clinicaltrials.gov/show/NCT04669925,2022-01-01,0,0
4921,NCT04670003,Completed,2021-03-30,2021-03-30,No Results Posted,"['Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study. J Med Internet Res. 2021 May 4;23(5):e26932. doi: 10.2196/26932.']",,2021-04-08,https://clinicaltrials.gov/show/NCT04670003,2021-03-30,0,1
4922,NCT04681365,Completed,2021-12-23,2021-12-31,Results Submitted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04681365,2021-12-23,0,0
4923,NCT04682548,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04682548,2021-12-01,0,0
4924,NCT04685447,Recruiting,2020-04-20,2021-12-01,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04685447,2020-04-20,0,0
4925,NCT04686734,"Active, not recruiting",2022-02-01,2022-08-01,No Results Posted,"['Lund Berven L, Selvakumar J, Havdal L, Stiansen-Sonerud T, Einvik G, Leegaard TM, Tjade T, Michelsen AE, Mollnes TE, Wyller VBB. Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults. Front Immunol. 2022 Feb 9;13:837288. doi: 10.3389/fimmu.2022.837288. eCollection 2022.']",,2022-02-14,https://clinicaltrials.gov/show/NCT04686734,2022-02-01,0,1
4926,NCT04688372,Completed,2021-02-15,2021-02-15,No Results Posted,"['Kadri SS, Sun J, Lawandi A, Strich JR, Busch LM, Keller M, Babiker A, Yek C, Malik S, Krack J, Dekker JP, Spaulding AB, Ricotta E, Powers JH 3rd, Rhee C, Klompas M, Athale J, Boehmer TK, Gundlapalli AV, Bentley W, Datta SD, Danner RL, Demirkale CY, Warner S. Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020. Ann Intern Med. 2021 Sep;174(9):1240-1251. doi: 10.7326/M21-1213. Epub 2021 Jul 6.']",,2021-04-06,https://clinicaltrials.gov/show/NCT04688372,2021-02-15,0,1
4927,NCT04710199,Completed,2021-07-08,2021-07-08,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04710199,2021-07-08,0,0
4928,NCT04716426,Completed,2021-03-25,2021-03-25,Study Results,,,2021-04-08,https://clinicaltrials.gov/show/NCT04716426,2021-03-25,1,0
4929,NCT04718220,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04718220,2022-11-01,0,0
4930,NCT04720235,Completed,2021-03-09,2021-03-30,No Results Posted,,,2021-04-12,https://clinicaltrials.gov/show/NCT04720235,2021-03-09,0,0
4931,NCT04732468,"Active, not recruiting",2022-04-01,2022-04-01,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04732468,2022-04-01,0,0
4932,NCT04734561,Completed,2021-07-31,2021-09-29,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04734561,2021-07-31,0,0
4933,NCT04734860,Withdrawn,2021-09-01,2021-11-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-25,https://clinicaltrials.gov/show/NCT04734860,2021-09-01,0,1
4934,NCT04736004,Recruiting,2022-09-30,2022-09-30,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04736004,2022-09-30,0,0
4935,NCT04747821,"Active, not recruiting",2021-05-01,2022-02-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04747821,2021-05-01,0,0
4936,NCT04748783,Terminated,2021-04-07,2021-04-07,Study Results,,,2022-02-16,https://clinicaltrials.gov/show/NCT04748783,2021-04-07,1,0
4937,NCT04751669,Not yet recruiting,2021-10-31,2021-12-31,No Results Posted,"['Shakoor H, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Ali HI, Alhebshi SH, Apostolopoulos V, Stojanovska L. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas. 2021 Oct;152:63-65. doi: 10.1016/j.maturitas.2021.03.006. Epub 2021 Mar 16.']",,2021-04-08,https://clinicaltrials.gov/show/NCT04751669,2021-10-31,0,1
4938,NCT04761107,Recruiting,2023-02-01,2026-02-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04761107,2023-02-01,0,0
4939,NCT04762173,Completed,2021-05-31,2021-05-31,No Results Posted,"['Rackoff GN, Fitzsimmons-Craft EE, Taylor CB, Eisenberg D, Wilfley DE, Newman MG. A Randomized Controlled Trial of Internet-Based Self-Help for Stress During the COVID-19 Pandemic. J Adolesc Health. 2022 Feb 4. pii: S1054-139X(22)00287-7. doi: 10.1016/j.jadohealth.2022.01.227. [Epub ahead of print]']",,2021-07-12,https://clinicaltrials.gov/show/NCT04762173,2021-05-31,0,1
4940,NCT04762771,Terminated,2021-03-12,2021-10-25,Study Results,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2022-03-14,https://clinicaltrials.gov/show/NCT04762771,2021-03-12,1,1
4941,NCT04771351,Withdrawn,2021-08-01,2021-10-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-02-25,https://clinicaltrials.gov/show/NCT04771351,2021-08-01,0,1
4942,NCT04781218,Withdrawn,2026-03-15,2026-03-15,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04781218,2026-03-15,0,0
4943,NCT04789499,Completed,2021-12-30,2021-12-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04789499,2021-12-30,0,0
4944,NCT04791423,"Active, not recruiting",2021-10-30,2022-04-30,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04791423,2021-10-30,0,0
4945,NCT04794036,Recruiting,2022-06-13,2022-12-01,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04794036,2022-06-13,0,0
4946,NCT04796402,"Active, not recruiting",2021-06-07,2021-12-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-26,https://clinicaltrials.gov/show/NCT04796402,2021-06-07,0,1
4947,NCT04798053,Recruiting,2023-04-01,2023-04-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04798053,2023-04-01,0,0
4948,NCT04800133,Recruiting,2025-03-31,2025-03-31,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04800133,2025-03-31,0,0
4949,NCT04800939,Completed,2021-04-15,2021-05-15,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04800939,2021-04-15,0,0
4950,NCT04808921,Completed,2021-01-18,2021-01-28,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04808921,2021-01-18,0,0
4951,NCT04810065,Completed,2021-07-29,2021-09-01,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04810065,2021-07-29,0,0
4952,NCT04815057,Completed,2020-11-23,2021-03-08,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04815057,2020-11-23,0,0
4953,NCT04817280,Completed,2021-01-17,2021-03-01,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04817280,2021-01-17,0,0
4954,NCT04817397,Completed,2021-07-30,2021-08-30,No Results Posted,,,2021-10-12,https://clinicaltrials.gov/show/NCT04817397,2021-07-30,0,0
4955,NCT04818281,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-07-13,https://clinicaltrials.gov/show/NCT04818281,2022-01-01,0,0
4956,NCT04818853,Recruiting,2023-03-01,2024-03-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04818853,2023-03-01,0,0
4957,NCT04830683,Recruiting,2021-03-25,2021-04-01,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04830683,2021-03-25,0,0
4958,NCT04830761,Recruiting,2022-04-01,2022-04-01,No Results Posted,"['Amrein MA, Ruschetti GG, Baeder C, Bamert M, Inauen J. Mobile intervention to promote correct hand hygiene at key times to prevent COVID-19 in the Swiss adult general population: study protocol of a multiphase optimisation strategy. BMJ Open. 2022 Mar 28;12(3):e055971. doi: 10.1136/bmjopen-2021-055971.']",,2021-12-08,https://clinicaltrials.gov/show/NCT04830761,2022-04-01,0,1
4959,NCT04832945,Completed,2020-09-20,2021-04-10,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04832945,2020-09-20,0,0
4960,NCT04833088,Enrolling by invitation,2022-04-01,2022-04-01,No Results Posted,,,2021-10-15,https://clinicaltrials.gov/show/NCT04833088,2022-04-01,0,0
4961,NCT04834089,Not yet recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834089,2022-05-01,0,0
4962,NCT04834128,"Active, not recruiting",2022-11-01,2022-11-01,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04834128,2022-11-01,0,0
4963,NCT04834739,Completed,2021-03-28,2021-04-30,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04834739,2021-03-28,0,0
4964,NCT04834752,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834752,2021-12-31,0,0
4965,NCT04834856,Completed,2021-08-20,2021-08-20,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04834856,2021-08-20,0,0
4966,NCT04834882,Recruiting,2021-05-20,2022-05-20,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834882,2021-05-20,0,0
4967,NCT04834934,Recruiting,2020-09-30,2021-06-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834934,2020-09-30,0,0
4968,NCT04834947,Not yet recruiting,2021-12-15,2021-12-15,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04834947,2021-12-15,0,0
4969,NCT04836039,Completed,2021-02-27,2021-02-27,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836039,2021-02-27,0,0
4970,NCT04836052,Recruiting,2021-08-24,2021-12-24,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836052,2021-08-24,0,0
4971,NCT04836065,Completed,2020-09-30,2020-12-31,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836065,2020-09-30,0,0
4972,NCT04836260,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836260,2021-12-31,0,0
4973,NCT04836299,Not yet recruiting,2021-07-08,2021-12-05,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836299,2021-07-08,0,0
4974,NCT04836351,Recruiting,2023-12-30,2023-12-30,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04836351,2023-12-30,0,0
4975,NCT04836754,Not yet recruiting,2022-07-01,2022-09-01,No Results Posted,,,2021-12-16,https://clinicaltrials.gov/show/NCT04836754,2022-07-01,0,0
4976,NCT04836780,Recruiting,2022-03-30,2022-03-30,No Results Posted,,"['Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.', 'Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.', 'RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.', 'WHO/2019-nCoV/Corticosteroids/2020.1', 'Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020 Jul;20(7):773. doi: 10.1016/S1473-3099(20)30195-X. Epub 2020 Mar 12.', 'Monedero P, Gea A, Castro P, Candela-Toha AM, Hern√°ndez-Sanz ML, Arruti E, Villar J, Ferrando C; COVID-19 Spanish ICU Network. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Crit Care. 2021 Jan 4;25(1):2. doi: 10.1186/s13054-020-03422-3.', 'Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS; Henry Ford COVID-19 Management Task Force. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19. Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.']",2021-09-20,https://clinicaltrials.gov/show/NCT04836780,2022-03-30,0,1
4977,NCT04837755,Recruiting,2025-12-31,2025-12-31,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04837755,2025-12-31,0,0
4978,NCT04838080,Recruiting,2021-06-01,2021-10-20,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04838080,2021-06-01,0,0
4979,NCT04838093,Completed,2020-12-01,2021-01-01,No Results Posted,,,2021-04-08,https://clinicaltrials.gov/show/NCT04838093,2020-12-01,0,0
4980,NCT04838106,"Active, not recruiting",2022-07-31,2022-07-31,No Results Posted,,,2022-01-06,https://clinicaltrials.gov/show/NCT04838106,2022-07-31,0,0
4981,NCT04838834,"Active, not recruiting",2024-12-31,2024-12-31,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04838834,2024-12-31,0,0
4982,NCT04838847,Withdrawn,2022-01-01,2022-09-01,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04838847,2022-01-01,0,0
4983,NCT04839068,Not yet recruiting,2022-05-01,2022-06-01,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04839068,2022-05-01,0,0
4984,NCT04839094,Completed,2021-02-01,2021-02-01,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04839094,2021-02-01,0,0
4985,NCT04839315,Recruiting,2022-05-01,2022-12-31,No Results Posted,,,2022-03-07,https://clinicaltrials.gov/show/NCT04839315,2022-05-01,0,0
4986,NCT04839913,Completed,2020-12-10,2021-01-10,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04839913,2020-12-10,0,0
4987,NCT04840082,Completed,2021-03-08,2021-03-08,No Results Posted,,,2021-04-09,https://clinicaltrials.gov/show/NCT04840082,2021-03-08,0,0
4988,NCT04840459,Recruiting,2022-12-31,2023-01-31,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04840459,2022-12-31,0,0
4989,NCT04840953,Completed,2021-01-01,2021-02-01,No Results Posted,,,2021-04-12,https://clinicaltrials.gov/show/NCT04840953,2021-01-01,0,0
4990,NCT04840992,Recruiting,2022-04-15,2022-07-15,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04840992,2022-04-15,0,0
4991,NCT04841681,Completed,2020-08-25,2020-08-26,No Results Posted,,"['Wei N, Huang BC, Lu SJ, Hu JB, Zhou XY, Hu CC, Chen JK, Huang JW, Li SG, Wang Z, Wang DD, Xu Y, Hu SH. Efficacy of internet-based integrated intervention on depression and anxiety symptoms in patients with COVID-19. J Zhejiang Univ Sci B. 2020 May;21(5):400-404. doi: 10.1631/jzus.B2010013. Epub 2020 Apr 1.', 'Liu K, Chen Y, Wu D, Lin R, Wang Z, Pan L. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. 2020 May;39:101132. doi: 10.1016/j.ctcp.2020.101132. Epub 2020 Mar 6.', 'Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail. 2012 Jan;18(1):10-20. doi: 10.1016/j.cardfail.2011.09.008. Epub 2011 Nov 9.', 'Conversano C, Di Giuseppe M, Miccoli M, Ciacchini R, Gemignani A, Orr√π G. Mindfulness, Age and Gender as Protective Factors Against Psychological Distress During COVID-19 Pandemic. Front Psychol. 2020 Sep 11;11:1900. doi: 10.3389/fpsyg.2020.01900. eCollection 2020.', 'Behan C. The benefits of meditation and mindfulness practices during times of crisis such as COVID-19. Ir J Psychol Med. 2020 Dec;37(4):256-258. doi: 10.1017/ipm.2020.38. Epub 2020 May 14.', 'Grazzi L, Rizzoli P, Andrasik F. Effectiveness of mindfulness by smartphone, for patients with chronic migraine and medication overuse during the Covid-19 emergency. Neurol Sci. 2020 Dec;41(Suppl 2):461-462. doi: 10.1007/s10072-020-04659-0.', 'Reyes AT. A Mindfulness Mobile App for Traumatized COVID-19 Healthcare Workers and Recovered Patients: A Response to ""The Use of Digital Applications and COVID-19"". Community Ment Health J. 2020 Oct;56(7):1204-1205. doi: 10.1007/s10597-020-00690-9. Epub 2020 Aug 9.']",2021-04-12,https://clinicaltrials.gov/show/NCT04841681,2020-08-25,0,1
4992,NCT04842708,Completed,2021-12-24,2021-12-24,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04842708,2021-12-24,0,0
4993,NCT04842734,"Active, not recruiting",2021-06-27,2022-02-27,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04842734,2021-06-27,0,0
4994,NCT04843878,Completed,2021-03-12,2021-03-12,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04843878,2021-03-12,0,0
4995,NCT04678830,Completed,2021-06-05,2021-07-08,No Results Posted,"['Chang XL, Wu HL, Webb GM, Tiwary M, Hughes C, Reed JS, Hwang J, Waytashek C, Boyle C, Pessoa C, Sylwester AW, Morrow D, Belica K, Fischer M, Kelly S, Pourhassan N, Bochart RM, Smedley J, Recknor CP, Hansen SG, Sacha JB. CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab. Front Immunol. 2021 Nov 19;12:794638. doi: 10.3389/fimmu.2021.794638. eCollection 2021.']",,2021-08-02,https://clinicaltrials.gov/show/NCT04678830,2021-06-05,0,1
4996,NCT04685655,Recruiting,2022-05-31,2022-12-31,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04685655,2022-05-31,0,0
4997,NCT04711863,Suspended,2021-05-31,2021-07-31,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04711863,2021-05-31,0,0
4998,NCT04716907,Recruiting,2023-03-19,2023-03-19,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04716907,2023-03-19,0,0
4999,NCT04737161,Withdrawn,2022-09-01,2022-09-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04737161,2022-09-01,0,0
5000,NCT04743011,Recruiting,2021-11-30,2021-12-31,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04743011,2021-11-30,0,0
5001,NCT04751474,Completed,2021-03-01,2021-03-31,No Results Posted,"['K√∂se S, Gezginci E, G√∂kta≈ü S, Murat M. The effectiveness of motivational messages to intensive care unit nurses during the COVID-19 pandemic. Intensive Crit Care Nurs. 2022 Apr;69:103161. doi: 10.1016/j.iccn.2021.103161. Epub 2021 Nov 1.']",,2021-04-20,https://clinicaltrials.gov/show/NCT04751474,2021-03-01,0,1
5002,NCT04773665,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04773665,2022-11-01,0,0
5003,NCT04780555,Completed,2021-07-25,2021-08-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04780555,2021-07-25,0,0
5004,NCT04800224,Recruiting,2021-06-30,2021-07-30,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04800224,2021-06-30,0,0
5005,NCT04800731,"Active, not recruiting",2023-12-31,2023-12-31,No Results Posted,,,2021-08-12,https://clinicaltrials.gov/show/NCT04800731,2023-12-31,0,0
5006,NCT04810728,Completed,2020-12-04,2021-01-30,No Results Posted,,,2021-04-20,https://clinicaltrials.gov/show/NCT04810728,2020-12-04,0,0
5007,NCT04817293,Recruiting,2021-09-01,2021-12-01,No Results Posted,,,2021-04-15,https://clinicaltrials.gov/show/NCT04817293,2021-09-01,0,0
5008,NCT04818463,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04818463,2021-12-31,0,0
5009,NCT04824625,Completed,2021-03-27,2021-04-10,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04824625,2021-03-27,0,0
5010,NCT04828902,Recruiting,2022-01-31,2022-08-31,No Results Posted,,,2021-04-15,https://clinicaltrials.gov/show/NCT04828902,2022-01-31,0,0
5011,NCT04830774,Recruiting,2021-12-31,2023-12-31,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04830774,2021-12-31,0,0
5012,NCT04832022,Recruiting,2023-04-01,2023-08-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04832022,2023-04-01,0,0
5013,NCT04834908,Recruiting,2022-03-01,2022-09-01,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04834908,2022-03-01,0,0
5014,NCT04837651,Completed,2021-07-01,2021-07-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04837651,2021-07-01,0,0
5015,NCT04838795,Recruiting,2022-03-31,2022-03-31,No Results Posted,"['Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE; Sisonke Protocol Team; Sisonke Study Team. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 Mar 19;399(10330):1141-1153. doi: 10.1016/S0140-6736(22)00007-1.']",,2021-10-18,https://clinicaltrials.gov/show/NCT04838795,2022-03-31,0,1
5016,NCT04839146,Completed,2021-12-30,2022-02-25,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04839146,2021-12-30,0,0
5017,NCT04840940,Recruiting,2021-12-21,2021-12-21,No Results Posted,,"[""Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O'Grady NP, Bartlett JG, Carratal√† J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14. Erratum in: Clin Infect Dis. 2017 May 1;64(9):1298. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1435. Clin Infect Dis. 2017 Nov 29;65(12):2161."", ""Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, Hanisch EW, Klarin B, Koeman M, Krueger WA, Lacherade JC, Lorente L, Memish ZA, Morrow LE, Nardi G, van Nieuwenhoven CA, O'Keefe GE, Nakos G, Scannapieco FA, Seguin P, Staudinger T, Topeli A, Ferrer M, Bonten MJ. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013 Aug;13(8):665-71. doi: 10.1016/S1473-3099(13)70081-1. Epub 2013 Apr 25."", 'Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess D, Hill NS, Horan T, Kollef M, Levy M, Septimus E, VanAntwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events*. Crit Care Med. 2013 Nov;41(11):2467-75. doi: 10.1097/CCM.0b013e3182a262db.', 'Erb CT, Patel B, Orr JE, Bice T, Richards JB, Metersky ML, Wilson KC, Thomson CC. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. Ann Am Thorac Soc. 2016 Dec;13(12):2258-2260.', 'Berton DC, Kalil AC, Teixeira PJ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006482. doi: 10.1002/14651858.CD006482.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD006482.', 'Fagon JY. Biological markers and diagnosis of ventilator-associated pneumonia. Crit Care. 2011;15(2):130. doi: 10.1186/cc10050. Epub 2011 Mar 9.', 'Luyt CE, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet JL, Bernard M, Chastre J. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med. 2008 Aug;34(8):1434-40. doi: 10.1007/s00134-008-1112-x. Epub 2008 Apr 18.', 'Luyt CE, Gu√©rin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005 Jan 1;171(1):48-53. Epub 2004 Sep 24.', 'COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.', 'Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:12-4. doi: 10.3109/14767058.2011.601923. Review.', 'Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011 Nov 20;412(23-24):2157-61. doi: 10.1016/j.cca.2011.07.024. Epub 2011 Aug 3.', 'Wu CC, Lan HM, Han ST, Chaou CH, Yeh CF, Liu SH, Li CH, Blaney GN 3rd, Liu ZY, Chen KF. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017 Sep 6;7(1):91. doi: 10.1186/s13613-017-0316-z.', 'Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G, Latini R, Gattinoni L. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Med. 2015 Jan;41(1):12-20. doi: 10.1007/s00134-014-3514-2. Epub 2014 Oct 16. Erratum in: Intensive Care Med. 2015 Sep;41(9):1736.', 'Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgr√≤ S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L; ALBIOS Study Investigators. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care. 2014 Jan 7;18(1):R6. doi: 10.1186/cc13183.', 'Klouche K, Cristol JP, Devin J, Gilles V, Kuster N, Larcher R, Amigues L, Corne P, Jonquet O, Dupuy AM. Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Ann Intensive Care. 2016 Dec;6(1):59. doi: 10.1186/s13613-016-0160-6. Epub 2016 Jul 7.', 'Zaninotto M, Mion MM, Cosma C, Rinaldi D, Plebani M. Presepsin in risk stratification of SARS-CoV-2 patients. Clin Chim Acta. 2020 Aug;507:161-163. doi: 10.1016/j.cca.2020.04.020. Epub 2020 Apr 22.', 'Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol. 2021 Jan;93(1):99-101. doi: 10.1002/jmv.26164. Epub 2020 Jun 24.', 'Schirinzi A, Cazzolla AP, Lovero R, Lo Muzio L, Testa NF, Ciavarella D, Palmieri G, Pozzessere P, Procacci V, Di Serio F, Santacroce L. New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract. Microorganisms. 2020 Nov 2;8(11). pii: E1718. doi: 10.3390/microorganisms8111718.', 'Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, Tsuboi N, Matsuo S, Maruyama S. Clinical impact of kidney function on presepsin levels. PLoS One. 2015 Jun 1;10(6):e0129159. doi: 10.1371/journal.pone.0129159. eCollection 2015.', 'Ferrarese A, Frigo AC, Mion MM, Plebani M, Russo FP, Germani G, Gambato M, Cillo U, Cattelan A, Burra P, Senzolo M. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection. Clin Chem Lab Med. 2020 Oct 23;59(4):775-782. doi: 10.1515/cclm-2020-1212. Print 2021 Mar 26.', 'Zhang X, Liu D, Liu YN, Wang R, Xie LX. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care. 2015 Sep 11;19:323. doi: 10.1186/s13054-015-1032-4.', 'Memar MY, Baghi HB. Presepsin: A promising biomarker for the detection of bacterial infections. Biomed Pharmacother. 2019 Mar;111:649-656. doi: 10.1016/j.biopha.2018.12.124. Epub 2019 Jan 3. Review.']",2021-04-19,https://clinicaltrials.gov/show/NCT04840940,2021-12-21,0,1
5018,NCT04840966,Completed,2021-01-15,2021-01-15,No Results Posted,"['Nettore IC, Cantone E, Palatucci G, Franchini F, Maturi R, Nerilli M, Manzillo E, Foggia M, Maione L, Ungaro P, Colao A, Macchia PE. Quantitative but not qualitative flavor recognition impairments in COVID-19 patients. Ir J Med Sci. 2021 Sep 25. doi: 10.1007/s11845-021-02786-x. [Epub ahead of print]']",,2021-04-15,https://clinicaltrials.gov/show/NCT04840966,2021-01-15,0,1
5019,NCT04842305,Not yet recruiting,2021-05-01,2024-03-15,No Results Posted,,,2021-04-13,https://clinicaltrials.gov/show/NCT04842305,2021-05-01,0,0
5020,NCT04843917,Recruiting,2022-06-09,2022-08-09,No Results Posted,,"['Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet. 2020 Sep 26;396(10255):887-897. doi: 10.1016/S0140-6736(20)31866-3. Epub 2020 Sep 4. Erratum in: Lancet. 2021 Jan 9;397(10269):98.', 'Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Egorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb 20;397(10275):671-681. doi: 10.1016/S0140-6736(21)00234-8. Epub 2021 Feb 2. Erratum in: Lancet. 2021 Feb 20;397(10275):670.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Di Pasquale A, Bonanni P, Gar√ßon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Vaccine safety evaluation: Practical aspects in assessing benefits and risks. Vaccine. 2016 Dec 20;34(52):6672-6680. doi: 10.1016/j.vaccine.2016.10.039. Epub 2016 Nov 8. Review.', ""Herv√© C, Laup√®ze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how's and what's of vaccine reactogenicity. NPJ Vaccines. 2019 Sep 24;4:39. doi: 10.1038/s41541-019-0132-6. eCollection 2019. Review."", 'Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics. 2000 Nov;106(5):E62.', 'Mitchell TC, Casella CR. No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. Curr Opin Immunol. 2017 Aug;47:17-25. doi: 10.1016/j.coi.2017.06.009. Epub 2017 Jul 17. Review.', 'Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, Berghmans PJ, Kimmel M, Van Damme P, de Hoon J, Smith W, Stephenson KE, De Rosa SC, Cohen KW, McElrath MJ, Cormier E, Scheper G, Barouch DH, Hendriks J, Struyf F, Douoguih M, Van Hoof J, Schuitemaker H. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med. 2021 May 13;384(19):1824-1835. doi: 10.1056/NEJMoa2034201. Epub 2021 Jan 13.', ""Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, T√∂r√∂k ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98."", 'Hope JL, Bradley LM. Lessons in antiviral immunity. Science. 2021 Jan 29;371(6528):464-465. doi: 10.1126/science.abf6446.']",2021-04-15,https://clinicaltrials.gov/show/NCT04843917,2022-06-09,0,1
5021,NCT04844268,Recruiting,2022-09-01,2022-10-01,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04844268,2022-09-01,0,0
5022,NCT04844346,Terminated,2022-01-11,2022-01-11,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04844346,2022-01-11,0,0
5023,NCT04844541,Recruiting,2022-09-01,2022-12-01,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04844541,2022-09-01,0,0
5024,NCT04844554,Recruiting,2022-04-12,2022-10-12,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04844554,2022-04-12,0,0
5025,NCT04844567,Completed,2021-04-06,2021-04-06,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04844567,2021-04-06,0,0
5026,NCT04844632,Recruiting,2022-04-01,2022-05-21,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04844632,2022-04-01,0,0
5027,NCT04844658,Completed,2021-10-29,2021-10-29,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04844658,2021-10-29,0,0
5028,NCT04844710,Completed,2020-11-15,2020-11-20,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04844710,2020-11-15,0,0
5029,NCT04845048,Not yet recruiting,2021-09-01,2021-11-01,No Results Posted,,,2021-04-14,https://clinicaltrials.gov/show/NCT04845048,2021-09-01,0,0
5030,NCT04845880,Completed,2021-03-01,2021-04-01,No Results Posted,,,2021-04-15,https://clinicaltrials.gov/show/NCT04845880,2021-03-01,0,0
5031,NCT04845971,Completed,2021-04-30,2021-06-30,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04845971,2021-04-30,0,0
5032,NCT04845984,Completed,2021-01-15,2021-01-15,No Results Posted,,,2021-04-15,https://clinicaltrials.gov/show/NCT04845984,2021-01-15,0,0
5033,NCT04845997,Recruiting,2022-06-30,2023-12-31,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04845997,2022-06-30,0,0
5034,NCT04846790,Enrolling by invitation,2022-12-01,2023-06-01,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04846790,2022-12-01,0,0
5035,NCT04846907,"Active, not recruiting",2022-07-01,2022-12-01,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04846907,2022-07-01,0,0
5036,NCT04847349,Completed,2021-11-01,2022-01-31,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04847349,2021-11-01,0,0
5037,NCT04847362,Recruiting,2021-11-22,2022-01-30,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04847362,2021-11-22,0,0
5038,NCT04847375,Not yet recruiting,2021-07-20,2021-09-20,No Results Posted,,"['Takian A, Raoofi A, Kazempour-Ardebili S. COVID-19 battle during the toughest sanctions against Iran. Lancet. 2020 Mar 28;395(10229):1035-1036. doi: 10.1016/S0140-6736(20)30668-1. Epub 2020 Mar 18. Erratum in: Lancet. 2020 Apr 18;395(10232):1258.', 'Zhang Y, Xu J, Li H, Cao B. A Novel Coronavirus (COVID-19) Outbreak: A Call for Action. Chest. 2020 Apr;157(4):e99-e101. doi: 10.1016/j.chest.2020.02.014. Epub 2020 Feb 19.', 'Yue H, Bai X, Wang J, Yu Q, Liu W, Pu J, Wang X, Hu J, Xu D, Li X, Kang N, Li L, Lu W, Feng T, Ding L, Li X, Qi X; Gansu Provincial Medical Treatment Expert Group of COVID-19. Clinical characteristics of coronavirus disease 2019 in Gansu province, China. Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.', 'INSPIRATION Investigators, Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 Apr 27;325(16):1620-1630. doi: 10.1001/jama.2021.4152.', 'Dabbagh A, Rajaei S, Ghahremani M, Fathi M, Massoudi N, Tavana S, Fani K, Nooraee N, Malekpour Alamdari N, Besharat S, Najafi Abrandabadi A, Pirsalehi A, Khabiri Khatiri MA. The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 11;21(1):919. doi: 10.1186/s13063-020-04815-z.', 'Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, Fathi M, Besharat S, Bagheri L, Pourmotahari F, Irvani SSN, Dabbagh A, Mousavi SA. Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran. Tohoku J Exp Med. 2020 Sep;252(1):73-84. doi: 10.1620/tjem.252.73.', 'Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;:.']",2021-04-19,https://clinicaltrials.gov/show/NCT04847375,2021-07-20,0,1
5039,NCT04847518,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04847518,2022-01-01,0,0
5040,NCT04847544,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847544,2021-12-31,0,0
5041,NCT04847622,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847622,2021-06-30,0,0
5042,NCT04847661,Recruiting,2021-07-30,2021-08-30,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847661,2021-07-30,0,0
5043,NCT04847687,Completed,2021-04-01,2021-04-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847687,2021-04-01,0,0
5044,NCT04847791,Recruiting,2022-01-31,2022-12-31,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847791,2022-01-31,0,0
5045,NCT04847804,Recruiting,2024-05-31,2024-05-31,No Results Posted,,,2021-08-27,https://clinicaltrials.gov/show/NCT04847804,2024-05-31,0,0
5046,NCT04847817,Recruiting,2021-12-31,2022-03-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04847817,2021-12-31,0,0
5047,NCT04848441,Not yet recruiting,2021-08-01,2021-08-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04848441,2021-08-01,0,0
5048,NCT04848610,Completed,2020-11-18,2021-02-25,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04848610,2020-11-18,0,0
5049,NCT04848831,Not yet recruiting,2022-12-31,2024-12-31,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04848831,2022-12-31,0,0
5050,NCT04849546,Completed,2020-08-31,2020-09-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04849546,2020-08-31,0,0
5051,NCT04849598,Completed,2021-08-27,2021-08-27,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04849598,2021-08-27,0,0
5052,NCT04849611,"Active, not recruiting",2021-03-30,2021-05-01,No Results Posted,,,2021-04-20,https://clinicaltrials.gov/show/NCT04849611,2021-03-30,0,0
5053,NCT04849624,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-04-19,https://clinicaltrials.gov/show/NCT04849624,2021-10-01,0,0
5054,NCT04849637,"Active, not recruiting",2022-04-09,2022-04-09,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04849637,2022-04-09,0,0
5055,NCT04849793,Completed,2021-05-15,2021-05-15,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04849793,2021-05-15,0,0
5056,NCT04851561,Completed,2021-08-24,2021-08-24,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04851561,2021-08-24,0,0
5057,NCT04852055,"Active, not recruiting",2022-06-15,2022-06-15,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04852055,2022-06-15,0,0
5058,NCT04852809,Not yet recruiting,2021-07-26,2021-12-14,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04852809,2021-07-26,0,0
5059,NCT04853316,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04853316,2022-06-30,0,0
5060,NCT04853901,Completed,2021-01-01,2021-03-01,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04853901,2021-01-01,0,0
5061,NCT04853953,Not yet recruiting,2021-07-01,2021-12-01,No Results Posted,,"['Makdisi G, Wang IW. Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015 Jul;7(7):E166-76. doi: 10.3978/j.issn.2072-1439.2015.07.17. Review.', 'Rawal G, Yadav S, Kumar R. Acute Respiratory Distress Syndrome: An Update and Review. J Transl Int Med. 2018 Jun 26;6(2):74-77. doi: 10.1515/jtim-2016-0012. eCollection 2018 Jun.', 'Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.']",2021-04-22,https://clinicaltrials.gov/show/NCT04853953,2021-07-01,0,1
5062,NCT04853966,Recruiting,2022-04-17,2022-04-18,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04853966,2022-04-17,0,0
5063,NCT04670094,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04670094,2021-12-01,0,0
5064,NCT04675281,Recruiting,2021-02-26,2021-06-24,No Results Posted,,,2021-04-20,https://clinicaltrials.gov/show/NCT04675281,2021-02-26,0,0
5065,NCT04681092,"Active, not recruiting",2022-02-28,2022-05-30,No Results Posted,"['Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Aminetzah A, Sollie F, Kruijff S, Brom M, van Dam GM, Zion TC. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2022 Feb 23;40(9):1253-1260. doi: 10.1016/j.vaccine.2022.01.043. Epub 2022 Jan 31.']",,2021-12-20,https://clinicaltrials.gov/show/NCT04681092,2022-02-28,0,1
5066,NCT04681859,Completed,2021-07-09,2021-08-09,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04681859,2021-07-09,0,0
5067,NCT04682132,"Active, not recruiting",2021-06-30,2021-07-31,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04682132,2021-06-30,0,0
5068,NCT04682197,Recruiting,2022-11-01,2023-11-01,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04682197,2022-11-01,0,0
5069,NCT04685213,Completed,2021-03-18,2021-03-18,Study Results,,,2022-01-21,https://clinicaltrials.gov/show/NCT04685213,2021-03-18,1,0
5070,NCT04723446,Completed,2021-10-25,2021-10-25,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04723446,2021-10-25,0,0
5071,NCT04741412,Completed,2021-05-31,2021-05-31,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04741412,2021-05-31,0,0
5072,NCT04748536,Completed,2021-04-05,2021-04-05,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04748536,2021-04-05,0,0
5073,NCT04748757,Recruiting,2022-03-01,2022-12-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04748757,2022-03-01,0,0
5074,NCT04751643,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04751643,2022-12-01,0,0
5075,NCT04756856,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-04-23,https://clinicaltrials.gov/show/NCT04756856,2021-12-01,0,0
5076,NCT04761874,Completed,2020-06-29,2020-09-29,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04761874,2020-06-29,0,0
5077,NCT04765371,Recruiting,2023-10-01,2023-10-01,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04765371,2023-10-01,0,0
5078,NCT04772859,Completed,2021-07-16,2021-07-16,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04772859,2021-07-16,0,0
5079,NCT04780321,Recruiting,2022-03-30,2022-03-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-28,https://clinicaltrials.gov/show/NCT04780321,2022-03-30,0,1
5080,NCT04783311,Recruiting,2022-03-01,2023-01-01,No Results Posted,"[""Sia ZR, He X, Zhang A, Ang JC, Shao S, Seffouh A, Huang WC, D'Agostino MR, Teimouri Dereshgi A, Suryaprakash S, Ortega J, Andersen H, Miller MS, Davidson BA, Lovell JF. A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge. Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). pii: e2025759118. doi: 10.1073/pnas.2025759118.""]",,2021-04-26,https://clinicaltrials.gov/show/NCT04783311,2022-03-01,0,1
5081,NCT04784481,Completed,2020-12-20,2021-01-18,No Results Posted,,"['Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.']",2021-04-26,https://clinicaltrials.gov/show/NCT04784481,2020-12-20,0,1
5082,NCT04784767,"Active, not recruiting",2022-10-30,2023-10-30,No Results Posted,,,2021-09-14,https://clinicaltrials.gov/show/NCT04784767,2022-10-30,0,0
5083,NCT04803409,"Active, not recruiting",2021-12-15,2021-12-31,No Results Posted,,,2021-12-10,https://clinicaltrials.gov/show/NCT04803409,2021-12-15,0,0
5084,NCT04809974,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04809974,2022-12-31,0,0
5085,NCT04833101,"Active, not recruiting",2021-06-15,2021-12-15,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04833101,2021-06-15,0,0
5086,NCT04834869,Recruiting,2021-12-31,2022-01-31,No Results Posted,"[""Riad A, Sch√ºnemann H, Attia S, Periƒçiƒá TP, ≈Ωuljeviƒá MF, J√ºrisson M, Kalda R, Lang K, Morankar S, Yesuf EA, Mekhemar M, Danso-Appiah A, Sofi-Mahmudi A, P√©rez-Gaxiola G, Dziedzic A, Ap√≥stolo J, Cardoso D, Marc J, Moreno-Casbas M, Wiysonge CS, Qaseem A, Gryschek A, Tadiƒá I, Hussain S, Khan MA, Klugarova J, Pokorna A, Ko≈°ƒç√≠k M, Klugar M. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects. Int J Environ Res Public Health. 2021 Jul 25;18(15). pii: 7859. doi: 10.3390/ijerph18157859.""]",,2021-10-13,https://clinicaltrials.gov/show/NCT04834869,2021-12-31,0,1
5087,NCT04839042,Recruiting,2022-07-31,2022-07-31,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04839042,2022-07-31,0,0
5088,NCT04847336,Enrolling by invitation,2021-03-15,2022-09-02,No Results Posted,"['Lazzerini M, Covi B, Mariani I, Drglin Z, Arendt M, Nedberg IH, Elden H, Costa R, Drandiƒá D, Radetiƒá J, Otelea MR, Miani C, Brigidi S, Roz√©e V, Ponikvar BM, Tasch B, Kongslien S, Linden K, Barata C, Kurbanoviƒá M, Ru≈æiƒçiƒá J, Batram-Zantvoort S, Casta√±eda LM, Rochebrochard E, Bohinec A, Vik ES, Zaigham M, Santos T, Wandschneider L, Viver AC, ƒÜerimagiƒá A, Sacks E, Valente EP; IMAgiNE EURO study group. Quality of facility-based maternal and newborn care around the time of childbirth during the COVID-19 pandemic: online survey investigating maternal perspectives in 12 countries of the WHO European Region. Lancet Reg Health Eur. 2022 Feb;13:100268. doi: 10.1016/j.lanepe.2021.100268. Epub 2021 Dec 24.']",,2021-04-21,https://clinicaltrials.gov/show/NCT04847336,2021-03-15,0,1
5089,NCT04847583,Terminated,2022-02-11,2022-02-11,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04847583,2022-02-11,0,0
5090,NCT04848493,Recruiting,2021-07-20,2022-04-20,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04848493,2021-07-20,0,0
5091,NCT04852705,Not yet recruiting,2021-11-01,2022-11-01,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04852705,2021-11-01,0,0
5092,NCT04852718,Recruiting,2021-04-13,2021-04-13,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04852718,2021-04-13,0,0
5093,NCT04852770,Recruiting,2021-09-30,2021-11-30,No Results Posted,,"['Neufeld CB, Palma PC, Caetano KAS, Brust-Renck PG, Curtiss J, Hofmann SG. A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder. Int J Clin Health Psychol. 2020 Jan-Apr;20(1):29-37. doi: 10.1016/j.ijchp.2019.11.004. Epub 2019 Dec 24.', 'Powell VB, Oliveira OH, Seixas C, Almeida C, Grangeon MC, Caldas M, Bonfim TD, Castro M, Galv√£o-de Almeida A, Moraes Rde O, Sudak D, de-Oliveira IR. Changing core beliefs with trial-based cognitive therapy may improve quality of life in social phobia: a randomized study. Braz J Psychiatry. 2013 Jul-Sep;35(3):243-7. doi: 10.1590/1516-4446-2012-0863. Erratum in: Rev Bras Psiquiatr. 2013 Dec;35(4):445. Galv√£o-de Almeida [corrected to Galv√£o-de Almeida, Amanda].', 'Oliveira IR. Trial-Based Thought Record (TBTR): preliminary data on a strategy to deal with core beliefs by combining sentence reversion and the use of analogy with a judicial process. Braz J Psychiatry. 2008 Mar;30(1):12-8.', 'de Oliveira IR, Powell VB, Wenzel A, Caldas M, Seixas C, Almeida C, Bonfim T, Grangeon MC, Castro M, Galv√£o A, de Oliveira Moraes R, Sudak D. Efficacy of the trial-based thought record, a new cognitive therapy strategy designed to change core beliefs, in social phobia. J Clin Pharm Ther. 2012 Jun;37(3):328-34. doi: 10.1111/j.1365-2710.2011.01299.x. Epub 2011 Sep 28.', 'Hemanny C, Carvalho C, Maia N, Reis D, Botelho AC, Bonavides D, Seixas C, de Oliveira IR. Efficacy of trial-based cognitive therapy, behavioral activation and treatment as usual in the treatment of major depressive disorder: preliminary findings from a randomized clinical trial. CNS Spectr. 2020 Aug;25(4):535-544. doi: 10.1017/S1092852919001457. Epub 2019 Nov 26.', 'de Oliveira IR, Hemmany C, Powell VB, Bonfim TD, Duran EP, Novais N, Velasquez M, Di Sarno E, Alves GL, Cesnik JA; Brazilian TBTR Study Group. Trial-based psychotherapy and the efficacy of trial-based thought record in changing unhelpful core beliefs and reducing self-criticism. CNS Spectr. 2012 Mar;17(1):16-23. doi: 10.1017/S1092852912000399.', 'Duran √âP, Corchs F, Vianna A, Ara√∫jo √ÅC, Del Real N, Silva C, Ferreira AP, De Vitto Francez P, God√≥i C, Silveira H, Matsumoto L, Gebara CM, de Barros Neto TP, Chilvarquer R, de Siqueira LL, Bernik M, Neto FL. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings. CNS Spectr. 2021 Aug;26(4):427-434. doi: 10.1017/S1092852920001455. Epub 2020 May 26.', 'Seligman MEP. Positive Psychology: A Personal History. Annu Rev Clin Psychol. 2019 May 7;15:1-23. doi: 10.1146/annurev-clinpsy-050718-095653. Epub 2018 Dec 10.', 'Duckworth AL, Steen TA, Seligman ME. Positive psychology in clinical practice. Annu Rev Clin Psychol. 2005;1:629-51. Review.', 'Mongrain M, Anselmo-Matthews T. Do positive psychology exercises work? A replication of Seligman et al. (2005). J Clin Psychol. 2012 Apr;68(4):382-9. doi: 10.1002/jclp.21839.', 'Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, Keane TM. Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans. Psychol Assess. 2016 Nov;28(11):1379-1391. doi: 10.1037/pas0000254. Epub 2015 Dec 14.', 'Trombka M, Demarzo M, Bacas DC, Antonio SB, Cicuto K, Salvo V, Claudino FCA, Ribeiro L, Christopher M, Garcia-Campayo J, Rocha NS. Study protocol of a multicenter randomized controlled trial of mindfulness training to reduce burnout and promote quality of life in police officers: the POLICE study. BMC Psychiatry. 2018 May 25;18(1):151. doi: 10.1186/s12888-018-1726-7.', ""de Oliveira IR. Kafka's trial dilemma: proposal of a practical solution to Joseph K.'s unknown accusation. Med Hypotheses. 2011 Jul;77(1):5-6. doi: 10.1016/j.mehy.2011.03.010. Epub 2011 Mar 31."", 'de Souza CM, Hidalgo MP. World Health Organization 5-item well-being index: validation of the Brazilian Portuguese version. Eur Arch Psychiatry Clin Neurosci. 2012 Apr;262(3):239-44. doi: 10.1007/s00406-011-0255-x. Epub 2011 Sep 7.']",2021-04-21,https://clinicaltrials.gov/show/NCT04852770,2021-09-30,0,1
5094,NCT04852796,Recruiting,2022-04-01,2023-04-01,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04852796,2022-04-01,0,0
5095,NCT04852978,"Active, not recruiting",2022-11-25,2022-11-25,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04852978,2022-11-25,0,0
5096,NCT04853004,Enrolling by invitation,2023-03-01,2023-03-01,No Results Posted,,,2021-10-28,https://clinicaltrials.gov/show/NCT04853004,2023-03-01,0,0
5097,NCT04853069,Not yet recruiting,2022-02-28,2022-03-31,No Results Posted,,,2021-04-21,https://clinicaltrials.gov/show/NCT04853069,2022-02-28,0,0
5098,NCT04853108,Enrolling by invitation,2022-06-01,2022-06-01,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04853108,2022-06-01,0,0
5099,NCT04853134,Withdrawn,2021-12-01,2021-12-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04853134,2021-12-01,0,0
5100,NCT04853836,Completed,2021-02-28,2021-10-01,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04853836,2021-02-28,0,0
5101,NCT04853927,Withdrawn,2021-10-30,2021-12-31,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04853927,2021-10-30,0,0
5102,NCT04854759,Recruiting,2022-03-31,2022-05-31,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04854759,2022-03-31,0,0
5103,NCT04854785,Recruiting,2023-04-01,2023-04-01,No Results Posted,,,2021-04-22,https://clinicaltrials.gov/show/NCT04854785,2023-04-01,0,0
5104,NCT04854824,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04854824,2022-12-01,0,0
5105,NCT04854837,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04854837,2022-07-01,0,0
5106,NCT04854941,Completed,2021-03-10,2021-04-10,No Results Posted,,"['Ivashkin V, Fomin V, Moiseev S, Brovko M, Maslennikov R, Ulyanin A, Sholomova V, Vasilyeva M, Trush E, Shifrin O, Poluektova E. Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial. Probiotics Antimicrob Proteins. 2021 Oct 13. doi: 10.1007/s12602-021-09858-5. [Epub ahead of print]']",2022-01-28,https://clinicaltrials.gov/show/NCT04854941,2021-03-10,0,1
5107,NCT04854980,Recruiting,2022-07-31,2022-07-31,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04854980,2022-07-31,0,0
5108,NCT04855162,Completed,2021-10-07,2021-10-23,No Results Posted,,"['Weiss TT, Cerda F, Scott JB, Kaur R, Sungurlu S, Mirza SH, Alolaiwat AA, Kaur R, Augustynovich AE, Li J. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study. Br J Anaesth. 2021 Jan;126(1):48-55. doi: 10.1016/j.bja.2020.09.042. Epub 2020 Oct 10.']",2021-11-15,https://clinicaltrials.gov/show/NCT04855162,2021-10-07,0,1
5109,NCT04855539,Recruiting,2021-05-01,2021-12-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04855539,2021-05-01,0,0
5110,NCT04858412,Recruiting,2023-03-31,2023-03-31,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04858412,2023-03-31,0,0
5111,NCT04858542,Completed,2021-05-01,2021-09-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04858542,2021-05-01,0,0
5112,NCT04858581,Not yet recruiting,2022-12-01,2023-12-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04858581,2022-12-01,0,0
5113,NCT04858620,Withdrawn,2021-08-30,2021-08-30,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04858620,2021-08-30,0,0
5114,NCT04858763,Not yet recruiting,2021-08-01,2021-12-01,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04858763,2021-08-01,0,0
5115,NCT04859881,Completed,2021-01-31,2021-01-31,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04859881,2021-01-31,0,0
5116,NCT04859894,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04859894,2022-06-01,0,0
5117,NCT04860193,Not yet recruiting,2021-11-01,2022-04-01,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04860193,2021-11-01,0,0
5118,NCT04860206,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04860206,2021-06-30,0,0
5119,NCT04860219,Recruiting,2020-09-18,2021-04-30,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04860219,2020-09-18,0,0
5120,NCT04860232,Not yet recruiting,2021-10-31,2022-04-26,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04860232,2021-10-31,0,0
5121,NCT04860245,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-04-26,https://clinicaltrials.gov/show/NCT04860245,2021-06-30,0,0
5122,NCT04860271,Completed,2021-04-30,2021-05-31,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04860271,2021-04-30,0,0
5123,NCT04860284,"Active, not recruiting",2021-02-09,2021-12-01,No Results Posted,"['Byakika-Kibwika P, Sekaggya-Wiltshire C, Semakula JR, Nakibuuka J, Musaazi J, Kayima J, Sendagire C, Meya D, Kirenga B, Nanzigu S, Kwizera A, Nakwagala F, Kisuule I, Wayengera M, Mwebesa HG, Kamya MR, Bazeyo W. Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial. BMC Infect Dis. 2021 Dec 6;21(1):1218. doi: 10.1186/s12879-021-06897-9.']",,2021-04-26,https://clinicaltrials.gov/show/NCT04860284,2021-02-09,0,1
5124,NCT04860518,Recruiting,2022-12-01,2023-04-01,No Results Posted,,,2022-01-03,https://clinicaltrials.gov/show/NCT04860518,2022-12-01,0,0
5125,NCT04860687,Recruiting,2021-11-30,2021-12-31,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04860687,2021-11-30,0,0
5126,NCT04861272,Recruiting,2021-05-05,2021-05-15,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04861272,2021-05-05,0,0
5127,NCT04861402,Recruiting,2021-07-15,2021-12-15,No Results Posted,,"['Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.', 'Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020 Mar 27;12(4). pii: E372. doi: 10.3390/v12040372. Review.', 'Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016 Jun;24(6):490-502. doi: 10.1016/j.tim.2016.03.003. Epub 2016 Mar 21. Review.', 'Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). 2022 Feb 5. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000 Sep 1;87(5):E1-9.', 'Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020 Aug;88:945-946. doi: 10.1016/j.bbi.2020.04.017. Epub 2020 Apr 10.', 'Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020 Jul;92(7):699-702. doi: 10.1002/jmv.25915.']",2021-04-27,https://clinicaltrials.gov/show/NCT04861402,2021-07-15,0,1
5128,NCT04668222,Not yet recruiting,2022-11-30,2022-11-30,No Results Posted,,"[""Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26. Review. Erratum in: Int J Surg. 2020 May;77:217."", 'Mahase E. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020 Feb 18;368:m641. doi: 10.1136/bmj.m641.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.']",2021-04-28,https://clinicaltrials.gov/show/NCT04668222,2022-11-30,0,1
5129,NCT04673318,Recruiting,2024-12-01,2024-12-01,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04673318,2024-12-01,0,0
5130,NCT04674410,"Active, not recruiting",2022-12-31,2022-12-31,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04674410,2022-12-31,0,0
5131,NCT04678778,Completed,2021-02-19,2021-02-19,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04678778,2021-02-19,0,0
5132,NCT04685681,"Active, not recruiting",2022-04-06,2022-04-06,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04685681,2022-04-06,0,0
5133,NCT04688502,Not yet recruiting,2022-01-28,2022-02-15,No Results Posted,,,2021-10-21,https://clinicaltrials.gov/show/NCT04688502,2022-01-28,0,0
5134,NCT04689724,Completed,2021-10-27,2021-10-27,No Results Posted,,"['Jarvis N, Schiavo S, Bartoszko J, Ma M, Chin KJ, Parotto M. A specialized airway management team for COVID-19 patients: a retrospective study of the experience of two Canadian hospitals in Toronto. Can J Anaesth. 2022 Mar;69(3):333-342. doi: 10.1007/s12630-021-02169-x. Epub 2021 Dec 8.']",2022-01-04,https://clinicaltrials.gov/show/NCT04689724,2021-10-27,0,1
5135,NCT04691908,Completed,2021-04-26,2021-07-11,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04691908,2021-04-26,0,0
5136,NCT04697654,Completed,2021-06-18,2021-06-18,No Results Posted,,,2021-11-26,https://clinicaltrials.gov/show/NCT04697654,2021-06-18,0,0
5137,NCT04698382,"Active, not recruiting",2022-12-01,2022-12-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04698382,2022-12-01,0,0
5138,NCT04700137,Completed,2022-01-06,2022-01-06,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04700137,2022-01-06,0,0
5139,NCT04703114,Completed,2021-09-15,2021-09-15,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04703114,2021-09-15,0,0
5140,NCT04703790,Enrolling by invitation,2022-08-01,2022-08-01,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04703790,2022-08-01,0,0
5141,NCT04712448,"Active, not recruiting",2021-10-30,2021-12-30,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04712448,2021-10-30,0,0
5142,NCT04715438,"Active, not recruiting",2021-06-04,2023-04-01,No Results Posted,"['Oosting SF, van der Veldt AAM, GeurtsvanKessel CH, Fehrmann RSN, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, van der Heiden M, Rimmelzwaan GF, Kvistborg P, Blank CU, Koopmans MPG, Huckriede ALW, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. Lancet Oncol. 2021 Dec;22(12):1681-1691. doi: 10.1016/S1470-2045(21)00574-X. Epub 2021 Nov 9.']",,2022-03-17,https://clinicaltrials.gov/show/NCT04715438,2021-06-04,0,1
5143,NCT04718519,Completed,2020-10-11,2020-10-11,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04718519,2020-10-11,0,0
5144,NCT04732819,Completed,2021-03-31,2021-04-16,Study Results,"['Berry SD, Goldfeld KS, McConeghy K, Gifford D, Davidson HE, Han L, Syme M, Gandhi A, Mitchell SL, Harrison J, Recker A, Johnson KS, Gravenstein S, Mor V. Evaluating the Findings of the IMPACT-C Randomized Clinical Trial to Improve COVID-19 Vaccine Coverage in Skilled Nursing Facilities. JAMA Intern Med. 2022 Mar 1;182(3):324-331. doi: 10.1001/jamainternmed.2021.8067.']",,2021-09-05,https://clinicaltrials.gov/show/NCT04732819,2021-03-31,1,1
5145,NCT04747990,Recruiting,2021-07-01,2021-09-01,No Results Posted,"['Podda M, Pellino G, Coccolini F, Gerardi C, Di Saverio S, Pata F, Ielpo B, Virdis F, Damaskos D, Gourgiotis S, Poillucci G, Pacella D, Jayant K, Agresta F, Sartelli M, Leppaniemi A, Kluger Y, Catena F, Pisanu A. Compliance with evidence-based clinical guidelines in the management of acute biliary pancreatitis: the MANCTRA-1 study protocol. Updates Surg. 2021 Oct;73(5):1757-1765. doi: 10.1007/s13304-021-01118-z. Epub 2021 Jun 17.']",,2021-05-03,https://clinicaltrials.gov/show/NCT04747990,2021-07-01,0,1
5146,NCT04748588,Suspended,2023-01-31,2023-03-31,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-15,https://clinicaltrials.gov/show/NCT04748588,2023-01-31,0,1
5147,NCT04750278,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04750278,2022-02-01,0,0
5148,NCT04767477,Completed,2021-08-31,2021-09-10,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04767477,2021-08-31,0,0
5149,NCT04779775,Not yet recruiting,2021-07-30,2021-09-30,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04779775,2021-07-30,0,0
5150,NCT04780373,Completed,2020-12-01,2020-12-01,No Results Posted,"[""Sinatti G, Santini SJ, Tarantino G, Picchi G, Cosimini B, Ranfone F, Casano N, Zingaropoli MA, Iapadre N, Bianconi S, Armiento A, Carducci P, Ciardi MR, Mastroianni CM, Grimaldi A, Balsano C. PaO(2)/FiO(2) ratio forecasts COVID-19 patients' outcome regardless of age: a cross-sectional, monocentric study. Intern Emerg Med. 2021 Oct 12. doi: 10.1007/s11739-021-02840-7. [Epub ahead of print]""]",,2021-04-29,https://clinicaltrials.gov/show/NCT04780373,2020-12-01,0,1
5151,NCT04782739,Recruiting,2022-04-19,2022-04-19,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04782739,2022-04-19,0,0
5152,NCT04790786,Recruiting,2023-02-01,2023-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Huang DT, McCreary EK, Bariola JR, Wadas RJ, Kip KE, Marroquin OC, Koscumb S, Collins K, Shovel JA, Schmidhofer M, Wisniewski MK, Sullivan C, Yealy DM, Axe M, Nace DA, Haidar G, Khadem T, Linstrum K, Snyder GM, Seymour CW, Montgomery SK, McVerry BJ, Berry L, Berry S, Meyers R, Weissman A, Peck-Palmer OM, Wells A, Bart R, Albin DL, Minnier T, Angus DC. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization. Trials. 2021 May 25;22(1):363. doi: 10.1186/s13063-021-05316-3.']",,2022-01-21,https://clinicaltrials.gov/show/NCT04790786,2023-02-01,0,1
5153,NCT04809389,"Active, not recruiting",2022-09-01,2022-09-01,No Results Posted,,,2021-09-27,https://clinicaltrials.gov/show/NCT04809389,2022-09-01,0,0
5154,NCT04810117,Recruiting,2021-08-30,2021-10-30,No Results Posted,,,2021-07-08,https://clinicaltrials.gov/show/NCT04810117,2021-08-30,0,0
5155,NCT04816318,Not yet recruiting,2021-05-31,2021-05-31,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04816318,2021-05-31,0,0
5156,NCT04817319,Not yet recruiting,2021-10-15,2022-10-15,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04817319,2021-10-15,0,0
5157,NCT04821921,Recruiting,2022-03-31,2022-06-30,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04821921,2022-03-31,0,0
5158,NCT04824365,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04824365,2022-05-01,0,0
5159,NCT04836767,"Active, not recruiting",2022-05-01,2022-06-01,No Results Posted,,"[""Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020 Aug;54(16):949-959. doi: 10.1136/bjsports-2020-102596. Epub 2020 May 31."", 'Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;:.', 'Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr√© syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1.', 'Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. Chinese.', 'Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S, Bertalli L, Cattini F, Lomazzo A, Dal Negro F, Giardini M, Franssen FME, Janssen DJA, Spruit MA. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. 2020 Oct 15;56(4). pii: 2002096. doi: 10.1183/13993003.02096-2020. Print 2020 Oct.']",2022-01-21,https://clinicaltrials.gov/show/NCT04836767,2022-05-01,0,1
5160,NCT04839107,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04839107,2021-12-31,0,0
5161,NCT04841746,Recruiting,2022-09-02,2022-09-02,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04841746,2022-09-02,0,0
5162,NCT04841785,"Active, not recruiting",2023-05-01,2023-12-31,No Results Posted,"['Bouwmans P, Messchendorp AL, Sanders JS, Hilbrands L, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel MA, Ten Dam MA, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH; RECOVAC Collaborators. Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study. BMC Nephrol. 2022 Feb 5;23(1):55. doi: 10.1186/s12882-022-02680-3.']","['Ahn C, Amer H, Anglicheau D, Ascher NL, Baan CC, Battsetset G, Bat-Ireedui B, Berney T, Betjes MGH, Bichu S, Birn H, Brennan D, Bromberg J, Caillard S, Cannon RM, Cantarovich M, Chan A, Chen ZS, Chapman JR, Cole EH, Cross N, Durand F, Egawa H, Emond JC, Farrero M, Friend PJ, Geissler EK, Ha J, Haberal MA, Henderson ML, Hesselink DA, Humar A, Jassem W, Jeong JC, Kaplan B, Kee T, Kim SJ, Kumar D, Legendre CM, Man K, Moulin B, Muller E, Munkhbat R, Od-Erdene L, Perrin P, Rela M, Tanabe K, Tedesco Silva H, Tinckam KT, Tullius SG, Wong G. Global Transplantation COVID Report March 2020. Transplantation. 2020 Oct;104(10):1974-1983. doi: 10.1097/TP.0000000000003258.', 'Baric RS. Emergence of a Highly Fit SARS-CoV-2 Variant. N Engl J Med. 2020 Dec 31;383(27):2684-2686. doi: 10.1056/NEJMcibr2032888. Epub 2020 Dec 16.', 'Robison SF, Mayhew RB, Cowan RD, Hawley RJ. Comparative study of deflection characteristics and fragility of 25-, 27-, and 30-gauge short dental needles. J Am Dent Assoc. 1984 Dec;109(6):920-4.', ""Berends SE, Bloem K, de Vries A, Schaap T, Rispens T, Strik AS, Talwar R, L√∂wenberg M, D'Haens GR, Math√¥t RA. Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood Samples. Ther Drug Monit. 2020 Apr;42(2):289-294. doi: 10.1097/FTD.0000000000000686."", 'Dearlove B, Lewitus E, Bai H, Li Y, Reeves DB, Joyce MG, Scott PT, Amare MF, Vasan S, Michael NL, Modjarrad K, Rolland M. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662. doi: 10.1073/pnas.2008281117. Epub 2020 Aug 31.', 'ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant. 2021 Jan 1;36(1):87-94. doi: 10.1093/ndt/gfaa314.', 'Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol. 2020 Dec;16(12):705-706. doi: 10.1038/s41581-020-00349-4.', 'Gezondheidsraad. Strategie√´n voor COVID-19-vaccinatie. Den Haag: Gezondheidsraad, 2020; publicatienr. 2020/23', 'Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, Kieneker LM, Noordzij M, Pena MJ, Vries H, Arroyo D, Covic A, Crespo M, Goffin E, Islam M, Massy ZA, Montero N, Oliveira JP, Roca Mu√±oz A, Sanchez JE, Sridharan S, Winzeler R, Gansevoort RT; ERACODA Collaborators. COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983. doi: 10.1093/ndt/gfaa261. Erratum in: Nephrol Dial Transplant. 2021 Feb 24;:.', 'Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2021 Feb;21(2):e26-e35. doi: 10.1016/S1473-3099(20)30773-8. Epub 2020 Oct 27. Review.', 'Katerinis I, Hadaya K, Duquesnoy R, Ferrari-Lacraz S, Meier S, van Delden C, Martin PY, Siegrist CA, Villard J. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant. 2011 Aug;11(8):1727-33. doi: 10.1111/j.1600-6143.2011.03604.x. Epub 2011 Jun 14.', 'Kotton CN. Immunization after kidney transplantation-what is necessary and what is safe? Nat Rev Nephrol. 2014 Oct;10(10):555-62. doi: 10.1038/nrneph.2014.122. Epub 2014 Jul 29. Review.', 'Mahase E. Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate. BMJ. 2020 Nov 9;371:m4347. doi: 10.1136/bmj.m4347.', 'Noordzij M, Duivenvoorden R, Pena MJ, de Vries H, Kieneker LM; collaborative ERACODA authors. ERACODA: the European database collecting clinical information of patients on kidney replacement therapy with COVID-19. Nephrol Dial Transplant. 2020 Dec 4;35(12):2023-2025. doi: 10.1093/ndt/gfaa179.', 'Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P√©rez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW Jr, Hammitt LL, T√ºreci √ñ, Nell H, Schaefer A, √únal S, Tresnan DB, Mather S, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.', 'Reddy S, Chitturi C, Yee J. Vaccination in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019 Jan;26(1):72-78. doi: 10.1053/j.ackd.2018.10.002. Review.', 'van der Willik EM, Meuleman Y, Prantl K, van Rijn G, Bos WJW, van Ittersum FJ, Bart HAJ, Hemmelder MH, Dekker FW. Patient-reported outcome measures: selection of a valid questionnaire for routine symptom assessment in patients with advanced chronic kidney disease - a four-phase mixed methods study. BMC Nephrol. 2019 Sep 2;20(1):344. doi: 10.1186/s12882-019-1521-9.', 'van Besouw NM, Yan L, de Kuiper R, Klepper M, Reijerkerk D, Dieterich M, Roelen DL, Claas FHJ, Clahsen-van Groningen MC, Hesselink DA, Baan CC. The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection. Front Immunol. 2019 Apr 9;10:748. doi: 10.3389/fimmu.2019.00748. eCollection 2019.', 'Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.']",2022-03-29,https://clinicaltrials.gov/show/NCT04841785,2023-05-01,0,1
5163,NCT04842721,Not yet recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04842721,2021-10-01,0,0
5164,NCT04843787,Not yet recruiting,2021-10-01,2021-10-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04843787,2021-10-01,0,0
5165,NCT04844580,Recruiting,2022-09-01,2022-12-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04844580,2022-09-01,0,0
5166,NCT04853940,Recruiting,2021-11-30,2022-03-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04853940,2021-11-30,0,0
5167,NCT04854486,Not yet recruiting,2022-03-30,2022-11-16,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04854486,2022-03-30,0,0
5168,NCT04854863,Recruiting,2022-08-01,2023-08-01,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04854863,2022-08-01,0,0
5169,NCT04854928,Recruiting,2022-02-01,2022-05-01,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04854928,2022-02-01,0,0
5170,NCT04856111,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04856111,2021-12-31,0,0
5171,NCT04857060,Recruiting,2023-01-01,2024-04-01,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04857060,2023-01-01,0,0
5172,NCT04858607,Recruiting,2024-05-01,2024-05-01,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04858607,2024-05-01,0,0
5173,NCT04859244,Completed,2021-05-01,2021-08-01,No Results Posted,,,2021-08-10,https://clinicaltrials.gov/show/NCT04859244,2021-05-01,0,0
5174,NCT04860297,Recruiting,2023-05-31,2024-01-31,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04860297,2023-05-31,0,0
5175,NCT04860739,"Active, not recruiting",2021-05-20,2022-04-30,No Results Posted,"['Borobia AM, Carcas AJ, P√©rez-Olmeda M, Casta√±o L, Bertran MJ, Garc√≠a-P√©rez J, Campins M, Portol√©s A, Gonz√°lez-P√©rez M, Garc√≠a Morales MT, Arana-Arri E, Aldea M, D√≠ez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Bar√≥n-Mira LE, Agust√≠ A, P√©rez-Ingidua C, G√≥mez de la C√°mara A, Arribas JR, Ochando J, Alcam√≠ J, Belda-Iniesta C, Fr√≠as J; CombiVacS Study Group. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Erratum in: Lancet. 2021 Aug 14;398(10300):582.']",,2021-05-04,https://clinicaltrials.gov/show/NCT04860739,2021-05-20,0,1
5176,NCT04860895,Recruiting,2021-05-01,2021-05-15,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04860895,2021-05-01,0,0
5177,NCT04860908,Recruiting,2022-01-01,2022-07-01,No Results Posted,,,2021-04-27,https://clinicaltrials.gov/show/NCT04860908,2022-01-01,0,0
5178,NCT04861298,Completed,2021-08-29,2021-08-29,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04861298,2021-08-29,0,0
5179,NCT04862806,Recruiting,2021-09-01,2022-03-01,No Results Posted,"['Herishanu Y, Rahav G, Levi S, Braester A, Itchaki G, Bairey O, Dally N, Shvidel L, Ziv-Baran T, Polliack A, Tadmor T, Benjamini O; Israeli CLL Study Group. Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination. Blood. 2022 Feb 3;139(5):678-685. doi: 10.1182/blood.2021014085.']",,2021-09-17,https://clinicaltrials.gov/show/NCT04862806,2021-09-01,0,1
5180,NCT04863131,Recruiting,2023-01-31,2023-01-31,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04863131,2023-01-31,0,0
5181,NCT04863534,Completed,2021-02-21,2021-02-21,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04863534,2021-02-21,0,0
5182,NCT04863547,Recruiting,2021-04-30,2021-05-31,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04863547,2021-04-30,0,0
5183,NCT04863573,Recruiting,2024-05-01,2024-05-01,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04863573,2024-05-01,0,0
5184,NCT04863586,Enrolling by invitation,2021-10-31,2022-05-31,No Results Posted,,,2021-04-28,https://clinicaltrials.gov/show/NCT04863586,2021-10-31,0,0
5185,NCT04864015,Completed,2021-05-15,2021-06-30,No Results Posted,,,2021-10-08,https://clinicaltrials.gov/show/NCT04864015,2021-05-15,0,0
5186,NCT04864899,Recruiting,2023-03-30,2023-12-31,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04864899,2023-03-30,0,0
5187,NCT04864925,Completed,2021-08-25,2021-08-25,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04864925,2021-08-25,0,0
5188,NCT04864938,Enrolling by invitation,2024-07-25,2024-07-25,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04864938,2024-07-25,0,0
5189,NCT04865029,Recruiting,2022-05-01,2022-05-01,No Results Posted,"['Lovre D, Bateman K, Sherman M, Fonseca VA, Lefante J, Mauvais-Jarvis F. Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial. BMJ Open. 2021 Nov 30;11(11):e053684. doi: 10.1136/bmjopen-2021-053684.']",,2021-07-23,https://clinicaltrials.gov/show/NCT04865029,2022-05-01,0,1
5190,NCT04865133,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04865133,2021-12-31,0,0
5191,NCT04865237,"Active, not recruiting",2022-06-03,2022-06-03,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04865237,2022-06-03,0,0
5192,NCT04865900,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04865900,2022-04-01,0,0
5193,NCT04865913,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-04-29,https://clinicaltrials.gov/show/NCT04865913,2022-05-01,0,0
5194,NCT04866082,Recruiting,2022-07-01,2022-12-01,No Results Posted,,,2022-03-03,https://clinicaltrials.gov/show/NCT04866082,2022-07-01,0,0
5195,NCT04866303,Recruiting,2021-08-01,2021-10-01,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04866303,2021-08-01,0,0
5196,NCT04867161,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04867161,2021-12-31,0,0
5197,NCT04867213,Recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-04-30,https://clinicaltrials.gov/show/NCT04867213,2021-12-31,0,0
5198,NCT04868188,Recruiting,2022-10-01,2023-05-01,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04868188,2022-10-01,0,0
5199,NCT04868435,Suspended,2021-07-31,2022-06-01,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04868435,2021-07-31,0,0
5200,NCT04868448,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04868448,2022-08-01,0,0
5201,NCT04868890,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04868890,2021-10-01,0,0
5202,NCT04868903,Recruiting,2022-06-30,2022-12-30,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04868903,2022-06-30,0,0
5203,NCT04869072,Completed,2020-11-30,2021-03-30,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04869072,2020-11-30,0,0
5204,NCT04869202,Recruiting,2021-11-30,2021-12-30,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04869202,2021-11-30,0,0
5205,NCT04869579,Not yet recruiting,2021-11-15,2021-12-15,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04869579,2021-11-15,0,0
5206,NCT04870307,Recruiting,2023-09-01,2023-09-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04870307,2023-09-01,0,0
5207,NCT04870333,Recruiting,2023-07-01,2024-10-01,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04870333,2023-07-01,0,0
5208,NCT04870723,Recruiting,2021-08-31,2021-12-31,No Results Posted,"['Newman PA, Chakrapani V, Williams C, Massaquoi N, Tepjan S, Roungprakhon S, Akkakanjanasupar P, Logie C, Rawat S. An eHealth Intervention for Promoting COVID-19 Knowledge and Protective Behaviors and Reducing Pandemic Distress Among Sexual and Gender Minorities: Protocol for a Randomized Controlled Trial (#SafeHandsSafeHearts). JMIR Res Protoc. 2021 Dec 10;10(12):e34381. doi: 10.2196/34381.']",,2021-07-20,https://clinicaltrials.gov/show/NCT04870723,2021-08-31,0,1
5209,NCT04870736,Withdrawn,2021-06-30,2021-09-01,No Results Posted,,,2021-05-03,https://clinicaltrials.gov/show/NCT04870736,2021-06-30,0,0
5210,NCT04870775,Completed,2021-10-10,2021-10-10,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04870775,2021-10-10,0,0
5211,NCT04871165,Recruiting,2024-03-01,2024-03-01,No Results Posted,"['Maneikis K, ≈†ablauskas K, Ringeleviƒçi≈´tƒó U, Vaitekƒónaitƒó V, ƒåekauskienƒó R, Kry≈æauskaitƒó L, Naumovas D, Banys V, Peƒçeli≈´nas V, Beinortas T, Gri≈°keviƒçius L. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.']",,2022-01-14,https://clinicaltrials.gov/show/NCT04871165,2024-03-01,0,1
5212,NCT04871633,Completed,2020-11-15,2020-12-30,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04871633,2020-11-15,0,0
5213,NCT04871685,"Active, not recruiting",2021-04-24,2021-05-03,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04871685,2021-04-24,0,0
5214,NCT04871776,Recruiting,2022-05-01,2023-01-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04871776,2022-05-01,0,0
5215,NCT04871789,Recruiting,2021-05-15,2021-06-15,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04871789,2021-05-15,0,0
5216,NCT04871802,Not yet recruiting,2021-09-01,2021-10-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04871802,2021-09-01,0,0
5217,NCT04871815,Completed,2022-03-07,2022-03-07,Study Results,,,2022-03-09,https://clinicaltrials.gov/show/NCT04871815,2022-03-07,1,0
5218,NCT04871841,"Active, not recruiting",2021-09-05,2021-12-05,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04871841,2021-09-05,0,0
5219,NCT04871867,Recruiting,2021-12-01,2021-12-15,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04871867,2021-12-01,0,0
5220,NCT04871893,Recruiting,2022-11-01,2022-12-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04871893,2022-11-01,0,0
5221,NCT04871945,Completed,2021-09-30,2021-10-31,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04871945,2021-09-30,0,0
5222,NCT04871958,Enrolling by invitation,2021-08-31,2021-09-30,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04871958,2021-08-31,0,0
5223,NCT04872309,Recruiting,2027-08-01,2027-08-01,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04872309,2027-08-01,0,0
5224,NCT04872699,Recruiting,2021-05-31,2022-05-31,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04872699,2021-05-31,0,0
5225,NCT04872712,Recruiting,2022-04-07,2022-04-07,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04872712,2022-04-07,0,0
5226,NCT04872764,Completed,2020-11-20,2020-12-20,No Results Posted,,,2021-05-04,https://clinicaltrials.gov/show/NCT04872764,2020-11-20,0,0
5227,NCT04874363,Completed,2020-05-15,2020-05-30,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04874363,2020-05-15,0,0
5228,NCT04874753,Completed,2020-12-01,2021-01-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04874753,2020-12-01,0,0
5229,NCT04874779,Completed,2020-11-18,2021-05-01,No Results Posted,,,2021-07-23,https://clinicaltrials.gov/show/NCT04874779,2020-11-18,0,0
5230,NCT03957447,"Active, not recruiting",2024-07-01,2024-07-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT03957447,2024-07-01,0,0
5231,NCT04668235,Recruiting,2022-03-01,2022-04-01,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04668235,2022-03-01,0,0
5232,NCT04681430,Completed,2021-10-29,2021-10-29,No Results Posted,"['Keitel V, Jensen B, Feldt T, Fischer JC, Bode JG, Matuschek C, B√∂lke E, Budach W, Plettenberg C, Scheckenbach K, Kindgen-Milles D, Timm J, M√ºller L, Kolbe H, St√∂hr A, Calles C, Hippe A, Verde P, Spinner CD, Schneider J, Wolf T, Kern WV, Nattermann J, Zoufaly A, Ohmann C, Luedde T; RES-Q-HR Trial Team. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17;22(1):343. doi: 10.1186/s13063-021-05181-0.']",,2022-02-10,https://clinicaltrials.gov/show/NCT04681430,2021-10-29,0,1
5233,NCT04715932,Completed,2021-05-25,2021-06-07,Results Submitted,,,2021-07-12,https://clinicaltrials.gov/show/NCT04715932,2021-05-25,0,0
5234,NCT04733807,Recruiting,2021-07-31,2022-02-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04733807,2021-07-31,0,0
5235,NCT04738721,Completed,2021-04-04,2021-05-04,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04738721,2021-04-04,0,0
5236,NCT04746430,Terminated,2021-04-23,2021-04-23,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04746430,2021-04-23,0,0
5237,NCT04753645,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04753645,2021-05-01,0,0
5238,NCT04757207,Completed,2021-05-03,2021-05-03,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04757207,2021-05-03,0,0
5239,NCT04760184,Completed,2021-08-30,2021-12-31,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04760184,2021-08-30,0,0
5240,NCT04762056,Completed,2021-05-30,2021-05-30,No Results Posted,,"['Elliott D, Denehy L, Berney S, Alison JA. Assessing physical function and activity for survivors of a critical illness: a review of instruments. Aust Crit Care. 2011 Aug;24(3):155-66. doi: 10.1016/j.aucc.2011.05.002. Epub 2011 Jul 1. Review.', 'Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, Negrini S, Zapparoli L. Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation. Arch Phys Med Rehabil. 2021 Jan;102(1):155-158. doi: 10.1016/j.apmr.2020.09.376. Epub 2020 Sep 28.', 'Denehy L, de Morton NA, Skinner EH, Edbrooke L, Haines K, Warrillow S, Berney S. A physical function test for use in the intensive care unit: validity, responsiveness, and predictive utility of the physical function ICU test (scored). Phys Ther. 2013 Dec;93(12):1636-45. doi: 10.2522/ptj.20120310. Epub 2013 Jul 25.', 'Curci C, Pisano F, Bonacci E, Camozzi DM, Ceravolo C, Bergonzi R, De Franceschi S, Moro P, Guarnieri R, Ferrillo M, Negrini F, de Sire A. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur J Phys Rehabil Med. 2020 Oct;56(5):633-641. doi: 10.23736/S1973-9087.20.06339-X. Epub 2020 Jul 15.', 'Parry SM, Granger CL, Berney S, Jones J, Beach L, El-Ansary D, Koopman R, Denehy L. Assessment of impairment and activity limitations in the critically ill: a systematic review of measurement instruments and their clinimetric properties. Intensive Care Med. 2015 May;41(5):744-62. doi: 10.1007/s00134-015-3672-x. Epub 2015 Feb 5. Review.', 'Holdar U, Eriksson F, Siesage K, Corner EJ, Ledstr√∂m V, Svensson-Raskh A, Kierkegaard M. Cross-cultural adaptation and inter-rater reliability of the Swedish version of the Chelsea critical care assessment tool (CPAX-Swe) in critically ill patients. Disabil Rehabil. 2021 Jun;43(11):1600-1604. doi: 10.1080/09638288.2019.1668971. Epub 2019 Sep 26.', 'Nordon-Craft A, Schenkman M, Edbrooke L, Malone DJ, Moss M, Denehy L. The physical function intensive care test: implementation in survivors of critical illness. Phys Ther. 2014 Oct;94(10):1499-507. doi: 10.2522/ptj.20130451. Epub 2014 May 8.', ""De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Rapha√´l JC, Outin H, Bastuji-Garin S; Groupe de R√©flexion et d'Etude des Neuromyopathies en R√©animation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002 Dec 11;288(22):2859-67.""]",2021-08-25,https://clinicaltrials.gov/show/NCT04762056,2021-05-30,0,1
5241,NCT04766333,Recruiting,2022-02-01,2022-08-01,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04766333,2022-02-01,0,0
5242,NCT04779827,Recruiting,2022-10-30,2022-12-30,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04779827,2022-10-30,0,0
5243,NCT04780113,Recruiting,2021-10-25,2021-10-25,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04780113,2021-10-25,0,0
5244,NCT04797858,Recruiting,2022-03-30,2022-10-31,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04797858,2022-03-30,0,0
5245,NCT04813770,Completed,2021-04-26,2021-04-26,No Results Posted,"[""Young B, Kotzur M, Gatting L, Bonner C, Ayre J, McConnachie A, Batcup C, McCaffery K, O'Carroll R, Robb KA. The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 29;22(1):311. doi: 10.1186/s13063-021-05277-7.""]",,2021-05-10,https://clinicaltrials.gov/show/NCT04813770,2021-04-26,0,1
5246,NCT04813796,"Active, not recruiting",2023-04-13,2023-04-13,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04813796,2023-04-13,0,0
5247,NCT04816019,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-11-15,https://clinicaltrials.gov/show/NCT04816019,2022-03-31,0,0
5248,NCT04816071,Withdrawn,2022-03-01,2022-03-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04816071,2022-03-01,0,0
5249,NCT04825301,Recruiting,2022-03-30,2022-04-30,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04825301,2022-03-30,0,0
5250,NCT04834583,"Active, not recruiting",2021-12-31,2023-12-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04834583,2021-12-31,0,0
5251,NCT04834726,Completed,2021-06-04,2021-07-06,Results Submitted,,,2021-09-01,https://clinicaltrials.gov/show/NCT04834726,2021-06-04,0,0
5252,NCT04841759,Completed,2021-12-03,2021-12-22,No Results Posted,,,2021-12-27,https://clinicaltrials.gov/show/NCT04841759,2021-12-03,0,0
5253,NCT04847479,Recruiting,2022-05-10,2022-10-30,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04847479,2022-05-10,0,0
5254,NCT04847596,Recruiting,2023-04-11,2023-04-11,No Results Posted,,,2021-11-03,https://clinicaltrials.gov/show/NCT04847596,2023-04-11,0,0
5255,NCT04852861,Enrolling by invitation,2021-07-30,2022-09-30,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04852861,2021-07-30,0,0
5256,NCT04854408,Completed,2021-05-07,2021-05-09,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04854408,2021-05-07,0,0
5257,NCT04858425,"Active, not recruiting",2022-01-06,2022-03-01,No Results Posted,,,2022-02-07,https://clinicaltrials.gov/show/NCT04858425,2022-01-06,0,0
5258,NCT04859023,Completed,2021-02-28,2021-02-28,No Results Posted,"['Verot E, Bonjean P, Chaux R, Gagnaire J, Gagneux-Brunon A, Pozzetto B, Berthelot P, Botelho-Nevers E, Chauvin F. Development and Validation of the COVID-19 Knowledges and Behavior Questionnaire in a French Population (CoVQuest-CC). Int J Environ Res Public Health. 2022 Feb 23;19(5). pii: 2569. doi: 10.3390/ijerph19052569.']",,2021-05-06,https://clinicaltrials.gov/show/NCT04859023,2021-02-28,0,1
5259,NCT04860258,Completed,2021-09-21,2021-09-21,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04860258,2021-09-21,0,0
5260,NCT04865107,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04865107,2022-04-01,0,0
5261,NCT04866069,Recruiting,2021-10-01,2022-04-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04866069,2021-10-01,0,0
5262,NCT04866589,Not yet recruiting,2021-05-21,2021-05-21,No Results Posted,"['Elgersma IH, Fretheim A, Indseth T, Munch AT, Johannessen LB, Hansen CE. Evaluation of a social media campaign to increase COVID-19 testing in migrant groups: A cluster randomized trial. J Med Internet Res. 2022 Feb 24. doi: 10.2196/34544. [Epub ahead of print]']",,2021-05-06,https://clinicaltrials.gov/show/NCT04866589,2021-05-21,0,1
5263,NCT04869228,Recruiting,2022-02-28,2022-05-30,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04869228,2022-02-28,0,0
5264,NCT04869592,Recruiting,2022-10-25,2022-10-25,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04869592,2022-10-25,0,0
5265,NCT04870164,Terminated,2022-01-06,2022-01-06,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04870164,2022-01-06,0,0
5266,NCT04871672,Completed,2021-12-26,2022-02-22,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04871672,2021-12-26,0,0
5267,NCT04871828,Recruiting,2021-09-01,2021-12-01,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04871828,2021-09-01,0,0
5268,NCT04872725,Completed,2020-06-30,2020-07-30,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04872725,2020-06-30,0,0
5269,NCT04872738,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04872738,2021-12-31,0,0
5270,NCT04872751,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04872751,2022-04-01,0,0
5271,NCT04873141,Completed,2020-06-22,2020-06-22,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04873141,2020-06-22,0,0
5272,NCT04873336,Completed,2021-10-15,2021-10-16,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04873336,2021-10-15,0,0
5273,NCT04873349,Not yet recruiting,2021-07-30,2021-09-30,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04873349,2021-07-30,0,0
5274,NCT04873388,Enrolling by invitation,2021-05-01,2022-03-01,No Results Posted,,,2021-05-05,https://clinicaltrials.gov/show/NCT04873388,2021-05-01,0,0
5275,NCT04873401,Recruiting,2022-08-20,2022-11-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04873401,2022-08-20,0,0
5276,NCT04874740,Recruiting,2022-10-30,2022-10-30,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04874740,2022-10-30,0,0
5277,NCT04874792,Completed,2020-11-30,2020-12-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04874792,2020-11-30,0,0
5278,NCT04874805,Not yet recruiting,2022-03-01,2022-03-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04874805,2022-03-01,0,0
5279,NCT04874818,Not yet recruiting,2022-05-01,2022-09-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04874818,2022-05-01,0,0
5280,NCT04875520,Recruiting,2022-12-31,2023-03-31,No Results Posted,,,2021-07-26,https://clinicaltrials.gov/show/NCT04875520,2022-12-31,0,0
5281,NCT04876417,Recruiting,2023-02-01,2023-02-01,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04876417,2023-02-01,0,0
5282,NCT04876443,Recruiting,2022-07-31,2022-07-31,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04876443,2022-07-31,0,0
5283,NCT04876560,Completed,2020-10-10,2021-04-15,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04876560,2020-10-10,0,0
5284,NCT04876573,Not yet recruiting,2021-12-31,2022-01-31,No Results Posted,,,2021-05-06,https://clinicaltrials.gov/show/NCT04876573,2021-12-31,0,0
5285,NCT04876872,Recruiting,2021-07-31,2021-09-15,No Results Posted,,"['Lambert V, Matthews A, MacDonell R, Fitzsimons J. Paediatric early warning systems for detecting and responding to clinical deterioration in children: a systematic review. BMJ Open. 2017 Mar 13;7(3):e014497. doi: 10.1136/bmjopen-2016-014497. Review.', 'Jagt EW. Improving Pediatric Survival from Resuscitation Events: The Role and Organization of Hospital-based Rapid Response Systems and Code Teams. Curr Pediatr Rev. 2013;9(2):158-74.', 'Skaletzky SM, Raszynski A, Totapally BR. Validation of a modified pediatric early warning system score: a retrospective case-control study. Clin Pediatr (Phila). 2012 May;51(5):431-5. doi: 10.1177/0009922811430342. Epub 2011 Dec 8.', 'Egdell P, Finlay L, Pedley DK. The PAWS score: validation of an early warning scoring system for the initial assessment of children in the emergency department. Emerg Med J. 2008 Nov;25(11):745-9. doi: 10.1136/emj.2007.054965.', 'Barak-Corren Y, Fine AM, Reis BY. Early Prediction Model of Patient Hospitalization From the Pediatric Emergency Department. Pediatrics. 2017 May;139(5). pii: e20162785. doi: 10.1542/peds.2016-2785.']",2021-05-12,https://clinicaltrials.gov/show/NCT04876872,2021-07-31,0,1
5286,NCT04876885,Not yet recruiting,2021-06-06,2021-06-06,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04876885,2021-06-06,0,0
5287,NCT04876898,Completed,2021-01-30,2021-02-28,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04876898,2021-01-30,0,0
5288,NCT04877002,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04877002,2021-05-01,0,0
5289,NCT04877509,Completed,2020-12-01,2021-05-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04877509,2020-12-01,0,0
5290,NCT04877704,Not yet recruiting,2022-04-30,2022-04-30,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04877704,2022-04-30,0,0
5291,NCT04877769,Completed,2021-08-31,2021-08-31,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04877769,2021-08-31,0,0
5292,NCT04877808,Completed,2021-08-15,2021-08-15,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04877808,2021-08-15,0,0
5293,NCT04878042,Recruiting,2021-06-01,2021-07-01,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04878042,2021-06-01,0,0
5294,NCT04878068,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-05-07,https://clinicaltrials.gov/show/NCT04878068,2021-06-30,0,0
5295,NCT04878328,Recruiting,2026-07-01,2026-07-01,No Results Posted,,,2021-08-12,https://clinicaltrials.gov/show/NCT04878328,2026-07-01,0,0
5296,NCT04878900,Completed,2021-03-01,2021-03-01,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04878900,2021-03-01,0,0
5297,NCT04879251,Recruiting,2022-08-31,2022-08-31,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04879251,2022-08-31,0,0
5298,NCT04880122,Completed,2020-09-30,2020-09-30,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04880122,2020-09-30,0,0
5299,NCT04880135,Completed,2021-08-30,2021-09-01,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04880135,2021-08-30,0,0
5300,NCT04880161,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-05-10,https://clinicaltrials.gov/show/NCT04880161,2021-10-01,0,0
5301,NCT04880174,"Active, not recruiting",2022-07-01,2022-07-01,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04880174,2022-07-01,0,0
5302,NCT04880317,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04880317,2022-12-01,0,0
5303,NCT04880668,Completed,2021-12-16,2021-12-16,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04880668,2021-12-16,0,0
5304,NCT04881266,Enrolling by invitation,2023-05-31,2023-12-31,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04881266,2023-05-31,0,0
5305,NCT04881305,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04881305,2021-10-01,0,0
5306,NCT04882865,Not yet recruiting,2022-02-15,2022-02-15,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04882865,2022-02-15,0,0
5307,NCT04884321,Completed,2021-03-30,2021-03-30,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04884321,2021-03-30,0,0
5308,NCT04884477,"Active, not recruiting",2021-06-30,2022-06-30,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04884477,2021-06-30,0,0
5309,NCT04884490,Not yet recruiting,2021-10-14,2021-11-14,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04884490,2021-10-14,0,0
5310,NCT04884776,Recruiting,2024-05-31,2024-05-31,No Results Posted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04884776,2024-05-31,0,0
5311,NCT04885192,Recruiting,2022-09-30,2023-01-11,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04885192,2022-09-30,0,0
5312,NCT04885764,Recruiting,2021-10-01,2021-12-01,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04885764,2021-10-01,0,0
5313,NCT04674566,Recruiting,2021-10-30,2021-10-30,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-08-04,https://clinicaltrials.gov/show/NCT04674566,2021-10-30,0,1
5314,NCT04684836,Recruiting,2022-04-01,2023-12-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04684836,2022-04-01,0,0
5315,NCT04707703,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04707703,2022-01-01,0,0
5316,NCT04724395,Recruiting,2023-03-01,2023-03-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04724395,2023-03-01,0,0
5317,NCT04729452,Recruiting,2023-10-01,2023-12-01,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04729452,2023-10-01,0,0
5318,NCT04742725,"Active, not recruiting",2021-07-30,2021-09-30,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04742725,2021-07-30,0,0
5319,NCT04771013,Completed,2021-05-14,2021-05-14,Study Results,,,2022-02-04,https://clinicaltrials.gov/show/NCT04771013,2021-05-14,1,0
5320,NCT04779450,Recruiting,2021-08-01,2021-12-01,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04779450,2021-08-01,0,0
5321,NCT04783025,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04783025,2022-03-31,0,0
5322,NCT04789603,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04789603,2021-06-01,0,0
5323,NCT04799392,Terminated,2021-10-28,2021-10-28,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04799392,2021-10-28,0,0
5324,NCT04801836,"Active, not recruiting",2022-03-04,2022-08-05,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04801836,2022-03-04,0,0
5325,NCT04805970,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04805970,2022-01-01,0,0
5326,NCT04818736,Withdrawn,2021-09-01,2021-12-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04818736,2021-09-01,0,0
5327,NCT04824469,Not yet recruiting,2022-05-01,2022-12-01,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04824469,2022-05-01,0,0
5328,NCT04832061,Completed,2021-04-20,2021-04-20,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04832061,2021-04-20,0,0
5329,NCT04832919,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04832919,2022-05-01,0,0
5330,NCT04839965,Recruiting,2021-10-01,2021-11-01,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04839965,2021-10-01,0,0
5331,NCT04842435,Recruiting,2021-09-30,2021-10-05,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04842435,2021-09-30,0,0
5332,NCT04844515,Recruiting,2021-04-23,2023-04-23,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04844515,2021-04-23,0,0
5333,NCT04844697,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04844697,2022-12-01,0,0
5334,NCT04847102,Recruiting,2021-11-30,2023-05-30,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04847102,2021-11-30,0,0
5335,NCT04863638,Recruiting,2022-03-31,2024-03-31,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04863638,2022-03-31,0,0
5336,NCT04864535,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04864535,2021-12-31,0,0
5337,NCT04870606,Recruiting,2022-01-24,2022-05-24,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04870606,2022-01-24,0,0
5338,NCT04871646,Recruiting,2022-03-01,2022-08-01,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04871646,2022-03-01,0,0
5339,NCT04872049,"Active, not recruiting",2021-10-27,2021-10-27,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04872049,2021-10-27,0,0
5340,NCT04872686,Completed,2021-05-25,2021-05-30,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04872686,2021-05-25,0,0
5341,NCT04878913,Completed,2021-08-31,2021-08-31,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04878913,2021-08-31,0,0
5342,NCT04880109,Recruiting,2023-02-01,2023-03-01,No Results Posted,,,2021-10-26,https://clinicaltrials.gov/show/NCT04880109,2023-02-01,0,0
5343,NCT04880642,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04880642,2022-05-01,0,0
5344,NCT04880720,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04880720,2021-12-01,0,0
5345,NCT04881214,Recruiting,2022-07-01,2022-11-25,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04881214,2022-07-01,0,0
5346,NCT04881253,Not yet recruiting,2021-12-01,2022-05-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04881253,2021-12-01,0,0
5347,NCT04881396,Not yet recruiting,2021-06-01,2022-06-01,No Results Posted,,,2021-05-11,https://clinicaltrials.gov/show/NCT04881396,2021-06-01,0,0
5348,NCT04882670,Completed,2021-07-30,2021-07-31,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04882670,2021-07-30,0,0
5349,NCT04883164,Recruiting,2023-03-31,2023-03-31,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04883164,2023-03-31,0,0
5350,NCT04883177,Recruiting,2023-05-10,2023-05-10,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04883177,2023-05-10,0,0
5351,NCT04883203,Completed,2020-09-30,2020-10-31,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04883203,2020-09-30,0,0
5352,NCT04883216,Recruiting,2021-11-24,2021-11-24,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04883216,2021-11-24,0,0
5353,NCT04883528,Recruiting,2022-08-30,2022-08-30,No Results Posted,,,2021-08-16,https://clinicaltrials.gov/show/NCT04883528,2022-08-30,0,0
5354,NCT04883788,Completed,2022-01-10,2022-01-10,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04883788,2022-01-10,0,0
5355,NCT04883801,Completed,2021-03-11,2021-05-05,No Results Posted,,,2021-05-12,https://clinicaltrials.gov/show/NCT04883801,2021-03-11,0,0
5356,NCT04884061,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04884061,2021-07-01,0,0
5357,NCT04884529,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-09-30,https://clinicaltrials.gov/show/NCT04884529,2021-12-01,0,0
5358,NCT04885452,Recruiting,2023-06-01,2023-06-01,No Results Posted,,,2022-02-14,https://clinicaltrials.gov/show/NCT04885452,2023-06-01,0,0
5359,NCT04885504,Recruiting,2025-12-31,2026-07-15,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04885504,2025-12-31,0,0
5360,NCT04885517,Recruiting,2021-08-01,2021-08-01,No Results Posted,,"['Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a ""Typical"" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.', ""Couzin-Frankel J. The mystery of the pandemic's 'happy hypoxia'. Science. 2020 May 1;368(6490):455-456. doi: 10.1126/science.368.6490.455."", 'Aliberti S, Radovanovic D, Billi F, Sotgiu G, Costanzo M, Pilocane T, Saderi L, Gramegna A, Rovellini A, Perotto L, Monzani V, Santus P, Blasi F. Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J. 2020 Oct 15;56(4). pii: 2001935. doi: 10.1183/13993003.01935-2020. Print 2020 Oct.', ""Elharrar X, Trigui Y, Dols AM, Touchon F, Martinez S, Prud'homme E, Papazian L. Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure. JAMA. 2020 Jun 9;323(22):2336-2338. doi: 10.1001/jama.2020.8255."", 'Chiumello D, Busana M, Coppola S, Romitti F, Formenti P, Bonifazi M, Pozzi T, Palumbo MM, Cressoni M, Herrmann P, Meissner K, Quintel M, Camporota L, Marini JJ, Gattinoni L. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med. 2020 Dec;46(12):2187-2196. doi: 10.1007/s00134-020-06281-2. Epub 2020 Oct 21.', 'Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.', 'Poston JT, Patel BK, Davis AM. Management of Critically Ill Adults With COVID-19. JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914.', 'Gattinoni L, Giosa L, Bonifazi M, Pasticci I, Busana M, Macri M, Romitti F, Vassalli F, Quintel M. Targeting transpulmonary pressure to prevent ventilator-induced lung injury. Expert Rev Respir Med. 2019 Aug;13(8):737-746. doi: 10.1080/17476348.2019.1638767. Epub 2019 Jul 5. Review.', 'Brochard L, Slutsky A, Pesenti A. Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. Am J Respir Crit Care Med. 2017 Feb 15;195(4):438-442. doi: 10.1164/rccm.201605-1081CP.', ""Tonelli R, Fantini R, Tabb√¨ L, Castaniere I, Pisani L, Pellegrino MR, Della Casa G, D'Amico R, Girardis M, Nava S, Clini EM, Marchioni A. Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study. Am J Respir Crit Care Med. 2020 Aug 15;202(4):558-567. doi: 10.1164/rccm.201912-2512OC."", 'Goligher EC, Jonkman AH, Dianti J, Vaporidi K, Beitler JR, Patel BK, Yoshida T, Jaber S, Dres M, Mauri T, Bellani G, Demoule A, Brochard L, Heunks L. Clinical strategies for implementing lung and diaphragm-protective ventilation: avoiding insufficient and excessive effort. Intensive Care Med. 2020 Dec;46(12):2314-2326. doi: 10.1007/s00134-020-06288-9. Epub 2020 Nov 2. Review.', 'Apigo M, Schechtman J, Dhliwayo N, Al Tameemi M, Gazmuri RJ. Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia. Crit Care. 2020 Jul 31;24(1):477. doi: 10.1186/s13054-020-03176-y.', 'Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L, Georgopoulos D. Respiratory Drive in Critically Ill Patients. Pathophysiology and Clinical Implications. Am J Respir Crit Care Med. 2020 Jan 1;201(1):20-32. doi: 10.1164/rccm.201903-0596SO.', 'Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, Camporota L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.']",2021-05-14,https://clinicaltrials.gov/show/NCT04885517,2021-08-01,0,1
5361,NCT04885543,Completed,2021-03-01,2021-03-01,No Results Posted,,,2021-05-13,https://clinicaltrials.gov/show/NCT04885543,2021-03-01,0,0
5362,NCT04886362,Not yet recruiting,2021-09-01,2021-12-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04886362,2021-09-01,0,0
5363,NCT04886414,Not yet recruiting,2022-01-01,2022-09-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04886414,2022-01-01,0,0
5364,NCT04887116,Not yet recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04887116,2022-12-01,0,0
5365,NCT04887129,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04887129,2022-12-31,0,0
5366,NCT04887142,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04887142,2023-05-01,0,0
5367,NCT04887207,Enrolling by invitation,2022-02-28,2022-12-31,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04887207,2022-02-28,0,0
5368,NCT04887220,"Active, not recruiting",2022-05-31,2023-05-31,No Results Posted,,,2021-09-21,https://clinicaltrials.gov/show/NCT04887220,2022-05-31,0,0
5369,NCT04887233,Not yet recruiting,2022-05-31,2022-06-30,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04887233,2022-05-31,0,0
5370,NCT04887246,Enrolling by invitation,2022-03-15,2022-03-15,No Results Posted,,,2021-08-17,https://clinicaltrials.gov/show/NCT04887246,2022-03-15,0,0
5371,NCT04887272,Not yet recruiting,2021-08-30,2021-11-30,No Results Posted,,,2021-05-14,https://clinicaltrials.gov/show/NCT04887272,2021-08-30,0,0
5372,NCT04887350,Recruiting,2022-08-08,2022-08-08,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04887350,2022-08-08,0,0
5373,NCT04887623,Recruiting,2022-07-01,2022-08-01,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04887623,2022-07-01,0,0
5374,NCT04888832,Not yet recruiting,2023-12-01,2023-12-01,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04888832,2023-12-01,0,0
5375,NCT04889274,Recruiting,2022-12-30,2022-12-30,No Results Posted,,"[""Rathod KS, Kapil V, Velmurugan S, Khambata RS, Siddique U, Khan S, Van Eijl S, Gee LC, Bansal J, Pitrola K, Shaw C, D'Acquisto F, Colas RA, Marelli-Berg F, Dalli J, Ahluwalia A. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017 Jan 3;127(1):169-182. doi: 10.1172/JCI89429. Epub 2016 Nov 28."", 'Kapil V, Khambata RS, Jones DA, Rathod K, Primus C, Massimo G, Fukuto JM, Ahluwalia A. The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway. Pharmacol Rev. 2020 Jul;72(3):692-766. doi: 10.1124/pr.120.019240. Review.', 'Shabbir A, Rathod KS, Khambata RS, Ahluwalia A. Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease. Annu Rev Pharmacol Toxicol. 2021 Jan 6;61:333-359. doi: 10.1146/annurev-pharmtox-010919-023229. Epub 2020 Oct 9. Review.']",2022-01-21,https://clinicaltrials.gov/show/NCT04889274,2022-12-30,0,1
5376,NCT04889313,Completed,2021-09-30,2021-10-30,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04889313,2021-09-30,0,0
5377,NCT04889326,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04889326,2023-05-01,0,0
5378,NCT04889365,"Active, not recruiting",2021-06-30,2021-07-10,No Results Posted,,,2021-05-17,https://clinicaltrials.gov/show/NCT04889365,2021-06-30,0,0
5379,NCT04893057,Not yet recruiting,2021-08-30,2021-08-30,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04893057,2021-08-30,0,0
5380,NCT04893122,Completed,2021-03-31,2021-03-31,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04893122,2021-03-31,0,0
5381,NCT04894682,Recruiting,2021-08-31,2022-05-31,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04894682,2021-08-31,0,0
5382,NCT04894721,Completed,2021-09-30,2021-10-01,No Results Posted,,,2021-12-07,https://clinicaltrials.gov/show/NCT04894721,2021-09-30,0,0
5383,NCT04895449,Recruiting,2022-03-01,2022-03-01,No Results Posted,,,2022-01-05,https://clinicaltrials.gov/show/NCT04895449,2022-03-01,0,0
5384,NCT04441047,Recruiting,2022-06-20,2022-12-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04441047,2022-06-20,0,0
5385,NCT04604145,Completed,2021-08-18,2021-08-18,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04604145,2021-08-18,0,0
5386,NCT04668950,Completed,2021-09-28,2021-09-28,No Results Posted,,,2022-01-13,https://clinicaltrials.gov/show/NCT04668950,2021-09-28,0,0
5387,NCT04672564,Recruiting,2022-07-28,2022-07-28,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04672564,2022-07-28,0,0
5388,NCT04677660,Completed,2022-02-22,2022-02-22,No Results Posted,"['Masuda T, Murakami K, Sugiura K, Sakui S, Philip Schuring R, Mori M. A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report. Vaccine. 2022 Mar 18;40(13):2044-2052. doi: 10.1016/j.vaccine.2022.02.030. Epub 2022 Feb 8.']",,2022-03-21,https://clinicaltrials.gov/show/NCT04677660,2022-02-22,0,1
5389,NCT04678193,Recruiting,2023-06-30,2025-06-30,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04678193,2023-06-30,0,0
5390,NCT04686760,Recruiting,2021-11-15,2021-11-15,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04686760,2021-11-15,0,0
5391,NCT04690816,Recruiting,2024-12-31,2024-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04690816,2024-12-31,0,0
5392,NCT04699916,Completed,2021-05-23,2021-09-23,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04699916,2021-05-23,0,0
5393,NCT04706299,Completed,2021-05-21,2021-05-21,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04706299,2021-05-21,0,0
5394,NCT04708340,"Active, not recruiting",2022-10-01,2023-02-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04708340,2022-10-01,0,0
5395,NCT04709120,Completed,2021-05-31,2021-12-31,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04709120,2021-05-31,0,0
5396,NCT04715243,Terminated,2021-08-09,2021-11-11,No Results Posted,,,2022-01-12,https://clinicaltrials.gov/show/NCT04715243,2021-08-09,0,0
5397,NCT04716985,Recruiting,2022-05-22,2023-05-22,No Results Posted,,,2021-10-25,https://clinicaltrials.gov/show/NCT04716985,2022-05-22,0,0
5398,NCT04718467,Withdrawn,2021-05-15,2022-03-15,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04718467,2021-05-15,0,0
5399,NCT04730895,Not yet recruiting,2021-09-01,2023-12-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04730895,2021-09-01,0,0
5400,NCT04732949,Completed,2022-02-10,2022-02-10,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04732949,2022-02-10,0,0
5401,NCT04738331,Recruiting,2022-05-20,2022-06-30,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04738331,2022-05-20,0,0
5402,NCT04743401,Recruiting,2022-09-30,2023-03-31,No Results Posted,,,2021-08-02,https://clinicaltrials.gov/show/NCT04743401,2022-09-30,0,0
5403,NCT04746183,Recruiting,2021-11-18,2022-04-30,No Results Posted,"['Walker LE, FitzGerald R, Saunders G, Lyon R, Fisher M, Martin K, Eberhart I, Woods C, Ewings S, Hale C, Rajoli RKR, Else L, Dilly-Penchala S, Amara A, Lalloo DG, Jacobs M, Pertinez H, Hatchard P, Waugh R, Lawrence M, Johnson L, Fines K, Reynolds H, Rowland T, Crook R, Okenyi E, Byrne K, Mozgunov P, Jaki T, Khoo S, Owen A, Griffiths G, Fletcher TE; AGILE platform. An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2. Clin Pharmacol Ther. 2022 Mar;111(3):585-594. doi: 10.1002/cpt.2463. Epub 2021 Nov 13.', 'Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.', 'Griffiths GO, FitzGerald R, Jaki T, Corkhill A, Reynolds H, Ewings S, Condie S, Tilt E, Johnson L, Radford M, Simpson C, Saunders G, Yeats S, Mozgunov P, Tansley-Hancock O, Martin K, Downs N, Eberhart I, Martin JWB, Goncalves C, Song A, Fletcher T, Byrne K, Lalloo DG, Owen A, Jacobs M, Walker L, Lyon R, Woods C, Gibney J, Chiong J, Chandiwana N, Jacob S, Lamorde M, Orrell C, Pirmohamed M, Khoo S; AGILE investigators. AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. Trials. 2021 Jul 26;22(1):487. doi: 10.1186/s13063-021-05458-4.']",,2021-08-25,https://clinicaltrials.gov/show/NCT04746183,2021-11-18,0,1
5404,NCT04750330,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04750330,2022-03-31,0,0
5405,NCT04753476,Recruiting,2022-02-01,2022-03-01,No Results Posted,,"['Harrell CR, Jovicic BP, Djonov V, Volarevic V. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome. Anal Cell Pathol (Amst). 2020 Nov 20;2020:1939768. doi: 10.1155/2020/1939768. eCollection 2020. Review.', 'Johnson BS, Laloraya M. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine Growth Factor Rev. 2020 Aug;54:32-42. doi: 10.1016/j.cytogfr.2020.06.014. Epub 2020 Jul 1. Review.']",2021-05-24,https://clinicaltrials.gov/show/NCT04753476,2022-02-01,0,1
5406,NCT04758299,Completed,2021-04-15,2021-04-30,No Results Posted,"['Woloshin S, Dewitt B, Krishnamurti T, Fischhoff B. Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial. JAMA Intern Med. 2022 Mar 1;182(3):332-341. doi: 10.1001/jamainternmed.2021.8075.']",,2021-05-25,https://clinicaltrials.gov/show/NCT04758299,2021-04-15,0,1
5407,NCT04761718,Recruiting,2022-02-22,2022-03-23,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04761718,2022-02-22,0,0
5408,NCT04762680,Recruiting,2023-02-14,2023-02-14,No Results Posted,"['Sridhar S, Joaquin A, Bonaparte MI, Bueso A, Chabanon AL, Chen A, Chicz RM, Diemert D, Essink BJ, Fu B, Grunenberg NA, Janosczyk H, Keefer MC, Rivera M DM, Meng Y, Michael NL, Munsiff SS, Ogbuagu O, Raabe VN, Severance R, Rivas E, Romanyak N, Rouphael NG, Schuerman L, Sher LD, Walsh SR, White J, von Barbier D, de Bruyn G, Canter R, Grillet MH, Keshtkar-Jahromi M, Koutsoukos M, Lopez D, Masotti R, Mendoza S, Moreau C, Ceregido MA, Ramirez S, Said A, Tavares-Da-Silva F, Shi J, Tong T, Treanor J, Diazgranados CA, Savarino S. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study. Lancet Infect Dis. 2022 Jan 25. pii: S1473-3099(21)00764-7. doi: 10.1016/S1473-3099(21)00764-7. [Epub ahead of print]']",,2022-03-31,https://clinicaltrials.gov/show/NCT04762680,2023-02-14,0,1
5409,NCT04764747,Completed,2021-04-25,2021-04-25,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04764747,2021-04-25,0,0
5410,NCT04765839,Completed,2021-04-03,2021-04-03,No Results Posted,,,2021-07-30,https://clinicaltrials.gov/show/NCT04765839,2021-04-03,0,0
5411,NCT04775069,Recruiting,2021-12-31,2022-03-31,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04775069,2021-12-31,0,0
5412,NCT04776174,Completed,2021-11-03,2021-11-03,No Results Posted,,,2021-11-22,https://clinicaltrials.gov/show/NCT04776174,2021-11-03,0,0
5413,NCT04785157,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04785157,2022-08-01,0,0
5414,NCT04789460,Completed,2021-03-28,2021-03-28,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04789460,2021-03-28,0,0
5415,NCT04790240,Recruiting,2022-12-01,2023-03-01,No Results Posted,,"['Wanzhu Hou, et al. Treating Autoimmune disease with Chinses Medicine, Elsevier, 2011']",2021-11-08,https://clinicaltrials.gov/show/NCT04790240,2022-12-01,0,1
5416,NCT04794387,Recruiting,2031-02-23,2031-02-23,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04794387,2031-02-23,0,0
5417,NCT04796584,Recruiting,2022-03-17,2022-06-17,No Results Posted,,,2022-02-17,https://clinicaltrials.gov/show/NCT04796584,2022-03-17,0,0
5418,NCT04798001,Recruiting,2022-10-31,2022-10-31,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04798001,2022-10-31,0,0
5419,NCT04805671,"Active, not recruiting",2022-01-01,2023-02-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-24,https://clinicaltrials.gov/show/NCT04805671,2022-01-01,0,1
5420,NCT04805931,Recruiting,2021-05-01,2021-11-01,No Results Posted,,,2021-06-28,https://clinicaltrials.gov/show/NCT04805931,2021-05-01,0,0
5421,NCT04806815,Completed,2021-05-30,2021-06-01,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04806815,2021-05-30,0,0
5422,NCT04813562,Recruiting,2022-07-30,2022-07-30,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04813562,2022-07-30,0,0
5423,NCT04816643,Recruiting,2024-06-14,2024-06-14,No Results Posted,"['Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Mu√±oz FM, Maldonado Y, Pahud BA, Domachowske JB, Sim√µes EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, R√§met M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, T√ºreci √ñ, Dormitzer PR, ≈ûahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.']",,2022-03-21,https://clinicaltrials.gov/show/NCT04816643,2024-06-14,0,1
5424,NCT04816669,Completed,2021-12-01,2021-12-01,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04816669,2021-12-01,0,0
5425,NCT04818970,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04818970,2021-12-31,0,0
5426,NCT04821037,Recruiting,2021-07-01,2021-08-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04821037,2021-07-01,0,0
5427,NCT04826640,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04826640,2023-05-01,0,0
5428,NCT04828135,Recruiting,2022-12-30,2022-12-30,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04828135,2022-12-30,0,0
5429,NCT04831866,Enrolling by invitation,2023-04-15,2023-04-15,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04831866,2023-04-15,0,0
5430,NCT04838119,Completed,2021-08-23,2021-08-23,No Results Posted,,,2021-08-26,https://clinicaltrials.gov/show/NCT04838119,2021-08-23,0,0
5431,NCT04838821,Recruiting,2021-07-29,2021-09-29,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04838821,2021-07-29,0,0
5432,NCT04842448,Recruiting,2022-12-31,2023-12-31,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04842448,2022-12-31,0,0
5433,NCT04844138,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,2022-02-01,https://clinicaltrials.gov/show/NCT04844138,2022-05-31,0,0
5434,NCT04846010,Recruiting,2022-05-01,2022-10-01,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04846010,2022-05-01,0,0
5435,NCT04847141,Terminated,2021-11-10,2021-12-27,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04847141,2021-11-10,0,0
5436,NCT04849585,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04849585,2022-02-01,0,0
5437,NCT04852757,Recruiting,2022-03-31,2022-06-30,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04852757,2022-03-31,0,0
5438,NCT04852835,Recruiting,2022-04-08,2022-04-08,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04852835,2022-04-08,0,0
5439,NCT04858568,"Active, not recruiting",2022-10-31,2023-06-30,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04858568,2022-10-31,0,0
5440,NCT04864132,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04864132,2022-04-30,0,0
5441,NCT04868864,Recruiting,2022-09-30,2022-12-31,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04868864,2022-09-30,0,0
5442,NCT04870385,"Active, not recruiting",2021-06-25,2021-08-01,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04870385,2021-06-25,0,0
5443,NCT04870411,Recruiting,2021-11-12,2022-11-12,No Results Posted,"['Hadjadj J, Planas D, Ouedrani A, Buffier S, Delage L, Nguyen Y, Bruel T, Stolzenberg MC, Staropoli I, Ermak N, Macraigne L, Morbieu C, Henriquez S, Veyer D, P√©r√© H, Casadevall M, Mouthon L, Rieux-Laucat F, Chatenoud L, Schwartz O, Terrier B. Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases. Ann Rheum Dis. 2022 Jan 12. pii: annrheumdis-2021-221508. doi: 10.1136/annrheumdis-2021-221508. [Epub ahead of print]']",,2021-05-24,https://clinicaltrials.gov/show/NCT04870411,2021-11-12,0,1
5444,NCT04871737,"Active, not recruiting",2021-08-21,2022-06-01,No Results Posted,"['Ponce-de-Le√≥n S, Torres M, Soto-Ram√≠rez LE, Jos√© Calva J, Santill√°n-Doherty P, Carranza-Salazar DE, Carre√±o JM, Carranza C, Ju√°rez E, Carreto-Binaghi LE, Ram√≠rez-Mart√≠nez L, la Rosa GP, Vigueras-Moreno R, Ortiz-Stern A, L√≥pez-Vidal Y, Mac√≠as AE, Torres-Flores J, Rojas-Mart√≠nez O, Su√°rez-Mart√≠nez A, Peralta-S√°nchez G, Kawabata H, Gonz√°lez-Dom√≠nguez I, Mart√≠nez-Guevara JL, Sun W, Sarfati-Mizrahi D, Soto-Priante E, Chagoya-Cort√©s HE, L√≥pez-Mac√≠as C, Castro-Peralta F, Palese P, Garc√≠a-Sastre A, Krammer F, Lozano-Dubernard B. Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico. medRxiv. 2022 Feb 9. pii: 2022.02.08.22270676. doi: 10.1101/2022.02.08.22270676.']",,2022-02-08,https://clinicaltrials.gov/show/NCT04871737,2021-08-21,0,1
5445,NCT04871932,Recruiting,2026-11-03,2026-12-03,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04871932,2026-11-03,0,0
5446,NCT04874766,Completed,2021-07-15,2021-08-31,No Results Posted,"['Shaw KA, Butcher S, Ko JB, Absher A, Gordon J, Tkachuk C, Zello GA, Chilibeck PD. Wearing a Surgical Face Mask Has Minimal Effect on Performance and Physiological Measures during High-Intensity Exercise in Youth Ice-Hockey Players: A Randomized Cross-Over Trial. Int J Environ Res Public Health. 2021 Oct 14;18(20). pii: 10766. doi: 10.3390/ijerph182010766.']",,2021-10-25,https://clinicaltrials.gov/show/NCT04874766,2021-07-15,0,1
5447,NCT04877496,Recruiting,2021-08-30,2021-10-31,No Results Posted,"['Moor MB, Suter-Riniker F, Horn MP, Aeberli D, Amsler J, M√∂ller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Radonjic-Hoesli S, Seyed Jafari SM, Chan A, Hoepner R, Bacher VU, Mani LY, Iype JM, Hirzel C, Maurer B, Sidler D. Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. Lancet Rheumatol. 2021 Nov;3(11):e789-e797. doi: 10.1016/S2665-9913(21)00251-4. Epub 2021 Sep 7. Erratum in: Lancet Rheumatol. 2022 Mar;4(3):e174.']",,2021-06-02,https://clinicaltrials.gov/show/NCT04877496,2021-08-30,0,1
5448,NCT04878822,"Active, not recruiting",2021-07-31,2023-04-30,No Results Posted,,,2021-09-13,https://clinicaltrials.gov/show/NCT04878822,2021-07-31,0,0
5449,NCT04883190,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04883190,2022-06-01,0,0
5450,NCT04884295,Recruiting,2022-04-01,2022-06-01,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04884295,2022-04-01,0,0
5451,NCT04885478,Recruiting,2022-06-30,2022-06-30,No Results Posted,,"['Garc√≠a-Sierra RM, Badia Perich E, Manresa Dominguez JM, Moreno Millan N, Sabat√© Cintas V, Romero Mart√≠nez M, Moreno Gabriel E, Pera G, Seda Gombau G, Montell√† Jordana N, Violan Fors C, Argerich Gonz√°lez MJ, Bonet Sim√≥ JM, Prat Gil N, Tor√°n Monserrat P. [Descriptive study of the health service workers of a Primary Care Department confined by Covid-19.]. Rev Esp Salud Publica. 2020 Sep 3;94. pii: e202009106. Spanish.', 'Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, Borgert BA, Moreno CA, Solomon BD, Trimmer-Smith L, Etienne V, Rodriguez-Barraquer I, Lessler J, Salje H, Burke DS, Wesolowski A, Cummings DAT. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020 Sep 17;11(1):4704. doi: 10.1038/s41467-020-18450-4.']",2021-05-21,https://clinicaltrials.gov/show/NCT04885478,2022-06-30,0,1
5452,NCT04885491,Recruiting,2022-07-15,2022-08-15,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04885491,2022-07-15,0,0
5453,NCT04888793,Completed,2021-09-01,2021-11-01,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04888793,2021-09-01,0,0
5454,NCT04889261,Recruiting,2021-11-30,2021-12-31,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04889261,2021-11-30,0,0
5455,NCT04890483,Recruiting,2021-05-17,2021-12-24,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04890483,2021-05-17,0,0
5456,NCT04890509,Completed,2021-05-25,2021-05-25,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04890509,2021-05-25,0,0
5457,NCT04890600,Completed,2021-04-01,2021-04-01,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04890600,2021-04-01,0,0
5458,NCT04890626,Recruiting,2021-11-30,2022-11-30,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04890626,2021-11-30,0,0
5459,NCT04890665,Recruiting,2022-06-20,2022-06-20,No Results Posted,,"['Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.', 'Spitzer RL, Kroenke K, Williams JB, L√∂we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.', 'Novy DM, Stanley MA, Averill P, Daza P. Psychometric comparability of English- and Spanish-language measures of anxiety and related affective symptoms. Psychol Assess. 2001 Sep;13(3):347-55.', 'Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychological assessment. 1997 Dec;9(4):445.', 'Gonz√°lez-Forteza C, Torres CS, Tapia AJ, Fern√°ndez IH, Gonz√°lez-Gonz√°lez A, Garcia FJ, Medina-Mora ME, Mej√≠a HFV. Confiabilidad y validez de la escala de depresi√≥n CES-D en un censo de estudiantes de nivel medio superior y superior, en la Ciudad de M√©xico [Reliability and validity of the depression scale CES-D in high school and college students from Mexico City: Results from a census]. Salud Mental. 2011; 34(1): 53-59.', 'Garc√≠a-Campayo J, Zamorano E, Ruiz MA, Pardo A, P√©rez-P√°ramo M, L√≥pez-G√≥mez V, Freire O, Rejas J. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010 Jan 20;8:8. doi: 10.1186/1477-7525-8-8.', 'Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82.', 'Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020 Mar 27:1-9. doi: 10.1007/s11469-020-00270-8. [Epub ahead of print]', 'Healy DJ, Barry K, Blow F, Welsh D, Milner KK. Routine use of the Beck Scale for Suicide Ideation in a psychiatric emergency department. Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):323-9.']",2021-10-05,https://clinicaltrials.gov/show/NCT04890665,2022-06-20,0,1
5460,NCT04891172,Recruiting,2022-03-01,2022-08-02,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04891172,2022-03-01,0,0
5461,NCT04891250,Withdrawn,2021-12-01,2022-06-01,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04891250,2021-12-01,0,0
5462,NCT04891276,Completed,2021-04-14,2021-04-14,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04891276,2021-04-14,0,0
5463,NCT04891302,Recruiting,2021-07-31,2021-10-31,No Results Posted,,,2021-05-18,https://clinicaltrials.gov/show/NCT04891302,2021-07-31,0,0
5464,NCT04892797,Recruiting,2023-02-02,2023-02-02,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04892797,2023-02-02,0,0
5465,NCT04892888,Not yet recruiting,2023-04-30,2023-04-30,No Results Posted,,,2022-02-18,https://clinicaltrials.gov/show/NCT04892888,2023-04-30,0,0
5466,NCT04892979,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-05-19,https://clinicaltrials.gov/show/NCT04892979,2022-03-31,0,0
5467,NCT04893031,Completed,2021-03-01,2021-04-01,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04893031,2021-03-01,0,0
5468,NCT04893265,Recruiting,2022-10-30,2022-10-30,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04893265,2022-10-30,0,0
5469,NCT04894214,Completed,2021-04-23,2021-05-01,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04894214,2021-04-23,0,0
5470,NCT04894227,"Active, not recruiting",2021-05-11,2021-11-30,No Results Posted,,,2021-08-18,https://clinicaltrials.gov/show/NCT04894227,2021-05-11,0,0
5471,NCT04894266,Recruiting,2022-03-22,2022-09-22,No Results Posted,,,2022-01-21,https://clinicaltrials.gov/show/NCT04894266,2022-03-22,0,0
5472,NCT04894279,Completed,2022-02-01,2022-02-20,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04894279,2022-02-01,0,0
5473,NCT04894331,Completed,2020-11-23,2020-11-30,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04894331,2020-11-23,0,0
5474,NCT04894409,Completed,2020-06-30,2020-09-29,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04894409,2020-06-30,0,0
5475,NCT04894760,Completed,2021-06-30,2021-07-31,No Results Posted,,,2022-01-19,https://clinicaltrials.gov/show/NCT04894760,2021-06-30,0,0
5476,NCT04895007,Recruiting,2022-06-01,2022-06-01,No Results Posted,,,2021-07-15,https://clinicaltrials.gov/show/NCT04895007,2022-06-01,0,0
5477,NCT04895085,"Active, not recruiting",2022-07-31,2022-07-31,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04895085,2022-07-31,0,0
5478,NCT04895189,Recruiting,2022-05-03,2022-05-03,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04895189,2022-05-03,0,0
5479,NCT04895267,"Active, not recruiting",2022-08-03,2022-09-17,No Results Posted,"['Dominguez-Nicolas SM, Manjarrez E. Low-field thoracic magnetic stimulation increases peripheral oxygen saturation levels in coronavirus disease (COVID-19) patients: A single-blind, sham-controlled, crossover study. Medicine (Baltimore). 2021 Oct 8;100(40):e27444. doi: 10.1097/MD.0000000000027444.']",,2022-03-16,https://clinicaltrials.gov/show/NCT04895267,2022-08-03,0,1
5480,NCT04895462,Recruiting,2021-08-31,2021-10-30,No Results Posted,,,2021-08-04,https://clinicaltrials.gov/show/NCT04895462,2021-08-31,0,0
5481,NCT04895475,"Active, not recruiting",2023-12-31,2024-12-31,No Results Posted,,,2021-05-20,https://clinicaltrials.gov/show/NCT04895475,2023-12-31,0,0
5482,NCT04895683,Not yet recruiting,2021-12-31,2022-05-11,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04895683,2021-12-31,0,0
5483,NCT04895982,Recruiting,2022-12-18,2022-12-18,No Results Posted,,,2022-03-21,https://clinicaltrials.gov/show/NCT04895982,2022-12-18,0,0
5484,NCT04896541,"Active, not recruiting",2022-06-14,2022-06-14,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-09,https://clinicaltrials.gov/show/NCT04896541,2022-06-14,0,1
5485,NCT04896606,Recruiting,2024-12-31,2025-12-31,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04896606,2024-12-31,0,0
5486,NCT04896762,Recruiting,2021-07-01,2021-10-01,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04896762,2021-07-01,0,0
5487,NCT04896788,Recruiting,2023-11-01,2024-05-01,No Results Posted,"['Bonnet B, Chabrolles H, Archimbaud C, Brebion A, Cosme J, Dutheil F, Lambert C, Junda M, Mirand A, Ollier A, Pereira B, Regagnon C, Vidal M, Evrard B, Henquell C. Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers. Front Immunol. 2022 Mar 2;13:842912. doi: 10.3389/fimmu.2022.842912. eCollection 2022.']",,2021-05-24,https://clinicaltrials.gov/show/NCT04896788,2023-11-01,0,1
5488,NCT04896840,Recruiting,2021-10-27,2021-10-27,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04896840,2021-10-27,0,0
5489,NCT04896853,Recruiting,2024-09-30,2024-12-31,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04896853,2024-09-30,0,0
5490,NCT04896866,Recruiting,2021-10-15,2022-01-01,No Results Posted,"['Chen JZ, Hoang HL, Yaskina M, Kabbani D, Doucette KE, Smith SW, Lau C, Stewart J, Zurek K, Schultz M, Cervera C. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalized with COVID-19: A protocol for a pragmatic clinical trial. PLoS One. 2022 Mar 23;17(3):e0265493. doi: 10.1371/journal.pone.0265493. eCollection 2022.']",,2022-01-10,https://clinicaltrials.gov/show/NCT04896866,2021-10-15,0,1
5491,NCT04896905,Completed,2021-02-28,2021-05-18,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04896905,2021-02-28,0,0
5492,NCT04896918,"Active, not recruiting",2022-08-31,2022-08-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04896918,2022-08-31,0,0
5493,NCT04896944,Completed,2021-04-30,2021-04-30,No Results Posted,,,2021-05-21,https://clinicaltrials.gov/show/NCT04896944,2021-04-30,0,0
5494,NCT04896957,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04896957,2022-09-01,0,0
5495,NCT04896970,Withdrawn,2021-07-01,2021-07-01,No Results Posted,,,2021-10-20,https://clinicaltrials.gov/show/NCT04896970,2021-07-01,0,0
5496,NCT04896983,Recruiting,2021-11-01,2022-03-01,No Results Posted,"['Mariƒá NP, Lazareviƒá LB, Mihiƒá L, Pejovic Milovancevic M, Terziƒá Z, To≈°koviƒá O, Todoroviƒá J, Vukoviƒá O, Knezevic G. Mental health in the second year of the COVID-19 pandemic: protocol for a nationally representative multilevel survey in Serbia. BMJ Open. 2021 Sep 21;11(9):e053835. doi: 10.1136/bmjopen-2021-053835.']",,2021-07-01,https://clinicaltrials.gov/show/NCT04896983,2021-11-01,0,1
5497,NCT04897152,Completed,2021-08-30,2021-08-31,No Results Posted,,,2021-10-01,https://clinicaltrials.gov/show/NCT04897152,2021-08-30,0,0
5498,NCT04898062,Recruiting,2022-06-30,2022-10-31,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04898062,2022-06-30,0,0
5499,NCT04898088,Completed,2020-08-30,2020-09-30,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04898088,2020-08-30,0,0
5500,NCT04898127,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04898127,2021-06-01,0,0
5501,NCT04898140,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04898140,2021-12-31,0,0
5502,NCT04898166,Completed,2021-03-31,2021-03-31,Study Results,,,2021-10-26,https://clinicaltrials.gov/show/NCT04898166,2021-03-31,1,0
5503,NCT04898192,Recruiting,2022-03-31,2022-08-01,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04898192,2022-03-31,0,0
5504,NCT04898205,Recruiting,2022-01-20,2022-01-20,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04898205,2022-01-20,0,0
5505,NCT04898738,Not yet recruiting,2022-09-01,2022-09-01,No Results Posted,,,2021-05-24,https://clinicaltrials.gov/show/NCT04898738,2022-09-01,0,0
5506,NCT04898946,Recruiting,2022-03-08,2022-03-08,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04898946,2022-03-08,0,0
5507,NCT04898985,Enrolling by invitation,2031-05-20,2031-05-20,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04898985,2031-05-20,0,0
5508,NCT04899232,Recruiting,2022-06-30,2022-07-21,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04899232,2022-06-30,0,0
5509,NCT04899245,Enrolling by invitation,2022-08-31,2022-08-31,No Results Posted,,,2022-03-23,https://clinicaltrials.gov/show/NCT04899245,2022-08-31,0,0
5510,NCT04900129,Completed,2020-12-30,2020-12-30,No Results Posted,,"['de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Review.']",2021-05-25,https://clinicaltrials.gov/show/NCT04900129,2020-12-30,0,1
5511,NCT04900155,Recruiting,2022-01-01,2022-05-01,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900155,2022-01-01,0,0
5512,NCT04900233,Completed,2021-05-06,2021-05-06,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900233,2021-05-06,0,0
5513,NCT04900259,Completed,2021-08-01,2021-08-15,No Results Posted,,,2021-10-06,https://clinicaltrials.gov/show/NCT04900259,2021-08-01,0,0
5514,NCT04900337,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900337,2021-12-31,0,0
5515,NCT04900376,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900376,2022-06-01,0,0
5516,NCT04900389,Not yet recruiting,2021-10-15,2021-10-15,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900389,2021-10-15,0,0
5517,NCT04900402,Completed,2021-07-18,2021-10-02,No Results Posted,,,2021-12-28,https://clinicaltrials.gov/show/NCT04900402,2021-07-18,0,0
5518,NCT04900415,Recruiting,2021-03-12,2021-06-30,No Results Posted,,,2021-05-25,https://clinicaltrials.gov/show/NCT04900415,2021-03-12,0,0
5519,NCT04900428,"Active, not recruiting",2022-03-23,2022-07-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-11,https://clinicaltrials.gov/show/NCT04900428,2022-03-23,0,1
5520,NCT04900441,Recruiting,2021-08-01,2022-04-01,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04900441,2021-08-01,0,0
5521,NCT04900454,Recruiting,2022-10-31,2022-12-31,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04900454,2022-10-31,0,0
5522,NCT04900961,Recruiting,2023-04-30,2033-07-31,No Results Posted,,,2021-09-05,https://clinicaltrials.gov/show/NCT04900961,2023-04-30,0,0
5523,NCT04901065,Completed,2021-06-07,2021-06-07,No Results Posted,,,2021-09-27,https://clinicaltrials.gov/show/NCT04901065,2021-06-07,0,0
5524,NCT04901624,Enrolling by invitation,2022-04-01,2022-08-01,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04901624,2022-04-01,0,0
5525,NCT04901676,Recruiting,2022-01-01,2022-02-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04901676,2022-01-01,0,0
5526,NCT04901689,Recruiting,2022-02-01,2022-02-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04901689,2022-02-01,0,0
5527,NCT04902118,Recruiting,2021-12-30,2021-12-30,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04902118,2021-12-30,0,0
5528,NCT04902157,Recruiting,2022-01-01,2022-02-01,No Results Posted,,,2021-05-26,https://clinicaltrials.gov/show/NCT04902157,2022-01-01,0,0
5529,NCT04902976,Completed,2021-05-30,2021-10-30,No Results Posted,,,2022-03-11,https://clinicaltrials.gov/show/NCT04902976,2021-05-30,0,0
5530,NCT04903132,Recruiting,2022-09-01,2023-03-01,No Results Posted,,,2022-01-24,https://clinicaltrials.gov/show/NCT04903132,2022-09-01,0,0
5531,NCT04903184,Recruiting,2021-09-01,2022-01-01,No Results Posted,,,2021-05-28,https://clinicaltrials.gov/show/NCT04903184,2021-09-01,0,0
5532,NCT04903327,Recruiting,2022-11-01,2023-03-01,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04903327,2022-11-01,0,0
5533,NCT04903834,"Active, not recruiting",2024-06-24,2024-06-24,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04903834,2024-06-24,0,0
5534,NCT04904445,Recruiting,2024-05-01,2024-05-01,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04904445,2024-05-01,0,0
5535,NCT04904471,Enrolling by invitation,2022-02-28,2022-12-31,No Results Posted,,,2021-12-21,https://clinicaltrials.gov/show/NCT04904471,2022-02-28,0,0
5536,NCT04904484,Not yet recruiting,2022-06-01,2022-10-01,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04904484,2022-06-01,0,0
5537,NCT04904497,Recruiting,2021-12-01,2021-12-31,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04904497,2021-12-01,0,0
5538,NCT04904510,Completed,2021-03-09,2021-03-09,Results Submitted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04904510,2021-03-09,0,0
5539,NCT04904523,Recruiting,2023-06-30,2023-06-30,No Results Posted,,,2021-05-27,https://clinicaltrials.gov/show/NCT04904523,2023-06-30,0,0
5540,NCT04904536,Not yet recruiting,2023-01-01,2023-06-01,No Results Posted,,,2021-10-07,https://clinicaltrials.gov/show/NCT04904536,2023-01-01,0,0
5541,NCT04904692,"Active, not recruiting",2020-07-23,2023-09-30,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04904692,2020-07-23,0,0
5542,NCT04904731,Completed,2021-05-12,2021-05-24,No Results Posted,"['Cammarota G, Rossi E, Vitali L, Simonte R, Sannipoli T, Anniciello F, Vetrugno L, Bignami E, Becattini C, Tesoro S, Azzolina D, Giacomucci A, Navalesi P, De Robertis E. Effect of awake prone position on diaphragmatic thickening fraction in patients assisted by noninvasive ventilation for hypoxemic acute respiratory failure related to novel coronavirus disease. Crit Care. 2021 Aug 24;25(1):305. doi: 10.1186/s13054-021-03735-x.']",,2021-05-27,https://clinicaltrials.gov/show/NCT04904731,2021-05-12,0,1
5543,NCT04904744,Completed,2021-10-31,2021-12-10,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04904744,2021-10-31,0,0
5544,NCT04905823,"Active, not recruiting",2021-10-31,2021-11-30,No Results Posted,,,2021-09-28,https://clinicaltrials.gov/show/NCT04905823,2021-10-31,0,0
5545,NCT04905836,Recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-11-30,https://clinicaltrials.gov/show/NCT04905836,2021-12-01,0,0
5546,NCT04905862,Recruiting,2022-08-31,2022-12-31,No Results Posted,,,2022-02-04,https://clinicaltrials.gov/show/NCT04905862,2022-08-31,0,0
5547,NCT04905875,Recruiting,2022-05-01,2022-05-01,No Results Posted,,"['Lucchini A, Bambi S, Mattiussi E, Elli S, Villa L, Bondi H, Rona R, Fumagalli R, Foti G. Prone Position in Acute Respiratory Distress Syndrome Patients: A Retrospective Analysis of Complications. Dimens Crit Care Nurs. 2020 Jan/Feb;39(1):39-46. doi: 10.1097/DCC.0000000000000393.', 'Carsetti A, Damia Paciarini A, Marini B, Pantanetti S, Adrario E, Donati A. Prolonged prone position ventilation for SARS-CoV-2 patients is feasible and effective. Crit Care. 2020 May 15;24(1):225. doi: 10.1186/s13054-020-02956-w.', 'Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, Cairo M, Mori S, Messinesi G, Contro E, Bonfanti P, Benini A, Valsecchi MG, Antolini L, Foti G. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020 Aug;8(8):765-774. doi: 10.1016/S2213-2600(20)30268-X. Epub 2020 Jun 19.']",2021-06-01,https://clinicaltrials.gov/show/NCT04905875,2022-05-01,0,1
5548,NCT04906694,Completed,2022-01-13,2022-01-13,No Results Posted,,,2022-02-03,https://clinicaltrials.gov/show/NCT04906694,2022-01-13,0,0
5549,NCT04906850,Completed,2021-04-15,2021-05-15,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04906850,2021-04-15,0,0
5550,NCT04907877,Recruiting,2022-03-01,2022-09-01,No Results Posted,,"['Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, Li P, Hu B, Wang J, Hu C, Jin Y, Niu X, Ping R, Du Y, Li T, Xu G, Hu Q, Tu L. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.', 'Smyk W, Janik MK, Portincasa P, Milkiewicz P, Lammert F, Krawczyk M. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. 2020 Sep;50(9):e13276. doi: 10.1111/eci.13276. Epub 2020 Jul 5. Review.', 'Westermann C, Gleinser M, Corr SC, Riedel CU. A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue. Front Microbiol. 2016 Aug 5;7:1220. doi: 10.3389/fmicb.2016.01220. eCollection 2016. Review.', 'Van Tassell ML, Miller MJ. Lactobacillus adhesion to mucus. Nutrients. 2011 May;3(5):613-36. doi: 10.3390/nu3050613. Epub 2011 May 20. Review.', 'Olaimat AN, Aolymat I, Al-Holy M, Ayyash M, Abu Ghoush M, Al-Nabulsi AA, Osaili T, Apostolopoulos V, Liu SQ, Shah NP. The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19. NPJ Sci Food. 2020 Oct 5;4:17. doi: 10.1038/s41538-020-00078-9. eCollection 2020. Review.', 'Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SSS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.', 'Chai W, Burwinkel M, Wang Z, Palissa C, Esch B, Twardziok S, Rieger J, Wrede P, Schmidt MF. Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Arch Virol. 2013 Apr;158(4):799-807. doi: 10.1007/s00705-012-1543-0. Epub 2012 Nov 28.', 'Miettinen M, Pietil√§ TE, Kekkonen RA, Kankainen M, Latvala S, Pirhonen J, √ñsterlund P, Korpela R, Julkunen I. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes. 2012 Nov-Dec;3(6):510-22. doi: 10.4161/gmic.21736. Epub 2012 Aug 16.', 'Nakayama Y, Moriya T, Sakai F, Ikeda N, Shiozaki T, Hosoya T, Nakagawa H, Miyazaki T. Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep. 2014 Apr 10;4:4638. doi: 10.1038/srep04638.', 'Gao X, Huang L, Zhu L, Mou C, Hou Q, Yu Q. Inhibition of H9N2 Virus Invasion into Dendritic Cells by the S-Layer Protein from L. acidophilus ATCC 4356. Front Cell Infect Microbiol. 2016 Oct 25;6:137. eCollection 2016.', 'Vouloumanou EK, Makris GC, Karageorgopoulos DE, Falagas ME. Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents. 2009 Sep;34(3):197.e1-10. doi: 10.1016/j.ijantimicag.2008.11.005. Epub 2009 Jan 28. Review.', 'Zimmermann P, Curtis N. The influence of probiotics on vaccine responses - A systematic review. Vaccine. 2018 Jan 4;36(2):207-213. doi: 10.1016/j.vaccine.2017.08.069. Epub 2017 Sep 18. Review.']",2022-01-06,https://clinicaltrials.gov/show/NCT04907877,2022-03-01,0,1
5551,NCT04907890,Not yet recruiting,2022-12-10,2023-05-30,No Results Posted,,"['COVID-19 RISK and Treatments (CORIST) Collaboration. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020 Dec;82:38-47. doi: 10.1016/j.ejim.2020.08.019. Epub 2020 Aug 25.', ""Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, Blandi L, Bruno R, Cauda R, Guaraldi G, My I, Menicanti L, Parruti G, Patti G, Perlini S, Santilli F, Signorelli C, Stefanini GG, Vergori A, Abdeddaim A, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Aucella F, Barbieri G, Bartoloni A, Bologna C, Bonfanti P, Brancati S, Cacciatore F, Caiano L, Cannata F, Carrozzi L, Cascio A, Cingolani A, Cipollone F, Colomba C, Crisetti A, Crosta F, Danzi GB, D'Ardes D, de Gaetano Donati K, Di Gennaro F, Di Palma G, Di Tano G, Fantoni M, Filippini T, Fioretto P, Fusco FM, Gentile I, Grisafi L, Guarnieri G, Landi F, Larizza G, Leone A, Maccagni G, Maccarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marotta C, Marra L, Mastroianni F, Mengozzi A, Menichetti F, Milic J, Murri R, Montineri A, Mussinelli R, Mussini C, Musso M, Odone A, Olivieri M, Pasi E, Petri F, Pinchera B, Pivato CA, Pizzi R, Poletti V, Raffaelli F, Ravaglia C, Righetti G, Rognoni A, Rossato M, Rossi M, Sabena A, Salinaro F, Sangiovanni V, Sanrocco C, Scarafino A, Scorzolini L, Sgariglia R, Simeone PG, Spinoni E, Torti C, Trecarichi EM, Vezzani F, Veronesi G, Vettor R, Vianello A, Vinceti M, De Caterina R, Iacoviello L; COvid-19 RISk and Treatments (CORIST) collaboration. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1899-1913. doi: 10.1016/j.numecd.2020.07.031. Epub 2020 Jul 31."", ""Di Castelnuovo A, Costanzo S, Antinori A, Berselli N, Blandi L, Bonaccio M, Cauda R, Guaraldi G, Menicanti L, Mennuni M, Parruti G, Patti G, Santilli F, Signorelli C, Vergori A, Abete P, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Arboretti R, Astuto M, Aucella F, Barbieri G, Bartoloni A, Bonfanti P, Cacciatore F, Caiano L, Carrozzi L, Cascio A, Ciccullo A, Cingolani A, Cipollone F, Colomba C, Colombo C, Crosta F, Danzi GB, D'Ardes D, de Gaetano Donati K, Di Gennaro F, Di Tano G, D'Offizi G, Fantoni M, Fusco FM, Gentile I, Gianfagna F, Grandone E, Graziani E, Grisafi L, Guarnieri G, Larizza G, Leone A, Maccagni G, Madaro F, Maitan S, Mancarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marongiu S, Marotta C, Marra L, Mastroianni F, Mazzitelli M, Mengozzi A, Menichetti F, Meschiari M, Milic J, Minutolo F, Molena B, Montineri A, Mussini C, Musso M, Niola D, Odone A, Olivieri M, Palimodde A, Parisi R, Pasi E, Pesavento R, Petri F, Pinchera B, Poletti V, Ravaglia C, Rognoni A, Rossato M, Rossi M, Sangiovanni V, Sanrocco C, Scorzolini L, Sgariglia R, Simeone PG, Taddei E, Torti C, Vettor R, Vianello A, Vinceti M, Virano A, Vocciante L, De Caterina R, Iacoviello L. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug;121(8):1054-1065. doi: 10.1055/a-1347-6070. Epub 2021 Jan 7."", 'COVID-19 RISk and Treatments (CORIST) Collaboration. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies. Vascul Pharmacol. 2020 Dec;135:106805. doi: 10.1016/j.vph.2020.106805. Epub 2020 Sep 28.', 'Di Castelnuovo A, De Caterina R, de Gaetano G, Iacoviello L. Controversial Relationship Between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy. Hypertension. 2020 Aug;76(2):312-313. doi: 10.1161/HYPERTENSIONAHA.120.15370. Epub 2020 May 8.', 'Ruggiero E, Mignogna C, Costanzo S, Persichillo M, Di Castelnuovo A, Esposito S, Cerletti C, Donati MB, de Gaetano G, Iacoviello L, Bonaccio M; Moli-LOCK Study Investigators. Changes in the consumption of foods characterising the Mediterranean dietary pattern and major correlates during the COVID-19 confinement in Italy: results from two cohort studies. Int J Food Sci Nutr. 2021 Dec;72(8):1105-1117. doi: 10.1080/09637486.2021.1895726. Epub 2021 Apr 6.', 'Bonaccio M, Costanzo S, Ruggiero E, Persichillo M, Esposito S, Olivieri M, Di Castelnuovo A, Cerletti C, Donati MB, de Gaetano G, Iacoviello L; Moli-LOCK Study Investigators. Changes in ultra-processed food consumption during the first Italian lockdown following the COVID-19 pandemic and major correlates: results from two population-based cohorts. Public Health Nutr. 2021 Aug;24(12):3905-3915. doi: 10.1017/S1368980021000999. Epub 2021 Mar 5.']",2022-01-12,https://clinicaltrials.gov/show/NCT04907890,2022-12-10,0,1
5552,NCT04907903,Not yet recruiting,2022-07-01,2023-06-01,No Results Posted,,,2022-03-22,https://clinicaltrials.gov/show/NCT04907903,2022-07-01,0,0
5553,NCT04907916,Not yet recruiting,2022-08-01,2023-01-01,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04907916,2022-08-01,0,0
5554,NCT04907942,Completed,2020-12-18,2021-06-20,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04907942,2020-12-18,0,0
5555,NCT04907994,Not yet recruiting,2022-09-01,2023-09-01,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04907994,2022-09-01,0,0
5556,NCT04908007,Recruiting,2021-12-01,2022-09-01,No Results Posted,,,2021-06-01,https://clinicaltrials.gov/show/NCT04908007,2021-12-01,0,0
5557,NCT04909892,Withdrawn,2022-01-01,2022-01-01,No Results Posted,,,2021-09-16,https://clinicaltrials.gov/show/NCT04909892,2022-01-01,0,0
5558,NCT04909918,Completed,2021-08-15,2021-08-20,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04909918,2021-08-15,0,0
5559,NCT04909996,Completed,2021-11-30,2021-11-30,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04909996,2021-11-30,0,0
5560,NCT04910113,Not yet recruiting,2021-12-01,2022-01-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910113,2021-12-01,0,0
5561,NCT04910191,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910191,2021-12-01,0,0
5562,NCT04910542,Recruiting,2021-11-12,2022-05-12,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910542,2021-11-12,0,0
5563,NCT04913116,Completed,2021-09-09,2021-09-09,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04913116,2021-09-09,0,0
5564,NCT04676867,Completed,2021-05-17,2021-05-17,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04676867,2021-05-17,0,0
5565,NCT04689464,Completed,2021-05-28,2021-06-01,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04689464,2021-05-28,0,0
5566,NCT04701489,Completed,2021-03-15,2021-04-07,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04701489,2021-03-15,0,0
5567,NCT04703608,Recruiting,2022-03-01,2022-07-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-06-04,https://clinicaltrials.gov/show/NCT04703608,2022-03-01,0,1
5568,NCT04705116,Recruiting,2025-12-31,2025-12-31,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04705116,2025-12-31,0,0
5569,NCT04710381,Completed,2021-06-02,2021-06-02,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04710381,2021-06-02,0,0
5570,NCT04720378,"Active, not recruiting",2022-05-01,2022-05-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04720378,2022-05-01,0,0
5571,NCT04727775,Recruiting,2021-11-25,2021-12-25,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04727775,2021-11-25,0,0
5572,NCT04730206,Recruiting,2022-05-01,2023-05-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04730206,2022-05-01,0,0
5573,NCT04730856,Completed,2021-10-20,2021-12-20,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.']",2022-03-11,https://clinicaltrials.gov/show/NCT04730856,2021-10-20,0,1
5574,NCT04763681,Recruiting,2022-08-31,2023-03-31,No Results Posted,,,2022-02-08,https://clinicaltrials.gov/show/NCT04763681,2022-08-31,0,0
5575,NCT04765449,Recruiting,2022-07-29,2022-07-29,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04765449,2022-07-29,0,0
5576,NCT04770467,Withdrawn,2022-10-01,2022-10-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-02,https://clinicaltrials.gov/show/NCT04770467,2022-10-01,0,1
5577,NCT04771000,Recruiting,2022-07-31,2022-10-31,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04771000,2022-07-31,0,0
5578,NCT04771611,Enrolling by invitation,2022-12-01,2023-06-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04771611,2022-12-01,0,0
5579,NCT04773067,"Active, not recruiting",2022-04-29,2022-04-29,No Results Posted,"['Wang CY, Hwang KP, Kuo HK, Peng WJ, Shen YH, Kuo BS, Huang JH, Liu H, Ho YH, Lin F, Ding S, Liu Z, Wu HT, Huang CT, Lee YJ, Liu MC, Yang YC, Lu PL, Tsai HC, Lee CH, Shi ZY, Liu CE, Liao CH, Chang FY, Cheng HC, Wang FD, Hou KL, Cheng J, Wang MS, Yang YT, Chiu HC, Jiang MH, Shih HY, Shen HY, Chang PY, Lan YR, Chen CT, Lin YL, Liang JJ, Liao CC, Chou YC, Morris MK, Hanson CV, Guirakhoo F, Hellerstein M, Yu HJ, King CC, Kemp T, Heppner DG, Monath TP. A multitope SARS-COV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest. 2022 Mar 22. pii: e157707. doi: 10.1172/JCI157707. [Epub ahead of print]']",,2022-03-08,https://clinicaltrials.gov/show/NCT04773067,2022-04-29,0,1
5580,NCT04773899,Recruiting,2022-07-09,2022-09-09,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04773899,2022-07-09,0,0
5581,NCT04780152,Recruiting,2022-08-01,2022-09-01,No Results Posted,,"['Jiang N, Wei J, Li G, Wei B, Zhu FF, Hu Y. Effect of dry-electrode-based transcranial direct current stimulation on chronic low back pain and low back muscle activities: A double-blind sham-controlled study. Restor Neurol Neurosci. 2020;38(1):41-54. doi: 10.3233/RNN-190922.', 'Kontoangelos K, Economou M, Papageorgiou C. Mental Health Effects of COVID-19 Pandemia: A Review of Clinical and Psychological Traits. Psychiatry Investig. 2020 Jun;17(6):491-505. doi: 10.30773/pi.2020.0161. Epub 2020 Jun 15.', 'Kuo MF, Paulus W, Nitsche MA. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex. 2008 Mar;18(3):648-51. Epub 2007 Jun 24.', 'Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012 Mar 17;379(9820):1045-55. doi: 10.1016/S0140-6736(11)60602-8. Epub 2011 Dec 19. Review.', 'Lefaucheur JP, Antal A, Ayache SS, Benninger DH, Brunelin J, Cogiamanian F, Cotelli M, De Ridder D, Ferrucci R, Langguth B, Marangolo P, Mylius V, Nitsche MA, Padberg F, Palm U, Poulet E, Priori A, Rossi S, Schecklmann M, Vanneste S, Ziemann U, Garcia-Larrea L, Paulus W. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol. 2017 Jan;128(1):56-92. doi: 10.1016/j.clinph.2016.10.087. Epub 2016 Oct 29. Review.', 'Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 1998 Nov;18(7):765-94. Review.', 'Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain. 2002 Oct;125(Pt 10):2238-47.', 'Liebetanz D, Koch R, Mayenfels S, K√∂nig F, Paulus W, Nitsche MA. Safety limits of cathodal transcranial direct current stimulation in rats. Clin Neurophysiol. 2009 Jun;120(6):1161-7. doi: 10.1016/j.clinph.2009.01.022. Epub 2009 Apr 28.', 'Loo CK, Sachdev P, Martin D, Pigot M, Alonzo A, Malhi GS, Lagopoulos J, Mitchell P. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010 Feb;13(1):61-9. doi: 10.1017/S1461145709990411. Epub 2009 Aug 12.', 'Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatry. 2012 Jan;200(1):52-9. doi: 10.1192/bjp.bp.111.097634.', ""Loo CK, Husain MM, McDonald WM, Aaronson S, O'Reardon JP, Alonzo A, Weickert CS, Martin DM, McClintock SM, Mohan A, Lisanby SH; International Consortium of Research in tDCS (ICRT). International randomized-controlled trial of transcranial Direct Current Stimulation in depression. Brain Stimul. 2018 Jan - Feb;11(1):125-133. doi: 10.1016/j.brs.2017.10.011. Epub 2017 Oct 27."", 'L√∂scher W, Cole AJ, McLean MJ. Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling. Neurotherapeutics. 2009 Apr;6(2):258-62. doi: 10.1016/j.nurt.2009.01.014. Review.', 'Maceira-Elvira P, Popa T, Schmid AC, Hummel FC. Feasibility of home-based, self-applied transcranial direct current stimulation to enhance motor learning in middle-aged and older adults. Brain Stimul. 2020 Jan - Feb;13(1):247-249. doi: 10.1016/j.brs.2019.08.014. Epub 2019 Sep 24.', 'Malhi GS, Mann JJ. Depression. Lancet. 2018 Nov 24;392(10161):2299-2312. doi: 10.1016/S0140-6736(18)31948-2. Epub 2018 Nov 2. Review.', 'Mattai A, Miller R, Weisinger B, Greenstein D, Bakalar J, Tossell J, David C, Wassermann EM, Rapoport J, Gogtay N. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimul. 2011 Oct;4(4):275-80. doi: 10.1016/j.brs.2011.01.001. Epub 2011 Feb 1.', 'Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000 Oct 15;48(8):830-43.', 'McCaig CD, Rajnicek AM, Song B, Zhao M. Controlling cell behavior electrically: current views and future potential. Physiol Rev. 2005 Jul;85(3):943-78. Review.', 'McLaren ME, Nissim NR, Woods AJ. The effects of medication use in transcranial direct current stimulation: A brief review. Brain Stimul. 2018 Jan - Feb;11(1):52-58. doi: 10.1016/j.brs.2017.10.006. Epub 2017 Oct 12. Review.', 'Merzagora AC, Foffani G, Panyavin I, Mordillo-Mateos L, Aguilar J, Onaral B, Oliviero A. Prefrontal hemodynamic changes produced by anodal direct current stimulation. Neuroimage. 2010 Feb 1;49(3):2304-10. doi: 10.1016/j.neuroimage.2009.10.044. Epub 2009 Oct 21.', 'Munz MT, Prehn-Kristensen A, Thielking F, M√∂lle M, G√∂der R, Baving L. Slow oscillating transcranial direct current stimulation during non-rapid eye movement sleep improves behavioral inhibition in attention-deficit/hyperactivity disorder. Front Cell Neurosci. 2015 Aug 11;9:307. doi: 10.3389/fncel.2015.00307. eCollection 2015.', 'Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 May 17;349(9063):1436-42.', 'Musazzi L, Treccani G, Mallei A, Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol Psychiatry. 2013 Jun 15;73(12):1180-8. doi: 10.1016/j.biopsych.2012.11.009. Epub 2012 Dec 28. Review.', 'Ngernyam N, Jensen MP, Auvichayapat N, Punjaruk W, Auvichayapat P. Transcranial Direct Current Stimulation in Neuropathic Pain. J Pain Relief. 2013 Apr 21;Suppl 3. pii: 001.', 'Nitsche MA, Liebetanz D, Antal A, Lang N, Tergau F, Paulus W. Modulation of cortical excitability by weak direct current stimulation--technical, safety and functional aspects. Suppl Clin Neurophysiol. 2003;56:255-76. Review.', 'Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, Henning S, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol. 2003 Nov 15;553(Pt 1):293-301. Epub 2003 Aug 29.', 'Nitsche MA, Liebetanz D, Schlitterlau A, Henschke U, Fricke K, Frommann K, Lang N, Henning S, Paulus W, Tergau F. GABAergic modulation of DC stimulation-induced motor cortex excitability shifts in humans. Eur J Neurosci. 2004 May;19(10):2720-6.', 'Nitsche MA, Niehaus L, Hoffmann KT, Hengst S, Liebetanz D, Paulus W, Meyer BU. MRI study of human brain exposed to weak direct current stimulation of the frontal cortex. Clin Neurophysiol. 2004 Oct;115(10):2419-23.', 'Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, Fricke K, Liebetanz D, Lang N, Antal A, Paulus W, Tergau F. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol. 2005 Oct 1;568(Pt 1):291-303. Epub 2005 Jul 7.', 'Nitsche MA, Cohen LG, Wassermann EM, Priori A, Lang N, Antal A, Paulus W, Hummel F, Boggio PS, Fregni F, Pascual-Leone A. Transcranial direct current stimulation: State of the art 2008. Brain Stimul. 2008 Jul;1(3):206-23. doi: 10.1016/j.brs.2008.06.004. Epub 2008 Jul 1. Review.', 'Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3:633-9.', 'Nitsche MA, Paulus W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology. 2001 Nov 27;57(10):1899-901.', 'Opitz A, Falchier A, Yan CG, Yeagle EM, Linn GS, Megevand P, Thielscher A, Deborah A R, Milham MP, Mehta AD, Schroeder CE. Spatiotemporal structure of intracranial electric fields induced by transcranial electric stimulation in humans and nonhuman primates. Sci Rep. 2016 Aug 18;6:31236. doi: 10.1038/srep31236.', 'Otto WR, Geoghegan S, Posch LC, Bell LM, Coffin SE, Sammons JS, Harris RM, Odom John AR, Luan X, Gerber JS. The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States. J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):523-529. doi: 10.1093/jpids/piaa074.', 'Palm U, Segmiller FM, Epple AN, Freisleder FJ, Koutsouleris N, Schulte-K√∂rne G, Padberg F. Transcranial direct current stimulation in children and adolescents: a comprehensive review. J Neural Transm (Vienna). 2016 Oct;123(10):1219-34. doi: 10.1007/s00702-016-1572-z. Epub 2016 May 12. Review.', 'Paniccia M, Paniccia D, Thomas S, Taha T, Reed N. Clinical and non-clinical depression and anxiety in young people: A scoping review on heart rate variability. Auton Neurosci. 2017 Dec;208:1-14. doi: 10.1016/j.autneu.2017.08.008. Epub 2017 Aug 26. Review.', 'Pelletier SJ, Cicchetti F. Cellular and molecular mechanisms of action of transcranial direct current stimulation: evidence from in vitro and in vivo models. Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu047. doi: 10.1093/ijnp/pyu047. Review.', 'Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.', 'Prehn-Kristensen A, Munz M, G√∂der R, Wilhelm I, Korr K, Vahl W, Wiesner CD, Baving L. Transcranial oscillatory direct current stimulation during sleep improves declarative memory consolidation in children with attention-deficit/hyperactivity disorder to a level comparable to healthy controls. Brain Stimul. 2014 Nov-Dec;7(6):793-9. doi: 10.1016/j.brs.2014.07.036. Epub 2014 Jul 23.', 'Priori A, Berardelli A, Rona S, Accornero N, Manfredi M. Polarization of the human motor cortex through the scalp. Neuroreport. 1998 Jul 13;9(10):2257-60.', 'Rafful C, Medina-Mora ME, Borges G, Benjet C, Orozco R. Depression, gender, and the treatment gap in Mexico. J Affect Disord. 2012 Apr;138(1-2):165-9. doi: 10.1016/j.jad.2011.12.040. Epub 2012 Feb 14.', 'Reato D, Rahman A, Bikson M, Parra LC. Low-intensity electrical stimulation affects network dynamics by modulating population rate and spike timing. J Neurosci. 2010 Nov 10;30(45):15067-79. doi: 10.1523/JNEUROSCI.2059-10.2010.', 'Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006 Sep;31(9):1841-53. Epub 2006 Jun 21. Review.', 'Sacher J, Neumann J, F√ºnfst√ºck T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord. 2012 Oct;140(2):142-8. doi: 10.1016/j.jad.2011.08.001. Epub 2011 Sep 3.', 'Salloum NC, Fava M, Ball S, Papakostas GI. Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review. Mol Psychiatry. 2020 Sep;25(9):1967-1974. doi: 10.1038/s41380-020-0646-3. Epub 2020 Jan 27. Review.', 'S√§mann PG, H√∂hn D, Chechko N, Kloiber S, Lucae S, Ising M, Holsboer F, Czisch M. Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. Eur Neuropsychopharmacol. 2013 Nov;23(11):1503-15. doi: 10.1016/j.euroneuro.2013.07.004. Epub 2013 Aug 3.', ""San-Juan D, Calc√°neo Jde D, Gonz√°lez-Arag√≥n MF, Berm√∫dez Maldonado L, Avell√°n AM, Argumosa EV, Fregni F. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis. Epilepsy Behav. 2011 Jan;20(1):126-31. doi: 10.1016/j.yebeh.2010.10.031. Epub 2010 Dec 17."", 'Schestatsky P, Morales-Quezada L, Fregni F. Simultaneous EEG monitoring during transcranial direct current stimulation. J Vis Exp. 2013 Jun 17;(76). doi: 10.3791/50426.', 'Schneider HD, Hopp JP. The use of the Bilingual Aphasia Test for assessment and transcranial direct current stimulation to modulate language acquisition in minimally verbal children with autism. Clin Linguist Phon. 2011 Jun;25(6-7):640-54. doi: 10.3109/02699206.2011.570852. Epub 2011 Jun 1.', 'Segrave RA, Arnold S, Hoy K, Fitzgerald PB. Concurrent cognitive control training augments the antidepressant efficacy of tDCS: a pilot study. Brain Stimul. 2014 Mar-Apr;7(2):325-31. doi: 10.1016/j.brs.2013.12.008. Epub 2013 Dec 19.', 'Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, Merli G, Cortese G, Corso RM, Bressan F, Pintaudi S, Greif R, Donati A, Petrini F; Societ√† Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group, and The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020 Jun;75(6):724-732. doi: 10.1111/anae.15049. Epub 2020 Mar 30.', ""Thair H, Holloway AL, Newport R, Smith AD. Transcranial Direct Current Stimulation (tDCS): A Beginner's Guide for Design and Implementation. Front Neurosci. 2017 Nov 22;11:641. doi: 10.3389/fnins.2017.00641. eCollection 2017."", 'Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT, Baguelin M, Bhatia S, Boonyasiri A, Cori A, Cucunub√° Z, FitzJohn R, Gaythorpe K, Green W, Hamlet A, Hinsley W, Laydon D, Nedjati-Gilani G, Riley S, van Elsland S, Volz E, Wang H, Wang Y, Xi X, Donnelly CA, Ghani AC, Ferguson NM. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30. Erratum in: Lancet Infect Dis. 2020 Apr 15;:. Lancet Infect Dis. 2020 May 4;:.', 'Villamar MF, Volz MS, Bikson M, Datta A, Dasilva AF, Fregni F. Technique and considerations in the use of 4x1 ring high-definition transcranial direct current stimulation (HD-tDCS). J Vis Exp. 2013 Jul 14;(77):e50309. doi: 10.3791/50309.', 'V√∂r√∂slakos M, Takeuchi Y, Brinyiczki K, Zombori T, Oliva A, Fern√°ndez-Ruiz A, Koz√°k G, Kincses ZT, Iv√°nyi B, Buzs√°ki G, Ber√©nyi A. Direct effects of transcranial electric stimulation on brain circuits in rats and humans. Nat Commun. 2018 Feb 2;9(1):483. doi: 10.1038/s41467-018-02928-3.', 'Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 29;:.', 'Xie X, Xue Q, Zhou Y, Zhu K, Liu Q, Zhang J, Song R. Mental Health Status Among Children in Home Confinement During the Coronavirus Disease 2019 Outbreak in Hubei Province, China. JAMA Pediatr. 2020 Sep 1;174(9):898-900. doi: 10.1001/jamapediatrics.2020.1619.', 'Yan T, Goldman RD. Time-to-effect of fluoxetine in children with depression. Can Fam Physician. 2019 Aug;65(8):549-551.', 'Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020 Mar 15;16(10):1753-1766. doi: 10.7150/ijbs.45134. eCollection 2020. Review.', 'Yip AG, George MS, Tendler A, Roth Y, Zangen A, Carpenter LL. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial. Brain Stimul. 2017 Jul - Aug;10(4):847-849. doi: 10.1016/j.brs.2017.02.013. Epub 2017 Mar 10.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.', 'Zewdie E, Ciechanski P, Kuo HC, Giuffre A, Kahl C, King R, Cole L, Godfrey H, Seeger T, Swansburg R, Damji O, Rajapakse T, Hodge J, Nelson S, Selby B, Gan L, Jadavji Z, Larson JR, MacMaster F, Yang JF, Barlow K, Gorassini M, Brunton K, Kirton A. Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020 May - Jun;13(3):565-575. doi: 10.1016/j.brs.2019.12.025. Epub 2019 Dec 30.', 'Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, Liu M, Chen X, Chen JX. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758. doi: 10.1007/s00787-020-01541-4. Epub 2020 May 3.']",2021-06-04,https://clinicaltrials.gov/show/NCT04780152,2022-08-01,0,1
5582,NCT04784897,Completed,2021-07-01,2021-07-30,No Results Posted,,,2021-08-13,https://clinicaltrials.gov/show/NCT04784897,2021-07-01,0,0
5583,NCT04789447,Completed,2021-05-06,2021-05-06,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04789447,2021-05-06,0,0
5584,NCT04793997,Suspended,2022-02-01,2022-02-01,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04793997,2022-02-01,0,0
5585,NCT04794400,Completed,2021-03-31,2021-03-31,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04794400,2021-03-31,0,0
5586,NCT04794985,Not yet recruiting,2023-09-01,2023-09-01,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04794985,2023-09-01,0,0
5587,NCT04813718,Recruiting,2022-05-01,2022-12-31,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04813718,2022-05-01,0,0
5588,NCT04818892,Recruiting,2022-08-01,2023-04-01,No Results Posted,,,2021-12-02,https://clinicaltrials.gov/show/NCT04818892,2022-08-01,0,0
5589,NCT04828434,"Active, not recruiting",2023-04-01,2025-09-01,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04828434,2023-04-01,0,0
5590,NCT04836793,Recruiting,2022-03-25,2023-03-25,No Results Posted,,"['Kroemer M, Spehner L, Vettoretti L, Bouard A, Eberst G, Pili Floury S, Capellier G, Lepiller Q, Orillard E, Mansi L, Clairet AL, Westeel V, Limat S, Dubois M, Malinowski L, Bohard L, Borg C, Chirouze C, Bouiller K. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity. J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.08.036. Epub 2020 Aug 25.']",2021-06-08,https://clinicaltrials.gov/show/NCT04836793,2022-03-25,0,1
5591,NCT04841707,Recruiting,2022-02-22,2023-02-22,No Results Posted,,,2021-11-10,https://clinicaltrials.gov/show/NCT04841707,2022-02-22,0,0
5592,NCT04848467,Withdrawn,2021-11-30,2022-11-15,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04848467,2021-11-30,0,0
5593,NCT04848584,Recruiting,2023-03-31,2023-03-31,No Results Posted,"['Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, Ranasinghe ON, Frankland TB, Ogun OA, Zamparo JM, Gray S, Valluri SR, Pan K, Angulo FJ, Jodar L, McLaughlin JM. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.']",,2022-02-14,https://clinicaltrials.gov/show/NCT04848584,2023-03-31,0,1
5594,NCT04851821,Completed,2021-05-30,2021-06-30,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04851821,2021-05-30,0,0
5595,NCT04852276,Recruiting,2025-06-30,2025-06-30,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04852276,2025-06-30,0,0
5596,NCT04854798,Completed,2022-02-01,2022-02-11,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04854798,2022-02-01,0,0
5597,NCT04854876,Withdrawn,2021-08-30,2021-08-30,No Results Posted,,,2021-09-22,https://clinicaltrials.gov/show/NCT04854876,2021-08-30,0,0
5598,NCT04860869,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04860869,2022-05-01,0,0
5599,NCT04867265,Completed,2021-06-02,2021-06-02,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04867265,2021-06-02,0,0
5600,NCT04869358,Recruiting,2022-05-31,2023-05-31,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04869358,2022-05-31,0,0
5601,NCT04873414,Recruiting,2021-10-30,2021-12-31,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04873414,2021-10-30,0,0
5602,NCT04878211,Recruiting,2023-08-30,2023-08-30,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04878211,2023-08-30,0,0
5603,NCT04878796,Recruiting,2021-10-01,2022-05-01,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04878796,2021-10-01,0,0
5604,NCT04883138,Terminated,2022-01-11,2022-01-11,No Results Posted,,,2022-01-26,https://clinicaltrials.gov/show/NCT04883138,2022-01-11,0,0
5605,NCT04884685,"Active, not recruiting",2021-08-01,2022-01-03,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04884685,2021-08-01,0,0
5606,NCT04885907,"Active, not recruiting",2021-07-30,2021-08-30,No Results Posted,"['Kumar D, Ferreira VH, Hall VG, Hu Q, Samson R, Ku T, Ierullo M, Majchrzak-Kita B, Tomlinson G, Gingras AC, Humar A. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial. Ann Intern Med. 2022 Feb;175(2):226-233. doi: 10.7326/M21-3480. Epub 2021 Nov 23.']",,2021-06-07,https://clinicaltrials.gov/show/NCT04885907,2021-07-30,0,1
5607,NCT04891133,Recruiting,2022-12-01,2025-12-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-04,https://clinicaltrials.gov/show/NCT04891133,2022-12-01,0,1
5608,NCT04892459,Completed,2021-07-25,2021-12-25,No Results Posted,"['Li J, Hou L, Guo X, Jin P, Wu S, Zhu J, Pan H, Wang X, Song Z, Wan J, Cui L, Li J, Chen Y, Wang X, Jin L, Liu J, Shi F, Xu X, Zhu T, Chen W, Zhu F. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nat Med. 2022 Feb;28(2):401-409. doi: 10.1038/s41591-021-01677-z. Epub 2022 Jan 27.']",,2022-03-31,https://clinicaltrials.gov/show/NCT04892459,2021-07-25,0,1
5609,NCT04893070,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2021-07-28,https://clinicaltrials.gov/show/NCT04893070,2022-07-01,0,0
5610,NCT04893512,"Active, not recruiting",2021-12-09,2022-12-09,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT04893512,2021-12-09,0,0
5611,NCT04893668,Not yet recruiting,2022-04-01,2022-06-01,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04893668,2022-04-01,0,0
5612,NCT04894305,Completed,2021-12-08,2021-12-08,No Results Posted,,,2021-12-22,https://clinicaltrials.gov/show/NCT04894305,2021-12-08,0,0
5613,NCT04895371,Not yet recruiting,2021-09-23,2021-10-15,No Results Posted,,"['Cort√©s-Telles A, L√≥pez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, Ryerson CJ, Guenette JA. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021 Jun;288:103644. doi: 10.1016/j.resp.2021.103644. Epub 2021 Feb 27.', 'Jenkins SC. 6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation. Physiotherapy. 2007 Sep 1;93(3):175-82.', 'Javaherian M, Shadmehr A, Keshtkar A, Beigmohammadi MT, Dabbaghipour N, Syed A, Moghaddam BA. Safety and efficacy of Pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID): A prospective, randomised, single-blind, controlled trial. medRxiv. 2021 Jan 1.']",2021-06-04,https://clinicaltrials.gov/show/NCT04895371,2021-09-23,0,1
5614,NCT04896710,Enrolling by invitation,2021-08-31,2021-08-31,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04896710,2021-08-31,0,0
5615,NCT04909476,Recruiting,2021-05-20,2021-06-10,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04909476,2021-05-20,0,0
5616,NCT04909879,Withdrawn,2022-02-01,2022-04-01,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04909879,2022-02-01,0,0
5617,NCT04909905,Completed,2021-10-25,2021-10-30,No Results Posted,,,2021-11-05,https://clinicaltrials.gov/show/NCT04909905,2021-10-25,0,0
5618,NCT04910230,Completed,2020-04-02,2020-04-02,No Results Posted,,,2021-11-08,https://clinicaltrials.gov/show/NCT04910230,2020-04-02,0,0
5619,NCT04910243,Completed,2021-10-14,2021-10-14,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04910243,2021-10-14,0,0
5620,NCT04910295,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910295,2021-12-31,0,0
5621,NCT04910334,Enrolling by invitation,2021-06-01,2021-09-01,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910334,2021-06-01,0,0
5622,NCT04910516,"Active, not recruiting",2021-05-25,2021-07-01,Results Submitted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910516,2021-05-25,0,0
5623,NCT04910633,Completed,2020-12-09,2021-01-22,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910633,2020-12-09,0,0
5624,NCT04910958,Recruiting,2022-01-31,2022-01-31,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910958,2022-01-31,0,0
5625,NCT04910971,Recruiting,2022-05-28,2022-07-28,No Results Posted,,,2021-06-02,https://clinicaltrials.gov/show/NCT04910971,2022-05-28,0,0
5626,NCT04911790,Recruiting,2021-10-05,2022-12-31,No Results Posted,,,2021-10-29,https://clinicaltrials.gov/show/NCT04911790,2021-10-05,0,0
5627,NCT04911868,Completed,2020-10-31,2021-05-01,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04911868,2020-10-31,0,0
5628,NCT04912011,Recruiting,2021-08-31,2021-12-31,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04912011,2021-08-31,0,0
5629,NCT04912700,Completed,2021-06-07,2021-06-07,Study Results,,,2021-09-30,https://clinicaltrials.gov/show/NCT04912700,2021-06-07,1,0
5630,NCT04912778,Completed,2021-08-30,2021-08-30,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04912778,2021-08-30,0,0
5631,NCT04912791,Not yet recruiting,2022-01-31,2022-02-01,No Results Posted,,,2021-10-28,https://clinicaltrials.gov/show/NCT04912791,2022-01-31,0,0
5632,NCT04912804,"Active, not recruiting",2021-06-01,2021-06-01,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04912804,2021-06-01,0,0
5633,NCT04912817,Not yet recruiting,2022-08-30,2022-12-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04912817,2022-08-30,0,0
5634,NCT04912895,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04912895,2022-12-01,0,0
5635,NCT04912921,Recruiting,2022-05-01,2022-05-01,No Results Posted,,,2021-12-02,https://clinicaltrials.gov/show/NCT04912921,2022-05-01,0,0
5636,NCT04912934,Completed,2020-11-20,2020-12-12,No Results Posted,,,2021-06-03,https://clinicaltrials.gov/show/NCT04912934,2020-11-20,0,0
5637,NCT04913129,Recruiting,2022-12-31,2022-12-31,No Results Posted,,,2021-12-08,https://clinicaltrials.gov/show/NCT04913129,2022-12-31,0,0
5638,NCT04913142,Not yet recruiting,2022-02-15,2022-02-15,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04913142,2022-02-15,0,0
5639,NCT04913701,Completed,2020-12-31,2020-12-31,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04913701,2020-12-31,0,0
5640,NCT04913740,"Active, not recruiting",2021-09-01,2022-01-01,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04913740,2021-09-01,0,0
5641,NCT04913779,Recruiting,2021-11-30,2021-12-31,No Results Posted,,,2021-09-17,https://clinicaltrials.gov/show/NCT04913779,2021-11-30,0,0
5642,NCT04913948,"Active, not recruiting",2021-09-30,2022-09-30,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04913948,2021-09-30,0,0
5643,NCT04914013,Not yet recruiting,2021-08-01,2021-09-01,No Results Posted,,,2021-06-04,https://clinicaltrials.gov/show/NCT04914013,2021-08-01,0,0
5644,NCT04914364,Recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-08-11,https://clinicaltrials.gov/show/NCT04914364,2022-06-30,0,0
5645,NCT04914377,Completed,2021-12-16,2022-01-01,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04914377,2021-12-16,0,0
5646,NCT04914754,Enrolling by invitation,2022-08-01,2022-08-01,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04914754,2022-08-01,0,0
5647,NCT04914767,Completed,2021-10-30,2021-12-31,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04914767,2021-10-30,0,0
5648,NCT04914832,Not yet recruiting,2022-05-31,2022-05-31,No Results Posted,,"['Fischer RJ, van Doremalen N, Adney DR, Yinda CK, Port JR, Holbrook MG, Schulz JE, Williamson BN, Thomas T, Barbian K, Anzick SL, Ricklefs S, Smith BJ, Long D, Martens C, Saturday G, de Wit E, Gilbert SC, Lambe T, Munster VJ. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. Nat Commun. 2021 Oct 7;12(1):5868. doi: 10.1038/s41467-021-26178-y.']",2021-06-07,https://clinicaltrials.gov/show/NCT04914832,2022-05-31,0,1
5649,NCT04915001,Completed,2020-03-15,2020-03-30,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04915001,2020-03-15,0,0
5650,NCT04915781,"Active, not recruiting",2021-12-30,2021-12-30,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04915781,2021-12-30,0,0
5651,NCT04915989,"Active, not recruiting",2021-07-31,2022-03-31,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04915989,2021-07-31,0,0
5652,NCT04916275,Completed,2021-08-31,2021-08-31,No Results Posted,,,2021-10-04,https://clinicaltrials.gov/show/NCT04916275,2021-08-31,0,0
5653,NCT04916561,Completed,2021-01-15,2021-05-15,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04916561,2021-01-15,0,0
5654,NCT04916639,Not yet recruiting,2021-10-10,2021-10-27,No Results Posted,,,2021-06-07,https://clinicaltrials.gov/show/NCT04916639,2021-10-10,0,0
5655,NCT04916873,Completed,2020-06-26,2020-07-30,No Results Posted,,"['Cacioppo M, Bouvier S, Bailly R, Houx L, Lempereur M, Mensah-Gourmel J, Kandalaft C, Varengue R, Chatelin A, Vagnoni J, Vuillerot C, Gautheron V, Dinomais M, Dheilly E, Brochard S, Pons C; ECHO Group. Emerging health challenges for children with physical disabilities and their parents during the COVID-19 pandemic: The ECHO French survey. Ann Phys Rehabil Med. 2021 May;64(3):101429. doi: 10.1016/j.rehab.2020.08.001. Epub 2020 Aug 18.', 'Dhiman S, Sahu PK, Reed WR, Ganesh GS, Goyal RK, Jain S. Impact of COVID-19 outbreak on mental health and perceived strain among caregivers tending children with special needs. Res Dev Disabil. 2020 Dec;107:103790. doi: 10.1016/j.ridd.2020.103790. Epub 2020 Oct 6.']",2021-06-08,https://clinicaltrials.gov/show/NCT04916873,2020-06-26,0,1
5656,NCT04916886,Recruiting,2022-05-01,2022-08-01,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04916886,2022-05-01,0,0
5657,NCT04917523,Not yet recruiting,2022-02-06,2022-02-06,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04917523,2022-02-06,0,0
5658,NCT04917549,Enrolling by invitation,2021-06-01,2021-06-01,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04917549,2021-06-01,0,0
5659,NCT04614701,Not yet recruiting,2022-12-31,2023-03-31,No Results Posted,,,2021-12-15,https://clinicaltrials.gov/show/NCT04614701,2022-12-31,0,0
5660,NCT04672291,Recruiting,2022-12-31,2023-01-31,No Results Posted,,"['Antonelli LR, Gigliotti Rothfuchs A, Gon√ßalves R, Roff√™ E, Cheever AW, Bafica A, Salazar AM, Feng CG, Sher A. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest. 2010 May;120(5):1674-82. doi: 10.1172/JCI40817. Epub 2010 Apr 12.', 'Balan S, Arnold-Schrauf C, Abbas A, Couespel N, Savoret J, Imperatore F, Villani AC, Vu Manh TP, Bhardwaj N, Dalod M. Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity. Cell Rep. 2018 Aug 14;24(7):1902-1915.e6. doi: 10.1016/j.celrep.2018.07.033.', 'Benveniste EN, Qin H. Type I interferons as anti-inflammatory mediators. Sci STKE. 2007 Dec 11;2007(416):pe70.', 'Boukhvalova MS, Sotomayor TB, Point RC, Pletneva LM, Prince GA, Blanco JC. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model. J Interferon Cytokine Res. 2010 Apr;30(4):229-42. doi: 10.1089/jir.2009.0025.', 'CDC COVID-19 Response Team. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481. doi: 10.15585/mmwr.mm6915e6.', 'Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet JP, Haddad EK, Breton G, Trumpfheller C, Pollak S, Shimeliovich I, Duque-Alarcon A, Pan L, Nelkenbaum A, Salazar AM, Schlesinger SJ, Steinman RM, S√©kaly RP. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med. 2011 Nov 21;208(12):2357-66. doi: 10.1084/jem.20111171. Epub 2011 Nov 7.', 'Christopher ME, Wong JP. Use of TLR3 receptor agaonists against respiratory viral infections. Anti-inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 2011;10:327-38.', 'Flynn BJ, Kastenm√ºller K, Wille-Reece U, Tomaras GD, Alam M, Lindsay RW, Salazar AM, Perdiguero B, Gomez CE, Wagner R, Esteban M, Park CG, Trumpfheller C, Keler T, Pantaleo G, Steinman RM, Seder R. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7131-6. doi: 10.1073/pnas.1103869108. Epub 2011 Apr 5.', 'Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, Garofalo RP. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol. 2005 Aug;79(16):10190-9.', 'Hill DA, Baron S, Perkins JC, Worthington M, Van Kirk JE, Mills J, Kapikian AZ, Chanock RM. Evaluation of an interferon inducer in viral respiratory disease. JAMA. 1972 Feb 28;219(9):1179-84.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006 May 4;441(7089):101-5. Epub 2006 Apr 9.', 'Kende M, Paragas J, Salazar AM. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys. Antiviral Res. 2019 Mar;163:179-184. doi: 10.1016/j.antiviral.2018.12.020. Epub 2019 Jan 3.', ""Kindler E, Gil-Cruz C, Spanier J, Li Y, Wilhelm J, Rabouw HH, Z√ºst R, Hwang M, V'kovski P, Stalder H, Marti S, Habjan M, Cervantes-Barragan L, Elliot R, Karl N, Gaughan C, van Kuppeveld FJ, Silverman RH, Keller M, Ludewig B, Bergmann CC, Ziebuhr J, Weiss SR, Kalinke U, Thiel V. Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog. 2017 Feb 3;13(2):e1006195. doi: 10.1371/journal.ppat.1006195. eCollection 2017 Feb."", 'Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(¬Æ) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res. 2017 Mar;139:1-12. doi: 10.1016/j.antiviral.2016.12.007. Epub 2016 Dec 9.', 'Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, Salazar AM, Colonna M, Steinman RM. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med. 2009 Jul 6;206(7):1589-602. doi: 10.1084/jem.20090247. Epub 2009 Jun 29.', 'Marcus PI, Sekellick MJ. Combined sequential treatment with interferon and dsRNA abrogates virus resistance to interferon action. J Interferon Cytokine Res. 2001 Jun;21(6):423-9.', 'Packard AE, Hedges JC, Bahjat FR, Stevens SL, Conlin MJ, Salazar AM, Stenzel-Poore MP. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2012 Feb;32(2):242-7. doi: 10.1038/jcbfm.2011.160. Epub 2011 Nov 16.', 'Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer Immunol Res. 2020 Jan;8(1):70-80. doi: 10.1158/2326-6066.CIR-19-0545. Epub 2019 Nov 7.', 'Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, van den Brand J, Baric R, Katze MG. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol. 2009 Jul;83(14):7062-74. doi: 10.1128/JVI.00127-09. Epub 2009 May 6. Erratum in: J Virol. 2009 Sep;83(17):9022.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Sabbatini P, Tsuji T, Ferran L, Ritter E, Sedrak C, Tuballes K, Jungbluth AA, Ritter G, Aghajanian C, Bell-McGuinn K, Hensley ML, Konner J, Tew W, Spriggs DR, Hoffman EW, Venhaus R, Pan L, Salazar AM, Diefenbach CM, Old LJ, Gnjatic S. Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients. Clin Cancer Res. 2012 Dec 1;18(23):6497-508. doi: 10.1158/1078-0432.CCR-12-2189. Epub 2012 Oct 2.', 'Salazar AM, Levy HB, Ondra S, Kende M, Scherokman B, Brown D, Mena H, Martin N, Schwab K, Donovan D, Dougherty D, Pulliam M, Ippolito M, Graves M, Brown H, Ommaya A. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery. 1996 Jun;38(6):1096-103; discussion 1103-4.', 'Sultan H, Wu J, Kumai T, Salazar AM, Celis E. Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice. Cancer Immunol Immunother. 2018 Jul;67(7):1091-1103. doi: 10.1007/s00262-018-2164-6. Epub 2018 Apr 25.', 'Walberg K, Baron S, Poast J, Schwartz B, Izotova L, Pestka S, Peterson JW. Interferon protects mice against inhalation anthrax. J Interferon Cytokine Res. 2008 Oct;28(10):597-601. doi: 10.1089/jir.2007.0143.', 'Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29. Review.', 'Wong JP, Christopher ME, Viswanathan S, Dai X, Salazar AM, Sun LQ, Wang M. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses. Curr Pharm Des. 2009;15(11):1269-74. Review.', 'Wong JP, Saravolac EG, Sabuda D, Levy HB, Kende M. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob Agents Chemother. 1995 Nov;39(11):2574-6.', 'Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Interferon-Œ±2b Treatment for COVID-19. Front Immunol. 2020 May 15;11:1061. doi: 10.3389/fimmu.2020.01061. eCollection 2020. Erratum in: Front Immunol. 2020 Oct 27;11:615275.', 'Zhu X, Fallert-Junecko BA, Fujita M, Ueda R, Kohanbash G, Kastenhuber ER, McDonald HA, Liu Y, Kalinski P, Reinhart TA, Salazar AM, Okada H. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners. Cancer Immunol Immunother. 2010 Sep;59(9):1401-9. doi: 10.1007/s00262-010-0876-3. Epub 2010 Jun 12.', 'Field AK, Tytell AA, Piperno E, Lampson GP, Nemes MM, Hilleman MR. Poly I:C, an inducer of interferon and interference against virus infections. Medicine (Baltimore). 1972 May;51(3):169-74.', 'Gesuete R, Christensen SN, Bahjat FR, Packard AE, Stevens SL, Liu M, Salazar AM, Stenzel-Poore MP. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury. Stroke. 2016 Jan;47(1):262-6. doi: 10.1161/STROKEAHA.115.010329. Epub 2015 Nov 12.', 'Harrington DG, Crabbs CL, Hilmas DE, Brown JR, Higbee GA, Cole FE Jr, Levy HB. Adjuvant effects of low doses of a nuclease-resistant derivative of polyinosinic acid . polycytidylic acid on antibody responses of monkeys to inactivated Venezuelan equine encephalomyelitis virus vaccine. Infect Immun. 1979 Apr;24(1):160-6.', 'Ivanova A, Qaqish BF, Schell MJ. Continuous toxicity monitoring in phase II trials in oncology. Biometrics. 2005 Jun;61(2):540-5.', 'Levine AS, Sivulich M, Wiernik PH, Levy HB. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res. 1979 May;39(5):1645-50.', 'Martins KAO, Cooper CL, Stronsky SM, Norris SLW, Kwilas SA, Steffens JT, Benko JG, van Tongeren SA, Bavari S. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity. EBioMedicine. 2015 Nov 27;3:67-78. doi: 10.1016/j.ebiom.2015.11.041. eCollection 2016 Jan.', 'Okada H, Butterfield LH, Hamilton RL, Hoji A, Sakaki M, Ahn BJ, Kohanbash G, Drappatz J, Engh J, Amankulor N, Lively MO, Chan MD, Salazar AM, Shaw EG, Potter DM, Lieberman FS. Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC. Clin Cancer Res. 2015 Jan 15;21(2):286-94. doi: 10.1158/1078-0432.CCR-14-1790. Epub 2014 Nov 25.', 'Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro Oncol. 2010 Oct;12(10):1071-7. doi: 10.1093/neuonc/noq071. Epub 2010 Jul 8.', 'Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, L√∂rks V, Sikorski J, Hilker R, Becker D, Eller AK, Gr√ºtzner J, Boesler C, Rosenbaum C, K√ºhnle MC, Luxemburger U, Kemmer-Br√ºck A, Langer D, Bexon M, Bolte S, Karik√≥ K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, T√ºreci √ñ. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30. Erratum in: Nature. 2021 Feb;590(7844):E17.', 'Stephen EL, Hilmas DE, Mangiafico JA, Levy HB. Swine influenza virus vaccine: potentiation of antibody responses in rhesus monkeys. Science. 1977 Sep 23;197(4310):1289-90.', 'Food and Drug Administration, HHS. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice. Fed Regist. 2012 Feb 21;77(34):9948-9.']",2021-08-18,https://clinicaltrials.gov/show/NCT04672291,2022-12-31,0,1
5661,NCT04681079,Completed,2021-11-22,2022-01-18,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04681079,2021-11-22,0,0
5662,NCT04699058,"Active, not recruiting",2021-11-30,2021-12-31,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04699058,2021-11-30,0,0
5663,NCT04708236,Withdrawn,2021-05-01,2021-07-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04708236,2021-05-01,0,0
5664,NCT04713553,Completed,2021-07-22,2021-07-22,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04713553,2021-07-22,0,0
5665,NCT04721444,Recruiting,2022-08-01,2023-01-01,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04721444,2022-08-01,0,0
5666,NCT04724720,"Active, not recruiting",2021-05-03,2021-12-01,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04724720,2021-05-03,0,0
5667,NCT04738136,Suspended,2021-10-31,2021-12-31,No Results Posted,,,2021-08-23,https://clinicaltrials.gov/show/NCT04738136,2021-10-31,0,0
5668,NCT04739449,Withdrawn,2022-02-01,2022-03-01,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04739449,2022-02-01,0,0
5669,NCT04740658,Recruiting,2022-06-30,2022-12-31,No Results Posted,,,2021-08-31,https://clinicaltrials.gov/show/NCT04740658,2022-06-30,0,0
5670,NCT04745351,"Active, not recruiting",2022-04-01,2022-05-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04745351,2022-04-01,0,0
5671,NCT04753242,Completed,2021-10-03,2021-10-03,No Results Posted,,,2021-10-28,https://clinicaltrials.gov/show/NCT04753242,2021-10-03,0,0
5672,NCT04766645,Recruiting,2022-11-01,2023-01-01,No Results Posted,,,2021-11-18,https://clinicaltrials.gov/show/NCT04766645,2022-11-01,0,0
5673,NCT04784754,Recruiting,2022-09-30,2022-12-31,No Results Posted,,,2022-03-14,https://clinicaltrials.gov/show/NCT04784754,2022-09-30,0,0
5674,NCT04798027,"Active, not recruiting",2022-11-02,2022-11-02,No Results Posted,,,2021-11-19,https://clinicaltrials.gov/show/NCT04798027,2022-11-02,0,0
5675,NCT04801056,Withdrawn,2021-09-01,2021-09-01,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04801056,2021-09-01,0,0
5676,NCT04804072,Enrolling by invitation,2024-11-30,2024-11-30,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04804072,2024-11-30,0,0
5677,NCT04805216,"Active, not recruiting",2022-04-30,2022-07-31,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04805216,2022-04-30,0,0
5678,NCT04805892,Recruiting,2021-07-27,2021-08-17,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04805892,2021-07-27,0,0
5679,NCT04806113,"Active, not recruiting",2021-06-13,2022-06-15,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04806113,2021-06-13,0,0
5680,NCT04811664,Recruiting,2021-12-22,2021-12-22,No Results Posted,,,2021-08-09,https://clinicaltrials.gov/show/NCT04811664,2021-12-22,0,0
5681,NCT04822025,"Active, not recruiting",2021-08-25,2022-05-01,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04822025,2021-08-25,0,0
5682,NCT04826809,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04826809,2022-06-01,0,0
5683,NCT04830735,Not yet recruiting,2023-12-15,2024-12-15,No Results Posted,,,2021-10-18,https://clinicaltrials.gov/show/NCT04830735,2023-12-15,0,0
5684,NCT04842292,Recruiting,2022-02-28,2022-03-31,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04842292,2022-02-28,0,0
5685,NCT04843722,Withdrawn,2022-03-01,2022-08-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04843722,2022-03-01,0,0
5686,NCT04843761,Recruiting,2022-10-01,2023-04-01,No Results Posted,,,2022-03-15,https://clinicaltrials.gov/show/NCT04843761,2022-10-01,0,0
5687,NCT04845191,Withdrawn,2022-03-01,2022-08-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04845191,2022-03-01,0,0
5688,NCT04847050,Recruiting,2023-06-01,2024-02-25,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04847050,2023-06-01,0,0
5689,NCT04853979,Recruiting,2021-08-30,2021-09-16,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04853979,2021-08-30,0,0
5690,NCT04858633,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04858633,2021-06-30,0,0
5691,NCT04864561,Recruiting,2022-02-28,2023-03-16,No Results Posted,,,2021-10-29,https://clinicaltrials.gov/show/NCT04864561,2022-02-28,0,0
5692,NCT04867174,"Active, not recruiting",2021-08-15,2022-05-24,No Results Posted,,,2022-02-10,https://clinicaltrials.gov/show/NCT04867174,2021-08-15,0,0
5693,NCT04869397,Recruiting,2022-06-30,2022-07-30,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04869397,2022-06-30,0,0
5694,NCT04871854,Recruiting,2022-07-26,2022-08-26,No Results Posted,,,2022-03-18,https://clinicaltrials.gov/show/NCT04871854,2022-07-26,0,0
5695,NCT04872673,Completed,2020-07-13,2020-09-15,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04872673,2020-07-13,0,0
5696,NCT04873128,Recruiting,2022-07-01,2023-07-01,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04873128,2022-07-01,0,0
5697,NCT04877743,Terminated,2021-11-24,2021-11-24,No Results Posted,,,2021-12-29,https://clinicaltrials.gov/show/NCT04877743,2021-11-24,0,0
5698,NCT04880447,"Active, not recruiting",2022-05-06,2022-05-06,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04880447,2022-05-06,0,0
5699,NCT04880694,Recruiting,2021-11-01,2021-11-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04880694,2021-11-01,0,0
5700,NCT04885361,Recruiting,2021-09-30,2022-03-31,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04885361,2021-09-30,0,0
5701,NCT04885530,Recruiting,2022-12-01,2023-03-01,No Results Posted,"['Dodds MG, Doyle EB, Reiersen AM, Brown F, Rayner CR. Fluvoxamine for the treatment of COVID-19. Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7.']",,2021-12-23,https://clinicaltrials.gov/show/NCT04885530,2022-12-01,0,1
5702,NCT04887948,Completed,2021-12-08,2021-12-08,No Results Posted,,,2022-03-25,https://clinicaltrials.gov/show/NCT04887948,2021-12-08,0,0
5703,NCT04894435,Recruiting,2023-03-01,2023-04-01,No Results Posted,,,2022-03-08,https://clinicaltrials.gov/show/NCT04894435,2023-03-01,0,0
5704,NCT04894474,Withdrawn,2022-05-23,2022-07-24,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-08,https://clinicaltrials.gov/show/NCT04894474,2022-05-23,0,1
5705,NCT04898179,Completed,2021-12-31,2022-01-16,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04898179,2021-12-31,0,0
5706,NCT04900467,"Active, not recruiting",2021-07-02,2022-01-01,No Results Posted,,,2021-08-03,https://clinicaltrials.gov/show/NCT04900467,2021-07-02,0,0
5707,NCT04902183,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04902183,2021-09-01,0,0
5708,NCT04904549,Recruiting,2023-04-13,2023-04-13,No Results Posted,,,2022-03-16,https://clinicaltrials.gov/show/NCT04904549,2023-04-13,0,0
5709,NCT04904783,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-07-27,https://clinicaltrials.gov/show/NCT04904783,2021-12-31,0,0
5710,NCT04907981,Completed,2021-04-26,2021-04-26,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04907981,2021-04-26,0,0
5711,NCT04910269,Recruiting,2023-08-01,2023-08-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04910269,2023-08-01,0,0
5712,NCT04910360,Enrolling by invitation,2021-05-08,2022-08-30,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04910360,2021-05-08,0,0
5713,NCT04910607,Recruiting,2022-10-01,2022-10-01,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04910607,2022-10-01,0,0
5714,NCT04910880,Completed,2021-06-15,2021-06-30,No Results Posted,,,2021-07-02,https://clinicaltrials.gov/show/NCT04910880,2021-06-15,0,0
5715,NCT04910932,Completed,2021-09-14,2021-09-14,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04910932,2021-09-14,0,0
5716,NCT04913675,"Active, not recruiting",2021-09-18,2022-08-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-17,https://clinicaltrials.gov/show/NCT04913675,2021-09-18,0,1
5717,NCT04916574,Completed,2021-03-28,2021-06-03,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04916574,2021-03-28,0,0
5718,NCT04916821,"Active, not recruiting",2021-07-15,2021-08-15,No Results Posted,,,2021-06-08,https://clinicaltrials.gov/show/NCT04916821,2021-07-15,0,0
5719,NCT04916834,Recruiting,2021-11-30,2022-11-30,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04916834,2021-11-30,0,0
5720,NCT04916847,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-01-14,https://clinicaltrials.gov/show/NCT04916847,2022-12-01,0,0
5721,NCT04918160,Completed,2021-07-02,2021-07-02,No Results Posted,['SRLF Trial Group. Sanitary safety of the 2021 French Intensive Care Society medical conference: a case/control study. Ann Intensive Care. 2022 Feb 11;12(1):11. doi: 10.1186/s13613-022-00986-x.'],,2021-10-21,https://clinicaltrials.gov/show/NCT04918160,2021-07-02,0,1
5722,NCT04918849,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04918849,2021-12-31,0,0
5723,NCT04918875,Not yet recruiting,2022-06-30,2022-06-30,No Results Posted,,,2021-10-05,https://clinicaltrials.gov/show/NCT04918875,2022-06-30,0,0
5724,NCT04918888,Completed,2021-09-30,2021-09-30,No Results Posted,,,2021-11-23,https://clinicaltrials.gov/show/NCT04918888,2021-09-30,0,0
5725,NCT04918901,"Active, not recruiting",2021-05-01,2022-05-01,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04918901,2021-05-01,0,0
5726,NCT04918914,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04918914,2021-12-31,0,0
5727,NCT04918927,Recruiting,2022-01-01,2022-03-01,No Results Posted,,,2021-10-19,https://clinicaltrials.gov/show/NCT04918927,2022-01-01,0,0
5728,NCT04918940,Recruiting,2021-08-21,2022-05-21,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04918940,2021-08-21,0,0
5729,NCT04919031,"Active, not recruiting",2022-02-23,2022-04-01,No Results Posted,,,2022-02-28,https://clinicaltrials.gov/show/NCT04919031,2022-02-23,0,0
5730,NCT04920357,Recruiting,2022-03-31,2024-12-31,No Results Posted,,,2021-06-09,https://clinicaltrials.gov/show/NCT04920357,2022-03-31,0,0
5731,NCT04920760,Not yet recruiting,2021-11-21,2021-12-19,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04920760,2021-11-21,0,0
5732,NCT04920773,Completed,2021-05-21,2021-06-06,No Results Posted,,,2021-06-10,https://clinicaltrials.gov/show/NCT04920773,2021-05-21,0,0
5733,NCT04920838,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-06-10,https://clinicaltrials.gov/show/NCT04920838,2021-12-01,0,0
5734,NCT04920851,Recruiting,2021-07-05,2021-07-20,No Results Posted,,"['Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, Zeng X, Zhang S. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25. Review.', 'Esmaeili Vardanjani A, Ronco C, Rafiei H, Golitaleb M, Pishvaei MH, Mohammadi M. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19. Blood Purif. 2021;50(2):257-260. doi: 10.1159/000509107. Epub 2020 Jun 26.', 'Houschyar KS, Pyles MN, Rein S, Nietzschmann I, Duscher D, Maan ZN, Weissenberg K, Philipps HM, Strauss C, Reichelt B, Siemers F. Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature. Int J Artif Organs. 2017 May 29;40(5):205-211. doi: 10.5301/ijao.5000591. Epub 2017 May 19. Review.']",2021-06-10,https://clinicaltrials.gov/show/NCT04920851,2021-07-05,0,1
5735,NCT04920890,Completed,2021-07-20,2021-11-29,No Results Posted,,,2021-12-23,https://clinicaltrials.gov/show/NCT04920890,2021-07-20,0,0
5736,NCT04920916,Completed,2021-12-09,2022-01-10,No Results Posted,,,2022-01-31,https://clinicaltrials.gov/show/NCT04920916,2021-12-09,0,0
5737,NCT04921228,Recruiting,2022-03-01,2022-04-01,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04921228,2022-03-01,0,0
5738,NCT04921241,Enrolling by invitation,2023-06-07,2023-06-07,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04921241,2023-06-07,0,0
5739,NCT04922632,Not yet recruiting,2022-10-01,2022-10-01,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04922632,2022-10-01,0,0
5740,NCT04922788,Recruiting,2022-07-07,2022-08-07,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04922788,2022-07-07,0,0
5741,NCT04922814,Not yet recruiting,2022-03-01,2022-08-01,No Results Posted,,"['Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020 Apr 16;55(4). pii: 2000607. doi: 10.1183/13993003.00607-2020. Print 2020 Apr.', 'Neto AS, Pereira VG, Esp√≥sito DC, Damasceno MC, Schultz MJ. Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials. Ann Intensive Care. 2012 Jul 26;2(1):33. doi: 10.1186/2110-5820-2-33.', 'Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Gu√©rin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.']",2021-06-11,https://clinicaltrials.gov/show/NCT04922814,2022-03-01,0,1
5742,NCT04922827,Recruiting,2022-09-01,2023-07-01,No Results Posted,,,2021-07-07,https://clinicaltrials.gov/show/NCT04922827,2022-09-01,0,0
5743,NCT04922905,Completed,2020-05-07,2021-04-02,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04922905,2020-05-07,0,0
5744,NCT04922918,Recruiting,2021-06-24,2021-07-01,No Results Posted,,,2021-06-11,https://clinicaltrials.gov/show/NCT04922918,2021-06-24,0,0
5745,NCT04922931,Completed,2021-03-05,2021-04-05,No Results Posted,,,2021-09-02,https://clinicaltrials.gov/show/NCT04922931,2021-03-05,0,0
5746,NCT04922957,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04922957,2022-06-01,0,0
5747,NCT04923061,Recruiting,2021-06-30,2022-07-01,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04923061,2021-06-30,0,0
5748,NCT04923386,Recruiting,2021-09-15,2021-10-15,No Results Posted,,,2021-09-08,https://clinicaltrials.gov/show/NCT04923386,2021-09-15,0,0
5749,NCT04924634,Completed,2021-03-15,2021-04-23,No Results Posted,,,2021-07-12,https://clinicaltrials.gov/show/NCT04924634,2021-03-15,0,0
5750,NCT04924660,Recruiting,2023-02-10,2023-04-15,No Results Posted,,,2022-03-09,https://clinicaltrials.gov/show/NCT04924660,2023-02-10,0,0
5751,NCT04924790,Recruiting,2022-05-01,2022-08-01,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04924790,2022-05-01,0,0
5752,NCT04924803,Not yet recruiting,2023-06-01,2023-12-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04924803,2023-06-01,0,0
5753,NCT04924816,Completed,2020-08-21,2020-12-26,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04924816,2020-08-21,0,0
5754,NCT04924829,Recruiting,2021-07-01,2021-08-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04924829,2021-07-01,0,0
5755,NCT04924842,Completed,2021-10-28,2021-10-28,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04924842,2021-10-28,0,0
5756,NCT04924855,Recruiting,2022-07-01,2022-08-01,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04924855,2022-07-01,0,0
5757,NCT04924881,Recruiting,2023-01-31,2023-06-30,No Results Posted,,,2022-01-28,https://clinicaltrials.gov/show/NCT04924881,2023-01-31,0,0
5758,NCT04924894,Not yet recruiting,2021-11-30,2022-06-10,No Results Posted,,,2021-06-14,https://clinicaltrials.gov/show/NCT04924894,2021-11-30,0,0
5759,NCT04925258,Recruiting,2021-06-30,2021-09-30,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04925258,2021-06-30,0,0
5760,NCT04926441,Completed,2021-03-01,2021-04-30,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04926441,2021-03-01,0,0
5761,NCT04930016,Completed,2021-10-07,2021-10-07,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04930016,2021-10-07,0,0
5762,NCT04930185,Not yet recruiting,2022-12-31,2023-01-31,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04930185,2022-12-31,0,0
5763,NCT04546581,Completed,2021-05-21,2021-05-21,Results Submitted,"['ITAC (INSIGHT 013) Study Group. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Lancet. 2022 Feb 5;399(10324):530-540. doi: 10.1016/S0140-6736(22)00101-5. Epub 2022 Jan 28.', 'Vandeberg P, Cruz M, Diez JM, Merritt WK, Santos B, Trukawinski S, Wellhouse A, Jose M, Willis T. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma. Transfusion. 2021 Jun;61(6):1705-1709. doi: 10.1111/trf.16378. Epub 2021 Mar 22.']",,2022-02-10,https://clinicaltrials.gov/show/NCT04546581,2021-05-21,0,1
5764,NCT04590547,Recruiting,2022-05-01,2022-09-01,No Results Posted,,,2022-03-29,https://clinicaltrials.gov/show/NCT04590547,2022-05-01,0,0
5765,NCT04667780,Completed,2021-07-09,2021-07-09,No Results Posted,,,2021-11-02,https://clinicaltrials.gov/show/NCT04667780,2021-07-09,0,0
5766,NCT04669015,Recruiting,2022-08-01,2022-08-01,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04669015,2022-08-01,0,0
5767,NCT04674189,"Active, not recruiting",2022-06-30,2022-07-12,No Results Posted,,,2022-02-25,https://clinicaltrials.gov/show/NCT04674189,2022-06-30,0,0
5768,NCT04684615,Enrolling by invitation,2022-07-31,2022-07-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04684615,2022-07-31,0,0
5769,NCT04698993,Terminated,2021-03-22,2021-03-22,Study Results,,,2021-07-20,https://clinicaltrials.gov/show/NCT04698993,2021-03-22,1,0
5770,NCT04699903,Completed,2021-01-29,2021-04-09,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04699903,2021-01-29,0,0
5771,NCT04701658,Completed,2021-06-22,2021-06-22,Study Results,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-16,https://clinicaltrials.gov/show/NCT04701658,2021-06-22,1,1
5772,NCT04703205,"Active, not recruiting",2021-10-22,2022-05-31,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04703205,2021-10-22,0,0
5773,NCT04705597,Recruiting,2022-09-01,2022-09-01,No Results Posted,,,2022-02-18,https://clinicaltrials.gov/show/NCT04705597,2022-09-01,0,0
5774,NCT04707664,Completed,2021-12-28,2022-01-31,No Results Posted,,,2022-03-10,https://clinicaltrials.gov/show/NCT04707664,2021-12-28,0,0
5775,NCT04723394,"Active, not recruiting",2021-08-21,2022-10-21,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-03-18,https://clinicaltrials.gov/show/NCT04723394,2021-08-21,0,1
5776,NCT04723537,"Active, not recruiting",2022-09-01,2022-09-01,No Results Posted,,,2021-11-16,https://clinicaltrials.gov/show/NCT04723537,2022-09-01,0,0
5777,NCT04728802,Completed,2021-04-15,2021-04-15,Study Results,,,2021-06-24,https://clinicaltrials.gov/show/NCT04728802,2021-04-15,1,0
5778,NCT04734873,Terminated,2021-08-18,2021-08-18,No Results Posted,,,2022-03-28,https://clinicaltrials.gov/show/NCT04734873,2021-08-18,0,0
5779,NCT04750629,Completed,2021-05-07,2021-05-14,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04750629,2021-05-07,0,0
5780,NCT04751682,"Active, not recruiting",2021-06-25,2021-11-30,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04751682,2021-06-25,0,0
5781,NCT04753619,Recruiting,2021-12-03,2021-12-03,Results Submitted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04753619,2021-12-03,0,0
5782,NCT04754594,"Active, not recruiting",2022-08-24,2022-08-24,No Results Posted,,,2022-02-23,https://clinicaltrials.gov/show/NCT04754594,2022-08-24,0,0
5783,NCT04754698,"Active, not recruiting",2021-12-30,2022-05-31,No Results Posted,"[""Pasoto SG, Halpern ASR, Guedes LKN, Ribeiro ACM, Yuki ENF, Saad CGS, da Silva CAA, de Vinci Kanda Kupa L, Villamar√≠n LEB, de Oliveira Martins VA, Martins CCMF, Deveza GBH, Leon EP, Bueno C, Pedrosa TN, Santos REB, Soares R, Aikawa NE, Bonfa E. Inactivated SARS-CoV-2 vaccine in primary Sj√∂gren's syndrome: humoral response, safety, and effects on disease activity. Clin Rheumatol. 2022 Mar 19. doi: 10.1007/s10067-022-06134-x. [Epub ahead of print]"", 'Aikawa NE, Kupa LVK, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Rojo PT, Pereira RMR, Shinjo SK, Sampaio-Barros PD, Andrade DCO, Halpern ASR, Fuller R, Souza FHC, Guedes LKN, Assad APL, Moraes JCB, Lopes MRU, Martins VAO, Betancourt L, Ribeiro CT, Sales LP, Bertoglio IM, Bonoldi VLN, Mello RLP, Balbi GGM, Sartori AMC, Antonangelo L, Silva CA, Bonfa E. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Ann Rheum Dis. 2022 Mar 11. pii: annrheumdis-2021-222096. doi: 10.1136/annrheumdis-2021-222096. [Epub ahead of print]', 'Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, da Silva HC, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CA, Pedrosa T, Kupa LVK, Silva MSR, Balbi GGM, Kallas EG, Aikawa NE, Bonfa E. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Ann Rheum Dis. 2022 Feb 8. pii: annrheumdis-2021-221735. doi: 10.1136/annrheumdis-2021-221735. [Epub ahead of print]', 'Gualano B, Lemes IR, Silva RP, Pinto AJ, Mazzolani BC, Smaira FI, Sieczkowska SM, Aikawa NE, Pasoto SG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Silva CA, Swinton P, Hallal PC, Roschel H, Bonfa E. Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases. Brain Behav Immun. 2022 Mar;101:49-56. doi: 10.1016/j.bbi.2021.12.016. Epub 2021 Dec 23.', 'Aikawa NE, Kupa LVK, Pasoto SG, Medeiros-Ribeiro AC, Yuki EFN, Saad CGS, Pedrosa T, Fuller R, Shinjo SK, Sampaio-Barros PD, Andrade DCO, Pereira RMR, Seguro LPC, Valim JML, Waridel F, Sartori AMC, Duarte AJS, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CA, Bonfa E. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet Rheumatol. 2022 Feb;4(2):e113-e124. doi: 10.1016/S2665-9913(21)00327-1. Epub 2021 Dec 3.', 'Sampaio-Barros PD, Medeiros-Ribeiro AC, Luppino-Assad AP, Miossi R, Carri√ßo da Silva H, Yuki EFVN, Pasoto SG, Saad CGS, Silva CA, Kupa LVK, Deveza GBH, Pedrosa TN, Aikawa NE, Bonf√° E. SARS-CoV-2 vaccine in patients with systemic sclerosis: Impact of disease subtype and therapy. Rheumatology (Oxford). 2021 Dec 11. pii: keab886. doi: 10.1093/rheumatology/keab886. [Epub ahead of print]', 'Yuki EFN, Borba EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Medeiros-Ribeiro AC, Silva CA, de Andrade DCO, Kupa LVK, Betancourt L, Bertoglio I, Valim J, Hoff C, Formiga FFC, Pedrosa T, Kallas EG, Aikawa NE, Bonfa E. Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2022 Apr;74(4):562-571. doi: 10.1002/acr.24824. Epub 2022 Mar 4.', 'Shinjo SK, de Souza FHC, Borges IBP, Dos Santos AM, Miossi R, Misse RG, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Kupa LVK, Ceneviva C, Seraphim JC, Pedrosa TN, Vendramini MBG, Silva CA, Aikawa NE, Bonf√° E. Systemic autoimmune myopathies: A prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2. Rheumatology (Oxford). 2021 Oct 19. pii: keab773. doi: 10.1093/rheumatology/keab773. [Epub ahead of print]', 'Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, Rojo PT, Pereira RMR, Shinjo SK, Andrade DCO, Sampaio-Barros PD, Ribeiro CT, Deveza GBH, Martins VAO, Silva CA, Lopes MH, Duarte AJS, Antonangelo L, Sabino EC, Kallas EG, Pasoto SG, Bonfa E. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med. 2021 Oct;27(10):1744-1751. doi: 10.1038/s41591-021-01469-5. Epub 2021 Jul 30.']",,2021-10-14,https://clinicaltrials.gov/show/NCT04754698,2021-12-30,0,1
5784,NCT04758962,"Active, not recruiting",2021-06-04,2022-05-02,No Results Posted,,,2021-12-27,https://clinicaltrials.gov/show/NCT04758962,2021-06-04,0,0
5785,NCT04761822,Recruiting,2022-02-01,2022-03-01,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04761822,2022-02-01,0,0
5786,NCT04765540,Completed,2021-05-06,2021-05-06,No Results Posted,,,2021-07-22,https://clinicaltrials.gov/show/NCT04765540,2021-05-06,0,0
5787,NCT04766294,Completed,2021-03-15,2021-04-01,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04766294,2021-03-15,0,0
5788,NCT04776317,Recruiting,2022-09-19,2022-09-19,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04776317,2022-09-19,0,0
5789,NCT04780698,"Active, not recruiting",2022-03-01,2022-07-01,No Results Posted,,,2022-01-11,https://clinicaltrials.gov/show/NCT04780698,2022-03-01,0,0
5790,NCT04782700,Withdrawn,2021-06-08,2021-06-08,No Results Posted,,,2022-02-16,https://clinicaltrials.gov/show/NCT04782700,2021-06-08,0,0
5791,NCT04784559,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04784559,2022-12-01,0,0
5792,NCT04785144,"Active, not recruiting",2022-08-31,2022-08-31,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04785144,2022-08-31,0,0
5793,NCT04794829,Recruiting,2026-12-31,2026-12-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04794829,2026-12-31,0,0
5794,NCT04794946,Recruiting,2022-03-19,2022-03-19,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04794946,2022-03-19,0,0
5795,NCT04795583,Not yet recruiting,2022-04-01,2022-08-01,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04795583,2022-04-01,0,0
5796,NCT04796896,Recruiting,2023-06-12,2023-06-12,No Results Posted,"['Lynch LR, Clifford H, Ko R, Hache M, Sun W. Primer of COVID-19 Vaccines for the Perioperative Physician. J Neurosurg Anesthesiol. 2022 Jan 1;34(1):101-106. doi: 10.1097/ANA.0000000000000802.']",,2021-12-21,https://clinicaltrials.gov/show/NCT04796896,2023-06-12,0,1
5797,NCT04805125,Recruiting,2022-07-01,2022-07-01,No Results Posted,"['Speich B, Chammartin F, Smith D, Stoeckle MP, Amico P, Eichenberger AL, Hasse B, Schuurmans MM, M√ºller T, Tamm M, Dickenmann M, Abela IA, Trkola A, Hirsch HH, Manuel O, Cavassini M, Hemkens LG, Briel M, Mueller NJ, Rauch A, G√ºnthard HF, Koller MT, Bucher HC, Kusejko K; study groups from the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty¬Æ and COVID-19 mRNA Vaccine Moderna¬Æ. Trials. 2021 Oct 21;22(1):724. doi: 10.1186/s13063-021-05664-0.']",,2022-02-02,https://clinicaltrials.gov/show/NCT04805125,2022-07-01,0,1
5798,NCT04815031,"Active, not recruiting",2022-10-22,2022-12-03,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04815031,2022-10-22,0,0
5799,NCT04818164,Completed,2021-09-30,2022-03-01,No Results Posted,,,2022-03-04,https://clinicaltrials.gov/show/NCT04818164,2021-09-30,0,0
5800,NCT04818216,Recruiting,2022-06-01,2023-06-01,No Results Posted,,,2021-08-05,https://clinicaltrials.gov/show/NCT04818216,2022-06-01,0,0
5801,NCT04818320,Completed,2021-07-01,2021-07-13,No Results Posted,,,2021-11-24,https://clinicaltrials.gov/show/NCT04818320,2021-07-01,0,0
5802,NCT04821531,Withdrawn,2022-02-23,2022-12-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04821531,2022-02-23,0,0
5803,NCT04822701,Terminated,2021-07-02,2021-10-04,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-11-19,https://clinicaltrials.gov/show/NCT04822701,2021-07-02,0,1
5804,NCT04823988,"Active, not recruiting",2022-11-30,2022-11-30,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04823988,2022-11-30,0,0
5805,NCT04824443,Recruiting,2023-03-29,2023-03-29,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04824443,2023-03-29,0,0
5806,NCT04826588,Recruiting,2022-07-01,2022-07-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-12-23,https://clinicaltrials.gov/show/NCT04826588,2022-07-01,0,1
5807,NCT04830033,Completed,2021-09-23,2021-09-23,No Results Posted,,,2021-12-03,https://clinicaltrials.gov/show/NCT04830033,2021-09-23,0,0
5808,NCT04832932,Recruiting,2022-06-15,2022-12-31,No Results Posted,,,2022-03-17,https://clinicaltrials.gov/show/NCT04832932,2022-06-15,0,0
5809,NCT04836806,Withdrawn,2022-07-01,2022-07-01,No Results Posted,,,2021-08-20,https://clinicaltrials.gov/show/NCT04836806,2022-07-01,0,0
5810,NCT04843930,Recruiting,2022-07-01,2022-09-01,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04843930,2022-07-01,0,0
5811,NCT04844242,Recruiting,2021-12-22,2021-12-22,No Results Posted,,,2021-09-20,https://clinicaltrials.gov/show/NCT04844242,2021-12-22,0,0
5812,NCT04844307,Withdrawn,2022-02-01,2022-02-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04844307,2022-02-01,0,0
5813,NCT04844489,Recruiting,2023-04-16,2023-07-31,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04844489,2023-04-16,0,0
5814,NCT04852289,Recruiting,2023-03-31,2024-03-31,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04852289,2023-03-31,0,0
5815,NCT04852822,Recruiting,2022-08-08,2024-08-08,No Results Posted,,,2022-03-24,https://clinicaltrials.gov/show/NCT04852822,2022-08-08,0,0
5816,NCT04854772,Recruiting,2022-05-01,2022-08-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04854772,2022-05-01,0,0
5817,NCT04858789,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04858789,2022-12-01,0,0
5818,NCT04859517,"Active, not recruiting",2022-07-01,2023-03-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2022-01-24,https://clinicaltrials.gov/show/NCT04859517,2022-07-01,0,1
5819,NCT04864548,Recruiting,2022-11-01,2022-11-01,No Results Posted,,,2022-01-20,https://clinicaltrials.gov/show/NCT04864548,2022-11-01,0,0
5820,NCT04867226,Completed,2021-06-18,2021-06-18,No Results Posted,"['Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 18;10:CD015045. doi: 10.1002/14651858.CD015045. Review.']",,2021-06-22,https://clinicaltrials.gov/show/NCT04867226,2021-06-18,0,1
5821,NCT04870593,"Active, not recruiting",2023-07-10,2023-07-10,No Results Posted,,,2021-11-17,https://clinicaltrials.gov/show/NCT04870593,2023-07-10,0,0
5822,NCT04872075,Completed,2021-06-13,2021-06-13,No Results Posted,"['Delaugerre C, Foissac F, Abdoul H, Masson G, Choupeaux L, Dufour E, Gastli N, Delarue SM, N√©r√© ML, Minier M, Gabassi A, Salmona M, Seguineau M, Schmitt S, Tonglet S, Olivier A, Poyart C, Le Goff J, Lescure X, Kern√©is S, Tr√©luyer JM; SPRING study group. Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial. Lancet Infect Dis. 2022 Mar;22(3):341-348. doi: 10.1016/S1473-3099(21)00673-3. Epub 2021 Nov 26.']",,2021-07-13,https://clinicaltrials.gov/show/NCT04872075,2021-06-13,0,1
5823,NCT04878055,Completed,2021-09-30,2021-10-31,No Results Posted,,,2022-01-18,https://clinicaltrials.gov/show/NCT04878055,2021-09-30,0,0
5824,NCT04878809,Completed,2021-06-17,2021-06-17,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04878809,2021-06-17,0,0
5825,NCT04881227,Recruiting,2023-05-01,2023-05-01,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04881227,2023-05-01,0,0
5826,NCT04888949,Recruiting,2022-09-30,2022-09-30,No Results Posted,,,2021-09-10,https://clinicaltrials.gov/show/NCT04888949,2022-09-30,0,0
5827,NCT04889209,Recruiting,2022-12-01,2022-12-01,No Results Posted,"[""Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW Jr, B√§cker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group. Homologous and Heterologous Covid-19 Booster Vaccinations. N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26."", ""Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, B√§cker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobryzynski D, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek J, Islas CPD, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O'Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH; DMID 21-0012 Study Group. Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report. medRxiv. 2021 Oct 15. pii: 2021.10.10.21264827. doi: 10.1101/2021.10.10.21264827.""]",,2022-03-08,https://clinicaltrials.gov/show/NCT04889209,2022-12-01,0,1
5828,NCT04894448,Recruiting,2022-03-31,2023-07-31,No Results Posted,"['Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open. 2021 Dec 16;11(12):e054208. doi: 10.1136/bmjopen-2021-054208.']",,2021-10-15,https://clinicaltrials.gov/show/NCT04894448,2022-03-31,0,1
5829,NCT04896060,Recruiting,2023-07-15,2023-07-15,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04896060,2023-07-15,0,0
5830,NCT04902911,Recruiting,2022-03-17,2022-03-17,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04902911,2022-03-17,0,0
5831,NCT04910282,Not yet recruiting,2021-12-01,2021-12-31,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04910282,2021-12-01,0,0
5832,NCT04911777,Recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-12-17,https://clinicaltrials.gov/show/NCT04911777,2021-12-01,0,0
5833,NCT04912284,Completed,2021-06-06,2021-06-06,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04912284,2021-06-06,0,0
5834,NCT04915820,Completed,2021-09-09,2021-09-09,No Results Posted,,,2021-09-14,https://clinicaltrials.gov/show/NCT04915820,2021-09-09,0,0
5835,NCT04920942,Completed,2021-10-31,2021-10-31,No Results Posted,"['Lim SCL, Hor CP, Tay KH, Mat Jelani A, Tan WH, Ker HB, Chow TS, Zaid M, Cheah WK, Lim HH, Khalid KE, Cheng JT, Mohd Unit H, An N, Nasruddin AB, Low LL, Khoo SWR, Loh JH, Zaidan NZ, Ab Wahab S, Song LH, Koh HM, King TL, Lai NM, Chidambaram SK, Peariasamy KM; I-TECH Study Group. Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial. JAMA Intern Med. 2022 Feb 18. doi: 10.1001/jamainternmed.2022.0189. [Epub ahead of print]']",,2021-12-08,https://clinicaltrials.gov/show/NCT04920942,2021-10-31,0,1
5836,NCT04922944,"Active, not recruiting",2022-02-01,2022-02-01,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04922944,2022-02-01,0,0
5837,NCT04924673,Completed,2021-03-05,2021-04-22,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04924673,2021-03-05,0,0
5838,NCT04925908,Recruiting,2021-12-12,2021-12-31,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04925908,2021-12-12,0,0
5839,NCT04925999,Enrolling by invitation,2021-09-01,2021-09-01,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04925999,2021-09-01,0,0
5840,NCT04926428,Completed,2021-03-30,2021-03-30,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04926428,2021-03-30,0,0
5841,NCT04926571,"Active, not recruiting",2021-12-31,2022-06-30,No Results Posted,,,2022-02-15,https://clinicaltrials.gov/show/NCT04926571,2021-12-31,0,0
5842,NCT04926779,Recruiting,2021-09-20,2021-09-21,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04926779,2021-09-20,0,0
5843,NCT04927065,Recruiting,2023-03-31,2023-03-31,No Results Posted,"['Chalkias S, Schwartz H, Nestorova B, Feng J, Chang Y, Zhou H, Dutko FJ, Edwards DK, Montefiori D, Pajon R, Leav B, Miller JM, Das R. Safety and Immunogenicity of a 100 Œºg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). medRxiv. 2022 Mar 7. pii: 2022.03.04.22271830. doi: 10.1101/2022.03.04.22271830.']",,2022-03-18,https://clinicaltrials.gov/show/NCT04927065,2023-03-31,0,1
5844,NCT04927078,Completed,2020-10-31,2020-10-31,No Results Posted,,,2021-06-15,https://clinicaltrials.gov/show/NCT04927078,2020-10-31,0,0
5845,NCT04927169,Recruiting,2021-12-30,2022-06-30,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. Erratum in: JAMA. 2021 Mar 16;325(11):1113.', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Boh√© J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2009 Apr;35(4):678-86. doi: 10.1007/s00134-008-1337-8. Epub 2008 Oct 23.']",2021-06-18,https://clinicaltrials.gov/show/NCT04927169,2021-12-30,0,1
5846,NCT04927182,Completed,2021-09-30,2021-09-30,No Results Posted,,,2021-10-20,https://clinicaltrials.gov/show/NCT04927182,2021-09-30,0,0
5847,NCT04927442,Recruiting,2023-01-31,2025-04-01,No Results Posted,,,2022-04-01,https://clinicaltrials.gov/show/NCT04927442,2023-01-31,0,0
5848,NCT04927845,Enrolling by invitation,2022-05-31,2022-06-30,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04927845,2022-05-31,0,0
5849,NCT04927936,Recruiting,2022-09-01,2022-09-01,No Results Posted,"['Sablerolles RSG, Rietdijk WJR, Goorhuis A, Postma DF, Visser LG, Geers D, Schmitz KS, Garcia Garrido HM, Koopmans MPG, Dalm VASH, Kootstra NA, Huckriede ALW, Lafeber M, van Baarle D, GeurtsvanKessel CH, de Vries RD, van der Kuy PHM; SWITCH Research Group. Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming. N Engl J Med. 2022 Mar 10;386(10):951-963. doi: 10.1056/NEJMoa2116747. Epub 2022 Jan 19.']",,2021-06-30,https://clinicaltrials.gov/show/NCT04927936,2022-09-01,0,1
5850,NCT04928430,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2021-11-29,https://clinicaltrials.gov/show/NCT04928430,2022-04-01,0,0
5851,NCT04928456,Recruiting,2022-09-01,2022-12-30,No Results Posted,,,2021-06-16,https://clinicaltrials.gov/show/NCT04928456,2022-09-01,0,0
5852,NCT04928469,Completed,2021-07-16,2021-07-16,No Results Posted,,,2021-07-20,https://clinicaltrials.gov/show/NCT04928469,2021-07-16,0,0
5853,NCT04928495,Not yet recruiting,2022-04-09,2022-06-09,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04928495,2022-04-09,0,0
5854,NCT04928911,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04928911,2021-12-01,0,0
5855,NCT04929691,Recruiting,2021-12-01,2021-12-01,No Results Posted,"['Ahonkhai AA, Musa AZ, Fenton AA, Aliyu MH, Ofotokun I, Hornstein A, Musa BM, Nwosu N, Ulasi I, Ajayi S, Falade C, Dada A, Abdu A, Sunday M, Odewabi A, Rotimi MK, Ogueh O, Steinbach A, Ogedegbe G, Salako BL, Ezechi OC. The CircumVent Project: a CPAP/O(2) helmet solution for non-invasive ventilation using an implementation research framework. Implement Sci Commun. 2021 Aug 26;2(1):93. doi: 10.1186/s43058-021-00193-y.']",,2021-06-23,https://clinicaltrials.gov/show/NCT04929691,2021-12-01,0,1
5856,NCT04929964,Completed,2021-01-31,2021-01-31,No Results Posted,,"['Elghazawy H, Bakkach J, Zaghloul MS, Abusanad A, Hussein MM, Alorabi M, Eldin NB, Helal T, Zaghloul TM, Venkatesulu BP, Elghazaly H, Al-Sukhun S. Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol. 2020 Nov;16(31):2551-2567. doi: 10.2217/fon-2020-0574. Epub 2020 Jul 27. Review.']",2021-08-11,https://clinicaltrials.gov/show/NCT04929964,2021-01-31,0,1
5857,NCT04930003,"Active, not recruiting",2021-12-01,2021-12-01,No Results Posted,,,2021-07-29,https://clinicaltrials.gov/show/NCT04930003,2021-12-01,0,0
5858,NCT04930055,Recruiting,2023-08-11,2023-08-11,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04930055,2023-08-11,0,0
5859,NCT04930120,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04930120,2021-12-31,0,0
5860,NCT04930731,Not yet recruiting,2022-06-01,2022-09-01,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04930731,2022-06-01,0,0
5861,NCT04930757,Recruiting,2022-02-01,2022-04-01,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04930757,2022-02-01,0,0
5862,NCT04930770,Not yet recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-06-18,https://clinicaltrials.gov/show/NCT04930770,2021-12-01,0,0
5863,NCT04930861,Completed,2021-05-27,2021-08-09,No Results Posted,,,2021-11-02,https://clinicaltrials.gov/show/NCT04930861,2021-05-27,0,0
5864,NCT04930874,Recruiting,2022-07-16,2022-07-16,No Results Posted,,,2022-01-04,https://clinicaltrials.gov/show/NCT04930874,2022-07-16,0,0
5865,NCT04930965,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2021-10-14,https://clinicaltrials.gov/show/NCT04930965,2022-03-31,0,0
5866,NCT04930978,Recruiting,2023-06-01,2023-06-01,No Results Posted,,,2021-09-24,https://clinicaltrials.gov/show/NCT04930978,2023-06-01,0,0
5867,NCT04931004,Not yet recruiting,2021-12-01,2022-02-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04931004,2021-12-01,0,0
5868,NCT04931238,Recruiting,2021-12-31,2022-12-31,No Results Posted,"['Dong R, Jiang L, Yang T, Wang C, Zhang Y, Chen X, Xie J, Guo Y, Weng L, Kang Y, Yu K, Qiu H, Du B; China Critical Care Clinical Trials Group (CCCCTG). Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0204521. doi: 10.1128/AAC.02045-21. Epub 2022 Mar 15.']","['Yang L, Liu W, Yu X, Wu M, Reichert JM, Ho M. COVID-19 antibody therapeutics tracker: a global online database of antibody therapeutics for the prevention and treatment of COVID-19. Antib Ther. 2020 Jul;3(3):205-212. doi: 10.1093/abt/tbaa020. Epub 2020 Aug 19. Review.']",2021-10-21,https://clinicaltrials.gov/show/NCT04931238,2021-12-31,0,1
5869,NCT04931888,Not yet recruiting,2022-10-31,2022-10-31,No Results Posted,,,2022-03-28,https://clinicaltrials.gov/show/NCT04931888,2022-10-31,0,0
5870,NCT04932824,Completed,2021-11-10,2021-12-16,No Results Posted,,,2022-02-11,https://clinicaltrials.gov/show/NCT04932824,2021-11-10,0,0
5871,NCT04932837,Withdrawn,2021-06-25,2021-07-02,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04932837,2021-06-25,0,0
5872,NCT04932850,"Active, not recruiting",2021-10-01,2021-10-01,No Results Posted,"['Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review.']",,2021-06-21,https://clinicaltrials.gov/show/NCT04932850,2021-10-01,0,1
5873,NCT04932863,Recruiting,2022-03-15,2023-03-15,No Results Posted,"[""Buttiron Webber T, Provinciali N, Musso M, Ugolini M, Boitano M, Clavarezza M, D'Amico M, Defferrari C, Gozza A, Briata IM, Magnani M, Paciolla F, Menghini N, Marcenaro E, De Palma R, Sacchi N, Innocenti L, Siri G, D'Ecclesiis O, Cevasco I, Gandini S, DeCensi A. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Eur J Cancer. 2021 Dec;159:105-112. doi: 10.1016/j.ejca.2021.09.030. Epub 2021 Oct 11.""]",,2021-06-21,https://clinicaltrials.gov/show/NCT04932863,2022-03-15,0,1
5874,NCT04932876,Recruiting,2021-12-01,2023-03-01,No Results Posted,,,2021-09-29,https://clinicaltrials.gov/show/NCT04932876,2021-12-01,0,0
5875,NCT04932889,Completed,2021-06-13,2021-06-14,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04932889,2021-06-13,0,0
5876,NCT04932915,Terminated,2022-01-10,2022-01-10,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04932915,2022-01-10,0,0
5877,NCT04932941,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04932941,2022-04-01,0,0
5878,NCT04932954,Recruiting,2022-01-01,2023-01-01,No Results Posted,,,2021-06-21,https://clinicaltrials.gov/show/NCT04932954,2022-01-01,0,0
5879,NCT04932967,Recruiting,2022-03-31,2022-03-31,No Results Posted,,,2022-03-02,https://clinicaltrials.gov/show/NCT04932967,2022-03-31,0,0
5880,NCT04933474,Recruiting,2023-12-31,2024-03-31,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04933474,2023-12-31,0,0
5881,NCT04933799,Recruiting,2022-03-06,2022-05-06,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04933799,2022-03-06,0,0
5882,NCT04933864,Completed,2020-05-20,2020-07-30,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04933864,2020-05-20,0,0
5883,NCT04933929,Recruiting,2021-12-01,2022-03-01,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04933929,2021-12-01,0,0
5884,NCT04933981,"Active, not recruiting",2020-12-15,2021-06-30,No Results Posted,"['Stemler J, Kramer T, Dimitriou V, Wieland U, Schumacher S, Sprute R, Oberste M, Wiesm√ºller G, Rau H, Pieper S, Bethe U, Lehmann C, Hellmich M, Klein F, Langebartels G, Cornely OA. Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study. Infection. 2021 Oct 20. doi: 10.1007/s15010-021-01716-4. [Epub ahead of print]']",,2021-06-22,https://clinicaltrials.gov/show/NCT04933981,2020-12-15,0,1
5885,NCT04933994,Completed,2020-02-28,2020-09-15,No Results Posted,,,2021-07-16,https://clinicaltrials.gov/show/NCT04933994,2020-02-28,0,0
5886,NCT04934020,Completed,2021-10-31,2021-12-09,No Results Posted,,,2021-12-14,https://clinicaltrials.gov/show/NCT04934020,2021-10-31,0,0
5887,NCT04934085,Completed,2021-07-30,2021-08-30,No Results Posted,,,2021-09-09,https://clinicaltrials.gov/show/NCT04934085,2021-07-30,0,0
5888,NCT04934111,Not yet recruiting,2022-06-01,2022-08-01,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04934111,2022-06-01,0,0
5889,NCT04934202,Recruiting,2022-05-05,2022-05-05,No Results Posted,,,2021-06-22,https://clinicaltrials.gov/show/NCT04934202,2022-05-05,0,0
5890,NCT04934215,Completed,2021-08-30,2021-11-03,No Results Posted,,"['Pean De Ponfilly G, Pilmis B, El Kaibi I, Castreau N, Laplanche S, Le Monnier A. Is the second dose of vaccination useful in previously SARS-CoV-2-infected healthcare workers? Infect Dis Now. 2021 Nov;51(8):673-675. doi: 10.1016/j.idnow.2021.07.001. Epub 2021 Jul 6.']",2022-01-21,https://clinicaltrials.gov/show/NCT04934215,2021-08-30,0,1
5891,NCT04935437,Recruiting,2021-09-01,2021-09-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04935437,2021-09-01,0,0
5892,NCT04935450,Recruiting,2021-08-15,2021-08-16,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04935450,2021-08-15,0,0
5893,NCT04935463,Enrolling by invitation,2022-06-01,2022-06-01,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04935463,2022-06-01,0,0
5894,NCT04935476,Recruiting,2022-03-31,2022-07-31,No Results Posted,,,2022-02-24,https://clinicaltrials.gov/show/NCT04935476,2022-03-31,0,0
5895,NCT04935489,Recruiting,2023-01-15,2023-09-15,No Results Posted,,,2022-01-27,https://clinicaltrials.gov/show/NCT04935489,2023-01-15,0,0
5896,NCT04935502,Completed,2021-08-30,2021-08-30,No Results Posted,,,2021-09-23,https://clinicaltrials.gov/show/NCT04935502,2021-08-30,0,0
5897,NCT04935515,Completed,2021-05-09,2021-06-06,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04935515,2021-05-09,0,0
5898,NCT04935528,Recruiting,2022-06-02,2022-06-02,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04935528,2022-06-02,0,0
5899,NCT04936503,Completed,2021-03-02,2021-03-02,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04936503,2021-03-02,0,0
5900,NCT04936893,"Active, not recruiting",2021-03-31,2021-07-31,No Results Posted,,,2021-06-23,https://clinicaltrials.gov/show/NCT04936893,2021-03-31,0,0
5901,NCT04936997,"Active, not recruiting",2021-08-25,2027-02-01,No Results Posted,"['Shroff RT, Chalasani P, Wei R, Pennington D, Quirk G, Schoenle MV, Peyton KL, Uhrlaub JL, Ripperger TJ, Jergoviƒá M, Dalgai S, Wolf A, Whitmer R, Hammad H, Carrier A, Scott AJ, Nikolich-≈Ωugich J, Worobey M, Sprissler R, Dake M, LaFleur BJ, Bhattacharya D. Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors. Nat Med. 2021 Nov;27(11):2002-2011. doi: 10.1038/s41591-021-01542-z. Epub 2021 Sep 30.']",,2022-02-25,https://clinicaltrials.gov/show/NCT04936997,2021-08-25,0,1
5902,NCT04937088,Recruiting,2022-12-05,2022-12-05,No Results Posted,,,2022-01-03,https://clinicaltrials.gov/show/NCT04937088,2022-12-05,0,0
5903,NCT04937543,Not yet recruiting,2021-10-30,2022-01-30,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04937543,2021-10-30,0,0
5904,NCT04937556,Recruiting,2022-02-28,2022-04-30,No Results Posted,,,2021-11-01,https://clinicaltrials.gov/show/NCT04937556,2022-02-28,0,0
5905,NCT04937569,Not yet recruiting,2021-09-01,2021-11-01,No Results Posted,,,2021-06-29,https://clinicaltrials.gov/show/NCT04937569,2021-09-01,0,0
5906,NCT04937582,Recruiting,2023-02-01,2025-02-01,No Results Posted,,,2022-02-21,https://clinicaltrials.gov/show/NCT04937582,2023-02-01,0,0
5907,NCT04937595,,,,,,,,https://clinicaltrials.gov/show/NCT04937595,,0,0
5908,NCT04937608,Enrolling by invitation,2022-12-31,2023-04-30,No Results Posted,,,2021-08-24,https://clinicaltrials.gov/show/NCT04937608,2022-12-31,0,0
5909,NCT04937621,Completed,2020-12-02,2020-12-31,No Results Posted,,,2021-06-24,https://clinicaltrials.gov/show/NCT04937621,2020-12-02,0,0
5910,NCT04937712,Recruiting,2022-07-01,2022-07-01,No Results Posted,,,2021-08-30,https://clinicaltrials.gov/show/NCT04937712,2022-07-01,0,0
5911,NCT04939155,"Active, not recruiting",2021-10-01,2022-03-10,No Results Posted,,,2021-06-30,https://clinicaltrials.gov/show/NCT04939155,2021-10-01,0,0
5912,NCT04939402,Recruiting,2022-05-01,2022-06-01,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04939402,2022-05-01,0,0
5913,NCT04939415,"Active, not recruiting",2022-07-01,2022-12-31,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04939415,2022-07-01,0,0
5914,NCT04939428,Recruiting,2022-08-26,2022-08-26,No Results Posted,,,2022-03-31,https://clinicaltrials.gov/show/NCT04939428,2022-08-26,0,0
5915,NCT04939506,Not yet recruiting,2023-03-01,2023-06-01,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04939506,2023-03-01,0,0
5916,NCT04939519,"Active, not recruiting",2022-09-22,2022-09-22,No Results Posted,,,2021-08-12,https://clinicaltrials.gov/show/NCT04939519,2022-09-22,0,0
5917,NCT04939532,"Active, not recruiting",2022-09-01,2022-09-01,No Results Posted,,,2022-01-10,https://clinicaltrials.gov/show/NCT04939532,2022-09-01,0,0
5918,NCT04939558,Enrolling by invitation,2022-03-31,2022-06-30,No Results Posted,,,2021-06-25,https://clinicaltrials.gov/show/NCT04939558,2022-03-31,0,0
5919,NCT04939714,Recruiting,2022-07-29,2022-07-29,No Results Posted,,,2022-02-09,https://clinicaltrials.gov/show/NCT04939714,2022-07-29,0,0
5920,NCT04940182,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,2021-07-01,https://clinicaltrials.gov/show/NCT04940182,2021-12-01,0,0
5921,NCT04940195,,,,,,,,https://clinicaltrials.gov/show/NCT04940195,,0,0
5922,NCT04940208,Completed,2022-01-01,2022-02-01,No Results Posted,,,2022-02-02,https://clinicaltrials.gov/show/NCT04940208,2022-01-01,0,0
5923,NCT04710381,Completed,2021-06-02,2021-06-02,No Results Posted,,,2021-07-21,https://clinicaltrials.gov/show/NCT04710381,2021-06-02,0,0
5924,NCT04382053,Completed,2020-12-10,2020-12-24,Study Results,,,2021-11-30,,2020-12-10,1,0
5925,ACTRN12620000421932,Recruiting,,2021-06-30,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000421932.aspx,2021-06-30,0,0
5926,ACTRN12620000443998,Not yet recruiting,,,,,,2020-04-06,https://anzctr.org.au/ACTRN12620000443998.aspx,,0,0
5927,ACTRN12620000444987,Not yet recruiting,,,,,,2020-04-06,https://anzctr.org.au/ACTRN12620000444987.aspx,,0,0
5928,ACTRN12620000448943,Stopped early,,2021-09-08,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-10-22,https://anzctr.org.au/ACTRN12620000448943.aspx,2021-09-08,0,1
5929,ACTRN12620000447954,Withdrawn,,2020-08-31,,,,2021-03-11,https://anzctr.org.au/ACTRN12620000447954.aspx,2020-08-31,0,0
5930,ACTRN12620000438954,Not yet recruiting,,2020-10-31,,,,2020-04-06,https://anzctr.org.au/ACTRN12620000438954.aspx,2020-10-31,0,0
5931,ACTRN12620000449932,Not yet recruiting,,2021-12-31,,,,2020-04-06,https://anzctr.org.au/ACTRN12620000449932.aspx,2021-12-31,0,0
5932,ACTRN12620000454976,Recruiting,,2021-04-09,,,,2020-09-04,https://anzctr.org.au/ACTRN12620000454976.aspx,2021-04-09,0,0
5933,ACTRN12620000468921,Completed,,2020-10-20,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-10-12,https://anzctr.org.au/ACTRN12620000468921.aspx,2020-10-20,0,1
5934,ACTRN12620000477921,Completed,,2020-04-23,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-09-08,https://anzctr.org.au/ACTRN12620000477921.aspx,2020-04-23,0,1
5935,ACTRN12620000472976,Not yet recruiting,,2020-10-27,,,,2020-04-15,https://anzctr.org.au/ACTRN12620000472976.aspx,2020-10-27,0,0
5936,ACTRN12620000479909,Not yet recruiting,,,,,,2020-04-16,https://anzctr.org.au/ACTRN12620000479909.aspx,,0,0
5937,ACTRN12620000470998,Withdrawn,,2020-06-30,,,,2021-10-12,https://anzctr.org.au/ACTRN12620000470998.aspx,2020-06-30,0,0
5938,ACTRN12620000473965,Completed,,2021-09-30,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-02-07,https://anzctr.org.au/ACTRN12620000473965.aspx,2021-09-30,0,1
5939,ACTRN12620000474954,"Active, not recruiting",,2021-03-08,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-09-17,https://anzctr.org.au/ACTRN12620000474954.aspx,2021-03-08,0,1
5940,ACTRN12620000478910,Not yet recruiting,,2022-12-31,,,,2021-05-03,https://anzctr.org.au/ACTRN12620000478910.aspx,2022-12-31,0,0
5941,ACTRN12620000480987,Not yet recruiting,,2020-10-18,,,,2020-04-16,https://anzctr.org.au/ACTRN12620000480987.aspx,2020-10-18,0,0
5942,ACTRN12620000417987,Stopped early,,2020-09-28,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-12-17,https://anzctr.org.au/ACTRN12620000417987.aspx,2020-09-28,0,1
5943,ACTRN12620000486921,Recruiting,,2021-09-01,,,,2021-03-22,https://anzctr.org.au/ACTRN12620000486921.aspx,2021-09-01,0,0
5944,ACTRN12620000457943,Withdrawn,,2021-01-29,,,,2020-10-23,https://anzctr.org.au/ACTRN12620000457943.aspx,2021-01-29,0,0
5945,ACTRN12620000492954,Not yet recruiting,,,,,,2020-04-20,https://anzctr.org.au/ACTRN12620000492954.aspx,,0,0
5946,ACTRN12620000482965,"Active, not recruiting",,2020-04-26,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-04-17,https://anzctr.org.au/ACTRN12620000482965.aspx,2020-04-26,0,1
5947,ACTRN12620000498998,Not yet recruiting,,,,,,2020-04-20,https://anzctr.org.au/ACTRN12620000498998.aspx,,0,0
5948,ACTRN12620000493943,Withdrawn,,2021-04-07,,,,2021-08-24,https://anzctr.org.au/ACTRN12620000493943.aspx,2021-04-07,0,0
5949,ACTRN12620000512921,Not yet recruiting,,2020-09-18,,,,2020-04-27,https://anzctr.org.au/ACTRN12620000512921.aspx,2020-09-18,0,0
5950,ACTRN12620000516987,"Active, not recruiting",,2021-03-15,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-01-22,https://anzctr.org.au/ACTRN12620000516987.aspx,2021-03-15,0,1
5951,ACTRN12620000517976,Recruiting,,2021-07-25,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000517976.aspx,2021-07-25,0,0
5952,ACTRN12620000527965,Withdrawn,,2022-11-30,,,,2021-08-27,https://anzctr.org.au/ACTRN12620000527965.aspx,2022-11-30,0,0
5953,ACTRN12620000487910,Recruiting,,2021-04-07,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000487910.aspx,2021-04-07,0,0
5954,ACTRN12620000524998,Not yet recruiting,,2021-04-30,,,,2020-04-28,https://anzctr.org.au/ACTRN12620000524998.aspx,2021-04-30,0,0
5955,ACTRN12620000555954,"Active, not recruiting",,2021-03-31,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-12-09,https://anzctr.org.au/ACTRN12620000555954.aspx,2021-03-31,0,1
5956,ACTRN12620000554965,Recruiting,,2022-05-31,,,,2022-02-16,https://anzctr.org.au/ACTRN12620000554965.aspx,2022-05-31,0,0
5957,ACTRN12620000557932,Recruiting,,2023-03-31,,,,2022-03-02,https://anzctr.org.au/ACTRN12620000557932.aspx,2023-03-31,0,0
5958,ACTRN12620000566932,Recruiting,,2023-06-30,,,,2022-03-30,https://anzctr.org.au/ACTRN12620000566932.aspx,2023-06-30,0,0
5959,ACTRN12620000445976,Recruiting,,,,,,2021-10-12,https://anzctr.org.au/ACTRN12620000445976.aspx,,0,0
5960,ACTRN12620000580976,Not yet recruiting,,,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000580976.aspx,,0,0
5961,ACTRN12620000588998,Withdrawn,,,,,,2020-07-30,https://anzctr.org.au/ACTRN12620000588998.aspx,,0,0
5962,ACTRN12620000571976,"Active, not recruiting",,2020-09-20,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-09-17,https://anzctr.org.au/ACTRN12620000571976.aspx,2020-09-20,0,1
5963,ACTRN12620000575932,Recruiting,,2020-08-31,,,,2020-05-18,https://anzctr.org.au/ACTRN12620000575932.aspx,2020-08-31,0,0
5964,ACTRN12620000579998,Completed,,2020-06-16,,"{'citations': [], 'basic_reporting_doc': '/Steps11and12/379818-(Uploaded-08-06-2021-14-11-16)-Basic results summary.docx'}",,2021-06-10,https://anzctr.org.au/ACTRN12620000579998.aspx,2020-06-16,0,1
5965,ACTRN12620000590965,Recruiting,,,,,,2020-09-04,https://anzctr.org.au/ACTRN12620000590965.aspx,,0,0
5966,ACTRN12620000602921,Recruiting,,,,,,2021-08-24,https://anzctr.org.au/ACTRN12620000602921.aspx,,0,0
5967,ACTRN12620000617965,Recruiting,,2021-03-28,,,,2020-05-27,https://anzctr.org.au/ACTRN12620000617965.aspx,2021-03-28,0,0
5968,ACTRN12620000593932,Not yet recruiting,,2021-12-31,,,,2020-05-22,https://anzctr.org.au/ACTRN12620000593932.aspx,2021-12-31,0,0
5969,ACTRN12620000609954,Recruiting,,2025-04-30,,,,2020-05-25,https://anzctr.org.au/ACTRN12620000609954.aspx,2025-04-30,0,0
5970,ACTRN12620000612910,Recruiting,,,,,,2021-03-22,https://anzctr.org.au/ACTRN12620000612910.aspx,,0,0
5971,ACTRN12620000640909,Recruiting,,2022-01-31,,,,2021-07-16,https://anzctr.org.au/ACTRN12620000640909.aspx,2022-01-31,0,0
5972,ACTRN12620000635965,Not yet recruiting,,2020-09-30,,,,2020-05-29,https://anzctr.org.au/ACTRN12620000635965.aspx,2020-09-30,0,0
5973,ACTRN12620000641998,Completed,,2020-06-05,,"{'citations': ['Published in European Heart Journal- 16th December 2020Catherine J O‚ÄôShea, Gijo Thomas, Melissa E Middeldorp, Curtis Harper, Adrian D Elliott, Noemi Ray, Dennis H Lau, Kevin Campbell, Prashanthan Sanders, Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic, European Heart Journal, , ehaa893, https://doi-org.proxy.library.adelaide.edu.au/10.1093/eurheartj/ehaa893'], 'basic_reporting_doc': ''}",,2021-01-27,https://anzctr.org.au/ACTRN12620000641998.aspx,2020-06-05,0,1
5974,ACTRN12620000636954,Recruiting,,,,,,2020-12-09,https://anzctr.org.au/ACTRN12620000636954.aspx,,0,0
5975,ACTRN12620000634976,Completed,,2020-09-17,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-01-22,https://anzctr.org.au/ACTRN12620000634976.aspx,2020-09-17,0,1
5976,ACTRN12620000620921,Recruiting,,2021-02-28,,,,2020-12-17,https://anzctr.org.au/ACTRN12620000620921.aspx,2021-02-28,0,0
5977,ACTRN12620000501943,Recruiting,,2021-04-30,,,,2020-12-09,https://anzctr.org.au/ACTRN12620000501943.aspx,2021-04-30,0,0
5978,ACTRN12620000500954,Not yet recruiting,,2020-06-01,,,,2020-04-22,https://anzctr.org.au/ACTRN12620000500954.aspx,2020-06-01,0,0
5979,ACTRN12620000674932,Recruiting,,,,,,2020-07-24,https://anzctr.org.au/ACTRN12620000674932.aspx,,0,0
5980,ACTRN12620000676910,Not yet recruiting,,2021-07-31,,,,2020-06-15,https://anzctr.org.au/ACTRN12620000676910.aspx,2021-07-31,0,0
5981,ACTRN12620000688987,Completed,,2020-06-05,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-06-19,https://anzctr.org.au/ACTRN12620000688987.aspx,2020-06-05,0,1
5982,ACTRN12620000698976,Recruiting,,2020-12-16,,,,2020-09-04,https://anzctr.org.au/ACTRN12620000698976.aspx,2020-12-16,0,0
5983,ACTRN12620000692932,Completed,,2020-06-28,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-06-30,https://anzctr.org.au/ACTRN12620000692932.aspx,2020-06-28,0,1
5984,ACTRN12620000707965,Withdrawn,,2021-03-30,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000707965.aspx,2021-03-30,0,0
5985,ACTRN12620000702910,Not yet recruiting,,,,,,2020-06-26,https://anzctr.org.au/ACTRN12620000702910.aspx,,0,0
5986,ACTRN12618000669291,Completed,,2017-12-30,,"{'citations': [], 'basic_reporting_doc': ''}",,2018-04-24,,2017-12-30,0,1
5987,ACTRN12610000006044,Recruiting,,,,,,2010-01-06,,,0,0
5988,ACTRN12613000511730,Recruiting,,,,,,2014-01-21,,,0,0
5989,ACTRN12614001069640,Recruiting,,,,,,2021-07-08,,,0,0
5990,ACTRN12615000883516,Completed,,2016-07-26,,"{'citations': [], 'basic_reporting_doc': ''}",,2016-08-05,,2016-07-26,0,1
5991,ACTRN12616000013460,Completed,,2017-04-27,,"{'citations': [], 'basic_reporting_doc': ''}",,2017-06-07,,2017-04-27,0,1
5992,ACTRN12619000250134,Not yet recruiting,,,,,,2020-02-12,,,0,0
5993,ACTRN12618000468224,Stopped early,,2020-02-06,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-09-15,,2020-02-06,0,1
5994,ACTRN12620000734965,Recruiting,,2022-04-30,,,,2021-08-27,https://anzctr.org.au/ACTRN12620000734965.aspx,2022-04-30,0,0
5995,ACTRN12620000740998,Not yet recruiting,,,,,,2020-07-16,https://anzctr.org.au/ACTRN12620000740998.aspx,,0,0
5996,ACTRN12620000731998,Not yet recruiting,,,,,,2020-07-13,https://anzctr.org.au/ACTRN12620000731998.aspx,,0,0
5997,ACTRN12620000737932,"Active, not recruiting",,2020-09-30,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-07-14,https://anzctr.org.au/ACTRN12620000737932.aspx,2020-09-30,0,1
5998,ACTRN12620000778987,Not yet recruiting,,,,,,2020-07-30,https://anzctr.org.au/ACTRN12620000778987.aspx,,0,0
5999,ACTRN12620000787987,Not yet recruiting,,2022-03-29,,,,2020-08-04,https://anzctr.org.au/ACTRN12620000787987.aspx,2022-03-29,0,0
6000,ACTRN12620000786998,Not yet recruiting,,2020-10-19,,,,2020-08-04,https://anzctr.org.au/ACTRN12620000786998.aspx,2020-10-19,0,0
6001,ACTRN12620000795998,"Active, not recruiting",,2021-03-31,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-08-07,https://anzctr.org.au/ACTRN12620000795998.aspx,2021-03-31,0,1
6002,ACTRN12620000799954,Not yet recruiting,,,,,,2020-08-10,https://anzctr.org.au/ACTRN12620000799954.aspx,,0,0
6003,ACTRN12620000808943,Recruiting,,,,,,2020-08-11,https://anzctr.org.au/ACTRN12620000808943.aspx,,0,0
6004,ACTRN12620000811909,"Active, not recruiting",,2022-02-08,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-10-28,https://anzctr.org.au/ACTRN12620000811909.aspx,2022-02-08,0,1
6005,ACTRN12618000245291,Suspended,,2020-11-30,,,,2020-08-18,,2020-11-30,0,0
6006,ACTRN12620000816954,Completed,,2020-11-01,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-06-28,https://anzctr.org.au/ACTRN12620000816954.aspx,2020-11-01,0,1
6007,ACTRN12620000840987,Recruiting,,2021-03-31,,,,2020-08-26,https://anzctr.org.au/ACTRN12620000840987.aspx,2021-03-31,0,0
6008,ACTRN12620000854932,Stopped early,,2021-07-22,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-02-16,https://anzctr.org.au/ACTRN12620000854932.aspx,2021-07-22,0,1
6009,ACTRN12620000843954,Not yet recruiting,,2021-12-01,,,,2020-08-26,https://anzctr.org.au/ACTRN12620000843954.aspx,2021-12-01,0,0
6010,ACTRN12620000842965,Not yet recruiting,,2021-12-01,,,,2020-08-26,https://anzctr.org.au/ACTRN12620000842965.aspx,2021-12-01,0,0
6011,ACTRN12620000841976,Not yet recruiting,,2021-12-01,,,,2020-08-26,https://anzctr.org.au/ACTRN12620000841976.aspx,2021-12-01,0,0
6012,ACTRN12620000844943,Not yet recruiting,,2021-12-01,,,,2020-08-26,https://anzctr.org.au/ACTRN12620000844943.aspx,2021-12-01,0,0
6013,ACTRN12620000876998,Completed,,2021-03-17,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-03-03,https://anzctr.org.au/ACTRN12620000876998.aspx,2021-03-17,0,1
6014,ACTRN12620000869976,"Active, not recruiting",,2020-09-18,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-08-31,https://anzctr.org.au/ACTRN12620000869976.aspx,2020-09-18,0,1
6015,ACTRN12620000817943,Recruiting,,2021-03-30,,,,2020-09-08,https://anzctr.org.au/ACTRN12620000817943.aspx,2021-03-30,0,0
6016,ACTRN12620000779976,Completed,,2020-09-30,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-12-17,https://anzctr.org.au/ACTRN12620000779976.aspx,2020-09-30,0,1
6017,ACTRN12620000860965,Not yet recruiting,,,,,,2020-08-28,https://anzctr.org.au/ACTRN12620000860965.aspx,,0,0
6018,ACTRN12620000909921,Recruiting,,,,,,2021-09-23,https://anzctr.org.au/ACTRN12620000909921.aspx,,0,0
6019,ACTRN12620000921987,Not yet recruiting,,2020-12-02,,,,2020-09-17,https://anzctr.org.au/ACTRN12620000921987.aspx,2020-12-02,0,0
6020,ACTRN12620000857909,"Active, not recruiting",,2020-12-31,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-08-28,https://anzctr.org.au/ACTRN12620000857909.aspx,2020-12-31,0,1
6021,ACTRN12620000922976,"Active, not recruiting",,2020-11-09,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-09-17,https://anzctr.org.au/ACTRN12620000922976.aspx,2020-11-09,0,1
6022,ACTRN12620000878976,"Active, not recruiting",,2023-01-31,,"{'citations': ['Hui L, Marzan MB, Potenza S, et alCollaborative maternity and newborn dashboard (CoMaND) for the COVID-19 pandemic: a protocol for timely, adaptive monitoring of perinatal outcomes in Melbourne, AustraliaBMJ Open 2021;11:e055902. doi: 10.1136/bmjopen-2021-055902', 'Potenza S, Marzan MB, Rolnik DL, Palmer K, Said J, Whitehead C, Sheehan P, Mol BW, Walker S, Hui L. Business as usual during the COVID-19 pandemic? Reflections on state-wide trends in maternity telehealth consultations during lockdown in Victoria and New South Wales. Aust N Z J Obstet Gynaecol. 2021 Dec;61(6):982-985. doi: 10.1111/ajo.13438.  '], 'basic_reporting_doc': ''}",,2022-03-04,https://anzctr.org.au/ACTRN12620000878976.aspx,2023-01-31,0,1
6023,ACTRN12620000834954,Not yet recruiting,,2020-11-27,,,,2020-08-24,https://anzctr.org.au/ACTRN12620000834954.aspx,2020-11-27,0,0
6024,ACTRN12620000977976,Not yet recruiting,,2020-11-15,,,,2020-09-30,https://anzctr.org.au/ACTRN12620000977976.aspx,2020-11-15,0,0
6025,ACTRN12620000975998,Not yet recruiting,,,,,,2020-12-17,https://anzctr.org.au/ACTRN12620000975998.aspx,,0,0
6026,ACTRN12620001048976,Recruiting,,2022-03-16,,,,2021-10-22,https://anzctr.org.au/ACTRN12620001048976.aspx,2022-03-16,0,0
6027,ACTRN12620001114932,Not yet recruiting,,2021-07-30,,,,2020-10-28,https://anzctr.org.au/ACTRN12620001114932.aspx,2021-07-30,0,0
6028,ACTRN12620001029987,Recruiting,,2022-05-31,,,,2021-10-22,https://anzctr.org.au/ACTRN12620001029987.aspx,2022-05-31,0,0
6029,ACTRN12620000982910,Not yet recruiting,,,,,,2021-01-27,https://anzctr.org.au/ACTRN12620000982910.aspx,,0,0
6030,ACTRN12620001104943,Completed,,2021-02-26,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-05-10,https://anzctr.org.au/ACTRN12620001104943.aspx,2021-02-26,0,1
6031,ACTRN12620001193965,Recruiting,,2020-11-30,,,,2020-11-10,https://anzctr.org.au/ACTRN12620001193965.aspx,2020-11-30,0,0
6032,ACTRN12620001167954,Not yet recruiting,,2021-03-31,,,,2020-12-17,https://anzctr.org.au/ACTRN12620001167954.aspx,2021-03-31,0,0
6033,ACTRN12620001265965,"Active, not recruiting",,2020-12-31,,"{'citations': [], 'basic_reporting_doc': ''}",,2020-11-25,https://anzctr.org.au/ACTRN12620001265965.aspx,2020-12-31,0,1
6034,ACTRN12620001279910,Not yet recruiting,,,,,,2020-11-26,https://anzctr.org.au/ACTRN12620001279910.aspx,,0,0
6035,ACTRN12620001269921,Not yet recruiting,,,,,,2020-11-25,https://anzctr.org.au/ACTRN12620001269921.aspx,,0,0
6036,ACTRN12620001249943,Recruiting,,2021-12-01,,,,2021-09-01,https://anzctr.org.au/ACTRN12620001249943.aspx,2021-12-01,0,0
6037,ACTRN12620000788976,Recruiting,,2021-04-17,,,,2020-12-03,https://anzctr.org.au/ACTRN12620000788976.aspx,2021-04-17,0,0
6038,ACTRN12620000674932,Recruiting,,,,,,2020-07-24,https://anzctr.org.au/ACTRN12620000674932.aspx,,0,0
6039,ACTRN12620001308987,Not yet recruiting,,,,,,2020-12-04,https://anzctr.org.au/ACTRN12620001308987.aspx,,0,0
6040,ACTRN12618001845224,"Active, not recruiting",,2022-06-30,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-02-18,https://anzctr.org.au/ACTRN12618001845224.aspx,2022-06-30,0,1
6041,ACTRN12620001371987,Completed,,2021-03-29,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-07-08,https://anzctr.org.au/ACTRN12620001371987.aspx,2021-03-29,0,1
6042,ACTRN12621000013864,Not yet recruiting,,2021-04-30,,,,2021-01-12,https://anzctr.org.au/ACTRN12621000013864.aspx,2021-04-30,0,0
6043,ACTRN12621000034831,Completed,,2020-12-15,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-09-02,https://anzctr.org.au/ACTRN12621000034831.aspx,2020-12-15,0,1
6044,ACTRN12621000048886,Recruiting,,2021-02-26,,,,2021-01-19,https://anzctr.org.au/ACTRN12621000048886.aspx,2021-02-26,0,0
6045,ACTRN12621000031864,Not yet recruiting,,2021-06-07,,,,2021-01-15,https://anzctr.org.au/ACTRN12621000031864.aspx,2021-06-07,0,0
6046,ACTRN12621000067875,Not yet recruiting,,2021-03-26,,,,2021-01-27,https://anzctr.org.au/ACTRN12621000067875.aspx,2021-03-26,0,0
6047,ACTRN12621000065897,Not yet recruiting,,,,,,2021-01-27,https://anzctr.org.au/ACTRN12621000065897.aspx,,0,0
6048,ACTRN12621000112864,Completed,,2021-03-31,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-11-22,https://anzctr.org.au/ACTRN12621000112864.aspx,2021-03-31,0,1
6049,ACTRN12621000130864,Completed,,2020-12-18,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-02-08,https://anzctr.org.au/ACTRN12621000130864.aspx,2020-12-18,0,1
6050,ACTRN12621000131853,Not yet recruiting,,2021-05-31,,,,2021-02-09,https://anzctr.org.au/ACTRN12621000131853.aspx,2021-05-31,0,0
6051,ACTRN12621000183886,Not yet recruiting,,2023-02-22,,,,2021-02-22,https://anzctr.org.au/ACTRN12621000183886.aspx,2023-02-22,0,0
6052,ACTRN12621000283875,Recruiting,,,,,,2022-03-07,https://anzctr.org.au/ACTRN12621000283875.aspx,,0,0
6053,ACTRN12619001134112,Recruiting,,2023-06-01,,,,2022-02-22,https://anzctr.org.au/ACTRN12619001134112.aspx,2023-06-01,0,0
6054,ACTRN12620001355965,Completed,,2021-03-22,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-03-24,https://anzctr.org.au/ACTRN12620001355965.aspx,2021-03-22,0,1
6055,ACTRN12621000344897,Recruiting,,2021-07-01,,,,2021-03-25,https://anzctr.org.au/ACTRN12621000344897.aspx,2021-07-01,0,0
6056,ACTRN12621000309886,Not yet recruiting,,2021-05-21,,,,2021-03-19,https://anzctr.org.au/ACTRN12621000309886.aspx,2021-05-21,0,0
6057,ACTRN12621000387820,"Active, not recruiting",,2022-04-29,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-03-11,https://anzctr.org.au/ACTRN12621000387820.aspx,2022-04-29,0,1
6058,ACTRN12621000347864,Not yet recruiting,,2021-05-15,,,,2021-03-26,https://anzctr.org.au/ACTRN12621000347864.aspx,2021-05-15,0,0
6059,ACTRN12621000420842,Not yet recruiting,,,,,,2021-10-22,https://anzctr.org.au/ACTRN12621000420842.aspx,,0,0
6060,ACTRN12621000460808,Not yet recruiting,,2022-12-01,,,,2021-04-20,https://anzctr.org.au/ACTRN12621000460808.aspx,2022-12-01,0,0
6061,ACTRN12621000468820,Recruiting,,2021-12-15,,,,2021-10-28,https://anzctr.org.au/ACTRN12621000468820.aspx,2021-12-15,0,0
6062,ACTRN12621000476831,Recruiting,,2022-06-24,,,,2022-03-23,https://anzctr.org.au/ACTRN12621000476831.aspx,2022-06-24,0,0
6063,ACTRN12621000533897,Recruiting,,2023-04-30,,,,2022-02-08,https://anzctr.org.au/ACTRN12621000533897.aspx,2023-04-30,0,0
6064,ACTRN12621000524897,Not yet recruiting,,2021-09-01,,,,2021-05-04,https://anzctr.org.au/ACTRN12621000524897.aspx,2021-09-01,0,0
6065,ACTRN12621000565842,Not yet recruiting,,2021-12-31,,,,2021-05-13,https://anzctr.org.au/ACTRN12621000565842.aspx,2021-12-31,0,0
6066,ACTRN12621000567820,Recruiting,,2022-10-31,,,,2021-09-01,https://anzctr.org.au/ACTRN12621000567820.aspx,2022-10-31,0,0
6067,ACTRN12621000607875,Not yet recruiting,,,,,,2021-05-20,https://anzctr.org.au/ACTRN12621000607875.aspx,,0,0
6068,ACTRN12621000538842,Recruiting,,2023-07-06,,,,2021-05-06,https://anzctr.org.au/ACTRN12621000538842.aspx,2023-07-06,0,0
6069,ACTRN12621000532808,Completed,,2021-11-30,,"{'citations': ['Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C. S., Kireta, S., Johnston, J., ... & Coates, P. T. (2022). Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19. Kidney International. Online ahead of print, 16 March 2022.'], 'basic_reporting_doc': ''}",,2022-03-21,https://anzctr.org.au/ACTRN12621000532808.aspx,2021-11-30,0,1
6070,ACTRN12621000661875,Recruiting,,,,,,2021-08-27,https://anzctr.org.au/ACTRN12621000661875.aspx,,0,0
6071,ACTRN12621000704897,Not yet recruiting,,,,,,2021-09-02,https://anzctr.org.au/ACTRN12621000704897.aspx,,0,0
6072,ACTRN12621000722897,Not yet recruiting,,,,,,2021-06-09,https://anzctr.org.au/ACTRN12621000722897.aspx,,0,0
6073,ACTRN12621000738820,"Active, not recruiting",,2022-02-22,,"{'citations': [], 'basic_reporting_doc': ''}",,2021-12-02,https://anzctr.org.au/ACTRN12621000738820.aspx,2022-02-22,0,1
6074,ACTRN12621000637842,Not yet recruiting,,2023-02-06,,,,2021-05-27,https://anzctr.org.au/ACTRN12621000637842.aspx,2023-02-06,0,0
6075,ACTRN12621000388819,Completed,,2021-10-07,,"{'citations': [], 'basic_reporting_doc': ''}",,2022-03-30,https://anzctr.org.au/ACTRN12621000388819.aspx,2021-10-07,0,1
6076,ChiCTR2000029953,Not yet recruiting,,2021-05-01,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49217,2021-05-01,0,0
6077,ChiCTR2000029949,Not yet recruiting,,2020-12-28,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49181,2020-12-28,0,0
6078,ChiCTR2000029947,Not yet recruiting,,2020-06-01,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49599,2020-06-01,0,0
6079,ChiCTR2000029941,Not yet recruiting,,2020-06-01,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49596,2020-06-01,0,0
6080,ChiCTR2000029939,Recruiting,,2021-02-06,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49612,2021-02-06,0,0
6081,ChiCTR2000029935,Recruiting,,2021-02-06,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49607,2021-02-06,0,0
6082,ChiCTR2000029907,Not yet recruiting,,2020-12-31,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49587,2020-12-31,0,0
6083,ChiCTR2000029905,Recruiting,,2020-03-15,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49595,2020-03-15,0,0
6084,ChiCTR2000029896,Recruiting,,2020-12-31,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49432,2020-12-31,0,0
6085,ChiCTR2000029883,Not yet recruiting,,2020-03-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=49549,2020-03-31,0,0
6086,ChiCTR2000029870,Recruiting,,2020-12-31,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49563,2020-12-31,0,0
6087,ChiCTR2000029869,Not yet recruiting,,2020-06-30,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49486,2020-06-30,0,0
6088,ChiCTR2000029867,Recruiting,,2021-02-28,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49514,2021-02-28,0,0
6089,ChiCTR2000029855,Recruiting,,,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49543,,0,0
6090,ChiCTR2000029853,Recruiting,,2020-04-16,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49532,2020-04-16,0,0
6091,ChiCTR2000029850,Recruiting,,2022-02-15,,,,2020-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49533,2022-02-15,0,0
6092,ChiCTR2000029849,Recruiting,,2021-02-01,,,,2020-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49530,2021-02-01,0,0
6093,ChiCTR2000029839,Recruiting,,2020-03-31,,,,2020-02-15,http://www.chictr.org.cn/showproj.aspx?proj=49439,2020-03-31,0,0
6094,ChiCTR2000029822,Suspending,,2020-04-30,,,,2020-08-10,http://www.chictr.org.cn/showproj.aspx?proj=49502,2020-04-30,0,0
6095,ChiCTR2000029821,Not yet recruiting,,2020-06-01,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49306,2020-06-01,0,0
6096,ChiCTR2000029819,Recruiting,,2020-08-11,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49490,2020-08-11,0,0
6097,ChiCTR2000029815,Recruiting,,2020-04-15,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49346,2020-04-15,0,0
6098,ChiCTR2000029814,Recruiting,,2020-12-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49387,2020-12-31,0,0
6099,ChiCTR2000029813,Recruiting,,2020-08-14,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49425,2020-08-14,0,0
6100,ChiCTR2000029811,Not yet recruiting,,2021-02-20,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49355,2021-02-20,0,0
6101,ChiCTR2000029810,Recruiting,,2020-03-20,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49407,2020-03-20,0,0
6102,ChiCTR2000029806,Recruiting,,2021-01-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49161,2021-01-31,0,0
6103,ChiCTR2000029805,Recruiting,,2021-01-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49188,2021-01-31,0,0
6104,ChiCTR2000029804,Recruiting,,2021-01-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49178,2021-01-31,0,0
6105,ChiCTR2000029790,Recruiting,,2020-10-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49453,2020-10-31,0,0
6106,ChiCTR2000029789,Recruiting,,2021-06-30,,,,2020-02-16,http://www.chictr.org.cn/showproj.aspx?proj=49348,2021-06-30,0,0
6107,ChiCTR2000029788,Not yet recruiting,,2020-12-30,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49452,2020-12-30,0,0
6108,ChiCTR2000029782,Not yet recruiting,,2020-02-29,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49445,2020-02-29,0,0
6109,ChiCTR2000029779,Recruiting,,2020-05-31,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49378,2020-05-31,0,0
6110,ChiCTR2000029778,Recruiting,,2020-05-13,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49422,2020-05-13,0,0
6111,ChiCTR2000029777,Recruiting,,2020-06-30,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49380,2020-06-30,0,0
6112,ChiCTR2000029776,Recruiting,,2020-12-31,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49342,2020-12-31,0,0
6113,ChiCTR2000029769,Not yet recruiting,,2020-04-30,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49415,2020-04-30,0,0
6114,ChiCTR2000029768,Recruiting,,2020-05-12,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49131,2020-05-12,0,0
6115,ChiCTR2000029765,Recruiting,,2020-05-10,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49409,2020-05-10,0,0
6116,ChiCTR2000029764,Not yet recruiting,,2020-12-31,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49388,2020-12-31,0,0
6117,ChiCTR2000029763,Recruiting,,2020-05-31,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=49408,2020-05-31,0,0
6118,ChiCTR2000029758,Recruiting,,2022-02-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49295,2022-02-01,0,0
6119,ChiCTR2000029756,Recruiting,,2022-02-15,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49222,2022-02-15,0,0
6120,ChiCTR2000029754,Recruiting,,2022-02-10,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49370,2022-02-10,0,0
6121,ChiCTR2000029751,Recruiting,,2020-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49354,2020-12-31,0,0
6122,ChiCTR2000029747,Recruiting,,2021-02-10,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49287,2021-02-10,0,0
6123,ChiCTR2000029742,Recruiting,,2020-12-31,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49297,2020-12-31,0,0
6124,ChiCTR2000029741,Recruiting,,2020-12-31,,,,2020-02-13,http://www.chictr.org.cn/showproj.aspx?proj=49263,2020-12-31,0,0
6125,ChiCTR2000029739,Recruiting,,2021-08-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49283,2021-08-31,0,0
6126,ChiCTR2000029735,Recruiting,,2020-03-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49279,2020-03-31,0,0
6127,ChiCTR2000029734,Recruiting,,2020-08-07,,,,2020-02-14,http://www.chictr.org.cn/showproj.aspx?proj=48868,2020-08-07,0,0
6128,ChiCTR2000029732,Not yet recruiting,,2020-04-10,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49302,2020-04-10,0,0
6129,ChiCTR2000029695,Not yet recruiting,,2021-03-31,,,,2021-08-24,http://www.chictr.org.cn/showproj.aspx?proj=49219,2021-03-31,0,0
6130,ChiCTR2000029656,Not yet recruiting,,2020-04-14,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49086,2020-04-14,0,0
6131,ChiCTR2000029639,Recruiting,,2020-09-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49187,2020-09-30,0,0
6132,ChiCTR2000029637,Not yet recruiting,,2020-04-10,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49127,2020-04-10,0,0
6133,ChiCTR2000029636,Recruiting,,2020-07-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49215,2020-07-30,0,0
6134,ChiCTR2000029628,Not yet recruiting,,2020-04-10,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49155,2020-04-10,0,0
6135,ChiCTR2000029626,Not yet recruiting,,2020-08-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49170,2020-08-01,0,0
6136,ChiCTR2000029625,Not yet recruiting,,2020-08-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49177,2020-08-01,0,0
6137,ChiCTR2000029624,Not yet recruiting,,2021-02-07,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49132,2021-02-07,0,0
6138,ChiCTR2000029621,Recruiting,,2020-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49165,2020-12-31,0,0
6139,ChiCTR2000029609,Not yet recruiting,,2020-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49145,2020-12-31,0,0
6140,ChiCTR2000029606,Recruiting,,2022-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49146,2022-12-31,0,0
6141,ChiCTR2000029603,Recruiting,,2020-05-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49075,2020-05-31,0,0
6142,ChiCTR2000029602,Recruiting,,2020-08-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48985,2020-08-01,0,0
6143,ChiCTR2000029601,Recruiting,,2020-08-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48988,2020-08-01,0,0
6144,ChiCTR2000029600,Recruiting,,2020-04-29,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49042,2020-04-29,0,0
6145,ChiCTR2000029578,Recruiting,,2020-04-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49080,2020-04-30,0,0
6146,ChiCTR2000029572,Not yet recruiting,,2021-04-30,,,,2020-09-29,http://www.chictr.org.cn/showproj.aspx?proj=41760,2021-04-30,0,0
6147,ChiCTR2000029569,Not yet recruiting,,2021-04-30,,,,2020-09-29,http://www.chictr.org.cn/showproj.aspx?proj=49062,2021-04-30,0,0
6148,ChiCTR2000029559,Recruiting,,2020-02-29,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48880,2020-02-29,0,0
6149,ChiCTR2000029558,Recruiting,,2020-05-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48792,2020-05-01,0,0
6150,ChiCTR2000029548,Not yet recruiting,,2020-06-03,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49015,2020-06-03,0,0
6151,ChiCTR2000029544,Not yet recruiting,,2020-05-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=49013,2020-05-31,0,0
6152,ChiCTR2000029542,Recruiting,,2020-07-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48968,2020-07-30,0,0
6153,ChiCTR2000029541,Not yet recruiting,,2020-12-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48992,2020-12-01,0,0
6154,ChiCTR2000029539,Recruiting,,2021-02-02,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48991,2021-02-02,0,0
6155,ChiCTR2000029518,Recruiting,,2020-04-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48860,2020-04-30,0,0
6156,ChiCTR2000029517,Recruiting,,2020-04-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48861,2020-04-30,0,0
6157,ChiCTR2000029495,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48971,2021-12-31,0,0
6158,ChiCTR2000029493,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48931,2021-12-31,0,0
6159,ChiCTR2000029487,Not yet recruiting,,2020-03-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48965,2020-03-31,0,0
6160,ChiCTR2000029468,Not yet recruiting,,2020-06-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48919,2020-06-30,0,0
6161,ChiCTR2000029462,Not yet recruiting,,2020-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48922,2020-12-31,0,0
6162,ChiCTR2000029461,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48927,2021-12-31,0,0
6163,ChiCTR2000029460,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48930,2021-12-31,0,0
6164,ChiCTR2000029459,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48929,2021-12-31,0,0
6165,ChiCTR2000029439,Not yet recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48904,2021-12-31,0,0
6166,ChiCTR2000029438,Not yet recruiting,,2021-12-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48911,2021-12-01,0,0
6167,ChiCTR2000029437,Not yet recruiting,,2021-12-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48913,2021-12-01,0,0
6168,ChiCTR2000029436,Not yet recruiting,,2020-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48884,2020-12-31,0,0
6169,ChiCTR2000029435,Not yet recruiting,,2020-03-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48827,2020-03-31,0,0
6170,ChiCTR2000029432,Not yet recruiting,,2020-04-30,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48881,2020-04-30,0,0
6171,ChiCTR2000029431,Recruiting,,2021-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48907,2021-12-31,0,0
6172,ChiCTR2000029430,Not yet recruiting,,2020-12-01,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48902,2020-12-01,0,0
6173,ChiCTR2000029418,Recruiting,,2020-08-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48886,2020-08-31,0,0
6174,ChiCTR2000029400,Recruiting,,2020-12-31,,,,2020-02-12,http://www.chictr.org.cn/showproj.aspx?proj=48824,2020-12-31,0,0
6175,ChiCTR2000029381,Completed,,2020-12-31,,,,2021-04-19,http://www.chictr.org.cn/showproj.aspx?proj=48768,2020-12-31,0,0
6176,ChiCTR2000030188,Recruiting,,2020-03-30,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50025,2020-03-30,0,0
6177,ChiCTR2000030185,Recruiting,,2020-12-31,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=50058,2020-12-31,0,0
6178,ChiCTR2000030179,Recruiting,,2020-04-24,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=50059,2020-04-24,0,0
6179,ChiCTR2000030173,Not yet recruiting,,2020-04-17,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49229,2020-04-17,0,0
6180,ChiCTR2000030170,Recruiting,,2020-07-31,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=50017,2020-07-31,0,0
6181,ChiCTR2000030167,Not yet recruiting,,2020-09-01,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49567,2020-09-01,0,0
6182,ChiCTR2000030166,Not yet recruiting,,2020-05-14,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49696,2020-05-14,0,0
6183,ChiCTR2000030165,Recruiting,,2020-12-31,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49947,2020-12-31,0,0
6184,ChiCTR2000030164,Not yet recruiting,,2020-03-24,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49983,2020-03-24,0,0
6185,ChiCTR2000030138,Not yet recruiting,,2020-05-31,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=50004,2020-05-31,0,0
6186,ChiCTR2000030137,Not yet recruiting,,2020-05-15,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50007,2020-05-15,0,0
6187,ChiCTR2000030136,Not yet recruiting,,2020-05-15,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50005,2020-05-15,0,0
6188,ChiCTR2000030118,Not yet recruiting,,2020-06-29,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49594,2020-06-29,0,0
6189,ChiCTR2000030117,Recruiting,,2021-12-14,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49762,2021-12-14,0,0
6190,ChiCTR2000030116,Recruiting,,2020-08-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49901,2020-08-31,0,0
6191,ChiCTR2000030115,Not yet recruiting,,2020-04-30,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49964,2020-04-30,0,0
6192,ChiCTR2000030113,Recruiting,,2020-05-31,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49988,2020-05-31,0,0
6193,ChiCTR2000030102,Recruiting,,2020-05-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49747,2020-05-31,0,0
6194,ChiCTR2000030096,Not yet recruiting,,2020-08-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49794,2020-08-31,0,0
6195,ChiCTR2000030094,Not yet recruiting,,2021-02-28,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49970,2021-02-28,0,0
6196,ChiCTR2000030093,Not yet recruiting,,2021-03-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49932,2021-03-31,0,0
6197,ChiCTR2000030092,Recruiting,,2022-02-12,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49880,2022-02-12,0,0
6198,ChiCTR2000030090,Not yet recruiting,,2020-03-22,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49910,2020-03-22,0,0
6199,ChiCTR2000030089,Not yet recruiting,,2020-08-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49889,2020-08-31,0,0
6200,ChiCTR2000030088,Not yet recruiting,,2021-12-31,,,,2020-02-23,http://www.chictr.org.cn/showproj.aspx?proj=49902,2021-12-31,0,0
6201,ChiCTR2000030087,Recruiting,,2023-02-12,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49919,2023-02-12,0,0
6202,ChiCTR2000030086,Recruiting,,,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49934,,0,0
6203,ChiCTR2000030084,Recruiting,,2022-02-01,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49952,2022-02-01,0,0
6204,ChiCTR2000030058,Not yet recruiting,,2020-05-30,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49831,2020-05-30,0,0
6205,ChiCTR2000030056,Not yet recruiting,,,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49904,,0,0
6206,ChiCTR2000030054,Not yet recruiting,,2020-05-21,,,,2020-02-22,http://www.chictr.org.cn/showproj.aspx?proj=49869,2020-05-21,0,0
6207,ChiCTR2000030046,Recruiting,,2020-04-07,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49861,2020-04-07,0,0
6208,ChiCTR2000030043,Not yet recruiting,,2020-12-31,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49866,2020-12-31,0,0
6209,ChiCTR2000030041,Not yet recruiting,,2020-06-30,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49891,2020-06-30,0,0
6210,ChiCTR2000030039,Recruiting,,2020-02-01,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49544,2020-02-01,0,0
6211,ChiCTR2000030034,Recruiting,,2020-06-30,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49647,2020-06-30,0,0
6212,ChiCTR2000030033,Not yet recruiting,,2020-06-30,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49703,2020-06-30,0,0
6213,ChiCTR2000030032,Recruiting,,2020-02-28,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49816,2020-02-28,0,0
6214,ChiCTR2000030030,Recruiting,,2021-05-01,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49841,2021-05-01,0,0
6215,ChiCTR2000030029,Not yet recruiting,,2020-05-30,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49824,2020-05-30,0,0
6216,ChiCTR2000030027,Recruiting,,2021-02-18,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49852,2021-02-18,0,0
6217,ChiCTR2000030021,Recruiting,,2020-02-29,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49690,2020-02-29,0,0
6218,ChiCTR2000030020,Recruiting,,2022-02-05,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49812,2022-02-05,0,0
6219,ChiCTR2000030019,Not yet recruiting,,2021-05-31,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49768,2021-05-31,0,0
6220,ChiCTR2000030017,Recruiting,,2020-12-31,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49798,2020-12-31,0,0
6221,ChiCTR2000030016,Recruiting,,2022-12-31,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49799,2022-12-31,0,0
6222,ChiCTR2000030015,Recruiting,,2020-08-19,,,,2020-02-20,http://www.chictr.org.cn/showproj.aspx?proj=49800,2020-08-19,0,0
6223,ChiCTR2000030012,Not yet recruiting,,,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49718,,0,0
6224,ChiCTR2000030010,Not yet recruiting,,2020-05-31,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49777,2020-05-31,0,0
6225,ChiCTR2000030008,Recruiting,,2021-02-12,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49426,2021-02-12,0,0
6226,ChiCTR2000030007,Not yet recruiting,,2020-04-10,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49619,2020-04-10,0,0
6227,ChiCTR2000030006,Recruiting,,2020-05-19,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49737,2020-05-19,0,0
6228,ChiCTR2000030004,Not yet recruiting,,2023-01-31,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49783,2023-01-31,0,0
6229,ChiCTR2000030003,Not yet recruiting,,2020-07-01,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49770,2020-07-01,0,0
6230,ChiCTR2000030002,Recruiting,,2020-07-30,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49738,2020-07-30,0,0
6231,ChiCTR2000030001,Recruiting,,2020-05-28,,,,2020-06-17,http://www.chictr.org.cn/showproj.aspx?proj=49723,2020-05-28,0,0
6232,ChiCTR2000030000,Recruiting,,,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49748,,0,0
6233,ChiCTR2000029999,Not yet recruiting,,,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49717,,0,0
6234,ChiCTR2000029996,Recruiting,,2020-04-20,,,,2020-02-21,http://www.chictr.org.cn/showproj.aspx?proj=49510,2020-04-20,0,0
6235,ChiCTR2000029995,Recruiting,,2020-12-31,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49418,2020-12-31,0,0
6236,ChiCTR2000029994,Not yet recruiting,,2020-08-19,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49309,2020-08-19,0,0
6237,ChiCTR2000029992,Not yet recruiting,,2020-05-20,,,,2020-02-19,http://www.chictr.org.cn/showproj.aspx?proj=49574,2020-05-20,0,0
6238,ChiCTR2000029990,Recruiting,,2020-03-31,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49674,2020-03-31,0,0
6239,ChiCTR2000029989,Not yet recruiting,,2020-05-31,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49720,2020-05-31,0,0
6240,ChiCTR2000029988,Recruiting,,2020-05-31,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49218,2020-05-31,0,0
6241,ChiCTR2000029985,Recruiting,,2020-02-29,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49711,2020-02-29,0,0
6242,ChiCTR2000029981,Recruiting,,2020-05-18,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49692,2020-05-18,0,0
6243,ChiCTR2000029978,Not yet recruiting,,2020-07-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49702,2020-07-31,0,0
6244,ChiCTR2000029974,Recruiting,,2020-08-31,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49321,2020-08-31,0,0
6245,ChiCTR2000029972,Recruiting,,2020-05-17,,,,2021-07-22,http://www.chictr.org.cn/showproj.aspx?proj=49664,2020-05-17,0,0
6246,ChiCTR2000029960,Not yet recruiting,,2020-05-31,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49639,2020-05-31,0,0
6247,ChiCTR2000029959,Recruiting,,2021-01-01,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49636,2021-01-01,0,0
6248,ChiCTR2000029956,Not yet recruiting,,2020-07-01,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49618,2020-07-01,0,0
6249,ChiCTR2000029954,Recruiting,,2020-02-10,,,,2020-02-17,http://www.chictr.org.cn/showproj.aspx?proj=49402,2020-02-10,0,0
6250,ChiCTR2000029866,Recruiting,,2020-05-31,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49519,2020-05-31,0,0
6251,ChiCTR2000029865,Recruiting,,2020-04-20,,,,2020-07-29,http://www.chictr.org.cn/showproj.aspx?proj=49545,2020-04-20,0,0
6252,ChiCTR2000029851,Recruiting,,2020-03-10,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49534,2020-03-10,0,0
6253,ChiCTR2000029803,Suspending,,2021-02-20,,,,2020-12-30,http://www.chictr.org.cn/showproj.aspx?proj=49428,2021-02-20,0,0
6254,ChiCTR2000029781,Recruiting,,2020-06-30,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49138,2020-06-30,0,0
6255,ChiCTR2000029780,Recruiting,,2020-06-09,,,,2020-02-18,http://www.chictr.org.cn/showproj.aspx?proj=49220,2020-06-09,0,0
6256,ChiCTR2000029740,Recruiting,,2020-02-29,,,,2020-02-24,http://www.chictr.org.cn/showproj.aspx?proj=49317,2020-02-29,0,0
6257,ChiCTR2000030442,Not yet recruiting,,2020-05-15,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50380,2020-05-15,0,0
6258,ChiCTR2000030433,Not yet recruiting,,2020-10-01,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50273,2020-10-01,0,0
6259,ChiCTR2000030432,Not yet recruiting,,2020-08-27,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50268,2020-08-27,0,0
6260,ChiCTR2000030424,Not yet recruiting,,2022-05-02,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50174,2022-05-02,0,0
6261,ChiCTR2000030420,Not yet recruiting,,2020-08-31,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=50286,2020-08-31,0,0
6262,ChiCTR2000030418,Recruiting,,2021-03-01,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50341,2021-03-01,0,0
6263,ChiCTR2000030398,Not yet recruiting,,,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50173,,0,0
6264,ChiCTR2000030391,Not yet recruiting,,,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=30796,,0,0
6265,ChiCTR2000030390,Recruiting,,2020-06-01,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50224,2020-06-01,0,0
6266,ChiCTR2000030389,Recruiting,,2020-08-23,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=50278,2020-08-23,0,0
6267,ChiCTR2000030387,Recruiting,,2020-12-31,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50329,2020-12-31,0,0
6268,ChiCTR2000030386,Not yet recruiting,,2020-12-31,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=50323,2020-12-31,0,0
6269,ChiCTR2000030382,Recruiting,,2020-05-31,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50325,2020-05-31,0,0
6270,ChiCTR2000030363,Recruiting,,2020-06-30,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49984,2020-06-30,0,0
6271,ChiCTR2000030334,Recruiting,,2020-06-19,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=49491,2020-06-19,0,0
6272,ChiCTR2000030327,Recruiting,,2020-03-08,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50214,2020-03-08,0,0
6273,ChiCTR2000030325,Not yet recruiting,,2020-04-28,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50227,2020-04-28,0,0
6274,ChiCTR2000030324,Not yet recruiting,,2020-05-28,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50231,2020-05-28,0,0
6275,ChiCTR2000030322,Recruiting,,2020-12-31,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50240,2020-12-31,0,0
6276,ChiCTR2000030317,Not yet recruiting,,2021-03-30,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50247,2021-03-30,0,0
6277,ChiCTR2000030315,Recruiting,,2020-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50255,2020-12-31,0,0
6278,ChiCTR2000030314,Not yet recruiting,,2020-04-28,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50248,2020-04-28,0,0
6279,ChiCTR2000030305,Not yet recruiting,,2020-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50223,2020-12-31,0,0
6280,ChiCTR2000030293,Recruiting,,2020-05-31,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=50195,2020-05-31,0,0
6281,ChiCTR2000030290,Completed,,2020-02-27,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=50175,2020-02-27,0,0
6282,ChiCTR2000030283,Recruiting,,2020-03-31,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=50119,2020-03-31,0,0
6283,ChiCTR2000030265,Not yet recruiting,,2021-02-23,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=49691,2021-02-23,0,0
6284,ChiCTR2000030264,Not yet recruiting,,2020-06-01,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50161,2020-06-01,0,0
6285,ChiCTR2000030263,Not yet recruiting,,2020-08-20,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50140,2020-08-20,0,0
6286,ChiCTR2000030261,Not yet recruiting,,2020-05-31,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=49963,2020-05-31,0,0
6287,ChiCTR2000030260,Not yet recruiting,,2021-02-26,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50130,2021-02-26,0,0
6288,ChiCTR2000030259,Recruiting,,2020-04-30,,,,2020-08-04,http://www.chictr.org.cn/showproj.aspx?proj=49918,2020-04-30,0,0
6289,ChiCTR2000030258,Not yet recruiting,,2020-08-20,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=49887,2020-08-20,0,0
6290,ChiCTR2000030257,Not yet recruiting,,2020-05-31,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50006,2020-05-31,0,0
6291,ChiCTR2000030255,Not yet recruiting,,2020-07-31,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50089,2020-07-31,0,0
6292,ChiCTR2000030253,Not yet recruiting,,2021-02-26,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50143,2021-02-26,0,0
6293,ChiCTR2000030226,Recruiting,,2020-06-30,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=49855,2020-06-30,0,0
6294,ChiCTR2000030225,Not yet recruiting,,2020-12-31,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=49945,2020-12-31,0,0
6295,ChiCTR2000030223,Recruiting,,2022-05-19,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50026,2022-05-19,0,0
6296,ChiCTR2000030222,Not yet recruiting,,2021-02-28,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=50048,2021-02-28,0,0
6297,ChiCTR2000030219,Recruiting,,2020-12-31,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50110,2020-12-31,0,0
6298,ChiCTR2000030218,Recruiting,,2020-06-25,,,,2020-02-26,http://www.chictr.org.cn/showproj.aspx?proj=50115,2020-06-25,0,0
6299,ChiCTR2000030215,Not yet recruiting,,2020-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50107,2020-12-31,0,0
6300,ChiCTR2000030196,Not yet recruiting,,2020-05-31,,,,2020-02-25,http://www.chictr.org.cn/showproj.aspx?proj=49883,2020-05-31,0,0
6301,ChiCTR2000030162,Not yet recruiting,,,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=49570,,0,0
6302,ChiCTR2000030091,Not yet recruiting,,2020-03-22,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=49914,2020-03-22,0,0
6303,ChiCTR2000030042,Recruiting,,2020-08-21,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49899,2020-08-21,0,0
6304,ChiCTR2000030022,Not yet recruiting,,2020-05-22,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49797,2020-05-22,0,0
6305,ChiCTR2000030013,Not yet recruiting,,2020-06-30,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49796,2020-06-30,0,0
6306,ChiCTR2000029991,Recruiting,,2020-07-18,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49666,2020-07-18,0,0
6307,ChiCTR2000029975,Not yet recruiting,,2020-05-31,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=49592,2020-05-31,0,0
6308,ChiCTR2000029952,Completed,,,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49630,,0,0
6309,ChiCTR2000029900,Not yet recruiting,,2020-02-29,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=49377,2020-02-29,0,0
6310,ChiCTR2000029899,Recruiting,,2020-04-30,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49536,2020-04-30,0,0
6311,ChiCTR2000029898,Recruiting,,2020-04-30,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=49482,2020-04-30,0,0
6312,ChiCTR2000029829,Not yet recruiting,,2022-02-15,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49520,2022-02-15,0,0
6313,ChiCTR2000029762,Suspending,,,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=49404,,0,0
6314,ChiCTR2000029761,Recruiting,,2020-04-30,,,,2020-03-01,http://www.chictr.org.cn/showproj.aspx?proj=49400,2020-04-30,0,0
6315,ChiCTR2000029760,Suspending,,2020-08-11,,,,2020-02-28,http://www.chictr.org.cn/showproj.aspx?proj=49369,2020-08-11,0,0
6316,ChiCTR2000029759,Suspending,,2020-05-01,,,,2020-02-27,http://www.chictr.org.cn/showproj.aspx?proj=49352,2020-05-01,0,0
6317,ChiCTR2000029755,Recruiting,,2020-05-30,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=49301,2020-05-30,0,0
6318,ChiCTR2000029728,Not yet recruiting,,2020-05-30,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=49250,2020-05-30,0,0
6319,ChiCTR2000029387,Recruiting,,2021-01-25,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=48782,2021-01-25,0,0
6320,ChiCTR2000029386,Recruiting,,2021-01-29,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=48777,2021-01-29,0,0
6321,ChiCTR2000030333,Recruiting,,2020-07-07,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=48801,2020-07-07,0,0
6322,ChiCTR2000030627,Recruiting,,2020-05-30,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50727,2020-05-30,0,0
6323,ChiCTR2000030593,Not yet recruiting,,2020-04-09,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50228,2020-04-09,0,0
6324,ChiCTR2000030581,Recruiting,,2021-03-02,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50394,2021-03-02,0,0
6325,ChiCTR2000030579,Not yet recruiting,,2020-05-01,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50692,2020-05-01,0,0
6326,ChiCTR2000030578,Not yet recruiting,,2021-02-01,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50690,2021-02-01,0,0
6327,ChiCTR2000030574,Recruiting,,2021-03-08,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=49953,2021-03-08,0,0
6328,ChiCTR2000030564,Recruiting,,2020-06-30,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50653,2020-06-30,0,0
6329,ChiCTR2000030559,Recruiting,,2020-06-30,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50583,2020-06-30,0,0
6330,ChiCTR2000030557,Recruiting,,2021-03-10,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50667,2021-03-10,0,0
6331,ChiCTR2000030556,Not yet recruiting,,2020-06-01,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50672,2020-06-01,0,0
6332,ChiCTR2000030552,Recruiting,,2020-05-08,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=49708,2020-05-08,0,0
6333,ChiCTR2000030544,Not yet recruiting,,2021-02-01,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50134,2021-02-01,0,0
6334,ChiCTR2000030543,Recruiting,,2020-03-31,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50541,2020-03-31,0,0
6335,ChiCTR2000030542,Recruiting,,2020-07-30,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50608,2020-07-30,0,0
6336,ChiCTR2000030541,Not yet recruiting,,2020-03-13,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50623,2020-03-13,0,0
6337,ChiCTR2000030540,Not yet recruiting,,2020-06-08,,,,2020-03-07,http://www.chictr.org.cn/showproj.aspx?proj=50658,2020-06-08,0,0
6338,ChiCTR2000030535,Recruiting,,2020-03-30,,,,2020-03-06,http://www.chictr.org.cn/showproj.aspx?proj=49790,2020-03-30,0,0
6339,ChiCTR2000030522,Completed,,2020-09-09,,,,2020-10-05,http://www.chictr.org.cn/showproj.aspx?proj=44213,2020-09-09,0,0
6340,ChiCTR2000030518,Recruiting,,2020-05-31,,,,2020-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50586,2020-05-31,0,0
6341,ChiCTR2000030503,Recruiting,,2022-06-30,,,,2020-03-05,http://www.chictr.org.cn/showproj.aspx?proj=49632,2022-06-30,0,0
6342,ChiCTR2000030493,Not yet recruiting,,2020-03-09,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50547,2020-03-09,0,0
6343,ChiCTR2000030492,Not yet recruiting,,2020-06-30,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50549,2020-06-30,0,0
6344,ChiCTR2000030491,Recruiting,,2022-02-01,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50552,2022-02-01,0,0
6345,ChiCTR2000030490,Recruiting,,2020-03-31,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50487,2020-03-31,0,0
6346,ChiCTR2000030489,Recruiting,,2020-06-30,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50490,2020-06-30,0,0
6347,ChiCTR2000030487,Recruiting,,2020-05-04,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50507,2020-05-04,0,0
6348,ChiCTR2000030485,Not yet recruiting,,2021-02-01,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50459,2021-02-01,0,0
6349,ChiCTR2000030484,Not yet recruiting,,2021-01-31,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50263,2021-01-31,0,0
6350,ChiCTR2000030482,Not yet recruiting,,2023-12-31,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50353,2023-12-31,0,0
6351,ChiCTR2000030481,Recruiting,,2020-04-30,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50453,2020-04-30,0,0
6352,ChiCTR2000030480,Recruiting,,2020-07-03,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50470,2020-07-03,0,0
6353,ChiCTR2000030479,Not yet recruiting,,2021-02-25,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50450,2021-02-25,0,0
6354,ChiCTR2000030477,Not yet recruiting,,2020-06-25,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50458,2020-06-25,0,0
6355,ChiCTR2000030475,Not yet recruiting,,2020-06-25,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50452,2020-06-25,0,0
6356,ChiCTR2000030472,Recruiting,,2020-06-30,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=49753,2020-06-30,0,0
6357,ChiCTR2000030471,Recruiting,,2020-04-30,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50421,2020-04-30,0,0
6358,ChiCTR2000030469,Recruiting,,2020-05-27,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50082,2020-05-27,0,0
6359,ChiCTR2000030468,Recruiting,,2020-07-30,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50390,2020-07-30,0,0
6360,ChiCTR2000030467,Not yet recruiting,,2020-08-31,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50378,2020-08-31,0,0
6361,ChiCTR2000030465,Not yet recruiting,,,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50388,,0,0
6362,ChiCTR2000030464,Recruiting,,2020-04-01,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50382,2020-04-01,0,0
6363,ChiCTR2000030453,Not yet recruiting,,,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50381,,0,0
6364,ChiCTR2000030436,Not yet recruiting,,2020-05-31,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50297,2020-05-31,0,0
6365,ChiCTR2000030312,Not yet recruiting,,2020-05-31,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=50258,2020-05-31,0,0
6366,ChiCTR2000030304,Not yet recruiting,,2022-12-31,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=49653,2022-12-31,0,0
6367,ChiCTR2000030163,Not yet recruiting,,2020-12-31,,,,2020-03-02,http://www.chictr.org.cn/showproj.aspx?proj=50031,2020-12-31,0,0
6368,ChiCTR2000030014,Suspending,,2020-06-30,,,,2020-03-05,http://www.chictr.org.cn/showproj.aspx?proj=49802,2020-06-30,0,0
6369,ChiCTR2000029993,Recruiting,,2020-08-20,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=49435,2020-08-20,0,0
6370,ChiCTR2000029958,Not yet recruiting,,,,,,2020-03-03,http://www.chictr.org.cn/showproj.aspx?proj=49635,,0,0
6371,ChiCTR2000029757,Recruiting,,2021-02-05,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=49081,2021-02-05,0,0
6372,ChiCTR2000029580,Recruiting,,2020-12-31,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=49088,2020-12-31,0,0
6373,ChiCTR2000029579,Recruiting,,2020-12-31,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=49045,2020-12-31,0,0
6374,ChiCTR2000029550,Recruiting,,2020-05-01,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=48775,2020-05-01,0,0
6375,ChiCTR2000029549,Recruiting,,2020-05-01,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=49014,2020-05-01,0,0
6376,ChiCTR2000029308,Recruiting,,2021-01-10,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=48684,2021-01-10,0,0
6377,ChiCTR2000030902,Recruiting,,2020-04-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51130,2020-04-30,0,0
6378,ChiCTR2000030901,Completed,,2020-03-14,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51064,2020-03-14,0,0
6379,ChiCTR2000030898,Recruiting,,2020-12-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50780,2020-12-31,0,0
6380,ChiCTR2000030897,Recruiting,,2021-05-01,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50462,2021-05-01,0,0
6381,ChiCTR2000030896,Recruiting,,2021-03-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51028,2021-03-30,0,0
6382,ChiCTR2000030895,Not yet recruiting,,2020-04-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51034,2020-04-30,0,0
6383,ChiCTR2000030893,Not yet recruiting,,2021-03-11,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51073,2021-03-11,0,0
6384,ChiCTR2000030892,Recruiting,,2020-12-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51118,2020-12-30,0,0
6385,ChiCTR2000030883,Recruiting,,2020-12-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50960,2020-12-31,0,0
6386,ChiCTR2000030866,Recruiting,,2020-12-31,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=50299,2020-12-31,0,0
6387,ChiCTR2000030865,Recruiting,,2020-04-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49933,2020-04-30,0,0
6388,ChiCTR2000030864,Recruiting,,2020-07-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50662,2020-07-31,0,0
6389,ChiCTR2000030863,Recruiting,,2021-03-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50767,2021-03-31,0,0
6390,ChiCTR2000030862,Not yet recruiting,,2020-06-16,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51107,2020-06-16,0,0
6391,ChiCTR2000030861,Recruiting,,2020-07-01,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51103,2020-07-01,0,0
6392,ChiCTR2000030860,Recruiting,,,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51102,,0,0
6393,ChiCTR2000030859,Not yet recruiting,,2020-06-01,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51025,2020-06-01,0,0
6394,ChiCTR2000030858,Recruiting,,2020-03-15,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51097,2020-03-15,0,0
6395,ChiCTR2000030857,Recruiting,,2020-04-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51040,2020-04-30,0,0
6396,ChiCTR2000030856,Recruiting,,2020-05-15,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51091,2020-05-15,0,0
6397,ChiCTR2000030855,Not yet recruiting,,2020-05-01,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51090,2020-05-01,0,0
6398,ChiCTR2000030854,Completed,,2020-03-15,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51083,2020-03-15,0,0
6399,ChiCTR2000030853,Not yet recruiting,,2020-05-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51081,2020-05-31,0,0
6400,ChiCTR2000030852,Completed,,2020-02-27,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51077,2020-02-27,0,0
6401,ChiCTR2000030850,Not yet recruiting,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51056,2020-04-30,0,0
6402,ChiCTR2000030849,Not yet recruiting,,2021-03-01,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51086,2021-03-01,0,0
6403,ChiCTR2000030841,Recruiting,,2020-05-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51072,2020-05-31,0,0
6404,ChiCTR2000030839,Not yet recruiting,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50904,2020-04-30,0,0
6405,ChiCTR2000030838,Completed,,2020-05-06,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51071,2020-05-06,0,0
6406,ChiCTR2000030836,Not yet recruiting,,2020-06-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51054,2020-06-30,0,0
6407,ChiCTR2000030835,Recruiting,,2021-02-14,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51050,2021-02-14,0,0
6408,ChiCTR2000030834,Not yet recruiting,,2020-03-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51047,2020-03-31,0,0
6409,ChiCTR2000030833,Not yet recruiting,,2020-03-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51035,2020-03-31,0,0
6410,ChiCTR2000030832,Not yet recruiting,,2020-07-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51044,2020-07-30,0,0
6411,ChiCTR2000030831,Not yet recruiting,,2020-06-15,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51036,2020-06-15,0,0
6412,ChiCTR2000030830,Recruiting,,2020-12-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51009,2020-12-31,0,0
6413,ChiCTR2000030819,Not yet recruiting,,2020-12-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51039,2020-12-31,0,0
6414,ChiCTR2000030818,Not yet recruiting,,2020-02-24,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51037,2020-02-24,0,0
6415,ChiCTR2000030816,Not yet recruiting,,2021-02-23,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51048,2021-02-23,0,0
6416,ChiCTR2000030814,Completed,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51042,2020-04-30,0,0
6417,ChiCTR2000030812,Recruiting,,2021-01-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50947,2021-01-31,0,0
6418,ChiCTR2000030810,Recruiting,,2020-03-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50986,2020-03-30,0,0
6419,ChiCTR2000030809,Recruiting,,2021-03-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51015,2021-03-30,0,0
6420,ChiCTR2000030807,Recruiting,,2020-03-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51019,2020-03-30,0,0
6421,ChiCTR2000030806,Recruiting,,2020-03-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51029,2020-03-31,0,0
6422,ChiCTR2000030805,Completed,,2020-06-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51026,2020-06-30,0,0
6423,ChiCTR2000030804,Recruiting,,2021-03-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51018,2021-03-31,0,0
6424,ChiCTR2000030803,Recruiting,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51007,2020-04-30,0,0
6425,ChiCTR2000030802,Not yet recruiting,,2020-06-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=51004,2020-06-30,0,0
6426,ChiCTR2000030801,Recruiting,,2020-02-29,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50998,2020-02-29,0,0
6427,ChiCTR2000030800,Completed,,2021-03-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50997,2021-03-31,0,0
6428,ChiCTR2000030799,Not yet recruiting,,2020-06-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50995,2020-06-30,0,0
6429,ChiCTR2000030798,Recruiting,,2020-05-01,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50994,2020-05-01,0,0
6430,ChiCTR2000030797,Recruiting,,2021-07-07,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50988,2021-07-07,0,0
6431,ChiCTR2000030796,Recruiting,,2022-01-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50991,2022-01-31,0,0
6432,ChiCTR2000030795,Not yet recruiting,,2020-05-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50982,2020-05-31,0,0
6433,ChiCTR2000030784,Recruiting,,2022-01-17,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50307,2022-01-17,0,0
6434,ChiCTR2000030782,Recruiting,,2020-03-31,,,,2020-12-03,http://www.chictr.org.cn/showproj.aspx?proj=50976,2020-03-31,0,0
6435,ChiCTR2000030779,Recruiting,,2020-05-31,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50973,2020-05-31,0,0
6436,ChiCTR2000030778,Completed,,2020-02-29,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50987,2020-02-29,0,0
6437,ChiCTR2000030773,Recruiting,,2020-07-12,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50934,2020-07-12,0,0
6438,ChiCTR2000030768,Recruiting,,2021-02-01,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50968,2021-02-01,0,0
6439,ChiCTR2000030764,Recruiting,,2020-12-01,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50852,2020-12-01,0,0
6440,ChiCTR2000030763,Recruiting,,2020-08-31,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50921,2020-08-31,0,0
6441,ChiCTR2000030762,Not yet recruiting,,2021-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50950,2021-12-31,0,0
6442,ChiCTR2000030761,Not yet recruiting,,2020-04-01,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50956,2020-04-01,0,0
6443,ChiCTR2000030760,Completed,,2020-03-02,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50955,2020-03-02,0,0
6444,ChiCTR2000030759,Not yet recruiting,,2020-05-17,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49284,2020-05-17,0,0
6445,ChiCTR2000030758,Not yet recruiting,,2020-04-30,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50590,2020-04-30,0,0
6446,ChiCTR2000030757,Not yet recruiting,,2020-06-30,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50648,2020-06-30,0,0
6447,ChiCTR2000030756,Recruiting,,2020-08-20,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50705,2020-08-20,0,0
6448,ChiCTR2000030755,Not yet recruiting,,2020-09-15,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50945,2020-09-15,0,0
6449,ChiCTR2000030754,Completed,,2020-06-30,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50824,2020-06-30,0,0
6450,ChiCTR2000030753,Suspending,,2020-08-31,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50901,2020-08-31,0,0
6451,ChiCTR2000030752,Recruiting,,2020-08-31,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50925,2020-08-31,0,0
6452,ChiCTR2000030751,Not yet recruiting,,2020-12-25,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50941,2020-12-25,0,0
6453,ChiCTR2000030747,Recruiting,,2020-08-01,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50000,2020-08-01,0,0
6454,ChiCTR2000030744,Recruiting,,2020-08-31,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50910,2020-08-31,0,0
6455,ChiCTR2000030742,Not yet recruiting,,2020-04-15,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50857,2020-04-15,0,0
6456,ChiCTR2000030741,Recruiting,,2020-08-31,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50907,2020-08-31,0,0
6457,ChiCTR2000030740,Recruiting,,2020-08-31,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50900,2020-08-31,0,0
6458,ChiCTR2000030739,Recruiting,,2020-06-30,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50896,2020-06-30,0,0
6459,ChiCTR2000030722,Not yet recruiting,,2020-06-30,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50338,2020-06-30,0,0
6460,ChiCTR2000030721,Not yet recruiting,,2020-04-26,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50759,2020-04-26,0,0
6461,ChiCTR2000030720,Recruiting,,2020-08-31,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50793,2020-08-31,0,0
6462,ChiCTR2000030719,Recruiting,,2020-12-31,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50867,2020-12-31,0,0
6463,ChiCTR2000030718,Recruiting,,2020-05-30,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50843,2020-05-30,0,0
6464,ChiCTR2000030717,Not yet recruiting,,2020-08-31,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50860,2020-08-31,0,0
6465,ChiCTR2000030716,Recruiting,,2020-06-30,,,,2020-03-12,http://www.chictr.org.cn/showproj.aspx?proj=50850,2020-06-30,0,0
6466,ChiCTR2000030708,Recruiting,,2020-04-02,,,,2020-03-11,http://www.chictr.org.cn/showproj.aspx?proj=50083,2020-04-02,0,0
6467,ChiCTR2000030707,Not yet recruiting,,2022-03-19,,,,2020-03-11,http://www.chictr.org.cn/showproj.aspx?proj=50160,2022-03-19,0,0
6468,ChiCTR2000030706,Recruiting,,2020-12-31,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50001,2020-12-31,0,0
6469,ChiCTR2000030703,Recruiting,,2020-05-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50251,2020-05-31,0,0
6470,ChiCTR2000030702,Recruiting,,2020-08-15,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50537,2020-08-15,0,0
6471,ChiCTR2000030701,Not yet recruiting,,2020-09-30,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50795,2020-09-30,0,0
6472,ChiCTR2000030700,Not yet recruiting,,2020-09-30,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50786,2020-09-30,0,0
6473,ChiCTR2000030697,Completed,,2021-03-10,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50781,2021-03-10,0,0
6474,ChiCTR2000030690,Recruiting,,2021-02-10,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50261,2021-02-10,0,0
6475,ChiCTR2000030687,Not yet recruiting,,2020-10-31,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50572,2020-10-31,0,0
6476,ChiCTR2000030686,Recruiting,,2020-07-03,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=50714,2020-07-03,0,0
6477,ChiCTR2000030683,Not yet recruiting,,2020-12-31,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=50633,2020-12-31,0,0
6478,ChiCTR2000030681,Not yet recruiting,,2021-11-16,,,,2020-03-09,http://www.chictr.org.cn/showproj.aspx?proj=50763,2021-11-16,0,0
6479,ChiCTR2000030679,Recruiting,,2022-12-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50730,2022-12-31,0,0
6480,ChiCTR2000030619,Completed,,2020-05-31,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50656,2020-05-31,0,0
6481,ChiCTR2000030606,Not yet recruiting,,2021-12-31,,,,2020-03-08,http://www.chictr.org.cn/showproj.aspx?proj=50713,2021-12-31,0,0
6482,ChiCTR2000030597,Not yet recruiting,,2021-12-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50702,2021-12-31,0,0
6483,ChiCTR2000030580,Recruiting,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50693,2020-04-30,0,0
6484,ChiCTR2000030558,Suspending,,2025-04-07,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50678,2025-04-07,0,0
6485,ChiCTR2000030545,Recruiting,,2020-04-30,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50126,2020-04-30,0,0
6486,ChiCTR2000030528,Not yet recruiting,,2020-05-25,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50641,2020-05-25,0,0
6487,ChiCTR2000030509,Not yet recruiting,,2021-02-01,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=49956,2021-02-01,0,0
6488,ChiCTR2000030483,Not yet recruiting,,2020-03-31,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50495,2020-03-31,0,0
6489,ChiCTR2000030478,Not yet recruiting,,2021-02-25,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50460,2021-02-25,0,0
6490,ChiCTR2000030476,Recruiting,,2020-07-01,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=50455,2020-07-01,0,0
6491,ChiCTR2000030466,Suspending,,2020-09-26,,,,2020-03-04,http://www.chictr.org.cn/showproj.aspx?proj=50387,2020-09-26,0,0
6492,ChiCTR2000030417,Suspending,,2020-06-30,,,,2020-03-13,http://www.chictr.org.cn/showproj.aspx?proj=50279,2020-06-30,0,0
6493,ChiCTR2000030388,Recruiting,,,,,,2021-04-19,http://www.chictr.org.cn/showproj.aspx?proj=50306,,0,0
6494,ChiCTR2000030381,Not yet recruiting,,2020-05-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=50290,2020-05-31,0,0
6495,ChiCTR2000030329,Not yet recruiting,,2021-02-17,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=49779,2021-02-17,0,0
6496,ChiCTR2000030306,Suspending,,2020-09-22,,,,2020-03-10,http://www.chictr.org.cn/showproj.aspx?proj=50222,2020-09-22,0,0
6497,ChiCTR2000030221,Recruiting,,2020-03-24,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=50071,2020-03-24,0,0
6498,ChiCTR2000030187,Recruiting,,2020-03-25,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=50057,2020-03-25,0,0
6499,ChiCTR2000030135,Not yet recruiting,,2021-02-28,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50002,2021-02-28,0,0
6500,ChiCTR2000030114,Not yet recruiting,,2020-08-24,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49987,2020-08-24,0,0
6501,ChiCTR2000030085,Suspending,,2020-12-31,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=49948,2020-12-31,0,0
6502,ChiCTR2000030082,Suspending,,2020-04-30,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49915,2020-04-30,0,0
6503,ChiCTR2000030055,Recruiting,,2020-04-10,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49864,2020-04-10,0,0
6504,ChiCTR2000030031,Suspending,,2021-03-20,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49806,2021-03-20,0,0
6505,ChiCTR2000030005,Not yet recruiting,,2020-04-21,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49669,2020-04-21,0,0
6506,ChiCTR2000029984,Not yet recruiting,,2021-12-31,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49712,2021-12-31,0,0
6507,ChiCTR2000029957,Not yet recruiting,,2021-02-28,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=49633,2021-02-28,0,0
6508,ChiCTR2000029895,Recruiting,,2020-12-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49569,2020-12-31,0,0
6509,ChiCTR2000029837,Not yet recruiting,,2020-03-17,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49495,2020-03-17,0,0
6510,ChiCTR2000029826,Not yet recruiting,,2020-03-17,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49481,2020-03-17,0,0
6511,ChiCTR2000029820,Suspending,,2020-02-18,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=49492,2020-02-18,0,0
6512,ChiCTR2000029818,Not yet recruiting,,2021-02-20,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49382,2021-02-20,0,0
6513,ChiCTR2000029817,Not yet recruiting,,2021-02-20,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49384,2021-02-20,0,0
6514,ChiCTR2000029816,Not yet recruiting,,2021-02-20,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49389,2021-02-20,0,0
6515,ChiCTR2000029812,Not yet recruiting,,2021-02-20,,,,2020-03-15,http://www.chictr.org.cn/showproj.aspx?proj=49374,2021-02-20,0,0
6516,ChiCTR2000029770,Recruiting,,2020-05-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49412,2020-05-31,0,0
6517,ChiCTR2000029592,Not yet recruiting,,2020-08-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=49069,2020-08-31,0,0
6518,ChiCTR2000031163,Completed,,2022-02-16,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51390,2022-02-16,0,0
6519,ChiCTR2000031150,Recruiting,,2020-12-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=51021,2020-12-31,0,0
6520,ChiCTR2000031140,Recruiting,,2020-08-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=50605,2020-08-31,0,0
6521,ChiCTR2000031139,Recruiting,,2021-03-19,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51404,2021-03-19,0,0
6522,ChiCTR2000031138,Recruiting,,2020-12-31,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51416,2020-12-31,0,0
6523,ChiCTR2000031115,Recruiting,,2021-03-31,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=51032,2021-03-31,0,0
6524,ChiCTR2000031104,Recruiting,,2020-12-01,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=51185,2020-12-01,0,0
6525,ChiCTR2000031090,Not yet recruiting,,2022-03-23,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=51148,2022-03-23,0,0
6526,ChiCTR2000031089,Not yet recruiting,,2020-04-30,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=51136,2020-04-30,0,0
6527,ChiCTR2000031088,Recruiting,,2022-02-09,,,,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=51132,2022-02-09,0,0
6528,ChiCTR2000031023,Recruiting,,2020-05-16,,,,2020-03-21,http://www.chictr.org.cn/showproj.aspx?proj=50984,2020-05-16,0,0
6529,ChiCTR2000031014,Not yet recruiting,,2020-09-19,,,,2020-03-21,http://www.chictr.org.cn/showproj.aspx?proj=51348,2020-09-19,0,0
6530,ChiCTR2000030996,Recruiting,,2020-10-26,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51349,2020-10-26,0,0
6531,ChiCTR2000030993,Not yet recruiting,,2020-06-12,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51342,2020-06-12,0,0
6532,ChiCTR2000030992,Recruiting,,2023-02-28,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51338,2023-02-28,0,0
6533,ChiCTR2000030989,Not yet recruiting,,2020-08-08,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51331,2020-08-08,0,0
6534,ChiCTR2000030986,Recruiting,,2020-03-01,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51316,2020-03-01,0,0
6535,ChiCTR2000030985,Completed,,2020-03-09,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51311,2020-03-09,0,0
6536,ChiCTR2000030961,Recruiting,,2020-12-31,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51291,2020-12-31,0,0
6537,ChiCTR2000030952,Recruiting,,2020-04-01,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51278,2020-04-01,0,0
6538,ChiCTR2000030951,Not yet recruiting,,2020-06-30,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51283,2020-06-30,0,0
6539,ChiCTR2000030950,Recruiting,,2022-02-10,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51272,2022-02-10,0,0
6540,ChiCTR2000030947,Recruiting,,2020-04-30,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51267,2020-04-30,0,0
6541,ChiCTR2000030946,Recruiting,,2020-04-10,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51265,2020-04-10,0,0
6542,ChiCTR2000030944,Not yet recruiting,,2020-08-31,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=50199,2020-08-31,0,0
6543,ChiCTR2000030943,Not yet recruiting,,2020-05-31,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=50898,2020-05-31,0,0
6544,ChiCTR2000030942,Completed,,2020-06-30,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=50981,2020-06-30,0,0
6545,ChiCTR2000030941,Recruiting,,2020-12-15,,,,2020-03-19,http://www.chictr.org.cn/showproj.aspx?proj=51000,2020-12-15,0,0
6546,ChiCTR2000030939,Recruiting,,2020-10-01,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51059,2020-10-01,0,0
6547,ChiCTR2000030934,Recruiting,,2021-02-28,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51160,2021-02-28,0,0
6548,ChiCTR2000030933,Not yet recruiting,,2020-12-31,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51184,2020-12-31,0,0
6549,ChiCTR2000030932,Recruiting,,2020-06-30,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51230,2020-06-30,0,0
6550,ChiCTR2000030931,Not yet recruiting,,2020-05-22,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51212,2020-05-22,0,0
6551,ChiCTR2000030929,Not yet recruiting,,2020-06-16,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=50696,2020-06-16,0,0
6552,ChiCTR2000030922,Recruiting,,2020-08-26,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=51141,2020-08-26,0,0
6553,ChiCTR2000030920,Recruiting,,2021-05-01,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=50476,2021-05-01,0,0
6554,ChiCTR2000030919,Not yet recruiting,,2020-05-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=51149,2020-05-31,0,0
6555,ChiCTR2000030906,Recruiting,,2020-12-31,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=51154,2020-12-31,0,0
6556,ChiCTR2000030771,Not yet recruiting,,2021-03-01,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=50961,2021-03-01,0,0
6557,ChiCTR2000030765,Not yet recruiting,,2021-12-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=50964,2021-12-31,0,0
6558,ChiCTR2000030539,Not yet recruiting,,2021-03-05,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=50660,2021-03-05,0,0
6559,ChiCTR2000030519,Not yet recruiting,,2021-03-05,,,,2020-03-05,http://www.chictr.org.cn/showproj.aspx?proj=50604,2021-03-05,0,0
6560,ChiCTR2000030254,Completed,,2020-03-20,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=50137,2020-03-20,0,0
6561,ChiCTR2000030224,Not yet recruiting,,2020-05-31,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49968,2020-05-31,0,0
6562,ChiCTR2000030168,Not yet recruiting,,2020-06-30,,,,2020-03-18,http://www.chictr.org.cn/showproj.aspx?proj=49433,2020-06-30,0,0
6563,ChiCTR2000030095,Recruiting,,2020-07-31,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49845,2020-07-31,0,0
6564,ChiCTR2000029955,Completed,,2020-03-01,,,,2021-07-10,http://www.chictr.org.cn/showproj.aspx?proj=49531,2020-03-01,0,0
6565,ChiCTR2000029868,Completed,,2020-06-30,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49524,2020-06-30,0,0
6566,ChiCTR2000029830,Not yet recruiting,,2020-04-12,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49511,2020-04-12,0,0
6567,ChiCTR2000029658,Suspending,,2020-04-06,,,,2020-03-17,http://www.chictr.org.cn/showproj.aspx?proj=49074,2020-04-06,0,0
6568,ChiCTR2000029573,Recruiting,,2020-06-30,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=49065,2020-06-30,0,0
6569,ChiCTR2000029496,Recruiting,,2021-01-29,,,,2020-03-22,http://www.chictr.org.cn/showproj.aspx?proj=48809,2021-01-29,0,0
6570,ChiCTR2000031366,Not yet recruiting,,2020-05-31,,,,2020-03-29,http://www.chictr.org.cn/showproj.aspx?proj=51692,2020-05-31,0,0
6571,ChiCTR2000031365,Recruiting,,2022-01-31,,,,2020-03-29,http://www.chictr.org.cn/showproj.aspx?proj=51694,2022-01-31,0,0
6572,ChiCTR2000031361,Not yet recruiting,,,,,,2020-03-28,http://www.chictr.org.cn/showproj.aspx?proj=51385,,0,0
6573,ChiCTR2000031356,Not yet recruiting,,2021-04-04,,,,2020-03-28,http://www.chictr.org.cn/showproj.aspx?proj=51499,2021-04-04,0,0
6574,ChiCTR2000031337,Recruiting,,2021-06-18,,,,2020-03-28,http://www.chictr.org.cn/showproj.aspx?proj=51170,2021-06-18,0,0
6575,ChiCTR2000031336,Not yet recruiting,,2021-03-31,,,,2020-03-28,http://www.chictr.org.cn/showproj.aspx?proj=51517,2021-03-31,0,0
6576,ChiCTR2000031330,Recruiting,,2021-06-18,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51504,2021-06-18,0,0
6577,ChiCTR2000031329,Recruiting,,2023-12-31,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51667,2023-12-31,0,0
6578,ChiCTR2000031328,Recruiting,,2020-04-30,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51425,2020-04-30,0,0
6579,ChiCTR2000031324,Not yet recruiting,,2021-01-01,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51668,2021-01-01,0,0
6580,ChiCTR2000031319,Not yet recruiting,,2020-07-31,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51647,2020-07-31,0,0
6581,ChiCTR2000031301,Not yet recruiting,,2020-04-27,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51603,2020-04-27,0,0
6582,ChiCTR2000031296,Completed,,2020-03-19,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51584,2020-03-19,0,0
6583,ChiCTR2000031293,Recruiting,,2020-05-16,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=51629,2020-05-16,0,0
6584,ChiCTR2000031272,Completed,,2020-03-02,,,,2020-03-26,http://www.chictr.org.cn/showproj.aspx?proj=51455,2020-03-02,0,0
6585,ChiCTR2000031271,Not yet recruiting,,2021-03-31,,,,2020-03-26,http://www.chictr.org.cn/showproj.aspx?proj=51194,2021-03-31,0,0
6586,ChiCTR2000031252,Completed,,2020-06-30,,,,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=51559,2020-06-30,0,0
6587,ChiCTR2000031247,Recruiting,,2021-03-01,,,,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=51540,2021-03-01,0,0
6588,ChiCTR2000031246,Not yet recruiting,,2021-04-30,,,,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=51535,2021-04-30,0,0
6589,ChiCTR2000031245,Recruiting,,2020-03-12,,,,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=51518,2020-03-12,0,0
6590,ChiCTR2000031244,Not yet recruiting,,2020-08-25,,,,2020-03-25,http://www.chictr.org.cn/showproj.aspx?proj=51486,2020-08-25,0,0
6591,ChiCTR2000031227,Not yet recruiting,,2020-04-06,,,,2020-03-28,http://www.chictr.org.cn/showproj.aspx?proj=51473,2020-04-06,0,0
6592,ChiCTR2000031214,Not yet recruiting,,2022-03-31,,,,2020-03-24,http://www.chictr.org.cn/showproj.aspx?proj=51509,2022-03-31,0,0
6593,ChiCTR2000031204,Recruiting,,2020-04-30,,,,2020-03-24,http://www.chictr.org.cn/showproj.aspx?proj=49420,2020-04-30,0,0
6594,ChiCTR2000031203,Recruiting,,2022-02-28,,,,2020-03-30,http://www.chictr.org.cn/showproj.aspx?proj=51030,2022-02-28,0,0
6595,ChiCTR2000031198,Recruiting,,2022-06-30,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51488,2022-06-30,0,0
6596,ChiCTR2000031196,Recruiting,,2020-12-31,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51112,2020-12-31,0,0
6597,ChiCTR2000031187,Not yet recruiting,,2020-04-30,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51442,2020-04-30,0,0
6598,ChiCTR2000031176,Recruiting,,2021-03-11,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51443,2021-03-11,0,0
6599,ChiCTR2000030988,Not yet recruiting,,2020-05-31,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51317,2020-05-31,0,0
6600,ChiCTR2000030962,Not yet recruiting,,2020-12-31,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51254,2020-12-31,0,0
6601,ChiCTR2000030940,Not yet recruiting,,2020-06-30,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51061,2020-06-30,0,0
6602,ChiCTR2000030938,Recruiting,,2021-06-30,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51239,2021-06-30,0,0
6603,ChiCTR2000030937,Recruiting,,2020-08-30,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51240,2020-08-30,0,0
6604,ChiCTR2000030936,Recruiting,,2020-05-10,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51100,2020-05-10,0,0
6605,ChiCTR2000030923,Recruiting,,2020-04-16,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=51139,2020-04-16,0,0
6606,ChiCTR2000030817,Recruiting,,2022-02-28,,,,2021-06-21,http://www.chictr.org.cn/showproj.aspx?proj=50631,2022-02-28,0,0
6607,ChiCTR2000030704,Suspending,,2020-03-10,,,,2020-03-26,http://www.chictr.org.cn/showproj.aspx?proj=50778,2020-03-10,0,0
6608,ChiCTR2000030330,Suspending,,2020-02-28,,,,2020-03-23,http://www.chictr.org.cn/showproj.aspx?proj=50274,2020-02-28,0,0
6609,ChiCTR2000030288,Recruiting,,2020-12-31,,,,2022-01-07,http://www.chictr.org.cn/showproj.aspx?proj=50202,2020-12-31,0,0
6610,ChiCTR2000030256,Completed,,2020-03-31,,,,2020-03-29,http://www.chictr.org.cn/showproj.aspx?proj=50078,2020-03-31,0,0
6611,ChiCTR2000030198,Not yet recruiting,,2020-08-24,,,,2020-03-27,http://www.chictr.org.cn/showproj.aspx?proj=50066,2020-08-24,0,0
6612,ChiCTR2000030028,Not yet recruiting,,2020-08-31,,,,2020-03-24,http://www.chictr.org.cn/showproj.aspx?proj=49840,2020-08-31,0,0
6613,ChiCTR2000029982,Recruiting,,2021-12-31,,,,2020-03-29,http://www.chictr.org.cn/showproj.aspx?proj=49724,2021-12-31,0,0
6614,ChiCTR2000030987,Recruiting,,2020-06-25,,,,2020-03-20,http://www.chictr.org.cn/showproj.aspx?proj=51329,2020-06-25,0,0
6615,ChiCTR2000031639,Not yet recruiting,,2021-03-27,,,,2020-04-05,http://www.chictr.org.cn/showproj.aspx?proj=51119,2021-03-27,0,0
6616,ChiCTR2000031630,Recruiting,,2020-06-17,,,,2020-04-05,http://www.chictr.org.cn/showproj.aspx?proj=50474,2020-06-17,0,0
6617,ChiCTR2000031627,Not yet recruiting,,2021-04-20,,,,2020-04-05,http://www.chictr.org.cn/showproj.aspx?proj=51865,2021-04-20,0,0
6618,ChiCTR2000031589,Completed,,2020-03-10,,,,2020-04-05,http://www.chictr.org.cn/showproj.aspx?proj=51969,2020-03-10,0,0
6619,ChiCTR2000031587,Recruiting,,2022-12-31,,,,2020-04-04,http://www.chictr.org.cn/showproj.aspx?proj=51952,2022-12-31,0,0
6620,ChiCTR2000031540,Recruiting,,2020-12-05,,,,2020-04-04,http://www.chictr.org.cn/showproj.aspx?proj=51684,2020-12-05,0,0
6621,ChiCTR2000031538,Not yet recruiting,,2020-09-30,,,,2020-04-03,http://www.chictr.org.cn/showproj.aspx?proj=51938,2020-09-30,0,0
6622,ChiCTR2000031533,Not yet recruiting,,2020-06-30,,,,2020-04-03,http://www.chictr.org.cn/showproj.aspx?proj=51835,2020-06-30,0,0
6623,ChiCTR2000031504,Not yet recruiting,,2021-03-31,,,,2020-04-03,http://www.chictr.org.cn/showproj.aspx?proj=51781,2021-03-31,0,0
6624,ChiCTR2000031503,Not yet recruiting,,2022-10-31,,,,2020-04-03,http://www.chictr.org.cn/showproj.aspx?proj=51911,2022-10-31,0,0
6625,ChiCTR2000031501,Suspending,,2020-07-17,,,,2020-09-21,http://www.chictr.org.cn/showproj.aspx?proj=50254,2020-07-17,0,0
6626,ChiCTR2000031500,Completed,,2020-04-12,,,,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=51897,2020-04-12,0,0
6627,ChiCTR2000031499,Completed,,2020-02-25,,,,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=51915,2020-02-25,0,0
6628,ChiCTR2000031494,Recruiting,,2020-12-02,,,,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=51904,2020-12-02,0,0
6629,ChiCTR2000031465,Not yet recruiting,,2021-03-31,,,,2020-04-02,http://www.chictr.org.cn/showproj.aspx?proj=51538,2021-03-31,0,0
6630,ChiCTR2000031454,Recruiting,,2021-07-31,,,,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51693,2021-07-31,0,0
6631,ChiCTR2000031453,Not yet recruiting,,2020-08-01,,,,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51859,2020-08-01,0,0
6632,ChiCTR2000031439,Completed,,2020-03-12,,,,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51837,2020-03-12,0,0
6633,ChiCTR2000031438,Not yet recruiting,,2020-04-30,,,,2020-04-01,http://www.chictr.org.cn/showproj.aspx?proj=51815,2020-04-30,0,0
6634,ChiCTR2000031432,Not yet recruiting,,2020-08-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=51646,2020-08-31,0,0
6635,ChiCTR2000031430,Recruiting,,2021-12-31,,,,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=49254,2021-12-31,0,0
6636,ChiCTR2000031429,Not yet recruiting,,2021-03-31,,,,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51816,2021-03-31,0,0
6637,ChiCTR2000031428,Completed,,2020-10-04,,,,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51813,2020-10-04,0,0
6638,ChiCTR2000031427,Not yet recruiting,,2020-03-31,,,,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51809,2020-03-31,0,0
6639,ChiCTR2000031376,Recruiting,,2020-05-29,,,,2020-03-31,http://www.chictr.org.cn/showproj.aspx?proj=51724,2020-05-29,0,0
6640,ChiCTR2000031199,Recruiting,,2020-04-09,,,,2020-04-05,http://www.chictr.org.cn/showproj.aspx?proj=51478,2020-04-09,0,0
6641,ChiCTR2000031860,Not yet recruiting,,2020-09-16,,,,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=52198,2020-09-16,0,0
6642,ChiCTR2000031836,Completed,,2020-12-31,,,,2020-04-11,http://www.chictr.org.cn/showproj.aspx?proj=52213,2020-12-31,0,0
6643,ChiCTR2000031834,Not yet recruiting,,2020-10-20,,,,2020-04-11,http://www.chictr.org.cn/showproj.aspx?proj=52216,2020-10-20,0,0
6644,ChiCTR2000031794,Not yet recruiting,,2020-05-08,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=52193,2020-05-08,0,0
6645,ChiCTR2000031783,Completed,,2020-03-13,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51832,2020-03-13,0,0
6646,ChiCTR2000031782,Not yet recruiting,,2020-06-30,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=51934,2020-06-30,0,0
6647,ChiCTR2000031781,Not yet recruiting,,2021-01-31,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=52006,2021-01-31,0,0
6648,ChiCTR2000031779,Not yet recruiting,,2021-04-01,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=52051,2021-04-01,0,0
6649,ChiCTR2000031772,Recruiting,,2020-10-31,,,,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=52165,2020-10-31,0,0
6650,ChiCTR2000031770,Completed,,2020-02-29,,,,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=52148,2020-02-29,0,0
6651,ChiCTR2000031752,Completed,,2020-04-15,,,,2020-04-09,http://www.chictr.org.cn/showproj.aspx?proj=52135,2020-04-15,0,0
6652,ChiCTR2000031751,Recruiting,,2022-04-01,,,,2020-04-08,http://www.chictr.org.cn/showproj.aspx?proj=52130,2022-04-01,0,0
6653,ChiCTR2000031735,Not yet recruiting,,2021-02-28,,,,2020-04-08,http://www.chictr.org.cn/showproj.aspx?proj=50613,2021-02-28,0,0
6654,ChiCTR2000031705,Recruiting,,2022-12-31,,,,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=51793,2022-12-31,0,0
6655,ChiCTR2000031700,Not yet recruiting,,2020-05-31,,,,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=52052,2020-05-31,0,0
6656,ChiCTR2000031699,Completed,,2021-01-31,,,,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=51924,2021-01-31,0,0
6657,ChiCTR2000031675,Recruiting,,,,,,2020-04-06,http://www.chictr.org.cn/showproj.aspx?proj=52037,,0,0
6658,ChiCTR2000031672,Not yet recruiting,,2020-12-31,,,,2020-09-14,http://www.chictr.org.cn/showproj.aspx?proj=51940,2020-12-31,0,0
6659,ChiCTR2000030750,Not yet recruiting,,2021-02-28,,,,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=50928,2021-02-28,0,0
6660,ChiCTR2000030494,Not yet recruiting,,2020-04-01,,,,2020-04-12,http://www.chictr.org.cn/showproj.aspx?proj=50077,2020-04-01,0,0
6661,ChiCTR2000030331,Recruiting,,2022-02-01,,,,2020-02-29,http://www.chictr.org.cn/showproj.aspx?proj=50271,2022-02-01,0,0
6662,ChiCTR2000030328,Not yet recruiting,,,,,,2020-04-10,http://www.chictr.org.cn/showproj.aspx?proj=50241,,0,0
6663,ChiCTR2000030894,Recruiting,,2020-05-31,,,,2020-03-16,http://www.chictr.org.cn/showproj.aspx?proj=51126,2020-05-31,0,0
6664,ChiCTR2000032098,Recruiting,,2020-07-31,,,,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=52477,2020-07-31,0,0
6665,ChiCTR2000032095,Recruiting,,2021-03-18,,,,2020-04-19,http://www.chictr.org.cn/showproj.aspx?proj=52565,2021-03-18,0,0
6666,ChiCTR2000032040,Recruiting,,2020-08-01,,,,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=52529,2020-08-01,0,0
6667,ChiCTR2000032013,Completed,,2020-06-30,,,,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=52483,2020-06-30,0,0
6668,ChiCTR2000032011,Not yet recruiting,,2020-05-17,,,,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=52142,2020-05-17,0,0
6669,ChiCTR2000032010,Not yet recruiting,,2022-04-30,,,,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=52479,2022-04-30,0,0
6670,ChiCTR2000032009,Not yet recruiting,,2020-04-30,,,,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=52490,2020-04-30,0,0
6671,ChiCTR2000031982,Not yet recruiting,,2020-08-31,,,,2020-04-20,http://www.chictr.org.cn/showproj.aspx?proj=52341,2020-08-31,0,0
6672,ChiCTR2000031955,Completed,,2020-12-31,,,,2020-09-21,http://www.chictr.org.cn/showproj.aspx?proj=52364,2020-12-31,0,0
6673,ChiCTR2000031954,Recruiting,,2020-04-30,,,,2020-04-16,http://www.chictr.org.cn/showproj.aspx?proj=52365,2020-04-30,0,0
6674,ChiCTR2000031944,Recruiting,,2020-12-31,,,,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=52414,2020-12-31,0,0
6675,ChiCTR2000031930,Completed,,2020-03-01,,,,2020-04-15,http://www.chictr.org.cn/showproj.aspx?proj=51602,2020-03-01,0,0
6676,ChiCTR2000031928,Not yet recruiting,,2021-04-14,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=52353,2021-04-14,0,0
6677,ChiCTR2000031888,Recruiting,,2020-11-30,,,,2020-04-13,http://www.chictr.org.cn/showproj.aspx?proj=52106,2020-11-30,0,0
6678,ChiCTR2000031712,Recruiting,,2021-03-31,,,,2020-04-07,http://www.chictr.org.cn/showproj.aspx?proj=51650,2021-03-31,0,0
6679,ChiCTR2000030300,Recruiting,,2021-02-20,,,,2020-04-13,http://www.chictr.org.cn/showproj.aspx?proj=50022,2021-02-20,0,0
6680,ChiCTR2000029976,Recruiting,,2022-02-19,,,,2020-04-19,http://www.chictr.org.cn/showproj.aspx?proj=49631,2022-02-19,0,0
6681,ChiCTR2000029434,Completed,,2020-04-30,,,,2021-08-08,http://www.chictr.org.cn/showproj.aspx?proj=48889,2020-04-30,0,0
6682,ChiCTR2000029433,Completed,,2020-12-01,,,,2020-04-17,http://www.chictr.org.cn/showproj.aspx?proj=48898,2020-12-01,0,0
6683,ChiCTR2000032412,Not yet recruiting,,2020-08-22,,,,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=52988,2020-08-22,0,0
6684,ChiCTR2000032400,Recruiting,,2020-06-01,,,,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=52958,2020-06-01,0,0
6685,ChiCTR2000032399,Recruiting,,2020-07-01,,,,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=52942,2020-07-01,0,0
6686,ChiCTR2000032368,Not yet recruiting,,2020-10-31,,,,2020-04-26,http://www.chictr.org.cn/showproj.aspx?proj=52933,2020-10-31,0,0
6687,ChiCTR2000032367,Recruiting,,2020-07-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=52972,2020-07-31,0,0
6688,ChiCTR2000032346,Recruiting,,2020-12-31,,,,2020-04-26,http://www.chictr.org.cn/showproj.aspx?proj=52692,2020-12-31,0,0
6689,ChiCTR2000032314,Recruiting,,2020-12-31,,,,2020-04-25,http://www.chictr.org.cn/showproj.aspx?proj=52867,2020-12-31,0,0
6690,ChiCTR2000032313,Not yet recruiting,,2020-12-31,,,,2020-04-26,http://www.chictr.org.cn/showproj.aspx?proj=52916,2020-12-31,0,0
6691,ChiCTR2000032242,Not yet recruiting,,2021-05-01,,,,2020-04-24,http://www.chictr.org.cn/showproj.aspx?proj=52824,2021-05-01,0,0
6692,ChiCTR2000032239,Recruiting,,2020-03-16,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52507,2020-03-16,0,0
6693,ChiCTR2000032237,Recruiting,,2020-06-30,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52699,2020-06-30,0,0
6694,ChiCTR2000032233,Completed,,2020-05-06,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52796,2020-05-06,0,0
6695,ChiCTR2000032214,Not yet recruiting,,2020-07-10,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52781,2020-07-10,0,0
6696,ChiCTR2000032213,Recruiting,,2020-05-23,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52788,2020-05-23,0,0
6697,ChiCTR2000032205,Not yet recruiting,,2020-07-15,,,,2020-04-23,http://www.chictr.org.cn/showproj.aspx?proj=52662,2020-07-15,0,0
6698,ChiCTR2000032165,Completed,,2021-03-31,,,,2020-08-31,http://www.chictr.org.cn/showproj.aspx?proj=52679,2021-03-31,0,0
6699,ChiCTR2000032162,Not yet recruiting,,2020-05-21,,,,2020-04-21,http://www.chictr.org.cn/showproj.aspx?proj=52694,2020-05-21,0,0
6700,ChiCTR2000032161,Recruiting,,2020-06-30,,,,2020-04-21,http://www.chictr.org.cn/showproj.aspx?proj=52561,2020-06-30,0,0
6701,ChiCTR2000032632,Recruiting,,2020-05-22,,,,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=53190,2020-05-22,0,0
6702,ChiCTR2000032574,Completed,,2020-02-29,,,,2020-05-03,http://www.chictr.org.cn/showproj.aspx?proj=53122,2020-02-29,0,0
6703,ChiCTR2000032573,Recruiting,,2021-05-01,,,,2021-01-25,http://www.chictr.org.cn/showproj.aspx?proj=53225,2021-05-01,0,0
6704,ChiCTR2000032527,Not yet recruiting,,2021-04-30,,,,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=53196,2021-04-30,0,0
6705,ChiCTR2000032514,Not yet recruiting,,2020-05-16,,,,2020-05-26,http://www.chictr.org.cn/showproj.aspx?proj=53181,2020-05-16,0,0
6706,ChiCTR2000032487,Not yet recruiting,,2020-09-30,,,,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=52394,2020-09-30,0,0
6707,ChiCTR2000032480,Not yet recruiting,,2021-04-22,,,,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=52698,2021-04-22,0,0
6708,ChiCTR2000032478,Recruiting,,2020-05-01,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=52777,2020-05-01,0,0
6709,ChiCTR2000032476,Recruiting,,2021-03-23,,,,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=53094,2021-03-23,0,0
6710,ChiCTR2000032461,Not yet recruiting,,2020-07-31,,,,2020-05-01,http://www.chictr.org.cn/showproj.aspx?proj=52482,2020-07-31,0,0
6711,ChiCTR2000032460,Completed,,2020-05-30,,,,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=52875,2020-05-30,0,0
6712,ChiCTR2000032459,Recruiting,,2021-11-28,,,,2020-08-14,http://www.chictr.org.cn/showproj.aspx?proj=53003,2021-11-28,0,0
6713,ChiCTR2000032458,Completed,,,,,,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=52779,,0,0
6714,ChiCTR2000032457,Recruiting,,2020-05-31,,,,2021-02-01,http://www.chictr.org.cn/showproj.aspx?proj=52925,2020-05-31,0,0
6715,ChiCTR2000032456,Completed,,2020-05-01,,,,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=53048,2020-05-01,0,0
6716,ChiCTR2000032455,Recruiting,,2021-12-31,,,,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=53050,2021-12-31,0,0
6717,ChiCTR2000032135,Not yet recruiting,,2020-12-31,,,,2020-04-27,http://www.chictr.org.cn/showproj.aspx?proj=52506,2020-12-31,0,0
6718,ChiCTR2000031896,Completed,,2020-02-10,,,,2020-04-29,http://www.chictr.org.cn/showproj.aspx?proj=52332,2020-02-10,0,0
6719,ChiCTR2000031327,Not yet recruiting,,2020-04-10,,,,2020-04-30,http://www.chictr.org.cn/showproj.aspx?proj=51669,2020-04-10,0,0
6720,ChiCTR2000031174,Not yet recruiting,,2020-09-30,,,,2020-05-04,http://www.chictr.org.cn/showproj.aspx?proj=51437,2020-09-30,0,0
6721,ChiCTR2000032770,Completed,,2020-03-31,,,,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=53228,2020-03-31,0,0
6722,ChiCTR2000032769,Recruiting,,,,,,2020-05-09,http://www.chictr.org.cn/showproj.aspx?proj=53368,,0,0
6723,ChiCTR2000032768,Completed,,2021-02-28,,,,2020-05-09,http://www.chictr.org.cn/showproj.aspx?proj=53460,2021-02-28,0,0
6724,ChiCTR2000032767,Completed,,2020-07-27,,,,2020-05-09,http://www.chictr.org.cn/showproj.aspx?proj=53476,2020-07-27,0,0
6725,ChiCTR2000032743,Completed,,2020-04-16,,,,2020-05-09,http://www.chictr.org.cn/showproj.aspx?proj=53431,2020-04-16,0,0
6726,ChiCTR2000032737,Not yet recruiting,,2021-06-08,,,,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=53458,2021-06-08,0,0
6727,ChiCTR2000032717,Completed,,2021-01-31,,,,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=53322,2021-01-31,0,0
6728,ChiCTR2000032716,Completed,,2020-04-30,,,,2020-05-08,http://www.chictr.org.cn/showproj.aspx?proj=53389,2020-04-30,0,0
6729,ChiCTR2000032686,Not yet recruiting,,2021-12-31,,,,2020-05-07,http://www.chictr.org.cn/showproj.aspx?proj=53153,2021-12-31,0,0
6730,ChiCTR2000032666,Recruiting,,2020-12-31,,,,2020-05-05,http://www.chictr.org.cn/showproj.aspx?proj=53285,2020-12-31,0,0
6731,ChiCTR2000032635,Not yet recruiting,,2021-03-31,,,,2020-05-10,http://www.chictr.org.cn/showproj.aspx?proj=52671,2021-03-31,0,0
6732,ChiCTR2000033003,Not yet recruiting,,2022-04-30,,,,2020-05-17,http://www.chictr.org.cn/showproj.aspx?proj=53790,2022-04-30,0,0
6733,ChiCTR2000032919,Recruiting,,2021-05-08,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=53274,2021-05-08,0,0
6734,ChiCTR2000032915,Recruiting,,2020-12-31,,,,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=53658,2020-12-31,0,0
6735,ChiCTR2000032895,Recruiting,,2021-04-01,,,,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=51841,2021-04-01,0,0
6736,ChiCTR2000032884,Completed,,2020-04-01,,,,2020-05-14,http://www.chictr.org.cn/showproj.aspx?proj=53473,2020-04-01,0,0
6737,ChiCTR2000032842,Not yet recruiting,,2021-03-19,,,,2020-05-13,http://www.chictr.org.cn/showproj.aspx?proj=53621,2021-03-19,0,0
6738,ChiCTR2000030262,Recruiting,,2020-12-31,,,,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=50136,2020-12-31,0,0
6739,ChiCTR2000029638,Recruiting,,2020-08-01,,,,2020-05-16,http://www.chictr.org.cn/showproj.aspx?proj=49224,2020-08-01,0,0
6740,ChiCTR2000029605,Recruiting,,2021-02-05,,,,2020-05-15,http://www.chictr.org.cn/showproj.aspx?proj=49051,2021-02-05,0,0
6741,ChiCTR2000033200,Recruiting,,2022-03-31,,,,2020-05-24,http://www.chictr.org.cn/showproj.aspx?proj=54056,2022-03-31,0,0
6742,ChiCTR2000033198,Recruiting,,2020-06-07,,,,2020-05-24,http://www.chictr.org.cn/showproj.aspx?proj=54015,2020-06-07,0,0
6743,ChiCTR2000033197,Not yet recruiting,,2020-05-27,,,,2020-05-24,http://www.chictr.org.cn/showproj.aspx?proj=53451,2020-05-27,0,0
6744,ChiCTR2000033190,Completed,,2021-03-01,,,,2020-05-23,http://www.chictr.org.cn/showproj.aspx?proj=54062,2021-03-01,0,0
6745,ChiCTR2000033186,Recruiting,,2022-02-01,,,,2021-04-23,http://www.chictr.org.cn/showproj.aspx?proj=53927,2022-02-01,0,0
6746,ChiCTR2000033133,Completed,,2020-04-20,,,,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=53925,2020-04-20,0,0
6747,ChiCTR2000033108,Recruiting,,2021-12-31,,,,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=54000,2021-12-31,0,0
6748,ChiCTR2000033107,Completed,,2020-08-01,,,,2020-05-21,http://www.chictr.org.cn/showproj.aspx?proj=54010,2020-08-01,0,0
6749,ChiCTR2000033105,Recruiting,,2021-02-20,,,,2020-07-05,http://www.chictr.org.cn/showproj.aspx?proj=52816,2021-02-20,0,0
6750,ChiCTR2000033104,Completed,,2020-03-20,,,,2020-05-21,http://www.chictr.org.cn/showproj.aspx?proj=53845,2020-03-20,0,0
6751,ChiCTR2000033057,Recruiting,,2020-09-01,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53529,2020-09-01,0,0
6752,ChiCTR2000033056,Completed,,2020-04-30,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53859,2020-04-30,0,0
6753,ChiCTR2000033055,Not yet recruiting,,2020-05-30,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53860,2020-05-30,0,0
6754,ChiCTR2000033054,Recruiting,,2020-05-31,,,,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=53894,2020-05-31,0,0
6755,ChiCTR2000033053,Completed,,2020-03-31,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53886,2020-03-31,0,0
6756,ChiCTR2000033052,Completed,,2020-05-11,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53892,2020-05-11,0,0
6757,ChiCTR2000033050,Recruiting,,2020-06-30,,,,2020-05-19,http://www.chictr.org.cn/showproj.aspx?proj=53590,2020-06-30,0,0
6758,ChiCTR2000033049,Recruiting,,2020-12-31,,,,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=53840,2020-12-31,0,0
6759,ChiCTR2000033433,Not yet recruiting,,2024-09-01,,,,2022-01-09,http://www.chictr.org.cn/showproj.aspx?proj=54482,2024-09-01,0,0
6760,ChiCTR2000033372,Completed,,2020-05-17,,,,2020-05-29,http://www.chictr.org.cn/showproj.aspx?proj=54408,2020-05-17,0,0
6761,ChiCTR2000033364,Recruiting,,2020-04-27,,,,2020-05-30,http://www.chictr.org.cn/showproj.aspx?proj=54280,2020-04-27,0,0
6762,ChiCTR2000033347,Completed,,2020-04-30,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=53976,2020-04-30,0,0
6763,ChiCTR2000033346,Completed,,2020-05-12,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=54388,2020-05-12,0,0
6764,ChiCTR2000033345,Not yet recruiting,,2020-12-31,,,,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=54282,2020-12-31,0,0
6765,ChiCTR2000033342,Not yet recruiting,,2020-11-30,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=54371,2020-11-30,0,0
6766,ChiCTR2000033323,Completed,,2020-05-19,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=54346,2020-05-19,0,0
6767,ChiCTR2000033320,Recruiting,,2020-12-31,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=54321,2020-12-31,0,0
6768,ChiCTR2000033319,Recruiting,,2021-05-31,,,,2020-05-27,http://www.chictr.org.cn/showproj.aspx?proj=54327,2021-05-31,0,0
6769,ChiCTR2000033318,Recruiting,,2020-12-30,,,,2020-05-28,http://www.chictr.org.cn/showproj.aspx?proj=54326,2020-12-30,0,0
6770,ChiCTR2000033317,Not yet recruiting,,2021-07-31,,,,2020-05-27,http://www.chictr.org.cn/showproj.aspx?proj=54295,2021-07-31,0,0
6771,ChiCTR2000033286,Completed,,2020-03-09,,,,2020-05-26,http://www.chictr.org.cn/showproj.aspx?proj=54176,2020-03-09,0,0
6772,ChiCTR2000033284,Not yet recruiting,,2025-05-31,,,,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=49590,2025-05-31,0,0
6773,ChiCTR2000033261,Completed,,2021-02-08,,,,2020-06-01,http://www.chictr.org.cn/showproj.aspx?proj=54185,2021-02-08,0,0
6774,ChiCTR2000031539,Not yet recruiting,,2020-06-30,,,,2020-05-25,http://www.chictr.org.cn/showproj.aspx?proj=51893,2020-06-30,0,0
6775,ChiCTR2000029479,Completed,,2020-05-01,,,,2020-05-31,http://www.chictr.org.cn/showproj.aspx?proj=48773,2020-05-01,0,0
6776,ChiCTR2000033627,Not yet recruiting,,2020-07-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=54707,2020-07-31,0,0
6777,ChiCTR2000033609,Not yet recruiting,,2020-06-17,,,,2020-06-07,http://www.chictr.org.cn/showproj.aspx?proj=54788,2020-06-17,0,0
6778,ChiCTR2000033580,Completed,,2020-03-20,,,,2020-06-06,http://www.chictr.org.cn/showproj.aspx?proj=54787,2020-03-20,0,0
6779,ChiCTR2000033517,Not yet recruiting,,2020-08-31,,,,2020-06-03,http://www.chictr.org.cn/showproj.aspx?proj=54668,2020-08-31,0,0
6780,ChiCTR2000033514,Recruiting,,2020-12-31,,,,2020-06-03,http://www.chictr.org.cn/showproj.aspx?proj=54579,2020-12-31,0,0
6781,ChiCTR2000033491,Completed,,2020-05-12,,,,2020-06-02,http://www.chictr.org.cn/showproj.aspx?proj=54278,2020-05-12,0,0
6782,ChiCTR2000031734,Recruiting,,2020-05-29,,,,2020-08-04,http://www.chictr.org.cn/showproj.aspx?proj=52103,2020-05-29,0,0
6783,ChiCTR2000033872,Completed,,2022-02-01,,,,2020-06-15,http://www.chictr.org.cn/showproj.aspx?proj=54781,2022-02-01,0,0
6784,ChiCTR2000033830,Not yet recruiting,,2021-06-12,,,,2020-06-14,http://www.chictr.org.cn/showproj.aspx?proj=54971,2021-06-12,0,0
6785,ChiCTR2000033798,Not yet recruiting,,2021-06-11,,,,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=55194,2021-06-11,0,0
6786,ChiCTR2000033782,Not yet recruiting,,2021-06-18,,,,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=55039,2021-06-18,0,0
6787,ChiCTR2000033781,Not yet recruiting,,2020-09-01,,,,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=55054,2020-09-01,0,0
6788,ChiCTR2000033780,Completed,,2020-06-19,,,,2020-06-12,http://www.chictr.org.cn/showproj.aspx?proj=55027,2020-06-19,0,0
6789,ChiCTR2000033774,Not yet recruiting,,2020-12-31,,,,2020-06-11,http://www.chictr.org.cn/showproj.aspx?proj=55097,2020-12-31,0,0
6790,ChiCTR2000033745,Not yet recruiting,,2020-12-31,,,,2020-06-11,http://www.chictr.org.cn/showproj.aspx?proj=55100,2020-12-31,0,0
6791,ChiCTR2000033723,Not yet recruiting,,2021-05-01,,,,2020-06-10,http://www.chictr.org.cn/showproj.aspx?proj=54977,2021-05-01,0,0
6792,ChiCTR2000033720,Not yet recruiting,,2020-12-31,,,,2020-06-11,http://www.chictr.org.cn/showproj.aspx?proj=55040,2020-12-31,0,0
6793,ChiCTR2000033719,Completed,,2020-05-30,,,,2020-06-10,http://www.chictr.org.cn/showproj.aspx?proj=55044,2020-05-30,0,0
6794,ChiCTR2000033705,Completed,,2020-03-14,,,,2020-06-10,http://www.chictr.org.cn/showproj.aspx?proj=54989,2020-03-14,0,0
6795,ChiCTR2000033980,Not yet recruiting,,2020-11-01,,,,2020-06-19,http://www.chictr.org.cn/showproj.aspx?proj=55355,2020-11-01,0,0
6796,ChiCTR2000033960,Recruiting,,2020-12-31,,,,2020-06-19,http://www.chictr.org.cn/showproj.aspx?proj=55376,2020-12-31,0,0
6797,ChiCTR2000033936,Recruiting,,2021-06-15,,,,2020-06-17,http://www.chictr.org.cn/showproj.aspx?proj=55291,2021-06-15,0,0
6798,ChiCTR2000033919,Recruiting,,2020-06-23,,,,2020-06-18,http://www.chictr.org.cn/showproj.aspx?proj=55301,2020-06-23,0,0
6799,ChiCTR2000033899,Completed,,2020-06-14,,,,2020-06-16,http://www.chictr.org.cn/showproj.aspx?proj=55295,2020-06-14,0,0
6800,ChiCTR2000031707,Recruiting,,2020-04-30,,,,2020-06-18,http://www.chictr.org.cn/showproj.aspx?proj=52079,2020-04-30,0,0
6801,ChiCTR2000034164,Not yet recruiting,,2021-03-31,,,,2022-03-21,http://www.chictr.org.cn/showproj.aspx?proj=55154,2021-03-31,0,0
6802,ChiCTR2000034112,Not yet recruiting,,2021-12-31,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=55524,2021-12-31,0,0
6803,ChiCTR2000034076,Recruiting,,2022-04-15,,,,2020-06-22,http://www.chictr.org.cn/showproj.aspx?proj=55582,2022-04-15,0,0
6804,ChiCTR2000029589,Recruiting,,2021-12-31,,,,2020-06-28,http://www.chictr.org.cn/showproj.aspx?proj=49104,2021-12-31,0,0
6805,ChiCTR2000034359,Not yet recruiting,,2021-09-30,,,,2020-07-05,http://www.chictr.org.cn/showproj.aspx?proj=56012,2021-09-30,0,0
6806,ChiCTR2000034346,Completed,,2020-06-10,,,,2020-07-03,http://www.chictr.org.cn/showproj.aspx?proj=55654,2020-06-10,0,0
6807,ChiCTR2000034287,Completed,,2020-06-15,,,,2020-07-05,http://www.chictr.org.cn/showproj.aspx?proj=55339,2020-06-15,0,0
6808,ChiCTR2000034588,Completed,,2020-05-15,,,,2020-07-11,http://www.chictr.org.cn/showproj.aspx?proj=56245,2020-05-15,0,0
6809,ChiCTR2000034563,Recruiting,,2021-12-31,,,,2020-07-10,http://www.chictr.org.cn/showproj.aspx?proj=51931,2021-12-31,0,0
6810,ChiCTR2000034537,Not yet recruiting,,2021-07-07,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=56285,2021-07-07,0,0
6811,ChiCTR2000034522,Recruiting,,2021-05-14,,,,2020-07-08,http://www.chictr.org.cn/showproj.aspx?proj=53548,2021-05-14,0,0
6812,ChiCTR2000034519,Not yet recruiting,,2020-09-30,,,,2020-07-09,http://www.chictr.org.cn/showproj.aspx?proj=56079,2020-09-30,0,0
6813,ChiCTR2000034798,Completed,,2020-05-25,,,,2020-07-20,http://www.chictr.org.cn/showproj.aspx?proj=55616,2020-05-25,0,0
6814,ChiCTR2000034795,Completed,,2020-02-29,,,,2020-07-19,http://www.chictr.org.cn/showproj.aspx?proj=56756,2020-02-29,0,0
6815,ChiCTR2000034794,Recruiting,,2021-04-30,,,,2020-07-20,http://www.chictr.org.cn/showproj.aspx?proj=56771,2021-04-30,0,0
6816,ChiCTR2000034784,Completed,,2020-05-25,,,,2020-07-19,http://www.chictr.org.cn/showproj.aspx?proj=55391,2020-05-25,0,0
6817,ChiCTR2000034781,Recruiting,,2021-05-30,,,,2020-07-18,http://www.chictr.org.cn/showproj.aspx?proj=56642,2021-05-30,0,0
6818,ChiCTR2000034780,Completed,,2021-07-15,,,,2021-01-18,http://www.chictr.org.cn/showproj.aspx?proj=56651,2021-07-15,0,0
6819,ChiCTR2000034680,Not yet recruiting,,2021-08-31,,,,2020-07-14,http://www.chictr.org.cn/showproj.aspx?proj=56364,2021-08-31,0,0
6820,ChiCTR2000034852,Recruiting,,2020-07-31,,,,2020-07-27,http://www.chictr.org.cn/showproj.aspx?proj=56528,2020-07-31,0,0
6821,ChiCTR2000034433,Completed,,2020-06-15,,,,2020-07-20,http://www.chictr.org.cn/showproj.aspx?proj=56104,2020-06-15,0,0
6822,ChiCTR2000035060,Not yet recruiting,,2022-03-31,,,,2020-07-29,http://www.chictr.org.cn/showproj.aspx?proj=57232,2022-03-31,0,0
6823,ChiCTR2000035362,Not yet recruiting,,2020-11-30,,,,2020-08-10,http://www.chictr.org.cn/showproj.aspx?proj=57875,2020-11-30,0,0
6824,ChiCTR2000035342,Recruiting,,2021-06-30,,,,2020-08-09,http://www.chictr.org.cn/showproj.aspx?proj=57431,2021-06-30,0,0
6825,ChiCTR2000035213,Not yet recruiting,,2021-07-22,,,,2020-08-03,http://www.chictr.org.cn/showproj.aspx?proj=57283,2021-07-22,0,0
6826,ChiCTR2000035691,Not yet recruiting,,2021-12-31,,,,2020-08-16,http://www.chictr.org.cn/showproj.aspx?proj=58207,2021-12-31,0,0
6827,ChiCTR2000035046,Recruiting,,2020-04-15,,,,2020-08-17,http://www.chictr.org.cn/showproj.aspx?proj=57179,2020-04-15,0,0
6828,ChiCTR2000035907,Completed,,2020-02-15,,,,2020-08-23,http://www.chictr.org.cn/showproj.aspx?proj=57893,2020-02-15,0,0
6829,ChiCTR2000035985,Not yet recruiting,,2022-09-30,,,,2020-08-29,http://www.chictr.org.cn/showproj.aspx?proj=59191,2022-09-30,0,0
6830,ChiCTR2000035633,Not yet recruiting,,2023-08-13,,,,2020-08-30,http://www.chictr.org.cn/showproj.aspx?proj=57741,2023-08-13,0,0
6831,ChiCTR2000034825,Completed,,2020-12-31,,,,2020-09-10,http://www.chictr.org.cn/showproj.aspx?proj=56834,2020-12-31,0,0
6832,ChiCTR2000036982,Recruiting,,2020-10-31,,,,2020-09-27,http://www.chictr.org.cn/showproj.aspx?proj=59893,2020-10-31,0,0
6833,ChiCTR2000039715,Recruiting,,2021-12-17,,,,2021-02-11,http://www.chictr.org.cn/showproj.aspx?proj=63754,2021-12-17,0,0
6834,ChiCTR2000039640,Recruiting,,2021-11-29,,,,2021-02-08,http://www.chictr.org.cn/showproj.aspx?proj=61895,2021-11-29,0,0
6835,ChiCTR2000039593,Completed,,2020-06-01,,,,2021-02-07,http://www.chictr.org.cn/showproj.aspx?proj=63496,2020-06-01,0,0
6836,ChiCTR2000039592,Completed,,2020-10-13,,,,2021-02-07,http://www.chictr.org.cn/showproj.aspx?proj=62882,2020-10-13,0,0
6837,ChiCTR2000039462,Recruiting,,2022-04-26,,,,2021-01-30,http://www.chictr.org.cn/showproj.aspx?proj=63353,2022-04-26,0,0
6838,ChiCTR2000039212,Recruiting,,2021-12-31,,,,2021-01-19,http://www.chictr.org.cn/showproj.aspx?proj=63183,2021-12-31,0,0
6839,ChiCTR2000039079,Recruiting,,2021-01-04,,,,2021-01-15,http://www.chictr.org.cn/showproj.aspx?proj=62482,2021-01-04,0,0
6840,ChiCTR2000039000,Recruiting,,2020-12-31,,,,2021-01-10,http://www.chictr.org.cn/showproj.aspx?proj=62581,2020-12-31,0,0
6841,ChiCTR2000038943,Recruiting,,2021-02-28,,,,2021-01-04,http://www.chictr.org.cn/showproj.aspx?proj=61717,2021-02-28,0,0
6842,ChiCTR2000038866,Not yet recruiting,,2021-12-31,,,,2020-12-28,http://www.chictr.org.cn/showproj.aspx?proj=61662,2021-12-31,0,0
6843,ChiCTR2000038864,Recruiting,,2022-12-31,,,,2020-11-09,http://www.chictr.org.cn/showproj.aspx?proj=62357,2022-12-31,0,0
6844,ChiCTR2000038827,Not yet recruiting,,2021-12-02,,,,2020-12-27,http://www.chictr.org.cn/showproj.aspx?proj=61884,2021-12-02,0,0
6845,ChiCTR2000038740,Not yet recruiting,,2021-08-01,,,,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=62250,2021-08-01,0,0
6846,ChiCTR2000038739,Not yet recruiting,,2021-08-01,,,,2020-09-30,http://www.chictr.org.cn/showproj.aspx?proj=62287,2021-08-01,0,0
6847,ChiCTR2000038471,Recruiting,,2022-09-25,,,,2020-12-24,http://www.chictr.org.cn/showproj.aspx?proj=61958,2022-09-25,0,0
6848,ChiCTR2000037782,Not yet recruiting,,2021-10-01,,,,2020-09-08,http://www.chictr.org.cn/showproj.aspx?proj=55421,2021-10-01,0,0
6849,ChiCTR2000037524,Not yet recruiting,,2020-12-31,,,,2020-10-26,http://www.chictr.org.cn/showproj.aspx?proj=60034,2020-12-31,0,0
6850,ChiCTR2000037518,Not yet recruiting,,2021-08-28,,,,2020-10-26,http://www.chictr.org.cn/showproj.aspx?proj=60581,2021-08-28,0,0
6851,ChiCTR2000037342,Recruiting,,2023-10-01,,,,2020-10-18,http://www.chictr.org.cn/showproj.aspx?proj=60400,2023-10-01,0,0
6852,ChiCTR2000037078,Recruiting,,2022-09-30,,,,2020-10-03,http://www.chictr.org.cn/showproj.aspx?proj=60149,2022-09-30,0,0
6853,ChiCTR2000036871,Not yet recruiting,,2021-04-24,,,,2020-09-20,http://www.chictr.org.cn/showproj.aspx?proj=55984,2021-04-24,0,0
6854,ChiCTR2000036849,Not yet recruiting,,2022-09-30,,,,2020-08-25,http://www.chictr.org.cn/showproj.aspx?proj=59903,2022-09-30,0,0
6855,ChiCTR2000036661,Not yet recruiting,,2022-10-30,,,,2020-09-18,http://www.chictr.org.cn/showproj.aspx?proj=59797,2022-10-30,0,0
6856,ChiCTR2000036333,Completed,,2020-04-30,,,,2020-08-22,http://www.chictr.org.cn/showproj.aspx?proj=57115,2020-04-30,0,0
6857,ChiCTR2000036217,Not yet recruiting,,2023-11-01,,,,2020-09-06,http://www.chictr.org.cn/showproj.aspx?proj=59358,2023-11-01,0,0
6858,ChiCTR2000038537,Completed,,2020-08-01,,,,2020-09-23,http://www.chictr.org.cn/showproj.aspx?proj=60821,2020-08-01,0,0
6859,ChiCTR2000038160,Recruiting,,2022-05-31,,,,2021-05-24,http://www.chictr.org.cn/showproj.aspx?proj=61045,2022-05-31,0,0
6860,ChiCTR2000038152,Completed,,2021-09-13,,,,2021-01-20,http://www.chictr.org.cn/showproj.aspx?proj=59326,2021-09-13,0,0
6861,ChiCTR2000038134,Recruiting,,2021-09-01,,,,2020-11-29,http://www.chictr.org.cn/showproj.aspx?proj=61155,2021-09-01,0,0
6862,ChiCTR2000034796,Recruiting,,2020-03-31,,,,2020-11-26,http://www.chictr.org.cn/showproj.aspx?proj=55775,2020-03-31,0,0
6863,ChiCTR2000038609,Recruiting,,,,,,2020-09-26,http://www.chictr.org.cn/showproj.aspx?proj=62070,,0,0
6864,ChiCTR2000038256,Recruiting,,2020-12-31,,,,2020-12-07,http://www.chictr.org.cn/showproj.aspx?proj=61345,2020-12-31,0,0
6865,ChiCTR2000038255,Recruiting,,2020-12-31,,,,2020-12-07,http://www.chictr.org.cn/showproj.aspx?proj=61390,2020-12-31,0,0
6866,ChiCTR2000038672,Not yet recruiting,,2021-08-05,,,,2020-12-13,http://www.chictr.org.cn/showproj.aspx?proj=59313,2021-08-05,0,0
6867,ChiCTR2000038343,Recruiting,,2021-08-01,,,,2020-12-14,http://www.chictr.org.cn/showproj.aspx?proj=61668,2021-08-01,0,0
6868,ChiCTR2000038333,Recruiting,,2021-09-01,,,,2020-12-14,http://www.chictr.org.cn/showproj.aspx?proj=61769,2021-09-01,0,0
6869,ChiCTR2000030136,Not yet recruiting,,2020-05-15,,,,2020-03-14,http://www.chictr.org.cn/showproj.aspx?proj=50005,2020-05-15,0,0
6870,ChiCTR2000038865,Completed,,2020-08-31,,,,2020-12-28,http://www.chictr.org.cn/showproj.aspx?proj=61044,2020-08-31,0,0
6871,ChiCTR2000040044,Not yet recruiting,,2021-12-31,,,,2020-11-19,http://www.chictr.org.cn/showproj.aspx?proj=64544,2021-12-31,0,0
6872,ChiCTR2000039002,Recruiting,,2021-12-31,,,,2021-01-10,http://www.chictr.org.cn/showproj.aspx?proj=62120,2021-12-31,0,0
6873,ChiCTR2000040179,Not yet recruiting,,2021-08-31,,,,2020-11-24,http://www.chictr.org.cn/showproj.aspx?proj=64541,2021-08-31,0,0
6874,ChiCTR2000040153,Not yet recruiting,,2021-12-31,,,,2020-11-22,http://www.chictr.org.cn/showproj.aspx?proj=64718,2021-12-31,0,0
6875,ChiCTR2000040146,Completed,,2021-12-15,,,,2021-11-22,http://www.chictr.org.cn/showproj.aspx?proj=64452,2021-12-15,0,0
6876,ChiCTR2000039369,Completed,,2020-06-03,,,,2021-01-27,http://www.chictr.org.cn/showproj.aspx?proj=63048,2020-06-03,0,0
6877,ChiCTR2000039364,Recruiting,,2020-11-30,,,,2021-01-27,http://www.chictr.org.cn/showproj.aspx?proj=63240,2020-11-30,0,0
6878,ChiCTR2000039567,Recruiting,,2020-11-13,,,,2021-02-06,http://www.chictr.org.cn/showproj.aspx?proj=62786,2020-11-13,0,0
6879,ChiCTR2000040366,Recruiting,,2021-05-01,,,,2021-02-15,http://www.chictr.org.cn/showproj.aspx?proj=63287,2021-05-01,0,0
6880,ChiCTR2000040324,Recruiting,,2022-11-30,,,,2020-11-27,http://www.chictr.org.cn/showproj.aspx?proj=65022,2022-11-30,0,0
6881,ChiCTR2000040265,Completed,,2020-06-30,,,,2020-11-26,http://www.chictr.org.cn/showproj.aspx?proj=64743,2020-06-30,0,0
6882,ChiCTR2000039711,Recruiting,,2020-12-08,,,,2021-02-11,http://www.chictr.org.cn/showproj.aspx?proj=63807,2020-12-08,0,0
6883,ChiCTR2000039994,Recruiting,,2021-11-18,,,,2021-02-22,http://www.chictr.org.cn/showproj.aspx?proj=64449,2021-11-18,0,0
6884,ChiCTR2000039855,Recruiting,,2022-08-31,,,,2021-02-20,http://www.chictr.org.cn/showproj.aspx?proj=63405,2022-08-31,0,0
6885,ChiCTR2000041375,Recruiting,,2021-05-07,,,,2021-03-08,http://www.chictr.org.cn/showproj.aspx?proj=62474,2021-05-07,0,0
6886,ChiCTR2000041578,Recruiting,,2021-12-31,,,,2021-03-15,http://www.chictr.org.cn/showproj.aspx?proj=119492,2021-12-31,0,0
6887,ChiCTR2000041481,Recruiting,,2022-12-31,,,,2021-03-13,http://www.chictr.org.cn/showproj.aspx?proj=66226,2022-12-31,0,0
6888,ChiCTR2000041425,Recruiting,,2022-02-01,,,,2021-03-11,http://www.chictr.org.cn/showproj.aspx?proj=65865,2022-02-01,0,0
6889,ChiCTR2000040571,Not yet recruiting,,2022-11-30,,,,2021-03-14,http://www.chictr.org.cn/showproj.aspx?proj=65024,2022-11-30,0,0
6890,ChiCTR2100041718,Recruiting,,2022-09-01,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=66415,2022-09-01,0,0
6891,ChiCTR2100041709,Completed,,2020-06-01,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=65920,2020-06-01,0,0
6892,ChiCTR2100041706,Recruiting,,2021-03-27,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=66405,2021-03-27,0,0
6893,ChiCTR2100041705,Recruiting,,2021-03-27,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=66407,2021-03-27,0,0
6894,ChiCTR2100041704,Completed,,2021-03-27,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=66464,2021-03-27,0,0
6895,ChiCTR2000040633,Completed,,2020-11-10,,,,2020-12-04,http://www.chictr.org.cn/showproj.aspx?proj=65196,2020-11-10,0,0
6896,ChiCTR2000040632,Completed,,2020-06-30,,,,2020-12-04,http://www.chictr.org.cn/showproj.aspx?proj=65372,2020-06-30,0,0
6897,ChiCTR2000040628,Recruiting,,2021-05-31,,,,2021-03-21,http://www.chictr.org.cn/showproj.aspx?proj=65329,2021-05-31,0,0
6898,ChiCTR2100041956,Recruiting,,2021-07-31,,,,2021-03-29,http://www.chictr.org.cn/showproj.aspx?proj=64751,2021-07-31,0,0
6899,ChiCTR2100041855,Recruiting,,2022-03-31,,,,2021-03-26,http://www.chictr.org.cn/showproj.aspx?proj=119719,2022-03-31,0,0
6900,ChiCTR2000040729,Recruiting,,,,,,2021-03-29,http://www.chictr.org.cn/showproj.aspx?proj=65466,,0,0
6901,ChiCTR2100043018,Recruiting,,2021-02-28,,,,2021-02-04,http://www.chictr.org.cn/showproj.aspx?proj=121435,2021-02-28,0,0
6902,ChiCTR2100043012,Not yet recruiting,,2021-12-01,,,,2021-02-04,http://www.chictr.org.cn/showproj.aspx?proj=120867,2021-12-01,0,0
6903,ChiCTR2100042192,Recruiting,,2021-12-31,,,,2021-04-10,http://www.chictr.org.cn/showproj.aspx?proj=119629,2021-12-31,0,0
6904,ChiCTR2100042177,Recruiting,,2021-12-31,,,,2021-04-10,http://www.chictr.org.cn/showproj.aspx?proj=120429,2021-12-31,0,0
6905,ChiCTR2100042150,Not yet recruiting,,2021-08-15,,,,2021-04-09,http://www.chictr.org.cn/showproj.aspx?proj=66096,2021-08-15,0,0
6906,ChiCTR2100042069,Recruiting,,2021-03-31,,,,2022-01-13,http://www.chictr.org.cn/showproj.aspx?proj=120071,2021-03-31,0,0
6907,ChiCTR2100042068,Recruiting,,2021-03-31,,,,2022-01-14,http://www.chictr.org.cn/showproj.aspx?proj=120075,2021-03-31,0,0
6908,ChiCTR2100042066,Recruiting,,2021-03-31,,,,2022-01-14,http://www.chictr.org.cn/showproj.aspx?proj=120077,2021-03-31,0,0
6909,ChiCTR2100042004,Suspending,,2020-12-31,,,,2021-04-11,http://www.chictr.org.cn/showproj.aspx?proj=65719,2020-12-31,0,0
6910,ChiCTR2100042003,Completed,,2020-07-31,,,,2021-04-11,http://www.chictr.org.cn/showproj.aspx?proj=64795,2020-07-31,0,0
6911,ChiCTR2000040847,Recruiting,,2023-12-31,,,,2021-04-01,http://www.chictr.org.cn/showproj.aspx?proj=53028,2023-12-31,0,0
6912,ChiCTR2000040770,Recruiting,,2021-05-30,,,,2020-12-09,http://www.chictr.org.cn/showproj.aspx?proj=65377,2021-05-30,0,0
6913,ChiCTR2000040765,Recruiting,,2021-01-31,,,,2020-12-09,http://www.chictr.org.cn/showproj.aspx?proj=65161,2021-01-31,0,0
6914,ChiCTR2100042356,Completed,,2020-06-30,,,,2021-04-19,http://www.chictr.org.cn/showproj.aspx?proj=120364,2020-06-30,0,0
6915,ChiCTR2100042315,Completed,,2020-10-30,,,,2021-04-17,http://www.chictr.org.cn/showproj.aspx?proj=120463,2020-10-30,0,0
6916,ChiCTR2100042314,Recruiting,,2021-12-31,,,,2021-04-17,http://www.chictr.org.cn/showproj.aspx?proj=120541,2021-12-31,0,0
6917,ChiCTR2100042222,Recruiting,,2022-01-13,,,,2021-04-16,http://www.chictr.org.cn/showproj.aspx?proj=120313,2022-01-13,0,0
6918,ChiCTR2100042401,Recruiting,,2021-12-31,,,,2021-04-24,http://www.chictr.org.cn/showproj.aspx?proj=120319,2021-12-31,0,0
6919,ChiCTR2100042375,Completed,,2020-08-10,,,,2021-04-23,http://www.chictr.org.cn/showproj.aspx?proj=120493,2020-08-10,0,0
6920,ChiCTR2100042374,Recruiting,,2022-04-29,,,,2021-04-23,http://www.chictr.org.cn/showproj.aspx?proj=120494,2022-04-29,0,0
6921,ChiCTR2100042528,Recruiting,,2021-05-01,,,,2021-05-01,http://www.chictr.org.cn/showproj.aspx?proj=120361,2021-05-01,0,0
6922,ChiCTR2100042804,Recruiting,,2021-02-14,,,,2021-05-10,http://www.chictr.org.cn/showproj.aspx?proj=121164,2021-02-14,0,0
6923,ChiCTR2100042780,Recruiting,,2021-02-14,,,,2021-05-10,http://www.chictr.org.cn/showproj.aspx?proj=121050,2021-02-14,0,0
6924,ChiCTR2100042726,Completed,,2020-06-25,,,,2021-05-09,http://www.chictr.org.cn/showproj.aspx?proj=66123,2020-06-25,0,0
6925,ChiCTR2100042717,Recruiting,,2021-07-01,,,,2021-05-09,http://www.chictr.org.cn/showproj.aspx?proj=121027,2021-07-01,0,0
6926,ChiCTR2100042634,Completed,,2021-02-28,,,,2021-05-06,http://www.chictr.org.cn/showproj.aspx?proj=52617,2021-02-28,0,0
6927,ChiCTR2000029618,Recruiting,,2022-12-31,,,,2021-05-10,http://www.chictr.org.cn/showproj.aspx?proj=48903,2022-12-31,0,0
6928,ChiCTR2100046272,Recruiting,,2022-12-31,,,,2021-12-20,http://www.chictr.org.cn/showproj.aspx?proj=126252,2022-12-31,0,0
6929,ChiCTR2100046227,Recruiting,,2022-02-28,,,,2021-12-19,http://www.chictr.org.cn/showproj.aspx?proj=126385,2022-02-28,0,0
6930,ChiCTR2100046174,Suspending,,2021-12-31,,,,2021-12-17,http://www.chictr.org.cn/showproj.aspx?proj=126277,2021-12-31,0,0
6931,ChiCTR2100045993,Recruiting,,2021-12-01,,,,2021-12-13,http://www.chictr.org.cn/showproj.aspx?proj=126032,2021-12-01,0,0
6932,ChiCTR2100045991,Recruiting,,2022-12-31,,,,2021-12-13,http://www.chictr.org.cn/showproj.aspx?proj=126041,2022-12-31,0,0
6933,ChiCTR2100045984,Recruiting,,2022-05-25,,,,2021-12-13,http://www.chictr.org.cn/showproj.aspx?proj=126046,2022-05-25,0,0
6934,ChiCTR2100045964,Completed,,2021-04-30,,,,2021-12-13,http://www.chictr.org.cn/showproj.aspx?proj=125970,2021-04-30,0,0
6935,ChiCTR2100045849,Recruiting,,2021-12-18,,,,2021-12-11,http://www.chictr.org.cn/showproj.aspx?proj=125745,2021-12-18,0,0
6936,ChiCTR2100045845,Completed,,2021-05-31,,,,2021-12-11,http://www.chictr.org.cn/showproj.aspx?proj=125761,2021-05-31,0,0
6937,ChiCTR2100045810,Recruiting,,2021-12-31,,,,2021-12-11,http://www.chictr.org.cn/showproj.aspx?proj=124457,2021-12-31,0,0
6938,ChiCTR2100045631,Recruiting,,2023-04-30,,,,2021-12-05,http://www.chictr.org.cn/showproj.aspx?proj=125427,2023-04-30,0,0
6939,ChiCTR2100045417,Recruiting,,2021-05-31,,,,2021-11-28,http://www.chictr.org.cn/showproj.aspx?proj=123288,2021-05-31,0,0
6940,ChiCTR2100045378,Recruiting,,2022-04-01,,,,2021-11-23,http://www.chictr.org.cn/showproj.aspx?proj=124299,2022-04-01,0,0
6941,ChiCTR2100045353,Recruiting,,2022-06-30,,,,2021-11-22,http://www.chictr.org.cn/showproj.aspx?proj=124953,2022-06-30,0,0
6942,ChiCTR2100045160,Recruiting,,2021-06-30,,,,2021-11-08,http://www.chictr.org.cn/showproj.aspx?proj=123525,2021-06-30,0,0
6943,ChiCTR2100045109,Recruiting,,2022-04-09,,,,2021-11-08,http://www.chictr.org.cn/showproj.aspx?proj=124650,2022-04-09,0,0
6944,ChiCTR2100045108,Recruiting,,2022-06-30,,,,2021-11-08,http://www.chictr.org.cn/showproj.aspx?proj=124140,2022-06-30,0,0
6945,ChiCTR2100045107,Recruiting,,2022-07-30,,,,2021-11-08,http://www.chictr.org.cn/showproj.aspx?proj=124702,2022-07-30,0,0
6946,ChiCTR2100044919,Recruiting,,2022-02-01,,,,2021-10-31,http://www.chictr.org.cn/showproj.aspx?proj=122521,2022-02-01,0,0
6947,ChiCTR2100044860,Recruiting,,2021-12-31,,,,2021-10-24,http://www.chictr.org.cn/showproj.aspx?proj=124310,2021-12-31,0,0
6948,ChiCTR2100044539,Recruiting,,2021-07-01,,,,2022-01-31,http://www.chictr.org.cn/showproj.aspx?proj=123658,2021-07-01,0,0
6949,ChiCTR2100044286,Completed,,2021-03-01,,,,2021-09-05,http://www.chictr.org.cn/showproj.aspx?proj=123279,2021-03-01,0,0
6950,ChiCTR2100044249,Recruiting,,2022-02-01,,,,2021-08-30,http://www.chictr.org.cn/showproj.aspx?proj=65034,2022-02-01,0,0
6951,ChiCTR2100044026,Completed,,2021-01-15,,,,2021-07-12,http://www.chictr.org.cn/showproj.aspx?proj=122577,2021-01-15,0,0
6952,ChiCTR2100043907,Recruiting,,2022-12-28,,,,2021-07-05,http://www.chictr.org.cn/showproj.aspx?proj=122756,2022-12-28,0,0
6953,ChiCTR2100043832,Recruiting,,2021-03-31,,,,2021-07-01,http://www.chictr.org.cn/showproj.aspx?proj=122718,2021-03-31,0,0
6954,ChiCTR2100042996,Not yet recruiting,,2021-09-01,,,,2021-05-17,http://www.chictr.org.cn/showproj.aspx?proj=121567,2021-09-01,0,0
6955,ChiCTR2100042931,Completed,,2020-11-26,,,,2021-05-15,http://www.chictr.org.cn/showproj.aspx?proj=120184,2020-11-26,0,0
6956,ChiCTR2100042862,Recruiting,,2024-12-31,,,,2021-05-13,http://www.chictr.org.cn/showproj.aspx?proj=121199,2024-12-31,0,0
6957,ChiCTR2100042832,Recruiting,,2021-05-01,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=121147,2021-05-01,0,0
6958,ChiCTR2100042831,Recruiting,,2021-07-31,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=121308,2021-07-31,0,0
6959,ChiCTR2100042822,Recruiting,,2022-01-28,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=121247,2022-01-28,0,0
6960,ChiCTR2100042821,Completed,,2020-12-31,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=66563,2020-12-31,0,0
6961,ChiCTR2100042820,Recruiting,,2023-01-28,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=121258,2023-01-28,0,0
6962,ChiCTR2100042819,Recruiting,,2021-03-31,,,,2021-05-11,http://www.chictr.org.cn/showproj.aspx?proj=120720,2021-03-31,0,0
6963,ChiCTR2100043210,Recruiting,,2021-04-29,,,,2021-05-24,http://www.chictr.org.cn/showproj.aspx?proj=121519,2021-04-29,0,0
6964,ChiCTR2100043183,Recruiting,,2022-02-21,,,,2021-05-23,http://www.chictr.org.cn/showproj.aspx?proj=121620,2022-02-21,0,0
6965,ChiCTR2100043178,Recruiting,,2021-05-31,,,,2021-05-23,http://www.chictr.org.cn/showproj.aspx?proj=121619,2021-05-31,0,0
6966,ChiCTR2100043108,Recruiting,,2022-12-31,,,,2021-05-22,http://www.chictr.org.cn/showproj.aspx?proj=66027,2022-12-31,0,0
6967,ChiCTR2100043045,Recruiting,,2022-03-31,,,,2021-05-20,http://www.chictr.org.cn/showproj.aspx?proj=121511,2022-03-31,0,0
6968,ChiCTR2100043500,Recruiting,,2022-12-31,,,,2021-06-07,http://www.chictr.org.cn/showproj.aspx?proj=121034,2022-12-31,0,0
6969,ChiCTR2100043428,Completed,,2020-03-07,,,,2021-06-06,http://www.chictr.org.cn/showproj.aspx?proj=122002,2020-03-07,0,0
6970,ChiCTR2100043350,Recruiting,,2021-02-25,,,,2021-06-01,http://www.chictr.org.cn/showproj.aspx?proj=121852,2021-02-25,0,0
6971,ChiCTR2100043319,Not yet recruiting,,2023-12-31,,,,2021-05-30,http://www.chictr.org.cn/showproj.aspx?proj=121890,2023-12-31,0,0
6972,ChiCTR2100043241,Recruiting,,,,,,2021-05-28,http://www.chictr.org.cn/showproj.aspx?proj=121773,,0,0
6973,ChiCTR2100043682,Not yet recruiting,,2023-09-30,,,,2021-06-21,http://www.chictr.org.cn/showproj.aspx?proj=122412,2023-09-30,0,0
6974,ChiCTR2100043802,Recruiting,,2023-05-23,,,,2021-06-28,http://www.chictr.org.cn/showproj.aspx?proj=122767,2023-05-23,0,0
6975,ChiCTR2100043801,Recruiting,,2023-05-23,,,,2021-06-28,http://www.chictr.org.cn/showproj.aspx?proj=122765,2023-05-23,0,0
6976,ChiCTR2100043788,Recruiting,,2021-06-30,,,,2021-06-27,http://www.chictr.org.cn/showproj.aspx?proj=65821,2021-06-30,0,0
6977,IRCT20181104041551N1,Recruitment complete,,,,,,2020-04-12,,,0,0
6978,IRCT20200324046852N1,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46706,,0,0
6979,IRCT20200310046736N1,Not yet recruiting,,,,,,2020-04-01,http://en.irct.ir/trial/46424,,0,0
6980,IRCT20151113025025N3,Recruitment complete,,,,,,2020-07-06,http://en.irct.ir/trial/46531,,0,0
6981,IRCT20100228003449N30,Recruitment complete,,,,,,2020-03-24,http://en.irct.ir/trial/46536,,0,0
6982,IRCT20100228003449N28,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46538,,0,0
6983,IRCT20100228003449N27,Recruitment complete,,,,,,2020-03-25,http://en.irct.ir/trial/46545,,0,0
6984,IRCT20200316046792N1,Recruitment complete,,,,,,2020-03-24,http://en.irct.ir/trial/46554,,0,0
6985,IRCT20151227025726N12,Recruitment complete,,,,,,2020-03-23,http://en.irct.ir/trial/46561,,0,0
6986,IRCT20170117032004N3,Recruitment complete,,,,,,2020-09-29,http://en.irct.ir/trial/46564,,0,0
6987,IRCT20100228003449N29,Recruitment complete,,,,,,2020-03-25,http://en.irct.ir/trial/46567,,0,0
6988,IRCT20200317046797N1,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46573,,0,0
6989,IRCT20160625028622N1,Recruitment complete,,,,,,2020-03-22,http://en.irct.ir/trial/46576,,0,0
6990,IRCT20120826010664N6,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46603,,0,0
6991,IRCT20131113015393N6,Recruitment complete,,,,,,2020-03-30,http://en.irct.ir/trial/46609,,0,0
6992,IRCT20140528017891N8,Recruitment complete,,,,,,2020-03-28,http://en.irct.ir/trial/46623,,0,0
6993,IRCT20200321046828N1,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46624,,0,0
6994,IRCT20190727044343N1,Recruitment complete,,2020-04-09,,,,2020-04-05,http://en.irct.ir/trial/46629,2020-04-09,0,0
6995,IRCT20140617018126N2,Recruitment complete,,,,,,2020-03-29,http://en.irct.ir/trial/46637,,0,0
6996,IRCT20150914024017N1,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46665,,0,0
6997,IRCT20140911019125N6,Recruitment complete,,,,,,2020-04-04,http://en.irct.ir/trial/46668,,0,0
6998,IRCT20160316027081N1,Recruitment complete,,2020-07-01,,,,2022-03-03,http://en.irct.ir/trial/46678,2020-07-01,0,0
6999,IRCT20151227025726N13,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46681,,0,0
7000,IRCT20160310026998N11,Recruitment complete,,,,,,2020-03-27,http://en.irct.ir/trial/46690,,0,0
7001,IRCT20160310026998N10,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46693,,0,0
7002,IRCT20180610040049N3,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46697,,0,0
7003,IRCT20200324046847N1,Recruitment complete,,,,,,2020-03-31,http://en.irct.ir/trial/46720,,0,0
7004,IRCT20140907019073N4,Recruitment complete,,,,,,2020-03-29,http://en.irct.ir/trial/46736,,0,0
7005,IRCT20200324046850N5,Recruitment complete,,,,,,2020-10-17,http://en.irct.ir/trial/46751,,0,0
7006,IRCT20200325046860N1,Recruitment complete,,,,,,2020-03-30,http://en.irct.ir/trial/46759,,0,0
7007,IRCT20101219005416N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46775,,0,0
7008,IRCT20200317046797N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46786,,0,0
7009,IRCT20200325046860N2,Recruitment complete,,2020-04-29,,,,2020-04-01,http://en.irct.ir/trial/46789,2020-04-29,0,0
7010,IRCT20170611034452N11,Recruitment complete,,,,,,2020-03-31,http://en.irct.ir/trial/46803,,0,0
7011,IRCT20190917044805N2,Recruitment complete,,,,,,2021-07-10,http://en.irct.ir/trial/46804,,0,0
7012,IRCT20120225009124N4,Recruitment complete,,,,,,2020-04-02,http://en.irct.ir/trial/46810,,0,0
7013,IRCT20180802040678N4,Recruitment complete,,,,,,2020-04-01,http://en.irct.ir/trial/46824,,0,0
7014,IRCT20150704023055N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46837,,0,0
7015,IRCT20200319046819N1,Recruitment complete,,,,,,2020-04-04,http://en.irct.ir/trial/46838,,0,0
7016,IRCT20200405046953N1,Recruitment complete,,,,,,2020-04-06,http://en.irct.ir/trial/46930,,0,0
7017,IRCT20200217046526N2,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/47073,,0,0
7018,IRCT20191228045924N1,Recruitment complete,,,,,,2020-09-20,http://en.irct.ir/trial/49767,,0,0
7019,IRCT20200314046764N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/46533,,0,0
7020,IRCT20150303021315N17,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/46550,,0,0
7021,IRCT20200312046749N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46551,,0,0
7022,IRCT20190727044343N2,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/46639,,0,0
7023,IRCT20171122037571N2,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46660,,0,0
7024,IRCT20200324046850N2,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/46713,,0,0
7025,IRCT20200323046841N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46715,,0,0
7026,IRCT20200322046833N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46731,,0,0
7027,IRCT20160131026298N2,Recruitment complete,,2020-03-24,,,,2020-11-05,http://en.irct.ir/trial/46733,2020-03-24,0,0
7028,IRCT20190804044429N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46741,,0,0
7029,IRCT20160313027033N2,Recruitment complete,,,,,,2020-04-16,http://en.irct.ir/trial/46762,,0,0
7030,IRCT20200204046369N1,Recruitment complete,,2020-11-15,,,,2020-12-07,http://en.irct.ir/trial/46776,2020-11-15,0,0
7031,IRCT20180712040449N2,Recruitment complete,,,,,,2020-04-28,http://en.irct.ir/trial/46782,,0,0
7032,IRCT20130812014333N145,Recruitment complete,,,,,,2020-04-07,http://en.irct.ir/trial/46790,,0,0
7033,IRCT20200325046859N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/46811,,0,0
7034,IRCT20161204031229N3,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46814,,0,0
7035,IRCT20151228025732N51,Recruitment complete,,,,,,2020-09-26,http://en.irct.ir/trial/46828,,0,0
7036,IRCT20130917014693N10,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46849,,0,0
7037,IRCT20180610040049N4,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46850,,0,0
7038,IRCT20130812014333N147,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/46853,,0,0
7039,IRCT20081019001369N2,Recruitment complete,,,,,,2020-04-07,http://en.irct.ir/trial/46868,,0,0
7040,IRCT20200402046923N1,Recruitment complete,,,,,,2020-04-09,http://en.irct.ir/trial/46879,,0,0
7041,IRCT20200328046886N1,Recruitment complete,,2020-05-04,,,,2020-04-12,http://en.irct.ir/trial/46885,2020-05-04,0,0
7042,IRCT20131215015805N2,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/46887,,0,0
7043,IRCT20200404046933N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46893,,0,0
7044,IRCT20200404046937N1,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/46903,,0,0
7045,IRCT20080901001157N16,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46907,,0,0
7046,IRCT20200404046934N1,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/46913,,0,0
7047,IRCT20200403046926N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46926,,0,0
7048,IRCT20151228025732N53,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46931,,0,0
7049,IRCT20180429039463N2,Recruitment complete,,2020-07-31,,,,2021-05-04,http://en.irct.ir/trial/46933,2020-07-31,0,0
7050,IRCT20200404046935N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/46940,,0,0
7051,IRCT20151227025726N14,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46942,,0,0
7052,IRCT20200405046958N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46946,,0,0
7053,IRCT20200406046965N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46958,,0,0
7054,IRCT20200405046960N1,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46961,,0,0
7055,IRCT20200318046812N2,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46968,,0,0
7056,IRCT20200317046797N4,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46969,,0,0
7057,IRCT20200404046948N1,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/46973,,0,0
7058,IRCT20180520039738N2,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46974,,0,0
7059,IRCT20081019001369N4,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/46977,,0,0
7060,IRCT20081019001369N3,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46978,,0,0
7061,IRCT20200408046992N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47006,,0,0
7062,IRCT20200408046987N1,Recruitment complete,,,,,,2020-07-21,http://en.irct.ir/trial/47012,,0,0
7063,IRCT20180129038542N1,Recruitment complete,,2020-04-13,,,,2020-04-13,http://en.irct.ir/trial/47013,2020-04-13,0,0
7064,IRCT20200317046797N3,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/47014,,0,0
7065,IRCT20200317046797N5,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/47015,,0,0
7066,IRCT20200404046937N2,Recruitment complete,,2020-06-01,,,,2020-08-01,http://en.irct.ir/trial/47016,2020-06-01,0,0
7067,IRCT20180923041093N5,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47018,,0,0
7068,IRCT20160131026298N3,Recruitment complete,,,,,,2020-11-02,http://en.irct.ir/trial/47019,,0,0
7069,IRCT20200406046968N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47021,,0,0
7070,IRCT20150808023559N20,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/47022,,0,0
7071,IRCT20130616013690N7,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47034,,0,0
7072,IRCT20200410047009N1,Recruitment complete,,,,,,2020-04-26,http://en.irct.ir/trial/47052,,0,0
7073,IRCT20200409047007N1,Recruitment complete,,2020-06-27,,,,2020-08-10,http://en.irct.ir/trial/47058,2020-06-27,0,0
7074,IRCT20200408046990N1,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/47061,,0,0
7075,IRCT20200411047025N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47078,,0,0
7076,IRCT20080901001165N46,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/47087,,0,0
7077,IRCT20200406046963N1,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47088,,0,0
7078,IRCT20190122042450N4,Recruitment complete,,,,,,2020-04-16,http://en.irct.ir/trial/47090,,0,0
7079,IRCT20200411047030N1,Recruitment complete,,,,,,2020-04-17,http://en.irct.ir/trial/47099,,0,0
7080,IRCT20200406046968N2,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47115,,0,0
7081,IRCT20200413047053N1,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/47139,,0,0
7082,IRCT20081019001369N5,Recruitment complete,,,,,,2020-04-26,http://en.irct.ir/trial/47141,,0,0
7083,IRCT20200408046988N1,Recruitment complete,,,,,,2020-04-29,http://en.irct.ir/trial/47142,,0,0
7084,IRCT20200413047062N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47146,,0,0
7085,IRCT20191125045492N2,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/47149,,0,0
7086,IRCT20200406046968N3,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47152,,0,0
7087,IRCT20200413047063N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47156,,0,0
7088,IRCT20200413047052N1,Recruitment complete,,,,,,2020-05-07,http://en.irct.ir/trial/47160,,0,0
7089,IRCT20200414047072N1,Recruitment complete,,,,,,2020-10-22,http://en.irct.ir/trial/47163,,0,0
7090,IRCT20200414047070N1,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47169,,0,0
7091,IRCT20170210032478N3,Recruitment complete,,,,,,2021-01-02,http://en.irct.ir/trial/47173,,0,0
7092,IRCT20200415047082N1,Recruitment complete,,,,,,2020-12-02,http://en.irct.ir/trial/47193,,0,0
7093,IRCT20200413047056N1,Recruitment complete,,,,,,2020-04-17,http://en.irct.ir/trial/47212,,0,0
7094,IRCT20200418047116N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47219,,0,0
7095,IRCT20200415047089N1,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/47234,,0,0
7096,IRCT20200415047092N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/47244,,0,0
7097,IRCT20200416047104N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/47251,,0,0
7098,IRCT20200417047113N1,Recruitment complete,,,,,,2020-04-24,http://en.irct.ir/trial/47264,,0,0
7099,IRCT20200416047099N1,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47266,,0,0
7100,IRCT20200418047122N1,Recruitment complete,,,,,,2020-05-03,http://en.irct.ir/trial/47268,,0,0
7101,IRCT20200418047121N2,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47275,,0,0
7102,IRCT20140407017169N2,Recruitment complete,,2020-08-30,,,,2021-02-02,http://en.irct.ir/trial/47295,2020-08-30,0,0
7103,IRCT20200329046892N1,Recruitment complete,,,,,,2020-05-02,http://en.irct.ir/trial/47300,,0,0
7104,IRCT20080901001165N48,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47318,,0,0
7105,IRCT20151222025660N2,Recruitment complete,,,,,,2020-08-20,http://en.irct.ir/trial/47319,,0,0
7106,IRCT20200420047147N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/47334,,0,0
7107,IRCT20200421047155N1,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47387,,0,0
7108,IRCT20080901001165N49,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47401,,0,0
7109,IRCT20200422047168N1,Recruitment complete,,,,,,2022-02-19,http://en.irct.ir/trial/47437,,0,0
7110,IRCT20200408046990N2,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47468,,0,0
7111,IRCT20180114038350N3,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47475,,0,0
7112,IRCT20200426047206N1,Recruitment complete,,,,,,2020-04-28,http://en.irct.ir/trial/47495,,0,0
7113,IRCT20120215009014N353,Recruitment complete,,,,,,2020-04-27,http://en.irct.ir/trial/47501,,0,0
7114,IRCT20140305016852N4,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47508,,0,0
7115,IRCT20180425039414N2,Recruitment complete,,,,,,2020-05-13,http://en.irct.ir/trial/47516,,0,0
7116,IRCT20200427047215N1,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47520,,0,0
7117,IRCT20121216011763N46,Recruitment complete,,,,,,2020-10-31,http://en.irct.ir/trial/47529,,0,0
7118,IRCT20200426047212N1,Recruitment complete,,,,,,2020-05-02,http://en.irct.ir/trial/47572,,0,0
7119,IRCT20080901001165N50,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47576,,0,0
7120,IRCT20080901001165N51,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47577,,0,0
7121,IRCT20200418047121N1,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47578,,0,0
7122,IRCT20150808023559N21,Recruitment complete,,,,,,2020-05-09,http://en.irct.ir/trial/47594,,0,0
7123,IRCT20200501047258N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47629,,0,0
7124,IRCT20131129015584N2,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47639,,0,0
7125,IRCT20080901001165N52,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47641,,0,0
7126,IRCT20160706028815N5,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47682,,0,0
7127,IRCT20171213037866N2,Recruitment complete,,,,,,2020-05-07,http://en.irct.ir/trial/47684,,0,0
7128,IRCT20200326046868N1,Recruitment complete,,,,,,2020-05-09,http://en.irct.ir/trial/47934,,0,0
7129,IRCT20200508047346N1,Recruitment complete,,,,,,2020-05-13,http://en.irct.ir/trial/47953,,0,0
7130,IRCT20120215009014N354,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/48043,,0,0
7131,IRCT20200509047366N1,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/48020,,0,0
7132,IRCT20150623022884N3,Recruitment complete,,2020-06-14,,,,2020-11-18,http://en.irct.ir/trial/49249,2020-06-14,0,0
7133,IRCT20200128046294N2,Recruitment complete,,2020-05-18,,,,2020-06-01,http://en.irct.ir/trial/46463,2020-05-18,0,0
7134,IRCT20200314046774N1,Recruitment complete,,2020-06-13,,,,2020-06-12,http://en.irct.ir/trial/46519,2020-06-13,0,0
7135,IRCT20200324046850N3,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/46718,,0,0
7136,IRCT20180923041093N3,Recruitment complete,,,,,,2020-06-03,http://en.irct.ir/trial/46721,,0,0
7137,IRCT20180923041093N4,Recruitment complete,,,,,,2020-06-06,http://en.irct.ir/trial/46728,,0,0
7138,IRCT20200324046850N1,Recruitment complete,,,,,,2020-06-03,http://en.irct.ir/trial/46732,,0,0
7139,IRCT20200318046812N1,Recruitment complete,,2020-08-20,,,,2020-09-19,http://en.irct.ir/trial/46783,2020-08-20,0,0
7140,IRCT20190810044500N5,Recruitment complete,,2021-01-14,,,,2021-04-12,http://en.irct.ir/trial/46867,2021-01-14,0,0
7141,IRCT20180725040596N2,Recruitment complete,,,,,,2020-08-04,http://en.irct.ir/trial/46897,,0,0
7142,IRCT20200404046947N1,Recruitment complete,,,,,,2020-05-22,http://en.irct.ir/trial/46904,,0,0
7143,IRCT20151228025732N52,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/46963,,0,0
7144,IRCT20081027001411N3,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46975,,0,0
7145,IRCT20091201002804N12,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46983,,0,0
7146,IRCT20200217046526N1,Recruitment complete,,2020-04-25,,,,2020-06-10,http://en.irct.ir/trial/47030,2020-04-25,0,0
7147,IRCT20200411047016N1,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/47044,,0,0
7148,IRCT20190727044343N3,Recruitment complete,,,,,,2020-06-12,http://en.irct.ir/trial/47062,,0,0
7149,IRCT20200223046586N2,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/47091,,0,0
7150,IRCT20081019001369N6,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47188,,0,0
7151,IRCT20091012002582N21,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/47197,,0,0
7152,IRCT20200325046859N2,Recruitment complete,,,,,,2020-06-12,http://en.irct.ir/trial/47200,,0,0
7153,IRCT20190418043307N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47209,,0,0
7154,IRCT20200411047019N1,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/47279,,0,0
7155,IRCT20150303021315N19,Recruitment complete,,,,,,2020-05-27,http://en.irct.ir/trial/47335,,0,0
7156,IRCT20080901001165N59,Recruitment complete,,2020-09-27,,,,2020-12-12,http://en.irct.ir/trial/47477,2020-09-27,0,0
7157,IRCT20200209046427N1,Recruitment complete,,,,,,2020-06-07,http://en.irct.ir/trial/47504,,0,0
7158,IRCT20200428047228N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47559,,0,0
7159,IRCT20200501047259N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47609,,0,0
7160,IRCT20200115046144N2,Recruitment complete,,,,,,2020-05-21,http://en.irct.ir/trial/47645,,0,0
7161,IRCT20131129015584N3,Recruitment complete,,,,,,2020-05-20,http://en.irct.ir/trial/47665,,0,0
7162,IRCT20150107020592N25,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/47666,,0,0
7163,IRCT20200502047268N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47692,,0,0
7164,IRCT20200503047280N1,Recruitment complete,,,,,,2020-06-02,http://en.irct.ir/trial/47704,,0,0
7165,IRCT20200418047126N1,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/47707,,0,0
7166,IRCT20200405046951N1,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/47722,,0,0
7167,IRCT20170211032494N3,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/47735,,0,0
7168,IRCT20081011001323N25,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47935,,0,0
7169,IRCT20200421047150N1,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/47964,,0,0
7170,IRCT20180923041093N6,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/47974,,0,0
7171,IRCT20200509047360N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47979,,0,0
7172,IRCT20140428017469N1,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/47989,,0,0
7173,IRCT20200506047323N2,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/47990,,0,0
7174,IRCT20200509047373N1,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48001,,0,0
7175,IRCT20151227025726N15,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/48018,,0,0
7176,IRCT20150716023235N15,Recruitment complete,,,,,,2020-05-29,http://en.irct.ir/trial/48019,,0,0
7177,IRCT20200510047383N1,Recruitment complete,,,,,,2020-05-15,http://en.irct.ir/trial/48024,,0,0
7178,IRCT20120215009014N355,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/48039,,0,0
7179,IRCT20200511047396N1,Recruitment complete,,,,,,2020-06-28,http://en.irct.ir/trial/48048,,0,0
7180,IRCT20170731035423N2,Recruitment complete,,,,,,2020-10-21,http://en.irct.ir/trial/48049,,0,0
7181,IRCT20090609002017N35,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/48058,,0,0
7182,IRCT20080901001165N55,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48061,,0,0
7183,IRCT20080901001165N53,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/48066,,0,0
7184,IRCT20200428047228N2,Recruitment complete,,,,,,2020-06-10,http://en.irct.ir/trial/48096,,0,0
7185,IRCT20080901001165N60,Recruitment complete,,,,,,2020-05-28,http://en.irct.ir/trial/48102,,0,0
7186,IRCT20200506047323N1,Recruitment complete,,,,,,2021-10-29,http://en.irct.ir/trial/48114,,0,0
7187,IRCT20080901001165N56,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48116,,0,0
7188,IRCT20200405046960N2,Recruitment complete,,,,,,2020-05-19,http://en.irct.ir/trial/48126,,0,0
7189,IRCT20200516047462N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/48141,,0,0
7190,IRCT20151227025726N17,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/48153,,0,0
7191,IRCT20200516047468N1,Recruitment complete,,,,,,2020-05-19,http://en.irct.ir/trial/48176,,0,0
7192,IRCT20150107020592N23,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/48185,,0,0
7193,IRCT20160809029275N1,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/48187,,0,0
7194,IRCT20151226025699N3,Recruitment complete,,,,,,2020-05-20,http://en.irct.ir/trial/48213,,0,0
7195,IRCT20180608040007N2,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/48218,,0,0
7196,IRCT20200517047485N1,Recruitment complete,,,,,,2020-05-29,http://en.irct.ir/trial/48226,,0,0
7197,IRCT20150107020592N22,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/48262,,0,0
7198,IRCT20200518047497N1,Recruitment complete,,,,,,2020-05-21,http://en.irct.ir/trial/48289,,0,0
7199,IRCT20200519047510N1,Recruitment complete,,,,,,2020-05-28,http://en.irct.ir/trial/48292,,0,0
7200,IRCT20151227025726N18,Recruitment complete,,,,,,2020-06-10,http://en.irct.ir/trial/48312,,0,0
7201,IRCT20161206031256N3,Recruitment complete,,,,,,2020-06-02,http://en.irct.ir/trial/48329,,0,0
7202,IRCT20080901001165N58,Recruitment complete,,,,,,2020-07-27,http://en.irct.ir/trial/48394,,0,0
7203,IRCT20160126026217N4,Recruitment complete,,,,,,2020-06-08,http://en.irct.ir/trial/48403,,0,0
7204,IRCT20200422047168N2,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/48444,,0,0
7205,IRCT20200525047562N1,Recruitment complete,,,,,,2020-06-24,http://en.irct.ir/trial/48493,,0,0
7206,IRCT20200523047550N1,Recruitment complete,,2020-05-25,,,,2020-06-06,http://en.irct.ir/trial/48495,2020-05-25,0,0
7207,IRCT20150107020592N24,Recruitment complete,,,,,,2020-06-08,http://en.irct.ir/trial/48534,,0,0
7208,IRCT20200518047497N2,Recruitment complete,,,,,,2020-06-06,http://en.irct.ir/trial/48644,,0,0
7209,IRCT20120703010178N20,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/48702,,0,0
7210,IRCT20200412047042N1,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/48749,,0,0
7211,IRCT20200401046909N2,Recruitment complete,,,,,,2020-05-27,http://en.irct.ir/trial/47010,,0,0
7212,IRCT20200401046909N1,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46875,,0,0
7213,IRCT20181104041551N1,Recruitment complete,,,,,,2020-04-12,,,0,0
7214,IRCT20200324046852N1,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46706,,0,0
7215,IRCT20200310046736N1,Not yet recruiting,,,,,,2020-04-01,http://en.irct.ir/trial/46424,,0,0
7216,IRCT20151113025025N3,Recruitment complete,,,,,,2020-07-06,http://en.irct.ir/trial/46531,,0,0
7217,IRCT20100228003449N30,Recruitment complete,,,,,,2020-03-24,http://en.irct.ir/trial/46536,,0,0
7218,IRCT20100228003449N28,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46538,,0,0
7219,IRCT20100228003449N27,Recruitment complete,,,,,,2020-03-25,http://en.irct.ir/trial/46545,,0,0
7220,IRCT20200316046792N1,Recruitment complete,,,,,,2020-03-24,http://en.irct.ir/trial/46554,,0,0
7221,IRCT20151227025726N12,Recruitment complete,,,,,,2020-03-23,http://en.irct.ir/trial/46561,,0,0
7222,IRCT20170117032004N3,Recruitment complete,,,,,,2020-09-29,http://en.irct.ir/trial/46564,,0,0
7223,IRCT20100228003449N29,Recruitment complete,,,,,,2020-03-25,http://en.irct.ir/trial/46567,,0,0
7224,IRCT20200317046797N1,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46573,,0,0
7225,IRCT20160625028622N1,Recruitment complete,,,,,,2020-03-22,http://en.irct.ir/trial/46576,,0,0
7226,IRCT20120826010664N6,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46603,,0,0
7227,IRCT20131113015393N6,Recruitment complete,,,,,,2020-03-30,http://en.irct.ir/trial/46609,,0,0
7228,IRCT20140528017891N8,Recruitment complete,,,,,,2020-03-28,http://en.irct.ir/trial/46623,,0,0
7229,IRCT20200321046828N1,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46624,,0,0
7230,IRCT20190727044343N1,Recruitment complete,,2020-04-09,,,,2020-04-05,http://en.irct.ir/trial/46629,2020-04-09,0,0
7231,IRCT20140617018126N2,Recruitment complete,,,,,,2020-03-29,http://en.irct.ir/trial/46637,,0,0
7232,IRCT20150914024017N1,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46665,,0,0
7233,IRCT20140911019125N6,Recruitment complete,,,,,,2020-04-04,http://en.irct.ir/trial/46668,,0,0
7234,IRCT20160316027081N1,Recruitment complete,,2020-07-01,,,,2022-03-03,http://en.irct.ir/trial/46678,2020-07-01,0,0
7235,IRCT20151227025726N13,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46681,,0,0
7236,IRCT20160310026998N11,Recruitment complete,,,,,,2020-03-27,http://en.irct.ir/trial/46690,,0,0
7237,IRCT20160310026998N10,Recruitment complete,,,,,,2020-03-26,http://en.irct.ir/trial/46693,,0,0
7238,IRCT20180610040049N3,Recruitment complete,,,,,,2020-04-05,http://en.irct.ir/trial/46697,,0,0
7239,IRCT20200324046847N1,Recruitment complete,,,,,,2020-03-31,http://en.irct.ir/trial/46720,,0,0
7240,IRCT20140907019073N4,Recruitment complete,,,,,,2020-03-29,http://en.irct.ir/trial/46736,,0,0
7241,IRCT20200324046850N5,Recruitment complete,,,,,,2020-10-17,http://en.irct.ir/trial/46751,,0,0
7242,IRCT20200325046860N1,Recruitment complete,,,,,,2020-03-30,http://en.irct.ir/trial/46759,,0,0
7243,IRCT20101219005416N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46775,,0,0
7244,IRCT20200317046797N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46786,,0,0
7245,IRCT20200325046860N2,Recruitment complete,,2020-04-29,,,,2020-04-01,http://en.irct.ir/trial/46789,2020-04-29,0,0
7246,IRCT20170611034452N11,Recruitment complete,,,,,,2020-03-31,http://en.irct.ir/trial/46803,,0,0
7247,IRCT20190917044805N2,Recruitment complete,,,,,,2021-07-10,http://en.irct.ir/trial/46804,,0,0
7248,IRCT20120225009124N4,Recruitment complete,,,,,,2020-04-02,http://en.irct.ir/trial/46810,,0,0
7249,IRCT20180802040678N4,Recruitment complete,,,,,,2020-04-01,http://en.irct.ir/trial/46824,,0,0
7250,IRCT20150704023055N2,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46837,,0,0
7251,IRCT20200319046819N1,Recruitment complete,,,,,,2020-04-04,http://en.irct.ir/trial/46838,,0,0
7252,IRCT20200405046953N1,Recruitment complete,,,,,,2020-04-06,http://en.irct.ir/trial/46930,,0,0
7253,IRCT20200217046526N2,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/47073,,0,0
7254,IRCT20191228045924N1,Recruitment complete,,,,,,2020-09-20,http://en.irct.ir/trial/49767,,0,0
7255,IRCT20200314046764N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/46533,,0,0
7256,IRCT20150303021315N17,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/46550,,0,0
7257,IRCT20200312046749N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46551,,0,0
7258,IRCT20190727044343N2,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/46639,,0,0
7259,IRCT20171122037571N2,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46660,,0,0
7260,IRCT20200324046850N2,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/46713,,0,0
7261,IRCT20200323046841N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46715,,0,0
7262,IRCT20200322046833N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46731,,0,0
7263,IRCT20160131026298N2,Recruitment complete,,2020-03-24,,,,2020-11-05,http://en.irct.ir/trial/46733,2020-03-24,0,0
7264,IRCT20190804044429N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46741,,0,0
7265,IRCT20160313027033N2,Recruitment complete,,,,,,2020-04-16,http://en.irct.ir/trial/46762,,0,0
7266,IRCT20200204046369N1,Recruitment complete,,2020-11-15,,,,2020-12-07,http://en.irct.ir/trial/46776,2020-11-15,0,0
7267,IRCT20180712040449N2,Recruitment complete,,,,,,2020-04-28,http://en.irct.ir/trial/46782,,0,0
7268,IRCT20130812014333N145,Recruitment complete,,,,,,2020-04-07,http://en.irct.ir/trial/46790,,0,0
7269,IRCT20200325046859N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/46811,,0,0
7270,IRCT20161204031229N3,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46814,,0,0
7271,IRCT20151228025732N51,Recruitment complete,,,,,,2020-09-26,http://en.irct.ir/trial/46828,,0,0
7272,IRCT20130917014693N10,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46849,,0,0
7273,IRCT20180610040049N4,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46850,,0,0
7274,IRCT20130812014333N147,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/46853,,0,0
7275,IRCT20081019001369N2,Recruitment complete,,,,,,2020-04-07,http://en.irct.ir/trial/46868,,0,0
7276,IRCT20200402046923N1,Recruitment complete,,,,,,2020-04-09,http://en.irct.ir/trial/46879,,0,0
7277,IRCT20200328046886N1,Recruitment complete,,2020-05-04,,,,2020-04-12,http://en.irct.ir/trial/46885,2020-05-04,0,0
7278,IRCT20131215015805N2,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/46887,,0,0
7279,IRCT20200404046933N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46893,,0,0
7280,IRCT20200404046937N1,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/46903,,0,0
7281,IRCT20080901001157N16,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46907,,0,0
7282,IRCT20200404046934N1,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/46913,,0,0
7283,IRCT20200403046926N1,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46926,,0,0
7284,IRCT20151228025732N53,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46931,,0,0
7285,IRCT20180429039463N2,Recruitment complete,,2020-07-31,,,,2021-05-04,http://en.irct.ir/trial/46933,2020-07-31,0,0
7286,IRCT20200404046935N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/46940,,0,0
7287,IRCT20151227025726N14,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46942,,0,0
7288,IRCT20200405046958N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46946,,0,0
7289,IRCT20200406046965N1,Recruitment complete,,,,,,2020-04-12,http://en.irct.ir/trial/46958,,0,0
7290,IRCT20200405046960N1,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46961,,0,0
7291,IRCT20200318046812N2,Recruitment complete,,,,,,2020-04-08,http://en.irct.ir/trial/46968,,0,0
7292,IRCT20200317046797N4,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/46969,,0,0
7293,IRCT20200404046948N1,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/46973,,0,0
7294,IRCT20180520039738N2,Recruitment complete,,,,,,2020-04-10,http://en.irct.ir/trial/46974,,0,0
7295,IRCT20081019001369N4,Recruitment complete,,,,,,2020-04-13,http://en.irct.ir/trial/46977,,0,0
7296,IRCT20081019001369N3,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/46978,,0,0
7297,IRCT20200408046992N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47006,,0,0
7298,IRCT20200408046987N1,Recruitment complete,,,,,,2020-07-21,http://en.irct.ir/trial/47012,,0,0
7299,IRCT20180129038542N1,Recruitment complete,,2020-04-13,,,,2020-04-13,http://en.irct.ir/trial/47013,2020-04-13,0,0
7300,IRCT20200317046797N3,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/47014,,0,0
7301,IRCT20200317046797N5,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/47015,,0,0
7302,IRCT20200404046937N2,Recruitment complete,,2020-06-01,,,,2020-08-01,http://en.irct.ir/trial/47016,2020-06-01,0,0
7303,IRCT20180923041093N5,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47018,,0,0
7304,IRCT20160131026298N3,Recruitment complete,,,,,,2020-11-02,http://en.irct.ir/trial/47019,,0,0
7305,IRCT20200406046968N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47021,,0,0
7306,IRCT20150808023559N20,Recruitment complete,,,,,,2020-04-11,http://en.irct.ir/trial/47022,,0,0
7307,IRCT20130616013690N7,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47034,,0,0
7308,IRCT20200410047009N1,Recruitment complete,,,,,,2020-04-26,http://en.irct.ir/trial/47052,,0,0
7309,IRCT20200409047007N1,Recruitment complete,,2020-06-27,,,,2020-08-10,http://en.irct.ir/trial/47058,2020-06-27,0,0
7310,IRCT20200408046990N1,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/47061,,0,0
7311,IRCT20200411047025N1,Recruitment complete,,,,,,2020-04-14,http://en.irct.ir/trial/47078,,0,0
7312,IRCT20080901001165N46,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/47087,,0,0
7313,IRCT20200406046963N1,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47088,,0,0
7314,IRCT20190122042450N4,Recruitment complete,,,,,,2020-04-16,http://en.irct.ir/trial/47090,,0,0
7315,IRCT20200411047030N1,Recruitment complete,,,,,,2020-04-17,http://en.irct.ir/trial/47099,,0,0
7316,IRCT20200406046968N2,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47115,,0,0
7317,IRCT20200413047053N1,Recruitment complete,,,,,,2020-04-15,http://en.irct.ir/trial/47139,,0,0
7318,IRCT20081019001369N5,Recruitment complete,,,,,,2020-04-26,http://en.irct.ir/trial/47141,,0,0
7319,IRCT20200408046988N1,Recruitment complete,,,,,,2020-04-29,http://en.irct.ir/trial/47142,,0,0
7320,IRCT20200413047062N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47146,,0,0
7321,IRCT20191125045492N2,Recruitment complete,,,,,,2020-04-18,http://en.irct.ir/trial/47149,,0,0
7322,IRCT20200406046968N3,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47152,,0,0
7323,IRCT20200413047063N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47156,,0,0
7324,IRCT20200413047052N1,Recruitment complete,,,,,,2020-05-07,http://en.irct.ir/trial/47160,,0,0
7325,IRCT20200414047072N1,Recruitment complete,,,,,,2020-10-22,http://en.irct.ir/trial/47163,,0,0
7326,IRCT20200414047070N1,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47169,,0,0
7327,IRCT20170210032478N3,Recruitment complete,,,,,,2021-01-02,http://en.irct.ir/trial/47173,,0,0
7328,IRCT20200415047082N1,Recruitment complete,,,,,,2020-12-02,http://en.irct.ir/trial/47193,,0,0
7329,IRCT20200413047056N1,Recruitment complete,,,,,,2020-04-17,http://en.irct.ir/trial/47212,,0,0
7330,IRCT20200418047116N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47219,,0,0
7331,IRCT20200415047089N1,Recruitment complete,,,,,,2020-04-19,http://en.irct.ir/trial/47234,,0,0
7332,IRCT20200415047092N1,Recruitment complete,,,,,,2020-04-20,http://en.irct.ir/trial/47244,,0,0
7333,IRCT20200416047104N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/47251,,0,0
7334,IRCT20200417047113N1,Recruitment complete,,,,,,2020-04-24,http://en.irct.ir/trial/47264,,0,0
7335,IRCT20200416047099N1,Recruitment complete,,,,,,2020-04-21,http://en.irct.ir/trial/47266,,0,0
7336,IRCT20200418047122N1,Recruitment complete,,,,,,2020-05-03,http://en.irct.ir/trial/47268,,0,0
7337,IRCT20200418047121N2,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47275,,0,0
7338,IRCT20140407017169N2,Recruitment complete,,2020-08-30,,,,2021-02-02,http://en.irct.ir/trial/47295,2020-08-30,0,0
7339,IRCT20200329046892N1,Recruitment complete,,,,,,2020-05-02,http://en.irct.ir/trial/47300,,0,0
7340,IRCT20080901001165N48,Recruitment complete,,,,,,2020-04-22,http://en.irct.ir/trial/47318,,0,0
7341,IRCT20151222025660N2,Recruitment complete,,,,,,2020-08-20,http://en.irct.ir/trial/47319,,0,0
7342,IRCT20200420047147N1,Recruitment complete,,,,,,2020-04-23,http://en.irct.ir/trial/47334,,0,0
7343,IRCT20200421047155N1,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47387,,0,0
7344,IRCT20080901001165N49,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47401,,0,0
7345,IRCT20200422047168N1,Recruitment complete,,,,,,2022-02-19,http://en.irct.ir/trial/47437,,0,0
7346,IRCT20200408046990N2,Recruitment complete,,,,,,2020-04-25,http://en.irct.ir/trial/47468,,0,0
7347,IRCT20180114038350N3,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47475,,0,0
7348,IRCT20200426047206N1,Recruitment complete,,,,,,2020-04-28,http://en.irct.ir/trial/47495,,0,0
7349,IRCT20120215009014N353,Recruitment complete,,,,,,2020-04-27,http://en.irct.ir/trial/47501,,0,0
7350,IRCT20140305016852N4,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47508,,0,0
7351,IRCT20180425039414N2,Recruitment complete,,,,,,2020-05-13,http://en.irct.ir/trial/47516,,0,0
7352,IRCT20200427047215N1,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47520,,0,0
7353,IRCT20121216011763N46,Recruitment complete,,,,,,2020-10-31,http://en.irct.ir/trial/47529,,0,0
7354,IRCT20200426047212N1,Recruitment complete,,,,,,2020-05-02,http://en.irct.ir/trial/47572,,0,0
7355,IRCT20080901001165N50,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47576,,0,0
7356,IRCT20080901001165N51,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47577,,0,0
7357,IRCT20200418047121N1,Recruitment complete,,,,,,2020-05-01,http://en.irct.ir/trial/47578,,0,0
7358,IRCT20150808023559N21,Recruitment complete,,,,,,2020-05-09,http://en.irct.ir/trial/47594,,0,0
7359,IRCT20200501047258N1,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47629,,0,0
7360,IRCT20131129015584N2,Recruitment complete,,,,,,2020-05-08,http://en.irct.ir/trial/47639,,0,0
7361,IRCT20080901001165N52,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47641,,0,0
7362,IRCT20160706028815N5,Recruitment complete,,,,,,2020-05-05,http://en.irct.ir/trial/47682,,0,0
7363,IRCT20171213037866N2,Recruitment complete,,,,,,2020-05-07,http://en.irct.ir/trial/47684,,0,0
7364,IRCT20200326046868N1,Recruitment complete,,,,,,2020-05-09,http://en.irct.ir/trial/47934,,0,0
7365,IRCT20200508047346N1,Recruitment complete,,,,,,2020-05-13,http://en.irct.ir/trial/47953,,0,0
7366,IRCT20120215009014N354,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/48043,,0,0
7367,IRCT20200509047366N1,Recruitment complete,,,,,,2020-05-12,http://en.irct.ir/trial/48020,,0,0
7368,IRCT20150623022884N3,Recruitment complete,,2020-06-14,,,,2020-11-18,http://en.irct.ir/trial/49249,2020-06-14,0,0
7369,IRCT20200128046294N2,Recruitment complete,,2020-05-18,,,,2020-06-01,http://en.irct.ir/trial/46463,2020-05-18,0,0
7370,IRCT20200314046774N1,Recruitment complete,,2020-06-13,,,,2020-06-12,http://en.irct.ir/trial/46519,2020-06-13,0,0
7371,IRCT20200324046850N3,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/46718,,0,0
7372,IRCT20180923041093N3,Recruitment complete,,,,,,2020-06-03,http://en.irct.ir/trial/46721,,0,0
7373,IRCT20180923041093N4,Recruitment complete,,,,,,2020-06-06,http://en.irct.ir/trial/46728,,0,0
7374,IRCT20200324046850N1,Recruitment complete,,,,,,2020-06-03,http://en.irct.ir/trial/46732,,0,0
7375,IRCT20200318046812N1,Recruitment complete,,2020-08-20,,,,2020-09-19,http://en.irct.ir/trial/46783,2020-08-20,0,0
7376,IRCT20190810044500N5,Recruitment complete,,2021-01-14,,,,2021-04-12,http://en.irct.ir/trial/46867,2021-01-14,0,0
7377,IRCT20180725040596N2,Recruitment complete,,,,,,2020-08-04,http://en.irct.ir/trial/46897,,0,0
7378,IRCT20200404046947N1,Recruitment complete,,,,,,2020-05-22,http://en.irct.ir/trial/46904,,0,0
7379,IRCT20151228025732N52,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/46963,,0,0
7380,IRCT20081027001411N3,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46975,,0,0
7381,IRCT20091201002804N12,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46983,,0,0
7382,IRCT20200217046526N1,Recruitment complete,,2020-04-25,,,,2020-06-10,http://en.irct.ir/trial/47030,2020-04-25,0,0
7383,IRCT20200411047016N1,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/47044,,0,0
7384,IRCT20190727044343N3,Recruitment complete,,,,,,2020-06-12,http://en.irct.ir/trial/47062,,0,0
7385,IRCT20200223046586N2,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/47091,,0,0
7386,IRCT20081019001369N6,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47188,,0,0
7387,IRCT20091012002582N21,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/47197,,0,0
7388,IRCT20200325046859N2,Recruitment complete,,,,,,2020-06-12,http://en.irct.ir/trial/47200,,0,0
7389,IRCT20190418043307N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47209,,0,0
7390,IRCT20200411047019N1,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/47279,,0,0
7391,IRCT20150303021315N19,Recruitment complete,,,,,,2020-05-27,http://en.irct.ir/trial/47335,,0,0
7392,IRCT20080901001165N59,Recruitment complete,,2020-09-27,,,,2020-12-12,http://en.irct.ir/trial/47477,2020-09-27,0,0
7393,IRCT20200209046427N1,Recruitment complete,,,,,,2020-06-07,http://en.irct.ir/trial/47504,,0,0
7394,IRCT20200428047228N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47559,,0,0
7395,IRCT20200501047259N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47609,,0,0
7396,IRCT20200115046144N2,Recruitment complete,,,,,,2020-05-21,http://en.irct.ir/trial/47645,,0,0
7397,IRCT20131129015584N3,Recruitment complete,,,,,,2020-05-20,http://en.irct.ir/trial/47665,,0,0
7398,IRCT20150107020592N25,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/47666,,0,0
7399,IRCT20200502047268N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47692,,0,0
7400,IRCT20200503047280N1,Recruitment complete,,,,,,2020-06-02,http://en.irct.ir/trial/47704,,0,0
7401,IRCT20200418047126N1,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/47707,,0,0
7402,IRCT20200405046951N1,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/47722,,0,0
7403,IRCT20170211032494N3,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/47735,,0,0
7404,IRCT20081011001323N25,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/47935,,0,0
7405,IRCT20200421047150N1,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/47964,,0,0
7406,IRCT20180923041093N6,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/47974,,0,0
7407,IRCT20200509047360N1,Recruitment complete,,,,,,2020-05-16,http://en.irct.ir/trial/47979,,0,0
7408,IRCT20140428017469N1,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/47989,,0,0
7409,IRCT20200506047323N2,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/47990,,0,0
7410,IRCT20200509047373N1,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48001,,0,0
7411,IRCT20151227025726N15,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/48018,,0,0
7412,IRCT20150716023235N15,Recruitment complete,,,,,,2020-05-29,http://en.irct.ir/trial/48019,,0,0
7413,IRCT20200510047383N1,Recruitment complete,,,,,,2020-05-15,http://en.irct.ir/trial/48024,,0,0
7414,IRCT20120215009014N355,Recruitment complete,,,,,,2020-05-18,http://en.irct.ir/trial/48039,,0,0
7415,IRCT20200511047396N1,Recruitment complete,,,,,,2020-06-28,http://en.irct.ir/trial/48048,,0,0
7416,IRCT20170731035423N2,Recruitment complete,,,,,,2020-10-21,http://en.irct.ir/trial/48049,,0,0
7417,IRCT20090609002017N35,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/48058,,0,0
7418,IRCT20080901001165N55,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48061,,0,0
7419,IRCT20080901001165N53,Recruitment complete,,,,,,2020-05-14,http://en.irct.ir/trial/48066,,0,0
7420,IRCT20200428047228N2,Recruitment complete,,,,,,2020-06-10,http://en.irct.ir/trial/48096,,0,0
7421,IRCT20080901001165N60,Recruitment complete,,,,,,2020-05-28,http://en.irct.ir/trial/48102,,0,0
7422,IRCT20200506047323N1,Recruitment complete,,,,,,2021-10-29,http://en.irct.ir/trial/48114,,0,0
7423,IRCT20080901001165N56,Recruitment complete,,,,,,2020-05-23,http://en.irct.ir/trial/48116,,0,0
7424,IRCT20200405046960N2,Recruitment complete,,,,,,2020-05-19,http://en.irct.ir/trial/48126,,0,0
7425,IRCT20200516047462N1,Recruitment complete,,,,,,2020-05-17,http://en.irct.ir/trial/48141,,0,0
7426,IRCT20151227025726N17,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/48153,,0,0
7427,IRCT20200516047468N1,Recruitment complete,,,,,,2020-05-19,http://en.irct.ir/trial/48176,,0,0
7428,IRCT20150107020592N23,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/48185,,0,0
7429,IRCT20160809029275N1,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/48187,,0,0
7430,IRCT20151226025699N3,Recruitment complete,,,,,,2020-05-20,http://en.irct.ir/trial/48213,,0,0
7431,IRCT20180608040007N2,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/48218,,0,0
7432,IRCT20200517047485N1,Recruitment complete,,,,,,2020-05-29,http://en.irct.ir/trial/48226,,0,0
7433,IRCT20150107020592N22,Recruitment complete,,,,,,2020-05-25,http://en.irct.ir/trial/48262,,0,0
7434,IRCT20200518047497N1,Recruitment complete,,,,,,2020-05-21,http://en.irct.ir/trial/48289,,0,0
7435,IRCT20200519047510N1,Recruitment complete,,,,,,2020-05-28,http://en.irct.ir/trial/48292,,0,0
7436,IRCT20151227025726N18,Recruitment complete,,,,,,2020-06-10,http://en.irct.ir/trial/48312,,0,0
7437,IRCT20161206031256N3,Recruitment complete,,,,,,2020-06-02,http://en.irct.ir/trial/48329,,0,0
7438,IRCT20080901001165N58,Recruitment complete,,,,,,2020-07-27,http://en.irct.ir/trial/48394,,0,0
7439,IRCT20160126026217N4,Recruitment complete,,,,,,2020-06-08,http://en.irct.ir/trial/48403,,0,0
7440,IRCT20200422047168N2,Recruitment complete,,,,,,2020-05-30,http://en.irct.ir/trial/48444,,0,0
7441,IRCT20200525047562N1,Recruitment complete,,,,,,2020-06-24,http://en.irct.ir/trial/48493,,0,0
7442,IRCT20200523047550N1,Recruitment complete,,2020-05-25,,,,2020-06-06,http://en.irct.ir/trial/48495,2020-05-25,0,0
7443,IRCT20150107020592N24,Recruitment complete,,,,,,2020-06-08,http://en.irct.ir/trial/48534,,0,0
7444,IRCT20200518047497N2,Recruitment complete,,,,,,2020-06-06,http://en.irct.ir/trial/48644,,0,0
7445,IRCT20120703010178N20,Recruitment complete,,,,,,2020-06-13,http://en.irct.ir/trial/48702,,0,0
7446,IRCT20200412047042N1,Recruitment complete,,,,,,2020-06-11,http://en.irct.ir/trial/48749,,0,0
7447,IRCT20200401046909N2,Recruitment complete,,,,,,2020-05-27,http://en.irct.ir/trial/47010,,0,0
7448,IRCT20200401046909N1,Recruitment complete,,,,,,2020-06-01,http://en.irct.ir/trial/46875,,0,0
7449,IRCT2014022816773N1,Recruitment complete,,,,,,,,,0,0
7450,IRCT20180223038837N1,Recruitment complete,,,,,,2018-12-08,http://en.irct.ir/trial/32039,,0,0
7451,IRCT20120728010430N8,Recruitment complete,,2018-02-01,,,,2019-05-12,,2018-02-01,0,0
7452,IRCT20190809044488N1,Recruitment complete,,,,,,2020-01-13,http://en.irct.ir/trial/41571,,0,0
7453,IRCT20200324046851N1,Recruitment complete,,,,,,2020-04-03,http://en.irct.ir/trial/46712,,0,0
7454,IRCT20170207032444N3,Recruitment complete,,,,,,2020-04-17,http://en.irct.ir/trial/47119,,0,0
7455,IRCT20200419047128N1,Recruitment complete,,,,,,2021-07-04,http://en.irct.ir/trial/47265,,0,0
7456,IRCT20190618043923N4,Recruitment complete,,,,,,2020-05-04,http://en.irct.ir/trial/47363,,0,0
7457,IRCT20200419047128N2,Recruitment complete,,,,,,2021-07-04,http://en.irct.ir/trial/47396,,0,0
7458,IRCT20160118026097N3,Recruitment complete,,,,,,2020-05-31,http://en.irct.ir/trial/48517,,0,0
7459,IRCT20200416047099N2,Recruitment complete,,,,,,2020-07-04,http://en.irct.ir/trial/47357,,0,0
7460,IRCT20200428047229N1,Recruitment complete,,,,,,2020-06-27,http://en.irct.ir/trial/47530,,0,0
7461,IRCT20200428047232N1,Recruitment complete,,,,,,2020-07-05,http://en.irct.ir/trial/47637,,0,0
7462,IRCT20200504047298N2,Recruitment complete,,,,,,2020-06-15,http://en.irct.ir/trial/47675,,0,0
7463,IRCT20171105037262N4,Recruitment complete,,,,,,2020-06-18,http://en.irct.ir/trial/47696,,0,0
7464,IRCT20200508047345N1,Recruitment complete,,,,,,2022-01-25,http://en.irct.ir/trial/47987,,0,0
7465,IRCT20180425039414N3,Recruitment complete,,,,,,2020-06-17,http://en.irct.ir/trial/48083,,0,0
7466,IRCT20200510047385N1,Recruitment complete,,,,,,2020-07-07,http://en.irct.ir/trial/48099,,0,0
7467,IRCT20200513047426N1,Recruitment complete,,,,,,2020-06-27,http://en.irct.ir/trial/48236,,0,0
7468,IRCT20110726007117N11,Recruitment complete,,,,,,2021-07-06,http://en.irct.ir/trial/48287,,0,0
7469,IRCT20200112046089N1,Recruitment complete,,,,,,2020-06-25,http://en.irct.ir/trial/48330,,0,0
7470,IRCT20200330046899N1,Recruitment complete,,,,,,2020-06-17,http://en.irct.ir/trial/48365,,0,0
7471,IRCT20081027001411N4,Recruitment complete,,,,,,2021-01-27,http://en.irct.ir/trial/48396,,0,0
7472,IRCT20200317046797N6,Recruitment complete,,,,,,2022-03-09,http://en.irct.ir/trial/48500,,0,0
7473,IRCT20200504047298N1,Recruitment complete,,,,,,2020-06-14,http://en.irct.ir/trial/48640,,0,0
7474,IRCT20200505047305N1,Recruitment complete,,,,,,2020-06-30,http://en.irct.ir/trial/48683,,0,0
7475,IRCT20150107020592N29,Recruitment complete,,2020-05-21,,,,2020-06-21,http://en.irct.ir/trial/48695,2020-05-21,0,0
7476,IRCT20200607047675N1,Recruitment complete,,,,,,2022-02-25,http://en.irct.ir/trial/48700,,0,0
7477,IRCT20200608047686N1,Recruitment complete,,,,,,2020-06-30,http://en.irct.ir/trial/48717,,0,0
7478,IRCT20150107020592N26,Recruitment complete,,2020-05-21,,,,2020-06-15,http://en.irct.ir/trial/48746,2020-05-21,0,0
7479,IRCT20200609047707N1,Recruitment complete,,,,,,2020-06-24,http://en.irct.ir/trial/48764,,0,0
7480,IRCT20200611047735N1,Recruitment complete,,,,,,2020-06-19,http://en.irct.ir/trial/48843,,0,0
7481,IRCT20150107020592N27,Recruitment complete,,,,,,2020-06-15,http://en.irct.ir/trial/48907,,0,0
7482,IRCT20200515047456N1,Recruitment complete,,,,,,2020-06-28,http://en.irct.ir/trial/48929,,0,0
7483,IRCT20200611047727N1,Recruitment complete,,,,,,2020-06-24,http://en.irct.ir/trial/48941,,0,0
7484,IRCT20150107020592N28,Recruitment complete,,,,,,2020-06-18,http://en.irct.ir/trial/48972,,0,0
7485,IRCT20150107020592N30,Recruitment complete,,,,,,2020-07-10,http://en.irct.ir/trial/48992,,0,0
7486,IRCT20200404046937N3,Recruitment complete,,,,,,2021-06-02,http://en.irct.ir/trial/49029,,0,0
7487,IRCT20150725023332N3,Recruitment complete,,,,,,2020-06-27,http://en.irct.ir/trial/49112,,0,0
7488,IRCT20180712040446N2,Recruitment complete,,,,,,2020-07-01,http://en.irct.ir/trial/49120,,0,0
7489,IRCT20190121042444N3,Recruitment complete,,,,,,2020-07-04,http://en.irct.ir/trial/49132,,0,0
7490,IRCT20111224008507N3,Recruitment complete,,,,,,2020-06-27,http://en.irct.ir/trial/49174,,0,0
7491,IRCT20180519039711N6,Recruitment complete,,,,,,2020-06-29,http://en.irct.ir/trial/49186,,0,0
7492,IRCT20200426047206N2,Recruitment complete,,,,,,2020-07-06,http://en.irct.ir/trial/49385,,0,0
7493,IRCT20200414047076N1,Recruitment complete,,,,,,2020-08-01,http://en.irct.ir/trial/47286,,0,0
7494,IRCT20170922036314N4,Recruitment complete,,,,,,2020-08-08,http://en.irct.ir/trial/47383,,0,0
7495,IRCT20200503047281N1,Recruitment complete,,,,,,2020-07-25,http://en.irct.ir/trial/47632,,0,0
7496,IRCT20200505047318N1,Recruitment complete,,,,,,2020-08-06,http://en.irct.ir/trial/48007,,0,0
7497,IRCT20110907007511N4,Recruitment complete,,,,,,2020-07-25,http://en.irct.ir/trial/48013,,0,0
7498,IRCT20200511047399N1,Recruitment complete,,,,,,2020-07-23,http://en.irct.ir/trial/48045,,0,0
7499,IRCT20200522047545N1,Recruitment complete,,,,,,2020-08-05,http://en.irct.ir/trial/48351,,0,0
7500,IRCT20200522047542N1,Recruitment complete,,,,,,2020-08-04,http://en.irct.ir/trial/48379,,0,0
7501,IRCT20200525047570N1,Recruitment complete,,,,,,2020-07-30,http://en.irct.ir/trial/48583,,0,0
7502,IRCT20200607047682N1,Recruitment complete,,,,,,2020-07-27,http://en.irct.ir/trial/48727,,0,0
7503,IRCT20200610047722N1,Recruitment complete,,,,,,2021-03-29,http://en.irct.ir/trial/48869,,0,0
7504,IRCT20190602043787N3,Recruitment complete,,,,,,2020-07-20,http://en.irct.ir/trial/49180,,0,0
7505,IRCT20190624043993N3,Recruitment complete,,,,,,2020-07-23,http://en.irct.ir/trial/49257,,0,0
7506,IRCT20190624043993N2,Recruitment complete,,,,,,2020-07-12,http://en.irct.ir/trial/49280,,0,0
7507,IRCT20200105046009N4,Recruitment complete,,,,,,2020-07-18,http://en.irct.ir/trial/49365,,0,0
7508,IRCT20200506047323N3,Recruitment complete,,,,,,2020-07-22,http://en.irct.ir/trial/49463,,0,0
7509,IRCT20200705048013N1,Recruitment complete,,2020-07-05,,,,2020-07-19,http://en.irct.ir/trial/49525,2020-07-05,0,0
7510,IRCT20190406043175N3,Recruitment complete,,,,,,2020-07-12,http://en.irct.ir/trial/49530,,0,0
7511,IRCT20170117032025N7,Recruitment complete,,,,,,2020-07-12,http://en.irct.ir/trial/49534,,0,0
7512,IRCT20190415043279N6,Recruitment complete,,,,,,2020-07-24,http://en.irct.ir/trial/49544,,0,0
7513,IRCT20200426047206N3,Recruitment complete,,,,,,2020-07-25,http://en.irct.ir/trial/49579,,0,0
7514,IRCT20200408046990N3,Recruitment complete,,,,,,2020-07-16,http://en.irct.ir/trial/49629,,0,0
7515,IRCT20151227025726N20,Recruitment complete,,,,,,2020-07-26,http://en.irct.ir/trial/49638,,0,0
7516,IRCT20101020004976N6,Recruitment complete,,,,,,2020-07-18,http://en.irct.ir/trial/49670,,0,0
7517,IRCT20180513039641N2,Recruitment complete,,,,,,2020-07-27,http://en.irct.ir/trial/49803,,0,0
7518,IRCT20200506047323N4,Recruitment complete,,,,,,2020-08-01,http://en.irct.ir/trial/49881,,0,0
7519,IRCT20200723048178N1,Recruitment complete,,,,,,2020-07-28,http://en.irct.ir/trial/49901,,0,0
7520,IRCT20160131026298N4,Recruitment complete,,,,,,2020-08-04,http://en.irct.ir/trial/49925,,0,0
7521,IRCT20200404046937N4,Recruitment complete,,,,,,2021-06-11,http://en.irct.ir/trial/49935,,0,0
7522,IRCT20200402046917N1,Recruitment complete,,,,,,2020-08-31,http://en.irct.ir/trial/46938,,0,0
7523,IRCT20170128032241N3,Recruitment complete,,,,,,2020-08-17,http://en.irct.ir/trial/47031,,0,0
7524,IRCT20200418047119N1,Recruitment complete,,,,,,2020-09-01,http://en.irct.ir/trial/47231,,0,0
7525,IRCT20200514047445N1,Recruitment complete,,,,,,2020-08-10,http://en.irct.ir/trial/48275,,0,0
7526,IRCT20190131042569N5,Recruitment complete,,,,,,2020-08-23,http://en.irct.ir/trial/48311,,0,0
7527,IRCT20200527047581N1,Recruitment complete,,,,,,2020-08-23,http://en.irct.ir/trial/48447,,0,0
7528,IRCT20200616047792N1,Recruitment complete,,,,,,2020-08-16,http://en.irct.ir/trial/48978,,0,0
7529,IRCT20200616047799N1,Recruitment complete,,,,,,2020-08-23,http://en.irct.ir/trial/49012,,0,0
7530,IRCT20090304001739N3,Recruitment complete,,2020-09-05,,,,2020-09-01,http://en.irct.ir/trial/49065,2020-09-05,0,0
7531,IRCT20200623047897N1,Recruitment complete,,,,,,2020-08-16,http://en.irct.ir/trial/49277,,0,0
7532,IRCT20200509047364N1,Recruitment complete,,,,,,2021-05-26,http://en.irct.ir/trial/49282,,0,0
7533,IRCT20200630047962N1,Recruitment complete,,,,,,2020-08-21,http://en.irct.ir/trial/49309,,0,0
7534,IRCT20200705048011N1,Recruitment complete,,,,,,2020-08-16,http://en.irct.ir/trial/49481,,0,0
7535,IRCT20190312043030N2,Recruitment complete,,,,,,2020-08-19,http://en.irct.ir/trial/49508,,0,0
7536,IRCT20170716035126N4,Recruitment complete,,,,,,2020-08-26,http://en.irct.ir/trial/49519,,0,0
7537,IRCT20200711048076N1,Recruitment complete,,,,,,2020-09-05,http://en.irct.ir/trial/49555,,0,0
7538,IRCT20200509047364N2,Recruitment complete,,,,,,2020-08-17,http://en.irct.ir/trial/49657,,0,0
7539,IRCT20200718048129N1,Recruitment complete,,,,,,2020-08-11,http://en.irct.ir/trial/49729,,0,0
7540,IRCT20200725048199N1,Recruitment complete,,,,,,2020-08-11,http://en.irct.ir/trial/49853,,0,0
7541,IRCT20160808029264N9,Recruitment complete,,,,,,2020-08-15,http://en.irct.ir/trial/49890,,0,0
7542,IRCT20190831044653N5,Recruitment complete,,,,,,2020-08-24,http://en.irct.ir/trial/49893,,0,0
7543,IRCT20200730048253N1,Recruitment complete,,,,,,2020-08-08,http://en.irct.ir/trial/50031,,0,0
7544,IRCT20091012002582N22,Recruitment complete,,,,,,2020-08-08,http://en.irct.ir/trial/50079,,0,0
7545,IRCT20101219005416N3,Recruitment complete,,,,,,2020-08-26,http://en.irct.ir/trial/50101,,0,0
7546,IRCT20200806048318N1,Recruitment complete,,,,,,2020-08-20,http://en.irct.ir/trial/50227,,0,0
7547,IRCT20200506047323N5,recruiting,,,,,,2020-08-14,http://en.irct.ir/trial/50239,,0,0
7548,IRCT20090701002113N2,Recruitment complete,,,,,,2020-08-25,http://en.irct.ir/trial/50275,,0,0
7549,IRCT20180922041089N4,Recruitment complete,,,,,,2020-08-23,http://en.irct.ir/trial/50305,,0,0
7550,IRCT20161108030776N3,Recruitment complete,,,,,,2020-08-26,http://en.irct.ir/trial/50341,,0,0
7551,IRCT20190810044500N7,Recruitment complete,,,,,,2020-09-19,http://en.irct.ir/trial/46826,,0,0
7552,IRCT20190717044241N2,Recruitment complete,,,,,,2020-09-14,http://en.irct.ir/trial/47110,,0,0
7553,IRCT20081019001369N7,Recruitment complete,,,,,,2020-09-27,http://en.irct.ir/trial/47441,,0,0
7554,IRCT20200504047295N1,Recruitment complete,,,,,,2020-09-16,http://en.irct.ir/trial/47661,,0,0
7555,IRCT20160118026097N4,Recruitment complete,,,,,,2020-09-13,http://en.irct.ir/trial/48310,,0,0
7556,IRCT20160118026097N5,Recruitment complete,,,,,,2020-09-19,http://en.irct.ir/trial/48401,,0,0
7557,IRCT20190226042851N1,Recruitment complete,,,,,,2020-10-05,http://en.irct.ir/trial/48462,,0,0
7558,IRCT20180624040213N2,Recruitment complete,,,,,,2020-09-14,http://en.irct.ir/trial/49420,,0,0
7559,IRCT20200504047298N3,Recruitment complete,,,,,,2020-09-09,http://en.irct.ir/trial/49696,,0,0
7560,IRCT20200727048217N1,Recruitment complete,,,,,,2020-12-10,http://en.irct.ir/trial/49924,,0,0
7561,IRCT20200802048266N1,Recruitment complete,,,,,,2020-09-22,http://en.irct.ir/trial/50035,,0,0
7562,IRCT20131112015390N5,Recruitment complete,,2020-08-10,,,,2020-09-26,http://en.irct.ir/trial/50268,2020-08-10,0,0
7563,IRCT20200317046797N7,Recruitment complete,,,,,,2020-09-14,http://en.irct.ir/trial/50556,,0,0
7564,IRCT20200831048568N1,Recruitment complete,,,,,,2020-09-11,http://en.irct.ir/trial/50601,,0,0
7565,IRCT20181203041832N1,Recruitment complete,,,,,,2020-10-05,http://en.irct.ir/trial/50750,,0,0
7566,IRCT20200902048598N1,Recruitment complete,,,,,,2020-09-28,http://en.irct.ir/trial/50796,,0,0
7567,IRCT20140911019125N8,Recruitment complete,,,,,,2020-09-26,http://en.irct.ir/trial/50848,,0,0
7568,IRCT20200913048701N1,Recruitment complete,,,,,,2020-09-22,http://en.irct.ir/trial/50912,,0,0
7569,IRCT20200907048644N1,Recruitment complete,,,,,,2020-10-04,http://en.irct.ir/trial/50932,,0,0
7570,IRCT20200913048708N1,Recruitment complete,,,,,,2020-10-01,http://en.irct.ir/trial/50959,,0,0
7571,IRCT20131115015405N4,Recruitment complete,,,,,,2020-10-03,http://en.irct.ir/trial/50977,,0,0
7572,IRCT20131125015536N13,Recruitment complete,,,,,,2020-10-03,http://en.irct.ir/trial/51310,,0,0
7573,IRCT20201001048893N1,Recruitment complete,,2020-05-14,,,,2020-10-03,http://en.irct.ir/trial/51328,2020-05-14,0,0
7574,IRCT20100623004251N13,Recruitment complete,,,,,,2020-10-09,http://en.irct.ir/trial/42393,,0,0
7575,IRCT20200328046885N1,Recruitment complete,,,,,,2020-10-12,http://en.irct.ir/trial/47565,,0,0
7576,IRCT20200531047619N1,Recruitment complete,,,,,,2020-10-18,http://en.irct.ir/trial/48766,,0,0
7577,IRCT20200516047462N2,Recruitment complete,,,,,,2021-10-05,http://en.irct.ir/trial/49628,,0,0
7578,IRCT20200802048267N1,Recruitment complete,,,,,,2020-10-20,http://en.irct.ir/trial/50162,,0,0
7579,IRCT20200816048422N1,Recruitment complete,,,,,,2020-10-16,http://en.irct.ir/trial/50363,,0,0
7580,IRCT20150808023559N23,Recruitment complete,,,,,,2020-10-11,http://en.irct.ir/trial/50405,,0,0
7581,IRCT20200825048514N1,Recruitment complete,,,,,,2020-10-10,http://en.irct.ir/trial/50543,,0,0
7582,IRCT20200328046886N2,Recruitment complete,,,,,,2020-10-12,http://en.irct.ir/trial/50980,,0,0
7583,IRCT20080901001165N63,Recruitment complete,,,,,,2020-10-26,http://en.irct.ir/trial/51157,,0,0
7584,IRCT20100228003449N31,Recruitment complete,,,,,,2020-10-08,http://en.irct.ir/trial/51163,,0,0
7585,IRCT20200923048815N1,Recruitment complete,,,,,,2020-10-15,http://en.irct.ir/trial/51166,,0,0
7586,IRCT20200922048804N1,Recruitment complete,,,,,,2020-10-06,http://en.irct.ir/trial/51177,,0,0
7587,IRCT20200404046937N5,Recruitment complete,,,,,,2020-10-14,http://en.irct.ir/trial/51178,,0,0
7588,IRCT20200928048867N1,Recruitment complete,,,,,,2020-10-22,http://en.irct.ir/trial/51319,,0,0
7589,IRCT20201003048904N1,Recruitment complete,,,,,,2020-10-11,http://en.irct.ir/trial/51364,,0,0
7590,IRCT20201003048905N1,Recruitment complete,,2020-07-31,,,,2020-10-07,http://en.irct.ir/trial/51394,2020-07-31,0,0
7591,IRCT20201004048922N1,Recruitment complete,,,,,,2020-10-10,http://en.irct.ir/trial/51443,,0,0
7592,IRCT20201005048936N1,Recruitment complete,,,,,,2020-10-26,http://en.irct.ir/trial/51499,,0,0
7593,IRCT20181208041886N1,Recruitment complete,,,,,,2020-10-18,http://en.irct.ir/trial/51501,,0,0
7594,IRCT20200128046294N3,Recruitment complete,,,,,,2020-10-22,http://en.irct.ir/trial/51585,,0,0
7595,IRCT20200930048892N1,Recruitment complete,,,,,,2020-10-18,http://en.irct.ir/trial/51595,,0,0
7596,IRCT20200415047080N2,Recruitment complete,,,,,,2020-11-07,http://en.irct.ir/trial/47186,,0,0
7597,IRCT20140312016968N2,Recruitment complete,,,,,,2020-12-07,http://en.irct.ir/trial/47381,,0,0
7598,IRCT20200415047080N1,Recruitment complete,,,,,,2020-11-02,http://en.irct.ir/trial/47982,,0,0
7599,IRCT20200608047686N2,Recruitment complete,,,,,,2020-11-19,http://en.irct.ir/trial/48933,,0,0
7600,IRCT20151227025726N24,Recruitment complete,,,,,,2020-11-25,http://en.irct.ir/trial/49043,,0,0
7601,IRCT20200624047908N1,Recruitment complete,,,,,,2020-11-09,http://en.irct.ir/trial/49198,,0,0
7602,IRCT20130428013151N2,Recruitment complete,,,,,,2020-10-28,http://en.irct.ir/trial/49356,,0,0
7603,IRCT20200506047323N6,Recruitment complete,,,,,,2020-11-17,http://en.irct.ir/trial/49501,,0,0
7604,IRCT20180103038199N3,Recruitment complete,,,,,,2021-01-27,http://en.irct.ir/trial/49775,,0,0
7605,IRCT20191211045691N1,Recruitment complete,,,,,,2021-01-05,http://en.irct.ir/trial/49879,,0,0
7606,IRCT20160131026298N5,Recruitment complete,,,,,,2020-12-13,http://en.irct.ir/trial/49886,,0,0
7607,IRCT20160131026298N6,Recruitment complete,,,,,,2020-11-01,http://en.irct.ir/trial/50246,,0,0
7608,IRCT20160919029870N3,Recruitment complete,,2020-06-20,,,,2020-11-24,http://en.irct.ir/trial/50425,2020-06-20,0,0
7609,IRCT20200711048077N1,Recruitment complete,,,,,,2020-11-16,http://en.irct.ir/trial/50721,,0,0
7610,IRCT20200818048444N1,Recruitment complete,,,,,,2020-12-13,http://en.irct.ir/trial/50780,,0,0
7611,IRCT20200408046987N2,Recruitment complete,,,,,,2020-11-07,http://en.irct.ir/trial/51007,,0,0
7612,IRCT20200921048786N1,Recruitment complete,,,,,,2020-11-11,http://en.irct.ir/trial/51086,,0,0
7613,IRCT20200921048794N1,Recruitment complete,,,,,,2021-01-09,http://en.irct.ir/trial/51120,,0,0
7614,IRCT20151227025726N23,Recruitment complete,,,,,,2020-11-10,http://en.irct.ir/trial/51473,,0,0
7615,IRCT20181030041504N1,Recruitment complete,,,,,,2020-11-08,http://en.irct.ir/trial/51482,,0,0
7616,IRCT20200428047229N3,Recruitment complete,,,,,,2020-11-25,http://en.irct.ir/trial/51516,,0,0
7617,IRCT20201012049010N1,Recruitment complete,,2020-10-30,,,,2020-11-12,http://en.irct.ir/trial/51591,2020-10-30,0,0
7618,IRCT20200426047206N4,Recruitment complete,,,,,,2020-11-01,http://en.irct.ir/trial/51687,,0,0
7619,IRCT20150825023753N17,Recruitment complete,,2020-07-20,,,,2020-11-01,http://en.irct.ir/trial/51709,2020-07-20,0,0
7620,IRCT20201015049030N1,Recruitment complete,,,,,,2020-11-07,http://en.irct.ir/trial/51736,,0,0
7621,IRCT20201020049088N1,Recruitment complete,,,,,,2020-11-15,http://en.irct.ir/trial/51748,,0,0
7622,IRCT20201016049048N1,Recruitment complete,,,,,,2020-11-04,http://en.irct.ir/trial/51767,,0,0
7623,IRCT20201015049036N1,Recruitment complete,,2020-11-16,,,,2020-11-27,http://en.irct.ir/trial/51772,2020-11-16,0,0
7624,IRCT20181208041886N2,Recruitment complete,,,,,,2020-10-29,http://en.irct.ir/trial/51774,,0,0
7625,IRCT20200720048139N1,Recruitment complete,,,,,,2020-11-09,http://en.irct.ir/trial/51784,,0,0
7626,IRCT20200404046936N4,Recruitment complete,,,,,,2020-11-01,,,0,0
7627,IRCT20201024049134N1,Recruitment complete,,,,,,2021-01-17,http://en.irct.ir/trial/51847,,0,0
7628,IRCT20200927048848N2,Recruitment complete,,,,,,2020-11-04,http://en.irct.ir/trial/51922,,0,0
7629,IRCT20170809035597N2,Recruitment complete,,,,,,2022-02-14,http://en.irct.ir/trial/51927,,0,0
7630,IRCT20191211045691N2,Recruitment complete,,,,,,2020-11-02,http://en.irct.ir/trial/51951,,0,0
7631,IRCT20190713044192N2,Recruitment complete,,,,,,2020-11-21,http://en.irct.ir/trial/52153,,0,0
7632,IRCT20170315033086N7,Recruitment complete,,,,,,2020-11-12,http://en.irct.ir/trial/52223,,0,0
7633,IRCT20190804044429N4,Recruitment complete,,,,,,2020-11-25,http://en.irct.ir/trial/52284,,0,0
7634,IRCT20200731048257N1,Recruitment complete,,,,,,2020-12-02,http://en.irct.ir/trial/50012,,0,0
7635,IRCT20200421047153N1,Recruitment complete,,,,,,2020-12-19,http://en.irct.ir/trial/47337,,0,0
7636,IRCT20180610040049N6,Recruitment complete,,,,,,2020-12-04,http://en.irct.ir/trial/47626,,0,0
7637,IRCT20200621047859N2,Recruitment complete,,2020-12-08,,,,2020-12-29,http://en.irct.ir/trial/49382,2020-12-08,0,0
7638,IRCT20120703010178N22,Recruitment complete,,,,,,2021-07-06,http://en.irct.ir/trial/49850,,0,0
7639,IRCT20161206031255N4,Recruitment complete,,,,,,2020-12-07,http://en.irct.ir/trial/50229,,0,0
7640,IRCT20170611034452N12,Recruitment complete,,2020-05-14,,,,2020-12-20,http://en.irct.ir/trial/50289,2020-05-14,0,0
7641,IRCT20150830023823N3,Recruitment complete,,,,,,2020-12-06,http://en.irct.ir/trial/50854,,0,0
7642,IRCT20200921048783N1,Recruitment complete,,,,,,2020-12-06,http://en.irct.ir/trial/51199,,0,0
7643,IRCT20200927048849N1,Recruitment complete,,2020-11-25,,,,2020-12-05,http://en.irct.ir/trial/51259,2020-11-25,0,0
7644,IRCT20201004048923N1,Recruitment complete,,,,,,2020-12-13,http://en.irct.ir/trial/51442,,0,0
7645,IRCT20201001048894N1,Recruitment complete,,,,,,2020-12-15,http://en.irct.ir/trial/51492,,0,0
7646,IRCT20181208041886N3,Recruitment complete,,,,,,2020-12-22,http://en.irct.ir/trial/51633,,0,0
7647,IRCT20201028049175N1,Recruitment complete,,,,,,2020-12-12,http://en.irct.ir/trial/51946,,0,0
7648,IRCT20200408046987N3,Recruitment complete,,,,,,2020-12-06,http://en.irct.ir/trial/51999,,0,0
7649,IRCT20080901001157N17,Recruitment complete,,,,,,2020-11-29,http://en.irct.ir/trial/52070,,0,0
7650,IRCT20180625040232N7,Recruitment complete,,,,,,2020-11-30,http://en.irct.ir/trial/52081,,0,0
7651,IRCT20110302005952N2,Recruitment complete,,,,,,2020-12-17,http://en.irct.ir/trial/52356,,0,0
7652,IRCT20180205038626N7,Recruitment complete,,,,,,2020-12-27,http://en.irct.ir/trial/52374,,0,0
7653,IRCT20201003048904N2,Recruitment complete,,,,,,2022-02-07,http://en.irct.ir/trial/52607,,0,0
7654,IRCT20201128049508N1,Recruitment complete,,,,,,2020-12-28,http://en.irct.ir/trial/52648,,0,0
7655,IRCT20171219037964N3,Recruitment complete,,,,,,2020-12-02,http://en.irct.ir/trial/52696,,0,0
7656,IRCT20201202049567N1,Recruitment complete,,,,,,2020-12-15,http://en.irct.ir/trial/52701,,0,0
7657,IRCT20171219037964N2,Recruitment complete,,,,,,2020-12-02,http://en.irct.ir/trial/52709,,0,0
7658,IRCT20100130003227N15,Recruitment complete,,,,,,2020-12-10,http://en.irct.ir/trial/52719,,0,0
7659,IRCT20190415043279N9,Recruitment complete,,,,,,2020-12-22,http://en.irct.ir/trial/52853,,0,0
7660,IRCT20170218032635N3,Recruitment complete,,,,,,2020-12-27,http://en.irct.ir/trial/53134,,0,0
7661,IRCT20200818048444N2,Recruitment complete,,,,,,2020-12-31,http://en.irct.ir/trial/53165,,0,0
7662,IRCT20190409043215N2,Recruitment complete,,,,,,2021-02-14,http://en.irct.ir/trial/46581,,0,0
7663,IRCT20150303021315N22,Recruitment complete,,,,,,2021-01-27,http://en.irct.ir/trial/46955,,0,0
7664,IRCT20200424047184N1,Recruitment complete,,2020-12-30,,,,2021-01-16,http://en.irct.ir/trial/47775,2020-12-30,0,0
7665,IRCT20200611047727N3,Recruitment complete,,,,,,2021-01-03,http://en.irct.ir/trial/49116,,0,0
7666,IRCT20200906048638N1,Recruitment complete,,,,,,2021-02-01,http://en.irct.ir/trial/50860,,0,0
7667,IRCT20200928048865N1,Recruitment complete,,2021-01-29,,,,2021-01-01,http://en.irct.ir/trial/51258,2021-01-29,0,0
7668,IRCT20191125045496N3,Recruitment complete,,2020-10-01,,,,2021-01-25,http://en.irct.ir/trial/51644,2020-10-01,0,0
7669,IRCT20111121008146N34,Recruitment complete,,,,,,2021-01-24,http://en.irct.ir/trial/51948,,0,0
7670,IRCT20201111049348N1,Recruitment complete,,,,,,2021-01-03,http://en.irct.ir/trial/52276,,0,0
7671,IRCT20200611047735N2,Recruitment complete,,,,,,2021-02-13,http://en.irct.ir/trial/52426,,0,0
7672,IRCT20201122049463N1,Recruitment complete,,2021-03-10,,,,2021-01-18,http://en.irct.ir/trial/52495,2021-03-10,0,0
7673,IRCT20200927048849N2,Recruitment complete,,,,,,2021-01-06,http://en.irct.ir/trial/52537,,0,0
7674,IRCT20201125049486N1,Recruitment complete,,,,,,2021-02-14,http://en.irct.ir/trial/52541,,0,0
7675,IRCT20170123032129N9,Recruitment complete,,,,,,2021-01-05,http://en.irct.ir/trial/52574,,0,0
7676,IRCT20201128049520N1,Recruitment complete,,,,,,2021-02-22,http://en.irct.ir/trial/52677,,0,0
7677,IRCT20201119049445N1,Recruitment complete,,,,,,2021-02-13,http://en.irct.ir/trial/52747,,0,0
7678,IRCT20201202049566N1,Recruitment complete,,,,,,2021-01-22,http://en.irct.ir/trial/52800,,0,0
7679,IRCT20190717044241N3,Recruitment complete,,,,,,2021-01-02,http://en.irct.ir/trial/52820,,0,0
7680,IRCT20160808029255N10,Recruitment complete,,,,,,2021-01-10,http://en.irct.ir/trial/52822,,0,0
7681,IRCT20200621047859N4,Recruitment complete,,,,,,2021-01-03,http://en.irct.ir/trial/52947,,0,0
7682,IRCT20201213049693N1,Recruitment complete,,,,,,2021-02-13,http://en.irct.ir/trial/53006,,0,0
7683,IRCT20180316039112N3,Recruitment complete,,2020-12-21,,,,2021-02-01,http://en.irct.ir/trial/53059,2020-12-21,0,0
7684,IRCT20200318046812N3,Recruitment complete,,,,,,2021-01-12,http://en.irct.ir/trial/53187,,0,0
7685,IRCT20201127049505N1,Recruitment complete,,,,,,2021-02-06,http://en.irct.ir/trial/53212,,0,0
7686,IRCT20170807035551N2,Recruitment complete,,,,,,2021-01-16,http://en.irct.ir/trial/53252,,0,0
7687,IRCT20160110025929N34,Recruitment complete,,,,,,2021-01-16,http://en.irct.ir/trial/53265,,0,0
7688,IRCT20201223049816N1,Recruitment complete,,,,,,2021-01-11,http://en.irct.ir/trial/53342,,0,0
7689,IRCT20201028049175N3,Recruitment complete,,,,,,2021-01-15,http://en.irct.ir/trial/53410,,0,0
7690,IRCT20200223046586N3,Recruitment complete,,,,,,2021-01-11,http://en.irct.ir/trial/53538,,0,0
7691,IRCT20210109049978N1,Recruitment complete,,,,,,2021-01-13,http://en.irct.ir/trial/53594,,0,0
7692,IRCT20110425006280N11,Recruitment complete,,,,,,2021-01-27,http://en.irct.ir/trial/53644,,0,0
7693,IRCT20210111050011N1,Recruitment complete,,,,,,2021-02-16,http://en.irct.ir/trial/53741,,0,0
7694,IRCT20210120050092N1,Recruitment complete,,,,,,2021-02-19,http://en.irct.ir/trial/53834,,0,0
7695,IRCT20190804044429N6,Recruitment complete,,,,,,2021-02-20,http://en.irct.ir/trial/54008,,0,0
7696,IRCT20210205050247N1,Recruitment complete,,,,,,2021-02-13,http://en.irct.ir/trial/54178,,0,0
7697,IRCT20200506047323N7,Recruitment complete,,,,,,2021-02-16,http://en.irct.ir/trial/54268,,0,0
7698,IRCT20210214050350N1,Recruitment complete,,,,,,2021-02-22,http://en.irct.ir/trial/54295,,0,0
7699,IRCT20210214050356N1,Recruitment complete,,,,,,2021-02-22,http://en.irct.ir/trial/54351,,0,0
7700,IRCT20200509047364N3,Recruitment complete,,,,,,2021-02-20,http://en.irct.ir/trial/54372,,0,0
7701,IRCT20190804044429N5,Recruitment complete,,,,,,2021-02-18,http://en.irct.ir/trial/54385,,0,0
7702,IRCT20150725023332N4,Recruitment complete,,,,,,2021-03-08,http://en.irct.ir/trial/49124,,0,0
7703,IRCT20150725023332N5,Recruitment complete,,,,,,2021-04-06,http://en.irct.ir/trial/49150,,0,0
7704,IRCT20200629047953N1,Recruitment complete,,,,,,2021-03-17,http://en.irct.ir/trial/49449,,0,0
7705,IRCT20200707048047N1,Recruitment complete,,,,,,2021-03-27,http://en.irct.ir/trial/49766,,0,0
7706,IRCT20200509047373N2,recruiting,,,,,,2021-10-13,http://en.irct.ir/trial/50551,,0,0
7707,IRCT20150815023620N9,Recruitment complete,,2020-08-01,,,,2021-03-13,http://en.irct.ir/trial/52045,2020-08-01,0,0
7708,IRCT20130812014333N164,Recruitment complete,,,,,,2021-04-01,http://en.irct.ir/trial/52416,,0,0
7709,IRCT20200927048849N3,Recruitment complete,,,,,,2021-03-17,http://en.irct.ir/trial/52429,,0,0
7710,IRCT20200823048495N1,Recruitment complete,,2020-07-01,,,,2021-03-21,http://en.irct.ir/trial/52742,2020-07-01,0,0
7711,IRCT20110423006257N3,Recruitment complete,,,,,,2021-04-03,http://en.irct.ir/trial/53279,,0,0
7712,IRCT20201111049348N2,Recruitment complete,,,,,,2021-02-25,http://en.irct.ir/trial/53645,,0,0
7713,IRCT20160516027929N8,Recruitment complete,,2020-11-21,,,,2021-03-02,http://en.irct.ir/trial/53646,2020-11-21,0,0
7714,IRCT20150902023864N2,Recruitment complete,,,,,,2021-03-15,http://en.irct.ir/trial/53653,,0,0
7715,IRCT20210102049912N1,Recruitment complete,,,,,,2021-04-07,http://en.irct.ir/trial/53693,,0,0
7716,IRCT20201212049681N1,Recruitment complete,,2021-04-19,,,,2021-02-28,http://en.irct.ir/trial/53702,2021-04-19,0,0
7717,IRCT20150711023153N2,Recruitment complete,,,,,,2021-02-28,http://en.irct.ir/trial/53860,,0,0
7718,IRCT20210123050116N1,Recruitment complete,,,,,,2021-03-04,http://en.irct.ir/trial/53872,,0,0
7719,IRCT20111224008507N4,Recruitment complete,,,,,,2021-03-06,http://en.irct.ir/trial/53949,,0,0
7720,IRCT20140810018754N12,Recruitment complete,,,,,,2021-03-15,http://en.irct.ir/trial/54036,,0,0
7721,IRCT20210203050233N1,Recruitment complete,,,,,,2021-04-14,http://en.irct.ir/trial/54085,,0,0
7722,IRCT20210202050219N1,Recruitment complete,,,,,,2021-04-08,http://en.irct.ir/trial/54110,,0,0
7723,IRCT20210204050238N1,Recruitment complete,,,,,,2021-03-02,http://en.irct.ir/trial/54136,,0,0
7724,IRCT20111224008507N5,Recruitment complete,,,,,,2021-03-04,http://en.irct.ir/trial/54402,,0,0
7725,IRCT20210218050404N1,recruiting,,,,,,2021-09-30,http://en.irct.ir/trial/54447,,0,0
7726,IRCT20180728040617N3,Recruitment complete,,,,,,2021-03-14,http://en.irct.ir/trial/54613,,0,0
7727,IRCT20200405046958N2,Recruitment complete,,,,,,2021-04-14,http://en.irct.ir/trial/54653,,0,0
7728,IRCT20160808029264N10,Recruitment complete,,,,,,2021-04-13,http://en.irct.ir/trial/54655,,0,0
7729,IRCT20210223050466N1,Recruitment complete,,,,,,2021-03-27,http://en.irct.ir/trial/54662,,0,0
7730,IRCT20201124049480N1,Recruitment complete,,,,,,2021-09-24,http://en.irct.ir/trial/54675,,0,0
7731,IRCT20210301050536N1,Recruitment complete,,,,,,2021-03-16,http://en.irct.ir/trial/54698,,0,0
7732,IRCT20210213050344N1,Recruitment complete,,,,,,2021-04-06,http://en.irct.ir/trial/54710,,0,0
7733,IRCT20180226038870N1,Recruitment complete,,,,,,2021-03-05,http://en.irct.ir/trial/54725,,0,0
7734,IRCT20201202049568N3,Recruitment complete,,,,,,2021-03-05,http://en.irct.ir/trial/54758,,0,0
7735,IRCT20200329046892N2,Recruitment complete,,,,,,2021-03-09,http://en.irct.ir/trial/54800,,0,0
7736,IRCT20200413047063N2,Recruitment complete,,,,,,2021-07-08,http://en.irct.ir/trial/54828,,0,0
7737,IRCT20201202049567N3,Recruitment complete,,,,,,2021-03-13,http://en.irct.ir/trial/54881,,0,0
7738,IRCT20200527047581N2,Recruitment complete,,,,,,2021-03-17,http://en.irct.ir/trial/54884,,0,0
7739,IRCT20201202049567N2,Recruitment complete,,,,,,2021-03-13,http://en.irct.ir/trial/54885,,0,0
7740,IRCT20210302050555N1,Recruitment complete,,,,,,2021-03-28,http://en.irct.ir/trial/54915,,0,0
7741,IRCT20180721040538N1,Recruitment complete,,,,,,2021-03-25,http://en.irct.ir/trial/54933,,0,0
7742,IRCT20180619040147N6,Recruitment complete,,,,,,2021-04-01,http://en.irct.ir/trial/54971,,0,0
7743,IRCT20210311050671N1,Recruitment complete,,,,,,2021-04-13,http://en.irct.ir/trial/54973,,0,0
7744,IRCT20171219037964N4,Recruitment complete,,2021-09-22,,,,2021-12-18,http://en.irct.ir/trial/55028,2021-09-22,0,0
7745,IRCT20180302038915N1,Recruitment complete,,,,,,2021-04-05,http://en.irct.ir/trial/55052,,0,0
7746,IRCT20151226025699N5,Recruitment complete,,,,,,2021-04-07,http://en.irct.ir/trial/55074,,0,0
7747,IRCT20131129015584N4,Recruitment complete,,,,,,2021-04-04,http://en.irct.ir/trial/55081,,0,0
7748,IRCT20190303042889N1,Recruitment complete,,,,,,2021-03-30,http://en.irct.ir/trial/55153,,0,0
7749,IRCT20210324050760N1,Recruitment complete,,,,,,2021-04-17,http://en.irct.ir/trial/55187,,0,0
7750,IRCT20200329046892N3,Recruitment complete,,,,,,2021-03-29,http://en.irct.ir/trial/55216,,0,0
7751,IRCT20201214049709N2,Recruitment complete,,2022-01-14,,,,2021-12-25,http://en.irct.ir/trial/55238,2022-01-14,0,0
7752,IRCT20111210008348N51,Recruitment complete,,,,,,2021-04-10,http://en.irct.ir/trial/55240,,0,0
7753,IRCT20210325050769N1,Recruitment complete,,,,,,2021-04-12,http://en.irct.ir/trial/55493,,0,0
7754,IRCT20200330046897N1,Recruitment complete,,,,,,2021-04-22,http://en.irct.ir/trial/46918,,0,0
7755,IRCT20201111049347N1,recruiting,,,,,,2021-04-27,http://en.irct.ir/trial/52245,,0,0
7756,IRCT20201127049504N1,Recruitment complete,,2021-03-24,,,,2021-05-17,http://en.irct.ir/trial/52621,2021-03-24,0,0
7757,IRCT20201204049600N1,Recruitment complete,,,,,,2021-04-27,http://en.irct.ir/trial/52772,,0,0
7758,IRCT20200904048616N1,Recruitment complete,,,,,,2021-05-06,http://en.irct.ir/trial/52777,,0,0
7759,IRCT20201229049872N1,Recruitment complete,,,,,,2021-04-22,http://en.irct.ir/trial/53333,,0,0
7760,IRCT20201229049873N1,Recruitment complete,,,,,,2021-05-23,http://en.irct.ir/trial/53791,,0,0
7761,IRCT20171203037733N3,recruiting,,,,,,2021-05-11,http://en.irct.ir/trial/54252,,0,0
7762,IRCT20170903036041N3,Recruitment complete,,,,,,2021-05-23,http://en.irct.ir/trial/54376,,0,0
7763,IRCT20210222050457N1,Recruitment complete,,,,,,2021-04-20,http://en.irct.ir/trial/54525,,0,0
7764,IRCT20210111050007N1,Recruitment complete,,,,,,2021-05-18,http://en.irct.ir/trial/54533,,0,0
7765,IRCT20180612040068N1,Recruitment complete,,,,,,2021-04-19,http://en.irct.ir/trial/54625,,0,0
7766,IRCT20210303050558N1,Recruitment complete,,,,,,2021-11-07,http://en.irct.ir/trial/54833,,0,0
7767,IRCT20180103038199N4,recruiting,,,,,,2022-02-08,http://en.irct.ir/trial/54965,,0,0
7768,IRCT20200611047727N4,Recruitment complete,,,,,,2021-04-28,http://en.irct.ir/trial/55024,,0,0
7769,IRCT20200325046854N2,Recruitment complete,,,,,,2021-05-03,http://en.irct.ir/trial/55085,,0,0
7770,IRCT20210317050734N1,Recruitment complete,,,,,,2021-05-03,http://en.irct.ir/trial/55130,,0,0
7771,IRCT20180205038626N8,Recruitment complete,,,,,,2021-05-09,http://en.irct.ir/trial/55208,,0,0
7772,IRCT20200721048159N2,Recruitment complete,,,,,,2021-04-22,http://en.irct.ir/trial/55368,,0,0
7773,IRCT20190101042197N2,Recruitment complete,,,,,,2021-04-19,http://en.irct.ir/trial/55380,,0,0
7774,IRCT20210327050775N1,Recruitment complete,,,,,,2021-05-25,http://en.irct.ir/trial/55405,,0,0
7775,IRCT20210406050871N1,Recruitment complete,,,,,,2021-04-25,http://en.irct.ir/trial/55531,,0,0
7776,IRCT20201129049525N1,Recruitment complete,,,,,,2021-05-16,http://en.irct.ir/trial/55602,,0,0
7777,IRCT20200411047029N1,Recruitment complete,,,,,,2021-04-24,http://en.irct.ir/trial/55615,,0,0
7778,IRCT20200914048719N2,Recruitment complete,,,,,,2021-05-03,http://en.irct.ir/trial/55619,,0,0
7779,IRCT20210413050957N1,Recruitment complete,,,,,,2021-05-01,http://en.irct.ir/trial/55660,,0,0
7780,IRCT20210416050988N1,Recruitment complete,,,,,,2021-05-24,http://en.irct.ir/trial/55671,,0,0
7781,IRCT20151020024625N12,Recruitment complete,,,,,,2021-04-30,http://en.irct.ir/trial/55690,,0,0
7782,IRCT20160516027929N10,Recruitment complete,,,,,,2021-05-03,http://en.irct.ir/trial/55715,,0,0
7783,IRCT20111224008507N6,Recruitment complete,,,,,,2021-05-07,http://en.irct.ir/trial/55727,,0,0
7784,IRCT20210408050899N1,Recruitment complete,,,,,,2021-05-25,http://en.irct.ir/trial/55757,,0,0
7785,IRCT20200723048178N2,recruiting,,,,,,2021-04-28,http://en.irct.ir/trial/55771,,0,0
7786,IRCT20210424051067N1,Recruitment complete,,,,,,2021-05-11,http://en.irct.ir/trial/55820,,0,0
7787,IRCT20160316027081N2,Recruitment complete,,,,,,2021-05-13,http://en.irct.ir/trial/56035,,0,0
7788,IRCT20210315050710N1,Recruitment complete,,,,,,2021-05-10,http://en.irct.ir/trial/56041,,0,0
7789,IRCT20121216011763N52,Recruitment complete,,,,,,2021-05-23,http://en.irct.ir/trial/56149,,0,0
7790,IRCT20150303021315N23,Recruitment complete,,,,,,2021-07-08,http://en.irct.ir/trial/56287,,0,0
7791,IRCT20210510051243N1,Recruitment complete,,,,,,2022-02-19,http://en.irct.ir/trial/56289,,0,0
7792,IRCT20080901001165N64,Recruitment complete,,,,,,2021-05-21,http://en.irct.ir/trial/56367,,0,0
7793,IRCT20200223046586N4,Recruitment complete,,,,,,2021-05-24,http://en.irct.ir/trial/56369,,0,0
7794,IRCT20200506047323N8,Recruitment complete,,,,,,2021-05-24,http://en.irct.ir/trial/56388,,0,0
7795,IRCT20160305026917N2,Recruitment complete,,,,,,2021-05-25,http://en.irct.ir/trial/56417,,0,0
7796,IRCT20191231045967N1,Recruitment complete,,,,,,2021-06-15,http://en.irct.ir/trial/45331,,0,0
7797,IRCT20170315033086N10,Recruitment complete,,,,,,2021-06-12,http://en.irct.ir/trial/51631,,0,0
7798,IRCT20201101049219N1,Recruitment complete,,,,,,2021-06-10,http://en.irct.ir/trial/52099,,0,0
7799,IRCT20201024049130N1,Recruitment complete,,,,,,2021-06-21,http://en.irct.ir/trial/52381,,0,0
7800,IRCT20200818048444N3,Recruitment complete,,,,,,2021-06-20,http://en.irct.ir/trial/52565,,0,0
7801,IRCT20201220049771N1,Recruitment complete,,,,,,2021-06-13,http://en.irct.ir/trial/53131,,0,0
7802,IRCT20210216050373N1,Recruitment complete,,,,,,2021-05-28,http://en.irct.ir/trial/54375,,0,0
7803,IRCT20210310050663N1,Recruitment complete,,,,,,2021-05-31,http://en.irct.ir/trial/54929,,0,0
7804,IRCT20200721048159N3,Recruitment complete,,,,,,2021-06-03,http://en.irct.ir/trial/54937,,0,0
7805,IRCT20210316050722N1,Recruitment complete,,,,,,2021-05-30,http://en.irct.ir/trial/55500,,0,0
7806,IRCT20210422051044N1,Recruitment complete,,,,,,2021-05-28,http://en.irct.ir/trial/55824,,0,0
7807,IRCT20210427051100N1,Recruitment complete,,,,,,2021-12-10,http://en.irct.ir/trial/55898,,0,0
7808,IRCT20210427051101N1,Recruitment complete,,,,,,2021-06-19,http://en.irct.ir/trial/55906,,0,0
7809,IRCT20150711023153N3,Recruitment complete,,,,,,2021-10-26,http://en.irct.ir/trial/55948,,0,0
7810,IRCT20210508051225N1,Recruitment complete,,,,,,2021-06-14,http://en.irct.ir/trial/56223,,0,0
7811,IRCT20201129049524N1,Recruitment complete,,,,,,2021-05-26,http://en.irct.ir/trial/56329,,0,0
7812,IRCT20140824018915N9,Recruitment complete,,,,,,2021-06-04,http://en.irct.ir/trial/56384,,0,0
7813,IRCT20210426051090N1,Recruitment complete,,,,,,2021-06-12,http://en.irct.ir/trial/56387,,0,0
7814,IRCT20140804018677N9,Recruitment complete,,,,,,2021-06-19,http://en.irct.ir/trial/56509,,0,0
7815,IRCT20141209020258N160,recruiting,,,,,,2021-06-06,http://en.irct.ir/trial/56545,,0,0
7816,IRCT20201024049134N2,Recruitment complete,,,,,,2021-06-04,http://en.irct.ir/trial/56613,,0,0
7817,IRCT20201024049134N3,Recruitment complete,,,,,,2021-06-21,http://en.irct.ir/trial/56624,,0,0
7818,IRCT20210522051363N1,Recruitment complete,,,,,,2021-06-13,http://en.irct.ir/trial/56697,,0,0
7819,IRCT20210423051056N1,Recruitment complete,,,,,,2021-06-18,http://en.irct.ir/trial/56733,,0,0
7820,IRCT20120215009014N398,Recruitment complete,,,,,,2021-06-20,http://en.irct.ir/trial/56922,,0,0
7821,NL9554,Open for patient inclusion,,2023-12-31,,,,,https://trialregister.nl/trial/9554,2023-12-31,0,0
7822,NL9553,"Inclusion stopped, follow up",,2022-09-01,,,,,https://trialregister.nl/trial/9553,2022-09-01,0,0
7823,NL9547,Open for patient inclusion,,2022-10-01,,Will follow,,,https://trialregister.nl/trial/9547,2022-10-01,0,1
7824,NL9538,"Inclusion stopped, follow up",,2023-01-05,,,,,https://trialregister.nl/trial/9538,2023-01-05,0,0
7825,NL9485,Open for patient inclusion,,2022-07-01,,,,,https://trialregister.nl/trial/9485,2022-07-01,0,0
7826,NL9459,Planned,,2022-05-02,,,,,https://trialregister.nl/trial/9459,2022-05-02,0,0
7827,NL9436,Open for patient inclusion,,2022-04-22,,,,,https://trialregister.nl/trial/9436,2022-04-22,0,0
7828,NL9430,Open for patient inclusion,,2021-06-01,,none yet,,,https://trialregister.nl/trial/9430,2021-06-01,0,1
7829,NL9419,Open for patient inclusion,,2022-10-19,,,,,https://trialregister.nl/trial/9419,2022-10-19,0,0
7830,NL9379,Open for patient inclusion,,2023-03-31,,,,,https://trialregister.nl/trial/9379,2023-03-31,0,0
7831,NL9378,Open for patient inclusion,,2021-05-16,,,,,https://trialregister.nl/trial/9378,2021-05-16,0,0
7832,NL9365,Open for patient inclusion,,2021-04-30,,,,,https://trialregister.nl/trial/9365,2021-04-30,0,0
7833,NL9354,Open for patient inclusion,,2021-07-01,,N.A.,,,https://trialregister.nl/trial/9354,2021-07-01,0,1
7834,NL9342,"Stopped, trial finished",,2021-12-31,,,,,https://trialregister.nl/trial/9342,2021-12-31,0,0
7835,NL9334,"Stopped, trial finished",,2022-02-25,,,,,https://trialregister.nl/trial/9334,2022-02-25,0,0
7836,NL9320,"Inclusion stopped, follow up",,2021-12-31,,,,,https://trialregister.nl/trial/9320,2021-12-31,0,0
7837,NL9307,Open for patient inclusion,,2021-03-10,,outcome will be published,,,https://trialregister.nl/trial/9307,2021-03-10,0,1
7838,NL9281,Open for patient inclusion,,2022-02-01,,,,,https://trialregister.nl/trial/9281,2022-02-01,0,0
7839,NL9279,Planned,,2026-09-01,,,,,https://trialregister.nl/trial/9279,2026-09-01,0,0
7840,NL9275,"Inclusion stopped, follow up",,2022-08-01,,,,,https://trialregister.nl/trial/9275,2022-08-01,0,0
7841,NL9250,Open for patient inclusion,,2021-02-26,,n.a.,,,https://trialregister.nl/trial/9250,2021-02-26,0,1
7842,NL9247,Open for patient inclusion,,2021-11-01,,,,,https://trialregister.nl/trial/9247,2021-11-01,0,0
7843,NL9238,Open for patient inclusion,,2021-02-15,,,,,https://trialregister.nl/trial/9238,2021-02-15,0,0
7844,NL9220,Open for patient inclusion,,2021-12-31,,,,,https://trialregister.nl/trial/9220,2021-12-31,0,0
7845,NL9214,Planned,,2022-01-01,,,,,https://trialregister.nl/trial/9214,2022-01-01,0,0
7846,NL9211,Open for patient inclusion,,2021-04-30,,,,,https://trialregister.nl/trial/9211,2021-04-30,0,0
7847,NL9177,"Inclusion stopped, follow up",,2021-02-28,,,,,https://trialregister.nl/trial/9177,2021-02-28,0,0
7848,NL9161,Recruitment status not public,,2022-10-23,,,,,https://trialregister.nl/trial/9161,2022-10-23,0,0
7849,NL9141,Open for patient inclusion,,2022-12-23,,,,,https://trialregister.nl/trial/9141,2022-12-23,0,0
7850,NL9093,Open for patient inclusion,,2021-12-31,,,,,https://trialregister.nl/trial/9093,2021-12-31,0,0
7851,NL9082,Planned,,2021-12-31,,,,,https://trialregister.nl/trial/9082,2021-12-31,0,0
7852,NL9081,"Stopped, trial finished",,2021-06-09,,,,,https://trialregister.nl/trial/9081,2021-06-09,0,0
7853,NL9067,"Inclusion stopped, follow up",,2021-07-01,,,,,https://trialregister.nl/trial/9067,2021-07-01,0,0
7854,NL9063,Planned,,2021-01-31,,,,,https://trialregister.nl/trial/9063,2021-01-31,0,0
7855,NL9053,Open for patient inclusion,,2021-01-15,,,,,https://trialregister.nl/trial/9053,2021-01-15,0,0
7856,NL9045,Open for patient inclusion,,2021-01-31,,N.A.,,,https://trialregister.nl/trial/9045,2021-01-31,0,1
7857,NL9019,Recruitment status not public,,2022-10-23,,,,,https://trialregister.nl/trial/9019,2022-10-23,0,0
7858,NL9018,Open for patient inclusion,,2020-12-31,,,,,https://trialregister.nl/trial/9018,2020-12-31,0,0
7859,NL9007,Open for patient inclusion,,2021-01-31,,,,,https://trialregister.nl/trial/9007,2021-01-31,0,0
7860,NL8993,Open for patient inclusion,,2022-07-01,,,,,https://trialregister.nl/trial/8993,2022-07-01,0,0
7861,NL8954,Open for patient inclusion,,2021-06-01,,,,,https://trialregister.nl/trial/8954,2021-06-01,0,0
7862,NL8947,"Inclusion stopped, follow up",,2022-10-05,,,,,https://trialregister.nl/trial/8947,2022-10-05,0,0
7863,NL8926,Planned,,2022-03-01,,,,,https://trialregister.nl/trial/8926,2022-03-01,0,0
7864,NL8922,Planned,,2022-10-01,,,,,https://trialregister.nl/trial/8922,2022-10-01,0,0
7865,NL8903,Open for patient inclusion,,2022-03-31,,,,,https://trialregister.nl/trial/8903,2022-03-31,0,0
7866,NL8882,"Inclusion stopped, follow up",,2021-09-30,,,,,https://trialregister.nl/trial/8882,2021-09-30,0,0
7867,NL8842,Open for patient inclusion,,2021-04-09,,,,,https://trialregister.nl/trial/8842,2021-04-09,0,0
7868,NL8841,"Inclusion stopped, follow up",,2023-03-31,,"Scientific results will be presented in scientific papers, and submitted for publication in international open access journals ",,,https://trialregister.nl/trial/8841,2023-03-31,0,1
7869,NL8837,Open for patient inclusion,,2020-12-31,,Scientific results will be presented in scientific papers and submitted for publication in international open access journals.,,,https://trialregister.nl/trial/8837,2020-12-31,0,1
7870,NL8836,Open for patient inclusion,,2022-08-14,,,,,https://trialregister.nl/trial/8836,2022-08-14,0,0
7871,NL8835,"Inclusion stopped, follow up",,2021-12-31,,,,,https://trialregister.nl/trial/8835,2021-12-31,0,0
7872,NL8821,Planned,,2020-09-30,,Not applicable,,,https://trialregister.nl/trial/8821,2020-09-30,0,1
7873,NL8818,Open for patient inclusion,,2020-10-01,,,,,https://trialregister.nl/trial/8818,2020-10-01,0,0
7874,NL8787,Open for patient inclusion,,2020-12-31,,,,,https://trialregister.nl/trial/8787,2020-12-31,0,0
7875,NL8775,Open for patient inclusion,,2020-12-22,,,,,https://trialregister.nl/trial/8775,2020-12-22,0,0
7876,NL8765,Open for patient inclusion,,2021-07-29,,,,,https://trialregister.nl/trial/8765,2021-07-29,0,0
7877,NL8735,Planned,,2021-07-16,,,,,https://trialregister.nl/trial/8735,2021-07-16,0,0
7878,NL8729,Planned,,2021-08-01,,,,,https://trialregister.nl/trial/8729,2021-08-01,0,0
7879,NL8726,Open for patient inclusion,,2020-09-09,,N.A.,,,https://trialregister.nl/trial/8726,2020-09-09,0,1
7880,NL8714,Planned,,2021-11-30,,,,,https://trialregister.nl/trial/8714,2021-11-30,0,0
7881,NL8710,Open for patient inclusion,,2023-09-01,,,,,https://trialregister.nl/trial/8710,2023-09-01,0,0
7882,NL8706,Open for patient inclusion,,2020-12-31,,,,,https://trialregister.nl/trial/8706,2020-12-31,0,0
7883,NL8705,Open for patient inclusion,,2020-12-01,,none,,,https://trialregister.nl/trial/8705,2020-12-01,0,1
7884,NL8694,Open for patient inclusion,,2020-12-31,,,,,https://trialregister.nl/trial/8694,2020-12-31,0,0
7885,NL8685,Open for patient inclusion,,2020-09-01,,planned,,,https://trialregister.nl/trial/8685,2020-09-01,0,1
7886,NL8668,Planned,,2020-12-31,,,,,https://trialregister.nl/trial/8668,2020-12-31,0,0
7887,NL8645,Open for patient inclusion,,2020-12-31,,,,,https://trialregister.nl/trial/8645,2020-12-31,0,0
7888,NL8633,Open for patient inclusion,,2021-05-01,,,,,https://trialregister.nl/trial/8633,2021-05-01,0,0
7889,NL8627,Planned,,2020-09-01,,,,,https://trialregister.nl/trial/8627,2020-09-01,0,0
7890,NL8625,Open for patient inclusion,,2021-01-01,,,,,https://trialregister.nl/trial/8625,2021-01-01,0,0
7891,NL8613,Open for patient inclusion,,2022-03-23,,"Tas J, van Gassel R, Heines S, et al. Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht. medRxiv doi: 10.1101/2020.04.27.20080309",,,https://trialregister.nl/trial/8613,2022-03-23,0,1
7892,NL8609,Planned,,2020-06-08,,,,,https://trialregister.nl/trial/8609,2020-06-08,0,0
7893,NL8589,Open for patient inclusion,,2020-09-30,,,,,https://trialregister.nl/trial/8589,2020-09-30,0,0
7894,NL8587,Open for patient inclusion,,2021-06-01,,None,,,https://trialregister.nl/trial/8587,2021-06-01,0,1
7895,NL8580,Open for patient inclusion,,2020-06-01,,,,,https://trialregister.nl/trial/8580,2020-06-01,0,0
7896,NL8578,Planned,,2022-07-13,,,,,https://trialregister.nl/trial/8578,2022-07-13,0,0
7897,NL8577,Planned,,2022-12-31,,,,,https://trialregister.nl/trial/8577,2022-12-31,0,0
7898,NL8576,Planned,,2020-07-01,,Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort (DOI: 10.1136/bmjresp-2020-000758),,,https://trialregister.nl/trial/8576,2020-07-01,0,1
7899,NL8575,Open for patient inclusion,,2020-06-30,,,,,https://trialregister.nl/trial/8575,2020-06-30,0,0
7900,NL8572,Open for patient inclusion,,2021-04-19,,we aim to publish our data in a peer reviewed journal,,,https://trialregister.nl/trial/8572,2021-04-19,0,1
7901,NL8570,Planned,,2020-12-31,,,,,https://trialregister.nl/trial/8570,2020-12-31,0,0
7902,NL8563,Open for patient inclusion,,2020-08-21,,,,,https://trialregister.nl/trial/8563,2020-08-21,0,0
7903,NL8562,"Stopped, trial finished",,2021-02-10,,https://www.sciencedirect.com/science/article/pii/S0261561420305513?via%3Dihub ,,,https://trialregister.nl/trial/8562,2021-02-10,0,1
7904,NL8551,Open for patient inclusion,,2020-07-31,,,,,https://trialregister.nl/trial/8551,2020-07-31,0,0
7905,NL8547,Open for patient inclusion,,2022-04-18,,,,,https://trialregister.nl/trial/8547,2022-04-18,0,0
7906,NL8544,Open for patient inclusion,,2020-06-01,,,,,https://trialregister.nl/trial/8544,2020-06-01,0,0
7907,NL8543,Open for patient inclusion,,2020-06-01,,,,,https://trialregister.nl/trial/8543,2020-06-01,0,0
7908,NL8538,Stopped,,2021-04-17,,,,,https://trialregister.nl/trial/8538,2021-04-17,0,0
7909,NL8536,Open for patient inclusion,,2020-07-31,,,,,https://trialregister.nl/trial/8536,2020-07-31,0,0
7910,NL8535,Open for patient inclusion,,2020-11-30,,,,,https://trialregister.nl/trial/8535,2020-11-30,0,0
7911,NL8531,Open for patient inclusion,,2021-04-04,,,,,https://trialregister.nl/trial/8531,2021-04-04,0,0
7912,NL8529,Planned,,2022-01-03,,,,,https://trialregister.nl/trial/8529,2022-01-03,0,0
7913,NL8528,Planned,,2020-08-31,,,,,https://trialregister.nl/trial/8528,2020-08-31,0,0
7914,NL8526,Stopped,,2020-06-26,,,,,https://trialregister.nl/trial/8526,2020-06-26,0,0
7915,NL8523,Planned,,2020-05-31,,,,,https://trialregister.nl/trial/8523,2020-05-31,0,0
7916,NL8522,Open for patient inclusion,,2020-09-01,,,,,https://trialregister.nl/trial/8522,2020-09-01,0,0
7917,NL8521,Planned,,2020-11-08,,,,,https://trialregister.nl/trial/8521,2020-11-08,0,0
7918,NL8520,Planned,,2022-02-01,,none,,,https://trialregister.nl/trial/8520,2022-02-01,0,1
7919,NL8513,Open for patient inclusion,,2021-04-13,,,,,https://trialregister.nl/trial/8513,2021-04-13,0,0
7920,NL8512,Open for patient inclusion,,2020-09-18,,,,,https://trialregister.nl/trial/8512,2020-09-18,0,0
7921,NL8504,"Stopped, trial finished",,2021-06-01,,,,,https://trialregister.nl/trial/8504,2021-06-01,0,0
7922,NL8501,Open for patient inclusion,,2020-06-30,,,,,https://trialregister.nl/trial/8501,2020-06-30,0,0
7923,NL8498,Open for patient inclusion,,2020-05-31,,Outcomes of this study will be published in international scientific peer-reviewed journals.,,,https://trialregister.nl/trial/8498,2020-05-31,0,1
7924,NL8497,Open for patient inclusion,,2020-06-30,,Outcomes of this study will be published in international scientific peer-reviewed journals.,,,https://trialregister.nl/trial/8497,2020-06-30,0,1
7925,NL8491,Open for patient inclusion,,2020-06-30,,,,,https://trialregister.nl/trial/8491,2020-06-30,0,0
7926,NL8490,Stopped,,2021-04-12,,,,,https://trialregister.nl/trial/8490,2021-04-12,0,0
7927,NL8485,Stopped,,2020-12-31,,,,,https://trialregister.nl/trial/8485,2020-12-31,0,0
7928,NL8483,Open for patient inclusion,,2020-03-29,,,,,https://trialregister.nl/trial/8483,2020-03-29,0,0
7929,NL8477,Planned,,2021-03-31,,,,,https://trialregister.nl/trial/8477,2021-03-31,0,0
7930,NL8473,Open for patient inclusion,,2024-12-31,,"https://pubmed.ncbi.nlm.nih.gov/33632374/
https://pubmed.ncbi.nlm.nih.gov/33624751/
https://pubmed.ncbi.nlm.nih.gov/33249407/
https://pubmed.ncbi.nlm.nih.gov/33772265/
https://pubmed.ncbi.nlm.nih.gov/34114187/",,,https://trialregister.nl/trial/8473,2024-12-31,0,1
7931,NL8460,Open for patient inclusion,,2020-08-16,,,,,https://trialregister.nl/trial/8460,2020-08-16,0,0
7932,NL8309,"Inclusion stopped, follow up",,2021-04-30,,,,,https://trialregister.nl/trial/8309,2021-04-30,0,0
7933,CTRI/2020/05/025271,Completed,,2021-07-13,,,,2021-12-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,2021-07-13,0,0
7934,CTRI/2020/04/024773,Open to Recruitment,,,,"Publication and dissemination plan_x000D_
This international collaboration is co-ordinated through the World Health Organization, which is also a sponsor of the trial. Any wholly reliable interim findings will be disseminated rapidly by the WHO. There will be group authorship recognizing the contribution of all national and local investigators and guided by the International Committee of Medical Journal Editors (ICMJE) recommendations._x000D_
_x000D_
IPD sharing statement:_x000D_
The current data sharing plans for this study are unknown and will be available at a later date.",,2022-02-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897,,0,1
7935,CTRI/2020/03/024402,Not Yet Recruiting,,,,,,2020-03-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,,0,0
7936,CTRI/2020/04/024442,Not Yet Recruiting,,,,,,2020-04-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,,0,0
7937,CTRI/2020/04/024413,Completed,,,,Published in doi.org/10.1371/journal.pone.0239646,,2021-10-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,,0,1
7938,CTRI/2020/04/024473,Open to Recruitment,,,,,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,,0,0
7939,CTRI/2020/04/024479,Not Yet Recruiting,,,,will be published in indexed medical journal,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,,0,1
7940,CTRI/2020/04/024636,Not Yet Recruiting,,,,Not Published,,2020-04-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,,0,1
7941,CTRI/2020/04/024659,Completed,,2020-05-28,,Sent for Publication.,,2020-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,2020-05-28,0,1
7942,CTRI/2020/04/024697,Not Yet Recruiting,,,,,,2020-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42835,,0,0
7943,CTRI/2020/04/024731,Not Yet Recruiting,,,,Nil,,2020-04-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,,0,1
7944,CTRI/2020/04/024729,Not Yet Recruiting,,,,,,2020-04-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,,0,0
7945,CTRI/2020/04/024772,Not Yet Recruiting,,,,,,2020-04-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43079,,0,0
7946,CTRI/2020/04/024747,Completed,,2020-05-01,,"Mouli TC, Davuluri A, Vijaya S, Priyanka AD, Mishra SK. Effectiveness of simulation based teaching of ventilatory management among non-anaesthesiology residents to manage COVID 19 pandemic - A quasi experimental cross sectional pilot study. Indian J Anaesth 2020;64:S136-40.",,2021-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,2020-05-01,0,1
7947,CTRI/2020/04/024775,Completed,,2020-08-10,,"Agarwal Anup, Mukherjee Aparna, Kumar Gunjan, Chatterjee Pranab, Bhatnagar Tarun, Malhotra Pankaj et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) BMJ 2020; 371 :m3939",,2021-02-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,2020-08-10,0,1
7948,CTRI/2020/04/024749,Closed to Recruitment of Participants,,,,,,2021-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,,0,0
7949,CTRI/2020/04/024806,Open to Recruitment,,,,,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,,0,0
7950,CTRI/2020/04/024804,Completed,,2020-10-23,,To be filled,,2021-06-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,2020-10-23,0,1
7951,CTRI/2020/04/024776,Open to Recruitment,,,,NIL,,2020-04-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,,0,1
7952,CTRI/2020/04/024784,Not Yet Recruiting,,,,NIL,,2020-06-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42939,,0,1
7953,CTRI/2020/04/024805,Not Yet Recruiting,,,,,,2020-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42979,,0,0
7954,CTRI/2020/04/024833,Not Yet Recruiting,,,,Study protocol not published. Recruitment not yet started,,2020-06-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,,0,1
7955,CTRI/2020/04/024857,Not Yet Recruiting,,,,NIL,,2020-04-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,,0,1
7956,CTRI/2020/04/024859,Not Yet Recruiting,,,,,,2020-04-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43232,,0,0
7957,CTRI/2020/04/024858,Not Yet Recruiting,,,,,,2020-04-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,,0,0
7958,CTRI/2020/04/024882,Not Yet Recruiting,,,,,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,,0,0
7959,CTRI/2020/04/024904,Not Yet Recruiting,,,,Will be published in indexed medical journal,,2020-04-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,,0,1
7960,CTRI/2020/04/024883,Completed,,2020-08-24,,,,2021-05-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,2020-08-24,0,0
7961,CTRI/2020/04/024914,Not Yet Recruiting,,,,not applicable,,2020-04-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43323,,0,1
7962,CTRI/2020/04/024915,Not Yet Recruiting,,,,,,2020-05-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,,0,0
7963,CTRI/2020/04/024948,Not Yet Recruiting,,,,,,2020-04-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,,0,0
7964,CTRI/2020/04/024949,Open to Recruitment,,,,Nil,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,,0,1
7965,CTRI/2020/04/024947,Not Yet Recruiting,,,,nil,,2020-04-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,,0,1
7966,CTRI/2020/05/024967,Completed,,,,NIL,,2021-09-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,,0,1
7967,CTRI/2020/05/024959,Completed,,2020-07-07,,None Yet,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,2020-07-07,0,1
7968,CTRI/2020/05/024969,Not Yet Recruiting,,,,,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,,0,0
7969,CTRI/2020/05/024962,Open to Recruitment,,,,,,2021-07-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,,0,0
7970,CTRI/2020/05/024981,Completed,,2020-10-15,,Not yet published,,2021-03-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,2020-10-15,0,1
7971,CTRI/2020/05/024982,Not Yet Recruiting,,,,,,2020-05-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43432,,0,0
7972,CTRI/2020/05/024983,Not Yet Recruiting,,,,,,2020-05-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,,0,0
7973,CTRI/2020/05/024984,Completed,,2020-05-09,,Not applicable,,2020-06-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43425,2020-05-09,0,1
7974,CTRI/2020/05/025010,Not Yet Recruiting,,,,,,2020-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43269,,0,0
7975,CTRI/2020/05/024989,Not Yet Recruiting,,,,NIL,,2020-05-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43377,,0,1
7976,CTRI/2020/05/024986,Completed,,,,None yet.,,2021-08-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,,0,1
7977,CTRI/2020/05/025013,Not Yet Recruiting,,,,none,,2020-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,,0,1
7978,CTRI/2020/05/025022,Suspended,,,,,,2021-12-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,,0,0
7979,CTRI/2020/05/025067,Closed to Recruitment of Participants,,,,NIL,,2021-05-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,,0,1
7980,CTRI/2020/05/025041,Not Yet Recruiting,,,,,,2020-05-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43277,,0,0
7981,CTRI/2020/05/025049,Not Yet Recruiting,,,,NIL,,2020-05-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,,0,1
7982,CTRI/2020/05/025069,Not Yet Recruiting,,,,NIL,,2020-10-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,,0,1
7983,CTRI/2020/05/025070,Not Yet Recruiting,,,,,,2020-05-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43343,,0,0
7984,CTRI/2020/05/025068,Not Yet Recruiting,,,,We will plan to publish the results of this study in reputed National and International Journals.,,2020-05-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,,0,1
7985,CTRI/2020/05/025071,Not Yet Recruiting,,,,NIL,,2020-05-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,,0,1
7986,CTRI/2020/05/025088,Not Yet Recruiting,,,,nil,,2020-05-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,,0,1
7987,CTRI/2020/05/025089,Completed,,2020-09-15,,NIL,,2022-03-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43506,2020-09-15,0,1
7988,CTRI/2020/05/025093,Not Yet Recruiting,,,,nil,,2020-05-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,,0,1
7989,CTRI/2020/05/025092,Not Yet Recruiting,,,,The results of this study will be published in the reputed National and International Journals.,,2020-05-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43608,,0,1
7990,CTRI/2020/05/025091,Completed,,2020-08-01,,NIL,,2020-09-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43622,2020-08-01,0,1
7991,CTRI/2020/05/025114,Completed,,2020-06-15,,NIL,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,2020-06-15,0,1
7992,CTRI/2020/05/025156,Completed,,2020-11-01,,The trial results is under publication process,,2021-07-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,2020-11-01,0,1
7993,CTRI/2020/05/025162,Other (Terminated),,,,,,2021-06-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,,0,0
7994,CTRI/2020/05/025161,Completed,,2020-06-15,,Publication is under process,,2020-10-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,2020-06-15,0,1
7995,CTRI/2020/05/025166,Not Yet Recruiting,,,,nil,,2020-05-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,,0,1
7996,CTRI/2020/05/025178,Not Yet Recruiting,,,,nil,,2020-05-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,,0,1
7997,CTRI/2020/05/025167,Open to Recruitment,,,,None yet,,2020-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,,0,1
7998,CTRI/2020/05/025171,Not Yet Recruiting,,,,under process,,2022-02-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,,0,1
7999,CTRI/2020/06/026228,Open to Recruitment,,,,Not yet,,2020-08-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,,0,1
8000,CTRI/2020/08/027109,Open to Recruitment,,,,"As the sponsor, Staidson (Beijing) Biopharmaceutical Co., Ltd. has the exclusive right to this research. The author and the manuscript will reflect many researchers and research centers, Staidson (Beijing) Biopharmaceutical Co., Ltd., Beijing Defengrui Cooperation between employees of Biotechnology Co., Ltd. The author should be determined before writing the manuscript. Because there are multiple research centers participating in this study, unless it is obtained by Staidson (Beijing) Biopharmaceutical Co., Ltd. and Beijing Defengrui Biotechnology Co., Ltd. The company agrees that individuals will not be allowed to publish articles before the final report of the multi-center research is completed. Staidson (Beijing) Biopharmaceutical Co., Ltd. has the final decision on the manuscript and publication",,2021-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44387,,0,1
8001,CTRI/2020/06/026194,Other (Terminated),,,,,,2021-02-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44341,,0,0
8002,CTRI/2020/04/024846,Completed,,2020-02-03,,,,2021-12-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,2020-02-03,0,0
8003,CTRI/2020/04/024706,Completed,,2020-05-30,,None Yet,,2020-06-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43039,2020-05-30,0,1
8004,CTRI/2020/08/027077,Closed to Recruitment of Participants,,,,NIL,,2021-02-16,,,0,1
8005,CTRI/2015/03/005657,Completed,,,,Nil,,2015-11-16,,,0,1
8006,CTRI/2017/02/007820,Completed,,,,None yet.,,2017-02-09,,,0,1
8007,CTRI/2020/04/024482,Completed,,2020-10-08,,,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42777,2020-10-08,0,0
8008,CTRI/2020/05/024985,Completed,,2020-05-30,,Not Applicable,,2020-12-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43462,2020-05-30,0,1
8009,CTRI/2020/05/025163,Closed to Recruitment of Participants,,,,"Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol_x000D_
. 2021 Nov;22(11):1507-1517.  doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5.",,2021-11-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43610,,0,1
8010,CTRI/2020/05/025160,Completed,,2020-09-01,,"1. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. _x000D_
J Clin Oncol. 2021 Jan 1;39(1):66-78.  doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6.",,2021-09-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43628,2020-09-01,0,1
8011,CTRI/2020/05/025184,Not Yet Recruiting,,,,Nil,,2020-05-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43600,,0,1
8012,CTRI/2020/05/025194,Not Yet Recruiting,,,,NIL,,2020-05-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43664,,0,1
8013,CTRI/2020/05/025182,Not Yet Recruiting,,,,nil,,2020-05-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43680,,0,1
8014,CTRI/2020/05/025213,Not Yet Recruiting,,,,"Outcomes of the study will be published in the reputed journal of the council, Journal of Research in Ayurvedic Sciences JRAS",,2020-05-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698,,0,1
8015,CTRI/2020/05/025205,Not Yet Recruiting,,,,None yet.,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721,,0,1
8016,CTRI/2020/05/025214,Completed,,2020-08-19,,under publication,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727,2020-08-19,0,1
8017,CTRI/2020/05/025183,Completed,,2020-09-30,,,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43241,2020-09-30,0,0
8018,CTRI/2020/05/025212,Not Yet Recruiting,,,,NIL till date but as the data is collected the resuLts will be published.,,2020-06-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43757,,0,1
8019,CTRI/2020/05/025209,Completed,,2020-10-15,,,,2021-02-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251,2020-10-15,0,0
8020,CTRI/2020/05/025216,Completed,,2021-01-18,,Nil,,2021-10-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43755,2021-01-18,0,1
8021,CTRI/2020/05/025215,Completed,,2020-06-15,,NIL,,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,2020-06-15,0,1
8022,CTRI/2020/05/025217,Open to Recruitment,,,,As per Publication policy,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43015,,0,1
8023,CTRI/2020/05/025220,Not Yet Recruiting,,,,NIL,,2020-05-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43619,,0,1
8024,CTRI/2020/05/025219,Not Yet Recruiting,,,,Nil,,2020-10-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43750,,0,1
8025,CTRI/2020/05/025221,Not Yet Recruiting,,,,Nil,,2020-11-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43753,,0,1
8026,CTRI/2020/05/025218,Not Yet Recruiting,,,,Nil,,2020-05-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43772,,0,1
8027,CTRI/2020/05/025222,Other (Terminated),,,,NIL,,2021-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803,,0,1
8028,CTRI/2020/05/025224,Not Yet Recruiting,,,,Results will be published in relevant open access peer-reviewed scientific journals.,,2020-05-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728,,0,1
8029,CTRI/2020/05/025242,Completed,,2021-04-09,,"After data analysis , study will publish.",,2021-09-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057,2021-04-09,0,1
8030,CTRI/2020/05/025243,Not Yet Recruiting,,,,Nil,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43615,,0,1
8031,CTRI/2020/05/025238,Not Yet Recruiting,,,,Will be published after completion of study,,2020-05-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43623,,0,1
8032,CTRI/2020/05/025272,Not Yet Recruiting,,,,This study will be published in an indexed journal,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790,,0,1
8033,CTRI/2020/05/025254,Completed,,2020-08-14,,NIL,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630,2020-08-14,0,1
8034,CTRI/2020/05/025276,Completed,,2020-06-17,,Nil,,2020-06-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892,2020-06-17,0,1
8035,CTRI/2020/05/025273,Completed,,2020-06-14,,Phytomedicine Volume 84 April 2021 153494,,2021-03-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900,2020-06-14,0,1
8036,CTRI/2020/05/025275,Completed,,2020-09-21,,NIL,,2020-10-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917,2020-09-21,0,1
8037,CTRI/2020/05/025274,Completed,,,,,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43921,,0,0
8038,CTRI/2020/05/025271,Completed,,2021-07-13,,,,2021-12-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,2021-07-13,0,0
8039,CTRI/2020/05/025248,Completed,,,,nil,,2022-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479,,0,1
8040,CTRI/2020/05/025247,Not Yet Recruiting,,,,NIL,,2020-05-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43762,,0,1
8041,CTRI/2020/05/025293,Completed,,,,NIL,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43824,,0,1
8042,CTRI/2020/05/025289,Not Yet Recruiting,,,,Nil,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43612,,0,1
8043,CTRI/2020/05/025291,Not Yet Recruiting,,,,NIL,,2020-07-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43654,,0,1
8044,CTRI/2020/05/025297,Not Yet Recruiting,,,,Nil,,2020-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43911,,0,1
8045,CTRI/2020/05/025290,Completed,,2020-06-22,,NIL,,2021-11-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43671,2020-06-22,0,1
8046,CTRI/2020/05/025277,Open to Recruitment,,,,,,2021-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176,,0,0
8047,CTRI/2020/05/025299,Completed,,2020-08-28,,NIL,,2020-12-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,2020-08-28,0,1
8048,CTRI/2020/05/025298,Not Yet Recruiting,,,,NIL,,2020-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761,,0,1
8049,CTRI/2020/05/025320,Open to Recruitment,,,,Nil,,2020-05-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576,,0,1
8050,CTRI/2020/05/025317,Completed,,2020-07-09,,The study results will be published in an appropriate journal,,2020-07-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754,2020-07-09,0,1
8051,CTRI/2020/05/025319,Open to Recruitment,,,,,,2020-06-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751,,0,0
8052,CTRI/2020/05/025331,Not Yet Recruiting,,,,,,2020-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339,,0,0
8053,CTRI/2020/05/025327,Not Yet Recruiting,,,,"https://doi.org/10.1016/S1473-3099(20)30198-5_x000D_
_x000D_
https://doi.org/10.1016/S1470-2045(20)30149-2",,2020-05-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43914,,0,1
8054,CTRI/2020/05/025326,Completed,,2020-09-17,,,,2021-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951,2020-09-17,0,0
8055,CTRI/2020/05/025328,Completed,,,,Nil,,2020-11-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703,,0,1
8056,CTRI/2020/05/025338,Completed,,2020-09-01,,Under Process,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033,2020-09-01,0,1
8057,CTRI/2020/05/025342,Completed,,2020-07-14,,NIL,,2020-07-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44039,2020-07-14,0,1
8058,CTRI/2020/05/025336,Not Yet Recruiting,,,,NIL,,2020-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934,,0,1
8059,CTRI/2020/05/025334,Not Yet Recruiting,,,,Nil,,2020-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935,,0,1
8060,CTRI/2020/05/025337,Not Yet Recruiting,,,,NIL,,2020-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940,,0,1
8061,CTRI/2020/05/025335,Completed,,2020-08-11,,Under process.,,2020-10-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949,2020-08-11,0,1
8062,CTRI/2020/05/025339,Not Yet Recruiting,,,,nil,,2020-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43959,,0,1
8063,CTRI/2020/05/025341,Open to Recruitment,,,,no,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013,,0,1
8064,CTRI/2020/05/025343,Not Yet Recruiting,,,,Nil,,2020-05-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919,,0,1
8065,CTRI/2020/05/025345,Open to Recruitment,,,,NONE YET,,2020-08-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43948,,0,1
8066,CTRI/2020/05/025347,Not Yet Recruiting,,,,NIL,,2020-05-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43958,,0,1
8067,CTRI/2020/05/025348,Not Yet Recruiting,,,,NIL,,2020-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43979,,0,1
8068,CTRI/2020/05/025344,Completed,,2020-11-04,,none,,2021-03-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44024,2020-11-04,0,1
8069,CTRI/2020/05/025346,Not Yet Recruiting,,,,not yet.,,2020-05-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005,,0,1
8070,CTRI/2020/05/025350,Not Yet Recruiting,,,,Results will be published in relevant open access peer-reviewed scientific journals.,,2020-05-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559,,0,1
8071,CTRI/2020/05/025370,Not Yet Recruiting,,,,NIL,,2020-05-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064,,0,1
8072,CTRI/2020/05/025385,Completed,,2020-08-17,,Nil,,2020-12-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953,2020-08-17,0,1
8073,CTRI/2020/05/025369,Completed,,2020-10-12,,NIL,,2020-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485,2020-10-12,0,1
8074,CTRI/2020/05/025371,Not Yet Recruiting,,,,NIL,,2020-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44023,,0,1
8075,CTRI/2020/05/025425,Completed,,2020-08-18,,Under Process,,2020-10-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043,2020-08-18,0,1
8076,CTRI/2020/05/025424,Not Yet Recruiting,,,,Nil,,2020-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44074,,0,1
8077,CTRI/2020/05/025398,Open to Recruitment,,,,NIL,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831,,0,1
8078,CTRI/2020/05/025397,Completed,,2020-08-19,,NIL,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702,2020-08-19,0,1
8079,CTRI/2020/05/025423,Open to Recruitment,,,,NIL,,2021-05-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43519,,0,1
8080,CTRI/2020/05/025429,Open to Recruitment,,,,"6.	Acharya YT, editor. Charaka Samhita (Ch. Chi. 3/). Varanasi: Chowkhamba Surbharati; 2000_x000D_
7.	Peruski, A. H., & Peruski, L. F., Jr (2003). Immunological methods for detection and identification of infectious disease and biological warfare agents. Clinical and diagnostic laboratory immunology, 10(4), 506‚Äì513. https://doi.org/10.1128/cdli.10.4.506-513.2003_x000D_
8.	KamWa Chan, Vivian Taam Wong, and Sydney Chi Wai Tang, COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese‚ÄìWestern Medicine for the Management of 2019 Novel Coronavirus Disease, The American Journal of Chinese Medicine, Vol. 48, No. 3, 1‚Äì26 , Published 13 March 2020, DOI: 10.1142/S0192415X20500378",,2020-07-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058,,0,1
8081,CTRI/2020/05/025430,Not Yet Recruiting,,,,Nil,,2020-05-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44060,,0,1
8082,CTRI/2020/05/025431,Not Yet Recruiting,,,,Results shall be published in peer reviewed journal,,2022-03-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44128,,0,1
8083,CTRI/2020/05/025428,Completed,,2020-08-31,,Nil,,2022-02-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43890,2020-08-31,0,1
8084,CTRI/2020/05/025427,Not Yet Recruiting,,,,"We have not commenced the study yet. Once finished, we intent to publish in the Indian Journal of Critical Care Medicine",,2020-05-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43933,,0,1
8085,CTRI/2020/05/025434,Open to Recruitment,,,,No publications done so far,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957,,0,1
8086,CTRI/2020/05/025466,Completed,,2020-10-19,,NIL.,,2020-10-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43209,2020-10-19,0,1
8087,CTRI/2020/05/025433,Completed,,2020-12-31,,Nil,,2021-07-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43743,2020-12-31,0,1
8088,CTRI/2020/05/025483,Completed,,2020-06-30,,Under publication process,,2020-07-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041,2020-06-30,0,1
8089,CTRI/2020/05/025485,Open to Recruitment,,,,NIL,,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052,,0,1
8090,CTRI/2020/05/025484,Open to Recruitment,,,,NIL,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055,,0,1
8091,CTRI/2020/05/025486,Not Yet Recruiting,,,,to be published,,2020-05-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44071,,0,1
8092,CTRI/2020/05/025487,Closed to Recruitment of Participants,,,,Still there is no any publication from this work. It is a new study.,,2020-09-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43586,,0,1
8093,CTRI/2020/05/025490,Open to Recruitment,,,,NIL,,2020-06-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042,,0,1
8094,CTRI/2020/05/025488,Not Yet Recruiting,,,,NOT YET DONE,,2020-05-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062,,0,1
8095,CTRI/2020/05/025491,Completed,,2020-07-27,,Under review process.,,2021-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065,2020-07-27,0,1
8096,CTRI/2020/05/025489,Completed,,,,,,2021-06-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376,,0,0
8097,CTRI/2020/05/025492,Not Yet Recruiting,,,,NIL,,2020-05-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382,,0,1
8098,CTRI/2020/05/025493,Not Yet Recruiting,,,,NIL,,2020-05-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44177,,0,1
8099,CTRI/2020/05/025494,Not Yet Recruiting,,,,NIL,,2020-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44179,,0,1
8100,CTRI/2020/05/025496,Completed,,2020-08-16,,Under review.,,2021-07-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192,2020-08-16,0,1
8101,CTRI/2020/05/025495,Not Yet Recruiting,,,,NIL,,2020-05-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44209,,0,1
8102,CTRI/2020/05/025497,Not Yet Recruiting,,,,NIL,,2020-05-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44257,,0,1
8103,CTRI/2020/06/025523,Completed,,2020-08-21,,,,2020-08-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396,2020-08-21,0,0
8104,CTRI/2020/06/025526,Not Yet Recruiting,,,,Nil,,2020-06-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44182,,0,1
8105,CTRI/2020/06/025522,Completed,,,,NIL,,2020-08-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438,,0,1
8106,CTRI/2020/06/025527,Completed,,,,NIL,,2021-02-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968,,0,1
8107,CTRI/2020/06/025557,Closed to Recruitment of Participants,,,,NIL,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812,,0,1
8108,CTRI/2020/06/025530,Completed,,2020-10-28,,To be published in the Annual Report of Cancer Aid Society,,2020-11-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305,2020-10-28,0,1
8109,CTRI/2020/06/025556,Completed,,2020-08-21,,Nil,,2021-01-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144,2020-08-21,0,1
8110,CTRI/2020/06/025558,Not Yet Recruiting,,,,Publication of Results in a Peer-reviewed scientific journal or presentation at a scientific Congress.,,2020-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411,,0,1
8111,CTRI/2020/06/025560,Not Yet Recruiting,,,,NIL,,2020-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43710,,0,1
8112,CTRI/2020/06/025529,Completed,,,,NIL,,2020-11-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44243,,0,1
8113,CTRI/2020/06/025575,Open to Recruitment,,,,Nil,,2020-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076,,0,1
8114,CTRI/2020/06/025588,Not Yet Recruiting,,,,NIL,,2020-06-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43851,,0,1
8115,CTRI/2020/06/025590,Completed,,2020-09-28,,Nil,,2020-10-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121,2020-09-28,0,1
8116,CTRI/2020/06/025589,Completed,,2021-01-12,,nil,,2022-01-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164,2021-01-12,0,1
8117,CTRI/2020/06/025561,Open to Recruitment,,,,nil,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44244,,0,1
8118,CTRI/2020/06/025613,Not Yet Recruiting,,,,Nil,,2021-10-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,,0,1
8119,CTRI/2020/06/025593,Not Yet Recruiting,,,,Nil,,2020-06-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44173,,0,1
8120,CTRI/2020/06/025637,Not Yet Recruiting,,,,NIL,,2020-06-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550,,0,1
8121,CTRI/2020/06/025625,Open to Recruitment,,,,,,2020-06-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345,,0,0
8122,CTRI/2020/06/025664,Completed,,2020-09-17,,NIL,,2021-05-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369,2020-09-17,0,1
8123,CTRI/2020/06/025634,Not Yet Recruiting,,,,Nil,,2020-06-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43893,,0,1
8124,CTRI/2020/06/025650,Completed,,,,"The recorded data, after analysis, may be published by sponsor or with the investigators consent in peer reviewed scientific journals without revealing the identity of any subject.",,2021-04-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412,,0,1
8125,CTRI/2020/06/025673,Completed,,2020-10-15,,nil,,2021-02-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44398,2020-10-15,0,1
8126,CTRI/2020/06/025672,Not Yet Recruiting,,,,"The recorded data, after analysis, may be published by sponsor or with the investigators consent in peer reviewed scientific journals without revealing the identity of any subject.",,2020-06-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415,,0,1
8127,CTRI/2020/06/025671,Not Yet Recruiting,,,,NIL,,2020-06-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425,,0,1
8128,CTRI/2020/06/025675,Not Yet Recruiting,,,,NIL,,2020-06-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44427,,0,1
8129,CTRI/2020/06/025674,Not Yet Recruiting,,,,NIL,,2020-06-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44431,,0,1
8130,CTRI/2020/06/025703,Not Yet Recruiting,,,,NIL,,2020-06-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44358,,0,1
8131,CTRI/2020/06/025702,Completed,,,,NIL,,2020-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376,,0,1
8132,CTRI/2020/06/025704,Completed,,2020-11-07,,NIL.,,2021-02-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170,2020-11-07,0,1
8133,CTRI/2020/06/025714,Not Yet Recruiting,,,,Not Applicable,,2020-05-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020,,0,1
8134,CTRI/2020/06/025763,Completed,,,,Nil,,2020-10-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340,,0,1
8135,CTRI/2020/06/025764,Not Yet Recruiting,,,,Paper will be published at the end of study after analysis of results,,2020-06-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44405,,0,1
8136,CTRI/2020/06/025766,Not Yet Recruiting,,,,"https://pubmed.ncbi.nlm.nih.gov/29732571/_x000D_
https://pubmed.ncbi.nlm.nih.gov/31930543/",,2020-06-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171,,0,1
8137,CTRI/2020/06/025760,Not Yet Recruiting,,,,Nil at present,,2020-06-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441,,0,1
8138,CTRI/2020/06/025768,Completed,,2020-12-11,,NIL,,2021-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445,2020-12-11,0,1
8139,CTRI/2020/06/025761,Suspended,,,,Not yet,,2021-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44258,,0,1
8140,CTRI/2020/06/025762,Suspended,,,,Not yet,,2021-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259,,0,1
8141,CTRI/2020/06/025769,Completed,,,,Not yet,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260,,0,1
8142,CTRI/2020/06/025801,Completed,,2020-08-25,,Nil,,2020-10-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293,2020-08-25,0,1
8143,CTRI/2020/06/025796,Not Yet Recruiting,,,,None yet,,2020-06-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181,,0,1
8144,CTRI/2020/06/025798,Not Yet Recruiting,,,,NIL,,2020-06-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460,,0,1
8145,CTRI/2020/06/025779,Not Yet Recruiting,,,,nil,,2020-06-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463,,0,1
8146,CTRI/2020/06/025802,Not Yet Recruiting,,,,NIL,,2020-06-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44476,,0,1
8147,CTRI/2020/06/025799,Suspended,,,,NIL,,2021-10-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480,,0,1
8148,CTRI/2020/06/025800,Closed to Recruitment of Participants,,2020-06-30,,The outcome of the Study will be published in International peer reviewed Journal.,,2020-07-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485,2020-06-30,0,1
8149,CTRI/2020/06/025797,Completed,,,,Nil,,2020-08-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43759,,0,1
8150,CTRI/2020/06/025804,Not Yet Recruiting,,,,NIL,,2020-06-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572,,0,1
8151,CTRI/2020/06/025803,Completed,,2020-12-15,,None Yet,,2021-06-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478,2020-12-15,0,1
8152,CTRI/2020/06/025848,Not Yet Recruiting,,,,NIL,,2020-06-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44593,,0,1
8153,CTRI/2020/06/025849,Completed,,2020-10-10,,NIL,,2021-06-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408,2020-10-10,0,1
8154,CTRI/2020/06/025852,Not Yet Recruiting,,,,none,,2020-06-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,,0,1
8155,CTRI/2020/06/025853,Not Yet Recruiting,,,,NIL,,2020-06-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44466,,0,1
8156,CTRI/2020/06/025850,Completed,,2020-08-31,,"Data analysis underway for following planned publications:_x000D_
_x000D_
‚Ä¢ Change in tobacco use behaviours (frequency, product substitution) of adult tobacco users during COVID-19 in India. _x000D_
_x000D_
‚Ä¢ COVID-19 and tobacco cessation, knowledge and tobacco control policies in India._x000D_
_x000D_
‚Ä¢ Knowledge of Covid-19, comorbidities and access to healthcare services among adult tobacco users in India._x000D_
_x000D_
‚Ä¢ Anxiety and depression among adult tobacco users during Covid-19 in India.",,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44518,2020-08-31,0,1
8157,CTRI/2020/06/025844,Completed,,2020-10-31,,None yet.,,2021-06-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760,2020-10-31,0,1
8158,CTRI/2020/06/025854,Closed to Recruitment of Participants,,,,Nil,,2021-09-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,,0,1
8159,CTRI/2020/06/025856,Not Yet Recruiting,,,,Nil,,2020-06-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606,,0,1
8160,CTRI/2020/06/025855,Completed,,2020-08-13,,not yet,,2020-09-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386,2020-08-13,0,1
8161,CTRI/2020/06/025858,Open to Recruitment,,,,None Yet,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44652,,0,1
8162,CTRI/2020/06/025857,Open to Recruitment,,,,NIL,,2020-11-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44663,,0,1
8163,CTRI/2020/06/025861,Open to Recruitment,,,,NIL,,2020-07-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072,,0,1
8164,CTRI/2020/06/025862,Open to Recruitment,,,,NIL,,2020-06-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,,0,1
8165,CTRI/2020/06/025874,Not Yet Recruiting,,,,NIL,,2020-06-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,,0,1
8166,CTRI/2020/06/025927,Not Yet Recruiting,,,,Nill,,2020-06-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316,,0,1
8167,CTRI/2020/06/025928,Closed to Recruitment of Participants,,,,NIL,,2021-05-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664,,0,1
8168,CTRI/2020/06/025917,Not Yet Recruiting,,,,None so far,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505,,0,1
8169,CTRI/2020/06/025957,Completed,,2020-08-27,,NIL,,2021-05-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709,2020-08-27,0,1
8170,CTRI/2020/06/025977,Completed,,2020-11-28,,No any publication planned yet.,,2021-07-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449,2020-11-28,0,1
8171,CTRI/2020/06/025996,Closed to Recruitment of Participants,,,,Not yet,,2020-09-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622,,0,1
8172,CTRI/2020/06/025998,Not Yet Recruiting,,,,"1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Role of Raj Nirvan Bati in treatment of COVID19 RT-PCR positive cases. IJSRM June 2020; Accepted for publication_x000D_
2. 1. Raj kumar, Ramakant Yadav, Ramakant Rawat, Prashant Kumar Bajpai, Indra Kumar Sharma, Sushil Kumar, Prashant Yadav. Raj Nirvan Bati (A novel ayurvedic preparation) in RT PCR positive COVID19 cases: An interventional study. IJMSCR June 2020;3(3)",,2020-06-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707,,0,1
8173,CTRI/2020/06/026000,Open to Recruitment,,,,In Indian or International Journals,,2020-10-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44567,,0,1
8174,CTRI/2020/06/026001,Completed,,,,Nil,,2021-04-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,,0,1
8175,CTRI/2020/06/025999,Not Yet Recruiting,,,,NIL,,2020-06-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764,,0,1
8176,CTRI/2020/06/026005,Not Yet Recruiting,,,,Nil,,2020-06-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44520,,0,1
8177,CTRI/2020/06/026002,Not Yet Recruiting,,,,NIL,,2020-06-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799,,0,1
8178,CTRI/2020/06/026039,Not Yet Recruiting,,,,NIL,,2020-06-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43815,,0,1
8179,CTRI/2020/06/026044,Not Yet Recruiting,,,,Nil,,2020-06-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44919,,0,1
8180,CTRI/2020/06/026045,Not Yet Recruiting,,,,"The manuscript of the trial will be prepared_x000D_
_x000D_
Research publication will be done in indexed peer reviewed journal",,2020-06-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677,,0,1
8181,CTRI/2020/06/026055,Not Yet Recruiting,,,,not yet,,2020-06-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306,,0,1
8182,CTRI/2020/06/026056,Not Yet Recruiting,,,,NIL,,2020-06-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130,,0,1
8183,CTRI/2020/06/026047,Completed,,,,NIL,,2021-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44913,,0,1
8184,CTRI/2020/06/026087,Completed,,2020-09-04,,NIL,,2020-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775,2020-09-04,0,1
8185,CTRI/2020/06/026118,Not Yet Recruiting,,,,study not yet started. After doing the study it will be published in Journal having good Impact factor.,,2020-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44829,,0,1
8186,CTRI/2020/06/026123,Not Yet Recruiting,,,,NIL,,2020-10-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,,0,1
8187,CTRI/2020/06/026120,Not Yet Recruiting,,,,Not published,,2020-06-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44931,,0,1
8188,CTRI/2020/06/026119,Not Yet Recruiting,,,,Not Yet,,2020-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218,,0,1
8189,CTRI/2020/06/026121,Open to Recruitment,,,,NIL,,2020-06-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45006,,0,1
8190,CTRI/2020/06/026147,Not Yet Recruiting,,,,NILL,,2020-06-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778,,0,1
8191,CTRI/2020/06/026151,Not Yet Recruiting,,,,not yet published,,2020-06-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770,,0,1
8192,CTRI/2020/06/026161,Closed to Recruitment of Participants,,,,nil,,2021-02-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832,,0,1
8193,CTRI/2020/06/026152,Completed,,,,In Indian or International Journals,,2020-12-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43879,,0,1
8194,CTRI/2020/06/026181,Completed,,2021-01-21,,NIL,,2021-09-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976,2021-01-21,0,1
8195,CTRI/2020/06/026190,Not Yet Recruiting,,,,NIL,,2020-06-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005,,0,1
8196,CTRI/2020/06/026188,Not Yet Recruiting,,,,NIL,,2020-06-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45024,,0,1
8197,CTRI/2020/06/026187,Not Yet Recruiting,,,,Nil,,2020-06-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027,,0,1
8198,CTRI/2020/06/026189,Not Yet Recruiting,,,,NIL,,2020-06-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,,0,1
8199,CTRI/2020/06/026184,Not Yet Recruiting,,,,NIL,,2020-06-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45031,,0,1
8200,CTRI/2020/06/026191,Not Yet Recruiting,,,,NIL,,2020-06-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,,0,1
8201,CTRI/2020/06/026192,Completed,,2020-09-30,,NIL,,2020-12-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815,2020-09-30,0,1
8202,CTRI/2020/06/026195,Completed,,,,None yet.,,2021-11-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129,,0,1
8203,CTRI/2020/06/026198,Not Yet Recruiting,,,,not yet,,2020-06-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43651,,0,1
8204,CTRI/2020/06/026196,Other (Terminated),,,,No Publications yet,,2021-09-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482,,0,1
8205,CTRI/2020/06/026193,Open to Recruitment,,,,NIL,,2020-06-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766,,0,1
8206,CTRI/2020/06/026197,Not Yet Recruiting,,,,Nil,,2020-06-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052,,0,1
8207,CTRI/2020/06/026228,Open to Recruitment,,,,Not yet,,2020-08-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,,0,1
8208,CTRI/2020/06/026222,Completed,,2020-09-12,,NIL,,2020-10-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299,2020-09-12,0,1
8209,CTRI/2020/06/026227,Completed,,2020-07-27,,Not yet,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584,2020-07-27,0,1
8210,CTRI/2020/06/026229,Open to Recruitment,,,,nil,,2020-11-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105,,0,1
8211,CTRI/2020/06/026220,Completed,,2020-09-05,,NIL,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350,2020-09-05,0,1
8212,CTRI/2020/06/026232,Not Yet Recruiting,,,,NIL,,2020-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,,0,1
8213,CTRI/2020/06/026231,Not Yet Recruiting,,,,NIL,,2020-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497,,0,1
8214,CTRI/2020/06/026221,Completed,,2020-08-10,,NIL,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542,2020-08-10,0,1
8215,CTRI/2020/06/026250,Not Yet Recruiting,,,,NIL,,2020-06-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45057,,0,1
8216,CTRI/2020/06/026256,Not Yet Recruiting,,,,NIL,,2020-06-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45115,,0,1
8217,CTRI/2020/06/026262,Completed,,2020-10-29,,NIL,,2020-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889,2020-10-29,0,1
8218,CTRI/2020/07/026301,Not Yet Recruiting,,,,Nil,,2020-07-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651,,0,1
8219,CTRI/2020/07/026299,Open to Recruitment,,,,NIL,,2020-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45163,,0,1
8220,CTRI/2020/07/026298,Not Yet Recruiting,,,,None,,2020-07-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43722,,0,1
8221,CTRI/2020/07/026337,Completed,,2020-08-31,,Nil,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863,2020-08-31,0,1
8222,CTRI/2020/07/026338,Not Yet Recruiting,,,,NIL,,2020-07-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181,,0,1
8223,CTRI/2020/07/026340,Not Yet Recruiting,,,,None yet,,2020-07-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929,,0,1
8224,CTRI/2020/07/026339,Open to Recruitment,,,,nil,,2020-12-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44951,,0,1
8225,CTRI/2020/07/026330,Not Yet Recruiting,,,,NIL,,2020-07-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45213,,0,1
8226,CTRI/2020/07/026331,Closed to Recruitment of Participants,,,,NIL,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45017,,0,1
8227,CTRI/2020/07/026351,Not Yet Recruiting,,,,NIL.,,2020-07-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45151,,0,1
8228,CTRI/2020/07/026343,Completed,,2021-12-23,,NIL,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204,2021-12-23,0,1
8229,CTRI/2020/07/026349,Open to Recruitment,,,,Not yet,,2020-07-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918,,0,1
8230,CTRI/2020/07/026350,Not Yet Recruiting,,,,nil,,2020-07-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44198,,0,1
8231,CTRI/2020/07/026355,Not Yet Recruiting,,,,Nil,,2020-07-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327,,0,1
8232,CTRI/2020/07/026354,Completed,,2020-09-04,,Nil,,2020-09-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173,2020-09-04,0,1
8233,CTRI/2020/07/026353,Completed,,2020-07-31,,Not yet done,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266,2020-07-31,0,1
8234,CTRI/2020/07/026352,Closed to Recruitment of Participants,,,,NIL,,2020-11-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306,,0,1
8235,CTRI/2020/07/026367,Open to Recruitment,,,,All data will be reported as a whole cohort. Unit level data for comparison will be fed back to collaborators to support local service improvement. This project will be submitted for presentation at national and international conferences. Manuscript(s) will be prepared following close of the project.,,2020-07-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45324,,0,1
8236,CTRI/2020/07/026369,Not Yet Recruiting,,,,No publications are available presently,,2020-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44880,,0,1
8237,CTRI/2020/07/026370,Not Yet Recruiting,,,,No publications are available presently,,2020-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45185,,0,1
8238,CTRI/2020/07/026368,Not Yet Recruiting,,,,Nil,,2020-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45232,,0,1
8239,CTRI/2020/07/026371,Completed,,,,NIL,,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272,,0,1
8240,CTRI/2020/07/026389,Completed,,2020-11-30,,NIL,,2022-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44395,2020-11-30,0,1
8241,CTRI/2020/07/026424,Not Yet Recruiting,,,,not yet published,,2020-07-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45337,,0,1
8242,CTRI/2020/07/026431,Not Yet Recruiting,,,,NIL,,2020-07-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340,,0,1
8243,CTRI/2020/07/026433,Completed,,2020-10-09,,NIL,,2021-01-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,2020-10-09,0,1
8244,CTRI/2020/07/026463,Open to Recruitment,,,,NIL,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844,,0,1
8245,CTRI/2020/07/026462,Completed,,2020-09-12,,Not yet,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637,2020-09-12,0,1
8246,CTRI/2020/07/026445,Completed,,2020-10-31,,Nil,,2021-12-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45445,2020-10-31,0,1
8247,CTRI/2020/07/026451,Not Yet Recruiting,,,,Nil,,2020-07-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44483,,0,1
8248,CTRI/2020/07/026471,Not Yet Recruiting,,,,Nil,,2020-08-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318,,0,1
8249,CTRI/2020/07/026469,Completed,,2020-07-18,,NIL,,2020-10-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336,2020-07-18,0,1
8250,CTRI/2020/07/026468,Closed to Recruitment of Participants,,,,Nil,,2021-07-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844,,0,1
8251,CTRI/2020/07/026470,Not Yet Recruiting,,,,NIL,,2020-07-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363,,0,1
8252,CTRI/2020/07/026472,Not Yet Recruiting,,,,The study results will be published in scientific journals,,2020-07-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45392,,0,1
8253,CTRI/2020/07/026499,Not Yet Recruiting,,,,Nil,,2020-07-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45406,,0,1
8254,CTRI/2020/07/026473,Completed,,2020-09-06,,Nil,,2021-12-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45448,2020-09-06,0,1
8255,CTRI/2020/07/026474,Not Yet Recruiting,,,,Nil,,2020-07-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45474,,0,1
8256,CTRI/2020/07/026510,Not Yet Recruiting,,,,NIL,,2020-07-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45415,,0,1
8257,CTRI/2020/07/026509,Not Yet Recruiting,,,,Nil,,2020-07-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45476,,0,1
8258,CTRI/2020/07/026508,Not Yet Recruiting,,,,We will publish the study as our own or as a part of larger pan India study,,2020-07-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44266,,0,1
8259,CTRI/2020/07/026514,Not Yet Recruiting,,,,NIL,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580,,0,1
8260,CTRI/2020/07/026515,Not Yet Recruiting,,,,NIL,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584,,0,1
8261,CTRI/2020/07/026532,Not Yet Recruiting,,,,Nil,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354,,0,1
8262,CTRI/2020/07/026534,Not Yet Recruiting,,,,NIL.,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137,,0,1
8263,CTRI/2020/07/026533,Not Yet Recruiting,,,,None,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45172,,0,1
8264,CTRI/2020/07/026529,Not Yet Recruiting,,,,Will be published in Pubmed indexed journal,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475,,0,1
8265,CTRI/2020/07/026516,Not Yet Recruiting,,,,NIL,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44982,,0,1
8266,CTRI/2020/07/026528,Completed,,2021-08-05,,Not yet published,,2022-01-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269,2021-08-05,0,1
8267,CTRI/2020/07/026530,Not Yet Recruiting,,,,NIL,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532,,0,1
8268,CTRI/2020/07/026535,Completed,,2020-08-31,,NIL,,2020-09-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535,2020-08-31,0,1
8269,CTRI/2020/07/026576,Not Yet Recruiting,,,,none,,2020-07-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45573,,0,1
8270,CTRI/2020/07/026560,Completed,,2020-12-09,,"Nesari TM, Bhardwaj A, ShriKrishna R, Ruknuddin G, Ghildiyal S, Das A, Pandey AK, Chaudhary N, Soman G, Barde M. Neem (Azadirachta Indica A. Juss) Capsules for Prophylaxis of COVID-19 Infection: A Pilot, Double-Blind, Randomized Controlled Trial. Altern Ther Health Med. 2021 Oct;27(S1):196-203. PMID: 33891569.",,2021-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385,2020-12-09,0,1
8271,CTRI/2020/07/026574,Open to Recruitment,,,,Nil,,2021-02-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45396,,0,1
8272,CTRI/2020/07/026571,Not Yet Recruiting,,,,NIL,,2020-07-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45426,,0,1
8273,CTRI/2020/07/026575,Not Yet Recruiting,,,,Nil,,2020-07-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500,,0,1
8274,CTRI/2020/07/026570,Completed,,2020-09-03,,"Protocol got published in BioMed Central, on 23 Nov 2020. Results are yet to be published",,2020-12-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007,2020-09-03,0,1
8275,CTRI/2020/07/026559,Not Yet Recruiting,,,,Nil,,2020-07-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45544,,0,1
8276,CTRI/2020/07/026579,Completed,,2020-09-07,,1)Evaluation of the Clinical Efficacy and safety of IM-133N as an Immunomodulator in various carcinoma :A prospective Clinical Study 2)A Clinical Analysis of Evaluating the Usefulness and Efficacy of the Ayurvedic Drug Tinospora cordifolia in Humans,,2020-12-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034,2020-09-07,0,1
8277,CTRI/2020/07/026568,Open to Recruitment,,,,Nil,,2021-05-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035,,0,1
8278,CTRI/2020/07/026611,Not Yet Recruiting,,,,Nil,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44568,,0,1
8279,CTRI/2020/07/026612,Not Yet Recruiting,,,,Nil,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45100,,0,1
8280,CTRI/2020/07/026602,Not Yet Recruiting,,,,Will be published in PubMed indexed journal.,,2020-07-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628,,0,1
8281,CTRI/2020/07/026608,Not Yet Recruiting,,,,NIL,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638,,0,1
8282,CTRI/2020/07/026610,Not Yet Recruiting,,,,None yet,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45643,,0,1
8283,CTRI/2020/07/026609,Not Yet Recruiting,,,,Nil,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139,,0,1
8284,CTRI/2020/07/026607,Not Yet Recruiting,,,,will be published in high impact journals,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998,,0,1
8285,CTRI/2020/07/026601,Completed,,2020-08-23,,NIL,,2021-01-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564,2020-08-23,0,1
8286,CTRI/2020/07/026630,Open to Recruitment,,,,Nil,,2020-10-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581,,0,1
8287,CTRI/2020/07/026632,Not Yet Recruiting,,,,nil,,2020-07-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680,,0,1
8288,CTRI/2020/07/026631,Completed,,2020-09-03,,uses of herbal powder in hot water taken after meals by oral route in covid 19 positive patients to improve their spo2 levels. It acts as a immunity booster .,,2020-09-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494,2020-09-03,0,1
8289,CTRI/2020/07/026658,Not Yet Recruiting,,,,None.,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45350,,0,1
8290,CTRI/2020/07/026667,Not Yet Recruiting,,,,,,2021-09-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342,,0,0
8291,CTRI/2020/07/026633,Completed,,,,"Journal: Heliyon_x000D_
Year: 2021_x000D_
Volume: 7_x000D_
Issue: 4_x000D_
Page: e06715",,2021-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45666,,0,1
8292,CTRI/2020/07/026659,Not Yet Recruiting,,,,Nil,,2020-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45431,,0,1
8293,CTRI/2020/07/026664,,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44690,,0,0
8294,CTRI/2020/07/026660,Completed,,2021-01-28,,Nil,,2021-05-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45715,2021-01-28,0,1
8295,CTRI/2020/07/026669,Not Yet Recruiting,,,,Nil,,2020-07-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623,,0,1
8296,CTRI/2020/07/026673,Not Yet Recruiting,,,,Not Applcaple,,2020-07-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673,,0,1
8297,CTRI/2020/07/026668,Open to Recruitment,,,,nil,,2021-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677,,0,1
8298,CTRI/2020/07/026670,Not Yet Recruiting,,,,Nil,,2020-07-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713,,0,1
8299,CTRI/2020/07/026671,Not Yet Recruiting,,,,NIL,,2020-07-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,,0,1
8300,CTRI/2020/07/026672,Closed to Recruitment of Participants,,,,NIL,,2021-06-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45764,,0,1
8301,CTRI/2020/07/026676,Not Yet Recruiting,,,,Nil,,2020-07-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44603,,0,1
8302,CTRI/2020/07/026674,Not Yet Recruiting,,,,NIL,,2020-07-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712,,0,1
8303,CTRI/2020/07/026675,Not Yet Recruiting,,,,,,2020-10-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,,0,0
8304,CTRI/2020/07/026677,Not Yet Recruiting,,,,Nil,,2020-07-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45780,,0,1
8305,CTRI/2020/07/026678,Open to Recruitment,,,,Nil,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45786,,0,1
8306,CTRI/2020/07/026705,Not Yet Recruiting,,,,not applicable as study not started yet,,2020-07-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088,,0,1
8307,CTRI/2020/07/026698,Not Yet Recruiting,,,,,,2020-07-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43604,,0,0
8308,CTRI/2020/07/026700,Not Yet Recruiting,,,,NIL,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,,0,1
8309,CTRI/2020/07/026701,Completed,,2020-09-01,,NIL,,2020-09-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44985,2020-09-01,0,1
8310,CTRI/2020/07/026714,Not Yet Recruiting,,,,Nil,,2020-07-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44848,,0,1
8311,CTRI/2020/07/026728,Not Yet Recruiting,,,,Intended for publication in MCI specified indexed Journal,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45408,,0,1
8312,CTRI/2020/07/026715,Not Yet Recruiting,,,,none,,2020-07-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45798,,0,1
8313,CTRI/2020/07/026757,Not Yet Recruiting,,,,NIL,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824,,0,1
8314,CTRI/2020/07/026758,Not Yet Recruiting,,,,This article will be published in MCI specified indexed Journal,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45877,,0,1
8315,CTRI/2020/07/026759,Completed,,,,Nil,,2021-06-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45882,,0,1
8316,CTRI/2020/07/026755,Not Yet Recruiting,,,,nil,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44619,,0,1
8317,CTRI/2020/07/026747,Open to Recruitment,,,,Not yet published,,2021-09-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45446,,0,1
8318,CTRI/2020/07/026756,Not Yet Recruiting,,,,Nil,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755,,0,1
8319,CTRI/2020/07/026791,Completed,,2021-01-27,,Nil,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814,2021-01-27,0,1
8320,CTRI/2020/07/026798,Not Yet Recruiting,,,,Nil,,2020-07-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45852,,0,1
8321,CTRI/2020/07/026796,Not Yet Recruiting,,,,NIL,,2020-07-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868,,0,1
8322,CTRI/2020/07/026792,Not Yet Recruiting,,,,Nil,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45616,,0,1
8323,CTRI/2020/07/026789,Completed,,2020-11-25,,NIL,,2021-09-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,2020-11-25,0,1
8324,CTRI/2020/07/026797,Not Yet Recruiting,,,,NIL,,2020-07-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45903,,0,1
8325,CTRI/2020/07/026790,Not Yet Recruiting,,,,None yet,,2020-07-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143,,0,1
8326,CTRI/2020/07/026800,Completed,,2020-11-02,,"1. ZHOU F et al. In their study Clinical course and risk factor for mortality of adult in patients with covid 19 in wuhan, china: a retrospective cohort study concluded that The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 √é¬ºg/mL could help clinicians to identify patients with poor prognosis at an early stage._x000D_
2. TOBIAS H et al. In their study Elevated Levels of IL-6 and CRP Predict the Need for Mechanical Ventilation in COVID-19 found that the maximal level of IL-6, followed by CRP level, was highly predictive of the need for mechanical ventilation. This suggests the possibility of using IL-6 or CRP level to guide escalation of treatment in patients with COVID-19-related hyperinflammatory syndrome.",,2021-02-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45937,2020-11-02,0,1
8327,CTRI/2020/07/026799,Completed,,2021-03-31,,Nil,,2022-02-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964,2021-03-31,0,1
8328,CTRI/2020/07/026793,Completed,,2020-12-15,,Nil,,2021-03-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721,2020-12-15,0,1
8329,CTRI/2020/07/026788,Not Yet Recruiting,,,,Paper will be published at the end of study after analysis of results.,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44768,,0,1
8330,CTRI/2020/07/026794,Not Yet Recruiting,,,,NIL.,,2020-07-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45802,,0,1
8331,CTRI/2020/07/026836,Not Yet Recruiting,,,,The data such as Severity of impact of Covid 19 pandemic on the life of researchers will be published,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45113,,0,1
8332,CTRI/2020/07/026831,Closed to Recruitment of Participants,,,,"The study will be conducted in the name of the ‚ÄòCLARITY Study Investigators‚Äô. Central project coordination and data management will be provided by The George Institute for Global Health, Delhi, India. Authorship of publications arising from the study will be the management committee with full credit assigned to all collaborating Institutions, investigators and site research staff. Responsibility for the content of manuscripts will rest with the writing committee, and, where listed, the chair of the writing committee will be listed first with subsequent members listed alphabetically. It is expected that findings will be disseminated via publication in high-quality peer reviewed journals in the medical literature. Study findings will also be presented at regional, national, international intensive care conferences, and results via social media and mainstream media platforms.",,2022-02-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605,,0,1
8333,CTRI/2020/07/026820,Not Yet Recruiting,,,,no,,2020-07-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936,,0,1
8334,CTRI/2020/07/026834,Not Yet Recruiting,,,,NIL,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953,,0,1
8335,CTRI/2020/07/026837,Completed,,,,Nil,,2021-06-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45957,,0,1
8336,CTRI/2020/07/026840,Completed,,2020-09-11,,Nil,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981,2020-09-11,0,1
8337,CTRI/2020/07/026821,Not Yet Recruiting,,,,NIL,,2020-07-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45989,,0,1
8338,CTRI/2020/07/026839,Completed,,2020-09-23,,"Dound YA, Suryavanshi S, Sehgal R, Naik A (2020) Comparative Clinical Study to Evaluate the Activity of CureqovitaaTM Formulation for_x000D_
Management of SARS-CoV-2 Infection (COVID-19). J Clin Trials. S3:004.",,2021-01-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994,2020-09-23,0,1
8339,CTRI/2020/07/026835,Completed,,2020-12-31,,Submitted for publication,,2021-02-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539,2020-12-31,0,1
8340,CTRI/2020/07/026832,Not Yet Recruiting,,,,NIL,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44797,,0,1
8341,CTRI/2020/07/026841,Not Yet Recruiting,,,,None yet.,,2020-07-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659,,0,1
8342,CTRI/2020/07/026902,Not Yet Recruiting,,,,Nil,,2020-07-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45977,,0,1
8343,CTRI/2020/07/026925,Not Yet Recruiting,,,,nil,,2020-07-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587,,0,1
8344,CTRI/2020/07/026922,Not Yet Recruiting,,,,the outcome of this study shall be published in a peer reviewed national or international journa.,,2020-07-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909,,0,1
8345,CTRI/2020/07/026954,Not Yet Recruiting,,,,NIL,,2020-08-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46080,,0,1
8346,CTRI/2020/07/026955,Not Yet Recruiting,,,,NIL,,2020-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46111,,0,1
8347,CTRI/2020/07/026943,Completed,,2020-10-07,,not applicable,,2021-01-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44582,2020-10-07,0,1
8348,CTRI/2020/07/026953,Not Yet Recruiting,,,,NIL,,2020-12-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668,,0,1
8349,CTRI/2020/07/026952,Not Yet Recruiting,,,,Nil,,2020-07-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683,,0,1
8350,CTRI/2020/07/026942,Not Yet Recruiting,,,,Nil,,2020-07-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45698,,0,1
8351,CTRI/2020/07/026926,Open to Recruitment,,,,NIL,,2020-09-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45456,,0,1
8352,CTRI/2020/08/026956,Not Yet Recruiting,,,,None,,2020-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46136,,0,1
8353,CTRI/2020/08/026957,Completed,,2020-12-01,,NIL,,2021-08-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825,2020-12-01,0,1
8354,CTRI/2020/08/026980,Not Yet Recruiting,,,,NIL,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082,,0,1
8355,CTRI/2020/08/026964,Not Yet Recruiting,,,,NIL,,2020-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46100,,0,1
8356,CTRI/2020/08/026977,Not Yet Recruiting,,,,NIL,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057,,0,1
8357,CTRI/2020/08/026962,Completed,,2020-09-07,,"1.	Saraswathy AS, Sanya R, Kumaran JA. Incubation period of COVID-19: analysis of COVID-19 cases admitted in a tertiary care center, northern district of Kerala, India. Int J Community Med Public Health. 2021 May;8(5):2451-2454.",,2021-07-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46133,2020-09-07,0,1
8358,CTRI/2020/08/026985,Not Yet Recruiting,,,,Nil,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168,,0,1
8359,CTRI/2020/08/026983,Not Yet Recruiting,,,,Nil,,2020-08-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45679,,0,1
8360,CTRI/2020/08/026978,Not Yet Recruiting,,,,Nil,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435,,0,1
8361,CTRI/2020/08/027007,Not Yet Recruiting,,,,Nill,,2020-08-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827,,0,1
8362,CTRI/2020/08/027008,Not Yet Recruiting,,,,NIL,,2021-02-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46099,,0,1
8363,CTRI/2020/08/026999,Completed,,2020-11-08,,Nil,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134,2020-11-08,0,1
8364,CTRI/2020/08/027005,Open to Recruitment,,,,None,,2021-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189,,0,1
8365,CTRI/2020/08/027000,Open to Recruitment,,,,None yet,,2020-08-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45722,,0,1
8366,CTRI/2020/08/026998,Completed,,,,Nil,,2022-01-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46243,,0,1
8367,CTRI/2020/08/027009,Completed,,,,Not yet finalised on the journal in which the data from the current study would be published.,,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269,,0,1
8368,CTRI/2020/08/027001,Not Yet Recruiting,,,,nil,,2020-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45531,,0,1
8369,CTRI/2020/08/027033,Not Yet Recruiting,,,,"Not Yet published, Publication is after completion of the study",,2020-08-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096,,0,1
8370,CTRI/2020/08/027032,Completed,,2020-10-28,,To be filled,,2021-06-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920,2020-10-28,0,1
8371,CTRI/2020/08/027034,Not Yet Recruiting,,,,Nil,,2020-08-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46193,,0,1
8372,CTRI/2020/08/027038,Not Yet Recruiting,,,,Nil,,2020-09-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197,,0,1
8373,CTRI/2020/08/027035,Open to Recruitment,,,,NIL,,2021-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262,,0,1
8374,CTRI/2020/08/027036,Completed,,,,"Jain D, Shukla U ,Madan J, Bhakri B ,Gupta D , Motiani P,Sharma V (2021). ‚ÄúEPIDEMIOLOGICAL AND CLINICAL CHARACTERIZATION OF COVID19 PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY OF 245 CASES IN A GOVERNMENT TEACHING INSTITUTE OF NORTH INDIA.‚Äù. INDIAN JOURNAL OF APPLIED RESEARCH. 50-53. 10.36106/ijar/0802091.",,2021-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46280,,0,1
8375,CTRI/2020/08/027037,Completed,,2021-02-26,,NIL,,2022-02-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324,2021-02-26,0,1
8376,CTRI/2020/08/027040,Not Yet Recruiting,,,,NIL,,2020-08-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846,,0,1
8377,CTRI/2020/08/027047,Not Yet Recruiting,,,,None,,2020-11-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46338,,0,1
8378,CTRI/2020/08/027048,Completed,,2021-04-30,,NIL,,2022-02-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344,2021-04-30,0,1
8379,CTRI/2020/08/027049,Not Yet Recruiting,,,,NIL,,2020-08-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46361,,0,1
8380,CTRI/2020/08/027051,Not Yet Recruiting,,,,None,,2020-08-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44061,,0,1
8381,CTRI/2020/08/027050,Completed,,2020-09-08,,None,,2020-12-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46415,2020-09-08,0,1
8382,CTRI/2020/08/027045,Not Yet Recruiting,,,,Will publish the data in peer reviewed journal after completion of the study and analysis,,2020-08-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226,,0,1
8383,CTRI/2020/08/027043,Not Yet Recruiting,,,,NIL,,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175,,0,1
8384,CTRI/2020/08/027046,Open to Recruitment,,,,Nil,,2021-07-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46254,,0,1
8385,CTRI/2020/08/027041,Completed,,,,NIL,,2020-10-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258,,0,1
8386,CTRI/2020/08/027042,Completed,,2020-09-11,,"3.	Anitha S Saraswathy, Rameela Sanya, Jayasree A. Kumaran. Secondary attack rate of COVID-19: Analysis of contacts of COVId-19 cases admitted in a tertiary care centre, Northern District of Kerala, India. International Journal of Community Medicine and Public Health. Saraswathy AS et al. Int J Community Med Public Health. 2020 Dec;7(12):5111-5114",,2021-07-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46277,2020-09-11,0,1
8387,CTRI/2020/08/027044,Not Yet Recruiting,,,,NIL,,2020-08-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249,,0,1
8388,CTRI/2020/08/027082,Not Yet Recruiting,,,,Nil,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46351,,0,1
8389,CTRI/2020/08/027078,Not Yet Recruiting,,,,nil,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45924,,0,1
8390,CTRI/2020/08/027079,Not Yet Recruiting,,,,nil,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46185,,0,1
8391,CTRI/2020/08/027084,Open to Recruitment,,,,Nil,,2021-03-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420,,0,1
8392,CTRI/2020/08/027061,Completed,,2020-11-01,,Nil,,2020-11-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729,2020-11-01,0,1
8393,CTRI/2020/08/027080,Not Yet Recruiting,,,,NIL,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272,,0,1
8394,CTRI/2020/08/027081,Not Yet Recruiting,,,,Nil,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289,,0,1
8395,CTRI/2020/08/027083,Completed,,2020-09-16,,Not yet done,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46331,2020-09-16,0,1
8396,CTRI/2020/08/027085,Completed,,2020-09-10,,none yet,,2020-10-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278,2020-09-10,0,1
8397,CTRI/2020/08/027094,Completed,,2020-12-31,,observational study on patient and health care worker for the use of digital communication in isolation facilities for covid.,,2021-11-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43763,2020-12-31,0,1
8398,CTRI/2020/08/027102,Not Yet Recruiting,,,,Nil,,2020-08-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658,,0,1
8399,CTRI/2020/08/027106,Completed,,,,NOT YET,,2021-07-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639,,0,1
8400,CTRI/2020/08/027104,Not Yet Recruiting,,,,not applicable,,2020-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45464,,0,1
8401,CTRI/2020/08/027118,Not Yet Recruiting,,,,Nil,,2020-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46509,,0,1
8402,CTRI/2020/08/027112,Completed,,2020-08-16,,nil,,2020-08-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46270,2020-08-16,0,1
8403,CTRI/2020/08/027110,Not Yet Recruiting,,,,nil,,2020-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46271,,0,1
8404,CTRI/2020/08/027103,Not Yet Recruiting,,,,Nil,,2020-08-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46285,,0,1
8405,CTRI/2020/08/027120,Completed,,2020-11-24,,"Rajesh Biswas, Kakoli Biswas, Parikshit Bansal and Shashi Gupta; ANTI-VIRAL (ANTI-FLU), ANTI-BACTERIAL IMMUNOBOOSTING ORAL COMPOSITION OF HERBAL EXTRACTS FOR TREATING RESPIRATORY INFECTIONS ‚Äì A CASE STUDY; ejpmr, 2020,7(6), 760-765.",,2021-01-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319,2020-11-24,0,1
8406,CTRI/2020/08/027166,Not Yet Recruiting,,,,None yet,,2020-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46395,,0,1
8407,CTRI/2020/08/027163,Closed to Recruitment of Participants,,,,Nil,,2021-04-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406,,0,1
8408,CTRI/2020/08/027165,Open to Recruitment,,,,"Global data publications can be seen at _x000D_
https://rheum-covid.org/media/",,2020-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46228,,0,1
8409,CTRI/2020/08/027162,Completed,,2020-10-03,,NIL,,2021-10-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240,2020-10-03,0,1
8410,CTRI/2020/08/027168,Completed,,,,NIL,,2021-12-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750,,0,1
8411,CTRI/2020/08/027164,Not Yet Recruiting,,,,,,2020-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46320,,0,0
8412,CTRI/2020/08/027170,Completed,,2021-06-02,,Nil,,2021-06-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186,2021-06-02,0,1
8413,CTRI/2020/08/027169,Not Yet Recruiting,,,,Nil,,2020-08-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46255,,0,1
8414,CTRI/2020/08/027171,Not Yet Recruiting,,,,Not Yet Published,,2020-08-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527,,0,1
8415,CTRI/2020/08/027175,Not Yet Recruiting,,,,nil,,2020-08-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44760,,0,1
8416,CTRI/2020/08/027174,Completed,,,,,,2021-06-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45547,,0,0
8417,CTRI/2020/08/027173,Not Yet Recruiting,,,,NIL,,2020-08-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46063,,0,1
8418,CTRI/2020/08/027172,Not Yet Recruiting,,,,Nil,,2020-08-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46077,,0,1
8419,CTRI/2020/08/027192,Not Yet Recruiting,,,,NIL,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45344,,0,1
8420,CTRI/2020/08/027193,Not Yet Recruiting,,,,NIL,,2020-08-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46646,,0,1
8421,CTRI/2020/08/027189,Not Yet Recruiting,,,,Nil,,2020-08-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46430,,0,1
8422,CTRI/2020/08/027224,Completed,,2021-02-21,,under publication,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608,2021-02-21,0,1
8423,CTRI/2020/08/027225,Completed,,2020-10-31,,NIL,,2021-01-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660,2020-10-31,0,1
8424,CTRI/2020/08/027226,Open to Recruitment,,,,NIL,,2020-08-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46685,,0,1
8425,CTRI/2020/08/027218,Open to Recruitment,,,,None Yet,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45967,,0,1
8426,CTRI/2020/08/027210,Not Yet Recruiting,,,,NIL,,2020-08-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46279,,0,1
8427,CTRI/2020/08/027222,Not Yet Recruiting,,,,Nil,,2020-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308,,0,1
8428,CTRI/2020/08/027244,Not Yet Recruiting,,,,Results of the analyzed data will be published in peer reviewed journals,,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46157,,0,1
8429,CTRI/2020/08/027247,Not Yet Recruiting,,,,NIL,,2020-08-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46417,,0,1
8430,CTRI/2020/08/027243,Not Yet Recruiting,,,,NIL,,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46500,,0,1
8431,CTRI/2020/08/027246,Not Yet Recruiting,,,,NIL,,2021-05-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46546,,0,1
8432,CTRI/2020/08/027275,Not Yet Recruiting,,,,NOT PUBLISHED YET,,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46386,,0,1
8433,CTRI/2020/08/027281,Not Yet Recruiting,,,,NONE YET,,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46396,,0,1
8434,CTRI/2020/08/027282,Not Yet Recruiting,,,,"1.	≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J_x000D_
Med Sci. 2020;50(SI-1):611-619. Published 2020 Apr 21._x000D_
doi:10.3906/sag-2004-145._x000D_
2.	Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDAapproved_x000D_
drug ivermectin inhibits the replication of SARS-CoV-2_x000D_
in vitro. Antiviral Res. 2020. https://doi.org/_x000D_
10.1016/j.antiviral.2020.104787_x000D_
3.	 Patr√¨ A, Fabbrocini G. Hydroxychloroquine and ivermectin: A_x000D_
synergistic combination for COVID-19 chemoprophylaxis and_x000D_
treatment?. J Am Acad Dermatol. 2020;82(6):e221._x000D_
doi:10.1016/j.jaad.2020.04.017.",,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676,,0,1
8435,CTRI/2020/08/027284,Suspended,,,,NIL,,2021-02-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679,,0,1
8436,CTRI/2020/08/027285,Open to Recruitment,,,,NIL,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45050,,0,1
8437,CTRI/2020/08/027283,Not Yet Recruiting,,,,NIL,,2020-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591,,0,1
8438,CTRI/2020/08/027301,Not Yet Recruiting,,,,NONE YET,,2020-08-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46394,,0,1
8439,CTRI/2020/08/027316,Not Yet Recruiting,,,,NIL,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680,,0,1
8440,CTRI/2020/08/027299,Not Yet Recruiting,,,,NIL,,2020-08-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46175,,0,1
8441,CTRI/2020/08/027286,Completed,,2020-12-31,,Protocol of the Study Published in BMC Trials Journal.,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511,2020-12-31,0,1
8442,CTRI/2020/08/027300,Not Yet Recruiting,,,,NIL,,2020-08-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285,,0,1
8443,CTRI/2020/08/027324,Not Yet Recruiting,,,,NIL,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339,,0,1
8444,CTRI/2020/08/027323,Not Yet Recruiting,,,,NIL,,2020-08-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46086,,0,1
8445,CTRI/2020/08/027345,Not Yet Recruiting,,,,NIL,,2020-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932,,0,1
8446,CTRI/2020/08/027346,Not Yet Recruiting,,,,Nil,,2020-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229,,0,1
8447,CTRI/2020/08/027359,Not Yet Recruiting,,,,"1. 	Arshad MS, Khan U, Sadiq A, Khalid W, Hussain M, Yasmeen A, et al. Coronavirus disease (COVID-19) and immunity booster green foods: A mini review. Food Sci Nutr. 2020;(June). _x000D_
2. 	AYUSH M of. Ayurveda‚Äôs immunity boosting measures for self care during COVID 19 crisis. 2020;1(1):4. _x000D_
3. 	Ministry of AYUSH RK. ADVISORY FROM MINISTRY OF AYUSH FOR MEETING THE CHALLENGE ARISING OUT OF SPREAD OF CORONA VIRUS (COVID-19) IN INDIA. 2020;9‚Äì12. _x000D_
4. 	Abascal K, Yarnell E. Herbal treatments for pandemic influenza: Learning from the eclectics‚Äô experience. Altern Complement Ther. 2006;12(5):214‚Äì21. _x000D_
5.       Ravi Philip Rajkumar. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning   response meet.  Brain Behav Immun. 2020 Jul; 87: 8‚Äì9. Published online 2020 Apr 22._x000D_
6. 	AYUSH, ministy of N. GUIDELINES for NATUROPATHY PRACTITIONERS for COVID 19. 2020;",,2020-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829,,0,1
8448,CTRI/2020/08/027396,Not Yet Recruiting,,,,NIL,,2020-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46853,,0,1
8449,CTRI/2020/08/027394,Closed to Recruitment of Participants,,,,publication after study is completed,,2021-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873,,0,1
8450,CTRI/2020/08/027403,Not Yet Recruiting,,,,NIL,,2020-08-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46923,,0,1
8451,CTRI/2020/08/027397,Open to Recruitment,,,,NIL,,2020-09-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165,,0,1
8452,CTRI/2020/08/027407,Not Yet Recruiting,,,,NIL,,2020-08-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46707,,0,1
8453,CTRI/2020/08/027395,Not Yet Recruiting,,,,NIL,,2020-08-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46716,,0,1
8454,CTRI/2020/08/027393,Not Yet Recruiting,,,,Nil,,2020-08-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46249,,0,1
8455,CTRI/2020/08/027420,Completed,,2020-09-30,,NIL,,2021-01-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46472,2020-09-30,0,1
8456,CTRI/2020/08/027418,Completed,,2020-11-10,,NIL,,2021-01-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46745,2020-11-10,0,1
8457,CTRI/2020/08/027419,Completed,,2020-09-24,,"Sci Rep.2021 Oct4;11(1):19618._x000D_
Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19",,2022-02-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46503,2020-09-24,0,1
8458,CTRI/2020/08/027435,Not Yet Recruiting,,,,NONE YET,,2020-08-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46530,,0,1
8459,CTRI/2020/08/027458,Not Yet Recruiting,,,,NONE YET,,2020-08-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46665,,0,1
8460,CTRI/2020/08/027460,Not Yet Recruiting,,,,NONE YET,,2020-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46545,,0,1
8461,CTRI/2020/08/027459,Not Yet Recruiting,,,,NONE YET,,2020-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46552,,0,1
8462,CTRI/2020/08/027465,Completed,,2021-01-05,,Preparing for Upload in Journal,,2021-01-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634,2021-01-05,0,1
8463,CTRI/2020/08/027466,Open to Recruitment,,,,None yet,,2022-02-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46198,,0,1
8464,CTRI/2020/08/027501,Closed to Recruitment of Participants,,,,none,,2020-10-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303,,0,1
8465,CTRI/2020/08/027494,Not Yet Recruiting,,,,A book will be published after completion of study,,2020-08-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46900,,0,1
8466,CTRI/2020/08/027475,Open to Recruitment,,,,Nil,,2020-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627,,0,1
8467,CTRI/2020/08/027502,Not Yet Recruiting,,,,Nil,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862,,0,1
8468,CTRI/2020/08/027477,Completed,,2020-10-08,,NIL,,2020-12-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654,2020-10-08,0,1
8469,CTRI/2020/08/027499,Open to Recruitment,,,,NIL,,2020-09-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927,,0,1
8470,CTRI/2020/08/027468,Not Yet Recruiting,,,,Publication is not yet done till now.,,2020-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46446,,0,1
8471,CTRI/2020/08/027500,Not Yet Recruiting,,,,NIL,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46721,,0,1
8472,CTRI/2020/08/027492,Not Yet Recruiting,,,,NIL,,2020-08-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46983,,0,1
8473,CTRI/2020/08/027490,Not Yet Recruiting,,,,NIL,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47009,,0,1
8474,CTRI/2020/08/027491,Completed,,2020-10-20,,Nil,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256,2020-10-20,0,1
8475,CTRI/2020/08/027503,Not Yet Recruiting,,,,Nil,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980,,0,1
8476,CTRI/2020/08/027467,Not Yet Recruiting,,,,NIL,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524,,0,1
8477,CTRI/2020/08/027470,Not Yet Recruiting,,,,None,,2020-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45806,,0,1
8478,CTRI/2020/08/027471,Not Yet Recruiting,,,,NIL,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45049,,0,1
8479,CTRI/2020/09/027516,Not Yet Recruiting,,,,Not yet,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46986,,0,1
8480,CTRI/2020/09/027517,Completed,,2020-09-25,,NIL,,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47025,2020-09-25,0,1
8481,CTRI/2020/09/027535,Open to Recruitment,,,,Nil,,2020-11-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236,,0,1
8482,CTRI/2020/09/027518,Not Yet Recruiting,,,,nil,,2020-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47089,,0,1
8483,CTRI/2020/09/027548,Completed,,2020-10-21,,none yet,,2020-11-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125,2020-10-21,0,1
8484,CTRI/2020/09/027560,Not Yet Recruiting,,,,Nil,,2020-09-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47165,,0,1
8485,CTRI/2020/09/027558,Completed,,,,NIL,,2021-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44917,,0,1
8486,CTRI/2020/09/027544,Completed,,,,Nil,,2021-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47068,,0,1
8487,CTRI/2020/09/027562,Not Yet Recruiting,,,,NIL,,2020-09-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47154,,0,1
8488,CTRI/2020/09/027572,Not Yet Recruiting,,,,nil,,2020-09-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46643,,0,1
8489,CTRI/2020/09/027596,Not Yet Recruiting,,,,NIL,,2020-09-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47171,,0,1
8490,CTRI/2020/09/027616,Not Yet Recruiting,,,,NIL,,2020-09-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155,,0,1
8491,CTRI/2020/09/027615,Not Yet Recruiting,,,,none yet,,2020-09-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648,,0,1
8492,CTRI/2020/09/027613,Not Yet Recruiting,,,,NIL,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46158,,0,1
8493,CTRI/2020/09/027617,Not Yet Recruiting,,,,Nil,,2020-09-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47239,,0,1
8494,CTRI/2020/09/027618,Not Yet Recruiting,,,,Nil,,2020-09-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47248,,0,1
8495,CTRI/2020/09/027614,Not Yet Recruiting,,,,The article will be published in peer reviewed journals accepted by the Medical Council of India,,2020-08-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46274,,0,1
8496,CTRI/2020/09/027622,Open to Recruitment,,,,nil,,2020-12-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908,,0,1
8497,CTRI/2020/09/027661,Not Yet Recruiting,,,,Nil,,2020-09-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273,,0,1
8498,CTRI/2020/09/027674,Completed,,,,Not applicable,,2021-05-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312,,0,1
8499,CTRI/2020/09/027684,Open to Recruitment,,,,NIL,,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179,,0,1
8500,CTRI/2020/09/027681,Completed,,2020-12-11,,"1. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021 Jun;76(6):748-758.  doi: 10.1111/anae.15458. Epub 2021 Mar 9._x000D_
2. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia. 2021 Aug 9.  doi: 10.1111/anae.15560._x000D_
3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg. 2021 Jul 6;znab183.  doi: 10.1093/bjs/znab183._x000D_
4. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study J Surg. 2021 Mar 24;znab101.  doi: 10.1093/bjs/znab101.  _x000D_
5. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2021 Aug 24.  doi: 10.1111/anae.15563.  Online ahead of print.",,2021-09-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46744,2020-12-11,0,1
8501,CTRI/2020/09/027687,Completed,,2020-10-25,,"Satomura K, Kitamura T, Kawamura T, Shimbo T, Watanabe M, Kamei M, et al. Prevention of Upper Respiratory Tract Infections by Gargling A Randomized Trial. American Journal of Preventive Medicine. 2005 Nov;29(4):302‚Äì7. _x000D_
_x000D_
12.Ananthanarayan R, Paniker Jayaram CK. Ananthanarayans and Panikers textbook of microbiology.7th ed. Hyderabad: Orient Longman Private Limited; 2005. p.434",,2021-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280,2020-10-25,0,1
8502,CTRI/2020/09/027683,Not Yet Recruiting,,,,nil,,2020-09-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47026,,0,1
8503,CTRI/2020/09/027685,Completed,,,,NIL,,2021-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321,,0,1
8504,CTRI/2020/09/027686,Not Yet Recruiting,,,,NIL,,2020-09-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47332,,0,1
8505,CTRI/2020/09/027689,Not Yet Recruiting,,,,NIL,,2020-09-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47353,,0,1
8506,CTRI/2020/09/027741,Open to Recruitment,,,,NIL,,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197,,0,1
8507,CTRI/2020/09/027719,Not Yet Recruiting,,,,Nil,,2020-09-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47277,,0,1
8508,CTRI/2020/09/027691,,,,,,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46833,,0,0
8509,CTRI/2020/09/027775,Completed,,2020-12-06,,None yet,,2020-12-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367,2020-12-06,0,1
8510,CTRI/2020/09/027769,Not Yet Recruiting,,,,"1-	ArRejaie AS, Nawasrah AM, Khan SQ, Farooqi FA, Somali R, Al-Mudani WF. Patients perception toward various dental treatments provided in the internship program. Saudi Med J. 2014;35(12):1513-1516.",,2020-09-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47390,,0,1
8511,CTRI/2020/09/027786,Not Yet Recruiting,,,,NIL,,2020-09-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950,,0,1
8512,CTRI/2020/09/027785,Completed,,2020-11-20,,Nil,,2021-01-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47016,2020-11-20,0,1
8513,CTRI/2020/09/027787,Not Yet Recruiting,,,,NIL,,2020-09-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47329,,0,1
8514,CTRI/2020/09/027782,Not Yet Recruiting,,,,NIL,,2020-09-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47085,,0,1
8515,CTRI/2020/09/027817,Open to Recruitment,,,,NIL,,2021-02-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041,,0,1
8516,CTRI/2020/09/027841,Open to Recruitment,,,,NIL,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174,,0,1
8517,CTRI/2020/09/027829,Closed to Recruitment of Participants,,,,"Together with the Sponsor, the Executive Committee will be responsible for the final overall study design, including the development of the study protocol and eCRF, supervision of the study conduct and progress, development of any protocol amendments needed during the study, liaison with the IDSMC as needed, development of the SAP, interpretation of the final data and reporting (presentations at international congresses and publications in peer reviewed journals) of the study. The Executive Committee will make recommendations to Saint Luke‚Äôs Hospital of Kansas City with regard to early stopping or modifications of the study based on the information received from the IDSMC._x000D_
The Executive Committee will be comprised of the overall study PI (Chair), designated international academic leaders, and non-voting members of AstraZeneca, and will operate under an Executive Committee Charter.",,2021-03-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521,,0,1
8518,CTRI/2020/09/027842,Not Yet Recruiting,,,,NIL,,2020-09-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591,,0,1
8519,CTRI/2020/09/027882,Not Yet Recruiting,,,,NIL,,2020-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632,,0,1
8520,CTRI/2020/09/027881,Completed,,2020-09-25,,The IgM test will be done to determine the presence of antibodies developed against COVID-19 infection. The test will be performed in a manner to check that subject may having the infection without knowing and recovered without having any symptoms so it will be assumed that subject has developed the antibodies for the infection or subject has got the HERD immunity. The impact of risk factors which may alter the immunity in the different age group which will also be studied.,,2020-10-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46661,2020-09-25,0,1
8521,CTRI/2020/09/027862,Not Yet Recruiting,,,,Nil,,2020-09-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47505,,0,1
8522,CTRI/2020/09/027908,Not Applicable,,,,DOI: 10.32113/wcrj_20221_2161,,2022-03-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47619,,0,1
8523,CTRI/2020/09/027904,Not Yet Recruiting,,,,NIL,,2020-09-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392,,0,1
8524,CTRI/2020/09/027903,Completed,,,,None (yet),,2021-01-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147,,0,1
8525,CTRI/2020/09/027910,Open to Recruitment,,,,NIL,,2021-02-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292,,0,1
8526,CTRI/2020/09/027907,Not Yet Recruiting,,,,NIL,,2020-09-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47598,,0,1
8527,CTRI/2020/09/027914,Completed,,2021-01-14,,Nil,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442,2021-01-14,0,1
8528,CTRI/2020/09/027917,Not Yet Recruiting,,,,nill,,2020-09-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47662,,0,1
8529,CTRI/2020/09/027915,Closed to Recruitment of Participants,,,,Nil,,2022-02-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754,,0,1
8530,CTRI/2020/09/027941,Completed,,2020-07-10,,None Yet,,2022-02-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023,2020-07-10,0,1
8531,CTRI/2020/09/027938,Not Yet Recruiting,,,,Publication which arise directly out of this trial results,,2021-01-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586,,0,1
8532,CTRI/2020/09/027916,Not Yet Recruiting,,,,NIL,,2020-09-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333,,0,1
8533,CTRI/2020/09/027974,Not Yet Recruiting,,,,NIL,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658,,0,1
8534,CTRI/2020/09/027944,Not Yet Recruiting,,,,NIL,,2020-09-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392,,0,1
8535,CTRI/2020/09/027975,Not Yet Recruiting,,,,Interim analysis shall be done after study completion of at least 25% of participants And final analysis will be after study.results will be published in journals,,2020-09-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748,,0,1
8536,CTRI/2020/09/027993,Completed,,,,NIL,,2021-03-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47645,,0,1
8537,CTRI/2020/09/027992,Not Yet Recruiting,,,,Nil,,2020-09-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389,,0,1
8538,CTRI/2020/09/028045,Not Yet Recruiting,,,,Nil,,2020-09-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046,,0,1
8539,CTRI/2020/09/028044,Open to Recruitment,,,,NIL,,2020-10-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432,,0,1
8540,CTRI/2020/09/028043,Not Yet Recruiting,,,,Nil,,2020-09-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443,,0,1
8541,CTRI/2020/09/028040,Closed to Recruitment of Participants,,,,Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children,,2020-12-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47809,,0,1
8542,CTRI/2020/09/028046,Other (Terminated),,,,NIL,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038,,0,1
8543,CTRI/2020/09/028049,Not Yet Recruiting,,,,Nil,,2020-09-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46447,,0,1
8544,CTRI/2020/09/028050,Not Yet Recruiting,,,,"1)	Meng, L., Qiu, H., Wan, L., Ai, Y., Xue, Z., Guo, Q., Deshpande, R., Zhang, L., Meng, J., Tong, C. and Liu, H., 2020. Intubation and Ventilation amid the COVID-19 OutbreakWuhan√¢‚Ç¨‚Ñ¢s Experience. Anesthesiology: The Journal of the American Society of Anesthesiologists, 132(6), pp.1317-1332._x000D_
_x000D_
2)	Sullivan, E.H., Gibson, L.E., Berra, L., Chang, M.G. and Bittner, E.A., 2020. In-hospital airway management of COVID-19 patients. Critical Care, 24(1), pp.1-8._x000D_
_x000D_
3)	Ziehr, D.R., Alladina, J., Petri, C.R., Maley, J.H., Moskowitz, A., Medoff, B.D., Hibbert, K.A., Thompson, B.T. and Hardin, C.C., 2020. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. American Journal of Respiratory and Critical Care Medicine, (ja)_x000D_
_x000D_
4)	Aziz, M.F., 2020. The COVID-19 intubation experience in Wuhan. British journal of anaesthesia, 125(1), pp.e25-e27.",,2020-09-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47764,,0,1
8545,CTRI/2020/09/028090,Not Yet Recruiting,,,,to be published in a peer-reviewed journal,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47924,,0,1
8546,CTRI/2020/09/028069,Not Yet Recruiting,,,,-- NIL --,,2020-09-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47703,,0,1
8547,CTRI/2020/09/028085,Not Yet Recruiting,,,,Nil,,2020-09-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47774,,0,1
8548,CTRI/2020/09/028087,Not Yet Recruiting,,,,Nil,,2020-09-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47816,,0,1
8549,CTRI/2020/09/028086,Not Yet Recruiting,,,,NIL,,2020-09-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819,,0,1
8550,CTRI/2020/09/028088,Not Yet Recruiting,,,,Nil,,2020-09-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829,,0,1
8551,CTRI/2020/09/028089,Not Yet Recruiting,,,,Nil,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47832,,0,1
8552,CTRI/2020/09/028083,Not Yet Recruiting,,,,NIL,,2020-09-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47599,,0,1
8553,CTRI/2020/09/028131,Completed,,2021-03-21,,Nil,,2022-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887,2021-03-21,0,1
8554,CTRI/2020/09/028122,Not Yet Recruiting,,,,Nil,,2020-10-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851,,0,1
8555,CTRI/2020/09/028132,Not Yet Recruiting,,,,None yet,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47860,,0,1
8556,CTRI/2020/09/028133,Completed,,,,Not yet,,2021-04-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866,,0,1
8557,CTRI/2020/09/028153,Not Yet Recruiting,,,,NIL,,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47878,,0,1
8558,CTRI/2020/09/028158,Completed,,,,It is anticipated that the results of this study may be presented at scientific meetings and/or published in a peer reviewed scientific or medical journal. Current guidelines and recommendations on good publication practice will be followed,,2021-04-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896,,0,1
8559,CTRI/2020/09/028162,Open to Recruitment,,,,"As stated in the protocol,""We will adopt the publication policy that has served the INTERGROWTH-21st Project successfully for the last 12 years: namely that the Principal Investigators and leading contributors at each site will be co-authors on all publications resulting from the INTERCOVID Study""",,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46374,,0,1
8560,CTRI/2020/09/028157,Completed,,2021-02-12,,NIL,,2021-05-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47423,2021-02-12,0,1
8561,CTRI/2020/09/028156,Not Yet Recruiting,,,,None yet,,2020-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47790,,0,1
8562,CTRI/2020/09/028165,Closed to Recruitment of Participants,,,,NIL,,2021-02-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47824,,0,1
8563,CTRI/2020/09/028164,Not Yet Recruiting,,,,NIL,,2020-09-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843,,0,1
8564,CTRI/2020/10/028195,Closed to Recruitment of Participants,,,,NIL,,2021-05-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893,,0,1
8565,CTRI/2020/10/028196,Completed,,,,NIL,,2021-02-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47979,,0,1
8566,CTRI/2020/10/028192,Not Yet Recruiting,,,,NIL,,2020-09-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47846,,0,1
8567,CTRI/2020/10/028179,Open to Recruitment,,,,NIL,,2020-10-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847,,0,1
8568,CTRI/2020/10/028230,Not Yet Recruiting,,,,NIL,,2020-10-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188,,0,1
8569,CTRI/2020/10/028233,Not Yet Recruiting,,,,Nil,,2020-10-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982,,0,1
8570,CTRI/2020/10/028231,Completed,,2020-12-01,,Nil,,2020-12-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237,2020-12-01,0,1
8571,CTRI/2020/10/028234,Not Yet Recruiting,,,,no,,2020-10-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844,,0,1
8572,CTRI/2020/10/028232,Not Yet Recruiting,,,,Nil,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48105,,0,1
8573,CTRI/2020/10/028254,Not Yet Recruiting,,,,NIL,,2020-10-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47156,,0,1
8574,CTRI/2020/10/028253,Completed,,2020-12-02,,NIL,,2021-01-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986,2020-12-02,0,1
8575,CTRI/2020/10/028257,Not Yet Recruiting,,,,Nil,,2020-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48025,,0,1
8576,CTRI/2020/10/028256,Not Yet Recruiting,,,,None,,2020-10-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118,,0,1
8577,CTRI/2020/10/028250,Other (Terminated),,,,Not yet,,2021-03-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119,,0,1
8578,CTRI/2020/10/028251,Not Yet Recruiting,,,,NIl yet,,2020-10-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47097,,0,1
8579,CTRI/2020/10/028280,Not Yet Recruiting,,,,None yet,,2020-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199,,0,1
8580,CTRI/2020/10/028277,Completed,,2021-10-14,,Nil,,2022-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691,2021-10-14,0,1
8581,CTRI/2020/10/028278,Not Yet Recruiting,,,,Not published yet,,2020-10-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47232,,0,1
8582,CTRI/2020/10/028279,Not Yet Recruiting,,,,NIL,,2020-10-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085,,0,1
8583,CTRI/2020/10/028295,Not Yet Recruiting,,,,Nil,,2020-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48202,,0,1
8584,CTRI/2020/10/028296,Not Yet Recruiting,,,,Not applicable,,2020-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46970,,0,1
8585,CTRI/2020/10/028297,Not Yet Recruiting,,,,NIL,,2020-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268,,0,1
8586,CTRI/2020/10/028333,Completed,,2021-02-26,,No,,2021-03-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137,2021-02-26,0,1
8587,CTRI/2020/10/028335,Not Yet Recruiting,,,,none yet,,2020-11-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359,,0,1
8588,CTRI/2020/10/028324,Completed,,,,NIL,,2021-03-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697,,0,1
8589,CTRI/2020/10/028326,Not Yet Recruiting,,,,,,2020-10-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214,,0,0
8590,CTRI/2020/10/028325,Not Yet Recruiting,,,,NIL,,,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319,,0,1
8591,CTRI/2020/10/028339,Not Yet Recruiting,,,,Nil,,2020-10-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47879,,0,1
8592,CTRI/2020/10/028340,Not Yet Recruiting,,,,Not applicable,,2020-10-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46861,,0,1
8593,CTRI/2020/10/028364,Completed,,2021-04-14,,NIL,,2021-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152,2021-04-14,0,1
8594,CTRI/2020/10/028363,Not Yet Recruiting,,,,NIL,,2020-10-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48039,,0,1
8595,CTRI/2020/10/028360,Completed,,2020-11-10,,Nil,,2021-01-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48352,2020-11-10,0,1
8596,CTRI/2020/10/028361,Completed,,2021-01-18,,Nil,,2021-10-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48356,2021-01-18,0,1
8597,CTRI/2020/10/028362,Not Yet Recruiting,,,,NONE YET,,2020-10-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109,,0,1
8598,CTRI/2020/10/028376,Not Yet Recruiting,,,,"""None Yet""",,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426,,0,1
8599,CTRI/2020/10/028372,Not Yet Recruiting,,,,None,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48321,,0,1
8600,CTRI/2020/10/028373,Not Yet Recruiting,,,,NIL,,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48335,,0,1
8601,CTRI/2020/10/028384,Not Yet Recruiting,,,,NIL,,2020-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48092,,0,1
8602,CTRI/2020/10/028412,Not Yet Recruiting,,,,Not yet started data collection.,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48163,,0,1
8603,CTRI/2020/10/028422,Not Yet Recruiting,,,,Nil,,2020-10-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47424,,0,1
8604,CTRI/2020/10/028414,Not Yet Recruiting,,,,Nil,,2020-10-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010,,0,1
8605,CTRI/2020/10/028423,Completed,,2021-03-18,,NIL,,2021-09-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514,2021-03-18,0,1
8606,CTRI/2020/10/028424,Not Yet Recruiting,,,,NIL,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294,,0,1
8607,CTRI/2020/10/028439,Not Yet Recruiting,,,,NIL,,2020-10-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44034,,0,1
8608,CTRI/2020/10/028437,Completed,,2021-06-22,,NIL,,2021-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956,2021-06-22,0,1
8609,CTRI/2020/10/028432,Not Yet Recruiting,,,,Not applicable,,2020-10-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48231,,0,1
8610,CTRI/2020/10/028438,Not Yet Recruiting,,,,nil,,2020-10-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48532,,0,1
8611,CTRI/2020/10/028436,Open to Recruitment,,,,NIL,,2021-03-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47604,,0,1
8612,CTRI/2020/10/028472,Closed to Recruitment of Participants,,,,NIL,,2021-06-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524,,0,1
8613,CTRI/2020/10/028470,Not Yet Recruiting,,,,Nil,,2020-10-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47547,,0,1
8614,CTRI/2020/10/028471,Not Yet Recruiting,,,,none yet,,2020-10-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593,,0,1
8615,CTRI/2020/10/028486,Completed,,2021-01-11,,Not yet,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223,2021-01-11,0,1
8616,CTRI/2020/10/028489,Not Yet Recruiting,,,,Nil,,2020-10-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48502,,0,1
8617,CTRI/2020/10/028488,Open to Recruitment,,,,Not Applicable,,2021-04-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48575,,0,1
8618,CTRI/2020/10/028485,Completed,,2020-12-22,,Not Yet,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619,2020-12-22,0,1
8619,CTRI/2020/10/028487,Not Yet Recruiting,,,,NIL,,2020-10-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48636,,0,1
8620,CTRI/2020/10/028523,Not Yet Recruiting,,,,not yet,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48500,,0,1
8621,CTRI/2020/10/028525,Not Yet Recruiting,,,,Not applicable,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48521,,0,1
8622,CTRI/2020/10/028524,Not Yet Recruiting,,,,nil,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48550,,0,1
8623,CTRI/2020/10/028520,Not Yet Recruiting,,,,NIL,,2020-10-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48305,,0,1
8624,CTRI/2020/10/028571,Not Yet Recruiting,,,,None yet,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47944,,0,1
8625,CTRI/2020/10/028569,Completed,,2020-12-07,,It will be done after study is completed.,,2020-12-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47444,2020-12-07,0,1
8626,CTRI/2020/10/028568,Completed,,2020-12-14,,Not Published,,2021-01-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761,2020-12-14,0,1
8627,CTRI/2020/10/028566,Completed,,2021-01-31,,Not Yet,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585,2021-01-31,0,1
8628,CTRI/2020/10/028537,Completed,,2021-02-05,,NIL,,2021-02-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342,2021-02-05,0,1
8629,CTRI/2020/10/028570,Not Yet Recruiting,,,,Nil,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600,,0,1
8630,CTRI/2020/10/028567,Not Yet Recruiting,,,,NIL,,2020-10-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46310,,0,1
8631,CTRI/2020/10/028539,Not Yet Recruiting,,,,NIL,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48627,,0,1
8632,CTRI/2020/10/028597,Completed,,,,"Interim results published under the title ""Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India"" DOI: 10.1016/j.radonc.2021.08.001",,2021-08-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730,,0,1
8633,CTRI/2020/10/028598,Not Yet Recruiting,,,,Nil,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47989,,0,1
8634,CTRI/2020/10/028602,Closed to Recruitment of Participants,,,,NIL,,2021-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797,,0,1
8635,CTRI/2020/10/028600,Not Yet Recruiting,,,,Nil,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46239,,0,1
8636,CTRI/2020/10/028581,Not Yet Recruiting,,,,Nil,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042,,0,1
8637,CTRI/2020/10/028580,Not Yet Recruiting,,,,No Publications yet,,2020-10-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581,,0,1
8638,CTRI/2020/10/028637,Completed,,2021-07-26,,trial will started after the ctri registration,,2021-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357,2021-07-26,0,1
8639,CTRI/2020/10/028635,Not Yet Recruiting,,,,NIL,,2020-10-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783,,0,1
8640,CTRI/2020/10/028634,Completed,,2021-02-16,,Nil.,,2021-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48823,2021-02-16,0,1
8641,CTRI/2020/10/028639,Open to Recruitment,,,,,,2021-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44503,,0,0
8642,CTRI/2020/10/028636,Not Yet Recruiting,,,,After the study is completed and data analysed,,2020-10-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48380,,0,1
8643,CTRI/2020/10/028648,Not Yet Recruiting,,,,NIL,,2020-10-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46401,,0,1
8644,CTRI/2020/10/028649,Not Yet Recruiting,,,,NIL,,2020-10-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48029,,0,1
8645,CTRI/2020/10/028657,Completed,,2021-10-05,,NIL yet,,2021-11-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47817,2021-10-05,0,1
8646,CTRI/2020/10/028672,Open to Recruitment,,,,NIL,,2022-03-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48895,,0,1
8647,CTRI/2020/10/028696,Not Yet Recruiting,,,,study not yet begun,,2020-10-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48669,,0,1
8648,CTRI/2020/10/028695,Open to Recruitment,,,,NIL,,2021-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749,,0,1
8649,CTRI/2020/10/028774,Not Yet Recruiting,,,,,,2020-10-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48412,,0,0
8650,CTRI/2020/10/028744,Not Yet Recruiting,,,,Nil,,2020-10-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48499,,0,1
8651,CTRI/2020/11/028799,Not Yet Recruiting,,,,NIL,,2020-10-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864,,0,1
8652,CTRI/2020/11/028813,Not Yet Recruiting,,,,nil,,2020-10-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48182,,0,1
8653,CTRI/2020/11/028811,Completed,,2021-01-30,,Results of study to be published in a peer review in Index journal.,,2021-03-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960,2021-01-30,0,1
8654,CTRI/2020/11/028800,Completed,,2021-03-01,,NIL,,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49028,2021-03-01,0,1
8655,CTRI/2020/11/028779,Closed to Recruitment of Participants,,,,None,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578,,0,1
8656,CTRI/2020/11/028836,Not Yet Recruiting,,,,NIL,,2020-11-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48390,,0,1
8657,CTRI/2020/11/028846,Not Yet Recruiting,,,,The results of the study shall be published in a reputed journal,,2020-10-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48947,,0,1
8658,CTRI/2020/11/028827,Completed,,,,NIL,,2021-10-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946,,0,1
8659,CTRI/2020/11/028843,Not Yet Recruiting,,,,Nil,,2020-11-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49036,,0,1
8660,CTRI/2020/11/028848,Not Yet Recruiting,,,,nil,,2020-11-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49115,,0,1
8661,CTRI/2020/11/028859,Not Yet Recruiting,,,,nil,,2020-11-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49144,,0,1
8662,CTRI/2020/11/028905,Completed,,2021-08-16,,NIL,,2021-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668,2021-08-16,0,1
8663,CTRI/2020/11/028903,Completed,,2021-02-07,,None Yet.,,2021-06-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964,2021-02-07,0,1
8664,CTRI/2020/11/028897,Not Yet Recruiting,,,,"The results of this study are planned to be published in order to provide information on efficacy_x000D_
and safety of ANT-V Syrup in management of upper respiratory tract infections, in Indian population",,2020-10-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480,,0,1
8665,CTRI/2020/11/028885,Open to Recruitment,,,,None,,2021-02-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47990,,0,1
8666,CTRI/2020/11/028938,Not Yet Recruiting,,,,Nil,,2020-11-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48595,,0,1
8667,CTRI/2020/11/028967,Not Yet Recruiting,,,,Nat required,,2021-08-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47399,,0,1
8668,CTRI/2020/11/028954,Not Yet Recruiting,,,,Not Yet,,2020-11-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48686,,0,1
8669,CTRI/2020/11/028969,Not Yet Recruiting,,,,NIL,,2020-11-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49266,,0,1
8670,CTRI/2020/11/028959,Not Yet Recruiting,,,,NIL,,2020-11-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272,,0,1
8671,CTRI/2020/11/028976,Closed to Recruitment of Participants,,,,"Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial,Citation DataThe Lancet, ISSN: 0140-6736, Vol: 398, Issue: 10317, Page: 2173-2184",,2022-03-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,,0,1
8672,CTRI/2020/11/029025,Open to Recruitment,,,,NIL,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174,,0,1
8673,CTRI/2020/11/029035,Completed,,,,NIL,,2022-01-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48696,,0,1
8674,CTRI/2020/11/029004,Open to Recruitment,,,,NOT YET DECIDED ABOUT PUBLICATION,,2021-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48969,,0,1
8675,CTRI/2020/11/029026,Not Yet Recruiting,,,,Nil,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49243,,0,1
8676,CTRI/2020/11/029006,Not Yet Recruiting,,,,Not applicable,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49299,,0,1
8677,CTRI/2020/11/029029,Open to Recruitment,,,,Not Applicable,,2021-05-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48282,,0,1
8678,CTRI/2020/11/029008,Not Yet Recruiting,,,,Not yet,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49069,,0,1
8679,CTRI/2020/11/029007,Not Yet Recruiting,,,,NIL,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49326,,0,1
8680,CTRI/2020/11/029009,Not Yet Recruiting,,,,NIL,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49077,,0,1
8681,CTRI/2020/11/029012,Not Yet Recruiting,,,,Not yet,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49084,,0,1
8682,CTRI/2020/11/029032,Closed to Recruitment of Participants,,,,None,,2021-01-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329,,0,1
8683,CTRI/2020/11/029030,Not Yet Recruiting,,,,none,,2020-12-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48102,,0,1
8684,CTRI/2020/11/029036,Not Yet Recruiting,,,,Nil,,2020-11-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46058,,0,1
8685,CTRI/2020/11/029037,Open to Recruitment,,,,none,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48368,,0,1
8686,CTRI/2020/11/029060,Not Yet Recruiting,,,,Not published,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49411,,0,1
8687,CTRI/2020/11/029059,Open to Recruitment,,,,Not yet decided about publication.,,2021-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48971,,0,1
8688,CTRI/2020/11/029040,Not Yet Recruiting,,,,not yet,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44640,,0,1
8689,CTRI/2020/11/029038,Completed,,2021-04-06,,NIL,,2021-07-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233,2021-04-06,0,1
8690,CTRI/2020/11/029041,Not Yet Recruiting,,,,NIL,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49076,,0,1
8691,CTRI/2020/11/029042,Not Yet Recruiting,,,,Not yet,,2020-11-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49098,,0,1
8692,CTRI/2020/11/029061,Open to Recruitment,,,,nil,,2020-12-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49371,,0,1
8693,CTRI/2020/11/029058,Open to Recruitment,,,,No publication has been made from the current trial yet,,2021-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392,,0,1
8694,CTRI/2020/11/029063,Completed,,2021-05-15,,None published yet,,2021-08-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939,2021-05-15,0,1
8695,CTRI/2020/11/029067,Not Yet Recruiting,,,,NIL,,2020-11-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47660,,0,1
8696,CTRI/2020/11/029068,Not Yet Recruiting,,,,Nil,,2020-11-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48973,,0,1
8697,CTRI/2020/11/029070,Not Yet Recruiting,,,,Nil,,2020-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49261,,0,1
8698,CTRI/2020/11/029084,Open to Recruitment,,,,,,2021-08-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49352,,0,0
8699,CTRI/2020/11/029124,Not Yet Recruiting,,,,NIL,,2020-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49435,,0,1
8700,CTRI/2020/11/029130,Not Yet Recruiting,,,,Not Applicable,,2020-11-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155,,0,1
8701,CTRI/2020/11/029143,Not Yet Recruiting,,,,Nil,,2020-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47626,,0,1
8702,CTRI/2020/11/029142,Not Yet Recruiting,,,,After study completion results will be published,,2020-11-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49439,,0,1
8703,CTRI/2020/11/029141,Not Yet Recruiting,,,,Not Yet Published,,2020-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49486,,0,1
8704,CTRI/2020/11/029144,Completed,,2020-12-28,,None yet,,2021-10-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49306,2020-12-28,0,1
8705,CTRI/2020/11/029146,Not Yet Recruiting,,,,Nil,,2020-11-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879,,0,1
8706,CTRI/2020/11/029170,Not Yet Recruiting,,,,None,,2020-11-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412,,0,1
8707,CTRI/2020/11/029148,Not Yet Recruiting,,,,None yet,,2020-11-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49160,,0,1
8708,CTRI/2020/11/029188,Not Yet Recruiting,,,,NIL,,2020-11-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47149,,0,1
8709,CTRI/2020/11/029174,Not Yet Recruiting,,,,NIL,,2020-11-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48433,,0,1
8710,CTRI/2020/11/029159,Not Yet Recruiting,,,,not yet,,2020-11-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44643,,0,1
8711,CTRI/2020/11/029173,Not Yet Recruiting,,,,"1. Nephrology. 2020;e13760. https://doi.org/10.1111/nep.13760_x000D_
_x000D_
_x000D_
2. Kidney360¬†August 2020,¬†1¬†(8)¬†755-762;¬†DOI: https://doi.org/10.34067/KID.0003672020_x000D_
_x000D_
3.¬†Kidney Int. 2020;98(1):27-34. doi:10.1016/j.kint.2020.04.031_x000D_
_x000D_
4.¬†Kidney Int Rep. 2020;5(5):580-585. Published 2020 Apr 4. doi:10.1016/j.ekir.2020.04.001_x000D_
_x000D_
_x000D_
5. Hemodialysis International. doi:10.1111/hdi.12861_x000D_
  _x000D_
6.¬†J Clin Med. 2020;9(6):1688. Published 2020 Jun 2. doi:10.3390/jcm9061688_x000D_
_x000D_
_x000D_
7. Iranian Journal of Kidney Diseases,¬†14(4), 267‚Äì277._x000D_
_x000D_
8. doi: https://doi.org/10.1681/ASN.2020050589_x000D_
 _x000D_
9. Zhenjian Xu,¬†Ying Tang,¬†Qiuyan Huang,¬†Sha Fu,¬†Xiaomei Li,¬†Baojuan Lin,¬†Anping Xu,¬†Junzhe Chen_x000D_
doi :10.21203/rs.3.rs-52615/v1",,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49522,,0,1
8712,CTRI/2020/11/029172,Not Yet Recruiting,,,,None yet,,2020-11-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49271,,0,1
8713,CTRI/2020/11/029166,Completed,,2021-05-16,,not applicable,,2021-07-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785,2021-05-16,0,1
8714,CTRI/2020/11/029171,Not Yet Recruiting,,,,NIL,,2020-11-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49097,,0,1
8715,CTRI/2020/11/029200,Not Yet Recruiting,,,,,,2020-11-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49556,,0,0
8716,CTRI/2020/11/029233,Not Yet Recruiting,,,,Nil,,2020-11-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177,,0,1
8717,CTRI/2020/11/029221,Not Yet Recruiting,,,,None Yet,,2020-11-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49250,,0,1
8718,CTRI/2020/11/029235,Not Yet Recruiting,,,,None yet,,2020-11-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49267,,0,1
8719,CTRI/2020/11/029232,Not Yet Recruiting,,,,,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293,,0,0
8720,CTRI/2020/11/029230,Not Yet Recruiting,,,,,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295,,0,0
8721,CTRI/2020/11/029236,Open to Recruitment,,,,Not yet started data collection,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48376,,0,1
8722,CTRI/2020/11/029263,Open to Recruitment,,,,None yet,,2021-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353,,0,1
8723,CTRI/2020/11/029265,Completed,,2021-01-19,,Not yet; to be published later,,2021-03-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401,2021-01-19,0,1
8724,CTRI/2020/11/029264,Not Yet Recruiting,,,,Nil,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47176,,0,1
8725,CTRI/2020/11/029266,Not Yet Recruiting,,,,nil,,2020-11-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49576,,0,1
8726,CTRI/2020/11/029289,Not Yet Recruiting,,,,Nil,,2021-05-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077,,0,1
8727,CTRI/2020/11/029297,Closed to Recruitment of Participants,,,,Nil,,2021-11-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47331,,0,1
8728,CTRI/2020/11/029305,Not Yet Recruiting,,,,Study will be published for academic purpose,,2020-11-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195,,0,1
8729,CTRI/2020/11/029328,Completed,,2021-04-22,,,,2022-02-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552,2021-04-22,0,0
8730,CTRI/2020/11/029335,Not Yet Recruiting,,,,NIL,,2020-11-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49555,,0,1
8731,CTRI/2020/11/029356,Completed,,2021-08-20,,NIL,,2021-10-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432,2021-08-20,0,1
8732,CTRI/2020/11/029346,Closed to Recruitment of Participants,,,,NOT YET PUBLISHED ANYWHERE,,2021-10-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444,,0,1
8733,CTRI/2020/11/029350,Not Yet Recruiting,,,,NIL,,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49535,,0,1
8734,CTRI/2020/11/029376,,,,,,,,,,0,0
8735,CTRI/2020/11/029396,Other (Terminated),,,,NIL,,2021-06-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442,,0,1
8736,CTRI/2020/11/029399,Not Yet Recruiting,,,,NIL,,2020-12-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714,,0,1
8737,CTRI/2020/11/029393,Not Yet Recruiting,,,,not published yet,,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48183,,0,1
8738,CTRI/2020/11/029398,Completed,,2021-01-31,,,,2021-03-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49741,2021-01-31,0,0
8739,CTRI/2020/11/029377,Completed,,2021-04-30,,Not applicable currently,,2022-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49498,2021-04-30,0,1
8740,CTRI/2020/11/029414,Not Yet Recruiting,,,,Nil at present,,2020-11-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49245,,0,1
8741,CTRI/2020/11/029388,Suspended,,,,NIL,,2022-01-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529,,0,1
8742,CTRI/2020/11/029394,Not Yet Recruiting,,,,"NIL;_x000D_
_x000D_
We are planning to communicate a manuscript from this data very soon",,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48280,,0,1
8743,CTRI/2020/11/029390,Not Yet Recruiting,,,,NIL,,2020-11-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49606,,0,1
8744,CTRI/2020/11/029444,Not Yet Recruiting,,,,NIL,,2020-11-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712,,0,1
8745,CTRI/2020/11/029437,Not Yet Recruiting,,,,Not published yet,,2020-11-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49744,,0,1
8746,CTRI/2020/11/029438,Open to Recruitment,,,,,,2021-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49809,,0,0
8747,CTRI/2020/07/026300,Completed,,,,NIL,,2021-03-17,,,0,1
8748,CTRI/2020/05/024959,Completed,,2020-07-07,,None Yet,,2020-08-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,2020-07-07,0,1
8749,CTRI/2021/01/030830,Not Yet Recruiting,,,,NIL,,2021-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52067,,0,1
8750,CTRI/2020/09/027833,Not Yet Recruiting,,,,Nil,,2020-09-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46839,,0,1
8751,CTRI/2020/11/029345,Open to Recruitment,,,,,,2021-10-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48213,,0,0
8752,CTRI/2020/11/029234,Closed to Recruitment of Participants,,,,Not Applicable,,2022-01-12,,,0,1
8753,CTRI/2020/11/028976,Closed to Recruitment of Participants,,,,"Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial,Citation DataThe Lancet, ISSN: 0140-6736, Vol: 398, Issue: 10317, Page: 2173-2184",,2022-03-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,,0,1
8754,CTRI/2020/08/027205,Closed to Recruitment of Participants,,,,NIL,,2021-07-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45488,,0,1
8755,CTRI/2020/09/027680,Open to Recruitment,,,,NIL,,2020-09-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46451,,0,1
8756,CTRI/2020/10/028731,Completed,,,,"Munch MW, Granholm A, Myatra SN, Vijayaraghavan B, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Kjaer MN, Vesterlund GK, Meyhoff TS, Helleberg M, M√∏ller MH, Benfield T, Venkatesh B, Hammond N, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, J√∏rgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Br√∏chner AC, Str√∏m T, M√∏ller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Gluud C, Lange T, Perner A. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2021 Feb 14:10.1111/aas.13795. doi: 10.1111/aas.13795. Epub ahead of print. PMID: 33583034; PMCID: PMC8014264.",,2021-09-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46442,,0,1
8757,CTRI/2020/12/029475,Not Yet Recruiting,,,,NIL,,2020-11-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49723,,0,1
8758,CTRI/2020/12/029476,Not Yet Recruiting,,,,NIL,,2020-11-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48455,,0,1
8759,CTRI/2020/12/029452,Not Yet Recruiting,,,,not yet published,,2020-11-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49272,,0,1
8760,CTRI/2020/12/029478,Not Yet Recruiting,,,,,,2020-11-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49796,,0,0
8761,CTRI/2020/12/029454,Not Yet Recruiting,,,,Nil,,2020-11-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49574,,0,1
8762,CTRI/2020/12/029463,Not Yet Recruiting,,,,NIL,,2020-11-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49849,,0,1
8763,CTRI/2020/12/029456,Not Yet Recruiting,,,,Not yet,,2020-12-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49340,,0,1
8764,CTRI/2020/12/029515,Not Yet Recruiting,,,,NIL,,2020-12-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49857,,0,1
8765,CTRI/2020/12/029575,Not Yet Recruiting,,,,Result of the trial will be published in open access Journal,,2020-12-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49430,,0,1
8766,CTRI/2020/12/029581,Not Yet Recruiting,,,,WILL BE PUBLISHED IN INDEXED JOURNAL .,,2020-12-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49709,,0,1
8767,CTRI/2020/12/029586,Not Yet Recruiting,,,,nil,,2020-12-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49982,,0,1
8768,CTRI/2020/12/029563,Not Yet Recruiting,,,,NIL,,2020-12-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49001,,0,1
8769,CTRI/2020/12/029584,Not Yet Recruiting,,,,not yet published any,,2020-11-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49269,,0,1
8770,CTRI/2020/12/029587,Not Yet Recruiting,,,,nil,,2020-12-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49803,,0,1
8771,CTRI/2020/12/029585,Not Yet Recruiting,,,,Nil,,2020-12-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49854,,0,1
8772,CTRI/2020/12/029614,Not Yet Recruiting,,,,NIL,,2020-12-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49680,,0,1
8773,CTRI/2020/12/029615,Not Yet Recruiting,,,,Nil,,2020-12-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731,,0,1
8774,CTRI/2020/12/029613,Not Yet Recruiting,,,,none,,2020-12-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026,,0,1
8775,CTRI/2020/12/029671,Not Yet Recruiting,,,,NIL,,2020-12-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48689,,0,1
8776,CTRI/2020/12/029668,Completed,,,,Nil,,2021-09-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45821,,0,1
8777,CTRI/2020/12/029669,Not Yet Recruiting,,,,NIL,,2020-12-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50175,,0,1
8778,CTRI/2020/12/029712,Not Yet Recruiting,,,,Not yet published,,2020-12-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49971,,0,1
8779,CTRI/2020/12/029724,Not Yet Recruiting,,,,NIL,,2020-12-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50076,,0,1
8780,CTRI/2020/12/029713,Open to Recruitment,,,,NOT YET PUBLISHED,,2020-12-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46813,,0,1
8781,CTRI/2020/12/029714,Open to Recruitment,,,,NOT YET PUBLISHED,,2020-12-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46814,,0,1
8782,CTRI/2020/12/029755,Not Yet Recruiting,,,,nil,,2020-12-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50254,,0,1
8783,CTRI/2020/12/029743,Not Yet Recruiting,,,,NIL,,2020-12-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48997,,0,1
8784,CTRI/2020/12/029733,Not Yet Recruiting,,,,Nil,,2020-12-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50279,,0,1
8785,CTRI/2020/12/029735,Completed,,2021-03-30,,NIL,,2021-05-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48763,2021-03-30,0,1
8786,CTRI/2020/12/029754,Not Yet Recruiting,,,,nil,,2020-12-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50080,,0,1
8787,CTRI/2020/12/029744,Not Yet Recruiting,,,,NIL,,2020-12-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49072,,0,1
8788,CTRI/2020/12/029745,Completed,,2021-02-28,,"We propose to publish the study protocol, results , perceptions and practice as three different research publications at the end of the study.",,2021-07-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49613,2021-02-28,0,1
8789,CTRI/2020/12/029761,Open to Recruitment,,,,NIL,,2021-06-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49404,,0,1
8790,CTRI/2020/12/029780,Not Yet Recruiting,,,,,,2020-12-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49510,,0,0
8791,CTRI/2020/12/029773,Not Yet Recruiting,,,,NIL,,2020-12-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50309,,0,1
8792,CTRI/2020/12/029772,Not Yet Recruiting,,,,Not yet,,2020-12-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50363,,0,1
8793,CTRI/2020/12/029783,Open to Recruitment,,,,NIL,,2021-06-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49405,,0,1
8794,CTRI/2020/12/029805,Not Yet Recruiting,,,,NIL,,2020-12-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50445,,0,1
8795,CTRI/2020/12/029812,Not Yet Recruiting,,,,NIL till date but as the data is collected the resuLts will be published.,,2020-12-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50458,,0,1
8796,CTRI/2020/12/029803,Not Yet Recruiting,,,,Nil,,2020-12-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49947,,0,1
8797,CTRI/2020/12/029814,Completed,,2021-03-31,,ON PROCESS,,2021-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49778,2021-03-31,0,1
8798,CTRI/2020/12/029793,Not Yet Recruiting,,,,nil,,2020-12-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50303,,0,1
8799,CTRI/2020/12/029841,Open to Recruitment,,,,None Yet,,2021-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48427,,0,1
8800,CTRI/2020/12/029847,Not Yet Recruiting,,,,None yet,,2020-12-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50526,,0,1
8801,CTRI/2020/12/029855,Closed to Recruitment of Participants,,,,NIL,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49858,,0,1
8802,CTRI/2020/12/029869,Not Yet Recruiting,,,,Not yet published,,2021-03-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50422,,0,1
8803,CTRI/2020/12/029873,Not Yet Recruiting,,,,nil,,2020-12-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50567,,0,1
8804,CTRI/2020/12/029887,Not Yet Recruiting,,,,None yet,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50575,,0,1
8805,CTRI/2020/12/029884,Completed,,2021-01-31,,under review,,2021-08-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50596,2021-01-31,0,1
8806,CTRI/2020/12/029885,Not Yet Recruiting,,,,NIL,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50606,,0,1
8807,CTRI/2020/12/029882,Not Yet Recruiting,,,,NIL,,2020-12-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50155,,0,1
8808,CTRI/2020/12/029894,Not Yet Recruiting,,,,Study will be published after completion in a peer reviewed journal,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49273,,0,1
8809,CTRI/2020/12/029896,Open to Recruitment,,,,Nil,,2021-06-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45178,,0,1
8810,CTRI/2020/12/029926,Completed,,2021-03-31,,Assessed results will be analyzed and published in a suitable indexed journals,,2021-04-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50574,2021-03-31,0,1
8811,CTRI/2020/12/029898,Open to Recruitment,,,,NIL,,2021-11-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48811,,0,1
8812,CTRI/2020/12/029902,Open to Recruitment,,,,None yet,,2021-01-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49842,,0,1
8813,CTRI/2020/12/029900,Completed,,2021-02-28,,Nil,,2021-05-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50369,2021-02-28,0,1
8814,CTRI/2020/12/029901,Not Yet Recruiting,,,,After completion of CTRI Registration,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50383,,0,1
8815,CTRI/2020/12/029897,Not Yet Recruiting,,,,NIL,,2020-12-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50388,,0,1
8816,CTRI/2020/12/029957,Not Yet Recruiting,,,,nil,,2020-12-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48186,,0,1
8817,CTRI/2020/12/029956,Not Yet Recruiting,,,,After completion of CTRI registration,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50542,,0,1
8818,CTRI/2020/12/029955,Completed,,2021-03-30,,NIL,,2021-05-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48528,2021-03-30,0,1
8819,CTRI/2020/12/029954,Not Yet Recruiting,,,,,,2020-12-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50385,,0,0
8820,CTRI/2020/12/029970,Not Yet Recruiting,,,,Nil,,2020-12-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46461,,0,1
8821,CTRI/2020/12/029982,Completed,,2021-04-14,,NIL,,2021-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50712,2021-04-14,0,1
8822,CTRI/2020/12/029985,Open to Recruitment,,,,None yet,,2021-05-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50354,,0,1
8823,CTRI/2020/12/029984,Open to Recruitment,,,,Not yet decided about publication.,,2021-05-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49872,,0,1
8824,CTRI/2020/12/029981,Not Yet Recruiting,,,,Nil,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50659,,0,1
8825,CTRI/2020/12/030015,Not Yet Recruiting,,,,NIL,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50436,,0,1
8826,CTRI/2020/12/030014,Not Yet Recruiting,,,,NIL,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50457,,0,1
8827,CTRI/2020/12/030013,Open to Recruitment,,,,Nil,,2022-01-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50222,,0,1
8828,CTRI/2020/12/030046,Not Yet Recruiting,,,,,,2020-12-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50693,,0,0
8829,CTRI/2020/12/030049,Not Yet Recruiting,,,,NIL,,2020-12-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50718,,0,1
8830,CTRI/2020/12/030050,Not Yet Recruiting,,,,nil,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50778,,0,1
8831,CTRI/2020/12/030044,Completed,,2021-02-28,,NIL,,2021-05-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50524,2021-02-28,0,1
8832,CTRI/2020/12/030072,Completed,,,,Data Will Be USed For Publication.,,2021-10-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50013,,0,1
8833,CTRI/2020/12/030048,Not Yet Recruiting,,,,NIL,,2020-12-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50284,,0,1
8834,CTRI/2020/12/030053,Not Yet Recruiting,,,,NIL,,2020-12-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50813,,0,1
8835,CTRI/2020/12/030070,Not Yet Recruiting,,,,NIL,,2020-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50147,,0,1
8836,CTRI/2020/12/030052,Not Yet Recruiting,,,,Nil None yet,,2020-12-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50149,,0,1
8837,CTRI/2020/12/030051,Open to Recruitment,,,,Nil,,2021-10-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48880,,0,1
8838,CTRI/2020/12/030083,Not Yet Recruiting,,,,Nil,,2021-01-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46899,,0,1
8839,CTRI/2020/12/030085,Not Yet Recruiting,,,,,,2020-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50812,,0,0
8840,CTRI/2020/12/030094,Not Yet Recruiting,,,,NIL,,2020-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49616,,0,1
8841,CTRI/2020/12/030082,Not Yet Recruiting,,,,NOT APPLICABLE,,2020-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50171,,0,1
8842,CTRI/2020/12/030113,Not Yet Recruiting,,,,,,2020-12-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50776,,0,0
8843,CTRI/2020/12/030127,Not Yet Recruiting,,,,not yet published,,2020-12-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49841,,0,1
8844,CTRI/2020/12/030165,Completed,,2021-02-24,,Not yet,,2021-02-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50753,2021-02-24,0,1
8845,CTRI/2020/12/030164,Not Yet Recruiting,,,,Nil,,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50578,,0,1
8846,CTRI/2020/12/030143,Not Yet Recruiting,,,,none,,2020-12-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50886,,0,1
8847,CTRI/2020/12/030156,Completed,,2021-04-29,,NIL,,2021-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50914,2021-04-29,0,1
8848,CTRI/2021/01/030169,Completed,,2021-07-10,,Nil,,2021-07-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50842,2021-07-10,0,1
8849,CTRI/2021/01/030186,Open to Recruitment,,,,Nil,,2021-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49335,,0,1
8850,CTRI/2021/01/030231,Closed to Recruitment of Participants,,,,Not applicable,,2021-05-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50985,,0,1
8851,CTRI/2021/01/030202,Not Yet Recruiting,,,,will be published after completion of CTRI approval,,2020-12-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51001,,0,1
8852,CTRI/2021/01/030212,Not Yet Recruiting,,,,Will be published after completion of study,,2020-12-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51005,,0,1
8853,CTRI/2021/01/030197,Not Yet Recruiting,,,,NIL,,2021-01-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49519,,0,1
8854,CTRI/2021/01/030213,Not Yet Recruiting,,,,None Yet,,2020-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50861,,0,1
8855,CTRI/2021/01/030241,Not Yet Recruiting,,,,NIL,,2021-01-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50515,,0,1
8856,CTRI/2021/01/030242,Not Yet Recruiting,,,,NIl,,2021-01-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51037,,0,1
8857,CTRI/2021/01/030236,Not Yet Recruiting,,,,Nil,,2021-01-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50290,,0,1
8858,CTRI/2021/01/030235,Completed,,,,The results of the study will be presented at the national and international meetings and published in the peer-reviewed journals.,,2021-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51076,,0,1
8859,CTRI/2021/01/030244,Not Yet Recruiting,,,,Nil,,2021-01-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51152,,0,1
8860,CTRI/2021/01/030297,Open to Recruitment,,,,Not applicable,,2021-01-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51101,,0,1
8861,CTRI/2021/01/030316,Not Yet Recruiting,,,,Not yet published. Will decide after data collection,,2021-01-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47274,,0,1
8862,CTRI/2021/01/030319,Not Yet Recruiting,,,,NIL,,2021-01-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50887,,0,1
8863,CTRI/2021/01/030333,Not Yet Recruiting,,,,Nil,,2021-01-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50964,,0,1
8864,CTRI/2021/01/030341,Not Yet Recruiting,,,,Nil,,2021-01-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51287,,0,1
8865,CTRI/2021/01/030344,Not Yet Recruiting,,,,NIL,,2021-01-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50637,,0,1
8866,CTRI/2021/01/030363,Not Yet Recruiting,,,,Nil,,2021-01-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50953,,0,1
8867,CTRI/2021/01/030364,Not Yet Recruiting,,,,NIL,,2021-01-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49740,,0,1
8868,CTRI/2021/01/030373,Open to Recruitment,,,,,,2022-02-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50288,,0,0
8869,CTRI/2021/01/030385,Not Yet Recruiting,,,,Nil,,2021-01-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51172,,0,1
8870,CTRI/2021/01/030384,Not Yet Recruiting,,,,"References _x000D_
_x000D_
1. Factors Associated with Mortality in Adult Population Admitted with COVID-19 Chilimuri et al._x000D_
_x000D_
2 .Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of_x000D_
probable bat origin. Nature. 2020;579(7798):270√¢‚Ç¨‚Äú273. doi:10.1038/s41586-020-2012-7_x000D_
_x000D_
3. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis [published online ahead of print, 2020 Mar 12]. Int J Infect Dis. 2020;S1201-9712(20)30136-3. doi:10.1016/j.ijid.2020.03.017_x000D_
_x000D_
4. A Machine Learning Model Reveals Older Age and Delayed Hospitalization_x000D_
as Predictors of Mortality in Patients with COVID-19 Jit Sarkar                                                         doi: https://doi.org/10.1101/2020.03.25.20043331",,2021-01-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50170,,0,1
8871,CTRI/2021/01/030416,Closed to Recruitment of Participants,,,,NIL,,2021-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51254,,0,1
8872,CTRI/2021/01/030414,Not Yet Recruiting,,,,NIL,,2021-01-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51377,,0,1
8873,CTRI/2021/01/030433,Not Yet Recruiting,,,,NIL,,2021-01-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49676,,0,1
8874,CTRI/2021/01/030432,Not Yet Recruiting,,,,One publication in International scopus indexed journal,,2021-01-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51518,,0,1
8875,CTRI/2021/01/030430,Completed,,2021-02-22,,Nil,,2021-07-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51547,2021-02-22,0,1
8876,CTRI/2021/01/030431,Completed,,2021-06-29,,Nil,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51381,2021-06-29,0,1
8877,CTRI/2021/01/030454,Completed,,,,Not yet done,,2021-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51491,,0,1
8878,CTRI/2021/01/030451,Not Yet Recruiting,,,,Nil,,2021-01-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49457,,0,1
8879,CTRI/2021/01/030477,Not Yet Recruiting,,,,NIL,,2021-01-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48197,,0,1
8880,CTRI/2021/01/030455,Closed to Recruitment of Participants,,,,Nil,,2021-06-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51086,,0,1
8881,CTRI/2021/01/030456,Not Yet Recruiting,,,,NIL,,2021-01-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51410,,0,1
8882,CTRI/2021/01/030485,Not Yet Recruiting,,,,nil,,2021-01-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51385,,0,1
8883,CTRI/2021/01/030488,Completed,,2021-04-30,,None,,2021-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51403,2021-04-30,0,1
8884,CTRI/2021/01/030522,Not Yet Recruiting,,,,Not published,,2021-01-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51566,,0,1
8885,CTRI/2021/01/030529,Not Yet Recruiting,,,,The outcome of the study will be published in appropriate journal,,2021-01-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51315,,0,1
8886,CTRI/2021/01/030534,Not Yet Recruiting,,,,Not yet,,2021-01-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51122,,0,1
8887,CTRI/2021/01/030533,Not Yet Recruiting,,,,WILL BE PUBLISHED AFTER APPROPRIATE STATISTICAL ANALYSIS,,2021-01-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51393,,0,1
8888,CTRI/2021/01/030546,Completed,,,,NILL,,2021-02-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51674,,0,1
8889,CTRI/2021/01/030573,Not Yet Recruiting,,,,None,,2021-01-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51269,,0,1
8890,CTRI/2021/01/030582,Not Yet Recruiting,,,,None,,2021-01-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51278,,0,1
8891,CTRI/2021/01/030603,Not Yet Recruiting,,,,NIL,,2021-01-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51728,,0,1
8892,CTRI/2021/01/030601,Open to Recruitment,,,,NIL,,2021-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50754,,0,1
8893,CTRI/2021/01/030630,Not Yet Recruiting,,,,Nil,,2021-01-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47720,,0,1
8894,CTRI/2021/01/030604,Not Yet Recruiting,,,,NIL,,2021-01-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49046,,0,1
8895,CTRI/2021/01/030652,Not Yet Recruiting,,,,NIL,,2021-01-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51761,,0,1
8896,CTRI/2021/01/030647,Not Yet Recruiting,,,,NIL,,2021-01-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51078,,0,1
8897,CTRI/2021/01/030651,Open to Recruitment,,,,NIL,,2021-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49805,,0,1
8898,CTRI/2021/01/030661,Not Yet Recruiting,,,,,,2021-01-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48292,,0,0
8899,CTRI/2021/01/030679,Not Yet Recruiting,,,,none,,2021-06-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50788,,0,1
8900,CTRI/2021/01/030680,Not Yet Recruiting,,,,NIL,,2021-01-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51368,,0,1
8901,CTRI/2021/01/030722,Not Yet Recruiting,,,,NIL,,2021-01-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51390,,0,1
8902,CTRI/2021/01/030733,Completed,,,,Not yet done,,2021-06-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51715,,0,1
8903,CTRI/2021/01/030743,Not Yet Recruiting,,,,nil,,2021-01-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48798,,0,1
8904,CTRI/2021/01/030729,Completed,,2021-03-01,,nil,,2021-06-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51654,2021-03-01,0,1
8905,CTRI/2021/01/030734,Closed to Recruitment of Participants,,,,,,2021-06-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50936,,0,0
8906,CTRI/2021/01/030789,Not Yet Recruiting,,,,NOT YET PUBLISHED,,2021-01-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50967,,0,1
8907,CTRI/2021/01/030782,Closed to Recruitment of Participants,,,,"Yes, we will publish the results",,2021-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52014,,0,1
8908,CTRI/2021/01/030752,Not Yet Recruiting,,,,NIL,,2021-01-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51380,,0,1
8909,CTRI/2021/01/030788,Completed,,2021-04-12,,NIL,,2021-06-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50911,2021-04-12,0,1
8910,CTRI/2021/01/030796,Completed,,2021-04-19,,NIL,,2022-03-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51818,2021-04-19,0,1
8911,CTRI/2021/01/030795,Completed,,2021-06-16,,NIL,,2021-07-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51391,2021-06-16,0,1
8912,CTRI/2021/01/030794,Not Yet Recruiting,,,,Not published.,,2021-04-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50368,,0,1
8913,CTRI/2021/01/030793,Open to Recruitment,,,,NIL,,2021-07-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48850,,0,1
8914,CTRI/2021/01/030816,Not Yet Recruiting,,,,NIL,,2021-01-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51937,,0,1
8915,CTRI/2021/01/030826,Not Yet Recruiting,,,,Results will be published after completion of the trail,,2021-01-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47638,,0,1
8916,CTRI/2021/01/030829,Completed,,2021-04-28,,nil,,2021-05-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51297,2021-04-28,0,1
8917,CTRI/2021/01/030830,Not Yet Recruiting,,,,NIL,,2021-08-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52067,,0,1
8918,CTRI/2021/01/030825,Open to Recruitment,,,,NIL,,2022-02-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51863,,0,1
8919,CTRI/2021/01/030824,Completed,,2021-11-30,,Nil,,2022-01-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50900,2021-11-30,0,1
8920,CTRI/2021/01/030843,Completed,,2021-08-08,,NIL,,2021-09-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46808,2021-08-08,0,1
8921,CTRI/2021/02/030887,Completed,,,,Data will be published upon completion by the Study Sponsor.,,2022-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48386,,0,1
8922,CTRI/2021/02/030892,Completed,,2021-06-16,,NIL,,2021-08-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49972,2021-06-16,0,1
8923,CTRI/2021/02/030878,Not Yet Recruiting,,,,NIL,,2021-01-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51853,,0,1
8924,CTRI/2021/02/030880,Completed,,2020-09-30,,NIL,,2022-01-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45246,2020-09-30,0,1
8925,CTRI/2021/02/030897,Open to Recruitment,,,,Nil,,2021-08-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52184,,0,1
8926,CTRI/2021/02/030946,Not Yet Recruiting,,,,Nil,,2021-02-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52174,,0,1
8927,CTRI/2021/02/030947,Not Yet Recruiting,,,,Nil,,2021-01-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52200,,0,1
8928,CTRI/2021/02/030957,Completed,,2021-05-16,,NIL,,2021-06-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52251,2021-05-16,0,1
8929,CTRI/2021/02/030950,Not Yet Recruiting,,,,nil,,2021-02-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52209,,0,1
8930,CTRI/2021/02/030986,Open to Recruitment,,,,NIL,,2021-09-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51800,,0,1
8931,CTRI/2021/02/031011,Not Yet Recruiting,,,,NIL,,2021-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52142,,0,1
8932,CTRI/2021/02/031012,Open to Recruitment,,,,Nil,,2021-02-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51954,,0,1
8933,CTRI/2021/02/031036,Not Yet Recruiting,,,,nil,,2021-02-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51219,,0,1
8934,CTRI/2021/02/031052,Completed,,2021-08-25,,NIL,,2022-02-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46372,2021-08-25,0,1
8935,CTRI/2021/02/031096,Not Yet Recruiting,,,,NIL,,2021-02-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51462,,0,1
8936,CTRI/2021/02/031079,Not Yet Recruiting,,,,The manuscript(s) for publication in international journals will be prepared after completion of the study.,,2021-02-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52326,,0,1
8937,CTRI/2021/02/031123,Not Yet Recruiting,,,,Nil,,2021-02-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51974,,0,1
8938,CTRI/2021/02/031115,Not Yet Recruiting,,,,NIL,,2021-02-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52268,,0,1
8939,CTRI/2021/02/031139,Not Yet Recruiting,,,,Not Published,,2021-02-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49499,,0,1
8940,CTRI/2021/02/031138,Not Yet Recruiting,,,,,,2021-02-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52439,,0,0
8941,CTRI/2021/02/031176,Not Yet Recruiting,,,,Nil,,2021-02-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52050,,0,1
8942,CTRI/2021/02/031197,Not Yet Recruiting,,,,Nil,,2021-02-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51049,,0,1
8943,CTRI/2021/02/031165,Not Yet Recruiting,,,,NIL,,2021-02-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52169,,0,1
8944,CTRI/2021/02/031232,Not Yet Recruiting,,,,NIL,,2021-02-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52011,,0,1
8945,CTRI/2021/02/031212,Not Yet Recruiting,,,,Nil,,2021-02-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48458,,0,1
8946,CTRI/2021/02/031230,Not Yet Recruiting,,,,Nil,,2021-02-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52097,,0,1
8947,CTRI/2021/02/031256,Completed,,2021-03-17,,Nil,,2021-04-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52613,2021-03-17,0,1
8948,CTRI/2021/02/031295,Completed,,,,NIL,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327,,0,1
8949,CTRI/2021/02/031286,Not Yet Recruiting,,,,NIL,,2021-02-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52451,,0,1
8950,CTRI/2021/02/031322,Open to Recruitment,,,,NIL,,2021-12-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52024,,0,1
8951,CTRI/2021/02/031353,Completed,,,,NIL,,2021-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52810,,0,1
8952,CTRI/2021/02/031357,Open to Recruitment,,,,,,2021-09-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52837,,0,0
8953,CTRI/2021/02/031370,Not Yet Recruiting,,,,nil,,2021-02-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52587,,0,1
8954,CTRI/2021/02/031375,Completed,,2021-05-20,,nil,,2021-05-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52608,2021-05-20,0,1
8955,CTRI/2021/02/031394,Not Yet Recruiting,,,,Trial has not been published yet.,,2021-02-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51833,,0,1
8956,CTRI/2021/02/031424,Not Yet Recruiting,,,,Medical journal,,2021-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51886,,0,1
8957,CTRI/2021/02/031420,Not Yet Recruiting,,,,Nil,,2021-02-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52957,,0,1
8958,CTRI/2021/02/031409,Not Yet Recruiting,,,,NIL,,2021-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50943,,0,1
8959,CTRI/2021/02/031451,Completed,,2021-03-04,,,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52576,2021-03-04,0,0
8960,CTRI/2021/02/031430,Completed,,2021-03-31,,NIL,,2021-06-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47292,2021-03-31,0,1
8961,CTRI/2021/02/031479,Completed,,2021-05-03,,not yet,,2021-05-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48898,2021-05-03,0,1
8962,CTRI/2021/02/031484,Not Yet Recruiting,,,,Nil,,2021-02-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52585,,0,1
8963,CTRI/2021/02/031472,Not Yet Recruiting,,,,NIL,,2021-02-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50600,,0,1
8964,CTRI/2021/02/031520,Completed,,2021-06-03,,NIL,,2021-09-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52515,2021-06-03,0,1
8965,CTRI/2021/02/031523,Not Yet Recruiting,,,,Not yet Published,,2021-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52370,,0,1
8966,CTRI/2021/02/031521,Not Yet Recruiting,,,,NIL,,2021-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50379,,0,1
8967,CTRI/2021/02/031570,Completed,,2021-05-30,,NIL,,2021-05-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53018,2021-05-30,0,1
8968,CTRI/2021/02/031541,Not Yet Recruiting,,,,to be published in peer reviewed journal when  the study is complete.,,2021-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52099,,0,1
8969,CTRI/2021/02/031566,Open to Recruitment,,,,Nil.,,2022-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51849,,0,1
8970,CTRI/2021/02/031547,Open to Recruitment,,,,published in Social Science Research Network website,,2022-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43929,,0,1
8971,CTRI/2021/02/031543,Open to Recruitment,,,,None,,2021-09-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52892,,0,1
8972,CTRI/2021/02/031554,Open to Recruitment,,,,Nil,,2021-09-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49327,,0,1
8973,CTRI/2021/02/031545,Not Yet Recruiting,,,,Nil,,2021-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52734,,0,1
8974,CTRI/2021/03/031616,Closed to Recruitment of Participants,,,,NIL,,2021-11-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52784,,0,1
8975,CTRI/2021/03/031615,Open to Recruitment,,,,NIL,,2021-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53060,,0,1
8976,CTRI/2021/03/031614,Not Yet Recruiting,,,,NIL,,2021-02-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52090,,0,1
8977,CTRI/2021/03/031617,Not Yet Recruiting,,,,nil,,2021-02-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53164,,0,1
8978,CTRI/2021/03/031663,Not Yet Recruiting,,,,NIL,,2021-02-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53270,,0,1
8979,CTRI/2021/03/031665,Not Yet Recruiting,,,,NIL,,2021-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53325,,0,1
8980,CTRI/2021/03/031668,Not Yet Recruiting,,,,nil,,2021-02-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52317,,0,1
8981,CTRI/2021/03/031664,Not Yet Recruiting,,,,The Publication will be done after study completion,,2021-05-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52574,,0,1
8982,CTRI/2021/03/031667,Not Yet Recruiting,,,,Nil,,2021-02-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53117,,0,1
8983,CTRI/2021/03/031666,Completed,,2021-09-30,,,,2021-10-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52917,2021-09-30,0,0
8984,CTRI/2021/03/031662,Not Yet Recruiting,,,,Nil,,2021-02-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51935,,0,1
8985,CTRI/2021/03/031684,Not Yet Recruiting,,,,NIL,,2021-03-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52741,,0,1
8986,CTRI/2021/03/031687,Not Yet Recruiting,,,,Nil,,2021-03-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53075,,0,1
8987,CTRI/2021/03/031685,Not Yet Recruiting,,,,nil,,2021-03-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53173,,0,1
8988,CTRI/2021/03/031686,Not Yet Recruiting,,,,,,2021-02-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53215,,0,0
8989,CTRI/2021/03/031721,Not Yet Recruiting,,,,NIL,,2021-03-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53532,,0,1
8990,CTRI/2021/03/031720,Not Yet Recruiting,,,,will be published on completion of study,,2021-03-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53161,,0,1
8991,CTRI/2021/03/031756,Completed,,2021-06-03,,Not Yet,,2021-03-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53298,2021-06-03,0,1
8992,CTRI/2021/03/031790,Completed,,2021-11-15,,NIL,,2021-12-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53090,2021-11-15,0,1
8993,CTRI/2021/03/031774,Not Yet Recruiting,,,,nil,,2021-03-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53613,,0,1
8994,CTRI/2021/03/031757,Completed,,2021-05-31,,NIL,,2021-06-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53151,2021-05-31,0,1
8995,CTRI/2021/03/031813,Completed,,2021-06-15,,Nil,,2021-07-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51555,2021-06-15,0,1
8996,CTRI/2021/03/031841,Not Yet Recruiting,,,,NIL,,2021-03-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51148,,0,1
8997,CTRI/2021/03/031815,Not Yet Recruiting,,,,NIL,,2021-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52987,,0,1
8998,CTRI/2021/03/031898,Not Yet Recruiting,,,,NIL,,2021-03-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53719,,0,1
8999,CTRI/2021/03/031933,Not Yet Recruiting,,,,nil,,2021-03-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53812,,0,1
9000,CTRI/2021/03/031907,Not Yet Recruiting,,,,Not yet published,,2021-03-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50741,,0,1
9001,CTRI/2021/03/031945,Completed,,2021-09-23,,NIL,,2021-09-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53809,2021-09-23,0,1
9002,CTRI/2021/03/031939,Not Yet Recruiting,,,,Nil,,2021-03-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49214,,0,1
9003,CTRI/2021/03/031940,Open to Recruitment,,,,none yet,,2021-12-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53172,,0,1
9004,CTRI/2021/03/031998,Open to Recruitment,,,,"The results from the study will be published in the following ways:_x000D_
1) Peer reviewed scientific journals & any other relevant journals_x000D_
2) Conference presentation_x000D_
3) Internal report",,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53828,,0,1
9005,CTRI/2021/03/031969,Not Yet Recruiting,,,,Nil,,2021-03-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52816,,0,1
9006,CTRI/2021/03/031970,Not Yet Recruiting,,,,Not yet published,,2021-03-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52372,,0,1
9007,CTRI/2021/03/032037,Completed,,2021-04-05,,NIL,,2021-04-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53771,2021-04-05,0,1
9008,CTRI/2021/03/032028,Not Yet Recruiting,,,,No publications yet,,2021-11-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53836,,0,1
9009,CTRI/2021/03/032051,Open to Recruitment,,,,,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53226,,0,0
9010,CTRI/2021/03/032072,Completed,,2021-05-10,,NIL,,2022-01-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53003,2021-05-10,0,1
9011,CTRI/2021/03/032066,Not Yet Recruiting,,,,Not yet published,,2021-03-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53263,,0,1
9012,CTRI/2021/03/032067,Not Yet Recruiting,,,,Nil,,2021-03-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52536,,0,1
9013,CTRI/2021/03/032063,Completed,,2021-05-16,,NIL,,2021-05-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53868,2021-05-16,0,1
9014,CTRI/2021/03/032059,Closed to Recruitment of Participants,,,,Nil,,2021-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53115,,0,1
9015,CTRI/2021/03/032065,Not Yet Recruiting,,,,NIL,,2021-03-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53939,,0,1
9016,CTRI/2021/03/032086,Not Yet Recruiting,,,,not applicable,,2021-03-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52929,,0,1
9017,CTRI/2021/03/032060,Completed,,,,nil,,2021-10-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53231,,0,1
9018,CTRI/2021/03/032135,Not Yet Recruiting,,,,Nil,,2021-03-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51532,,0,1
9019,CTRI/2021/03/032159,Not Yet Recruiting,,,,NIL,,2021-03-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52882,,0,1
9020,CTRI/2021/03/032158,Open to Recruitment,,,,None yet,,2021-03-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54015,,0,1
9021,CTRI/2021/03/032202,Not Yet Recruiting,,,,Nil,,2021-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53825,,0,1
9022,CTRI/2021/03/032199,Not Yet Recruiting,,,,None yet,,2021-03-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49593,,0,1
9023,CTRI/2021/03/032226,Not Yet Recruiting,,,,NIL,,2021-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54283,,0,1
9024,CTRI/2021/03/032225,Not Yet Recruiting,,,,None Yet,,2021-03-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50734,,0,1
9025,CTRI/2021/03/032204,Not Yet Recruiting,,,,Not published,,2021-03-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53623,,0,1
9026,CTRI/2021/03/032223,Not Yet Recruiting,,,,nil,,2021-03-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52880,,0,1
9027,CTRI/2021/03/032224,Not Yet Recruiting,,,,Nil,,2021-03-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50863,,0,1
9028,CTRI/2021/03/032227,Not Yet Recruiting,,,,Will be published after the study is completed,,2021-03-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54263,,0,1
9029,CTRI/2021/03/032279,Completed,,2021-12-21,,Nil,,2022-02-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54146,2021-12-21,0,1
9030,CTRI/2021/03/032276,Not Yet Recruiting,,,,Nil,,2021-03-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53439,,0,1
9031,CTRI/2021/03/032293,Not Yet Recruiting,,,,Nil,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45649,,0,1
9032,CTRI/2021/03/032292,Not Yet Recruiting,,,,NIL,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51793,,0,1
9033,CTRI/2021/03/032312,Not Yet Recruiting,,,,Nil,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54355,,0,1
9034,CTRI/2021/03/032357,Not Yet Recruiting,,,,,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54371,,0,0
9035,CTRI/2021/03/032356,Not Yet Recruiting,,,,,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54399,,0,0
9036,CTRI/2021/03/032361,Not Yet Recruiting,,,,Nil,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54426,,0,1
9037,CTRI/2021/03/032325,Completed,,2021-10-30,,nil,,2021-12-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53663,2021-10-30,0,1
9038,CTRI/2021/03/032348,Not Yet Recruiting,,,,Nil,,2021-03-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54210,,0,1
9039,CTRI/2021/03/032322,Not Yet Recruiting,,,,NIL,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51948,,0,1
9040,CTRI/2021/03/032410,Open to Recruitment,,,,Nil,,2022-01-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54078,,0,1
9041,CTRI/2021/03/032369,Not Yet Recruiting,,,,NIL,,2021-03-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52318,,0,1
9042,CTRI/2021/03/032368,Not Yet Recruiting,,,,NIL,,2021-03-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52589,,0,1
9043,CTRI/2021/03/032385,Not Yet Recruiting,,,,NIL,,2021-03-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54420,,0,1
9044,CTRI/2021/03/032367,Not Yet Recruiting,,,,NIL,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50375,,0,1
9045,CTRI/2021/03/032453,Not Yet Recruiting,,,,NIL,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54590,,0,1
9046,CTRI/2021/03/032444,Not Yet Recruiting,,,,,,2021-03-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54405,,0,0
9047,CTRI/2021/03/032471,Completed,,2020-11-16,,NIL,,2021-06-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54671,2020-11-16,0,1
9048,CTRI/2021/03/032451,Not Yet Recruiting,,,,nil,,2021-03-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44442,,0,1
9049,CTRI/2021/04/032473,Not Yet Recruiting,,,,NIL,,2021-03-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53763,,0,1
9050,CTRI/2021/04/032501,Not Yet Recruiting,,,,,,2021-04-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54364,,0,0
9051,CTRI/2021/04/032541,Open to Recruitment,,,,Nil,,2021-04-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54622,,0,1
9052,CTRI/2021/04/032531,Open to Recruitment,,,,NIL,,2021-05-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53930,,0,1
9053,CTRI/2021/04/032535,Not Yet Recruiting,,,,Nil,,2021-04-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54519,,0,1
9054,CTRI/2021/04/032572,Not Yet Recruiting,,,,NIL,,2021-04-01,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54034,,0,1
9055,CTRI/2021/04/032555,Open to Recruitment,,,,NIL,,2022-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54560,,0,1
9056,CTRI/2021/04/032619,Not Yet Recruiting,,,,NIL,,2021-04-05,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50992,,0,1
9057,CTRI/2021/04/032613,Not Yet Recruiting,,,,NIL,,2021-04-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54677,,0,1
9058,CTRI/2021/04/032627,Not Yet Recruiting,,,,NIL,,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54680,,0,1
9059,CTRI/2021/04/032615,Not Yet Recruiting,,,,NIL,,2021-04-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54741,,0,1
9060,CTRI/2021/04/032593,Open to Recruitment,,,,None,,2022-02-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54510,,0,1
9061,CTRI/2021/04/032670,Not Yet Recruiting,,,,NIL,,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54909,,0,1
9062,CTRI/2021/04/032647,Not Yet Recruiting,,,,Nil,,2021-04-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53666,,0,1
9063,CTRI/2021/04/032688,Closed to Recruitment of Participants,,,,Not Available,,2022-02-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54697,,0,1
9064,CTRI/2021/04/032648,Closed to Recruitment of Participants,,,,NIL,,2021-08-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51131,,0,1
9065,CTRI/2021/04/032707,Completed,,2021-05-17,,Nil,,2021-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52020,2021-05-17,0,1
9066,CTRI/2021/04/032705,Not Yet Recruiting,,,,NIL,,2021-04-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54965,,0,1
9067,CTRI/2021/04/032729,Not Yet Recruiting,,,,NIL,,2021-04-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54807,,0,1
9068,CTRI/2021/04/032747,Not Yet Recruiting,,,,NIL,,2021-04-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54580,,0,1
9069,CTRI/2021/04/032755,Completed,,,,Not yet decided on the journal,,2021-08-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54896,,0,1
9070,CTRI/2021/04/032757,Not Yet Recruiting,,,,,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54915,,0,0
9071,CTRI/2021/04/032743,Not Yet Recruiting,,,,Publication will be done after completion of the work.,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55001,,0,1
9072,CTRI/2021/04/032766,Not Yet Recruiting,,,,NIL,,2021-05-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54786,,0,1
9073,CTRI/2021/04/032804,Completed,,2021-08-27,,Nil,,2021-09-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54539,2021-08-27,0,1
9074,CTRI/2021/04/032767,Not Yet Recruiting,,,,nil,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53787,,0,1
9075,CTRI/2021/04/032791,Completed,,2022-02-10,,None,,2022-03-08,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53300,2022-02-10,0,1
9076,CTRI/2021/04/032768,Not Yet Recruiting,,,,NIL,,2021-04-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54913,,0,1
9077,CTRI/2021/04/032795,Not Yet Recruiting,,,,NIL,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53163,,0,1
9078,CTRI/2021/04/032793,Not Yet Recruiting,,,,Nil,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54760,,0,1
9079,CTRI/2021/04/032788,Not Yet Recruiting,,,,nil,,2021-04-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55016,,0,1
9080,CTRI/2021/04/032845,Not Yet Recruiting,,,,Not yet published,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52521,,0,1
9081,CTRI/2021/04/032816,Not Yet Recruiting,,,,nil,,2021-04-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53584,,0,1
9082,CTRI/2021/04/032823,Not Yet Recruiting,,,,NIL,,2021-04-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54865,,0,1
9083,CTRI/2021/04/032825,Not Yet Recruiting,,,,,,2021-04-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55151,,0,0
9084,CTRI/2021/04/032865,Not Yet Recruiting,,,,NIL,,2021-04-15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54950,,0,1
9085,CTRI/2021/04/032876,Closed to Recruitment of Participants,,,,Nil,,2021-05-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55211,,0,1
9086,CTRI/2021/04/032864,Open to Recruitment,,,,NIL,,2021-07-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54968,,0,1
9087,CTRI/2021/04/032904,Not Yet Recruiting,,,,will be published in standard journal . deidentified data will be presented.,,2021-04-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54297,,0,1
9088,CTRI/2021/04/032943,Not Yet Recruiting,,,,,,2021-04-16,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54906,,0,0
9089,CTRI/2021/04/032952,Not Yet Recruiting,,,,not yet,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55118,,0,1
9090,CTRI/2021/04/032976,Open to Recruitment,,,,No publication as yet,,2021-12-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50046,,0,1
9091,CTRI/2021/04/032964,Not Yet Recruiting,,,,,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54185,,0,0
9092,CTRI/2021/04/032965,Not Yet Recruiting,,,,nil not yet published,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55271,,0,1
9093,CTRI/2021/04/033000,Open to Recruitment,,,,NIL,,2022-02-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55380,,0,1
9094,CTRI/2021/04/033004,Not Yet Recruiting,,,,NIL,,2021-04-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55269,,0,1
9095,CTRI/2021/04/032989,Completed,,2021-07-26,,NIL,,2022-03-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55273,2021-07-26,0,1
9096,CTRI/2021/04/033047,Not Yet Recruiting,,,,Not yet published,,2021-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53102,,0,1
9097,CTRI/2021/04/033038,Not Yet Recruiting,,,,Nil,,2021-04-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52346,,0,1
9098,CTRI/2021/04/033068,Open to Recruitment,,,,Nil,,2021-05-17,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55435,,0,1
9099,CTRI/2021/04/033058,Open to Recruitment,,,,NIL,,2021-04-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46761,,0,1
9100,CTRI/2021/04/033073,Completed,,2021-08-06,,"To be published in  Cancer Aid Society Annual Report, Website and other Journals",,2021-08-31,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55218,2021-08-06,0,1
9101,CTRI/2021/04/033078,Completed,,2022-02-18,,nil,,2022-02-18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53377,2022-02-18,0,1
9102,CTRI/2021/04/033108,Not Yet Recruiting,,,,Not any,,2021-04-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54531,,0,1
9103,CTRI/2021/04/033118,Open to Recruitment,,,,NIL,,2021-07-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53211,,0,1
9104,CTRI/2021/04/033175,Closed to Recruitment of Participants,,,,Nil,,2021-09-07,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44604,,0,1
9105,CTRI/2021/04/033158,Not Yet Recruiting,,,,NIL,,2021-04-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55418,,0,1
9106,CTRI/2021/04/033143,Open to Recruitment,,,,NIL,,2021-06-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55493,,0,1
9107,CTRI/2021/04/033142,Not Yet Recruiting,,,,not published yet,,2021-04-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55513,,0,1
9108,CTRI/2021/04/033188,Open to Recruitment,,,,NIL,,2021-11-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55568,,0,1
9109,CTRI/2021/04/033201,Not Yet Recruiting,,,,Not yet published,,2021-04-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52520,,0,1
9110,CTRI/2021/04/033191,Not Yet Recruiting,,,,Nil,,2021-04-26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51618,,0,1
9111,CTRI/2021/04/033193,Not Yet Recruiting,,,,nil,,2021-04-27,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55279,,0,1
9112,CTRI/2021/04/033257,Not Yet Recruiting,,,,NIL,,2021-04-28,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55549,,0,1
9113,CTRI/2021/04/033263,Not Yet Recruiting,,,,nil,,2021-04-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55585,,0,1
9114,CTRI/2021/04/033264,Not Yet Recruiting,,,,Nil,,2021-04-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51322,,0,1
9115,CTRI/2021/04/033260,Not Yet Recruiting,,,,Nil,,2021-04-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54998,,0,1
9116,CTRI/2021/05/033327,Open to Recruitment,,,,NIL,,2021-08-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47913,,0,1
9117,CTRI/2021/05/033301,Open to Recruitment,,,,Not yet published,,2021-07-09,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55614,,0,1
9118,CTRI/2021/05/033303,Not Yet Recruiting,,,,Nil,,2021-04-30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48255,,0,1
9119,CTRI/2021/05/033339,Completed,,2021-06-06,,NIL,,2021-06-23,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55649,2021-06-06,0,1
9120,CTRI/2021/05/033373,Not Yet Recruiting,,,,NIL,,2021-05-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55705,,0,1
9121,CTRI/2021/05/033338,Open to Recruitment,,,,None Yet,,2021-11-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54722,,0,1
9122,CTRI/2021/05/033374,Not Yet Recruiting,,,,NIL,,2021-05-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55771,,0,1
9123,CTRI/2021/05/033402,Not Yet Recruiting,,,,Nil,,2021-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55460,,0,1
9124,CTRI/2021/05/033409,Open to Recruitment,,,,,,2021-05-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54271,,0,0
9125,CTRI/2021/05/033446,Completed,,,,"Mortality in covid-19 - clinical, demographic and laboratory parameters",,2021-09-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55837,,0,1
9126,CTRI/2021/05/033472,Completed,,2021-08-31,,The outcome of the study will be published in peer reviewed journal,,2021-09-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55846,2021-08-31,0,1
9127,CTRI/2021/05/033471,Not Yet Recruiting,,,,"1)	A Miskovic, A B Lumb  Postoperative pulmonary complications. Br J Anaesth_x000D_
           2017 Mar 1;118(3):317-334.  doi: 10.1093/bja/aex002._x000D_
2)	Qi-Wen Deng , Wen-Cheng Tan , Bing-Cheng Zhao , Shi-Hong Wen1, Jian-Tong Shen , Miao Xu .  Intraoperative ventilation strategies to prevent postoperative pulmonary complications: a network meta-analysis of randomised controlled trials Br J Anaesth  2020 Mar;124(3):324-335. doi: 10.1016/j.bja.2019.10.024",,2021-05-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54655,,0,1
9128,CTRI/2021/05/033518,Not Yet Recruiting,,,,NIL,,2021-05-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54053,,0,1
9129,CTRI/2021/05/033523,Not Yet Recruiting,,,,NIL,,2021-05-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55876,,0,1
9130,CTRI/2021/05/033499,Open to Recruitment,,,,None,,2021-09-20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55679,,0,1
9131,CTRI/2021/05/033526,Not Yet Recruiting,,,,nil,,2021-05-04,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55487,,0,1
9132,CTRI/2021/05/033545,Completed,,2021-06-21,,"The research paper was published in the journal of Obstetrics and Gynecology in the month of September 2021. The volume, issue and page number  are 71(S1): S28-S35.",,2021-12-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55823,2021-06-21,0,1
9133,CTRI/2021/05/033537,Not Yet Recruiting,,,,NIL,,2021-05-10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55323,,0,1
9134,CTRI/2021/05/033543,Completed,,2021-06-25,,Outcome of the study will be published in peer reviewed journal,,2021-09-21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55879,2021-06-25,0,1
9135,CTRI/2021/05/033544,Open to Recruitment,,,,NIL,,2021-06-02,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55941,,0,1
9136,CTRI/2021/05/033546,Open to Recruitment,,,,,,2021-06-25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48547,,0,0
9137,CTRI/2021/05/033588,Not Yet Recruiting,,,,Nil,,2021-05-11,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54860,,0,1
9138,CTRI/2021/05/033576,Completed,,,,NIL,,2022-01-03,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54949,,0,1
9139,CTRI/2021/05/033592,Closed to Recruitment of Participants,,,,NIL,,2022-01-06,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55994,,0,1
9140,CTRI/2021/05/033599,Not Yet Recruiting,,,,NIL,,2021-05-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55286,,0,1
9141,CTRI/2021/05/033622,Not Yet Recruiting,,,,Nil,,2021-05-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56002,,0,1
9142,CTRI/2021/05/033623,Not Yet Recruiting,,,,,,2021-05-14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56044,,0,0
9143,CTRI/2021/05/033626,Completed,,2021-07-23,,Nil,,2021-07-12,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54292,2021-07-23,0,1
9144,CTRI/2021/05/033651,Not Yet Recruiting,,,,NIL,,2021-05-13,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55951,,0,1
9145,CTRI/2021/05/033665,Closed to Recruitment of Participants,,,,Not Applicable,,2021-09-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56122,,0,1
9146,CTRI/2021/05/033703,Closed to Recruitment of Participants,,,,NIL,,2021-09-22,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56095,,0,1
9147,CTRI/2021/05/033712,Not Yet Recruiting,,,,Nil,,2021-05-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55864,,0,1
9148,CTRI/2021/05/033693,Open to Recruitment,,,,Nil,,2021-06-29,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55936,,0,1
9149,CTRI/2021/05/033696,Open to Recruitment,,,,Till today no publication is done,,2021-08-24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56026,,0,1
9150,CTRI/2021/05/033695,Not Yet Recruiting,,,,not yet published,,2021-05-19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56031,,0,1
9151,DRKS00021300,"Recruiting complete, follow-up complete",,2021-01-27,,,,2021-04-28,,2021-01-27,0,0
9152,DRKS00021199,"Recruiting complete, follow-up continuing",,,,,,2021-04-08,,,0,0
9153,DRKS00021238,Recruiting stopped after recruiting started,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04447-3'}]",,2020-12-03,,,0,1
9154,DRKS00021248,Recruiting stopped after recruiting started,,2021-02-26,,,,2021-04-28,,2021-02-26,0,0
9155,DRKS00021626,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=da225054-5519-46d2-b2dc-fa9f4bc2b7a1&LOCALE=en&FILENAME=2020-05-08 Tillst%C3%A5nd.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=5f75105e-8061-436f-8355-689ad0200e47&LOCALE=en&FILENAME=200419 COVID-19-HBO Kjellberg Lindholm Submitted Study Plan.pdf'}]",,2020-05-11,,,0,1
9156,DRKS00021439,Recruiting ongoing,,,,,,2020-10-26,http://www.drks.de/DRKS00021439,,0,0
9157,DRKS00021443,"Recruiting complete, follow-up complete",,2021-01-15,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1007/s00391-021-01899-3 '}]",,2021-05-03,http://www.drks.de/DRKS00021443,2021-01-15,0,1
9158,DRKS00021447,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b9e5f46a-f347-48b2-90e3-fe4b70c1b05b&LOCALE=en&FILENAME=069_20 Enghard 2.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=40e74eeb-cd3d-4b5f-b8bb-631311f34d4e&LOCALE=en&FILENAME=Studienprotokoll CytoResc_new.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=facec8e3-9c30-4c09-bf36-fe8c6235fb3f&LOCALE=en&FILENAME=EA1_069_20 Votum vom 27.11.2020.pdf'}]",,2021-05-17,http://www.drks.de/DRKS00021447,,0,1
9159,DRKS00021416,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=a692f5a6-4a65-4dd1-a01e-4cec41cf3672&LOCALE=en&FILENAME=Ethikvotum.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=a3c9c7e8-f5d0-4085-b00f-2b70da8e7ae6&LOCALE=en&FILENAME=Studienprotokoll.docx'}]",,2020-12-01,http://www.drks.de/DRKS00021416,,0,1
9160,DRKS00021420,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=575eb75e-6a49-456f-a8cc-2db0bbc02711&LOCALE=en&FILENAME=3_Protokoll.pdf'}]",,2020-04-16,http://www.drks.de/DRKS00021420,,0,1
9161,DRKS00021424,"Recruiting complete, follow-up complete",,2020-12-29,,,,2021-04-20,http://www.drks.de/DRKS00021424,2020-12-29,0,0
9162,DRKS00021432,"Recruiting complete, follow-up continuing",,,,,,2021-12-09,http://www.drks.de/DRKS00021432,,0,0
9163,DRKS00021468,Recruiting planned,,,,,,2020-06-04,http://www.drks.de/DRKS00021468,,0,0
9164,DRKS00021399,Recruiting ongoing,,,,,,2020-04-21,http://www.drks.de/DRKS00021399,,0,0
9165,DRKS00021395,Recruiting planned,,,,,,2020-04-17,http://www.drks.de/DRKS00021395,,0,0
9166,DRKS00021516,"Recruiting complete, follow-up complete",,2020-12-01,,,,2021-04-15,http://www.drks.de/DRKS00021516,2020-12-01,0,0
9167,DRKS00021521,Recruiting ongoing,,,,,,2021-07-27,http://www.drks.de/DRKS00021521,,0,0
9168,DRKS00021523,"Recruiting complete, follow-up complete",,2020-07-31,,,,2021-05-03,http://www.drks.de/DRKS00021523,2020-07-31,0,0
9169,DRKS00021522,"Recruiting complete, follow-up continuing",,,,,,2021-12-21,http://www.drks.de/DRKS00021522,,0,0
9170,DRKS00021527,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://doi.org/10.2196/27865'}]",,2022-02-07,http://www.drks.de/DRKS00021527,,0,1
9171,DRKS00021506,Recruiting ongoing,,,,,,2020-04-22,http://www.drks.de/DRKS00021506,,0,0
9172,DRKS00021514,Recruiting planned,,,,,,2020-04-24,http://www.drks.de/DRKS00021514,,0,0
9173,DRKS00021574,Recruiting ongoing,,,,,,2020-05-19,http://www.drks.de/DRKS00021574,,0,0
9174,DRKS00021573,"Recruiting complete, follow-up complete",,,,,,2022-01-27,http://www.drks.de/DRKS00021573,,0,0
9175,DRKS00021575,Recruiting ongoing,,,,,,2020-10-23,http://www.drks.de/DRKS00021575,,0,0
9176,DRKS00021578,"Recruiting complete, follow-up complete",,2020-09-01,,"[{'document_type': 'Paper', 'link_to_document': 'http:// https://doi.org/10.1371/journal.pone.0241740'}]",,2020-11-16,http://www.drks.de/DRKS00021578,2020-09-01,0,1
9177,DRKS00021537,Recruiting ongoing,,,,,,2020-04-30,http://www.drks.de/DRKS00021537,,0,0
9178,DRKS00021585,"Recruiting complete, follow-up complete",,2021-04-21,,,,2021-04-30,http://www.drks.de/DRKS00021585,2021-04-21,0,0
9179,DRKS00021588,Recruiting ongoing,,,,,,2020-06-10,http://www.drks.de/DRKS00021588,,0,0
9180,DRKS00021581,"Recruiting complete, follow-up complete",,2021-02-05,,,,2021-04-30,http://www.drks.de/DRKS00021581,2021-02-05,0,0
9181,DRKS00021582,Recruiting planned,,,,,,2020-05-12,http://www.drks.de/DRKS00021582,,0,0
9182,DRKS00021591,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=7eb5fe58-80d3-4d06-9a6d-0c5631b88263&LOCALE=en&FILENAME=VotumEthik-Komission,%C3%84rztekammerBerlin_COVID-19_Serumstudie_gescannt_200416.pdf'}]",,2020-12-16,http://www.drks.de/DRKS00021591,,0,1
9183,DRKS00021206,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1093/infdis/jiaa741'}, {'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1093/ajh/hpaa169'}, {'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1007/s11239-020-02202-8'}]",,2021-07-21,http://www.drks.de/DRKS00021206,,0,1
9184,DRKS00021208,Recruiting ongoing,,,,,,2022-01-07,http://www.drks.de/DRKS00021208,,0,0
9185,DRKS00021214,Recruiting ongoing,,,,,,2021-08-16,http://www.drks.de/DRKS00021214,,0,0
9186,DRKS00021255,Recruiting planned,,,,,,2020-04-28,http://www.drks.de/DRKS00021255,,0,0
9187,DRKS00021254,"Recruiting complete, follow-up continuing",,,,,,2020-08-24,http://www.drks.de/DRKS00021254,,0,0
9188,DRKS00021226,Recruiting planned,,,,,,2020-05-04,http://www.drks.de/DRKS00021226,,0,0
9189,DRKS00021225,Recruiting ongoing,,,,,,2020-11-04,http://www.drks.de/DRKS00021225,,0,0
9190,DRKS00021220,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.medrxiv.org/content/10.1101/2020.10.01.20203836v1'}, {'document_type': 'Paper', 'link_to_document': 'https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0247918'}]",,2021-08-02,http://www.drks.de/DRKS00021220,,0,1
9191,DRKS00021231,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=e5c6d756-30c4-41f8-abda-70d47ad87439&LOCALE=en&FILENAME=20-619aV_Ethikvortum Frankfurt am Main.pdf'}]",,2020-05-04,http://www.drks.de/DRKS00021231,,0,1
9192,DRKS00021166,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8066e171-a3d1-4efa-86e1-7fed25df019e&LOCALE=en&FILENAME='}]",,2021-10-26,http://www.drks.de/DRKS00021166,,0,1
9193,DRKS00021161,Recruiting ongoing,,,,,,2020-04-20,http://www.drks.de/DRKS00021161,,0,0
9194,DRKS00021164,"Recruiting complete, follow-up complete",,2020-03-30,,,,2020-10-26,http://www.drks.de/DRKS00021164,2020-03-30,0,0
9195,DRKS00021145,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=59a8c20e-dd72-4bf8-b9e5-3737a2bf0364&LOCALE=en&FILENAME=Votum Frankfurt.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=557deffc-f05d-4c3f-8e6c-6ba7b79d4f02&LOCALE=en&FILENAME=LEOSS Protocol 20200318 Version 2.0_JV_2020-11-06.pdf'}, {'document_type': 'Further trial documents', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=e41a9e98-947e-449d-b706-955b1e17cde5&LOCALE=en&FILENAME=Appendix C_Data Use and Access Policy V2.1.pdf'}]",,2021-05-25,http://www.drks.de/DRKS00021145,,0,1
9196,DRKS00021152,Enrolling by invitation,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=a1c1e49c-cf1b-4e65-a468-dbe07d538777&LOCALE=en&FILENAME=Ethikvotum Nr. 8973_BO_K_2020, Immunreaktion nach m%C3%B6glichem COVID-19 Kontakt.pdf'}]",,2020-04-14,http://www.drks.de/DRKS00021152,,0,1
9197,DRKS00021153,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.karger.com/Article/FullText/521302'}]",,2022-01-27,http://www.drks.de/DRKS00021153,,0,1
9198,DRKS00021186,Recruiting ongoing,,,,,,2020-03-26,http://www.drks.de/DRKS00021186,,0,0
9199,DRKS00021301,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.3389/fpsyt.2021.768132'}]",,2021-11-08,http://www.drks.de/DRKS00021301,,0,1
9200,DRKS00021306,"Recruiting complete, follow-up complete",,2020-04-09,,"[{'document_type': 'Paper', 'link_to_document': 'https://dx.doi.org/10.1038%2Fs41467-020-19509-y'}]",,2021-02-04,http://www.drks.de/DRKS00021306,2020-04-09,0,1
9201,DRKS00021289,"Recruiting complete, follow-up complete",,2020-05-16,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.asu-arbeitsmedizin.com/wissenschaft/geringe-anti-sars-cov-2-seropraevalenz-unter-beschaeftigten-des-oeffentlichen-dienstes'}]",,2020-11-20,http://www.drks.de/DRKS00021289,2020-05-16,0,1
9202,DRKS00021295,Recruiting ongoing,,,,,,2020-05-04,http://www.drks.de/DRKS00021295,,0,0
9203,DRKS00021297,Recruiting ongoing,,,,,,2020-05-04,http://www.drks.de/DRKS00021297,,0,0
9204,DRKS00021268,Recruiting ongoing,,,,,,2020-06-18,http://www.drks.de/DRKS00021268,,0,0
9205,DRKS00021276,"Recruiting complete, follow-up continuing",,2020-07-16,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=89c66111-4150-4423-ba96-fbc28cb05308&LOCALE=en&FILENAME=Studienprotokoll COVID 19 EIT LUS.pdf'}]",,2020-09-22,http://www.drks.de/DRKS00021276,2020-07-16,0,1
9206,DRKS00021270,Recruiting ongoing,,,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1016/j.ijid.2020.10.026'}]",,2020-12-01,http://www.drks.de/DRKS00021270,,0,1
9207,DRKS00021273,Recruiting ongoing,,,,,,2021-02-15,http://www.drks.de/DRKS00021273,,0,0
9208,DRKS00021134,Recruiting planned,,,,,,2020-03-25,http://www.drks.de/DRKS00021134,,0,0
9209,DRKS00022057,"Recruiting complete, follow-up complete",,2020-06-02,,,,2020-12-07,http://www.drks.de/DRKS00022057,2020-06-02,0,0
9210,DRKS00022054,"Recruiting complete, follow-up complete",,,,,,2022-01-27,http://www.drks.de/DRKS00022054,,0,0
9211,DRKS00022067,Recruiting planned,,,,,,2020-06-12,http://www.drks.de/DRKS00022067,,0,0
9212,DRKS00022071,"Recruiting complete, follow-up complete",,,,,,2021-05-26,http://www.drks.de/DRKS00022071,,0,0
9213,DRKS00022083,Recruiting ongoing,,,,,,2021-10-15,http://www.drks.de/DRKS00022083,,0,0
9214,DRKS00022088,Recruiting ongoing,,,,,,2020-07-20,http://www.drks.de/DRKS00022088,,0,0
9215,DRKS00021815,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=fb0e150c-6aa5-457d-acf3-654d1d3d364d&LOCALE=en&FILENAME=2020-07-23_Studienprotokoll_COVID-PraxImmun_final.pdf'}, {'document_type': 'Further trial documents', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=e386b02d-05fc-452d-87ba-4e07599c0c60&LOCALE=en&FILENAME=Aufklaerungsbogen_mit_Einwilligungserklaerung.pdf'}]",,2022-01-11,http://www.drks.de/DRKS00021815,,0,1
9216,DRKS00021823,Recruiting planned,,,,,,2020-05-28,http://www.drks.de/DRKS00021823,,0,0
9217,DRKS00021810,Recruiting ongoing,,,,,,2021-04-16,http://www.drks.de/DRKS00021810,,0,0
9218,DRKS00021605,"Recruiting complete, follow-up continuing",,,,,,2021-04-22,http://www.drks.de/DRKS00021605,,0,0
9219,DRKS00021611,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=2f8a2934-b4c0-4f7f-934e-1ad68642de6f&LOCALE=en&FILENAME=273-20_Votum.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=919126a4-ece0-47e3-bbcb-7f6b0ec28103&LOCALE=en&FILENAME=Studienprotokoll.pdf'}]",,2020-05-12,http://www.drks.de/DRKS00021611,,0,1
9220,DRKS00021612,Recruiting ongoing,,,,,,2020-04-30,http://www.drks.de/DRKS00021612,,0,0
9221,DRKS00021638,"Recruiting complete, follow-up complete",,2020-04-30,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=88fe4577-0f3f-4369-b9f9-738a40487c68&LOCALE=en&FILENAME=20-1179_2020-04-17_ANDERE Bewertung retro.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8445b476-a749-4cf9-9d36-01dc9d77e71e&LOCALE=en&FILENAME=Beatmungsprojekt Studienplan V02 16.04.2020.pdf'}]",,2020-05-11,http://www.drks.de/DRKS00021638,2020-04-30,0,1
9222,DRKS00021653,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': None}]",,2021-12-22,http://www.drks.de/DRKS00021653,,0,1
9223,DRKS00021630,"Recruiting complete, follow-up complete",,,,,,2021-08-09,http://www.drks.de/DRKS00021630,,0,0
9224,DRKS00021688,Recruiting ongoing,,,,,,2020-05-13,http://www.drks.de/DRKS00021688,,0,0
9225,DRKS00021680,Recruiting ongoing,,,,,,2020-05-12,http://www.drks.de/DRKS00021680,,0,0
9226,DRKS00021699,Recruiting planned,,,,,,2020-05-11,http://www.drks.de/DRKS00021699,,0,0
9227,DRKS00021698,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'http:// https://doi.org/10.1101/2020.04.28.20082743'}]",,2021-10-06,http://www.drks.de/DRKS00021698,,0,1
9228,DRKS00021658,"Recruiting complete, follow-up complete",,2020-04-30,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=9d2a1f2e-92d2-4279-b02f-272ba211f4b5&LOCALE=en&FILENAME=276-20_Votum.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=540aeac3-00f7-4910-ac31-6d8d4ff4ab8f&LOCALE=en&FILENAME=Studienprotokoll.docx'}]",,2020-05-05,http://www.drks.de/DRKS00021658,2020-04-30,0,1
9229,DRKS00021664,Recruiting planned,,,,,,2020-05-14,http://www.drks.de/DRKS00021664,,0,0
9230,DRKS00021675,Recruiting ongoing,,,,,,2020-05-08,http://www.drks.de/DRKS00021675,,0,0
9231,DRKS00021677,Recruiting ongoing,,,,,,2021-10-07,http://www.drks.de/DRKS00021677,,0,0
9232,DRKS00021676,"Recruiting complete, follow-up complete",,,,,,2022-02-04,http://www.drks.de/DRKS00021676,,0,0
9233,DRKS00021671,Recruiting ongoing,,,,,,2020-05-06,http://www.drks.de/DRKS00021671,,0,0
9234,DRKS00021727,Recruiting planned,,,,,,2020-05-12,http://www.drks.de/DRKS00021727,,0,0
9235,DRKS00021729,Enrolling by invitation,,,,,,2020-05-25,http://www.drks.de/DRKS00021729,,0,0
9236,DRKS00021732,Recruiting ongoing,,,,,,2020-11-09,,,0,0
9237,DRKS00021706,Enrolling by invitation,,,,,,2021-05-27,http://www.drks.de/DRKS00021706,,0,0
9238,DRKS00021709,Recruiting ongoing,,,,,,2020-07-02,http://www.drks.de/DRKS00021709,,0,0
9239,DRKS00021757,Enrolling by invitation,,,,,,2020-05-19,http://www.drks.de/DRKS00021757,,0,0
9240,DRKS00021763,"Recruiting complete, follow-up complete",,,,,,2021-07-01,http://www.drks.de/DRKS00021763,,0,0
9241,DRKS00021772,Recruiting ongoing,,,,,,2020-05-18,http://www.drks.de/DRKS00021772,,0,0
9242,DRKS00021775,Recruiting ongoing,,,,,,2020-06-10,http://www.drks.de/DRKS00021775,,0,0
9243,DRKS00021740,Recruiting ongoing,,,,,,2020-05-15,http://www.drks.de/DRKS00021740,,0,0
9244,DRKS00021752,"Recruiting complete, follow-up complete",,2020-07-15,,"[{'document_type': 'Paper', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/33387261/'}]",,2021-02-11,http://www.drks.de/DRKS00021752,2020-07-15,0,1
9245,DRKS00021791,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=3abb51d4-2bee-46a0-88a9-fdc9d31564bf&LOCALE=en&FILENAME=Bauer2020_medRxiv.pdf'}]",,2020-12-07,http://www.drks.de/DRKS00021791,,0,1
9246,DRKS00022729,Recruiting ongoing,,,,,,2020-07-30,http://www.drks.de/DRKS00022729,,0,0
9247,DRKS00022761,Recruiting planned,,,,,,2020-07-30,http://www.drks.de/DRKS00022761,,0,0
9248,DRKS00022790,"Recruiting complete, follow-up complete",,2020-10-10,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=4e6997a3-bd87-4bfd-bb95-d6a342203fd7&LOCALE=en&FILENAME=Moritz Dr._Infektiologie_RESTART-19_Scan_07_2020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=5ec3ff48-55d8-4d5d-8c9c-ba4e3609b318&LOCALE=en&FILENAME=2020_07_08_Studienprotokoll_RESTART-19.pdf'}]",,2020-11-10,http://www.drks.de/DRKS00022790,2020-10-10,0,1
9249,DRKS00019207,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8f1348bc-87cf-4b02-9440-951603013c75&LOCALE=en&FILENAME=Ethikvotum_EPICS14_Point of Care.pdf'}]",,2020-10-22,http://www.drks.de/DRKS00019207,,0,1
9250,DRKS00022845,Recruiting ongoing,,,,,,2020-09-01,http://www.drks.de/DRKS00022845,,0,0
9251,DRKS00007246,"Recruiting complete, follow-up continuing",,,,,,2015-04-24,,,0,0
9252,DRKS00022868,Recruiting ongoing,,,,,,2021-03-05,http://www.drks.de/DRKS00022868,,0,0
9253,DRKS00022871,Recruiting ongoing,,,,,,2020-11-05,http://www.drks.de/DRKS00022871,,0,0
9254,DRKS00022874,Recruiting ongoing,,,,,,2020-08-20,http://www.drks.de/DRKS00022874,,0,0
9255,DRKS00003600,Recruiting ongoing,,,,,,2014-02-13,http://www.drks.de/DRKS00003600,,0,0
9256,DRKS00022500,Recruiting ongoing,,,,,,2020-11-05,http://www.drks.de/DRKS00022500,,0,0
9257,DRKS00022504,Recruiting ongoing,,,,,,2020-08-06,http://www.drks.de/DRKS00022504,,0,0
9258,DRKS00022533,Recruiting planned,,,,,,2020-08-19,http://www.drks.de/DRKS00022533,,0,0
9259,DRKS00022534,Recruiting ongoing,,,,,,2020-11-04,http://www.drks.de/DRKS00022534,,0,0
9260,DRKS00022536,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=6bcbe024-306c-4608-9181-be91a5a292a1&LOCALE=en&FILENAME=Ethikvotum_23062020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=bafa9ae3-0417-4d85-9a60-a53ee9ac14ca&LOCALE=en&FILENAME=Ethikantrag_Studienprotokoll Covid-1_Suizid.pdf'}]",,2020-10-21,http://www.drks.de/DRKS00022536,,0,1
9261,DRKS00022506,Recruiting ongoing,,,,,,2020-07-22,http://www.drks.de/DRKS00022506,,0,0
9262,DRKS00022507,Recruiting ongoing,,,,,,2020-07-22,http://www.drks.de/DRKS00022507,,0,0
9263,DRKS00021247,Recruiting ongoing,,,,,,2020-07-08,http://www.drks.de/DRKS00021247,,0,0
9264,DRKS00022549,Recruiting ongoing,,,,,,2020-07-29,http://www.drks.de/DRKS00022549,,0,0
9265,DRKS00022553,Recruiting ongoing,,,,,,2021-03-15,http://www.drks.de/DRKS00022553,,0,0
9266,DRKS00021229,Recruiting ongoing,,,,,,2020-07-27,http://www.drks.de/DRKS00021229,,0,0
9267,DRKS00022564,Recruiting ongoing,,,,,,2020-09-07,http://www.drks.de/DRKS00022564,,0,0
9268,DRKS00022498,Recruiting planned,,,,,,2020-07-23,http://www.drks.de/DRKS00022498,,0,0
9269,DRKS00022496,Enrolling by invitation,,,,,,2020-07-20,http://www.drks.de/DRKS00022496,,0,0
9270,DRKS00022495,Recruiting ongoing,,,,,,2020-08-25,http://www.drks.de/DRKS00022495,,0,0
9271,DRKS00022475,Recruiting ongoing,,,,,,2020-09-24,http://www.drks.de/DRKS00022475,,0,0
9272,DRKS00022479,Recruiting planned,,,,,,2020-07-16,http://www.drks.de/DRKS00022479,,0,0
9273,DRKS00022473,Recruiting ongoing,,,,,,2020-08-27,http://www.drks.de/DRKS00022473,,0,0
9274,DRKS00022484,"Recruiting complete, follow-up complete",,2020-07-31,,,,2021-02-10,http://www.drks.de/DRKS00022484,2020-07-31,0,0
9275,DRKS00021305,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=6b98b3f3-b361-4533-afa9-913c97762f7a&LOCALE=en&FILENAME=20-337_Votum mit Bedingungen.pdf'}]",,2020-06-26,http://www.drks.de/DRKS00021305,,0,1
9276,DRKS00022305,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=63c57106-04a9-42bc-805c-8fda71ef1fa6&LOCALE=en&FILENAME=23062020Studienplan.pdf'}]",,2021-12-10,http://www.drks.de/DRKS00022305,,0,1
9277,DRKS00022335,Recruiting ongoing,,,,,,2020-07-08,http://www.drks.de/DRKS00022335,,0,0
9278,DRKS00022337,Recruiting ongoing,,,,,,2020-07-22,http://www.drks.de/DRKS00022337,,0,0
9279,DRKS00022259,Recruiting ongoing,,,,,,2020-11-05,http://www.drks.de/DRKS00022259,,0,0
9280,DRKS00023584,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1016/j.cmi.2021.07.020'}]",,2022-03-24,http://www.drks.de/DRKS00023584,,0,1
9281,DRKS00022251,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/34128776/'}]",,2022-02-10,http://www.drks.de/DRKS00022251,,0,1
9282,DRKS00023595,"Recruiting complete, follow-up complete",,,,,,2021-05-17,http://www.drks.de/DRKS00023595,,0,0
9283,DRKS00023561,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=c5d47862-5f79-4241-8ee0-adc49db853d5&LOCALE=en&FILENAME=Zustimmung L%C3%84KBB_03_08_2020_09_05_51.pdf'}]",,2020-11-13,http://www.drks.de/DRKS00023561,,0,1
9284,DRKS00022292,Recruiting ongoing,,,,,,2020-06-26,http://www.drks.de/DRKS00022292,,0,0
9285,DRKS00022294,Recruiting ongoing,,,,,,2020-09-14,http://www.drks.de/DRKS00022294,,0,0
9286,DRKS00022277,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=0d3cfda2-0804-4578-8cc8-8ed0f02c89d8&LOCALE=en&FILENAME=CORE THROMBOSIS_14990_EK-Votum_2020-04-15.pdf'}]",,2021-07-02,http://www.drks.de/DRKS00022277,,0,1
9287,DRKS00022280,"Recruiting complete, follow-up complete",,,,,,2021-12-06,http://www.drks.de/DRKS00022280,,0,0
9288,DRKS00005743,"Recruiting complete, follow-up complete",,2018-12-31,,"[{'document_type': 'Abstract', 'link_to_document': 'https://www.ncbi.nlm.nih.gov/pubmed/31236731'}]",,2020-10-21,,2018-12-31,0,1
9289,DRKS00022406,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=d7067427-7bea-4418-acad-a82908b212ff&LOCALE=en&FILENAME=Abschlussbericht RBAG-SARSCoV2-01.pdf'}]",,2022-03-21,http://www.drks.de/DRKS00022406,,0,1
9290,DRKS00022416,"Recruiting complete, follow-up continuing",,,,,,2020-09-22,http://www.drks.de/DRKS00022416,,0,0
9291,DRKS00022418,Recruiting ongoing,,,,,,2020-07-14,http://www.drks.de/DRKS00022418,,0,0
9292,DRKS00022424,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://www.frontiersin.org/articles/10.3389/fpsyt.2021.643957/full'}, {'document_type': 'Trial results', 'link_to_document': 'https://www.frontiersin.org/articles/10.3389/fpsyt.2021.790974/full'}]",,2022-02-07,http://www.drks.de/DRKS00022424,,0,1
9293,DRKS00022403,Recruiting ongoing,,,,,,2020-07-15,http://www.drks.de/DRKS00022403,,0,0
9294,DRKS00022402,Recruiting ongoing,,,,,,2020-07-09,http://www.drks.de/DRKS00022402,,0,0
9295,DRKS00022455,"Recruiting complete, follow-up continuing",,,,,,2020-07-23,http://www.drks.de/DRKS00022455,,0,0
9296,DRKS00022463,Recruiting ongoing,,,,,,2022-03-03,http://www.drks.de/DRKS00022463,,0,0
9297,DRKS00022432,"Recruiting complete, follow-up continuing",,,,,,2020-07-21,http://www.drks.de/DRKS00022432,,0,0
9298,DRKS00022434,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=3fb81f52-32e9-4c3d-9099-cf7dec800af8&LOCALE=en&FILENAME=6927_Votum.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=79ecfb9d-830f-45f4-b771-8f9dbf108765&LOCALE=en&FILENAME=CorKidBMBF_Antrag.pdf'}]",,2021-11-25,http://www.drks.de/DRKS00022434,,0,1
9299,DRKS00022433,Recruiting ongoing,,,,,,2021-02-05,http://www.drks.de/DRKS00022433,,0,0
9300,DRKS00022438,"Recruiting complete, follow-up continuing",,,,,,2021-12-09,http://www.drks.de/DRKS00022438,,0,0
9301,DRKS00022448,"Recruiting complete, follow-up complete",,,,,,2022-02-01,http://www.drks.de/DRKS00022448,,0,0
9302,DRKS00022371,"Recruiting complete, follow-up complete",,2020-06-28,,,,2020-07-06,http://www.drks.de/DRKS00022371,2020-06-28,0,0
9303,DRKS00022387,"Recruiting complete, follow-up complete",,,,,,2021-11-26,http://www.drks.de/DRKS00022387,,0,0
9304,DRKS00022380,Recruiting ongoing,,,,,,2021-06-11,http://www.drks.de/DRKS00022380,,0,0
9305,DRKS00022359,Recruiting ongoing,,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=267c3434-44db-44a4-ab49-7e1effac344c&LOCALE=en&FILENAME=200904_Kurzfassung-Studienbericht-DB_V1.3.pdf'}, {'document_type': 'Trial results', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=922839fe-0319-4cba-aea0-b37f77683a2a&LOCALE=en&FILENAME=210107_Kurzfassung-Studienbericht-DB_Zwischenbericht_Version5 0.pdf'}, {'document_type': 'Trial results', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=346c4275-64cb-483c-9b35-4a91cf3f6ad5&LOCALE=en&FILENAME=210511_Coronastudie_DB_Abschlussbericht_final_V4.0 pdf.pdf'}, {'document_type': 'Trial results', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=f59ac2c4-22e7-409d-a810-3fcd24c2909c&LOCALE=en&FILENAME=English_Translation_210511_Coronastudie_DB_Abschlussbericht_final_V4.0.pdf'}]",,2021-05-27,http://www.drks.de/DRKS00022359,,0,1
9306,DRKS00022395,"Recruiting complete, follow-up continuing",,,,,,2020-08-27,http://www.drks.de/DRKS00022395,,0,0
9307,DRKS00005847,"Recruiting complete, follow-up complete",,2014-07-01,,,,2015-01-27,,2014-07-01,0,0
9308,DRKS00017593,Recruiting ongoing,,,,,,2020-10-01,http://www.drks.de/DRKS00017593,,0,0
9309,DRKS00023418,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1'}, {'document_type': 'Paper', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/33303542/'}]",,2021-11-11,http://www.drks.de/DRKS00023418,,0,1
9310,DRKS00023435,Recruiting ongoing,,,,,,2020-12-29,http://www.drks.de/DRKS00023435,,0,0
9311,DRKS00023430,"Recruiting complete, follow-up continuing",,,,,,2021-11-29,http://www.drks.de/DRKS00023430,,0,0
9312,DRKS00023406,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b2f935b5-780e-4b65-9609-56b99eec160b&LOCALE=en&FILENAME=20-1465_2020-10-26_ANDERE Erf%C3%BCllung Bedingungen_signatur.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=63f1b7f9-ebf2-40fd-a052-4254e45397ab&LOCALE=en&FILENAME=version_22_10_2020_Ethikantrag_COVID_VieScope.pdf'}]",,2020-11-09,http://www.drks.de/DRKS00023406,,0,1
9313,DRKS00023322,Recruiting ongoing,,,,,,2020-12-07,http://www.drks.de/DRKS00023322,,0,0
9314,DRKS00023334,Recruiting ongoing,,,,,,2020-10-30,http://www.drks.de/DRKS00023334,,0,0
9315,DRKS00023385,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=1c71ae96-f3b6-4a66-99b9-b9a36d31b944&LOCALE=en&FILENAME=ProMusik_Studienprotokoll_final_20200903_plus_amendment.pdf'}]",,2022-01-25,http://www.drks.de/DRKS00023385,,0,1
9316,DRKS00023393,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1275-3792'}]",,2021-11-12,http://www.drks.de/DRKS00023393,,0,1
9317,DRKS00022035,Recruiting ongoing,,,,,,2021-01-22,http://www.drks.de/DRKS00022035,,0,0
9318,DRKS00022032,Enrolling by invitation,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b6f6f831-4ca4-4cfa-ac76-c497389f3d03&LOCALE=en&FILENAME=260-20-ek-18052020(1).pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=104f85d0-34de-4038-871a-64e4cefeaeb9&LOCALE=en&FILENAME=studienprotokoll-schuco-neueinsendung-ethik.pdf'}]",,2020-06-30,http://www.drks.de/DRKS00022032,,0,1
9319,DRKS00023364,Recruiting suspended on temporary hold,,,,,,2021-10-26,http://www.drks.de/DRKS00023364,,0,0
9320,DRKS00022082,Recruiting ongoing,,,,,,2021-02-01,http://www.drks.de/DRKS00022082,,0,0
9321,DRKS00004377,"Recruiting complete, follow-up continuing",,,,,,2015-08-06,,,0,0
9322,DRKS00023500,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/33388748/'}]",,2021-08-27,http://www.drks.de/DRKS00023500,,0,1
9323,DRKS00023507,Recruiting ongoing,,,,,,2020-11-27,http://www.drks.de/DRKS00023507,,0,0
9324,DRKS00022224,"Recruiting complete, follow-up complete",,2021-05-01,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8deab70f-a165-44c2-a418-e6af692b751f&LOCALE=en&FILENAME=2020-06-15 ZB 41820.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=866f9da2-a3f6-4388-8ad3-62854b35968f&LOCALE=en&FILENAME=Studienprotokoll_PrimaryCovCare_16062020.pdf'}]",,2021-05-10,http://www.drks.de/DRKS00022224,2021-05-01,0,1
9325,DRKS00022226,"Recruiting complete, follow-up continuing",,,,,,2021-02-19,http://www.drks.de/DRKS00022226,,0,0
9326,DRKS00023558,Recruiting planned,,,,,,2020-11-16,http://www.drks.de/DRKS00023558,,0,0
9327,DRKS00023525,Recruiting planned,,,,,,2020-11-10,http://www.drks.de/DRKS00023525,,0,0
9328,DRKS00022203,Recruiting ongoing,,,,,,2020-09-29,http://www.drks.de/DRKS00022203,,0,0
9329,DRKS00022147,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=0017fc9c-11d4-4296-b95a-3747d0b05233&LOCALE=en&FILENAME=e Votum.pdf'}]",,2020-07-13,http://www.drks.de/DRKS00022147,,0,1
9330,DRKS00023447,Recruiting ongoing,,,,,,2022-03-10,http://www.drks.de/DRKS00023447,,0,0
9331,DRKS00022185,Recruiting ongoing,,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=0d555867-9f4a-4137-83db-6704a8bc10e4&LOCALE=en&FILENAME=Urbach et al_JMIR Public Health Surveill 2020_6_4_e22521.pdf'}]",,2021-01-08,http://www.drks.de/DRKS00022185,,0,1
9332,DRKS00022188,Recruiting planned,,,,,,2020-06-15,http://www.drks.de/DRKS00022188,,0,0
9333,DRKS00022157,Recruiting stopped after recruiting started,,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/34631041/'}]",,2021-11-02,http://www.drks.de/DRKS00022157,,0,1
9334,DRKS00023499,Recruiting ongoing,,,,,,2020-11-03,http://www.drks.de/DRKS00023499,,0,0
9335,DRKS00022166,Recruiting ongoing,,,,,,2020-06-15,http://www.drks.de/DRKS00022166,,0,0
9336,DRKS00023113,"Recruiting complete, follow-up complete",,,,,,2022-03-16,http://www.drks.de/DRKS00023113,,0,0
9337,DRKS00023117,Recruiting ongoing,,,,,,2020-09-21,http://www.drks.de/DRKS00023117,,0,0
9338,DRKS00023180,"Recruiting complete, follow-up complete",,,,,,2022-04-01,http://www.drks.de/DRKS00023180,,0,0
9339,DRKS00023184,Recruiting ongoing,,,,,,2020-10-07,http://www.drks.de/DRKS00023184,,0,0
9340,DRKS00023171,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': None}]",,2020-10-26,http://www.drks.de/DRKS00023171,,0,1
9341,DRKS00023312,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=58a0c882-87bc-472d-b23d-16900be995c6&LOCALE=en&FILENAME=20-9284-BO endg%C3%BCtiges Votum 11.05.2020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=870f9b55-81fe-4dd6-9693-f1ccb4e4601b&LOCALE=en&FILENAME=Ethikantrag_COVID Neuro final zu Verwenden.pdf'}]",,2020-10-13,http://www.drks.de/DRKS00023312,,0,1
9342,DRKS00005132,"Recruiting complete, follow-up complete",,2011-03-24,,"[{'document_type': 'Abstract', 'link_to_document': None}]",,2013-07-08,,2011-03-24,0,1
9343,DRKS00000302,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'http://www.ncbi.nlm.nih.gov/pubmed/23188563'}]",,2017-08-11,,,0,1
9344,DRKS00006420,Recruiting ongoing,,,,"[{'document_type': 'Further trial documents', 'link_to_document': 'http://www.meditrialeurope.com'}, {'document_type': 'Further trial documents', 'link_to_document': 'http://www.covidien.com'}]",,2014-11-21,,,0,1
9345,DRKS00023001,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=85b1fd75-b4f5-4ea9-b110-3a871e059e59&LOCALE=en&FILENAME=Ethikantrag KHK Covid19_final.docx'}, {'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=5841ec23-63b9-4ee5-9676-ee96429a8f1e&LOCALE=en&FILENAME=fmed-08-760265(1).pdf'}]",,2022-01-13,http://www.drks.de/DRKS00023001,,0,1
9346,DRKS00023014,Recruiting ongoing,,,,,,2022-03-16,http://www.drks.de/DRKS00023014,,0,0
9347,DRKS00023012,Recruiting ongoing,,,,"[{'document_type': 'Abstract', 'link_to_document': 'https://www.researchgate.net/publication/344617429_Characteristics_and_clinical_course_of_SARS-CoV-2_infection_in_tumor_patients_in_Germany_Results_of_the_ADHOK_Coronavirus_Cancer_Registry_CoRe'}, {'document_type': 'Paper', 'link_to_document': None}, {'document_type': 'Trial results', 'link_to_document': None}]",,2020-10-27,http://www.drks.de/DRKS00023012,,0,1
9348,DRKS00023069,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.aerzteblatt.de/archiv/223760/Persistierende-Symptome-nach-COVID-19'}]",,2022-03-21,http://www.drks.de/DRKS00023069,,0,1
9349,DRKS00023086,Recruiting planned,,,,,,2020-10-09,http://www.drks.de/DRKS00023086,,0,0
9350,DRKS00023087,Recruiting planned,,,,,,2020-09-15,http://www.drks.de/DRKS00023087,,0,0
9351,DRKS00023091,"Recruiting complete, follow-up complete",,2020-11-15,,,,2021-04-09,http://www.drks.de/DRKS00023091,2020-11-15,0,0
9352,DRKS00023092,"Recruiting complete, follow-up complete",,2020-11-19,,"[{'document_type': 'Background literature', 'link_to_document': None}]",,2021-03-30,http://www.drks.de/DRKS00023092,2020-11-19,0,1
9353,DRKS00021813,"Recruiting complete, follow-up complete",,2020-08-31,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713905/'}]",,2021-02-11,http://www.drks.de/DRKS00021813,2020-08-31,0,1
9354,DRKS00021812,Recruiting ongoing,,,,,,2021-10-13,http://www.drks.de/DRKS00021812,,0,0
9355,DRKS00021909,Recruiting ongoing,,,,,,2020-07-02,http://www.drks.de/DRKS00021909,,0,0
9356,DRKS00022926,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255513'}]",,2022-03-03,http://www.drks.de/DRKS00022926,,0,1
9357,DRKS00022925,Recruiting planned,,,,,,2020-09-24,http://www.drks.de/DRKS00022925,,0,0
9358,DRKS00021604,Recruiting ongoing,,,,,,2020-07-01,http://www.drks.de/DRKS00021604,,0,0
9359,DRKS00022941,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=13ac32f6-4bb4-4ae9-bc70-776382bc7eb5&LOCALE=en&FILENAME=Hildebrandt et al., 2021 SARS CoV 2 study.pdf'}, {'document_type': 'Paper', 'link_to_document': 'https://pubmed.ncbi.nlm.nih.gov/35206589/'}]",,2022-03-03,http://www.drks.de/DRKS00022941,,0,1
9360,DRKS00022909,Recruiting planned,,,,,,2020-08-31,http://www.drks.de/DRKS00022909,,0,0
9361,DRKS00021649,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://dx.doi.org/10.3205/000298'}]",,2021-10-15,http://www.drks.de/DRKS00021649,,0,1
9362,DRKS00022958,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Background literature', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=95a91263-edba-4c33-96c4-c0877a517bc0&LOCALE=en&FILENAME=Hintergrundliteratur_Studie 2_Care +.pdf'}]",,2021-07-16,http://www.drks.de/DRKS00022958,,0,1
9363,DRKS00022964,Recruiting ongoing,,,,,,2020-09-07,http://www.drks.de/DRKS00022964,,0,0
9364,DRKS00020352,Enrolling by invitation,,,,,,2021-09-14,http://www.drks.de/DRKS00020352,,0,0
9365,DRKS00021705,Recruiting planned,,,,,,2020-08-03,http://www.drks.de/DRKS00021705,,0,0
9366,DRKS00021756,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=43131a78-db48-4818-b3d6-4290c7f0829a&LOCALE=en&FILENAME=2020-975 Jansen_pos Votum zum Antrag nach Auflagen.pdf'}]",,2020-10-28,http://www.drks.de/DRKS00021756,,0,1
9367,DRKS00021788,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1002/jmv.27385'}]",,2022-01-19,http://www.drks.de/DRKS00021788,,0,1
9368,DRKS00021780,Recruiting ongoing,,,,"[{'document_type': 'Background literature', 'link_to_document': None}]",,2020-06-29,http://www.drks.de/DRKS00021780,,0,1
9369,DRKS00014593,"Recruiting complete, follow-up continuing",,,,,,2020-11-13,http://www.drks.de/DRKS00014593,,0,0
9370,DRKS00021440,Recruiting ongoing,,,,,,2021-01-28,http://www.drks.de/DRKS00021440,,0,0
9371,DRKS00025089,Recruiting ongoing,,,,,,2021-04-19,http://www.drks.de/DRKS00025089,,0,0
9372,DRKS00025090,"Recruiting complete, follow-up complete",,2021-01-07,,,,2021-05-07,http://www.drks.de/DRKS00025090,2021-01-07,0,0
9373,DRKS00025091,Recruiting ongoing,,,,,,2021-04-19,http://www.drks.de/DRKS00025091,,0,0
9374,DRKS00025094,Recruiting planned,,,,,,2021-04-22,http://www.drks.de/DRKS00025094,,0,0
9375,DRKS00022857,Recruiting ongoing,,,,,,2021-07-30,http://www.drks.de/DRKS00022857,,0,0
9376,DRKS00022841,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=85a06f74-7c39-4fda-b252-57e49d57ff7e&LOCALE=en&FILENAME=20-9242-BO finales Votum 16.04.2020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=25160f5b-f0dd-452c-8798-15db648095b3&LOCALE=en&FILENAME=Musterantrag Berufsordnung_Risikopr%C3%A4diktion bei Covid-19  amendment (2).pdf'}]",,2021-05-17,http://www.drks.de/DRKS00022841,,0,1
9377,DRKS00025007,Recruiting ongoing,,,,,,2022-03-07,http://www.drks.de/DRKS00025007,,0,0
9378,DRKS00025004,Recruiting planned,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=44874a2e-2e49-4f78-af90-0876d9f4ef3b&LOCALE=en&FILENAME=Studienprotokoll_COViK_20210528.pdf'}]",,2021-05-31,http://www.drks.de/DRKS00025004,,0,1
9379,DRKS00025013,"Recruiting complete, follow-up complete",,2021-02-15,,,,2021-05-04,http://www.drks.de/DRKS00025013,2021-02-15,0,0
9380,DRKS00023821,"Recruiting complete, follow-up complete",,2020-04-30,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=c0ee0121-f759-43ad-843e-2b1727110d4a&LOCALE=en&FILENAME=2020_04_03_18_28_40.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=30af96a3-b3a0-4711-a118-c71ef5054851&LOCALE=en&FILENAME=Anfrage_Ethikvotum_SARSCoV2_Diagnostik_unterschr.pdf'}]",,2020-12-11,http://www.drks.de/DRKS00023821,2020-04-30,0,1
9381,DRKS00023822,"Recruiting complete, follow-up complete",,,,,,2022-02-17,http://www.drks.de/DRKS00023822,,0,0
9382,DRKS00023831,Recruiting ongoing,,,,,,2021-04-06,http://www.drks.de/DRKS00023831,,0,0
9383,DRKS00023806,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': None}]",,2022-03-08,http://www.drks.de/DRKS00023806,,0,1
9384,DRKS00023807,"Recruiting complete, follow-up complete",,2020-10-03,,,,2020-12-10,http://www.drks.de/DRKS00023807,2020-10-03,0,0
9385,DRKS00023812,"Recruiting complete, follow-up complete",,,,,,2022-03-03,http://www.drks.de/DRKS00023812,,0,0
9386,DRKS00022514,Recruiting planned,,,,,,2020-12-03,http://www.drks.de/DRKS00022514,,0,0
9387,DRKS00023880,Recruiting ongoing,,,,,,2021-01-07,http://www.drks.de/DRKS00023880,,0,0
9388,DRKS00023904,Recruiting ongoing,,,,,,2021-01-19,http://www.drks.de/DRKS00023904,,0,0
9389,DRKS00023903,"Recruiting complete, follow-up complete",,,,,,2022-01-25,http://www.drks.de/DRKS00023903,,0,0
9390,DRKS00023911,"Recruiting complete, follow-up complete",,2021-03-26,,,,2021-04-30,http://www.drks.de/DRKS00023911,2021-03-26,0,0
9391,DRKS00023913,Recruiting ongoing,,,,,,2021-01-11,http://www.drks.de/DRKS00023913,,0,0
9392,DRKS00023917,Recruiting ongoing,,,,,,2021-01-25,http://www.drks.de/DRKS00023917,,0,0
9393,DRKS00023921,Recruiting planned,,,,,,2020-12-17,http://www.drks.de/DRKS00023921,,0,0
9394,DRKS00023934,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=19b11e99-36fb-4e2a-8bb5-6db5a329f008&LOCALE=en&FILENAME=20-9242-BO finales Votum 16.04.2020.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=39f3abc9-dbaa-401b-a210-d1d4eb6a19b6&LOCALE=en&FILENAME=02 Aachen Ethics Approval Oliver Grottke.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8152a603-5196-4ac8-9118-df50b75ecc99&LOCALE=en&FILENAME=04 Munich Ethikvotum_LMU_20-296.pdf'}, {'document_type': 'Background literature', 'link_to_document': None}]",,2021-07-05,http://www.drks.de/DRKS00023934,,0,1
9395,DRKS00023957,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=4ca6355f-02d5-4691-b161-f350f1f2f06c&LOCALE=en&FILENAME=COVID-19_Protokoll_Prof. J%C3%A4ckle_HDZNRW.pdf'}]",,2022-03-10,http://www.drks.de/DRKS00023957,,0,1
9396,DRKS00023971,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://medrxiv.org/cgi/content/short/2021.12.03.21266946v1'}]",,2021-12-06,http://www.drks.de/DRKS00023971,,0,1
9397,DRKS00023972,Recruiting planned,,,,,,2020-12-30,http://www.drks.de/DRKS00023972,,0,0
9398,DRKS00024958,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=842426fc-716c-409b-bc5f-013d599337be&LOCALE=en&FILENAME=21-9983-BO Votum 24.03.2021.pdf'}]",,2021-03-30,http://www.drks.de/DRKS00024958,,0,1
9399,DRKS00023667,Recruiting ongoing,,,,,,2021-05-17,http://www.drks.de/DRKS00023667,,0,0
9400,DRKS00024992,Recruiting planned,,,,,,2021-04-07,http://www.drks.de/DRKS00024992,,0,0
9401,DRKS00024990,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.friedrich-verlag.de/pflegen-demenz-palliativ/qualifizierung/pallpan-9843'}, {'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1371/journal.pone.0254056'}, {'document_type': 'Paper', 'link_to_document': 'https://doi.org/10.1007/s00761-021-00974-z'}]",,2021-10-19,http://www.drks.de/DRKS00024990,,0,1
9402,DRKS00023642,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8d4a6b63-b61a-4376-abb4-77e3840dbce8&LOCALE=en&FILENAME=Studyprotocol 2021_ReCo.pdf'}]",,2021-11-22,http://www.drks.de/DRKS00023642,,0,1
9403,DRKS00024979,"Recruiting complete, follow-up complete",,2021-02-18,,,,2021-04-08,http://www.drks.de/DRKS00024979,2021-02-18,0,0
9404,DRKS00023659,Recruiting ongoing,,,,,,2021-01-14,http://www.drks.de/DRKS00023659,,0,0
9405,DRKS00023650,Recruiting planned,,,,,,2021-03-18,http://www.drks.de/DRKS00023650,,0,0
9406,DRKS00023567,Recruiting ongoing,,,,,,2022-03-25,http://www.drks.de/DRKS00023567,,0,0
9407,DRKS00024896,Recruiting ongoing,,,,,,2022-01-11,http://www.drks.de/DRKS00024896,,0,0
9408,DRKS00022244,"Recruiting complete, follow-up continuing",,,,,,2022-02-22,http://www.drks.de/DRKS00022244,,0,0
9409,DRKS00023713,"Recruiting complete, follow-up complete",,,,,,2021-11-08,http://www.drks.de/DRKS00023713,,0,0
9410,DRKS00022409,"Recruiting complete, follow-up continuing",,,,,,2021-07-23,http://www.drks.de/DRKS00022409,,0,0
9411,DRKS00023742,Recruiting ongoing,,,,,,2021-06-11,http://www.drks.de/DRKS00023742,,0,0
9412,DRKS00023717,Recruiting ongoing,,,,,,2021-06-15,http://www.drks.de/DRKS00023717,,0,0
9413,DRKS00023721,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=8bc3170b-7454-4a61-ac01-6ac3d59dffe4&LOCALE=en&FILENAME=study_protocol_v30.pdf'}, {'document_type': 'Paper', 'link_to_document': 'https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787578?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010422'}]",,2022-01-14,http://www.drks.de/DRKS00023721,,0,1
9414,DRKS00023725,Recruiting planned,,,,,,2021-01-04,http://www.drks.de/DRKS00023725,,0,0
9415,DRKS00023789,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=be638978-6002-45ae-b7d9-cd279341fe25&LOCALE=en&FILENAME=20-1160_Votum.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=57598e65-e5cd-4a28-9835-f0e78628c825&LOCALE=en&FILENAME=Studienprotokoll_Arsmoriendi_COVID.pdf'}]",,2021-06-24,http://www.drks.de/DRKS00023789,,0,1
9416,DRKS00023770,Recruiting ongoing,,,,,,2021-03-22,http://www.drks.de/DRKS00023770,,0,0
9417,DRKS00023685,Recruiting planned,,,,,,2020-12-18,http://www.drks.de/DRKS00023685,,0,0
9418,DRKS00024710,Recruiting planned,,,,,,2021-03-26,http://www.drks.de/DRKS00024710,,0,0
9419,DRKS00024701,Recruiting ongoing,,,,,,2021-03-08,http://www.drks.de/DRKS00024701,,0,0
9420,DRKS00024702,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=2520a693-9b26-447d-8d67-cc7cf1c58655&LOCALE=en&FILENAME=20-1222_Ethikvotum_BIOMASOTA_COVID-19_2020-06-10.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=d1e707ae-83c1-4227-b4fa-0fa3818cf885&LOCALE=en&FILENAME=Revision_Projektbeschreibung_COVID-19_Biomasota_ 2020-07-15_v2.0.pdf'}]",,2021-03-11,http://www.drks.de/DRKS00024702,,0,1
9421,DRKS00023401,Recruiting ongoing,,,,,,2020-11-30,http://www.drks.de/DRKS00023401,,0,0
9422,DRKS00023402,Enrolling by invitation,,,,,,2020-11-30,http://www.drks.de/DRKS00023402,,0,0
9423,DRKS00024739,Recruiting ongoing,,,,,,2022-03-07,http://www.drks.de/DRKS00024739,,0,0
9424,DRKS00024688,Recruiting planned,,,,,,2021-03-16,http://www.drks.de/DRKS00024688,,0,0
9425,DRKS00024687,"Recruiting complete, follow-up complete",,,,,,2021-12-06,http://www.drks.de/DRKS00024687,,0,0
9426,DRKS00024664,Recruiting ongoing,,,,,,2021-02-26,http://www.drks.de/DRKS00024664,,0,0
9427,DRKS00024668,Recruiting ongoing,,,,,,2022-03-29,http://www.drks.de/DRKS00024668,,0,0
9428,DRKS00024695,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': None}]",,2021-10-26,http://www.drks.de/DRKS00024695,,0,1
9429,DRKS00024800,Recruiting ongoing,,,,,,2021-04-26,http://www.drks.de/DRKS00024800,,0,0
9430,DRKS00023501,"Recruiting complete, follow-up complete",,,,,,2022-01-04,http://www.drks.de/DRKS00023501,,0,0
9431,DRKS00024835,Recruiting ongoing,,,,,,2021-03-16,http://www.drks.de/DRKS00024835,,0,0
9432,DRKS00024845,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://doi.org/10.1136/bmjpo-2021-001262'}]",,2022-03-24,http://www.drks.de/DRKS00024845,,0,1
9433,DRKS00024879,Recruiting ongoing,,,,,,2021-06-02,http://www.drks.de/DRKS00024879,,0,0
9434,DRKS00023553,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Trial results', 'link_to_document': 'https://www.medrxiv.org/content/10.1101/2021.10.08.21264767v1'}]",,2022-01-03,http://www.drks.de/DRKS00023553,,0,1
9435,DRKS00024860,"Recruiting complete, follow-up complete",,2021-03-02,,,,2021-04-27,http://www.drks.de/DRKS00024860,2021-03-02,0,0
9436,DRKS00024777,Recruiting planned,,,,,,2021-04-12,http://www.drks.de/DRKS00024777,,0,0
9437,DRKS00022110,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=63c9289d-565e-4916-81f5-9a0c2425b901&LOCALE=en&FILENAME=Patients with chronic pain....2021.pdf'}]",,2021-12-27,http://www.drks.de/DRKS00022110,,0,1
9438,DRKS00024787,Recruiting planned,,,,,,2021-05-05,http://www.drks.de/DRKS00024787,,0,0
9439,DRKS00024511,Recruiting ongoing,,,,,,2021-02-23,http://www.drks.de/DRKS00024511,,0,0
9440,DRKS00024520,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': None}]",,2021-10-04,http://www.drks.de/DRKS00024520,,0,1
9441,DRKS00024505,Recruiting planned,,,,,,2021-02-19,http://www.drks.de/DRKS00024505,,0,0
9442,DRKS00024434,Recruiting planned,,,,,,2021-02-05,http://www.drks.de/DRKS00024434,,0,0
9443,DRKS00024445,Recruiting ongoing,,,,,,2021-02-19,http://www.drks.de/DRKS00024445,,0,0
9444,DRKS00024440,Recruiting ongoing,,,,,,2021-09-16,http://www.drks.de/DRKS00024440,,0,0
9445,DRKS00024412,"Recruiting complete, follow-up complete",,,,,,2022-03-28,http://www.drks.de/DRKS00024412,,0,0
9446,DRKS00024422,Recruiting planned,,,,,,2021-02-19,http://www.drks.de/DRKS00024422,,0,0
9447,DRKS00024455,Recruiting planned,,,,,,2021-02-09,http://www.drks.de/DRKS00024455,,0,0
9448,DRKS00024454,"Recruiting complete, follow-up complete",,2021-02-06,,,,2021-02-08,http://www.drks.de/DRKS00024454,2021-02-06,0,0
9449,DRKS00024462,Enrolling by invitation,,2021-02-08,,,,2021-03-08,http://www.drks.de/DRKS00024462,2021-02-08,0,0
9450,DRKS00024604,Recruiting ongoing,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=aac64893-1692-440a-9816-0778db51d80e&LOCALE=en&FILENAME=20-1023cVotum.pdf'}]",,2021-10-27,http://www.drks.de/DRKS00024604,,0,1
9451,DRKS00024633,Recruiting ongoing,,,,,,2021-04-23,http://www.drks.de/DRKS00024633,,0,0
9452,DRKS00024635,Recruiting ongoing,,,,,,2021-03-09,http://www.drks.de/DRKS00024635,,0,0
9453,DRKS00024616,Recruiting ongoing,,,,,,2021-02-22,http://www.drks.de/DRKS00024616,,0,0
9454,DRKS00024613,Recruiting ongoing,,,,,,2021-02-23,http://www.drks.de/DRKS00024613,,0,0
9455,DRKS00024622,"Recruiting complete, follow-up continuing",,,,,,2022-01-11,http://www.drks.de/DRKS00024622,,0,0
9456,DRKS00024621,"Recruiting complete, follow-up complete",,,,,,2021-08-30,http://www.drks.de/DRKS00024621,,0,0
9457,DRKS00024551,Recruiting planned,,,,,,2021-03-08,http://www.drks.de/DRKS00024551,,0,0
9458,DRKS00024531,Recruiting ongoing,,,,,,2021-02-18,http://www.drks.de/DRKS00024531,,0,0
9459,DRKS00023263,Recruiting ongoing,,,,,,2021-12-03,http://www.drks.de/DRKS00023263,,0,0
9460,DRKS00023271,"Recruiting complete, follow-up complete",,2020-12-18,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=7acbb167-380e-4a7f-b239-636f316a2dd1&LOCALE=en&FILENAME=Ethikvotum_2020-11-02 ZB 79020.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=d51a0d38-d78d-4799-b201-b9fc69e61e35&LOCALE=en&FILENAME=Surveillance_Studienprotokoll_03Nov2020_v1_2.pdf'}, {'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=a1b88b4e-05ed-4a9f-9870-20179482cc57&LOCALE=en&FILENAME=Ethikvotum_2020-11-09 ZB 79020.pdf'}]",,2021-04-12,http://www.drks.de/DRKS00023271,2020-12-18,0,1
9461,DRKS00024578,"Recruiting complete, follow-up continuing",,,,,,2021-08-30,http://www.drks.de/DRKS00024578,,0,0
9462,DRKS00023241,Recruiting ongoing,,,,,,2021-02-09,http://www.drks.de/DRKS00023241,,0,0
9463,DRKS00024585,Recruiting stopped after recruiting started,,,,,,2021-09-21,http://www.drks.de/DRKS00024585,,0,0
9464,DRKS00025519,"Recruiting complete, follow-up complete",,,,,,2021-06-08,http://www.drks.de/DRKS00025519,,0,0
9465,DRKS00025525,"Recruiting complete, follow-up complete",,,,,,2021-06-18,http://www.drks.de/DRKS00025525,,0,0
9466,DRKS00025567,"Recruiting complete, follow-up continuing",,,,,,2021-07-08,http://www.drks.de/DRKS00025567,,0,0
9467,DRKS00024378,Recruiting ongoing,,,,,,2021-02-02,http://www.drks.de/DRKS00024378,,0,0
9468,DRKS00024376,Recruiting ongoing,,,,,,2021-08-12,http://www.drks.de/DRKS00024376,,0,0
9469,DRKS00025333,"Recruiting complete, follow-up complete",,,,,,2022-01-11,http://www.drks.de/DRKS00025333,,0,0
9470,DRKS00025316,"Recruiting complete, follow-up complete",,,,,,2021-10-20,http://www.drks.de/DRKS00025316,,0,0
9471,DRKS00025373,Recruiting ongoing,,,,,,2021-05-21,http://www.drks.de/DRKS00025373,,0,0
9472,DRKS00025374,Recruiting planned,,,,,,2021-05-20,http://www.drks.de/DRKS00025374,,0,0
9473,DRKS00024046,Enrolling by invitation,,,,,,2021-02-25,http://www.drks.de/DRKS00024046,,0,0
9474,DRKS00024028,"Recruiting complete, follow-up complete",,,,,,2021-09-09,http://www.drks.de/DRKS00024028,,0,0
9475,DRKS00025392,Recruiting ongoing,,,,,,2021-06-15,http://www.drks.de/DRKS00025392,,0,0
9476,DRKS00025406,"Recruiting complete, follow-up complete",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.researchgate.net/publication/354837237_Well-Being_and_Mental_Health_of_Students_during_the_COVID-19_Pandemic'}]",,2021-12-27,http://www.drks.de/DRKS00025406,,0,1
9477,DRKS00024117,Recruiting ongoing,,,,,,2021-02-09,http://www.drks.de/DRKS00024117,,0,0
9478,DRKS00024128,"Recruiting complete, follow-up complete",,,,,,2022-03-07,http://www.drks.de/DRKS00024128,,0,0
9479,DRKS00025452,Recruiting planned,,,,,,2021-05-28,http://www.drks.de/DRKS00025452,,0,0
9480,DRKS00024104,"Recruiting complete, follow-up complete",,,,,,2021-10-26,http://www.drks.de/DRKS00024104,,0,0
9481,DRKS00024162,Recruiting planned,,,,,,2021-02-09,http://www.drks.de/DRKS00024162,,0,0
9482,DRKS00024165,Recruiting ongoing,,,,,,2021-03-01,http://www.drks.de/DRKS00024165,,0,0
9483,DRKS00024143,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Paper', 'link_to_document': 'https://www.mdpi.com/2673-8112/1/1/29'}]",,2021-09-09,http://www.drks.de/DRKS00024143,,0,1
9484,DRKS00024196,Recruiting ongoing,,,,,,2021-01-28,http://www.drks.de/DRKS00024196,,0,0
9485,DRKS00024199,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=358ac0ef-865d-49ad-ad9e-4b4a69f438cb&LOCALE=en&FILENAME=2021-742_2_Final_EK_Multicenter_HDZ_COVID19_10.03.2021.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=83cd5fb8-fa82-4d15-b00c-2c031a95310e&LOCALE=en&FILENAME=01_Studienprotokoll_ Multizentrisch_COVID19_Vers.1.3_track.pdf'}]",,2022-03-08,http://www.drks.de/DRKS00024199,,0,1
9486,DRKS00024176,Recruiting planned,,,,,,2021-03-01,http://www.drks.de/DRKS00024176,,0,0
9487,DRKS00024184,"Recruiting complete, follow-up continuing",,,,,,2022-03-21,http://www.drks.de/DRKS00024184,,0,0
9488,DRKS00022928,Recruiting planned,,,,,,2021-08-30,http://www.drks.de/DRKS00022928,,0,0
9489,DRKS00025199,"Recruiting complete, follow-up complete",,2020-11-12,,,,2021-04-30,http://www.drks.de/DRKS00025199,2020-11-12,0,0
9490,DRKS00021686,Recruiting ongoing,,,,,,2022-03-11,http://www.drks.de/DRKS00021686,,0,0
9491,DRKS00021672,Recruiting ongoing,,,,,,2020-12-01,http://www.drks.de/DRKS00021672,,0,0
9492,DRKS00025127,"Recruiting complete, follow-up complete",,,,,,2021-12-06,http://www.drks.de/DRKS00025127,,0,0
9493,DRKS00025125,"Recruiting complete, follow-up continuing",,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://doi.org/10.1186/s12887-021-02869-9'}]",,2022-01-04,http://www.drks.de/DRKS00025125,,0,1
9494,DRKS00025123,Recruiting ongoing,,,,,,2021-06-07,http://www.drks.de/DRKS00025123,,0,0
9495,DRKS00025112,"Recruiting complete, follow-up complete",,,,,,2021-09-30,http://www.drks.de/DRKS00025112,,0,0
9496,DRKS00025153,Recruiting ongoing,,,,,,2021-04-29,http://www.drks.de/DRKS00025153,,0,0
9497,DRKS00025217,Recruiting ongoing,,,,,,2022-03-09,http://www.drks.de/DRKS00025217,,0,0
9498,DRKS00025242,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=52471903-433a-46ac-9271-760200542dc6&LOCALE=en&FILENAME=21-0490 KB.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=5a08ddae-5e3a-4a22-bfc8-46e1a380cd86&LOCALE=en&FILENAME=Studienprotokoll_20210519.pdf'}]",,2021-05-21,http://www.drks.de/DRKS00025242,,0,1
9499,DRKS00025254,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=38dff9e3-ba7e-450f-afdf-80fa98443c95&LOCALE=en&FILENAME=Protokoll COVID Impfungen bei krebskranken Jugendlichen 03.05.2021.pdf'}]",,2021-05-26,http://www.drks.de/DRKS00025254,,0,1
9500,DRKS00025221,Recruiting planned,,,,,,2021-05-03,http://www.drks.de/DRKS00025221,,0,0
9501,DRKS00025222,Recruiting planned,,,,,,2021-04-30,http://www.drks.de/DRKS00025222,,0,0
9502,DRKS00025271,Recruiting ongoing,,,,,,2021-05-11,http://www.drks.de/DRKS00025271,,0,0
9503,2020-000890-25,['Ongoing'],,,,,,,,,0,0
9504,2020-000919-69,['Completed'],,2021-03-17,,,,,,2021-03-17,0,0
9505,2020-001271-33,['Completed'],,,,,,,,,0,0
9506,2020-001281-11,['Prematurely Ended'],,2020-04-28,,,,,,2020-04-28,0,0
9507,2020-001236-10,"['Completed', 'Ongoing']",,,,,,,,,0,0
9508,2020-001010-38,['Prematurely Ended'],,2020-05-20,,,,,,2020-05-20,0,0
9509,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9510,2020-001513-20,['Ongoing'],,,,,,,,,0,0
9511,2020-001301-23,['Prematurely Ended'],,2022-02-03,,,,,,2022-02-03,0,0
9512,2020-001381-11,['Completed'],,2020-11-28,,,,,,2020-11-28,0,0
9513,2020-001442-19,['Ongoing'],,,,,,,,,0,0
9514,2020-001385-11,['Completed'],,2021-07-11,,,,,,2021-07-11,0,0
9515,2020-001409-21,['Ongoing'],,,,,,,,,0,0
9516,2020-001333-13,['Prematurely Ended'],,2020-08-07,,,,,,2020-08-07,0,0
9517,2020-001492-33,['Completed'],,2021-12-15,,,,,,2021-12-15,0,0
9518,2020-001194-69,['Ongoing'],,,,,,,,,0,0
9519,2020-001565-37,['Ongoing'],,,,,,,,,0,0
9520,2020-001421-31,['Ongoing'],,,,,,,,,0,0
9521,2020-001606-33,['Ongoing'],,,,,,,,,0,0
9522,2020-001307-16,['Prematurely Ended'],,2020-06-03,,,,,,2020-06-03,0,0
9523,2020-001110-38,['Ongoing'],,,,,,,,,0,0
9524,2020-001275-32,['Prematurely Ended'],,2020-10-09,,,,,,2020-10-09,0,0
9525,2020-001167-93,['Prematurely Ended'],,,View results,,,,,,1,0
9526,2020-001357-52,['Ongoing'],,,,,,,,,0,0
9527,2020-001442-19,['Ongoing'],,,,,,,,,0,0
9528,2020-001445-39,['Prematurely Ended'],,2020-06-29,,,,,,2020-06-29,0,0
9529,2020-001250-21,['Completed'],,2021-06-10,,,,,,2021-06-10,0,0
9530,2020-001224-33,['Prematurely Ended'],,2021-02-26,View results,,,,,2021-02-26,1,0
9531,2020-001156-18,['Ongoing'],,,,,,,,,0,0
9532,2019-002688-89,['Ongoing'],,,,,,,,,0,0
9533,2020-001160-28,['Ongoing'],,,,,,,,,0,0
9534,2020-001262-11,['Ongoing'],,,,,,,,,0,0
9535,2020-001290-74,['Prematurely Ended'],,2021-05-05,,,,,,2021-05-05,0,0
9536,2020-001406-27,['Prematurely Ended'],,2020-06-08,,,,,,2020-06-08,0,0
9537,2020-001321-31,['Ongoing'],,,,,,,,,0,0
9538,2020-001437-12,['Ongoing'],,,,,,,,,0,0
9539,2020-001530-35,['Prematurely Ended'],,2020-12-29,,,,,,2020-12-29,0,0
9540,2020-001587-29,['Ongoing'],,,,,,,,,0,0
9541,2020-001689-12,"['Ongoing', 'GB - no longer in EU/EEA', 'Prematurely Ended', 'Prematurely Ended']",,2021-01-19,,,,,,2021-01-19,0,0
9542,2020-001765-37,['Prematurely Ended'],,2020-06-26,,,,,,2020-06-26,0,0
9543,2020-001379-34,['Prematurely Ended'],,2021-03-31,,,,,,2021-03-31,0,0
9544,2020-001511-25,['Ongoing'],,,,,,,,,0,0
9545,2020-001266-11,['Prematurely Ended'],,2020-11-11,,,,,,2020-11-11,0,0
9546,2017-000584-33,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9547,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9548,2020-001278-31,['Ongoing'],,,,,,,,,0,0
9549,2020-001413-20,['Temporarily Halted'],,,,,,,,,0,0
9550,2020-001306-35,['Prematurely Ended'],,2021-04-26,,,,,,2021-04-26,0,0
9551,2020-001335-28,"['Completed', 'Completed', 'Completed', 'Ongoing']",,2021-12-01,,,,,,2021-12-01,0,0
9552,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9553,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9554,2020-001457-43,['Ongoing'],,,,,,,,,0,0
9555,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9556,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9557,2020-001266-11,['Prematurely Ended'],,2020-11-11,,,,,,2020-11-11,0,0
9558,2020-001405-23,['Ongoing'],,,,,,,,,0,0
9559,2020-001951-42,['Ongoing'],,,,,,,,,0,0
9560,2020-001391-15,['Completed'],,2021-04-12,,,,,,2021-04-12,0,0
9561,2020-001329-30,['Ongoing'],,,,,,,,,0,0
9562,2020-001527-14,['Ongoing'],,,,,,,,,0,0
9563,2017-001100-30,['Completed'],,2021-06-07,,,,,,2021-06-07,0,0
9564,2020-001255-40,['Ongoing'],,,View results,,,,,,1,0
9565,2020-001659-42,['Completed'],,2021-01-15,,,,,,2021-01-15,0,0
9566,2020-001622-64,['Ongoing'],,,,,,,,,0,0
9567,2020-001440-26,['Prematurely Ended'],,2020-04-08,,,,,,2020-04-08,0,0
9568,2020-001327-13,['Completed'],,2021-06-14,,,,,,2021-06-14,0,0
9569,2020-001459-42,['Prematurely Ended'],,2022-02-17,,,,,,2022-02-17,0,0
9570,2020-001417-21,['Prematurely Ended'],,2020-06-26,View results,,,,,2020-06-26,1,0
9571,2020-001500-41,['Completed'],,2021-05-21,,,,,,2021-05-21,0,0
9572,2020-001254-22,['Completed'],,2021-02-26,View results,,,,,2021-02-26,1,0
9573,2020-001500-41,['Completed'],,2021-05-21,,,,,,2021-05-21,0,0
9574,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9575,2020-001039-29,['Ongoing'],,,,,,,,,0,0
9576,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9577,2020-001570-30,['Completed'],,,,,,,,,0,0
9578,2020-001302-30,['Ongoing'],,,,,,,,,0,0
9579,2020-001466-11,['Ongoing'],,,,,,,,,0,0
9580,2020-001251-41,['Prematurely Ended'],,2021-01-29,,,,,,2021-01-29,0,0
9581,2020-001634-36,['Ongoing'],,,,,,,,,0,0
9582,2020-001531-27,['Completed'],,2021-04-06,,,,,,2021-04-06,0,0
9583,2020-001732-10,['Completed'],,2021-07-30,,,,,,2021-07-30,0,0
9584,2020-001303-16,['Prematurely Ended'],,2021-06-02,,,,,,2021-06-02,0,0
9585,2020-001366-11,"['Temporarily Halted', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9586,2020-000982-18,"['Ongoing', 'Prematurely Ended']",,,,,,,,,0,0
9587,2020-002060-31,['Prematurely Ended'],,,,,,,,,0,0
9588,2020-001549-38,['Prematurely Ended'],,,,,,,,,0,0
9589,2020-001723-13,['Ongoing'],,,,,,,,,0,0
9590,2020-001198-55,['Prematurely Ended'],,2022-01-16,View results,,,,,2022-01-16,1,0
9591,2020-001686-36,['Ongoing'],,,,,,,,,0,0
9592,2020-001823-15,['Ongoing'],,,,,,,,,0,0
9593,2020-001722-66,['Ongoing'],,,,,,,,,0,0
9594,2020-001505-22,['Ongoing'],,,,,,,,,0,0
9595,2020-001717-20,['Ongoing'],,,,,,,,,0,0
9596,2020-001541-39,['Ongoing'],,,,,,,,,0,0
9597,2020-001618-39,['Ongoing'],,,,,,,,,0,0
9598,2020-001408-41,['Prematurely Ended'],,2020-08-31,View results,,,,,2020-08-31,1,0
9599,2020-001200-42,['Prematurely Ended'],,2021-09-06,,,,,,2021-09-06,0,0
9600,2020-001385-11,['Completed'],,2021-07-11,,,,,,2021-07-11,0,0
9601,2020-001481-11,['Completed'],,2021-06-30,,,,,,2021-06-30,0,0
9602,2020-001640-26,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9603,2020-001682-36,['Ongoing'],,,,,,,,,0,0
9604,2020-001700-42,['Ongoing'],,,,,,,,,0,0
9605,2020-001635-27,['Ongoing'],,,,,,,,,0,0
9606,2020-001766-11,['Ongoing'],,,,,,,,,0,0
9607,2020-001709-21,['Ongoing'],,,,,,,,,0,0
9608,2020-001768-27,['Completed'],,2021-11-05,,,,,,2021-11-05,0,0
9609,2020-001598-66,['Ongoing'],,,,,,,,,0,0
9610,2020-001786-36,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9611,2020-001632-10,['Ongoing'],,,,,,,,,0,0
9612,2020-001783-28,['Ongoing'],,,,,,,,,0,0
9613,2020-000705-86,['Ongoing'],,,,,,,,,0,0
9614,2020-001891-14,['Ongoing'],,,,,,,,,0,0
9615,2020-001825-29,['Ongoing'],,,,,,,,,0,0
9616,2020-002032-69,['Ongoing'],,,,,,,,,0,0
9617,2020-001697-30,['Ongoing'],,,,,,,,,0,0
9618,2020-001603-16,['Temporarily Halted'],,,,,,,,,0,0
9619,2020-001375-32,['Completed'],,,,,,,,,0,0
9620,2020-001994-66,['Prematurely Ended'],,2020-12-31,,,,,,2020-12-31,0,0
9621,2020-001934-37,['Ongoing'],,,,,,,,,0,0
9622,2020-002123-11,['Ongoing'],,,,,,,,,0,0
9623,2020-001474-29,['Ongoing'],,,View results,,,,,,1,0
9624,2020-001953-36,['Ongoing'],,,View results,,,,,,1,0
9625,2020-001888-90,['Completed'],,2021-07-31,,,,,,2021-07-31,0,0
9626,2020-001475-33,['Ongoing'],,,,,,,,,0,0
9627,2020-001052-18,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-09-10,View results,,,,,2020-09-10,1,0
9628,2020-001455-40,['Completed'],,,,,,,,,0,0
9629,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9630,2020-001602-34,['Completed'],,,,,,,,,0,0
9631,2020-001411-25,"['Completed', 'Completed', 'Completed', 'GB - no longer in EU/EEA', 'Temporarily Halted', 'Prematurely Ended']",,2021-01-13,View results,,,,,2021-01-13,1,0
9632,2020-001616-18,['Ongoing'],,,,,,,,,0,0
9633,2020-001512-26,['Prematurely Ended'],,2020-10-12,View results,,,,,2020-10-12,1,0
9634,2020-001644-25,"['Completed', 'Completed', 'Ongoing', 'Completed', 'Completed']",,2020-11-17,View results,,,,,2020-11-17,1,0
9635,2020-001450-22,['Prematurely Ended'],,,View results,,,,,,1,0
9636,2020-001264-28,"['Completed', 'Completed', 'Completed', 'Completed']",,2021-02-23,,,,,,2021-02-23,0,0
9637,2020-001644-25,"['Completed', 'Completed', 'Ongoing', 'Completed', 'Completed']",,2020-11-17,View results,,,,,2020-11-17,1,0
9638,2020-001928-34,['Ongoing'],,,,,,,,,0,0
9639,2020-002130-33,['Completed'],,2021-05-27,,,,,,2021-05-27,0,0
9640,2020-001678-31,['Ongoing'],,,,,,,,,0,0
9641,2020-001331-26,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9642,2020-001909-22,['Ongoing'],,,,,,,,,0,0
9643,2020-001734-36,['Prematurely Ended'],,,,,,,,,0,0
9644,2020-001393-30,,,,,,,,,,0,0
9645,2020-001786-36,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9646,2020-001598-66,['Ongoing'],,,,,,,,,0,0
9647,2020-001023-14,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9648,2020-001448-24,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9649,2020-004144-28,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9650,2020-001684-89,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9651,2020-001805-21,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9652,2020-001614-38,['Prematurely Ended'],,2021-03-15,View results,,,,,2021-03-15,1,0
9653,2020-001770-30,['Prematurely Ended'],,,,,,,,,0,0
9654,2020-001995-13,['Ongoing'],,,,,,,,,0,0
9655,2020-002274-28,['Ongoing'],,,,,,,,,0,0
9656,2020-001704-42,['Ongoing'],,,,,,,,,0,0
9657,2020-001258-23,['Completed'],,,,,,,,,0,0
9658,2020-001708-41,['Prematurely Ended'],,,,,,,,,0,0
9659,2020-002035-30,['Ongoing'],,,,,,,,,0,0
9660,2020-001354-22,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9661,2020-001490-68,['Completed'],,2021-04-15,,,,,,2021-04-15,0,0
9662,2020-001673-75,"['Prematurely Ended', 'Completed', 'GB - no longer in EU/EEA', 'Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended']",,2021-04-16,View results,,,,,2021-04-16,1,0
9663,2020-001721-31,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9664,2020-002869-34,['Prematurely Ended'],,2022-01-06,,,,,,2022-01-06,0,0
9665,2020-001643-13,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9666,2020-001573-78,['Ongoing'],,,,,,,,,0,0
9667,2020-001754-21,['Prematurely Ended'],,2021-07-09,,,,,,2021-07-09,0,0
9668,2020-001536-98,['Prematurely Ended'],,2020-04-27,,,,,,2020-04-27,0,0
9669,2020-001673-75,"['Prematurely Ended', 'Completed', 'GB - no longer in EU/EEA', 'Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended']",,2021-04-16,View results,,,,,2021-04-16,1,0
9670,2020-001497-30,"['GB - no longer in EU/EEA', 'Prematurely Ended', 'Prematurely Ended', 'Temporarily Halted', 'Ongoing']",,2021-09-01,,,,,,2021-09-01,0,0
9671,2020-001739-28,['Completed'],,2021-05-04,,,,,,2021-05-04,0,0
9672,2020-001623-13,['Prematurely Ended'],,,View results,,,,,,1,0
9673,2020-002287-31,['Ongoing'],,,,,,,,,0,0
9674,2020-002037-15,['Ongoing'],,,,,,,,,0,0
9675,2020-001960-28,['Ongoing'],,,,,,,,,0,0
9676,2020-001841-38,['Ongoing'],,,,,,,,,0,0
9677,2020-001420-34,['Completed'],,2021-01-25,View results,,,,,2021-01-25,1,0
9678,2020-001732-10,['Completed'],,2021-07-30,,,,,,2021-07-30,0,0
9679,2020-001605-23,['Prematurely Ended'],,2020-10-05,,,,,,2020-10-05,0,0
9680,2020-002312-43,['Ongoing'],,,,,,,,,0,0
9681,2020-001671-32,['Prematurely Ended'],,2021-12-25,,,,,,2021-12-25,0,0
9682,2020-001469-35,['Completed'],,2020-12-31,,,,,,2020-12-31,0,0
9683,2020-001882-36,['Ongoing'],,,,,,,,,0,0
9684,2020-001228-32,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9685,2020-002503-19,"['Completed', 'GB - no longer in EU/EEA']",,,,,,,,,0,0
9686,2020-001324-33,['Completed'],,2021-02-02,,,,,,2021-02-02,0,0
9687,2020-001367-88,['Prematurely Ended'],,,View results,,,,,,1,0
9688,2020-001482-37,['Prematurely Ended'],,2021-01-07,View results,,,,,2021-01-07,1,0
9689,2020-001886-35,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9690,2020-004123-16,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9691,2020-001972-13,['Ongoing'],,,,,,,,,0,0
9692,2020-001597-30,['GB - no longer in EU/EEA'],,,View results,,,,,,1,0
9693,2020-001546-19,['Prematurely Ended'],,2020-10-26,View results,,,,,2020-10-26,1,0
9694,2020-002111-22,['Ongoing'],,,,,,,,,0,0
9695,2020-001904-41,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9696,2020-002091-12,['Completed'],,2020-10-08,,,,,,2020-10-08,0,0
9697,2020-001849-39,['Ongoing'],,,,,,,,,0,0
9698,2020-001951-42,['Ongoing'],,,,,,,,,0,0
9699,2015-002340-14,"['Ongoing', 'Ongoing', 'Ongoing', 'GB - no longer in EU/EEA', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9700,2020-001038-36,['Ongoing'],,,,,,,,,0,0
9701,2020-002130-33,['Completed'],,2021-05-27,,,,,,2021-05-27,0,0
9702,2020-000842-32,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-06-26,View results,,,,,2020-06-26,1,0
9703,2020-000841-15,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-06-30,View results,,,,,2020-06-30,1,0
9704,2020-001154-22,"['Completed', 'Completed', 'Completed', 'Completed', 'GB - no longer in EU/EEA', 'Completed', 'Ongoing']",,2020-07-28,View results,,,,,2020-07-28,1,0
9705,2020-001345-38,['Completed'],,,View results,,,,,,1,0
9706,2020-001623-13,['Prematurely Ended'],,,View results,,,,,,1,0
9707,2020-001501-24,['Prematurely Ended'],,,,,,,,,0,0
9708,2020-001587-29,['Ongoing'],,,,,,,,,0,0
9709,2020-000936-23,"['Ongoing', 'Ongoing', 'Temporarily Halted', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9710,2020-001349-37,['Ongoing'],,,,,,,,,0,0
9711,2020-001269-35,,,,,,,,,,0,0
9712,2020-001456-18,['Prematurely Ended'],,,,,,,,,0,0
9713,2020-001993-31,,,,,,,,,,0,0
9714,2020-002282-33,['Prematurely Ended'],,,,,,,,,0,0
9715,2020-001591-15,['Completed'],,2021-09-22,,,,,,2021-09-22,0,0
9716,2020-001257-51,['Prematurely Ended'],,2020-12-16,,,,,,2020-12-16,0,0
9717,2020-001363-85,['Prematurely Ended'],,,View results,,,,,,1,0
9718,2020-001270-29,"['Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended']",,2020-06-25,View results,,,,,2020-06-25,1,0
9719,2020-001376-15,['Prematurely Ended'],,2020-09-03,View results,,,,,2020-09-03,1,0
9720,2020-001498-63,"['Ongoing', 'Ongoing', 'GB - no longer in EU/EEA']",,,,,,,,,0,0
9721,2020-001937-11,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9722,2020-001244-26,['Prematurely Ended'],,2021-08-23,,,,,,2021-08-23,0,0
9723,2020-001431-27,['Prematurely Ended'],,,,,,,,,0,0
9724,2020-001160-28,['Ongoing'],,,,,,,,,0,0
9725,2020-001544-26,['Ongoing'],,,,,,,,,0,0
9726,2020-001571-32,['Ongoing'],,,,,,,,,0,0
9727,2020-001364-29,['Ongoing'],,,,,,,,,0,0
9728,2020-002641-42,['Ongoing'],,,,,,,,,0,0
9729,2020-001740-26,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9730,2020-001889-10,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9731,2020-002259-39,['Prematurely Ended'],,2021-01-15,View results,,,,,2021-01-15,1,0
9732,2020-001441-39,"['GB - no longer in EU/EEA', 'Prematurely Ended']",,,,,,,,,0,0
9733,2020-001689-12,"['Ongoing', 'GB - no longer in EU/EEA', 'Prematurely Ended', 'Prematurely Ended']",,2021-01-19,,,,,,2021-01-19,0,0
9734,2020-001320-34,['Prematurely Ended'],,2021-05-25,View results,,,,,2021-05-25,1,0
9735,2020-001553-48,['Prematurely Ended'],,2020-08-18,,,,,,2020-08-18,0,0
9736,2020-001996-33,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9737,2020-001206-35,"['Ongoing', 'Completed']",,,,,,,,,0,0
9738,2020-001435-27,['Completed'],,2021-10-22,,,,,,2021-10-22,0,0
9739,2020-001667-85,['Ongoing'],,,,,,,,,0,0
9740,2020-001370-30,"['Completed', 'GB - no longer in EU/EEA', 'Completed', 'Ongoing', 'Completed', 'Completed']",,2020-12-22,View results,,,,,2020-12-22,1,0
9741,2020-001963-10,['Ongoing'],,,,,,,,,0,0
9742,2020-003056-32,,,,,,,,,,0,0
9743,2020-001548-24,['Ongoing'],,,,,,,,,0,0
9744,2020-001608-40,['Prematurely Ended'],,2021-02-15,,,,,,2021-02-15,0,0
9745,2020-002326-90,,,,,,,,,,0,0
9746,2020-001243-15,['Prematurely Ended'],,2020-06-10,View results,,,,,2020-06-10,1,0
9747,2020-001636-95,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9748,2020-002293-28,['Prematurely Ended'],,2021-06-18,,,,,,2021-06-18,0,0
9749,2020-001889-10,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9750,2020-002120-37,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9751,2020-002233-15,['Temporarily Halted'],,,,,,,,,0,0
9752,2020-001784-88,['Ongoing'],,,,,,,,,0,0
9753,2020-001736-95,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9754,2020-001373-70,['Prematurely Ended'],,2021-07-06,,,,,,2021-07-06,0,0
9755,2020-001870-32,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-12-24,View results,,,,,2020-12-24,1,0
9756,2020-001803-17,"['GB - no longer in EU/EEA', 'Ongoing']",,,,,,,,,0,0
9757,2020-001696-32,['Ongoing'],,,View results,,,,,,1,0
9758,2020-001031-27,['Ongoing'],,,,,,,,,0,0
9759,2020-001453-49,['Ongoing'],,,View results,,,,,,1,0
9760,2020-001188-96,['Ongoing'],,,,,,,,,0,0
9761,2020-001172-15,"['Completed', 'Completed', 'Completed', 'GB - no longer in EU/EEA']",,2020-12-26,,,,,,2020-12-26,0,0
9762,2020-001386-37,['Prematurely Ended'],,,,,,,,,0,0
9763,2020-001473-79,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9764,2020-001662-11,"['Completed', 'GB - no longer in EU/EEA', 'Completed', 'Ongoing', 'Completed']",,2020-10-17,View results,,,,,2020-10-17,1,0
9765,2020-001709-21,['Ongoing'],,,,,,,,,0,0
9766,2020-001449-38,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9767,2020-001759-42,"['GB - no longer in EU/EEA', 'Completed', 'Ongoing', 'Completed', 'Completed', 'Completed']",,2021-08-16,View results,,,,,2021-08-16,1,0
9768,2020-002713-17,['Completed'],,2021-02-12,View results,,,,,2021-02-12,1,0
9769,2020-001052-18,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-09-10,View results,,,,,2020-09-10,1,0
9770,2020-001807-18,"['GB - no longer in EU/EEA', 'Completed']",,2021-04-21,View results,,,,,2021-04-21,1,0
9771,2020-001573-78,['Ongoing'],,,,,,,,,0,0
9772,2020-002275-34,['Completed'],,2021-03-08,View results,,,,,2021-03-08,1,0
9773,2020-001748-24,['Completed'],,2021-05-17,,,,,,2021-05-17,0,0
9774,2020-002448-21,['Ongoing'],,,,,,,,,0,0
9775,2020-001296-33,['Completed'],,2021-04-26,,,,,,2021-04-26,0,0
9776,2020-001517-21,"['GB - no longer in EU/EEA', 'Completed', 'Completed', 'Completed']",,2021-06-10,View results,,,,,2021-06-10,1,0
9777,2017-000632-34,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9778,2020-003690-21,['Ongoing'],,,,,,,,,0,0
9779,2020-002537-15,['Ongoing'],,,,,,,,,0,0
9780,2020-001308-40,['Ongoing'],,,,,,,,,0,0
9781,2020-001310-38,['Restarted'],,,,,,,,,0,0
9782,2020-001675-33,['Completed'],,2021-10-12,,,,,,2021-10-12,0,0
9783,2020-001483-28,['Ongoing'],,,,,,,,,0,0
9784,2020-002283-32,['Ongoing'],,,,,,,,,0,0
9785,2020-001827-15,['Ongoing'],,,,,,,,,0,0
9786,2020-001872-13,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9787,2020-002011-21,['Ongoing'],,,,,,,,,0,0
9788,2020-002458-25,['Prematurely Ended'],,2021-03-30,,,,,,2021-03-30,0,0
9789,2020-001209-22,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9790,2020-001767-86,['Ongoing'],,,,,,,,,0,0
9791,2020-001777-71,['GB - no longer in EU/EEA'],,,View results,,,,,,1,0
9792,2020-001745-40,['Ongoing'],,,,,,,,,0,0
9793,2020-001501-24,['Prematurely Ended'],,,,,,,,,0,0
9794,2020-001390-76,['Ongoing'],,,,,,,,,0,0
9795,2020-001528-32,['Ongoing'],,,,,,,,,0,0
9796,2020-001987-28,['Ongoing'],,,,,,,,,0,0
9797,2020-001921-30,['Ongoing'],,,,,,,,,0,0
9798,2020-001795-15,['Ongoing'],,,,,,,,,0,0
9799,2020-001854-23,['Ongoing'],,,,,,,,,0,0
9800,2020-001558-23,['Ongoing'],,,,,,,,,0,0
9801,2020-001072-15,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9802,2020-001113-21,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9803,2020-001395-15,['Prematurely Ended'],,2021-06-12,,,,,,2021-06-12,0,0
9804,2020-001162-12,"['Completed', 'Completed', 'Completed', 'Completed']",,2020-09-02,View results,,,,,2020-09-02,1,0
9805,2020-001325-31,['Completed'],,2021-01-21,,,,,,2021-01-21,0,0
9806,2020-001747-21,['Ongoing'],,,,,,,,,0,0
9807,2020-002106-68,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9808,2020-001808-42,['Ongoing'],,,View results,,,,,,1,0
9809,2020-001707-16,['Ongoing'],,,,,,,,,0,0
9810,2020-001890-56,['Ongoing'],,,,,,,,,0,0
9811,2020-001794-77,['Ongoing'],,,,,,,,,0,0
9812,2020-001929-31,['Ongoing'],,,,,,,,,0,0
9813,2020-002186-34,['Prematurely Ended'],,2021-02-10,View results,,,,,2021-02-10,1,0
9814,2020-002310-41,['Ongoing'],,,,,,,,,0,0
9815,2020-002166-13,['Completed'],,2022-03-17,,,,,,2022-03-17,0,0
9816,2020-002449-41,['Ongoing'],,,,,,,,,0,0
9817,2020-002668-29,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9818,2020-002494-10,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9819,2020-002476-13,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9820,2020-002952-18,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9821,2020-002102-58,['Ongoing'],,,,,,,,,0,0
9822,2020-002574-27,['Ongoing'],,,,,,,,,0,0
9823,2020-001786-36,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9824,2020-002038-33,['Prematurely Ended'],,2021-01-30,,,,,,2021-01-30,0,0
9825,2020-002458-25,['Prematurely Ended'],,2021-03-30,,,,,,2021-03-30,0,0
9826,2020-002283-32,['Ongoing'],,,,,,,,,0,0
9827,2020-003628-18,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9828,2020-002394-94,['Ongoing'],,,,,,,,,0,0
9829,2015-002340-14,"['Ongoing', 'Ongoing', 'Ongoing', 'GB - no longer in EU/EEA', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9830,2020-002314-40,['Ongoing'],,,,,,,,,0,0
9831,2020-002027-10,['Prematurely Ended'],,2021-05-26,,,,,,2021-05-26,0,0
9832,2020-002299-11,['Ongoing'],,,,,,,,,0,0
9833,2020-002728-35,['Ongoing'],,,,,,,,,0,0
9834,2020-001645-40,['Prematurely Ended'],,,,,,,,,0,0
9835,2020-003470-47,['Ongoing'],,,,,,,,,0,0
9836,2020-001736-95,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9837,2020-001805-21,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9838,2020-002110-41,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9839,2020-001610-38,['Ongoing'],,,,,,,,,0,0
9840,2020-001608-40,['Prematurely Ended'],,2021-02-15,,,,,,2021-02-15,0,0
9841,2020-003349-12,['Ongoing'],,,,,,,,,0,0
9842,2020-004928-42,['Ongoing'],,,,,,,,,0,0
9843,2020-001867-94,['Prematurely Ended'],,2021-03-22,,,,,,2021-03-22,0,0
9844,2020-001504-42,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9845,2020-003486-19,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9846,2020-003689-37,['Ongoing'],,,,,,,,,0,0
9847,2020-002677-95,['Ongoing'],,,,,,,,,0,0
9848,2020-002122-82,['Ongoing'],,,,,,,,,0,0
9849,2020-001936-86,['Prematurely Ended'],,2021-11-15,,,,,,2021-11-15,0,0
9850,2020-001782-37,['Completed'],,2021-03-05,View results,,,,,2021-03-05,1,0
9851,2020-002472-12,['Completed'],,2021-02-25,,,,,,2021-02-25,0,0
9852,2020-001903-17,['Ongoing'],,,,,,,,,0,0
9853,2020-002114-40,['Ongoing'],,,,,,,,,0,0
9854,2020-001852-16,['Ongoing'],,,,,,,,,0,0
9855,2020-001857-31,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9856,2020-002497-27,['Ongoing'],,,,,,,,,0,0
9857,2020-002225-29,['Completed'],,2021-06-21,,,,,,2021-06-21,0,0
9858,2020-001467-82,['Ongoing'],,,,,,,,,0,0
9859,2020-004743-83,"['GB - no longer in EU/EEA', 'Completed', 'Ongoing', 'Completed', 'Completed', 'Ongoing', 'Completed']",,2022-02-10,,,,,,2022-02-10,0,0
9860,2020-001319-26,['Ongoing'],,,,,,,,,0,0
9861,2020-002456-21,['Completed'],,2020-09-03,,,,,,2020-09-03,0,0
9862,2020-002009-25,['Ongoing'],,,,,,,,,0,0
9863,2020-001971-33,['Ongoing'],,,,,,,,,0,0
9864,2020-002234-32,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9865,2020-004682-39,['Ongoing'],,,,,,,,,0,0
9866,2020-002322-85,"['Completed', 'Prematurely Ended']",,2021-08-07,,,,,,2021-08-07,0,0
9867,2020-003936-25,"['Prematurely Ended', 'Ongoing']",,,,,,,,,0,0
9868,2020-003904-15,['Ongoing'],,,,,,,,,0,0
9869,2020-001904-41,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9870,2020-002504-39,['Ongoing'],,,,,,,,,0,0
9871,2020-004695-18,['Completed'],,2021-10-29,,,,,,2021-10-29,0,0
9872,2020-002119-23,['Ongoing'],,,,,,,,,0,0
9873,2020-003872-42,['Ongoing'],,,,,,,,,0,0
9874,2020-004408-32,['Prematurely Ended'],,2021-09-30,,,,,,2021-09-30,0,0
9875,2018-004318-16,"['Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended', 'Prematurely Ended']",,,View results,,,,,,1,0
9876,2020-001273-73,['Prematurely Ended'],,2020-06-18,,,,,,2020-06-18,0,0
9877,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9878,2020-001038-36,['Ongoing'],,,,,,,,,0,0
9879,2020-001502-38,['Completed'],,2020-10-13,View results,,,,,2020-10-13,1,0
9880,2020-001636-95,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9881,2020-002104-39,,,,,,,,,,0,0
9882,2020-002230-32,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9883,2020-002027-10,['Prematurely Ended'],,2021-05-26,,,,,,2021-05-26,0,0
9884,2020-001246-18,['Prematurely Ended'],,2020-11-26,,,,,,2020-11-26,0,0
9885,2020-003125-39,"['Completed', 'GB - no longer in EU/EEA', 'Ongoing']",,2021-11-30,,,,,,2021-11-30,0,0
9886,2020-001953-36,['Ongoing'],,,View results,,,,,,1,0
9887,2020-002106-68,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9888,2020-001493-29,['Prematurely Ended'],,2022-01-06,,,,,,2022-01-06,0,0
9889,2020-003278-37,"['Temporarily Halted', 'GB - no longer in EU/EEA', 'Prematurely Ended', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9890,2020-002632-75,"['GB - no longer in EU/EEA', 'Ongoing']",,,,,,,,,0,0
9891,2020-002211-21,"['GB - no longer in EU/EEA', 'Completed', 'Completed']",,2021-05-12,View results,,,,,2021-05-12,1,0
9892,2020-001805-21,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9893,2020-002234-32,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9894,2020-001823-15,['Ongoing'],,,,,,,,,0,0
9895,2020-001281-11,['Prematurely Ended'],,2020-04-28,,,,,,2020-04-28,0,0
9896,2020-003267-26,['Completed'],,2022-02-07,,,,,,2022-02-07,0,0
9897,2020-001849-39,['Ongoing'],,,,,,,,,0,0
9898,2020-002504-39,['Ongoing'],,,,,,,,,0,0
9899,2020-003107-34,,,,,,,,,,0,0
9900,2020-001654-21,['Ongoing'],,,,,,,,,0,0
9901,2020-002039-31,['Prematurely Ended'],,2021-06-16,,,,,,2021-06-16,0,0
9902,2020-001750-22,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9903,2020-001420-34,['Completed'],,2021-01-25,View results,,,,,2021-01-25,1,0
9904,2020-003369-20,"['Completed', 'Completed', 'Ongoing']",,2021-12-20,,,,,,2021-12-20,0,0
9905,2020-002295-13,['Ongoing'],,,,,,,,,0,0
9906,2020-001857-31,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9907,2020-002193-27,['Ongoing'],,,,,,,,,0,0
9908,2020-002056-20,['Completed'],,2021-06-13,,,,,,2021-06-13,0,0
9909,2020-001635-27,['Ongoing'],,,,,,,,,0,0
9910,2020-001766-11,['Ongoing'],,,,,,,,,0,0
9911,2020-002293-28,['Prematurely Ended'],,2021-06-18,,,,,,2021-06-18,0,0
9912,2020-003510-12,"['Completed', 'GB - no longer in EU/EEA', 'Completed']",,2021-05-06,View results,,,,,2021-05-06,1,0
9913,2020-002584-63,"['Completed', 'Completed', 'Restarted', None]",,2022-03-09,,,,,,2022-03-09,0,0
9914,2020-002542-16,"['GB - no longer in EU/EEA', 'Completed', 'Completed', 'Completed']",,2021-05-21,,,,,,2021-05-21,0,0
9915,2020-003367-26,"['Completed', 'GB - no longer in EU/EEA', 'Completed', 'Completed', 'Completed']",,2021-08-11,,,,,,2021-08-11,0,0
9916,2020-004356-16,"['GB - no longer in EU/EEA', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9917,2020-004719-28,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9918,2020-002913-16,"['Ongoing', 'Ongoing', '', 'Ongoing', 'Ongoing', 'Ongoing', '', 'Ongoing']",,,,,,,,,0,0
9919,2020-002111-22,['Ongoing'],,,,,,,,,0,0
9920,2020-003998-22,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9921,2020-002733-15,['Completed'],,2021-08-06,,,,,,2021-08-06,0,0
9922,2020-001255-40,['Ongoing'],,,View results,,,,,,1,0
9923,2020-005887-70,['Ongoing'],,,,,,,,,0,0
9924,2020-001860-27,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9925,2020-002567-57,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9926,2020-002502-75,['Completed'],,2021-09-21,,,,,,2021-09-21,0,0
9927,2020-003368-24,"['GB - no longer in EU/EEA', 'Completed', 'Ongoing', 'Completed']",,,,,,,,,0,0
9928,2020-004123-16,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9929,2020-003643-29,"['GB - no longer in EU/EEA', 'Ongoing', 'Ongoing', 'Temporarily Halted', 'Ongoing']",,,,,,,,,0,0
9930,2020-003654-71,"['Ongoing', 'Completed']",,,,,,,,,0,0
9931,2020-004994-27,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9932,2020-004323-16,['Completed'],,,,,,,,,0,0
9933,2020-004285-19,['Ongoing'],,,,,,,,,0,0
9934,2020-004206-59,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9935,2020-003505-58,['Ongoing'],,,,,,,,,0,0
9936,2020?003363?25,[None],,,,,,,,,0,0
9937,2020-002233-15,['Temporarily Halted'],,,,,,,,,0,0
9938,2021-000166-15,['Ongoing'],,,,,,,,,0,0
9939,2020-005539-62,['Prematurely Ended'],,2022-01-20,,,,,,2022-01-20,0,0
9940,2021-000516-37,['Completed'],,2022-01-21,,,,,,2022-01-21,0,0
9941,2020-005915-39,['Ongoing'],,,,,,,,,0,0
9942,2021-001072-41,['Ongoing'],,,,,,,,,0,0
9943,2021-001054-57,['Ongoing'],,,,,,,,,0,0
9944,2021-001279-18,[None],,,,,,,,,0,0
9945,2020-005979-12,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
9946,2020-005963-29,['Ongoing'],,,,,,,,,0,0
9947,2020-005961-16,['Ongoing'],,,,,,,,,0,0
9948,2021-000320-35,['Completed'],,2021-05-28,,,,,,2021-05-28,0,0
9949,2021-000710-42,['Completed'],,2022-02-16,,,,,,2022-02-16,0,0
9950,2021-000842-16,['Ongoing'],,,,,,,,,0,0
9951,2020-002982-33,['Restarted'],,,,,,,,,0,0
9952,2018-002571-18,['Ongoing'],,,,,,,,,0,0
9953,2020-001154-22,"['Completed', 'Completed', 'Completed', 'Completed', 'GB - no longer in EU/EEA', 'Completed', 'Ongoing']",,2020-07-28,View results,,,,,2020-07-28,1,0
9954,2020-005801-14,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9955,2021-000182-33,['Ongoing'],,,,,,,,,0,0
9956,2021-000206-17,['Ongoing'],,,,,,,,,0,0
9957,2021-000349-42,['Ongoing'],,,,,,,,,0,0
9958,2020-005291-35,['Ongoing'],,,,,,,,,0,0
9959,2020-005763-31,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9960,2021-000454-26,['Ongoing'],,,,,,,,,0,0
9961,2020-005828-11,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9962,2020-002772-12,['Completed'],,2021-09-01,,,,,,2021-09-01,0,0
9963,2020-001749-38,['Ongoing'],,,,,,,,,0,0
9964,2020-002345-42,"['Completed', 'Completed']",,2021-06-29,,,,,,2021-06-29,0,0
9965,2020-003614-13,['Ongoing'],,,,,,,,,0,0
9966,2020-004571-41,"['Completed', 'Prematurely Ended']",,2021-08-10,,,,,,2021-08-10,0,0
9967,2020-005919-51,['Ongoing'],,,,,,,,,0,0
9968,2018-003377-97,['Ongoing'],,,,,,,,,0,0
9969,2020-005447-23,['Prematurely Ended'],,2022-03-21,,,,,,2022-03-21,0,0
9970,2020-003363-25,['Completed'],,2021-12-14,,,,,,2021-12-14,0,0
9971,2020-002190-10,['Completed'],,2021-05-14,,,,,,2021-05-14,0,0
9972,2021-000515-24,['Ongoing'],,,,,,,,,0,0
9973,2020-003734-20,['Prematurely Ended'],,,,,,,,,0,0
9974,2020-005410-18,['Ongoing'],,,,,,,,,0,0
9975,2021-000868-30,['Ongoing'],,,,,,,,,0,0
9976,2021-000412-28,['Ongoing'],,,,,,,,,0,0
9977,2021-000461-33,['Ongoing'],,,,,,,,,0,0
9978,2020-001760-29,['Ongoing'],,,,,,,,,0,0
9979,2020-006042-39,['Prematurely Ended'],,2021-12-08,,,,,,2021-12-08,0,0
9980,2020-004715-27,['Ongoing'],,,,,,,,,0,0
9981,2021-000413-17,['Ongoing'],,,,,,,,,0,0
9982,2020-001251-41,['Prematurely Ended'],,2021-01-29,,,,,,2021-01-29,0,0
9983,2020-005828-11,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
9984,2020-001643-13,['GB - no longer in EU/EEA'],,,,,,,,,0,0
9985,2020-005827-35,['Ongoing'],,,,,,,,,0,0
9986,2021-000880-63,['Ongoing'],,,,,,,,,0,0
9987,2021-000905-26,['Ongoing'],,,,,,,,,0,0
9988,2021-000864-32,['Ongoing'],,,,,,,,,0,0
9989,2021-001028-16,['Ongoing'],,,,,,,,,0,0
9990,2020-005128-12,['Ongoing'],,,,,,,,,0,0
9991,2020-005214-18,['Ongoing'],,,,,,,,,0,0
9992,2021-000566-14,['Ongoing'],,,,,,,,,0,0
9993,2020-006130-12,['Ongoing'],,,,,,,,,0,0
9994,2021-000365-33,['Completed'],,2021-08-20,,,,,,2021-08-20,0,0
9995,2020-006075-15,['Ongoing'],,,,,,,,,0,0
9996,2021-000701-24,['Ongoing'],,,,,,,,,0,0
9997,2021-001655-13,['Ongoing'],,,,,,,,,0,0
9998,2021-001414-10,['Ongoing'],,,,,,,,,0,0
9999,2021-001080-24,['Prematurely Ended'],,2022-01-11,,,,,,2022-01-11,0,0
10000,2021-000440-22,['Ongoing'],,,,,,,,,0,0
10001,2021-001665-20,['Ongoing'],,,,,,,,,0,0
10002,2021-000455-39,['Temporarily Halted'],,,,,,,,,0,0
10003,2020-004272-17,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
10004,2021-000175-37,['Ongoing'],,,,,,,,,0,0
10005,2021-000872-13,['Ongoing'],,,,,,,,,0,0
10006,2020-004070-22,['Completed'],,2021-09-21,,,,,,2021-09-21,0,0
10007,2020-006003-42,['Ongoing'],,,,,,,,,0,0
10008,2020-003779-17,['Completed'],,2021-07-19,,,,,,2021-07-19,0,0
10009,2020-003210-13,['Ongoing'],,,,,,,,,0,0
10010,2021-000893-27,['Ongoing'],,,,,,,,,0,0
10011,2021-000930-32,['Ongoing'],,,,,,,,,0,0
10012,2021-001040-10,['Ongoing'],,,,,,,,,0,0
10013,2020-005580-32,['Ongoing'],,,,,,,,,0,0
10014,2021-000492-36,[''],,,,,,,,,0,0
10015,2021-001144-98,['Ongoing'],,,,,,,,,0,0
10016,2020-005849-16,"['Ongoing', 'Ongoing']",,,,,,,,,0,0
10017,2020-004066-19,['Ongoing'],,,,,,,,,0,0
10018,2020-002208-37,['Ongoing'],,,,,,,,,0,0
10019,2020-005015-40,['Prematurely Ended'],,2021-06-21,,,,,,2021-06-21,0,0
10020,2021-000235-30,['Prematurely Ended'],,2021-04-23,,,,,,2021-04-23,0,0
10021,2020-005020-11,['Ongoing'],,,,,,,,,0,0
10022,2020-005280-31,['Ongoing'],,,,,,,,,0,0
10023,2020-003369-20,"['Completed', 'Completed', 'Ongoing']",,2021-12-20,,,,,,2021-12-20,0,0
10024,2021-000988-68,['Ongoing'],,,,,,,,,0,0
10025,2021-000981-13,['Ongoing'],,,,,,,,,0,0
10026,2021-001304-15,['Ongoing'],,,,,,,,,0,0
10027,2021-001520-18,['Ongoing'],,,,,,,,,0,0
10028,2021-001357-31,['Ongoing'],,,,,,,,,0,0
10029,2020-005952-39,['Ongoing'],,,,,,,,,0,0
10030,2021-001202-30,['Ongoing'],,,,,,,,,0,0
10031,2021-001978-37,['Ongoing'],,,,,,,,,0,0
10032,2020-004695-18,['Completed'],,2021-10-29,,,,,,2021-10-29,0,0
10033,2021-000683-30,['Ongoing'],,,,,,,,,0,0
10034,2020-005759-18,"['Completed', 'Completed', 'Prematurely Ended', 'Ongoing', 'Ongoing', 'Temporarily Halted']",,2021-12-02,,,,,,2021-12-02,0,0
10035,2021-001031-72,['Ongoing'],,,,,,,,,0,0
10036,2020-005576-35,['Completed'],,,,,,,,,0,0
10037,2021-001512-28,['Completed'],,2021-12-30,,,,,,2021-12-30,0,0
10038,2021-002014-14,['Ongoing'],,,,,,,,,0,0
10039,2020-005299-36,"['Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
10040,2020-003403-33,"['Completed', 'Completed']",,2021-09-24,,,,,,2021-09-24,0,0
10041,2020-005315-44,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,,,,,,,0,0
10042,2021-001769-19,['Ongoing'],,,,,,,,,0,0
10043,2020-005366-34,"['Completed', 'Completed', 'Ongoing', 'Completed', 'Completed']",,2021-10-13,,,,,,2021-10-13,0,0
10044,2021-002245-15,['Ongoing'],,,,,,,,,0,0
10045,2021-002327-38,['Prematurely Ended'],,2022-02-28,,,,,,2022-02-28,0,0
10046,2021-002098-25,['Ongoing'],,,,,,,,,0,0
10047,2021-000724-35,"['Completed', 'Completed']",,,,,,,,,0,0
10048,2021-001177-22,['Ongoing'],,,,,,,,,0,0
10049,2021-000307-20,['Ongoing'],,,,,,,,,0,0
10050,2020-005524-11,['Completed'],,2021-06-02,,,,,,2021-06-02,0,0
10051,2020-001793-30,['Ongoing'],,,,,,,,,0,0
10052,2021-000408-39,['Prematurely Ended'],,,View results,,,,,,1,0
10053,2021-002348-57,['Ongoing'],,,,,,,,,0,0
10054,2021-000291-11,['Ongoing'],,,,,,,,,0,0
10055,2020-006082-11,"['Ongoing', 'Ongoing', 'Completed', 'Temporarily Halted', '']",,,,,,,,,0,0
10056,2021-001735-10,['Completed'],,2021-08-25,,,,,,2021-08-25,0,0
10057,2020-005752-38,['Ongoing'],,,,,,,,,0,0
10058,2021-000627-12,"['Completed', 'Ongoing', 'Completed', 'Ongoing', 'Ongoing']",,2022-03-16,,,,,,2022-03-16,0,0
10059,2021-002184-22,['Completed'],,2021-09-01,,,,,,2021-09-01,0,0
10060,2020-005227-37,['Ongoing'],,,,,,,,,0,0
10061,2021-001036-25,['Prematurely Ended'],,2021-12-10,,,,,,2021-12-10,0,0
10062,2020-005997-82,['Ongoing'],,,,,,,,,0,0
10063,2021-000673-83,['Ongoing'],,,,,,,,,0,0
10064,2020-005911-27,['Ongoing'],,,,,,,,,0,0
10065,2020-005085-33,,,,,,,,,,0,0
10066,2020-005524-11,['Completed'],,2021-06-02,,,,,,2021-06-02,0,0
10067,2021-001070-38,['Restarted'],,,,,,,,,0,0
10068,2021-000045-41,['Completed'],,2022-01-07,,,,,,2022-01-07,0,0
10069,2021-002174-52,['Ongoing'],,,,,,,,,0,0
10070,2020-005523-37,['Prematurely Ended'],,2022-02-14,,,,,,2022-02-14,0,0
10071,2021-003388-90,['Ongoing'],,,,,,,,,0,0
10072,2020-001870-32,"['Completed', 'Completed', 'Completed', 'Completed', 'Completed']",,2020-12-24,View results,,,,,2020-12-24,1,0
10073,ISRCTN16993428,Ongoing,,2029-08-31,,2021 Preprint results in https://doi.org/10.1101/2021.03.10.21252820 (added 01/06/2021) 2021 Preprint results in https://doi.org/10.1101/2021.03.04.21252931 (added 01/06/2021) 2021 Preprint results in https://www.biorxiv.org/content/10.1101/2021.04.21.440697v1 (added 01/06/2021) 2021 Results article in https://doi.org/10.1038/s41586-020-03065-y genome-wide association study results (added 01/06/2021) 2022 Results article in https://doi.org/10.1038/s41586-022-04576-6 Critical COVID-19 results (added 31/03/2022),,2022-03-31,http://isrctn.com/ISRCTN16993428,2029-08-31,0,1
10074,ISRCTN16269648,Ongoing,,2022-06-28,,,,2021-06-24,http://isrctn.com/ISRCTN16269648,2022-06-28,0,0
10075,ISRCTN79488368,Ongoing,,2030-04-20,,,,2021-09-17,http://isrctn.com/ISRCTN79488368,2030-04-20,0,0
10076,ISRCTN98833037,Ongoing,,2023-12-01,,,,2021-07-12,http://isrctn.com/ISRCTN98833037,2023-12-01,0,0
10077,ISRCTN15689873,Completed,,2021-11-01,,,,2021-06-16,http://isrctn.com/ISRCTN15689873,2021-11-01,0,0
10078,ISRCTN30075312,Completed,,2021-03-31,,,,2021-07-08,http://isrctn.com/ISRCTN30075312,2021-03-31,0,0
10079,ISRCTN23403781,Completed,,2021-07-28,,,,2021-07-08,http://isrctn.com/ISRCTN23403781,2021-07-28,0,0
10080,ISRCTN15162325,Completed,,2021-06-22,,,,2021-06-15,http://isrctn.com/ISRCTN15162325,2021-06-22,0,0
10081,ISRCTN38734433,Ongoing,,2023-06-30,,,,2022-01-31,http://isrctn.com/ISRCTN38734433,2023-06-30,0,0
10082,ISRCTN29153109,Ongoing,,2022-08-01,,,,2021-08-09,http://isrctn.com/ISRCTN29153109,2022-08-01,0,0
10083,ISRCTN48554326,Completed,,2021-12-30,,2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35101094/ (added 02/02/2022),,2022-02-02,http://isrctn.com/ISRCTN48554326,2021-12-30,0,1
10084,ISRCTN31161020,Completed,,2022-04-01,,,,2021-10-29,http://isrctn.com/ISRCTN31161020,2022-04-01,0,0
10085,ISRCTN82492510,Ongoing,,2022-09-01,,,,2021-11-30,http://isrctn.com/ISRCTN82492510,2022-09-01,0,0
10086,ISRCTN15317247,Completed,,2021-07-01,,,,2021-07-08,http://isrctn.com/ISRCTN15317247,2021-07-01,0,0
10087,ISRCTN23016116,Completed,,2021-09-12,,,,2021-10-22,http://isrctn.com/ISRCTN23016116,2021-09-12,0,0
10088,ISRCTN14624773,Ongoing,,2024-05-24,,,,2021-05-25,http://isrctn.com/ISRCTN14624773,2024-05-24,0,0
10089,ISRCTN17395671,Ongoing,,2023-11-30,,,,2021-12-30,http://isrctn.com/ISRCTN17395671,2023-11-30,0,0
10090,ISRCTN14643181,Ongoing,,2022-10-31,,,,2021-06-01,http://isrctn.com/ISRCTN14643181,2022-10-31,0,0
10091,ISRCTN18003630,Completed,,2021-08-31,,,,2021-10-08,http://isrctn.com/ISRCTN18003630,2021-08-31,0,0
10092,ISRCTN47802196,Completed,,2021-12-31,,,,2021-05-19,http://isrctn.com/ISRCTN47802196,2021-12-31,0,0
10093,ISRCTN66682918,Ongoing,,2022-12-31,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35137110/ ontrolled interrupted time series analysis of organization-level data (added 25/03/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34062898/ retrospective observational study results (added 25/03/2022),,2022-03-25,http://isrctn.com/ISRCTN66682918,2022-12-31,0,1
10094,ISRCTN73765130,Ongoing,,2022-08-01,,2021 Results article in https://doi.org/10.1016/S0140-6736(21)02717-3 (added 03/12/2021),,2022-02-01,http://isrctn.com/ISRCTN73765130,2022-08-01,0,1
10095,ISRCTN13857593,Completed,,2021-12-31,,,,2022-03-21,http://isrctn.com/ISRCTN13857593,2021-12-31,0,0
10096,ISRCTN26200758,Completed,,2021-05-21,,,,2021-06-04,http://isrctn.com/ISRCTN26200758,2021-05-21,0,0
10097,ISRCTN13848929,Completed,,2020-03-08,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34217258/ (added 05/07/2021),,2021-07-05,http://isrctn.com/ISRCTN13848929,2020-03-08,0,1
10098,ISRCTN18100261,Completed,,2021-06-30,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34534517/ (added 21/09/2021),,2021-09-21,http://isrctn.com/ISRCTN18100261,2021-06-30,0,1
10099,ISRCTN18018895,Completed,,2021-07-30,,,,2021-04-30,http://isrctn.com/ISRCTN18018895,2021-07-30,0,0
10100,ISRCTN12721265,Completed,,2021-10-20,,,,2021-05-04,http://isrctn.com/ISRCTN12721265,2021-10-20,0,0
10101,ISRCTN10839729,Completed,,2021-02-28,,,,2021-04-29,http://isrctn.com/ISRCTN10839729,2021-02-28,0,0
10102,ISRCTN47104509,Ongoing,,2022-08-06,,,,2021-05-04,http://isrctn.com/ISRCTN47104509,2022-08-06,0,0
10103,ISRCTN79815558,Ongoing,,2022-06-30,,,,2021-06-07,http://isrctn.com/ISRCTN79815558,2022-06-30,0,0
10104,ISRCTN23769228,Ongoing,,2023-04-01,,,,2021-11-19,http://isrctn.com/ISRCTN23769228,2023-04-01,0,0
10105,ISRCTN91172459,Ongoing,,2022-06-30,,,,2022-03-14,http://isrctn.com/ISRCTN91172459,2022-06-30,0,0
10106,ISRCTN12272130,Ongoing,,2022-10-31,,,,2021-06-14,http://isrctn.com/ISRCTN12272130,2022-10-31,0,0
10107,ISRCTN48563324,Ongoing,,2023-10-31,,,,2021-09-17,http://isrctn.com/ISRCTN48563324,2023-10-31,0,0
10108,ISRCTN15851697,Ongoing,,2024-01-31,,,,2021-04-21,http://isrctn.com/ISRCTN15851697,2024-01-31,0,0
10109,ISRCTN34804192,Ongoing,,2023-01-30,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34446502/ (added 31/08/2021) 2021 Preprint results in https://doi.org/10.21203/rs.3.rs-798316/v1 (added 30/09/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35143770/ (added 11/02/2022),,2022-02-11,http://isrctn.com/ISRCTN34804192,2023-01-30,0,1
10110,ISRCTN15677965,Completed,,2021-11-01,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35156709/ (added 15/02/2022),,2022-02-15,http://isrctn.com/ISRCTN15677965,2021-11-01,0,1
10111,ISRCTN18304314,Completed,,2021-01-10,,,,2021-04-14,http://isrctn.com/ISRCTN18304314,2021-01-10,0,0
10112,ISRCTN14396374,Ongoing,,2022-12-31,,,,2021-04-20,http://isrctn.com/ISRCTN14396374,2022-12-31,0,0
10113,ISRCTN17472338,Ongoing,,2022-12-31,,,,2021-12-30,http://isrctn.com/ISRCTN17472338,2022-12-31,0,0
10114,ISRCTN22331899,Completed,,2020-08-01,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33819910/ (added 13/01/2022),,2022-01-13,http://isrctn.com/ISRCTN22331899,2020-08-01,0,1
10115,ISRCTN14081521,Ongoing,,2023-09-30,,,,2021-04-01,http://isrctn.com/ISRCTN14081521,2023-09-30,0,0
10116,ISRCTN14391248,Ongoing,,2022-09-30,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34774197/ (added 15/11/2021),,2022-02-15,http://isrctn.com/ISRCTN14391248,2022-09-30,0,1
10117,ISRCTN27841311,Ongoing,,2022-09-01,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34883053/ (added 10/12/2021),,2021-12-10,http://isrctn.com/ISRCTN27841311,2022-09-01,0,1
10118,ISRCTN72605600,Completed,,2021-06-28,,2021 Funder report results in https://d2tic4wvo1iusb.cloudfront.net/documents/pages/projects/TP_RE_RCT_-_Report_Final.pdf?v=1630925173 (added 21/03/2022),,2022-03-21,http://isrctn.com/ISRCTN72605600,2021-06-28,0,1
10119,ISRCTN16393332,Completed,,2021-07-31,,,,2021-03-24,http://isrctn.com/ISRCTN16393332,2021-07-31,0,0
10120,ISRCTN21085622,Completed,,2021-03-10,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34379337/ (added 09/12/2021),,2021-12-09,http://isrctn.com/ISRCTN21085622,2021-03-10,0,1
10121,ISRCTN70307341,Ongoing,,2023-12-03,,,,2022-03-02,http://isrctn.com/ISRCTN70307341,2023-12-03,0,0
10122,ISRCTN17441953,Ongoing,,2023-05-31,,,,2021-09-07,http://isrctn.com/ISRCTN17441953,2023-05-31,0,0
10123,ISRCTN17401860,Completed,,2021-06-30,,,,2021-10-06,http://isrctn.com/ISRCTN17401860,2021-06-30,0,0
10124,ISRCTN15499304,Ongoing,,2022-12-31,,,,2021-03-19,http://isrctn.com/ISRCTN15499304,2022-12-31,0,0
10125,ISRCTN68832164,Completed,,2022-04-01,,,,2021-06-14,http://isrctn.com/ISRCTN68832164,2022-04-01,0,0
10126,ISRCTN17846723,Ongoing,,2023-03-31,,,,2021-03-24,http://isrctn.com/ISRCTN17846723,2023-03-31,0,0
10127,ISRCTN10182320,Ongoing,,2023-12-30,,2021 Preprint results in https://www.medrxiv.org/content/10.1101/2021.09.06.21263154v1?ct= non-peer reviewed 1st year results (added 21/09/2021),,2021-09-21,http://isrctn.com/ISRCTN10182320,2023-12-30,0,1
10128,ISRCTN46897021,Ongoing,,2022-12-31,,,,2022-01-17,http://isrctn.com/ISRCTN46897021,2022-12-31,0,0
10129,ISRCTN32077121,Completed,,2021-08-30,,2020 Preprint results in https://doi.org/10.1101/2020.12.15.20248254 non-peer-reviewed protocol in preprint (added 08/03/2021),,2021-03-12,http://isrctn.com/ISRCTN32077121,2021-08-30,0,1
10130,ISRCTN15328700,Ongoing,,2022-04-30,,,,2022-02-15,http://isrctn.com/ISRCTN15328700,2022-04-30,0,0
10131,ISRCTN16806663,Completed,,2021-02-05,,,,2021-03-19,http://isrctn.com/ISRCTN16806663,2021-02-05,0,0
10132,ISRCTN51046126,Ongoing,,2022-04-30,,,,2021-04-06,http://isrctn.com/ISRCTN51046126,2022-04-30,0,0
10133,ISRCTN16275601,Ongoing,,2022-12-31,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34319235/ (added 29/07/2021),,2021-12-13,http://isrctn.com/ISRCTN16275601,2022-12-31,0,1
10134,ISRCTN76339681,Ongoing,,2046-12-31,,,,2021-04-06,http://isrctn.com/ISRCTN76339681,2046-12-31,0,0
10135,ISRCTN39426207,Ongoing,,2023-01-30,,,,2021-12-30,http://isrctn.com/ISRCTN39426207,2023-01-30,0,0
10136,ISRCTN78284710,Completed,,2021-01-10,,,,2021-04-01,http://isrctn.com/ISRCTN78284710,2021-01-10,0,0
10137,ISRCTN17354061,Ongoing,,2023-10-31,,2021 Interim results article in http://dx.doi.org/10.2139/ssrn.3796835 non-peer-reviewed interim results on effectiveness of first dose of COVID-19 vaccines in preprint (added 19/03/2021) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34174190/ (added 07/12/2021),,2022-01-20,http://isrctn.com/ISRCTN17354061,2023-10-31,0,1
10138,ISRCTN16205138,Completed,,2021-07-01,Basic results see attached file 39512 BasicResults 10Jan2022.pdf (added 10/01/2022),,,2022-01-10,http://isrctn.com/ISRCTN16205138,2021-07-01,0,0
10139,ISRCTN55371988,Ongoing,,2023-02-23,,"2021 Other publications in https://doi.org/10.3390/vaccines9070685 Correlation with Age, Gender and BMI (added 05/08/2021) 2021 Other publications in https://doi.org/10.1016/j.eclinm.2021.100928 Effect of age, gender and BMI on vaccine response (added 05/08/2021)",,2021-08-05,http://isrctn.com/ISRCTN55371988,2023-02-23,0,1
10140,ISRCTN15615992,Ongoing,,2022-07-31,,,,2022-01-24,http://isrctn.com/ISRCTN15615992,2022-07-31,0,0
10141,ISRCTN14962466,Completed,,2021-06-30,,,,2021-02-19,http://isrctn.com/ISRCTN14962466,2021-06-30,0,0
10142,ISRCTN11204126,Ongoing,,2023-01-31,,,,2021-02-17,http://isrctn.com/ISRCTN11204126,2023-01-31,0,0
10143,ISRCTN12821688,Ongoing,,2022-07-31,,2021 Preprint results in https://dx.doi.org/10.2139/ssrn.3910058 (added 31/08/2021),,2021-10-11,http://isrctn.com/ISRCTN12821688,2022-07-31,0,1
10144,ISRCTN15638344,Ongoing,,2022-09-30,,,,2021-06-09,http://isrctn.com/ISRCTN15638344,2022-09-30,0,0
10145,ISRCTN61884303,Completed,,2022-03-30,,,,2021-02-10,http://isrctn.com/ISRCTN61884303,2022-03-30,0,0
10146,ISRCTN85874083,Ongoing,,2022-09-01,,,,2022-02-07,http://isrctn.com/ISRCTN85874083,2022-09-01,0,0
10147,ISRCTN11203922,Ongoing,,2022-10-31,,,,2021-10-27,http://isrctn.com/ISRCTN11203922,2022-10-31,0,0
10148,ISRCTN85436698,Completed,,2022-02-11,,,,2022-03-03,http://isrctn.com/ISRCTN85436698,2022-02-11,0,0
10149,ISRCTN69254139,Ongoing,,2022-11-05,,2021 Results article in https://doi.org/10.1016/S0140-6736(21)01115-6 early results of reactogenicity data (added 18/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34370971/ (added 10/08/2021),,2021-09-27,http://isrctn.com/ISRCTN69254139,2022-11-05,0,1
10150,ISRCTN15615697,Ongoing,,2022-10-16,,,,2021-11-17,http://isrctn.com/ISRCTN15615697,2022-10-16,0,0
10151,ISRCTN11265821,Completed,,2022-03-30,,,,2021-03-19,http://isrctn.com/ISRCTN11265821,2022-03-30,0,0
10152,ISRCTN13593711,Completed,,2020-07-28,,2020 Preprint results in https://doi.org/10.1101/2020.08.27.20183442 non-peer-reviewed results in preprint (added 21/01/2021) 2021 Results article in https://doi.org/10.1056/NEJMoa2028700 results (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN13593711,2020-07-28,0,1
10153,ISRCTN17941313,Completed,,2022-02-20,,,,2021-01-20,http://isrctn.com/ISRCTN17941313,2022-02-20,0,0
10154,ISRCTN51124684,Ongoing,,2022-08-31,,,,2021-09-29,http://isrctn.com/ISRCTN51124684,2022-08-31,0,0
10155,ISRCTN37254291,Completed,,2021-02-01,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33991482/ (added 17/05/2021),,2021-05-17,http://isrctn.com/ISRCTN37254291,2021-02-01,0,1
10156,ISRCTN13450549,Completed,,2021-01-14,,,,2022-02-14,http://isrctn.com/ISRCTN13450549,2021-01-14,0,0
10157,ISRCTN11041050,Completed,,2022-03-31,,2020 Preprint results in https://doi.org/10.1101/2020.12.15.20247981 protocol (not peer reviewed) in preprint (added 08/01/2021) 2021 Preprint results in http://dx.doi.org/10.2139/ssrn.3790399 non-peer-reviewed results on efficacy of BNT162b2 mRNA vaccine in preprint (added 16/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35172051/ (added 17/02/2022),,2022-02-17,http://isrctn.com/ISRCTN11041050,2022-03-31,0,1
10158,ISRCTN18107122,Completed,,2020-10-14,,2021 Preprint results in https://preprints.jmir.org/preprint/34002 (added 10/11/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35044927/ (added 20/01/2022),,2022-01-20,http://isrctn.com/ISRCTN18107122,2020-10-14,0,1
10159,ISRCTN85787008,Completed,,2020-10-12,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33682592/ results (added 09/03/2021),,2021-03-09,http://isrctn.com/ISRCTN85787008,2020-10-12,0,1
10160,ISRCTN14376817,Completed,,2022-03-18,,,,2022-03-14,http://isrctn.com/ISRCTN14376817,2022-03-18,0,0
10161,ISRCTN14037053,Completed,,2022-01-31,,,,2020-12-30,http://isrctn.com/ISRCTN14037053,2022-01-31,0,0
10162,ISRCTN27707558,Completed,,2021-06-30,,,,2020-12-31,http://isrctn.com/ISRCTN27707558,2021-06-30,0,0
10163,ISRCTN95881792,Ongoing,,2025-12-31,,,,2021-02-16,http://isrctn.com/ISRCTN95881792,2025-12-31,0,0
10164,ISRCTN14652655,Completed,,2020-12-16,,2020 Preprint results in https://doi.org/10.2196/preprints.26858 (added 14/01/2022),,2022-01-14,http://isrctn.com/ISRCTN14652655,2020-12-16,0,1
10165,ISRCTN82411169,Completed,,2021-08-31,,,,2021-03-25,http://isrctn.com/ISRCTN82411169,2021-08-31,0,0
10166,ISRCTN69564614,Completed,,2022-01-31,,2022 Protocol article in https://doi.org/10.1186/s40814-022-00984-7 (added 01/02/2022),,2022-02-01,http://isrctn.com/ISRCTN69564614,2022-01-31,0,1
10167,ISRCTN91064601,Completed,,2020-08-06,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33557402/ (added 25/03/2021),,2021-03-25,http://isrctn.com/ISRCTN91064601,2020-08-06,0,1
10168,ISRCTN14159936,Completed,,2021-08-01,,,,2021-01-04,http://isrctn.com/ISRCTN14159936,2021-08-01,0,0
10169,ISRCTN27106947,Ongoing,,2022-12-31,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32560744/ protocol (added 03/12/2020),,2021-08-20,http://isrctn.com/ISRCTN27106947,2022-12-31,0,1
10170,ISRCTN11713182,Completed,,2021-09-30,,,,2020-12-02,http://isrctn.com/ISRCTN11713182,2021-09-30,0,0
10171,ISRCTN12735607,Completed,,2021-03-31,,,,2020-12-01,http://isrctn.com/ISRCTN12735607,2021-03-31,0,0
10172,ISRCTN19845486,Completed,,2021-03-31,,,,2020-12-01,http://isrctn.com/ISRCTN19845486,2021-03-31,0,0
10173,ISRCTN77689525,Completed,,2021-05-31,,,,2021-06-02,http://isrctn.com/ISRCTN77689525,2021-05-31,0,0
10174,ISRCTN33037282,Completed,,2020-11-15,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34033648/ (added 14/03/2022),,2022-03-14,http://isrctn.com/ISRCTN33037282,2020-11-15,0,1
10175,ISRCTN11811602,Ongoing,,2045-08-01,,2021 Preprint results in https://doi.org/10.1101/2021.02.23.21251975 non-peer-reviewed protocol in preprint (added 17/03/2021) 2021 Preprint results in https://doi.org/10.1101/2021.03.03.21252737 non-peer-reviewed results in preprint (added 17/03/2021) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34535484/ (added 21/09/2021),,2021-09-21,http://isrctn.com/ISRCTN11811602,2045-08-01,0,1
10176,ISRCTN11466448,Ongoing,,2023-06-30,,2021 Protocol article in https://doi.org/10.1186/s13063-020-04978-9 protocol (added 07/01/2021),,2022-02-22,http://isrctn.com/ISRCTN11466448,2023-06-30,0,1
10177,ISRCTN77941736,Completed,,2021-03-30,,,,2020-12-04,http://isrctn.com/ISRCTN77941736,2021-03-30,0,0
10178,ISRCTN11946807,Completed,,2021-11-30,,,,2021-11-01,http://isrctn.com/ISRCTN11946807,2021-11-30,0,0
10179,ISRCTN11970082,Completed,,2021-01-01,,2020 Preprint results in https://doi.org/10.1101/2020.12.14.20245266 non-peer-reviewed results in preprint (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN11970082,2021-01-01,0,1
10180,ISRCTN63459073,Completed,,2021-06-01,,,,2020-11-20,http://isrctn.com/ISRCTN63459073,2021-06-01,0,0
10181,ISRCTN12792822,Completed,,2021-06-30,,,,2021-03-16,http://isrctn.com/ISRCTN12792822,2021-06-30,0,0
10182,ISRCTN90437126,Ongoing,,2022-08-30,,,,2022-02-24,http://isrctn.com/ISRCTN90437126,2022-08-30,0,0
10183,ISRCTN40292537,Completed,,2021-09-30,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32565483/ protocol published at: 2021 Preprint results in http://dx.doi.org/10.2139/ssrn.3789264 non-peer-reviewed results (added 23/03/2021),,2021-03-23,http://isrctn.com/ISRCTN40292537,2021-09-30,0,1
10184,ISRCTN14810048,Completed,,2020-07-31,,2020 Preprint results in https://doi.org/10.1101/2020.07.21.20158972 non-peer-reviewed results in preprint (added 17/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33730058/ (added 16/04/2021),,2021-04-16,http://isrctn.com/ISRCTN14810048,2020-07-31,0,1
10185,ISRCTN12833010,Completed,,2020-12-31,,,,2020-12-03,http://isrctn.com/ISRCTN12833010,2020-12-31,0,0
10186,ISRCTN15019599,Ongoing,,2022-08-24,,,,2021-03-17,http://isrctn.com/ISRCTN15019599,2022-08-24,0,0
10187,ISRCTN16842454,Completed,,2020-12-13,,,,2020-11-10,http://isrctn.com/ISRCTN16842454,2020-12-13,0,0
10188,ISRCTN25647404,Completed,,2020-12-27,Basic results see attached file ISRCTN25647404_BasicResults_24Feb22.pdf (added 24/02/2022),2022 Preprint results in https://doi.org/10.1101/2022.02.16.22270842 (added 18/02/2022),,2022-02-24,http://isrctn.com/ISRCTN25647404,2020-12-27,0,1
10189,ISRCTN10989132,Ongoing,,2023-11-01,,,,2022-02-01,http://isrctn.com/ISRCTN10989132,2023-11-01,0,0
10190,ISRCTN63911163,Ongoing,,2025-06-05,,,,2020-11-05,http://isrctn.com/ISRCTN63911163,2025-06-05,0,0
10191,ISRCTN14722499,Ongoing,,2023-05-10,,,,2021-11-18,http://isrctn.com/ISRCTN14722499,2023-05-10,0,0
10192,ISRCTN79623250,Completed,,2020-09-02,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33237877/ protocol (added 12/01/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34738912/ (added 08/11/2021),,2021-11-08,http://isrctn.com/ISRCTN79623250,2020-09-02,0,1
10193,ISRCTN15874265,Completed,,2020-06-30,"Basic results in https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/results,",2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32459919/ results (added 29/10/2020),,2021-03-19,http://isrctn.com/ISRCTN15874265,2020-06-30,0,1
10194,ISRCTN85762140,Completed,,2020-06-26,Basic results in https://clinicaltrials.gov/ct2/show/results/NCT04292730,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32821939/ (added 25/03/2021),,2021-03-25,,2020-06-26,0,1
10195,ISRCTN16865246,Completed,,2021-07-30,,2021 Results article in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892300/ results of association between sleep disordered breathing and respiratory symptoms (added 19/03/2021),,2021-03-19,http://isrctn.com/ISRCTN16865246,2021-07-30,0,1
10196,ISRCTN13953727,Completed,,2021-05-30,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33939619/ (added 05/05/2021),,2021-05-05,http://isrctn.com/ISRCTN13953727,2021-05-30,0,1
10197,ISRCTN13539303,Ongoing,,2024-04-30,,,,2020-10-28,http://isrctn.com/ISRCTN13539303,2024-04-30,0,0
10198,ISRCTN18172749,Completed,,2022-03-31,,,,2022-02-11,http://isrctn.com/ISRCTN18172749,2022-03-31,0,0
10199,ISRCTN12890382,Ongoing,,2023-03-31,,,,2021-11-11,http://isrctn.com/ISRCTN12890382,2023-03-31,0,0
10200,ISRCTN66141262,Completed,,2021-04-30,,,,2021-08-12,http://isrctn.com/ISRCTN66141262,2021-04-30,0,0
10201,ISRCTN13773960,Ongoing,,2025-03-31,,2021 Preprint results in https://doi.org/10.1101/2021.03.08.21252839 non-peer-reviewed results in preprint (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN13773960,2025-03-31,0,1
10202,ISRCTN13235264,Completed,,2021-11-30,,,,2022-02-03,http://isrctn.com/ISRCTN13235264,2021-11-30,0,0
10203,ISRCTN45562523,Completed,,2020-07-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33357491/ (added 25/03/2021),,2021-03-25,http://isrctn.com/ISRCTN45562523,2020-07-31,0,1
10204,ISRCTN21447815,Completed,,2021-09-19,,2021 Preprint results in https://doi.org/10.1101/2021.01.29.21250552 non-peer-reviewed aerosol emission results in preprint (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34700360/ manual facemask ventilation quantitative evaluation (added 27/10/2021) 2021 Preprint results in https://doi.org/10.1101/2021.12.12.21267658 tracheal intubation and extubation sequences quantitative evaluation in preprint (added 16/12/2021),,2021-12-16,http://isrctn.com/ISRCTN21447815,2021-09-19,0,1
10205,ISRCTN82901740,Completed,,2022-03-31,,,,2021-09-02,http://isrctn.com/ISRCTN82901740,2022-03-31,0,0
10206,ISRCTN18428598,Ongoing,,2023-01-31,,,,2020-10-01,http://isrctn.com/ISRCTN18428598,2023-01-31,0,0
10207,ISRCTN10197987,Completed,,2020-11-20,Basic results see attached file ISRCTN10197987_BasicResults_04May2021.docx (added 05/05/2021),2020 Preprint results in https://doi.org/10.1101/2020.11.27.20234997 non-peer-reviewed results in preprint (added 16/03/2021),,2021-05-05,http://isrctn.com/ISRCTN10197987,2020-11-20,0,1
10208,ISRCTN32891583,Completed,,2021-10-15,,,,2020-10-01,http://isrctn.com/ISRCTN32891583,2021-10-15,0,0
10209,ISRCTN14707226,Ongoing,,2023-12-31,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34055711/ (added 01/06/2021),,2021-06-01,http://isrctn.com/ISRCTN14707226,2023-12-31,0,1
10210,ISRCTN18395399,Ongoing,,2022-04-23,,2021 Preprint results in https://doi.org/10.1101/2021.01.21.20240887 non-peer-reviewed baseline mental health survey results in preprint (added 19/03/2021),,2021-03-19,http://isrctn.com/ISRCTN18395399,2022-04-23,0,1
10211,ISRCTN57085639,Completed,,2021-09-04,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32736596/ (added 13/08/2021),,2021-08-13,http://isrctn.com/ISRCTN57085639,2021-09-04,0,1
10212,ISRCTN53038326,Ongoing,,2023-06-30,,,,2021-09-29,http://isrctn.com/ISRCTN53038326,2023-06-30,0,0
10213,ISRCTN56609224,Completed,,2021-06-01,,"2021 Preprint results in https://doi.org/10.1101/2021.01.30.21250777 comparing AbC-19‚Ñ¢ Rapid Test, OrientGene COVID IgG/IgM Rapid Test Cassette, SureScreen COVID-19 Rapid Test Cassette, and Biomerica COVID-19 IgG/IgM Rapid Test (added 13/08/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33177070/ AbC-19 Rapid Test (added 13/08/2021)",,2021-08-13,http://isrctn.com/ISRCTN56609224,2021-06-01,0,1
10214,ISRCTN45176516,Completed,,2021-10-08,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33903149/ SARS-CoV-2 vaccine immunogenicity results (added 13/08/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33753421/ anti-SARS-CoV-2 antibody response result (added 13/08/2021),,2021-08-13,http://isrctn.com/ISRCTN45176516,2021-10-08,0,1
10215,ISRCTN10373531,Completed,,2020-03-06,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34023324/ (added 09/08/2021),,2021-08-09,http://isrctn.com/ISRCTN10373531,2020-03-06,0,1
10216,ISRCTN51232965,Completed,,2021-09-22,,,,2020-09-10,http://isrctn.com/ISRCTN51232965,2021-09-22,0,0
10217,ISRCTN34160010,Completed,,2020-09-02,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34098889/ (added 09/06/2021),,2021-06-09,http://isrctn.com/ISRCTN34160010,2020-09-02,0,1
10218,ISRCTN21086382,Ongoing,,2023-07-31,,2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/33308423/ interim results for April to November (added 16/12/2020) 2021 Preprint results in https://doi.org/10.1101/2021.01.13.21249721 non-peer-reviewed results on prevalence of new variant in preprint (added 19/03/2021) 2021 Preprint results in https://doi.org/10.1101/2021.04.22.21255913 non-peer-reviewed results (added 11/06/2021) 2021 Preprint results in https://www.medrxiv.org/content/10.1101/2021.09.13.21263487v1 non-peer-reviewed results (added 21/09/2021) 2021 Preprint results in https://doi.org/10.1101/2021.11.15.21266255 non-peer-reviewed results of the behavioural effects of COVID-19 vaccination in the UK (added 19/11/2021),,2021-11-19,http://isrctn.com/ISRCTN21086382,2023-07-31,0,1
10219,ISRCTN13177364,Completed,,2022-01-31,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34039574/ (added 28/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34724949/ (added 14/02/2022),,2022-02-14,http://isrctn.com/ISRCTN13177364,2022-01-31,0,1
10220,ISRCTN95933274,Completed,,2021-06-16,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33315181/ results (added 16/12/2020),,2020-12-16,http://isrctn.com/ISRCTN95933274,2021-06-16,0,1
10221,ISRCTN31062548,Ongoing,,2023-03-31,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33213530/ protocol (added 23/11/2020),,2022-03-21,http://isrctn.com/ISRCTN31062548,2023-03-31,0,1
10222,ISRCTN89159899,Completed,,2021-04-14,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35139037/ (added 10/02/2022),,2022-02-14,http://isrctn.com/ISRCTN89159899,2021-04-14,0,1
10223,ISRCTN33260034,Stopped,,2021-12-31,,,,2021-10-20,http://isrctn.com/ISRCTN33260034,2021-12-31,0,0
10224,ISRCTN12154994,Completed,,2021-03-01,,2020 Preprint results in https://doi.org/10.21203/rs.3.rs-77405/v2 non-peer-reviewed protocol in preprint (added 17/03/2021) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33964872/ (added 11/05/2021),,2021-05-11,http://isrctn.com/ISRCTN12154994,2021-03-01,0,1
10225,ISRCTN15634328,Completed,,2021-03-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33987193/ 3-month follow-up results (added 28/01/2022),,2022-01-28,http://isrctn.com/ISRCTN15634328,2021-03-31,0,1
10226,ISRCTN14602359,Completed,,2021-03-10,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33836825/ (added 12/04/2021),,2021-04-20,http://isrctn.com/ISRCTN14602359,2021-03-10,0,1
10227,ISRCTN74727214,Completed,,2020-08-15,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33217576/ results (added 15/01/2021),,2021-01-15,http://isrctn.com/ISRCTN74727214,2020-08-15,0,1
10228,ISRCTN59449699,Completed,,2021-08-05,,,,2020-09-29,http://isrctn.com/ISRCTN59449699,2021-08-05,0,0
10229,ISRCTN15913068,Ongoing,,2022-06-30,,,,2021-06-02,,2022-06-30,0,0
10230,ISRCTN36352994,Completed,,2021-03-01,,2021 Results article in https://doi.org/10.1136/oemed-2021-107628 (added 01/09/2021),,2021-09-01,http://isrctn.com/ISRCTN36352994,2021-03-01,0,1
10231,ISRCTN13455972,Completed,,2020-09-30,,,,2020-10-30,http://isrctn.com/ISRCTN13455972,2020-09-30,0,0
10232,ISRCTN58667920,Ongoing,,2022-07-31,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34112195/ (added 14/06/2021),,2021-06-14,http://isrctn.com/ISRCTN58667920,2022-07-31,0,1
10233,ISRCTN93382525,Ongoing,,2024-11-30,,,,2020-11-23,http://isrctn.com/ISRCTN93382525,2024-11-30,0,0
10234,ISRCTN17782018,Completed,,2022-03-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34531224/ Cancer symptom experience and help-seeking behaviour (added 21/09/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34599921/ cancer screening intentions (added 30/12/2021),,2021-12-30,http://isrctn.com/ISRCTN17782018,2022-03-31,0,1
10235,ISRCTN60033461,Ongoing,,2022-09-30,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33181124/ results (added 16/02/2021),,2022-03-17,http://isrctn.com/ISRCTN60033461,2022-09-30,0,1
10236,ISRCTN21598625,Completed,,2020-07-13,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33262714/ results (added 08/03/2021),,2021-03-08,http://isrctn.com/ISRCTN21598625,2020-07-13,0,1
10237,ISRCTN16561225,Completed,,2021-11-30,,2020 Preprint results in https://doi.org/10.1101/2020.10.29.20215996 non-peer-reviewed survey results on service innovation and practice change in preprint (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33556496/ survey results on challenges (added 19/03/2021) 2021 Funder report results in https://www.mariecurie.org.uk/globalassets/media/documents/policy/policy-publications/2021/better-end-of-life-research-report.pdf (added 24/11/2021),,2021-11-24,http://isrctn.com/ISRCTN16561225,2021-11-30,0,1
10238,ISRCTN17896927,Completed,,2020-07-24,,2020 Preprint results in https://doi.org/10.21203/rs.3.rs-96261/v1 non-peer-reviewed results in preprint (added 19/03/2021),,2021-03-19,http://isrctn.com/ISRCTN17896927,2020-07-24,0,1
10239,ISRCTN13035264,Completed,,2020-08-30,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32445440/ (added 14/04/2021),,2021-04-14,http://isrctn.com/ISRCTN13035264,2020-08-30,0,1
10240,ISRCTN17717312,Ongoing,,2025-04-24,,,,2020-08-07,http://isrctn.com/ISRCTN17717312,2025-04-24,0,0
10241,ISRCTN17301812,Completed,,2020-12-31,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33153065/ results (added 19/03/2021),,2021-03-19,http://isrctn.com/ISRCTN17301812,2020-12-31,0,1
10242,ISRCTN14990068,Ongoing,,2022-09-30,,Preprint results in https://doi.org/10.1101/2020.12.21.20248619 non-peer-reviewed results of efficacy of a proximity tracing app in preprint (added 17/03/2021) 2021 Preprint results in https://doi.org/10.1101/2021.02.27.21252572 non-peer-reviewed results on long-term disease burden in preprint (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN14990068,2022-09-30,0,1
10243,ISRCTN14212905,Ongoing,,2022-12-01,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34911721/ (added 17/12/2021),,2022-02-04,http://isrctn.com/ISRCTN14212905,2022-12-01,0,1
10244,ISRCTN10980107,Ongoing,,2046-12-31,,"2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34404775/ Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern (added 19/08/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34627560/ (added 11/10/2021) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34693230/ Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19 (added 26/10/2021) 2021 Preprint results in https://doi.org/10.1101/2021.12.13.21267471 preprint of clinical characteristics with inflammation profiling of Long-COVID and association with one-year recovery following hospitalisation in the UK (added 16/12/2021)",,2021-12-16,http://isrctn.com/ISRCTN10980107,2046-12-31,0,1
10245,ISRCTN10207947,Completed,,2022-03-21,,,,2022-01-28,http://isrctn.com/ISRCTN10207947,2022-03-21,0,0
10246,ISRCTN14241621,Completed,,2021-05-31,,2020 Results article in https://doi.org/10.1016/S2213-2600(20)30511-7 pilot results in hospitalised patients (added 26/11/2020),,2020-11-26,http://isrctn.com/ISRCTN14241621,2021-05-31,0,1
10247,ISRCTN14226970,Ongoing,,2022-10-03,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33557927/ protocol (added 10/02/2021),,2022-03-16,http://isrctn.com/ISRCTN14226970,2022-10-03,0,1
10248,ISRCTN67000769,Ongoing,,2023-12-31,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32267771/ protocol (added 16/07/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32876697/ results for hydrocortisone (added 03/09/2020) 2021 Preprint results in https://doi.org/10.1101/2021.01.07.21249390 results for tocilizumab and sarilumab in preprint (added 08/01/2021) 2021 Results article in https://doi.org/10.1056/NEJMoa2100433 results for tocilizumab and sarilumab (added 18/03/2021),,2022-02-09,http://isrctn.com/ISRCTN67000769,2023-12-31,0,1
10249,ISRCTN60069084,Completed,,2021-10-01,,,,2020-08-03,http://isrctn.com/ISRCTN60069084,2021-10-01,0,0
10250,ISRCTN86124626,Ongoing,,2022-10-01,,,,2022-03-23,http://isrctn.com/ISRCTN86124626,2022-10-01,0,0
10251,ISRCTN89573163,Ongoing,,2025-04-30,,,,2020-07-21,http://isrctn.com/ISRCTN89573163,2025-04-30,0,0
10252,ISRCTN91495258,Completed,,2021-12-31,,,,2021-04-01,http://isrctn.com/ISRCTN91495258,2021-12-31,0,0
10253,ISRCTN10175886,Completed,,2022-03-17,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33737439/ (added 11/03/2022),,2022-03-11,http://isrctn.com/ISRCTN10175886,2022-03-17,0,1
10254,ISRCTN18181860,Ongoing,,2022-12-31,,2020 Results article in https://www.doi.org/10.1016/S0140-6736(20)31304-0 early results (added 09/07/2020) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33098441/ protocol (added 26/10/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35296242/ Seroprevalence and attitudes of care home and in-home care staff (added 18/03/2022),,2022-03-18,http://isrctn.com/ISRCTN18181860,2022-12-31,0,1
10255,ISRCTN48734830,Stopped,,2022-01-31,,,,2021-12-13,http://isrctn.com/ISRCTN48734830,2022-01-31,0,0
10256,ISRCTN10378358,Stopped,,2022-03-01,,,,2022-03-15,http://isrctn.com/ISRCTN10378358,2022-03-01,0,0
10257,ISRCTN14025343,Completed,,2020-06-19,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32560550/ results (added 04/07/2020) 2020 Results article in https://doi.org/10.3390/nu12082289 results (added 04/08/2020),,2020-08-04,http://isrctn.com/ISRCTN14025343,2020-06-19,0,1
10258,ISRCTN18077365,Completed,,2021-06-24,,,,2020-07-02,http://isrctn.com/ISRCTN18077365,2021-06-24,0,0
10259,ISRCTN68675756,Completed,,2020-03-22,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33192723/ results (added 17/11/2020),,2020-11-17,http://isrctn.com/ISRCTN68675756,2020-03-22,0,1
10260,ISRCTN13990999,Completed,,2020-05-25,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32899333/ results (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN13990999,2020-05-25,0,1
10261,ISRCTN12394803,Ongoing,,2025-05-30,,,,2020-06-22,http://isrctn.com/ISRCTN12394803,2025-05-30,0,0
10262,ISRCTN60400862,Completed,,2020-07-03,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33987193/ (added 28/01/2022),,2022-01-28,http://isrctn.com/ISRCTN60400862,2020-07-03,0,1
10263,ISRCTN13471603,Completed,,2020-11-01,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33139334/ (added 18/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33401942/ (added 18/05/2021),,2021-05-18,http://isrctn.com/ISRCTN13471603,2020-11-01,0,1
10264,ISRCTN54917435,Completed,,2021-06-25,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34127046/ (added 13/08/2021),,2021-08-13,http://isrctn.com/ISRCTN54917435,2021-06-25,0,1
10265,ISRCTN89951424,Ongoing,,2023-03-31,,2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/33306989/ interim results (added 09/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33617777/ results (added 23/02/2021),,2022-01-19,http://isrctn.com/ISRCTN89951424,2023-03-31,0,1
10266,ISRCTN93266696,Ongoing,,2022-06-06,,,,2020-08-18,http://isrctn.com/ISRCTN93266696,2022-06-06,0,0
10267,ISRCTN15475176,Completed,,2021-02-28,,,,2020-06-16,http://isrctn.com/ISRCTN15475176,2021-02-28,0,0
10268,ISRCTN94091479,Completed,,2021-12-31,,2021 Results article in https://doi.org/10.1371/journal.pmed.1003779 (added 13/10/2021),,2021-10-13,http://isrctn.com/ISRCTN94091479,2021-12-31,0,1
10269,ISRCTN14447421,Ongoing,,2023-03-31,,2020 Protocol article in https://doi.org/10.12688/wellcomeopenres.16193.2 (added 05/02/2021) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33564722/ protocol (added 05/02/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34174193/ first dose results (added 28/06/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34430954/ observational cohort sub-study (added 26/08/2021),,2022-04-01,http://isrctn.com/ISRCTN14447421,2023-03-31,0,1
10270,ISRCTN59048638,Completed,,2020-11-30,Basic results see attached file ISRCTN59048638_BasicResults_04Dec2020.pdf (added 11/12/2020),2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33677827/ results (added 08/03/2021),,2021-03-08,http://isrctn.com/ISRCTN59048638,2020-11-30,0,1
10271,ISRCTN17072692,Completed,,2021-07-31,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35043093/ (added 20/01/2022),,2022-01-20,http://isrctn.com/ISRCTN17072692,2021-07-31,0,1
10272,ISRCTN33578935,Completed,,2020-12-31,,,,2020-06-08,http://isrctn.com/ISRCTN33578935,2020-12-31,0,0
10273,ISRCTN69546370,Ongoing,,2022-05-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34133854/ (added 17/06/2021),,2021-06-17,http://isrctn.com/ISRCTN69546370,2022-05-31,0,1
10274,ISRCTN55886926,Completed,,2021-06-06,,,,2020-07-07,http://isrctn.com/ISRCTN55886926,2021-06-06,0,0
10275,ISRCTN15324611,Completed,,2020-05-15,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33039952/ results (added 17/03/2021),,2021-03-17,http://isrctn.com/ISRCTN15324611,2020-05-15,0,1
10276,ISRCTN11952463,Ongoing,,2022-06-30,,,,2021-11-05,,2022-06-30,0,0
10277,ISRCTN99248812,Completed,,2020-07-10,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35174419/ (added 04/03/2022),,2022-03-04,http://isrctn.com/ISRCTN99248812,2020-07-10,0,1
10278,ISRCTN15571919,Completed,,2022-02-01,,,,2020-05-28,http://isrctn.com/ISRCTN15571919,2022-02-01,0,0
10279,ISRCTN11060415,Completed,,2020-10-28,,2020 Preprint results in https://doi.org/10.1101/2020.11.02.20221309 non-peer-reviewed results in preprint (added 16/03/2021),,2021-03-16,http://isrctn.com/ISRCTN11060415,2020-10-28,0,1
10280,ISRCTN12107048,Completed,,2021-09-30,,,,2022-01-21,http://isrctn.com/ISRCTN12107048,2021-09-30,0,0
10281,ISRCTN40302986,Completed,,2020-10-06,,2021 Results article in https://doi.org/10.1093/qjmed/hcab035 (added 23/03/2021),,2021-03-23,http://isrctn.com/ISRCTN40302986,2020-10-06,0,1
10282,ISRCTN11384058,Completed,,2020-06-15,,2020 Preprint results in https://doi.org/10.1101/2020.07.21.20157719 non-peer-reviewed results in preprint (added 17/03/2021) 2021 Results article in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845497/ results (added 17/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33640936/ (added 16/04/2021),,2021-04-16,http://isrctn.com/ISRCTN11384058,2020-06-15,0,1
10283,ISRCTN99916292,Completed,,2022-01-11,,,,2022-01-10,,2022-01-11,0,0
10284,ISRCTN15254871,Completed,,2020-12-15,,,,2020-05-21,http://isrctn.com/ISRCTN15254871,2020-12-15,0,0
10285,ISRCTN13447477,Completed,,2021-02-28,,,,2020-10-23,http://isrctn.com/ISRCTN13447477,2021-02-28,0,0
10286,ISRCTN64783542,Completed,,2020-11-30,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33351117/ (added 13/07/2021),,2021-07-13,http://isrctn.com/ISRCTN64783542,2020-11-30,0,1
10287,ISRCTN10437835,Ongoing,,2023-07-31,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33049385/ results (added 16/10/2020),,2021-12-30,http://isrctn.com/ISRCTN10437835,2023-07-31,0,1
10288,ISRCTN30564012,Completed,,2021-02-28,,,,2021-11-01,,2021-02-28,0,0
10289,ISRCTN50212645,Completed,,2021-07-31,,,,2022-02-15,http://isrctn.com/ISRCTN50212645,2021-07-31,0,0
10290,ISRCTN21363594,Completed,,2020-12-29,,2020 Protocol article in https://doi.org/10.1186/s13063-020-04454-4 protocol (added 10/06/2020),,2020-06-10,http://isrctn.com/ISRCTN21363594,2020-12-29,0,1
10291,ISRCTN44324934,Completed,,2021-12-31,,,,2021-03-16,http://isrctn.com/ISRCTN44324934,2021-12-31,0,0
10292,ISRCTN11188345,Completed,,2021-10-01,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32641154/ protocol (added 10/07/2020),,2021-09-07,http://isrctn.com/ISRCTN11188345,2021-10-01,0,1
10293,ISRCTN40580903,Completed,,2021-05-01,,2021 Preprint results in https://doi.org/10.1101/2021.02.10.21251478 non-peer-reviewed protocol in preprint (added 23/03/2021) 2021 Preprint results in https://doi.org/10.1101/2021.06.02.21258204 non-peer-reviewed results in preprint (added 11/06/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34922649/ (added 20/12/2021),,2021-12-20,,2021-05-01,0,1
10294,ISRCTN88057279,Ongoing,,2025-05-03,,,,2021-03-25,http://isrctn.com/ISRCTN88057279,2025-05-03,0,0
10295,ISRCTN85216856,Completed,,2020-12-31,,,,2020-05-08,http://isrctn.com/ISRCTN85216856,2020-12-31,0,0
10296,ISRCTN90906759,Ongoing,,2023-03-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33220855/ results (added 19/11/2020) 2021 Interim results article in https://doi.org/10.1016/S0140-6736(20)32661-1 interim results (added 09/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33617777/ results (added 23/02/2021) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34480858/ Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK (added 06/09/2021),,2022-03-14,http://isrctn.com/ISRCTN90906759,2023-03-31,0,1
10297,ISRCTN87832712,Completed,,2020-10-01,,,,2020-05-05,http://isrctn.com/ISRCTN87832712,2020-10-01,0,0
10298,ISRCTN20867558,Completed,,2021-12-31,,,,2020-08-10,http://isrctn.com/ISRCTN20867558,2021-12-31,0,0
10299,ISRCTN97041334,Completed,,2022-03-23,,Other publications in https://www.covidsocialstudy.org/results link to live results data at (added 24/03/2021),,2021-03-25,http://isrctn.com/ISRCTN97041334,2022-03-23,0,1
10300,ISRCTN44152751,Completed,,2020-09-30,,,,2020-09-07,http://isrctn.com/ISRCTN44152751,2020-09-30,0,0
10301,ISRCTN28342533,Completed,,2021-10-31,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33273040/ post-exertion oxygen saturation sub-study results (added 07/12/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33237907/ results (added 15/01/2021) 2021 Preprint results in https://doi.org/10.1101/2021.01.23.21249978 non-peer-reviewed analysis of DNAR status in preprint (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33481930/ triage tool development results (added 19/03/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33961960/ secondary analysis results (added 10/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34083427/ (added 07/06/2021) 2021 Preprint results in https://doi.org/10.1101/2021.07.27.21261031 Prognostic accuracy study results (added 30/07/2021) 2021 Preprint results in https://doi.org/10.1101/2021.10.12.21264136 Observational cohort study results (added 21/10/2021) 2021 Preprint results in https://doi.org/10.1101/2021.06.24.21259441 Accuracy of telephone triage (added 03/12/2021) 2021 Preprint results in https://doi.org/10.1101/2020.09.01.20185793 Prognostic accuracy results for children (added 03/12/2021),,2021-12-03,http://isrctn.com/ISRCTN28342533,2021-10-31,0,1
10302,ISRCTN68026880,Completed,,2021-09-30,,2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33514576/ protocol (added 01/02/2021),,2021-02-01,http://isrctn.com/ISRCTN68026880,2021-09-30,0,1
10303,ISRCTN13311119,Completed,,2020-06-26,,,,2021-03-19,http://isrctn.com/ISRCTN13311119,2020-06-26,0,0
10304,ISRCTN17898730,Completed,,2020-12-20,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33240180/ results (added 27/11/2020),,2020-11-27,http://isrctn.com/ISRCTN17898730,2020-12-20,0,1
10305,ISRCTN10666798,Completed,,2020-10-01,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32788191/ protocol (added 17/08/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33832926/ (added 12/04/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34244282/ (added 12/07/2021),,2021-07-12,http://isrctn.com/ISRCTN10666798,2020-10-01,0,1
10306,ISRCTN18348009,Completed,,2020-04-22,,,,2020-04-15,http://isrctn.com/ISRCTN18348009,2020-04-22,0,0
10307,ISRCTN51255782,Completed,,2021-12-31,,,,2020-04-14,http://isrctn.com/ISRCTN51255782,2021-12-31,0,0
10308,ISRCTN14326006,Completed,,2020-10-07,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32665039/ structured summary of protocol (added 17/07/2020),,2021-07-28,http://isrctn.com/ISRCTN14326006,2020-10-07,0,1
10309,ISRCTN80453162,Completed,,2022-04-01,,2021 Abstract results in https://doi.org/10.1093/bjsopen/zrab033.004 Presented at National Research Collaborative Meeting Conference 2020 (added 06/12/2021) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33378387/ (added 06/12/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33378307/ (added 06/12/2021) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33405234/ (added 06/12/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34860123/ Qualitative results of clinician survey (added 06/12/2021),,2022-03-10,http://isrctn.com/ISRCTN80453162,2022-04-01,0,1
10310,ISRCTN43900695,Ongoing,,2022-04-06,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32771068/ protocol (added 13/08/2020) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34895327/ (added 14/12/2021),,2021-12-22,http://isrctn.com/ISRCTN43900695,2022-04-06,0,1
10311,ISRCTN77353041,Completed,,2020-12-31,,,,2020-05-26,http://isrctn.com/ISRCTN77353041,2020-12-31,0,0
10312,ISRCTN10077335,Completed,,2020-04-30,,2020 Preprint results in https://doi.org/10.1101/2020.09.11.20192526 non-peer-reviewed results in preprint (added 16/03/2021),,2021-03-16,http://isrctn.com/ISRCTN10077335,2020-04-30,0,1
10313,ISRCTN15281137,Ongoing,,2023-03-31,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32702298/ preliminary results (added 20/07/2020) 2021 Interim results article in https://doi.org/10.1016/S0140-6736(20)32661-1 interim results (added 09/12/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33617777/ results (added 23/02/2021) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/34480858/ Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK (added 06/09/2021),,2022-01-24,http://isrctn.com/ISRCTN15281137,2023-03-31,0,1
10314,ISRCTN16912075,Completed,,2021-06-02,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32727624/ protocol (added 03/08/2020) 2021 Preprint results in https://doi.org/10.1101/2021.08.02.21261379 (added 31/08/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35072713/ (added 25/01/2022),,2022-01-25,http://isrctn.com/ISRCTN16912075,2021-06-02,0,1
10315,ISRCTN50189673,Ongoing,,2032-11-30,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/32678530/ Dexamethasone results (added 20/07/2020) 2020 Results article in https://doi.org/10.1016/S0140-6736(20)32013-4 Lopinavir‚Äìritonavir results (added 06/10/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33031652/ Hydroxychloroquine results (added 09/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33545096/ Azithromycin results (added 03/02/2021) 2021 Preprint results in https://doi.org/10.1101/2021.02.11.21249258 Tocilizumab results (added 12/02/2021) 2021 Preprint results in https://doi.org/10.1101/2021.03.09.21252736 Non-peer-reviewed convalescent plasma results (added 18/03/2021) 2021 Preprint results in https://doi.org/10.1101/2021.06.15.21258542 Non-peer-reviewed results for REGEN-COV (casirivimab and imdevimab) (added 23/07/2021) 2021 Preprint results in https://doi.org/10.1101/2021.06.08.21258132 Non-peer-reviewed results for aspirin (added 23/07/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34000257/ Convalescent plasma results (added 23/07/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33933206/ Tocilizumab results (added 23/07/2021) 2021 Preprint results in https://www.medrxiv.org/content/10.1101/2021.05.18.21257267v1 Non-peer-reviewed results for colchicine (added 21/10/2021) 2021 Results article in https://doi.org/10.1016/S2213-2600(21)00435-5 Colchicine results (added 21/10/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34800427/ Aspirin results (added 24/11/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35151397/ Casirivimab and imdevimab results (added 14/02/2022) 2022 Preprint results in https://doi.org/10.1101/2022.03.02.22271623 Baricitinib results (added 28/03/2022),,2022-03-28,,2032-11-30,0,1
10316,ISRCTN40092247,Ongoing,,2023-03-31,,"2020 Results article in https://doi.org/10.1136/bmj.m2107 results (added 10/06/2020) 2021 Preprint results in https://doi.org/10.1101/2021.07.22.21261000 Impact of SARS-CoV-2 variant (added 31/08/2021) 2022 Interim results article in http://dx.doi.org/10.1136/bmjmed-2021-000053 comparison between outcomes collected in the periods in which wildtype, alpha variant, and delta variant of SARS-CoV-2 were dominant in the UK (added 09/03/2022) 2021 Interim results article in https://pubmed.ncbi.nlm.nih.gov/33951100/ population level data on risk factors, incidence and impact of SARS-CoV-2 infection in pregnant women (added 09/03/2022) 2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35213734/ secondary analysis of data (added 09/03/2022)",,2022-03-09,http://isrctn.com/ISRCTN40092247,2023-03-31,0,1
10317,ISRCTN13694948,Completed,,2021-05-01,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32737101/ protocol (added 04/08/2020),,2021-01-05,http://isrctn.com/ISRCTN13694948,2021-05-01,0,1
10318,ISRCTN83971151,Completed,,2021-03-25,,"2020 Interim results article in https://doi.org/10.1101/2020.10.15.20209817 interim results in preprint (added 19/10/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33264556/ interim results for remdesivir, hydroxychloroquine, lopinavir and interferon (added 25/03/2021)",,2021-03-25,http://isrctn.com/ISRCTN83971151,2021-03-25,0,1
10319,ISRCTN86534580,Ongoing,,2022-09-24,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33676597/ Azithromycin results (added 08/03/2021) 2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34145016/ (added 21/06/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34329624/ Doxycycline results (added 02/08/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34388395/ budesonide results (added 16/08/2021) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35057841/ (added 24/01/2022),,2022-01-27,http://isrctn.com/ISRCTN86534580,2022-09-24,0,1
10320,ISRCTN14966673,Completed,,2021-04-01,,2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33038974/ results (added 13/10/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34363885/ SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death (added 09/08/2021),,2021-08-09,http://isrctn.com/ISRCTN14966673,2021-04-01,0,1
10321,ISRCTN14966097,Completed,,2021-04-01,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/34995345/ (added 10/01/2022),,2022-01-10,http://isrctn.com/ISRCTN14966097,2021-04-01,0,1
10322,ISRCTN47591507,Completed,,2021-02-28,,,,2021-03-01,http://isrctn.com/ISRCTN47591507,2021-02-28,0,0
10323,ISRCTN53431343,Completed,,2020-11-30,,,,2021-02-18,http://isrctn.com/ISRCTN53431343,2020-11-30,0,0
10324,ISRCTN37530113,Completed,,2021-12-31,,2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33203621/ protocol (added 19/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34481523/ (added 09/09/2021),,2021-09-09,http://isrctn.com/ISRCTN37530113,2021-12-31,0,1
10325,ISRCTN10974028,Ongoing,,2022-06-01,,,,2021-10-29,http://isrctn.com/ISRCTN10974028,2022-06-01,0,0
10326,ISRCTN15644757,Ongoing,,2022-12-31,,2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32066404 protocol (added 24/02/2020),,2021-10-06,http://isrctn.com/ISRCTN15644757,2022-12-31,0,1
10327,ISRCTN51287266,Ongoing,,2022-08-05,,,,2021-03-12,http://isrctn.com/ISRCTN51287266,2022-08-05,0,0
10328,ISRCTN16483855,Ongoing,,2022-04-30,,,,2021-04-21,http://isrctn.com/ISRCTN16483855,2022-04-30,0,0
10329,ISRCTN18274006,Ongoing,,2023-12-30,,,,2021-12-22,http://isrctn.com/ISRCTN18274006,2023-12-30,0,0
10330,ISRCTN55218215,Ongoing,,2022-11-30,,2021 Protocol article in https://doi.org/10.1186/s13063-021-05480-6 (added 19/08/2021),,2021-08-19,http://isrctn.com/ISRCTN55218215,2022-11-30,0,1
10331,ISRCTN12455871,Ongoing,,2022-05-02,,2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35121633/ (added 07/02/2022),,2022-02-07,http://isrctn.com/ISRCTN12455871,2022-05-02,0,1
10332,ISRCTN14884587,Completed,,2016-06-20,,,,2019-08-27,,2016-06-20,0,0
10333,ISRCTN87329095,Ongoing,,2022-07-31,,,,2021-02-23,http://isrctn.com/ISRCTN87329095,2022-07-31,0,0
10334,ISRCTN55201674,Ongoing,,2022-12-31,,,,2021-05-11,http://isrctn.com/ISRCTN55201674,2022-12-31,0,0
10335,ISRCTN16473881,Completed,,2019-10-31,,2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33452217/ results (added 18/01/2021),,2021-01-18,,2019-10-31,0,1
10336,ISRCTN75313566,Completed,,2021-05-27,,2020 Protocol article in https://journals.sagepub.com/doi/full/10.1177/2397198320957552 protocol (added 09/11/2020),,2021-07-28,http://isrctn.com/ISRCTN75313566,2021-05-27,0,1
10337,ISRCTN38642364,Completed,,2016-12-08,,2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30228886 results,,2018-09-27,,2016-12-08,0,1
10338,ISRCTN11028739,Completed,,2017-06-30,Basic results see attached file ISRCTN11028739_BasicResults_15Oct18.pdf (added 15/10/2018),2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30425114 results,,2018-12-11,,2017-06-30,0,1
10339,ISRCTN13646289,Completed,,2014-08-22,,,,2016-12-15,,2014-08-22,0,0
10340,ISRCTN15554338,Completed,,2008-10-31,,2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26141306 results,,2016-03-15,,2008-10-31,0,1
10341,ISRCTN18948812,Stopped,,2014-12-01,,,,2015-04-13,,2014-12-01,0,0
10342,ISRCTN72343080,Completed,,2016-12-01,,2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29669856/ results (added 17/08/2020),,2020-08-17,,2016-12-01,0,1
10343,JPRN-jRCTs031190226,Complete,,,,,,2022-03-31,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,,0,0
10344,JPRN-jRCT2031200126,Suspended,,,,,,2021-09-28,https://jrct.niph.go.jp/latest-detail/jRCT2031200126,,0,0
10345,JPRN-jRCT2031190264,Complete,,,,,,2021-08-11,https://jrct.niph.go.jp/latest-detail/jRCT2031190264,,0,0
10346,JPRN-jRCT1032200025,Not Recruiting,,,,,,2020-08-07,https://jrct.niph.go.jp/latest-detail/jRCT1032200025,,0,0
10347,JPRN-jRCTs031190227,Complete,,,,,,2021-07-20,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,,0,0
10348,JPRN-jRCTs031190269,Not Recruiting,,,,,,2021-12-06,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,,0,0
10349,JPRN-jRCTs031200026,Not Recruiting,,,,,,2022-03-23,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,,0,0
10350,JPRN-jRCTs032200044,Recruiting,,,,,,2020-06-03,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,,0,0
10351,JPRN-jRCTs041190120,Complete,,,,,,2020-08-31,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,,0,0
10352,JPRN-jRCTs061200002,Recruiting,,,,,,2021-09-16,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,,0,0
10353,JPRN-jRCT2031200035,Complete,,,,,,2021-09-05,https://jrct.niph.go.jp/latest-detail/jRCT2031200035,,0,0
10354,JPRN-jRCTs041200025,Complete,,,,,,2021-08-08,https://jrct.niph.go.jp/latest-detail/jRCTs041200025,,0,0
10355,JPRN-jRCTs051200036,Recruiting,,,,,,2021-08-17,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,,0,0
10356,JPRN-jRCT2071200023,Not Recruiting,,,,,,2021-12-25,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,,0,0
10357,JPRN-jRCTs021200020,Recruiting,,,,,,2021-11-09,https://jrct.niph.go.jp/latest-detail/jRCTs021200020,,0,0
10358,JPRN-jRCT2031200120,Not Recruiting,,,,,,2021-10-30,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,,0,0
10359,JPRN-jRCTs031200124,Not Recruiting,,,,,,2022-03-22,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,,0,0
10360,JPRN-jRCTs032200131,Recruiting,,,,,,2021-06-22,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,,0,0
10361,JPRN-jRCTs051200060,Suspended,,,,,,2021-05-20,https://jrct.niph.go.jp/latest-detail/jRCTs051200060,,0,0
10362,JPRN-jRCT2021200018,Complete,,,,,,2021-08-13,https://jrct.niph.go.jp/latest-detail/jRCT2021200018,,0,0
10363,JPRN-jRCT2071200041,Recruiting,,,,,,2021-02-08,https://jrct.niph.go.jp/latest-detail/jRCT2071200041,,0,0
10364,JPRN-jRCTs031200150,Recruiting,,,,,,2022-03-01,https://jrct.niph.go.jp/latest-detail/jRCTs031200150,,0,0
10365,JPRN-jRCTs051200049,Recruiting,,,,,,2021-10-13,https://jrct.niph.go.jp/latest-detail/jRCTs051200049,,0,0
10366,JPRN-jRCTs052200053,Recruiting,,,,,,2021-06-15,https://jrct.niph.go.jp/latest-detail/jRCTs052200053,,0,0
10367,JPRN-jRCTs071200048,Complete,,,,,,2022-03-16,https://jrct.niph.go.jp/latest-detail/jRCTs071200048,,0,0
10368,JPRN-jRCT1051200078,Not Recruiting,,,,,,2022-01-23,https://jrct.niph.go.jp/latest-detail/jRCT1051200078,,0,0
10369,JPRN-jRCT1052200041,Complete,,,,,,2021-01-07,https://jrct.niph.go.jp/latest-detail/jRCT1052200041,,0,0
10370,JPRN-jRCT2031200180,Not Recruiting,,,,,,2021-11-09,https://jrct.niph.go.jp/latest-detail/jRCT2031200180,,0,0
10371,JPRN-jRCT2051200085,Complete,,,,,,2022-03-22,https://jrct.niph.go.jp/latest-detail/jRCT2051200085,,0,0
10372,JPRN-jRCTs031200196,Complete,,,,,,2022-02-15,https://jrct.niph.go.jp/latest-detail/jRCTs031200196,,0,0
10373,JPRN-jRCT2071200045,Complete,,,,,,2022-03-03,https://jrct.niph.go.jp/latest-detail/jRCT2071200045,,0,0
10374,JPRN-jRCT2031200174,Not Recruiting,,,,,,2021-04-22,,,0,0
10375,JPRN-JRCT2031200252,,,,,,,,,,0,0
10376,JPRN-jRCT2051200088,Not Recruiting,,,,,,2021-02-19,https://jrct.niph.go.jp/latest-detail/jRCT2051200088,,0,0
10377,JPRN-jRCT1030200309,Recruiting,,,,,,2021-01-18,https://jrct.niph.go.jp/latest-detail/jRCT1030200309,,0,0
10378,JPRN-jRCT1030200310,Recruiting,,,,,,2021-01-18,https://jrct.niph.go.jp/latest-detail/jRCT1030200310,,0,0
10379,JPRN-jRCTs052200134,Recruiting,,,,,,2022-03-22,https://jrct.niph.go.jp/latest-detail/jRCTs052200134,,0,0
10380,JPRN-jRCT2032200381,Recruiting,,,,,,2021-03-08,https://jrct.niph.go.jp/latest-detail/jRCT2032200381,,0,0
10381,JPRN-jRCT2051200153,Complete,,,,,,2021-07-15,https://jrct.niph.go.jp/latest-detail/jRCT2051200153,,0,0
10382,JPRN-jRCT1030200279,Suspended,,,,,,2021-11-27,https://jrct.niph.go.jp/latest-detail/jRCT1030200279,,0,0
10383,JPRN-jRCT1030210037,Not Recruiting,,,,,,2022-03-14,https://jrct.niph.go.jp/latest-detail/jRCT1030210037,,0,0
10384,JPRN-jRCT1051200148,Recruiting,,,,,,2021-10-20,https://jrct.niph.go.jp/latest-detail/jRCT1051200148,,0,0
10385,JPRN-jRCT1052200163,Pending,,,,,,2021-03-31,https://jrct.niph.go.jp/latest-detail/jRCT1052200163,,0,0
10386,JPRN-jRCT1061200057,Not Recruiting,,,,,,2021-12-01,https://jrct.niph.go.jp/latest-detail/jRCT1061200057,,0,0
10387,JPRN-jRCT2031200092,Not Recruiting,,,,,,2020-12-24,https://jrct.niph.go.jp/latest-detail/jRCT2031200092,,0,0
10388,JPRN-jRCT2031200198,Complete,,,,,,2021-10-29,https://jrct.niph.go.jp/latest-detail/jRCT2031200198,,0,0
10389,JPRN-jRCT2031200252,Not Recruiting,,,,,,2021-10-13,https://jrct.niph.go.jp/latest-detail/jRCT2031200252,,0,0
10390,JPRN-jRCT2031200368,Not Recruiting,,,,,,2021-09-29,https://jrct.niph.go.jp/latest-detail/jRCT2031200368,,0,0
10391,JPRN-jRCT2031210010,Complete,,,,,,2022-03-17,https://jrct.niph.go.jp/latest-detail/jRCT2031210010,,0,0
10392,JPRN-jRCT2051200159,Recruiting,,,,,,2022-01-25,https://jrct.niph.go.jp/latest-detail/jRCT2051200159,,0,0
10393,JPRN-jRCT2071200078,Not Recruiting,,,,,,2022-03-17,https://jrct.niph.go.jp/latest-detail/jRCT2071200078,,0,0
10394,JPRN-jRCT2071200109,Complete,,,,,,2021-06-17,https://jrct.niph.go.jp/latest-detail/jRCT2071200109,,0,0
10395,JPRN-jRCT2071200110,Not Recruiting,,,,,,2021-07-09,https://jrct.niph.go.jp/latest-detail/jRCT2071200110,,0,0
10396,JPRN-jRCT2071200117,Complete,,,,,,2021-11-27,https://jrct.niph.go.jp/latest-detail/jRCT2071200117,,0,0
10397,JPRN-jRCTs052200157,Complete,,,,,,2021-12-01,https://jrct.niph.go.jp/latest-detail/jRCTs052200157,,0,0
10398,JPRN-jRCT1021210009,Recruiting,,,,,,2022-01-13,https://jrct.niph.go.jp/latest-detail/jRCT1021210009,,0,0
10399,JPRN-jRCT1071210024,Not Recruiting,,,,,,2022-03-12,https://jrct.niph.go.jp/latest-detail/jRCT1071210024,,0,0
10400,JPRN-jRCT2021210006,Recruiting,,,,,,2021-09-10,https://jrct.niph.go.jp/latest-detail/jRCT2021210006,,0,0
10401,JPRN-jRCT2031200443,Recruiting,,,,,,2022-02-25,https://jrct.niph.go.jp/latest-detail/jRCT2031200443,,0,0
10402,JPRN-jRCT2031210095,Pending,,,,,,2022-02-10,https://jrct.niph.go.jp/latest-detail/jRCT2031210095,,0,0
10403,JPRN-jRCT2041210004,Recruiting,,,,,,2021-11-24,https://jrct.niph.go.jp/latest-detail/jRCT2041210004,,0,0
10404,JPRN-jRCT2041210013,Suspended,,,,,,2021-05-21,https://jrct.niph.go.jp/latest-detail/jRCT2041210013,,0,0
10405,JPRN-jRCT2051200092,Not Recruiting,,,,,,2021-09-06,https://jrct.niph.go.jp/latest-detail/jRCT2051200092,,0,0
10406,JPRN-jRCT2071200106,Not Recruiting,,,,,,2021-11-17,https://jrct.niph.go.jp/latest-detail/jRCT2071200106,,0,0
10407,JPRN-jRCT2071200111,Not Recruiting,,,,,,2021-07-16,https://jrct.niph.go.jp/latest-detail/jRCT2071200111,,0,0
10408,JPRN-jRCTs031200374,Not Recruiting,,,,,,2021-12-03,https://jrct.niph.go.jp/latest-detail/jRCTs031200374,,0,0
10409,JPRN-jRCTs031200436,Complete,,,,,,2022-03-31,https://jrct.niph.go.jp/latest-detail/jRCTs031200436,,0,0
10410,JPRN-jRCTs031210123,Recruiting,,,,,,2021-08-04,https://jrct.niph.go.jp/latest-detail/jRCTs031210123,,0,0
10411,JPRN-jRCTs041200072,Recruiting,,,,,,2022-01-19,https://jrct.niph.go.jp/latest-detail/jRCTs041200072,,0,0
10412,JPRN-jRCTs071210011,Recruiting,,,,,,2021-12-28,https://jrct.niph.go.jp/latest-detail/jRCTs071210011,,0,0
10413,KCT0004907,Recruiting,,,,,,2020-04-02,,,0,0
10414,KCT0005105,Recruiting,2021-04-16,2021-04-16,,,,2020-06-10,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,2021-04-16,0,0
10415,KCT0005005,Not yet recruiting,2020-07-31,2020-12-31,,,,2020-05-10,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16339,2020-07-31,0,0
10416,KCT0005003,Not yet recruiting,2021-03-31,2021-04-21,,,,2020-05-07,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,2021-03-31,0,0
10417,KCT0003331,Recruiting,2018-10-18,2018-12-31,,,,2018-11-01,,2018-10-18,0,0
10418,KCT0002700,Recruiting,2018-06-01,2018-06-01,,,,2018-02-02,,2018-06-01,0,0
10419,KCT0002336,Completed,2017-02-01,2017-02-10,,,,2017-04-06,,2017-02-01,0,0
10420,KCT0005096,Recruiting,2021-04-30,2021-04-30,,,,2020-06-06,,2021-04-30,0,0
10421,KCT0005307,Recruiting,2021-11-30,2021-11-30,,,,2020-08-04,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062,2021-11-30,0,0
10422,KCT0005226,Completed,2020-04-24,2020-04-27,,"Yes_x000D_
									_x000D_
								_x000D_
								Published",,2020-07-08,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16997,2020-04-24,0,1
10423,KCT0005634,Completed,2020-06-30,2020-10-30,,,,2020-11-10,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18110,2020-06-30,0,0
10424,KCT0005344,Completed,2021-02-04,2021-02-15,,,,2021-08-12,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17363,2021-02-04,0,0
10425,KCT0005649,Completed,2021-01-22,2021-02-28,,,,2022-01-11,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17659,2021-01-22,0,0
10426,KCT0005711,Completed,2021-03-19,2021-05-31,,,,2021-09-07,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18369,2021-03-19,0,0
10427,KCT0005907,Recruiting,2021-02-22,2022-01-27,,,,2021-02-04,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18774,2021-02-22,0,0
10428,KCT0005834,Recruiting,2021-05-12,2021-05-12,,,,2021-02-08,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18138,2021-05-12,0,0
10429,KCT0005896,Completed,2020-10-22,2021-04-05,,"Yes_x000D_
									_x000D_
								_x000D_
								_x000D_
								Results Upload",,2021-12-29,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18143,2020-10-22,0,1
10430,KCT0006152,Not yet recruiting,2021-12-31,2023-01-31,,,,2021-04-30,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19307,2021-12-31,0,0
10431,KCT0006252,Recruiting,,,,,,2021-07-27,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19179,,0,0
10432,PACTR202004801273802,Stopped early/ terminated,,2021-01-15,,,,2021-10-08,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,2021-01-15,0,0
10433,PACTR202004693933092,Not yet recruiting,,2020-06-30,,,,2020-04-16,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,2020-06-30,0,0
10434,PACTR202004761408382,Not yet recruiting,,2020-08-31,,,,2020-06-09,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,2020-08-31,0,0
10435,PACTR202005599385499,Not yet recruiting,,2020-05-21,,,,2020-05-11,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,2020-05-21,0,0
10436,PACTR202004893013257,Not yet recruiting,,2021-04-25,,,,2020-04-23,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,2021-04-25,0,0
10437,PACTR202005681895696,Recruiting,,2022-05-31,,,,2021-06-11,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,2022-05-31,0,0
10438,PACTR202005622389003,Not yet recruiting,,2020-07-15,,,,2020-05-28,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,2020-07-15,0,0
10439,PACTR202006717277937,Not yet recruiting,,2021-02-28,,,,2020-06-10,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,2021-02-28,0,0
10440,PACTR202006899597082,Completed,,2020-11-25,,,,2021-03-19,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,2020-11-25,0,0
10441,PACTR202009786901147,Recruiting,,2022-04-30,,,,2021-06-10,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,2022-04-30,0,0
10442,PACTR202006473370201,Not yet recruiting,,2021-08-31,,,,2020-06-17,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037,2021-08-31,0,0
10443,PACTR202007653923168,Not yet recruiting,,2021-12-31,,,,2020-08-19,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047,2021-12-31,0,0
10444,PACTR202007589336711,Not yet recruiting,,2021-12-31,,,,2020-07-14,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115,2021-12-31,0,0
10445,PACTR202010519682638,Not yet recruiting,,2021-03-01,,,,2020-10-26,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147,2021-03-01,0,0
10446,PACTR202006537901307,Recruiting,,2021-12-31,,,,2021-09-07,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150,2021-12-31,0,0
10447,PACTR202007606032743,Recruiting,,2020-07-31,,,,2020-07-07,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158,2020-07-31,0,0
10448,PACTR202006922165132,Recruiting,,2021-12-30,,,,2020-07-07,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166,2021-12-30,0,0
10449,PACTR202006760881890,Recruiting,,2020-11-30,,,,2020-09-24,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,2020-11-30,0,0
10450,PACTR202006883882711,Not yet recruiting,,2021-01-01,,,,2020-06-30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175,2021-01-01,0,0
10451,PACTR202007720062393,Not yet recruiting,,2020-10-20,,,,2020-07-13,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,2020-10-20,0,0
10452,PACTR202007611764617,Not yet recruiting,,2020-10-23,,,,2020-07-07,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192,2020-10-23,0,0
10453,PACTR202007700757139,Not yet recruiting,,2021-07-31,,,,2020-07-14,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194,2021-07-31,0,0
10454,PACTR202008485004797,Completed,,2021-08-31,,,,2021-11-30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214,2021-08-31,0,0
10455,PACTR202009726132275,Completed,,2020-09-30,,,,2022-02-22,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,2020-09-30,0,0
10456,PACTR202009769021840,Not yet recruiting,,2020-12-15,,,,2020-09-04,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333,2020-12-15,0,0
10457,PACTR202009642148520,Recruiting,,2022-11-01,,,,2021-04-15,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343,2022-11-01,0,0
10458,PACTR202010537777617,Not yet recruiting,,2021-01-31,,,,2020-10-22,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365,2021-01-31,0,0
10459,PACTR202009483194545,Recruiting,,2021-03-30,,,,2020-12-15,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381,2021-03-30,0,0
10460,PACTR202010729372570,Not yet recruiting,,2021-01-31,,,,2020-10-01,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392,2021-01-31,0,0
10461,PACTR202010690466874,Not yet recruiting,,2021-01-29,,,,2020-10-07,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403,2021-01-29,0,0
10462,PACTR202010781639956,Recruiting,,2022-05-31,,,,2020-10-12,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420,2022-05-31,0,0
10463,PACTR202010472402152,"Active, not recruiting",,2021-04-30,,,,2020-10-09,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421,2021-04-30,0,0
10464,PACTR202010718451278,Not yet recruiting,,2021-06-01,,,,2020-10-19,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432,2021-06-01,0,0
10465,PACTR202011523101903,Withdrawn,,2022-04-30,,,,2021-04-08,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475,2022-04-30,0,0
10466,PACTR202008855701534,Not yet recruiting,,2021-01-21,,,,2020-09-01,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12266,2021-01-21,0,0
10467,PACTR202009726132275,Completed,,2020-09-30,,,,2022-02-22,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,2020-09-30,0,0
10468,PACTR202007720062393,Not yet recruiting,,2020-10-20,,,,2020-07-13,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,2020-10-20,0,0
10469,PACTR202101544570971,"Active, not recruiting",,2021-12-30,,,,2021-01-21,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13461,2021-12-30,0,0
10470,PACTR202101794986980,Not yet recruiting,,2021-11-29,,,,2021-04-29,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14507,2021-11-29,0,0
10471,PACTR202012892855610,Not yet recruiting,,2021-06-30,,,,2020-12-17,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14510,2021-06-30,0,0
10472,PACTR202012898601759,Not yet recruiting,,2021-08-27,,,,2020-12-04,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14547,2021-08-27,0,0
10473,PACTR202102846261362,Not yet recruiting,,2021-09-30,,,,2021-02-17,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14631,2021-09-30,0,0
10474,PACTR202101875903773,Completed,,2021-07-01,,,,2021-06-30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14632,2021-07-01,0,0
10475,PACTR202102867544936,Recruiting,,2021-07-07,,,,2021-02-22,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14657,2021-07-07,0,0
10476,PACTR202102588777597,Stopped early/ terminated,,2022-02-03,,,,2021-02-12,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14661,2022-02-03,0,0
10477,PACTR202102616421588,"Closed to recruitment,follow-up continuing",,2021-07-31,,,,2021-08-02,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14670,2021-07-31,0,0
10478,PACTR202102848675636,Not yet recruiting,,2021-10-31,,,,2021-02-11,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14678,2021-10-31,0,0
10479,PACTR202102855526180,Recruiting,,2023-09-30,,,,2021-03-06,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15686,2023-09-30,0,0
10480,PACTR202102535686338,Not yet recruiting,,2021-08-22,,,,2021-02-16,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15689,2021-08-22,0,0
10481,PACTR202103574924457,"Closed to recruitment,follow-up continuing",,2021-05-22,,,,2021-03-26,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15726,2021-05-22,0,0
10482,PACTR202103845381761,Not yet recruiting,,2022-08-31,,,,2021-03-04,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15727,2022-08-31,0,0
10483,PACTR202103601407640,Completed,,2021-06-01,,,,2021-03-24,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15764,2021-06-01,0,0
10484,PACTR202104601572565,Not yet recruiting,,2021-12-01,,,,2021-04-16,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15817,2021-12-01,0,0
10485,PACTR202106588702901,Not yet recruiting,,2022-11-30,,,,2021-06-01,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15870,2022-11-30,0,0
10486,PACTR202105817814362,Recruiting,,2022-12-14,,,,2021-05-24,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15890,2022-12-14,0,0
10487,JPRN-UMIN000039686,Open public recruiting,,2023-08-31,,,,2022-03-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,2023-08-31,0,0
10488,JPRN-UMIN000039986,Main results already published,,2020-03-28,,,,2021-12-20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,2020-03-28,0,0
10489,JPRN-UMIN000040185,Enrolling by invitation,,2023-03-31,,,,2020-04-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,2023-03-31,0,0
10490,JPRN-UMIN000040188,Main results already published,,2021-03-31,,,,2021-12-20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045825,2021-03-31,0,0
10491,JPRN-UMIN000039873,Open public recruiting,,2022-03-31,,,,2021-03-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,2022-03-31,0,0
10492,JPRN-UMIN000040162,Completed,,2021-03-31,,,,2020-10-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,2021-03-31,0,0
10493,JPRN-UMIN000040193,No longer recruiting,,2021-03-31,,,,2020-04-18,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045831,2021-03-31,0,0
10494,JPRN-UMIN000040211,No longer recruiting,,2020-06-30,,,,2020-10-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045861,2020-06-30,0,0
10495,JPRN-UMIN000040235,Completed,,2021-04-23,,,,2021-05-31,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,2021-04-23,0,0
10496,JPRN-UMIN000040250,Terminated,,2020-12-31,,,,2021-02-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045918,2020-12-31,0,0
10497,JPRN-UMIN000040278,Completed,,2021-03-31,,,,2021-05-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045953,2021-03-31,0,0
10498,JPRN-UMIN000040286,Main results already published,,2020-05-14,,,,2021-11-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,2020-05-14,0,0
10499,JPRN-UMIN000040289,Main results already published,,2020-05-08,,,,2020-11-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045947,2020-05-08,0,0
10500,JPRN-UMIN000040295,Open public recruiting,,2021-12-31,,,,2020-05-02,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045974,2021-12-31,0,0
10501,JPRN-UMIN000040335,Preinitiation,,2021-08-31,,,,2020-05-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045960,2021-08-31,0,0
10502,JPRN-UMIN000040401,Enrolling by invitation,,2025-03-31,,,,2020-05-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,2025-03-31,0,0
10503,JPRN-UMIN000039997,Completed,,2021-03-31,,,,2022-01-23,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,2021-03-31,0,0
10504,JPRN-UMIN000040219,Main results already published,,2020-10-31,,,,2021-11-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045877,2020-10-31,0,0
10505,JPRN-UMIN000040333,No longer recruiting,,2021-07-30,,,,2021-11-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046025,2021-07-30,0,0
10506,JPRN-UMIN000040341,Completed,,2020-05-16,,,,2021-09-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,2020-05-16,0,0
10507,JPRN-UMIN000040353,Terminated,,2020-05-20,,,,2020-05-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046029,2020-05-20,0,0
10508,JPRN-UMIN000040405,Completed,,2021-01-30,,,,2021-05-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046103,2021-01-30,0,0
10509,JPRN-UMIN000040407,Completed,,2020-05-20,,,,2021-09-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,2020-05-20,0,0
10510,JPRN-UMIN000040451,Preinitiation,,2021-03-31,,,,2020-05-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046169,2021-03-31,0,0
10511,JPRN-UMIN000040453,No longer recruiting,,2023-03-31,,,,2021-11-18,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046159,2023-03-31,0,0
10512,JPRN-UMIN000040479,Completed,,2020-06-30,,,,2021-09-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,2020-06-30,0,0
10513,JPRN-UMIN000040516,Enrolling by invitation,,2023-03-31,,,,2020-05-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046253,2023-03-31,0,0
10514,JPRN-UMIN000040520,No longer recruiting,,2020-05-20,,,,2020-06-03,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046256,2020-05-20,0,0
10515,JPRN-UMIN000040563,Enrolling by invitation,,2023-12-31,,,,2020-05-28,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046299,2023-12-31,0,0
10516,JPRN-UMIN000040587,Main results already published,,2020-07-31,,,,2021-11-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046321,2020-07-31,0,0
10517,JPRN-UMIN000040598,Main results already published,,2023-03-31,,,,2021-06-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046132,2023-03-31,0,0
10518,JPRN-UMIN000040602,Completed,,2021-04-14,,,,2022-03-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,2021-04-14,0,0
10519,JPRN-UMIN000040614,Enrolling by invitation,,2020-12-31,,,,2020-06-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046354,2020-12-31,0,0
10520,JPRN-UMIN000040616,Enrolling by invitation,,2020-12-31,,,,2020-06-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046355,2020-12-31,0,0
10521,JPRN-UMIN000040617,Enrolling by invitation,,2020-12-31,,,,2020-06-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046356,2020-12-31,0,0
10522,JPRN-UMIN000040679,No longer recruiting,,2021-06-07,,,,2020-12-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046429,2021-06-07,0,0
10523,JPRN-UMIN000040683,Enrolling by invitation,,2022-03-30,,,,2021-05-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046432,2022-03-30,0,0
10524,JPRN-UMIN000040694,Preinitiation,,2021-03-31,,,,2020-06-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,2021-03-31,0,0
10525,JPRN-UMIN000004030,Terminated,,2012-02-01,,,,2012-02-13,,2012-02-01,0,0
10526,JPRN-UMIN000005451,Completed,,2010-12-01,,,,2011-06-05,,2010-12-01,0,0
10527,JPRN-UMIN000007147,Completed,,2013-01-31,,,,2013-05-17,,2013-01-31,0,0
10528,JPRN-UMIN000021203,Terminated,,,,,,2017-06-01,,,0,0
10529,JPRN-UMIN000023311,No longer recruiting,,2018-12-31,,,,2021-01-31,,2018-12-31,0,0
10530,JPRN-UMIN000026993,Completed,,2018-05-06,,,,2018-10-26,,2018-05-06,0,0
10531,JPRN-UMIN000038838,Open public recruiting,,2021-06-30,,,,2021-06-11,,2021-06-30,0,0
10532,JPRN-UMIN000040476,Enrolling by invitation,,2021-03-31,,,,2020-05-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046085,2021-03-31,0,0
10533,JPRN-UMIN000040409,Preinitiation,,2022-03-31,,,,2020-05-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046113,2022-03-31,0,0
10534,JPRN-UMIN000040733,Preinitiation,,2022-03-31,,,,2020-06-12,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461,2022-03-31,0,0
10535,JPRN-UMIN000040816,Preinitiation,,2021-03-31,,,,2020-06-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046573,2021-03-31,0,0
10536,JPRN-UMIN000040838,Preinitiation,,2022-03-31,,,,2020-06-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628,2022-03-31,0,0
10537,JPRN-UMIN000040656,Preinitiation,,2022-03-31,,,,2020-06-04,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046390,2022-03-31,0,0
10538,JPRN-UMIN000041021,Completed,,2021-07-31,,,,2021-09-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046800,2021-07-31,0,0
10539,JPRN-UMIN000041073,Completed,,2020-09-29,,,,2021-06-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046864,2020-09-29,0,0
10540,JPRN-UMIN000041102,Open public recruiting,,2025-03-31,,,,2021-11-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045985,2025-03-31,0,0
10541,JPRN-UMIN000041160,Preinitiation,,2023-03-31,,,,2020-07-20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000,2023-03-31,0,0
10542,JPRN-UMIN000041186,Enrolling by invitation,,2030-03-31,,,,2020-07-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047028,2030-03-31,0,0
10543,JPRN-UMIN000041191,Open public recruiting,,2022-06-30,,,,2021-12-28,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047033,2022-06-30,0,0
10544,JPRN-UMIN000041226,Enrolling by invitation,,2022-05-31,,,,2021-03-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045903,2022-05-31,0,0
10545,JPRN-UMIN000041301,Enrolling by invitation,,2021-09-30,,,,2020-08-04,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047163,2021-09-30,0,0
10546,JPRN-UMIN000040837,No longer recruiting,,2020-12-31,,,,2020-08-30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623,2020-12-31,0,0
10547,JPRN-UMIN000041276,No longer recruiting,,2022-12-31,,,,2021-05-27,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047140,2022-12-31,0,0
10548,JPRN-UMIN000041402,Preinitiation,,2021-03-31,,,,2020-08-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047146,2021-03-31,0,0
10549,JPRN-UMIN000041430,Open public recruiting,,2020-08-16,,,,2020-08-16,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046347,2020-08-16,0,0
10550,JPRN-UMIN000041450,Open public recruiting,,2026-03-31,,,,2020-08-18,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047316,2026-03-31,0,0
10551,JPRN-UMIN000041557,Preinitiation,,2021-03-31,,,,2020-08-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047450,2021-03-31,0,0
10552,JPRN-UMIN000041579,Completed,,2020-12-31,,,,2022-02-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047464,2020-12-31,0,0
10553,JPRN-UMIN000043369,Terminated,,2023-07-31,,,,2021-09-27,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049195,2023-07-31,0,0
10554,JPRN-UMIN000040931,Completed,,2021-01-31,,,,2021-09-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046736,2021-01-31,0,0
10555,JPRN-UMIN000041168,No longer recruiting,,2022-03-31,,,,2022-04-03,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046991,2022-03-31,0,0
10556,JPRN-UMIN000041387,No longer recruiting,,2021-03-31,,,,2021-10-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047141,2021-03-31,0,0
10557,JPRN-UMIN000041458,No longer recruiting,,2021-09-01,,,,2021-10-20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327,2021-09-01,0,0
10558,JPRN-UMIN000041526,Completed,,2020-09-30,,,,2021-08-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047400,2020-09-30,0,0
10559,JPRN-UMIN000041705,Completed,,2020-09-11,,,,2021-03-12,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047583,2020-09-11,0,0
10560,JPRN-UMIN000041893,No longer recruiting,,2021-09-24,,,,2021-03-27,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046668,2021-09-24,0,0
10561,JPRN-UMIN000041227,No longer recruiting,,2021-12-31,,,,2020-10-29,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047079,2021-12-31,0,0
10562,JPRN-UMIN000041427,Completed,,2020-09-15,,,,2020-10-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047297,2020-09-15,0,0
10563,JPRN-UMIN000041769,No longer recruiting,,2022-09-10,,,,2022-03-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047674,2022-09-10,0,0
10564,JPRN-UMIN000041990,Completed,,2021-03-31,,,,2022-04-04,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925,2021-03-31,0,0
10565,JPRN-UMIN000042034,No longer recruiting,,2024-03-31,,,,2022-02-02,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574,2024-03-31,0,0
10566,JPRN-UMIN000042052,Completed,,2020-05-26,,,,2020-10-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047986,2020-05-26,0,0
10567,JPRN-UMIN000042061,No longer recruiting,,2021-02-28,,,,2021-10-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047878,2021-02-28,0,0
10568,JPRN-UMIN000042106,No longer recruiting,,2023-03-31,,,,2020-10-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048052,2023-03-31,0,0
10569,JPRN-UMIN000042142,Completed,,2020-05-28,,,,2020-11-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047872,2020-05-28,0,0
10570,JPRN-UMIN000042211,No longer recruiting,,2020-10-15,,,,2020-10-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048176,2020-10-15,0,0
10571,JPRN-UMIN000042235,Main results already published,,2021-02-01,,,,2021-05-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048031,2021-02-01,0,0
10572,JPRN-UMIN000040349,Completed,,2021-11-11,,,,2021-11-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046043,2021-11-11,0,0
10573,JPRN-UMIN000040386,Enrolling by invitation,,2023-06-30,,,,2021-02-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046087,2023-06-30,0,0
10574,JPRN-UMIN000040402,Completed,,2020-06-30,,,,2021-05-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046105,2020-06-30,0,0
10575,JPRN-UMIN000040539,Preinitiation,,2025-03-31,,,,2020-11-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046274,2025-03-31,0,0
10576,JPRN-UMIN000040744,Completed,,2020-10-31,,,,2021-09-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508,2020-10-31,0,0
10577,JPRN-UMIN000041421,Completed,,2020-11-05,,,,2021-02-03,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290,2020-11-05,0,0
10578,JPRN-UMIN000041428,Completed,,2020-07-25,,,,2021-02-27,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046671,2020-07-25,0,0
10579,JPRN-UMIN000042076,Completed,,2020-10-11,,,,2021-07-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048016,2020-10-11,0,0
10580,JPRN-UMIN000042214,Open public recruiting,,2025-11-14,,,,2021-05-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048185,2025-11-14,0,0
10581,JPRN-UMIN000042248,Open public recruiting,,2030-06-30,,,,2020-10-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048215,2030-06-30,0,0
10582,JPRN-UMIN000042299,Enrolling by invitation,,2030-03-31,,,,2021-02-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048241,2030-03-31,0,0
10583,JPRN-UMIN000042384,Completed,,2021-03-31,,,,2022-02-19,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379,2021-03-31,0,0
10584,JPRN-UMIN000042424,Completed,,2020-11-11,,,,2021-07-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048431,2020-11-11,0,0
10585,JPRN-UMIN000042453,Completed,,2020-06-10,,,,2020-11-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048463,2020-06-10,0,0
10586,JPRN-UMIN000042477,Completed,,2021-07-01,,,,2021-10-10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432,2021-07-01,0,0
10587,JPRN-UMIN000042489,Completed,,2020-06-30,,,,2020-11-18,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048499,2020-06-30,0,0
10588,JPRN-UMIN000042522,Enrolling by invitation,,2023-03-31,,,,2021-02-20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048542,2023-03-31,0,0
10589,JPRN-UMIN000042270,No longer recruiting,,2024-03-31,,,,2022-02-02,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048258,2024-03-31,0,0
10590,JPRN-UMIN000042599,Preinitiation,,2022-03-31,,,,2020-11-30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048622,2022-03-31,0,0
10591,JPRN-UMIN000042681,Completed,,2020-09-30,,,,2020-12-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048694,2020-09-30,0,0
10592,JPRN-UMIN000042717,No longer recruiting,,2021-09-30,,,,2021-06-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048021,2021-09-30,0,0
10593,JPRN-UMIN000042723,Enrolling by invitation,,2022-12-31,,,,2021-10-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048652,2022-12-31,0,0
10594,JPRN-UMIN000042807,Preinitiation,,2021-05-31,,,,2020-12-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048854,2021-05-31,0,0
10595,JPRN-UMIN000042939,Completed,,2021-12-31,,,,2022-01-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049014,2021-12-31,0,0
10596,JPRN-UMIN000042919,Open public recruiting,,2021-03-30,,,,2021-01-05,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048996,2021-03-30,0,0
10597,JPRN-UMIN000043167,Completed,,2021-02-26,,,,2022-02-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049272,2021-02-26,0,0
10598,JPRN-UMIN000043256,Preinitiation,,2025-03-31,,,,2021-08-19,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049370,2025-03-31,0,0
10599,JPRN-UMIN000043377,No longer recruiting,,2022-03-31,,,,2022-04-02,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049528,2022-03-31,0,0
10600,JPRN-UMIN000043367,Completed,,2021-02-15,,,,2022-03-29,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049469,2021-02-15,0,0
10601,JPRN-UMIN000043400,Terminated,,2022-12-31,,,,2022-01-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049552,2022-12-31,0,0
10602,JPRN-UMIN000043403,Enrolling by invitation,,2022-05-31,,,,2022-02-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049453,2022-05-31,0,0
10603,JPRN-UMIN000043443,Open public recruiting,,2022-03-31,,,,2021-02-25,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049018,2022-03-31,0,0
10604,JPRN-UMIN000043459,Completed,,2021-08-31,,,,2022-03-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049628,2021-08-31,0,0
10605,JPRN-UMIN000043530,Preinitiation,,2025-12-31,,,,2021-03-05,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049709,2025-12-31,0,0
10606,JPRN-UMIN000043537,Open public recruiting,,2021-02-28,,,,2021-03-05,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049715,2021-02-28,0,0
10607,JPRN-UMIN000043545,Enrolling by invitation,,2022-03-31,,,,2021-03-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049729,2022-03-31,0,0
10608,JPRN-UMIN000043558,No longer recruiting,,2026-03-31,,,,2021-09-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049712,2026-03-31,0,0
10609,JPRN-UMIN000043566,No longer recruiting,,2021-06-30,,,,2021-05-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049753,2021-06-30,0,0
10610,JPRN-UMIN000043622,Preinitiation,,2023-06-30,,,,2021-09-15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049811,2023-06-30,0,0
10611,JPRN-UMIN000040672,Completed,,2020-06-30,,,,2021-12-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046408,2020-06-30,0,0
10612,JPRN-UMIN000043174,Completed,,2022-03-31,,,,2021-12-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049282,2022-03-31,0,0
10613,JPRN-UMIN000043350,No longer recruiting,,2024-03-31,,,,2022-02-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049495,2024-03-31,0,0
10614,JPRN-UMIN000043368,Preinitiation,,2022-12-31,,,,2021-12-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049503,2022-12-31,0,0
10615,JPRN-UMIN000043369,Terminated,,2023-07-31,,,,2021-09-27,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049195,2023-07-31,0,0
10616,JPRN-UMIN000043532,Preinitiation,,2021-03-22,,,,2021-03-10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049691,2021-03-22,0,0
10617,JPRN-UMIN000043534,Main results already published,,2022-08-31,,,,2022-03-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049704,2022-08-31,0,0
10618,JPRN-UMIN000043538,Completed,,2021-12-31,,,,2021-03-22,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049716,2021-12-31,0,0
10619,JPRN-UMIN000043546,Completed,,2021-03-30,,,,2021-03-30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049731,2021-03-30,0,0
10620,JPRN-UMIN000043589,Preinitiation,,2023-03-31,,,,2021-03-11,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049773,2023-03-31,0,0
10621,JPRN-UMIN000043671,Open public recruiting,,2023-12-31,,,,2021-07-10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049869,2023-12-31,0,0
10622,JPRN-UMIN000043769,Completed,,2022-03-31,,,,2022-02-28,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049963,2022-03-31,0,0
10623,JPRN-UMIN000043788,Enrolling by invitation,,2021-04-30,,,,2021-03-30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049983,2021-04-30,0,0
10624,JPRN-UMIN000043802,Enrolling by invitation,,2021-09-30,,,,2021-04-01,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049989,2021-09-30,0,0
10625,JPRN-UMIN000043820,Enrolling by invitation,,2021-12-31,,,,2021-10-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049505,2021-12-31,0,0
10626,JPRN-UMIN000043821,Open public recruiting,,2022-03-31,,,,2021-04-02,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050013,2022-03-31,0,0
10627,JPRN-UMIN000043851,No longer recruiting,,2021-10-07,,,,2021-10-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050049,2021-10-07,0,0
10628,JPRN-UMIN000043864,Completed,,2021-12-31,,,,2021-04-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049072,2021-12-31,0,0
10629,JPRN-UMIN000043867,Preinitiation,,2023-12-31,,,,2021-04-08,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050077,2023-12-31,0,0
10630,JPRN-UMIN000043873,No longer recruiting,,2020-12-31,,,,2021-04-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050087,2020-12-31,0,0
10631,JPRN-UMIN000042556,Completed,,2021-03-31,,,,2020-11-26,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048548,2021-03-31,0,0
10632,JPRN-UMIN000043340,No longer recruiting,,2025-03-31,,,,2021-05-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049480,2025-03-31,0,0
10633,JPRN-UMIN000043830,Enrolling by invitation,,2026-12-31,,,,2022-04-03,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049997,2026-12-31,0,0
10634,JPRN-UMIN000044145,Preinitiation,,2022-12-31,,,,2022-02-09,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050128,2022-12-31,0,0
10635,JPRN-UMIN000044213,Enrolling by invitation,,2022-03-31,,,,2021-05-14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050488,2022-03-31,0,0
10636,JPRN-UMIN000044237,Main results already published,,2021-07-01,,,,2021-05-17,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050500,2021-07-01,0,0
10637,JPRN-UMIN000044254,Preinitiation,,2022-05-31,,,,2021-05-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049979,2022-05-31,0,0
10638,JPRN-UMIN000044261,Completed,,2021-12-28,,,,2022-02-05,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050555,2021-12-28,0,0
10639,JPRN-UMIN000044291,No longer recruiting,,2022-05-24,,,,2021-11-21,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050592,2022-05-24,0,0
10640,JPRN-UMIN000044332,No longer recruiting,,2021-12-31,,,,2021-11-24,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050574,2021-12-31,0,0
10641,JPRN-UMIN000044355,Preinitiation,,2023-03-31,,,,2021-07-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050657,2023-03-31,0,0
10642,JPRN-UMIN000044435,Enrolling by invitation,,2021-09-30,,,,2021-12-06,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050475,2021-09-30,0,0
10643,JPRN-UMIN000044456,Enrolling by invitation,,2023-03-31,,,,2021-06-07,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049508,2023-03-31,0,0
10644,JPRN-UMIN000044486,Completed,,2021-04-14,,,,2021-06-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050823,2021-04-14,0,0
10645,JPRN-UMIN000044519,Preinitiation,,2025-03-31,,,,2021-06-13,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050864,2025-03-31,0,0
10646,RPCEC00000306,Recruiting,,2020-07-15,,,,2020-07-07,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,2020-07-15,0,0
10647,RPCEC00000307,Recruiting,,2020-07-30,,,,2020-07-09,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,2020-07-30,0,0
10648,RPCEC00000308,Pending,,2020-06-09,,,,2020-07-13,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,2020-06-09,0,0
10649,RPCEC00000309,Recruiting,,2021-01-15,,,,2021-03-01,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,2021-01-15,0,0
10650,RPCEC00000310,Recruiting,,2021-06-30,,,,2020-07-14,https://rpcec.sld.cu/en/trials/RPCEC00000310-En,2021-06-30,0,0
10651,RPCEC00000311,Recruiting,,2020-07-31,,,,2020-08-13,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,2020-07-31,0,0
10652,RPCEC00000312,Recruiting,,2020-12-31,,,,2020-08-13,https://rpcec.sld.cu/en/trials/RPCEC00000312-En,2020-12-31,0,0
10653,RPCEC00000313,Complete,,2020-04-30,,,,2020-08-13,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,2020-04-30,0,0
10654,RPCEC00000314,Recruiting,,2020-06-30,,,,2020-10-21,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,2020-06-30,0,0
10655,RPCEC00000315,Recruiting,,2020-06-30,,,,2020-10-21,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,2020-06-30,0,0
10656,RPCEC00000316,Complete,,2020-09-03,,,,2022-03-30,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,2020-09-03,0,0
10657,RPCEC00000317,Pending,,2020-06-29,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,2020-06-29,0,0
10658,RPCEC00000318,Recruiting,,2020-08-14,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000318-En,2020-08-14,0,0
10659,RPCEC00000319,Complete,,2020-06-18,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000319-En,2020-06-18,0,0
10660,RPCEC00000320,Pending,,2020-08-23,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,2020-08-23,0,0
10661,RPCEC00000321,Recruiting,,2020-08-30,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000321-En,2020-08-30,0,0
10662,RPCEC00000322,Recruiting,,2020-12-15,,,,2020-09-14,https://rpcec.sld.cu/en/trials/RPCEC00000322-En,2020-12-15,0,0
10663,RPCEC00000323,Recruiting,,2020-10-12,,,,2020-08-19,https://rpcec.sld.cu/en/trials/RPCEC00000323-En,2020-10-12,0,0
10664,RPCEC00000330,Pending,,2020-09-30,,,,2020-10-05,https://rpcec.sld.cu/en/trials/RPCEC00000330-En,2020-09-30,0,0
10665,RPCEC00000332,Recruiting,,2021-01-11,,,,2020-10-12,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,2021-01-11,0,0
10666,RPCEC00000334,Recruiting,,2020-12-31,,,,2020-10-23,https://rpcec.sld.cu/en/trials/RPCEC00000334-En,2020-12-31,0,0
10667,RPCEC00000335,Recruiting,,2020-12-31,,,,2020-10-23,https://rpcec.sld.cu/en/trials/RPCEC00000335-En,2020-12-31,0,0
10668,RPCEC00000337,Pending,,2020-11-06,,,,2020-10-05,https://rpcec.sld.cu/en/trials/RPCEC00000337-En,2020-11-06,0,0
10669,RPCEC00000338,Complete,,2021-01-31,,,,2021-08-18,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,2021-01-31,0,0
10670,RPCEC00000340,Complete,,2021-01-06,,,,2021-06-15,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,2021-01-06,0,0
10671,RPCEC00000341,Complete,,2020-10-25,,,,2020-10-28,https://rpcec.sld.cu/en/trials/RPCEC00000341-En,2020-10-25,0,0
10672,RPCEC00000342,Complete,,2020-08-15,,,,2020-12-21,https://rpcec.sld.cu/en/trials/RPCEC00000342-En,2020-08-15,0,0
10673,RPCEC00000344,Complete,,2020-04-18,,,,2020-12-21,https://rpcec.sld.cu/en/trials/RPCEC00000344-En,2020-04-18,0,0
10674,RPCEC00000345,Pending,,2021-05-31,,,,2020-11-27,https://rpcec.sld.cu/en/trials/RPCEC00000345-En,2021-05-31,0,0
10675,RPCEC00000346,Pending,,2021-05-31,,,,2020-11-27,https://rpcec.sld.cu/en/trials/RPCEC00000346-En,2021-05-31,0,0
10676,RPCEC00000347,Complete,,2021-03-12,,,,2022-01-28,https://rpcec.sld.cu/en/trials/RPCEC00000347-En,2021-03-12,0,0
10677,RPCEC00000348,Pending,,2021-07-11,,,,2021-01-26,https://rpcec.sld.cu/en/trials/RPCEC00000348-En,2021-07-11,0,0
10678,RPCEC00000349,Complete,,2021-02-13,,,,2021-04-27,https://rpcec.sld.cu/en/trials/RPCEC00000349-En,2021-02-13,0,0
10679,RPCEC00000350,Complete,,2020-10-21,,,,2021-01-25,https://rpcec.sld.cu/en/trials/RPCEC00000350-En,2020-10-21,0,0
10680,RPCEC00000351,Complete,,2020-11-26,,,,2021-01-25,https://rpcec.sld.cu/en/trials/RPCEC00000351-En,2020-11-26,0,0
10681,RPCEC00000352,Complete,,2020-11-25,,,,2021-01-25,https://rpcec.sld.cu/en/trials/RPCEC00000352-En,2020-11-25,0,0
10682,RPCEC00000353,Pending,,2022-04-30,,,,2021-03-02,https://rpcec.sld.cu/en/trials/RPCEC00000353-En,2022-04-30,0,0
10683,RPCEC00000354,Complete,,2021-11-07,,,,2021-10-30,https://rpcec.sld.cu/en/trials/RPCEC00000354-En,2021-11-07,0,0
10684,RPCEC00000356,Pending,,2021-08-12,,,,2021-03-15,https://rpcec.sld.cu/en/trials/RPCEC00000356-En,2021-08-12,0,0
10685,RPCEC00000357,Complete,,2020-11-20,,,,2021-03-22,https://rpcec.sld.cu/en/trials/RPCEC00000357-En,2020-11-20,0,0
10686,RPCEC00000359,Complete,,2021-06-25,,,,2022-04-04,https://rpcec.sld.cu/en/trials/RPCEC00000359-En,2021-06-25,0,0
10687,RPCEC00000360,Pending,,2022-08-01,,,,2021-11-09,https://rpcec.sld.cu/en/trials/RPCEC00000360-En,2022-08-01,0,0
10688,RPCEC00000361,Pending,,2021-06-30,,,,2021-03-26,https://rpcec.sld.cu/en/trials/RPCEC00000361-En,2021-06-30,0,0
10689,RPCEC00000363,Pending,,2021-09-30,,,,2021-04-08,https://rpcec.sld.cu/en/trials/RPCEC00000363-En,2021-09-30,0,0
10690,RPCEC00000366,Complete,,2021-06-14,,,,2021-11-19,https://rpcec.sld.cu/en/trials/RPCEC00000366-En,2021-06-14,0,0
10691,RPCEC00000369,Pending,,2021-07-31,,,,2021-06-15,https://rpcec.sld.cu/en/trials/RPCEC00000369-En,2021-07-31,0,0
10692,RPCEC00000374,Complete,,2021-10-07,,,,2022-04-01,https://rpcec.sld.cu/en/trials/RPCEC00000374-En,2021-10-07,0,0
10693,RPCEC00000375,Pending,,2023-01-30,,,,2021-12-06,https://rpcec.sld.cu/en/trials/RPCEC00000375-En,2023-01-30,0,0
10694,RPCEC00000376,Pending,,2023-12-30,,,,2021-12-27,https://rpcec.sld.cu/en/trials/RPCEC00000376-En,2023-12-30,0,0
10695,TCTR20200601002,Recruiting,2020-06-30,2020-07-31,,,,2020-05-31,www.thaiclinicaltrials.org/show/TCTR20200601002,2020-06-30,0,0
10696,TCTR20200527001,Completed,2020-04-17,2020-04-30,,,,2020-05-27,www.thaiclinicaltrials.org/show/TCTR20200527001,2020-04-17,0,0
10697,TCTR20200514001,Completed,2021-08-05,2022-02-28,,,,2022-03-22,www.thaiclinicaltrials.org/show/TCTR20200514001,2021-08-05,0,0
10698,TCTR20200426002,Recruiting,2020-06-26,2021-03-19,,,,2020-07-05,www.thaiclinicaltrials.org/show/TCTR20200426002,2020-06-26,0,0
10699,TCTR20200425001,Recruiting,2021-04-21,2021-05-31,,,,2021-07-06,www.thaiclinicaltrials.org/show/TCTR20200425001,2021-04-21,0,0
10700,TCTR20200409006,Pending (Not yet recruiting),2021-05-01,2022-05-01,,,,2020-04-09,www.thaiclinicaltrials.org/show/TCTR20200409006,2021-05-01,0,0
10701,TCTR20200405001,Recruiting,2020-06-30,2020-07-24,,,,2020-05-25,www.thaiclinicaltrials.org/show/TCTR20200405001,2020-06-30,0,0
10702,TCTR20200404004, Terminated (Halted Prematurely),2020-05-31,2021-03-03,,,,2021-08-27,www.thaiclinicaltrials.org/show/TCTR20200404004,2020-05-31,0,0
10703,TCTR20200401002,Completed (Has Results),2020-12-31,2021-04-30,,,,2021-10-14,www.thaiclinicaltrials.org/show/TCTR20200401002,2020-12-31,0,0
10704,TCTR20200324001,Pending (Not yet recruiting),2020-03-31,2020-04-30,,,,2020-03-24,www.thaiclinicaltrials.org/show/TCTR20200324001,2020-03-31,0,0
10705,TCTR20200321001,Pending (Not yet recruiting),2020-04-15,2020-04-30,,,,2020-03-24,www.thaiclinicaltrials.org/show/TCTR20200321001,2020-04-15,0,0
10706,TCTR20201124002,Pending (Not yet recruiting),2021-05-31,2021-09-30,,,,2021-08-24,www.thaiclinicaltrials.org/show/TCTR20201124002,2021-05-31,0,0
10707,TCTR20201027002,Pending (Not yet recruiting),2020-10-27,2020-10-31,,,,2020-10-27,www.thaiclinicaltrials.org/show/TCTR20201027002,2020-10-27,0,0
10708,TCTR20201015003,Recruiting,2020-11-01,2021-11-01,,,,2020-10-15,www.thaiclinicaltrials.org/show/TCTR20201015003,2020-11-01,0,0
10709,TCTR20200901001,Completed (No Results),2021-07-16,2021-07-17,,,,2020-08-31,www.thaiclinicaltrials.org/show/TCTR20200901001,2021-07-16,0,0
10710,TCTR20200828001,Pending (Not yet recruiting),2021-07-01,2021-08-01,,,,2021-08-23,www.thaiclinicaltrials.org/show/TCTR20200828001,2021-07-01,0,0
10711,TCTR20200822003,Recruiting,2021-03-08,2021-05-31,,,,2020-08-22,www.thaiclinicaltrials.org/show/TCTR20200822003,2021-03-08,0,0
10712,TCTR20200822002,Completed (Has Results),2020-11-21,2021-05-01,,,,2021-08-20,www.thaiclinicaltrials.org/show/TCTR20200822002,2020-11-21,0,0
10713,TCTR20200820006,Completed (Has Results),2020-10-21,2021-01-28,,,,2021-08-20,www.thaiclinicaltrials.org/show/TCTR20200820006,2020-10-21,0,0
10714,TCTR20200819003,Completed (No Results),2020-11-11,2020-12-15,,,,2022-04-18,,2020-11-11,0,0
10715,TCTR20200709002,Recruiting,2021-06-21,2022-06-20,,,,2020-08-10,www.thaiclinicaltrials.org/show/TCTR20200709002,2021-06-21,0,0
10716,TCTR20200708001,Completed (No Results),2020-06-30,2020-07-10,,,,2020-12-06,www.thaiclinicaltrials.org/show/TCTR20200708001,2020-06-30,0,0
10717,TCTR20210617008,Recruiting,2021-11-19,2022-02-18,,,,2021-06-17,www.thaiclinicaltrials.org/show/TCTR20210617008,2021-11-19,0,0
10718,TCTR20210617006,Pending (Not yet recruiting),2022-09-30,2023-09-30,,,,2021-06-16,www.thaiclinicaltrials.org/show/TCTR20210617006,2022-09-30,0,0
10719,TCTR20210615002,Completed (No Results),2022-02-22,2022-04-30,,,,2022-04-05,www.thaiclinicaltrials.org/show/TCTR20210615002,2022-02-22,0,0
10720,TCTR20210615001," Active, not recruiting",2022-06-30,2022-06-30,,,,2021-06-15,www.thaiclinicaltrials.org/show/TCTR20210615001,2022-06-30,0,0
10721,TCTR20210613001,Completed (No Results),2021-01-19,2021-01-31,,,,2021-06-13,www.thaiclinicaltrials.org/show/TCTR20210613001,2021-01-19,0,0
10722,TCTR20210611006,Recruiting,2021-09-30,2021-09-30,,,,2021-06-04,www.thaiclinicaltrials.org/show/TCTR20210611006,2021-09-30,0,0
10723,TCTR20210610004,Completed (Has Results),2021-05-31,2021-07-01,,,,2021-08-20,www.thaiclinicaltrials.org/show/TCTR20210610004,2021-05-31,0,0
10724,TCTR20210610003,Pending (Not yet recruiting),2021-06-30,2021-09-01,,,,2021-06-10,www.thaiclinicaltrials.org/show/TCTR20210610003,2021-06-30,0,0
10725,TCTR20210609001,Completed (No Results),2021-09-30,2022-04-30,,,,2022-04-05,www.thaiclinicaltrials.org/show/TCTR20210609001,2021-09-30,0,0
10726,TCTR20210603002,Completed (Has Results),2020-05-31,2020-06-15,,,,2021-08-20,www.thaiclinicaltrials.org/show/TCTR20210603002,2020-05-31,0,0
10727,TCTR20210602002,Completed (Has Results),2020-11-27,2020-11-27,,,,2021-06-01,www.thaiclinicaltrials.org/show/TCTR20210602002,2020-11-27,0,0
10728,TCTR20210526004,Pending (Not yet recruiting),2022-07-01,2022-09-01,,,,2021-06-10,www.thaiclinicaltrials.org/show/TCTR20210526004,2022-07-01,0,0
10729,TCTR20210525005,Pending (Not yet recruiting),2022-07-01,2022-09-01,,,,2021-06-10,www.thaiclinicaltrials.org/show/TCTR20210525005,2022-07-01,0,0
10730,TCTR20210524002,Completed (No Results),2021-09-30,2021-09-30,,,,2022-03-04,www.thaiclinicaltrials.org/show/TCTR20210524002,2021-09-30,0,0
10731,TCTR20210523002,Completed (No Results),2021-11-02,2021-11-02,,,,2021-11-27,www.thaiclinicaltrials.org/show/TCTR20210523002,2021-11-02,0,0
10732,TCTR20210520004,Completed (Has Results),2021-08-13,2022-04-15,,,,2022-04-16,www.thaiclinicaltrials.org/show/TCTR20210520004,2021-08-13,0,0
10733,TCTR20210517006,Recruiting,2021-07-31,2022-07-31,,,,2022-02-08,www.thaiclinicaltrials.org/show/TCTR20210517006,2021-07-31,0,0
10734,TCTR20210517005,Recruiting,2024-12-01,2026-12-01,,,,2021-05-17,www.thaiclinicaltrials.org/show/TCTR20210517005,2024-12-01,0,0
10735,TCTR20210514003,Pending (Not yet recruiting),2021-10-31,2021-11-30,,,,2021-10-20,www.thaiclinicaltrials.org/show/TCTR20210514003,2021-10-31,0,0
10736,TCTR20210510009,Pending (Not yet recruiting),2022-01-31,2022-05-31,,,,2021-06-17,www.thaiclinicaltrials.org/show/TCTR20210510009,2022-01-31,0,0
10737,TCTR20210510008,Completed (No Results),2021-04-07,2021-04-28,,,,2021-06-11,www.thaiclinicaltrials.org/show/TCTR20210510008,2021-04-07,0,0
10738,TCTR20210503001,Completed (No Results),2021-01-20,2021-05-01,,,,2021-05-03,www.thaiclinicaltrials.org/show/TCTR20210503001,2021-01-20,0,0
10739,TCTR20210430003,Completed (No Results),2021-01-06,2021-01-06,,,,2021-04-30,www.thaiclinicaltrials.org/show/TCTR20210430003,2021-01-06,0,0
10740,TCTR20210412005,Recruiting,2021-06-30,2021-11-30,,,,2021-04-12,www.thaiclinicaltrials.org/show/TCTR20210412005,2021-06-30,0,0
10741,TCTR20210330003,Completed (No Results),2020-11-30,2021-03-31,,,,2021-03-30,www.thaiclinicaltrials.org/show/TCTR20210330003,2020-11-30,0,0
10742,TCTR20210329003,Pending (Not yet recruiting),2021-10-31,2021-11-30,,,,2021-03-29,www.thaiclinicaltrials.org/show/TCTR20210329003,2021-10-31,0,0
10743,TCTR20210325003,Pending (Not yet recruiting),2023-10-31,2023-12-31,,,,2021-03-25,www.thaiclinicaltrials.org/show/TCTR20210325003,2023-10-31,0,0
10744,TCTR20210319003,Completed (Has Results),2021-05-31,2021-12-31,,,,2022-04-16,www.thaiclinicaltrials.org/show/TCTR20210319003,2021-05-31,0,0
10745,TCTR20210319001," Active, not recruiting",2021-04-30,2021-06-30,,,,2021-03-19,www.thaiclinicaltrials.org/show/TCTR20210319001,2021-04-30,0,0
10746,TCTR20210310004,Pending (Not yet recruiting),2021-07-01,2021-09-01,,,,2021-03-08,www.thaiclinicaltrials.org/show/TCTR20210310004,2021-07-01,0,0
10747,TCTR20210310002,Pending (Not yet recruiting),2021-10-31,2023-01-31,,,,2021-03-10,www.thaiclinicaltrials.org/show/TCTR20210310002,2021-10-31,0,0
10748,TCTR20210308003,Completed (Has Results),2021-06-23,2021-08-23,,,,2022-01-06,www.thaiclinicaltrials.org/show/TCTR20210308003,2021-06-23,0,0
10749,TCTR20210226002,Completed (Has Results),2021-07-18,2021-07-30,,,,2022-02-01,www.thaiclinicaltrials.org/show/TCTR20210226002,2021-07-18,0,0
10750,TCTR20210202005,Completed (Has Results),2020-10-30,2020-11-15,,,,2020-05-14,www.thaiclinicaltrials.org/show/TCTR20210202005,2020-10-30,0,0
10751,TCTR20210125002,Completed (Has Results),2021-06-30,2021-08-30,,,,2022-04-09,www.thaiclinicaltrials.org/show/TCTR20210125002,2021-06-30,0,0
10752,TCTR20201215003,Completed (No Results),2020-05-05,2020-12-31,,,,2021-08-20,www.thaiclinicaltrials.org/show/TCTR20201215003,2020-05-05,0,0
10753,TCTR20201215001,Pending (Not yet recruiting),2021-06-30,2021-08-31,,,,2020-12-14,www.thaiclinicaltrials.org/show/TCTR20201215001,2021-06-30,0,0
10754,TCTR20201214005,Pending (Not yet recruiting),2021-04-30,2021-06-30,,,,2020-12-14,www.thaiclinicaltrials.org/show/TCTR20201214005,2021-04-30,0,0
10755,JPRN-JapicCTI-205238,Completed,,2020-10-14,,,,2021-07-15,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,2020-10-14,0,0
10756,JPRN-JapicCTI-205270,Completed,,2021-07-21,,Registry results,,2022-03-23,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,2021-07-21,0,1
10757,JPRN-JapicCTI-205326,Completed,,2020-08-17,,Registry results and https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13052,,2021-08-05,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205326,2020-08-17,0,1
10758,JPRN-JapicCTI-205416,Completed,,2021-02-02,,,,2021-07-06,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416,2021-02-02,0,0
10759,JPRN-JapicCTI-205465,Progressing,,,,,,2022-04-22,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465,,0,0
10760,LBCTR2020043459,Pending,,2020-05-18,,,,2020-04-16,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/3459,2020-05-18,0,0
10761,LBCTR2020043495,Pending,,2021-04-01,,,,2020-04-23,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4658,2021-04-01,0,0
10762,LBCTR2021014651,Pending,,2021-02-01,,,,2021-02-07,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4651,2021-02-01,0,0
10763,LBCTR2021034768,Complete,,2020-09-30,,,,2021-03-07,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4770,2020-09-30,0,0
10764,LBCTR2021044780,Pending,,2021-06-18,,,,2021-04-18,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4780,2021-06-18,0,0
10765,PER-002-21,,,,,,,,https://repec.ins.gob.pe/maestro/ajax/exportar-ficha-datos-publico/5/en/,,0,0
10766,PER-010-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=010-20,,0,0
10767,PER-013-20,Enrollment stopped,,2021-05-31,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,2021-05-31,0,0
10768,PER-016-20,Enrollment closed,,2021-04-17,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=016-20,2021-04-17,0,0
10769,PER-018-20,In enrollment,,2020-11-12,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=018-20,2020-11-12,0,0
10770,PER-027-20,In enrollment,,,,,,,,,0,0
10771,PER-030-20,Enrollment closed,,2020-10-19,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=030-20,2020-10-19,0,0
10772,PER-031-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20,,0,0
10773,PER-032-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20,,0,0
10774,PER-034-20,In enrollment,,2021-04-28,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20,2021-04-28,0,0
10775,PER-042-20,Enrollment closed,,2021-01-10,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=042-20,2021-01-10,0,0
10776,PER-048-20,,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=048-20,,0,0
10777,PER-050-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20,,0,0
10778,PER-054-20,Enrollment closed,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20,,0,0
10779,PER-055-20,In enrollment,,2020-12-24,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=055-20,2020-12-24,0,0
10780,PER-055-20,In enrollment,,2020-12-24,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=055-20,2020-12-24,0,0
10781,PER-059-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=059-20,,0,0
10782,PER-060-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,,0,0
10783,PER-064-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20,,0,0
10784,PER-067-20,Without starting enrollment,,2021-06-14,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20,2021-06-14,0,0
10785,PER-069-20,Without starting enrollment,,2021-03-26,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=069-20,2021-03-26,0,0
10786,PER-081-20,In enrollment,,,,,,,,,0,0
10787,PER-090-20,In enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=090-20,,0,0
10788,PER-093-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=093-20,,0,0
10789,PER-095-20,Enrollment closed,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=095-20,,0,0
10790,PER-099-20,In enrollment,,2022-02-03,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=099-20,2022-02-03,0,0
10791,PER-101-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=101-20,,0,0
10792,PER-105-20,,,,,,,,,,0,0
10793,PER-106-20,,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=106-20,,0,0
10794,PER-108-20,Without starting enrollment,,,,,,,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=108-20,,0,0
10795,SLCTR/2020/011,Terminated,,2020-05-31,,,,2020-10-02,https://slctr.lk/trials/slctr-2020-011,2020-05-31,0,0
10796,SLCTR/2020/026,Suspended,,2021-03-15,,,,2021-08-31,https://slctr.lk/trials/slctr-2020-026,2021-03-15,0,0
10797,SLCTR/2021/001,Recruiting,,2021-01-31,,,,2021-02-25,https://slctr.lk/trials/slctr-2021-001,2021-01-31,0,0
10798,SLCTR/2021/002,Pending,,2021-03-31,,,,2021-10-18,https://slctr.lk/trials/slctr-2021-002,2021-03-31,0,0
10799,SLCTR/2021/005,Pending,,2021-09-15,,,,2021-03-01,https://slctr.lk/trials/slctr-2021-005,2021-09-15,0,0
10800,SLCTR/2021/008,Pending,,2021-06-01,,,,2021-03-16,https://slctr.lk/trials/slctr-2021-008,2021-06-01,0,0
